APPLICATION_ID,ACTIVITY,ADMINISTERING_IC,APPLICATION_TYPE,ARRA_FUNDED,AWARD_NOTICE_DATE,BUDGET_START,BUDGET_END,CFDA_CODE,CORE_PROJECT_NUM,ED_INST_TYPE,OPPORTUNITY NUMBER,FULL_PROJECT_NUM,FUNDING_ICs,FUNDING_MECHANISM,FY,IC_NAME,NIH_SPENDING_CATS,ORG_CITY,ORG_COUNTRY,ORG_DEPT,ORG_DISTRICT,ORG_DUNS,ORG_FIPS,ORG_IPF_CODE,ORG_NAME,ORG_STATE,ORG_ZIPCODE,PHR,PI_IDS,PI_NAMEs,PROGRAM_OFFICER_NAME,PROJECT_START,PROJECT_END,PROJECT_TERMS,PROJECT_TITLE,SERIAL_NUMBER,STUDY_SECTION,STUDY_SECTION_NAME,SUBPROJECT_ID,SUFFIX,SUPPORT_YEAR,DIRECT_COST_AMT,INDIRECT_COST_AMT,TOTAL_COST,TOTAL_COST_SUB_PROJECT
11189290,ZIA,AI,1,N,NA,NA,NA,NA,ZIAAI000580,NA,NA,1ZIAAI000580-35,NIAID:379860\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,6568487 (contact),"CAUGHEY, BYRON  (contact)",NA,NA,NA,Bovine Spongiform Encephalopathy;Characteristics;Chronic Wasting Disease;Clinical;Creutzfeldt-Jakob Syndrome;Detergents;Disease;disease transmission;Goals;in silico;Learning;Lesion;Molecular;molecular dynamics;Neurodegenerative Disorders;neuropathology;Pathogenesis;Pathologic;Prion Diseases;Prions;PrP;Rodent;Scrapie;Structure;Time;transmission process;Work,Structures and Activities of Prions and Prion Proteins,580,NA,NA,NA,NA,35,NA,NA,379860,NA
11189291,ZIA,AI,1,N,NA,NA,NA,NA,ZIAAI000581,NA,NA,1ZIAAI000581-36,NIAID:162749\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,1940988 (contact),"MATZINGER, POLLY C (contact)",NA,NA,NA,Adult;Area;Autoimmune Responses;Autoimmunity;Cells;Chicago;Collaborations;Communication;Development;Education;fighting;Genes;healing;Health;humoral immunity deficiency;Immune;Immune response;Immune system;Immunity;Immunoglobulin A;Immunologist;immunoreaction;infancy;Infection;intestinal epithelium;Intestines;Malignant Neoplasms;Modeling;Mus;National Institute of Allergy and Infectious Disease;Natural regeneration;Neonatal;neonate;Organism;Parasitology;pathogen;Research;response;Scientist;Signal Transduction;System;T-Lymphocyte;Testing;Thymus Gland;Tissues;Transplantation;Universities;Vaccines;Virus Diseases,The Danger Model 2: how tissues control Immunity,581,NA,NA,NA,NA,36,NA,NA,162749,NA
11189292,ZIA,AI,1,N,NA,NA,NA,NA,ZIAAI000614,NA,NA,1ZIAAI000614-34,NIAID:250630\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,6568505 (contact),"LETO, THOMAS  (contact)",NA,NA,NA,Acute;Affect;Agammaglobulinaemia tyrosine kinase;Agonist;Anabolism;Animal Model;Anti-Inflammatory Agents;Anti-viral Response;antifibrotic treatment;antimicrobial;Apoptosis;Area;B lymphoid malignancy;Biochemical;Biological Assay;Brain Neoplasms;Breast;Cancer Patient;candidate identification;Cell Aging;Cell Culture Techniques;Cell model;cell motility;Cell Survival;Cells;chemokine;Chronic Granulomatous Disease;Chronic Hepatitis C;chronic inflammatory disease;Cirrhosis;Colon;cytokine;Defect;Disease;Disease Progression;DNA Sequence Alteration;Dose;Enzymes;Epithelial Cell Proliferation;Epithelial Cells;epithelial to mesenchymal transition;Epithelium;Exhibits;Extracellular Matrix;Family;Fibrosis;Follow-Up Studies;Gastrointestinal tract structure;gene expression database;Genes;Genetic Polymorphism;Growth Factor;Hematopoietic;Hepatic;Hepatitis C;Hepatocyte;HepG2;Homologous Gene;Hormones;Host Defense;Hot Spot;Human;Hypoxia;Immune;in vivo;Infection;Inflammation;Inflammatory;Inflammatory Bowel Diseases;Inflammatory Response;inhibitor;insight;interest;Isoenzymes;Kidney;KPC model;KRAS2 gene;Liver;Lung;Lymphoid Cell;Macrophage;Malignant Neoplasms;Matrix Metalloproteinases;Mediating;Metastatic Carcinoma;microbial;microbicide;MMP2 gene;MMP9 gene;Molecular;mouse model;Mucous Membrane;Mus;mutant;Mutation;Mycoses;Myeloid Cells;NADPH Oxidase;National Center for Advancing Translational Sciences;Natural Immunity;Neoplasm Metastasis;neoplastic cell;neutrophil;neutrophil cytosol factor 40K;Normal tissue morphology;novel;Nox enzyme;overexpression;Oxidases;Oxidation-Reduction;Oxidative Stress;Pancreas;Pancreatic Ductal Adenocarcinoma;pathogen;patient population;Patients;Pattern;Pattern Recognition;Peroxidases;peroxiredoxin;Phagocytes;Pharmacodynamics;pharmacologic;Phenotype;Phospholipase A2;Phosphorylation;Population;Predisposition;prevent;Primary carcinoma of the liver cells;Primary Neoplasm;Process;Production;programs;Proliferating;protective effect;Reactive Oxygen Species;receptor;Recombinants;reconstitution;recruit;Research;Respiratory System;Respiratory Tract Infections;response;Role;screening;senescence;Signal Transduction;Specificity;Surface;Surveys;Testing;The Cancer Genome Atlas;Therapeutic;therapeutic target;Tissues;TP53 gene;transcriptomics;Transforming Growth Factor beta;translational goal;Traumatic Brain Injury;tumor;Tumor Cell Migration;tumor microenvironment;tumor progression;Work;wound closure;wound healing,NOX family NADPH oxidases: roles in innate immunity and inflammatory disease,614,NA,NA,NA,NA,34,NA,NA,250630,NA
11189293,ZIA,AI,1,N,NA,NA,NA,NA,ZIAAI000615,NA,NA,1ZIAAI000615-34,NIAID:2818392\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,6479505 (contact),"MURPHY, PHILIP  (contact)",NA,NA,NA,6 year old;Adult;Age;Alveolar Bone Loss;AMD3100;antagonist;Area;Biological;Blood;Bone Marrow;Bone Pain;boys;Caring;Cell surface;Cells;Cellular biology;chemokine receptor;Chemotactic Factors;Clinical;clinical phenotype;cohort;congenital immunodeficiency;Cross-Over Trials;CXCR4 gene;Diagnosis;Disease;disease model;early onset;Epidemiology;Evaluation;Exanthema;Failure;Family;fMet-Leu-Phe receptor;gain of function;Gender;Gene Family;Genes;Genetic;Genetic Polymorphism;Genomics;Goals;granulocyte;healthy volunteer;Hematology;Herpesviridae;Heterogeneity;Heterozygote;HIV;Human;human disease;Immunologic Deficiency Syndromes;improved;Incidence;Individual;Infection;Journals;knockout gene;Knockout Mice;Knowledge;leukocyte activation;Leukocytes;Ligature;Lymphocyte Count;Lymphopenia;Masks;Mediating;Medical;member;Methods;migration;Molecular;Molecular Analysis;Molecular Biology;mouse model;Mus;Mutation;Neutropenia;neutrophil;new therapeutic target;novel;Oral;Pathogenesis;Patients;Periodontitis;Pharmaceutical Preparations;Phase;Phenotype;Poxviridae;Predisposition;preference;primary endpoint;Process;Property;Proteins;Quality of life;Randomized;receptor;Receptor Gene;Reporting;Research;Research Personnel;Risk Factors;Role;Safety;Serious Adverse Event;Severe congenital neutropenia;Severities;Signal Transduction;Site;standard of care;Structure;System;Testing;Tissues;Translating;trial comparing;Virus;WHIM syndrome,Molecular Analysis Of Leukocyte Activation By Chemoattractants,615,NA,NA,NA,NA,34,NA,NA,2818392,NA
11189294,ZIA,AI,1,N,NA,NA,NA,NA,ZIAAI000622,NA,NA,1ZIAAI000622-33,NIAID:741518\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,8620541 (contact),"MARGULIES, DAVID  (contact)",NA,NA,NA,Adaptive Immune System;Affinity;Alleles;Antigen Presentation;Antigen Presentation Pathway;base;Binding;Binding Proteins;Cell Surface Receptors;Complex;Cross Presentation;Cryoelectron Microscopy;diagnostic development;Event;flexibility;Goals;HLA-B Antigens;Immune;Immune system;Immunologic Receptors;Innate Immune System;knockout animal;Knockout Mice;Knowledge;Laboratories;Ligands;Lymphoid Cell;macromolecule;Methods;Molecular;Molecular Chaperones;Molecular Conformation;molecular recognition;Molecular Structure;Pathway interactions;Peptides;Play;Process;receptor;Receptor Cell;Reporting;Roentgen Rays;Role;Signal Transduction;Structure;System;tapasin;Therapeutic;tool;Tumor Antigens;Viral Antigens;X-Ray Crystallography,Molecular Interactions Of Lymphoid Cell Receptors,622,NA,NA,NA,NA,33,NA,NA,741518,NA
11189295,ZIA,AI,1,N,NA,NA,NA,NA,ZIAAI000644,NA,NA,1ZIAAI000644-33,NIAID:796377\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,9413709 (contact),"MALECH, HARRY L (contact)",NA,NA,NA,"Acute Graft Versus Host Disease;adeno-associated viral vector;adenosine deaminase deficiency;Affect;Alkylating Agents;Allogenic;Animal Model;Antibodies;Antibody-drug conjugates;Artemis deficiency;Autoimmunity;autoinflammation;Autologous;base editing;Biological Products;Blood;CD34 gene;Cell Line;Cell model;Cell Physiology;Cell Therapy;Cells;chimeric antigen receptor T cells;chronic graft versus host disease;Chronic Granulomatous Disease;Clinic;Clinical;Clinical Research;Clinical Trials;Clustered Regularly Interspaced Short Palindromic Repeats;Collaborations;conditioning;congenital immunodeficiency;Defect;design;Development;Disease;Dose;Elements;Engineering;Engraftment;Epidemiology;Failure;Functional disorder;gain of function;gene therapy;gene therapy clinical trial;gene transfer vector;gene-editing approach;Genes;Genetic;Goals;graft vs host disease;Hematological Disease;Hematopoiesis;hematopoietic stem cell differentiation;Hematopoietic Stem Cell Research;Hematopoietic Stem Cell Transplantation;Hematopoietic stem cells;Homologous Transplantation;Human;Hypersensitivity;Immune;immune function;Immune System Diseases;Immunity;Immunoglobulin M;Immunologic Deficiency Syndromes;Impairment;improved;induced pluripotent stem cell;Infection;Infection Control;infection management;infection risk;Inflammation;Inflammatory Bowel Diseases;Inherited;Institution;Laboratories;Lentivirus Vector;Link;Marrow;Mediating;Medical;member;Messenger RNA;Methods;mouse model;Mutation;National Heart, Lung, and Blood Institute;National Human Genome Research Institute;National Institute of Allergy and Infectious Disease;Natural History;Neutropenia;novel;novel strategies;Omenn syndrome;Other Genetics;Outcome;Oxidases;Patients;Pharmaceutical Preparations;Physiology;pre-clinical;preclinical development;prevent;Prevention;primary immune regulatory disorders;prime editing;programs;Publications;Reagent;Recovery;Regimen;Reporting;Research;Research Personnel;Safety;Severe Combined Immunodeficiency;Small Interfering RNA;Source;STAT1 gene;stem cell engraftment;stem cell gene therapy;Syndrome;Testing;Therapeutic;Therapeutic Clinical Trial;Therapy Clinical Trials;tool;Transfection;Translations;Transplantation;transplantation therapy;United States National Institutes of Health;vector;WHIM syndrome;Wiskott-Aldrich Syndrome;Work;x-linked Hyper-IgM Syndrome;Xenograft procedure",Gene Therapy and Hematopoietic Stem Cell Research to Treat Inherited Primary Immune Deficiencies,644,NA,NA,NA,NA,33,NA,NA,796377,NA
11189296,ZIA,AI,1,N,NA,NA,NA,NA,ZIAAI000645,NA,NA,1ZIAAI000645-33,NIAID:796377\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,78347146 (contact),"DE RAVIN, SUK SEE  (contact)",NA,NA,NA,Address;aged;Antibodies;Autoimmune;Autologous;base editing;Blood Cells;CD34 gene;Cell Survival;Cell Therapy;Cells;cellular transduction;Chronic Granulomatous Disease;Clinical;clinical application;Clinical Trials;Clonal Expansion;Clustered Regularly Interspaced Short Palindromic Repeats;comparative efficacy;conditioning;congenital immunodeficiency;CRISPR/Cas technology;CTLA4 gene;CXCR4 gene;Data;Dependovirus;design;Development;Disease;DNA Damage;DNA Double Strand Break;DNA Sequence;Engineering;Enhancers;Enzymes;experience;Exposure to;gene correction;Gene Expression Regulation;gene therapy;gene therapy clinical trial;Genes;Genetic;genome editing;Genomic Instability;genotoxicity;Goals;granulocyte;Guide RNA;Hematopoietic stem cells;HMGA2 gene;IL2RG gene;immune reconstitution;Immunity;immunodeficiency;improved;in vivo;Individual;Infusion procedures;Institutional Review Boards;Laboratories;Link;Longterm Follow-up;manufacture;Mediating;Messenger RNA;Mission;Modification;Molecular;Mutation;mutation correction;Myelogenous;National Institute of Allergy and Infectious Disease;novel therapeutics;nuclease;older patient;Oligonucleotides;Outcome;Patients;Phase;Phase I/II Clinical Trial;pre-clinical;preclinical study;Preparation;prime editing;Procedures;programs;Prostaglandins;Recording of previous events;Regimen;repaired;response;RNA Splicing;Safety;safety study;Severe Combined Immunodeficiency;Site;Specificity;stem cell genes;stem cells;tool;Transcript;transduction efficiency;Transfection;Translating;Translations;tumorigenesis;Variant;vector;Virus;X-Linked Severe Combined Immunodeficiency,Development and Clinical Application of Gene and Cell therapies for Patients with Immune Deficiencies,645,NA,NA,NA,NA,33,NA,NA,796377,NA
11189297,ZIA,AI,1,N,NA,NA,NA,NA,ZIAAI000669,NA,NA,1ZIAAI000669-32,NIAID:2430109\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,6568546 (contact),"STREBEL, KLAUS  (contact)",NA,NA,NA,Actin-Binding Protein;Actins;Adopted;Affect;Affinity;Affinity Chromatography;Aneuploidy;Anti-viral Therapy;Automobile Driving;Binding;Binding Sites;Biochemical;Biological;Biological Assay;Blood;C-terminal;CD4 Positive T Lymphocytes;Cell Lineage;Cells;Centrioles;Centrosome;Co-Immunoprecipitations;Code;Collaborations;Complex;CSF1 gene;Dendritic Cells;Development;Elements;Endothelial Cells;env Genes;Environment;Equilibrium;Event;Exhibits;experimental study;Feedback;Fellowship;GAG Gene;Gel;Gelsolin;Gene Expression;Gene Expression Regulation;Genes;Genetic Transcription;Goals;Health;HIV;HIV-1;HIV-2;Human;Individual;Infection;insight;Integration Host Factors;interest;Link;Liver;Lymphatic;Macrophage;Malignant Neoplasms;mannose receptor;Molecular;Molecular Analysis;Molecular Conformation;monocyte;Mutation;Myelogenous;novel;particle;Pathway interactions;Persons;PLK1 gene;pol genes;Portugal;posttranscriptional;Primate Lentiviruses;Procentriole;Process;Proliferating;promoter;Property;Proteins;proto-oncogene protein Spi-1;Publishing;receptor;Receptor Gene;receptor-mediated signaling;Reporting;Research;Risk;Role;Surface;T-Cell Lymphoma;Tissues;transcription factor;transmission process;tumorigenesis;ubiquitin-protein ligase;V3 Loop;vif Gene Products;Viral;Viral Genes;Viral Physiology;Virion;Virus;virus host interaction;Virus Latency;Virus Replication;Work,Molecular Analysis Of Retroviral Genes And Their Products,669,NA,NA,NA,NA,32,NA,NA,2430109,NA
11189298,ZIA,AI,1,N,NA,NA,NA,NA,ZIAAI000693,NA,NA,1ZIAAI000693-32,NIAID:1829520\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,9691547 (contact),"BARRY, CLIFTON  (contact)",NA,NA,NA,absorption;Adverse event;Anabolism;Antibiotic Therapy;Area;ATP phosphohydrolase;Bacteria;Binding;Binding Sites;Biochemical;Biochemistry;Biological Assay;Biology;Cell Wall;chemical synthesis;Chemicals;Coculture Techniques;cofactor;Collaborations;Collection;crosslink;Cryoelectron Microscopy;cytotoxic;Data;Development;DNA Resequencing;Dose;Drops;drug development;efficacy study;Enzymes;Equilibrium;Exclusion;Excretory function;follow-up;Frequencies;functional genomics;fungus;Gene Cluster;Genes;Genome;genome sequencing;Genus Mycobacterium;Granuloma;Growth;high throughput screening;Human;Human Microbiome;Hypoxia;improved;in vivo;inhibitor;interest;Kinetics;Label;Lead;lead optimization;lead series;Libraries;Ligands;Maps;Medical Research;member;Metabolism;metabolomics;microbial;Microsomes;Mutation;mycobacterial;Mycobacterium tuberculosis;nanomolar;Natural Products;Natural Source;new chemical entity;novel;Nutrient;Organism;Oxazolidinones;oxidation;pathogen;Pathogenesis;pathogenic bacteria;Pathway interactions;Peat;pharmacokinetics and pharmacodynamics;Pharmacologic Substance;pharmacophore;Phase I Clinical Trials;Phenotype;Physiological;Physiology;Positioning Attribute;pre-clinical;Probability;Process;Prodrugs;Production;Property;protein complex;Proteins;Recombinants;research clinical testing;Research Institute;Resistance;resistance frequency;resistance mutation;Respiration;respiratory;response;Ribosomes;scaffold;screening;secondary metabolite;Series;Site;small molecule libraries;Solubility;Sphagnum Moss;Stress;Sulfhydryl Compounds;Superhelical DNA;Testing;Therapeutic;Thermodynamics;Titrations;transcriptome sequencing;Traumeel S;Tuberculosis;tuberculosis chemotherapy;tuberculosis treatment;uptake;whole genome;Work;Xenobiotics,Development Of New Chemotherapeutics For Tuberculosis,693,NA,NA,NA,NA,32,NA,NA,1829520,NA
11189299,ZIA,AI,1,N,NA,NA,NA,NA,ZIAAI000695,NA,NA,1ZIAAI000695-29,NIAID:625029\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,6568741 (contact),"MARQUES, ADRIANA R (contact)",NA,NA,NA,Address;Annual Reports;Antibiotic Therapy;Antibiotics;Area;Arthralgia;biobank;Biological Markers;Borrelia burgdorferi;Borrelia Infections;Case Study;clinical database;Clinical Protocols;Clinical Research;Country;Development;erythema migrans;Europe;European;Fatigue;Frequencies;Headache;Health;Heart;Human;Immune response;Immunity;Individual;Infection;Investigation;Joints;Lyme Disease;Lyme disease diagnosis;Memory;Myalgia;Names;Neck;Nervous System;Order Spirochaetales;Outcome;Paresthesia;Patients;Post Treatment Lyme Disease Syndrome;recruit;Research;Role;Skin;sleep difficulty;Sleep Disorders;Symptoms;Syndrome;System;Testing;Tick-Borne Diseases;Ticks;treatment response;Work,Assessment Of Patients With Borrelia Infection,695,NA,NA,NA,NA,29,NA,NA,625029,NA
11189300,ZIA,AI,1,N,NA,NA,NA,NA,ZIAAI000697,NA,NA,1ZIAAI000697-31,NIAID:1683228\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,6968267 (contact),"SUN, PETER D. (contact)",NA,NA,NA,Adoptive Transfer;Alloantigen;Allogenic;Amino Acids;Animal Model;Animals;Antigen-Presenting Cells;Antigens;B-Lymphocytes;Binding;Biological Models;CD8-Positive T-Lymphocytes;CD94 Antigen;Cell Communication;Cell Physiology;Cells;Charge;Chemotherapy and/or radiation;Clinical;Clonal Deletion;Collaborations;comparative;Competence;complementarity-determining region 3;Cysteine;Donor person;Exhibits;Frequencies;Genotype;Germ Lines;Goals;graft vs host disease;HLA-C Antigens;Hydrophobicity;Immunologic Surveillance;Immunotherapeutic agent;Immunotherapy;Individual;insight;interest;KRAS2 gene;Length;Malignant Neoplasms;Melanoma;Mixed Lymphocyte Culture Test;Molecular;Mus;Mutate;Mutation;neoantigens;Peptides;Proliferating;Property;Proteins;receptor;Receptor Cell;Role;Sequence Analysis;Spleen;stem;T cell therapy;T-Cell Development;T-Cell Receptor;T-cell receptor repertoire;T-Lymphocyte;Therapeutic;Thymus Gland;Time;tool;Transplantation;Treatment Efficacy;tumor;Tumor-Infiltrating Lymphocytes;V(D)J Recombination;Viral;Work,Structural and functional characterization of T and NK cell receptors,697,NA,NA,NA,NA,31,NA,NA,1683228,NA
11189301,ZIA,AI,1,N,NA,NA,NA,NA,ZIAAI000712,NA,NA,1ZIAAI000712-31,NIAID:1381179\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,6568586 (contact),"KRISTIE, THOMAS M (contact)",NA,NA,NA,Address;Afferent Neurons;Animal Model;Biochemical;Biological Models;Cell Communication;Cell Culture System;Cell Culture Techniques;Chromatin;chromatin modification;Complex;Data;design;Disease;DNA Binding;Early Gene Transcriptions;Enhancers;Enzymes;Epigenetic Process;Eye diseases;Gene Expression;Genes;Genetic Transcription;Genitalia;Goals;host cell factor C1;Immediate-Early Genes;in vivo;Individual;inhibitor;insight;latent infection;Lesion;Life Cycle Stages;Lytic;Lytic Phase;Mediating;Multiprotein Complexes;Neurons;nucleocytoplasmic transport;Oral;Play;Primary Cell Cultures;Primary Infection;Productivity;protein complex;Proteins;reactivation from latency;Recurrence;Role;Signal Transduction;Simplexvirus;Stimulus;Transcription Coactivator;Transcriptional Elongation Factors;Transcriptional Regulation;Viral;Viral Genes;Viral Genome;Virus;Virus Assembly;Virus Latency,Transcriptional control of herpes simplex virus lytic infection and latency-reactivation cycles,712,NA,NA,NA,NA,31,NA,NA,1381179,NA
11189302,ZIA,AI,1,N,NA,NA,NA,NA,ZIAAI000713,NA,NA,1ZIAAI000713-31,NIAID:722740\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,9691557 (contact),"MCBRIDE, ALISON  (contact)",NA,NA,NA,Architecture;Autonomous Replication;Cell Differentiation process;Cell division;Cell Line;Cell Nucleus;Cells;chromosome conformation capture;Chromosomes;daughter cell;design;Development;DNA;DNA amplification;DNA biosynthesis;Elements;Epithelium;Genome;Host Defense;Human papilloma virus infection;Human Papillomavirus;In Situ;Life Cycle Stages;Maintenance;Malignant Neoplasms;Microscopy;Molecular;Papillomavirus;Phase;Resolution;Stratified Epithelium;Surface;Therapeutic;Time;viral DNA;Virus;Virus Diseases;Virus Replication;Visualization,Replication mechanisms of human papillomaviruses (HPV),713,NA,NA,NA,NA,31,NA,NA,722740,NA
11189303,ZIA,AI,1,N,NA,NA,NA,NA,ZIAAI000717,NA,NA,1ZIAAI000717-30,NIAID:244258\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,10526060 (contact),"SU, HELEN  (contact)",NA,NA,NA,12 year old;4 year old;Affect;Age;Age of Onset;Animal Model;Antigen Targeting;antigen-specific T cells;Antigens;Apoptosis;apoptosis in lymphocytes;Attention;Autoimmune Diseases;autoimmune pathogenesis;Autoimmunity;Autopsy;biobank;Biological;Blinded;British Columbia;Canada;Categories;causal variant;Cell Death Induction;Cells;Central Nervous System;Cerebrospinal Fluid;Cessation of life;Clinical Treatment;cohort;Colitis;Collaborations;Correlation Studies;Demyelinating Diseases;Demyelinations;Diagnosis;disability;Disease;Disease Outcome;Distant;DNA;exome sequencing;Family;Family member;FDA approved;fitness;follow-up;Genes;Genetic;genetic approach;Genetic Predisposition to Disease;genetic variant;genome wide association study;Genomics;Goals;Immune;Immune System Diseases;Immunity;immunodeficiency;Immunologics;indexing;individualized medicine;Inflammatory;Inherited;inhibitor;International;Investigation;Knowledge;Lesion;lymphadenopathy;man;member;Molecular;molecular targeted therapies;Multiple Sclerosis;multiple sclerosis patient;Mutation;Myelin Proteins;National Institute of Neurological Disorders and Stroke;next generation sequencing;novel;novel diagnostics;novel therapeutic intervention;novel therapeutics;Pathogenesis;Pathogenicity;Pathway interactions;Patients;Phase;Phase I Clinical Trials;PIK3CG gene;Population;precision medicine;Predisposition;prevent;Process;programs;Progressive Disease;Proteins;randomized placebo controlled study;Recombinants;Regulation;Relapsing-Remitting Multiple Sclerosis;Research;Research Personnel;Retrospective Studies;Role;Sampling;senescence;Single Nucleotide Polymorphism;small molecule;Specificity;Spinal Cord;T-Lymphocyte;targeted treatment;Techniques;Testing;Therapeutic;therapeutically effective;Time;Twin Studies;Universities;Variant,Molecular Mechanisms and Treatment Of Autoimmunity In Man And Animal Models,717,NA,NA,NA,NA,30,NA,NA,244258,NA
11189304,ZIA,AI,1,N,NA,NA,NA,NA,ZIAAI000718,NA,NA,1ZIAAI000718-25,NIAID:244258\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,10526060 (contact),"SU, HELEN  (contact)",NA,NA,NA,Allergic;Antigens;Apoptosis;Autoimmune;Autoimmune Diseases;Biological Process;Candidate Disease Gene;candidate identification;Cell Death;Cell Death Induction;Cell Survival;Cells;Cessation of life;Coin;Contracts;CRISPR/Cas technology;Disease;Embryonic Development;Equilibrium;Event;experimental study;Genes;genome-wide;Graft Rejection;Homeostasis;Human;Immune response;Immune system;Immunity;Immunosuppressive Agents;interest;Knock-out;Libraries;Life;Lymphocyte;Lymphoproliferative Disorders;Medicine;Methods;Molecular;Mus;Outcome;Pathway interactions;Phase;Process;Proliferating;Proteins;Reagent;receptor;Resources;Rest;screening;side effect;Signal Transduction;Specificity;T-Cell Activation;T-Cell Receptor;T-Lymphocyte;therapeutic development;Therapeutic Intervention;therapeutically effective;Viral,Molecular Pathways of Programmed Cell Death  And Viral Cytopathicity,718,NA,NA,NA,NA,25,NA,NA,244258,NA
11189305,ZIA,AI,1,N,NA,NA,NA,NA,ZIAAI000725,NA,NA,1ZIAAI000725-27,NIAID:1875086\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,2091338 (contact),"FARBER, JOSHUA M (contact)",NA,NA,NA,Agonist;antagonist;Autoimmune Diseases;Bacteria;Binding Sites;Biological;Biological Process;Blood;Blood Vessels;CCR6 gene;CD4 Positive T Lymphocytes;Cell Differentiation process;Cell Line;cell motility;cell type;Cells;chemokine;chemokine receptor;Chromatin;circadian;Circadian Rhythms;Communicable Diseases;counterregulation;cytokine;Dermis;Disease;DNA Methylation;driving force;Endothelial Cells;Epidermis;Experimental Models;experimental study;Extravasation;Family;G-Protein-Coupled Receptors;Gene Expression Profiling;gene regulatory network;Genes;genome-wide analysis;Goals;Health;Hematopoietic;Host Defense;Human;Human Activities;Immune response;Immune system;immunopathology;in vivo;Infection;Inflammation;Inflammatory;Inflammatory Response;interest;intravital microscopy;Investigation;knock-down;Knockout Mice;Leukocyte Trafficking;Leukocytes;Ligands;Maintenance;Malignant Neoplasms;Mediating;member;Memory;memory CD4 T lymphocyte;microorganism;migration;Molecular;mouse model;Mouse Strains;Mucous Membrane;Mus;novel;overexpression;Pathway interactions;Pattern;Pharmaceutical Preparations;Phenotype;Population;Process;programs;Proteins;Psoriasis;receptor;Research;response;Role;Site;Skin;Stimulus;Subgroup;Surface;System;T cell differentiation;T memory cell;T-Cell Activation;T-Lymphocyte;T-Lymphocyte Subsets;targeted treatment;Tissues;trafficking;transcription factor;Translating;Tuberculosis;Work,Activities Of Chemokines In Health and Disease,725,NA,NA,NA,NA,27,NA,NA,1875086,NA
11189306,ZIA,AI,1,N,NA,NA,NA,NA,ZIAAI000732,NA,NA,1ZIAAI000732-30,NIAID:1217919\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,79358139 (contact),"RAO, V KONETI  (contact)",NA,NA,NA,1 year old;Adult;Affect;Algorithms;Apoptosis;apoptosis in lymphocytes;Autoimmune;autoimmune lymphoproliferative syndrome;Autoimmunity;autoinflammatory;bench to bedside;Biological Response Modifier Therapy;Biology;Blood;Blood Cells;Candidate Disease Gene;Cell Death;Cells;Cellular biology;Child;Childhood;Chronic;Classification;Clinic;Clinical;Clinical Trials;cohort;Collaborations;CTLA4 gene;cytopenia;Data;Defect;Development;Disease;DNA analysis;DNA Sequence Alteration;DNA sequencing;Dose;Dose Limiting;Double-Blind Method;efficacy study;Enrollment;Epigenetic Process;Etiology;exome;experimental study;follow-up;Gene Targeting;Genes;Genetic;genetic analysis;Genetic Diseases;genetic disorder diagnosis;genetic variant;Genomics;Germ Cells;Goals;Grant;Hematology;Histopathology;Homeostasis;Human Genetics;Hypersensitivity;Hypersplenism;Immune;immune activation;immune modulating agents;Immune system;Immune System Diseases;immunodeficiency;Immunologics;Indolent Clinical Course;inhibitor;insight;International;Journals;Juvenile Myelomonocytic Leukemia;Knowledge;KRAS2 gene;Licensing;lymph nodes;lymphadenopathy;Lymphoma;Lymphomagenesis;Lymphoproliferative Disorders;Malignant lymphoid neoplasm;Manuscripts;Mediating;meetings;Molecular;Monocytosis;mouse model;Multi-Institutional Clinical Trial;Mutation;Myelogenous;Natural History;Non-Malignant;novel;novel marker;novel therapeutics;older patient;open label;Outcome;Paper;participant enrollment;PASLI disease;Pathogenesis;Pathogenicity;Pathway interactions;patient subsets;Patients;Pharmacological Treatment;phase III trial;Phosphatidylinositols;Phosphotransferases;PIK3CG gene;Placebo Control;placebo controlled study;Plasma;prevent;Process;Protein Kinase;Publishing;Randomized;randomized placebo controlled trial;rare genetic disorder;recruit;Refractory;Research;Role;Safety;safety assessment;Schedule;senescence;Serum;Signal Pathway;small molecule;Somatic Cell;Somatic Mutation;specific biomarkers;Splenomegaly;STAT3 gain of function;STAT3 gene;Syndrome;System;T cell differentiation;T-cell receptor repertoire;T-Lymphocyte;targeted therapy trials;targeted treatment;Therapeutic Intervention;therapeutic target;therapy duration;Thymus Gland;TLR8 gene;tool;Toxic effect;transcriptomics;Validation;Variant;Vitamin B 12,"Clinical, Immunological and Genetic  Analyses of ALPS and Related Immunedysregulatory Disorders",732,NA,NA,NA,NA,30,NA,NA,1217919,NA
11189307,ZIA,AI,1,N,NA,NA,NA,NA,ZIAAI000734,NA,NA,1ZIAAI000734-29,NIAID:1413031\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,9691547 (contact),"BARRY, CLIFTON  (contact)",NA,NA,NA,Acetylation;Advanced Development;Alcohols;animal facility;Animal Model;Animals;anti-microbial peptide;Antibiotics;Antitubercular Agents;Bacille Calmette-Guerin vaccination;Bacteria;bacterial metabolism;Barbering;Benchmarking;bevacizumab;black hole;Blood Vessels;Callithrix;Cell Wall;chemotherapy;Clinical assessments;Clinical Research;Clinical Trials;Collaborations;cytokine;Data;Deoxyglucose;Development;Disabling;Disease;Disease Progression;Dose;drug candidate;Drug Combinations;Drug Delivery Systems;drug distribution;drug efficacy;Drug Kinetics;drug testing;enzyme activity;Enzymes;Eukaryotic Cell;experience;Experimental Animal Model;Extracellular Matrix;FDA approved;fluorodeoxyglucose;Foundations;Functional Imaging;Gene Expression;Genes;Genus Mycobacterium;Goals;Granuloma;Human;human data;Image;Imaging Techniques;Immunologics;improved;in silico;in vivo;Individual;Infection;Infection Control;Inflammation;Inflammatory;inflammatory marker;inhibitor;Kinetics;Knowledge;Label;Lesion;Linezolid;Losartan;Lung;Maintenance;Mammalian Cell;Manuscripts;Mediating;metabolic abnormality assessment;Metabolism;Modeling;Modernization;Monitor;Moxifloxacin;Mus;Mycobacterium tuberculosis;Mycobacterium tuberculosis antigens;Nitroimidazoles;nonhuman primate;novel therapeutics;Organ;Organism;Oryctolagus cuniculus;Outcome;Oxazolidinones;Pathology;Patients;Penetration;Pharmaceutical Preparations;Pharmacotherapy;Positron-Emission Tomography;Pre-Clinical Model;predictive modeling;Prodrugs;Production;quinoline;radiotracer;rational design;Regimen;Reporter;Reporting;response;Role;Safety;secondary metabolite;Series;small molecule;Spatial Distribution;structural imaging;Techniques;Technology;Testing;Therapeutic;Time;Tissues;Tracer;transcriptome sequencing;treatment effect;Treatment Protocols;treatment response;Trehalose;Tuberculosis;tuberculosis chemotherapy;tuberculosis drugs;tuberculosis granuloma;tuberculosis treatment;uptake;Work;X-Ray Computed Tomography,Experimental Animal Models of TB: Chemotherapeutics and Imaging,734,NA,NA,NA,NA,29,NA,NA,1413031,NA
11189308,ZIA,AI,1,N,NA,NA,NA,NA,ZIAAI000738,NA,NA,1ZIAAI000738-29,NIAID:1291785\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,6568620 (contact),"KEHRL, JOHN H (contact)",NA,NA,NA,Acceleration;Adhesions;Automobile Driving;B Cell Proliferation;B-Cell Activation;B-Cell Development;B-Lymphocytes;Behavior;beta-arrestin;Binding;Biological Assay;Blood;Blood Vessels;Bone Marrow;Breeding;C-terminal;C2 Domain;Calcium;cell assembly;Cell Line;Cell membrane;cell motility;Cell Polarity;Cell Surface Receptors;cell type;Cells;Cellularity;chemokine;chemokine receptor;Chemotactic Factors;Chemotaxis;Chimera organism;Chromosome 1;Complex;CRISPR/Cas technology;CXCL13 gene;Data;Defect;density;desensitization;dimer;Dissociation;Elements;Embryo;Endothelium;Event;Exhibits;F-Actin;G-Protein-Coupled Receptors;Gene Cluster;Genes;Goals;GTP Binding;GTP-Binding Protein alpha Subunits;GTP-Binding Protein Regulators;GTP-Binding Proteins;Guanosine Triphosphate;Guanosine Triphosphate Phosphohydrolases;Hela Cells;Heterotrimeric GTP-Binding Proteins;Human;Humoral Immunities;Image;Immune;Immunoglobulin A;Impairment;in vivo;Individual;Inflammatory;inhibitor;Injections;insertion/deletion mutation;insight;Intercellular adhesion molecule 1;interstitial;intravital imaging;Investigation;Knockout Mice;Lamina Propria;Lateral;Ligand Binding;link protein;lymph nodes;Lymphatic;Lymphocyte;Lymphopenia;Lysine;Mammalian Cell;Mediating;Methodology;Microscopy;migration;Minor;Motility;Mus;N-terminal;Nonmuscle Myosin Type IIA;Nucleotides;Pathway interactions;Peyer&apos;s Patches;PH Domain;pharmacologic;Phenotype;Phospholipase C;Phosphotransferases;PIK3CG gene;Play;Property;Protein Family;Proteins;Proto-Oncogene Proteins c-akt;pup;ras GTPase-Activating Proteins;receptor;Receptor Signaling;recruit;response;Rest;RGS Proteins;Role;Sepharose;Sequence Homology;Side;Signal Pathway;Signal Transduction;Signaling Molecule;Signaling Protein;Sinus;Splenomegaly;success;T-Lymphocyte;Thick;Time;transmission process;Western Blotting;Wild Type Mouse;wortmannin,Control of G-protein Signaling: Role of RGSs,738,NA,NA,NA,NA,29,NA,NA,1291785,NA
11189309,ZIA,AI,1,N,NA,NA,NA,NA,ZIAAI000739,NA,NA,1ZIAAI000739-29,NIAID:1033429\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,6568620 (contact),"KEHRL, JOHN H (contact)",NA,NA,NA,Activated Natural Killer Cell;Adoptive Transfer;Affect;Alanine;Alleles;Anhidrosis;Annual Reports;Antibody-Producing Cells;Autoimmune Diseases;autoinflammatory diseases;Autophagocytosis;autosome;B-Lymphocytes;biological adaptation to stress;c-myc Genes;Calcium;Cancer Biology;cancer type;Cell membrane;cell motility;Cell Physiology;Cell Polarity;Cell Size;Cell Surface Receptors;Cell Volumes;Cells;chemokine receptor;chloride-cotransporter potassium;Complex;Coupled;CRISPR/Cas technology;Crohn&apos;s disease;Cyclic AMP-Dependent Protein Kinases;Data;Defect;Disease;DNA;Edema;EIF-2alpha;Enterobacteria phage P1 Cre recombinase;Exhibits;Exposure to;extracellular;F-Actin;Failure;Family;Family member;Flow Cytometry;FOXO1A gene;gain of function;Gene Expression Profile;Gene Expression Profiling;Genetic;Genetic Transcription;germinal center kinases;Gram-Negative Bacteria;Headache;Host Defense;Hour;Immune;Immune response;Immunity;Immunoglobulin A;Impairment;Inflammasome;Inflammation;Inflammatory;Inherited;inhibitor;Innate Immune System;Integration Host Factors;interest;Interferon Type I;Interferons;Interleukin-2;Ions;kinase inhibitor;Knock-in;LATS1 gene;LATS2 gene;Leprosy;light scattering;Link;Liquid substance;LoxP-flanked allele;LRRK2 gene;Lymphocyte;lymphoid organ;Lysine;Lysosomes;Macrophage;Mediating;Mediation;member;Metabolism;migration;Motility;mRNA sequencing;mTOR inhibition;Mucosal Immunity;Mus;mutant;Mutate;Mutation;Natural Immunity;Natural Killer Cells;Neoplasm Metastasis;NF-kappa B;Optic Nerve;Organism;Osmoregulation;Osmosis;Osmotic Pressure;Oxidative Stress;Parkinson Disease;pathogen;Pathogenesis;Pathway interactions;Patients;pharmacologic;Phenotype;Phospholipase C;Phospholipases A;Phosphoric Monoester Hydrolases;Phosphorylation;Phosphotransferases;Physiological;Play;Process;Production;Proline;Protein Kinase;Protein-Serine-Threonine Kinases;Proteins;Proto-Oncogene Proteins c-akt;Protons;receptor;Reporting;response;Rest;Retinal Dystrophy;Risk Factors;RNA;Role;Second Messenger Systems;Serine;Side;Signal Induction;Signal Pathway;Signal Transduction;Signaling Molecule;Site;solute;Splenomegaly;Stress;symporter;synergism;Testing;Threonine;Tissues;TRAF2 gene;transcription factor;tumor;Tyrosine Phosphorylation,Signal Transduction In B Lymphocytes and Macrophages: Identification Of Key Signaling Molecules,739,NA,NA,NA,NA,29,NA,NA,1033429,NA
11189310,ZIA,AI,1,N,NA,NA,NA,NA,ZIAAI000744,NA,NA,1ZIAAI000744-28,NIAID:954819\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,9691495 (contact),"KWON-CHUNG, KYUNG  (contact)",NA,NA,NA,Acquired Immunodeficiency Syndrome;Affect;Agrobacterium;Air;Alanine;Amino Acids;Animals;Antibodies;antimicrobial;Australia;Autoantibodies;base;Biological;Biology;Brain;CD4 Positive T Lymphocytes;CD8-Positive T-Lymphocytes;Central Nervous System;China;Classification;Clinical;Containment;Cryptococcosis;Cryptococcus;Cryptococcus gattii;Cryptococcus neoformans;Cryptococcus neoformans infection;cytokine;Data;Defense Mechanisms;Disease;Drug resistance;Ecology;Environment;Epidemiology;Etiology;Extravasation;Feedback;fluorescein isothiocyanate dextran;Frequencies;fungus;Genes;genetic makeup;Genomics;Granulocyte-Macrophage Colony-Stimulating Factor;Granuloma;Host-Parasite Relations;Immune response;Immunocompetent;Immunocompromised Host;Immunoglobulin G;Immunologic Factors;Immunologics;Individual;Infection;Inflammatory;Interferons;Interleukin-1;Interleukin-6;Intravenous;Invaded;Iron;Libraries;Liquid substance;Lung;Macroglobulins;Macrophage;Mediating;Molecular;Mus;mutant;Mycoses;Names;Natural Killer Cells;Nitrogen;Organ;Pathogenicity;Patients;Pattern;Plasma;Predisposing Factor;prevent;Proline;recruit;Risk;Risk Factors;Role;Sampling;Serum;Serum Iron Level;Serum Proteins;Siblings;Signal Transduction;Source;Structure;therapeutic target;tool;Vascular Permeabilities;Virulent,Pathogenic differences between Cryptococcus neoformans and C. gattii,744,NA,NA,NA,NA,28,NA,NA,954819,NA
11189311,ZIA,AI,1,N,NA,NA,NA,NA,ZIAAI000746,NA,NA,1ZIAAI000746-27,NIAID:115626\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,6479630 (contact),"DRUEY, KIRK M (contact)",NA,NA,NA,"Acceleration;Adenylate Cyclase;Allergens;Allergic;Allergic inflammation;allergic response;Area;Asthma;Basophils;Binding;Biochemical;cell growth;cell motility;Cell Proliferation;Cells;chemokine;Clinical;Coupled;Cyclic AMP;desensitization;Development;disease phenotype;Effector Cell;Extrinsic asthma;Family;G(q) Alpha;G-Protein-Coupled Receptors;Gene Deletion;genetic approach;Germ-Line Mutation;GNAI2 gene;Goals;granulocyte;GTP Binding;GTP-Binding Protein alpha Subunits;GTP-Binding Protein alpha Subunits, Gs;GTP-Binding Protein Regulators;GTP-Binding Proteins;GTPase-Activating Proteins;Guanosine Triphosphate;Guanosine Triphosphate Phosphohydrolases;Hereditary Disease;Heterotrimeric GTP-Binding Proteins;Human;human subject;Immune;Immunity;immunodeficiency;Impairment;Inflammation;Inflammatory;Investigation;Knowledge;Laboratories;leukocyte activation;Leukocyte Trafficking;Leukocytes;Ligands;Lung;Lymphocyte;MAP Kinase Gene;mast cell;Mediating;Modeling;Mus;mutant;Mutation;neutrophil;novel;overexpression;Pathway interactions;Patients;Phenotype;Physiological;PIK3CG gene;Process;Production;Property;Proteins;Proto-Oncogene Proteins c-akt;Pulmonary Inflammation;receptor;Receptor Activation;Receptor Signaling;recruit;release of sequestered calcium ion into cytoplasm;response;Role;Signal Pathway;Signal Transduction;Signaling Protein;Site;T-Cell Receptor;Time;trafficking",Heterotrimeric G Protein Signaling In Allergic Inflammation,746,NA,NA,NA,NA,27,NA,NA,115626,NA
11189312,ZIA,AI,1,N,NA,NA,NA,NA,ZIAAI000752,NA,NA,1ZIAAI000752-29,NIAID:1139579\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,8237033 (contact),"PRIOLA, SUZETTE ALISE (contact)",NA,NA,NA,Ablation;Acute;Address;Affect;Alzheimer&apos;s Disease;Amino Acids;Animals;Annual Reports;Apoptosis;Autophagocytosis;Axon;axonal degeneration;Biochemical;Biological Assay;Bovine Spongiform Encephalopathy;Brain;Cells;Cellular Stress;Chronic Wasting Disease;Clinical Treatment;Collaborations;Creutzfeldt-Jakob Syndrome;Data;Deer;Development;Diet;Disease;disease phenotype;Disease Progression;Equine mule;Event;experimental study;Genus Hippocampus;Great Britain;Health;Hospitals;Human;Iatrogenesis;Immunohistochemistry;Impairment;in vivo;Infection;Infectious Agent;inhibitor;Knowledge;Laboratories;Manuscripts;Mass Spectrum Analysis;Measures;Mediating;metabolomics;Methods;Mitochondria;mitochondrial dysfunction;Molecular;Molecular Biology;Molecular Genetics;Mus;Mutation;Nerve Degeneration;Neurodegenerative Disorders;Neurons;Oxidation-Reduction;Parkin;Parkinson Disease;Pathogenesis;Pathogenicity;Pathologic;Pathology;Pathway interactions;Peptide Hydrolases;Phenotype;PINK1 gene;Post-Translational Protein Processing;Postdoctoral Fellow;Predisposition;Preparation;Prion Diseases;Prions;Process;Production;Prophylactic treatment;protective effect;protein aggregation;protein misfolding;protein transport;Proteins;Protocols documentation;PrP;PrPSc Proteins;Public Health;Publishing;Reactive Oxygen Species;Regulation;Research;Resistance;Respiration;response;Retina;Rodent;Role;Sampling;Scrapie;secretory protein;Sheep;Sterilization;System;Techniques;Therapeutic;therapeutically effective;trafficking;Transgenic Mice;transmission process;Vaccination;Western Blotting;Work,Molecular Genetics Of Scrapie Pathogenesis,752,NA,NA,NA,NA,29,NA,NA,1139579,NA
11189313,ZIA,AI,1,N,NA,NA,NA,NA,ZIAAI000758,NA,NA,1ZIAAI000758-27,NIAID:1574498\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,11242108 (contact),"GERMAIN, RONALD N (contact)",NA,NA,NA,Adjuvant;Affect;Affinity;Animals;Antibody Response;Antibody-mediated protection;Antigen Presentation;Antigen-Presenting Cells;Antigens;Architecture;Atlases;Autoantigens;Autoimmune;Autoimmune Diabetes;Autoimmune Diseases;Autoimmune Process;Autoimmune Responses;Autoimmunity;autoreactivity;B-Lymphocytes;Bacteria;Behavior;Binding;Biology;Blood;Bone Marrow;cancer cell;cancer immunotherapy;CD28 gene;CD4 Positive T Lymphocytes;CD8-Positive T-Lymphocytes;CD80 gene;Cell Communication;cell cortex;Cell Cycle;cell type;Cells;central tolerance;Chicago;Chronic;Collaborations;combat;Complex;Computer Models;Consumption;CRISPR/Cas technology;CTLA4 gene;cytokine;Data;Dendritic Cells;deprivation;Development;Effector Cell;Engineering;Enhancers;Epithelial Cells;Event;expectation;Feedback;fungus;Generations;Genetic;Genotype;Goals;Homeostasis;Human;IL2RA gene;Image;image registration;imaging platform;Immune;immune checkpoint blockade;Immune response;Immunologic Memory;In Situ;In Vitro;Infection;Inflammation;insight;Interleukin-2;intravital imaging;Laboratories;Ligands;Link;Lymphocyte;Lymphoid Tissue;Maintenance;MAPK8 gene;Maps;mathematical model;Mediating;Memory;Methods;Microscopy;migration;mimetics;minimal risk;Minor;Molecular;Monitor;Movement;multiplexed imaging;Mus;NF-kappa B;nuclear factors of activated T-cells;p38 Mitogen Activated Protein Kinase;p65;pathogen;Pathology;Pathway interactions;Pattern;PD-1/PD-L1;Peptide/MHC Complex;Peripheral;Phenotype;Plasma Cells;Play;Predisposition;Prevention;Production;programmed cell death ligand 1;programmed cell death protein 1;Proliferating;Property;Protozoa;Regulation;Regulatory T-Lymphocyte;Reporter;Reporting;Research;Research Personnel;response;Rest;Role;sample fixation;Scientist;selective expression;Shapes;Signal Transduction;Site;Software Tools;Specificity;Statistical Data Interpretation;Structure;Structure of germinal center of lymph node;T cell differentiation;T cell regulation;T cell response;T-Cell Activation;T-Cell Proliferation;T-Lymphocyte;Testing;Theft;Three-Dimensional Imaging;Thymus Gland;Time;Tissue imaging;Tissues;tumor;tumor microenvironment;Up-Regulation;Vaccination;Vaccine Design;Vaccine Research;Viral Cancer;Virus;Virus Diseases;Work,Functional Biology Of T Cells,758,NA,NA,NA,NA,27,NA,NA,1574498,NA
11189314,ZIA,AI,1,N,NA,NA,NA,NA,ZIAAI000769,NA,NA,1ZIAAI000769-28,NIAID:1628379\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,10526060 (contact),"SU, HELEN  (contact)",NA,NA,NA,Abdominal Pain;Affect;Anaphylatoxins;Animal Experiments;Antibodies;Apoptosis;Autoimmune;Autoimmune Diseases;autoimmune lymphoproliferative syndrome;autoimmune pathogenesis;Autoimmune Process;autosome;Binding;Biochemical;Candidate Disease Gene;casein kinase II;CD55 Antigens;Cell Aging;Cell Death;Cell Line;Cells;Ceramides;Cessation of life;China;Clinical;clinical diagnostics;clinical investigation;Clinical Protocols;Clinical Research;Clinical Trials;comparative genomic hybridization;Complement;Complement 3 Convertase;Complement 3d;Complement Membrane Attack Complex;congenital immunodeficiency;cost;Cytolysis;Deposition;Deterioration;Development;Diabetes Mellitus;Diarrhea;dihydroceramide desaturase;Disease;DNA Sequence Alteration;DNA sequencing;early onset;Edema;effective therapy;Endothelial Cells;Enrollment;Equilibrium;Evaluation;exome sequencing;Failure;Family;Flare;Gene Mutation;Genes;Genetic;Genetic Diseases;Genetic study;genetic variant;Genomics;Guanosine Triphosphate Phosphohydrolases;gut inflammation;healthspan;Homeostasis;Human;Hypoproteinemia;Immune;immune function;Immune system;Immune System Diseases;immunodeficiency;Immunoglobulins;Immunologic Deficiency Syndromes;Immunologics;immunoregulation;immunosenescence;India;Infection;Infectious Agent;Inflammatory;insight;interest;Intravenous;Investigation;Link;Liver Dysfunction;Longevity;lymph nodes;Lymphangiectasis;Lymphatic;Lymphocyte;lymphoid organ;Malabsorption Syndromes;Malignant lymphoid neoplasm;Mammals;Mediating;Meleagris gallopavo;Molecular;Molecular Abnormality;Monoclonal Antibodies;mortality;Multiple Sclerosis;Mutation;Names;National Institute of Allergy and Infectious Disease;next generation;Pathogenesis;Pathologic;Pathway interactions;Patients;Pharmaceutical Preparations;pharmacologic;Pharmacologic Substance;precision medicine;prevent;Process;programs;protein expression;Protein Kinase;Protein-Losing Enteropathies;Protocols documentation;Reaction;reconstitution;Recovery;recurrent infection;Regulation;Reporting;Rheumatoid Arthritis;Scientist;selective expression;Serum Albumin;side effect;subcutaneous;Swelling;Symptoms;Syndrome;T-Lymphocyte;Technology;Therapeutic;Thrombosis;Tissues;transcriptome;transcriptome sequencing;United States Food and Drug Administration;United States National Institutes of Health;Variant;whole genome,Molecular Mechanisms Of The Autoimmune Lymphoproliferative Syndrome And Other Immunoregulatory Disorders,769,NA,NA,NA,NA,28,NA,NA,1628379,NA
11189315,ZIA,AI,1,N,NA,NA,NA,NA,ZIAAI000805,NA,NA,1ZIAAI000805-28,NIAID:515069\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,9691541 (contact),"NUTMAN, THOMAS  (contact)",NA,NA,NA,airborne allergen;Allergens;Allergic;Allergic inflammation;allergic response;Antibodies;Antigens;Ascaris;asthmatic;atopy;Barbering;Basophils;Bystander Effect;CCL11 gene;CCL24 gene;CD30L;Cells;Chronic;Clonal Expansion;cohort;Collaborations;Color;cytokine;Data;Development;Disease;Down-Regulation;Effector Cell;effector T cell;eosinophil;Eosinophilia;eosinophilic inflammation;Eotaxin;Fibroblasts;filaria;Flow Cytometry;Frequencies;Gene Expression Profile;helminth infection;Helminths;Heterogeneity;Human;Hygiene;Hypersensitivity;IgE;IgG1;IgG4;IL13 gene;IL4 gene;IL5 gene;Immune response;Immunoglobulins;Impairment;In Vitro;Individual;Infection;Inflammation;Inflammation Mediators;insight;Interleukin-10;Interleukin-13;Interleukin-4;Interleukin-5;Interleukin-9;Interleukins;KLRB1 gene;Lung;Lymphoid Cell;Macrophage;Maps;mast cell;Mediating;Memory;memory CD4 T lymphocyte;Modeling;Molecular;monocyte;mouse model;Mucous Membrane;Mus;National Institute of Allergy and Infectious Disease;Nematoda;neutralizing antibody;novel;Parasites;Pathogenesis;Pathogenicity;Patients;Phase;Phenotype;Play;Population;prevent;Process;Production;Pulmonary Inflammation;Regulation;response;Role;self organization;Signal Transduction;single cell sequencing;single-cell RNA sequencing;Sorting;Structure of parenchyma of lung;T-Lymphocyte;T-Lymphocyte Subsets;Techniques;terminally differentiated effector memory (TEM) T cells;Th2 Cells;Tissues;tool;trafficking,Th2-associated responses and their control in parasitic helminth infections and related disorders,805,NA,NA,NA,NA,28,NA,NA,515069,NA
11189316,ZIA,AI,1,N,NA,NA,NA,NA,ZIAAI000810,NA,NA,1ZIAAI000810-28,NIAID:1202956\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,9413749 (contact),"RIBEIRO, JOSE  (contact)",NA,NA,NA,Acid Phosphatase;Address;Adult;Aedes;Animals;Anti-Inflammatory Agents;Argasidae;arm;Arthropods;Artificial Feeding;Biogenic Amines;Bioinformatics;Biological;Biological Assay;Biology;Blood;Blood coagulation;Blood Platelets;Blood Proteins;Borrelia;Brazil;Castor Bean Tick;Cattle;cDNA Library;Cell Line;Chemicals;Chromatography;co-infection;Coagulation Process;Collaborations;Complement;Complex;Crithidia;Culicidae;Diagnosis;Diet;Disease Vectors;Eukaryotic Cell;European;Evolution;Experimental Designs;Fat Body;feeding;Fleas;Future;Genome;Goals;Greek;Hemolymph;Hemorrhage;Hemostatic Agents;Hemostatic function;Immune;Immune response;immunoreaction;immunoregulation;in vitro testing;in vivo;Individual;Injury;Insecta;insight;interest;Invaded;Laboratories;Learning;Leishmania infantum;Leukotrienes;Lyme Disease;Magic;Maps;member;Methodology;Methods;Midgut;Modification;Molecular Biology;National Institute of Allergy and Infectious Disease;novel;Organism;Ornithodoros;pathogen;Peptides;pharmacologic;Pharmacologic Substance;Phlebotominae;Physiological Processes;Plague;Platelet aggregation;prevent;Process;programs;Property;Protein Family;Proteins;Proteome;Proteomics;Publications;Reaction;Recombinants;Refractory;Relapse;Research;Rhipicephalus;Saliva;Salivary;Salivary Glands;Salivary Proteins;Site;skills;success;sucking;System;Techniques;tick feeding;Ticks;Time;transcriptome;transcriptomics;transmission process;vaccine development;Vaccines;vasoconstriction;Vasodilator Agents;vector;vector tick;Vector-transmitted infectious disease;Visceral Leishmaniasis;Work,Vector-Borne Diseases: Biology Of Vector Host Relationship,810,NA,NA,NA,NA,28,NA,NA,1202956,NA
11189317,ZIA,AI,1,N,NA,NA,NA,NA,ZIAAI000825,NA,NA,1ZIAAI000825-27,NIAID:1480637\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,6479726 (contact),"MOIR, SUSAN  (contact)",NA,NA,NA,2019-nCoV;Address;Affect;Annual Reports;Antibodies;Antibody Repertoire;Antibody Response;Antibody Therapy;Antibody titer measurement;Antigens;antiretroviral therapy;Architecture;arm;Autologous;B-Lymphocytes;Binding;booster vaccine;Cell Culture Techniques;Cell Lineage;Cell Physiology;Cell surface;Clinical;Clinical Research Protocols;Cloning;COVID-19;Cryoelectron Microscopy;design;Detection;Development;Disease;Disease Progression;Dose;Early identification;Ebola;Ebola Vaccines;Emerging Communicable Diseases;Enrollment;experience;experimental study;Family;Flow Cytometry;Follow-Up Studies;Formalin;Genomics;Glycoproteins;Goals;Health;HIV;HIV Antibodies;HIV envelope protein;HIV Envelope Protein gp120;HIV Infections;Human;imaging platform;immune function;Immune response;immunogenicity;Immunoglobulin G;Immunoglobulin M;Immunologics;Immunology;In Vitro;indexing;Interruption;Knowledge;Life Cycle Stages;lymph node biopsy;Lymph Node Tissue;Lymphoid;Lymphoid Tissue;Maryland;Measures;Memory B-Lymphocyte;Metalloproteases;Mutation;National Institute of Allergy and Infectious Disease;National Institute of Child Health and Human Development;neutralizing antibody;Outcome;Paraffin;Participant;Pathogenesis;peripheral blood;Persons;Phase;Phenotype;Pilot Projects;Placebo Control;placebo group;Plasma;Plasma Cells;prevent;Process;Property;Proteins;Recombinants;Recommendation;Regulation;Reporting;Research;Research Personnel;Resistance;Resistance profile;Resources;response;RNA;RNA Stability;RNA vaccination;RNA vaccine;Role;Safety;Sampling;screening;Serology;Serum;Severe Acute Respiratory Syndrome;Somatic Mutation;Specimen;superinfection;Technology;Therapeutic Intervention;Time;transcriptomics;Universities;Vaccination;vaccine platform;Vaccines;Vesicular stomatitis Indiana virus;Viral;Viral reservoir;Viremia;Virus;Visualization;Zaire Ebola virus,Role of B Lymphocytes In HIV Infection And Pathogenesis,825,NA,NA,NA,NA,27,NA,NA,1480637,NA
11189318,ZIA,AI,1,N,NA,NA,NA,NA,ZIAAI000833,NA,NA,1ZIAAI000833-27,NIAID:1784886\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,6568735 (contact),"KELSALL, BRIAN  (contact)",NA,NA,NA,acquired immunity;Acute;Affect;Antigen Presentation Pathway;Antigen-Presenting Cells;Antigens;Automobile Driving;B cell clonality;B-Lymphocytes;Bacteria;base;Blood;Blood specimen;Blood Vessels;Cell Differentiation process;Cell Physiology;Cell Separation;Cells;Cholera Toxin;Colitis;Collaborations;Colon;commensal bacteria;commensal microbes;Complex;Crohn&apos;s disease;cytokine;Defect;Dendritic Cells;Development;dextran sulfate sodium induced colitis;Disease;effector T cell;enteric infection;Epithelial Cells;Experimental Models;experimental study;Exposure to;Flow Cytometry;Gene Expression;Gene Expression Profiling;Gene Expression Regulation;Generations;genome wide association study;Goals;gut inflammation;gut microbiota;Heterogeneity;Homeostasis;Humoral Immunities;IL6 gene;Immune;Immune response;Immune system;Immunity;Immunofluorescence Immunologic;Immunofluorescence Microscopy;Immunoglobulin A;Immunoglobulin Class Switching;Immunosuppression;In Situ;in vitro Assay;Infection;Inflammasome;Inflammation;Inflammatory;Inflammatory Bowel Diseases;Interleukin-10;Interleukin-6;Intestines;knockout gene;Knockout Mice;Laboratories;Lamina Propria;lymphatic drainage;Lymphoid Follicle;Macrophage;Memory B-Lymphocyte;Messenger RNA;Methods;microbial products;migration;Modeling;Molecular;monocyte;Mononuclear;mouse model;mRNA Expression;Mucosal Immune Responses;Mucous Membrane;Mus;Myeloid Cells;Natural Immunity;novel;oral vaccine;Organism;Outcome;pathogen;Pathogenicity;Pathway interactions;Patients;Peripheral;Peyer&apos;s Patches;Phagocytes;Phenotype;Physiological;Play;Population;population based;Post-Transcriptional Regulation;posttranscriptional;Predisposition;Production;protein expression;Proteins;Pulmonary Inflammation;receptor;Regulation;Regulatory T-Lymphocyte;Reovirus;repaired;Resolution;response;Rest;Role;Sampling;Silicosis;single-cell RNA sequencing;Skin;Surface;Susceptibility Gene;T cell differentiation;T cell response;T-Lymphocyte;Time;Tissues;TNF gene;Ulcerative Colitis;uptake;Vaccination;Vaccines;Vibrio cholerae infection,Antigen Processing And Presentation In The Intestine,833,NA,NA,NA,NA,27,NA,NA,1784886,NA
11189319,ZIA,AI,1,N,NA,NA,NA,NA,ZIAAI000851,NA,NA,1ZIAAI000851-24,NIAID:3250628\OD:150000\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,6479766 (contact),"CHUN, TAE-WOOK  (contact)",NA,NA,NA,Acute;Address;Adherence;Affect;Anti-Retroviral Agents;antiretroviral therapy;Biological Markers;CD4 Positive T Lymphocytes;Cell Count;Cells;Chronic;Chronic Phase;Clonal Expansion;cohort;CPG-oligonucleotide;cytotoxic;cytotoxicity;Data;Development;Disease;Disease remission;DNA;DNA Folding;Effector Cell;exhaustion;experience;FCGR3B gene;Frequencies;Goals;Health;high dimensionality;HIV;Immune;Immunity;Immunologic Markers;Immunologics;improved;Infection;interest;Interruption;Life Expectancy;longitudinal analysis;Mediating;Mucous Membrane;Natural Immunity;Natural Killer Cells;novel therapeutic intervention;novel therapeutics;Participant;Pathogenesis;perforin;peripheral blood;Persons;Pharmaceutical Preparations;Phase;Phenotype;Plasma;Play;Primary Infection;programmed cell death ligand 1;Proviruses;Research;Residual state;RNA;Role;Sequence Analysis;study population;T-Cell Activation;T-Lymphocyte;Time;viral rebound;Viral reservoir;Viremia;Virion;Virus,Role of Viral Reservoirs in the Pathogenesis of HIV Disease,851,NA,NA,NA,NA,24,NA,NA,3400628,NA
11189320,ZIA,AI,1,N,NA,NA,NA,NA,ZIAAI000855,NA,NA,1ZIAAI000855-26,NIAID:1122303\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,6479774 (contact),"CONNORS, MARK  (contact)",NA,NA,NA,Acceleration;Alleles;Antigens;antiretroviral therapy;Area;Autologous;Benchmarking;Biological Assay;CD4 Positive T Lymphocytes;CD8-Positive T-Lymphocytes;Cell Count;cell killing;Cells;chronic infection;cohort;Conserved Sequence;cytotoxic;cytotoxicity;Data;Detection;Development;Disease Progression;Epitopes;experience;Frequencies;Genetic;Goals;HIV;HIV Infections;HIV vaccine;HIV-1;Immune;immune function;Immune response;Immune system;Immunity;Immunologics;Immunotherapy;In Vitro;Individual;Infection;insight;Lentivirus;Link;Maintenance;Measurable;Measures;Mediating;Methods;milliliter;Modeling;Nature;patient response;patient subsets;Patients;Peptides;perforin;Plasma;Process;Proliferating;protective allele;protective effect;Reporting;response;Sampling;segregation;SIV;Specificity;T cell response;T-Lymphocyte;Vaccinated;Vaccination;vaccine development;Vaccinee;Vaccines;viral RNA;Viral Vector;Virus;Virus Replication;Work,Mechanisms Of Immune Mediated Restriction Of HIV Replication In LTNP,855,NA,NA,NA,NA,26,NA,NA,1122303,NA
11189321,ZIA,AI,1,N,NA,NA,NA,NA,ZIAAI000860,NA,NA,1ZIAAI000860-25,NIAID:1554690\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,9413768 (contact),"LOBANENKOV, VICTOR  (contact)",NA,NA,NA,16q22;3-Dimensional;acronyms;Address;Affect;Algorithms;Animals;Apoptosis;Architecture;base;Binding;Binding Sites;Biological;Boundary Elements;Brothers;cancer cell;Cancer Center;cancer/testis antigen;CCCTC-binding factor;Cell Lineage;Cell Nucleus;Cell Proliferation;cell type;Cells;Cessation of life;ChIP-seq;Chromatin;Chromatin Loop;Chromosomes;Clinical;Code;Codon Nucleotides;cohesin;Collaborations;combinatorial;Communication;Communities;Complex;Data;Data Set;Development;Disease;Distal;Distant;DNA;DNA Binding Domain;DNA Methylation;DNA Polymerase II;DNA Sequence;DNA-Binding Proteins;DNase-I Footprinting;dosage;Drosophila genus;Elements;encryption;Enhancers;Epigenetic Process;epigenetic regulation;epigenome;Eukaryota;Evolution;falls;Fertility;Fertilization;Fingers;fly;Future;Gene Expression;gene regulatory network;gene repression;Genes;Genetic Code;Genetic Diseases;genetic information;Genetic Transcription;Genome;genome-wide;Genomic Segment;Genomics;Genotype;Germ Cells;Goals;Haploidy;Heritability;Histones;Human;Human Genetics;Human Genome;human subject;immunotherapy trials;imprint;in vivo;Individual;Length;Letters;Link;Literature;Mammalian Cell;Maps;Meiosis;Messenger RNA;Modification;Molecular Biology;monomer;Mothers;mouse genetics;mouse genome;Mus;mutant;Mutate;Mutation;Names;National Institute of Allergy and Infectious Disease;Nature;next generation sequencing;novel;Nucleosomes;Nucleotides;Open Reading Frames;Organism;Paper;paralogous gene;Pathology;Persuasive Communication;Phylogenetic Analysis;Play;postmitotic;Prevention;Process;promoter;Promoter Regions;Protamines;Proteins;Reproduction;Resources;Ribosomes;Role;Sagittaria;Site;Somatic Cell;sperm cell;Spermatids;Spermatogenesis;Spottings;Techniques;Time;transcription factor;Transcription Initiation Site;transcription regulatory network;Transcriptional Activation;Transcriptional Regulation;Translational Research;Translations;Trinucleotide Repeat Expansion;tumor;Untranslated RNA;Viral;Vocabulary;X Inactivation;Zinc Fingers,Deciphering CTCF code in mammalian host and viral epigenomes,860,NA,NA,NA,NA,25,NA,NA,1554690,NA
11189322,ZIA,AI,1,N,NA,NA,NA,NA,ZIAAI000872,NA,NA,1ZIAAI000872-25,NIAID:590592\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,9691353 (contact),"STROBER, WARREN  (contact)",NA,NA,NA,Ablation;activin A;Activins;Address;alpha ketoglutarate;arm;Asthma;asthmatic;Autoantigens;Autoimmune;Autoimmune Diseases;autoimmune pancreatitis;Autoimmunity;beta-Chemokines;beta-Glucans;Binding;Candida albicans;Cell Communication;Cell Physiology;cell type;Cells;chemokine;chemokine receptor;Cholangitis;Circulation;Citric Acid Cycle;Clinical;Complex;Consumption;CREB1 gene;CXCL10 gene;CXCL9 gene;cytokine;Data;dectin 1;Dendritic Cells;deprivation;Dermatophagoides Antigens;Development;differential expression;Disease;Distal;effector T cell;Enzyme Precursors;eosinophil;Epigenetic Process;Event;Exhibits;Experimental Models;Exposure to;Feedback;Follistatin;FOXP3 gene;FRAP1 gene;GATA3 gene;Generations;Genes;Genetic Transcription;Glutamate Metabolism Pathway;Glutamates;Glutaminase;Glutamine;Helper-Inducer T-Lymphocyte;Histologic;Histone Acetylation;Human;Hyphae;IgE;IgG4;IgG4-related disease;In Vitro;Inflammation;Inflammatory;Inflammatory Bowel Diseases;INHA gene;inhibin;Inhibin A;inhibitor;Injections;Interferon alpha;Interferon Type I;Interleukin-10;Interleukin-4;Laboratories;Ligands;Link;Lysosomes;Measures;Mediating;Metabolic;Metabolic Pathway;metabolic profile;metabolome;migration;Mitochondria;Modeling;Molecular;mouse model;MRL/MpJ Mouse;mTOR Signaling Pathway;Mus;Nature;Norleucine;Organ;Organism;Oxygen Consumption;Pancreas;Pancreatitis;Pathogenesis;Pathogenicity;Pathway interactions;Patients;Permeability;Phenotype;Phosphorylation;Poly I-C;Population;Process;Production;promoter;Protein Isoforms;Pulmonary Inflammation;receptor;Regulation;Regulatory T-Lymphocyte;release factor;Reporting;Research;Respiration;response;Role;Serum;Sialadenitis;Signal Transduction;Site;Source;Stimulant;Study models;systemic autoimmune disease;T cell differentiation;T cell regulation;T cell response;T-Cell Activation;T-Cell Development;T-Lymphocyte;T-Lymphocyte Subsets;Testing;TGF-beta type I receptor;Th2 Cells;Time;Tissues;TLR3 gene;Training;transcription factor;transcriptome sequencing;Transforming Growth Factor beta;Yeasts;Zymosan,Regulation of T cell Differentiation,872,NA,NA,NA,NA,25,NA,NA,590592,NA
11189323,ZIA,AI,1,N,NA,NA,NA,NA,ZIAAI000880,NA,NA,1ZIAAI000880-24,NIAID:420807\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,6968267 (contact),"SUN, PETER D. (contact)",NA,NA,NA,adhesion receptor;Anti-Retroviral Agents;Anti-viral Agents;antiretroviral therapy;Apoptotic;Binding;C Type Lectin Receptors;Caspase;Caspase Inhibitor;CD4 Antigens;CD4 Positive T Lymphocytes;Cell surface;Cells;chemokine receptor;Chronic;cytokine;Exhibits;Family;fitness;Goals;HIV;HIV 1 Envelope Protein gp120;HIV Infections;HIV-1;Individual;Infection;inhibitor;L-Selectin;Life Cycle Stages;Mediating;memory CD4 T lymphocyte;Metalloproteases;nef Genes;Pathway interactions;Patients;Phase;Phosphatidylserines;Polysaccharides;Production;receptor;Role;Selectins;SELL gene;sialic acid binding Ig-like lectin;Signal Pathway;small molecule inhibitor;Supporting Cell;T memory cell;Viral;Viral reservoir;Virion;Virus;Virus Activation;Virus Diseases;Virus Shedding,Mechanism and pathways controlling HIV-1 viral release,880,NA,NA,NA,NA,24,NA,NA,420807,NA
11189324,ZIA,AI,1,N,NA,NA,NA,NA,ZIAAI000882,NA,NA,1ZIAAI000882-24,NIAID:1606900\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,6944837 (contact),"DESAI, SANJAY A (contact)",NA,NA,NA,Ablation;Acceleration;Adhesions;Agonist;analog;Anions;Anti-malarials;antibody-dependent cell cytotoxicity;Binding;Biological Assay;Biology;biophysical properties;Blocking Antibodies;Blood;Blood Circulation;Buffers;burden of illness;Carrier Proteins;CD58 gene;Cell membrane;Cell Membrane Permeability;Cell Physiology;Cell Separation;Cell surface;Cells;Cellular biology;Chemicals;Collaborations;Communities;Complex;Computational Biology;CRISPR/Cas technology;Culicidae;Cytolysis;Dependence;Development;DNA;drug development;drug discovery;Electron Microscopy;Electroporation;Engineering;Epitopes;Erythrocytes;Evaluation;Excision;Exhibits;experimental study;extracellular;Florida;Flow Cytometry;Future;gene cloning;Gene Family;Genes;Genetic;genetic manipulation;Genetic study;Glutathione;Goals;Growth;high throughput screening;Human;human model;human pathogen;Image Cytometry;Immune;Immunoglobulin G;Impairment;improved;In Vitro;Incubated;Individual;Infection;Inflammation;inhibitor;insight;instrumentation;Integrins;intercellular cell adhesion molecule;Invaded;Ion Channel;Ion Transport;Ions;Killer Cells;knock-down;Knock-out;Ligands;Link;Lipid Bilayers;Lipid Biochemistry;Macrophage-1 Antigen;Malaria;Mediating;member;Membrane;Methods;microorganism;model organism;Molecular;Molecular and Cellular Biology;Molecular Biology;Molecular Chaperones;monocyte;multidisciplinary;Multigene Family;mutant;National Institute of Allergy and Infectious Disease;Natural Killer Cells;novel;novel strategies;Nutrient;paralogous gene;parasite genome;Parasites;pathogen;Peptide Hydrolases;Peptides;Permeability;Phagocytosis;Pharmaceutical Preparations;Pharmacologic Substance;Phenotype;Physiological;Physiology;Plasma;Plasmids;Plasmodium;Plasmodium falciparum;Procedures;Process;Property;Protein Biochemistry;Protein Export Pathway;Proteins;reconstitution;Reporter;Research;Resistance;Resources;rhoptry;Role;seal;small molecule libraries;solute;Structure;Structure-Activity Relationship;Study Section;Surface;Symptoms;Synapses;Technology;therapy development;trafficking;transcriptome;Transfection;Transmembrane Transport;uptake;vaccine development;Vaccines;Vacuole;Variant;vector mosquito;Vesicle;Work,Cellular and Molecular Physiology of Bloodstream Malaria Parasites,882,NA,NA,NA,NA,24,NA,NA,1606900,NA
11189325,ZIA,AI,1,N,NA,NA,NA,NA,ZIAAI000883,NA,NA,1ZIAAI000883-24,NIAID:1028402\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,8803227 (contact),"ARTHOS, JAMES L (contact)",NA,NA,NA,acute infection;adaptive immune response;Affinity;Annual Reports;Area;Basic Science;Binding;Biology;CD4 Antigens;CD4 Positive T Lymphocytes;Cell Surface Receptors;Development;Epitopes;Event;Future;Goals;Gut associated lymphoid tissue;HIV;HIV envelope protein;HIV Envelope Protein gp120;HIV Infections;HIV Receptors;HIV vaccine;Immune;Immunology;Infection;Infection prevention;integrin alpha4beta7;Knowledge;Lymphoid;Mediating;mesenteric lymph node;migration;Mucous Membrane;novel;novel strategies;novel therapeutics;prevent;Prevention;Prevention strategy;programs;Publishing;receptor;receptor binding;Reporting;Research;Role;Site;Surface;T cell regulation;Time;transmission process;Tropism;vaccine development;Viral;Viral reservoir;Virus;Work,Interaction of HIV envelope with cell surface receptors,883,NA,NA,NA,NA,24,NA,NA,1028402,NA
11189326,ZIA,AI,1,N,NA,NA,NA,NA,ZIAAI000887,NA,NA,1ZIAAI000887-24,NIAID:1028402\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,7339361 (contact),"CICALA, CLAUDIA  (contact)",NA,NA,NA,Acute;CCR5 gene;CD28 gene;CD4 Positive T Lymphocytes;CD8-Positive T-Lymphocytes;CD8B1 gene;Cells;Development;HIV;HIV envelope protein;HIV Envelope Protein gp120;HIV Infections;HIV-1;Immune System Diseases;Immunologic Surveillance;Immunotherapy;In Vitro;Infection;Ligands;lymph nodes;Maintenance;Mediating;Methods;mucosal addressin cell adhesion molecule-1;Mucous Membrane;Pathogenesis;Play;Productivity;Reporting;Research;Role;Signal Transduction;Site;SIV;Testing;tissue resident memory T cell;Tissues;Transforming Growth Factor beta;transmission process;Tretinoin;Tropism;Vaccines;Vascular Cell Adhesion Molecule-1;Viral reservoir;Virus;Virus Replication,Role of HIV Envelope Proteins  In Viral Replication and HIV Pathogenesis,887,NA,NA,NA,NA,24,NA,NA,1028402,NA
11189327,ZIA,AI,1,N,NA,NA,NA,NA,ZIAAI000891,NA,NA,1ZIAAI000891-24,NIAID:1196438\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,11597548 (contact),"WHITEHEAD, STEPHEN  (contact)",NA,NA,NA,Accounting;Admixture;Antibodies;Asia;Attention;Attenuated;Attenuated Live Virus Vaccine;Attenuated Vaccines;attenuation;Basic Science;Binding;Biochemical;Biological Assay;Brain;Brazil;cancer type;Case Study;Cells;Cessation of life;China;Clinical;clinical application;Clinical Distribution;clinical lot;Clinical Research;Clinical Trials;Collaborations;Collecting Cell;Culicidae;Cyclic GMP;Data;Dengue Fever;Dengue Vaccine;Dengue Virus;Development;E protein;Engineering;Epididymis;Epitopes;Evaluation;Family;Flaviviridae;Flavivirus;Formulation;Generations;Genes;Genome;Goals;Harvest;Human;human subject;Immune;Immune response;immunogenicity;Immunology;In Situ;Individual;Infection;Innate Immune Response;Institution;interest;Japanese Encephalitis;Japanese encephalitis virus;Laboratories;Laboratory Study;Length;Licensing;Macaca mulatta;Macrophage;Maintenance;manufacture;manufacturing process development;member;Methods;MicroRNAs;Modeling;Molecular;Monkeys;mosquito-borne;Mus;Mutation;Neutralizing antibody assay;nonhuman primate;Pathogenicity;Pathology;Phase;phase 3 testing;Placenta;preclinical study;Preclinical Testing;Preparation;programs;Proteins;Qualifying;recombinant virus;Recombinants;research clinical testing;Research Personnel;RNA;Role;Saliva;Salivary Glands;Sequence Analysis;Serotyping;Shipping;Southeastern Asia;Sterility;Structure;Syndrome;Techniques;Technology;Tight Junctions;Time;Tissues;trial planning;Untranslated Regions;vaccine candidate;vaccine formulation;vaccine immunogenicity;vaccine platform;Vaccines;Viral;Viral Encephalitis;Viral Pathogenesis;virology;Virulent;Virus;Virus Replication;Visit;West Nile Fever;Work;Yellow Fever;ZIKA;Zika Virus;ZIKV infection,Laboratory And Preclinical Studies Of Flaviviruses,891,NA,NA,NA,NA,24,NA,NA,1196438,NA
11189328,ZIA,AI,1,N,NA,NA,NA,NA,ZIAAI000892,NA,NA,1ZIAAI000892-24,NIAID:1578252\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,6950850 (contact),"SU, XINZHUAN  (contact)",NA,NA,NA,3-Dimensional;5&apos; Untranslated Regions;Address;Affect;Alleles;Amino Acid Substitution;Amino Acids;Anemia;benflumetol;Candidate Disease Gene;Cell membrane;Cerebral Malaria;Collaborations;Cytoplasm;Development;Disease;Drug resistance;Evaluation;Experimental Designs;experimental study;functional genomics;Gene Expression;Genes;Genetic;Genetic Crosses;Genetic Polymorphism;Genome;genome annotation;genome-wide;genomic locus;Genomics;Genotype;Goals;Human;Immune;Immune response;Immunologics;Impairment;improved;Infection;Interferon Type I;Interruption;Introns;IRF3 gene;Malaria;malaria infection;Malignant Neoplasms;Manuscripts;Maps;Measures;Mediating;Mefloquine;Messenger RNA;Metabolic;Methods;MMP3 gene;Molecular;Motility;Movement;Multi-Drug Resistance;Mus;Mutation;Nucleotides;olfactory receptor;overexpression;Paper;parasite genome;Parasites;Parasitic infection;Pathogenesis;Pharmaceutical Preparations;Phosphorylation;Plasmodium;Plasmodium berghei;Plasmodium yoelii;Play;Proteins;Publications;Published Comment;Publishing;Quantitative Trait Loci;Receptor Gene;Research Project Grants;response;RNA;Role;Signal Pathway;Sporozoites;Suggestion;Symptoms;TBK1 gene;transcriptome sequencing;transmission process;ubiquitin isopeptidase;Ubiquitination;Universities;Vacuole;vector;Virulence;Work,"Malaria Parasite Genomics, Development, Drug Resistance, Pathogenesis, and host-parasite interaction",892,NA,NA,NA,NA,24,NA,NA,1578252,NA
11189329,ZIA,AI,1,N,NA,NA,NA,NA,ZIAAI000897,NA,NA,1ZIAAI000897-24,NIAID:1988093\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,6568525 (contact),"GREEN, KIM Y. (contact)",NA,NA,NA,Acute Diarrhea;Address;age group;Anti-viral Agents;Basic Science;Biological Models;Biopsy;burden of illness;Calicivirus;Cell Culture System;Cell Line;Cells;Characteristics;Child;Chronic;Chronic Disease;chronic infection;Clinic;Clinical;Clinical Research;Clinical Trials;cohort;Collaborations;Conduct Clinical Trials;congenital immunodeficiency;continuous cell line;Data Analyses;Death Rate;Defect;design;diarrheal disease;Disease;Disease Outbreaks;Dissociation;effective therapy;Engineering;Epidemic;exome sequencing;experimental study;Family;Gastroenteritis;Gene Mutation;Genetic Variation;Genome;Genotype;Goals;Human;Immune;immune reconstitution;Immune response;Immunocompromised Host;immunodeficiency;Immunotherapy;improved;Individual;Infection;Institutional Review Boards;Integration Host Factors;Intestines;Intravenous Immunoglobulins;Investigation;Laboratories;Lagovirus;lytic replication;Medical center;member;Modeling;Molecular;Molecular Epidemiology;Monkeys;Morbidity - disease rate;mortality;Mus;National Institute of Allergy and Infectious Disease;Natural History;nitazoxanide;Norovirus;participant enrollment;Pathogenesis;pathogenic virus;Patients;Performance;Play;Population;preclinical study;Prevention;receptor;Recombinants;Reporting;Research;research and development;Research Personnel;Research Support;RNA;RNA Viruses;Safety;Sapovirus;Shock;single-cell RNA sequencing;Specificity;surveillance study;System;T cell therapy;T-Lymphocyte;Techniques;Therapeutic;therapeutically effective;Therapy trial;Time;Tissues;tool;transcriptomics;Translating;Translational Research;United States National Institutes of Health;vaccine development;vaccine trial;Variant;Vesivirus;Viral;Virus;Washington;Work,Noroviruses and Epidemic Gastroenteritis,897,NA,NA,NA,NA,24,NA,NA,1988093,NA
11189330,ZIA,AI,1,N,NA,NA,NA,NA,ZIAAI000898,NA,NA,1ZIAAI000898-24,NIAID:2631859\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,9691539 (contact),"PIERCE, SUSAN  (contact)",NA,NA,NA,Affinity;Antibodies;antigen challenge;Antigen Presentation;Antigens;autoreactivity;B cell repertoire;B-Cell Activation;B-Cell Antigen Receptor;B-Lymphocytes;Binding;Blood Cells;Calcium;Calcium Channel;CD19 gene;Cell Communication;Cell Compartmentation;Cell membrane;Cell surface;Cells;Cellular biology;Centenarian;Characteristics;cohort;Collaborations;COVID-19 vaccination;design;Dose;Event;experience;fluorescence lifetime imaging;Generations;Germ Lines;Goals;HPV analysis;Human;Human papilloma virus infection;Human Papilloma Virus-Related Malignant Neoplasm;Human Papillomavirus;Human papillomavirus HPV L1 protein;Immune;Immunoglobulin G;Immunoglobulin M;In Vitro;in vivo;Individual;Induction of Apoptosis;Influenza vaccination;influenza virus vaccine;inhibitor;knock-down;Laboratories;Membrane;Memory;memory acquisition;Memory B-Lymphocyte;Molecular;Mutate;Mutation;neutralizing antibody;Older Population;Outcome;pandemic disease;particle;pathogen;peripheral blood;Phenotype;Phosphorylation;Piezo 1 ion channel;Piezo ion channels;Plasma;Plasma Cells;PLCgamma2;Population;prophylactic;recruit;Recurrence;response;Role;Second Messenger Systems;secondary lymphoid organ;single-cell RNA sequencing;Somatic Mutation;Stimulus;Stretching;Structure of germinal center of lymph node;Surface;tool;vaccination strategy;Vaccinee;Vaccines;Variant;Virus-like particle,B Cell Biology,898,NA,NA,NA,NA,24,NA,NA,2631859,NA
11189331,ZIA,AI,1,N,NA,NA,NA,NA,ZIAAI000903,NA,NA,1ZIAAI000903-22,NIAID:393729\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,9691353 (contact),"STROBER, WARREN  (contact)",NA,NA,NA,Abdominal Pain;Adverse effects;Adverse event;Agammaglobulinaemia tyrosine kinase;Albumins;Alkaline Phosphatase;anakinra;Anti-Inflammatory Agents;Antibodies;Area;Autoimmune;Autoimmune Hepatitis;B-Cell Activation;B-Lymphocytes;Benign;Biological Response Modifier Therapy;Blood Vessels;Bone Marrow Transplantation;CD8-Positive T-Lymphocytes;Cell Physiology;Cells;Chronic;Clinical;clinical remission;Clinical Research;clinically significant;cohort;Collaborations;Common Variable Immunodeficiency;Complex;Complication;Crohn&apos;s disease;cytokine;Data;Dendritic Cells;Disease;Disease Progression;Disease remission;disorder risk;effective therapy;Enrollment;Environmental Risk Factor;Enzymes;Evaluation;Exhibits;experience;Failure;Feces;FOXP3 gene;Functional disorder;Gamma globulin;gastrointestinal function;Gastrointestinal tract structure;Generations;Genes;Genetic Polymorphism;Goals;gut inflammation;gut microbiome;HDAC4 gene;healing;Hepatic;High Prevalence;Histologic;Histology;Histone Deacetylase Inhibitor;Hyperplasia;hypogammaglobulinemia;IL18 gene;Immune;immunodeficiency;immunological status;Immunologics;Immunosuppressive Agents;Impairment;improved;Individual;Infiltration;Inflammasome;Inflammation;Inflammatory Bowel Diseases;inhibitor;Integrins;Interferon Type II;Interleukin-12;Intestinal Mucosa;Intestines;Intravenous;kinase inhibitor;Laboratories;large bowel Crohn&apos;s disease;life span;Liver;Liver diseases;Liver Failure;liver transplantation;LRRK2 gene;Macrophage;Malabsorption Syndromes;Mediating;Medical center;Methods;microorganism;Modality;Modification;Molecular;Molecular Abnormality;Mucosal Immune Responses;Mucosal Immunity;Mucositis;Mucous Membrane;Mutation;Nature;Neutropenia;New York;Nigericin;Organism;Pathologic;patient population;Patients;peripheral blood;Peripheral Blood Mononuclear Cell;Phase;Phosphorylation;Phosphotransferases;Portal Hypertension;preservation;Process;Production;Progressive Disease;Proteins;Recording of previous events;recurrent infection;regenerative;Relapse;Reporting;Research;research study;resident commensals;response;Safety;safety study;Severity of illness;Side;side effect;Signaling Molecule;Small Intestines;Source;Splenomegaly;standard of care;Steroid therapy;Study Section;subcutaneous;Subgroup;Suppressor-Effector T-Lymphocytes;Symptoms;T-Lymphocyte;Therapeutic immunosuppression;Thrombocytopenia;Tissues;TNF gene;trafficking;Transaminases;Treatment Protocols;Trypsin;Ulcerative Colitis;Villous Atrophy;virtual;Vorinostat;X-Linked Agammaglobulinemia,Clinical Studies of Inflammatory Bowel Diseases,903,NA,NA,NA,NA,22,NA,NA,393729,NA
11189332,ZIA,AI,1,N,NA,NA,NA,NA,ZIAAI000904,NA,NA,1ZIAAI000904-23,NIAID:1678003\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,9691571 (contact),"OTTO, MICHAEL  (contact)",NA,NA,NA,Bacteria;Bacterial Infections;Collaborations;Disease;Genus staphylococcus;Goals;Hospitals;Host Defense;Human;Immune Evasion;Infection;Institution;Invaded;Investigation;Microbial Biofilms;Molecular;pathogen;Pathogenesis;pathogenic bacteria;Phenols;Phenotype;Process;quorum sensing;Research Personnel;Sepsis;Series;Signal Transduction;Staphylococcal Infections;Staphylococcus aureus;Toxin;Virulence;Virulence Factors;Virulent;Work,Staphylococcal pathogenesis,904,NA,NA,NA,NA,23,NA,NA,1678003,NA
11189333,ZIA,AI,1,N,NA,NA,NA,NA,ZIAAI000909,NA,NA,1ZIAAI000909-23,NIAID:904812\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,7339771 (contact),"STEELE-MORTIMER, OLIVIA  (contact)",NA,NA,NA,Actins;Acute;Affect;Animals;Bacteria;Binding;Biological Models;Biomedical Engineering;Cells;Chemoreceptors;Chemotaxis;Chronic;chronic infection;cohort;Complement;Complex;Cytosol;cytosolic receptor;Disease;Enterocolitis;Environment;Epithelial Cells;Feces;Fluorescence;Frequencies;Gastrointestinal tract structure;Gene Expression;Genes;Genetic Transcription;Goals;Growth;gut colonization;Hela Cells;Human;human model;human pathogen;In Vitro;in vitro Model;Individual;Infection;Inflammation;Integration Host Factors;Interleukin-8;intestinal epithelium;Intestines;Invaded;lytic gene expression;Mediating;Membrane;methyl-accepting chemotaxis proteins;Modeling;Molecular;Motility;Mus;mutant;Natural Resistance;NF-kappa B;oral infection;Oxygen;pathogen;Pathogenesis;Pathogenicity Island;Pathway interactions;Phase;Physiological;Play;polymerization;Polymers;Population;Predisposition;Process;protein expression;Proteins;Regulation;Regulon;Reporting;Role;Salmonella;Salmonella enterica;Salmonella typhimurium;Signal Pathway;Signal Transduction;Swimming;System;trafficking;transcriptomics;Type III Secretion System Pathway;Typhoid Fever;Vacuole;Virulence;Work;Zinc,Invasion and intracellular replication of Salmonella Typhimurium in epithelial cells,909,NA,NA,NA,NA,23,NA,NA,904812,NA
11189334,ZIA,AI,1,N,NA,NA,NA,NA,ZIAAI000912,NA,NA,1ZIAAI000912-23,NIAID:1758316\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,7339777 (contact),"BOLLAND, SILVIA  (contact)",NA,NA,NA,Adaptor Signaling Protein;Antigen Receptors;Arthritis;Autoantibodies;Autoimmune;Autoimmune Diseases;Autoimmunity;B-Cell Antigen Receptor;B-Lymphocytes;clinical risk;Collaborations;Development;Diabetes Mellitus;Disease;Double-Stranded RNA;effective therapy;Environmental Risk Factor;fitness;Future;Genes;Genetic;Goals;Human;IgG Receptors;Immune response;Infection;insight;Interferon Inducers;Interferon Type I;Interferons;Investigation;Link;Lupus;Malaria;malaria infection;member;metabolic fitness;Methods;Mitochondria;Molecular;mouse model;Mus;National Institute of Allergy and Infectious Disease;Other Genetics;Pathogenicity;Pathology;Pathway interactions;Patients;Predisposition;pressure;Prevention;programs;Research;Role;sensor;Signal Transduction;systemic autoimmune disease;Systemic Lupus Erythematosus;Therapeutic;TLR7 gene;Viral;viral RNA;Virus Diseases;working group,Genetic and Environmental Modifiers Of Autoimmune Disease,912,NA,NA,NA,NA,23,NA,NA,1758316,NA
11189335,ZIA,AI,1,N,NA,NA,NA,NA,ZIAAI000913,NA,NA,1ZIAAI000913-23,NIAID:1172211\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,9413516 (contact),"COHEN, JEFFREY  (contact)",NA,NA,NA,Allogenic;Asia;asparaginase;B-Lymphocytes;Blood;Burkitt Lymphoma;cancer cell;Cells;chemotherapy;Chronic;Complication;curative treatments;Dexamethasone;Diagnosis;Diagnostic;diagnostic criteria;Disease;Early Diagnosis;EBV-associated disease;Epithelial Cells;Epstein-Barr Virus Infections;Etoposide;Europe;Goals;Hematopoietic Stem Cell Transplantation;Hemophagocytic Lymphohistiocytoses;Hodgkin Disease;human disease;Human Herpesvirus 4;Immune response;Immunologics;Infectious Mononucleosis;Infiltration;latent infection;Leukemic Natural Killer Cell;Life;Lymphoma;Modality;Molecular Abnormality;morphological criteria;Multiple Organ Failure;Nasopharynx Carcinoma;Natural Killer Cells;Organ failure;Oropharyngeal;Pathogenesis;Patients;Prognosis;Reporting;response;Role;Severity of illness;Standardization;Stomach Carcinoma;Tissues;United States;Virus;Virus Diseases,Epstein-Barr Virus Associated Disorders,913,NA,NA,NA,NA,23,NA,NA,1172211,NA
11189336,ZIA,AI,1,N,NA,NA,NA,NA,ZIAAI000916,NA,NA,1ZIAAI000916-23,NIAID:928083\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,7339801 (contact),"JIN, TIAN  (contact)",NA,NA,NA,Actins;Amoeba genus;Bacteria;Binding;Binding Sites;Biochemical;Biological Models;Biology;cell motility;Cells;Chemotactic Factors;Chemotaxis;Complex;Computer Assisted;Computer Simulation;Consumption;Coupled;Cues;Cyclic AMP;Cyclic AMP Receptors;Detection;Dictyostelium discoideum;Endowment;Eukaryotic Cell;experimental study;Exposure to;extracellular;fluorescence imaging;folate-binding protein;Folic Acid;Food;G-Protein-Coupled Receptors;Genome;Goals;Heterotrimeric GTP-Binding Proteins;imaging modality;Immunity;Immunoglobulins;Invaded;Invertebrates;Investments;Life;Lipopolysaccharides;Mediating;member;microbial;Modeling;Molecular;Organism;Orphan;Orthologous Gene;particle;pathogen;pathogenic bacteria;Pattern;Pattern recognition receptor;Phagocytes;Phagocytosis;Proteomics;Protozoa;receptor;response;Signal Pathway;Signal Transduction;social;Surface;Techniques;Toll-like receptors;Venus Flytrap;Vertebrates,The mechanisms underlying the GPCR-mediated chemotaxis in D. discoideum,916,NA,NA,NA,NA,23,NA,NA,928083,NA
11189337,ZIA,AI,1,N,NA,NA,NA,NA,ZIAAI000929,NA,NA,1ZIAAI000929-22,NIAID:933913\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,9691479 (contact),"LEPPLA, STEPHEN  (contact)",NA,NA,NA,Affinity;Amino Acids;Animals;Anthrax disease;anthrax toxin;Anthrax Vaccines;Antibodies;anticancer activity;Antigens;Bacillus anthracis;Bacteria;Bacterial Infections;Binding;Biochemical;Biological Assay;Calorimetry;Cell Nucleus;Cell surface;cell type;Cells;Chimeric Proteins;Community Developments;Complex;Cultured Cells;Cytosol;cytotoxicity;Data;Distant;Edema;efficacy evaluation;Engineering;Enterobacteria phage P1 Cre recombinase;Eukaryotic Cell;Genes;Human;improved;Infection;Infection prevention;Intervention;lethal factor;Macrophage;MAP2K1 gene;MEKs;Metalloproteases;Methods;Modeling;Monoclonal Antibodies;Mus;mutant;Mutation;N-terminal;Names;neoplastic cell;Normal tissue morphology;pathogen;Peptide Hydrolases;Peptides;Pharmaceutical Preparations;Predisposition;prevent;Property;protein expression;Proteins;Rattus;Reporter;Reporting;research and development;Role;Septic Toxemia;Specificity;Symptoms;System;Testing;Therapeutic;Therapeutic Index;Tomatoes;tool;Toxic Actions;Toxic effect;Toxin;Transcription Coactivator;tumor;Tumor Tissue;Urokinase;vaccine candidate;vaccine efficacy;Vaccines;Variant;Virulence Factors;Work,Vaccines and Therapeutics for Anthrax,929,NA,NA,NA,NA,22,NA,NA,933913,NA
11189338,ZIA,AI,1,N,NA,NA,NA,NA,ZIAAI000932,NA,NA,1ZIAAI000932-22,NIAID:1126987\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,7841134 (contact),"VALENZUELA, JESUS  (contact)",NA,NA,NA,Address;adenosine deaminase;Adopted;Aedes;Animal Model;Animals;Anopheles Genus;anti-tick vaccine;Antibodies;Antibody Response;Antigens;arm;asexual;Attenuated;B-Lymphocyte Epitopes;Binding;Biochemical;Bioinformatics;Biological Markers;Biopsy;Bite;Blood;Borrelia burgdorferi;Brazil;Cambodia;Canada;CD8-Positive T-Lymphocytes;Cell fusion;Cellular Immunity;Child;Chimeric Proteins;Clinical Protocols;Cohort Studies;Collaborations;Communicable Diseases;comparison control;Complex;cross reactivity;Culex (Genus);Culicidae;Cutaneous Leishmaniasis;Dengue;Development;disease transmission;disorder control;DNA;Electron Microscope;Elements;Enrollment;Enzyme-Linked Immunosorbent Assay;eosinophil;epidemiology study;Event;exposed human population;Exposure to;Female;fitness;Future;gastrointestinal epithelium;Genetic;Glycoside Hydrolases;Goals;good laboratory practice;Guidelines;Health Sciences;Hematoxylin and Eosin Staining Method;Human;Human Volunteers;Hybrids;Hyperpigmentation;Hypersensitivity skin testing;Immune;Immune response;Immunization;immunogenic;Immunoglobulin G;Immunoglobulin M;Immunologics;improved;In Vitro;in vivo;Incidence;Infection;Infiltration;Ingestion;Insect Bites;Insect Vectors;Integration Host Factors;Interferon Type II;Interleukin-10;Knowledge;Laboratories;large scale production;Leishmania;Leishmania donovani;Leishmania major;Leishmaniasis;leishmanin;lipophosphonoglycan;Lyme Disease;macula;Malaria;Measures;Mediating;Medicine;Membrane;microorganism;Midgut;Mite Controls;Mites;Molecular;Molecular Biology;molecular vector;Mononuclear;Morphology;mortality;mouse model;Mus;National Institute of Allergy and Infectious Disease;natural antibodies;neglect;Nymph;Parasites;Parasitic Diseases;Parasitology;Partner in relationship;pathogen;Pathogenicity;Pattern;Pediatric cohort;Peptides;Peripheral Blood Mononuclear Cell;Phenotype;Phlebotominae;Phlebotomus;Plasma;Play;Population;Population Sizes;Production;Productivity;Proteins;Punch Biopsy;Reaction;Recombinant Proteins;Recombinants;Reporting;Research;Resistance;response;RNA vaccination;Role;Route;Saliva;Salivary;Salivary Glands;Salivary Proteins;Sampling;Scanning;Seasons;serosurvey;Serum;Site;Skin;Stains;Standardization;success;Surface;Taxonomy;Testing;tick bite;Tick Infestations;Tick-Borne Diseases;tick-borne pathogen;Ticks;Time;tool;Transcript;Translating;transmission process;United States National Institutes of Health;Universities;University Health Services;Vaccination;Vaccine Clinical Trial;Vaccines;vector;vector-borne;Virulence;volunteer;Western Blotting;whole genome,Molecular approaches to understand vector-host and vector-pathogen interactions,932,NA,NA,NA,NA,22,NA,NA,1126987,NA
11189339,ZIA,AI,1,N,NA,NA,NA,NA,ZIAAI000937,NA,NA,1ZIAAI000937-21,NIAID:1103424\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,9691420 (contact),"CHESEBRO, BRUCE  (contact)",NA,NA,NA,Animals;Biological Assay;Biology;Brain;brain cell;Brain Injuries;C57BL/10 Mouse;C57BL/6 Mouse;Cells;coisogenic;Cone;Dendrites;design;Disease;DLG4 gene;Electroretinography;Exclusion;experimental study;Focal Adhesions;Genetic Transcription;Gliosis;Host Defense;Human;human disease;Immunohistochemistry;Individual;Infection;Infiltration;Inflammation;Integrins;ITGAX gene;ITGB2 gene;Knockout Mice;Macrophage;Measures;Methodology;Microglia;Minor;Modeling;monocyte;Morphology;Mouse Strains;Mus;Mutation;Nature;Nervous System;Neurodegenerative Disorders;neuroprotection;Optical Coherence Tomography;Pathogenesis;Pathologic;Pathway interactions;Peptide Hydrolases;Phagocytosis;Phase;Photoreceptors;Population;Predisposition;Prevention strategy;Prion Diseases;Prions;protein expression;Proteins;PrP;receptor;Resistance;Resolution;response;Retina;Retinal Cone;ribbon synapse;Signal Transduction;Site;Synapses;Testing;Thick;Time;Tissues,Biology of Prion Protein and the TSE Diseases,937,NA,NA,NA,NA,21,NA,NA,1103424,NA
11189340,ZIA,AI,1,N,NA,NA,NA,NA,ZIAAI000938,NA,NA,1ZIAAI000938-21,NIAID:227201\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,77880414 (contact),"BUCHHOLZ, URSULA  (contact)",NA,NA,NA,Adult;Adverse event;Aerosols;airway epithelium;Alpha Virus;Animal Experiments;Animals;Antibodies;Antibody Response;Antibody titer measurement;antigen test;Antigens;Attenuated;attenuation;Avian Influenza A Virus;Avulavirus;Biological Assay;Cattle;Cavia;CD4 Positive T Lymphocytes;CD8-Positive T-Lymphocytes;Cell Culture Techniques;Cells;Child;Chimera organism;Clinical;Clinical Research;cohort;Coronavirus spike protein;Cytoplasm;Data Analyses;design;Development;Dose;Ebola virus;Ebola virus envelope glycoprotein;Effectiveness;emerging pathogen;Engineering;expression vector;Family member;Future;Gene Order;Generations;Genes;Genetic Transcription;Genome;Genomics;Glycoproteins;Helper-Inducer T-Lymphocyte;Human;Immune response;Immunity;immunogenic;immunogenicity;Immunoglobulin A;Immunoglobulin G;Infant;Infection;Influenza Hemagglutinin;Inpatients;Intranasal Administration;Lung;Macaca;Macaca mulatta;Measures;Mediating;Membrane Glycoproteins;Membrane Proteins;Messenger RNA;Modification;Mucosal Immunity;Mucous Membrane;Murine pneumonia virus;Mus;Nasal Lavage Fluid;neutralizing antibody;Newcastle disease virus;nonhuman primate;open label;Para-Influenza Virus Type 1;Para-Influenza Virus Type 3;parainfluenza virus;Paramyxovirus;Participant;pathogen;pathogenic virus;Pathogenicity;phase 1 study;Phase I Clinical Trials;Placebos;Pneumovirus;Polymerase;Population;Preparation;Primates;Proteins;Public Health Schools;Publications;Quantitative Reverse Transcriptase PCR;Randomized;respiratory;respiratory pathogen;Respiratory syncytial virus;Respiratory System;response;reverse genetics;RNA;Rodent;Route;Safety;safety study;Sampling;SARS coronavirus;seropositive;Serum;Severe Acute Respiratory Syndrome;Signal Transduction;Surface Antigens;System;Testing;Time;tissue tropism;TRIP10 gene;United States National Institutes of Health;Upper respiratory tract;Vaccination;vaccine candidate;vaccine delivery;vaccine development;Vaccines;vector;vector vaccine;vector-based vaccine;Viral;viral detection;Viral Vaccines;Virion;Virus;Virus Replication;Virus Shedding;volunteer;Work,Paramyxoviruses as Vaccine Vectors Against Highly Pathogenic Viruses,938,NA,NA,NA,NA,21,NA,NA,227201,NA
11189341,ZIA,AI,1,N,NA,NA,NA,NA,ZIAAI000939,NA,NA,1ZIAAI000939-21,NIAID:693754\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,6479630 (contact),"DRUEY, KIRK M (contact)",NA,NA,NA,"Actins;Adenosine;Adrenal Cortex Hormones;Adrenergic beta-Agonists;Affect;Affinity;aggressive therapy;Agonist;airway hyperresponsiveness;airway obstruction;Albuterol;Allergens;allergic airway inflammation;anti-fungal agents;Area;Aspergillus fumigatus;Asthma;asthma model;asthmatic;asthmatic airway;Autopsy;Binding;Bradykinin;Bronchoconstriction;Bronchodilator Agents;Calcium;Cells;Cessation of life;Collaborations;Coupled;Cyclic AMP;cysteinyl-leukotriene;Disease susceptibility;Drug Targeting;efficacy study;Endothelin-1;eosinophil;eosinophilic inflammation;Exhibits;experience;Experimental Models;Extracellular Matrix;Extrinsic asthma;fungus;G alpha q Protein;G Protein-Coupled Receptor Signaling;G-Protein-Coupled Receptors;Gene Deletion;Goals;Grant;granule cell;GTP-Binding Protein alpha Subunits;GTP-Binding Protein alpha Subunits, Gs;GTP-Binding Protein Regulators;GTP-Binding Proteins;Guanosine Triphosphate Phosphohydrolases;Hepatitis C;Hepatitis C Therapy;Heterotrimeric GTP-Binding Proteins;Histamine;Human;Hypersensitivity;IgE;In Vitro;in vivo;Infection;Inflammation Mediators;Inflammatory Response;inhibitor;Inhibitory G-Protein Gi;insight;interest;Knock-in Mouse;Knockout Mice;Lead;Leukotriene Antagonists;Leukotriene D4;Life;Ligands;Link;Lung;mast cell;Mediating;Modeling;Molds;Monoclonal Antibodies;mouse model;Mus;Muscle Contraction;Muscle Fibers;Muscle function;Muscle relaxation phase;mutant;Myosin ATPase;Natural Substance;novel;novel therapeutics;omalizumab;PAR-2 Receptor;Pathologic;Peptide Hydrolases;Persons;Physiological;PIK3CG gene;preservation;Proliferating;Proteins;pulmonary function;Pulmonary Inflammation;receptor;Regulation;Relaxation;respiratory;respiratory smooth muscle;RGS Domain;RGS Proteins;Role;Serine Protease;Signal Induction;Signal Pathway;Signal Transduction;Slice;Smooth Muscle;Smooth Muscle Myocytes;Specimen;STAT1 gene;success;Therapeutic;Therapeutic Uses;Thrombin;Tissue Banks;Tissues",Regulation of Normal and Asthmatic Lung Function by G-Protein-Coupled Receptors,939,NA,NA,NA,NA,21,NA,NA,693754,NA
11189342,ZIA,AI,1,N,NA,NA,NA,NA,ZIAAI000940,NA,NA,1ZIAAI000940-21,NIAID:1612179\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,6479347 (contact),"BLOOM, MARSHALL ELLIOTT (contact)",NA,NA,NA,Acinus organ component;acute infection;Adult;Alaska;Allergic Reaction;alpha helix;Amino Acid Sequence;anatomic imaging;Animal Model;Anti-viral Agents;Appearance;Area;Argas;Arthropods;Artificial Feeding;Artificial Intelligence;Artificial Membranes;Attenuated;Basic Science;beta pleated sheet;Biology;Birds;Bite;Black-legged Tick;Blood;Borrelia;Borrelia burgdorferi;California;Cell Culture System;Cell Culture Techniques;Cell Line;cell type;Cells;Cellular biology;cellular imaging;Cessation of life;Chiroptera;chronic infection;Classification;Codon Nucleotides;Collaborations;Data;Development;Disease;Dissection;Dissociation;Domestic Fowls;Entomology;Experimental Models;experimental study;Family;feeding;Female;Flavivirus;Flavivirus Infections;Gene Expression;Genes;genetic approach;Genetic Transcription;Genome;Genomics;Geography;Goals;Growth;Histologic;Human;human pathogen;Image;Imaging Techniques;Immunology;improved;in silico;In Situ Hybridization;Indigenous;Individual;Infection;Investigation;Island;Laboratories;Langat virus;Laridae;Leg;Libraries;Lyme Disease;male;Mammals;member;Methods;Microbe;microbiome;Midgut;Modeling;Modification;Molecular;Molecular Biology;Molting;Montana;Mus;North Dakota;novel;Nymph;Organ;Organ Culture Techniques;pathogen;Pathogenesis;Pathogenicity;Pathway interactions;Phylogenetic Analysis;Plasmid Cloning Vector;Powassan virus;Preparation;Procedures;Process;programs;Protein Analysis;protein structure prediction;Proteins;Proteomics;Protocols documentation;Public Health;Publications;Reaction;Recording of previous events;Relapsing Fever;Reporting;reproductive;Research;reverse genetics;Risk;RNA;RNA Viruses;Rodent Model;Salivary Glands;Sea Cucumbers;Sequence Alignment;single cell analysis;single cell technology;Specimen;Structure;System;Tail;Testing;tick feeding;tick-borne;Tick-Borne Diseases;tick-borne flavivirus;tick-borne virus;Ticks;Tissues;Transcript;transcriptome;transmission process;Trinidad;Universities;vector;vector transmission;vector-borne;Viral;Viral Proteins;virology;Virus;Virus Diseases;virus identification;Virus Replication;Work,Pathogenesis of Tick-Borne Flavivirus Infections,940,NA,NA,NA,NA,21,NA,NA,1612179,NA
11189343,ZIA,AI,1,N,NA,NA,NA,NA,ZIAAI000947,NA,NA,1ZIAAI000947-21,NIAID:1978615\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,8182461 (contact),"BARILLAS-MURY, CAROLINA  (contact)",NA,NA,NA,Acceleration;Adult;Aedes;Affect;Affinity;African;Anopheles gambiae;Anopheles Genus;antiviral immunity;Apoptosis;Apoptotic;Asia;Asian;Binding;Caspase;cell injury;cell type;Cells;Code;Complement Activation;Complex;Computer software;Culicidae;Cytolysis;defense response;Dengue Infection;Dengue Virus;disease transmission;Double-Stranded RNA;Drosophila genus;env Gene Products;Epithelial Cells;Epithelium;Falciparum Malaria;Female;Genes;genetic analysis;Genome;Glycoproteins;Goals;Gorilla gorilla;granulocyte;gut microbiota;Haplotypes;Heat shock proteins;Hemocytes;Heterozygote;Hsc70 protein;Human;Image;Immobilization;Immune;Immune Evasion;Immune response;Immune system;Immunity;Immunoglobulin binding proteins;Immunologic Memory;Individual;Infection;ING1 gene;Injections;Invaded;Kinetics;Knock-out;Malaria;malaria infection;malaria transmission;Maps;Mass Spectrum Analysis;Mediating;Membrane Proteins;microvesicles;Midgut;Molecular;mRNA Expression;nitration;novel;Oocysts;Orthologous Gene;Papua New Guinea;Parasites;pathogen;Pathway interactions;Phagocytosis;Plasmodium;Plasmodium berghei;Plasmodium falciparum;Population;precursor cell;Prevalence;prevent;progenitor;Proliferating;protein E;Protein Isoforms;Proteins;receptor;Receptor Gene;Recombinants;response;RNA;RNA Splicing;Role;Serotyping;single cell analysis;Site;stem cell proliferation;stem cells;Surface;Surface Plasmon Resonance;Time;Tissues;tool;Transcript;transcriptome;transcriptome sequencing;transcriptomics;transmission process;Trypsin;Untranslated RNA;vector;vesicular release;Virion,Mosquito Immune Responses and Malaria  Transmission,947,NA,NA,NA,NA,21,NA,NA,1978615,NA
11189344,ZIA,AI,1,N,NA,NA,NA,NA,ZIAAI000959,NA,NA,1ZIAAI000959-19,NIAID:1618046\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,9691503 (contact),"SHEVACH, ETHAN  (contact)",NA,NA,NA,Adipocytes;Adipose tissue;Age;antagonist;Antibodies;Antibody Specificity;Antigen Targeting;Area;Autoantibodies;Autoantigens;Autoimmune;Autoimmune Diseases;Autoimmunity;B-Lymphocyte Epitopes;beta catenin;Birth;CCR6 gene;CD4 Positive T Lymphocytes;CD44 Antigens;CD8-Positive T-Lymphocytes;CD8B1 gene;Cells;Collaborations;congenic;Cytoplasmic Granules;cytotoxic;deprivation;Development;directed differentiation;Disease;disease phenotype;Effector Cell;Equilibrium;exhaust;Exhibits;Family;Family member;Fatty Liver;Flow Cytometry;FOXP3 gene;Frequencies;G-Protein-Coupled Receptors;Gene Expression;Gene Family;Goals;HDAC1 gene;Hypergammaglobulinemia;IL2RA gene;immune activation;Immunofluorescence Microscopy;Immunoprecipitation;In Vitro;in vivo;Inbred BALB C Mice;Infiltration;Inflammatory;Insulin Resistance;Integrins;Interleukin-2;Knock-out;Knockout Mice;Libraries;Life;Lipodystrophy;Lymphocytic Infiltrate;Maintenance;Mediating;member;Memory;migration;Molecular;Monoclonal Antibodies;Mus;NFAT Pathway;offspring;Organ;Parabiosis;Pathogenesis;Pathway interactions;perilipin;Peripheral;Phage Display;Phage ImmunoPrecipitation Sequencing;Phenotype;Play;Population;prevent;Process;Property;Proteins;Proteome;Regulation;Regulatory T-Lymphocyte;response;Role;Self Tolerance;Serum;Signal Pathway;single-cell RNA sequencing;Site;Splenocyte;Structure of germinal center of lymph node;Structure of thymic medulla;systemic autoimmunity;T memory cell;T-Cell Immunologic Specificity;T-Lymphocyte;T-Lymphocyte Epitopes;T-Lymphocyte Subsets;Technology;Thymus Gland;transcription factor;transcriptome;transcriptome sequencing;Transforming Growth Factor beta;Tumor Necrosis Factor Ligand Superfamily Member 6;Wild Type Mouse,Studies of the Function of Naturally Occurring and Adaptive T Regulatory Cells,959,NA,NA,NA,NA,19,NA,NA,1618046,NA
11189345,ZIA,AI,1,N,NA,NA,NA,NA,ZIAAI000974,NA,NA,1ZIAAI000974-19,NIAID:61746\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,11242108 (contact),"GERMAIN, RONALD N (contact)",NA,NA,NA,Animals;Antigens;assay development;Autoimmune;Bacterial Infections;Behavior;Biochemical;biochemical model;Biological Models;CD8B1 gene;Cell Communication;Cell Death;Cell division;Cells;Cluster Analysis;Collaborations;Complex;Computer Models;Data;Development;Disease;drug development;Environment;Event;experience;Experimental Animal Model;Exposure to;Gene Expression;Genetic Transcription;Goals;Hour;Human;human model;Immune;Immune response;Immune system;immune system function;Immunological Models;Immunology;In Situ;Individual;Infection;Infectious Agent;Inflammatory;insight;Laboratories;Ligands;Link;Lymphoid Cell;Macrophage;Malignant - descriptor;Measurement;member;Methods;Modeling;Myeloid Cells;Nuclear;nuclear factors of activated T-cells;Organism;pathogen;Pathogenicity;Pathway interactions;Peptide/MHC Complex;Phenotype;predictive modeling;Process;programs;Proteins;Reagent;real-time images;Real-Time Systems;receptor expression;Regulatory Pathway;Research;response;Role;Signal Pathway;Signal Transduction;single cell analysis;single-cell RNA sequencing;Stains;Stimulus;success;System;Systems Biology;T-Lymphocyte;Tail;Time;Tissue imaging;Tissues;tool;vaccine development;Vaccines;Variant;Virus Diseases,Immunology Team Contributions to the LSB,974,NA,NA,NA,NA,19,NA,NA,61746,NA
11189346,ZIA,AI,1,N,NA,NA,NA,NA,ZIAAI000976,NA,NA,1ZIAAI000976-17,NIAID:705216\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,8818835 (contact),"LUSSO, PAOLO  (contact)",NA,NA,NA,Affect;Anatomy;antagonist;antimicrobial;Blood Cells;cancer therapy;CCL3 gene;CCL4 gene;Cells;chemokine;Chemotherapy-Oncologic Procedure;Collaborations;Communicable Diseases;Complex;COVID-19;cytokine;Disease;experimental study;Face;Gene Expression;Genes;HIV;HIV-1;HIV/AIDS;Homeostasis;Homing;Human;IL7 gene;Immune;immune function;immune modulating agents;Immune response;Immune system;Immunologics;immunoregulation;In Vitro;in vivo;Inflammatory;Integrins;interest;Interferon alpha;Interferon Type II;Intervention;Intestines;Invaded;Knowledge;Laboratories;Lymphocyte;Lymphopenia;Macaca;Mediating;Medical;Microbe;microorganism;Modeling;monocyte;novel;P-selectin ligand protein;pathogen;Pathogenesis;pathogenic microbe;Patients;Physiological;Prevention;Production;programs;RANTES;Readiness;receptor;reconstitution;recruit;Research;response;Rest;Role;Signal Transduction;Stimulant;T-Cell Activation;T-Lymphocyte;TNF gene;Toll-like receptors;transcriptome sequencing;Virion;Work,Role of IL-7 in Immune Defense against HIV-1 and Other Infectious Pathogens,976,NA,NA,NA,NA,17,NA,NA,705216,NA
11189347,ZIA,AI,1,N,NA,NA,NA,NA,ZIAAI000977,NA,NA,1ZIAAI000977-19,NIAID:1744070\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,15700778 (contact),"HACKSTADT, TED  (contact)",NA,NA,NA,Ablation;Actins;Address;Affect;Amblyomma;Animal Model;Antibodies;Apoptosis;Arizona;Attenuated;Awareness;Bacteria;Biological Models;Biology;Bite;Brazil;Cavia;Cell Culture Techniques;Cells;Characteristics;Clinical;clinically relevant;comparative genomics;Cytolysis;Cytoplasm;Data;Dermal;design;Disease;Disease Outbreaks;Disease Progression;emerging pathogen;Etiology;Exanthema;experimental study;Extravasation;Fever;Future;Genes;Genetic;genetic technology;Genome;Genomics;Goals;Golgi Apparatus;Growth;Human;human disease;IFNAR2 gene;Immunologics;improved;in vivo;Infection;Interferon-beta;Interferons;Iowa;Knock-out;Laboratory Animals;Length;Life;Life Style;Liquid substance;member;Membrane;Mexico;Microfilaments;Molecular;monolayer;Motility;mutant;N-terminal;Nature;Organism;Outcome;overexpression;Pathogenesis;Pathogenicity;Peptide Hydrolases;periplasm;Phenotype;Polymers;Process;Production;Productivity;prototype;Publishing;Recombinants;reconstitution;Recording of previous events;Regulation;response;Rhipicephalus sanguineus;Rickettsia;Rickettsia Infections;Rickettsia rickettsii;Rocky Mountain Spotted Fever;SCA2 protein;Serial Passage;Severities;spotted fever;Stains;Surface;Surface Antigens;System;Tail;tick-borne;Ticks;trafficking;transmission process;Variant;Vascular Endothelial Cell;Vascular Permeabilities;vector tick;Vero Cells;Virulence;Virulence Factors;Virulent;Work,Biology of Rickettsia,977,NA,NA,NA,NA,19,NA,NA,1744070,NA
11189348,ZIA,AI,1,N,NA,NA,NA,NA,ZIAAI000978,NA,NA,1ZIAAI000978-19,NIAID:1172211\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,9413516 (contact),"COHEN, JEFFREY  (contact)",NA,NA,NA,Adopted;Adult;Animal Model;Animals;Antibodies;B-Cell Receptor Binding;B-Lymphocytes;Binding;Biological Assay;Burkitt Lymphoma;cancer cell;Cell fusion;Cells;Clinic;clinical center;Complex;Congenital Abnormality;Control Animal;Crystallography;Cytomegalovirus;Cytomegalovirus Infections;design;Disease;Electron Microscopy;Epithelial Cells;Epstein-Barr Virus Infections;Epstein-Barr Virus-Related Lymphoma;Epstein-Barr Virus-Related Malignant Neoplasm;Ferrets;Ferritin;Globulins;Glycoproteins;Goals;Herpesviridae;Herpesvirus Vaccines;Hodgkin Disease;Human;Human Herpesvirus 4;humanized mouse;Immune;Immune response;Immunoglobulin G;in vivo;Infection;Infectious Mononucleosis;Knowledge;Licensing;Lymphoproliferative Disorders;Mediating;Membrane Fusion;Minnesota;Molecular Conformation;Monoclonal Antibodies;Mus;nanoparticle;Nasopharynx Carcinoma;neutralizing antibody;nonhuman primate;Pathogenesis;Patients;phase I trial;Phase I/II Trial;Population;post-transplant;prevent;Prophylactic treatment;receptor binding;Reporting;self assembly;Site;Stomach Carcinoma;Structure;Testing;Therapeutic;Therapeutic antibodies;United States National Institutes of Health;Universities;Vaccinated;vaccine candidate;vaccine development;Vaccines;Viral;Viremia;Virus;Virus Diseases;X-Linked lymphoproliferative disorders,Herpesvirus Pathogenesis and Vaccine Development,978,NA,NA,NA,NA,19,NA,NA,1172211,NA
11189349,ZIA,AI,1,N,NA,NA,NA,NA,ZIAAI000983,NA,NA,1ZIAAI000983-19,NIAID:275857\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,9691420 (contact),"CHESEBRO, BRUCE  (contact)",NA,NA,NA,Address;Affect;Animals;Biochemical;Biological Assay;Brain;cervid;Chronic Wasting Disease;Clinical;cross-species transmission;Deer;Disease;disease transmission;experimental study;Failure;False Positive Reactions;Genes;Genetic Polymorphism;Geographic Locations;Human;Infection;insight;Macaca;Macaca fascicularis;Modeling;Mus;Nature;Nervous System Disorder;Neurologic Signs;neuropathology;nonhuman primate;Oral;overexpression;Pathologic;Predisposition;prevent;Prion Diseases;prion seeds;Prions;Property;PrP;Reaction;Reindeer;Relative Risks;Residual state;Route;Saimiri;Sampling;Testing;Tissues;Transgenic Mice;transmission process;United States;Zoonoses,Study of CWD Deer and Elk Prion Disease in Nonhuman Primates and transgenic mice,983,NA,NA,NA,NA,19,NA,NA,275857,NA
11189350,ZIA,AI,1,N,NA,NA,NA,NA,ZIAAI000984,NA,NA,1ZIAAI000984-18,NIAID:4224059\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,9413695 (contact),"DAVEY, RICHARD  (contact)",NA,NA,NA,"2019-nCoV;Acute;Adrenal Cortex Hormones;Adult;Africa;African;anti-influenza;Anti-viral Agents;Antibodies;Antibody Response;Antibody titer measurement;arm;Avidity;B-Lymphocytes;Birds;booster vaccine;care systems;Caring;Childhood;Clinical;clinical center;Clinical Research;Clinical Trials;Cohort Analysis;Collaborations;Communicable Diseases;Communities;Consensus;Containment;Coronavirus;Country;COVID-19;COVID-19 patient;COVID-19 therapeutics;COVID-19 treatment;Democratic Republic of the Congo;design;Development;Dexamethasone;Disease Outbreaks;Disease Outcome;Dose;Double-Blind Method;double-blind placebo controlled trial;Ebola;Ebola Hemorrhagic Fever;Ebola virus;effective therapy;Emergency Situation;Emerging Communicable Diseases;Enrollment;epidemic potential;epidemic virus;Exposure to;Funding;Goals;Harvest;Health Personnel;Healthcare;high risk;Hospitalization;Human;Human Resources;Immunization;Immunize;immunogenicity;Immunologics;Immunotherapeutic agent;improved;Infection;Infectious Agent;Influenza;Influenza A Virus, H1N1 Subtype;Influenza A Virus, H5N1 Subtype;Influenza A Virus, H7N9 Subtype;Influenza B Virus;influenza virus strain;influenzavirus;Inpatients;insight;interest;International;Intervention;Intravenous Immunoglobulins;Investigation;Investigational Therapies;Laboratories;Lead;Leadership;lectures;Licensing;Licensure;Medical;medical countermeasure;meetings;men who have sex with men;Methods;Microbiology;Middle East Respiratory Syndrome Coronavirus;Monkeypox;Monoclonal Antibodies;Morbidity - disease rate;mortality;National Institute of Allergy and Infectious Disease;Nebraska;novel;novel coronavirus;Outcome;pandemic coronavirus;pandemic disease;Participant;participant enrollment;pathogen;Patient Care;Patients;pediatric patients;Performance;Pharmaceutical Preparations;Phase;Phase II/III Trial;Placebo Control;Placebos;Plasma;Population;Poxviridae;pre-clinical;pre-exposure prophylaxis;pre-pandemic;prevent;Preventive vaccine;Process;Prophylactic treatment;Protocols documentation;Public Health;Publications;Publishing;Randomized;Randomized Controlled Clinical Trials;randomized placebo controlled trial;randomized, clinical trials;Recombinants;Recording of previous events;remdesivir;Research;respiratory;respiratory pathogen;Respiratory Tract Infections;response;Risk;Role;Route;Safety;Sampling;Schedule;seasonal influenza;Seasons;Secondary Immunization;Severe Acute Respiratory Syndrome;Sudan;Surface;SYK gene;symposium;Testing;Therapeutic;Time;Training;Training and Education;treatment center;treatment strategy;treatment trial;Tyrosine Kinase Inhibitor;United States;United States National Institutes of Health;Universities;Vaccinated;Vaccination;vaccination protocol;vaccine evaluation;Vaccines;Validation;Variant;Vertebral column;Vesicular stomatitis Indiana virus;Viral;Virus;Virus Diseases;Zaire Ebola virus",Influenza and Emerging Infectious Diseases,984,NA,NA,NA,NA,18,NA,NA,4224059,NA
11189351,ZIA,AI,1,N,NA,NA,NA,NA,ZIAAI000986,NA,NA,1ZIAAI000986-18,NIAID:2517484\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,9413717 (contact),"TAUBENBERGER, JEFFERY  (contact)",NA,NA,NA,"1918 influenza pandemic;Animal Experiments;Annual Reports;Avian Influenza;B-Lymphocytes;Birds;Cattle;Cessation of life;clinical development;Country;Dairying;Disease Progression;Domestic Fowls;enzootic;Epidemic;epizootic;Family suidae;future pandemic;Goals;Hemagglutinin;Human;human pathogen;Infection;Influenza;Influenza A virus;Influenza A Virus, H1N1 Subtype;Influenza A Virus, H5N1 Subtype;Influenza A Virus, H7N9 Subtype;influenza epidemic;influenza infection;Influenza prevention;influenza virus vaccine;insight;Integration Host Factors;Mammals;Maps;Modeling;Morbidity - disease rate;mortality;new pandemic;novel;novel therapeutic intervention;novel therapeutics;novel vaccines;pandemic disease;pandemic influenza;pandemic potential;pandemic virus;Pathogenesis;pathogenic virus;Pathogenicity;Persons;prevent;previous pandemic;protective efficacy;Public Health;Reporting;T-Lymphocyte Epitopes;universal influenza vaccine;universal vaccine;vaccine strategy;Vaccines;Viral;Viral Genome;Viral Pathogenesis;Virulence Factors;Virus;Virus Diseases;wild bird;Work",Influenza Viral Pathogenesis,986,NA,NA,NA,NA,18,NA,NA,2517484,NA
11189352,ZIA,AI,1,N,NA,NA,NA,NA,ZIAAI000987,NA,NA,1ZIAAI000987-18,NIAID:3063895\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,11597548 (contact),"WHITEHEAD, STEPHEN  (contact)",NA,NA,NA,Admixture;Age;age group;Anti-viral Agents;Area;Attenuated;Attenuated Vaccines;Bangladesh;biodefense;Biological Assay;Brazil;CD8-Positive T-Lymphocytes;Cells;Child;Clinical;clinical development;Clinical Research;clinical research site;Clinical Trials;Contracts;Cooperative Research and Development Agreement;cross immunity;cross reactivity;Culicidae;Cyclic GMP;Dengue;Dengue Vaccine;Dengue Virus;Development;Dose;effectiveness evaluation;Ensure;Evaluation;Exposure to;feeding;Flavivirus;Formulation;Goals;Human;Immune response;Immunization;immunogenic;immunogenicity;improved;India;Infant;Infection;Innate Immune Response;Intention;Intervention;Laboratories;Manufacturer;Medical;men;MicroRNAs;Modeling;Mus;National Institute of Allergy and Infectious Disease;Neurologic;neutralizing antibody;Nicaragua;novel;older adult;panacea;Participant;pathogen;Phase;phase 3 testing;Phenotype;Placenta;Preparation;Publications;reproductive;Research;research clinical testing;response;Risk;Safety;Sampling;seropositive;Serotyping;Serum;T cell response;Taiwan;Technology;Testing;Tissues;transmission process;Tropism;United States;Vaccination;vaccine candidate;vaccine development;vaccine evaluation;vaccine response;Vaccines;Vietnam;Virus;Virus Replication;Woman;Zika Virus;Zika virus vaccine,Clinical Trials of  Biodefense Vaccines (Dengue),987,NA,NA,NA,NA,18,NA,NA,3063895,NA
11189353,ZIA,AI,1,N,NA,NA,NA,NA,ZIAAI000989,NA,NA,1ZIAAI000989-18,NIAID:1592752\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,9413707 (contact),"KANG, ELIZABETH  (contact)",NA,NA,NA,adverse outcome;Agreement;Allogenic;Amendment;Antibodies;autoinflammatory;Autologous;Autologous Transplantation;autosome;Biological Products;Blood;Bone Marrow;Bone Marrow Transplantation;Busulfan;Cells;Cerebral hemisphere hemorrhage;Characteristics;chemotherapeutic agent;Chimerism;Clinical;clinical application;Clinical Immunology;Clinical Protocols;Clinical Research;Clinical Trials;Collaborations;Complication;conditioning;congenital immunodeficiency;curative treatments;Cyclophosphamide;cytokine;Data;Development;Disease;Dose;Eligibility Determination;Engraftment;Enrollment;Evaluation;Exclusion;follow-up;Future;Gene Modified;gene therapy;gene therapy clinical trial;Genetic;genetically modified cells;Goals;graduate school;Graft Rejection;graft vs host disease;Heart;Hematopoietic;Hematopoietic stem cells;high risk;Homologous Transplantation;Hypersensitivity;Idiopathic Thrombocytopenic Purpura;immunodeficiency;improved;improved outcome;Infection;Inflammation;Inflammatory;Inflammatory Bowel Diseases;inflammatory milieu;Institutional Review Boards;Interferon Type II;Journals;Laboratories;Lentivirus Vector;London;Lung;MabCampath;Malignant - descriptor;Malignant Neoplasms;Medical;medical schools;Medicine;meetings;member;Methods;microbiome analysis;Modification;mortality;mortality risk;mouse model;Mucositis;Mus;Mycoses;Nature;Non-Malignant;North America;novel;Outcome;Oxidases;Pathway interactions;patient subsets;Patients;post-transplant;Postdoctoral Fellow;Protocols documentation;Publications;Publishing;Radiation Dose Unit;Refractory;Regimen;Resolution;Risk;RNA;RNA Sequence Analysis;Sampling;Site;stem cell gene therapy;stem cell therapy;Stem cell transplant;Syndrome;Techniques;Testing;tocilizumab;Toxic effect;transduction efficiency;transplant model;Transplant Recipients;Transplantation;United States National Institutes of Health;vector;Work;Zea,Development and conduct of allogeneic stem cell transplant and autologous stem cell gene therapy for inherited immune deficiencies,989,NA,NA,NA,NA,18,NA,NA,1592752,NA
11189354,ZIA,AI,1,N,NA,NA,NA,NA,ZIAAI000999,NA,NA,1ZIAAI000999-18,NIAID:2252657\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,9413723 (contact),"FARCI, PATRIZIA  (contact)",NA,NA,NA,Accounting;Acute;Acute Hepatitis;acute infection;acute liver disease;Acute Liver Failure;Affect;Age;Allografting;Animal Model;Antigen Presentation;Apoptosis;B-Lymphocytes;Basic Science;Biological Markers;Biology;burden of illness;Cancer Etiology;carcinogenesis;Caucasians;Cause of Death;Cessation of life;Chronic;Chronic Hepatitis;Chronic Hepatitis B;Chronic Hepatitis D;chronic infection;chronic liver disease;Chronic viral hepatitis;Cirrhosis;Clinical;Clinical Research;Cohort Studies;Collaborations;Communicable Diseases;Comparative Study;Complex;Complication;CTLA4 gene;CTNNB1 gene;cytokine;Data;Death Rate;Development;Diagnosis;Disease Progression;Early identification;Etiology;exome sequencing;Functional disorder;Future;Genes;Genotype;Gerbils;Goals;HBV Genotype;Hepatic;Hepatitis;Hepatitis A;Hepatitis B;Hepatitis B e Antigens;Hepatitis B Infection;Hepatitis B Surface Antigens;Hepatitis B Vaccines;Hepatitis B Virus;Hepatitis C virus;Hepatitis Delta Virus;Hepatitis E virus;Hepatitis Viruses;Hepatocarcinogenesis;Hepatocyte;high risk;Human;Immune;Immune checkpoint inhibitor;Immune response;Immunocompetent;Immunocompromised Host;Immunoglobulin M;Immunohistochemistry;Immunophenotyping;immunosuppressed;Immunosuppression;Immunotherapy;Implant;In Vitro;Individual;Infection;Infiltration;Inflammation;innovation;insight;Integration Host Factors;Knowledge;Liver;Liver Cirrhosis;Liver diseases;Liver Failure;Liver Fibrosis;liver injury;long-term sequelae;Lymphocytic Infiltrate;Mediating;Medical center;Missense Mutation;Modeling;Molecular;mutant;Mutation;Nature;novel strategies;Nucleotides;Oncogenic;organ transplant recipient;Outcome;Pathogenesis;Pathogenicity;Patients;Persons;Pharmaceutical Preparations;Phenotype;Play;Population;Population Heterogeneity;predictive marker;Prevention strategy;Primary carcinoma of the liver cells;programmed cell death ligand 1;programmed cell death protein 1;programs;Public Health;Reporting;Research;response;Risk Factors;Role;Sampling;Series;Serology;Serum;Solid;Specimen;subcutaneous;Symbiosis;System;T-Lymphocyte;Tacrolimus;Tissues;transcriptomics;Transplantation;Tuberculosis;tumor;tumor microenvironment;Tumor Subtype;Universities;Viral;viral DNA;Viral hepatitis;Viral Pathogenesis;viral RNA;Viremia;Virus;Virus Diseases;virus infection mechanism;Virus Replication;Virus Shedding;World Health Organization,Molecular Mechanisms of Pathogenesis of Acute and Chronic Liver Diseases,999,NA,NA,NA,NA,18,NA,NA,2252657,NA
11189355,ZIA,AI,1,N,NA,NA,NA,NA,ZIAAI001007,NA,NA,1ZIAAI001007-18,NIAID:1059874\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,10686351 (contact),"DUFFY, PATRICK  (contact)",NA,NA,NA,Adjuvant;Alhydrogel;Antibodies;Antigens;Area;Binding;Blocking Antibodies;burden of illness;candidate identification;cohort;Culicidae;Exposure to;Expression Library;Formulation;Frequencies;Genes;Germ Lines;Goals;Human;human monoclonal antibodies;Immunity;Immunization;Immunize;Individual;interest;Investigation;Legal patent;Malaria;malaria transmission;malaria transmission-blocking vaccine;Malaria Vaccines;Methods;Monoclonal Antibodies;novel;Parasites;Participant;Plasmodium;Plasmodium falciparum;prevent;Proteins;Publications;Recombinant Proteins;Recombinants;Reporting;Sampling;screening;Serum;Testing;tool;transmission blocking;transmission process;transmission-blocking vaccine;Vaccination;Vaccine Antigen;vaccine candidate;vaccine discovery;Vaccines;Work,Malaria Transmission Blocking Vaccine Discovery,1007,NA,NA,NA,NA,18,NA,NA,1059874,NA
11189356,ZIA,AI,1,N,NA,NA,NA,NA,ZIAAI001008,NA,NA,1ZIAAI001008-18,NIAID:2649684\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,10686351 (contact),"DUFFY, PATRICK  (contact)",NA,NA,NA,Adjuvant;Aluminum;aluminum sulfate;Antigens;Area;burden of illness;Carrier Proteins;Collaborations;Communicable Diseases;controlled release;cross reacting material 197;Dedications;Development;Effectiveness;Evaluation;Failure;Formulation;Future;Goals;Human;Immune response;improved;In Vitro;Infection;Interruption;Liposomes;Malaria;malaria transmission;malaria transmission-blocking vaccine;Malaria Vaccines;Membrane;Membrane Proteins;Messenger RNA;Microbiology;Mus;Nature;Needles;Neisseria meningitidis;novel;novel vaccines;Parasites;Parasitic Diseases;Peptide Signal Sequences;Plasmodium;Plasmodium vivax;Polysaccharides;protein complex;Proteins;Publications;Recombinant Proteins;Reporting;RNA vaccine;Salmonella typhi;Sexual Development;success;Surface;Surveys;System;Technology;Testing;Tetanus Toxoid;Transmembrane Domain;transmission blocking;transmission process;transmission-blocking vaccine;vaccine delivery;vaccine development;vaccine platform;Vaccines,Optimizing malaria transmission-blocking vaccines with improved platforms,1008,NA,NA,NA,NA,18,NA,NA,2649684,NA
11189357,ZIA,AI,1,N,NA,NA,NA,NA,ZIAAI001009,NA,NA,1ZIAAI001009-18,NIAID:6889173\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,10686351 (contact),"DUFFY, PATRICK  (contact)",NA,NA,NA,Abnormal Hemoglobins;Abnormal Neutrophil;Adjuvant;Adult;Age;aged;Alanine Transaminase;Alhydrogel;Antibody Response;Area;Blood specimen;burden of illness;Carrier Proteins;Child;Clinical;clinical care;Clinical Chemistry;Complete Blood Count;cooking;Creatinine;Databases;Dose;Double-Blind Method;Family;Feeds;Formulation;Hematology;Hemoglobin concentration result;immunogenicity;Individual;Laboratories;Malaria;malaria transmission;Malaria Vaccines;Mali;Manufacturer;Manuscripts;Measurable;mutant;National Institute of Allergy and Infectious Disease;Older Population;Outcome;Parasites;Phase;Plasmodium falciparum;Population;Proteins;Protocols documentation;Pseudomonas aeruginosa;Publications;Randomized;Recombinants;Reference Values;Rural;Safety;screening;sex;Sex Differences;Site;Skin;Surface;Test Result;Toxin;transmission blocking;transmission process;transmission-blocking vaccine;vaccine development;vaccine trial;Vaccines;zygote,Malaria Vaccines:  Pfs25-rEPA and Pfs230-rEPA,1009,NA,NA,NA,NA,18,NA,NA,6889173,NA
11189358,ZIA,AI,1,N,NA,NA,NA,NA,ZIAAI001012,NA,NA,1ZIAAI001012-18,NIAID:747668\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,9413749 (contact),"RIBEIRO, JOSE  (contact)",NA,NA,NA,Aedes;Affect;Alternative Complement Pathway;Anaphylatoxins;Anti-Bacterial Agents;Arthropods;assay development;Atlases;Binding;Biochemistry;Bioinformatics;Biological;Biological Assay;biophysical analysis;Blood;Blood Coagulation Factor VII;cancer procoagulant;Clustered Regularly Interspaced Short Palindromic Repeats;Coagulation Process;Collaborations;Complement;Complement 3 Convertase;Complement 3b;Complement Activation;complement C3 precursor;Complement Inactivators;complement system;Complex;Cryoelectron Microscopy;Crystallography;Culicidae;Data;Data Analyses;dimer;Dimerization;disease transmission;Disease Vectors;Dose;Environment;Eukaryotic Cell;Factor VIIa;Factor X;Factor Xa;Fat Body;feeding;Gel Chromatography;Goals;Gram-Negative Bacteria;Hemolymph;Hemostatic Agents;Hemostatic function;hormone binding protein;human tissue;Image;Immune response;Immunity;Infection;Inflammation;Inflammatory;Inflammatory Response;inhibitor;Insect Vectors;Insecta;Juvenile Hormones;Knock-out;Link;Lipids;Membrane;Methodology;Methods;microorganism;Molecular;Molecular Mechanisms of Action;mutant;novel;particle;pathogen;Pathogenicity;Pathway interactions;Pharmacologic Actions;Physiology;Preparation;Process;Production;protein purification;Proteins;Proteome;Proteomics;Publishing;Recombinant Proteins;Research;Resolution;response;Role;Saliva;Salivary;Salivary Proteins;Sequence Analysis;Simuliidae;small molecule;Structure;Surface;System;Techniques;Testing;Thromboplastin;tick saliva;Ticks;Tissues;Transcript;transcriptome;transcriptomics;transmission process;vector;Vector-transmitted infectious disease;Work,Vector-Borne Diseases: Molecular Mechanisms in Vector-Host Interactions,1012,NA,NA,NA,NA,18,NA,NA,747668,NA
11189359,ZIA,AI,1,N,NA,NA,NA,NA,ZIAAI001013,NA,NA,1ZIAAI001013-18,NIAID:1324096\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,9413751 (contact),"BOSIO, CATHARINE  (contact)",NA,NA,NA,adaptive immune response;adaptive immunity;Address;Age;Anti-Inflammatory Agents;Attenuated;Attenuated Vaccines;Bacteria;Bordetella pertussis;capsule;Cause of Death;Cell Death;cell type;Cells;Cessation of life;Child;Data;Development;Dose;Early identification;effector T cell;Elements;Francisella;Francisella tularensis;Generations;Genomics;Goals;Image;Imaging technology;Immune response;Immunity;Immunosuppression;Impairment;in vivo;Individual;Infection;Infection prevention;Infectious Agent;Inflammation;Inflammatory Response;Innate Immune Response;insight;Klebsiella pneumoniae;Lipid Synthesis Pathway;lipidomics;Lipids;Location;Lower Respiratory Tract Infection;Lung;Lung infections;lung pathogen;Macrophage;Mediating;Metabolic;Metabolic syndrome;Metabolism;metabolomics;microbial;microorganism;Mitochondria;Modeling;mouse model;multiple omics;Mutation;novel therapeutics;novel vaccines;Obesity;Organ;Outcome;pathogen;Pathogenesis;Pathway interactions;Pattern;Peripheral;Phase;Play;Population;Primary Infection;Production;programs;protective efficacy;Pulmonary tularemia;Recording of previous events;Reproducibility;Resolution;response;Role;Route;secondary infection;Structure;Surface;T cell response;T-Lymphocyte;Tissues;tool;Tularemia;Vaccination;vaccination strategy;Vaccines;Virulent,Immunity to Pulmonary Infections,1013,NA,NA,NA,NA,18,NA,NA,1324096,NA
11189360,ZIA,AI,1,N,NA,NA,NA,NA,ZIAAI001017,NA,NA,1ZIAAI001017-18,NIAID:671626\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,9413761 (contact),"GRIGG, MICHAEL  (contact)",NA,NA,NA,Acute;Alleles;Animals;Antibodies;Antigens;Attenuated;B-Lymphocytes;Bacterial Adhesins;Binding;Biochemical;CASP1 gene;Categories;Cells;chronic infection;Clinical;Competence;Complement;Complement Factor H;Data;Defect;Deposition;Development;Disease;Disease Outbreaks;Endocrine;Evolution;falls;Female;forward genetics;Foundations;GDF15 gene;genetic approach;Genetic Determinism;Germ Cells;Glycosaminoglycans;Goals;gut microbiome;Heparitin Sulfate;Human;IL18 gene;Ileitis;Immune;Immune signaling;Immunity;Immunologics;immunoregulation;in vivo;Infection;Inflammasome;Inflammatory;Interferon Type II;Interleukin-1 beta;Interleukin-12;Interruption;Invaded;Investigation;knockout gene;Lectin;Life Cycle Stages;male;Mediating;Molecular;mouse model;mucosal site;Mus;mutant;NF-kappa B;Nuclear Translocation;Outcome;overexpression;Parasites;Parasitic infection;Partner in relationship;pathogen;Pathogenesis;Pathogenicity;Pathology;Pathway interactions;Pharmaceutical Preparations;Polysaccharides;Predisposition;Production;Proliferating;prophylactic;protein protein interaction;Proteins;recruit;Regulation;Regulatory T-Lymphocyte;response;reverse genetics;Role;sensor;Series;Serology test;Serum;sex;Signal Pathway;Site;Stimulus;Structure;Surface;Surface Antigens;Testing;Therapeutic Intervention;TLR2 gene;TLR4 gene;Toxoplasma;Toxoplasma gondii;Toxoplasmosis;Transgenic Organisms;transmission process;transmission-blocking vaccine;unpublished works;Vaccines;virtual;Virulence;Virulence Factors;Virulent;Work;Zoonoses,Toxoplasma Surface Antigens and Immunity,1017,NA,NA,NA,NA,18,NA,NA,671626,NA
11189361,ZIA,AI,1,N,NA,NA,NA,NA,ZIAAI001018,NA,NA,1ZIAAI001018-18,NIAID:1007438\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,9413761 (contact),"GRIGG, MICHAEL  (contact)",NA,NA,NA,Admixture;Animals;Apicomplexa;Area;B-Cell Activation;Biochemical Epidemiology;Birds;Blastocystis;Blood;CD4 Positive T Lymphocytes;Cells;Chronic;Clinical;Communities;Complex;Data;Data Set;Dendritic Cells;Development;diagnostic tool;Disease;Disease Outbreaks;Eimeria;Elements;Entamoeba;Enteral;Environment;Epidemic;Epidemiology;Evolution;fungus;Genetic;Genetic Determinism;genetic epidemiology;Genetic Polymorphism;Genetic Recombination;genetic variant;Genome;genome sequencing;genome wide association study;Genotype;Geography;Giardia;Goals;Growth;gut dysbiosis;gut inflammation;gut microbiota;Homeostasis;host-microbe interactions;Human;Immune;immune function;Immunological Models;Infection;Inflammasome;Inflammation;Inflammatory;insight;interest;Isospora;Leishmania;Life Cycle Stages;Mammals;Metabolic;Metagenomics;microbial;microbial host;microorganism interaction;Modeling;Molecular;Molecular Epidemiology;Nature;Neospora;new therapeutic target;novel diagnostics;Parasites;Parasitic Diseases;Parasitology;Partner in relationship;pathogen;Pathogenesis;Pathogenicity;Pathway interactions;Periodicals;Phylogenetic Analysis;Population;population genetic structure;Population Genetics;Prevalence;Protozoa;reconstruction;Recording of previous events;Regulation;Research;response;reverse genetics;Route;Sampling;Sarcocystis;Severity of illness;Sexual Reproduction;Site;Stimulus;Testing;Therapeutic Intervention;Tissues;Toxoplasma;Toxoplasma gondii;transmission process;Trichomonas;Trypanosoma;Variant;Virulence;Virulent;whole genome;Work;Zoonoses,Parasite Population Genetics and Inflammation,1018,NA,NA,NA,NA,18,NA,NA,1007438,NA
11189362,ZIA,AI,1,N,NA,NA,NA,NA,ZIAAI001020,NA,NA,1ZIAAI001020-18,NIAID:992457\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,9413765 (contact),"LONG, CAROLE  (contact)",NA,NA,NA,Address;Adjuvant;Adult;African;Anopheles Genus;Antibodies;Antigens;Area;asexual;Attention;B-Lymphocytes;Biological;Biological Assay;Biology;Blood;Blood Tests;Bone Marrow;Burkina Faso;Cells;Characteristics;Child;Clinical;Clinical Trials;Clone Cells;Coculture Techniques;Collaborations;Combined Vaccines;Complex;Culicidae;Cysteine;Data;Development;differentiation in vitro;Disease;efficacy trial;Enzyme-Linked Immunosorbent Assay;Epitopes;Erythrocytes;Evaluation;feeding;Ferritin;first-in-human;Formulation;Future;Generations;Genes;Germ Lines;Goals;Growth;Hepatitis;Human;Immune response;Immune system;Immunity;Immunization;Immunize;immunogenicity;Immunoglobulin G;Immunology;improved;In Vitro;in vivo;Infant;Infection;Interferons;Invaded;Investigation;Investments;Laboratories;Malaria;malaria infection;malaria transmission;Malaria Vaccines;Manuscripts;Mass Spectrum Analysis;Measurement;member;Membrane;Methods;Monoclonal Antibodies;Myeloid Cells;nanoparticle;novel;Oocysts;Parasites;Phase;Phase II Clinical Trials;Plasmodium falciparum;Plasmodium vivax;polyclonal antibody;Preparation;Process;Production;protein complex;Proteins;Recombinants;Reporting;Research;Research Personnel;Resistance development;response;Rodent;Role;Safety;Sampling;Serum;Silk;Standardization;Surface Antigens;System;Testing;Time;tool;Transcript;transcriptome sequencing;transmission process;transmission-blocking vaccine;Universities;vaccine candidate;Vaccines;vector;vector mosquito;Virus-like particle;volunteer;Weight;Work,Host Immune Responses to Antigens of Malaria Parasites,1020,NA,NA,NA,NA,18,NA,NA,992457,NA
11189363,ZIA,AI,1,N,NA,NA,NA,NA,ZIAAI001021,NA,NA,1ZIAAI001021-18,NIAID:666296\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,9413768 (contact),"LOBANENKOV, VICTOR  (contact)",NA,NA,NA,3-Dimensional;4T1;Adenoviruses;Affect;Alpha Virus;Animals;Antigens;ATAC-seq;Attention;Autologous;Binding;Binding Sites;Breast Cancer Model;Brothers;cancer cell;Cancer cell line;cancer immunotherapy;Cancer Patient;cancer site;cancer stem cell;cancer survival;cancer therapy;Cell Maintenance;cell type;Cells;Cessation of life;chemotherapy;ChIP-seq;Chromatin;chromatin immunoprecipitation;Chromatin Loop;chromatin remodeling;Chromatin Remodeling Factor;Clinic;clinical application;clinical trial protocol;Control Animal;Coupled;CRISPR/Cas technology;Data;Defect;Dendritic Cells;Dependence;Disease;disease diagnosis;Distant;DNA;DNA Binding;DNA Binding Domain;driving force;Elements;Embryo;Endogenous Retroviruses;Epigenetic Process;ERBB2 gene;Experimental Designs;Family;FDA approved;Gametogenesis;Gene Expression;Gene Expression Profiling;Gene Expression Regulation;gene product;Generations;Genes;Genetic;Genetic Transcription;Genome;genome-wide;Genomic Segment;Germ Cells;Germ Lines;Goals;Hi-C;Homologous Gene;Housekeeping;Human;human model;humanized mouse;Immune;Immunize;Immunodiagnostics;immunogenic;Immunotherapeutic agent;Immunotherapy;imprint;improved;In Vitro;in vivo;inhibitor;Journals;K-562;K562 Cells;knock-down;Knock-out;knockout animal;Knockout Mice;Lead;Link;Malignant Breast Neoplasm;Malignant Epithelial Cell;Malignant Neoplasms;Maps;MCF7 cell;Mediating;Meiosis;Methods;Mitotic;Modeling;Molecular;mouse model;Mus;Mutate;MYCN gene;Names;Nature;Neoplasm Metastasis;Neuroblastoma;next generation sequencing;NIH 3T3 Cells;NIH Mouse;Oncogenic;Organ;Outcome;overexpression;paralogous gene;Pathologic;Patients;Peripheral Blood Mononuclear Cell;Phenotype;Play;Population;pre-clinical;Primates;programs;Proliferating;promoter;Protein Isoforms;Proteins;Protocols documentation;Rattus;Recombinants;recruit;Recurrence;refractory cancer;Regulation;Regulatory Element;Reporting;Research;Resistance;Retrotransposon;Role;senescence;Side;Site;Somatic Cell;Specificity;Spermatids;Spermatocytes;Spermatogenesis;stemness;Structure;subfertility;Tandem Repeat Sequences;Testing;Testis;therapy resistant;tissue culture;Tissues;tool;Transcript;Transcription Initiation;Transcription Initiation Site;Transcriptional Activation;transcriptome sequencing;Transfection;Translating;Translational Research;treatment site;tumor;tumor growth;Tumor Suppressor Genes;Ukraine;Undifferentiated;Up-Regulation;Vaccines;virtual;working group;zinc finger nuclease,Regulation of CTCF Functions and Target Sites by Cancer/Testis-specific CTCF Like BORIS Factor,1021,NA,NA,NA,NA,18,NA,NA,666296,NA
11189364,ZIA,AI,1,N,NA,NA,NA,NA,ZIAAI001028,NA,NA,1ZIAAI001028-17,NIAID:370759\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,8620541 (contact),"MARGULIES, DAVID  (contact)",NA,NA,NA,2019-nCoV;Adaptive Immune System;Address;Amino Acids;Antibodies;Antibody Binding Sites;Antigen Presentation;Antigen Presentation Pathway;Antigens;Benign;Binding;Biochemical;Biochemistry;Biophysics;Cell Communication;Cell surface;Cells;Communicable Diseases;Complement;Complex;complex IV;Coronavirus;Cytomegalovirus;Databases;Degradation Pathway;DNA Viruses;Endoplasmic Reticulum;Engineering;Evolution;experimental study;Family;Frequencies;Functional disorder;Goals;Herpesviridae;Homologous Gene;I-antigen;Immune Evasion;Immune response;Immune system;immunodeficiency;improved;Innate Immune System;Insecta;insight;interest;Intervention;Knowledge;Lead;Major Histocompatibility Complex;Malignant Neoplasms;Mammals;member;Methods;Molecular;molecular dynamics;Molecular Structure;Molluscum Contagiosum;Molluscum contagiosum virus;Murid herpesvirus 1;nanobodies;Natural Killer Cells;Nature;Neoplasms;novel;pathogen;Pathway interactions;Peptides;Poxviridae;Procedures;Proteins;receptor;receptor binding;Recombinants;Role;SARS-CoV-2 spike protein;Site;Structure;Surface;System;T-Cell Receptor;T-Lymphocyte;tapasin;Vaccine Design;vaccine strategy;Vaccine Therapy;Viral;Viral Physiology;Virus;Virus Diseases;Work,Structure and Function of Viral Immunoevasins,1028,NA,NA,NA,NA,17,NA,NA,370759,NA
11189365,ZIA,AI,1,N,NA,NA,NA,NA,ZIAAI001029,NA,NA,1ZIAAI001029-17,NIAID:2221813\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,12213449 (contact),"BRENCHLEY, JASON  (contact)",NA,NA,NA,Acquired Immunodeficiency Syndrome;Acute;Address;African;African Green Monkey;Animal Model;Animals;Architecture;arm;Asian;ATAC-seq;CD4 Positive T Lymphocytes;CD8-Positive T-Lymphocytes;Cell Physiology;cell type;Chronic;Chronic Phase;Circulation;Clinical;Data;design;Disease;Disease Progression;Down-Regulation;Elements;Epigenetic Process;Evolution;experience;Gastrointestinal tract structure;Genetic Transcription;High Prevalence;HIV;Human;immune activation;immune function;Immune system;Immune System Diseases;Immunity;immunodeficiency;Immunologics;improved;In Vitro;in vivo;Individual;Infection;Inflammation;interest;Knowledge;Laboratories;Lamina Propria;Lead;Lymphoid Tissue;Macaca;Maintenance;Measures;member;microbial;microbial products;microbiome;Modification;Monkeys;Nature;nonhuman primate;novel therapeutic intervention;Outcome;Pathogenesis;Peripheral;Phase;Philosophy;Population;Primate Lentiviruses;Primates;Productivity;Prognosis;Recording of previous events;Reporting;Research;Resistance;Role;Simian Acquired Immunodeficiency Syndrome;SIV;Study Section;Supporting Cell;Technology;Time;Tissue Sample;Tissues;United States National Institutes of Health;Virus;Virus Replication;Work,Mechanisms of Immune Activation and Disease Progression in Animal Models,1029,NA,NA,NA,NA,17,NA,NA,2221813,NA
11189366,ZIA,AI,1,N,NA,NA,NA,NA,ZIAAI001030,NA,NA,1ZIAAI001030-17,NIAID:466957\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,9691479 (contact),"LEPPLA, STEPHEN  (contact)",NA,NA,NA,Affect;Animals;Anthrax disease;anthrax toxin;Anthrax Vaccines;Antigens;aptamer;ATP phosphohydrolase;attenuation;Bacillus;Bacillus anthracis;Bacillus subtilis;Bacteria;Bicarbonates;Binding;Binding Sites;Biochemical;candidate identification;capsule;Carbon Dioxide;Cell Death;Cells;Chromosomes;Complex;Consensus;Cysteine;Data;Defect;Development;Disease;DNA Sequence;DNA-Directed RNA Polymerase;edema factor;Electrophoretic Mobility Shift Assay;Enzymes;Escherichia coli;Exclusion;Gene Deletion;Gene Expression;Gene Expression Profiling;Gene Expression Regulation;Genes;Genetic;genetic manipulation;Genetic Transcription;genome sequencing;Genomics;Glucose;glucose permease;Goals;Growth;Helix-Turn-Helix Motifs;Histidine;Homologous Gene;Human;in silico;In Vitro;in vivo evaluation;Individual;Infection;Learning;lethal factor;Life;Life Cycle Stages;Mediating;Metabolic;Methods;Modification;Molecular Genetics;mouse model;mutant;Mutation Analysis;Nature;pathogen;Pathogenesis;pathogenic bacteria;Pathway interactions;Peptide Hydrolases;permease;peroxiredoxin I;Phosphoenolpyruvate;Phosphoric Monoester Hydrolases;Phosphorylation;Phosphotransferases;Physiological;Plasmids;Play;Polymerase;Positioning Attribute;Post-Translational Protein Processing;Probability;Process;Production;promoter;Promoter Regions;protein degradation;Protein Kinase;Protein Secretion;Protein-Serine-Threonine Kinases;Proteins;Proteomics;Pyruvate Carboxylase;Regulation;Reporter;Reporting;Reproduction spores;response;RNA;RNA Polymerase II;Role;Sequence Alignment;Serine;Serine Protease;Signal Transduction;Small RNA;Stimulus;sugar;System;Threonine;tool;Toxin;Transcription Coactivator;transcription factor;Transcriptional Regulation;vaccine candidate;Vegetative States;Virulence;Virulence Factors;virulence gene;Virulent;Work,Molecular Genetics and Pathogenesis of Anthrax,1030,NA,NA,NA,NA,17,NA,NA,466957,NA
11189367,ZIA,AI,1,N,NA,NA,NA,NA,ZIAAI001032,NA,NA,1ZIAAI001032-17,NIAID:466957\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,9691479 (contact),"LEPPLA, STEPHEN  (contact)",NA,NA,NA,Adenocarcinoma;adenoma;Adenylate Cyclase;Animal Model;Animals;Anthrax disease;anthrax toxin;antigen binding;Antigens;Area;Bacterial Toxins;Blood Vessels;Breast Epithelial Cells;Breeding;Canis familiaris;Cell Death;Cell model;cell type;Cells;Cessation of life;Chromosome Mapping;Collection;Cyclic AMP;cytokine;Cytoplasm;Development;Disease;disorder control;Dose;edema factor;efficacy testing;Eicosanoids;Engineering;Enterobacteria phage P1 Cre recombinase;enzyme substrate;Event;Extravasation;Family;Future;Genetic Predisposition to Disease;genetic resistance;Goals;Hour;Inbred Strains Mice;Inflammasome;inhibitor;Injections;Innate Immune Response;insight;Intoxication;Laboratories;Learning;lethal factor;Link;Malignant Neoplasms;Mammary Neoplasms;MEKs;Methods;Modification;mouse model;Mus;mutant;Mutation;neoplastic cell;novel;novel strategies;Organ;Outcome;overexpression;Pathogenesis;Pathologic;Pathway interactions;Peptide Hydrolases;pharmacologic;Phenotype;Phosphotransferases;Physiological;PIK3CG gene;Play;prevent;Prevention approach;Proteins;Publishing;Rattus;receptor;recombinase;Reporter;Reporting;Resistance;response;Role;sensor;Signal Pathway;Site;Substrate Specificity;System;Targeted Toxins;Therapeutic;Tissues;tool;Toxic effect;Toxin;tumor;Tumor Cell Line;Universities;uptake;Virulence;Visualization,Pathophysiological Actions of Anthrax Virulence Determinants,1032,NA,NA,NA,NA,17,NA,NA,466957,NA
11189368,ZIA,AI,1,N,NA,NA,NA,NA,ZIAAI001035,NA,NA,1ZIAAI001035-17,NIAID:1107862\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,77852597 (contact),"PREVOTS, D. REBECCA  (contact)",NA,NA,NA,"12 year old;Acid Fast Bacillae Staining Method;Age;age group;aged;Agreement;Antibiotic Resistance;Antibiotics;Area;Asian population;Automobile Driving;Bacillus;beneficiary;Biological;Black Populations;burden of illness;Case/Control Studies;Centers for Disease Control and Prevention (U.S.);climatic factors;Clinical;clinical care;clinical epidemiology;clinically relevant;cohort;County;Cystic Fibrosis;cystic fibrosis patients;Data;Data Set;data sharing;Data Sources;Demographic Factors;Development;Diagnosis;Disease;Disinfectants;disorder risk;drinking water;Enrollment;Epidemiology;epidemiology study;Ethnic Origin;Ethnic Population;Future;Geography;Goals;ground water;High Prevalence;high risk population;Hispanic Populations;human old age (65+);ICD-9;improved;Incidence;Individual;Infection;infection risk;insight;interest;International Statistical Classification of Diseases and Related Health Problems, Tenth Revision (ICD-10);Laboratories;Link;Logistic Regressions;Lung;Lung Diseases;Lung infections;Medicare;men;Metal exposure;Methods;Midwestern United States;Modeling;Molybdenum;Monitor;Municipalities;Mycobacterium abscessus;Mycobacterium avium;Mycobacterium avium Complex;Mycobacterium bovis;Mycobacterium gordonae;Mycobacterium Infections;Natural History;non-tuberculosis mycobacteria;non-tuberculous mycobacterial infection;novel therapeutics;Outcome;patient registry;Patients;Pattern;Persons;Population;population based;Population Study;Predisposition;Prevalence;Prevention strategy;Race;racial population;Regimen;Reporting;residence;respiratory;Risk;Risk Factors;Sampling;sex;sociodemographics;Source;Southeastern United States;Surface;System;Testing;Time;Trace metal;Treatment Effectiveness;trend;United States;United States Centers for Medicare and Medicaid Services;United States Environmental Protection Agency;United States National Institutes of Health;Vanadium;Water;Woman;Women&apos;s prevalence",Epidemiology of Mycobacterial Infections,1035,NA,NA,NA,NA,17,NA,NA,1107862,NA
11189369,ZIA,AI,1,N,NA,NA,NA,NA,ZIAAI001040,NA,NA,1ZIAAI001040-17,NIAID:1380818\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,9691493 (contact),"QUINN, THOMAS  (contact)",NA,NA,NA,6 year old;Address;Adherence;Africa;Africa South of the Sahara;Age;age related;aged;AIDS prevention;Alcohol consumption;Anti-Retroviral Agents;antiretroviral therapy;Appointment;Area;Automobile Driving;Burkitt Lymphoma;care delivery;Caring;Client;Clinical;cohort;Cohort Studies;Communities;Continuity of Patient Care;Counseling;Couples;Data;dietary requirement;Disclosure;Eastern Africa;Eligibility Determination;Enrollment;Epidemic;epidemic response;Female Adolescents;flexibility;follow-up;Frequencies;Gender;General Population;genetic risk factor;girls;Goals;Herpesviridae;high risk;HIV;HIV anti-retroviral;HIV risk;HIV Seronegativity;immune activation;Immunologics;implementation barriers;improved;Incidence;Individual;Infection;infection burden;Injectable;Injections;interest;international center;Intervention;Investments;latent HIV reservoir;Malaria;male;male health;men;migration;Modeling;Monitor;Morbidity - disease rate;mortality;older men;Oral;Participant;person centered;Persons;Pharmaceutical Preparations;Phase;Phylogenetic Analysis;pill;Population;population based;Population Group;pre-exposure prophylaxis;Prevention;Prevention strategy;Privacy;programs;Prostitution;Public Health;Quality of Care;Reaction;Reporting;reproductive;Research;Resources;Rural;Rural Community;scale up;Schedule;Services;social stigma;Southern Africa;success;System;Testing;therapy adherence;tool;transmission process;Travel;treatment as prevention;Uganda;uptake;Viral;Viral Load result;viral rebound;Viremia;Woman,International Center for Excellence in Research (ICER) in Uganda: Impact of ARVs,1040,NA,NA,NA,NA,17,NA,NA,1380818,NA
11189370,ZIA,AI,1,N,NA,NA,NA,NA,ZIAAI001042,NA,NA,1ZIAAI001042-17,NIAID:954819\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,9691495 (contact),"KWON-CHUNG, KYUNG  (contact)",NA,NA,NA,ABCB1 gene;Acquired Immunodeficiency Syndrome;Aerobic Bacteria;Affect;Africa South of the Sahara;Aneuploidy;anti-fungal agents;Atmosphere;ATP-Binding Cassette Transporters;Azole resistance;Azoles;Behavior;Binding Proteins;Brain;Bypass;Carbon Dioxide;Categories;cell behavior;Cell Nucleus;Cells;Cellular Stress;Chemical Agents;Chromosome 1;Chromosome 4;chromosome missegregation;Chromosomes;Collaborations;Cryptococcal Meningitis;Cryptococcosis;Cryptococcus;Cryptococcus gattii;Cryptococcus neoformans;Cytosine;DNA Sequence Rearrangement;Drug resistance;Endoplasmic Reticulum;Environment;Ergosterol;Etiology;Fluconazole;Fluconazole resistance;Flucytosine;Frequencies;fungus;gene function;Gene Mutation;Genes;Goals;Growth;Habitats;Histones;HIV Seropositivity;Human;Hypersensitivity;Hypoxia;Immunity;In Vitro;Individual;Infection;Intermediate resistance;Libraries;Link;London;Maintenance Therapy;man;Meningoencephalitis;minimal inhibitory concentration;Molecular;Monitor;Mus;mutant;Mutation;Neoadjuvant Therapy;neurotropic;Nitrogen;Nuclear;Nuclear Fusion;Organism;Oxygen;pathogen;Pathway interactions;Patients;Pharmaceutical Preparations;Phenotype;Phosphorylation;Polyenes;Predisposition;Pump;Reactive Nitrogen Species;Reactive Oxygen Species;Regulatory Element;Research Personnel;Resistance;resistance mechanism;Role;Serotyping;Signal Pathway;Sister;Source;Sterol Biosynthesis Pathway;Sterols;Stress;stress management;Substrate Specificity;System;T-Lymphocyte;Time;Treatment Failure;Universities;Virulence,Stress Management of Cryptococcal Pathogens,1042,NA,NA,NA,NA,17,NA,NA,954819,NA
11189371,ZIA,AI,1,N,NA,NA,NA,NA,ZIAAI001043,NA,NA,1ZIAAI001043-17,NIAID:1652722\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,14291601 (contact),"MYLES, IAN  (contact)",NA,NA,NA,Acute;adaptive immune response;adaptive immunity;Atopic Dermatitis;Autoimmunity;Back;Bacteria;Bacterial Infections;Chronic;Clinical Research;Development;Disease;Eczema;Formulation;Genetic;Goals;Host Defense;host-microbe interactions;Human;human pathogen;Hypersensitivity;Immune;Immune response;Immunity;Immunologics;improved;Infection;Innate Immune Response;interest;Knowledge;Licensing;Longevity;Lotion;Malignant Neoplasms;Mediating;mouse model;Mucous Membrane;Mus;Natural Immunity;Participant;Pathogenesis;pathogenic bacteria;Pathologic;Pathway interactions;Patients;Phase;placebo group;Placebos;prebiotics;Predisposition;response;Role;Shapes;Skin;Staphylococcus aureus;Symptoms;T cell differentiation;T memory cell;tool;vaccine efficacy,Host Immunity Against Bacteria,1043,NA,NA,NA,NA,17,NA,NA,1652722,NA
11189372,ZIA,AI,1,N,NA,NA,NA,NA,ZIAAI001046,NA,NA,1ZIAAI001046-17,NIAID:970827\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,9691503 (contact),"SHEVACH, ETHAN  (contact)",NA,NA,NA,Activated Natural Killer Cell;Adaptive Immune System;adaptive immunity;Amino Acids;Antigen-Presenting Cells;antigen-specific T cells;Antitumor Response;Area;Autoimmune Diseases;Binding;Binding Sites;Biological;Biological Assay;Biological Products;cancer therapy;CD8-Positive T-Lymphocytes;Cell Line;Cell Physiology;Cell Proliferation;Cells;checkpoint inhibition;Complex;Cooperative Research and Development Agreement;Cytolysis;Development;differential expression;effector T cell;Engineering;Equilibrium;Fab Immunoglobulins;Family;Globulins;Graft Rejection;Growth;HLA Antigens;HLA-A gene;Homeostasis;Human;humanized mouse;Hybridomas;IL2RA gene;Immune;Immune checkpoint inhibitor;Immune response;Immunize;immunodeficiency;Immunodeficient Mouse;Immunoglobulins;immunoregulation;In Vitro;in vivo;inhibitor;Innate Immune System;Interferon Type II;Interleukin-15;Interleukin-2;Killer Cells;Leukocytes;Light;Malignant Neoplasms;man;Measures;Mediating;Melanoma;member;Membrane;Memory;Monoclonal Antibodies;mouse model;Mus;Myeloid Cells;Natural Immunity;Natural Killer Cells;neoplastic cell;NK Cell Activation;novel therapeutic intervention;Pancreatic Adenocarcinoma;pathogen;Pathway interactions;Patients;Peripheral Blood Mononuclear Cell;Pharmacologic Substance;Phenotype;Phosphorylation;Play;prevent;Prevention;Production;programs;Proliferating;Property;Reaction;receptor;reconstitution;Regulatory T-Lymphocyte;Resistance;Role;Signal Transduction;Stat5 protein;Structure;Suppressor-Effector T-Lymphocytes;Surface Antigens;T cell regulation;T-Cell Activation;T-Lymphocyte;Therapeutic Effect;Transgenes;Translating;tumor;Tumor Antigens;tumor growth;Tumor Immunity;tumor microenvironment,Studies of Human T Regulatory Cells,1046,NA,NA,NA,NA,17,NA,NA,970827,NA
11189373,ZIA,AI,1,N,NA,NA,NA,NA,ZIAAI001056,NA,NA,1ZIAAI001056-17,NIAID:1706624\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,10686351 (contact),"DUFFY, PATRICK  (contact)",NA,NA,NA,Benchmarking;Biological Assay;Communities;Culicidae;design;Development;epidemiology study;Failure;feeding;Future;Human;improved;Life Cycle Stages;Malaria;malaria transmission;malaria transmission-blocking vaccine;Malaria Vaccines;Measures;Microbiology;Modeling;Nature;Parasitemia;Parasites;Parasitic Diseases;Plasmodium;Population;Publishing;Skin;Standardization;success;Surveys;tool;transmission blocking;transmission process;transmission-blocking vaccine;vaccine candidate;vaccine trial;Vaccines,Assays to Support Development of Malaria Transmission Blocking Vaccines,1056,NA,NA,NA,NA,17,NA,NA,1706624,NA
11189374,ZIA,AI,1,N,NA,NA,NA,NA,ZIAAI001059,NA,NA,1ZIAAI001059-17,NIAID:807920\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,10526060 (contact),"SU, HELEN  (contact)",NA,NA,NA,Apoptosis;Autoimmune;autoimmune lymphoproliferative syndrome;Autoimmunity;B-Lymphocytes;Bacterial Infections;Biochemical;Brain;Candidate Disease Gene;CASP8 gene;Cells;cellular longevity;Ceramides;Clinical;Common Variable Immunodeficiency;comparative genomic hybridization;CTLA4 haploinsufficiency;Defect;Development;Diagnosis;Disease;Endocrine;Epstein-Barr Virus Infections;Evaluation;Evans Syndrome;exome sequencing;experimental study;Genes;Genetic;genome sequencing;Genomics;GTP-Binding Proteins;Human;Human Herpesvirus 4;Hybridization Array;Hyper-IgE Syndrome;Hypersensitivity;Immune;Immune system;Immune System Diseases;immunodeficiency;immunoregulation;improved;In Vitro;Infection;Infiltration;Inflammation;influenzavirus;Inherited;Intake;Knowledge;Link;Liver diseases;lymphadenopathy;Lymphocyte;Lymphocyte Activation;Lymphoid;Lymphopenia;Magnesium;Molecular;Molecular Target;Mutation;Mycoses;Natural History;Natural Immunity;Neoplasms;NF-kappa B;optimal treatments;Organ;Pathogenesis;patient subsets;Patients;Play;Predisposition;prevent;Rare Diseases;Reporting;Research;Respiratory syncytial virus;respiratory virus;Rhinovirus;Role;Scientific Advances and Accomplishments;screening;senescence;Signaling Protein;skeletal;Stimulus;Syndrome;System;T cell anergy;T-Lymphocyte;Technology;Testing;Tissues;transcriptome sequencing;Variant;Virus Diseases;whole genome;Work,Defining New Human Immunodeficiency and Immunodysregulation Disorders,1059,NA,NA,NA,NA,17,NA,NA,807920,NA
11189375,ZIA,AI,1,N,NA,NA,NA,NA,ZIAAI001060,NA,NA,1ZIAAI001060-17,NIAID:167088\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,6568505 (contact),"LETO, THOMAS  (contact)",NA,NA,NA,Actins;Adaptive Immune System;Arthritis;Autoimmune Diseases;B-Lymphocytes;Bacterial Infections;Binding;Biological;Biological Models;Blood;Blood specimen;Case Study;Cells;Chronic;Chronic Granulomatous Disease;Clinical;Clinical Data;Clinical Management;cohort;Confocal Microscopy;Cytoskeleton;Defect;Dendritic Cells;Development;Disease;disease phenotype;Dominant-Negative Mutation;early onset;Enzymes;Exhibits;Family;Functional disorder;Generations;Genetic;genetic manipulation;genetic variant;Goals;Human;Hydrogen Peroxide;Immune System Diseases;Immunity;immunodeficiency;Immunoglobulins;Impairment;In Vitro;in vitro Assay;infancy;Inflammatory;Inflammatory Bowel Diseases;Inherited;insight;Leukocyte Adhesion Deficiency;Link;Location;Lower Respiratory Tract Infection;Lupus;Lymphocyte;Lymphopenia;Mediating;Membrane;migration;Molecular;mouse model;Multicenter Studies;mutant;Mutation;Myelogenous;NADP;NADPH Oxidase;Natural History;Neonatal;Neutropenia;neutrophil;novel;Nox enzyme;Oncogenic;Oxidases;Oxidation-Reduction;Oxidative Stress;Oxygen;Pathologic Processes;Patients;Predisposition;Process;Production;programs;Property;Proteins;Proto-Oncogene Proteins c-akt;Publishing;Reactive Oxygen Species;reconstitution;Regulation;Reporting;Research;Respiratory Burst;Role;Severe Combined Immunodeficiency;Severity of illness;Signal Transduction;Signaling Molecule;Superoxides;System;T-Lymphocyte;Testing;tumor microenvironment;Variant;Virus Diseases;Work,Role of Reactive Oxygen Species in Lymphocyte Development and Function,1060,NA,NA,NA,NA,17,NA,NA,167088,NA
11189376,ZIA,AI,1,N,NA,NA,NA,NA,ZIAAI001062,NA,NA,1ZIAAI001062-17,NIAID:1151910\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,77880721 (contact),"LEHMANN, TOVI  (contact)",NA,NA,NA,16S ribosomal RNA sequencing;Address;Adult;Affect;Affinity Chromatography;Africa;Africa South of the Sahara;African;Age;age group;alpha-Thalassemia;Altitude;Animals;Anopheles gambiae;Anopheles Genus;Antibodies;Antigens;Arboviruses;Area;arm;avian plasmodia;Avidity;Bacteria;beta Globin;Binding Sites;Biological Assay;Biology;Blood;Caring;Cells;Centers of Research Excellence;Characteristics;Child;climate change;Clinic;Clinical;Clinical Research;Clinical Trials;Collaborations;Collection;Communicable Diseases;Complex;Culicidae;Cutaneous Leishmaniasis;Dengue;Dengue Virus;Detection;Disease;Disease Outbreaks;disease transmission;Disease Vectors;Distant;DNA;DNA sequencing;Dryness;Ecology;efficacy study;Endothelium;Enrollment;enzootic;Epidemiology;epizootic;Female;filaria;forest;frontier;Functional disorder;Funding;Genetic;genetic variant;Genotype;Goals;ground water;Growth;gut microbiota;Hemoglobin;Hemoglobinopathies;Human;human monoclonal antibodies;immunogenic;Immunoglobulin G;Immunology;Individual;Infection;infection rate;Insecticide Resistance;Institutional Review Boards;international center;Intervention;Invaded;Investigation;Investments;iron deficiency;Knowledge;Laboratory Research;Leishmania;Length of Stay;Lesion;Malaria;malaria infection;malaria mosquito;malaria transmission;Malaria Vaccines;male;Mali;Manuscripts;Measures;Medical;Metagenomics;Methods;microbial community;microbiota;microbiota composition;migration;Molecular;Morbidity - disease rate;mortality;Movement;National Institute of Allergy and Infectious Disease;Natural History;Natural Selections;Nature;Nitric Oxide;novel;Observational Study;Parasites;Participant;pathogen;Pathology;Phlebotominae;Phlebotomus;Plasmodium;Plasmodium falciparum;polyclonal antibody;Preparation;Prevalence;Process;programs;Proteins;Protocols documentation;Rain;Reporting;Research;Research Personnel;Rift Valley Fever;Risk;Role;Route;Sampling;Science;Scientist;Seasons;Senegal;Serology;Severities;Sickle Cell;Sickle Cell Anemia;sickling;Signal Transduction;Site;Skin;skin microbiota;Source;Specificity;Specimen;Sporozoites;Structure;Surveillance Program;Swab;symptomatic improvement;Techniques;Technology;Testing;Time;tool;Training;transmission process;transmission-blocking vaccine;Travel;United States National Institutes of Health;Universities;Vaccination;vaccine candidate;vaccine-induced antibodies;Vaccines;Vascular Endothelium;Vascular System;vector;vector competence;vector mosquito;Vector-transmitted infectious disease;Virus;Visual System;volunteer;West Nile;Work;Zoonoses,Mali International Center for Excellence in Research: Vectors and Hosts of Parasitic Infectious Diseases,1062,NA,NA,NA,NA,17,NA,NA,1151910,NA
11189377,ZIA,AI,1,N,NA,NA,NA,NA,ZIAAI001063,NA,NA,1ZIAAI001063-16,NIAID:64858\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,9691541 (contact),"NUTMAN, THOMAS  (contact)",NA,NA,NA,Acute;Affect;Area;burden of illness;Caring;Child;Clinical;Clinical Trials;Communicable Diseases;cost;Cost Savings;Data;Dentistry;Dipetalonema Infections;Disease;economic impact;effective intervention;Eosinophilic Esophagitis;Faculty;Filaria bancrofti;Filarial Elephantiases;Filariasis;Frequencies;Goals;Health;Hygiene;Immune;Infection;international center;Interruption;laboratory facility;Limb structure;Lymphedema;Mali;Medicine;Molecular;Monitor;neglected tropical diseases;novel diagnostics;novel strategies;novel therapeutic intervention;Onchocerciasis;Participant;Pathogenesis;Patients;Pharmacy facility;Physicians;Pilot Projects;Prevalence;programs;Quality of life;Research;Research Design;rural area;Schistosomiasis;Scientist;socioeconomics;transmission process;Universities,Mali International Center for Excellence in Research: Filariasis,1063,NA,NA,NA,NA,16,NA,NA,64858,NA
11189378,ZIA,AI,1,N,NA,NA,NA,NA,ZIAAI001064,NA,NA,1ZIAAI001064-17,NIAID:4036507\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,9691539 (contact),"PIERCE, SUSAN  (contact)",NA,NA,NA,Adult;Africa;African;antagonist;Anti-malarials;Antigens;arm;Authorization documentation;Blood brain barrier dysfunction;Blood Vessels;Brain;Brain Edema;Brain Stem;CD3 Antigens;CD8-Positive T-Lymphocytes;Cerebral Malaria;Cerebrovascular system;Cessation of life;Child;Childhood;Clinical;Clinical Protocols;Clinical Trials;co-infection;Communicable Diseases;Complication;Cross Presentation;Culicidae;Data;Development;Disease;Dose;Endothelium;Falciparum Malaria;Funding;Glutamine;Goals;Grant;hearing impairment;Hemorrhage;HIV;human disease;Immune;immune cell infiltrate;Immunology;Impaired cognition;Impairment;Infection;Inflammation;Institutional Review Boards;Knowledge;Life;Magnetic Resonance Imaging;Malaria;Malawi;Mechanics;medical schools;Molecular;Morbidity - disease rate;mortality;mouse model;National Institute of Allergy and Infectious Disease;Nature;Obstruction;Parasites;Pathology;Pattern;Pediatric Hospitals;Phase;Placebo Control;Plasmodium falciparum;Public Health;recruit;Research;Safety;safety study;safety testing;Senior Scientist;Side;Site;Syndrome;T cell therapy;Time;transmission process;Venous;Visual impairment,Malaria immunology,1064,NA,NA,NA,NA,17,NA,NA,4036507,NA
11189379,ZIA,AI,1,N,NA,NA,NA,NA,ZIAAI001065,NA,NA,1ZIAAI001065-17,NIAID:1082746\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,9691541 (contact),"NUTMAN, THOMAS  (contact)",NA,NA,NA,2019-nCoV;Acute-Phase Proteins;Address;adipokines;adiponectin;Adult;Advocate;age group;Anthelmintics;Antigens;Antitubercular Agents;Area;Bilateral;Biochemical;Biological Markers;biomarker discovery;Biotechnology;Blood Glucose;burden of illness;C-Peptide;C3bi;CCL11 gene;CCL2 gene;Characteristics;chemokine;Child;Childhood;Clinical;clinical research site;co-infection;cohort;Collaborations;Communicable Diseases;comorbidity;Complement;Complement 1q;Complement 3b;Complement 4b;Complement 5a;Complement Activation;Complement Factor B;Complement Factor D;Complex;Country;COVID-19;COVID-19 vaccination;CSF3 gene;CXCL1 gene;CXCL10 gene;cyber infrastructure;cytokine;Dengue;Developing Countries;diabetes management;Diabetes Mellitus;Disease;drug-sensitive;EGF gene;Elderly;Emerging Communicable Diseases;Endemic Diseases;Enzyme-Linked Immunosorbent Assay;Epidemiology;Exhibits;Family;Female;FGF2 gene;Filariasis;Fostering;Future;Gelatinase B;genetic regulatory protein;Glucagon;Glycosylated Hemoglobin;Goals;Granulocyte-Macrophage Colony-Stimulating Factor;Growth Factor;Health;Healthcare;helminth infection;Helminths;Hemoglobin concentration result;HIV;Homeostasis;Hookworm Infections;Hookworms;Hospitals;IL17 gene;IL18 gene;IL8 gene;Immune;Immune response;Immune system;Immunologic Markers;Immunologics;Immunology;immunoregulation;improved;India;Individual;Infection;Inflammation;Inflammatory;insight;Institution;Insulin;Interferon alpha;Interferon Type II;Interleukin-1 alpha;Interleukin-1 beta;Interleukin-10;Interleukin-12;Interleukin-13;Interleukin-2;Interleukin-4;Interleukin-5;Interleukin-6;International;international center;Intervention Studies;Lectin;Link;Lung;Lung Diseases;lung lesion;Malaria;male;Malnutrition;Matrix Metalloproteinases;Medical Research;Metabolic Diseases;microbial;Morbidity - disease rate;mortality;Multisystem Inflammatory Syndrome in Children;National Institute of Allergy and Infectious Disease;Neutrophil Collagenase;Newly Diagnosed;Non-Insulin-Dependent Diabetes Mellitus;novel therapeutic intervention;Obesity;Odds Ratio;Outcome;Pancreatic Hormones;Pathogenesis;Patient Care;Patient Recruitments;Patient-Focused Outcomes;Patients;Physicians;platelet-derived growth factor AB;Play;Population;Postdoctoral Fellow;predictive marker;Process;Profibrotic signal;programs;protective effect;Pulmonary Pathology;Pulmonary Tuberculosis;Regional Disease;Regulation;Research;Research Institute;Research Personnel;Resources;Risk;Role;Rural;SARS-CoV-2 infection;SARS-CoV-2 pathogenesis;Scientist;seropositive;Severities;Severity of illness;sex;Sex Differences;Site;Sputum;Strongyloides stercoralis;Strongyloidiasis;student mentoring;Thoracic Radiography;Tissues;TNF gene;Training;Transforming Growth Factor alpha;Treatment outcome;Tuberculosis;tuberculosis diagnostics;tuberculosis immunity;tuberculosis treatment;United States National Institutes of Health;Vaccination;vaccine immunogenicity;Vascular Endothelial Growth Factors;Virus;Virus Diseases;welfare;Work;working group,India International Center for Excellence in Research,1065,NA,NA,NA,NA,17,NA,NA,1082746,NA
11189380,ZIA,AI,1,N,NA,NA,NA,NA,ZIAAI001066,NA,NA,1ZIAAI001066-17,NIAID:1364178\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,79973344 (contact),"YEK, CHRISTINA  (contact)",NA,NA,NA,2019-nCoV;Acinetobacter;Acinetobacter baumannii;Acute;Adult;Aedes;Age Years;aged;Agriculture;Animal Husbandry;Animals;Antibodies;Antibody-Dependent Enhancement;Antigens;Antimicrobial Resistance;Arboviruses;betacoronavirus;Biological Assay;Biology;biomarker identification;Birds;Burkholderia pseudomallei;Cambodia;Cambodian;carbapenem resistant Enterobacterales;Categories;Cells;chikungunya;Chikungunya virus;Child;Chiroptera;Climate;Clinical;clinical center;Clinical Research;clinical sequencing;cohort;community transmission;Country;COVID-19 pandemic;cross reactivity;Culicidae;Data;Dengue;Dengue Infection;Dengue Virus;design;Detection;Development;diagnostic algorithm;diagnostic development;Disease;Disease Outbreaks;disorder risk;Distant;Drug resistance;Emerging infection;Environment;Enzyme-Linked Immunosorbent Assay;Epidemic;Epidemiology;Escherichia coli;Evolution;Exposure to;Extramural Activities;Fever;Flavivirus;follow-up;forest;Forestry;Genes;Genetic Markers;genomic biomarker;Genomics;Genotype;Geography;Goals;healthy volunteer;Helminths;Henipavirus;HIV;Home;Human;human disease;Humoral Immunities;Immune;Immunity;Immunoglobulin G;Immunology;Immunotherapy;Incidence;Infection;Infrastructure;International;international center;Intervention;Intramural Research;Laboratory Research;Leptospirosis;Low Prevalence;Malaria;man;Manuscripts;metagenomic sequencing;Microbiology;Molecular Weight;Monitor;national surveillance;Nature;Neutralization Tests;novel;observational cohort study;Organism;pandemic disease;Participant;pathogen;Pathogenesis;pathogenic bacteria;Patients;Pattern;Pediatric cohort;peri-urban;Persons;Phylogenetic Analysis;Pilot Projects;Plasmodium falciparum;Plasmodium knowlesi;Plasmodium vivax;Population;programs;Proteins;Publishing;rapid test;Recombinant Proteins;Reporting;Research;research clinical testing;Research Personnel;Research Priority;Rickettsia;Risk;Salivary;Salivary Glands;Salmonella;Sampling;Sanitation;Sarbecovirus;SARS-CoV-2 immunity;Scrub Typhus;Seasons;secondary infection;Seroprevalences;Serotyping;Specificity;Streptococcus suis;surveillance network;Surveys;System;Testing;transmission process;Tropical Medicine;Typhoid Fever;United States National Institutes of Health;vector;vector control;vector-borne;vector-borne pathogen;Vector-transmitted infectious disease;Viral;Viral Genome;virology;Virus;West Nile virus;Western Blotting;whole genome;Zika Virus;Zoonoses,International Research in Cambodia: Tropical Medicine and Vector Research,1066,NA,NA,NA,NA,17,NA,NA,1364178,NA
11189381,ZIA,AI,1,N,NA,NA,NA,NA,ZIAAI001071,NA,NA,1ZIAAI001071-17,NIAID:97669\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,9691557 (contact),"MCBRIDE, ALISON  (contact)",NA,NA,NA,Acceleration;Amino Acid Sequence;bioinformatics resource;Clinical;Communities;Country;Databases;Detection;Diagnosis;Disease;Family;functional genomics;Genes;Genome;Genomics;Goals;Image;Information Resources;Link;National Institute of Allergy and Infectious Disease;Papillomavirus;protein structure;relational database;Research;Research Personnel;Resources;Sequence Alignment;tool;United States National Institutes of Health;Update;Viral;Viral Genome;Virus;Virus Diseases;Visualization;web app;web site,Papillomavirus Bioinformatics Resource,1071,NA,NA,NA,NA,17,NA,NA,97669,NA
11189382,ZIA,AI,1,N,NA,NA,NA,NA,ZIAAI001076,NA,NA,1ZIAAI001076-17,NIAID:1946106\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,9691563 (contact),"MEIER-SCHELLERSHEIM, MARTIN  (contact)",NA,NA,NA,Address;Affect;Algorithms;Amino Acids;Antibodies;Behavior;Binding;Binding Sites;Biochemical;Biological;Biological Models;Biological Process;biophysical properties;cell behavior;Cell model;Cells;Cellular biology;Cellular Membrane;Cellular Morphology;Classification;Collaborations;Complex;Computational Biology;Computational Technique;Computer Models;Computer Simulation;Computer software;cross reactivity;cytokine;Cytokine Receptors;Data;Data Set;Databases;Development;Diffusion;Dose;Engineering;Formulation;Geometry;Goals;graphical user interface;Immune;Immune response;Immune signaling;Immune system;Immunologic Receptors;Immunology;improved;Individual;infectious disease model;information display;information organization;interactive visualization;intercellular communication;interest;Intervention;Intuition;Laboratories;Language;Ligands;Link;Macrophage;Mathematics;Measurement;Measures;Mediating;Membrane;Methods;model building;Modeling;Modernization;Modification;Molecular;Molecular Target;Morphology;Motion;Organ;particle;pathogen;Pathway interactions;Peptides;Persons;Phosphorylation;Phosphotransferases;Physiological;Process;Proteomics;Pythons;Reaction;receptor;recruit;Research;Resolution;response;Risk Reduction;Shapes;Signal Pathway;Signal Transduction;Signaling Molecule;simulation;simulation software;Specific qualifier value;Stimulus;Surface;System;Systems Biology;T-Cell Receptor;T-Lymphocyte;Techniques;Technology;Tertiary Protein Structure;Testing;Time;Tissues;Toll-like receptors;tool;transcription factor;Translating;Translations;Whole Organism;Work,Computational Biology in Systems Immunology and Infectious Disease Modeling,1076,NA,NA,NA,NA,17,NA,NA,1946106,NA
11189383,ZIA,AI,1,N,NA,NA,NA,NA,ZIAAI001079,NA,NA,1ZIAAI001079-17,NIAID:637952\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,9691569 (contact),"DELEO, FRANK  (contact)",NA,NA,NA,Antibiotic Resistance;Area;Bacteria;Biology;Blood Circulation;Development;Diagnostic;Disease;Goals;healthcare-associated infections;human disease;Infection;Innate Immune Response;Lower Respiratory Tract Infection;methicillin resistant Staphylococcus aureus;Modeling;Multi-Drug Resistance;neutrophil;pathogen;Pathogenesis;pathogenic bacteria;Predisposition;prophylactic;Research;Skin Tissue;soft tissue;Staphylococcus aureus;Staphylococcus aureus infection;Testing;United States;Vancomycin;Virulence,Mechanisms of Staphylococcus aureus virulence,1079,NA,NA,NA,NA,17,NA,NA,637952,NA
11189384,ZIA,AI,1,N,NA,NA,NA,NA,ZIAAI001080,NA,NA,1ZIAAI001080-17,NIAID:1227486\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,9691571 (contact),"OTTO, MICHAEL  (contact)",NA,NA,NA,Acne;anti-microbial peptide;Bacteria;Bacterial Infections;bacteriocin;Collaborations;Epithelium;Genetic;Genus staphylococcus;Goals;Health;Human;Human body;Human Microbiome;human microbiota;Infection;interest;Intestines;Investigation;Left;Maryland;member;microorganism;Molecular;Nose;Probiotics;professor;Role;Site;Skin;Source;Surface;Therapeutic;tool;Universities,Role of the human microbiota and probiotics,1080,NA,NA,NA,NA,17,NA,NA,1227486,NA
11189385,ZIA,AI,1,N,NA,NA,NA,NA,ZIAAI001081,NA,NA,1ZIAAI001081-15,NIAID:1276926\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,9691547 (contact),"BARRY, CLIFTON  (contact)",NA,NA,NA,Aminoglycosides;Antitubercular Agents;Applied Research;Area;arm;Award;bactericide;Biological Markers;Cause of Death;Characteristics;China;Chinese;Classification;Clinical;clinical candidate;clinical development;clinical diagnostics;Clinical Research;Clinical Trials;Collaborations;Conduct Clinical Trials;COVID-19 complications;COVID-19 pandemic;Cross-Sectional Studies;cytokine;Data;Data Analyses;Developing Countries;Diagnostic tests;Diagnostics Research;Disease;disease diagnosis;disorder risk;drug candidate;Drug Combinations;Drug resistance;Drug resistant Mycobacteria Tuberculosis;drug testing;drug-sensitive;effective therapy;Enrollment;European;Extreme drug resistant tuberculosis;Failure;Fluoroquinolones;follow-up;Foundations;Funding;Future;Goals;Immunologic Markers;improved;Infectious Agent;International;Intervention;Isoniazid resistance;Journals;Lesion;Lung;Manuscripts;Measurement;Medical;medication compliance;Medicine;Meropenem;Methodology;Methods;Microbiology;Molecular;Monobactams;Multidrug-Resistant Tuberculosis;Mutation;Mycobacterium tuberculosis;National Institute of Allergy and Infectious Disease;Natural Sciences;New England;novel;novel diagnostics;novel therapeutics;Participant;Patients;Pattern;PET/CT scan;Pharmaceutical Preparations;Phase;prospective;Protocols documentation;Province;Public Health;Publishing;radiological imaging;Radiology Specialty;rate of change;Regimen;Relapse;Reporting;Research;Research Personnel;Residual state;Resource-limited setting;Resources;Risk;Sampling;Sampling Studies;Science;secondary analysis;South Africa;South African;South Carolina;South Korea;Sputum;standard care;success;Technology;Testing;Thoracic Radiography;Translational Research;treatment duration;Treatment Protocols;treatment response;treatment strategy;Tuberculosis;tuberculosis chemotherapy;Tuberculosis diagnosis;tuberculosis drugs;tuberculosis treatment;United States National Institutes of Health;Universities;week trial,International Tuberculosis Clinical Research,1081,NA,NA,NA,NA,15,NA,NA,1276926,NA
11189386,ZIA,AI,1,N,NA,NA,NA,NA,ZIAAI001083,NA,NA,1ZIAAI001083-16,NIAID:1503131\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,6479630 (contact),"DRUEY, KIRK M (contact)",NA,NA,NA,Actins;Acute;Address;Adherens Junction;Adult;Alleles;Anaphylaxis;anasarca;angiogenesis;Angiogenic Proteins;Angioneurotic Edema;Angiopoietin-2;Antigen Targeting;arginine methyl ester;attenuation;Biological;Biological Assay;biomedical referral center;Blood;Blood capillaries;Blood Cells;Blood Vessels;cadherin 5;Capillary Leak Syndrome;CCL2 gene;chemotherapy;Child;clinical center;Clinical Protocols;cohort;CXCL10 gene;cytokine;Death Rate;Defect;density;Diagnosis;Disease;disease model;Disease remission;DNA sequencing;Edema;Endothelial Cells;Endothelial Growth Factors;Endothelium;Etiology;Event;exome sequencing;experience;Extravasation;Flare;Functional disorder;Genes;Genetic;genetic association;genome sequencing;genome-wide;Goals;Growth and Development function;Hematopoietic;Histamine;Human;Hypotension;Hypotensives;Hypovolemia;Hypovolemics;Immune;Immunoglobulin G;Immunoglobulins;immunoregulation;Inflammation Mediators;Inflammatory;influenza infection;insight;Interleukin-6;Intravenous Immunoglobulins;Link;Liquid substance;Literature;macromolecule;Mediator;Medical;Modeling;Monoclonal Antibodies;Monoclonal Gammapathies;Monoclonal gammopathy of uncertain significance;Morbidity - disease rate;mortality;mouse model;Multiple Myeloma;Mutation;Nature;NOS3 gene;novel therapeutic intervention;Odds Ratio;Oliguria;Paraproteins;Parents;Pathogenesis;Patient Admission;Patients;Penetrance;Permeability;Plasma;Plasma Cells;Plasmacytic Leukemia;Polymorphism Analysis;Population;Predisposition;premalignant;Process;Property;Protein Array;Protein phosphatase;Proteins;Proteome;Protocols documentation;Rare Diseases;Receptor Protein-Tyrosine Kinases;Reporting;Research;response;RNA;Role;Sample Size;Sepsis;Serum;Shock;Signs and Symptoms;Single Nucleotide Polymorphism;Single Nucleotide Polymorphism Map;SJL/J Mouse;solute;Source;specific biomarkers;Stimulus;Stress Fibers;stressor;Susceptibility Gene;Symptoms;Syndrome;Testing;Therapeutic;TIE-2 Receptor;Tissues;transcriptome;United States National Institutes of Health;Variant;Vascular Endothelial Cell;Vascular Endothelial Growth Factors;Vascular Endothelium;whole genome;Xenograft Model,Studies in the Pathogenesis of Systemic Capillary Leak Syndrome,1083,NA,NA,NA,NA,16,NA,NA,1503131,NA
11189387,ZIA,AI,1,N,NA,NA,NA,NA,ZIAAI001084,NA,NA,1ZIAAI001084-16,NIAID:1072043\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,10269151 (contact),"NITA-LAZAR, ALEKSANDRA  (contact)",NA,NA,NA,adaptive immune response;Adipose tissue;ADP ribosylation;analog;Antibiotic Resistance;Antibiotic Therapy;Autoimmune Diseases;Biological;Biological Assay;Biopsy;Cell Line;Cell Physiology;cell type;Cells;Child;chronic inflammatory disease;Clustered Regularly Interspaced Short Palindromic Repeats;Collaborations;Complex;Computational Biology;Computer Models;CRISPR/Cas technology;cytokine;Data;Data Correlations;Data Set;design;Diet;dietary;Disease;Disease Progression;Distal part of ileum;dosage;Elements;Endotoxins;Enzyme-Linked Immunosorbent Assay;Eosinophilic Esophagitis;Esophagus;Event;exhaustion;experimental study;Exposure to;Family;Flow Cytometry;follow-up;Gastrointestinal tract structure;Gene Expression;Genes;Germ-Free;Goals;gut bacteria;Homologous Gene;Host Defense;host-microbe interactions;Human;Hydrolase;ileum;Immune;Immune signaling;Immune system;Individual;Infection;Inflammasome;Inflammatory;Inflammatory Response;Innate Immune Response;insight;Integral Membrane Protein;interest;Interleukin-1 Receptors;Intervention;Kinetics;knock-down;Knock-out;Legionella pneumophila;Legionnaires&apos; Disease;Ligands;Literature;Lupus;Lymphocyte Biology;Macrophage;Maryland;Mass Spectrum Analysis;Measures;Mediating;Meta-Analysis;Metabolic;Metabolic Diseases;Metabolism;microbiota;Mitochondria;MME gene;Modeling;Modification;Molecular;Molecular Profiling;molecular recognition;Mucous Membrane;Mus;mutant;Myelogenous;National Institute of Allergy and Infectious Disease;National Institute of Child Health and Human Development;Nuclear;Nucleic Acids;Oregon;pathogen;pathogen exposure;Pathogenesis;Pathway interactions;Patients;Pattern;pharmacologic;Phosphoproteins;phosphoproteomics;Phosphorylation;Phosphotransferases;Population;Post-Translational Protein Processing;Process;Production;protein complex;protein expression;Protein Secretion;Proteins;Proteolysis;Proteome;Proteomics;Protocols documentation;receptor;Receptor Signaling;Regulation;Reporting;Resolution;response;RNA;RNA Interference;Role;Roseomonas;Sampling;sensor;Sepsis;Serine;Signal Pathway;Signal Transduction;Site;Site-Directed Mutagenesis;Small Interfering RNA;Staphylococcus aureus;Staphylococcus aureus infection;Structure;System;Thailand;therapy development;Threonine;Time;Tissues;TLR2 gene;TLR4 gene;TLR7 gene;TNF Receptor-Associated Factors;Toll-Like Receptor Pathway;Toll-like receptors;Toxoplasma;transcriptome;Tyrosine;Ubiquitination;Universities;Western Blotting,Protein Modifications Involved in Cell Signaling,1084,NA,NA,NA,NA,16,NA,NA,1072043,NA
11189388,ZIA,AI,1,N,NA,NA,NA,NA,ZIAAI001085,NA,NA,1ZIAAI001085-16,NIAID:950679\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,10269151 (contact),"NITA-LAZAR, ALEKSANDRA  (contact)",NA,NA,NA,3-Dimensional;Affinity;Behavior;Binding;Bioinformatics;Biological;Biological Assay;Biological Models;bone;Cell Line;Cells;chemokine;Chemotaxis;Collaborations;Complex;Computational Biology;Computer Models;Coupled;Data;Data Set;deamidation;design;differential expression;Exposure to;Freedom;G Protein-Coupled Receptor Signaling;Geometry;Immune signaling;Immune system;in silico;In Vitro;Inflammasome;insight;Label;Length;Ligands;Liquid Chromatography;Literature;Macrophage;Mammalian Cell;mass spectrometer;Mass Spectrum Analysis;mathematical model;Measurement;Measures;Mediating;Methodology;Methods;model building;Modeling;Modification;Molecular;Monitor;monocyte;Mouse Protein;Mus;Mutation;nano;network models;Osteoclasts;oxidation;pathogen;Pathway interactions;Peptides;Phosphorylated Peptide;predictive modeling;protein expression;protein structure;Proteins;Proteome;Proteomics;PubMed;Qi;Reaction;receptor;Receptor Signaling;response;RNA;Sampling;Set protein;Shotguns;Signal Pathway;Signal Transduction;Signaling Molecule;simulation;Site;software development;sphingosine 1-phosphate;Sphingosine-1-Phosphate Receptor;Stimulus;Study models;success;synthetic peptide;System;Testing;text searching;TLR4 gene;Transcript;transcriptome sequencing;transcriptomics;Work,Absolute Quantification of Molecular Representation and Interaction,1085,NA,NA,NA,NA,16,NA,NA,950679,NA
11189389,ZIA,AI,1,N,NA,NA,NA,NA,ZIAAI001086,NA,NA,1ZIAAI001086-16,NIAID:1599406\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,6568487 (contact),"CAUGHEY, BYRON  (contact)",NA,NA,NA,Acceleration;Adopted;Affect;Age;alpha synuclein;ALS patients;Alzheimer&apos;s Disease;Alzheimer&apos;s disease brain;Amyloid;Amyloid Fibrils;Amyotrophic Lateral Sclerosis;Animals;Antibodies;Apical;Area;Astrocytes;Autopsy;Back;Binding;Biological Assay;Biological Markers;Blood Vessels;Bovine Spongiform Encephalopathy;Brain;brain control;brain tissue;C9ORF72;Cattle;Cells;Cerebellar Cortex;Cerebellum;Cerebrospinal Fluid;Cerebrum;cervid;Characteristics;chronic traumatic encephalopathy;Chronic Wasting Disease;Clinical;cofactor;cohort;Collaborations;conditional knockout;Cortical Cord;Creutzfeldt-Jakob Syndrome;Deacetylase;Dedications;Dementia with Lewy Bodies;Deposition;dermatome;Detection;detection assay;Development;Diagnosis;diagnostic value;Diamond;Disease;disorder control;Drainage procedure;Dryness;Ear;Early Diagnosis;Enzymes;Etiology;Exposure to;extracellular;Extracellular Matrix;Extracellular Space;familial amyotrophic lateral sclerosis;Frontotemporal Dementia;Gene Mutation;Genes;Genetic;Genetic Polymorphism;genetic testing;Growth;Head;Heparitin Sulfate;Human;illness length;In Vitro;Infection;Knock-in Mouse;Knockout Mice;Laboratories;Lewy Bodies;Lewy Body Dementia;Link;Measures;Methionine;Molecular Conformation;Monoclonal Antibodies;Motor Cortex;Mus;Mutation;Nerve Degeneration;neural;Neurodegenerative Disorders;Neurons;neuropathology;novel;Parietal Lobe;Parkinson Disease;Pathologic;Pathology;Patients;Persons;pharmacodynamic biomarker;Physiological;polymerization;Polymers;Prion Diseases;prion seeds;prion-like;Prions;Prognostic Marker;protein aggregation;protein misfolding;Protocols documentation;prototype;PrP;PrP gene;PrPSc Proteins;Recombinants;Role;Sampling;Scrapie;Sheep;Skin;Solid;Source;Specificity;Specimen;Spinal Cord;sporadic amyotrophic lateral sclerosis;Stainless Steel;Steel;Sterilization;Sulfate;sulfotransferase;sulfurtransferase;superoxide dismutase 1;Surface;Surgical Instruments;tau aggregation;tau function;tau Proteins;Tauopathies;Testing;therapeutic development;Time;Tissues;Transgenic Mice;Universities;validation studies;Valine,Detection of Prions,1086,NA,NA,NA,NA,16,NA,NA,1599406,NA
11189390,ZIA,AI,1,N,NA,NA,NA,NA,ZIAAI001087,NA,NA,1ZIAAI001087-15,NIAID:19993\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,6568487 (contact),"CAUGHEY, BYRON  (contact)",NA,NA,NA,Address;alpha synuclein;Binding;Biological Assay;Catalytic Domain;cost;Dementia with Lewy Bodies;Development;Disease;drug discovery;effective therapy;Failure;Goals;inhibitor;Lead;Machine Learning;machine learning method;Multiple System Atrophy;Neurodegenerative Disorders;Parkinson Disease;Pathologic;Pharmaceutical Preparations;Prion Diseases;Process;Proliferating;protein aggregation;Reporting;small molecule inhibitor;Structure;Surface;synuclein;synucleinopathy;Testing;Therapeutic;Toxic effect;Universities,Prion Disease Therapeutics,1087,NA,NA,NA,NA,15,NA,NA,19993,NA
11189391,ZIA,AI,1,N,NA,NA,NA,NA,ZIAAI001089,NA,NA,1ZIAAI001089-16,NIAID:6531361\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,10269158 (contact),"FELDMANN, HEINRICH  (contact)",NA,NA,NA,"Alpha Virus;Andes Virus;Animal Model;Animals;Anti-viral Agents;Antigen Presentation;Area;Arenavirus;Avian Influenza;Avian Influenza A Virus;Biology;Breeding;Cattle;Cells;Chiroptera;Communicable Diseases;Containment;Coronavirus;COVID-19 pandemic;Crimean-Congo Hemorrhagic Fever Virus;Data;Diagnostic;Diagnostic tests;disease model;Disease Outbreaks;disease transmission;Domestic Fowls;drug repurposing;Ebola;Ebola Vaccines;Ebola virus;Ecology;efficacy testing;Emergency Situation;emerging virus;Encephalitis;Enterovirus;Enterovirus 68;epidemiology study;Evaluation;Family suidae;Ferrets;Filovirus;Flavivirus;Fostering;Functional disorder;Generations;Genome;Glycoproteins;Goat;Health;Heartland virus;Human;Immune;Immune response;Immunization;In Vitro;in vivo;Infection;Influenza A Virus, H5N1 Subtype;innovation;Intervention;Lassa virus;Learning;Licensing;Life Cycle Stages;Livestock;Mastomys;Mission;Modeling;Molecular;Monkeypox;Monoclonal Antibodies;Mus;Nanostructures;neglect;Nipah Virus;nonhuman primate;novel vaccines;Orthobunyavirus;Orthomyxoviridae;pathogen;Pathogenesis;pathogenic virus;Pathogenicity;Pathology;Pattern;Play;Prevention Measures;Prophylactic treatment;Public Health;Rattus;Recombinants;remdesivir;Replicon;Research;Research Activity;research clinical testing;research facility;Respiratory distress;response;reverse genetics;Ribavirin;RNA;RNA amplification;Rodent;Role;SARS-CoV-2 antibody;Severe Fever with Thrombocytopenia Syndrome Virus;Sheep;structured lipid;Sudan Ebola virus;System;Technology;Therapeutic;transmission process;Vaccination;vaccine candidate;vaccine development;vaccine platform;Vaccines;vector;vector vaccine;Vesicular stomatitis Indiana virus;Viral;Viral Hemorrhagic Fevers;Viral reservoir;Virus;Virus Diseases;Visit;wild bird;Work",Viral Hemorrhagic Fevers: Disease Modeling and Transmission,1089,NA,NA,NA,NA,16,NA,NA,6531361,NA
11189392,ZIA,AI,1,N,NA,NA,NA,NA,ZIAAI001090,NA,NA,1ZIAAI001090-16,NIAID:1122303\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,6479774 (contact),"CONNORS, MARK  (contact)",NA,NA,NA,Address;Antibodies;Antibody Binding Sites;Antibody Response;Antigen Presentation;Antigen-Presenting Cells;Antigens;B Cell Proliferation;B-Lymphocytes;Binding;CD28 gene;CD3 Antigens;CD4 Positive T Lymphocytes;CD40 Ligand;CD8-Positive T-Lymphocytes;Cell Differentiation process;Cell Line;Cell Separation;Cells;Characteristics;Chronic;Clinical;clinical development;Clone Cells;cohort;Collaborations;Coupled;Cultured Cells;cytokine;Data;design;Development;Dose;egg;Epitopes;Exhibits;experience;Exposure to;Genetic;Glycoproteins;glycosylation;Goals;HIV;HIV envelope protein;HIV Infections;HIV vaccine;HIV-1;Human;human monoclonal antibodies;Immune response;Immunity;immunogenic;Immunoglobulin Genes;Immunoglobulins;Immunotherapy;Individual;Infection;Inflammation;Inflammatory;Interleukin-2;interleukin-21;Knowledge;lead candidate;Macaca mulatta;manufacturability;Mediating;member;Membrane;Membrane Glycoproteins;Memory B-Lymphocyte;Molecular Conformation;Monoclonal Antibodies;Mucous Membrane;neutralizing antibody;neutralizing monoclonal antibodies;novel;Nucleic Acids;Participant;patient response;Patient Selection;patient subsets;Patients;peripheral blood;Phenotype;preclinical development;Prophylactic treatment;recruit;Research;research and development;Research Personnel;Resistance;response;Route;Site;SIV;Specificity;Techniques;Testing;Therapeutic;therapy development;Time;Toll-like receptors;Vaccination;vaccine access;vaccine platform;Vaccine Production;Vaccine Research;Vaccinee;Vaccines;vector;Viral;Virus;Virus Diseases;virus testing;Work,Mechanisms of Effective Humoral Immune Responses to HIV-1,1090,NA,NA,NA,NA,16,NA,NA,1122303,NA
11189393,ZIA,AI,1,N,NA,NA,NA,NA,ZIAAI001092,NA,NA,1ZIAAI001092-16,NIAID:989897\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,8818872 (contact),"CARTER, MELODY C (contact)",NA,NA,NA,Adverse reactions;alpha-gal syndrome;Anaphylaxis;Antigens;Basophils;Biopsy;Bone Marrow;Bone Marrow Aspiration;Clinical;clinical center;clinical phenotype;cohort;Collaborations;Core Facility;Data;Diagnosis;Disease;Drug Hypersensitivity;Etiology;European;experience;Food;High Prevalence;Idiopathic anaphylaxis;Immunotherapy;Inherited;Inpatients;Insect Sting;Investigation;Legal patent;Manuscripts;mast cell;mastocytosis;Mediator;Mutation;Myelogenous;participant enrollment;Pathogenesis;Pathway interactions;Patient Admission;patient population;Patients;Pharmaceutical Preparations;pharmacologic;Prevalence;Procedures;Prospective Studies;Proto-Oncogene Protein c-kit;Protocols documentation;Reaction;Recurrence;Reporting;Risk;Safety;Serum;Severities;Syndrome;Systemic Mastocytosis;targeted treatment;trait;Tryptase;Uncertainty;United States National Institutes of Health;Validation;Venoms,Pathogenesis and Treatment of Anaphylaxis,1092,NA,NA,NA,NA,16,NA,NA,989897,NA
11189394,ZIA,AI,1,N,NA,NA,NA,NA,ZIAAI001097,NA,NA,1ZIAAI001097-16,NIAID:931662\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,9413751 (contact),"BOSIO, CATHARINE  (contact)",NA,NA,NA,Acellular Vaccines;Acute;adaptive immunity;Aerosols;Anti-Inflammatory Agents;Bacteria;Bacterial Infections;bioweapon;capsule;carbohydrate structure;Carbohydrates;cell killing;Cells;cytokine;Dangerousness;Data;Death Rate;Defect;Dendritic Cells;Dengue Virus;Development;Disease;Francisella;Francisella tularensis;Goals;Health;Human;Immune response;Immune system;Immunosuppression;Impairment;In Vitro;in vivo;Incubated;Individual;Infection;Infectious Agent;Inflammation;Inflammatory;Inflammatory Response;Inhalation;Invaded;Laboratories;Legal patent;Lipid Synthesis Pathway;Lipids;Liposomes;Macrophage;Mediating;Membrane;Metabolic;Metabolic Pathway;Metabolism;Microbe;Mus;mutant;Natural Immunity;novel;novel therapeutics;novel vaccines;O Antigens;pathogen;pathogenic bacteria;Pathogenicity;Play;Predisposition;prevent;programs;Proteins;Pulmonary tularemia;receptor;Research;response;Role;Route;Secondary to;Sentinel;Signal Pathway;Signaling Molecule;Stimulus;Structure;Surface;Symptoms;Testing;Therapeutic;Time;transmission process;Tularemia;United States;USSR;vector-borne;Virulence;Virulent;weapons,Modulation of Human Cells by Virulent Francisella tularensis,1097,NA,NA,NA,NA,16,NA,NA,931662,NA
11189395,ZIA,AI,1,N,NA,NA,NA,NA,ZIAAI001102,NA,NA,1ZIAAI001102-16,NIAID:1676438\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,10269182 (contact),"PETERSON, KARIN  (contact)",NA,NA,NA,Address;Affect;Alpha Virus;Animal Model;Apoptosis;Apoptotic;Arboviruses;Blood;Blood - brain barrier anatomy;Bone Marrow;Brain;cell type;Cells;Central Nervous System;Childhood;Clinical;Disease;Disease Outcome;Elements;emerging pathogen;fetal;Fetus;Fibroblasts;Flavivirus;Functional disorder;genomic variation;Goals;Golgi Apparatus;Human;Immune;Immune response;In Vitro;in vivo;Infection;Infectious Skin Diseases;Inflammatory;Innate Immune Response;Jamestown Canyon virus;keratinocyte;La Crosse virus;Ligands;Mammals;Mediating;Modeling;monocyte;mosquito-borne;Mus;Muscle Cells;Neck;Nervous System;Nervous System Disorder;Neurons;Neuropathogenesis;novel;Pathogenesis;Pathway interactions;Phagocytes;Phenotype;Placenta;Population;receptor;recruit;response;Signal Transduction;Signs and Symptoms;Simplexvirus;Skin;Specificity;Tahyna virus;Technetium Tc 99m ciprofloxacin;Therapeutic;Time;Tissues;transmission process;United States;vector;Vertical Transmission;Viral;Viral Encephalitis;Viral Pathogenesis;viral transmission;Virus;Virus Diseases;virus-induced neurologic disease;Zika Virus;ZIKV infection,Mechanisms of Viral Pathogenesis in the Central Nervous System,1102,NA,NA,NA,NA,16,NA,NA,1676438,NA
11189396,ZIA,AI,1,N,NA,NA,NA,NA,ZIAAI001105,NA,NA,1ZIAAI001105-16,NIAID:379861\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,8237033 (contact),"PRIOLA, SUZETTE ALISE (contact)",NA,NA,NA,Affect;alpha synuclein;Alzheimer&apos;s Disease;Amyloid;Amyloid beta-Protein;amyloid formation;Amyloid Proteins;Annual Reports;Biochemistry;Biological Assay;Biological Models;Bovine Spongiform Encephalopathy;Brain;Cell Physiology;cell type;Cells;Chronic Wasting Disease;Collaborations;Complex;Creutzfeldt-Jakob Syndrome;Data;Deer;Deposition;Diffuse;dimer;Disease;Environment;Equine mule;Exposure to;Familial Creutzfeldt-Jakob Disease;Human;Iatrogenesis;In Vitro;in vivo Model;Incidence;Individual;Infection;Infectious Agent;insight;instrument;interest;Journals;Laboratories;Manuscripts;Medical;misfolded protein;Modeling;Molecular;Molecular Chaperones;Monitor;mouse model;Mutation;Nerve Degeneration;Neurodegenerative Disorders;Parkinson Disease;particle;Pathogenesis;Pathogenicity;Pathway interactions;Peptide Hydrolases;Persons;Physiological;Preparation;Prion Diseases;prion-like;Prions;Process;protein aggregation;protein misfolding;Proteins;PrP;PrP amyloid;PrP gene;PrPSc Proteins;Publications;Publishing;Research;Resistance;Science;Scrapie;Sheep;Structure;tau Proteins;Time;Transgenic Mice;uptake;Work,Molecular Mechanisms of Prion Protein Amyloid Formation,1105,NA,NA,NA,NA,16,NA,NA,379861,NA
11189397,ZIA,AI,1,N,NA,NA,NA,NA,ZIAAI001106,NA,NA,1ZIAAI001106-16,NIAID:1019714\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,10269192 (contact),"FRASER, IAIN  (contact)",NA,NA,NA,Acetylation;Address;Adopted;analytical method;ATAC-seq;Behavior;beta-Glucans;Bioinformatics;Biological;Biological Assay;Biology;biomaterial compatibility;Cell Line;Cell Lineage;Cell membrane;Cell Membrane Permeability;Cell model;Cell Survival;Cell Therapy;Cells;Cellular Indexing of Transcriptomes and Epitopes by Sequencing;Chromatin;clinical center;Clustered Regularly Interspaced Short Palindromic Repeats;cohort;Collaborations;Computer software;Control Groups;Coronavirus;COVID-19;COVID-19 patient;CRISPR screen;CRISPR/Cas technology;cytokine;cytotoxic CD8 T cells;Data;Development;Devices;Dose;Doxycycline;Drug Delivery Systems;electric field;Electrochemistry;Electrodes;Electroporation;Enhancers;epigenetic memory;Exhibits;Face;FDA approved;Gene Expression Profile;gene function;Genes;Genetic Materials;Genetic Screening;Genome;genome editing;genome wide screen;genome-wide;Goals;Hematopoietic;Heterogeneity;histone modification;Human;Image;Immune;immune activation;Immune response;Immunity;Immunology;immunosuppressive macrophages;improved;In Vitro;Inflammatory;Inflammatory Response Pathway;Influenza;information processing;inhibitor;innate immune mechanisms;Innate Immune Response;insight;Interleukin-12;Knock-out;Lentivirus;Ligands;Macrophage;Mammalian Cell;Mediating;Membrane;Metabolic;Methodology;Methylation;microbial;Microfluidics;Modeling;Molecular;Mus;Natural Immunity;Nuclear;nucleic acid delivery;Nucleic Acids;Outcome;Output;Oxidation-Reduction;particle;pathogen;pathogenic bacteria;pathogenic virus;Pathogenicity;Patients;Peripheral Blood Mononuclear Cell;personalized medicine;Phosphotransferases;Physiologic pulse;Poison;Polymers;Positioning Attribute;progenitor;programs;promoter;Property;Protocols documentation;Reaction;Reporter;Research;Research Personnel;Resistance;response;Rest;RNA Interference;RNA interference screen;Running;SARS-CoV-2 variant;screening;Screening Result;Secondary to;small molecule;Statistical Data Interpretation;Stimulus;Surface;System;systemic toxicity;T cell response;Technology;TNF gene;tool;Toxic effect;Training;transduction efficiency;Transfection;tumor;tumor microenvironment;United States National Institutes of Health;Up-Regulation;Validation;Variant;Viral;Virus Diseases;voltage;Work,RNAi Screening in Hematopoietic Cells,1106,NA,NA,NA,NA,16,NA,NA,1019714,NA
11189398,ZIA,AI,1,N,NA,NA,NA,NA,ZIAAI001107,NA,NA,1ZIAAI001107-16,NIAID:1019714\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,10269192 (contact),"FRASER, IAIN  (contact)",NA,NA,NA,Acids;Acute;American;Antibiotic Therapy;Antibiotics;Arachidonic Acids;Attenuated;Bacteremia;Bacteria;Bacterial DNA;Bacterial Infections;bactericide;Biochemical;Biosensor;C-terminal;Calcium;Caspase;Categories;cell behavior;Cell model;Cells;Chemicals;chemotherapy;Clinical;clinically relevant;combinatorial;Communicable Diseases;Complex;Coupled;cytokine;Cytosol;Data;Data Set;Development;Disease;DNA;Event;Exposure to;Fasting;Fatty Acids;Gene Expression Profiling;Genes;Genetic;genetic approach;Genetic Transcription;Goals;Growth;Human;Immune;Immune response;Immune signaling;Immune system;Immunologics;Individual;Infection;Infection Control;Inflammasome;Inflammation;Inflammatory;Inflammatory Response;inhibitor;Innate Immune Response;insight;Intervention;Investigation;Laboratories;Life Style;Ligands;Literature;Macrophage;MAP3K7 gene;MAPK8 gene;MAPK9 gene;Mediating;Microbe;microbial;Mitochondria;Mitogen-Activated Protein Kinases;Modeling;Modern Medicine;Modernization;mouse model;Mus;N-terminal;Non-Steroidal Anti-Inflammatory Agents;novel;Nuclear;Operative Surgical Procedures;Outcome;Output;p38 Mitogen Activated Protein Kinase;Palmitic Acids;pathogen;Pathogenicity;Pathway interactions;Pattern recognition receptor;Pharmaceutical Preparations;pharmacologic;Pharmacy facility;Phosphorylation;Phosphotransferases;Post-Translational Protein Processing;Protein translocation;Reactive Oxygen Species;Regulation;Reporter;Reporting;Research;response;Role;Saturated Fatty Acids;screening;Second Messenger Systems;Sepsis;Signal Pathway;Signal Transduction;Sterility;Stimulant;Stimulus;Stress;survival outcome;Systems Biology;Technology;Therapeutic Intervention;Time;Tissues;Transplantation;Unsaturated Fatty Acids;Work;Xanthine Oxidase,Analysis of Innate Immune Signaling Networks,1107,NA,NA,NA,NA,16,NA,NA,1019714,NA
11189399,ZIA,AI,1,N,NA,NA,NA,NA,ZIAAI001115,NA,NA,1ZIAAI001115-16,NIAID:1994610\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,9691533 (contact),"BELKAID, YASMINE  (contact)",NA,NA,NA,adaptive immune response;Address;Adjuvant;Affect;Bacteria;Cardiovascular Physiology;Cells;Cellular Immunology;Collaborations;Development;Epithelium;Fortification;fungus;Genetic;Genomic approach;gut microbes;Health;Homeostasis;Human;Immune;Immune system;Immunity;Infection;Infection Control;Inflammation;Lung;Maintenance;Mediation;member;Metabolic;Metabolic Control;microbial;Microbiology;microbiota;Molecular;multidisciplinary;Nervous System Physiology;nutrition;Oral cavity;Organism;pathogen;Pathogenicity;Pathology;Physiology;Play;Population;Preventive;programs;Regulation;Research;resident commensals;response;Role;Site;Skin;Surface;T-Lymphocyte;Therapeutic;tissue repair;Tissues;Vaccines;Vagina;Virus;Work,Role of the microbiota in immunity,1115,NA,NA,NA,NA,16,NA,NA,1994610,NA
11189400,ZIA,AI,1,N,NA,NA,NA,NA,ZIAAI001119,NA,NA,1ZIAAI001119-09,NIAID:1499175\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,6479748 (contact),"LONG, ERIC O (contact)",NA,NA,NA,Agonist;Allogenic;Amino Acids;antimicrobial;Binding;CD94 Antigen;Cell Separation;cell type;Cells;Cysteine;disulfide bond;Disulfides;early pregnancy;Endosomes;fetal;Fetal Development;Fetal Tissues;Fetus;Gatekeeping;Genes;genetic association;genetic signature;Genetic Transcription;Histocompatibility Antigens Class I;HLA G antigen;Impairment;Interferons;Invaded;Isomerase;Killer Cells;Ligand Binding;Mass Spectrum Analysis;maternal immune system;Maternal-Fetal Exchange;Molecular;Monoclonal Antibodies;Mutagenesis;mutant;Natural Killer Cells;NF-kappa B;NK Cell Activation;Nuclear Translocation;Oxidation-Reduction;Phenotype;Phosphorylation;Placenta;Placentation;Pre-Eclampsia;Pregnancy;programs;Protein Disulfide Isomerase;Protein Inhibition;receptor;Regulation;Reporter;response;Risk;Role;senescence;Signal Transduction;single-cell RNA sequencing;Structure;Sulfhydryl Compounds;Tissues;transcription factor USF;Transfection;trophoblast;Uterus;Vascular remodeling,Natural Killer Cells in Pregnancy,1119,NA,NA,NA,NA,9,NA,NA,1499175,NA
11189401,ZIA,AI,1,N,NA,NA,NA,NA,ZIAAI001121,NA,NA,1ZIAAI001121-15,NIAID:1138006\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,10671942 (contact),"SERETI, IRINI  (contact)",NA,NA,NA,Acute;Affect;Africa;Age;Aging;Antibodies;antiretroviral therapy;Autoantibodies;Autoimmune;belimumab;Binding;Biological Markers;biomarker validation;Blood Coagulation Disorders;Body mass index;C-reactive protein;Cardiovascular Diseases;Case Series;CD4 Lymphocyte Count;CD4 Positive T Lymphocytes;Cell Count;Cell Survival;Cells;Central America;Cessation of life;Chronic;Classification;Clinical;clinical predictors;Clinical Research;cohort;comorbidity;Complement;Complement Activation;Country;Cryptococcus;Cryptococcus neoformans;CXCL9 gene;cytokine;cytotoxicity;Defect;Depressed mood;Development;Disease;disease prognosis;Disease remission;dysbiosis;Etiology;Event;Feces;Ferritin;Fiber;Fibrin fragment D;fluorodeoxyglucose positron emission tomography;Glucose Transporter;glucose uptake;Glycolysis;Goals;gut microbiome;Hematopoiesis;Hematopoietic;Hemoglobin;Hemoglobin concentration result;Hemophagocytic Lymphohistiocytoses;Heterogeneity;High Prevalence;high risk;Histoplasma;Histoplasmosis;HIV;HIV diagnosis;HIV Infections;Human;humanized mouse;Immigration;Immune;immune reconstitution;Immune response;immunodeficiency;Immunosuppression;Impairment;improved;Incidence;Infection;Inflammasome;Inflammation;Inflammatory;interest;Interleukin-6;International;Intervention;Link;Lymphocyte;Lymphopenia;Malignant Neoplasms;Measurement;Measures;Mediating;Metabolism;microbial;microbiome;microbiome alteration;Minority;monocyte;Morbidity - disease rate;mortality;mortality risk;mouse model;Mucous Membrane;Mus;Mutation;mycobacterial;Mycobacterium avium Complex;Mycobacterium tuberculosis;new therapeutic target;novel therapeutic intervention;Opportunistic Infections;opportunistic pathogen;Participant;Pathogenesis;pathogenic fungus;pathogenic virus;Patients;Peripheral;Peripheral Blood Mononuclear Cell;Persons;Phenotype;pilot trial;Plasma;Play;Population;Positron-Emission Tomography;Predisposition;Prevalence;Prognosis;Propionates;prospective;Reaction;reconstitution;Regulatory T-Lymphocyte;Reporting;Research;Residual state;response;restoration;Risk;Risk Factors;Role;Sampling;Seminal;Serum;Site;Somatic Mutation;Standardization;Symptoms;Syndrome;System;T-Cell Development;T-Lymphocyte;targeted treatment;Time;tool;uptake;Viral reservoir;Virus Diseases;Work,Immunopathogenic Mechanisms of Human Immunodeficiency Virus (HIV) Disease,1121,NA,NA,NA,NA,15,NA,NA,1138006,NA
11189402,ZIA,AI,1,N,NA,NA,NA,NA,ZIAAI001122,NA,NA,1ZIAAI001122-15,NIAID:4772016\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,10686452 (contact),"ROSENZWEIG, SERGIO  (contact)",NA,NA,NA,Adult;Antibodies;Antigens;Aspergillus;Autoimmune;Autoimmune Polyendocrinopathies;Autoimmunity;autosome;Blood;Candida;Candidiasis;Case Study;Childhood;Chromosomes;Chronic Mucocutaneous Candidiasis;Clinical;Clinical Immunology;Clinical Research;Communicable Diseases;Complex;congenital immunodeficiency;Consultations;curative treatments;cytokine;dectin 1;Dendritic Cells;design;diabetic;Diagnosis;Diagnostic;Disease;Dominant-Negative Mutation;Ectopic Expression;Enrollment;Evaluation;Exhibits;Failure;gain of function;gain of function mutation;Gene Expression;Gene Mutation;Genes;Genetic;Genetic Diseases;genetic immunotherapy;Genotype;Heterozygote;Human;Hypersensitivity;Hypersensitivity skin testing;Hypoparathyroidism;Immune system;immunodeficiency;Immunologic Deficiency Syndromes;Immunologics;Individual;infancy;Infection;Inflammatory;Inheritance Patterns;Inherited;Intercellular adhesion molecule 1;interest;Interferons;Investments;IRF4 gene;Laboratories;Longterm Follow-up;Medical;Microbiology;monocyte;Mucocutaneous Candidiasis;Mus;Mutation;Mycoses;Nature;novel;Online Mendelian Inheritance In Man;Paper;Pathway interactions;Patients;Phenotype;Pneumocystis carinii;Polyglandular Autoimmune Syndrome Type I;Predisposition;Prevalence;Production;programs;Protocols documentation;Publishing;Recommendation;Recurrence;Regulator Genes;response;Role;Sampling;Signal Pathway;Source;Specialist;STAT1 gene;Subjects Selections;Syndrome;TCF3 gene;Testing;Thymic epithelial cell;Tissues;trait;United States National Institutes of Health;volunteer,Studies of Inherited Causes of Fungal Susceptability,1122,NA,NA,NA,NA,15,NA,NA,4772016,NA
11189403,ZIA,AI,1,N,NA,NA,NA,NA,ZIAAI001123,NA,NA,1ZIAAI001123-15,NIAID:716820\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,10686454 (contact),"WILLIAMSON, PETER  (contact)",NA,NA,NA,Affect;Amphotericin;Amphotericin B;Antifungal Therapy;attributable mortality;Autoimmunity;Binding;Biological Markers;Blood;Blood - brain barrier anatomy;Brain;Candida;Candida albicans;candidemia;Cessation of life;Clinical Research;cohort;cost;Cryptococcal Meningitis;Cryptococcosis;Cryptococcus;Cryptococcus neoformans;Disease;Endothelial Cells;Event;Flucytosine;fungus;Gene Expression;Genes;Genetic Transcription;HIV;Human;human disease;Hyphae;improved;Individual;Infection;Inflammatory Response;inhibitor;Intravenous;Invaded;Lung Diseases;Meningitis;Methods;migration;Modernization;Molecular;Morbidity - disease rate;mortality;mouse model;Mucous Membrane;neuroinflammation;novel;novel therapeutics;Oral;Outcome;overexpression;pathogen;Pathway interactions;Patient-Focused Outcomes;Patients;preclinical study;Predisposition;Preparation;prevent;Process;Recombinants;Role;Safety;Series;Signal Pathway;Source;Stream;Surface;Syndrome;Therapeutic;Toxic effect;Transplant Recipients;Uganda;Validation;Viral;Virulence;Work,Molecular Pathobiology of Cryptococcus neoformans,1123,NA,NA,NA,NA,15,NA,NA,716820,NA
11189404,ZIA,AI,1,N,NA,NA,NA,NA,ZIAAI001124,NA,NA,1ZIAAI001124-15,NIAID:716820\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,10686454 (contact),"WILLIAMSON, PETER  (contact)",NA,NA,NA,Acute;Adrenal Cortex Hormones;Amphotericin;Amphotericin B;Animal Model;anti-fungal agents;Antigens;attributable mortality;Autoantibodies;Autophagocytosis;bench to bedside;clinical efficacy;Clinical Treatment;cohort;Collaborations;Consumption;Convalescence;Cryptococcal Meningitis;Cryptococcosis;Cryptococcus;Cryptococcus gattii;cytokine;Developing Countries;Disease;Evaluation;exome sequencing;Flucytosine;Funding;Genes;Genetic;granulocyte;Granulocyte-Macrophage Colony-Stimulating Factor;Human;Immunologics;Immunosuppressive Agents;improved;improved outcome;Individual;ineffective therapies;Inflammasome;Inflammatory Response;inhibitor;Intervention;Intravenous;Janus kinase;Laboratories;Lung Diseases;Macrophage;Magnetic Resonance Imaging;Meningitis;Meningoencephalitis;Methods;Monitor;monocyte;mortality;mouse model;Mutation;Mycoses;nano-string;novel;novel therapeutics;Oral;pathogen;Pathway interactions;Patients;Pharmaceutical Preparations;Phase;Physiologic pulse;Play;preclinical study;preclinical trial;Predisposition;Preparation;Protocols documentation;recruit;Refractory;Regimen;Regulatory Pathway;Reporting;Risk Factors;Role;Route;Safety;Signal Transduction;STAT protein;Steroids;Susceptibility Gene;Syndrome;Testing;Therapeutic;Therapeutic Trials;Time;tocilizumab;Toxic effect;Translating;Translational Research;Translations;Uganda;Virulence,Translational Research: Host-Pathogen Interactions in Patient Fungal Diseases,1124,NA,NA,NA,NA,15,NA,NA,716820,NA
11189405,ZIA,AI,1,N,NA,NA,NA,NA,ZIAAI001125,NA,NA,1ZIAAI001125-15,NIAID:2438675\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,10686457 (contact),"BEST, SONJA  (contact)",NA,NA,NA,adaptive immune response;Affect;Alkhurma Virus;Amino Acids;Animal Model;Anti-viral Response;Antigen Presentation;Area;arthropod-borne;Automobile Driving;B-Cell Activation;Biology;burden of illness;Capsid;Categories;CD4 Positive T Lymphocytes;Cell Physiology;Cell Survival;Cells;Central Nervous System Infections;Characteristics;chemokine;Clinical;Complex;Coronavirus;Culicidae;cytokine;Cytotoxic T-Lymphocytes;Dendritic Cells;Dengue Virus;Development;Electron Transport;Endoplasmic Reticulum;Event;Flavivirus;Flavivirus Infections;Gene Expression;Genes;Genetic;Genetic Transcription;Genome;Goals;Growth;hemorrhagic fever virus;Host resistance;Hour;Human;human pathogen;Hyperactivity;Immune;immune activation;Immune Evasion;Immune response;Immune system;Immunity;improved;Infection;Inflammation Mediators;Inflammatory Response;innate immune mechanisms;Innate Immune Response;Interferon alpha;Interferon Type I;Interferons;Janus kinase;Japanese encephalitis virus;Kyasanur Forest disease virus;Laboratories;Ligation;Macaca mulatta;Macrophage;member;Membrane;Metabolic;Methyltransferase;Mitochondria;Modeling;mosquito-borne;mouse model;National Institute of Allergy and Infectious Disease;Natural Immunity;neutralizing antibody;Nonstructural Protein;novel;Nuclear;Nucleic Acids;Open Reading Frames;pathogen;Pathogenesis;pathogenic virus;Pathway interactions;Pattern recognition receptor;Peptide Hydrolases;Persons;Polyproteins;prevent;programs;Proteins;Reactive Oxygen Species;receptor;Receptor Signaling;Research;Resistance;Respiration;response;Retroviridae;RNA;RNA Processing;RNA Viruses;RNA-Directed RNA Polymerase;Role;Signal Pathway;Signal Transduction;Signal Transduction Pathway;Site;success;T-Lymphocyte;Therapeutic;Tick-Borne Encephalitis;Tick-Borne Encephalitis Virus;tick-borne flavivirus;Ticks;Toll-like receptors;transcription factor;Transcriptional Activation;Transducers;Translating;transmission process;Tretinoin;TRIM Gene;TRIM Motif;vaccine effectiveness;Vaccinee;Vaccines;Viral;Viral Hemorrhagic Fevers;Viral Pathogenesis;Viremia;Virulent;Virus;Virus Diseases;virus host interaction;Virus Replication;West Nile virus;Work;Yellow Fever;Yellow Fever Vaccine;Yellow fever virus;Zika Virus,Virus-Host Interactions: Induction and Evasion of Host Innate Immunity,1125,NA,NA,NA,NA,15,NA,NA,2438675,NA
11189406,ZIA,AI,1,N,NA,NA,NA,NA,ZIAAI001130,NA,NA,1ZIAAI001130-15,NIAID:2075838\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,10686462 (contact),"KLION, AMY  (contact)",NA,NA,NA,2019-nCoV;Address;Affect;Aftercare;Allergens;Allergic;Angioneurotic Edema;Asthma;Automobile Driving;Barbering;Benign;Blocking Antibodies;Blood;Bone Marrow;Cells;Chemotaxis;Clinical;clinical subtypes;cohort;Collaborations;conventional therapy;COVID-19;Data;diagnostic tool;Disease;Disseminated eosinophilic collagen disease;effective therapy;Effector Cell;Enrollment;eosinophil;Eosinophilia;Eosinophilic leukemia;Eotaxin;Failure;Fasciitis;Filariasis;Follow-Up Studies;fusion gene;Goals;helminth infection;Homeostasis;Human;human disease;Hypersensitivity;Imatinib;Immune response;improved;Infection;interest;Interleukin 4 Receptor;Interleukin-5;investigator-initiated trial;Longterm Follow-up;Lung;Lung infections;Lymphocyte;Mediating;mepolizumab;microbial;migration;Monoclonal Antibodies;mouse model;Mycobacterium tuberculosis;Myelogenous;neoplastic;neutrophil;novel;novel diagnostics;Organ;participant enrollment;pathogen;Pathogenesis;Pathway interactions;patient subsets;Patients;PDGFRA gene;Periodicity;Peripheral;peripheral blood;Peripheral Blood Eosinophilia;phase III trial;Phenotype;Pilot Projects;Population Characteristics;predicting response;Production;Pulmonary Eosinophilia;Rare Diseases;Reaction;recruit;Refractory;response;Role;SARS-CoV-2 infection;Serum;Serum Markers;Site;Steroids;Study of serum;Symptoms;targeted treatment;Therapeutic Agents;Tissues;Tyrosine Kinase Inhibitor;Universities;Variant,Eosinophils and Eosinophil Activation in the Pathogenesis of Human Disease,1130,NA,NA,NA,NA,15,NA,NA,2075838,NA
11189407,ZIA,AI,1,N,NA,NA,NA,NA,ZIAAI001131,NA,NA,1ZIAAI001131-15,NIAID:477662\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,10686464 (contact),"MULJO, STEFAN  (contact)",NA,NA,NA,3&apos; Untranslated Regions;Ablation;ATAC-seq;Attention;Autoimmune Diseases;Autoimmunity;Biogenesis;Biological;Biological Models;CD4 Positive T Lymphocytes;Cell Differentiation process;Cell Reprogramming;Cells;Cleavage Under Targets and Release Using Nuclease;Communicable Diseases;crosslinking and immunoprecipitation sequencing;Data;Dedications;deep sequencing;Diagnosis;Dicer Enzyme;Disease;disease model;DNA;dynamic system;Exhibits;fundamental research;Gene Expression;Genetic;Genetic Code;Genetic Transcription;Genetically Engineered Mouse;genome wide methylation;Genomics;Goals;Health;Helper-Inducer T-Lymphocyte;Hematopoietic System;histone methylation;Human;Hypersensitivity;Immune response;Immune system;Immunity;Immunobiology;immunodeficiency;immunopathology;improved;insight;interest;Knowledge;Laboratories;Lymphocyte;Malignant lymphoid neoplasm;Malignant Neoplasms;Mammals;Maps;Massive Parallel Sequencing;Messenger RNA;Methods;MicroRNAs;Mining;mouse genetics;mouse model;novel;Pattern;Performance;Play;Post-Transcriptional Regulation;posttranscriptional;programs;Proteins;Publications;Research;RNA;RNA-Binding Proteins;RNA-Induced Silencing Complex;Role;Signal Pathway;System;T-Lymphocyte;Techniques;Testing;Th1 Cells;tool;transcriptome;transcriptome sequencing;Untranslated RNA;Work,Roles of non-Coding RNAs in Programming Lymphocyte Differentiation and Function,1131,NA,NA,NA,NA,15,NA,NA,477662,NA
11189408,ZIA,AI,1,N,NA,NA,NA,NA,ZIAAI001132,NA,NA,1ZIAAI001132-14,NIAID:319138\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,9691533 (contact),"BELKAID, YASMINE  (contact)",NA,NA,NA,Antigens;Cells;Complex;Cues;cytokine;Development;Effector Cell;Elements;Exposure to;Failure;Food;Homeostasis;Immune response;Immunity;Immunologics;Inflammation;Inflammatory;Maintenance;Outcome;pathogen;Pathologic;Population;preservation;Regulation;Regulatory Pathway;response;restoration;Role;Site;Skin;Tissues;Work,Role of Tissue-Specific Factors in the Control of Immunity,1132,NA,NA,NA,NA,14,NA,NA,319138,NA
11189409,ZIA,AI,1,N,NA,NA,NA,NA,ZIAAI001133,NA,NA,1ZIAAI001133-15,NIAID:345734\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,9691533 (contact),"BELKAID, YASMINE  (contact)",NA,NA,NA,Antigen-Presenting Cells;Caloric Restriction;Cell Physiology;Cells;Cues;Development;immune function;Immune system;immune system function;Immunity;Infection;Macronutrients Nutrition;Malnutrition;Metabolic;microbiota composition;Micronutrients;Nutrient;nutrition;Nutritional;oral tolerance;Population;response;Role;Stress;T-Lymphocyte;Vaccines;Work,Role of nutrition in the Control of Immunity,1133,NA,NA,NA,NA,15,NA,NA,345734,NA
11189410,ZIA,AI,1,N,NA,NA,NA,NA,ZIAAI001134,NA,NA,1ZIAAI001134-15,NIAID:800611\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,10686351 (contact),"DUFFY, PATRICK  (contact)",NA,NA,NA,Africa;African;Animals;Antibodies;Antigens;Cell Communication;Child;Chromosomes;Complex;Country;efficacy evaluation;Encapsulated;Erythrocytes;frontier;Genes;Genetic;genomic epidemiology;Genomic Segment;Human;Immune response;Immunization;Immunology;In Vitro;Infection;inhibiting antibody;Integration Host Factors;Invaded;Lipids;Malaria;Malaria Vaccines;Merozoite Surface Protein 1;Messenger RNA;Methods;Microbe;Mus;Names;nonhuman primate;offspring;Outcome;Parasitemia;Parasites;Pathogenesis;plasmid DNA;Plasmodium falciparum;Plasmodium falciparum genome;Population Study;Pregnancy;Prevention;Proteins;Proteome;Publications;Recombinant Proteins;Reporting;Resistance;Sampling;Scientist;screening;vaccine development;vaccine discovery;Variant;Work,Malaria Pathogenesis in young children and vaccine discovery,1134,NA,NA,NA,NA,15,NA,NA,800611,NA
11189411,ZIA,AI,1,N,NA,NA,NA,NA,ZIAAI001135,NA,NA,1ZIAAI001135-15,NIAID:238020\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,10686351 (contact),"DUFFY, PATRICK  (contact)",NA,NA,NA,"Adult;Animal Model;Animals;Anti-malarials;Antibodies;Antibody titer measurement;Antigen Targeting;Antigens;Binding;booster vaccine;CD8B1 gene;Cells;child bearing;Clinical;Communicable Diseases;Conceptions;Dose;double-blind placebo controlled trial;efficacy evaluation;Erythrocytes;Evaluation;Extracellular Domain;Flow Cytometry;Goals;Human;Hybridomas;Immune;Immune response;Immunity;Immunize;Infection;Malaria;malaria infection;Mali;Mammalian Cell;Monoclonal Antibodies;Mus;novel;Parasites;Peptides;Phase;Placebo Control;Plasmodium falciparum;Plasmodium falciparum vaccine;Pregnancy;Progress Reports;protective efficacy;Proteins;Publications;Randomized;Randomized, Controlled Trials;Rattus;receptor;Recombinant Proteins;Reporting;response;Safety;Sampling;Serology;Sorting;Specificity;Surface;T-Lymphocyte;Technology;Testing;Vaccination;vaccine candidate;vaccine efficacy;vaccine trial;vaccine-induced antibodies;Vaccines;Variant;Woman;Work",Evaluation of Novel Preerythrocytic Anti-infection Malaria Vaccine Candidates,1135,NA,NA,NA,NA,15,NA,NA,238020,NA
11189412,ZIA,AI,1,N,NA,NA,NA,NA,ZIAAI001145,NA,NA,1ZIAAI001145-14,NIAID:58602\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,9691557 (contact),"MCBRIDE, ALISON  (contact)",NA,NA,NA,Area;autoinflammatory diseases;Cells;clinical center;Communicable Diseases;Epithelial Cells;Fibroblasts;gene therapy;Genetic;Genetic Diseases;Goals;Human;Individual;inhibitor;Investigation;keratinocyte;Research;Rho-associated kinase;Source;Techniques;United States National Institutes of Health;Virus,Efficient Immortalization of Primary Human Keratinocytes,1145,NA,NA,NA,NA,14,NA,NA,58602,NA
11189413,ZIA,AI,1,N,NA,NA,NA,NA,ZIAAI001147,NA,NA,1ZIAAI001147-14,NIAID:21640\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,10686351 (contact),"DUFFY, PATRICK  (contact)",NA,NA,NA,"Adult;aged;Anti-malarials;Antibodies;Antibody Response;Area;Binding;booster vaccine;CD3 Antigens;CD4 Positive T Lymphocytes;child bearing;Church;Clinical;clinical investigation;co-infection;cohort;Communicable Diseases;Complement;Conceptions;Deposition;Dose;double-blind placebo controlled trial;exhaustion;follow-up;Hepatocyte;HIV;HIV Infections;HIV Seronegativity;HIV Seropositivity;Human;Immune response;Immunization;Immunization Programs;Immunosuppression;Individual;Invaded;Journals;Malaria;malaria infection;malaria transmission;Mali;Mass Vaccinations;Measures;Participant;Phase;Placebos;Plasmodium falciparum;Plasmodium falciparum vaccine;Population;Pregnancy;protective efficacy;Publishing;Randomized;Randomized, Controlled Trials;Regulation;Regulatory T-Lymphocyte;response;Safety;safety assessment;Saline;Schedule;Seasons;Site;Sporozoites;Sterility;T cell response;T-Lymphocyte;Vaccination;vaccine efficacy;vaccine immunogenicity;vaccine response;vaccine trial;Vaccinee;Vaccines;Woman;Work; T cells",T Cell Regulatory and Suppression Mechanisms in Malaria,1147,NA,NA,NA,NA,14,NA,NA,21640,NA
11189414,ZIA,AI,1,N,NA,NA,NA,NA,ZIAAI001150,NA,NA,1ZIAAI001150-12,NIAID:2194965\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,11118637 (contact),"ACKERMAN, HANS  (contact)",NA,NA,NA,2019-nCoV;Abdomen;ACE2;Adipose tissue;Adult;alpha Globin;alpha-Thalassemia;Animal Model;Arginine;Arteries;Atherosclerosis;Bacteria;beta Globin;Biochemical;Biological Availability;Biological Models;Biology;Biopsy;Black race;Blood;Blood Circulation;Blood Pressure;blood pressure medication;Blood Vessels;Brain;Brain Edema;Brazil;Calcium Signaling;Cardiovascular Physiology;Cardiovascular system;Cells;Cerebral cortex;Cerebral Malaria;Cessation of life;Child;Chronic;clinical center;clinical investigation;Coculture Techniques;cofactor;Collaborations;Coma;Complex;COVID-19;COVID-19 pandemic;COVID-19 treatment;CRISPR/Cas technology;Data;design;Diffusion;Disease;Drainage procedure;Early Diagnosis;Education;Endothelial Cells;endothelial dysfunction;Endothelium;Erythrocytes;Exercise;Exhalation;Extramural Activities;Functional disorder;Future;Gap Junctions;Gene Deletion;Gene Proteins;Gene Silencing;Genes;Genetic;Genetic Variation;Genomics;Germ Lines;Globin;Glycosylated hemoglobin A;grasp;Guide RNA;Hand;Hemoglobin;Hospitalization;Hospitals;Human;human model;Impairment;improved;In Vitro;in vivo;Individual;Inflammation;Inhalation;Inherited;intercellular communication;Intercellular Junctions;interest;Internal Medicine;Interruption;Intervention Studies;Intravenous;Investigation;Kidney Diseases;knock-down;Knock-out;Knowledge;Laboratories;Lead;Learning;Liquid substance;Lisinopril;Lung;Lung Diseases;Magnetic Resonance Imaging;Malaria;Malawi;Mali;Measures;Metabolic;Modeling;Modification;mouse model;Mus;Mutation;National Institute of Allergy and Infectious Disease;Near-Infrared Spectroscopy;Nitric Oxide;Nitric Oxide Synthase;Nitric Oxide Synthetase Inhibitor;NOS3 gene;novel marker;novel strategies;novel therapeutic intervention;Operative Surgical Procedures;Organ;Orthostasis;Parasites;Pathogenesis;Patients;Perfusion;Persons;Pharmaceutical Preparations;Pharmacologic Substance;Physiology;Populations at Risk;Porosity;Prevention;programs;Proteins;Published Comment;pulmonary function;receptor;Recombinants;Regulation;Renal Blood Flow;Research;response;Resuscitation;Role;Severity of illness;Sickle Cell;Sickle Cell Anemia;Sickle Cell Trait;Side;Signal Pathway;Signal Transduction;Smooth Muscle Myocytes;Specificity;Stem cell transplant;Stimulus;subcutaneous;Technology;Testing;tetrahydrobiopterin;Therapeutic;Time;Tissues;Translating;transmission process;treatment center;United States National Institutes of Health;Universities;Variant;Vascular Diseases;Vascular Endothelium;Vascular Smooth Muscle;vasoconstriction;Vasodilation;Veins;Venous;Viral Load result;Virginia;virology;Virus;Work,Nitric Oxide and Endothelial Function in Patients with Malaria,1150,NA,NA,NA,NA,12,NA,NA,2194965,NA
11189415,ZIA,AI,1,N,NA,NA,NA,NA,ZIAAI001153,NA,NA,1ZIAAI001153-14,NIAID:1205169\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,11118631 (contact),"FRIED, MICHAL  (contact)",NA,NA,NA,Adhesions;Antibodies;Antigens;Binding;bioinformatics tool;Biological Assay;Biological Markers;Birth;Blood Platelets;Blood specimen;CD36 gene;Child;Chondroitin Sulfate A;Clinical;cohort;density;Development;Disease;Disease Pathway;Enrollment;follow-up;Genes;Genetic;Genetic Variation;Genets;genome wide association study;Goals;Heritability;Humoral Immunities;Immune response;Immunity;Immunoprecipitation;improved;Infection;Introns;Malaria;malaria infection;Mali;Measures;Mediating;Mediator;Membrane;Membrane Proteins;Newborn Infant;novel;Parasites;Pathogenesis;Phenotype;Placenta;Plasmodium falciparum;Platelet Count measurement;PPBP gene;Predisposition;Pregnancy;Pregnancy loss;Pregnancy Outcome;Pregnant Women;Premature Birth;Proteins;Proteome;Proteomics;Publications;Recombinants;Reporting;Risk;Role;Severity of illness;Surface;System;Time;tool;Variant;Woman,Malaria Pathogenesis in Pregnant Women and Young Children,1153,NA,NA,NA,NA,14,NA,NA,1205169,NA
11189416,ZIA,AI,1,N,NA,NA,NA,NA,ZIAAI001155,NA,NA,1ZIAAI001155-14,NIAID:2650143\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,11118644 (contact),"CROMPTON, PETER  (contact)",NA,NA,NA,acquired immunity;adaptive immune response;Address;Adult;Africa;aged;Anti-malarial drug resistance;Anti-malarials;Antibodies;Antibody Response;Antigens;Area;Artemisinins;Beds;Biology;Child;Clinical Data;Clinical Trials;Cohort Studies;Collaborations;Combined Modality Therapy;Communicable Diseases;Computational Biology;Country;Culicidae;Data;Development;Double-blind trial;Drug Controls;Entomology;Epidemiology;experience;Exposure to;Falciparum Malaria;Future;Genomics;Geographic Locations;Healthcare;Human;human monoclonal antibodies;Immune;Immune response;Immune system;Immunity;Immunologics;Immunology;Individual;Infant;Infection;Inflammation;Infrastructure;Innate Immune Response;Insecticide Resistance;Insecticides;insight;Intervention;Kinetics;Knowledge;Life Cycle Stages;Longitudinal cohort study;Maintenance;Malaria;malaria transmission;Malaria Vaccines;Mali;Molecular;Molecular Profiling;Monoclonal Antibodies;National Institute of Allergy and Infectious Disease;Observational Study;optimism;Parasites;phase III trial;Plasmodium falciparum;Play;Population;Pregnancy;prevent;Public Health;Randomized;Risk;safety testing;Science;Scientist;Seasons;Site;Specificity;Systems Biology;Techniques;Technology;technology/technique;tool;Translating;Universities;vaccine-induced antibodies;Vaccines;vector control;Work,Mechanisms of naturally-acquired immunity to malaria,1155,NA,NA,NA,NA,14,NA,NA,2650143,NA
11189417,ZIA,AI,1,N,NA,NA,NA,NA,ZIAAI001156,NA,NA,1ZIAAI001156-14,NIAID:823017\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,7339801 (contact),"JIN, TIAN  (contact)",NA,NA,NA,Actins;Bacteria;cancer cell;cell motility;Cells;chemokine;chemokine receptor;Chemotactic Factors;Chemotaxis;cofilin;Coupled;Defect;Escherichia coli;Exhibits;fighting;fMet-Leu-Phe receptor;G-Protein-Coupled Receptors;Goals;GTP-Binding Proteins;Human;Human body;IL8 gene;Immobilization;Immune;Immunoglobulin G;Invaded;Mediating;migration;Molecular;Mus;Natural Immunity;Neoplasm Metastasis;neutrophil;Opsonin;Phagocytes;Phagocytosis;Phosphorylation;polymerization;Polymers;Protein Tyrosine Kinase;Proto-Oncogene Proteins c-akt;receptor;response;Signal Transduction;Surface;trafficking;Work,The Mechanisms Involved in Chemotaxis of Immune and Cancer Cells,1156,NA,NA,NA,NA,14,NA,NA,823017,NA
11189418,ZIA,AI,1,N,NA,NA,NA,NA,ZIAAI001157,NA,NA,1ZIAAI001157-13,NIAID:981112\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,15222221 (contact),"MEMOLI, MATTHEW  (contact)",NA,NA,NA,"1918 influenza pandemic;Adult;Avian Influenza A Virus;Cessation of life;Child;Clinical Protocols;Clinical Research;Collaborations;COVID-19 pandemic;COVID-19 vaccination;Development;diagnostic tool;Enrollment;Epidemic;Family suidae;Goals;Human;human pathogen;Human Volunteers;Immunity;Individual;Influenza;Influenza A virus;Influenza A Virus, H1N1 Subtype;Influenza A Virus, H3N2 Subtype;Influenza B Virus;influenza epidemic;influenza infection;Influenza vaccination;influenzavirus;Investments;Longitudinal Studies;manufacture;Modeling;Morbidity - disease rate;mortality;Mucosal Immunity;Mucous Membrane;National Institute of Allergy and Infectious Disease;Natural History;novel;novel therapeutics;novel vaccines;novel virus;pandemic disease;pandemic influenza;Pathogenesis;patient population;Persons;post-COVID-19;post-pandemic;pre-pandemic;previous pandemic;Process;programs;Protocols documentation;Public Health;Publishing;response;seasonal influenza;Serology;Switzerland;System;Therapeutic;Translational Research;vaccine strategy;Virus;Virus Diseases;volunteer;Work",Pandemic Influenza Translational Research and novel universal countermeasure development,1157,NA,NA,NA,NA,13,NA,NA,981112,NA
11189419,ZIA,AI,1,N,NA,NA,NA,NA,ZIAAI001167,NA,NA,1ZIAAI001167-13,NIAID:16391\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,11597548 (contact),"WHITEHEAD, STEPHEN  (contact)",NA,NA,NA,12 year old;17 year old;4 year old;Acceleration;Admixture;Adolescent;Adult;Age;age group;Agreement;antibody test;Area;Attenuated;Attenuated Vaccines;Biological Assay;Cellular Immunity;Child;Clinical;Clinical Research;Clinical Trials;cohort;Controlled Clinical Trials;COVID-19;Data;Databases;Dengue;Dengue Vaccine;Dengue Virus;Dengvaxia;Dose;Double-Blind Method;efficacy trial;Enrollment;Evaluation;experience;Flavivirus;follow-up;Funding;Genetic;Goals;Human;Immune response;Immunity;immunogenicity;Individual;Infant;Manuscripts;Medical Research;National Institute of Allergy and Infectious Disease;Phase;phase 2 study;Placebo Control;Process;Program Evaluation;programs;Publications;Published Comment;Publishing;Safety;Sampling;Sampling Studies;Serology test;Thailand;Vaccination;vaccine candidate;Vaccinee;Vaccines;Viremia;Virus;Work;Writing,CAP:Evaluation of a Dengue Vaccine in Adults with Preexisting Flavivirus Immunity,1167,NA,NA,NA,NA,13,NA,NA,16391,NA
11189420,ZIA,AI,1,N,NA,NA,NA,NA,ZIAAI001169,NA,NA,1ZIAAI001169-13,NIAID:2120586\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,11597551 (contact),"ZHU, JINFANG  (contact)",NA,NA,NA,adaptive immune response;Address;Affect;Allergic Disease;Amino Acids;Antigen Receptors;Asthma;Autoimmune Diseases;Autoimmunity;Bacteria;Binding Sites;Biology;BLR1 gene;CD4 Positive T Lymphocytes;Cell Differentiation process;Cell Lineage;Cell Physiology;cell type;Cells;chronic infection;Classification;Collaborations;Complex;CRISPR/Cas technology;cytokine;Data;Development;Disease;DNA;DNase I hypersensitive sites sequencing;draining lymph node;effector T cell;Elements;Enhancers;epigenomics;extracellular;Failure;Female;Follow-Up Studies;FOXP3 gene;frontier;fungus;GATA3 gene;Gene Expression Profile;Gene Expression Regulation;Genes;Genetic Transcription;Goals;Health;Helminths;Helper-Inducer T-Lymphocyte;Heterogeneity;Heterozygote;Host Defense;Hypersensitivity;IL17 gene;Immune;Immune response;Immunity;Immunodysregulation polyendocrinopathy enteropathy X-linked syndrome;Immunology;immunoregulation;in vivo;Infection;Inflammation;Inflammatory;Inflammatory Bowel Diseases;Interferon Type II;Interleukin-13;Interleukin-2;interleukin-22;Interleukin-4;Interleukin-5;Knock-in;Knock-in Mouse;Knockout Mice;Locus Control Region;Lymphocyte;Lymphoid;Lymphoid Cell;Lymphoid Tissue;male;Manuscripts;Mediating;microorganism;migration;Molecular;Mouse Strains;Multiple Sclerosis;Mus;Mutant Strains Mice;Mutation;National Center for Advancing Translational Sciences;Natural Killer Cells;novel;Organ;Organogenesis;Papain;Parasite Control;Parasites;pathogen;Pathogenesis;pathogenic microbe;Pathologic;Pathology;Pathway interactions;Patients;Play;Population;Process;Production;Proteins;Regulation;Regulatory Element;Regulatory T-Lymphocyte;Reporter;Reporting;Research;response;Rheumatoid Arthritis;Role;Self Tolerance;Signal Transduction;Site;Structure of germinal center of lymph node;Structure of parenchyma of lung;T cell differentiation;T-Cell Activation;Th1 Cells;Th2 Cells;Tissues;tool;Toxoplasmosis;transcription factor;transcription regulatory network;Transcriptional Regulation;transcriptome;transcriptomics;Up-Regulation;Virus;Work,"Transcriptional Regulation of Immune Cell Development, Activation and Functions",1169,NA,NA,NA,NA,13,NA,NA,2120586,NA
11189421,ZIA,AI,1,N,NA,NA,NA,NA,ZIAAI001170,NA,NA,1ZIAAI001170-13,NIAID:216382\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,10686351 (contact),"DUFFY, PATRICK  (contact)",NA,NA,NA,"Adult;Adverse event;Africa;African;aged;Anti-malarials;Antibodies;Attenuated;Binding;Bite;CD3 Antigens;CD4 Positive T Lymphocytes;Chemoprophylaxis;child bearing;Chloroquine;Church;circumsporozoite protein;Clinical;clinical investigation;Clinical Trials;Collaborations;Communicable Diseases;Complement;Conceptions;Cryopreservation;Culicidae;Deposition;design;Dose;double-blind placebo controlled trial;Good Manufacturing Process;Hepatocyte;HIV;HIV Seronegativity;HIV Seropositivity;Human;Immunity;Immunization Programs;immunogenicity;Individual;intravenous administration;Invaded;Journals;Malaria;malaria infection;Mali;man;manufacturing process;Mass Vaccinations;Mus;National Institute of Allergy and Infectious Disease;Needles;Participant;Phase;Placebos;Plasmodium falciparum;Pregnancy;primary outcome;Procedures;protective efficacy;Protocols documentation;Publications;Pyrimethamine;Radiation;Randomized;Randomized, Controlled Trials;Regimen;Reporting;Safety;safety assessment;Saline;Schedule;secondary outcome;Series;Sporozoite vaccine;Sporozoites;Sterility;Syringes;T cell response;T-Lymphocyte;Testing;United States National Institutes of Health;unpublished works;Vaccination;vaccine efficacy;vaccine safety;vaccine trial;Vaccinee;Vaccines;volunteer;Whole Organism;Woman",Assessment of malaria whole organism vaccines,1170,NA,NA,NA,NA,13,NA,NA,216382,NA
11189422,ZIA,AI,1,N,NA,NA,NA,NA,ZIAAI001171,NA,NA,1ZIAAI001171-13,NIAID:1328731\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,11597554 (contact),"BARBER, DANIEL  (contact)",NA,NA,NA,Adverse event;Animal Model;antigen-specific T cells;Autoimmune;Biological Products;cancer immunotherapy;cancer therapy;Case Study;Cause of Death;CD4 Positive T Lymphocytes;CD8-Positive T-Lymphocytes;Cell Physiology;Cellular Immunology;Cessation of life;checkpoint inhibition;Chronic;Clinical;Clinical Trials;co-infection;CTLA4 gene;Cytomegalovirus;Cytomegalovirus Infections;Disease;Dose;efficacy testing;Enteritis;Equilibrium;Goals;HIV;Hodgkin Disease;Hospitalization;Human;Human Herpesvirus 8;immune checkpoint blockade;immunopathology;immunoregulation;in vivo;Individual;Infection;Inflammation;Inflammatory;Inflammatory Response;Infusion procedures;Intestines;Intra-abdominal;Kaposi Sarcoma;lymph nodes;Lymphocytic choriomeningitis virus;Lymphoid Tissue;Malignant Neoplasms;Merkel cell carcinoma;microbial;Modality;Modeling;mouse model;Mucous Membrane;Mus;Mycobacterium Infections;Mycobacterium tuberculosis;Mycoses;non-tuberculosis mycobacteria;non-tuberculous mycobacterial infection;nonhuman primate;novel;Outcome;Pain;pathogen;Pathogenicity;Pathology;Pathway interactions;patient population;Patients;PD-1 blockade;pembrolizumab;Peripheral;Persons;Pharmaceutical Preparations;Play;Primary carcinoma of the liver cells;programmed cell death protein 1;Property;Pulmonary Tuberculosis;Reaction;Regulatory Pathway;Research;Role;safety assessment;Site;T cell differentiation;T cell regulation;T cell response;T-Lymphocyte;Techniques;Tuberculosis;tumor;United States Food and Drug Administration;Viral;Virus;Virus Diseases;Work,Immune Regulation in Mycobacterial and Fungal Infections,1171,NA,NA,NA,NA,13,NA,NA,1328731,NA
11189423,ZIA,AI,1,N,NA,NA,NA,NA,ZIAAI001175,NA,NA,1ZIAAI001175-13,NIAID:2505178\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,11597559 (contact),"LIONAKIS, MICHAIL  (contact)",NA,NA,NA,Acquired Immunodeficiency Syndrome;adaptive immune response;Affect;Agammaglobulinaemia tyrosine kinase;Alleles;Anatomy;Animal Model;anti-fungal agents;Antibiotics;Antifungal Therapy;Aspergillosis;Aspergillus;Aspergillus fumigatus;Autoimmune;Autoimmunity;autosome;Biological;Biological Process;Candida;Candidiasis;Cell Culture System;Cells;Cellular Immunity;Central Nervous System;Cessation of life;Chemotactic Factors;Chronic Granulomatous Disease;Chronic Mucocutaneous Candidiasis;Clinical;clinical center;Clinical Protocols;Clinical Trials;clinically relevant;cohort;Communicable Diseases;conditional knockout;congenital immunodeficiency;Critical Illness;Defect;Diagnosis;diagnostic criteria;Disease;disease phenotype;Disseminated candidiasis;DOCK8 deficiency;Event;Filament;Fungal Drug Resistance;gain of function mutation;Genetic;Genetic Polymorphism;Genetic Predisposition to Disease;genetic testing;genetic variant;Genomics;Germination;Goals;Hematopoietic Stem Cell Transplantation;Host Defense;Human;Hyphae;Iatrogenesis;imaging approach;Immune;immune activation;Immune response;Immunogenomics;Immunologics;immunosuppressed;Impairment;improved;In Vitro;in vivo;Infection;Inhalation;Inherited;Innate Immune Response;Integration Host Factors;interest;Knockout Mice;Knowledge;Laboratories;Laboratory Research;Laboratory Study;Lung;Macrophage;Malignant Neoplasms;Mediating;member;Molds;Molecular;monocyte;Morbidity - disease rate;mortality;mouse model;Mucous Membrane;Mus;mutant;Mutation;Mycoses;National Institute of Allergy and Infectious Disease;neutrophil;novel;novel strategies;Oral;Oral candidiasis;Organ;Outcome;pathogenic fungus;Patient Recruitments;Patients;Phagocytes;Pharmacotherapy;Polyglandular Autoimmune Syndrome Type I;Predisposition;Prevention approach;Prevention strategy;Process;programs;recruit;Respiratory Burst;Role;Sampling;Sepsis;Site;STAT1 gene;Syndrome;System;Testing;Tissues;trafficking;Transplant Recipients;treatment strategy;Tyrosine Kinase Inhibitor;United States;United States National Institutes of Health;vaginal candidiasis;Woman;Yeasts,Immunopathogenesis of Fungal Infections,1175,NA,NA,NA,NA,13,NA,NA,2505178,NA
11189424,ZIA,AI,1,N,NA,NA,NA,NA,ZIAAI001176,NA,NA,1ZIAAI001176-13,NIAID:757335\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,10686351 (contact),"DUFFY, PATRICK  (contact)",NA,NA,NA,Adhesions;Alleles;Anemia;Animals;Antibodies;Antigens;Aotus primate;Area;Binding;Birth;Blocking Antibodies;Chondroitin Sulfate A;Congenital Abnormality;cross reactivity;design;Elements;Enzyme-Linked Immunosorbent Assay;Erythrocytes;experimental study;Exposure to;fetal;Genitourinary system;Goals;Gravid;Gravidity;Human;Immune response;Immunity;Immunization;Immunize;inclusion criteria;Infant Mortality;inhibiting antibody;Journals;Length;Link;Literature;Low Birth Weight Infant;Malaria;malaria transmission;Malaria Vaccines;male;Mediating;Modeling;Molecular;Monkeys;Neonatal Mortality;nonhuman primate;obstetric outcomes;Outcome;Parasites;pathogen;Pathogenesis;phase I trial;Placenta;placental malaria;Plasmodium falciparum;Pre-Eclampsia;predictive modeling;Pregnancy;Pregnancy loss;Pregnancy Outcome;Pregnant Women;Premature Birth;prevent;Production;Prospective Studies;Proteins;Public Health;Publications;Reaction;receptor;receptor binding;Reporting;Residual state;Risk;Structure;Surface;systematic review;Testing;vaccination strategy;vaccine candidate;vaccine development;Vaccines;Variant;vector control;Woman,Pregnancy Malaria Vaccine development,1176,NA,NA,NA,NA,13,NA,NA,757335,NA
11189425,ZIA,AI,1,N,NA,NA,NA,NA,ZIAAI001179,NA,NA,1ZIAAI001179-12,NIAID:3605688\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,11999617 (contact),"MUNSTER, VINCENT  (contact)",NA,NA,NA,Aerosols;Air Movements;Animals;Arenavirus;Birds;Chiroptera;Communities;Coronavirus;cross-species transmission;Data;data exchange;Detection;Development;Disease;Disease Outbreaks;Disease Surveillance;Ebola virus;Ecology;emerging virus;Event;experimental study;Filovirus;foodborne;future outbreak;Genetic;Goals;Henipavirus;Human;Humidity;immunological status;infectious disease treatment;interest;Intervention;Knowledge;Link;medical countermeasure;Middle East Respiratory Syndrome Coronavirus;Modeling;Molecular;Monkeypox virus;Nipah Virus;novel;Orthobunyavirus;Orthomyxoviridae;Orthopoxvirus;pathogen;Pathogen detection;pathogenic virus;Pathogenicity;Prevalence;prevent;Prevention;Prevention strategy;programs;prophylactic;Public Health;receptor;Research;Resource-limited setting;Risk;Rodent;Route;Sampling;Serology;Site;Temperature;Therapeutic;Therapeutic Intervention;tool;transmission blocking;transmission process;Variant;Vertical Transmission;Virus;Virus Shedding;Work;Zoonoses,Virus Ecology Unit,1179,NA,NA,NA,NA,12,NA,NA,3605688,NA
11189426,ZIA,AI,1,N,NA,NA,NA,NA,ZIAAI001180,NA,NA,1ZIAAI001180-12,NIAID:711010\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,11999619 (contact),"HARRIS, AUDRAY  (contact)",NA,NA,NA,"1918 influenza pandemic;3-Dimensional;adaptive immune response;Address;Affect;alpha helix;Animals;Antibodies;Antigens;Architecture;Area;arm;Attenuated;B-Lymphocytes;Binding;Biochemical;Coin;Communicable Diseases;Competence;Complex;design;Development;Electron Microscopy;Engineering;Epitopes;Evaluation;Formulation;future pandemic;Geometry;Goals;Health;Hemagglutinin;Human;Immune response;Immune system;Immunity;immunogenicity;Immunologics;improved;Influenza;Influenza A virus;Influenza A Virus, H1N1 Subtype;Influenza A Virus, H7N9 Subtype;influenza outbreak;influenza virus vaccine;influenzavirus;Innate Immune Response;innovation;Investigation;Membrane Glycoproteins;Mission;Molecular;molecular modeling;nanoparticle;nanotechnology platform;Nature;neutralizing antibody;Nucleoproteins;pandemic disease;particle;Persons;Pharmaceutical Preparations;Phase;Population;Proteins;Public Health;Recombinants;Research;scaffold;Scaffolding Protein;Seasons;structural biology;Structure;Subunit Vaccines;T-Lymphocyte;T-Lymphocyte Epitopes;Testing;transmission process;United States National Institutes of Health;universal influenza vaccine;vaccine formulation;Vaccine Production;Vaccines;Viral Vaccines;Virus;Virus-like particle;Work;Zoonoses",Structural Biology of Influenza Epitopes,1180,NA,NA,NA,NA,12,NA,NA,711010,NA
11189427,ZIA,AI,1,N,NA,NA,NA,NA,ZIAAI001185,NA,NA,1ZIAAI001185-12,NIAID:1432986\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,10686464 (contact),"MULJO, STEFAN  (contact)",NA,NA,NA,3&apos; Untranslated Regions;Ablation;Adult;Affect;Africa;Alternative Splicing;Amyotrophic Lateral Sclerosis;Asia;Autoimmune Diseases;Autoimmunity;autoinflammation;autoinflammatory;B-Lymphocytes;beta Thalassemia;Binding;Biogenesis;Birth;Blood;Bone Marrow;CD34 gene;Cell Culture System;Cell Reprogramming;cell type;Cells;Child;Clinic;Collaborations;Communicable Diseases;congenital immunodeficiency;CRISPR/Cas technology;crosslink;Data;Data Set;Development;Diagnosis;Disease;Ectopic Expression;Engineering;Erythroid;erythroid differentiation;familial amyotrophic lateral sclerosis;Family;fetal;Fetal Hemoglobin;Gene Cluster;Gene Expression;Gene set enrichment analysis;Genes;Genetic;Genetically Engineered Mouse;Genome;Genomics;Globin;Goals;Growth;Health;Hematological Disease;Hematopoietic Stem Cell Transplantation;Hematopoietic stem cells;Hematopoietic System;Hemoglobin;Human;Human Cell Line;Hypersensitivity;Immune system;Immunobiology;immunodeficiency;immunopathology;Immunoprecipitation;improved;in utero;insight;interest;Introns;Investigation;Knowledge;Life;Lymphocyte;Malignant lymphoid neoplasm;Malignant Neoplasms;Mammals;Maps;Mediating;Medical;Messenger RNA;MicroRNAs;Molecular;Mus;Mutate;Mutation;National Institute of Diabetes and Digestive and Kidney Diseases;Nervous System Disorder;novel;Pathogenesis;Patients;Phenotype;Play;posttranscriptional;Primary Cell Cultures;progenitor;Programmed Instruction;programs;Property;Proteins;Public Health;Regulation;Reporting;Research;Ribonucleosides;RNA;RNA-Binding Proteins;Role;Science;Shapes;Sickle Cell Anemia;Tertiary Protein Structure;Therapeutic;Transcript;Transcriptional Regulation;transcriptome;transcriptome sequencing;Untranslated RNA;Work,Roles of RNA-binding Proteins in Programming Gene Expression in Mammals,1185,NA,NA,NA,NA,12,NA,NA,1432986,NA
11189428,ZIA,AI,1,N,NA,NA,NA,NA,ZIAAI001187,NA,NA,1ZIAAI001187-12,NIAID:488515\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,10526060 (contact),"SU, HELEN  (contact)",NA,NA,NA,Adenosine;Adult;Affect;Allergic;Autoimmune;Behavioral;Binding;Biological Response Modifiers;Body System;Case Study;cell behavior;cell growth regulation;Cells;Collaborations;Complex;Congenital disorders of glycosylation;congenital immunodeficiency;Cyclosporine;Defect;Disabling;Disease;Divalent Cations;Drug Targeting;Epstein-Barr Virus Infections;Equilibrium;Eukaryotic Cell;Exhibits;Experimental Animal Model;Genes;glycosylation;Graft Rejection;Human Herpesvirus 4;immune function;Immune response;Immunity;immunodeficiency;Immunosuppressive Agents;in vivo;Individual;Inositol;insight;Ions;Link;loss of function mutation;Lymphocyte Activation;Magnesium;Magnesium Deficiency;magnesium ion;Malignant Neoplasms;Mammalian Cell;Measures;Mediator;Modeling;Molecular;Mus;Names;Neoplasms;Nerve Degeneration;Neurologic;novel therapeutics;Nucleic Acids;Organism;Pathogenicity;Pathway interactions;Patients;Pharmacologic Substance;Phospholipids;Physiological;PLC gamma1;Production;Proteins;Recurrence;Regulation;response;Role;Second Messenger Systems;Stimulus;Symptoms;T-Lymphocyte;T-Lymphocyte and Natural Killer Cell;Testing;Time;tool;tripolyphosphate;Update,New Roles of Magnesium as a Regulatory Ion in Immune Responses and Cell Behavior,1187,NA,NA,NA,NA,12,NA,NA,488515,NA
11189429,ZIA,AI,1,N,NA,NA,NA,NA,ZIAAI001188,NA,NA,1ZIAAI001188-11,NIAID:182814\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,10269158 (contact),"FELDMANN, HEINRICH  (contact)",NA,NA,NA,Africa;Animal Model;Animals;antibody detection;Antigens;Arenavirus;Arthropods;Bacteria;Biological Assay;Cell Culture System;Circulation;Clinical Trials;clinically relevant;cohort;Collaborations;Collection;Communities;Coronavirus;Country;Crimean-Congo Hemorrhagic Fever Virus;Data;detection assay;Development;Disease;Ecology;emerging virus;Ensure;Enzyme-Linked Immunosorbent Assay;Epidemiology;Equipment;Etiology;experience;Extramural Activities;Fever;field study;Filovirus;Fishes;Flavivirus;Funding;global health;Health;Human;Immunity;In Vitro;in vivo;Individual;insight;instrument;interest;International;international center;Intervention;Laboratories;Lassa virus;Link;Livestock;Manuscripts;Microbiology;Modernization;Molecular;National Institute of Allergy and Infectious Disease;operation;Orthobunyavirus;Participant;pathogen;pathogenic bacteria;Population;Population Surveillance;Postbaccalaureate;postgraduate education;preclinical study;Preparation;programs;Public Health;Reader;Research;Research Institute;Research Personnel;Resources;Rift Valley Fever;Rift Valley fever virus;Risk Assessment;RNA vaccine;Rodent;Role;Sampling;Schedule;Schools;screening;Serology;Serology test;seropositive;Seroprevalences;Serum;Site;Students;Surveillance Program;Therapeutic;tick-borne pathogen;Training;Training and Education;training opportunity;transmission process;Uganda;United States National Institutes of Health;Universities;Vaccines;vector;vector-borne pathogen;Viral;Virus;Zoonoses,Uganda International Center for Excellence in Research,1188,NA,NA,NA,NA,11,NA,NA,182814,NA
11189430,ZIA,AI,1,N,NA,NA,NA,NA,ZIAAI001189,NA,NA,1ZIAAI001189-11,NIAID:40505\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,10269158 (contact),"FELDMANN, HEINRICH  (contact)",NA,NA,NA,"2019-nCoV;adaptive immune response;Animal Model;Animals;Arboviruses;Area;Arenavirus;Back;Bacteria;Blood;Borrelia;British;Camels;Cattle;chikungunya;Chikungunya virus;Clinical;Clinical Research;Contracts;Coronavirus;Coronavirus Infections;COVID-19;COVID-19 testing;Crimean-Congo Hemorrhagic Fever Virus;Cytomegalovirus;Dengue;Dengue Virus;Diagnostic;Diagnostic tests;Disease;Doctor of Philosophy;Ebola;Etiology;experience;experimental study;falls;Fever;field study;Filovirus;Flavivirus;Follow-Up Studies;Future;Genetic;Geographic Distribution;Geographic Locations;Hantavirus;Health;Hospitals;Human;human study;Immunoglobulin G;Incidence;infected vector rodent;Infection;infection rate;Influenza A Virus, H5N1 Subtype;Innate Immune Response;international center;Laboratories;Lassa;Lassa Fever;Lassa virus;Leptospira;Livestock;Lujo virus;Macaca fascicularis;Mali;Manuscripts;Maps;Marburgvirus;Mastomys;Medical;Medical Students;Methodology;Middle East Respiratory Syndrome Coronavirus;Molecular Biology;Monkeypox virus;Order Spirochaetales;Orthobunyavirus;Paramyxovirus;pathogen;pathogenic virus;Pathogenicity;Population;preclinical efficacy;Preclinical Testing;Prevalence;programs;Public Health;Publishing;Relapsing Fever;Reporting;Research;Respiratory Disease;response;Rift Valley Fever;Rift Valley fever virus;Rodent;Route;Sampling;Scientist;Serology;Seroprevalences;serosurvey;Serum;Site;Students;Technology;Testing;Time;Tissue Sample;Togaviridae;tool;Training;transmission process;Universities;vaccine evaluation;Vaccine Research;Vaccines;vector;vector vaccine;Vesicular stomatitis Indiana virus;Viral Antigens;Virulent;Virus;Virus Diseases;Virus Shedding;Work;ZIKA;Zika Virus;Zoonoses",Mali International Center for Excellence in Research,1189,NA,NA,NA,NA,11,NA,NA,40505,NA
11189431,ZIA,AI,1,N,NA,NA,NA,NA,ZIAAI001190,NA,NA,1ZIAAI001190-11,NIAID:371892\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,11999617 (contact),"MUNSTER, VINCENT  (contact)",NA,NA,NA,Aedes;African;Animals;Arboviruses;Arenavirus;Birds;Cambodia;Chikungunya virus;Chiroptera;Communities;Congo;Coronavirus;COVID-19;cross-species transmission;Data;Detection;detection assay;Diagnosis;Diagnostic;Disease Outbreaks;Disease Surveillance;Ecology;emerging virus;Equipment;Fever;Filovirus;Genetic;Ghana;Goals;Henipavirus;interest;International;Laboratories;Link;Mali;Molecular;Monkeypox;Monkeypox virus;Orthobunyavirus;Orthopoxvirus;pathogen;Pathogen detection;pathogenic virus;Prevalence;Public Health;Research;Risk;Rodent;Sampling;Serology;serosurvey;Site;solidarity;tool;Training;Variant;vector;Virus;Work;Zoonoses,International Research in Congo,1190,NA,NA,NA,NA,11,NA,NA,371892,NA
11189432,ZIA,AI,1,N,NA,NA,NA,NA,ZIAAI001193,NA,NA,1ZIAAI001193-11,NIAID:153891\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,10526060 (contact),"SU, HELEN  (contact)",NA,NA,NA,Affect;Allergic Disease;Asthma;Atopic Dermatitis;Autoimmunity;autosome;Collaborations;Diagnosis;Disease;DOCK8 deficiency;Eczema;Eosinophilia;Food Hypersensitivity;General Population;Goals;Health;Hematopoietic Stem Cell Transplantation;Herpesvirus Type 3;human disease;Human Papillomavirus;IgE;Immune;immunodeficiency;Infection;Infectious Skin Diseases;interest;Knowledge;Life;Lymphocyte;Lymphoma;Malignant Neoplasms;microbial;Molluscum contagiosum virus;Morbidity - disease rate;mortality;Mutation;Outcome;Pathogenesis;Patients;Recurrence;Refractory;Research Personnel;Serum;Simplexvirus;Skin;Squamous cell carcinoma;Syndrome;Vascular Diseases;Viral;Virus Diseases,Understanding DOCK8 Function in Health and Human Disease,1193,NA,NA,NA,NA,11,NA,NA,153891,NA
11189433,ZIA,AI,1,N,NA,NA,NA,NA,ZIAAI001195,NA,NA,1ZIAAI001195-11,NIAID:1531839\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,9691569 (contact),"DELEO, FRANK  (contact)",NA,NA,NA,Antibiotic Resistance;beta-Lactams;carbapenem resistance;carbapenemase;Community Healthcare;Community-Acquired Infections;comorbidity;Complement;Development;Enterobacteriaceae;Goals;health care settings;Hospitals;Immune response;immunoprophylaxis;Immunosuppression;Immunotherapy;Incidence;Individual;Infection;Innate Immune System;Klebsiella pneumoniae;Microbe;Molecular;Multi-Drug Resistance;neutrophil;novel therapeutic intervention;opportunistic pathogen;Organism;Phenotype;Phylogeny;Plasmids;Prevention approach;Resistance;resistant Klebsiella pneumoniae;Serum;success;United States;virtual;Virulence,Basis for Success of Multidrug-Resistant Enterobacteriaceae,1195,NA,NA,NA,NA,11,NA,NA,1531839,NA
11189434,ZIA,AI,1,N,NA,NA,NA,NA,ZIAAI001196,NA,NA,1ZIAAI001196-11,NIAID:600010\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,77880721 (contact),"LEHMANN, TOVI  (contact)",NA,NA,NA,Address;Adult;Aedes;Africa;African;Alpha Virus;Altitude;Anopheles Genus;Arboviruses;Area;Asia;Behavioral;Biology;Blood;Cessation of life;Cities;climate change;Collaborations;Culex (Genus);Culicidae;Data;Databases;Dengue;Destinations;Deuterium;Diffusion;Disease;Disease Outbreaks;Disease Surveillance;Disease Vectors;disorder control;Distant;doctoral student;Dryness;Ecology;Ecosystem;Emerging Communicable Diseases;Environmental Wind;enzootic;Epidemiology;epizootic;experience;Female;filaria;Flavivirus;Florida;food security;forest;Frequencies;frontier;Ghana;Goals;Guinea;Health;Horns;Hour;improved;Infection;infection rate;Insecta;insight;Intercept;Invaded;Joints;Kenya;Knowledge;Leafhoppers;Link;literature survey;Location;Maintenance;Malaria;malaria mosquito;malaria transmission;male;Mali;Mansonia;Maps;Mediating;member;Migrant;migration;Molecular;Monitor;Mosquito Control;Mosquito-borne infectious disease;mosquito-borne pathogen;Movement;National Institute of Allergy and Infectious Disease;Nature;New Territories;Nigeria;novel;Orthobunyavirus;Paper;pathogen;Pattern;Physiological;Plasmodium;Population;Postdoctoral Fellow;predictive modeling;pressure;prevent;Prevention;Process;Public Health;Rain;Records;Reporting;Risk;Role;rural area;Sampling;Science;Seasons;Senegal;Site;Source;South American;Specimen;success;Surface;Technology;Time;Translating;transmission process;United States National Institutes of Health;Universities;urban area;Validation;vector;vector control;Vector-transmitted infectious disease;Vertebrates;Virus;Vision;Water;West Nile;Zoonoses,Ecology of Disease Vectors,1196,NA,NA,NA,NA,11,NA,NA,600010,NA
11189435,ZIA,AI,1,N,NA,NA,NA,NA,ZIAAI001197,NA,NA,1ZIAAI001197-11,NIAID:1410429\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,8818835 (contact),"LUSSO, PAOLO  (contact)",NA,NA,NA,Adopted;Affinity;Animals;Antibodies;Antibody Response;Antibody-mediated protection;Antigenic Variation;Antigens;autoreactivity;B-Cell Activation;Binding;Binding Sites;Biological;chimeric antibody;Clinical;Complex;Cryoelectron Microscopy;design;Development;disulfide bond;Dose;Engraftment;Epitopes;Evaluation;Family;Formulation;Framework Regions;Generations;Genes;Genetic Transcription;Germ Lines;Glycoproteins;glycosylation;Goals;Half-Life;High Prevalence;HIV;HIV Envelope Protein gp120;HIV Infections;HIV therapy;HIV vaccine;HIV-1;HIV-1 vaccine;HIV/AIDS;Immune Evasion;Immunization;Immunize;immunogenic;immunogenicity;immunoprophylaxis;improved;in vivo;Infection;insight;Knock-in;Knock-in Mouse;Knowledge;Length;Libraries;Link;Macaca;Macaca mulatta;Measures;Membrane;Messenger RNA;Modification;Molecular Conformation;Mucous Membrane;Mus;natural antibodies;neutralizing antibody;novel;particle;Peptide Hydrolases;Physiological;pre-clinical;preclinical evaluation;prevent;Prevention;Production;Property;Protomer;rational design;receptor;Recombinants;Reporting;Risk;RNA vaccine;Rodent;screening;Serum;Shapes;simian human immunodeficiency virus;single-molecule FRET;Site;Structure;Structure-Activity Relationship;Surface;Technology;Toxic effect;Transcript;Vaccinated;Vaccine Design;vaccine platform;Vaccines;Viral;Virus-like particle,Structure-Function Studies of the HIV-1 Envelope Glycoproteins and Development of a VLP-forming mRNA vaccine for HIV-1,1197,NA,NA,NA,NA,11,NA,NA,1410429,NA
11189436,ZIA,AI,1,N,NA,NA,NA,NA,ZIAAI001199,NA,NA,1ZIAAI001199-11,NIAID:301606\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,7339771 (contact),"STEELE-MORTIMER, OLIVIA  (contact)",NA,NA,NA,129 Mouse;Affect;Africa South of the Sahara;Appearance;Bacteria;Bacterial Meningitis;Biological Models;Blood;Blood Vessels;blood-brain barrier crossing;blood-brain barrier penetration;Brain;C57BL/6 Mouse;Cells;Central Nervous System;Chronic;cytokine;Dendritic Cells;Development;Encephalitis;Extravasation;Genetic Determinism;Genetic Diseases;Goals;Gram-Negative Bacteria;HIV/AIDS;Human;Immune response;immunodeficiency;Infection;Inflammation;intravenous administration;Iron;Laboratory mice;Macrophage;Malaria;Malnutrition;Meninges;Meningitis;mouse model;Mus;Mutation;natural resistance-associated macrophage protein 1;neutrophil;Oral Administration;pathogenic bacteria;Persons;Play;pleiotropism;Predisposition;reconstitution;Resistance;Role;Salmonella;Salmonella enterica;Salmonella infections;Salmonella typhimurium;Sickle Cell Anemia;Systemic disease;Systemic infection;T-Lymphocyte;trait,Salmonella infection in the murine brain,1199,NA,NA,NA,NA,11,NA,NA,301606,NA
11189437,ZIA,AI,1,N,NA,NA,NA,NA,ZIAAI001200,NA,NA,1ZIAAI001200-11,NIAID:804278\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,7339771 (contact),"STEELE-MORTIMER, OLIVIA  (contact)",NA,NA,NA,adaptive immunity;Anaerobic Bacteria;anti-cancer;anticancer activity;Attenuated;Bacteria;Biomedical Engineering;Cell Communication;Cells;chemotherapy;Clinical Trials;Development;Engineering;Engraftment;experience;Flow Cytometry;Future;Genes;Genetic Engineering;Goals;Human;Immune;Immune checkpoint inhibitor;Immune response;Immunohistochemistry;Immunotherapy;Infection;interest;Interleukin-2;Laboratories;Malignant Neoplasms;Mediating;Melanoma;Melanoma Cell;Modeling;Mouse Strains;Mucous Membrane;Mus;mutant;Natural Immunity;Neoplasm Metastasis;neoplastic cell;Oral;Organ;Patients;plasmid DNA;prevent;Proteins;Recombinants;reconstitution;recruit;Resistance;Salmonella;Salmonella typhimurium;screening;Solid Neoplasm;success;Testing;Therapeutic;tumor;tumor growth;tumor microenvironment;Xenograft procedure,Development of Salmonella for cancer therapeutics,1200,NA,NA,NA,NA,11,NA,NA,804278,NA
11189438,ZIA,AI,1,N,NA,NA,NA,NA,ZIAAI001202,NA,NA,1ZIAAI001202-10,NIAID:582293\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,78834489 (contact),"FRISCHMEYER-GUERRERIO, PAMELA  (contact)",NA,NA,NA,accurate diagnosis;Age;Allergic;Allergic Conjunctivitis;Allergic Disease;Allergic Reaction;Allergic rhinitis;Allergy to eggs;American;Anaphylaxis;androgenic;Asthma;Atopic Dermatitis;Australia;autosome;Biological Markers;Birth;Boston;Breastfed infant;Catalogs;Child;cholest-4-en-3-one;clinical biomarkers;clinical care;clinical practice;Clinical Treatment;Clinical Trials;cohort;Collaborations;Communities;Cutaneous;Data;Defense Mechanisms;Development;Diagnosis;diagnosis standard;Diagnostic;Disease;Double-Blind Method;Eczema;effectiveness evaluation;Elements;Enrollment;Event;Exclusive Breastfeeding;Exhibits;Exposure to;Familial Platelet Disorder;Food;food allergen;food antigen;food challenge;Food Hypersensitivity;Fright;Fungal Genome;Future;General Population;Genome;Genotype;Germ Lines;high risk;Human;IgE;Immunologics;improved;infancy;Infant;insight;Life;Lipids;Mediating;Mendelian disorder;metabolomics;Metagenomics;microbial;Milk;Modality;Mothers;Myeloproliferative disease;Oral;oral tolerance;orotidine;Pathogenesis;Pathogenicity;Pathway interactions;Patient Recruitments;patient stratification;Patients;Physicians;Placebo Control;Placebos;Plasma;population based;potential biomarker;Predictive Value;Predisposition;Pregnenolone;Prevalence;Prevention trial;primary outcome;prospective;racial diversity;Randomized;Reaction;Recording of previous events;recruit;Refractory;Research Institute;Research Personnel;Risk;Risk Factors;risk stratification;RUNX1 gene;Sampling;Severities;Severity of illness;Shotguns;Skin;skin barrier;skin damage;skin microbiome;Standardization;Steroids;Swab;Testing;Tryptase;Universities;Variant;Viral;Visit;Vitamin D;Vitamin D Deficiency;Vitamin D supplementation,Pathogenesis of Food Allergy,1202,NA,NA,NA,NA,10,NA,NA,582293,NA
11189439,ZIA,AI,1,N,NA,NA,NA,NA,ZIAAI001203,NA,NA,1ZIAAI001203-10,NIAID:582293\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,78834489 (contact),"FRISCHMEYER-GUERRERIO, PAMELA  (contact)",NA,NA,NA,Adoptive Transfer;Affect;Allergic;Allergic Disease;Allergic inflammation;Allergic rhinitis;Antibodies;Antibody Response;Antibody titer measurement;Antigens;Asthma;Atopic Dermatitis;autosome;B Cell Proliferation;B-Lymphocytes;Biochemical;Biological Assay;BLR1 gene;Bone Marrow;CD4 Positive T Lymphocytes;Cell Physiology;Cell secretion;Cells;Chimera organism;Chronic;Colitis;comparison control;Connective Tissue Diseases;crosslink;cytokine;Defect;Development;Disease;effective therapy;engineered T cells;eosinophil;Eosinophilic Esophagitis;Epithelial Cells;Esophagus;Exhibits;experimental study;Fetal Liver;Food;food antigen;Food Hypersensitivity;FOXO1A gene;FRAP1 gene;Frequencies;Generations;Genes;Genetic;Goals;Helper-Inducer T-Lymphocyte;high risk;Human;Humoral Immunities;IgE;IgG1;Immunoglobulin Class Switching;Immunologics;Impairment;In Vitro;in vivo;inhibitor;Interleukin-13;Interleukin-4;Investigation;Link;Loeys-Dietz Syndrome;Low Prevalence;MADH4 gene;Mediating;Medical;Mendelian disorder;mesenteric lymph node;Methods;Modeling;mouse model;Mus;Mutation;Myhre syndrome;Nature;Oral;Ovalbumin;Pathogenesis;Pathogenicity;Pathway interactions;Patients;Peyer&apos;s Patches;Phase;phosphatidylinositol 3-kinase gamma;Phosphorylation;Plasmablast;Play;prevent;Production;receptor;Regulatory T-Lymphocyte;Reporting;response;Risk;Role;Sampling;Signal Transduction;Signaling Molecule;Structure of germinal center of lymph node;T-Cell Receptor;T-Lymphocyte;TGFBR1 gene;TGFBR2 gene;Transforming Growth Factor beta;Vaccines;Work,The Role of Transforming Growth Factor Beta (TGFbeta) in Promoting Allergic Inflammation,1203,NA,NA,NA,NA,10,NA,NA,582293,NA
11189440,ZIA,AI,1,N,NA,NA,NA,NA,ZIAAI001204,NA,NA,1ZIAAI001204-10,NIAID:86987\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,14291601 (contact),"MYLES, IAN  (contact)",NA,NA,NA,Analytical Chemistry;Antigens;Biological Assay;CD8B1 gene;Cellular Immunity;Cloning;Disease;Goals;Human;Human Milk;Hybrids;Immunotherapeutic agent;Interleukin-6;Memory;Modeling;Morphologic artifacts;Mucous Membrane;Mus;novel;Peptides;Physiology;Proteins;Reporting;response;Role;Secure;T memory cell;Transfer Factor;Tuberculosis;Work,Use of Transfer Factor as a Novel Immune Therapeutic,1204,NA,NA,NA,NA,10,NA,NA,86987,NA
11189441,ZIA,AI,1,N,NA,NA,NA,NA,ZIAAI001206,NA,NA,1ZIAAI001206-10,NIAID:989897\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,79358273 (contact),"OLIVERA, ANA  (contact)",NA,NA,NA,Abdominal Pain;Acute;adaptive immune response;Adaptive Immune System;Affinity;Allergens;Allergic;Allergic Disease;Allergic inflammation;Allergic Reaction;Anaphylaxis;Antigens;ATR gene;Awareness;B-Lymphocytes;Bacteria;Basophils;Binding;Biological;Biological Process;biomarker identification;Blood Vessels;Body Fluids;Bone Density;Bone Diseases;Cell Communication;Cell Count;cell type;Cells;Characteristics;Chemotactic Factors;Clinical;cytokine;Diarrhea;Disease;Disease Management;draining lymph node;Etiology;Exposure to;extracellular vesicles;Family;Flushing;food allergen;food challenge;Food Hypersensitivity;Foundations;FPR1 gene;frontier;gain of function mutation;Goals;healthy volunteer;Hematopoietic;Hepatic Stellate Cell;Histamine;Human;Hypersensitivity;Hypotension;IgE;IgE Receptors;Immunity;Immunization;Immunology;immunoregulation;In Vitro;Incidence;Indolent;Infiltration;Inflammation;Inflammation Mediators;Inflammatory;inflammatory milieu;inhibitor;Innate Immune Response;Innate Immune System;insight;intercellular communication;Intercept;Intestinal permeability;Knowledge;leucyl-phenylalanine;Ligands;Link;lipid mediator;Liver;liver development;Liver Fibrosis;lymph nodes;Lymphocyte;Manuscripts;mast cell;mastocytosis;Mediating;Mediator;member;MicroRNAs;Mus;Musculoskeletal Pain;Mutation;nanosized;neoplastic;neutrophil;novel;Oncogenic;Osteoblasts;Osteoclasts;Pathogenesis;Pathology;Patients;Peptide Hydrolases;Phenotype;Plasma;Play;Process;Productivity;progenitor;programs;Proteomics;Pruritus;Publications;Publishing;Reaction;receptor;Receptor Activation;Receptor Protein-Tyrosine Kinases;Recovery;recruit;Regulation;Reporting;response;Role;Serum;Signal Pathway;Signal Transduction;Signaling Molecule;sphingosine 1-phosphate;stem cells;Stimulus;Structure;Structure of germinal center of lymph node;substantia spongiosa;Symptoms;Syncope;Systemic Mastocytosis;T-Lymphocyte;Technology;Tissues;vesicular release,Identification and Characterization of Signaling Pathways and Mediators Regulating Mast Cell-Related Disorders,1206,NA,NA,NA,NA,10,NA,NA,989897,NA
11189442,ZIA,AI,1,N,NA,NA,NA,NA,ZIAAI001207,NA,NA,1ZIAAI001207-10,NIAID:1460145\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,14291604 (contact),"MAYER-BARBER, KATRIN  (contact)",NA,NA,NA,Address;arm;Autoimmune Diseases;autoinflammatory diseases;Bacillus;bactericide;Barbering;Biological;Categories;Cell Communication;cell type;Cells;Chronic;Chronic Disease;chronic infection;Clinical;Clinical Research;clinical translation;Complex;cytokine;Cytosol;Defect;Development;Disease;Disease Progression;experimental study;Genes;Goals;granulocyte;Host resistance;Human;IL1R1 gene;Immunity;Immunologic Techniques;Immunologics;Immunology;immunoregulation;Immunotherapy;in vivo;Infection;Inflammation;Inflammatory;Inflammatory Response;Influenza A virus;insight;Interferon Type I;Interferons;Interleukin-1;Investigation;lipid mediator;Lung;Lung infections;Malignant Neoplasms;Mediating;Modeling;Molecular;mouse model;Mouse Strains;Mus;Mycobacterium avium;Mycobacterium tuberculosis;Mycoses;neutrophil;non-tuberculosis mycobacteria;novel;novel therapeutic intervention;Outcome;Pathogenesis;Pathology;Pathway interactions;Patients;Phagocytes;Phase;Play;predictive modeling;Predisposition;Production;programs;Property;Publishing;receptor;Research;respiratory;Respiratory Tract Infections;response;Role;Runaway;System;Therapeutic;Thinking;Tissues;translational pipeline;Tuberculosis;Vaccines;Viral;Virulence Factors;Work,Innate inflammatory responses during pulmonary infections,1207,NA,NA,NA,NA,10,NA,NA,1460145,NA
11189443,ZIA,AI,1,N,NA,NA,NA,NA,ZIAAI001210,NA,NA,1ZIAAI001210-09,NIAID:746970\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,9691521 (contact),"YEWDELL, JONATHAN W (contact)",NA,NA,NA,Binding;Biogenesis;CD8-Positive T-Lymphocytes;CD8B1 gene;Cell Cycle;Cell Physiology;cell type;Cells;Dizziness;Endoplasmic Reticulum;Flow Cytometry;Immune;immune activation;immune function;Immunity;insight;Knowledge;Ligands;Lymphocyte;Major Histocompatibility Complex;Molecular Conformation;novel;novel marker;pathogen;peptide I;Peptides;Play;Proteins;Ribosomes;Role;Site;T-Lymphocyte;Techniques;Tissues;Translations;tumor;Viral;Virus;Virus Activation;Virus Diseases,Translation in Immunity,1210,NA,NA,NA,NA,9,NA,NA,746970,NA
11189444,ZIA,AI,1,N,NA,NA,NA,NA,ZIAAI001211,NA,NA,1ZIAAI001211-09,NIAID:1105451\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,9691521 (contact),"YEWDELL, JONATHAN W (contact)",NA,NA,NA,Amino Acid Substitution;Antibodies;Antibody Affinity;Antibody Response;B-Lymphocytes;cost;deep sequencing;Economic Burden;Evolution;fitness;Glycoproteins;Goals;Head;Hemagglutinin;Humanities;Humoral Immunities;Immunity;Immunobiology;Immunoglobulin Class Switching;In Vitro;in vivo;Individual;Influenza;Influenza A virus;Membrane Glycoproteins;Mutation;Mutation Detection;Neuraminidase;neutralizing antibody;novel strategies;Polymerase;pressure;Process;response;seasonal influenza;Site;socioeconomics;Somatic Mutation;stem;Time;Vaccination;Viral;Viral Antigens;Virion;virology,Immunobiology and Virology of Influenza A Virus,1211,NA,NA,NA,NA,9,NA,NA,1105451,NA
11189445,ZIA,AI,1,N,NA,NA,NA,NA,ZIAAI001213,NA,NA,1ZIAAI001213-09,NIAID:2164017\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,9413721 (contact),"MARTIN, MALCOLM  (contact)",NA,NA,NA,2019-nCoV;Acute;Address;Adoptive Transfer;Affect;Affinity;Agonist;Animal Model;Animals;Antibodies;Antibody Therapy;antiretroviral therapy;B-Lymphocytes;Binding;Biology of HIV Infection;C-terminal;CD4 Positive T Lymphocytes;CD8-Positive T-Lymphocytes;CD8B1 gene;Cells;Cellular Immunity;Chronic;Clinical;Combination immunotherapy;Complex;CRISPR/Cas technology;Development;Disease;disease model;Disease remission;emerging virus;env Gene Products;Exhibits;Fab domain;Fc domain;Future;gene-editing approach;Genes;Gorilla gorilla;HIV;HIV Infections;HIV-1;HIV/AIDS;Human;immune activation;immunodeficiency;In Vitro;in vivo Model;Infection;Interleukin-15;lymph nodes;Macaca;Macaca mulatta;Mediating;Modeling;Monkeys;Morbidity - disease rate;mouse model;Mus;Mutation;neutralizing antibody;neutralizing monoclonal antibodies;nonhuman primate;Open Reading Frames;Opportunistic Infections;Outcome;Pan Genus;Pathogenesis;peripheral blood;Peripheral Blood Mononuclear Cell;Phenotype;Plasma;Point Mutation;Prevention;Productivity;Property;Prospective Studies;protein expression;Proteins;Protocols documentation;receptor;Recombinant adeno-associated virus (rAAV);Recombinant Antibody;repaired;Reporting;Resistance;Retroviridae;Serotyping;Shapes;simian human immunodeficiency virus;SIV;Source;Splenocyte;synergism;T-Lymphocyte;Testing;Tetracyclines;Therapeutic;therapeutic protein;Variant;vector;Viral;viral rebound;Viral reservoir;Viremia;Virus,The Biology of HIV Infections,1213,NA,NA,NA,NA,9,NA,NA,2164017,NA
11189446,ZIA,AI,1,N,NA,NA,NA,NA,ZIAAI001217,NA,NA,1ZIAAI001217-08,NIAID:895330\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,15222261 (contact),"MARCOTRIGIANO, JOSEPH  (contact)",NA,NA,NA,Affect;Anti-viral Therapy;Binding;Biochemical;biophysical techniques;Biophysics;CD81 gene;Cell Line;Cells;Centers for Disease Control and Prevention (U.S.);Chronic Hepatitis C;claudin-1 protein;Complex;cost;Data;Development;Docking;Endocytosis;Endosomes;extracellular;Foundations;Genotype;Glycoproteins;Goals;Hepatitis C;Hepatitis C Vaccine;Hepatitis C virus;Hepatocyte;Individual;Infection;Infection prevention;intravenous drug use;Investments;Length;Mediating;Membrane;Membrane Fusion;Modeling;Molecular;Molecular Conformation;neutralizing antibody;occludin;Patients;Persons;Pharmacotherapy;Polyvalent Vaccine;Preparation;Process;Public Health;receptor;receptor binding;Resources;Rest;Risk Behaviors;RNA Viruses;Role;Route;Secondary to;Series;SR-BI receptor;Structure;Surface;Tight Junctions;Vaccine Design;Vaccines;Viral;Virion,"Entry and replication of positive-sense, RNA viruses",1217,NA,NA,NA,NA,8,NA,NA,895330,NA
11189447,ZIA,AI,1,N,NA,NA,NA,NA,ZIAAI001219,NA,NA,1ZIAAI001219-08,NIAID:750935\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,15222264 (contact),"HAIGH, CATHRYN  (contact)",NA,NA,NA,3-Dimensional;Activities of Daily Living;Address;Affect;Animals;Architecture;Autopsy;Back;Biomass;Bovine Spongiform Encephalopathy;Brain;brain cell;brain dysfunction;brain tissue;Catabolism;Cell Death;Cell model;Cell Physiology;Cells;Cellular biology;Cellular Stress;Cerebrum;cervid;Cessation of life;Chronic Wasting Disease;Communicable Diseases;conformer;Country;Cytoskeleton;Disease;disease-causing mutation;Effectiveness;Emerging infection;Epidermal Growth Factor Receptor;Equipment;European;Event;experimental study;Exposure to;Failure;fluorescence imaging;fluorescence microscope;Functional disorder;gamma secretase;Gene Expression;gene function;Genus Hippocampus;Growth;Homeostasis;Human;human induced pluripotent stem cells;human stem cells;imaging system;improved;in vivo;Infection;interest;International;Knock-out;Link;Malignant Neoplasms;Methods;Microscopy;Mitochondria;Modeling;Monitor;Mus;nerve stem cell;Neurons;neuroprotection;North America;Organoids;Oxidation-Reduction;oxidative damage;Pathogenesis;Pathogenicity;Pathologic;Pathway interactions;Patients;Post-Translational Protein Processing;Predisposition;prevent;Prion Diseases;Prions;Process;Production;protein expression;protein function;Proteins;Proteolysis;PrP;Publishing;Pyruvate;Quality of life;Reader;recruit;Research;RNA;Role;senescence;Signal Transduction;South Korea;stem cell division;stem cell growth;stem cell model;Symptoms;System;Techniques;Testing;Therapeutic;Tissue Model,Prion protein function in redox homeostasis and associated failure in prion disease,1219,NA,NA,NA,NA,8,NA,NA,750935,NA
11189448,ZIA,AI,1,N,NA,NA,NA,NA,ZIAAI001220,NA,NA,1ZIAAI001220-08,NIAID:2682681\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,15222266 (contact),"GOLDBACH-MANSKY, RAPHAELA  (contact)",NA,NA,NA,"Adhesions;Adrenal Cortex Hormones;Adult;American;Amyloidosis;anakinra;Animal Model;antagonist;Arthralgia;Arthritis;autoinflammatory;autoinflammatory diseases;Biological Markers;biomarker validation;Blocking Antibodies;Blood Vessels;bone;CDC42 gene;Cell Culture System;Cell Differentiation process;Cell Line;Cell Physiology;Central Nervous System;Childhood;Chronic;Chronic atypical neutrophilic dermatosis with lipodystrophy and elevated temperature;Clinic;Clinical;clinical phenotype;cohort;Collaborations;college;Combined Modality Therapy;Complex;COVID-19 patient;cytokine;Cytokine Signaling;Dasatinib;Data;de novo mutation;design;Development;Diagnosis;disability;Disease;disorder control;Dose;Drops;Drug Modelings;drug testing;DYSF gene;early onset;Early treatment;Endothelial Cells;Endothelium;European;Evaluation;Exanthema;Expert Opinion;Eye;Fatty acid glycerol esters;Fever;Fibrosis;Flare;follow-up;Follow-Up Studies;gain of function mutation;Genes;Genetic;genetic signature;Goals;Hemophagocytic Lymphohistiocytoses;Heterozygote;human induced pluripotent stem cells;human model;Iatrogenesis;IFNAR1 gene;IL18 gene;IL1R1 gene;Immune;improved;In Vitro;induced pluripotent stem cell;infancy;Inflammation;Inflammation Mediators;Inflammatory;Inflammatory Bowel Diseases;inhibitor;Injections;Integrins;Intercellular adhesion molecule 1;Interferon Type II;Interferons;Interleukin-1;Interleukin-1 beta;Interleukin-1 Receptors;Interstitial Lung Diseases;Intervention;Kidney;kidney amyloidosis;kinase inhibitor;Laboratories;Labyrinth;Life;Liver Fibrosis;Longterm Follow-up;Lung Diseases;LYN gene;Macrophage;Macrophage activation syndrome;Mass Spectrum Analysis;Measures;Mediating;Medical;Mendelian disorder;migration;Modeling;Molecular;Monitor;monocyte;mortality;multicatalytic endopeptidase complex;Muscle;Mutation;Myeloid Cells;National Heart, Lung, and Blood Institute;National Institute of Allergy and Infectious Disease;Natural History;Neonatal Onset Multisystem Inflammatory Disease;Nephrotic Syndrome;neutrophil;novel;Organ;Organ Model;Outcome;participant enrollment;Pathogenesis;Pathogenicity;Patient Selection;patient subsets;Patients;pediatric patients;peripheral blood;Pharmaceutical Preparations;Phosphotransferases;Pilot Projects;Polyglandular Autoimmune Syndrome Type I;prevent;Prevention strategy;Process;Production;programs;Protocols documentation;Publishing;Pulmonary Alveolar Proteinosis;Rare Diseases;receptor;Recombinant Proteins;Recombinants;Reporting;Resolution;response;Rheumatology;Rhubarb food;Risk;RNA Splicing;Role;Safety;Sampling;Secondary to;Serum;side effect;Signal Transduction;Site;Skin;small molecule;Source;src-Family Kinases;stem cells;STING-associated vasculopathy;Syndrome;systemic inflammatory response;targeted treatment;Tissues;tool;transcriptomics;Treatment Efficacy;Treatment Protocols;Undifferentiated;Validation;Variant;Vascular Diseases;Vasculitis;Viral;Visit","Pathogenesis, and Outcome of Autoinflammatory Diseases, NOMID/CAPS, DIRA, CANDLE, SAVI, NLRC4-MAS, Still's-like Diseases, and other Undifferentiated Autoinflammatory Diseases",1220,NA,NA,NA,NA,8,NA,NA,2682681,NA
11189449,ZIA,AI,1,N,NA,NA,NA,NA,ZIAAI001222,NA,NA,1ZIAAI001222-08,NIAID:361036\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,15222269 (contact),"NOTARANGELO, LUIGI  (contact)",NA,NA,NA,"Accounting;Affect;Animal Model;Antibodies;Antibody-drug conjugates;Autoimmune;Autoimmune Diseases;Autoimmune hemolytic anemia;autoinflammatory diseases;Automobile Driving;B cell differentiation;B-Cell Antigen Receptor;base;Biological Assay;Biological Markers;Bone Marrow Purging;California;Candidiasis;Cells;Cephalic;Cervical;Chronic Granulomatous Disease;Clinical;Collaborations;Complex;congenital immunodeficiency;Cutaneous;Data;Defect;Development;differentiation in vitro;Disease;DNA Polymerase III;Engraftment;Evaluation;Facies;FLT3 ligand;France;gene therapy;Generations;Genes;Genetic Diseases;genetic variant;genotyped patients;Goals;Hematopoietic;Hematopoietic Stem Cell Transplantation;Hematopoietic stem cells;Heterogeneity;Human;human model;humanized mouse;Immune;immune reconstitution;Immune system;Immune Tolerance;immunopathology;Immunotoxins;Impairment;In Vitro;in vivo;Individual;Infection;Inflammatory;insight;Interferon Type I;Interferon Type II;Investigation;Knowledge;Laboratories;Life;loss of function;Loss of Heterozygosity;Lymphopenia;member;Molecular;molecular pathology;Monoclonal Antibodies;mouse model;Mucous Membrane;Multicenter Studies;Mus;Mutate;Mutation;Natural History;Nature;neutrophil;NFKB Signaling Pathway;novel;novel therapeutic intervention;Omenn syndrome;Outcome;Oxidases;Paris, France;pathogen;patient derived induced pluripotent stem cells;Patients;Phenotype;Platelet Count measurement;Polyglandular Autoimmune Syndrome Type I;pre-clinical;pre-T cell receptor alpha;Predisposition;prevent;Production;PTPRC gene;reconstitution;Reporting;Research Project Grants;Review Literature;Risk;Role;San Francisco;Series;Severe Combined Immunodeficiency;skin microbiome;Structure;Structure of thymic medulla;Surface;Syndrome;T-Cell Receptor;T-Lymphocyte;targeted treatment;Testing;Therapeutic;Thymus Gland;Tissues;TNFRSF5 gene;tool;Transplantation;United States National Institutes of Health;Universities;Variant;Virus Diseases;Visceral Leishmaniasis;Wiskott-Aldrich Syndrome",Characterization of the cellular and molecular bases of inborn errors of immunity,1222,NA,NA,NA,NA,8,NA,NA,361036,NA
11189450,ZIA,AI,1,N,NA,NA,NA,NA,ZIAAI001223,NA,NA,1ZIAAI001223-08,NIAID:97669\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,9691557 (contact),"MCBRIDE, ALISON  (contact)",NA,NA,NA,cancer cell;Cancer Cell Growth;Cell Death;Cells;Cervical;chromosome conformation capture;design;Development;Genetic;Genetic Transcription;Genome;Goals;Growth;Human;Human Genome;Human Papilloma Virus-Related Malignant Neoplasm;Human Papillomavirus;insight;Malignant neoplasm of cervix uteri;malignant oropharynx neoplasm;Oncogenes;Oncogenic;Play;Process;Role;targeted treatment;Techniques;Therapeutic Intervention;tumorigenesis;Viral;Viral Oncogene;Virus Integration,The Role and Mechanism of Integration in Oncogenic Progression of HPV associated cancers,1223,NA,NA,NA,NA,8,NA,NA,97669,NA
11189451,ZIA,AI,1,N,NA,NA,NA,NA,ZIAAI001224,NA,NA,1ZIAAI001224-08,NIAID:86556\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,10686351 (contact),"DUFFY, PATRICK  (contact)",NA,NA,NA,Acceleration;Adjuvant;Adult;Africa;African;Agreement;Anopheles Genus;Antibodies;Antibody Response;Antibody titer measurement;Antigens;Area;arm;Biological Assay;Blocking Antibodies;Blood;Blood Group Antigens;Brazil;burden of illness;Cambodia;cell bank;Cells;cGMP production;chemical conjugate;chemokine receptor;Chimeric Proteins;circumsporozoite protein;Clinical;clinical center;clinical development;Clinical Research;Clinical Trials;Conjugate Vaccines;COVID-19;Culicidae;Cyclic GMP;density;Development;Disease;Documentation;Dose;efficacy study;Erythrocytes;Erythroid;Escherichia coli;Ethics;experience;feeding;field study;first-in-human;Formulation;Funding;Generations;genetic variant;Germ Cells;Goals;healthy volunteer;Hepatitis B Virus;Human;human study;immunogenic;immunogenicity;Individual;Infection;Interruption;Invaded;Investigational New Drug Application;Length;Malaria;malaria transmission;Malaria Vaccines;man;manufacture;Membrane;Microbe;model development;Modeling;Monkeys;monomer;Mus;mutant;nanoparticle;National Institute of Allergy and Infectious Disease;Oryctolagus cuniculus;Parasites;Participant;Patients;Pharmaceutical Preparations;Phase;Phase I Clinical Trials;phase II trial;Plasmodium falciparum;Plasmodium vivax;Plasmodium vivax vaccine;Population;preclinical development;preclinical evaluation;Preparation;Process;product development;Production;Progress Reports;Proteins;Protocols documentation;Pseudomonas aeruginosa;Publications;Published Comment;receptor;Recombinant Proteins;Recombinants;Reporting;Safety;Saimiri;Saponins;Series;Serum;Site;Skin;Specific qualifier value;Sporozoites;Surface;Testing;timeline;Toxicology;Toxin;transmission blocking;transmission process;transmission-blocking vaccine;United States National Institutes of Health;Universities;Vaccinated;vaccine candidate;vaccine development;Vaccines;Validation;validation studies;Vial device;Virus-like particle;Vivax Malaria;volunteer,Malaria Vaccines:  Pvs230D1-EPA and PvCSP,1224,NA,NA,NA,NA,8,NA,NA,86556,NA
11189452,ZIA,AI,1,N,NA,NA,NA,NA,ZIAAI001225,NA,NA,1ZIAAI001225-08,NIAID:1443916\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,15222273 (contact),"HICKMAN, HEATHER  (contact)",NA,NA,NA,adaptive immune response;Anatomy;antiviral immunity;cell type;Cells;Chikungunya virus;Color;Complex;Confocal Microscopy;DNA Viruses;draining lymph node;Effector Cell;experimental study;Fluorescence;Generations;Goals;Image;imaging modality;Immune;Immune response;Immunity;Immunologics;in vivo;Infection;interest;intravital imaging;Location;lymph nodes;Mediating;Memory;Modeling;multiphoton microscopy;Mus;nonhuman primate;Pathogenesis;pathogenic virus;Peripheral;prevent;Process;response;RNA Viruses;secondary lymphoid organ;Shapes;Simplexvirus;Site;SIV;Small RNA;Techniques;Time;Tissues;Viral;Virus;Visualization;Zika Virus;ZIKV infection,Imaging Antiviral Immunity,1225,NA,NA,NA,NA,8,NA,NA,1443916,NA
11189453,ZIA,AI,1,N,NA,NA,NA,NA,ZIAAI001228,NA,NA,1ZIAAI001228-07,NIAID:21640\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,10686351 (contact),"DUFFY, PATRICK  (contact)",NA,NA,NA,Alleles;Anti-malarial drug resistance;Biological;Blood;Chemicals;Child;Chloroquine resistance;Codon Nucleotides;cohort;cost effective;Deoxyribonucleases;Diagnostic;Dideoxy Chain Termination DNA Sequencing;DNA;Drug Monitoring;Drug resistance;drug-sensitive;Dryness;epidemiology study;Ethanol;Filariasis;Frequencies;Genes;Genotype;Guinea;Health;improved;Infection;Liberia;Malaria;Mali;Measures;Merozoite Surface Protein 1;Methods;Molecular Epidemiology;molecular marker;Monitor;Mutation;Organism;Paper;Parasitemia;Parasitic infection;Performance;Plasmodium;Plasmodium falciparum;population based;Pregnant Women;Prevalence;prevent;Progress Reports;Protocols documentation;Public Health;Publications;research study;Resistance;resistance allele;resistance gene;resistant Plasmodium falciparum;Sampling;Schistosoma;Science;Seasons;Spottings;Strongyloides stercoralis;surveillance study;Surveys;Techniques;Testing;Variant;Water,Malaria Surveillance and Research Studies in Liberia and Guinea-Conakry,1228,NA,NA,NA,NA,7,NA,NA,21640,NA
11189454,ZIA,AI,1,N,NA,NA,NA,NA,ZIAAI001232,NA,NA,1ZIAAI001232-07,NIAID:460393\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,6568586 (contact),"KRISTIE, THOMAS M (contact)",NA,NA,NA,Biochemical;Cells;clinical phenotype;Cobalamin;Data Set;Development;Disease;Enzymes;Epilepsy;Fibroblasts;Genetic Transcription;Genome;Homocystinuria;host cell factor C1;Intellectual functioning disability;Link;Metabolism;methylmalonic aciduria;Molecular;mouse model;Mutation;Neurologic;Pathway interactions;Patients;Phenotype;Proteins;recruit;Syndrome;Tissues;Transcription Coactivator;Vitamin B 12,Molecular basis of cblX syndrome,1232,NA,NA,NA,NA,7,NA,NA,460393,NA
11189455,ZIA,AI,1,N,NA,NA,NA,NA,ZIAAI001234,NA,NA,1ZIAAI001234-07,NIAID:257535\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,9691541 (contact),"NUTMAN, THOMAS  (contact)",NA,NA,NA,Adrenal Cortex Hormones;Adult;Affect;Antibodies;Antigens;Archives;Area;Autoantibodies;biobank;Biological Assay;Biological Markers;Blood;Brain;Case Series;CD4 Positive T Lymphocytes;Cell Line;Cells;Central Nervous System;Cestoda;chemokine;Clinical;Clinical Data;Clinical Laboratory Improvement Amendments;Clinical Protocols;clinical research site;cohort;Collaborations;Country;Cross Reactions;Cyst;cytokine;Data;Detection;Development;Diagnosis;diagnostic assay;Disease;Disease Outcome;Epilepsy;experience;follow-up;Genus Tenia;Helminths;Historical Cohort Studies;Human;Human Subject Research;Image;improved;indexing;Infection;Inflammation;Inflammatory;Interleukin-10;Intervention;Longterm Follow-up;Manuscripts;Mediating;Morbidity - disease rate;mortality;Natural History;Nature;neglect;Nervous System Disorder;Neurocysticercosis;neuroimmunology;neuroinflammation;Neurology;neurotoxic;Organism;Outcome;Parasites;Pathogenesis;Pathology;Patients;Persons;Phenotype;Population;Process;Productivity;Proteins;Publications;Publishing;Reaction;Recruitment Activity;Regulatory T-Lymphocyte;Relapse;Reporting;research study;Retrospective Studies;Risk;Role;Sampling;Seizures;self-renewal;Series;Source;Spinal Cord;standard care;stem cells;Subarachnoid Space;Sylvius fissure;Taenia solium;Teniasis;Testing;Time;treatment planning;treatment response;Ventricular,Biomarkers and host-parasite interactions in neurocysticercosis and other helminths,1234,NA,NA,NA,NA,7,NA,NA,257535,NA
11189456,ZIA,AI,1,N,NA,NA,NA,NA,ZIAAI001236,NA,NA,1ZIAAI001236-07,NIAID:780221\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,15700997 (contact),"TOLIA, NIRAJ  (contact)",NA,NA,NA,acquired immunity;Adult;Antibodies;Antibody Response;Antibody-mediated protection;Antigen Targeting;Antigenic Variation;Antigens;apical membrane;B-Lymphocytes;Binding;Binding Sites;Biology;Cells;Cessation of life;Clinical;Collaborations;Communication;Complex;Culicidae;Data;design;Development;Disease;Disease Progression;Engineering;Epitopes;Exhibits;Florida;Goals;Human;Immune response;Immune system;Immunity;Immunize;improved;in vivo;Infection;insight;Intervention;Invaded;Knowledge;Life Cycle Stages;Liver;liver infection;Malaria;malaria transmission-blocking vaccine;Malaria Vaccines;manufacture;Maps;Mediating;Membrane Proteins;Modality;Monoclonal Antibodies;Mus;Nature;Neck;neutralizing antibody;next generation;novel;Parasites;Parasitic infection;pathogen;Pathogenesis;Plasmodium falciparum;Plasmodium vivax;prevent;Protein Family;Proteins;Publishing;Reporting;Research;response;rhoptry;Sterility;Structure;T-Lymphocyte;Technology;Therapeutic Intervention;Transcend;Transgenic Organisms;transmission process;Universities;Vaccine Antigen;vaccine candidate;Vaccine Design;vaccine development;vaccine immunogenicity;Vivax Malaria;Work,Mechanisms of effective antibody neutralization,1236,NA,NA,NA,NA,7,NA,NA,780221,NA
11189457,ZIA,AI,1,N,NA,NA,NA,NA,ZIAAI001237,NA,NA,1ZIAAI001237-07,NIAID:780221\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,15700997 (contact),"TOLIA, NIRAJ  (contact)",NA,NA,NA,Antigen Receptors;Avidity;Binding;Binding Sites;Biology;Blood;Blood Group Antigens;CD44 gene;Cell surface;Cell Surface Proteins;Cells;chemokine receptor;Collaborations;Complex;Culicidae;Cytoskeleton;Diagnostic;editorial;Erythrocytes;Erythroid;experimental study;Glycophorin C;Goals;GYPA gene;Human;Immunoglobulin Constant Region;Individual;Infection;insight;Intervention;Invaded;Knowledge;Life Cycle Stages;Ligands;Malaria;malaria transmission;Microbe;Modality;Modeling;Molecular;monomer;novel vaccines;parasite invasion;Parasites;Parasitology;pathogen;Pathogenesis;Phenotype;Plasmodium falciparum;Plasmodium vivax;Polysaccharides;prevent;protein complex;protein structure;Proteins;Publishing;rational design;receptor;receptor binding;Reporting;Resistance;Reticulocytes;Role;Source;Structure;Surface;Testing;Therapeutic;therapy development;Tight Junctions;trend;Universities;vaccine candidate;Vaccine Design;vaccinology;vector;vector mosquito;vector transmission,Structural characterization of host-pathogen interactions,1237,NA,NA,NA,NA,7,NA,NA,780221,NA
11189458,ZIA,AI,1,N,NA,NA,NA,NA,ZIAAI001240,NA,NA,1ZIAAI001240-06,NIAID:2322792\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,16161411 (contact),"SCHWARTZBERG, PAMELA  (contact)",NA,NA,NA,adaptive immunity;Adhesions;Adhesives;Affect;Affinity;Antibodies;Antibody Formation;Antibody-mediated protection;Area;Asthma;Autoantibodies;Autoimmunity;B-Lymphocytes;Biochemical;cancer therapy;CD4 Positive T Lymphocytes;CD8-Positive T-Lymphocytes;CD8B1 gene;Cell Adhesion;Cell Communication;Cell Differentiation process;cell growth;Cell Physiology;Cells;Cellular biology;chronic infection;Clustered Regularly Interspaced Short Palindromic Repeats;Collaborations;Complement;congenital immunodeficiency;Coupled;CRISPR library;CRISPR screen;cytokine;Cytokine Signaling;cytotoxic CD8 T cells;Defect;Development;Disease;Effector Cell;Eosinophilic Esophagitis;Epigenetic Process;Epstein-Barr Virus Infections;exhaust;exhaustion;Extrinsic asthma;Feedback;FRAP1 gene;frontier;Functional disorder;gene function;Gene Targeting;Generations;Genes;Genetic;genetic approach;Genetic Diseases;Genetic Transcription;Genomics;Goals;Growth;GTPase-Activating Proteins;Guanosine Triphosphate Phosphohydrolases;Health;Helper-Inducer T-Lymphocyte;HIV/HCV;Homeostasis;Human;Human Herpesvirus 4;human model;Humoral Immunities;Hypersensitivity;Immune;immune checkpoint blockade;immune function;Immune response;Immunity;Immunization;immunodeficiency;Immunoglobulin Class Switching;immunopathology;In Vitro;in vivo;Infection;Infectious Agent;Inflammatory Response;insight;interdisciplinary approach;interest;Interferon Type II;Interleukin-2;Interleukin-9;Link;Lymphocyte;Lymphocyte Function;Lymphoma;Malignant Neoplasms;Mediating;Memory;Metabolic;Methods;Modeling;mouse model;Mus;Mutagenesis;Mutation;National Institute of Allergy and Infectious Disease;Nature;Paper;Pathology;Pathway interactions;Patients;Pattern;Phenotype;Phosphatidylinositols;Phosphorylation;Phosphotransferases;Play;Population;Preparation;prevent;Production;progenitor;Protein Biochemistry;Protein Tyrosine Kinase;Pulmonary Pathology;Pyroglyphidae;Qi;Regulation;Reporting;Repression;resident commensals;response;Role;sharpin;Signal Pathway;Signal Transduction;Signaling Molecule;single-cell RNA sequencing;stem;stem-like cell;Steroid-resistant asthma;Structure of germinal center of lymph node;Syndrome;T cell response;T-Lymphocyte;TCF Transcription Factor;Technology;Th2 Cells;tool;trafficking;transcription factor;trend;tumor;Viral;whole genome;Work,Genetic and Biochemical Approaches to Tyrosine Kinase and Lymphocyte Signaling,1240,NA,NA,NA,NA,6,NA,NA,2322792,NA
11189459,ZIA,AI,1,N,NA,NA,NA,NA,ZIAAI001241,NA,NA,1ZIAAI001241-06,NIAID:29037\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,16161411 (contact),"SCHWARTZBERG, PAMELA  (contact)",NA,NA,NA,"Adjuvant;Affect;Autoimmune Diseases;Biological;Biological Assay;Blood;Cells;Cellular Indexing of Transcriptomes and Epitopes by Sequencing;Chronic Disease;Communicable Diseases;Complement;Data;Databases;design;Development;Diabetes Mellitus;Disease;Equine mule;Evaluation;follow-up;Follow-Up Studies;Functional disorder;Generations;Heart Diseases;high dimensionality;Human;Immune;Immune response;Immune system;Immune System Diseases;Immunity;Immunization;Immunology;improved;Individual;Inflammation;Influenza A Virus, H5N1 Subtype;Influenza vaccination;influenza virus vaccine;Laboratories;Lupus;Malignant Neoplasms;Modeling;Molecular;Nerve Degeneration;New York;novel vaccines;Obesity;Paper;Pathogenesis;Prevention;Productivity;Proteomics;response;sample collection;Serum;Severe Acute Respiratory Syndrome;Severities;Systems Biology;Technology;Therapeutic;Time;United States National Institutes of Health;Vaccination;vaccine efficacy;vaccine immunogenicity;vaccine response;vaccine trial;Vaccines;Variant;Work",Immune Responses to Influenza Vaccination,1241,NA,NA,NA,NA,6,NA,NA,29037,NA
11189460,ZIA,AI,1,N,NA,NA,NA,NA,ZIAAI001242,NA,NA,1ZIAAI001242-06,NIAID:1388137\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,16161414 (contact),"BIELEKOVA, BIBIANA  (contact)",NA,NA,NA,Acceleration;Accelerometer;Age;Aging;Algorithms;Annexins;Atrophic;Autoimmune;autoinflammatory;axon injury;B cell clonality;B-Cell Antigen Receptor;Binding;Biological Markers;Brain;Categories;Cells;Cellular Phone;Central Nervous System;Central Nervous System Diseases;Central Nervous System Infections;central nervous system injury;Cerebrospinal Fluid;Cervical spinal cord structure;Clinical;Clinical/Radiologic;clinically relevant;cohort;comparison control;corticobasal degeneration;COVID-19 pandemic;Cytomegalovirus;Data;Databases;Development;Diagnosis;Diagnostic;digital;Digital biomarker;disability;Disability scale;Disease;Early treatment;effective therapy;Elderly;Epitopes;Epstein-Barr Virus latency;Exons;Family;Flow Cytometry;foot;frontotemporal lobar dementia amyotrophic lateral sclerosis;Functional disorder;Gait;Genes;glial activation;Healthcare;Human;Human Herpesvirus 4;Image;Immune;Immune response;Immune system;Immunoassay;immunomodulatory therapies;immunoregulation;Inflammatory;Influenza;Interferon Type I;Knowledge;Learning;Length;Libraries;Lower Extremity;Lysosomes;Lytic Virus;Machine Learning;Magnetic Resonance Imaging;Measures;Mediating;Messenger RNA;Modification;molecular marker;Movement;multimodality;Multiple Sclerosis;multiple sclerosis patient;multiple sclerosis treatment;Muscle;Nerve Degeneration;Nervous System Disorder;Nervous System Physiology;Nervous System Trauma;Neurofilament-L;Neuroimmune;neuroimmunologic disease;Neurologic Deficit;Neurologic Dysfunctions;Neurologic Examination;Neurologist;Neurology;neuroprotection;novel;optimal treatments;Outcome;Paper;Patients;Persons;phase II trial;Physicians;Physiological;Population;Posture;predictive marker;prevent;Process;Prognostic Marker;Property;protein TDP-43;Proteins;Protocols documentation;Psychometrics;Publishing;Rare Diseases;Relapsing-Remitting Multiple Sclerosis;Reporting;Research;Research Personnel;response;rho;RNA;Role;Sampling;screening;Self Administration;Sensitivity and Specificity;Signal Transduction;Specialist;Spinal Cord;Spinal Cord Lesions;Syndrome;T cell clonality;T-Cell Receptor;T-cell receptor repertoire;T-Lymphocyte;Telemedicine;Testing;Therapeutic Agents;Time;tissue repair;Toes;tool;Transcript;transcriptomics;United States Food and Drug Administration;Validation;Variant;Viral;Viral Proteins;Walking;Writing,Comprehensive multimodal analysis of patients with neuroimmunological diseases,1242,NA,NA,NA,NA,6,NA,NA,1388137,NA
11189461,ZIA,AI,1,N,NA,NA,NA,NA,ZIAAI001243,NA,NA,1ZIAAI001243-06,NIAID:1388137\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,16161414 (contact),"BIELEKOVA, BIBIANA  (contact)",NA,NA,NA,Acute;Age;arm;Axon;Benefits and Risks;Biological Markers;Biological Process;Blinded;Blood - brain barrier anatomy;Blood Cells;Cardiovascular Diseases;Caring;Central Nervous System;Cessation of life;Characteristics;Chronic;clinical practice;Clinical Trials;Combined Modality Therapy;comorbidity;Complex;Data;Demyelinations;disability;Disability outcome;Disease;Disease remission;Drug Combinations;drug development;drug efficacy;Drug Targeting;drug testing;effective therapy;Endothelium;Enhancing Lesion;Etiology;Exclusion;exhaust;FDA approved;Functional disorder;glucose metabolism;hazard;Heart;Hypertension;illness length;Immune;immunoregulation;Individual;individual patient;Infection;Inflammation;Injury;Knowledge;knowledge base;Lesion;Lifelong disability;lipid disorder;lipid metabolism;Magnetic Resonance Imaging;Measurable;Measurement;Measures;Meta-Analysis;Methodology;Modeling;Molecular;Morbidity - disease rate;mortality;mortality risk;Multiple Sclerosis Lesions;multiple sclerosis patient;multiple sclerosis treatment;Nervous System Trauma;Neurological disability;neuron loss;Neurons;novel;Online Systems;Paper;Pathogenicity;Pathology;patient population;Patient Recruitments;Patients;Pharmaceutical Preparations;Pharmacodynamics;Phase;Phase II Clinical Trials;Placebos;precision medicine;Prevalence;Printing;Process;prospective;Protocols documentation;Publishing;Randomized;Relapse;repaired;Residual state;Risk;risk/benefit ratio;Sample Size;screening;Severity of illness;successful intervention;System;Testing;Therapeutic;Therapeutic Agents;Thrombophilia;Tight Junctions;Time;treatment duration;Treatment Efficacy;treatment risk;Validation,From therapeutic mechanisms to unraveling the pathophysiology of MS,1243,NA,NA,NA,NA,6,NA,NA,1388137,NA
11189462,ZIA,AI,1,N,NA,NA,NA,NA,ZIAAI001246,NA,NA,1ZIAAI001246-06,NIAID:1532625\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,16161417 (contact),"CALVO, ERIC  (contact)",NA,NA,NA,Aedes;Affect;Alpha-glucosidase;Anopheles gambiae;Anti-Inflammatory Agents;Arboviruses;Arthropods;Binding;Biochemical;Biogenic Amines;Biological;Biological Assay;Biology;Bite;Blood;Blood Proteins;Calcium ion;Comprehension;cost;CRISPR/Cas technology;Culex (Genus);Culicidae;Dengue Infection;Dengue Virus;Development;Digestion;disease transmission;Docking;drug development;Eicosanoids;Engineering;Entomology;Enzymes;Exhibits;feeding;fitness;Flavivirus Infections;gene drive system;gene editing technology;Gene Expression;gene product;Genes;Hemostatic function;Human;Immune;Immune response;Immune signaling;Impairment;In Vitro;in vivo;Infection;Inflammasome;Ingestion;insight;Invaded;Knock-out;Laboratories;Leukotrienes;loss of function;Malaria;malaria transmission;male;Mediating;Medical;Midgut;Modeling;Molecular;Monosaccharides;mutant;Natural Immunity;novel;Orthologous Gene;Parasites;Parasitic infection;pathogen;Pathogenesis;Pathway interactions;Plasmodium;Plasmodium falciparum;Plasmodium gallinaceum;Play;Polysaccharides;preference;prevent;Process;Property;Proteins;receptor;Research;Resolution;Rodent;Role;Saliva;saliva secretion;Salivary;salivary gene;Salivary Glands;Salivary Proteins;sex;Signaling Molecule;Site;Skin;Specificity;Structural Models;Structure;Sucrose;sugar;Tissues;transmission process;vector;vector mosquito;Vector-transmitted infectious disease;Viral;Viral Physiology;Virus;Virus Diseases;Work;Yellow Fever;Zika Virus;ZIKV infection,Arthropod saliva in vector-borne disease transmission: Functional analysis of novel domains in salivary secretions,1246,NA,NA,NA,NA,6,NA,NA,1532625,NA
11189463,ZIA,AI,1,N,NA,NA,NA,NA,ZIAAI001247,NA,NA,1ZIAAI001247-06,NIAID:1217919\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,16161419 (contact),"FREEMAN, ALEXANDRA  (contact)",NA,NA,NA,"Air;airway epithelium;Aneurysm;angiogenesis;anti-microbial peptide;Aorta;Area;Arteries;artery stenosis;Arthritis;Atherosclerosis;Autoimmune;Autoimmunity;Award;bench to bedside;biomedical referral center;Blood Vessels;Bone Marrow Transplantation;bronchial epithelium;Bronchiectasis;Bronchoscopy;calcification;Candida;cerebral artery;Clinic;Clinical;clinical care;clinical phenotype;Clinical Protocols;Clinical Research;cohort;Collaborations;Collection;Complex;congenital immunodeficiency;Connective Tissue;Coronary artery;COVID-19;COVID-19 pandemic;COVID-19 vaccine;cytopenia;Data;Defect;Dental;Dermatology;Diagnosis;Diffuse;Disease;DOCK8 deficiency;Dominant-Negative Mutation;Early Diagnosis;Eczema;Education;Epithelial Cells;Etiology;experience;Funding;Gastrointestinal Hemorrhage;Genetic Predisposition to Disease;Genus staphylococcus;Goals;Grant;Hematopoietic Stem Cell Transplantation;Hemorrhage;HIF1A gene;HIV Seronegativity;Host Defense;Human Papillomavirus;Hyper-IgE Syndrome;Hypersensitivity;IgE;IL2RG gene;Image;Immune;Immune response;immunodeficiency;Immunologics;improved;In Vitro;Incidence;Individual;Infection;insight;interest;Interferons;interleukin-12 receptor;Kaposi Sarcoma;Laboratories;Laboratory Research;Laboratory Study;Liver diseases;Longterm Follow-up;Lung;Lung Diseases;Lung infections;Lupus;lupus-like;Malignant Neoplasms;Manuscripts;Matrix Metalloproteinases;Mendelian disorder;microbial;microbiome;Morbidity - disease rate;mortality;Mucins;Mutation;Myocardial Infarction;National Heart, Lung, and Blood Institute;National Institute of Allergy and Infectious Disease;National Institute of Arthritis, and Musculoskeletal, and Skin Diseases;National Institute of Diabetes and Digestive and Kidney Diseases;Natural History;neutrophil;novel;Occupations;Omenn syndrome;Operative Surgical Procedures;Osteoporosis;Paper;pathogen;Pathogenesis;Pathologic;Pathway interactions;patient oriented;patient population;Patient Selection;Patients;Phenotype;Population;Predisposition;Prospective Studies;Protocols documentation;Publishing;recurrent infection;Research;research study;response;Risk Factors;Safety;scoliosis;Signal Transduction;Site;skeletal abnormality;skin biopsy;skin disorder;skin microbiome;Spain;Sputum;STAT1 gene;STAT3 gene;Subarachnoid Hemorrhage;Syndrome;System;Thinness;Tissues;Training;transplant centers;Transplantation;United States National Institutes of Health;Vaccines;vascular abnormality;Vascular Diseases;Vasculitis;viral DNA;Viral Load result;Virus;wound healing",Primary Immune Deficiency Clinic,1247,NA,NA,NA,NA,6,NA,NA,1217919,NA
11189464,ZIA,AI,1,N,NA,NA,NA,NA,ZIAAI001249,NA,NA,1ZIAAI001249-06,NIAID:2313646\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,16161421 (contact),"DEKKER, JOHN  (contact)",NA,NA,NA,Acute;Alleles;Animals;Antibiotic Resistance;antibiotic resistant infections;Antibiotic Therapy;Antibiotics;Antimicrobial Resistance;Area;attributable mortality;auxotrophy;Bacteremia;Bacterial Genome;Bacteroides fragilis;Biology;Bordetella;Burkholderia;Carbapenems;Ceftazidime;Cell Line;Chickens;Chromosome Deletion;chromosome fusion;Chromosomes;chronic infection;Citric Acid Cycle;Clinical;clinical center;Collaborations;Collection;Communication;Complex;Cryoelectron Microscopy;Development;digital;DNA;DNA Insertion Elements;DNA Polymerase III;DNA Replication Proofreading;DNA Restriction-Modification Enzymes;Down-Regulation;efflux pump;Electron Microscopy;emerging pathogen;Engineering;Environment;Enzymes;Event;Evolution;experimental study;Fluorescence;gastrointestinal;Gene Expression;Generations;Genes;Genetic Drift;Genetic Transcription;Genome;genome sequencing;Genomic approach;Genomics;Gluconeogenesis;Goals;homologous recombination;Host Defense;Human;IL12RB1 gene;Image;Immune Evasion;Immunocompromised Host;in vivo;Individual;Infection;infectious disease treatment;Insertional Mutagenesis;Interruption;Investigation;Measurement;Mediating;Mediator;Meropenem;Metabolic;Metabolism;metabolomics;Methylation;methylome;Methyltransferase;Mismatch Repair Deficiency;Modeling;Modern Medicine;Modification;Motility;Multi-Drug Resistance;Mutation;nanopore;National Institute of Diabetes and Digestive and Kidney Diseases;Nature;novel;Ontology;Operon;Organism;Parents;pathogen;Pathogenesis;pathogenic bacteria;Pathway interactions;Patients;Phenotype;Phenylalanine;Physiology;Population Dynamics;Positioning Attribute;Predisposition;promoter;Proteins;Pseudomonas aeruginosa;Publishing;Reporter;Resistance;resistance gene;resistance mechanism;resistance mutation;Reverse Transcriptase Polymerase Chain Reaction;Role;single molecule;Structure;System;Systems Biology;Tazobactam;Testing;transcriptome;transcriptomics;United States National Institutes of Health;vector;whole genome;Work;Zoonoses,Application of Genomic Approaches to Bacterial Pathogenesis and Mechanisms of Antimicrobial Resistance,1249,NA,NA,NA,NA,6,NA,NA,2313646,NA
11189465,ZIA,AI,1,N,NA,NA,NA,NA,ZIAAI001250,NA,NA,1ZIAAI001250-06,NIAID:1414629\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,16161423 (contact),"VEGA-RODRIGUEZ, JOEL  (contact)",NA,NA,NA,Actomyosin;Adjuvant;Affect;Alteplase;Anopheles Genus;Anti-malarials;Antibodies;Apyrase;Area;Bacteria;Binding;Biological Assay;Biology;Bite;Blood;Blood Vessels;Bolus Infusion;Cell Surface Receptors;Cells;Communication;comparison control;Complement;complement system;Complex;Complex Mixtures;Culicidae;Data;Deposition;Development;disease transmission;enolase;Enzyme Precursors;Enzyme-Linked Immunosorbent Assay;Enzymes;Extracellular Matrix;Extracellular Matrix Proteins;feeding;Fertilization;Fibrin;Fibrin fragment D;Fibrinolysis;fungus;Gene Expression;Germ Cells;Goals;Hemolymph;Hemostatic Agents;Hemostatic function;Human;Immune response;Immunize;Immunohistochemistry;Impairment;In Vitro;Individual;Infection;Ingestion;Innate Immune Response;Innate Immune System;Integration Host Factors;Interruption;Intervention;Invaded;Kringles;Laboratories;Life Cycle Stages;Liver;Malaria;malaria transmission;Mammals;Measures;Mediating;microorganism;Midgut;migration;Molecular;Molecular Target;Mosquito Control;Mosquito-borne infectious disease;Motility;Motor;Mus;Nature;Oocysts;Outcome;P-Selectin;Parasites;Parasitic infection;pathogen;Pathogenicity;Pattern;Peptide Hydrolases;Plasmin;Plasminogen;Plasminogen Activator;Plasminogen Activator Inhibitor 1;plasminogen receptor;Plasmodium;Plasmodium falciparum;Platelet Activation;Platelet aggregation;Play;Prevalence;Property;Proteins;receptor;Recombinant Proteins;recruit;Reporting;Research;Role;Saliva;Salivary;Salivary Proteins;Science;Serine Protease;Sexual Development;Sexual Reproduction;Site;Skin;small molecule;Sporozoites;Stains;Supplementation;Surface;System;Testing;Tissues;Transcript;transcriptome;Transgenic Organisms;transmission blocking;transmission process;Urokinase;Vaccines;vector;vector mosquito;Virulence;Viscosity;Work;zygote,Host-parasite-vector interactions during malaria transmission,1250,NA,NA,NA,NA,6,NA,NA,1414629,NA
11189466,ZIA,AI,1,N,NA,NA,NA,NA,ZIAAI001253,NA,NA,1ZIAAI001253-06,NIAID:780221\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,15700997 (contact),"TOLIA, NIRAJ  (contact)",NA,NA,NA,acquired immunity;Antibodies;Antibody Response;Antigen Presentation;Antigenic Variation;Antigens;B-Lymphocytes;Binding Proteins;Biology;Blocking Antibodies;Blood;chemical conjugate;Clinical;clinically relevant;Communicable Diseases;Communication;Complex;computer cluster;Cryoelectron Microscopy;Culicidae;Data;design;Development;Epitopes;Erythrocytes;Ferritin;Foundations;Genetic;high end computer;Human;Immune;Immune response;Immunity;immunogenic;immunogenicity;improved;In Vitro;Infection;Length;Life Cycle Stages;Malaria;Malaria Vaccines;manufacture;Methods;Molecular Conformation;Names;nanoparticle;National Institute of Allergy and Infectious Disease;Nature;neutralizing antibody;novel;novel vaccines;Parasites;pathogen;placental malaria;Plasmodium;Plasmodium vivax;prevent;Procedures;Production;protein complex;Protein Conformation;Protein Engineering;Proteins;Publishing;receptor;receptor binding;Recombinant Proteins;Reporting;response;scaffold;Science;screening;self assembly;Serum;Sterility;Structure;Surface Antigens;Symptoms;System;T-Lymphocyte;Technology;thermostability;three dimensional structure;Transcend;transmission process;transmission-blocking vaccine;Vaccination;Vaccine Antigen;vaccine candidate;vaccine development;vaccine efficacy;vaccine platform;Vaccine Production;vaccine strategy;vaccine trial;Vaccines;vaccinology;Work;X-Ray Crystallography,Structural vaccinology for infectious diseases,1253,NA,NA,NA,NA,6,NA,NA,780221,NA
11189467,ZIA,AI,1,N,NA,NA,NA,NA,ZIAAI001254,NA,NA,1ZIAAI001254-05,NIAID:2104975\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,77880646 (contact),"MARZI, ANDREA  (contact)",NA,NA,NA,"Action Potentials;Adenoviruses;Aerosols;Africa;Alpha Virus;Animal Disease Models;Animal Model;Animals;Anti-viral Therapy;Antigens;B-Cell Activation;Bacille Calmette-Guerin vaccination;Blood;Blood specimen;Cavia;Cells;Chiroptera;Clinical;cohort;Collaborations;comparative;Containment;Cote d&apos;Ivoire Ebola virus;cross immunity;cross reactivity;Data;Development;Disease;disease model;Disease Outbreaks;Disease Progression;Dose;Eastern Africa;Ebola Vaccines;Ebola virus;efficacy study;Emerging Communicable Diseases;emerging virus;Equatorial Guinea;Euthanasia;Evaluation;Exhibits;exposure route;Ferrets;Fever;Filovirus;forest;Future;genetic approach;Genetic Transcription;Genomics;Ghana;Glycoproteins;Guinea;guinea pig model;Hamsters;Human;Hungary;Immune response;Immunobiology;immunogenicity;Immunoglobulin G;improved;Infection;Inflammation Mediators;Influenza A virus;Influenza A Virus, H5N1 Subtype;innovation;Institution;Intramuscular;Intranasal Administration;Kentucky;Knockout Mice;Knowledge;Kyasanur Forest disease virus;Laboratories;Legal patent;Licensing;Link;longitudinal analysis;Lung;Macaca;Macaca fascicularis;Manuscripts;Maps;Marburg Virus Disease;Marburgvirus;Microbe;Modeling;Molecular Virology;Mucous Membrane;Mus;National Institute of Allergy and Infectious Disease;neutralizing antibody;North Carolina;novel;Pan Genus;pathogen;Pathogenesis;pathogenic virus;Pathway interactions;pre-clinical;Predisposition;Preparation;protective efficacy;Public Health;public health emergency;Replicon;Research;response;reverse genetics;RNA;Rodent;Route;seroconversion;Severity of illness;Sudan Ebola virus;Tanzania;Therapeutic;Thrombocytopenia;Translations;TRIM5 gene;Uganda;United States National Institutes of Health;Vaccinated;Vaccination;vaccination outcome;vaccine development;vaccine efficacy;vaccine immunogenicity;vaccine platform;vaccine trial;Vaccines;Vesicular stomatitis Indiana virus;Viral;Viral Antigens;Viral Genes;Viremia;Virulence Factors;Virus;Virus Diseases;Virus Replication;Virus Shedding;Whole Blood","Immunobiology, molecular virology and countermeasures of highly pathogenic viruses",1254,NA,NA,NA,NA,5,NA,NA,2104975,NA
11189468,ZIA,AI,1,N,NA,NA,NA,NA,ZIAAI001255,NA,NA,1ZIAAI001255-05,NIAID:510258\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,77880648 (contact),"LOKE, P'NG  (contact)",NA,NA,NA,Affect;B-Lymphocytes;Blood;Clinical;Clinical Research;co-infection;Collaborations;Complex;Computational Biology;cytokine;Data;Diet;Disease;Environment;environmental change;Environmental Risk Factor;Equilibrium;field study;Future;Gene Expression Profile;Genetic;Genetic Variation;Genomics;Genotype;Goals;gut microbiome;helminth infection;Heterogeneity;High Prevalence;Homeostasis;Immune;Immune response;Immunity;Immunologics;Inbred Strains Mice;Individual;Infection;insight;inter-individual variation;Laboratories;large datasets;Maintenance;Malaysia;Metagenomics;metatranscriptomics;microbial;microbial community;microbiome;microbiota;Molecular;mouse model;Mucosal Immune Responses;mucosal site;Mucous Membrane;Mus;Mycoses;Native-Born;Parasites;Parasitic infection;Pathology;Phenotype;Regulation;research study;Resources;response;Sampling;Site;skin microbiome;System;T-Lymphocyte;Technology;Tissues;Translational Research;Trichuris;Universities;Urbanization;Variant;virome,Regulation of mucosal immune responses by helminth infections,1255,NA,NA,NA,NA,5,NA,NA,510258,NA
11189469,ZIA,AI,1,N,NA,NA,NA,NA,ZIAAI001256,NA,NA,1ZIAAI001256-05,NIAID:510261\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,77880648 (contact),"LOKE, P'NG  (contact)",NA,NA,NA,Acute;Adopted;Affect;B-Lymphocytes;BCL6 gene;Behavior;BIRC5 gene;CD4 Positive T Lymphocytes;cell type;Cells;chromatin remodeling;Chronic;chronic infection;chronic inflammatory disease;cytokine;Disease;Epigenetic Process;Equilibrium;fitness;Genetic;Genetic Variation;Goals;helminth infection;Heterogeneity;Homing;Immune;Immune response;Inbred BALB C Mice;Inbred Strains Mice;Individual;Infection;Inflammation;Inflammatory Response;Interleukin-13;Interleukin-4;Liver;Macrophage;Macrophage Activation;Maintenance;Mouse Strains;Mus;Myeloid Cells;NF-kappa B;Nippostrongylus;novel;Parasites;Pathway interactions;Phenotype;Point Mutation;Population;Production;programmed cell death protein 1;response;Role;Schistosoma mansoni;Schistosoma mansonii infection;single-cell RNA sequencing;Spleen;System;T cell response;T-Lymphocyte;Testing;tissue repair;Tissues;Translating;Work;wound;wound healing,Alternatively activated macrophages during type 2 immune responses,1256,NA,NA,NA,NA,5,NA,NA,510261,NA
11189470,ZIA,AI,1,N,NA,NA,NA,NA,ZIAAI001258,NA,NA,1ZIAAI001258-05,NIAID:213441\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,9413516 (contact),"COHEN, JEFFREY  (contact)",NA,NA,NA,2019-nCoV;Acceleration;acute infection;anti-CD20;Antibodies;Antibody Response;antigen test;Antigens;B lymphoid malignancy;B-Lymphocytes;Biological Assay;Cessation of life;cohort;Collaborations;COVID-19;Disease;Dose;epidemiology study;Epitopes;Functional disorder;Goals;Hairy Cell Leukemia;hairy cell leukemia cell;Hairy Cell Leukemia Variant;Human;Immune response;Immunocompromised Host;Immunologic Markers;Immunosuppression;Infection;leukemia;Measures;Monitor;Monoclonal Antibody CD20;mortality;Nucleocapsid;Organ;Outcome;Patients;Persons;Polymerase Chain Reaction;Prevalence;prospective;Recovery;respiratory;response;Role;SARS-CoV-2 exposure;SARS-CoV-2 infection;Serology;Serology test;Symptoms;T cell response;T-Lymphocyte;Testing;Time;transmission process;Vaccination;Viral;viral detection;Virus,Serologic studies of persons with COVID-19 infection,1258,NA,NA,NA,NA,5,NA,NA,213441,NA
11189471,ZIA,AI,1,N,NA,NA,NA,NA,ZIAAI001259,NA,NA,1ZIAAI001259-05,NIAID:2081320\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,77880654 (contact),"DE WIT, EMMIE  (contact)",NA,NA,NA,"2019-nCoV;adult stem cell;African Green Monkey;age related changes;Air;Alveolar;Alveolar Cell Type I;animal data;Animal Model;Animals;Area;Basal Cell;Biological Models;Blood;Brain;Cattle;Cause of Death;Cell Death Induction;cell type;Cells;Central Nervous System;Cerebrum;Cessation of life;Clinical Research;Communicable Diseases;Coronavirus;COVID-19 pandemic;COVID-19 patient;Dairying;Data;Development;Disease;Disease Progression;druggable target;effective therapy;emerging virus;Ensure;Epithelial Cells;Evolution;Exhibits;Extravasation;fitness;Gases;Goals;Histologic;Human;immune activation;Immune Evasion;in vitro Model;Individual;induced pluripotent stem cell;Infection;Inflammatory Response;Influenza A virus;Influenza A Virus, H5N1 Subtype;insight;interest;Interferons;Kinetics;Liquid substance;Lower Respiratory Tract Infection;Lower respiratory tract structure;Lung;Mesocricetus auratus;Methods;model development;Molecular;Montana;Mountain Lion;Nasal Epithelium;Nervous System Disorder;Neurologic;Neurologic Signs;Neurological Models;Neuronal Differentiation;Neuropathogenesis;Nipah Virus;Nose;Organ;Organoids;Pathogenesis;Pathogenicity;Pathway interactions;Phenotype;pneumocyte;Population;Predisposition;Procedures;Protocols documentation;Public Health;remdesivir;Respiratory Disease;Respiratory System;Respiratory Tract Diseases;respiratory virus;response;SARS-CoV-2 B.1.1.529;SARS-CoV-2 B.1.617.2;SARS-CoV-2 variant;stem cells;Syndrome;System;Therapeutic;Time;Tissues;tool;transmission process;Upper respiratory tract;Variant;variants of concern;Viral;Viral Pathogenesis;Virus;Work",Emerging respiratory viruses - pathogenesis and countermeasures,1259,NA,NA,NA,NA,5,NA,NA,2081320,NA
11189472,ZIA,AI,1,N,NA,NA,NA,NA,ZIAAI001260,NA,NA,1ZIAAI001260-05,NIAID:2338839\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,79973437 (contact),"TAN, JOSHUA  (contact)",NA,NA,NA,2019-nCoV;Adjuvant;Antibodies;Antibody Response;Antigens;B-Lymphocytes;Biological Assay;Biology;Blood;Cells;Chromosomes;cohort;combat;Communicable Diseases;cost;COVID-19 pandemic;Disease;Engineering;Epitopes;Exposure to;fighting;Genes;Goals;Human;human monoclonal antibodies;Immune response;improved;in vivo;Infection;Learning;Life Cycle Stages;lonely individuals;Malaria;Monoclonal Antibodies;Mycobacterium tuberculosis;Paper;pathogen;Plasmodium;Plasmodium falciparum;prevent;Process;Prophylactic treatment;Proteins;Publishing;Reaction;Reporting;Research Project Grants;Resolution;response;Site;Somatic Mutation;Sporozoites;Structure of germinal center of lymph node;Surface;Technology;tool;Vaccinated;vaccine candidate;Vaccine Design;Vaccines;Work,Human monoclonal antibodies targeting infectious pathogens,1260,NA,NA,NA,NA,5,NA,NA,2338839,NA
11189473,ZIA,AI,1,N,NA,NA,NA,NA,ZIAAI001261,NA,NA,1ZIAAI001261-05,NIAID:13666\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,10686351 (contact),"DUFFY, PATRICK  (contact)",NA,NA,NA,2019-nCoV;acute COVID-19;Adjuvant;age stratification;Antibodies;Antibody Response;Area;Blood;Blood specimen;Carrier Proteins;Clinical;Clinical Trials;Collaborations;Communities;Conceptions;Conjugate Vaccines;cost;cost effective;COVID-19;COVID-19 pandemic;COVID-19 prevalence;COVID-19 vaccine;Culicidae;Disease Surveillance;Dose;Epidemiology;Evaluation;feeding;frontier;Funding;Future;Goals;Health;Hour;Household;Human;Human Bites;human disease;Immune Sera;immunogenicity;Immunoglobulin G;Immunology procedure;improved;Individual;Laboratories;Location;low and middle-income countries;Macaca mulatta;Malaria;Mali;Manuscripts;Messenger RNA;Methods;Monitor;Mus;nonhuman primate;Outcome;pandemic disease;Participant;Penetration;performance tests;Phase;Population Surveillance;Postpartum Women;pre-pandemic;pregnant;Preparation;Production;programs;Progress Reports;Publications;Publishing;Reagent;receptor binding;Recombinants;Research;response;Rhesus;RNA vaccine;Rural;Rural Community;Rural Population;Sampling;SARS-CoV-2 antibody;SARS-CoV-2 antigen;SARS-CoV-2 B.1.1.529;Sentinel;seroconversion;Serology test;seropositive;Seroprevalences;serosurveillance;serosurvey;Site;Specificity;Time;Urban Population;vaccination outcome;vaccine candidate;vaccine development;vaccine platform;vaccine trial;Variant;Venous;Viral;viral detection;Virus,COVID-19 Serosurveys and Vaccine Study Site Preparations,1261,NA,NA,NA,NA,5,NA,NA,13666,NA
11189474,ZIA,AI,1,N,NA,NA,NA,NA,ZIAAI001262,NA,NA,1ZIAAI001262-05,NIAID:164252\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,15700997 (contact),"TOLIA, NIRAJ  (contact)",NA,NA,NA,2019-nCoV;Amino Acids;Antibodies;Antibody titer measurement;Antigens;Area;B-Lymphocytes;Collaborations;COVID-19;COVID-19 vaccine;Data;design;Development;Epitopes;Generations;Goals;Human;Immune response;Immunity;improved;In Vitro;Knowledge;lead candidate;Malaria Vaccines;Methods;Modification;Molecular;Molecular Structure;nanoparticle;neutralizing antibody;next generation;nonhuman primate;novel;novel vaccines;Parents;pathogen;Production;Proteins;Publishing;receptor binding;Research;research and development;Resistance;response;Rodent;SARS-CoV-2 antigen;SARS-CoV-2 spike protein;screening;self assembly;Technology;Time;Vaccination;vaccine candidate;vaccine development;Vaccine Research;Vaccines;vaccinology;Variant;Viral;Virus;Work,COVID-19 Structural Vaccinology,1262,NA,NA,NA,NA,5,NA,NA,164252,NA
11189475,ZIA,AI,1,N,NA,NA,NA,NA,ZIAAI001263,NA,NA,1ZIAAI001263-05,NIAID:130540\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,6968267 (contact),"SUN, PETER D. (contact)",NA,NA,NA,2019-nCoV;Acute;acute COVID-19;Acute Respiratory Distress Syndrome;Anticoagulants;Blood Coagulation Factor;Blood Vessels;Breathing;Bronchoalveolar Lavage Fluid;Cell surface;Cells;Cessation of life;Clinical;Clinical Trials;Coagulation Process;COVID-19;COVID-19 mortality;COVID-19 patient;COVID-19 severity;COVID-19 susceptibility;current pandemic;Deposition;design;Epithelial Cells;experience;Fiber;Fibrin;Fibrinogen;Fibrosis;Hospitalization;Human;Individual;Infection;inhibitor;insight;interest;Liquid substance;Lung;matriptase;Mechanical ventilation;Mediating;member;Membrane;Modeling;Molecular;mortality;pandemic disease;Peptide Hydrolases;Persons;pharmacologic;Plasma;Proteomics;Prothrombin;Public Health;Pulmonary Fibrosis;Recombinants;respiratory;response;SARS-CoV-2 infection;Serine Protease;severe COVID-19;Severities;ST14 gene;Testing;Therapeutic;Thrombin;Thrombus;Trypsin;Viral;Virus Diseases,Inhibition of COVID-19 associated acute fibrin deposition in lung,1263,NA,NA,NA,NA,5,NA,NA,130540,NA
11189476,ZIA,AI,1,N,NA,NA,NA,NA,ZIAAI001265,NA,NA,1ZIAAI001265-05,NIAID:628084\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,10526060 (contact),"SU, HELEN  (contact)",NA,NA,NA,2019-nCoV;acute COVID-19;adaptive immune response;Affect;Agreement;American;Americas;Autoantibodies;Biochemical;Child;Collaborations;comorbidity;Complication;consanguineous family;Convalescence;COVID-19;COVID-19 susceptibility;Defect;Development;Disease;Double-Stranded RNA;Family member;Far East;Genetic;genetic approach;Genetic Determinism;Genetic Predisposition to Disease;genetic variant;Genome;Health Sciences;Human;Human Genetics;Immune;Immune response;In Vitro;Individual;Innate Immune Response;Institutional Review Boards;Integration Host Factors;Interferons;International;Intramural Research Program;Italy;Knowledge;Life;Middle East;Molecular;molecular targeted therapies;Multisystem Inflammatory Syndrome in Children;National Institute of Allergy and Infectious Disease;NF-kappa B;Other Genetics;Outcome;Paper;participant enrollment;Pathogenesis;Pathway interactions;Patients;Persons;Population Genetics;Predisposition;Principal Investigator;Program Research Project Grants;Protocols documentation;Recording of previous events;Research;Research Personnel;respiratory;response;Role;Sampling;SARS-CoV-2 infection;sensor;severe COVID-19;Susceptibility Gene;Therapeutic Intervention;Thymus Gland;University Health Services;Validation;Variant;variant of interest;Virus;Work;Writing;young adult,Host factors contributing to susceptibility to COVID-19 disease,1265,NA,NA,NA,NA,5,NA,NA,628084,NA
11189477,ZIA,AI,1,N,NA,NA,NA,NA,ZIAAI001268,NA,NA,1ZIAAI001268-05,NIAID:123282\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,15222221 (contact),"MEMOLI, MATTHEW  (contact)",NA,NA,NA,2019-nCoV;Address;Affect;Antibodies;Antibody titer measurement;betacoronavirus;betacoronavirus vaccine;Biological;Clinical;Clinical Trials;Collaborations;Communities;Coronavirus;coronavirus vaccine;COVID-19;COVID-19 pandemic;Data;Data Analyses;Databases;Decision Making;design;Economics;Enrollment;Epidemiology;follow-up;Future;future pandemic;General Population;healthy volunteer;Immune response;Immunity;Individual;Infection;insight;Knowledge;large scale data;Lead;male;manufacture;Manuscripts;Modeling;Morbidity - disease rate;mortality;National Center for Advancing Translational Sciences;pandemic disease;pandemic virus;Participant;Pathogenesis;Patients;Personality;Personality Traits;Persons;Play;Population;post-pandemic;Prevalence;Production;programs;Psychology;Public Health;Publishing;Rare Diseases;response;Role;Sampling;SARS-CoV-2 infection;SARS-CoV-2 pathogenesis;serosurvey;Severities;Sex Differences;Surveys;Time;Universities;vaccine development;vaccine evaluation;Vaccines;Virus;women patients;Work,Coronavirus Pathogenesis and Broadly Protective Vaccine Development,1268,NA,NA,NA,NA,5,NA,NA,123282,NA
11189478,ZIA,AI,1,N,NA,NA,NA,NA,ZIAAI001269,NA,NA,1ZIAAI001269-05,NIAID:144905\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,10526060 (contact),"SU, HELEN  (contact)",NA,NA,NA,2019-nCoV;adaptive immune response;Cell Death;Cells;Characteristics;Clinical Data;congenital immunodeficiency;COVID-19;COVID-19 pandemic;COVID-19 patient;COVID-19 susceptibility;Databases;Disease;Disease susceptibility;drug development;Drug Targeting;Elderly;Ethnic Population;Goals;Human;Immune response;Immunologics;impaired capacity;Individual;Infection;Innate Immune Response;interest;International;Medical;Molecular;Mutation;National Institute of Allergy and Infectious Disease;new therapeutic target;Pathogenicity;Patients;Population;post SARS-CoV-2 infection;predict clinical outcome;prevent;Public Health;Research Personnel;Respiratory Failure;RNA vaccine;RNA Viruses;Sampling;SARS-CoV-2 infection;Site;Standardization;Symptoms;T cell response;Therapeutic;therapeutic target;United States National Institutes of Health;Viral Pathogenesis;Virus;Work,Molecular Mechanisms of SARS-CoV-2 Infection and Therapeutic Targets,1269,NA,NA,NA,NA,5,NA,NA,144905,NA
11189479,ZIA,AI,1,N,NA,NA,NA,NA,ZIAAI001270,NA,NA,1ZIAAI001270-05,NIAID:236110\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,15222269 (contact),"NOTARANGELO, LUIGI  (contact)",NA,NA,NA,2019-nCoV;acute COVID-19;acute infection;adaptive immune response;Adult;Adverse event;Antibody Response;B cell repertoire;Biological;Biological Markers;biomarker identification;Blood;breakthrough infection;burden of illness;Child;Childhood;Chile;Clinical;Collaborations;congenital immunodeficiency;COVID-19 pandemic;COVID-19 susceptibility;COVID-19 vaccine;Data;Development;Disease;genetic variant;Goals;Health Personnel;Heterogeneity;Hospitalization;Immune response;Immune System Diseases;Immunologics;Incidence;Individual;Infection;Inflammation;Inflammatory Response;Italy;Laboratories;Molecular;Molecular Profiling;Multisystem Inflammatory Syndrome in Children;Outcome;Patients;Peripheral Blood Mononuclear Cell;Phenotype;Play;Research Personnel;Resolution;Risk;Risk Factors;Role;Sampling;SARS-CoV-2 infection;severe COVID-19;Severities;Severity of illness;Specimen;T-Lymphocyte;Time;United States;Vaccines,Characterization of host immune responses to SARS-CoV-2,1270,NA,NA,NA,NA,5,NA,NA,236110,NA
11189480,ZIA,AI,1,N,NA,NA,NA,NA,ZIAAI001271,NA,NA,1ZIAAI001271-05,NIAID:145518\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,9413717 (contact),"TAUBENBERGER, JEFFERY  (contact)",NA,NA,NA,2019-nCoV;airway epithelium;Animal Experimentation;Animals;betacoronavirus;cell injury;COVID-19 vaccine;Endothelial Cells;Epithelial Cells;Gene Expression;Goals;Histopathology;Human;human model;Immunization;Immunologic Markers;Inactivated Vaccines;Infection;inflammatory marker;Inflammatory Response;Influenza A virus;Intramuscular;Laboratory Animal Models;laboratory experiment;Lung;Molecular Analysis;Molecular Virology;Morbidity - disease rate;mortality;Neutrophil Activation;novel;novel coronavirus;novel vaccines;Organ;pandemic disease;Pathogenesis;pre-clinical;preclinical study;Pulmonary Pathology;Reporting;Research;Research Project Grants;respiratory;Role;Route;SARS-CoV-2 infection;SARS-CoV-2 pathogenesis;SARS-CoV-2 variant;severe COVID-19;Systems Biology;Thrombosis;vaccine development;Vaccines;Viral;Virus Diseases;Work,SARS-CoV-2 Pathogenesis,1271,NA,NA,NA,NA,5,NA,NA,145518,NA
11189481,ZIA,AI,1,N,NA,NA,NA,NA,ZIAAI001272,NA,NA,1ZIAAI001272-05,NIAID:147159\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,6568620 (contact),"KEHRL, JOHN H (contact)",NA,NA,NA,2019-nCoV;ACE2;Affect;Affinity Chromatography;Alanine;Antibodies;Antibody Formation;Apoptosis;Autophagocytosis;B cell differentiation;B Cell Proliferation;B-Lymphocyte Subsets;B-Lymphocytes;betacoronavirus;Binding;Binding Proteins;Biological Assay;Blood;Blood Cells;Bone Marrow;C-terminal;Carbohydrates;CCL17 gene;CD8-Positive T-Lymphocytes;Cell Culture Techniques;Cell Death;Cell Line;Cell membrane;Cell Physiology;Cell Surface Receptors;Cell Survival;cell type;Cell-Mediated Cytolysis;Cells;Chemotactic Factors;Chloride Channels;Co-Immunoprecipitations;Confocal Microscopy;COVID-19;COVID-19 pathogenesis;COVID-19 patient;CXCL10 gene;Cysteine;cytokine;Disease;disulfide bond;E protein;Endoplasmic Reticulum;Endothelial Cells;env Gene Products;Enzymes;exposed human population;extracellular;extracellular vesicles;Family;Flow Cytometry;Gel Chromatography;Generations;Genes;glycosylation;Human;Human Cell Line;IgG1;IgG2;IgG3;IL6 gene;Image;Immune;Immune response;immunogenic;Immunoglobulin A;Immunoglobulin M;in vitro Model;in vivo;Individual;Inflammasome;Inflammation;Inflammatory;Injections;insight;Integral Membrane Protein;Interleukin-1;Interleukin-12;interleukin-23;Intravenous;intravital microscopy;IRF4 gene;Label;Leukocytes;Lipids;Liver;Lung;lymph nodes;Lymphatic Endothelial Cells;Macrophage;Mammalian Cell;Manuscripts;Mediating;Membrane;Membrane Proteins;Microscopy;Mitochondria;Molecular;monocyte;Morphology;Mus;Mutation;nanodisk;Natural Immunity;Necrosis;Nonstructural Protein;novel;Open Reading Frames;Oryctolagus cuniculus;overexpression;particle;Pathogenesis;Pathogenicity;Pathway interactions;Pattern;peripheral blood;Peripheral Blood Mononuclear Cell;Plasma;Plasmablast;Population;Preparation;Process;Production;Property;Protein Secretion;Protein Truncation;Proteins;Proteomics;receptor;Recombinant Proteins;Recombinants;recruit;Regulatory Element;RNA Viruses;RNF139 gene;Role;Route;SARS coronavirus;SARS-CoV-2 genome;SARS-CoV-2 spike protein;Severe Acute Respiratory Syndrome;SH2D3C gene;Signal Transduction;Spleen;Sterols;targeted treatment;Techniques;TNF gene;TNF receptor-associated factor 3;TRAF6 gene;transcription factor;transcriptome sequencing;Transfection;Transgenic Mice;ubiquitin-protein ligase;Vaccine Design;Vesicle;Viral;Virion;Virus;Virus Replication;Work;Xenopus oocyte,Role of SARS-CoV-2 Spike Protein and Accessory ORFs in the immune pathogenesis of COVID-19,1272,NA,NA,NA,NA,5,NA,NA,147159,NA
11189482,ZIA,AI,1,N,NA,NA,NA,NA,ZIAAI001276,NA,NA,1ZIAAI001276-05,NIAID:164279\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,77880648 (contact),"LOKE, P'NG  (contact)",NA,NA,NA,2019-nCoV;Ablation;ACE2;Acute Respiratory Distress Syndrome;Affect;Alveolar Macrophages;Antibodies;asymptomatic COVID-19;CD8-Positive T-Lymphocytes;CD8B1 gene;co-infection;COVID-19;COVID-19 severity;COVID-19 vaccine;Developing Countries;Disease;Disease Outcome;Enrollment;Environment;epidemiologic data;epidemiology study;Epigenetic Process;Exposure to;Genetic Transcription;Goals;helminth infection;Helminths;Household;Human;Immune response;Immune system;Immunologics;immunoregulation;India;Individual;Infection;K-18 conjugate;Lung;Lymphocytic Infiltrate;Macrophage;Mediating;microbiota;migration;mouse model;Multiple Organ Failure;Mus;Parasites;Participant;Pathogenesis;recruit;Rodent;SARS-CoV-2 infection;seropositive;Seroprevalences;Severe Acute Respiratory Syndrome;Severity of illness;study population;survival outcome;T cell response;Transgenic Mice;Vaccinated;Vaccination;Variant;Viral;Viral Load result,immune regulation by helminths and the microbiota with SARS-Cov2 infection,1276,NA,NA,NA,NA,5,NA,NA,164279,NA
11189483,ZIA,AI,1,N,NA,NA,NA,NA,ZIAAI001278,NA,NA,1ZIAAI001278-05,NIAID:102819\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,15222273 (contact),"HICKMAN, HEATHER  (contact)",NA,NA,NA,2019-nCoV;ACE2;Animal Model;Cells;Coronavirus;Coronavirus Infections;COVID-19;cytokine;Disease;Enterobacteria phage P1 Cre recombinase;Epidemic;Epithelium;Human;human disease;human model;Immune;Infection;Inflammatory;Knock-in Mouse;Knowledge;Lung;lymph nodes;Morbidity - disease rate;mortality;mouse model;Mouse Strains;Mus;pandemic disease;Pathogenesis;Phase;Population;Production;pulmonary function;receptor;SARS-CoV-2 infection;SARS-CoV-2 pathogenesis;Severe Acute Respiratory Syndrome;T cell response;Tissues;Transgenic Mice;Transgenic Organisms;Viral,Antiviral T cell Responses During SARS-CoV-2 Infection,1278,NA,NA,NA,NA,5,NA,NA,102819,NA
11189484,ZIA,AI,1,N,NA,NA,NA,NA,ZIAAI001280,NA,NA,1ZIAAI001280-05,NIAID:251276\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,12213449 (contact),"BRENCHLEY, JASON  (contact)",NA,NA,NA,2019-nCoV;Animals;Asian;Benign;Blood Coagulation Disorders;Cardiovascular Diseases;Cessation of life;Circulation;Coronavirus;COVID-19;Dexamethasone;Diabetes Mellitus;Diarrhea;Disease;Disease Progression;Elderly;experimental analysis;Gastrointestinal tract structure;Goals;granulocyte;Human;Immunity;Incidence;Individual;Inflammation;Lead;longitudinal analysis;Lymphocyte;Macaca;microbial;microbial products;microbiome composition;neutrophil;nonhuman primate;Obesity;Risk Factors;SARS-CoV-2 infection;SARS-CoV-2 pathogenesis;seasonal coronavirus;severe COVID-19;stool sample;Testing;viral RNA;Work,Pathogenesis of SARSCov2 infection,1280,NA,NA,NA,NA,5,NA,NA,251276,NA
11189485,ZIA,AI,1,N,NA,NA,NA,NA,ZIAAI001281,NA,NA,1ZIAAI001281-05,NIAID:269478\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,9413751 (contact),"BOSIO, CATHARINE  (contact)",NA,NA,NA,2019-nCoV;adaptive immune response;adaptive immunity;Age;animal imaging;Animals;Cause of Death;Cell Physiology;cell type;Cells;Cessation of life;Child;Communicable Diseases;comorbidity;Data;Development;diet-induced obesity;Disease;Disease Progression;early phase clinical trial;Elements;Environment;experience;Flow Cytometry;Generations;Genomics;Goals;Human;Imaging technology;Immune;Immune response;Immunity;In Vitro;in vivo;Infection;Inflammation;Inflammatory Response;Innate Immune Response;insight;lipid mediator;lipidomics;Lipids;Location;Long COVID;Lower Respiratory Tract Infection;Lung;Lung infections;lung pathogen;Mediator;Metabolic;Metabolic Pathway;Metabolism;metabolomics;model development;Modeling;mouse model;multiple omics;Mus;Natural Immunity;new therapeutic target;novel therapeutics;novel vaccines;Obesity;Organ;pandemic disease;pathogen;Pathogenesis;Pathway interactions;Peripheral;Persons;Pharmaceutical Preparations;Phenotype;Population;post SARS-CoV-2 infection;prevent;Primary Infection;Production;pulmonary function;Resolution;Role;Sampling;SARS-CoV-2 immunity;SARS-CoV-2 infection;secondary infection;Symptoms;T-Lymphocyte;Techniques;Telemetry;temporal measurement;Therapeutic;Therapeutic Intervention;Tissues;Vaccination;Vaccines;Virion;Virus,Effect of SARS-CoV-2 on host metabolism and its influence on innate and adaptive immunity,1281,NA,NA,NA,NA,5,NA,NA,269478,NA
11189486,ZIA,AI,1,N,NA,NA,NA,NA,ZIAAI001283,NA,NA,1ZIAAI001283-05,NIAID:300675\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,9691479 (contact),"LEPPLA, STEPHEN  (contact)",NA,NA,NA,2019-nCoV;Alkaline Phosphatase;Antibodies;Antibody Therapy;Area;Bacillus anthracis;Binding;Biological Assay;Biotinylation;C-terminal;Chimeric Proteins;Chinese Hamster Ovary Cell;commercialization;coronavirus pandemic;cost;COVID-19;COVID-19 detection;cross reactivity;Detection;detection method;diagnostic assay;diagnostic development;diagnostic platform;Diagnostic Procedure;Diagnostic Reagent Kits;dimer;DNA;DNA biosynthesis;DNA Probes;Dot Immunoblotting;Embryo;Enzyme-Linked Immunosorbent Assay;Enzymes;Equipment;Fab Immunoglobulins;Foundations;Genetic;Genetic Transcription;Human Papillomavirus;Hybrids;Immunoglobulin G;improved;In Vitro;innovation;interest;Lateral;Licensing;Messenger RNA;Methods;microbial;milligram;Modification;Monoclonal Antibodies;monomer;Mus;nanoGold;Nucleic Acids;pathogen;Pathogenesis;Pathologic;Peptidyltransferase;point-of-care diagnostics;polyclonal antibody;Preparation;Production;Protein phosphatase;Proteins;Reagent;Recombinant Proteins;Recombinants;Reporter;Research;Research Personnel;Resource-limited setting;Resources;RNA;SARS coronavirus;Single-Stranded DNA;sortase;Specificity;Structure;success;Surface;Suspension Culture;Swab;synthetic construct;System;Testing;Therapeutic Agents;tool;Toxoplasma gondii;Translating;United States National Institutes of Health;Vagina;Variant;viral detection;viral RNA;Work,SARS CoV2 Studies in the Microbial Pathogenesis Section/LPD,1283,NA,NA,NA,NA,5,NA,NA,300675,NA
11189487,ZIA,AI,1,N,NA,NA,NA,NA,ZIAAI001285,NA,NA,1ZIAAI001285-05,NIAID:339952\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,79973437 (contact),"TAN, JOSHUA  (contact)",NA,NA,NA,2019-nCoV;Acute;Antibodies;betacoronavirus;Biology;combat;Coronavirus;COVID-19;COVID-19 prevention;Disease;follow-up;global health;Goals;human monoclonal antibodies;Immune response;improved;Individual;interest;neutralizing antibody;next generation;novel;novel coronavirus;Peptides;Plasma;Resolution;SARS-CoV-2 antibody;SARS-CoV-2 spike protein;SARS-CoV-2 variant;stem;Technology;Testing;tool;Vaccine Design;variants of concern;Virus;Work,Human monoclonal antibodies against SARS-CoV-2,1285,NA,NA,NA,NA,5,NA,NA,339952,NA
11189488,ZIA,AI,1,N,NA,NA,NA,NA,ZIAAI001289,NA,NA,1ZIAAI001289-05,NIAID:357333\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,11999617 (contact),"MUNSTER, VINCENT  (contact)",NA,NA,NA,2019-nCoV;ACE2;Address;Aerosols;Animal Model;AstraZeneca COVID-19 vaccine;Birds;China;Chiroptera;COVID-19;cross-species transmission;Decontamination;design;Disease;disease transmission;Ecology;efficacy study;emerging virus;Evolution;Goals;Hamsters;Human;Immunocompromised Host;in vivo Model;Infection;Intranasal Administration;Link;Modeling;Monoclonal Antibodies;nonhuman primate;pandemic disease;Pathogenesis;pre-clinical;preclinical efficacy;programs;public health emergency;receptor;Reporting;Research;response;Rodent;SARS-CoV-2 B.1.351;SARS-CoV-2 transmission;Severity of illness;Surface;transmission process;Vaccination;vaccine efficacy;vaccine platform;Vaccines;Variant;variants of concern;Virus;Work;Zoonoses,Virus Ecology Unit - COVID-19 response,1289,NA,NA,NA,NA,5,NA,NA,357333,NA
11189489,ZIA,AI,1,N,NA,NA,NA,NA,ZIAAI001292,NA,NA,1ZIAAI001292-05,NIAID:499801\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,10686457 (contact),"BEST, SONJA  (contact)",NA,NA,NA,"Acute;adaptive immune response;Alveolar;Animals;Anti-Inflammatory Agents;Anti-viral Agents;Avian Influenza;Body Weight decreased;Brain;Bypass;Cause of Death;CCL2 gene;CD8-Positive T-Lymphocytes;Cells;Cessation of life;Clinical;clinical effect;Colchicine;Combined Modality Therapy;Complement;COVID-19;COVID-19 pandemic;COVID-19 treatment;COVID-19/ARDS;cytokine;Cytotoxic T-Lymphocytes;Data;Disease;disease phenotype;Dose;drug action;drug testing;Early treatment;Epithelial Cells;Epithelium;Equilibrium;Failure;follow-up;Genetic Variation;Goals;Hospitalization;Host Defense Mechanism;House mice;Human;human disease;Image;Immune;Immune mediated destruction;Immune response;Immunity;immunopathology;Immunotherapy;Impairment;improved;Inbred BALB C Mice;Infection;Infiltration;Inflammation;Inflammatory;inflammatory marker;Inflammatory Response;Influenza;Influenza A Virus, H1N1 Subtype;Influenza A Virus, H5N1 Subtype;influenza infection;Innate Immune Response;inorganic phosphate;Inosine;Interferons;Interleukin-6;Intervention;Laboratories;Literature;Lung;Lung infections;lung injury;lung lobe;lung repair;Mediating;Methods;Modeling;Molecular;Morbidity - disease rate;mortality;mouse model;Mouse Strains;Mus;Myeloid Cells;Nasopharynx;Natural Immunity;Neutrophil Infiltration;novel strategies;Organ;Oseltamivir;Outcome;Pathologic;Pathology;Patients;Phase;pneumocyte;preservation;prevent;Process;Production;Proliferating;Publishing;pulmonary function;Recommendation;Recovery of Function;repaired;Residual state;Resistance;response;Risk;Role;SARS-CoV-2 infection;severe COVID-19;Sex Bias;Sex Differences;Signal Transduction;Stains;Structure;Structure of parenchyma of lung;success;surfactant;T-Cell Depletion;T-Lymphocyte;Testing;therapeutic development;Thrombus;Tissues;transcriptome sequencing;transcriptomics;transmission process;Update;Vaccination;Viral;Viral Pneumonia;Virus;Virus Replication;Work;Zileuton","Mechanisms of immunopathology of COVID-19/ARDS, and strategies to mitigate detrimental inflammatory responses",1292,NA,NA,NA,NA,5,NA,NA,499801,NA
11189490,ZIA,AI,1,N,NA,NA,NA,NA,ZIAAI001293,NA,NA,1ZIAAI001293-05,NIAID:105946\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,14291604 (contact),"MAYER-BARBER, KATRIN  (contact)",NA,NA,NA,2019-nCoV;Acute Respiratory Distress Syndrome;adaptive immune response;adaptive immunity;Animal Model;Animals;antiviral immunity;biosafety level 3 facility;Cause of Death;Cessation of life;co-infection;Complex;Containment;cytokine;cytokine release syndrome;Environment;Etiology;Functional disorder;Immune response;in vivo;Inflammatory;Inflammatory Response;innate immune mechanisms;Innate Immune Response;insight;Interleukin-1;Interleukin-6;Investigation;Lung;Lung infections;lung pathogen;Molecular;Mus;Mycobacterium tuberculosis;novel therapeutic intervention;operation;pathogen;Pathogenesis;Patients;Pneumonia;programs;Research;response;SARS coronavirus;SARS-CoV-2 infection;severe COVID-19;Tissues;Viral;Virus Diseases;Virus Replication;Work,Interrogating inflammatory responses to SARS-CoV-2 infection in vivo,1293,NA,NA,NA,NA,5,NA,NA,105946,NA
11189491,ZIA,AI,1,N,NA,NA,NA,NA,ZIAAI001294,NA,NA,1ZIAAI001294-05,NIAID:397520\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,11597554 (contact),"BARBER, DANIEL  (contact)",NA,NA,NA,2019-nCoV;ACE2;Acute Respiratory Distress Syndrome;Anti-Inflammatory Agents;Anti-viral Response;aspirate;BCG Live;CD8-Positive T-Lymphocytes;cellular imaging;Child;Clinical;Clonal Expansion;confocal imaging;Coronavirus;Coronavirus Infections;COVID-19;COVID-19 severity;CXCL10 gene;cytokine;Development;Disease;Disease Outcome;Disease Progression;Encephalitis;Experimental Models;experimental study;Flow Cytometry;fluorodeoxyglucose;Goals;Host resistance;Human;IFNGR1 gene;Immune;Immune response;Immune system;Immunocompromised Host;immunoregulation;In Vitro;Individual;Infection;Infection Control;Inflammatory Response;interest;Interferon Type II;Interferons;Interleukin-10;Interleukin-6;Intravenous;lung development;Lung Diseases;lung lesion;Macaca;Macaca mulatta;Measurement;Mediating;Modeling;mortality;mouse model;Multisystem Inflammatory Syndrome in Children;Mus;nonhuman primate;Nose;Outcome;Pathology;PET/CT scan;Plasma;post SARS-CoV-2 infection;predictive marker;prevent;prototype;Pulmonary Inflammation;Pulmonary Pathology;receptor;recruit;Regulation;Reporting;Resolution;Role;SARS-CoV-2 infection;SARS-CoV-2 inhibitor;severe COVID-19;Signal Transduction;Structure of mucous membrane of nose;T-Lymphocyte Subsets;tissue resident memory T cell;TNF gene;Transgenic Mice;Tuberculosis Vaccines;Viral;Viral Load result;Virus;X-Ray Computed Tomography,SARS-CoV-2 infection of non-human primates,1294,NA,NA,NA,NA,5,NA,NA,397520,NA
11189492,ZIA,AI,1,N,NA,NA,NA,NA,ZIAAI001298,NA,NA,1ZIAAI001298-05,NIAID:496575\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,77880414 (contact),"BUCHHOLZ, URSULA  (contact)",NA,NA,NA,2019-nCoV;5 year old;ACE2;Adult;airway epithelium;Animals;Antibodies;Antibody Response;Attenuated;Attenuated Vaccines;attenuation;Avulavirus;Cattle;CD8-Positive T-Lymphocytes;Cell Culture Techniques;Cells;Child;Childhood;Clinical Research;Clinical Trials;Collaborations;community transmission;Complement;Complementary DNA;COVID-19;COVID-19 burden;COVID-19 vaccine;Data Analyses;design;dimer;Disease;Dose;Epithelial Cells;Evaluation;Family;Generations;Genes;Hamsters;Homologous Gene;Human;Human Parainfluenza Virus 2;Immune response;Immunity;Immunization;Immunize;immunogenic;immunogenicity;Immunoglobulin A;Immunoglobulin G;improved;In Vitro;Infant;Infection;Injectable;insight;interest;lead candidate;Macaca;Macaca mulatta;manufacture;Manuscripts;Memory;Modeling;Morbidity - disease rate;Mucosal Immune Responses;Mucosal Immunity;mucosal vaccine;Mucous Membrane;murine antibody;Murine pneumonia virus;Mus;neutralizing antibody;next generation;nonhuman primate;Para-Influenza Virus Type 3;parainfluenza virus;Paramyxovirus;pathogen;Phase;phase 1 study;Pneumovirus;Population;preclinical development;preclinical study;prevent;Primates;programs;protective efficacy;Proteins;receptor binding;Recovery;research clinical testing;respiratory;Respiratory syncytial virus;Respiratory System;respiratory virus;reverse genetics;Route;Safety;Sampling;SARS-CoV-2 antibody;SARS-CoV-2 antigen;SARS-CoV-2 immunity;SARS-CoV-2 infection;SARS-CoV-2 spike protein;SARS-CoV-2 transmission;Serum;severe COVID-19;symptomatic COVID-19;System;T-Lymphocyte;Tissues;translational goal;transmission process;Tropism;Upper respiratory tract;vaccine candidate;Vaccine Design;vaccine development;vaccine response;vaccine trial;Vaccines;Variant;variants of concern;vector;vector vaccine;vector-based vaccine;Viral Vector;Virion;Virus Replication,Paramyxoviruses as Vaccine Vectors Against Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2),1298,NA,NA,NA,NA,5,NA,NA,496575,NA
11189493,ZIA,AI,1,N,NA,NA,NA,NA,ZIAAI001299,NA,NA,1ZIAAI001299-05,NIAID:210857\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,6479505 (contact),"MURPHY, PHILIP  (contact)",NA,NA,NA,2019-nCoV;3p21;African;Alleles;Animals;Antibodies;Antibody titer measurement;Antigen Receptors;Appearance;arteriole;beta Chain Antigen T Cell Receptor;beta-Chemokines;Binding;bioinformatics tool;Blood;Blood Chemical Analysis;Body Weight decreased;Carbon Dioxide;Cerebellum;Cervical;chemokine;chemokine receptor;Clinical;Clinical Data;cohort;Collaborations;congenital immunodeficiency;COVID-19;COVID-19 mortality;COVID-19 patient;CXC Chemokines;cytokine;Data;Disease;Disease Progression;Dislocations;Dose;drug development;Drug Targeting;Elderly;Endothelial Cells;Endothelium;Epithelial Cells;Epitopes;Erythrocytes;Euthanasia;experience;experimental study;Extravasation;Feces;Female;Genes;Genetic;genome wide association study;Goals;High-Throughput Nucleotide Sequencing;Histopathology;Human;Immune;Immune response;immunodeficiency;immunopathology;immunoregulation;impaired capacity;in vivo;Individual;Infection;infectious disease model;Inflammatory;insight;Interferons;Knock-out;Lethal Dose 50;Leukocyte Trafficking;Leukocytes;Lung;male;Modeling;mortality;Motivation;mouse model;Mus;National Institute of Child Health and Human Development;new therapeutic target;older patient;Pathogenesis;Patients;Pharmaceutical Preparations;Pharyngeal structure;Play;Population;post SARS-CoV-2 infection;Production;Productivity;protective effect;Proteome;Purkinje Cells;receptor;Recovery;Regulation;Reporting;response;RNA vaccination;RNA vaccine;Role;SARS coronavirus;SARS-CoV-2 immune response;SARS-CoV-2 infection;SARS-CoV-2 pathogenesis;screening;seroconversion;Serum;severe COVID-19;Sex Differences;Shapes;Site;small molecule;Swab;System;T cell response;T-Lymphocyte;Techniques;Testing;Transgenic Mice;translational potential;Veins;Viral;Viral Pathogenesis;Virus;Work,Immunopathogenesis of SARS-CoV-2 infection,1299,NA,NA,NA,NA,5,NA,NA,210857,NA
11189494,ZIA,AI,1,N,NA,NA,NA,NA,ZIAAI001308,NA,NA,1ZIAAI001308-05,NIAID:162051\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,10671942 (contact),"SERETI, IRINI  (contact)",NA,NA,NA,2019-nCoV;Acute;Affect;Antibody Response;Biological Markers;Blood Coagulation Disorders;Clinical;Coagulation Process;Complement Activation;COVID-19;COVID-19 pathogenesis;COVID-19 patient;COVID-19 vaccine;Disease;Endothelium;Enrollment;Evaluation;Functional disorder;Immunity;Immunocompromised Host;Immunologics;Inflammasome;Inflammation;Inflammatory;insight;interest;Intervention;Lymphopenia;mortality;nasal swab;novel coronavirus;pandemic disease;Pathogenesis;Pathway interactions;Patients;Peripheral Blood Mononuclear Cell;Persons;Phenotype;Plasma;Protocols documentation;respiratory;Role;sample collection;Sampling;Serum;Syndrome;T-Lymphocyte;Vaccination;Variant,Role of lymphopenia and inflammation in COVID-19 pathogenesis,1308,NA,NA,NA,NA,5,NA,NA,162051,NA
11189495,ZIA,AI,1,N,NA,NA,NA,NA,ZIAAI001309,NA,NA,1ZIAAI001309-05,NIAID:71700\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,77880704 (contact),"LISCO, ANDREA  (contact)",NA,NA,NA,2019-nCoV;Clinical;clinical predictors;Collaborations;COVID-19;COVID-19 severity;COVID-19 vaccine;Disease;Goals;human pathogen;Immune response;Immunization;Immunocompetent;Immunocompromised Host;Immunologics;Individual;Longevity;Medical center;Messenger RNA;National Institute of Allergy and Infectious Disease;novel;Outcome;Research Personnel;response;SARS-CoV-2 infection;T cell response,Identification of immunological predictors of COVID-19 clinical outcomes,1309,NA,NA,NA,NA,5,NA,NA,71700,NA
11189496,ZIA,AI,1,N,NA,NA,NA,NA,ZIAAI001310,NA,NA,1ZIAAI001310-05,NIAID:564060\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,77880704 (contact),"LISCO, ANDREA  (contact)",NA,NA,NA,Ablation;acquired immunodeficiency;Antigen-Presenting Cells;antiretroviral therapy;Anus;Blood Cells;Bone Marrow Transplantation;Cells;Characteristics;Chemicals;Clinic;Clinical;clinical care;clinical center;clinical efficacy;cohort;congenital immunodeficiency;cytotoxic;Development;Diagnosis;Disease;Disease Progression;Dysplasia;Epidemiology;Epithelium;exome sequencing;Gene Expression Profiling;genome sequencing;Goals;HIV;HIV/AIDS;Human;Human Papilloma Virus-Related Malignant Neoplasm;Human Papillomavirus;IL7 gene;Image;Immune;immune reconstitution;Immune Targeting;Immunity;Immunization;Immunocompetent;Immunocompromised Host;immunodeficiency;Immunologics;Individual;Intervention;Langerhans cell;Lesion;Lymphoid;Lymphopenia;Malignant Neoplasms;Mediating;men who have sex with men;microbiome analysis;Modeling;Molecular;Molecular Epidemiology;Morbidity - disease rate;Mucous Membrane;Natural History;Natural Killer Cells;next generation;novel;Operative Surgical Procedures;Patients;Persons;Predisposition;Prevention strategy;Proteins;Recombinants;recruit;Recurrence;Reporting;Role;Site;Skin;T cell response;T-Lymphocyte;tool;trafficking;transgender;treatment strategy;United States National Institutes of Health;Viral;Viral Epidemiology;Virion;whole genome;Woman;Work,Immunopathogenesis of skin and mucosal Human Papillomavirus (HPV)-related diseases,1310,NA,NA,NA,NA,5,NA,NA,564060,NA
11189497,ZIA,AI,1,N,NA,NA,NA,NA,ZIAAI001314,NA,NA,1ZIAAI001314-05,NIAID:133896\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,8818835 (contact),"LUSSO, PAOLO  (contact)",NA,NA,NA,2019-nCoV;Adenovirus Vector;Animal Model;Animals;Antibodies;Antigens;Autoantibodies;Autologous;Binding;Blood donor;Blood Vessels;Cardiac Surgery procedures;Characteristics;chemokine;Clinical;Collaborations;Communicable Diseases;Complex;Complication;Core Protein;COVID-19;COVID-19 complications;COVID-19 pathogenesis;COVID-19 patient;COVID-19 vaccine;Cytoplasmic Tail;Data;design;Development;Diffuse;Dose;Enzyme-Linked Immunosorbent Assay;Epitopes;experience;extracellular;Glycoproteins;Harvest;Heparin;heparin-induced thrombocytopenia;HIV-1;HIV-1 vaccine;Hospitalization;Hybrids;Immune response;Immunize;Immunoassay;immunogenic;immunogenicity;Immunology procedure;improved;In Vitro;in vivo;Inbred BALB C Mice;Individual;Lentivirus;Life;Mammalian Cell;Membrane;Messenger RNA;Molecular;Monoclonal Antibodies;mouse model;Multiple Organ Failure;Mus;neutralizing antibody;Normal Range;novel coronavirus;Orthopedic Surgery;Pathogenesis;Pathogenicity;Patients;PF4 Gene;Platelet Activation;Platelet Count measurement;Prevention;Production;Protein Subunits;Proteins;Reporting;Research;Role;SARS-CoV-2 spike protein;Serum;severe COVID-19;Severity of illness;SIV;SIV envelope protein gp41;success;Sucrose;Surface;Syndrome;Tail;Technology;Testing;Therapeutic;Thrombocytopenia;Thrombosis;Time;Ultracentrifugation;Vaccinated;Vaccination;vaccine platform;Vaccines;variants of concern;Virion;Virus;Virus Assembly;Virus-like particle;Western Blotting,Pathogenesis studies on COVID-19 and development of a VLP-forming mRNA vaccine against SARS-CoV2,1314,NA,NA,NA,NA,5,NA,NA,133896,NA
11189498,ZIA,AI,1,N,NA,NA,NA,NA,ZIAAI001316,NA,NA,1ZIAAI001316-05,NIAID:360385\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,9413761 (contact),"GRIGG, MICHAEL  (contact)",NA,NA,NA,2019-nCoV;ACE2;Address;Amino Acids;Antibody Response;betacoronavirus;Binding;Birds;Camels;Cells;Complex;Conserved Sequence;Coronavirus;COVID-19;cytotoxic;Disease Outbreaks;Dromedaries;Endosomes;Epidemic;Etiology;Evolution;experience;Genetic;Genetic Drift;Genetic Recombination;Genome;genome-wide;Genomic Segment;Genomics;Giardia;Goals;Haploidy;Human;Immune response;immunogenic;Kinetics;Knowledge;Membrane;Methodology;Middle East Respiratory Syndrome Coronavirus;Molecular;mosaic;Mucosal Immunity;Mutation;N-Glycosylation Site;N-terminal;National Institute of Allergy and Infectious Disease;neutralizing antibody;Nucleic Acids;Oral;pandemic disease;Parasites;Parasitology;Parents;Pathogenesis;Poly A;Population;population genetic structure;Positioning Attribute;programs;Protein Region;Proteins;public health emergency;receptor;respiratory;respiratory virus;RNA Viruses;Role;SARS coronavirus;SARS-CoV-2 antigen;SARS-CoV-2 immunity;SARS-CoV-2 spike protein;Saudi Arabia;scaffold;Shapes;Sorting;Structural Models;Surface Antigens;surveillance study;Techniques;ubiquitin ligase;Ubiquitination;vaccine development;Vaccines;Viral;Viral Genome;Virion;Virus;Virus-like particle;Visualization,"Virus evolution, entry, pathogenesis and vaccine development",1316,NA,NA,NA,NA,5,NA,NA,360385,NA
11189499,ZIA,AI,1,N,NA,NA,NA,NA,ZIAAI001319,NA,NA,1ZIAAI001319-05,NIAID:200298\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,2091338 (contact),"FARBER, JOSHUA M (contact)",NA,NA,NA,2019-nCoV;Antibodies;Blood;Cell Line;cell motility;Cells;chemokine;chemokine receptor;Complex;Coupled;COVID-19;cytokine;Data;Dendritic Cells;Disease;experimental study;Extravasation;FDA approved;Flow Cytometry;Genes;Genetic Polymorphism;genome wide association study;Goals;GTP-Binding Proteins;Hospitalization;Host Defense;Human;Immune response;Immune system;Individual;Infection;Inflammation;inflammatory milieu;interest;Leukocyte Trafficking;Leukocytes;Ligands;Lymphocyte;Lymphocyte Subset;lymphocyte trafficking;Mediating;migration;monocyte;Mononuclear;Morbidity - disease rate;Mus;Natural Killer Cells;Pathogenesis;Pathology;Patients;Pattern;Pneumonia;prevent;Production;Proteins;receptor;receptor expression;Role;small molecule;System;T-Lymphocyte;therapeutic target;tissue injury;Tissues;trafficking;Viral,Trafficking of Lymphocyte Subsets in Host Defense and Immunopathogenesis in COVID-19,1319,NA,NA,NA,NA,5,NA,NA,200298,NA
11189500,ZIA,AI,1,N,NA,NA,NA,NA,ZIAAI001320,NA,NA,1ZIAAI001320-05,NIAID:634568\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,9691521 (contact),"YEWDELL, JONATHAN W (contact)",NA,NA,NA,2019-nCoV;A549;ACE2;Affinity;Alanine;Antibody Specificity;antigen processing;Binding;Biological;Biological Assay;Cells;Cellular biology;chemokine;Coronavirus;Coronavirus Infections;cytokine;Epitopes;Goals;Histocompatibility Antigens Class I;Human;Interferometry;Libraries;MHC Class I Genes;Monoclonal Antibodies;Mus;Nucleocapsid Proteins;Pathway interactions;Peptide Hydrolases;peptide I;Process;Proteins;Proteome;receptor;Recombinants;Reporter;SARS-CoV-2 immunity;SARS-CoV-2 spike protein;seasonal coronavirus;Sleeping Beauty;Stomatitis;System;TMPRSS2 gene;Transfection;translatome;Transposase;vector;Vesicular stomatitis Indiana virus;Viral Physiology;Virus;Virus Receptors,SARS-CoV2 Immunity and Cell Biology,1320,NA,NA,NA,NA,5,NA,NA,634568,NA
11189501,ZIA,AI,1,N,NA,NA,NA,NA,ZIAAI001322,NA,NA,1ZIAAI001322-05,NIAID:473393\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,77880715 (contact),"GHEDIN, ELODIE  (contact)",NA,NA,NA,Acetylcholine;Address;Adopted;Adult;Affect;analog;Animal Model;Animals;Antibiotics;Arbovirus Infections;Arboviruses;Arthropods;Autophagocytosis;Bacteria;Bacterial Proteins;Biological Assay;Biological Availability;Biology;Brugia;Brugia malayi;Cell Physiology;Cells;Characteristics;Collaborations;Cues;Culicidae;design;Development;Drug Combinations;Drug Interactions;drug repurposing;Drug Targeting;Elements;Elephantiasis;endosymbiont;Enzymes;Ethanolamines;Evaluation;experimental study;Family;FDA approved;Female;Filarial Elephantiases;fitness;Fluorescence Microscopy;G-Protein-Coupled Receptors;Genes;Gerbils;Germany;Goals;Health;Human;Immune;Immune system;immunoregulation;in silico;In Vitro;in vitro Model;in vitro testing;in vivo;in vivo Model;Infection;Insecta;insight;Laboratories;Life Cycle Stages;Litomosoides;Lymphatic;Lymphatic Endothelial Cells;male;Manuscripts;Mediating;Messenger RNA;Metabolic;metabolomics;MicroRNAs;Modeling;Molecular;Morbidity - disease rate;Motility;neglected tropical diseases;Nematoda;novel;novel strategies;novel therapeutic intervention;Onchocerciasis;Organism;Outcome;Parasite Control;Parasites;Parasitic infection;Parasitic nematode;parasitism;pathogen;Pathology;Pathway interactions;Pharmaceutical Preparations;Pharmacotherapy;Phase;Population;protein expression;Proteins;Proteomics;Pyruvate Kinase;reconstruction;Research;Role;rottlerin;symbiont;Symbiosis;Systems Biology;Technology;Testing;Therapeutic;Time;transcriptomics;transmission process;Vaccines;Variant;vector;Virus Diseases;Wolbachia;Work;Zika Virus;ZIKV infection,Host-pathogen interactions in filarial worm infections,1322,NA,NA,NA,NA,5,NA,NA,473393,NA
11189502,ZIA,AI,1,N,NA,NA,NA,NA,ZIAAI001323,NA,NA,1ZIAAI001323-05,NIAID:1420176\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,77880715 (contact),"GHEDIN, ELODIE  (contact)",NA,NA,NA,Affect;Age;American;Anatomy;Behavior;Biodiversity;Biological;Biological Assay;biomarker identification;Bronchoscopy;Carbon Nanotubes;Cells;Chronic Obstructive Pulmonary Disease;Classification;Clinical;Collaborations;Communicable Diseases;comorbidity;Complex;Computer Vision Systems;Critical Care;Data;deep learning;design;Detection;Development;diagnostic platform;Disease;Disease Progression;Disease susceptibility;dysbiosis;Effectiveness;Environment;Evolution;exposure to cigarette smoke;Ferrets;flu transmission;follow-up;Frequencies;Gambia;Gene Expression;Gene Expression Profile;generative adversarial network;Genes;Genetic Variation;genomic profiling;Goals;Health;Immune;Immune response;improved;Individual;individual response;Infection;infection risk;Inflammatory;inflammatory marker;Influenza;Influenza A virus;influenza infection;Influenza vaccination;influenza virus vaccine;influenzavirus;innovation;Integration Host Factors;Intervention;Journals;Lung Diseases;Machine Learning;machine learning model;Manuscripts;Medicine;metabolomics;Metagenomics;Methods;microbial colonization;microbial community;microbiome;microbiome analysis;Microfluidics;Modeling;Molecular;Mothers;mouse model;multiscale data;Mutation;Neonatal;neonatal infection;neonate;Newborn Infant;Non obese;novel;novel diagnostics;novel therapeutics;obese person;Obesity;Optics;oral commensal;Oropharyngeal;pathogen;Pathogenesis;Pattern;Physiological;Population;pre-clinical;predictive marker;Preparation;pressure;Process;programs;Proteins;Proteomics;Publishing;Raman Spectrum Analysis;rapid detection;rapid test;Recurrence;Reporting;Research Design;respiratory;respiratory microbiome;respiratory pathogen;Respiratory System;Respiratory Tract Infections;response;response biomarker;Risk;Risk Factors;RNA;Running;Sample Size;Sampling;seasonal influenza;Severities;Severity of illness;simulation;Smoker;Source;Staphylococcus aureus;System;Systems Biology;Taxonomy;Techniques;Testing;Time;Tissues;Training;trait;Transcript;transcriptomic profiling;transcriptomics;transmission process;Vaccinated;Vaccination;Vaccine Design;vaccine effectiveness;vaccine immunogenicity;vaccine response;vaccine strategy;vaccine trial;Vaccinee;Vaccines;Variant;Viral;viral detection;viral transmission;Virion;virology;Virus;virus classification;virus identification;Weight;Whole Blood;Whole Organism;Work,Genomic profiling of influenza infections to identify biomarkers of disease severity,1323,NA,NA,NA,NA,5,NA,NA,1420176,NA
11189503,ZIA,AI,1,N,NA,NA,NA,NA,ZIAAI001324,NA,NA,1ZIAAI001324-05,NIAID:812851\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,77880715 (contact),"GHEDIN, ELODIE  (contact)",NA,NA,NA,2019-nCoV;ACE2;adaptive immunity;Animal Model;Animals;Anti-viral Agents;Autopsy;B-Lymphocytes;Base Sequence;Binding;Biological Assay;Bronchoscopy;Caribbean region;Clinical;clinical diagnostics;cohort;Collaborations;Communication;Communities;Consensus;Country;COVID-19;COVID-19 diagnosis;COVID-19 patient;Critical Illness;Cross-Sectional Studies;Data;Data Set;Death Rate;deep sequencing;Defect;Defense Mechanisms;Disease;Dominican Republic;epidemiology study;Europe;Evaluation;Event;Evolution;follow-up;Follow-Up Studies;genetic analysis;Genetic Variation;genome sequencing;genomic epidemiology;Genomics;Genotype;Goals;Haiti;Haplotypes;Hereditary Disease;Hospitals;Human;Immune response;Immunocompromised Host;In Vitro;Individual;Infection;Integration Host Factors;Intubation;Island;Libraries;Logistic Regressions;longitudinal analysis;Manuscripts;Measures;Mechanical ventilation;Mesocricetus auratus;Metadata;Metagenomics;metatranscriptomics;Methodist Church;Methods;microbial community;Minority;Modeling;Molecular Epidemiology;Morphologic artifacts;Mutation;nasopharyngeal swab;National Institute of Allergy and Infectious Disease;Nature;nirmatrelvir;North America;novel;Nucleotides;Obesity;Outcome;pandemic disease;Pathogenesis;Patients;Peptide Hydrolases;Persons;Phylogenetic Analysis;Population;Populations at Risk;Preparation;pressure;Proteins;Public Health;Publications;Publishing;random forest;Readiness;receptor;receptor binding;Recording of previous events;Regimen;remdesivir;Research Design;Resistance;respiratory;respiratory microbiome;Respiratory System;Ritonavir;RNA-Directed RNA Polymerase;Role;Route;Sampling;SARS-CoV-2 genome;SARS-CoV-2 infection;SARS-CoV-2 positive;Sequence Analysis;severe COVID-19;Severity of illness;Specimen;Surveillance Program;Symptoms;System;Testing;Therapeutic;Tissues;Training;transmission process;Travel;Variant;Viral;viral genomics;Viral Load result;Virus;Virus Replication;Visit;West Indies;whole genome,Determining factors of transmission and evolution of SARS-CoV-2 in populations at risk,1324,NA,NA,NA,NA,5,NA,NA,812851,NA
11189504,ZIA,AI,1,N,NA,NA,NA,NA,ZIAAI001325,NA,NA,1ZIAAI001325-05,NIAID:361442\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,6479726 (contact),"MOIR, SUSAN  (contact)",NA,NA,NA,2019-nCoV;acute infection;Address;Adenoidal structure;Affect;Antibodies;Antibody Response;Antibody Therapy;Antibody titer measurement;Antigens;Attenuated;Autoimmune Diseases;B-Lymphocyte Subsets;B-Lymphocytes;Binding;Biological Assay;Blood;Blood specimen;booster vaccine;breakthrough infection;CD8-Positive T-Lymphocytes;Cell Physiology;Cells;Child;Chronic;Circulation;cohort;Collaborations;COVID-19;COVID-19 vaccination;COVID-19 vaccine;design;Development;Disease;Disease Progression;Dose;Eligibility Determination;emerging pathogen;Enrollment;Evaluation;Extramural Activities;Flow Cytometry;Frequencies;Generations;Goals;Health;Hepatitis C;high dimensionality;HIV;HIV Infections;HIV vaccine;Hospitalization;Human;Humoral Immunities;Immune;Immune response;Immunologics;Immunology;Immunophenotyping;imprint;Individual;Infection;Inferior;Knowledge;Longitudinal Studies;Lymphoid Tissue;Manuscripts;Measures;Messenger RNA;National Institute of Allergy and Infectious Disease;neutralizing antibody;Outcome;Participant;participant enrollment;Patients;Persons;Pharyngeal structure;Phenotype;Preparation;prevent;Protein Binding Domain;Protocols documentation;Publishing;receptor binding;Research Personnel;response;RNA vaccine;Role;Sampling;SARS-CoV-2 exposure;SARS-CoV-2 immunity;SARS-CoV-2 infection;SARS-CoV-2 spike protein;Specimen;Survivors;symptomatic COVID-19;T cell response;Therapeutic Intervention;Time;Tissues;Tonsil;Universities;Vaccination;vaccine immunogenicity;vaccine response;vaccine trial;Vaccines;Variant;Virus;Visit;Writing,Immunologic Studies Associated with COVID-19,1325,NA,NA,NA,NA,5,NA,NA,361442,NA
11189505,ZIA,AI,1,N,NA,NA,NA,NA,ZIAAI001326,NA,NA,1ZIAAI001326-05,NIAID:80385\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,77852597 (contact),"PREVOTS, D. REBECCA  (contact)",NA,NA,NA,"2019-nCoV;Address;Adoption;Age;Americas;Antibodies;Antibody Response;Behavioral;Binomial Model;Blood specimen;Cervical;Clinical;cohort;Collaborations;Communities;Complex;Costa Rica;Costa Rican;COVID-19;COVID-19 pandemic;COVID-19 patient;Crowding;Diagnosis;Disease;Enrollment;follow-up;Goals;Healthcare Systems;Heterogeneity;Household;Human Papilloma Virus Vaccine;Immune response;Immunoglobulin G;Immunology;indexing;Individual;Infection;infection rate;infection risk;Infrastructure;Interview;Malignant Neoplasms;Masks;Medical;Methods;National Cancer Institute;Nucleocapsid;Patient Self-Report;Prevention Measures;primary endpoint;Prospective Studies;Prospective, cohort study;protective efficacy;randomized trial;Recording of previous events;Research;Research Institute;Risk;Risk Factors;SARS-CoV-2 antibody;SARS-CoV-2 infection;SARS-CoV-2 positive;SARS-CoV-2 transmission;secondary infection;Serology;Serum;sex;Signs and Symptoms;Socioeconomic Status;Source;Testing;transmission process;Vaccines;Viral",Household transmission of COVID19 in Costa Rica,1326,NA,NA,NA,NA,5,NA,NA,80385,NA
11189506,ZIA,AI,1,N,NA,NA,NA,NA,ZIAAI001327,NA,NA,1ZIAAI001327-05,NIAID:37880\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,6479774 (contact),"CONNORS, MARK  (contact)",NA,NA,NA,2019-nCoV;acute infection;Adenoviruses;Agonist;Animal Experiments;Animal Model;Animals;Antibodies;Antibody Response;Antibody titer measurement;Antigens;Area;Attenuated;Authorization documentation;B-Lymphocytes;Body Weight decreased;Complement;COVID-19 survivors;COVID-19 vaccine;cytokine;Disease;Dose;Frequencies;Gastrointestinal tract structure;gene product;Goals;HIV;Household;Human;Human poliovirus;Immune response;Immunity;Immunization;Immunize;immunogenic;immunogenicity;Immunology;Infection;Inflammatory;Influenza;influenzavirus;Interruption;Intramuscular;Laboratories;Licensing;Measurement;Measures;Membrane Glycoproteins;Mesocricetus auratus;Messenger RNA;Modeling;Molecular Conformation;Mucosal Immune Responses;Mucosal Immunity;Mucous Membrane;Mus;Natural History;Nature;neutralizing antibody;Oryctolagus cuniculus;Participant;Particulate;Pathology;Peripheral Blood Mononuclear Cell;Play;recombinant adenovirus;Recombinants;Respiratory Syncytial Virus Infections;response;Role;Sampling;SARS-CoV-2 B.1.617.2;SARS-CoV-2 immunity;SARS-CoV-2 infection;SARS-CoV-2 spike protein;SARS-CoV-2 transmission;Science;Serum;Severity of illness;Stimulus;success;T-Lymphocyte;Testing;Time;transmission process;Upper respiratory tract;Vaccination;vaccine platform;Vaccinee;Vaccines;vector;Vietnam;Viral;Viral Vaccines;Viral Vector;Virus;Virus Replication;Virus-like particle;Work,Immunity to SARS-CoV-2 After Natural Infection or Vaccination,1327,NA,NA,NA,NA,5,NA,NA,37880,NA
11189507,ZIA,AI,1,N,NA,NA,NA,NA,ZIAAI001328,NA,NA,1ZIAAI001328-05,NIAID:731182\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,77880721 (contact),"LEHMANN, TOVI  (contact)",NA,NA,NA,2019-nCoV;3 year old;Affect;Africa;Africa South of the Sahara;African;Age;Americas;Antibodies;antibody detection;Antibody titer measurement;Antigens;Area;Asia;Biological Assay;Blood;Blood specimen;Burkina Faso;Cities;Collaborations;Country;COVID-19;COVID-19 monitoring;Culicidae;Data;density;Disease Surveillance;Environment;Enzyme-Linked Immunosorbent Assay;Epidemiology;epidemiology study;Europe;experimental study;feeding;Female;frontier;Home;Hour;Human;Human Bites;human disease;human subject;Immunoassay;Immunoglobulin G;Individual;Infection;Laboratories;Mali;Measures;Methods;Monitor;novel;Nucleocapsid;pandemic disease;Paper;Population;pre-pandemic;Process;Protocols documentation;Publishing;receptor binding;Rest;Route;Rural;Rural Community;rural setting;Sampling;SARS-CoV-2 infection;SARS-CoV-2 transmission;Serology;seropositive;Seroprevalences;serosurveillance;Shapes;Site;spatiotemporal;Specificity;Specimen;System;Techniques;Time;Training;Transportation;United States National Institutes of Health;vector-borne;Visit;Widespread Disease;Withdrawal;Work;Writing,"Evaluating the determinants of the spread of COVID-19 between and within rural communities in Mali, West Africa based on blood-fed mosquitoes",1328,NA,NA,NA,NA,5,NA,NA,731182,NA
11189508,ZIA,AI,1,N,NA,NA,NA,NA,ZIAAI001329,NA,NA,1ZIAAI001329-05,NIAID:10914\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,6568735 (contact),"KELSALL, BRIAN  (contact)",NA,NA,NA,2019-nCoV;Address;Alcohol consumption;Anatomy;Autopsy;Biological Markers;Blood;brain fog;Case/Control Studies;Cells;chemokine;Collaborations;Colon;COVID-19 patient;Development;dysbiosis;enteric infection;Epithelial Cells;Fatigue;Functional disorder;Genes;Goals;Hospitals;Human;Immunofluorescence Immunologic;In Situ Hybridization;in vivo;Individual;Infection;intestinal barrier;intestinal epithelium;Intestinal permeability;Intestines;Laboratories;Long COVID;Macrophage;Manuscripts;Medical center;Messenger RNA;microbial;mouse model;Mus;National Institute of Allergy and Infectious Disease;Nuclear Proteins;Obesity;Patients;Physiological;Preparation;receptor;Research Personnel;Role;Route;Sampling;SARS-CoV-2 antibody;SARS-CoV-2 infection;SARS-CoV-2 spike protein;Stains;Symptoms;systemic inflammatory response;Technology;Thinking;Time;Tissues;Viral;Viral Load result;viral RNA;Virus,SARS-CoV2 infection in the intestine,1329,NA,NA,NA,NA,5,NA,NA,10914,NA
11189509,ZIA,AI,1,N,NA,NA,NA,NA,ZIAAI001331,NA,NA,1ZIAAI001331-05,NIAID:539385\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,79358354 (contact),"LONG, CARRIE MAE  (contact)",NA,NA,NA,Aerosols;Animal Model;Bacteria;Bacteriology;Biological;bioweapon;Cavia;Collaborations;Communicable Diseases;Coxiella burnetii;Dairying;Delayed Hypersensitivity;Development;Disease;Disease Outbreaks;DNA Sequence Alteration;Economics;flu;Gene Modified;Genes;genetic manipulation;Genome;genome sequencing;Goat;guinea pig model;Health;Human;Human Characteristics;human disease;human model;Hypersensitivity;Immune;Immune response;Immunity;Immunobiology;Immunologics;improved;in vivo;Induced Mutation;Infection;Integration Host Factors;interest;Length;Licensing;Lipopolysaccharides;Mediating;Modeling;mouse model;Mutation;National Institute of Allergy and Infectious Disease;Netherlands;novel;Organism;Oxidative Stress;pathogen;Phase;programs;Proteins;Public Health;Q Fever;Reaction;Reagent;Research;response;RNA;Ruminants;Severities;sex;single cell sequencing;Structure;System;Techniques;Testing;Therapeutic;therapeutic target;Tissues;transmission process;Type IV Secretion System Pathway;United States;United States National Institutes of Health;Vaccination;vaccine candidate;vaccine evaluation;vaccine platform;Vaccines;Virulence;Virulence Factors;whole genome;Work;Zoonoses,"Coxiella burnetii immunobiology, host-pathogen modeling, and countermeasure development",1331,NA,NA,NA,NA,5,NA,NA,539385,NA
11189510,ZIA,AI,1,N,NA,NA,NA,NA,ZIAAI001332,NA,NA,1ZIAAI001332-05,NIAID:117229\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,1940988 (contact),"MATZINGER, POLLY C (contact)",NA,NA,NA,Age;Age Months;Agriculture;Asthma;Bacille Calmette-Guerin vaccination;Cessation of life;chemical reaction;Child;Complex;Control Groups;Country;COVID-19;COVID-19 mortality;COVID-19 pandemic;COVID-19 sequelae;Crowding;Data;Death Rate;Development;Diabetes Mellitus;Disease;Drops;Epidemiologic Methods;Equation;Ethnic Origin;Frequencies;Frontline worker;Future;future pandemic;Government;Graph;Hispanic;Hospitalization;Immigrant;Incidence;Individual;Infection;infection rate;Intervention;Kinetics;Late Effects;Latino;Latino Population;Masks;mathematical methods;Methods;Modeling;Not Hispanic or Latino;pandemic disease;Persons;Policies;Policy Developments;Population;Predisposition;Race;Reaction;Regression Analysis;Relaxation;Resistance;Restaurants;Risk;Risk Factors;school closure;Schools;Series;Statistical Methods;Time;Visual;Visualization;Vitamin D;Work,Analyzing Covid-19,1332,NA,NA,NA,NA,5,NA,NA,117229,NA
11189511,ZIA,AI,1,N,NA,NA,NA,NA,ZIAAI001333,NA,NA,1ZIAAI001333-04,NIAID:1537444\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,6568741 (contact),"MARQUES, ADRIANA R (contact)",NA,NA,NA,adaptive immune response;Anaplasma phagocytophilum;Anaplasmosis;Animal Model;Animals;anti-tick vaccine;Arthropods;Babesia microti;Babesiosis;Bacteriology;Biological Process;Biopsy;Black-legged Tick;Blood;Blood Platelets;Body Weight;Borrelia burgdorferi;Borrelia mayonii;Borrelia miyamotoi;Case Study;Cavia;Cells;Cessation of life;Clinical;clinical development;Coagulation Process;Diagnosis;differential expression;Disease;Dissociation;Ehrlichia;Ehrlichiosis;experience;Exposure to;feeding;Future;Genes;Histopathology;Human;human disease;Immune response;Immunity;immunoregulation;Individual;Infection;Innate Immune Response;Ixodes;Ixodidae;Laboratories;Life;Lyme Disease;Malaria;Methodology;Molecular;Molecular Biology;molecular vector;Monitor;nano-string;National Institute of Allergy and Infectious Disease;Nature;Oryctolagus cuniculus;Paraffin;Participant;pathogen;Persons;Powassan virus;preservation;Process;Proteins;Proteomics;Protocols documentation;Pruritus;Public Health;Research;Resistance;Resolution;response;RNA;Role;Salivary;Salivary Proteins;single cell analysis;single-cell RNA sequencing;Skin;skin irritation;Standardization;Suspensions;System;Technology;tick bite;tick feeding;tick saliva;Tick-Borne Diseases;Tick-Borne Encephalitis;Ticks;Time;transcriptome sequencing;transcriptomics;transmission process;United States;Vaccine Design;vector;Virus;Xenodiagnosis,Investigating the Human Immune Response to Ixodes scapularis Tick Bites,1333,NA,NA,NA,NA,4,NA,NA,1537444,NA
11189512,ZIA,AI,1,N,NA,NA,NA,NA,ZIAAI001334,NA,NA,1ZIAAI001334-04,NIAID:1514206\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,78347401 (contact),"KAMHAWI, SHADEN  (contact)",NA,NA,NA,Active Sites;Adenosine;Africa;Animals;Antibodies;antigen test;Antigens;Arthropod Vectors;Attenuated;Attenuated Vaccines;Automobile Driving;Award;Beds;Biological Markers;Bite;Blood;Cellular Immunity;Chronic;Chronic Phase;Clinical;clinical center;Clinical Trials;Collaborations;Communities;Cutaneous Leishmaniasis;Data;Data Collection;Deposition;Development;Disease;Disease Outcome;disease transmission;DNA analysis;Eastern Africa;effectiveness testing;Ethics;Ethiopia;Exposure to;Faculty;Female;Frequencies;Funding;Future;Gene Deletion;gene function;Genetic;Goals;Grant;Guidelines;Health Sciences;Human;Hybrids;Hypersensitivity skin testing;Immune response;Immunity;immunogenic;immunogenicity;Immunoglobulin M;In Vitro;in vivo;India;Individual;Infection;Inflammasome;Inflammatory Response;Innate Immune Response;Insecticides;Institutional Review Boards;interdisciplinary approach;interest;Interferon Type II;International;international center;Interruption;Investigation;Italy;Kenya;Knowledge;Laboratories;Laboratory Finding;Laboratory Research;Leishmania;Leishmania donovani;Leishmaniasis;leishmanin;Mali;Malnutrition;manufacture;Manuscripts;Mediating;Medical center;Medicine;Midgut;Mite Infestations;Mites;Modeling;National Institute of Allergy and Infectious Disease;natural antibodies;Nature;novel;Ohio;Parasites;Partner in relationship;pathogen;Pathogenesis;Pathogenicity;Peer Review;Peripheral Blood Mononuclear Cell;Phlebotominae;Phlebotomus;Post Kala-Azar Dermal Leishmaniasis;Printing;Process;Production;Productivity;programs;Protocols documentation;Publications;Publishing;Recombinants;Research;Resources;Review Committee;Risk Factors;RNA;Rodent Model;Role;Salivary;Salivary Glands;Salivary Proteins;sample collection;Site;Skin;Source;Specimen Handling;Sri Lanka;Sudan;tool;transmission process;Trimethoprim-Sulfamethoxazole;Tunisia;United States National Institutes of Health;Universities;University Health Services;vaccine candidate;Vaccines;Validation;vector;vector competence;vector-borne pathogen;Vector-transmitted infectious disease;Vertebrates;Visceral Leishmaniasis;volunteer;Work,Vector-borne pathogen transmission,1334,NA,NA,NA,NA,4,NA,NA,1514206,NA
11189513,ZIA,AI,1,N,NA,NA,NA,NA,ZIAAI001335,NA,NA,1ZIAAI001335-04,NIAID:294282\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,79358358 (contact),"RICOTTA, EMILY  (contact)",NA,NA,NA,2019-nCoV;ACE2;Anaphylaxis;Antibodies;Attenuated Vaccines;Authorization documentation;B-Cell Antigen Receptor;B-Lymphocytes;Binding;Chickenpox Vaccine;Chronic Granulomatous Disease;chronic infection;cohort;Common Variable Immunodeficiency;Complement;congenital immunodeficiency;COVID-19;COVID-19 prevalence;COVID-19 vaccination;COVID-19 vaccine;Cytokinesis;Data;Defect;Disease;DNA;Dose;Dryness;Emergency Situation;Enrollment;Epstein-Barr Virus Infections;Exclusion;experience;Functional disorder;Funding;GATA2 deficiency;General Population;Genes;Genetic Recombination;Haemophilus influenzae type b;healthy volunteer;Herd Immunity;Hyper-IgE Syndrome;Immune;immune activation;Immune response;Immune System Diseases;immunodeficiency;immunogenicity;Immunoglobulin G;Immunologics;immunomodulatory therapies;Impairment;Individual;Inflammasome;Inflammatory;Influenza;interest;Interferon Type II;Interleukin-12;Laboratories;Leukocyte Adhesion Deficiency;Life;Light;Link;Literature;Magnesium;Measles-Mumps-Rubella Vaccine;Measures;Medicine;Minority Groups;National Institute of Allergy and Infectious Disease;Neonatal Onset Multisystem Inflammatory Disease;Neoplasms;neutrophil;novel;Participant;participant enrollment;Pathway interactions;Peripheral Blood Mononuclear Cell;Persons;Phosphatidylinositols;Phosphotransferases;Plasma;Polyglandular Autoimmune Syndrome Type I;Population;post SARS-CoV-2 infection;Reporting;response;RNA;RNA vaccine;Safety;saliva sample;sample collection;Sampling;SARS-CoV-2 BA.1;SARS-CoV-2 infection;seroconversion;Serum;Severe Combined Immunodeficiency;Severities;Severity of illness;STAT1 gene;Stat3 protein;Symptoms;T cell response;T-Lymphocyte;United States;Update;Vaccination;vaccine immunogenicity;vaccine trial;Vaccines;Variant;Whole Blood;Wiskott-Aldrich Syndrome;X-Linked Agammaglobulinemia,Immune response to COVID-19 vaccination in individuals with immune disorders,1335,NA,NA,NA,NA,4,NA,NA,294282,NA
11189514,ZIA,AI,1,N,NA,NA,NA,NA,ZIAAI001336,NA,NA,1ZIAAI001336-04,NIAID:369941\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,78834489 (contact),"FRISCHMEYER-GUERRERIO, PAMELA  (contact)",NA,NA,NA,Abdominal Pain;Acute;Age;Airway Resistance;Allergic;Allergic Reaction;allergic response;Ambulatory Care Facilities;Anaphylaxis;Anxiety;Blinded;blood pressure elevation;booster vaccine;Chest;Chronic;Classification;Clinical;clinical center;cohort;Complement 5a;Complement Activation;COVID-19;COVID-19 vaccine;detection method;Disease;Distress;Dizziness;Dose;double-blind placebo controlled trial;Event;Excipients;experience;Female;Goals;Heart Rate;high risk;Histamine;Hour;Hydrocortisone;Hypersensitivity skin testing;Hypothalamic structure;IgE;Immunization;Individual;Injections;Intensive Care Units;Leukotriene E4;mast cell;Mediating;Messenger RNA;Meta-Analysis;Metanephrine;Neurologic;Neurologic Symptoms;novel;open label;Organ;Outcome;Outpatients;Paresthesia;Participant;Pathway interactions;Patients;Pfizer-BioNTech COVID-19 vaccine;Pharyngeal structure;Phase;Pituitary Gland;Placebos;Plasma;Polyethylene Glycols;prevent;Process;Public Health;Randomized;Reaction;Recording of previous events;Recurrence;Reporting;Research Personnel;response;Risk;RNA vaccine;Safety;Saline;Screening procedure;Sensory;Serum;severe COVID-19;Severities;Site;Stress;Sympathetic Nervous System;Symptoms;System;trend;Tryptase;United States National Institutes of Health;Urine;Vaccination;Vaccines,COVID vaccine-associated allergic reactions,1336,NA,NA,NA,NA,4,NA,NA,369941,NA
11189515,ZIA,AI,1,N,NA,NA,NA,NA,ZIAAI001337,NA,NA,1ZIAAI001337-04,NIAID:2397882\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,78347404 (contact),"TIRLONI, LUCAS  (contact)",NA,NA,NA,Adult women;Amblyomma;Ambylomma americanum;Animal Model;Antibodies;Argasidae;B-Lymphocyte Epitopes;Bacteria;Binding;Biochemical;Biological Assay;Biology;Bite;Black-legged Tick;Blood;Blood coagulation;Borrelia;Borrelia burgdorferi;C3H/HeN Mouse;cadherin 5;Catalogs;Categories;Cattle;cell motility;Chromatography;Coagulation Process;Code;Competitive Binding;Complement;Complement Membrane Attack Complex;complement system;Cyclophilin A;Data Set;Deposition;Development;differential expression;Dimensions;DNA;Dose;Elongation Factor;Embryonic Development;Endothelial Cells;Enzyme-Linked Immunosorbent Assay;Epitope Mapping;Epitopes;Family;feeding;Female;Fibrin;functional group;Gelatinase A;Gene Expression;Gene Expression Profile;Gene Silencing;Generations;Genes;Genetic Transcription;Heart;heme-binding protein;Hemorrhage;Hemostatic function;Histone H3;histopathological examination;Hour;Housekeeping Gene;Immune response;Immune Sera;Immune system;Immunization;Immunoglobulin G;in silico;In Vitro;in vitro Assay;in vivo;Individual;Inflammation;Insecta;insight;internal control;Ixodes persulcatus;Ixodidae;keratinocyte;Larva;Lectin;Link;Location;Lyme Disease;Maps;Mediating;Medical;Metabolic Pathway;Methods;Midgut;migration;Modeling;Molecular Biology;Ornithodoros;Oryctolagus cuniculus;pathogen;Pathway interactions;Pattern;Peptide Hydrolases;Peptides;Permeability;Phase;Physiology;Plasmin;Precipitation;Process;Protease Inhibitor;protein aminoacid sequence;Protein Biosynthesis;protein degradation;protein expression;Proteins;Proteomics;Recombinant Proteins;Recombinants;Research;Rhipicephalus;Ribosomal Proteins;Role;Saliva;saliva proteome;Salivary;Salivary Glands;Salivary Proteins;screening;Serine Protease;Serpins;Site;Skin;Structure;System;Techniques;Testing;Thrombin;Tick Control;tick feeding;tick saliva;tick transmission;tick-borne pathogen;Ticks;Tissues;tool;Transcript;transcriptome;transcriptomics;transmission process;Vaccines;vector;wound healing;Wound models;Yeasts,Tick saliva and its importance for tick feeding and pathogen transmission,1337,NA,NA,NA,NA,4,NA,NA,2397882,NA
11189516,ZIA,AI,1,N,NA,NA,NA,NA,ZIAAI001339,NA,NA,1ZIAAI001339-04,NIAID:1599657\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,78347407 (contact),"GROSHONG, ASHLEY  (contact)",NA,NA,NA,Ablation;Amino Acid Transporter;Amino Acids;Argasidae;Bacteria;bacterial metabolism;Bacterial Physiology;Binding;Binding Proteins;Blood;Borrelia;Borrelia burgdorferi;Case Study;cell motility;Characteristics;Complement;Complex;conventional therapy;Data;deprivation;differential expression;Disease;Environment;enzootic;Evolution;Genome;Genomics;Goals;Growth;Healthcare Systems;Homology Modeling;Human;Immune response;Incidence;Individual;Infection;Ingestion;Ixodes;Ixodidae;Larva;Life Cycle Stages;Lyme Disease;Maintenance;Mammals;Membrane Proteins;Modeling;Molting;Morphology;mortality;Mutagenesis;Nature;new therapeutic target;Nutrient;Nutritional;Oligopeptides;Order Spirochaetales;Ornithodoros;pathogen;Patients;peptide permease;Peptide Transport;Peptides;permissiveness;Peromyscus;Phase;Phenotype;Physiological;Physiological Adaptation;Population;Post Treatment Lyme Disease Syndrome;programs;Proliferating;Quality of life;Regulation;Relapse;Relapsing Fever;Reporting;response;Role;Source;Spirochaetales Infections;Symptoms;System;therapeutic development;tick-borne;Ticks;Tissues;transmission process;United States;uptake;vector;vector tick;Vector-transmitted infectious disease;White-Footed Mouse,Borrelia burgdorferi nutrient acquisition throughout the enzootic cycle,1339,NA,NA,NA,NA,4,NA,NA,1599657,NA
11189517,ZIA,AI,1,N,NA,NA,NA,NA,ZIAAI001340,NA,NA,1ZIAAI001340-04,NIAID:277491\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,78347409 (contact),"MANTHIRAM, KALPANA  (contact)",NA,NA,NA,Adenitis;airway obstruction;Anatomy;Aphthous Stomatitis;Apnea;CD4 Positive T Lymphocytes;CD8-Positive T-Lymphocytes;Cells;Cervical;Child;Childhood;craniofacial;Craniofacial Abnormalities;Data;Deformity;Disease;Down-Regulation;Fever;Flare;Flow Cytometry;Gene Expression;Genes;Genetic Predisposition to Disease;Goals;Helper-Inducer T-Lymphocyte;Histology;IL17 gene;Immune;Immunologics;Immunology;Immunophenotyping;Inflammatory;Interferon Type II;Ionomycin;Myeloid Cells;Natural Killer Cells;Obstructive Sleep Apnea;Palatine Tonsil;Pathogenesis;Patients;Pediatric Surgical Procedures;Periodicals;peripheral blood;Pharyngitis;Population;Procedures;Recurrence;reduce symptoms;Sampling;Sleep Apnea Syndromes;Sorting;Structure of germinal center of lymph node;Susceptibility Gene;Syndrome;T-Cell Activation;Tonsil;Tonsillectomy;ventilation,Immunology of Pediatric Tonsil Disorders,1340,NA,NA,NA,NA,4,NA,NA,277491,NA
11189518,ZIA,AI,1,N,NA,NA,NA,NA,ZIAAI001342,NA,NA,1ZIAAI001342-04,NIAID:1670518\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,78347412 (contact),"BONSIGNORI, MATTIA  (contact)",NA,NA,NA,2019-nCoV;Affinity;Anti-viral Response;Antibodies;Antibody Repertoire;Antibody Therapy;Antibody-Dependent Enhancement;Antigens;Area;Avian Influenza A Virus;B-Lymphocytes;Binding Proteins;Cell Maturation;Clonal Expansion;cross reactivity;Dengue Virus;design;Development;Equilibrium;Evolution;experience;Flavivirus;Flavivirus Infections;Growth;Hepatitis C virus;HIV-1;Human;Humoral Immunities;Immune system;Immunity;Immunization;Immunobiology;Immunoglobulin M;Infection;Influenza;influenzavirus;information gathering;innovation;interest;Investigation;Licensing;Memory;Memory B-Lymphocyte;Modeling;Mutate;neutralizing antibody;nonhuman primate;novel;pathogen;pathogenic virus;Plasma Cells;Preventive vaccine;prophylactic;Regimen;Research;response;Role;Shapes;Specimen;translational goal;Vaccination;vaccine formulation;Vaccines;Virus;Virus Diseases;Zika Virus,Origin and maturation of protective memory B cell responses against pathogenic viruses in natural infections and upon vaccination.,1342,NA,NA,NA,NA,4,NA,NA,1670518,NA
11189519,ZIA,AI,1,N,NA,NA,NA,NA,ZIAAI001343,NA,NA,1ZIAAI001343-04,NIAID:36631\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,11242108 (contact),"GERMAIN, RONALD N (contact)",NA,NA,NA,Acceleration;adaptive immunity;Adaptor Signaling Protein;Anti-viral Agents;Anti-viral Response;Antigen-Antibody Complex;Binding;cell type;Cells;Cellular Immunity;Complex;computational pipelines;Computing Methodologies;Data;Disease;disease model;draining lymph node;Ebola virus;Elements;Environment;Event;experimental study;Generations;Genetic Predisposition to Disease;Goals;Health;Hematopoietic;Human;Immune response;Immunomodulators;In Vitro;in vivo;Individual;Infection;Infectious Agent;innovation;Interferon Type I;Interferons;Knock-out;Knowledge;Measurement;Methods;Mitochondria;Molecular;Mus;Output;pathogen;Pathogenesis;Pathway interactions;Play;preservation;prevent;Process;Productivity;protein biomarkers;Protein Deficiency;Proteins;receptor;Regulation;Resolution;response;RNA Viruses;Role;Sampling;Shapes;Signal Transduction;Signaling Protein;single-cell RNA sequencing;Site;Skin;Stains;Technology;temporal measurement;Testing;Therapeutic;Time;tissue fixing;Tissue imaging;Tissue Sample;Tissues;transcriptomics;Vesicular stomatitis Indiana virus;Viral;Virus;Virus Replication;Work;Zoonoses,Determining the spatial-temporal and transcriptomic host response to emerging RNA viruses at a single cell resolution,1343,NA,NA,NA,NA,4,NA,NA,36631,NA
11189520,ZIA,AI,1,N,NA,NA,NA,NA,ZIAAI001344,NA,NA,1ZIAAI001344-04,NIAID:1784535\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,79973486 (contact),"SAITO, TAIS B  (contact)",NA,NA,NA,Affect;Animals;Antigens;Arthropod Vectors;Arthropods;Bacteria;Behavior Therapy;Behavioral;Cells;Cutaneous;Dermal;Development;Disease;Disease Outcome;Disease Progression;Ehrlichia;Ehrlichiosis;Evaluation;Immune;Immune response;Immune signaling;Immunity;immunoregulation;Immunotherapy;in vivo;Infection;Infectious Skin Diseases;Infiltration;Inflammation;Inflammatory Infiltrate;Inflammatory Response;Injections;innovation;interest;Link;mouse model;Needles;Nerve Tissue;Nervous System;Outcome;pathogen;Pathogenesis;Pattern;Physiological;Physiology;Reaction;Research;response;Rickettsia Infections;Role;Severity of illness;Site;Skin;tick feeding;tick transmission;Ticks;Time;Tissues;transmission process;vector;vector tick;vector transmission;vector-borne infection,Vector-pathogen-host interaction and immunopathogenesis of disease progression,1344,NA,NA,NA,NA,4,NA,NA,1784535,NA
11189521,ZIA,AI,1,N,NA,NA,NA,NA,ZIAAI001345,NA,NA,1ZIAAI001345-04,NIAID:327273\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,16161411 (contact),"SCHWARTZBERG, PAMELA  (contact)",NA,NA,NA,2019-nCoV;acute infection;adaptive immune response;Adenoidal structure;Anti-viral Response;Awareness;B-Lymphocytes;Blood;CD4 Positive T Lymphocytes;CD8B1 gene;cell motility;Cells;Cellular Indexing of Transcriptomes and Epitopes by Sequencing;Child;Clone Cells;COVID-19;CXCR3 gene;Epidemiology;Evaluation;Flow Cytometry;Goals;Helper-Inducer T-Lymphocyte;high dimensionality;Hispanic;Hospitals;Immune;Immune response;Immunity;Immunize;Immunoglobulin Class Switching;Immunoglobulin Somatic Hypermutation;Immunologic Memory;In Situ;Infection;insight;Interferon Type II;Intramuscular;Laryngoscopes;Lymphoid Tissue;Memory B-Lymphocyte;mucosal vaccine;Mucous Membrane;Nature;Operative Surgical Procedures;Oropharyngeal;Palatine Tonsil;pandemic disease;Participant;Patients;peripheral blood;Population;Poverty;Prevalence;programmed cell death protein 1;Reporting;response;Risk Factors;RNA vaccine;Sampling;SARS-CoV-2 infection;SARS-CoV-2 negative;SARS-CoV-2 spike protein;Serology test;Severe Acute Respiratory Syndrome;Site;Structure of germinal center of lymph node;T-Lymphocyte;Testing;tissue resident memory T cell;Tissues;Tonsil;Tonsillectomy;Upper respiratory tract;Vaccination;vaccine trial;viral RNA;Work,Evaluation of Oropharyngeal responses to SARS-CoV-2,1345,NA,NA,NA,NA,4,NA,NA,327273,NA
11189522,ZIA,AI,1,N,NA,NA,NA,NA,ZIAAI001346,NA,NA,1ZIAAI001346-04,NIAID:1494560\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,78347419 (contact),"KATZELNICK, LEAH  (contact)",NA,NA,NA,Adult;Aedes;Age;age related;age stratification;Antibodies;Antibody titer measurement;Antibody-Dependent Enhancement;Arboviruses;Area;Automobile Driving;Binding;Biological;Cambodia;Cells;Chikungunya virus;Child;Cities;Clinical;cohort;Collaborations;Collection;Computing Methodologies;Confidence Intervals;cross reactivity;Data;Dengue;Dengue Infection;Dengue Vaccine;Dengue Virus;Dengvaxia;Development;dimer;Disease;Disease Outbreaks;Disease Outcome;disorder risk;Dose;Ecuador;emerging virus;Enzyme-Linked Immunosorbent Assay;Epidemic;epidemiologic data;Epidemiologic Methods;Epidemiology;Epitopes;Evolution;experience;Extramural Activities;Flavivirus;geographic difference;Health;Herd Immunity;high risk;Hospitalization;Hospitals;Human;Immune;Immunity;Immunoglobulin G;Immunology;Immunology procedure;Incidence;Individual;Infection;insight;interdisciplinary approach;Manuscripts;Measurement;Measures;Michigan;Modeling;Nature;neutralizing antibody;Nicaragua;Nicaraguan;observational cohort study;Observational Study;Participant;Performance;Periodicals;Periodicity;Phase I Clinical Trials;Philippines;Population;Population Sizes;Predisposition;Prevention;Primary Infection;Printing;protective effect;Province;Publishing;Recording of previous events;Relative Risks;reproductive;Resolution;Risk;Role;rural area;Science;Scientific Advances and Accomplishments;Serology;Serotyping;severe dengue;sex;Shapes;Site;Statistical Methods;System;Testing;Thailand;Time;Titrations;United States National Institutes of Health;Universities;unvaccinated;urban area;Vaccinated;vaccine efficacy;vaccine safety;vaccine trial;Vaccines;vector;Viral Epidemiology;viral transmission;virology;Virus;Water;Work;ZIKA;Zika Virus;ZIKV infection,"Immunology, virology, and epidemiology of flaviviruses and other emerging viruses",1346,NA,NA,NA,NA,4,NA,NA,1494560,NA
11189523,ZIA,AI,1,N,NA,NA,NA,NA,ZIAAI001347,NA,NA,1ZIAAI001347-04,NIAID:94072\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,78347419 (contact),"KATZELNICK, LEAH  (contact)",NA,NA,NA,15 year old;2019-nCoV;Adolescent;Affect;Age;aged;Animal Model;Antibodies;Antibody Response;Antibody titer measurement;B-Cell Antigen Receptor;betacoronavirus;Binding;Biological Assay;Cells;Cellular Immunity;Circulation;Collaborations;comparative;Coronavirus;COVID-19;COVID-19 pandemic;COVID-19 pandemic effects;COVID-19 vaccination;COVID-19 vaccine;Data Set;Dengue;Dengue Vaccine;Dengue Virus;Diamond;Enzyme-Linked Immunosorbent Assay;Epidemiology;Evaluation;Evolution;Exposure to;Ferrets;Flavivirus;Frequencies;Hamsters;Human;human coronavirus;human model;Immune;Immune Sera;Immunity;Immunologics;Immunology;Individual;Infection;Influenza;insight;interdisciplinary approach;Maps;Measures;Meta-Analysis;Methods;Mutation;neutralizing antibody;nonhuman primate;pandemic disease;Participant;pathogen;Persons;Philippines;pre-pandemic;Predisposition;Primary Infection;Printing;Publications;Publishing;PubMed;Random Allocation;receptor binding;response;Rest;Risk;Sampling;SARS-CoV-2 B.1.1.529;SARS-CoV-2 immunity;SARS-CoV-2 infection;SARS-CoV-2 negative;SARS-CoV-2 variant;Serology;seropositive;Seroprevalences;Serum;Testing;transmission process;Update;Vaccination;vaccine trial;Variant;Viral;Viral Epidemiology;Virus Diseases,"Epidemiology, immunology, and evolution of SARS-CoV-2 and other coronaviruses before and during the COVID-19 pandemic",1347,NA,NA,NA,NA,4,NA,NA,94072,NA
11189524,ZIA,AI,1,N,NA,NA,NA,NA,ZIAAI001348,NA,NA,1ZIAAI001348-04,NIAID:1679080\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,78347422 (contact),"FOX, JULIE  (contact)",NA,NA,NA,Acute;adaptive immune response;Alpha Virus;Alphavirus Infections;alphavirus receptor;Americas;Antibodies;Antibody Therapy;Antibody-mediated protection;Arthralgia;Arthritogenic;Attenuated;Australia;Chikungunya virus;Chronic;cross immunity;Culicidae;design;Development;Disease;Disease Outbreaks;Encephalitis;Exanthema;Fever;Geography;Goals;Headache;Human;IgG Receptors;Immune;Immunity;Individual;Infection;Innate Immune Response;Laboratories;Malaise;Mayaro virus;Mediating;Monoclonal Antibodies;monocyte;mortality;mouse model;Movement;Myalgia;Neurologic;novel therapeutics;novel vaccines;Pacific Islands;Pathogenesis;Pathogenicity;Polyarthralgias;Polyarthritides;prevent;RNA Viruses;Role;South America;System;Therapeutic;Therapeutic Monoclonal Antibodies;transmission process;Vaccine Design;Vaccines;Venezuelan Equine Encephalitis Virus;Venezuelan Equine Encephalomyelitis;Viral;Virus;Virus Diseases,Mechanisms of immune-mediated protection and pathogenesis during viral infections,1348,NA,NA,NA,NA,4,NA,NA,1679080,NA
11189525,ZIA,AI,1,N,NA,NA,NA,NA,ZIAAI001349,NA,NA,1ZIAAI001349-04,NIAID:136546\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,10686457 (contact),"BEST, SONJA  (contact)",NA,NA,NA,animal model development;Anti-viral Therapy;Attenuated Vaccines;Case Fatality Rates;Cell Death;cell killing;Cell Line;Cell Survival;Cells;comparison control;CRISPR-mediated transcriptional activation;Data;Ebola virus;emerging virus;Genes;Genetic Transcription;genome wide screen;genome-wide;Goals;Guide RNA;helicase;Human;in vivo;Infection;Interferon Type I;Interferon-beta;Interferons;Life Cycle Stages;Liver;Medical;Methods;Microbe;Molecular;Mus;novel;Organ;promoter;Proteins;Public Health;RNA Viruses;Signal Transduction;Transcription Initiation;transmission process;Vaccine Design;Viral;Viral Genes;Viral Hemorrhagic Fevers;viral outbreak;Viral Pathogenesis;Viral Proteins;Virulence;Virus;Virus Diseases;Virus Replication;Zinc Fingers,Genome-wide CRISPRa screen to determine the antiviral repertoire of the cell,1349,NA,NA,NA,NA,4,NA,NA,136546,NA
11189526,ZIA,AI,1,N,NA,NA,NA,NA,ZIAAI001356,NA,NA,1ZIAAI001356-03,NIAID:566304\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,78834598 (contact),"LACSINA, JOSHUA  (contact)",NA,NA,NA,Address;Apoptotic;Atlases;B-Lymphocytes;Biopsy;Biopsy Specimen;Bite;CD8-Positive T-Lymphocytes;cell type;Cells;Cellular Stress;Clinic;cohort;Collaborations;Cryopreservation;Cutaneous;Cutaneous Leishmaniasis;CXCL9 gene;CXCR3 gene;CXCR6 gene;Data;Data Set;deep learning algorithm;Dendritic Cells;Development;Devices;Dimensions;Disease;DNA;Enrollment;Equilibrium;Exhibits;Female;Fibroblasts;Frequencies;Gene Expression;Genes;Goals;Growth;Growth Factor;healing;Helper-Inducer T-Lymphocyte;heterogenous data;Human;IL7 gene;IL7R gene;Immune;Immune response;Immunity;Immunology;immunopathology;Infection;Infectious Skin Diseases;keratinocyte;Knowledge;Laboratories;Leishmania;Leishmaniasis;Lesion;Ligands;Lymphoid Cell;Macrophage;Maps;Mediating;MHC Class II Genes;monocyte;Morphologic artifacts;Mucocutaneous leishmaniasis;multiple omics;Myeloid Cells;National Institute of Allergy and Infectious Disease;neglected tropical diseases;novel;Parasites;participant enrollment;Pathogenesis;Patient Schedules;Patients;Phenotype;Phlebotominae;Pilot Projects;Population;Procedures;programs;Protocols documentation;Publishing;Punch Biopsy;Puncture biopsy;Quality Control;receptor;recruit;Regulatory T-Lymphocyte;Relapse;Research;RNA;Sampling;self supervised learning;Signal Pathway;Signal Transduction;single-cell RNA sequencing;Site;Skin;Skin Tissue;Stromal Cells;System;T-Cell Activation;T-Lymphocyte;T-Lymphocyte Subsets;Testing;Th1 Cells;Time;Tissue Sample;transcriptome;transcriptome sequencing;transcriptomics;transmission process;United States National Institutes of Health;Universities;Vaccines; T cells,Defining human skin immunity to cutaneous leishmaniasis via systems immunology approaches,1356,NA,NA,NA,NA,3,NA,NA,566304,NA
11189527,ZIA,AI,1,N,NA,NA,NA,NA,ZIAAI001357,NA,NA,1ZIAAI001357-03,NIAID:37228\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,78834600 (contact),"HOURIGAN, SUCHITRA  (contact)",NA,NA,NA,"Antibiotic Resistance;arm;associated symptom;Biological Products;Calendar;Chronic;Chronic Granulomatous Disease;Clinical;Clinical Trials;Colitis;Colonoscopy;congenital immunodeficiency;Data;design;Disease;effective therapy;Enrollment;Evaluation;fecal microbiome;fecal transplantation;Granulomatous disease;gut dysbiosis;gut inflammation;gut microbiota;Immune system;Immunomodulators;improved;Inflammation;Inflammatory Bowel Diseases;Inherited;Institutional Review Boards;Investigational New Drug Application;Investigational Therapies;Leukocyte L1 Antigen Complex;Measures;microbiome;open label;Participant;Pharmaceutical Preparations;Pilot Projects;pilot trial;Population;prospective;Randomized, Controlled Trials;Risk;Safety;Signal Transduction;Site;Symptoms;systemic inflammatory response;United States Food and Drug Administration;United States National Institutes of Health",A pilot study of fecal microbiota transplantation for Chronic Granulomatous Disorder Associated Colitis (CGD-AC),1357,NA,NA,NA,NA,3,NA,NA,37228,NA
11189528,ZIA,AI,1,N,NA,NA,NA,NA,ZIAAI001358,NA,NA,1ZIAAI001358-03,NIAID:119564\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,78347422 (contact),"FOX, JULIE  (contact)",NA,NA,NA,2019-nCoV;Animal Model;Antibodies;antibody test;Cessation of life;COVID-19;design;Development;Disease;efficacy evaluation;Evaluation;Goals;Hospitalization;immune activation;Immune response;Immunity;immunoregulation;In Vitro;in vivo;Infection;Inflammation;Inflammatory Response;Laboratories;Macrophage;Monoclonal Antibodies;Mutation;Neutralizing antibody assay;novel therapeutics;Pathogenesis;post SARS-CoV-2 infection;Primary Cell Cultures;protective efficacy;Reagent;recombinant virus;Respiratory Failure;Respiratory Tract Infections;response;SARS-CoV-2 immune response;SARS-CoV-2 infection;SARS-CoV-2 variant;Therapeutic;Treatment Protocols;Vaccination;Vaccines;Virus Diseases,Pathogenesis and immunity during SARS-CoV-2 infection,1358,NA,NA,NA,NA,3,NA,NA,119564,NA
11189529,ZIA,AI,1,N,NA,NA,NA,NA,ZIAAI001360,NA,NA,1ZIAAI001360-03,NIAID:1853864\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,78834604 (contact),"DOLAN, PATRICK  (contact)",NA,NA,NA,Animal Model;Biochemical;Biological;Biological Assay;Biophysics;Capsid;Cells;Code;Complex;Cultured Cells;Dengue Virus;Engineering;Enterovirus;Enterovirus 71;Environment;Evolution;Flavivirus;Future;Gene Expression;Genotype;Heterogeneity;Human;Immune response;In Vitro;in vivo;Infection;Intention;Libraries;Methods;Mutation;mutation screening;Pathogenesis;Phenotype;Population;Positioning Attribute;Printing;Process;programs;protein function;Proteins;Publishing;reconstruction;Recording of previous events;Research;RNA Viruses;Shapes;single cell sequencing;Structural Protein;Technology;tool;Viral;Viral Proteins;virology;Virus;Visit;West Nile virus;Work;Zika Virus,Virus evolution and host responses in positive-sense RNA viruses,1360,NA,NA,NA,NA,3,NA,NA,1853864,NA
11189530,ZIA,AI,1,N,NA,NA,NA,NA,ZIAAI001361,NA,NA,1ZIAAI001361-03,NIAID:912047\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,78834600 (contact),"HOURIGAN, SUCHITRA  (contact)",NA,NA,NA,"2 year old;3 year old;abdominal fat;Adverse event;Animal Model;arm;beneficial microorganism;Birth;Body mass index;Cesarean section;Child Health;Clinical;Clinical Research;Clinical Trials;comparison control;Data;Data Collection;Development;Disease;Electronic Health Record;Engraftment;Enrollment;experimental arm;Exposure to;Feces;follow-up;Germ-Free;gut microbiota;Health;health of the mother;Health protection;high risk;Human;Immune;immune health;Immune response;Immune System Diseases;Infant;Inflammatory;Intervention;Intra-abdominal;Life;Link;maternal microbiome;Mediating;Metabolic;Metabolic Diseases;Methods;Microbe;microbiome;microbiome analysis;microbiome composition;microbiota composition;Mothers;Mus;neonate;Newborn Infant;normal microbiota;Obesity;obesity risk;offspring;Operative Surgical Procedures;Oral cavity;Outcome;Outcome Measure;Persons;phase 1 study;phase 2 study;Pilot Projects;primary outcome;Procedures;Randomized;Randomized, Controlled Trials;Regulation;Research Personnel;restoration;Safety;sample collection;Sampling;secondary outcome;Site;Skin;skin microbiota;Structure;Surveys;Swab;Testing;Transplantation;treatment arm;Vagina;vaginal microbiome;vaginal microbiota;Visit",Vaginal microbiome seeding and health outcomes in Cesarean-delivered neonates: a randomized controlled trial,1361,NA,NA,NA,NA,3,NA,NA,912047,NA
11189531,ZIA,AI,1,N,NA,NA,NA,NA,ZIAAI001362,NA,NA,1ZIAAI001362-03,NIAID:912046\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,78834600 (contact),"HOURIGAN, SUCHITRA  (contact)",NA,NA,NA,2019-nCoV;Adult;Anti-Inflammatory Agents;Area;atopy;Bacteria;Bacteriophages;bariatric surgery;Cesarean section;Child;Childhood;Cholestasis;Clinical Research;Clostridium difficile;colonization resistance;COVID-19;Development;Disease;early childhood;Early identification;Eczema;Future;Goals;Health;host microbiome;Immune;Immune response;Impairment;Infection;Inflammatory;Inflammatory Bowel Diseases;insight;Life;Malignant Childhood Neoplasm;Metabolic;microbial;microbiome;Neonatal;Obesity;Observational Study;persistent symptom;Physiological;Regulation;Role;SARS-CoV-2 infection;Scientific Advances and Accomplishments;Shapes;skin microbiome;therapeutic target;Time;Vaginal delivery procedure,The role of the microbiome in childhood disease,1362,NA,NA,NA,NA,3,NA,NA,912046,NA
11189532,ZIA,AI,1,N,NA,NA,NA,NA,ZIAAI001363,NA,NA,1ZIAAI001363-03,NIAID:647476\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,78347409 (contact),"MANTHIRAM, KALPANA  (contact)",NA,NA,NA,Adenitis;Affect;Alleles;Antigen-Presenting Cells;Aphthous Stomatitis;autoinflammatory diseases;Behcet Syndrome;Biological;Biological Assay;CCR1 gene;chemokine;Child;Childhood;Clinical;cohort;Complex;Disease;disease phenotype;disease-causing mutation;effective therapy;Family;Fever;Flare;Genes;genetic architecture;Genetic Diseases;genetic predictors;Genetic Predisposition to Disease;Genetic Risk;genome wide association study;Genomics;Health;Hospitals;IL12A gene;Immune;Immune system;Immunologics;Indiana;Individual;Inflammatory;Institutional Review Boards;Interferon Type II;Interferons;Interleukin-10;Interleukin-12;Link;lymphadenopathy;microorganism antigen;monocyte;Mosaicism;Oropharyngeal;Pathway interactions;Patient Recruitments;Patients;Penetrance;Periodicals;peripheral blood;Pharyngitis;polygenic risk score;Production;Protocols documentation;rare variant;Recurrence;Risk;risk variant;Role;Sampling;Site;STAT4 gene;Susceptibility Gene;Syndrome;T-Lymphocyte;Tonsillitis;Transcript;treatment response;Trisomy 8;Ulcer;United States National Institutes of Health;Universities;Up-Regulation;Variant,Genetic susceptibility loci for PFAPA,1363,NA,NA,NA,NA,3,NA,NA,647476,NA
11189533,ZIA,AI,1,N,NA,NA,NA,NA,ZIAAI001364,NA,NA,1ZIAAI001364-02,NIAID:1399953\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,79358384 (contact),"DANG, ERIC  (contact)",NA,NA,NA,25-hydroxycholesterol;Ablation;Address;Alveolar Macrophages;Antigen-Antibody Complex;Area;Asthma;Automobile Driving;Bacteria;Basophils;Biochemical;Biochemistry;Biological Assay;Biology;Bone Marrow;Bronchioles;CD4 Positive T Lymphocytes;Cell Differentiation process;Cells;Ceramide glucosyltransferase;chemical genetics;Chimera organism;Cholesterol;Chromatography;Circulation;Colon;Cryptococcus neoformans;Cryptococcus neoformans infection;cytokine;Cytokine Signaling;Data;Disease;Distal;Down-Regulation;Enzymes;eosinophil;Epithelial Cells;Eukaryota;experimental study;extracellular;Flow Cytometry;Food;fungal genetics;Fungal Proteins;fungus;G-Protein-Coupled Receptors;Genetic Screening;global health;Goals;Granuloma;Granulomatous;Growth;gut microbiota;health care settings;Iatrogenesis;Image;Immunity;Immunocompromised Host;Immunologics;In Vitro;Infection;Inflammation;Innate Immune Response;interest;Interferons;Interleukin-13;Interleukin-4;intestinal crypt;Intestines;Knock-in Mouse;Knock-out;Lamina Propria;latent infection;latent persistent infection;Ligands;Link;LoxP-flanked allele;Lung;Macrophage;Microscopy;Mixed Function Oxygenases;Modeling;mouse genetics;Mus;Mycoses;Oral;Organ;Organoids;Outcome;pathogen;pathogenic fungus;Pathway interactions;Peptide Hydrolases;Physiology;Positioning Attribute;prevent;Primary Infection;Process;Production;Protein Secretion;pulmonary granuloma;recruit;Refractory;Reporter;Research;response;Sensory;single-cell RNA sequencing;Site;Small Intestines;Source;stem cell differentiation;stem cells;Structure;Testing;Textbooks;Th2 Cells;Time;Tissues;Wild Type Mouse,Investigating mammalian innate immune responses to pathogenic fungi,1364,NA,NA,NA,NA,2,NA,NA,1399953,NA
11189534,ZIA,AI,1,N,NA,NA,NA,NA,ZIAAI001366,NA,NA,1ZIAAI001366-02,OD:323196\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,79404436 (contact),"GOODENOW, MAUREEN  (contact)",NA,NA,NA,"Address;Adolescent Medicine Trials Network;Adult;Affinity;Age;Age Years;Antiinflammatory Effect;antiretroviral therapy;Apoptosis;Archives;B-Lymphocytes;Basic Science;biobank;Biodiversity;Biological Markers;Birth;Blood;Blood Cells;Blood Tests;Caring;Cell Communication;cell growth;Cell Physiology;cell type;Cells;Childhood;Chronic;Clinical;Clinical Data;Clinical Trials;Clonality;comorbidity;Complex;complex chronic conditions;Consequences of HIV;CXCL9 gene;design;Development;differential expression;disability;Disease Progression;DNA Repair;Educational workshop;Exposure to;Funding;Gender;Gene Expression;Gene Expression Profile;Genes;genome-wide;Germany;Goals;Health;Heterogeneity;HIV;HIV Infections;HIV-1;HIV-exposed uninfected infant;HIV/AIDS;Homeostasis;Immune;immune activation;Immune Plasma;Immune response;Immune system;Immunoglobulin Somatic Hypermutation;Immunoglobulins;Immunologic Markers;immunological status;immunoregulation;Individual;individual response;Infant;Infection;Inflammation;Inflammatory;inflammatory marker;innate immune pathways;insight;International;International AIDS;Intervention;Knowledge;Laboratories;Length;Libraries;Life;life span;Link;Long-Term Effects;Machine Learning;Macrophage;Marijuana;marijuana use;maternal imprint;Maternally-Acquired Immunity;Measures;men;Messenger RNA;Metabolic;metabolic profile;Metabolism;Methods;Molecular;Molecular Analysis;monocyte;Mothers;multiple omics;National Institute of Allergy and Infectious Disease;National Institute of Child Health and Human Development;Nepal;neuroAIDS;Neurocognition;Neurocognitive;Newborn Infant;novel;older adult;older men;older women;Opportunistic Infections;Oral;Outcome;Outcome Measure;oxidation;Paris, France;Participant;Pathogenesis;Pathway interactions;Pattern;peripheral blood;Persons;Plasma;Policies;Post-Translational Protein Processing;posters;PPAR alpha;Pregnancy;prenatal;Property;prospective;Protein Biosynthesis;Quality of life;random forest;Recreation;Regulation;Research;Research Priority;research study;Research Technics;Resources;response;Retroviridae Infections;Role;Sampling;secondary analysis;Shapes;Signal Pathway;Signal Transduction;Specimen;Structure of germinal center of lymph node;Subgroup;substance use;symposium;targeted treatment;Testing;therapy development;Tobacco;Tobacco use;Transcriptional Regulation;transcriptome;transcriptome sequencing;treatment strategy;Umbilical Cord Blood;United States National Institutes of Health;Up-Regulation;Viral;Viremia;Virus;Virus Diseases;virus host interaction;Washington;Woman;Yin;young man;young woman;Youth",HIV-1 and host interactions at molecular level,1366,NA,NA,NA,NA,2,NA,NA,323196,NA
11189535,ZIA,AI,1,N,NA,NA,NA,NA,ZIAAI001367,NA,NA,1ZIAAI001367-02,NIAID:194408\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,79358358 (contact),"RICOTTA, EMILY  (contact)",NA,NA,NA,"Adopted;Attention;Characteristics;Clinical;clinical decision support;clinical decision-making;clinical epidemiology;Clinical Research;Communicable Diseases;Community Health;Consensus;COVID-19 pandemic;Data;Data Collection;data collection methodology;data management;data mining;Data Sources;design;Development;Disease;disease natural history;Disease Outbreaks;Ebola;Educational workshop;Elements;Epidemic;Epidemiologist;epidemiology study;Ethicists;Ethics;flexibility;Funding;Future;global health;Goals;Health;Immune System Diseases;immunodeficiency;improved;Influenza A Virus, H1N1 Subtype;interest;Intervention;Legal;Libraries;Literature;Medical;Medicine;Methods;Morbidity - disease rate;Nature;novel;Outcome;pandemic preparedness;pandemic response;Policies;Population;Population Study;prevent pandemics;Protocols documentation;Public Health;public health emergency;Publications;Publishing;relative cost;Research;Research Design;response;Risk;Role;SARS coronavirus;Scientist;social;Speed;statistical and machine learning;Time;United States National Institutes of Health;Vaccines;Work;ZIKA",The study and improvement of data collection and management for infectious diseases and immunodeficiencies,1367,NA,NA,NA,NA,2,NA,NA,194408,NA
11189536,ZIA,AI,1,N,NA,NA,NA,NA,ZIAAI001368,NA,NA,1ZIAAI001368-02,NIAID:166632\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,79358358 (contact),"RICOTTA, EMILY  (contact)",NA,NA,NA,Acceleration;Agriculture;Animal Diseases;Animals;Area;Attention;Award;Biodiversity;Catalogs;Climate;climate change;climate-related health;Collaborations;Communicable Diseases;Country;Data;Data Analyses;Data Collection;data management;data sharing;Databases;Detection;Development;Disease;Disease Outbreaks;Disease Surveillance;Emerging Communicable Diseases;Epidemic;epidemic response;Evaluation;Frequencies;Funding;global health;Grant;Health;Health Sciences;Healthcare;Human;human disease;improved;Infection;Information Systems;Investigation;lens;Maps;Modeling;National Institute of Environmental Health Sciences;open data;outbreak concern;outbreak prediction;outbreak response;pandemic preparedness;pandemic response;Pattern;Performance;Personnel Management;Policies;Politics;Postdoctoral Fellow;Preparation;pressure;programs;Proxy;Readiness;Recommendation;Regression Analysis;Reporting;Research;Research Personnel;Research Project Grants;response;Risk;Risk Assessment;Risk Factors;secondary analysis;Security;Time;Training;Travel;Universities;Vector-transmitted infectious disease;weapons;World Bank;Zoonoses,Analysis of data management capacity in regions with high infectious disease spillover risk,1368,NA,NA,NA,NA,2,NA,NA,166632,NA
11189537,ZIA,AI,1,N,NA,NA,NA,NA,ZIAAI001369,NA,NA,1ZIAAI001369-02,NIAID:499896\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,79358388 (contact),"SAFAVI, FARINAZ  (contact)",NA,NA,NA,Address;autoinflammatory;bench to bedside;Biological Assay;Brain;Cells;Cellular Indexing of Transcriptomes and Epitopes by Sequencing;Central Nervous System;Cerebrospinal Fluid;Clinical;clinical center;Clinical Protocols;Collection;Color;congenital immunodeficiency;CRISPR/Cas technology;Defect;Development;Disease;early childhood;Electrophysiology (science);Engineering;Evaluation;Flow Cytometry;Gene Mutation;Genes;glial cell development;Goals;Immune;immune function;Immune System Diseases;Immunity;immunodeficiency;Immunophenotyping;immunoregulation;induced pluripotent stem cell;Induced pluripotent stem cell derived neurons;Infection;Institutional Review Boards;interest;Investigation;Methods;Molecular Biology;Morbidity - disease rate;Morphology;mortality;multiple omics;Mutation;Nervous System;Nervous System Disorder;Neuroglia;neuroinflammation;Neurologic;Neurologic Symptoms;Neurological observations;neuronal survival;Neurons;Neuropathogenesis;Organoids;patient derived induced pluripotent stem cells;Patients;Peripheral Blood Mononuclear Cell;Phenotype;programs;Protocols documentation;rare genetic disorder;recruit;Refractory;Research;Role;Sampling;Serum;single-cell RNA sequencing;Syndrome;System;Techniques;transcriptome;United States National Institutes of Health,Neuropathogenesis of Errors of Immunity,1369,NA,NA,NA,NA,2,NA,NA,499896,NA
11189538,ZIA,AI,1,N,NA,NA,NA,NA,ZIAAI001370,NA,NA,1ZIAAI001370-02,NIAID:2513196\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,11999619 (contact),"HARRIS, AUDRAY  (contact)",NA,NA,NA,"1918 influenza pandemic;3-Dimensional;Address;Adjuvant;Admixture;Affect;Animals;Antibodies;Antigenic Variation;Antigens;Architecture;Area;Attenuated;B-Lymphocytes;Biochemical;Biochemistry;Communicable Diseases;Competence;Complex;Coupled;cross reactivity;design;Development;Electron Microscopy;Epitopes;Evaluation;future pandemic;Goals;Health;Hemagglutinin;Human;Immune response;Immunity;Immunoassay;immunogenic;immunogenicity;Immunologics;Influenza;Influenza A virus;Influenza A Virus, H1N1 Subtype;Influenza A Virus, H7N9 Subtype;Influenza Hemagglutinin;influenza outbreak;influenza virus vaccine;influenzavirus;innovation;Investigation;Membrane Glycoproteins;Mission;Molecular;Molecular Conformation;molecular modeling;mosaic;nanotechnology platform;Nature;neutralizing antibody;pandemic disease;particle;Persons;Pharmaceutical Preparations;Phase;Population;Proteins;Public Health;Recombinants;Research;Seasons;Structure;Subunit Vaccines;Testing;transmission process;United States National Institutes of Health;universal influenza vaccine;vaccine formulation;Vaccine Production;Vaccines;Viral Vaccines;Virus;Virus-like particle;Work;Zoonoses",Development of Broadly Immunogenic and Universal Influenza Virus Vaccines,1370,NA,NA,NA,NA,2,NA,NA,2513196,NA
11189539,ZIA,AI,1,N,NA,NA,NA,NA,ZIAAI001371,NA,NA,1ZIAAI001371-02,NIAID:957836\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,79358391 (contact),"GOUGH, PORTIA  (contact)",NA,NA,NA,"Adhesions;Affect;Anti-Inflammatory Agents;anti-microbial peptide;Antiinflammatory Effect;antimicrobial;Atopic Dermatitis;Bacteria;Binding;Cell Death;Cell Death Induction;Cells;chemokine;Coculture Techniques;commensal bacteria;commensal microbes;CXCL10 gene;cytokine;Data;Data Analyses;Data Set;Detection;Disease;Eczema;Epithelial Cells;Evaluation;Fibroblasts;Goals;Health;Homeostasis;host-microbe interactions;Human;human data;IL18 gene;IL8 gene;Immune signaling;Immunologic Receptors;immunoregulation;In Vitro;in vitro Model;in vivo;Incubated;Infection;Infectious Skin Diseases;Inflammation;Inflammatory;Inflammatory Response;inhibitor;Innate Immune Response;interest;Investigation;IRAK3 gene;keratinocyte;Knockout Mice;Lesion;MAP Kinase Gene;MAPK3 gene;Mediating;Microbe;Modeling;Mucous Membrane;multiple omics;Mus;Natural Immunity;Nature;NF-kappa B;Organism;p38 Mitogen Activated Protein Kinase;pathobiont;pathogen;pathogenic bacteria;pathogenic microbe;Pathogenicity;Physiology;Production;Proteins;Proteobacteria;Proteomics;Receptors, Tumor Necrosis Factor, Type II;Research;response;Roseomonas;Signal Transduction;Site;Skin;Staphylococcus aureus;Systems Biology;Testing;Therapeutic;TLR2 gene;TLR5 gene;TNFRSF1B gene;Variant;Wild Type Mouse",Mechanisms of host-commensal interactions with Roseomonas mucosa that modulate innate immune responses to infection with Staphylococcus aureus and support homeostasis of human skin,1371,NA,NA,NA,NA,2,NA,NA,957836,NA
11189540,ZIA,AI,1,N,NA,NA,NA,NA,ZIAAI001372,NA,NA,1ZIAAI001372-02,NIAID:2885419\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,9413717 (contact),"TAUBENBERGER, JEFFERY  (contact)",NA,NA,NA,"1918 influenza pandemic;Antigenic Variation;Avian Influenza A Virus;B-Lymphocytes;Birds;Cessation of life;Clinical;clinical development;Clinical Research;comparison control;Control Animal;Country;Domestic Fowls;efficacy study;Epidemic;Experimental Animal Model;Family suidae;Ferrets;Goals;Hemagglutinin;Human;human pathogen;immunogenicity;Inactivated Vaccines;Infection;Inflammatory Response;Influenza;Influenza A virus;Influenza A Virus, H3N8 Subtype;Influenza A Virus, H5N1 Subtype;Influenza A Virus, H7N9 Subtype;influenza epidemic;influenza infection;influenza virus vaccine;influenzavirus;Intramuscular;Modeling;Morbidity - disease rate;mortality;Mus;Neuraminidase;new pandemic;novel;novel vaccines;pandemic disease;pandemic virus;Pathogenicity;Persons;Phase;prevent;previous pandemic;Public Health;Pulmonary Pathology;Reporting;Route;Safety;Spanish flu;T-Lymphocyte Epitopes;universal influenza vaccine;universal vaccine;Vaccinated;Vaccination;vaccine candidate;vaccine development;vaccine strategy;Vaccines;Viral;Virus;wild bird;Work",Universal Influenza Vaccine Development,1372,NA,NA,NA,NA,2,NA,NA,2885419,NA
11189541,ZIA,AI,1,N,NA,NA,NA,NA,ZIAAI001374,NA,NA,1ZIAAI001374-02,NIAID:1279747\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,79358394 (contact),"JIN, HAO  (contact)",NA,NA,NA,Ablation;Afferent Neurons;anatomical tracing;Animals;Anti-Inflammatory Agents;Area;Brain;brain control;Brain region;Cells;Cementation;Complex;conditional knockout;cytokine;designer receptors exclusively activated by designer drugs;Dopamine-beta-monooxygenase;Dorsal;Enterobacteria phage P1 Cre recombinase;experimental study;Feedback;Functional Imaging;Ganglia;Genes;Genetic;genetic effector;Genetic Epistasis;Genetic Identity;genetic manipulation;Genetic Recombination;Goals;Gram-Negative Bacteria;imaging platform;Immediate-Early Genes;Immune;immune function;Immune response;Immune signaling;Immune Targeting;Immunity;Immunology;immunoregulation;in vivo;Inflammation;Inflammatory;inflammatory modulation;Inflammatory Response;Innate Immune Response;Label;Link;Mediating;Membrane;Monitor;Mus;Nature;neural;Neuroimmune;neuronal circuitry;Neurons;neuroregulation;Neurosciences;Nodose Ganglion;Nucleus solitarius;Peripheral;Population;Positioning Attribute;Proxy;receptor;Regulation;response;Role;Scanning;Sensory;Signal Transduction;single-cell RNA sequencing;Site;Spleen;Stimulus;Structure of area postrema;System;systemic inflammatory response;Test Result;Testing;Translating;Vagus nerve structure,Elucidating the basis of brain control of innate immune responses,1374,NA,NA,NA,NA,2,NA,NA,1279747,NA
11189542,ZIA,AI,1,N,NA,NA,NA,NA,ZIAAI001375,NA,NA,1ZIAAI001375-02,NIAID:472124\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,79358396 (contact),"ABERS, MICHAEL  (contact)",NA,NA,NA,acquired immunodeficiency;Adrenal Cortex Hormones;Animal Model;Autoantibodies;cell type;Chronic Granulomatous Disease;Clinical;clinically relevant;Communities;Complex;Defect;Environment;experimental study;Exposure to;Flow Cytometry;Generations;Goals;Granulocyte-Macrophage Colony-Stimulating Factor;Hereditary Disease;high dimensionality;Host Defense;Human;human model;Iatrogenesis;Immune;Immunocompromised Host;Immunologics;Immunosuppression;Impairment;improved;in vivo;Individual;Infection;Inhalation;interest;Knowledge;Modeling;mouse model;Nocardia;Nocardia Infections;novel;Outcome;pathogen;Pathogenesis;Patients;Performance;Phagocytosis;Population;Reporter;Research;Site;Stromal Cells;System;Therapeutic Intervention;Time;Tissues,Immunopathogenesis of Nocardia infections,1375,NA,NA,NA,NA,2,NA,NA,472124,NA
11189543,ZIA,AI,1,N,NA,NA,NA,NA,ZIAAI001376,NA,NA,1ZIAAI001376-01,NIAID:111089\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,79973510 (contact),"DELMONTE, OTTAVIA  (contact)",NA,NA,NA,"2019-nCoV;adaptive immune response;Adult;Affect;Age;aggressive therapy;Antibodies;Autoimmune Diseases;Autoimmunity;B cell differentiation;B-Lymphocytes;Caring;causal variant;Cell Compartmentation;Cephalic;Cervical;Cessation of life;Clinical;cohort;Collaborations;congenital immunodeficiency;Consensus;COVID-19 vaccination;COVID-19 vaccine;Critical Care;CTLA4 gene;CTLA4 haploinsufficiency;Cytokine Signaling;Data;Defect;Development;Diagnosis;Differentiation and Growth;disability;Disease;Disease Progression;effectiveness evaluation;Evaluation;Evolution;Facies;FLT3 ligand;FOXP3 gene;France;Generations;Genes;genetic variant;Genomics;Goals;Hematopoietic Stem Cell Transplantation;Hematopoietic stem cells;Hospitalization;Hospitals;Human;Human Herpesvirus 4;humanized mouse;Immune;immune modulating agents;Immune response;Immune System Diseases;Immunity;immunodeficiency;Immunoglobulin G;immunomodulatory therapies;immunopathology;Impairment;Infection;Inflammation;insight;Interferons;Knowledge;Laboratories;Link;Longitudinal Studies;loss of function;Molecular;molecular pathology;Morbidity - disease rate;mouse model;Mutate;Mutation;NF-kappa B;NFKB Signaling Pathway;NFKB2 gene;Non-Malignant;novel;novel therapeutic intervention;Omenn syndrome;Organ;Outcome;Paris, France;Pathogenesis;Patients;Pattern;Pediatric cohort;pharmacologic;Phenotype;pre-clinical;pre-T cell receptor alpha;Predisposition;prevent;primary immune regulatory disorders;primary outcome;Production;Publishing;Quality of life;Registries;Regulatory T-Lymphocyte;Review Literature;Risk;Risk Reduction;Role;Scientist;Secondary Immunization;severe COVID-19;Severities;Signal Pathway;Signal Transduction;skin microbiome;STAT1 gene;STAT3 gain of function;STAT3 gene;Structure;Structure of thymic medulla;Symptoms;Syndrome;T-Cell Receptor;T-cell receptor repertoire;T-Lymphocyte;targeted treatment;Testing;Therapeutic;Thymus Gland;treatment and outcome;United States National Institutes of Health;Variant","Primary Immune Regulatory Disorders (PIRD): Longitudinal Study of Clinical Presentation, Treatment and Outcomes",1376,NA,NA,NA,NA,1,NA,NA,111089,NA
11189544,ZIA,AI,1,N,NA,NA,NA,NA,ZIAAI001377,NA,NA,1ZIAAI001377-01,NIAID:1422509\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,79973512 (contact),"ROCCO, JOSEPH  (contact)",NA,NA,NA,Adult;adverse outcome;Autoimmune Diseases;Biological Markers;CAR T cell therapy;CD22 gene;CD8-Positive T-Lymphocytes;Cell-Mediated Cytolysis;Cessation of life;Child;chimeric antigen receptor T cells;Clinical;Clinical Management;clinical translation;cohort;Collaborations;Complex;Complication;CXCL9 gene;cytopenia;cytotoxicity;Data;Defect;Diagnosis;diagnostic criteria;Disease;effective therapy;Effector Cell;Etiology;familial hemophagocytic lymphohistiocytosis;Fever;follow-up;Functional disorder;Future;gain of function;Genes;Genetic;genetic risk factor;genetic testing;Goals;Hemophagocytic Lymphohistiocytoses;HIV;HIV Infections;Human Herpesvirus 8;IL18 gene;Immune;immune activation;immune reconstitution;Immunophenotyping;improved;Individual;Infant;Infection;Inflammasome;Inflammation;Inflammatory;Inherited;Interferon Type II;Link;longitudinal analysis;longitudinal course;longitudinal design;Longitudinal Studies;Macrophage activation syndrome;Malignant Neoplasms;meetings;Monitor;mortality;Multiple Organ Failure;mycobacterial;Mycobacterium Infections;Myelogenous;Myeloid Cells;Natural Killer Cells;neglect;novel;optimal treatments;Outcome;Pathogenesis;Pathway interactions;patient population;Patients;personalized therapeutic;Persons;Phenotype;Population;Predisposing Factor;Predisposition;Process;Production;profiles in patients;programs;prospective;Prospective cohort;Proteins;Reaction;recruit;Recurrence;Regulatory T-Lymphocyte;Research;Retrospective Studies;Rheumatism;Sampling;Syndrome;systemic juvenile idiopathic arthritis;T-Cell Activation;T-Lymphocyte;Therapeutic Clinical Trial;Therapeutic Intervention;translational research program;Treatment outcome;treatment response;Variant,Pathogenesis of Secondary Hemophagocytic Lymphohistiocytosis,1377,NA,NA,NA,NA,1,NA,NA,1422509,NA
11189545,ZIA,AI,1,N,NA,NA,NA,NA,ZIAAI001378,NA,NA,1ZIAAI001378-01,NIAID:582293\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,77880741 (contact),"KHOURY, PANEEZ  (contact)",NA,NA,NA,Affect;Allergic;Allergic Disease;Area;Artificial Intelligence;biobank;Biological;Blood;Body Fluids;Caring;Clinic;Clinical;clinical care;Code;cohort;Common Data Element;Data;Data Analytics;Diagnostic;Disease;Disease Outcome;disease phenotype;epidemiology study;Goals;Immunologist;Individual;Infrastructure;Institutional Review Boards;Laboratories;Laboratory Personnel;Machine Learning;Outcome;Phenotype;Population;predictive marker;Process;Protocols documentation;repository;Resources;Sampling;Sinus;Source;Specimen;Tissues,Multiple Allergic Diseases REPository (MADREP),1378,NA,NA,NA,NA,1,NA,NA,582293,NA
11189546,ZIA,AI,1,N,NA,NA,NA,NA,ZIAAI001380,NA,NA,1ZIAAI001380-01,NIAID:499896\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,79973515 (contact),"KOZYCKI, CHRISTINA  (contact)",NA,NA,NA,Anhidrosis;Awareness;Caring;Characteristics;Clinical;clinical phenotype;cohort;Collaborations;Diagnosis;Disease;disease natural history;Edema;Enrollment;Genetic Counseling;Goals;Headache;Human Biology;Immune;Immunologics;immunomodulatory therapies;Individual;insight;Mediating;Mendelian disorder;Molecular;Mutation;Natural History;Optic Nerve;Patients;Protocols documentation;Retinal Dystrophy;Role;Sampling;sensor;Splenomegaly;Work,"Study of ROSAH (retinal dystrophy, optic nerve edema, splenomegaly, anhidrosis, and headache) and related diseases",1380,NA,NA,NA,NA,1,NA,NA,499896,NA
11189547,ZIA,AI,1,N,NA,NA,NA,NA,ZIAAI001381,NA,NA,1ZIAAI001381-01,NIAID:1851493\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,79973517 (contact),"MATHIAS, RASIKA  (contact)",NA,NA,NA,Adrenal Cortex Hormones;African;African ancestry;Allergic;Allergic Disease;Allergic rhinitis;Allergy to peanuts;Americas;Asthma;Atopic Dermatitis;atopy;Binding;Biological Products;Child;clinical translation;Communication;Coupled;Data;Development;Disease;disease diagnosis;Disease susceptibility;disorder prevention;DNA Methylation;Early Intervention;efficacious treatment;epidemiology study;Epigenetic Process;Extrinsic asthma;Food Hypersensitivity;Gene Expression;Gene Expression Profile;gene network;Genes;Genetic;Genetic Code;Genetic Predisposition to Disease;Genetic Risk;genetic signature;genome resource;genome-wide;Genomics;Glucocorticoid Receptor;Goals;health disparity;health equity;Healthcare;Hypersensitivity;IgE;Immunity;Impairment;Individual;individualized medicine;Infant;Inflammation;Inhalation;insight;Learning;Libraries;Life Cycle Stages;Mediating;Methylation;Molecular;Molecular Chaperones;Multiomic Data;multiple omics;Names;Nasal Epithelium;Natural History;Nature;Onset of illness;Outcome;Peripheral Blood Mononuclear Cell;Pharmaceutical Preparations;Phenotype;Play;polygenic risk score;Population;Population Dynamics;Precision Health;Preparation;Prevention strategy;Process;Proteomics;Publications;Quality Control;Receptor Signaling;repository;Research;response;Rhinovirus;Risk;risk prediction;RNA Sequence Analysis;Role;Sampling;Severities;Severity of illness;Systems Biology;Tissues;trait;transcriptome sequencing;transcriptomics;Underrepresented Populations;Variant;wound healing,Integrative-omics and Systems Biology across the atopic march,1381,NA,NA,NA,NA,1,NA,NA,1851493,NA
11189548,ZIA,AI,1,N,NA,NA,NA,NA,ZIAAI001382,NA,NA,1ZIAAI001382-01,NIAID:553044\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,79973517 (contact),"MATHIAS, RASIKA  (contact)",NA,NA,NA,Address;Age;Aging;aging related disease;All of Us Research Program;Alzheimer&apos;s Disease;Area;Asthma;Attention;BCL10 gene;biological age;Biological Aging;Biological Markers;Brain;brain tissue;burden of illness;Chronology;clinical implementation;clinical phenotype;clinical translation;cohort;Collaborations;Communities;Complex;dashboard;Data;Data Set;Development;Disease;disease diagnosis;disorder prevention;DNA copy number;Early Intervention;efficacious treatment;Environment;Epigenetic Process;Equity;exome;Female;follow-up;frailty;Gender;Genes;Genetic;Genetic Code;genetic variant;Genetic Variation;Genome;genome sequencing;genome wide association study;Genomics;Germ Lines;Goals;Health;health disparity;Healthcare;Heart Diseases;Hematological Disease;Hematopoiesis;high risk;Human;Human Genome;Human Genome Diversity Project;human genome sequencing;human population genetics;Individual;Inherited;Lead;Length;Literature;Lung Diseases;Measures;Metadata;Methods;Methylation;Minority Groups;Mission;Mitochondrial DNA;Mosaicism;Mucosa- associated lymphoid tissue lymphoma translocation protein-1;National Institute of Allergy and Infectious Disease;Outcome;Participant;Pathologic;Pharmaceutical Preparations;Phenotype;polygenic risk score;Population;Precision Health;Prevention strategy;programs;Protocols documentation;Publications;recruit;Research;research study;Resources;response;Risk;Risk Factors;risk prediction;Role;Science;Severity of illness;Signal Transduction;Sleep Disorders;stem;Study Subject;telomere;tool;training opportunity;Trans-Omics for Precision Medicine;Underrepresented Minority;Update;Variant;whole genome;Work,Genomic underpinnings of human health and disease in the context of health disparities,1382,NA,NA,NA,NA,1,NA,NA,553044,NA
11189549,ZIA,AI,1,N,NA,NA,NA,NA,ZIAAI001383,NA,NA,1ZIAAI001383-01,NIAID:895330\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,15222261 (contact),"MARCOTRIGIANO, JOSEPH  (contact)",NA,NA,NA,Apolipoprotein A-I;Apolipoproteins;Cells;Cholesterol Esters;density;Family;Flaviviridae;Hepatitis C virus;Hepatocyte;High Density Lipoproteins;human disease;Lipoproteins;Low Density Lipoprotein Receptor;Low-Density Lipoproteins;Mediating;member;Proteins;receptor;Role;SR-BI receptor;Very low density lipoprotein;Viral;Virion;Virus,The role of apolipoproteins in viral entry and human disease,1383,NA,NA,NA,NA,1,NA,NA,895330,NA
11189550,ZIA,AI,1,N,NA,NA,NA,NA,ZIAAI001384,NA,NA,1ZIAAI001384-01,NIAID:750935\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,15222264 (contact),"HAIGH, CATHRYN  (contact)",NA,NA,NA,Activities of Daily Living;Acute;Address;Affect;Aftercare;Animal Model;Biological Sciences;Borrelia;Brain;Cardiac;Cell membrane;Cell Physiology;Cells;Central Nervous System;Cephalic;Cerebrum;Chromium;Chronic;Disease;Distress;Down-Regulation;Encephalitis;Encephalopathies;Environment;Equipment;erythema migrans;Europe;Exanthema;experience;Fatigue;Fever;fluorescence imaging;fluorescence microscope;Genes;Genus Hippocampus;Glucose;Headache;Human;human induced pluripotent stem cells;human model;human stem cells;imaging system;Immune;Immunofluorescence Immunologic;Impairment;in vivo;Incubated;Individual;Infection;insight;Lyme Disease;Lyme Infection;Lyme Neuroborreliosis;Meningitis;Methods;Microscopy;Mitochondria;Modeling;Morphology;Neuritis;Neurologic;Neurologic Symptoms;neuron loss;Neurons;North America;Order Spirochaetales;Organoids;Pathway interactions;Patients;Penetration;Persons;Primates;Prosencephalon;Proteins;radiculoneuritis;RANTES;Reader;Research;RNA;Scanning Electron Microscopy;Site;Skin;Spinal Cord;stem cell model;Stress;stressor;System;Techniques;tick bite;Tick-Borne Diseases;Tissues,Neuroborreliosis in human neuronal and brain models.,1384,NA,NA,NA,NA,1,NA,NA,750935,NA
11189551,ZIA,AI,1,N,NA,NA,NA,NA,ZIAAI001385,NA,NA,1ZIAAI001385-01,NIAID:1821885\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,79973522 (contact),"IVANOVIC, TIJANA  (contact)",NA,NA,NA,Anti-viral Agents;Antibodies;Cells;Complement;Development;Environment;Evolution;genetic selection;Genetic Variation;Immune system;Infection;insight;Integration Host Factors;Methods;Mutation;next generation;novel;Pathway interactions;Phenotype;pressure;Probability;Productivity;programs;Publishing;Regulation;Research;Shapes;Technology;Viral;Virion;Virus;Virus Assembly;virus host interaction,Phenotypic diversity in viral evolution,1385,NA,NA,NA,NA,1,NA,NA,1821885,NA
11189552,ZIA,AI,1,N,NA,NA,NA,NA,ZIAAI001386,NA,NA,1ZIAAI001386-01,NIAID:1842672\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,79973524 (contact),"OYESOLA, OYEBOLA  (contact)",NA,NA,NA,Antigens;Automobile Driving;burden of illness;Cells;Color;design;Development;Environment;environmental change;Environmental Risk Factor;experimental study;Exposure to;Flow Cytometry;Genetic;helminth infection;Helminths;Heritability;Host resistance;Immune;Immune response;Immune system;Immunologics;improved;Inbred Strains Mice;Individual;individual response;Infection;Inflammatory;Injury;Intervention;Mediator;Modeling;mouse model;Outcome;Parasitic infection;Play;Predisposition;programs;prophylactic;Recording of previous events;Research;response;Role;Shapes;Stimulus;Therapeutic;Thromboplastin;Tissues;Variant;Viral Respiratory Tract Infection;Virus Diseases,Investigating reprogramming of the immune system by parasitic helminths and environmental antigens,1386,NA,NA,NA,NA,1,NA,NA,1842672,NA
11189553,ZIA,AI,1,N,NA,NA,NA,NA,ZIAAI001387,NA,NA,1ZIAAI001387-01,NIAID:41866\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,79973526 (contact),"SEAMAN, WILLIAM  (contact)",NA,NA,NA,2019-nCoV;Acquired Immunodeficiency Syndrome;Adult;Affect;Amylases;Automobile Driving;Bacteria;Biological Assay;BK Virus;Cell Physiology;Cells;chronic inflammatory disease;cross reactivity;Development;Disease;DNA Tumor Viruses;Elements;Epigenetic Process;Epithelial Cells;Epithelium;Etiology;expression vector;Fractionation;Functional disorder;G-Protein-Coupled Receptors;gammaherpesvirus;Gene Expression;Goals;Head and Neck Cancer;HIV;HIV-1;Human;Human Herpesvirus 4;Human papilloma virus infection;Human Papillomavirus;Human papillomavirus 16;Immunoblot Analysis;Immunofluorescence Immunologic;Immunoglobulin M;Immunosuppression;in vivo;Infection;Inflammation;insight;keratinocyte;Lesion;Lymphoid;Lymphoid Cell;Lytic;Malignant Neoplasms;Mediating;microbial;MicroRNAs;mimicry;Modification;Molecular Mimicry;Monitor;Mouth Diseases;Mucous Membrane;Nuclear Export;Nucleoproteins;Oncogenic;Oncogenic Viruses;Oral;Oral cavity;oral cavity epithelium;oral HPV;oral HPV-positive head and neck cancers;oral infection;oral pathogen;Oral Pathology;Oropharyngeal;Papillomavirus;particle;pathogen;Pathogenesis;pathogenic bacteria;Pathway interactions;Patients;Periodontitis;periodontopathogen;permissiveness;Persons;pharmacologic;Phase;Phenotype;Play;prevent;Production;promoter;Protein Secretion;Proteins;Reagent;response;RNA Stability;Role;Saliva;Salivary Gland Diseases;Salivary Glands;SARS-CoV-2 transmission;Severities;Signal Pathway;Sjogren&apos;s Syndrome;Sodium Butyrate;Symptoms;targeted treatment;Telomerase;transcriptome sequencing;transmission process;tumorigenesis;United States;Viral;Viral Genes;Viral Genome;Viral Load result;Viral Pathogenesis;viral transmission;Virus;Virus Diseases;Western Blotting,Viral Oral Infections in Immunosuppression and Cancer Section,1387,NA,NA,NA,NA,1,NA,NA,41866,NA
11189554,ZIA,AI,1,N,NA,NA,NA,NA,ZIAAI001388,NA,NA,1ZIAAI001388-01,NIAID:617358\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,79973528 (contact),"MCCAFFREY, ERIN  (contact)",NA,NA,NA,3-Dimensional;adaptive immunity;Algorithms;Antibodies;antimicrobial;Bacteria;Barbering;Benchmarking;biobank;Biological Assay;Biological Models;Blood Banks;Cells;Clinical;cohort;Collaborations;Collagen;Communicable Diseases;Containment;COVID-19;Cytokine Signaling;Data;data analysis pipeline;Data Set;Disease;Doctor of Philosophy;effective therapy;Environment;Goals;Granuloma;high dimensionality;HIV;Human;human imaging;human model;Humanities;Hypoxia;Image;imaging approach;imaging platform;imaging program;Imaging Techniques;Immune;Immune Evasion;Immune response;Immunity;Immunologics;Immunology;In Situ;In Vitro;Individual;Infection;Inflammation;Investigation;Label;Laboratories;Link;Lung;Lymph Node Tuberculosis;lymph nodes;Macaca fascicularis;Macaca mulatta;Macrophage;Maps;Metabolic Pathway;Metabolism;microbial;Modeling;mouse model;multi-scale imaging data;Multiplexed Ion Beam Imaging;Mus;Mycobacterium tuberculosis;National Institute of Allergy and Infectious Disease;nonhuman primate;Organoids;Outcome;Parasitic Diseases;pathogen;Pathogenesis;Pathology;Pathway interactions;peripheral blood;Peripheral Blood Mononuclear Cell;permissiveness;Pimonidazole;Postdoctoral Fellow;prevent;Proteins;Proteome;Protocols documentation;Publishing;Regimen;Reporter;Reporting;Research;response;Sarcoidosis;single-cell RNA sequencing;Site;small molecule;Specimen;Structure;System;Technology;Therapeutic;Time;tissue mapping;Tissues;Training;transcriptome;transcriptomics;Treatment Protocols;Tuberculosis;tuberculosis granuloma;tuberculosis treatment;tumor;United States National Institutes of Health;Universities;Vaccines;Visualization;Work,Spatially mapping and modeling tuberculosis granulomas to define the immunological determinants of infection outcome,1388,NA,NA,NA,NA,1,NA,NA,617358,NA
11189555,ZIA,ES,1,N,NA,NA,NA,NA,ZIAES103367,NA,NA,1ZIAES103367-04,NIEHS:144446\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES,NA,NA,NA,7136495 (contact),"GERMOLEC, DORI R (contact)",NA,NA,NA,2019-nCoV;adaptive immune response;Address;Adoption;adverse outcome;Affect;Age;Animals;Anosmia;Antibodies;authority;Awareness;Biological;Biological Assay;Biological Models;Biology;Blood;California;Cell Culture Techniques;Cell Physiology;Cell-Mediated Cytolysis;Cells;chemokine;Clinical;Clinical Data;clinical database;Communicable Diseases;Complex;COVID-19;COVID-19 pathogenesis;COVID-19 patient;COVID-19 susceptibility;COVID-19 therapeutics;COVID-19 treatment;cytokine;cytotoxicity;Data;Database Management Systems;Databases;demographics;design;Development;Discipline;Disease;Disease Progression;Educational workshop;Ensure;Environment;Environmental Exposure;Environmental Impact;Environmental Risk Factor;epidemic potential;Ethnic Origin;Evaluation;Event;exposed human population;Funding;Future;Gender;Government;Human;human tissue;Immune;immune function;Immune response;In Vitro;in vitro Assay;in vitro testing;in vivo;Individual;induced pluripotent stem cell;Inflammatory;Influenza;Informatics;Innate Immune Response;International;Knowledge;Laboratories;Link;Literature;Maps;member;microphysiology system;Modeling;Multiple Organ Failure;National Institute of Allergy and Infectious Disease;Natural Killer Cells;network models;novel therapeutics;Outcome;Paper;Pathogenesis;Pathway interactions;Performance;Phase;Population;pre-clinical;Predisposition;Production;programs;prospective;Protocols documentation;Public Health;Publications;Publishing;Readiness;Recording of previous events;repository;Reproductive Health;Research;Research Personnel;respiratory;Respiratory distress;response;Risk;safety assessment;San Francisco;Scientist;Series;Site;Source;Standardization;statistics;Stream;System;systematic review;T-Lymphocyte;Technology;technology platform;Tissue Microarray;Toxicology;Translating;Universities;uptake;validation studies;Viral;Viral Antigens;Viral Respiratory Tract Infection;virtual;Virus;Virus Diseases;webinar;Whole Blood;Work;working group,Research Initiatives on COVID-19 in the Division of Translational Toxicology,103367,NA,NA,NA,NA,4,NA,NA,144446,NA
11189556,ZIA,ES,1,N,NA,NA,NA,NA,ZIAES103369,NA,NA,1ZIAES103369-04,NIEHS:677093\OD:749992\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES,NA,NA,NA,78333796 (contact),"SANTOS, JANINE  (contact)",NA,NA,NA,1 year old;abacavir;Acceleration;Acquired Immunodeficiency Syndrome;Address;Adult;Adult Children;Adverse drug effect;Adverse effects;Age Months;age related;aged;Aging;Anatomy;Animal Experimentation;animal old age;Animals;antiretroviral therapy;Area;Astrocytes;Axon;behavior test;Behavioral;Biochemical;biological adaptation to stress;Body System;Body Weight;Bone Growth;Brain region;Carbon;Cardiac Myocytes;Cardiovascular system;Cell Culture Techniques;Cells;Child;Chronic;Clinical;cognitive function;cohort;Combination Drug Therapy;Combined Modality Therapy;Complex;Data;Development;Developmental Gene;Disease;Drug Exposure;Echocardiography;Electrocardiogram;Electrophysiology (science);Environment;Evaluation;evidence base;Experimental Animal Model;experimental study;Exposure to;fatty acid metabolism;Fatty Acids;Female;fetal;Fetus;food consumption;Fright;Funding;Future;Gene Expression;Gene Expression Profile;Generations;Genetic Transcription;Genomics;Glucose;Glutamates;Guidelines;Health;Heart;heart function;Histopathology;HIV;HIV Infections;HIV/AIDS;Human;human induced pluripotent stem cells;Immune response;improved;In Vitro;indexing;Infection;Inflammaging;interest;Kinetics;Laboratory Animals;Lactation;Lamivudine;late life;Left atrial structure;Left ventricular structure;Life;life span;lipid metabolism;Lipids;Lipopolysaccharides;Long-Term Effects;Macrophage;Maintenance;male;Mass Spectrum Analysis;Maternal Health;maternal risk;Measures;Medicine;Metabolism;Microglia;Mitochondria;Modeling;Morphology;Motor;Myocardial dysfunction;Nervous System;neural network;Neuroimmune;Neurologic;Neurotransmitters;Nucleotides;offspring;older patient;Outcome;Patients;Pattern;pediatric patients;Perinatal Exposure;Pharmaceutical Preparations;pharmacologic;postnatal;Postpartum Period;Pregnancy;pregnant;Pregnant Women;prenatal exposure;Process;Productivity;programs;pup;Rattus;Regimen;Reproduction;reproductive;Research;response;Reverse Transcriptase Inhibitors;Risk;risk minimization;Rodent;Rodent Model;Role;Severity of illness;Sex Differences;side effect;synaptogenesis;System;Therapeutic;Therapeutic Effect;Therapeutic Intervention;Tissues;Toxic effect;Toxicology;transcriptome sequencing;Viral Load result;Viral Proteins;Virus;Virus Replication;Vulnerable Populations;Weaning;Weight Gain;Work;Yolk Sac;young adult,Research Initiatives on AIDS and HIV in the Division of Translational Toxicology,103369,NA,NA,NA,NA,4,NA,NA,1427085,NA
11189557,ZIA,ES,1,N,NA,NA,NA,NA,ZIAES103373,NA,NA,1ZIAES103373-03,NIEHS:1372236\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES,NA,NA,NA,78846326 (contact),"RIDER, CYNTHIA  (contact)",NA,NA,NA,Address;adverse outcome;Animals;Area;Aromatic Polycyclic Hydrocarbons;Biological Assay;Botanicals;carcinogenicity;Carcinogens;Cells;Chemical Actions;Chemicals;Collaborations;Communities;Community of Practice;Complex;Complex Mixtures;Data;Data Analyses;Decision Making;dietary supplements;Dose;Drug Kinetics;Environmental Exposure;Evaluation;Exposure to;Foundations;Fractionation;Future;Garcinia cambogia;Goals;hazard;Human;in silico;In Vitro;Individual;Joints;Learning;Methods;Modeling;National Center for Advancing Translational Sciences;Pathway interactions;Poly-fluoroalkyl substances;predictive modeling;programs;Public Health;public-private partnership;Reporting;Research;response;Risk;Risk Assessment;Safety;Sampling;Serum;Smoke;stressor;Structure;superfund site;Systems Biology;Testing;tool;Toxic effect;Toxicology;Translating;Uncertainty;Valerian;Wildfire;wood smoke;Work,Combined Exposures and Mixtures Research Program,103373,NA,NA,NA,NA,3,NA,NA,1372236,NA
11189558,ZIA,ES,1,N,NA,NA,NA,NA,ZIAES103374,NA,NA,1ZIAES103374-03,NIEHS:1877797\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES,NA,NA,NA,78847063 (contact),"RYAN, KRISTEN  (contact)",NA,NA,NA,Acute;Address;Aerosols;Affect;Agreement;Air;Amphiboles;Asbestosis;Asthma;Body System;Cancer Etiology;Cessation of life;Chronic;Data;Decision Making;Dermal;design;Development;Disease;Dose;double walled carbon nanotube;Ensure;Environment;Evaluation;exposed human population;exposure route;Exposure to;Fibrosis;Future;Gasoline;General Population;Goals;graphene;Guidelines;hazard;Health;health assessment;Health Hazards;Histopathology;Human;Hypersensitivity;In Vitro;in vitro Model;in vivo;in vivo monitoring;Industry;Inhalation;Inhalation Exposure;Inhalation Toxicology;innovation;International;interstitial;Link;Liquid substance;Lung;Lung Diseases;Malignant neoplasm of lung;Manuscripts;method development;microphysiology system;Mineral Fibers;Modeling;Monoterpenes;Mus;Nail plate;National Institute for Occupational Safety and Health;National Institute of Environmental Health Sciences;novel;Occupational;Occupational Diseases;Occupational Exposure;Organ;Physiologic Monitoring;Pleural Diseases;Poison;Poly-fluoroalkyl substances;Process;programs;Protocols documentation;Publications;Published Comment;Radiation;Rattus;Reporting;Research;Respiratory Disease;Respiratory System;response;Risk;Route;Science;Silicosis;Stachybotrys;symposium;System;Techniques;technology development;Tissues;tool;Toxic effect;Toxicology;Trust;Validation;volatile organic compound;Work;Workplace,Occupational and Inhalation Exposures Research Program,103374,NA,NA,NA,NA,3,NA,NA,1877797,NA
11189559,ZIA,ES,1,N,NA,NA,NA,NA,ZIAES103375,NA,NA,1ZIAES103375-03,NIEHS:1227790\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES,NA,NA,NA,79973534 (contact),"BLYSTONE, CHAD  (contact)",NA,NA,NA,Acute;Address;Adult;Affect;Agreement;Boron;carcinogenicity;Case Study;chemical release;Chemicals;Child;Chronic;Clothing;Collaborations;Color;Communities;Community of Practice;Data;Development;developmental toxicity;Disasters;Disease;drinking water;Dyes;Educational workshop;Emergency Situation;Engineering;Environment;Evaluation;expectation;exposed human population;Exposure to;food consumption;Genetic;genomic signature;genotoxicity;Goals;Half-Life;hazard;Health;health assessment;Health Hazards;Heavy Metals;Human;Immune;immunotoxicity;improved;Infant;Integrative Medicine;interest;Knowledge;Lead;Legal;Link;Malignant Neoplasms;Manuscripts;marginalized community;Medicine;meetings;member;Metabolism;Methods;Mission;mortality;Mothers;Mus;nano;Ohio;Oncorhynchus kisutch;Oral;Outcome;Peer Review;Perinatal;Perinatal Exposure;persistent organic pollutants;Phenylenediamines;Pilot Projects;Plasma;Politics;Population;Predisposition;Program Research Project Grants;Program Reviews;programs;Public Health;public health research;Publications;Published Comment;Rain;Rattus;Reporting;reproductive toxicity;Research;Resources;response;Rewards;Risk;Risk Assessment;Scanning;Science;Series;Source;success;Summary Reports;systematic review;Thallium;Time;tool;Toxic effect;Toxicology;Training;Umbilical Cord Blood;United States National Academy of Sciences;United States National Institutes of Health;Validation;Water consumption;Water Pollutants;Work;working group,Emerging Contaminants and Issues of Concern Research Program,103375,NA,NA,NA,NA,3,NA,NA,1227790,NA
11189560,ZIA,ES,1,N,NA,NA,NA,NA,ZIAES103379,NA,NA,1ZIAES103379-03,NIEHS:2275023\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES,NA,NA,NA,79330085 (contact),"TAYLOR, KYLA  (contact)",NA,NA,NA,Address;Adopted;Adult;Case Study;Categories;chemical group;Chemicals;cheminformatics;Classification;Combined Modality Therapy;Communication;consumer product;Country;Data;Decision Making;Development;Disease;Educational workshop;effectiveness evaluation;Evaluation;evidence base;Exposure to;Fetal Growth;Fetal Growth Retardation;Fire - disasters;Flame Retardants;Goals;Grouping;halogenation;hazard;Hazard Assessment;Health;Health Hazards;HIV;Human;Information Dissemination;interest;Investigation;late life;Life;Literature;Malignant Neoplasms;Maps;meetings;Methodology;Methods;National Institute for Occupational Safety and Health;Nongovernmental Organizations;novel;novel strategies;Participant;Patients;personal care products;Persons;Pregnancy;programs;Property;pubertal timing;Puberty;Public Health;Publications;Research;Risk;Risk Assessment;side effect;Targeted Research;Therapeutic;Therapeutic Effect;Therapeutic Research;tool;Toxic effect;Toxicity Tests;Toxicology;United States Environmental Protection Agency;United States National Institutes of Health,Consumer Products and Therapeutics Research Program,103379,NA,NA,NA,NA,3,NA,NA,2275023,NA
11189561,ZIA,ES,1,N,NA,NA,NA,NA,ZIAES103381,NA,NA,1ZIAES103381-03,NIEHS:1588905\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES,NA,NA,NA,78847067 (contact),"FERGUSON, STEPHEN  (contact)",NA,NA,NA,Address;aqueous;aspirate;bioaccumulation;Chemicals;Chemistry;Collaborations;Communication;community engagement;Companions;Complex;Complex Mixtures;Data;data streams;Department of Defense;design;Development;Educational workshop;Environmental Exposure;Environmental Health;Film;Fostering;Generations;Goals;Half-Life;Health;Hepatocyte;Human;In Vitro;in vivo;Individual;innovation;Interagency Coordinating Committee on the Validation of Alternative Methods;Kidney;Liver;Manuscripts;Maps;meetings;microphysiology system;Modeling;next generation;Oral;Poly-fluoroalkyl substances;Positioning Attribute;programs;prospective;public-private partnership;Publications;Qualifying;Research;Research Design;Risk Assessment;Safety;Sampling;Science;screening;Series;Structure;System;Technology;Testing;Time;Tissue Microarray;Tissue Model;tool;tool development;Toxic effect;Toxicology;Work;working group,Safe and Sustainable Alternatives Research Program,103381,NA,NA,NA,NA,3,NA,NA,1588905,NA
11189562,ZIC,AI,1,N,NA,NA,NA,NA,ZICAI001051,NA,NA,1ZICAI001051-17,NIAID:16477283\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,78347461 (contact),"CHERRY, JAMES  (contact)",NA,NA,NA,"3-Dimensional;Address;animation;Antibodies;Area;artificial intelligence model;Ascites;assay development;ATAC-seq;Biochemical;Bioinformatics;Biological;Biological Assay;Biometry;biophysical analysis;Biophysics;Biotechnology;biotypes;Cell Separation;Cells;Chemicals;Chemistry;ChIP-seq;Collaborations;Collection;Color;Communicable Diseases;Communication;Communities;Complex;complex data;Computational Biology;Computational Science;Computer software;Computers;Confocal Microscopy;Consultations;cost;Coupling;Cryoelectron Microscopy;Custom;Cytometry;Data;Data Analyses;Data Collection;Data Display;data integration;Data Science;data science resource;Dedications;design;detection method;Development;Discipline;DNA;DNA sequencing;Educational process of instructing;Educational workshop;Electron Microscopy;Electrons;Environment;Equipment;experience;experimental analysis;Experimental Designs;experimental study;Explosion;Extramural Activities;Flow Cytometry;Fluorescence;Fluorochrome;Genetic;genome-wide;Genomics;Goals;High-Throughput Nucleotide Sequencing;Hybridomas;Image;Image Analysis;Image Cytometry;image processing;image visualization;Imaging technology;Immune Sera;Immunology;Industry;Infrastructure;innovation;instrument;instrumentation;interest;Interferometry;Internet;Intramural Research;Intramural Research Program;intravital imaging;Investigation;Kinetics;Label;Lasers;Licensing;Light;Light Cell;light microscopy;Link;lipidomics;Machine Learning;macromolecule;Manuscripts;Maryland;Mass Spectrum Analysis;metabolomics;method development;Methods;Microscope;Microscopy;Mission;models and simulation;molecular modeling;Montana;multi-photon;multiple omics;National Heart, Lung, and Blood Institute;National Institute of Allergy and Infectious Disease;National Institute of Arthritis, and Musculoskeletal, and Skin Diseases;National Institute of Diabetes and Digestive and Kidney Diseases;new technology;next generation sequencing;operation;Optics;outreach;Pamphlets;posters;Preparation;Printing;programs;Protein Chemistry;protein folding;Proteins;proteogenomics;Proteomics;Protocols documentation;Publications;reconstruction;Regimen;Research;Research Activity;Research Personnel;Reservations;Resources;Rest;RNA;Roentgen Rays;Running;Sampling;Science;Scientist;Services;Site;Sorting;Speed;Statistical Data Interpretation;structural biology;Structure;System;Techniques;Technology;technology development;Testing;three-dimensional modeling;Time;Training;Training and Education;transcriptome sequencing;Transportation;United States National Institutes of Health;web interface;web site;Work",Infectious Diseases Collaborative Technological Research Resources - Bethesda,1051,NA,NA,NA,NA,17,NA,NA,16477283,NA
11189563,ZIC,AI,1,N,NA,NA,NA,NA,ZICAI001052,NA,NA,1ZICAI001052-17,NIAID:18580765\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,78347461 (contact),"CHERRY, JAMES  (contact)",NA,NA,NA,3-Dimensional;Address;animation;Antibodies;Antigens;Area;Arts;Ascites;ATAC-seq;Bacteria;Bioinformatics;Biological;Biological Assay;Biotechnology;Cell Separation;Cells;Chemicals;ChIP-seq;Collaborations;Color;Communicable Diseases;Communication;Communities;Complex;Computational Biology;Computers;Confocal Microscopy;Consultations;Contracts;cost;Coupling;Cryoelectron Microscopy;cryogenics;Custom;Data;Data Analyses;Data Collection;data management;Dedications;design;Development;digital;digital technology;Discipline;DNA;DNA sequencing;Educational process of instructing;Electron Microscopy;Electrons;Environment;Equipment;experience;experimental analysis;Experimental Designs;experimental study;Explosion;Extramural Activities;Flow Cytometry;Fluorochrome;Freezing;Genetic;genome-wide;Genomics;Goals;High-Throughput Nucleotide Sequencing;Human;Human Resources;Hybridomas;Image;imaging informatics;Imaging technology;Immune;Immune Sera;Immunology;improved;Industry;innovation;instrumentation;interest;Internet;Internships;Intramural Research;Intramural Research Program;Investigation;Ions;Label;Laboratories;Lasers;Light;light microscopy;Lighting;Link;Machine Learning;Macromolecular Complexes;Maryland;Medical;meetings;method development;Methods;Microscope;Microscopy;Mission;Montana;National Institute of Allergy and Infectious Disease;new technology;next generation sequencing;operation;Optics;outreach;Pamphlets;Parasites;pathogen;Photography;Preparation;preservation;Proteins;proteogenomics;Proteomics;Protocols documentation;Research;Research Personnel;Reservations;Resolution;Resources;Rest;RNA;Running;Sampling;Scanning Electron Microscopy;Scientist;Services;Site;Sorting;Specimen;Speed;Statistical Data Interpretation;Structure;superresolution microscopy;System;Techniques;Technology;technology development;technology/technique;Testing;Three-dimensional analysis;three-dimensional visualization;Time;Training;Training and Education;transcriptome sequencing;Transportation;United States National Institutes of Health;Virus;Visual;Visualization;web interface;web site;Work,Infectious Diseases Collaborative Technological Research Resources- RML,1052,NA,NA,NA,NA,17,NA,NA,18580765,NA
11189564,ZIC,AI,1,N,NA,NA,NA,NA,ZICAI001226,NA,NA,1ZICAI001226-07,NIAID:3604228\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,78347461 (contact),"CHERRY, JAMES  (contact)",NA,NA,NA,2019-nCoV;Biological;Biological Assay;Categories;Cells;Cellular Indexing of Transcriptomes and Epitopes by Sequencing;clinical application;Clinical Research;Collaborations;Computer Analysis;computer framework;Computer Models;Data;data management;data mining;data modeling;Data Set;Development;Ensure;Experimental Designs;experimental study;falls;Flow Cytometry;Goals;high dimensionality;Human;Immune;Immunologic Monitoring;Immunologics;Immunology;Immunotherapy;Infection;insight;Intervention;Leadership;Mission;Molecular;Monitor;Outcome;Phase;Procedures;Proteomics;Reporting;Research;Research Design;Research Personnel;Resources;sample collection;System;Technology;technology development;transcriptomics;Translational Research;United States National Institutes of Health;Vaccination;web site;Work,Center for Human Immunology,1226,NA,NA,NA,NA,7,NA,NA,3604228,NA
11189565,ZIC,AI,1,N,NA,NA,NA,NA,ZICAI001233,NA,NA,1ZICAI001233-07,NIAID:2436832\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,11597559 (contact),"LIONAKIS, MICHAIL  (contact)",NA,NA,NA,Affect;animal facility;Antibiotics;Autoimmune Diseases;Cardiovascular Physiology;Cells;Chronic;Circadian Rhythms;Clinical;clinical center;Collaborations;Country;design;Diet;Disease;Equipment;facility renovation;Genes;Gnotobiotic;gut microbiota;Health;Hematopoietic;Homeostasis;Human;Hypersensitivity;Immunologics;Income;Infection;Inflammation;Inflammatory;Insect Vectors;Institution;International;Lung;lung microbiota;Macaca;Maintenance;Metabolic;Metabolism;metabolome;metagenome;microbial;Microbiology;microbiome;microbiome research;microbiome sequencing;microbiota;Mission;multi-drug resistant pathogen;Mus;National Institute of Allergy and Infectious Disease;neoplastic;Nervous System Physiology;Neurologic;novel;Parasitic infection;pathogen;pathogenic microbe;Pathology;Physiology;Play;Prevention;programs;Research;Research Personnel;Research Support;resilience;Role;Sampling;Scientist;sequencing platform;Severities;Site;Skin;skin microbiota;Structure;Tissues;Vaccines;Work,NIAID Microbiome Program,1233,NA,NA,NA,NA,7,NA,NA,2436832,NA
11189566,ZIC,AI,1,N,NA,NA,NA,NA,ZICAI001321,NA,NA,1ZICAI001321-05,NIAID:625921\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,79973542 (contact),"ARORA, GUNJAN  (contact)",NA,NA,NA,2019-nCoV;Animal Model;Animals;Anosmia;Anti-viral Agents;Benign;betacoronavirus;Biology;Birds;Camels;Case Fatality Rates;Cellular biology;Cessation of life;Child;China;Chiroptera;Circulation;Cities;Clinical;Clinical Research;Common Cold;Containment;Core Facility;Coronavirus;Coughing;Country;COVID-19;COVID-19 pandemic;COVID-19 patient;Development;Diarrhea;Disease;Disease Outbreaks;Elderly;Environment;Evolution;experimental study;Family;Fatigue;Fever;Genome;Goals;Headache;Hospitalization;Human;Immunocompromised Host;Individual;Infection;Intramural Research;Intramural Research Program;Intubation;Link;Mammals;Middle East Respiratory Syndrome Coronavirus;Molecular Biology;Monoclonal Antibodies;Morbidity - disease rate;mortality;Myalgia;Names;National Institute of Allergy and Infectious Disease;Nausea;new pandemic;novel coronavirus;Patients;Persons;Pneumonia;Population;Province;Public Health;Research;Research Personnel;respiratory;Respiratory Disease;response;RNA;Sampling;SARS coronavirus;SARS-CoV-2 immunity;SARS-CoV-2 pathogenesis;seasonal coronavirus;Severe Acute Respiratory Syndrome;Shortness of Breath;Sore Throat;Source;Stress;Symptoms;Taste Perception;Training;translational study;transmission process;United States National Institutes of Health;Vaccination;Vaccines;Variant;virology;Virus;Viverridae;Vomiting;Zoonoses,SARS-CoV-2 Virology Core,1321,NA,NA,NA,NA,5,NA,NA,625921,NA
11189567,ZIC,ES,1,N,NA,NA,NA,NA,ZICES103377,NA,NA,1ZICES103377-03,NIEHS:4369489\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES,NA,NA,NA,7388969 (contact),"WALKER, NIGEL J (contact)",NA,NA,NA,Adverse effects;Area;Aromatic Hydrocarbons;Aromatic Polycyclic Hydrocarbons;biological systems;Botanical dietary supplements;carcinogenicity;Carcinogens;Cardiovascular system;Chemicals;Cimicifuga racemosa;Collaborations;Communication;Congresses;Data;data management;Database Management Systems;Development;disorder prevention;Economics;Evaluation;exposed human population;Exposure to;Flame Retardants;Fluorides;genotoxicity;Goals;halogenation;hazard;Hazard Assessment;Hazardous Substances;Health;Health Policy;Human;Immune system;in vitro Model;in vivo;interactive tool;Journals;Knowledge;Literature;Malignant Neoplasms;Mission;Monograph;nanomaterials;National Institute for Occupational Safety and Health;National Institute of Environmental Health Sciences;National Toxicology Program;Nervous System;operation;Peer Review;Persons;phthalates;Poly-fluoroalkyl substances;Preparation;programs;Public Health;Publications;Quinones;Reporting;Reproduction;Research;Research Activity;Research Design;Research Infrastructure;Research Support;Safety;Science;Sunscreening Agents;systematic review;Toxic effect;Toxicology;Triclosan;United States;United States Dept. of Health and Human Services;United States Food and Drug Administration;web site;wood smoke;Work,Research Infrastructure and Operations  Supporting  the National Toxicology Program (NTP),103377,NA,NA,NA,NA,3,NA,NA,4369489,NA
11189568,ZIE,AI,1,N,NA,NA,NA,NA,ZIEAI001120,NA,NA,1ZIEAI001120-16,NIAID:2834438\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,79371596 (contact),"SHAFFER, MEREDITH  (contact)",NA,NA,NA,"Appointment;Board Certification;Canada;Clinical;clinical center;Clinical Investigator;Clinical Research;Credentialing;Doctor of Medicine;Doctor of Philosophy;Eligibility Determination;experience;falls;Industry;Laboratories;Left;Mississippi;National Heart, Lung, and Blood Institute;National Institute of Allergy and Infectious Disease;National Institute of Arthritis, and Musculoskeletal, and Skin Diseases;Participant;Physicians;Positioning Attribute;programs;Qualifying;Research Personnel;System;tenure track;Training;Translational Research;United States National Institutes of Health;Universities",NIAID Transition Program in Clinical Research,1120,NA,NA,NA,NA,16,NA,NA,2834438,NA
11189569,ZIE,AI,1,N,NA,NA,NA,NA,ZIEAI001148,NA,NA,1ZIEAI001148-14,NIAID:2031470\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,77880741 (contact),"KHOURY, PANEEZ  (contact)",NA,NA,NA,academic review;Accreditation;Allergic;Allergic Disease;Area;Artificial Intelligence;Autoimmune Diseases;base;Basic Science;candidate selection;career;career development;certificate program;Climate;Clinic;Clinical;clinical center;clinical development;Clinical Immunology;clinical investigation;Clinical Protocols;Clinical Research;clinical training;Clinical Trials;congenital immunodeficiency;Continuity of Patient Care;design;Development;didactic education;disparity reduction;diversity and equity;Education;Ensure;experience;Extramural Activities;Faculty;Faculty Workshop;Fellowship;Fellowship Program;flipped classroom;Foundations;Genetic;Genomics;Goals;Government;graduate medical education;Grant;Health;health disparity;human subject protection;Hypersensitivity;Immersion;Immune Complex Diseases;Immune System Diseases;immunodeficiency;Immunology;improved;In Situ;Inosine Diphosphate;Internist;Interview;Intramural Research Program;Investigation;lectures;medical specialties;Mentors;Mentorship;Mind;Mission;National Institute of Allergy and Infectious Disease;Patient Care;Patients;pediatrician;Pharmacologic Substance;Physicians;Policies;Pollution;Preparation;Productivity;programs;Protocols documentation;Qualifying;recruit;Research;Research Personnel;Research Project Grants;Research Subjects;Research Training;Residencies;Resources;Review Committee;Rotation;Science;Series;simulation;Site;Teacher Professional Development;Time;Training;Training Programs;Translational Research;Transplantation;United States National Institutes of Health;Universities;virtual reality;Work;Writing,Allergy and Immunology Clinical Fellowship Program Support,1148,NA,NA,NA,NA,14,NA,NA,2031470,NA
11189570,ZIE,AI,1,N,NA,NA,NA,NA,ZIEAI001248,NA,NA,1ZIEAI001248-06,NIAID:4161584\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,16162380 (contact),"ZERBE, CHRISTA  (contact)",NA,NA,NA,Academic Medical Centers;academic review;Accreditation;American;antimicrobial;Antimicrobial Resistance;base;Basic Science;career;career preparation;Certification;Child;Childhood;Clinical;clinical center;Clinical Research;Clinical Skills;clinical training;Clinical Trials;Collaborations;Communicable Diseases;Complex;Consult;design;driving force;Eligibility Determination;Environment;experience;Extramural Activities;faculty research;falls;Fellowship;Fellowship Program;Functional disorder;Funding;Goals;graduate medical education;Hearing;Hospitals;Host Defense;Immunology;Individual;Internal Medicine;Internist;Interview;Intramural Research Program;Laboratories;Leadership;Medical center;medical specialties;Medicine;Mentors;Microbiology;Mission;National Institute of Allergy and Infectious Disease;Pathogenesis;Pathology;Patients;Physicians;Private Practice;Process;Productivity;programs;Qualifying;recruit;Research;Research Personnel;Research Project Grants;Research Training;Resources;Review Committee;Rotation;Supervision;Training;Training Programs;Translational Research;Transplantation;United States National Institutes of Health;University Hospitals;vaccine development;virology;Washington;Work,Infectious Diseases Fellowship Program,1248,NA,NA,NA,NA,6,NA,NA,4161584,NA
11189571,ZIG,AI,1,N,NA,NA,NA,NA,ZIGAI001047,NA,NA,1ZIGAI001047-17,NIAID:46528760\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,9691505 (contact),"ELKINS, WILLIAM  (contact)",NA,NA,NA,2019-nCoV;ACE2;Aerobic;Affect;air filter;Amino Acids;Animal Experimentation;Animal Model;animal model development;Animals;assisted reproduction;Autopsy;Backcrossings;Beds;Binding;Biopsy Specimen;Bioterrorism;Board Certification;Books;Breeding;Caring;Cell Transplantation;Cells;cerebral vascularization;Cerebrum;Cessation of life;Clinical;Clustered Regularly Interspaced Short Palindromic Repeats;Coculture Techniques;Collaborations;Communicable Diseases;comparative;Complex;Confounding Factors (Epidemiology);congenic;Congenic Mice;Contracts;cost;COVID-19;CRISPR/Cas technology;Cryopreservation;Data;Derivation procedure;design;Diagnosis;Diagnostic;Diagnostic tests;Disease;Disease Progression;Distress;DNA Sequence Analysis;Electroporation;Embryo;embryo cryopreservation;Emerging Communicable Diseases;Endothelial Cells;Environment;Equipment;Evaluation;Exclusion;experience;Experimental Designs;experimental study;Female;Fertilization in Vitro;Food;Formalin;Gene Modified;Gene Targeting;Generations;Genes;Genetic;genome editing;Germ-Free;Gnotobiotic;Health;Hematopoietic stem cells;Hematoxylin and Eosin Staining Method;high efficiency particulate air filter;Human;human induced pluripotent stem cells;Human Resources;Hypersensitivity;IACUC;Immunofluorescence Immunologic;Immunohistochemistry;improved;In Situ Hybridization;Individual;induced pluripotent stem cell;Infection;Insertion Mutation;Internal Ribosome Entry Site;Journals;Knock-in;Knockout Mice;Knowledge;Label;Laboratories;Laboratory Animal Medicine;Laboratory Animals;Manuscripts;Medical;medical countermeasure;medical specialties;Medicine;Methods;Microglia;microorganism;Microscopic;Microscopy;Mission;Modeling;Modification;Molecular;mouse genetics;mouse model;Mus;National Institute of Allergy and Infectious Disease;Neuroglia;Neurons;Newborn Infant;novel;novel marker;Organism;Organoids;Pain;Paraffin Embedding;Pathogenesis;Pathologist;Pathology;Pathology Report;Patients;Peer Review;Peptides;Play;Pluripotent Stem Cells;posters;Preparation;Prevention;Principal Investigator;Process;programs;Proteins;Protocols documentation;PTPRC gene;Public Health;Publications;Publishing;pup;receptor;repository;Research;Research Activity;Research Personnel;Research Support;Resources;Role;routine imaging;SARS-CoV-2 infection;Services;Side;Slide;Source;Specialist;sperm cell;sperm cryopreservation;Stains;stem cells;success;System;Technical Expertise;Techniques;therapy development;Time;Tissue Banks;Tissue Embedding;Tissues;Titrations;Training;United States National Institutes of Health;Veterinary Pathology;Virus;Vision;Work,Comparative Medicine Infectious Diseases- Bethesda,1047,NA,NA,NA,NA,17,NA,NA,46528760,NA
11189572,ZIG,AI,1,N,NA,NA,NA,NA,ZIGAI001048,NA,NA,1ZIGAI001048-17,NIAID:10464271\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,78853738 (contact),"HANLEY, PATRICK  (contact)",NA,NA,NA,Affect;Animal Experimentation;Animal Model;Animals;Bioterrorism;Caring;Clinical;Communicable Diseases;Data;Development;Disease;Environment;experience;Goals;Human;infectious disease treatment;Infectious Diseases Research;Investigation;Knowledge;Laboratory Animal Medicine;Laboratory Animal Models;Laboratory Animals;Medical;Mission;Mus;National Institute of Allergy and Infectious Disease;Organism;Pathology;Research;Research Activity;Research Personnel;Research Support;Resources;Services;Side;Technical Expertise;Work,Veterinary Services Core for Infectious Diseases Research- RML,1048,NA,NA,NA,NA,17,NA,NA,10464271,NA
11189573,ZIG,AI,1,N,NA,NA,NA,NA,ZIGAI001330,NA,NA,1ZIGAI001330-05,NIAID:2495018\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,78853738 (contact),"HANLEY, PATRICK  (contact)",NA,NA,NA,Affect;Animal Experimentation;Animal Model;Animals;Bioterrorism;Caring;Clinical;Communicable Diseases;COVID-19;Data;Development;Disease;Environment;experience;Goals;Histopathology;Human;infectious disease treatment;Infectious Diseases Research;Investigation;Knowledge;Laboratory Animal Medicine;Laboratory Animal Models;Laboratory Animals;Medical;Mission;Mus;National Institute of Allergy and Infectious Disease;Organism;Pathology;Research;Research Activity;Research Personnel;Research Support;Resources;Side;Technical Expertise;Work,Animal Research Support of COVID Studies,1330,NA,NA,NA,NA,5,NA,NA,2495018,NA
11189574,ZIJ,AI,1,N,NA,NA,NA,NA,ZIJAI001245,NA,NA,1ZIJAI001245-06,NIAID:2331593\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,16127240 (contact),"SOUCY, KATHRYN  (contact)",NA,NA,NA,Advisory Committees;Agreement;Area;Award;Awareness;Back;Bibliometrics;Biomedical Research;Caliber;career;career development;Chalk;Clinical;Clinical Investigator;cohort;Collaborations;college;Communication;Data;Databases;design;Development;Development Plans;diversity and inclusion;Education;Educational Status;Educational workshop;Electronic Mail;Elements;Ensure;Equilibrium;Evaluation;Event;experience;Exposure to;Faculty;Feedback;Fellowship;Fellowship Program;flexibility;Fostering;Funding;Goals;graduate school;graduate student;Grant;high school;improved;Individual;insight;Institution;interest;Internships;Interview;Job Application;Laboratories;Learning;lectures;Lightning;Maryland;matriculation;medical schools;Medical Students;member;Mentors;Mission;Montana;National Institute of Allergy and Infectious Disease;Occupations;outreach;Participant;Personal Communication;Persons;Population;Population Heterogeneity;Positioning Attribute;Postbaccalaureate;Postdoctoral Fellow;posters;pre-doctoral;Problem Solving;Process;Professional Organizations;Program Evaluation;programs;prospective;recruit;Reporting;Research;research and development;Research Training;Resources;Role;Running;Schedule;Science;Series;Site;skill acquisition;skills;social media;Societies;Specialist;Students;summer internship;summer student;System;Time;Time Management;Training;training opportunity;Training Programs;trend;Underrepresented Populations;United States National Institutes of Health;Universities;virtual;Visit;Vocational Guidance;web page;web site;Writing,Office of Research Training and Development,1245,NA,NA,NA,NA,6,NA,NA,2331593,NA
11189881,R56,AT,1,N,2024-09-24,2024-09-24,2025-08-31,213,R56AT012463,SCHOOLS OF MEDICINE,PA-20-185,1R56AT012463-01A1,NCCIH:340449\,NON-SBIR/STTR RPGS,2024,NATIONAL CENTER FOR COMPLEMENTARY & INTEGRATIVE HEALTH,NA,PROVIDENCE,UNITED STATES,MICROBIOLOGY/IMMUN/VIROLOGY,01,001785542,US,1003201,BROWN UNIVERSITY,RI,029034202,NARRATIVE Antibiotic-induced microbiome disruption is associated with acute and long-term morbidity. Here we propose that a mechanistic understanding of the impact of the redox environment on gut antibiotic toxicity may be used to identify anti-disruptive therapies. Developing anti-destructive therapies will help the millions of Americans that receive antibiotics each year by reducing the risk of detrimental outcomes and improving the use of our current antimicrobial arsenal while we fight the antibiotic resistance crisis.,12566295 (contact),"BELENKY, PETER  (contact)","KIM, HYE-SOOK",2024-09-24,2025-08-31,Acute;Aerobic;American;Anti-microbial susceptibility;Antibiotic Resistance;Antibiotic susceptibility;Antibiotic Therapy;Antibiotics;antimicrobial;Automobile Driving;Bacterial Antibiotic Resistance;Basic Science;Clostridium difficile;Colitis;combat;Communities;Complex;Data;Diabetes Mellitus;Dietary Fiber;dietary supplements;dysbiosis;Effectiveness;Environment;evidence base;Fermentation;Fiber;fighting;Functional disorder;gut microbiome;Health;improved;Intervention;Link;Measurement;Mediating;Metabolic;metabolic rate;Metabolism;microbial;microbiome;microbiome components;Morbidity - disease rate;novel;novel therapeutics;Obesity;Organ;Outcome;Oxidation-Reduction;pathobiont;Pathway interactions;Plants;Polysaccharides;prebiotics;Predisposition;preservation;Probiotics;Production;Recovery;Research;resilience;respiratory;Risk Reduction;Role;small molecule;Solid;Supplementation;Testing;Therapeutic;Time;Tissues;Toxic effect;Translating;translational impact;Vulnerable Populations,Alleviating antibiotic-induced microbiome dysfunction by quenching the microbial redox environment,12463,IMII,Interspecies Microbial Interactions and Infectious Study Section[IMII],NA,A1,1,213431,127018,340449,NA
11189960,P01,CA,3,N,2024-09-17,2024-07-01,2025-06-30,NA,P01CA233432,NA,PA-20-272,3P01CA233432-05S2,NCI:100000\,NON-SBIR/STTR RPGS,2024,NATIONAL CANCER INSTITUTE,NA,Oakland,UNITED STATES,NA,12,150829349,US,3497005,KAISER FOUNDATION RESEARCH INSTITUTE,CA,946123610,NA,1917949 (contact),"KUSHI, LAWRENCE H (contact)","MOLLICA, MICHELLE A",2020-09-15,2026-06-30,Adolescent and Young Adult;Adolescent and young adult cancer patients;Advocacy;Agreement;American Cancer Society;Ancillary Study;Area;Biometry;Budgets;California;Cancer Survivor;Cancer Survivorship;Caregivers;Clinical;clinical care;Committee Members;Committee Membership;Communication;Communities;Contracts;Dana-Farber Cancer Institute;Data;data acquisition;Data Analyses;data resource;Development;Disparate;Ensure;experience;Financial Hardship;Growth;Health;Healthcare;Hospitals;Individual;insight;Institution;Institutional Review Boards;interest;Leadership;Los Angeles;Malignant Neoplasms;Manuscripts;member;Methods;Michigan;Modification;North Carolina;organizational structure;patient engagement;Patients;Pediatric Hospitals;Population;Principal Investigator;programs;Provider;psychosocial;Publications;Quality of life;Research;Research Personnel;Resource Allocation;Resource Sharing;Resources;Robin bird;Saint Jude Children&apos;s Research Hospital;Site;Source;Surveys;Survivors;synergism;timeline;Universities;Washington;Work,Core A: Administrative Core,233432,ZCA1,ZCA1,8748,S2,5,83979,16021,NA,100000
11190013,U01,CA,1,N,2024-09-26,2024-09-26,2025-08-31,393,U01CA301988,NA,PAR-22-213,1U01CA301988-01,NCI:641508\,NON-SBIR/STTR RPGS,2024,NATIONAL CANCER INSTITUTE,NA,BOSTON,UNITED STATES,NA,08,073130411,US,4907701,MASSACHUSETTS GENERAL HOSPITAL,MA,021142621,NA,8735819 (contact),"WARNER, ERICA T (contact)","UMAR, ASAD",2024-09-26,2029-08-31,"Accounting;Address;Adult;Age;aged;Aged, 80 and over;aging biomarker;aging related disease;Alzheimer&apos;s disease related dementia;arm;Aspirin;Benefits and Risks;Biologic Characteristic;Biological;Biological Markers;cancer risk;Cardiovascular Diseases;cardiovascular disorder prevention;cardiovascular disorder risk;Cessation of life;Characteristics;Chronology;Clinical;cohort;Colorectal Cancer;colorectal cancer screening;Data;Dementia;dementia risk;Diabetes Mellitus;disability;disorder risk;Dose;Elderly;Epigenetic age;Equilibrium;Ethnic Origin;Evaluation;Event;experience;follow-up;frailty;Future;Gastrointestinal Hemorrhage;Guidelines;gut microbiome;Health Benefit;Hematopoiesis;Hemorrhage;high risk;high risk population;human old age (65+);improved;Incidence;indexing;Individual;Inflammatory;Life Style;Long-Term Effects;Machine Learning;Malignant Neoplasms;Modeling;Molecular;mortality;novel;older adult;Participant;personalized approach;Positioning Attribute;Predictive Factor;Preventive;Primary Prevention;Race;Randomized;randomized, clinical trials;Recommendation;Research;Risk;Risk Factors;risk prediction;risk prediction model;risk stratification;Safety;Screening for cancer;sex;social;socioeconomics;Subgroup;Testing;United States Preventative Services Task Force;Update;Work",Aspirins legacy on cancer and overall benefit: risk balance over a 15-year horizon,301988,ZCA1,ZCA1-SRC(99),NA,NA,1,545429,96079,641508,NA
11190033,R01,GM,7,N,2024-10-30,2024-10-01,2024-11-30,859,R01GM102187,SCHOOLS OF ARTS AND SCIENCES,PA-24-254,7R01GM102187-11,NIGMS:144805\,NON-SBIR/STTR RPGS,2024,NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES,NA,BOCA RATON,UNITED STATES,CHEMISTRY,23,004147534,US,513803,FLORIDA ATLANTIC UNIVERSITY,FL,334316424,"NARRATIVE Thiol groups can undergo numerous modifications, making cysteine a unique molecular switch. Cysteine plays structural and regulatory roles as part of proteins or glutathione, contributing to maintain redox homeostasis and regulate signaling within and amongst cells. Not surprisingly therefore, cysteines are associated with many he- reditary and acquired diseases  the research described herein will elucidate regulatory functions performed by protein cysteine residues and provide a framework for understanding how mutation and/or (in)activation of this key amino acid can cause disease.",8965564 (contact),"CARROLL, KATE SUZANNE (contact)","ANSONG, CHARLES KWAKU",2012-08-01,2026-11-30,NA,Chemical Tools for Probing Cysteine Sulfenation and Sulfination Redox Biology,102187,SBCB,Synthetic and Biological Chemistry B Study Section[SBCB],NA,NA,11,94954,49851,144805,NA
11190055,P01,AI,5,N,2024-05-01,2024-05-01,2025-04-30,NA,P01AI168148,NA,PAR-20-072,5P01AI168148-02,NIAID:4801\,NON-SBIR/STTR RPGS,2024,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,LOS ANGELES,UNITED STATES,NA,36,092530369,US,577505,UNIVERSITY OF CALIFORNIA LOS ANGELES,CA,900952000,NA,1894289 (contact),"HAAKE, DAVID A (contact)","MUKHOPADHYAY, SUMAN",2023-05-16,2028-04-30,NA,ConProject-006,168148,ZAI1,ZAI1-CAB-M(J1),7990,NA,2,6546,526,NA,4801
11190056,P01,AI,5,N,2024-05-01,2024-05-01,2025-04-30,NA,P01AI168148,NA,PAR-20-072,5P01AI168148-02,NIAID:22221\,NON-SBIR/STTR RPGS,2024,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,LOS ANGELES,UNITED STATES,NA,36,092530369,US,577505,UNIVERSITY OF CALIFORNIA LOS ANGELES,CA,900952000,NA,1894289 (contact),"HAAKE, DAVID A (contact)","MUKHOPADHYAY, SUMAN",2023-05-16,2028-04-30,NA,ConProject-007,168148,ZAI1,ZAI1-CAB-M(J1),7991,NA,2,33537,322,NA,22221
11190057,P01,AI,5,N,2024-05-01,2024-05-01,2025-04-30,NA,P01AI168148,NA,PAR-20-072,5P01AI168148-02,NIAID:48368\,NON-SBIR/STTR RPGS,2024,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,LOS ANGELES,UNITED STATES,NA,36,092530369,US,577505,UNIVERSITY OF CALIFORNIA LOS ANGELES,CA,900952000,NA,1894289 (contact),"HAAKE, DAVID A (contact)","MUKHOPADHYAY, SUMAN",2023-05-16,2028-04-30,NA,ConProject-008,168148,ZAI1,ZAI1-CAB-M(J1),7992,NA,2,72999,701,NA,48368
11190058,P01,AI,5,N,2024-05-01,2024-05-01,2025-04-30,NA,P01AI168148,NA,PAR-20-072,5P01AI168148-02,NIAID:37361\,NON-SBIR/STTR RPGS,2024,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,LOS ANGELES,UNITED STATES,NA,36,092530369,US,577505,UNIVERSITY OF CALIFORNIA LOS ANGELES,CA,900952000,NA,1894289 (contact),"HAAKE, DAVID A (contact)","MUKHOPADHYAY, SUMAN",2023-05-16,2028-04-30,NA,ConProject-009,168148,ZAI1,ZAI1-CAB-M(J1),7993,NA,2,56343,570,NA,37361
11190081,U01,AR,3,N,2024-09-13,2024-09-20,2025-08-31,846,U01AR079717,SCHOOLS OF MEDICINE,PAR-21-036,3U01AR079717-03S1,NIAMS:148419\,NON-SBIR/STTR RPGS,2024,NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES,NA,WASHINGTON,UNITED STATES,INTERNAL MEDICINE/MEDICINE,98,043990498,US,2863301,GEORGE WASHINGTON UNIVERSITY,DC,200520042,"NARRATIVE The objective of this proposal is to determine the efficacy and histopathologic effects on synovitis of 6 months of methotrexate (n=100) versus placebo (n=50) therapy for chronic CHIKV arthritis in Colombia in a randomized controlled trial. Our central hypothesis is that methotrexate will significantly decrease chronic CHIKV arthritis disease severity compared to placebo and suppress leukocyte accumulation and inflammatory cytokine expression in synovial tissue. In Aim 1, we will determine the efficacy of oral methotrexate treatment versus placebo for 6 months in chronic CHIKV arthritis, in Aim 2, we will determine the effect of methotrexate on synovial inflammation by obtaining synovial biopsy samples before and after treatment in order to precisely define the role of methotrexate in the treatment of chronic CHIKV arthritis with the goal of advancing the field towards an evidence-based standard treatment.",15227875 (contact);1864505,"CHANG, AILEEN  (contact);FIRESTEIN, GARY S","MAO, SU-YAU",2022-09-01,2027-08-31,"Affect;Aftercare;Alpha Virus;American;arm;Arthritis;ATAC-seq;Autoimmune Process;B-Lymphocytes;Biopsy;Biopsy Specimen;California;Cell Lineage;chemokine;chikungunya;chikungunya infection;Chikungunya virus;Chronic;Clinical;college;Colombia;Culicidae;cytokine;Degenerative polyarthritis;disability;Disease;Disease Outbreaks;Dose;efficacy evaluation;Evaluation;evidence base;Evidence based treatment;Folic Acid;follow-up;Gene Expression;Goals;Guidelines;Immune;Immunoassay;Immunohistochemistry;improved;Individual;Infection;Infiltration;Inflammatory;Janus kinase;kinase inhibitor;Leukocytes;Macrophage;Measures;Mediating;Methotrexate;novel;open label;Oral;Outcome;Pain;Pain Measurement;Pathogenicity;Pathologic;Patient Outcomes Assessments;patient subsets;Patients;Persons;Pharmaceutical Preparations;Placebos;primary endpoint;Proteins;Quality of life;Randomized;randomized placebo controlled trial;Randomized, Controlled Trials;Recommendation;Reporting;response;Rheumatoid Arthritis;Rheumatology;rituximab;Role;secondary endpoint;Severity of illness;single-cell RNA sequencing;standard care;Synovial Fluid;Synovitis;T-Cell Activation;T-Lymphocyte;Therapeutic;Therapeutic Agents;therapeutic target;therapeutically effective;Tissue Sample;Tissues;treatment guidelines;United States;Universities;Viral Arthritis;Work",Methotrexate treatment of Arthritis caused by Chikungunya virus (MARCH): A randomized controlled trial of methotrexate versus placebo in the treatment of chronic arthritis after chikungunya infection,79717,AMSC,Arthritis and Musculoskeletal and Skin Diseases Clinical Trials Study Section [AMSC],NA,S1,3,130877,17542,148419,NA
11190100,OT2,OD,3,N,2024-09-25,2024-09-24,2025-12-31,310,OT2OD035404,NA,OTA-23-001,3OT2OD035404-01S5,NEI:570000\OD:3550558\,OTHERS,2024,"OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH",NA,NASHVILLE,UNITED STATES,NA,07,079917897,US,10040927,VANDERBILT UNIVERSITY MEDICAL CENTER,TN,372320011,NA,78905736;15018191;8801360 (contact);12616796;1881721,"BASFORD, MELISSA ;GLAZER, DAVID ;HARRIS, PAUL A. (contact);PHILIPPAKIS, ANTHONY ;RODEN, DAN M","AZUINE, ROMULADUS EMEKA",2024-09-24,2025-12-31,All of Us Research Program;Data;data infrastructure;Disease;Goals;Health;prevent;Research;Research Personnel;Vision,All of Us Research Program Data and Research Center,35404,ZOD1,ZOD1-SRC(99),NA,S5,1,4120558,0,4120558,NA
11190134,OT2,HL,3,N,2024-09-10,2017-09-30,2026-06-30,837,OT2HL142340,NA,RFA-HL-17-036,3OT2HL142340-01S6,NHLBI:1496402\,OTHERS,2024,"NATIONAL HEART, LUNG, AND BLOOD INSTITUTE",NA,ROCKVILLE,UNITED STATES,NA,08,096360284,US,1381101,"THE EMMES COMPANY, LLC",MD,208501737,No PHR,9772868 (contact),"COLEMAN-COWGER, VICTORIA HOPE (contact)","MONDORO, TRACI",2017-09-30,2026-06-30,Sickle Cell Anemia,Sickle Cell Disease Cure Initiative (SCDC),142340,ZHL1,ZHL1-SRC(99),NA,S6,1,1496402,0,1496402,NA
11190167,R01,DE,7,N,2024-12-18,2024-09-15,2025-03-31,121,R01DE030413,BIOMED ENGR/COL ENGR/ENGR STA,PA-24-254,7R01DE030413-04,NIDCR:441321\,NON-SBIR/STTR RPGS,2024,NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH,NA,WEST LAFAYETTE,UNITED STATES,ENGINEERING (ALL TYPES),04,072051394,US,1481402,PURDUE UNIVERSITY,IN,47906,"PROJECT NARRATIVE The project will identify the optimal intermittent vibration force stimulation to control orthodontic tooth movement rate through a rat study and scale it up for other species, including dogs and humans. The relevance of this project is that, once successful, the technology will enable clinicians to shorten the treatment time with reduced side-effects. The long term goal is to translate this technology into devices that can be used c linic ally.",6951931 (contact),"CHEN, JIE  (contact)","WAN, JASON",2022-04-01,2027-03-31,NA,Dose analysis for translating animal based vibrational force study for accelerating orthodontic tooth movement to clinic,30413,ODCS,"Oral, Dental and Craniofacial Sciences Study Section[ODCS]",NA,NA,4,337357,103964,441321,NA
11190205,U19,AG,3,N,2024-09-12,2024-09-01,2025-08-31,NA,U19AG074866,NA,PA-20-272,3U19AG074866-03S2,NIA:376991\,NON-SBIR/STTR RPGS,2024,NATIONAL INSTITUTE ON AGING,NA,PITTSBURGH,UNITED STATES,NA,12,004514360,US,2059802,UNIVERSITY OF PITTSBURGH AT PITTSBURGH,PA,152133320,NA,15826417 (contact),"SILVA, AFONSO C (contact)","REFOLO, LORENZO",2022-09-01,2027-08-31,Advisory Committees;Alzheimer&apos;s disease model;animal care;Animal Testing;Area;Bioinformatics;Breeding;Budgets;Callithrix;Communities;community engagement;Community Outreach;Data;data integration;Data Reporting;Development;Disease;Ensure;equipment acquisition;Evaluation;experimental study;Fibroblasts;Genetic Engineering;Goals;Institution;Knowledge Portal;Leadership;Measures;medical schools;meetings;Mission;Modeling;Monitor;multimodality;open data;outreach;Progress Reports;Protocols documentation;Reagent;Research;Research Personnel;Research Project Grants;Resources;Schedule;Science;success;symposium;The Jackson Laboratory;Time;United States National Institutes of Health;Universities,Administrative Core,74866,ZAG1,ZAG1,6588,S2,3,248671,128320,NA,376991
11190422,R01,AI,7,N,2025-01-08,2024-11-01,2025-04-30,855,R01AI148431,SCHOOLS OF MEDICINE,PA-24-254,7R01AI148431-06,NIAID:224440\,NON-SBIR/STTR RPGS,2024,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,BOSTON,UNITED STATES,BIOCHEMISTRY,07,039318308,US,8422704,TUFTS UNIVERSITY BOSTON,MA,021111901,High-risk human papillomavirus infections cause cervical cancer and other genital and oropharyngeal cancers that account for nearly 5% of cancers worldwide. HPV-positive cancers are poorly differentiated and restoring differentiation in a cancer caused by HPV infection has high therapeutic potential. The goal of this proposal is to understand how the high-risk HPV E7 oncoprotein inhibits epithelial differentiation.,9261130 (contact),"WHITE, ELIZABETH A (contact)","LINDE, AMBER SHRYER",2020-05-14,2025-04-30,NA,Human Papillomavirus Manipulation of Epithelial Differentiation,148431,VIRA,Virology - A Study Section[VIRA],NA,NA,6,136024,88416,224440,NA
11190561,U54,CA,3,N,2024-09-10,2024-09-01,2025-08-31,NA,U54CA261701,NA,PA-20-272,3U54CA261701-04S1,NCI:183375\,RESEARCH CENTERS,2024,NATIONAL CANCER INSTITUTE,NA,NEW YORK,UNITED STATES,NA,12,071037113,US,7056601,ROCKEFELLER UNIVERSITY,NY,100656399,"The MetNet Center for Systems-level Study of Metastasis will elucidate how dynamic interactions between neuronal cells, localized lymphatics, metabolites and cancer cells collectively contribute to the emergence of metastatic disease - thereby identifying critical genes as therapeutic targets for its eradication.",10377558 (contact),"BIRSOY, KIVANC  (contact)","GRIL, BRUNILDE M",2021-09-23,2026-08-31,Address;Breast Cancer Cell;breast cancer metastasis;cancer cell;cancer heterogeneity;Cancer Model;Cell Communication;cell type;Cells;Clinical;Clustered Regularly Interspaced Short Palindromic Repeats;Computational Biology;CRISPR screen;Dependence;Disease;Distant;Environment;extracellular;Extracellular Matrix;gain of function;Gene Expression Profile;Genes;Genetic;Liver;loss of function;lung colonization;Lymphatic;Maps;Metabolic;Metabolism;metabolomics;Metastatic Neoplasm to the Lung;Modeling;Molecular;multidisciplinary;Neoplasm Circulating Cells;Neoplasm Metastasis;neoplastic cell;Neurons;Normal Cell;Nutrient;Nutrient availability;Organ;Oxygen;Pathway interactions;Population;Process;programs;Repression;Role;single cell sequencing;Site;Starvation;System;Techniques;Testing;Therapeutic;therapeutic target;transcriptomics;treatment response;tumor;tumor metabolism;Work,Project 3: The role of microenvironmental metabolites on metastatic progression,261701,ZCA1,ZCA1(M1),5959,S1,4,131250,52125,NA,183375
11190642,ZIA,AA,1,N,NA,NA,NA,NA,ZIAAA000036,NA,NA,1ZIAAA000036-38,NIAAA:1061357\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM,NA,NA,NA,6568011 (contact),"SONG, BYOUNG-JOON  (contact)",NA,NA,NA,Acetaldehyde;Acetaminophen;Acetylation;Actins;Acute;acute liver injury;adduct;Adherens Junction;Affect;Aftercare;Age;age related neurodegeneration;Albumins;alcohol exposure;alcohol prevention;Alcohols;aldehyde dehydrogenases;Aldehydes;animal tissue;antioxidant enzyme;Antioxidants;Apoptosis;Award;Basic Science;Biochemical;Brain;Brain Injuries;Carbon Tetrachloride;CASP3 gene;cell injury;Cells;Cessation of life;Cisplatin;Collaborations;Collagen;confocal imaging;Cultured Cells;CYP2E1 gene;cytokine;Diabetes Mellitus;dietary;dietary supplements;Disease;disease model;Dose;drinking water;Ellagic Acid;Endoplasmic Reticulum;endoplasmic reticulum stress;Endotoxemia;Endotoxins;Enzymes;Epithelial Cells;Ethanol;Ethanol Metabolism;Excision;Exposure to;extracellular;Fatty acid glycerol esters;Fibrosis;Fructose;Functional disorder;Future;Gene Expression Regulation;Ginseng Preparation;Goals;gut-liver axis;Hepatic;Hepatocyte;Hepatotoxicity;High Fat Diet;Histology;HIV-1;Immunoblot Analysis;In Situ Nick-End Labeling;Inflammatory;Injections;Injury;intestinal barrier;intestinal epithelium;Intestines;Juglans;Knockout Mice;Leaky Gut;Lipid Peroxides;Lipopolysaccharides;Liver;Liver diseases;Liver Fibrosis;liver injury;Malnutrition;Manuscripts;MAP Kinase Gene;Mediating;Melatonin;member;Metabolic syndrome;Metabolism;Methods;Mitochondria;mitochondrial dysfunction;Mitochondrial Proteins;Modeling;Molecular;Mus;nanocarrier;nanosized;nanovesicle;NF-kappa B;Nicotine;nitration;non-alcoholic;non-alcoholic fatty liver disease;Nuclear Proteins;Obesity;Oral Administration;Organ;organ injury;Organelles;oxidation;Oxidative Stress;Pathologic;Pathway interactions;Pattern;permissiveness;Phosphorylation;Physiological;Plant Preparations;Plants;Poison;Pomegranate;Post-Translational Protein Processing;pre-clinical research;prevent;Protective Agents;Protein Acetylation;protein biomarkers;Proteins;Proteolysis;Publications;Publishing;Rat Transgene;Rattus;Reactive Oxygen Species;Reperfusion Injury;Reporting;research and development;research study;Resistance;Risk Factors;Rodent;Role;Serum;Severities;sex;Signal Pathway;Signal Transduction;Sirius Red F3B;SIRT1 gene;Smooth Muscle;Sodium Dextran Sulfate;Stains;Stress;Thioacetamide;Tight Junctions;Time;tissue injury;Tissues;TP53 gene;Translational Research;Ubiquitin;United States National Institutes of Health;Vimentin;virtual;Virus Diseases;Wild Type Mouse,"Alcohol Metabolism, Functional Consequences and Apoptosis Signaling Mechanism",36,NA,NA,NA,NA,38,NA,NA,1061357,NA
11190643,ZIA,AA,1,N,NA,NA,NA,NA,ZIAAA000124,NA,NA,1ZIAAA000124-10,NIAAA:396682\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM,NA,NA,NA,78880548 (contact),"MOMENAN, REZA  (contact)",NA,NA,NA,alcohol abuse therapy;alcohol cue;alcohol use disorder;Alcoholic Beverages;Alcohols;Amygdaloid structure;antisocial behavior;Arousal;Attention;attentional bias;Awareness;Behavior;Beverages;Categories;Clinical;Cognition;Cognitive;combat;coping;craving;Cues;Data Analyses;Decision Making;Development;discounting;Disease;efficacy evaluation;emotion dysregulation;Emotional;Emotions;executive function;Fortune;Functional Magnetic Resonance Imaging;functional MRI scan;functional near infrared spectroscopy;Image;Impairment;Impulsivity;Journals;Learning;Maintenance;Manuscripts;Memory;Morals;Motivation;negative affect;neural;neural correlate;novel;Outcome;Participant;Patient Recruitments;Patients;Perception;Play;Predisposition;Publications;Regrets;resilience;Rewards;Risk;Role;social neuroscience;social stigma;Stimulus;Stress;Structure of middle temporal gyrus;Structure of supramarginal gyrus;substance use,"fMRI study of cognition, motivation, decision-making, reward, risk, aversion, negative emotion, arousal, craving, impulsivity, and stress in alcohol use disorder",124,NA,NA,NA,NA,10,NA,NA,396682,NA
11190644,ZIA,AA,1,N,NA,NA,NA,NA,ZIAAA000125,NA,NA,1ZIAAA000125-09,NIAAA:1190044\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM,NA,NA,NA,78880548 (contact),"MOMENAN, REZA  (contact)",NA,NA,NA,Abstinence;acamprosate;Adult;Affect;Age;Alcohol consumption;alcohol effect;alcohol use disorder;Amygdaloid structure;Appearance;Area;Bacteria;Bacteroides;Bayesian Modeling;Behavioral;Biological;Biological Markers;Body mass index;Brain;Brain Diseases;Brain region;Butyrates;Calibration;Childhood;Cigarette;Classification;Clinical;cognitive function;Collaborations;comorbidity;Complex;cost;Data;Data Analyses;Development;Disease;disorder subtype;Double-Blind Method;drinking;drug misuse;early life stress;Electroencephalography;Emotional;Emotions;Encapsulated;Escherichia coli;executive function;experience;FDA approved;Functional disorder;Functional Magnetic Resonance Imaging;gamma-Aminobutyric Acid;Glutamates;Goals;gut microbiome;Image;improved;Individual;Inpatients;insight;Institutional Review Boards;Intention;Journals;Laboratories;large scale data;Link;Longevity;Magnetic Resonance Imaging;Manuscripts;marijuana use disorder;Mental disorders;mental state;Metabolism;morphometry;Motor;neural;Neurobiology;neuroimaging;neuromechanism;neuropsychopharmacology;nicotine use;nicotine user;non-smoker;Obesity;opioid use disorder;Outcome;Participant;Pathologic;Patients;personalized medicine;Pharmaceutical Preparations;Phenotype;Pilot Projects;Placebos;Play;polygenic risk score;Population Intervention;Prediction of Response to Therapy;Prevotella;Probability;Process;Protocols documentation;psychological distress;psychological symptom;Psychopathology;Publications;Publishing;Recording of previous events;Recovery;Relapse;Research;Rest;Risk;Role;Ruminococcus;Sample Size;Science;Sensory;Shapes;Social support;somatosensory;Substance Use Disorder;substance user;Symptoms;temporal measurement;Testing;Time;tool;Trauma;Treatment Efficacy;Variant;Visual;white matter;Work,Neuroimaging of Alcohol Use Disorder,125,NA,NA,NA,NA,9,NA,NA,1190044,NA
11190645,ZIA,AA,1,N,NA,NA,NA,NA,ZIAAA000126,NA,NA,1ZIAAA000126-05,NIAAA:396682\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM,NA,NA,NA,78880548 (contact),"MOMENAN, REZA  (contact)",NA,NA,NA,Affect;Alcohol consumption;alcohol craving;alcohol measurement;alcohol use disorder;Alcohols;Anterior;Area;Behavioral;Beverages;Bilateral;Brain;Brain region;caudate nucleus;Cephalic;cingulate cortex;cingulate gyrus;Cities;college;comorbidity;Control Groups;craving;Cues;Data;Data Analyses;Desire for food;Double-Blind Method;emotion regulation;Exhibits;Feedback;follow-up;Food;food craving;Functional Magnetic Resonance Imaging;Image;Impulsivity;Individual;Inpatients;Insula of Reil;Left;neural;neurofeedback;Neurons;neurophysiology;neuroregulation;New York;Outcome;Pain;Participant;Patient Self-Report;Pattern;Phase II Clinical Trials;Placebo Control;Precentral gyrus;Protocols documentation;putamen;Randomized;Regulation;repetitive transcranial magnetic stimulation;response;Rewards;somatosensory;success;Superior temporal gyrus;symposium;Time;Ventral Striatum;visual processing,Neuromodulation Applications in Alcohol Use Disorder,126,NA,NA,NA,NA,5,NA,NA,396682,NA
11190646,ZIA,AA,1,N,NA,NA,NA,NA,ZIAAA000130,NA,NA,1ZIAAA000130-08,NIAAA:6107809\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM,NA,NA,NA,15205950 (contact),"SCHWANDT, MELANIE  (contact)",NA,NA,NA,addiction;Adult;adverse childhood events;Aggressive behavior;Albumins;Alcohol abuse;alcohol abuse therapy;alcohol behavior;alcohol comorbidity;Alcohol consumption;alcohol cue;Alcohol dependence;alcohol misuse;alcohol rehabilitation;alcohol response;alcohol risk;alcohol seeking behavior;alcohol sensitivity;alcohol use disorder;Alcohol withdrawal syndrome;Alcoholic Hepatitis;Alcoholism;Alcohols;Annual Reports;anxiety symptoms;Archives;Back;Behavior;behavior measurement;behavioral health;binge drinking;biobehavior;Biochemical;Biological Markers;Body mass index;Boston;Brain;Buffers;cardiometabolism;Cardiovascular system;Characteristics;Chronic stress;Cirrhosis;Clinic;Clinical;clinical care;clinical pain;Clinical Research;Collaborations;Collection;comorbidity;Consumption;craving;Data;Data Analyses;data sharing;data submission;Database Management Systems;Databases;Deposition;depressive symptoms;Diagnosis;Dimensions;Disease;disorder control;DNA Methylation;drinking;drinking behavior;early life stress;Electrocardiogram;Eligibility Determination;Emotional;Ensure;Environment;epidemiology study;ethnic disparity;Ethnic Origin;Etiology;Evaluation;Event;exome sequencing;Facial Expression;Fibrosis;follow-up;Food;Foundations;Future;Gender;Genes;Genetic;Genetic Predisposition to Disease;genetic variant;Genetic Variation;Genome;genome wide association study;genomic data;Genomics;Genotype;Goals;Hepatology;Heterogeneity;Human;human data;hypothalamic-pituitary-adrenal axis;Image;Immunoglobulins;Impairment;Impulsivity;Indiana;Individual;Individual Differences;Inflammation;inpatient service;Inpatients;Investigation;Ions;iron metabolism;Laboratories;Laboratory Research;Life;Link;Liver;Lupus;Machine Learning;Major Depressive Disorder;Manuscripts;Measurement;Measures;medical schools;Mental Depression;Mental Health;Metabolic;Metals;methylation pattern;Micronutrients;Modeling;Monitor;National Institute of Drug Abuse;National Institute on Alcohol Abuse and Alcoholism;Natural History;Neurobiology;neurogenetics;neuroimaging;Nicotine;Office Management;Oral health;Outcome;Outpatients;Pain;participant enrollment;participant retention;Patient Admission;Patients;Pattern;Pediatric Hospitals;pediatric trauma;Personal Satisfaction;Personality;phenome;Phenotype;phenotypic data;pleiotropism;polygenic risk score;polysubstance use;Population;Post-Traumatic Stress Disorders;posters;Preparation;Prevalence;prevent;problem drinker;programs;Protocols documentation;psychiatric comorbidity;Psychiatric Diagnosis;Psychopathology;Public Health;Publications;Publishing;quality assurance;Quality of life;Race;racial disparity;Receptor Gene;Recovery;Relapse;Reporting;repository;Research;Research Personnel;Research Project Grants;resilience;resilience scale;Resource Sharing;Resources;response;Rest;reward anticipation;Risk Factors;Role;Safety;Sampling;screening;Series;Severities;Sex Differences;sleep quality;Smoking;Smoking and Health Research;SNP genotyping;Social support;Standardization;Stress;stressor;Subgroup;Substance abuse problem;substance use;suicidal;Taste Buds;Therapeutic;timeline;Tissues;Trauma;trend;United States;United States National Institutes of Health;Universities;volunteer;Weight;Work,NIAAA Repository/Screening Database Management and Research,130,NA,NA,NA,NA,8,NA,NA,6107809,NA
11190647,ZIA,AA,1,N,NA,NA,NA,NA,ZIAAA000137,NA,NA,1ZIAAA000137-04,NIAAA:161593\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM,NA,NA,NA,78351012 (contact),"JOSEPH, PAULE  (contact)",NA,NA,NA,addiction;Addictive Behavior;Animal Model;Behavior;Biological;Brain;Brain region;brain shape;Cessation of life;Chronic;Clinical;Collaborations;Consumption;Corpus striatum structure;Cues;design;Detection;Diet;diet-induced obesity;dietary;Dietary Intervention;differential expression;Discrimination;Disease;Eating Behavior;Electrophysiology (science);Energy Intake;Esthesia;Extramural Activities;Fatty acid glycerol esters;Food;Gene Expression;Genes;Genetic;Genomics;Goals;gut-brain axis;Health;hedonic;High Fat Diet;Immune;immune function;improved;Incidence;Inflammation;interest;International;Intervention;Journals;Mediator;Metabolic dysfunction;Metabolic Pathway;Metabolism;Methods;misuse of prescription only drugs;mitochondrial dysfunction;Molecular;Mus;Mutation;Neurobiology;neuronal circuitry;Neurons;Obese Mice;Obesity;olfactory bulb;Olfactory Cortex;opioid overdose;opioid use;opioid use disorder;optogenetics;Oxidative Stress;Pain;pain perception;Paper;Pathway interactions;pharmacologic;Phenotype;Physiological;pleasure;Population;preclinical study;prescription pain reliever;Property;Proteins;Protocols documentation;Publishing;Quality of life;Research;response;reward circuitry;Rewards;Role;Science;Sensory;sensory system;Smell Perception;Substance Use Disorder;sugar;Taste Perception;Taste preferences;Techniques;Testing;Tissues;transcriptome;transcriptome sequencing;transcriptomics;Translating,"Neurobiology of chemosensation, reward and eating behaviors; molecular and neuronal mechanisms along the gut-brain-axis in animal models",137,NA,NA,NA,NA,4,NA,NA,161593,NA
11190648,ZIA,AA,1,N,NA,NA,NA,NA,ZIAAA000355,NA,NA,1ZIAAA000355-04,NIAAA:1246202\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM,NA,NA,NA,78340838 (contact),"CINAR, RESAT  (contact)",NA,NA,NA,Acute Lung Injury;Affect;Alcohol consumption;alcohol use disorder;Alcohols;Alveolar Macrophages;Animal Model;antagonist;antifibrotic treatment;Bleomycin;cannabinoid receptor antagonist;Cannabinoids;cell injury;Cells;Chemicals;Chronic;chronic alcohol ingestion;Chronic Disease;Clinical Medicine;CNR1 gene;Collaborations;Complex;Cre lox recombination system;Deposition;Development;Disease;Disease Progression;Drug Delivery Systems;Economic Burden;Endocannabinoids;Etiology;Extracellular Matrix;Fibroblasts;Fibrosis;Functional disorder;Goals;Hermanski-Pudlak Syndrome;Human;Hybrids;idiopathic pulmonary fibrosis;Immunity;improved;indium-bleomycin;Inflammation;Inflammatory;inhibitor;Injury;insight;interest;Interleukin-11;Knockout Mice;Liver;Lung;Lung Diseases;lung health;lung injury;Magnetic Resonance Imaging;male;Medical;Metabolic;Mitochondria;Modality;Modeling;Molecular;mortality;mouse model;multiple omics;Mus;Mutant Strains Mice;National Human Genome Research Institute;National Institute on Alcohol Abuse and Alcoholism;new therapeutic target;NOS2A gene;novel therapeutics;Organ;Outcome;Outcomes Research;Oxidative Stress;Pathogenicity;Pathologic;Pathologic Processes;Pathology;Pathway interactions;Patients;Peripheral;Pharmaceutical Chemistry;Pharmacology;Pharmacotherapy;Physiology;Pneumonia;problem drinker;Process;Publishing;Pulmonary Fibrosis;pulmonary function;rare genetic disorder;Recommendation;Research;Research Project Grants;Role;Route;Safety;Scientist;Scleroderma;Secondary to;sexual dimorphism;skin fibrosis;Study Section;System;Systems Biology;targeted treatment;Testing;Therapeutic;therapeutic candidate;therapeutic target;tissue injury;translational medicine;Treatment Efficacy;wound healing,Fibroproliferative mechanisms in organ fibrosis,355,NA,NA,NA,NA,4,NA,NA,1246202,NA
11190649,ZIA,AA,1,N,NA,NA,NA,NA,ZIAAA000360,NA,NA,1ZIAAA000360-04,NIAAA:1202847\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM,NA,NA,NA,78340840 (contact),"IYER, MALLIGA  (contact)",NA,NA,NA,Acute;Acute Lung Injury;Adenosine Monophosphate;Affect;Affinity;Agonist;Alcohol consumption;analog;antagonist;Anti-diabetic Drugs;Anti-Obesity Agents;Arachidonic Acids;Architecture;arm;Attenuated;Biguanides;Binding;Biochemical;Biological;Biological Assay;Biological Availability;Biological Process;Body Weight;Brain;brain dysfunction;cannabinoid receptor;CB1 receptor antagonist;Cell membrane;Cell Nucleus;Cells;chemical synthesis;Chronic Disease;Clinic;Clinical;CNR1 gene;CNR2 gene;Complex;Cytochrome P450;Derivation procedure;design;Development;Diabetic Nephropathy;diet-induced obesity;Disease;Drug or chemical Tissue Distribution;Drug Targeting;Eating;Eicosanoids;endogenous cannabinoid system;Enzymes;Epoxide hydrolase;Evaluation;Fatty acid glycerol esters;Fluorescence;G-Protein-Coupled Receptors;Generations;Glean;glucose tolerance;Goals;Half-Life;Human;human disease;improved;In Vitro;in vivo;Inflammatory;inflammatory marker;inhibitor;Insulin Resistance;insulin sensitivity;Intraperitoneal Injections;Investigation;Kinetics;Laboratories;lead candidate;lead optimization;Legal patent;Licensing;Ligands;Magnetic Resonance Imaging;Mediating;Metabolic;Metabolic syndrome;Metformin;Methodology;Methods;Modeling;Molecular;mouse model;Names;NOS2A gene;novel;novel therapeutics;Obese Mice;Obesity;Oral;Oral Administration;oxidation;Pain management;pain model;Pathway interactions;Penetrance;Penetration;Peripheral;personalized medicine;Pharmaceutical Chemistry;Pharmaceutical Preparations;pharmacologic;phase I trial;Phase II Clinical Trials;phase II trial;Phosphotransferases;Physiological;programs;Property;Pyrazoles;radioligand;reduced food intake;Reflex action;Reporting;Resolution;response;rimonabant;Rodent Model;Role;Safety;scaffold;sensor;Series;side effect;Signal Pathway;Specificity;Structure;Structure-Activity Relationship;Tail;targeted agent;Testing;tool;trafficking;Work,Novel Cannabinoid Receptor Modulators,360,NA,NA,NA,NA,4,NA,NA,1202847,NA
11190650,ZIA,AA,1,N,NA,NA,NA,NA,ZIAAA000369,NA,NA,1ZIAAA000369-23,NIAAA:2809173\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM,NA,NA,NA,1869201 (contact),"GAO, BIN  (contact)",NA,NA,NA,Acetaldehyde;Actins;Acute;Adenosine;Adenoviruses;Affect;Aging;alcohol abuse therapy;Alcohol consumption;alcohol use disorder;Alcoholic Hepatitis;Alcoholic Liver Diseases;aldehyde dehydrogenases;angiogenesis;Angiogenesis Inhibition;Area;Attenuated;Automobile Driving;Bile fluid;Bioinformatics;capsule;Carbon Tetrachloride;Cell Death Induction;Cells;Chronic;chronic liver disease;Complement 1q;Data;Diethylnitrosamine;drinking behavior;Drug Metabolic Detoxication;Encapsulated;Environment;Ethanol;Ethanol Metabolism;Excision;Excretory function;fatty liver disease;Gastrointestinal tract structure;Gene Delivery;Genetic;Goals;gut-liver axis;Hepatic;Hepatic Stellate Cell;Hepatocarcinogenesis;Hepatocyte;Homologous Protein;Hypoxia;Hypoxia Inducible Factor;IL8 gene;Immune;Immunologics;Immunosuppression;implantation;In Vitro;in vivo;Infiltration;Inflammation;Inflammatory;Injections;Injury;Knockout Mice;Laboratories;Lesion;Liver;liver cancer model;liver cell proliferation;liver inflammation;liver injury;liver repair;Macrophage;Malignant Epithelial Cell;Malignant neoplasm of liver;Mediating;microRNA delivery;MicroRNAs;Modeling;monocyte;Morbidity - disease rate;mortality;mouse model;Mus;Myeloid Cells;Natural regeneration;Necrosis;Necrotic Lesion;necrotic tissue;neoplastic cell;neutrophil;new therapeutic target;notch protein;Organ;Pathogenesis;Pathway interactions;patient subsets;PD-1/PD-L1;Persons;Pharmacological Treatment;Play;Primary carcinoma of the liver cells;programmed cell death ligand 1;programmed cell death protein 1;recruit;Regimen;repaired;Resistance;Resolution;RNA analysis;Role;Serum;Signal Transduction;Site;Smooth Muscle;T-Lymphocyte;Therapeutic;transcription factor;transcriptome sequencing;tumor;tumor hypoxia;tumor microenvironment;Wild Type Mouse,Pathogenesis and Novel Therapeutic Targets of Fatty Liver Disease and Cancer,369,NA,NA,NA,NA,23,NA,NA,2809173,NA
11190651,ZIA,AA,1,N,NA,NA,NA,NA,ZIAAA000375,NA,NA,1ZIAAA000375-19,NIAAA:2195535\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM,NA,NA,NA,8823580 (contact),"PACHER, PAL  (contact)",NA,NA,NA,2-arachidonylglycerol;Acetaldehyde;Acquired Immunodeficiency Syndrome;acute liver injury;Acute Renal Failure with Renal Papillary Necrosis;Age;age related;age related biomarkers;Aging;Agonist;Alcohol consumption;alcohol use disorder;Alcohols;Animal Disease Models;Animal Experiments;Animal Model;Antibodies;antinociception;Attenuated;Behavior;Bile fluid;Biological Assay;Biological Availability;Blood;Brain;cardiometabolism;Cardiomyopathies;Cardiovascular Diseases;cardiovascular injury;Cardiovascular Physiology;cardiovascular risk factor;Cardiovascular system;Cell Death;Cells;Chronic;chronic alcohol ingestion;Clinical;clinical development;clinically relevant;CNR1 gene;CNR2 gene;Collaborations;Complex;Coupled;Development;digital;Disease;Dose;Drug Kinetics;endocannabinoid signaling;Endocannabinoids;endogenous cannabinoid system;Enzymes;Excretory function;Fibrosis;Functional disorder;Future;G-Protein-Coupled Receptors;Gastrointestinal tract structure;gut-liver axis;Heart;Heart failure;hepatoprotective;Human;humanized mouse;improved;In Vitro;industry partner;Inflammation;Inflammatory;Injury to Kidney;innovation;Institution;Ischemia;Kidney;Kidney Diseases;Laboratories;Left;Ligands;Lipids;Liver;Liver diseases;liver injury;MAGL inhibitor;Metabolic;Methods;minority patient;Modeling;Molecular;Monoacylglycerol Lipases;mouse model;Mus;Nature;neuroinflammation;new therapeutic target;nitrosative stress;non-alcoholic fatty liver disease;novel therapeutic intervention;Oral;Oxidative Stress;Pain;Pathology;Pathway interactions;Peripheral;Peripheral arterial disease;Pharmaceutical Preparations;pharmacologic;Play;Poly(ADP-ribose) Polymerases;Positioning Attribute;potential biomarker;Pre-Clinical Model;preclinical study;Property;Proprotein Convertases;Pyrazoles;Radiolabeled;Rattus;Reperfusion Injury;Reperfusion Therapy;Reporting;Research;Research Personnel;Role;screening;Serum;Signal Transduction;Source;Stress;Subtilisins;targeted biomarker;Therapeutic;therapeutic biomarker;therapeutic target;tissue injury;Tissues;Uncertainty;Universities;Ureteral obstruction;Validation;Ventricular;Work,Mechanism of oxidative/nitrosative stress and inflammation-induced tissue injury,375,NA,NA,NA,NA,19,NA,NA,2195535,NA
11190652,ZIA,AA,1,N,NA,NA,NA,NA,ZIAAA000440,NA,NA,1ZIAAA000440-05,NIAAA:1477472\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM,NA,NA,NA,77844086 (contact),"ANTOINE, MICHELLE  (contact)",NA,NA,NA,Achievement;adolescent with autism spectrum disorder;Adverse effects;Age;Amphetamines;Animal Care and Use Committees;Animal Model;Animals;Antipsychotic Agents;Area;aripiprazole;ASD patient;associated symptom;autism spectrum disorder;autism symptoms;autistic children;Behavior;Behavioral;Benign;Body Temperature;Brain;Brain region;Cells;Certification;Child;Clinical;Cocaine;Communication;COVID-19 pandemic;Development;Diagnostic;Disease;DNA Sequence Alteration;effective therapy;Exhibits;Exposure to;extreme heat;Fever;Future;Genetic;genetic variant;Goals;Hyperactivity;improved;individuals with autism spectrum disorder;Infection;Innovative Therapy;insight;interest;Knowledge;Learning;Manuscripts;Mediating;Medicine;model of autism spectrum disorder;Modeling;neural circuit;Neurons;new therapeutic target;Normal Range;Patients;Pharmaceutical Preparations;pharmacologic;Predisposition;Process;Protocols documentation;reduce symptoms;repetitive behavior;Reporting;Research;response;Risperidone;Seizures;Symptoms;Temperature;United States Food and Drug Administration;voltage gated channel,Deciphering the mechanisms mediating the dichotomous effects of fever on brain function and behavior,440,NA,NA,NA,NA,5,NA,NA,1477472,NA
11190653,ZIA,AA,1,N,NA,NA,NA,NA,ZIAAA000455,NA,NA,1ZIAAA000455-03,NIAAA:608850\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM,NA,NA,NA,78857770 (contact),"KESNER, ANDREW  (contact)",NA,NA,NA,Abstinence;Acetylcholine;Action Potentials;Affect;Animal Model;Animals;Annual Reports;Appetitive Behavior;Apple;Architecture;Area;Arousal;Automobile Driving;Behavior;Behavioral Model;Blood Pressure;Brain;brain circuitry;Brain region;Calcium;Cannabis;cannabis cessation;cannabis withdrawal;CNR1 gene;cognitive enhancement;cohort;Consumption;Control Groups;Cues;Custom;Data;designer receptors exclusively activated by designer drugs;Dopamine;Drops;Drug usage;Drug Withdrawal Symptoms;Electroencephalography;Electronic Nicotine Delivery Systems;Endocannabinoids;Exposure to;Fiber;Flavoring;flexibility;gamma-Aminobutyric Acid;Glutamates;Goals;High Prevalence;Homing;Illicit Drugs;in vivo;Individual;Inhalation;Injections;interest;Intraperitoneal Injections;Journals;Learning;Legal;maladaptive behavior;marijuana use;marijuana use disorder;marijuana user;Measures;Medial;Mediating;Methodology;Methods;Modeling;Morphologic artifacts;motivated behavior;Motivation;Mus;National Institute of Environmental Health Sciences;Nature;neural;neural circuit;neuromechanism;Neuromodulator;Neurons;Neurotransmitters;Nucleus Accumbens;Peer Review;Photometry;Plasma;pre-clinical;presynaptic neurons;Presynaptic Terminals;Procedures;Process;programs;Property;Proteins;Psychological reinforcement;Psychotropic Drugs;Publications;Publishing;Rattus;receptor;Records Controls;reduce symptoms;Reinforcement Schedule;Relapse;REM Sleep;Reporting;Research;Research Personnel;Resistance;response;Retrieval;reward circuitry;Rewards;Role;Route;Self Administration;sensor;Signal Transduction;Sleep;sleep behavior;Sleep disturbances;Specificity;Stimulus;substance misuse;substance use;Substance Use Disorder;synergism;System;Techniques;Tetrahydrocannabinol;THC concentration;timeline;Training;Transgenic Organisms;trend;vapor;vaporization;vigilance;Withdrawal;Withdrawal Symptom;Work,Understanding interactions between brain reward and sleep systems in driving maladaptive behaviors,455,NA,NA,NA,NA,3,NA,NA,608850,NA
11190654,ZIA,AR,1,N,NA,NA,NA,NA,ZIAAR041232,NA,NA,1ZIAAR041232-03,NIAMS:3661767\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES,NA,NA,NA,78876939 (contact),"HASNI, SARFARAZ  (contact)",NA,NA,NA,Adult;Affect;Atherosclerosis;Autoimmune;Biological;Biological Markers;biomarker identification;Blood;Blood flow;Blood Vessels;candidate marker;Cardiovascular system;Caring;Clinical;Clinical Trials;comorbidity;Consultations;COVID-19;Data;Diagnosis;Disease;disease natural history;Drug Monitoring;Eligibility Determination;Endothelium;Enrollment;Genetic study;Glucocorticoids;Goals;healthy volunteer;Image;Immune system;Informed Consent;Laboratories;Laboratory Study;Longterm Follow-up;Lupus;Lupus Nephritis;Medical;Natural History;Observational Study;Organ;Outcome;Pathogenesis;Pathogenicity;patient subsets;Patients;pediatric patients;Physical Examination;Physicians;premature atherosclerosis;Prognosis;Protocols documentation;Publications;Recommendation;Recording of previous events;Reporting;Research;research study;response;Risk;sample collection;Sampling;Severities;Skin;Specimen;systemic autoimmunity;systemic inflammatory response;Systemic Lupus Erythematosus;Testing;Therapeutic immunosuppression;Toxic effect;United States National Institutes of Health;Urine;Vaccines;Validation;Vascular Diseases;vascular inflammation;Viral,Lupus Clinical Trials,41232,NA,NA,NA,NA,3,NA,NA,3661767,NA
11190655,ZIA,CL,1,N,NA,NA,NA,NA,ZIACL008063,NA,NA,1ZIACL008063-21,NA,INTRAMURAL RESEARCH,2024,CLINICAL CENTER,NA,NA,NA,NA,NA,NA,NA,NA,CLINICAL CENTER,NA,NA,NA,2432508 (contact),"SUFFREDINI, ANTHONY F. (contact)",NA,NA,NA,Acinetobacter baumannii;Acute Lung Injury;Acute Respiratory Distress Syndrome;Allergic Bronchopulmonary Aspergillosis;Animal Model;Anti-Inflammatory Agents;Antibiotics;Aspergillus;Bacteria;Bacterial Infections;beta-Lactamase;Biological;Biological Markers;Biological Models;biomarker identification;Blood;Bronchoalveolar Lavage;Bronchoalveolar Lavage Fluid;Bronchoscopy;Burkholderia cepacia complex;candidate identification;candidate marker;canine model;carbapenemase;Cells;Censuses;Childhood;chymotrypsin;Clinical;clinical application;clinical center;clinical diagnosis;Clinical Microbiology;co-infection;colistin resistance;Collection;Communities;Complement;Culture-independent methods;Cytomegalovirus;Databases;Detection;Diagnosis;diagnostic biomarker;Diagnostic Procedure;Digestion;Elements;Engraftment;Enrollment;Enzymes;Etiology;Excision;expectation;Family;Gene Expression Profile;genomic data;Goals;Heart;High Pressure Liquid Chromatography;Immune response;Immunity;Immunoassay;improved;in vivo;Individual;Infection;Infiltration;Inflammation;Informed Consent;interest;Ions;Klebsiella pneumoniae;Label;Laboratories;Lavage;Leukocytes;Link;liquid chromatography mass spectrometry;Lung;Lung Diseases;Lung infections;lung pathogen;Malignant Neoplasms;Mass Spectrum Analysis;Measures;Methods;microorganism;Modeling;Moraxella catarrhalis;multiplex assay;mycobacterial;Mycoses;novel diagnostics;novel strategies;opportunistic pathogen;Oryctolagus cuniculus;Outcome;pandemic disease;Parasitic infection;Participant;participant enrollment;pathogen;pathogenic fungus;pathogenic microbe;patient oriented;Patients;Pattern;Peptides;Pneumonia;pneumonia model;pre-pandemic;Process;Prognostic Marker;Protein Analysis;protein biomarkers;protein expression;Proteins;Proteomics;Protocols documentation;Pseudomonas aeruginosa;Pulmonary Inflammation;Research;Research Personnel;Resolution;response;Sampling;Sensitivity and Specificity;Serum;Source;specific biomarkers;Specific qualifier value;Specificity;Specimen;Stains;Staphylococcal Pneumonia;Stenotrophomonas maltophilia;Sterility;study population;Syndrome;System;Techniques;Time;Trypsin;Two-Dimensional Gel Electrophoresis;Virus Diseases,Diagnostic and Prognostic Biomarkers in Pneumonia,8063,NA,NA,NA,NA,21,NA,NA,0,NA
11190656,ZIA,CL,1,N,NA,NA,NA,NA,ZIACL009024,NA,NA,1ZIACL009024-08,NA,INTRAMURAL RESEARCH,2024,CLINICAL CENTER,NA,NA,NA,NA,NA,NA,NA,NA,CLINICAL CENTER,NA,NA,NA,15186973 (contact),"CHERTOW, DANIEL S (contact)",NA,NA,NA,Acute;Admission activity;Africa;Aliquot;Antibody Response;Bacteremia;Biological Assay;Blood specimen;Caring;Clinical;clinical center;Clinical Data;Clinical Trials;Convalescence;Critical Illness;Data;Databases;Diagnostic;Disease Outbreaks;Ebola;Ebola Hemorrhagic Fever;Ebola virus;efficacy evaluation;Electronics;Enrollment;Epidemiology;Flow Cytometry;Genetic;Genetic Transcription;Glycoproteins;Goals;Immunophenotyping;improved;Individual;Infection;Kinetics;Laboratories;Leukocytes;Liberia;Link;longitudinal analysis;Love;mathematical model;Molecular;Multiple Organ Failure;National Institute of Allergy and Infectious Disease;Natural History;older men;Outcome;pathogen;Patients;peripheral blood;Peripheral Blood Mononuclear Cell;Plasma Proteins;Proteome;Proteomics;Publishing;Recovery;Recrudescences;Research;response;Seminal fluid;Serum;Sierra Leone;single cell sequencing;Specimen;Supportive care;Survivors;Therapeutic;Time;United States National Institutes of Health;Vaccine Design;Viral;Viral Load result;Work,Clinical and Molecular Features of Ebola Virus Disease,9024,NA,NA,NA,NA,8,NA,NA,0,NA
11190657,ZIA,CL,1,N,NA,NA,NA,NA,ZIACL010523,NA,NA,1ZIACL010523-10,NA,INTRAMURAL RESEARCH,2024,CLINICAL CENTER,NA,NA,NA,NA,NA,NA,NA,NA,CLINICAL CENTER,NA,NA,NA,6480151 (contact),"GRADY, CHRISTINE P (contact)",NA,NA,NA,California;COVID-19 impact;COVID-19 pandemic effects;Data Analyses;Data Collection;Distress;Ethical Issues;Ethics;experience;Healthcare;Individual;Maryland;Massachusetts;member;Morals;Nurses;Ohio;Outcome;Patients;Personal Satisfaction;professional atmosphere;Registered nurse;Social Workers;Surveys;Time,Ethical Experiences of Registered Nurses,10523,NA,NA,NA,NA,10,NA,NA,0,NA
11190658,ZIA,CL,1,N,NA,NA,NA,NA,ZIACL090045,NA,NA,1ZIACL090045-08,NA,INTRAMURAL RESEARCH,2024,CLINICAL CENTER,NA,NA,NA,NA,NA,NA,NA,NA,CLINICAL CENTER,NA,NA,NA,15187039 (contact),"KADRI, SAMEER  (contact)",NA,NA,NA,"Academic Medical Centers;Acute;Admission activity;Adrenal Cortex Hormones;Alberta province;Algorithms;Antibiotics;Antimicrobial Resistance;Bacterial Infections;beta-Lactams;Big Data;Biological Markers;Body mass index;booster vaccine;burden of illness;Canada;Candidiasis;Cardiac;Caring;Characteristics;Clindamycin;Clinical;Clinical Data;clinical epidemiology;Clinical Trials;Code;cohort;Collaborations;Communicable Diseases;Communities;community transmission;Consensus;cost;Country;COVID-19;COVID-19 mortality;COVID-19 pandemic;COVID-19 patient;COVID-19 risk;Critical Care;Critical Illness;cytokine;cytokine release syndrome;Data;Data Set;Death Rate;Development;Disease;Dose;drug repurposing;Electronic Health Record;epidemiologic data;Epidemiology;Exotoxins;FDA Emergency Use Authorization;Frequencies;Functional disorder;Generations;health care delivery;health care disparity;Healthcare;Hematologic Neoplasms;Heterogeneity;Hospital Mortality;Hospitalization;Hospitals;Hydroxychloroquine;Immune;improved;improved outcome;Incidence;indexing;Infection;infection rate;Inflammation;interest;Intravenous Immunoglobulins;Intubation;Investigation;Literature;Lower Respiratory Tract Infection;lung injury;Machine Learning;Measures;Mediating;medical schools;Medicine;Meta-Analysis;Methods;Modeling;Morbidity - disease rate;mortality;Mortality Decline;mortality risk;Movement;Necrotizing fasciitis;Obesity;Observational Study;Oncology;Ontario;opioid use;opioid user;Organ;Outcome;Outcome Study;pandemic disease;Patient Admission;Patient Care;Patient Transfer;Patient-Focused Outcomes;Patients;Pattern;Performance;Pharmaceutical Preparations;Population;pre-pandemic;Prevalence;procalcitonin;Provider;Publishing;Quality of Care;randomized trial;Randomized, Controlled Trials;repository;Research;Research Personnel;Resources;respiratory;Risk;Risk Adjustment;Risk Factors;Rural;SARS-CoV-2 B.1.1.529;SARS-CoV-2 infection;Sepsis;Septic Shock;Severities;Severity of illness;Shock;smoke inhalation;Streptococcal Infections;Streptococcus Group B;Streptococcus pyogenes;Surveys;systematic review;T cell therapy;T-Lymphocyte;Testing;Therapeutic;Time;Toxic effect;trend;Triage;Undifferentiated;United States;uptake;US State;Vaccination;Vaccinee;Validation;Variant;variants of concern;Vasoconstrictor Agents;ventilation;Ventilator",Big Data - Epidemiology of Critical Illness and Sepsis,90045,NA,NA,NA,NA,8,NA,NA,0,NA
11190659,ZIA,CL,1,N,NA,NA,NA,NA,ZIACL090046,NA,NA,1ZIACL090046-08,NA,INTRAMURAL RESEARCH,2024,CLINICAL CENTER,NA,NA,NA,NA,NA,NA,NA,NA,CLINICAL CENTER,NA,NA,NA,15187039 (contact),"KADRI, SAMEER  (contact)",NA,NA,NA,acquired factor;Admission activity;Aminoglycosides;Antibiotic Resistance;Antibiotic Therapy;Antibiotics;antimicrobial;Antimicrobial Resistance;Bacteremia;beta-Lactams;Big Data;Blood;Carbapenems;Ceftazidime;Cephalosporin Resistance;Clinical;clinical database;Clinical effectiveness;clinically relevant;Colistin;Collaborations;Combined Antibiotics;Communicable Diseases;Communities;Consensus;Correlation Studies;COVID-19 pandemic;Critical Care;Data;Development;digital repositories;drug resistant pathogen;Electronic Health Record;epidemiologic data;Equipoise;Failure;Fluoroquinolones;Funding;Future;future pandemic;Health;Hospitals;improved;In Vitro;Industry;Infection;infection rate;Inpatients;Journals;Levaquin;Manuscripts;Marketing;Mediator;Medicine;meetings;Minimum Inhibitory Concentration measurement;mortality risk;Needs Assessment;New Agents;next generation;novel;Outcome;Outcomes Research;pathogen;Patients;Pattern;Phenotype;point-of-care diagnostics;Polymyxin B;Population;Predisposition;Prevalence;Prevalence Study;Publishing;Rapid diagnostics;repository;Research Personnel;Residual state;Resistance;Resistance profile;Risk Adjustment;Risk Factors;Role;Sepsis;Societies;Staphylococcus aureus;Stenotrophomonas maltophilia;Stream;Survival Rate;Testing;tigecycline;trend;trial comparing;Trimethoprim-Sulfamethoxazole;United States National Institutes of Health;Work,Big Data- Epidemiology of Antimicrobial Resistance,90046,NA,NA,NA,NA,8,NA,NA,0,NA
11190660,ZIA,CL,1,N,NA,NA,NA,NA,ZIACL090047,NA,NA,1ZIACL090047-08,NA,INTRAMURAL RESEARCH,2024,CLINICAL CENTER,NA,NA,NA,NA,NA,NA,NA,NA,CLINICAL CENTER,NA,NA,NA,15186973 (contact),"CHERTOW, DANIEL S (contact)",NA,NA,NA,animal care;Animal Model;Animals;Antibiotics;Bacteremia;Clinical;Clinical Management;Critical Care;Critical Illness;Diagnosis;Dose;Ebola virus;Emerging infection;Escherichia coli;Failure;Functional disorder;Goals;Human;Immunologics;improved;Individual;Infection;Intensive Care Units;Intervention Trial;Klebsiella pneumoniae;Manuscripts;Modeling;Molecular;National Institute of Allergy and Infectious Disease;Organ;Pathogenesis;Peer Review;Phylogenetic Analysis;Physiological;Pilot Projects;Prevention approach;Publications;Publishing;Research;research facility;response;Sepsis;Severities;Supportive care;Syndrome;targeted treatment;Virus Diseases;Work,Animal Models of Emerging Viral Infection,90047,NA,NA,NA,NA,8,NA,NA,0,NA
11190661,ZIA,CL,1,N,NA,NA,NA,NA,ZIACL090052,NA,NA,1ZIACL090052-08,NA,INTRAMURAL RESEARCH,2024,CLINICAL CENTER,NA,NA,NA,NA,NA,NA,NA,NA,CLINICAL CENTER,NA,NA,NA,9692744 (contact),"QUEZADO, ZENAIDE  (contact)",NA,NA,NA,autism spectrum disorder;Behavior;behavior change;Behavioral;behavioral response;Belief;Caring;chronic pain;Communication;Communication impairment;comorbidity;Conscious;Development;Developmental Disabilities;Disadvantaged;Disease;Dyskinetic syndrome;Electroencephalography;Esthesia;experience;Face;functional near infrared spectroscopy;Galvanic Skin Response;Gene Mutation;Heart Rate;hemodynamics;High Prevalence;Hip region structure;Human;Immobilization;Impaired cognition;Incidence;indexing;Individual;Intellectual functioning disability;Judgment;Limb structure;Medical;Methods;Mobility decline;motor impairment;mouse model;Muscle Contraction;Mydriasis;Nature;Nervous System;neural;Neurobiology;Nociception;Operative Surgical Procedures;Osteopenia;Pain;Pain Measurement;pain processing;Pain Research;pain sensitivity;Pathological fracture;Patient Self-Report;Patients;Pattern;physically handicapped;Physiological;Population;Problem Solving;Rare Diseases;Reporting;Research;Research Personnel;response;Risk;Sampling;scoliosis;severe intellectual disability;skeletal abnormality;skills;social;somatosensory;Source;spasticity;spatial relationship;Spectrum Analysis;Stimulus;subluxation;Temporal Lobe;Thinking;verbal;Vulnerable Populations,Neurobiology of pain and behavior changes associated with rare diseases and developmental disabilities,90052,NA,NA,NA,NA,8,NA,NA,0,NA
11190662,ZIA,CL,1,N,NA,NA,NA,NA,ZIACL090053,NA,NA,1ZIACL090053-08,NA,INTRAMURAL RESEARCH,2024,CLINICAL CENTER,NA,NA,NA,NA,NA,NA,NA,NA,CLINICAL CENTER,NA,NA,NA,9692744 (contact),"QUEZADO, ZENAIDE  (contact)",NA,NA,NA,"Acute Pain;Advocacy;African ancestry;Agammaglobulinaemia tyrosine kinase;American Society of Hematology;Analgesics;Behavior;beta Globin;Blood Platelets;Body System;Cell Adhesion Molecules;Chronic;Clinical;Cognitive deficits;Complex;cytokine;Data;Development;diphosphoglycerate;Disease;efficacy testing;Erythrocyte Membrane;Erythrocytes;Etiology;Event;Functional disorder;Genes;Goals;health care disparity;Hematology;Hemoglobin;hemoglobin AA;Hemoglobin concentration result;hemoglobin polymer;Hemolysis;Hepatic;Human;improved;In Vitro;Individual;Inflammasome;Inflammation;Inflammatory;inhibitor;Injury;Leukocytosis;Life Expectancy;Liver;Macrophage;mast cell;Measurement;Mediating;Mitochondria;Molecular;Morbidity - disease rate;mouse model;Mus;Mutation;National Heart, Lung, and Blood Institute;National Institute on Minority Health and Health Disparities;Neutrophil Activation;novel;novel strategies;novel therapeutics;Organ;organ injury;Outcome;Oxidative Stress;Pain;Pain management;pain sensitivity;Parents;Pathway interactions;Patients;pharmacologic;Platelet aggregation;polymerization;Polymers;pre-clinical;preclinical evaluation;programs;Protein Kinase;Pyruvate Kinase;Quality of life;Recurrence;Sickle Cell;Sickle Cell Anemia;Sickle Hemoglobin;sickling;societal costs;Therapeutic;Therapeutic Agents;Thrombus;Vascular Endothelium;Work",Pathobiology of pain in sickle cell disease,90053,NA,NA,NA,NA,8,NA,NA,0,NA
11190663,ZIA,CL,1,N,NA,NA,NA,NA,ZIACL090054,NA,NA,1ZIACL090054-08,NA,INTRAMURAL RESEARCH,2024,CLINICAL CENTER,NA,NA,NA,NA,NA,NA,NA,NA,CLINICAL CENTER,NA,NA,NA,9692744 (contact),"QUEZADO, ZENAIDE  (contact)",NA,NA,NA,"Acute;Acute Pain;Acute pain management;Adjuvant;Adjuvant Analgesic;Admission activity;Adolescent;Adolescent obesity;Adult;Afferent Neurons;Age;Agonist;Analgesics;Anesthetics;Animals;antagonist;antinociception;awake;bariatric surgery;Brain;cancer pain;central sensitization;Cerebrum;Characteristics;Chest Pain;Child;Childhood;Chronic;chronic pain;chronic pain management;Chronic pain syndrome;Clinical;clinical diagnosis;Clinical Research;cohort;Communication Disability;Complex Regional Pain Syndromes;Consensus;Data;design;Development;Developmental Disabilities;Dexmedetomidine;Dose;efficacy testing;experimental study;Expert Opinion;FMR1 gene;Fragile X Syndrome;functional disability;Goals;Hospitals;Human;Hyperalgesia;improved;in vivo;inflammatory pain;Infusion procedures;Inpatients;Ketamine;Laboratories;Location;male;Measurement;Measures;Modeling;Mood Disorders;mouse model;Multivariate Analysis;Mus;N-Methyl-D-Aspartate Receptors;Nitric Oxide;Nociception;non-opioid analgesic;novel;novel strategies;novel therapeutic intervention;Opioid;Opioid Receptor;opioid use;Outpatients;Pain;Pain intensity;Pain management;pain model;pain reduction;pain score;pain sensitivity;painful neuropathy;Participant;Patient Admission;Patients;pediatric patients;Perioperative;Pharmacological Treatment;Phenotype;Postoperative Period;postsynaptic;pre-clinical;Pre-Clinical Model;Property;Protein Biosynthesis;randomized, clinical trials;Rare Diseases;Receptor Activation;Role;safety and feasibility;Sampling;Sedation procedure;sedative;sex;Sickle Cell;Sickle Cell Anemia;side effect;Tonsillectomy;treatment duration;treatment strategy;Visceral pain;Work",Development of novel strategies for the treatment of pain in children,90054,NA,NA,NA,NA,8,NA,NA,0,NA
11190664,ZIA,CL,1,N,NA,NA,NA,NA,ZIACL090070,NA,NA,1ZIACL090070-05,NA,INTRAMURAL RESEARCH,2024,CLINICAL CENTER,NA,NA,NA,NA,NA,NA,NA,NA,CLINICAL CENTER,NA,NA,NA,15186973 (contact),"CHERTOW, DANIEL S (contact)",NA,NA,NA,2019-nCoV;Acute;Autopsy;Biological Markers;Brain;Bronchoalveolar Lavage;Caring;Cellular Tropism;Clinical;clinical center;Clinical Data;Clinical Research;cohort;Collaborations;COVID-19;COVID-19 mortality;COVID-19 pandemic;COVID-19 patient;Critical Illness;Data;Disease;Drug or chemical Tissue Distribution;Evolution;Extracorporeal Membrane Oxygenation;Goals;Human;Human body;Immune;Immune response;Immunologics;improved;Individual;insight;Investigation;Kinetics;Laboratories;Manuscripts;Maryland;Medical center;Molecular;nasopharyngeal swab;Natural History;oropharyngeal swab;participant enrollment;pathogen;pathogenic virus;Pathologic;Peripheral Blood Mononuclear Cell;Plasma;Preparation;preservation;Publishing;Recovery;Research;response;Sampling;severe COVID-19;Therapeutic;thrombotic;United States National Institutes of Health;Universities;unvaccinated;Vaccine Design;Vaccines;Variant;Viral;Virus;Work,Clinical and Molecular Features of Coronavirus Disease 2019,90070,NA,NA,NA,NA,5,NA,NA,0,NA
11190665,ZIA,CL,1,N,NA,NA,NA,NA,ZIACL090111,NA,NA,1ZIACL090111-01,NA,INTRAMURAL RESEARCH,2024,CLINICAL CENTER,NA,NA,NA,NA,NA,NA,NA,NA,CLINICAL CENTER,NA,NA,NA,6480151 (contact),"GRADY, CHRISTINE P (contact)",NA,NA,NA,Benefits and Risks;Clinical Research;Common Good;Communities;Data;Ethics;Human;Informed Consent;Investigation;Literature;Methods;Monitor;Participant;participant enrollment;Publishing;recruit;Research;Research Design;Research Ethics;Science;Social Values,Challenges in Research Ethics,90111,NA,NA,NA,NA,1,NA,NA,0,NA
11190666,ZIA,DK,1,N,NA,NA,NA,NA,ZIADK032103,NA,NA,1ZIADK032103-25,NIDDK:621127\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES,NA,NA,NA,9415259 (contact),"BEWLEY, CAROLE  (contact)",NA,NA,NA,2019-nCoV;Antigens;Binding Sites;Biochemical;Bispecific Antibodies;carbohydrate binding protein;carbohydrate receptor;Carbohydrates;chimeric antibody;Coronavirus;cost;Cryoelectron Microscopy;design;design and construction;Development;Disease;Drug resistance;drug resistance development;Engineering;env Gene Products;Foundations;Glycoproteins;Goals;Hepatitis C virus;HIV;HIV Envelope Protein gp120;HIV-1;HIV/AIDS;Human;Immune system;in vivo;Individual;Infection;inhibitor;Life Expectancy;Local Microbicides;Mannose;Mannose Binding Lectin;Mediating;Natural product discovery;NMR Spectroscopy;novel;Oligosaccharides;Peptides;Polysaccharides;Prevention strategy;Protein Engineering;Proteins;Publications;receptor;receptor binding;Research;Site;small molecule;small molecule inhibitor;small molecule therapeutics;Structure;Therapeutic;Therapeutic Uses;Translating;Translations;Vaccine Design;vaccine development;Vaccines;Viral;Viral Genome;Viral Proteins;Virus;virus envelope;Work;X-Ray Crystallography,"HIV Neutralization Inhibitors: Engineering, characterization, and functions",32103,NA,NA,NA,NA,25,NA,NA,621127,NA
11190667,ZIA,DK,1,N,NA,NA,NA,NA,ZIADK047053,NA,NA,1ZIADK047053-18,NIDDK:373765\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES,NA,NA,NA,15191619 (contact),"KLUBO-GWIEZDZINSKA, JOANNA  (contact)",NA,NA,NA,"Adult;Adverse event;Benign;Blood specimen;cancer cell;Cancer Patient;Cardiac;Case/Control Studies;cohort;Cohort Studies;Confidence Intervals;Diagnosis;Diagnostic;Disease;Disease-Free Survival;Excision;Exclusion;Fine needle aspiration biopsy;follow-up;Guidelines;hazard;Heterogeneity;high risk;immunohistochemical markers;Incidence;Malignant - descriptor;Malignant neoplasm of thyroid;Malignant Neoplasms;Meta-Analysis;Methods;Modeling;Molecular;molecular marker;Multiple Endocrine Neoplasia Type 2a;Natural History;Nodule;Operative Surgical Procedures;Outcome;Outcome Assessment;Outcome Measure;Patient Participation;patient screening;Patients;prevent;primary outcome;Prognosis;Progression-Free Survivals;Protocols documentation;Radioactive Iodine;Randomized, Controlled Trials;Recommendation;Recurrent disease;Reference Values;Relapse;research study;Risk;Role;Sampling;Scanning;screening;secondary outcome;skeletal;Specimen;standard care;Study Subject;survival outcome;systematic review;Techniques;Text;Thyroid Diseases;Thyroid Gland;Thyroid Hormones;Thyroid Nodule;Thyrotropin;Thyrotropin Receptor;Tissues;treatment response;tumor;tumor growth",Studies of Benign and Malignant Thyroid Disease,47053,NA,NA,NA,NA,18,NA,NA,373765,NA
11190668,ZIA,DK,1,N,NA,NA,NA,NA,ZIADK052034,NA,NA,1ZIADK052034-18,NIDDK:3115229\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES,NA,NA,NA,9415465 (contact),"CAMERINI-OTERO, RAFAEL  (contact)",NA,NA,NA,Affect;African;Alleles;base;Binding;Binding Sites;Biochemistry;Biological Assay;Cell Nucleus;Cells;ChIP-seq;Chromatin;chromatin immunoprecipitation;Chromosomes;cohesin;Collaborations;Consensus;CRISPR/Cas technology;CYP2D6 gene;density;Detection;Development;Distant;DNA biosynthesis;DNA sequencing;Drug Prescriptions;Elements;Enhancers;Epigenetic Process;Eukaryota;Exhibits;Foundations;functional genomics;Genes;Genetic Crossing Over;Genetic Determinism;Genetic Predisposition to Disease;Genetic Recombination;Genome;genome-wide;Goals;Health Sciences;Heterozygote;Hi-C;High-Throughput Nucleotide Sequencing;Human;human male;human population genetics;in silico;In Situ;Individual;insight;interest;Laboratories;Libraries;Link;Location;male;mammalian genome;Mammals;Maps;Meiosis;Meiotic Prophase I;Meiotic Recombination;Methods;Methylation;Methyltransferase;Mitotic;Modeling;Molecular Biology;MSH4 gene;Mus;Nature;novel;Nucleosomes;Nucleotides;Organism;Pattern;Play;Population;Positioning Attribute;preference;Preparation;Procedures;Process;promoter;Proteins;Pseudogenes;Replication Initiation;Replication Origin;Resolution;Role;S phase;Science;Sex Bias;Sex Differences;Shapes;Signal Transduction;Single-Stranded DNA;Site;Sorting;Specificity;Spermatocytes;Spermatogenesis;Spermatogonia;SS DNA BP;Technology;telomere;Testis;Time;Transcription Initiation Site;University Health Services;Variant,What determines the location of meiotic crossovers in the mammalian genome?,52034,NA,NA,NA,NA,18,NA,NA,3115229,NA
11190669,ZIA,DK,1,N,NA,NA,NA,NA,ZIADK075021,NA,NA,1ZIADK075021-16,NIDDK:3176124\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES,NA,NA,NA,12672769 (contact),"WESS, JURGEN  (contact)",NA,NA,NA,Acetylcholine;Adenosine;Adipocytes;ADORA2A gene;ADRBK1 gene;Adult;Agonist;Alpha Cell;Arrestin Beta 1;autocrine;beta-arrestin;Binding;Blood Glucose;blood glucose regulation;cell type;Clozapine;Coupled;Coupling;Cre driver;Critical Pathways;designer receptors exclusively activated by designer drugs;Development;Diabetes Mellitus;Disease;drug development;Endowment;Ensure;Enteroendocrine Cell;Family;Functional disorder;G protein coupled receptor kinase;G Protein-Coupled Receptor Signaling;G-Protein-Coupled Receptors;G12 Protein;gain of function;gastric inhibitory polypeptide receptor;Genes;Genetic;Glucagon;Glucose;glucose metabolism;glucose production;glucose tolerance;Goals;GTP-Binding Proteins;Health;Hepatic;Hepatocyte;Homeostasis;Hormones;Human;Hypothalamic structure;Impairment;improved;in vivo;insight;Insulin;Insulin Resistance;insulin sensitivity;Investigation;Investments;islet;Killer Cells;Knockout Mice;Ligands;Link;Lipids;Liver;liver function;loss of function;MAPK8 gene;Mediating;Membrane;Metabolic;metabolic abnormality assessment;Metabolic Diseases;Metabolic Pathway;metabolic phenotype;Methamphetamine;Molecular;mouse model;Mouse Strains;Mus;Muscarinic Acetylcholine Receptor;Muscle Fibers;mutant mouse model;Mutant Strains Mice;Nature;Neurons;Non-Insulin-Dependent Diabetes Mellitus;novel;novel drug class;novel therapeutics;Obesity;overexpression;Oxides;paracrine;Paracrine Communication;Pathway interactions;pharmacologic;Phenotype;Phosphorylation;Physiological;Physiology;Plasma;Play;Point Mutation;Process;proglucagon;Property;receptor;Regulation;ROCK1 gene;Role;Signal Pathway;Signal Transduction;Structure;Structure of alpha Cell of islet;Structure of beta Cell of islet;Tamoxifen;Technology;Therapeutic;Tissues;tool;virtual;Wing;Work,Role of G protein-coupled receptors in regulating glucose and energy homeostasis,75021,NA,NA,NA,NA,16,NA,NA,3176124,NA
11190670,ZIA,DK,1,N,NA,NA,NA,NA,ZIADK075138,NA,NA,1ZIADK075138-08,NIDDK:280324\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES,NA,NA,NA,15191619 (contact),"KLUBO-GWIEZDZINSKA, JOANNA  (contact)",NA,NA,NA,absorption;Adult;Adult women;Adverse event;Aftercare;Agonist;analog;anti-cancer research;Askenazy Cells;Blood;Bone Marrow;Case Series;Clinical;cohort;Diagnosis;Diagnostic Imaging;Dose;Dose Limiting;dosimetry;efficacy evaluation;Enrollment;Evaluable Disease;Event;Exposure to;follow-up;Histologic;improved;in vivo Model;Kidney;lean body mass;Lesion;Liver;male;Malignant - descriptor;Malignant neoplasm of thyroid;Malignant Neoplasms;Methods;molecular targeted therapies;Neuroendocrine Tumors;Normal Range;novel;objective response rate;open label;Organ;Oxyphil Cells;Participant;Patients;Pharmaceutical Preparations;Phase;phase 1 designs;Phase I/II Clinical Trial;Pituitary Gland;pre-clinical;Progression-Free Survivals;Quality of Life Assessment;Questionnaires;Radioactive Iodine;radioiodine therapy;Radiolabeled;Refractory;Regimen;residence;response;Safety;safety study;Somatostatin Receptor;somatostatin receptor 2;Spleen;Standardization;Therapeutic;Thyroglobulin;Thyroglobulin antibody;Thyroid Diseases;Thyroid Gland;Thyroid Nodule;Thyroidectomy;Time;Toxic effect;Treatment Efficacy;tumor;Tumor Markers;United States National Institutes of Health;uptake,Somatostatin receptors in the diagnosis and treatment of thyroid cancer,75138,NA,NA,NA,NA,8,NA,NA,280324,NA
11190671,ZIA,DK,1,N,NA,NA,NA,NA,ZIADK075139,NA,NA,1ZIADK075139-08,NIDDK:560648\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES,NA,NA,NA,15191619 (contact),"KLUBO-GWIEZDZINSKA, JOANNA  (contact)",NA,NA,NA,Age;Benign;cancer risk;Characteristics;Clinical Data;ClinVar;Data;Databases;Diagnostic;diagnostic accuracy;Diagnostic Procedure;DNA;exome sequencing;Family;Follicular thyroid carcinoma;Formalin;Foundations;FUS-1 Protein;General Population;Genomics;Goals;Growth;guanine nucleotide binding protein;improved;KRAS2 gene;Libraries;Malignant - descriptor;Malignant neoplasm of thyroid;Malignant Neoplasms;Methods;Modeling;Molecular;molecular diagnostics;Molecular Profiling;Monomeric GTP-Binding Proteins;Mutation;Nuclear Receptors;Ovarian Teratoma;Papillary thyroid carcinoma;Paraffin Embedding;Pathogenicity;Patients;Process;receptor binding;risk stratification;RNA;RNA Splicing;Role;Sampling;SET Domain;Site;Therapeutic procedure;Thyroglobulin;Thyroid Gland;Thyroid Nodule;Thyroidectomy;Tissue Sample;Tissues;TP53 gene;transcriptome sequencing;transcriptomics;tumor;Tumor Tissue;ultrasound;Unnecessary Surgery;Variant;Woman,Application of molecular diagnostics in thyroid cancer,75139,NA,NA,NA,NA,8,NA,NA,560648,NA
11190672,ZIA,DK,1,N,NA,NA,NA,NA,ZIADK075140,NA,NA,1ZIADK075140-08,NIDDK:560648\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES,NA,NA,NA,15191619 (contact),"KLUBO-GWIEZDZINSKA, JOANNA  (contact)",NA,NA,NA,aerobic glycolysis;Affect;Binding;BRAF gene;Cancer cell line;Carbohydrates;Categories;Cells;Cellular Metabolic Process;Characteristics;Citric Acid Cycle;cohort;Combined Modality Therapy;Deoxyglucose;Expression Profiling;FRAP1 gene;Functional Imaging;Gene Expression;Genes;Genetic;genetic analysis;Genotype;Glucose;glucose metabolism;glucose uptake;Glycolysis;Goals;Growth;Human;Image;In Vitro;in vitro Model;Knowledge;Lesion;Malignant neoplasm of thyroid;MAP Kinase Gene;MEKs;Metabolic;Metabolic Pathway;metabolic phenotype;metabolomics;Molecular Profiling;mutant;Mutation;neoplastic cell;Oncogenes;Oxidative Phosphorylation;Oxygen;Pathway interactions;Performance;PI3K/AKT;Play;Population;Positron-Emission Tomography;precision medicine;Radioactive Iodine;Regulation;Role;Signal Pathway;Signal Transduction;SLC5A5 gene;Stromal Cells;targeted treatment;Testing;The Cancer Genome Atlas;Tissue Sample;transcriptomics;tumor;tumor growth;tumor metabolism;uptake;Warburg Effect,Cross-talk between oncogene-driven signaling pathways and thyroid cancer metabolism,75140,NA,NA,NA,NA,8,NA,NA,560648,NA
11190673,ZIA,ES,1,N,NA,NA,NA,NA,ZIAES103387,NA,NA,1ZIAES103387-03,NIEHS:1263902\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES,NA,NA,NA,78847071 (contact),"MCPHERSON, CHRISTOPHER ANTHONY (contact)",NA,NA,NA,3-Dimensional;Address;Adoption;Animal Model;Apoptosis;Astrocytes;Behavior;Behavioral;Biological Assay;Botanicals;brain cell;Cannabinoids;Case Study;cell type;Chemical Exposure;Chemicals;Communication;Communities;Contracts;Data;data integration;data visualization;Decision Making;Development;developmental neurotoxicity;Drosophila genus;environmental chemical;Evaluation;Event;Experimental Designs;exposed human population;Exposure to;Flame Retardants;fungicide;Goals;hazard;Health;Herbicides;Histology;Home;Human;human induced pluripotent stem cells;human migration;improved;in silico;In Vitro;in vitro Assay;in vivo;in vivo Model;Industrialization;innovation;Insecticides;International;Knowledge;Laboratories;Libraries;Link;Magnetic Resonance;Manuscripts;Methods;Microglia;migration;Mission;Modeling;Monitor;Movement;multi-electrode arrays;nerve stem cell;Nervous System Physiology;Neural Crest Cell;neural network;Neurites;neuroimaging;Neurons;Neurosphere;Neurotoxins;novel;Organophosphates;Outcome;Pattern;Pharmaceutical Preparations;Phase;phase 1 testing;phase 2 testing;Planarians;Preparation;Process;programs;Proliferating;Public Health;Quality Control;Rattus;Research;Resources;response;Rodent;Running;screening;small molecule libraries;Structure;synaptogenesis;Technology;Testing;Therapeutic;Toxic effect;Update;Visualization;web app;Weight;Xenobiotics;Zebrafish,Developmental Neurotoxicity Health Effects Innovation Research Program,103387,NA,NA,NA,NA,3,NA,NA,1263902,NA
11190674,ZIC,AR,1,N,NA,NA,NA,NA,ZICAR041186,NA,NA,1ZICAR041186-15,NIAMS:1010530\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES,NA,NA,NA,77880738 (contact),"RANDAZZO, DAVIDE  (contact)",NA,NA,NA,"Algorithms;Area;Automobile Driving;Carbon Dioxide;career;Cell membrane;Cells;cellular imaging;charge coupled device camera;Collaborations;Color;Communities;Complex;Computer software;Confocal Microscopy;Core Facility;Coupled;Darkness;Detection;detector;digital;Dyes;Elbow;Electrons;Elements;Equipment;Ethics;Event;Exocytosis;experimental study;flasks;flexibility;Fluorescence;Fluorescence Microscopy;fluorophore;gallium arsenide;Genomics;Glass;Heating;high resolution imaging;Histology;Histopathology;Humidity;Hybrids;Image;image processing;imager;imaging capabilities;imaging facilities;Imaging Techniques;improved;Incubators;Individual;innovation;instrument;Knowledge;Label;Lasers;Lateral;lens;Light;light transmission;Lightning;lightspeed;live cell imaging;Manufacturer;Marketing;Mathematics;member;metal oxide;Methodology;Methods;Microscope;microscopic imaging;Microscopy;Mission;Motor;multiplexed imaging;National Heart, Lung, and Blood Institute;National Human Genome Research Institute;National Institute of Allergy and Infectious Disease;National Institute of Arthritis, and Musculoskeletal, and Skin Diseases;National Institute of Child Health and Human Development;Noise;optical lattices;Optics;Ownership;Philosophy;Photobleaching;photomultiplier;Photons;Phototoxicity;Process;Reporting;Research Personnel;Research Project Grants;Resolution;Running;Sampling;sapphire laser;Scanning;Scientist;second harmonic generation imaging;Semiconductors;Series;Shapes;Slide;Solid;solid state;Source;Speed;Stains;submicron;superresolution imaging;superresolution microscopy;System;Techniques;Technology;Temperature;Thick;Time;Tissues;tool;Training;transcriptomics;Tube;two-photon;ultra high resolution;virtual;Work;Writing",NIAMS Light Imaging Facility,41186,NA,NA,NA,NA,15,NA,NA,1010530,NA
11190675,ZIC,DE,1,N,NA,NA,NA,NA,ZICDE000750,NA,NA,1ZICDE000750-06,NIDCR:1290711\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH,NA,NA,NA,16134217 (contact),"TRAN, DUY  (contact)",NA,NA,NA,Biology;Communities;Data Analyses;Development;Environment;Epithelium;Equipment;Experimental Designs;experimental study;Goals;Histology;Hour;Image;imaging approach;imaging modality;imaging platform;imaging system;Immunology;Individual;Inflammation;Infrastructure;instrumentation;Learning;Life Cycle Stages;Microbiology;Microscope;Mission;National Institute of Dental and Craniofacial Research;outreach;Pain;Preparation;programs;Research;Research Personnel;Research Support;Running;Salivary Glands;Sampling;Sensory;Series;Services;skeletal;stem cell fate;theories;Tissues;Training;Work,Imaging Core,750,NA,NA,NA,NA,6,NA,NA,1290711,NA
11190676,ZIC,ES,1,N,NA,NA,NA,NA,ZICES103386,NA,NA,1ZICES103386-03,NIEHS:686118\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES,NA,NA,NA,78847076 (contact),"KLEINSTREUER, NICOLE  (contact)",NA,NA,NA,Animal Model;animal pain;Animals;Biochemical;Bioinformatics;Cells;chemical safety;Chemicals;Communication;Communities;computational toxicology;Computer Models;Data;Development;Distress;Educational workshop;Evaluation;Fostering;Funding Opportunities;improved;Interagency Coordinating Committee on the Validation of Alternative Methods;interest;International;Knowledge;Medical;method development;Methods;Mission;Mus;National Institute of Environmental Health Sciences;National Toxicology Program;novel strategies;Operations Research;Personal Satisfaction;Procedures;Public Health;Publishing;Recommendation;Research;safety testing;symposium;System;Testing;Toxicity Tests;Toxicology;United States;Validation;web site;Work,Research Operations Supporting the National Toxicology Program Interagency Center for the Evaluation of Alternative Toxicological Methods,103386,NA,NA,NA,NA,3,NA,NA,686118,NA
11190677,ZIC,ES,1,N,NA,NA,NA,NA,ZICES103391,NA,NA,1ZICES103391-02,NIEHS:1300013\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES,NA,NA,NA,79330097 (contact),"WAIDYANATHA, SURAMYA  (contact)",NA,NA,NA,absorption;Academia;ADME Study;Agreement;analytical method;Animal Model;Animals;Biological;Biological Assay;Botanical dietary supplements;Budgets;Cells;Chemical Agents;Chemicals;Chemistry;Complex Mixtures;Consumption;Contract Services;Contracts;Data;Data Reporting;design;Development;Dyes;Ensure;Environment;Environmental Pollutants;Excretory function;exposed human population;Exposure to;Flame Retardants;Formulation;Fractionation;Goals;Health;Heavy Metals;Human;Human Resources;improved;in silico;In Vitro;in vitro Model;in vivo;in vivo Model;Industry;Inhalation;inorganic phosphate;Isomerism;Knowledge;Liver;Materials Testing;Metabolism;metabolomics;method development;Mission;multidisciplinary;National Institute for Occupational Safety and Health;National Institute of Environmental Health Sciences;novel;operation;Oral;Outcome;Phytochemical;Plasma;programs;Proteomics;Public Health;Rattus;Reporting;Research;Research Contracts;Resources;Rodent;Rodent Model;Sampling;Scientist;screening;Services;System;Techniques;Testing;Toluene;Toxic effect;Toxicokinetics;Toxicology;Translating;Valerian;Validation;Vision;Work,Chemistry Services Supporting the Division of Translational Toxicology,103391,NA,NA,NA,NA,2,NA,NA,1300013,NA
11190764,U01,CK,6,N,2024-09-06,2024-09-30,2025-09-29,084,U01CK000666,NA,RFA-CK-22-001,6U01CK000666-03M001,NCEZID:100000\,NON-SBIR/STTR RPGS,2024,National Center for Emerging and Zoonotic Infectious Diseases,NA,KINSHASA,CONGO DEM REP,NA,NA,565493868,CG,10002505,KINSHASA SCHOOL OF PUBLIC HEALTH,NA,11850,"Project Narrative Zoonotic diseases like Monkeypox and Ebola virus disease are a significant public health threat in Democratic Republic of the Congo (DRC) and have a high risk of international exportation. This project aims to improve the ability of DRC to respond to zoonotic diseases by developing rigorous surveillance systems, investigating medical countermeasures and clinical treatments, identifying key risk factors in primary transmission of disease, and creating a resilient interdisciplinary public health workforce.",16299234 (contact),"KABA, DIDINE KINKODI (contact)",NA,2022-09-30,2027-09-29,NA,"RFA-CK-22-001, Investigation of Monkeypox and Other Zoonotic Diseases in the Democratic Republic of the Congo (DRC) - 2022",666,ZCK1,ZCK1-GCA(51)R,NA,M001,3,NA,NA,100000,NA
11191007,OT2,OD,3,N,2024-09-20,2024-09-01,2025-12-31,310,OT2OD036464,NA,OTA-23-002,3OT2OD036464-01S1,NCCIH:725000\NEI:150000\OD:1111614\,OTHERS,2024,"OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH",NA,CHICAGO,UNITED STATES,NA,07,069512291,US,5730401,NATIONAL OPINION RESEARCH CENTER,IL,606035713,NA,79171295;12653610 (contact),"LEINTZ, JEFFREY ;SMITH, STEPHEN  (contact)","MCCLAIN, JAMES J",2024-09-01,2025-12-31,Address;Age;All of Us Research Program;Ancillary Study;Behavior;Characteristics;Chicago;Child;Code;Collaborations;Communication;Communities;Complex;Data;Data Collection;Data Set;design;Disability status;Disclosure;Educational Status;Enrollment;Ensure;Ethnic Origin;experience;flexibility;Future;Gender Identity;Genetic;Geographic Locations;Goals;Health Status;improved;Knowledge;Measures;Methodology;Methods;Monitor;multimodal data;operation;outreach;Participant;participant enrollment;patient engagement;Patient Recruitments;Phase;Physical activity;Population;Population Group;Population Heterogeneity;precision medicine;Process;programs;Protocols documentation;Race;Recording of previous events;recruit;remote assessment;Reporting;Research;Research Design;Research Personnel;research study;Research Support;Secure;Services;Sex Orientation;Socioeconomic Status;success;System;Technical Expertise;Technology;technology platform;Testing;Time;tool;United States National Institutes of Health;Universities;user-friendly;wearable device;Work,Partnering for Precision Medicine: A Collaborative Services Center for the All of Us Program,36464,ZPM1,ZPM1(99),NA,S1,1,1986614,0,1986614,NA
11191010,OT2,OD,3,N,2024-09-16,2024-09-25,2025-09-24,310,OT2OD032100,NA,OTA-21-006,3OT2OD032100-01S9,NCI:10000\NHLBI:2750000\NICHD:750000\NIDA:80000\NIDCR:200175\,OTHERS,2024,"OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH",NA,ROUND ROCK,UNITED STATES,NA,17,149530219,US,10065401,DELL FEDERAL SYSTEMS L.P.,TX,786827000,No PHR,78171056 (contact);78362163,"HAMMONDODWYER, AMY K (contact);SIDDIQUI, ERUM","WEBER, MICHAEL NICHOLAS N",2021-09-25,2026-06-30,Services;Training;United States National Institutes of Health,NIH STRIDES - Azure and Associated Services and Training.,32100,ZOD1,ZOD1-SRC(99),NA,S9,1,3790175,0,8179252,NA
11191033,R01,GM,7,N,2024-11-07,2024-10-15,2025-08-31,859,R01GM087638,SCHOOLS OF ARTS AND SCIENCES,PA-24-254,7R01GM087638-13,NIGMS:343123\,NON-SBIR/STTR RPGS,2024,NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES,NA,BOCA RATON,UNITED STATES,CHEMISTRY,23,004147534,US,513803,FLORIDA ATLANTIC UNIVERSITY,FL,334316424,"NARRATIVE Bacteria, differently from mammals, assimilate inorganic sulfur into the amino acid, L-cysteine, the precursor of key metabolites including reducing agents, cofactors and membrane components. Inhibition of cysteine biosynthesis interferes with the ability of pathogens to fight oxidative stress, to infect the host and to establish long-term infections. The proposed research is expected to lead to a new class of antibacterial agents that operate by a unique mechanism of action through disruption of sulfur metabolism.",8965564 (contact),"CARROLL, KATE SUZANNE (contact)","SIMONOVIC, MILJAN",2008-12-08,2026-08-31,NA,Sulfur Metabolism in Human Pathogens,87638,MSFA,Macromolecular Structure and Function A Study Section[MSFA],NA,NA,13,224999,118124,343123,NA
11191065,UH3,HL,3,N,2024-09-19,2024-09-20,2025-07-31,839,UH3HL165839,SCHOOLS OF MEDICINE,RFA-AT-23-002,3UH3HL165839-02S1,NINDS:351124\,NON-SBIR/STTR RPGS,2024,"NATIONAL HEART, LUNG, AND BLOOD INSTITUTE",NA,PITTSBURGH,UNITED STATES,INTERNAL MEDICINE/MEDICINE,12,004514360,US,2059802,UNIVERSITY OF PITTSBURGH AT PITTSBURGH,PA,152133320,PROJECT NARRATIVE Peer suppoRt for adolescents and Emerging adults with Sickle cell pain: promoting ENgagement in Cognitive behavioral thErapy (PRESENCE) will be the first study to compare the effectiveness of a cognitive behavioral therapy (CBT) program with and without peer support to usual care as a non-pharmaceutical option for pain management in people living with sickle cell disease. CBT is delivered through an innovative digital app that is accessed on a mobile device with one group receiving self-guided CBT and the other receiving CBT plus peer support. The PRESENCE program is comprised of strong community partnerships that provide the peer support component of the intervention.,15628812;10415707 (contact);11023107,"COLVIN, ALICIA ;JONASSAINT, CHARLES RICHARD (contact);RADOVIC-STAKIC, ANA","LOUDEN, ANDREW",2023-08-10,2028-07-31,"Address;Adolescent;Adolescent and Young Adult;adolescent health outcomes;Advocate;Age;Anxiety;Behavioral;behavioral health;Black race;Caring;Chronic;chronic pain;Clinical;clinical research site;Cognitive;Cognitive Therapy;community organizations;community partners;community partnership;compare effectiveness;coping;cost;daily pain;Data;design;Development;diaries;digital;digital applications;digital intervention;digital treatment;Disparity;E-learning;Education;Educational process of instructing;Effectiveness;effectiveness evaluation;Emergency department visit;emerging adult;Empathy;Enrollment;evidence base;Exercise;experience;Exposure to;Family member;Focus Groups;Future;General Population;handheld mobile device;healing;health care service utilization;Healthcare Systems;Hospitalization;human centered design;implicit bias;improved;Individual;Infrastructure;innovation;internalized stigma;Intervention;Learning Skill;Libraries;Lived experience;meetings;Mental Depression;Mental Health;Minority Groups;Moods;Multicenter Trials;National Center for Advancing Translational Sciences;non-opioid analgesic;Opioid;opioid use;Outcome;Pain;Pain intensity;Pain interference;Pain management;pain outcome;pain reduction;pain symptom;Parents;Participant;patient engagement;Patients;peer;peer coaching;peer support;personalized approach;personalized learning;Persons;Phase;Population;preference;prescription opioid;primary outcome;programs;Provider;psychologic;psychological outcomes;psychological symptom;psychosocial;racial bias;Randomized;randomized trial;Randomized, Controlled Trials;Reporting;Research Design;Resources;Running;secondary outcome;Secondary pain;Secure;Sickle Cell;Sickle Cell Anemia;Site;social stigma;Stress;stressor;support network;Symptoms;Technology;telephone based;Testing;Text;Therapeutic Intervention;Therapy trial;Training;transition to adulthood;treatment as usual;treatment group;uptake;video chat;virtual delivery;Voice;Work",Peer suppoRt for adolescents and Emerging adults with Sickle cell pain: promoting ENgagement in Cognitive behavioral thErapy,165839,ZAT1,ZAT1-SN(10),NA,S1,2,220833,130291,351124,NA
11191088,U54,CA,3,N,2024-09-12,2024-09-01,2025-08-31,NA,U54CA233444,NA,PAR-22-249,3U54CA233444-07S1,NCI:36263\,RESEARCH CENTERS,2024,NATIONAL CANCER INSTITUTE,NA,GAINESVILLE,UNITED STATES,NA,03,969663814,US,513806,UNIVERSITY OF FLORIDA,FL,326115500,NA,1942894 (contact),"WILKIE, DIANA J (contact)","BARFIELD-STEWARD, WHITNEY",2018-09-17,2028-08-31,NA,"Administrative Core - 2/3 Florida-California Cancer Research, Education and Engagement (CaRE2) Health Equity Center",233444,ZCA1,ZCA1-SRB-2(A1),5649,S1,7,25838,10425,NA,36263
11191089,U54,CA,3,N,2024-09-12,2024-09-01,2025-08-31,NA,U54CA233444,NA,PAR-22-249,3U54CA233444-07S1,NCI:3039\,RESEARCH CENTERS,2024,NATIONAL CANCER INSTITUTE,NA,GAINESVILLE,UNITED STATES,NA,03,969663814,US,513806,UNIVERSITY OF FLORIDA,FL,326115500,NA,8240680 (contact),"LEE, JI-HYUN  (contact)","BARFIELD-STEWARD, WHITNEY",2018-09-17,2028-08-31,NA,"Bioinformatics, Statistical and Methodological Shared Resources Core",233444,ZCA1,ZCA1-SRB-2(A1),5650,S1,7,2165,874,NA,3039
11191090,U54,CA,3,N,2024-09-12,2024-09-01,2025-08-31,NA,U54CA233444,NA,PAR-22-249,3U54CA233444-07S1,NCI:5533\,RESEARCH CENTERS,2024,NATIONAL CANCER INSTITUTE,NA,GAINESVILLE,UNITED STATES,NA,03,969663814,US,513806,UNIVERSITY OF FLORIDA,FL,326115500,NA,2221788 (contact),"OKUNIEFF, PAUL  (contact)","BARFIELD-STEWARD, WHITNEY",2018-09-17,2028-08-31,NA,Tissue Modeling & Drug Development Shared Resources Core,233444,ZCA1,ZCA1-SRB-2(A1),5651,S1,7,3942,1591,NA,5533
11191091,U54,CA,3,N,2024-09-12,2024-09-01,2025-08-31,NA,U54CA233444,NA,PAR-22-249,3U54CA233444-07S1,NCI:3988\,RESEARCH CENTERS,2024,NATIONAL CANCER INSTITUTE,NA,GAINESVILLE,UNITED STATES,NA,03,969663814,US,513806,UNIVERSITY OF FLORIDA,FL,326115500,NA,8010551 (contact),"SCHMITTGEN, THOMAS D. (contact)","BARFIELD-STEWARD, WHITNEY",2018-09-17,2028-08-31,NA,Project 3 ADM,233444,ZCA1,ZCA1-SRB-2(A1),5652,S1,7,2842,1146,NA,3988
11191092,U54,CA,3,N,2024-09-12,2024-09-01,2025-08-31,NA,U54CA233444,NA,PAR-22-249,3U54CA233444-07S1,NCI:3962\,RESEARCH CENTERS,2024,NATIONAL CANCER INSTITUTE,NA,GAINESVILLE,UNITED STATES,NA,03,969663814,US,513806,UNIVERSITY OF FLORIDA,FL,326115500,NA,9837699 (contact),"HUANG, YONG  (contact)","BARFIELD-STEWARD, WHITNEY",2018-09-17,2028-08-31,NA,Project 4 LUNG,233444,ZCA1,ZCA1-SRB-2(A1),5653,S1,7,2823,1139,NA,3962
11191093,U54,CA,3,N,2024-09-12,2024-09-01,2025-08-31,NA,U54CA233444,NA,PAR-22-249,3U54CA233444-07S1,NCI:1740\,RESEARCH CENTERS,2024,NATIONAL CANCER INSTITUTE,NA,GAINESVILLE,UNITED STATES,NA,03,969663814,US,513806,UNIVERSITY OF FLORIDA,FL,326115500,NA,15599018 (contact),"ROGERS, SHERISE C. (contact)","BARFIELD-STEWARD, WHITNEY",2018-09-17,2028-08-31,NA,Pilot Project 5,233444,ZCA1,ZCA1-SRB-2(A1),5654,S1,7,1240,500,NA,1740
11191094,U54,CA,3,N,2024-09-12,2024-09-01,2025-08-31,NA,U54CA233444,NA,PAR-22-249,3U54CA233444-07S1,NCI:1513\,RESEARCH CENTERS,2024,NATIONAL CANCER INSTITUTE,NA,GAINESVILLE,UNITED STATES,NA,03,969663814,US,513806,UNIVERSITY OF FLORIDA,FL,326115500,NA,8694196 (contact),"EZENWA, MIRIAM OMELEBELE (contact)","BARFIELD-STEWARD, WHITNEY",2018-09-17,2028-08-31,NA,Planning and Evaluation Core,233444,ZCA1,ZCA1-SRB-2(A1),5655,S1,7,1078,435,NA,1513
11191095,U54,CA,3,N,2024-09-12,2024-09-01,2025-08-31,NA,U54CA233444,NA,PAR-22-249,3U54CA233444-07S1,NCI:4029\,RESEARCH CENTERS,2024,NATIONAL CANCER INSTITUTE,NA,GAINESVILLE,UNITED STATES,NA,03,969663814,US,513806,UNIVERSITY OF FLORIDA,FL,326115500,NA,16054449 (contact),"ALLEN, JOHN M (contact)","BARFIELD-STEWARD, WHITNEY",2018-09-17,2028-08-31,NA,Research Education Core,233444,ZCA1,ZCA1-SRB-2(A1),5656,S1,7,2871,1158,NA,4029
11191096,U54,CA,3,N,2024-09-12,2024-09-01,2025-08-31,NA,U54CA233444,NA,PAR-22-249,3U54CA233444-07S1,NCI:5063\,RESEARCH CENTERS,2024,NATIONAL CANCER INSTITUTE,NA,GAINESVILLE,UNITED STATES,NA,03,969663814,US,513806,UNIVERSITY OF FLORIDA,FL,326115500,NA,2277587 (contact),"WEBB, FERN JUREIDINI (contact)","BARFIELD-STEWARD, WHITNEY",2018-09-17,2028-08-31,NA,Community Outreach Core,233444,ZCA1,ZCA1-SRB-2(A1),5657,S1,7,3608,1455,NA,5063
11191115,OT2,OD,3,N,2024-09-12,2024-09-12,2025-04-30,368,OT2OD037644,SCHOOLS OF MEDICINE,OTA-22-006,3OT2OD037644-01S1,NEI:450000\,OTHERS,2024,"OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH",NA,NEW HAVEN,UNITED STATES,INTERNAL MEDICINE/MEDICINE,03,043207562,US,9420201,YALE UNIVERSITY,CT,065208327,NA,3163082;1868382;2020115;14964291;10453826;10753735;1900244 (contact);79849374;9814079,"BOROWSKY, ALEXANDER D;GOODMAN, MARC T;HIATT, ROBERT A;KIM, SUE ELIZABETH;MEEKER, DANIELLA ;MONTALVO-ORTIZ, JANITZA LIZ;OHNO-MACHADO, LUCILA  (contact);SILVA, AMARILYS ;SITAPATI, AMY MONTAGUE","ALEXANDER-TROUPE, STEPHANIE MELANIA",2024-09-12,2025-04-30,Absenteeism at work;All of Us Research Program;Area;Awareness;Biomedical Research;Blood Banks;California;Catchment Area;Childhood;Church;Clinic;clinical infrastructure;clinical research site;Collaborations;collaborative environment;Collection;Communication;Communities;Community Healthcare;community organizations;community partners;Complement;Computers;Connecticut;Consent;Contract Services;cost;cost estimate;Costs and Benefits;Country;Creativeness;Data;data dictionary;data exchange;data sharing;Decision Making;Disease;Doctor of Philosophy;Education;Electronic Health Record;Enrollment;Equilibrium;ethnic minority population;Ethnic Origin;Ethnic Population;Event;experience;Faith-based organization;Geography;Goals;Grant;Growth;Health;Health Insurance Portability and Accountability Act;Health Personnel;Health system;Healthcare;Hot Spot;implementation science;improved;Income;Information Technology;Infrastructure;innovation;Institution;Internet;Joints;Knowledge;Latinx;Leadership;Learning;lens;Life Cycle Stages;literacy;Location;Low income;male;Marketing;Measurement;Medical center;member;Mission;Modeling;Monitor;multidisciplinary;novel;Outcome;outreach;outreach program;Participant;patient outreach;Patient Schedules;Patients;pediatrician;Persons;Population;Population Heterogeneity;Poverty;Precision Health;precision medicine;precision nutrition;Process;programs;Provider;Puerto Rico;Qualifying;Race;racial minority population;racial population;recruit;Research;Research Institute;retention rate;Retrieval;Rhode Island;Rural;rural area;rural setting;safety net;Schedule;Site;skills;Socioeconomic Status;socioeconomics;Spanish;success;Support Groups;System;Training;Underserved Population;United States;United States National Institutes of Health;Universities;urban setting;volunteer;Vulnerable Populations;wireless fidelity;Work;Youth,"All of Us Coast-to-Coast Strong UBR Recruitment, Retention, and Facilitation (C2C SURRF) through Innovation",37644,ZOD1,ZOD1-SRC(99),NA,S1,1,382343,67657,450000,NA
11191143,R01,HL,3,N,2024-09-12,2024-07-01,2025-06-30,838,R01HL159764,SCHOOLS OF ARTS AND SCIENCES,RFA-OD-19-029,3R01HL159764-04S1,NHLBI:174691\,NON-SBIR/STTR RPGS,2024,"NATIONAL HEART, LUNG, AND BLOOD INSTITUTE",NA,BLOOMINGTON,UNITED STATES,SOCIAL SCIENCES,09,006046700,US,577805,TRUSTEES OF INDIANA UNIVERSITY,IN,474013654,"NARRATIVE Sex and gender disparities in the severity and frequency of asthma exacerbations have been extensively reported, yet the biological and hormonal basis of these differences have not been elucidated. Here, we investigate the mechanisms by which estrogen triggers inflammation in the male and female asthmatic lung. Our findings will determine the molecular basis of hormonal triggers of asthma exacerbations in cis and transgender women and lead to the future development of better personalized therapeutic options for lung disease.",10901734 (contact),"SILVEYRA, PATRICIA  (contact)","LACHOWICZ-SCROGGINS, MARRAH ELIZABETH",2021-07-10,2025-06-30,"Accounting;Adult;Adult women;Affect;Agonist;Air Movements;Air Pollution;airway hyperresponsiveness;airway obstruction;Allergens;antagonist;Asthma;asthma exacerbation;asthma model;asthma prevention;asthmatic;asthmatic patient;Automobile Driving;Award;Binding;Biological;bronchial epithelium;Cells;cis-female;cost;cytokine;Data;Development;Diagnosis;differential expression;Disease;Disparity;dosage;Environmental Exposure;Environmental Risk Factor;Epithelial Cells;Estradiol;Estrogen Receptors;Estrogens;Estrous Cycle;Experimental Models;experimental study;Exposure to;Female;female sex hormone;Feminization;Four Core Genotypes;Frequencies;Future;Gender;gender difference;gender disparity;Gene Expression;Genes;Genomics;Goals;Gonadal Hormones;Gonadal Steroid Hormones;GPER gene;Health;Hormonal;hormone therapy;Hormones;Hospitalization;House mice;Human;Incidence;Individual;Individual Differences;Inflammation;Inflammatory;Inflammatory Response;Knockout Mice;Knowledge;Laboratories;Life;Liquid substance;Lung;Lung Diseases;male;Measures;Mediating;Mediator;Membrane;men;Menstrual cycle;Menstruation;middle age;Modeling;Molecular;Morbidity - disease rate;mortality;mouse model;Mus;National Heart, Lung, and Blood Institute;non-genomic;novel therapeutics;Nuclear;Orchiectomy;Outcome;Ovariectomy;Pathway interactions;Patients;personalized therapeutic;Phenotype;Physiological;Ploidies;Population;Prevalence;prevent;Puberty;Public Health;Pulmonary Inflammation;Pyroglyphidae;Receptor Signaling;Recommendation;Recording of previous events;Reporting;Research;Research Priority;respiratory;Respiratory Failure;response;Role;Severities;sex;sex as a biological variable;Sex Chromosomes;Sex Differences;sex disparity;Signal Transduction;Stimulus;Strategic Planning;Structure of parenchyma of lung;Symptoms;Testing;Therapeutic Agents;transgender;transgender women;United States National Institutes of Health;Variant;Woman;Women&apos;s Health;Women&apos;s Role;women&apos;s treatment",Gonadal hormones as mediators of sex and gender influences in asthma,159764,ZRG1,Special Emphasis Panel[ZRG1-EMNR-H(53)R],NA,S1,4,110215,64476,174691,NA
11191164,R00,AA,4,N,2024-09-18,2024-09-20,2025-08-31,273,R00AA029454,SCHOOLS OF MEDICINE,PA-20-188,4R00AA029454-03,NIAAA:249000\,NON-SBIR/STTR RPGS,2024,NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM,NA,BALTIMORE,UNITED STATES,PSYCHIATRY,07,188435911,US,820104,UNIVERSITY OF MARYLAND BALTIMORE,MD,212011508,"PROJECT NARRATIVE Alcohol consumption is the leading risk factor for premature death in individuals ranging from 15 to 49 years of age. Mounting evidence indicates a role for the gut microbiota in behavioral, gastrointestinal, and inflammatory consequences of alcohol consumption that may contribute to relapse. This proposal will provide critical training in cutting edge approaches for quantifying the relationships between alcohol seeking, reward-related decision- making, and the gut microbiota with the goal of investigating novel treatment options for alcohol use disorders.",11103553 (contact),"THOMPSON, SUMMER LORETTA (contact)","PERRUCCIO, ELIZABETH M",2024-09-20,2027-08-31,Accounting;addiction;Age Years;alcohol consequences;Alcohol consumption;alcohol effect;alcohol exposure;alcohol research;alcohol reward;alcohol seeking behavior;alcohol testing;alcohol use disorder;Alcohol withdrawal syndrome;Alcohol-Induced Disorders;Alcohols;alternative treatment;Antibiotics;Bacteria;Behavior;behavior measurement;Behavior Therapy;Behavioral;behavioral impairment;Behavioral Mechanisms;Bioinformatics;Biological Models;career;Career Mobility;Cessation of life;Chronic;chronic alcohol ingestion;Clinical;Cognition;Cognitive;Communication;Computer Models;Data;Decision Making;Development;Diet;disability;Donor person;Ensure;experience;experimental study;feasibility testing;fecal transplantation;Fiber;gastrointestinal;Gastrointestinal tract structure;Goals;gut microbes;gut microbiome;gut microbiota;gut-brain axis;Heavy Drinking;host-microbe interactions;Human;Impairment;Individual;Inflammation;Inflammatory;Instruction;Intestinal permeability;Intestines;Knowledge;Learning;Measures;Mediating;Memory;Mental disorders;Mentors;Mentorship;metagenomic sequencing;Microbiology;microbiota;Modeling;Molecular Biology;mouse model;Mus;Nervous System;neuromechanism;Neurosciences;new therapeutic target;novel;Operant Conditioning;Play;Positioning Attribute;prebiotics;premature;programs;Public Health;Recording of previous events;Regimen;Relapse;Research;reward processing;Rewards;Risk Factors;Rodent;Rodent Model;Role;Self Administration;Shotguns;skills;stool sample;systemic inflammatory response;Techniques;Testing;Therapeutic;tool;Training;treatment strategy;Withdrawal Symptom,The role of the gut microbiota in alcohol seeking and decision-making,29454,NSS,NSS,NA,NA,3,174334,74666,249000,NA
11191198,UH3,MD,3,N,2024-09-22,2024-09-01,2025-06-30,307,UH3MD018358,SCHOOLS OF MEDICINE,PA-20-272,3UH3MD018358-03S1,NIMHD:619264\,NON-SBIR/STTR RPGS,2024,NATIONAL INSTITUTE ON MINORITY HEALTH AND HEALTH DISPARITIES,NA,HONOLULU,UNITED STATES,INTERNAL MEDICINE/MEDICINE,01,965088057,US,820005,UNIVERSITY OF HAWAII AT MANOA,HI,968222234,"PROJECT NARRATIVE We propose to enlarge the target sample size of the current projects 2 pilot studies involving fatty liver disease by 600 participants, and to extend the study from the City and County of Honolulu on the island of Oahu to rural community primary care clinics on the neighbor islands - the Big Island of Hawaii, Kauai and Molokai.",14456888;2660382;1963109 (contact),"BALARAMAN, VENKATARAMAN ;SETO, TODD B;SHIKUMA, CECILIA M. (contact)","OLADEINDE, YEWANDE A",2022-09-24,2025-06-30,Administrative Supplement;Adult;Advocate;Affect;Agriculture;Area;Cities;Clinical Research;Code;community clinic;community setting;County;Diabetes Mellitus;Early Diagnosis;ethnic diversity;Evaluation;Fatty acid glycerol esters;Fatty Liver;fatty liver disease;Federally Qualified Health Center;Fibrosis;food insecurity;Goals;Grant;Hawaii;health disparity;health equity;Health Policy;HIV;Home;Homeless persons;Inflammatory;Insulin Resistance;Island;Link;Liver;Liver Cirrhosis;liver development;Liver diseases;Liver Dysfunction;low socioeconomic status;Measurement;Measures;medical schools;Metabolic dysfunction;Native Hawaiian or Other Pacific Islander;Native-Born;non-alcoholic fatty liver disease;nonalcoholic steatohepatitis;Obesity;Participant;patient population;Patients;Persons;Pilot Projects;point of care;point of care testing;Population;Population Heterogeneity;portability;Prevalence;Preventive measure;Primary carcinoma of the liver cells;Primary Care;primary care clinic;primary care setting;Public Health;Rest;Risk Factors;Rural;rural area;Rural Community;Rural Population;Sample Size;Sampling;screening;Site;social health determinants;standard of care;Techniques;ultrasound;Underinsured;Uninsured;urban area;Urban Community,HAWAII CLINICAL RESEARCH NETWORK FOR HEALTH EQUITY,18358,NA,NA,NA,S1,3,513269,105995,619264,NA
11191204,R01,ES,3,N,2024-09-19,2024-09-20,2025-06-30,113,R01ES031139,SCHOOLS OF ARTS AND SCIENCES,PA-19-056,3R01ES031139-04S1,NIEHS:12953\,NON-SBIR/STTR RPGS,2024,NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES,NA,IRVINE,UNITED STATES,ANATOMY/CELL BIOLOGY,47,046705849,US,577504,UNIVERSITY OF CALIFORNIA-IRVINE,CA,926970001,"Obesity is a major public health problem. We propose to elucidate how maternal and early life exposure to obesogens interacts with diet leading to increased obesity on a Western-style diet and resistance to fat loss during fasting. The successful completion of this research will make important contributions to understanding the developmental programming of obesity, how obesogens affect this process, and the interactions between diet and obesogen exposure on energy balance.",1900163 (contact);3124209,"BLUMBERG, BRUCE  (contact);SHIODA, TOSHIHIRO","SCHUG, THADDEUS",2020-09-16,2026-06-30,Address;Adipocytes;Adipose tissue;Adult;Affect;Age;Animals;ATAC-seq;Award;Basal metabolic rate;Black Populations;Blood;Blood Glucose;Body mass index;Cardiovascular Diseases;Cell Compartmentation;Cell Count;cell type;Chemicals;ChIP-seq;Chromatin;Chromatin Structure;Clinical;Clinical Management;combat;Desire for food;Development;Diabetes Mellitus;Diet;diet and exercise;Dietary Fats;Dietary Practices;dieting;Disease;DNA;DNA Methylation;early life exposure;Endocrine Disruptors;Endocrine system;energy balance;Energy Intake;Energy Metabolism;Environment;Environmental Risk Factor;epigenome;epigenomics;Exhibits;experimental study;exposed human population;Exposure to;falls;Fasting;Fatty acid glycerol esters;Female;Generations;Genes;Germ Lines;Health;Health Care Costs;Hi-C;High Fat Diet;Hispanic;Hispanic Populations;hormone regulation;Human;Hypertension;in vivo;Individual;insight;Knowledge;Lead;Leisures;Leptin;Link;Lipids;Liver;male;Malignant Neoplasms;Mediating;Mesenchymal Stem Cells;Metabolic;Metabolism;Modeling;Molecular;mRNA Expression;multiple omics;Mus;non-alcoholic fatty liver disease;Non-Insulin-Dependent Diabetes Mellitus;Obese Mice;Obesity;Obesity Epidemic;obesity management;obesogen;obesogenic;offspring;Patients;Persons;Phenotype;Physical activity;Plasma;Predisposition;pregnant;prenatal;prenatal exposure;prevent;Preventive;Process;Public Health;Research;Resistance;Rodent;Role;Satiation;Signal Transduction;sperm cell;Testing;Testis;Therapeutic;Thinking;Time;Tissues;transcriptome;transcriptome sequencing;tributyltin;Weight;Weight Gain;western diet;Woman;Xenobiotics;Youth,Interactions between prenatal obesogen exposure and Total Western diet lead to a transgenerational thrifty phenotype: functional and epigenomic analysis of effects in fat and liver,31139,SIEE,Systemic Injury by Environmental Exposure[SIEE],NA,S1,4,8250,4703,12953,NA
11191209,R01,NS,7,N,2024-11-25,2024-10-01,2025-05-31,853,R01NS131227,BIOMED ENGR/COL ENGR/ENGR STA,PA-24-254,7R01NS131227-03,NINDS:361021\,NON-SBIR/STTR RPGS,2024,NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE,NA,RIVERSIDE,UNITED STATES,ENGINEERING (ALL TYPES),39,627797426,US,577506,UNIVERSITY OF CALIFORNIA RIVERSIDE,CA,925210001,"In accordance with NINDS scientific goals to understand the basic mechanisms of neurological disorders, and to discover and validate biomarkers and outcome measures, the proposed work will advance the understanding of the neurobiological basis for poststroke spasticity and provide quantitative neuroimaging biomarkers to be used as outcome measures in clinical trials. This research will solve an urgent public health need to provide a more complete understanding of the neural mechanisms of poststroke spasticity by characterizing the functions of major descending and ascending circuits in relation to spastic hypertonia and hyperreflexia.",15072294 (contact),"VAHDAT, SHAHABEDDIN  (contact)","CHEN, DAOFEN",2023-07-01,2028-05-31,NA,The function of descending and ascending pathways in spastic hypertonia and hyperreflexia after stroke,131227,MFSR,"Motor Function, Speech and Rehabilitation Study Section[MFSR]",NA,NA,3,237977,123044,361021,NA
11191232,ZIA,AA,1,N,NA,NA,NA,NA,ZIAAA000242,NA,NA,1ZIAAA000242-10,NIAAA:2034423\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM,NA,NA,NA,14282136 (contact),"LOHOFF, FALK  (contact)",NA,NA,NA,accelerated epigenetic aging;Acetaldehyde;Acetylation;Acute;Address;Affect;Age;age acceleration;Age Years;Aging;aging biomarker;aging process;Alcohol consumption;alcohol exposure;alcohol misuse;alcohol use disorder;Alcoholic beverage heavy drinker;Alcoholic liver damage;Alcoholic Liver Diseases;Alcohols;Algorithms;Animal Model;Area;Attenuated;Behavior;Biological;biological age;Biological Markers;Blood Cells;Brain;Chronic;chronic alcohol ingestion;Chronology;Clinical;Clinical Research;cohort;comparison control;Complex;Conduct Clinical Trials;CpG dinucleotide;Data;Development;Disease;Disease Outcome;DNA Methylation;DNA methyltransferase inhibition;Double-Blind Method;endophenotype;Environment;Environmental Risk Factor;Enzymes;epigenetic clock;epigenetic marker;Epigenetic Process;epigenome;epigenome-wide association studies;epigenomics;Ethanol Metabolism;Family;FDA approved;Folic Acid;follow-up;Gender;Generations;Genes;Genetic;Genetic Heterogeneity;genetic risk factor;Genome;Genomic approach;Genomics;Goals;Health;Hepatic;hepatocellular injury;Heritability;histone methylation;Human;Individual;Inflammatory;inhibitor;Investigational Therapies;Lifestyle-related condition;Link;Literature;Liver diseases;liver inflammation;liver injury;Longevity;Medicine;Mendelian randomization;Methionine;methyl group;Methylation;Modeling;Modification;Molecular;mortality;multiple omics;Nature;Neurobiology;new therapeutic target;novel;novel strategies;novel therapeutics;Outcome;Oxidative Stress;Pathway interactions;Pharmaceutical Preparations;Phase;Phenotype;Placebo Control;pre-clinical;Pre-Clinical Model;Production;protein expression;Public Health;Randomized;Rattus;Reactive Oxygen Species;Relapse;Risk;Role;S-Adenosylhomocysteine;S-Adenosylmethionine;Safety;safety study;Sample Size;Sampling;Site;social;Stress;Study models;Target Populations;Therapeutic Studies;Tissues;Translational Research;Triglycerides;Validation;Work,Clinical Genomics and Experimental Therapeutics,242,NA,NA,NA,NA,10,NA,NA,2034423,NA
11191233,ZIA,AA,1,N,NA,NA,NA,NA,ZIAAA000351,NA,NA,1ZIAAA000351-24,NIAAA:1151007\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM,NA,NA,NA,6997028 (contact),"KUNOS, GEORGE  (contact)",NA,NA,NA,Afferent Neurons;Alcohol consumption;alcohol craving;alcohol seeking behavior;alcohol use disorder;Alcohols;Anxiety;AVIL gene;Behavior Control;Behavioral;Brain;Cardiovascular Physiology;CB1 knockout;CB1 receptor antagonist;Cells;CNR1 gene;CNR2 gene;Coupled;Desire for food;disease model;drinking;drinking behavior;Emotional;Endocannabinoids;endogenous cannabinoid system;food craving;Gastrointestinal tract structure;Genetic Markers;Genotype;ghrelin;ghrelin receptor;GLP-I receptor;gut-brain axis;Hormones;interest;Laboratories;Ligands;Lipids;Location;Magnetic Resonance Imaging;Marijuana;Mediating;Mental Depression;Metabolic;Metabolic Diseases;Metabolic syndrome;Motivation;Mucous Membrane;Mus;Muscle;Mutant Strains Mice;NBPhox protein;neurobehavioral;Neurons;Nodose Ganglion;novel;obese person;Obesity;Pathology;Peripheral;permissiveness;Persons;Pharmaceutical Preparations;Phase Ib Clinical Trial;Physiological;Population;pre-clinical;preference;Psychological reinforcement;Publications;receptor;Reporting;Role;selective expression;Sensory;Signal Transduction;Smooth Muscle;Spinal Ganglia;Stomach;Therapeutic;therapeutic evaluation;Tissues;Treatment Efficacy,Endocannabinoids and the Control Of Behavior and Cardiovascular Function,351,NA,NA,NA,NA,24,NA,NA,1151007,NA
11191234,ZIA,AI,1,N,NA,NA,NA,NA,ZIAAI000585,NA,NA,1ZIAAI000585-35,NIAID:757218\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,11999342 (contact),"LANE, CLIFFORD  (contact)",NA,NA,NA,Acquired Immunodeficiency Syndrome;Anti-Retroviral Agents;Antibodies;Antibody Response;antiretroviral therapy;Bar Codes;Binding;Biological Markers;Blood;Case/Control Studies;CD4 Antigens;CD4 Positive T Lymphocytes;CD8-Positive T-Lymphocytes;Cell Count;Cell Survival;Cells;Cessation of life;Chronic;Coagulation Process;cohort;Congenital Abnormality;Data;Detection;DNA;DNA Sequence Alteration;efavirenz;emtricitabine;Environment;experience;Failure;Fibrin fragment D;Fumarates;Genetic Transcription;Genome;genome sequencing;HIV;HIV Infections;HIV-1;HLA-DR Antigens;Homeostasis;immune activation;Immune response;Immune system;immunodeficiency;Immunologic Stimulation;immunological status;Immunologics;Immunosuppression;in vivo;Individual;Infection;Inflammation;inhibitor;innovation;Interleukin-6;Knowledge;Lamivudine;Ligands;Live Birth;low and middle-income countries;Measurement;Measures;nef Protein;novel;Nucleosides;Open Reading Frames;Participant;Pathogenesis;patient population;Patients;peripheral blood;Peripheral Blood Mononuclear Cell;Persons;Pharmaceutical Preparations;Phenotype;Positron-Emission Tomography;Pregnancy;Production;protein expression;Proteins;Proviruses;Randomized;Recovery;Resistance;Reverse Transcriptase Inhibitors;Risk;Ritonavir;RNA;RNA Viruses;Secondary to;Tenofovir;Thromboplastin;TNF gene;Transcript;Translations;treatment guidelines;Treatment Protocols;treatment strategy;Viral;Viral Proteins;Viremia;Virus;Virus Replication;Western Blotting,Pathogenesis and Treatment of HIV Infection,585,NA,NA,NA,NA,35,NA,NA,757218,NA
11191235,ZIA,AI,1,N,NA,NA,NA,NA,ZIAAI000936,NA,NA,1ZIAAI000936-21,NIAID:73280\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,11999342 (contact),"LANE, CLIFFORD  (contact)",NA,NA,NA,"2019-nCoV;Acceleration;acute hypoxemic respiratory failure;Adult;Adverse event;adverse pregnancy outcome;Age;Anthrax Attack;Anthrax disease;Anti-viral Therapy;Antibiotics;Antibodies;Antigens;Area;Asian;Bacterial Pneumonia;biological heterogeneity;Biological Markers;biomarker identification;Birth;Black race;Blood;Blood Coagulation Disorders;C-reactive protein;Categories;Cessation of life;Characteristics;Child;Childhood;Clinical;Clinical Trials;cohort;community acquired pneumonia;Conduct Clinical Trials;COVID-19;COVID-19 patient;COVID-19 treatment;Data;Death Rate;Democratic Republic of the Congo;Diagnostic;Diarrhea;Disease;Disease Progression;Ebola;Ebola Hemorrhagic Fever;Ebola virus;Emerging Communicable Diseases;Endothelium;Enrollment;Enzyme-Linked Immunosorbent Assay;Epidemiology;epithelial injury;Evaluation;Event;Female;Fever;hazard;high risk;Hispanic;Hospitalization;Hypoxemic Respiratory Failure;IL8 gene;immunomodulatory therapies;improved;Individual;Indonesia;Infant;Infection;Inflammation;Inflammatory;Influenza;Inhalation;Injury;Institution;Interleukin-10;Interleukin-6;Investigational Therapies;Laboratories;long term consequences of COVID-19;long-term sequelae;Longitudinal Studies;Longterm Follow-up;Lung;Lymphocyte;Measurement;Measures;Methods;Modeling;Monkeypox;mortality;Mothers;Neuropeptides;neutrophil;new pandemic;novel strategies;Nucleocapsid;Nucleocapsid Proteins;Odds Ratio;Organ failure;Outcome;Outcome Study;Participant;participant enrollment;Pathogenesis;Patient Self-Report;Patients;Perinatal;Persons;placebo group;Placebos;Placenta;Plasma;Plasma Proteins;Pneumonia;Post-Acute Sequelae of SARS-CoV-2 Infection;Postpartum Period;predictive marker;Predictive Value;Pregnancy;Pregnancy Outcome;Prevention;procalcitonin;protein biomarkers;randomized placebo controlled trial;Randomized, Controlled Trials;Recovery;remdesivir;Reporting;Research;Respiratory Tract Infections;response;Risk;RNA;Role;Safety;safety outcomes;Sampling;SARS-CoV-2 infection;Seasons;Sensitivity and Specificity;Serious Adverse Event;seropositive;Severe Acute Respiratory Syndrome;severe COVID-19;Severity of illness;soluble RAGE;supplemental oxygen;Survivors;Temperature;Therapeutic Intervention;Thrombomodulin;treatment effect;treatment response;Umbilical Cord Blood;Upper respiratory tract;Vaccines;Viral;Viral Antigens;Viral Pneumonia;viral RNA;Virus Diseases;volunteer;White Blood Cell Count procedure","Pathogenesis, Treatment and Prevention of Emerging Infectious Diseases",936,NA,NA,NA,NA,21,NA,NA,73280,NA
11191236,ZIA,AI,1,N,NA,NA,NA,NA,ZIAAI001354,NA,NA,1ZIAAI001354-04,NIAID:459134\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,6568333 (contact),"SNELLER, MICHAEL C (contact)",NA,NA,NA,2019-nCoV;Acute;acute COVID-19;acute infection;Acute Respiratory Distress Syndrome;Adult;Antibodies;Antibody Response;Cardiopulmonary;cell mediated immune response;Cessation of life;Characteristics;Clinical;cognitive function;cohort;Control Groups;COVID-19;COVID-19 sequelae;Data Analyses;Data Collection;design;Disease;Enrollment;Evaluation;Evolution;follow-up;Future;Health Status;Household;Immune response;Immunity;Incidence;Infection;Internal Medicine;Laboratories;Longitudinal cohort;Longitudinal cohort study;Longitudinal Studies;Mediating;Medical;Mental Health;Natural History;pandemic disease;Participant;Patients;Peripheral Blood Mononuclear Cell;persistent symptom;Persons;Physical Examination;Plasma;Pneumonia;post-COVID-19;Publishing;Questionnaires;Recording of previous events;Recovery;recruit;Reporting;Resolution;Respiratory Failure;response;Risk Factors;Sampling;SARS-CoV-2 immunity;SARS-CoV-2 infection;Serology;Serum;Severe Acute Respiratory Syndrome;Severities;Severity of illness;Survivors;Symptoms;T-Lymphocyte;Testing;Time;Trauma;Virus;Virus Diseases,A Longitudinal Study of COVID-19 Sequelae and Immunity,1354,NA,NA,NA,NA,4,NA,NA,459134,NA
11191237,ZIA,AR,1,N,NA,NA,NA,NA,ZIAAR041148,NA,NA,1ZIAAR041148-20,NIAMS:775341\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES,NA,NA,NA,9691690 (contact),"O'SHEA, JOHN  (contact)",NA,NA,NA,Acceleration;Architecture;Autoimmune Diseases;B-Lymphocytes;Binding;Biological Assay;Bromodomain;Bruck-de Lange syndrome;cancer cell;Cell Aging;Cell Cycle Regulation;Cell Proliferation;cell type;Cells;Chemoresistance;chemotherapeutic agent;chemotherapy;Chromatin;Chromosome Structures;cohesin;Colon Carcinoma;Communication;comparative genomics;Complex;Confocal Microscopy;Coupled;CRISPR/Cas technology;Cryoelectron Microscopy;Data;Data Set;Defect;Development;Disease;DNA;DNA Damage;DNA Repair;Double Strand Break Repair;Doxorubicin;Drosophila genus;Drug resistance;Elements;Enhancers;Etiology;Eukaryota;Event;Evolution;Exhibits;Fluorescence-Activated Cell Sorting;FOXO1A gene;Frequencies;Future;Gene Expression;Gene Expression Regulation;gene network;Generations;Genes;Genetic Diseases;Genetic Recombination;Genetic Screening;Genetic Transcription;Genome;genome-wide;Genomic Instability;Genomics;Glycogen Synthase Kinase 3;Host Defense;Human;Human Genome;Immune;Immune Response Genes;Immune System Diseases;immunopathology;inhibitor;insight;interest;Interferon alpha;interferon-stimulated gene factor 3;Interferons;Label;Length;lymphoblastoid cell line;Lymphoma;Malignant Neoplasms;Mammalian Cell;Mass Spectrum Analysis;mathematical model;Mediating;Mediator;Messenger RNA;Microscopy;Molecular;Molecular Target;mouse genome;mouse model;Mus;neural network;Nonhomologous DNA End Joining;novel;Nuclear;Organism;Pathway Analysis;Patients;Phosphoric Monoester Hydrolases;Phosphorylation;Phosphotransferases;Physiological;Population;prevent;Process;Prognostic Marker;promoter;Protein Complex Subunit;Proteins;Proteome;Reaction;Regulator Genes;Regulatory Element;residence;Resistance;Resolution;response;RNA Binding;RNA Polymerase II;Role;Screening Result;Signal Transduction;single molecule;single-cell RNA sequencing;Sirolimus;Stimulus;Structure;Structure of germinal center of lymph node;System;Technology;temporal measurement;Time;Tissue-Specific Gene Expression;Tissues;tool;Transcription Coactivator;transcription factor;Transcription Initiation;Transcriptional Regulation;transcriptome;transcriptomic profiling;transcriptomics;treatment response;ubiquitin-protein ligase;Up-Regulation;Work,Mechanisms of gene expression and recombination,41148,NA,NA,NA,NA,20,NA,NA,775341,NA
11191238,ZIA,AR,1,N,NA,NA,NA,NA,ZIAAR041198,NA,NA,1ZIAAR041198-11,NIAMS:1627899\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES,NA,NA,NA,12449969 (contact),"OMBRELLO, MICHAEL  (contact)",NA,NA,NA,"16 year old;Address;Adult;Adult-Onset Still&apos;s Disease;Affect;Age of Onset;Algorithms;Alleles;Arthritis;Atherosclerosis;Atherosclerosis Risk in Communities;Autoimmunity;autoinflammation;autoinflammatory;autoinflammatory diseases;autosome;B-Cell Antigen Receptor;Biochemical;Bioinformatics;Biology;boys;case control;Cell Line;Cells;Child;Childhood;Chronic;Chronic Childhood Arthritis;CHS1 gene;Clinical;Clinical Immunology;Code;cohort;Collaborations;Collection;Complex;Custom;Cytoplasmic Granules;Data;database of Genotypes and Phenotypes;Daughter;Development;Disease;Dominant-Negative Mutation;Drug Exposure;Environmental Risk Factor;Eosinophilia;Etiology;Exanthema;exome sequencing;experience;familial hemophagocytic lymphohistiocytosis;Family;Fathers;Fever;Frequencies;Functional disorder;Genes;Genetic;genetic risk factor;Genetic study;genetic variant;Genomics;girls;Goals;Hemophagocytic Lymphohistiocytoses;Hereditary Periodic Fever Syndromes;Herpesviridae Infections;Heterogeneity;Heterozygote;HLA-DRB1;Human;humoral immunity deficiency;Hypersensitivity;IL-6 inhibitor;Immune;immune activation;immunodeficiency;improved;improved outcome;in silico;In Vitro;Individual;Infection;Inflammation;Inflammatory;Inflammatory Arthritis;Interleukin-1;Interleukin-6;International;Intramural Research;Investigation;Joints;Journals;Lesion;Life;loss of function;Loss of Heterozygosity;Lung;Lung Diseases;lymphoid hyperplasia;Macrophage activation syndrome;Manuscripts;Mediating;Medicine;Mendelian disorder;Morbidity - disease rate;mortality;Mutation;National Institute of Arthritis, and Musculoskeletal, and Skin Diseases;Natural Killer Cells;Non-Insulin-Dependent Diabetes Mellitus;novel;Outcome;Paper;Pathogenesis;Pathway interactions;patient subsets;Patients;Pattern;Peripheral;Pharmaceutical Preparations;Phenotype;Phospholipases A;Phosphorylation;PLCG2 gene;Population;Population Control;predictive marker;Predisposition;Prevalence;Proteins;Protocols documentation;prototype;Publishing;rare variant;Reaction;Recommendation;recruit;Refractory;release of sequestered calcium ion into cytoplasm;Reporting;Resolution;Resources;Rheumatology;risk variant;Role;Salmon;Serositis;skin color;Source;Symptoms;Syndrome;systemic juvenile idiopathic arthritis;Technology;Testing;therapy outcome;transcriptomics;Translational Research;United States National Institutes of Health;Urticaria;Variant;Work",Genetics and pathophysiology of systemic juvenile idiopathic arthritis and other complex autoinflammatory diseases,41198,NA,NA,NA,NA,11,NA,NA,1627899,NA
11191239,ZIA,AR,1,N,NA,NA,NA,NA,ZIAAR041199,NA,NA,1ZIAAR041199-11,NIAMS:2694565\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES,NA,NA,NA,12449971 (contact),"KAPLAN, MARIANA  (contact)",NA,NA,NA,"Abnormal Neutrophil;Acceleration;Address;Adult;Affect;Apoptosis;Area;arthropathies;ATAC-seq;Atherosclerosis;Autoantigens;Autoimmune Diseases;Autoimmune Responses;Binding;Biological Assay;Biology;Blood Proteins;Blood Vessels;bone;cardiovascular disorder risk;Cells;Cessation of life;Chromatin;clinical center;Clinical Trials;Coronary Arteriosclerosis;cytokine;Cytoplasmic Protein;Development;Disease;Endothelial Cells;Etiology;Event;extracellular;Female of child bearing age;Functional disorder;Future;Gene Expression;Generations;genetic signature;Goals;Health;Heterogeneity;human model;Image;Immune;Impairment;Inflammatory;innate immune pathways;interest;Interferon Type I;Intervention;Investigation;Lead;Lupus;Mediating;Molecular;mouse model;multiple omics;National Institute of Arthritis, and Musculoskeletal, and Skin Diseases;Natural History;Natural Immunity;neutrophil;Organ;organ growth;Pathogenesis;Pathogenicity;Pathway interactions;Patients;Periodontitis;pharmacologic;Post-Translational Protein Processing;premature;Process;repaired;Reporting;Research Personnel;Rheumatism;Rheumatoid Arthritis;Risk;Risk Factors;Role;Sex Differences;single-cell RNA sequencing;Structure;Syndrome;systemic autoimmune disease;systemic autoimmunity;Systemic disease;Systemic Lupus Erythematosus;Techniques;Thromboplastin;thrombotic;Tissues;transcriptome sequencing;Vascular Diseases;Vasomotor;Work",Systemic Autoimmunity,41199,NA,NA,NA,NA,11,NA,NA,2694565,NA
11191240,ZIA,AR,1,N,NA,NA,NA,NA,ZIAAR041210,NA,NA,1ZIAAR041210-05,NIAMS:409165\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES,NA,NA,NA,77865659 (contact),"FRANCO, LUIS  (contact)",NA,NA,NA,Anti-Inflammatory Agents;Autoimmune Diseases;Cell Line;cell type;Cells;Clinical;clinical practice;Clinical Research;Clinical Trials Data Monitoring Committees;cohort;COVID-19 pandemic;Data;Data Analyses;Development;Dose;functional genomics;Generations;Genomics;Glucocorticoids;Goals;Human;Immune;Immune system;Knowledge;Laboratories;Methylprednisolone;Participant;Patients;preclinical study;Protocols documentation;recruit;Rodent Model;sample collection;Sampling;Serious Adverse Event;side effect;System;Systemic Lupus Erythematosus;targeted treatment;Therapeutic Intervention,Genomic Effects of Glucocorticoids in Patients with Systemic Lupus Erythematosus,41210,NA,NA,NA,NA,5,NA,NA,409165,NA
11191241,ZIA,EB,1,N,NA,NA,NA,NA,ZIAEB000051,NA,NA,1ZIAEB000051-17,NIBIB:1425266\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING,NA,NA,NA,2397763 (contact),"SCHUCK, PETER  (contact)",NA,NA,NA,2019-nCoV;Acceleration;Algorithmic Analysis;analytical ultracentrifugation;Artificial Intelligence;Biological Products;Biotechnology;Calibration;Chemicals;Communication;Complex;Computational algorithm;Computer software;Cytosol;Data;Data Analyses;design;Detection;Development;Diffusion;Documentation;Drug Delivery Systems;Ensure;Environment;Equilibrium;Exhibits;Expert Systems;Formulation;Future;gene therapy;Goals;Immunoglobulin G;Laboratories;lens;light scattering;lipid nanoparticle;Lipids;Liquid substance;macromolecular assembly;Macromolecular Complexes;Malignant Neoplasms;Manufacturer;manufacturing run;Measurement;Measures;Mechanics;Methods;Modeling;Morphologic artifacts;Multiprotein Complexes;nano;nanomedicine;nanoparticle;Nature;Noise;novel strategies;Optics;Particle Size;Pattern;Peer Review;Preparation;Process;Production;Protein Dynamics;Proteins;prototype;Publications;Publishing;Quality Control;Radial;Reaction;Reporting;Research;Resolution;RNA vaccine;Sampling;sedimentation coefficient;Sedimentation process;sedimentation velocity;Serum Albumin;Serum Proteins;Standardization;Techniques;Testing;Therapeutic;therapeutic protein;Time;tool;Update;Vaccine Therapy;Vaccines;Viral;Viral Vector;Work,Dynamics of Protein Assemblies by Analytical Ultracentrifugation,51,NA,NA,NA,NA,17,NA,NA,1425266,NA
11191242,ZIA,EB,1,N,NA,NA,NA,NA,ZIAEB000088,NA,NA,1ZIAEB000088-08,NIBIB:218333\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING,NA,NA,NA,15200394 (contact),"PIERPAOLI, CARLO  (contact)",NA,NA,NA,Algorithms;analysis pipeline;Atlases;base;Biological;Brain;Cardiac;Clinical;Computer software;Data;data quality;denoising;Diffusion;Diffusion Magnetic Resonance Imaging;Dropout;Echo-Planar Imaging;elastography;empowerment;Ensure;Goals;Image;image registration;improved;Individual;Magnetic Resonance Imaging;Maps;Mathematics;Methods;Modeling;Morphologic artifacts;Morphology;Motion;novel;Phase;Picture Archiving and Communication System;Population;Population Study;prevent;Process;processing speed;Programming Languages;Property;Recording of previous events;Reproducibility;Research Personnel;Series;Signal Transduction;System;Time;Translating;Turtles;Update;user friendly software,Processing and Analysis of Quantitative Diffusion MRI Data,88,NA,NA,NA,NA,8,NA,NA,218333,NA
11191243,ZIA,EB,1,N,NA,NA,NA,NA,ZIAEB000093,NA,NA,1ZIAEB000093-05,NIBIB:873333\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING,NA,NA,NA,77858067 (contact),"SADTLER, KAITLYN  (contact)",NA,NA,NA,2019-nCoV;Autoimmune;Autoimmune Responses;Autoimmunity;Biocompatible Materials;cell type;Collaborations;Collagen;Communities;COVID-19;Data;Deposition;eosinophil;Family suidae;Fibrosis;Foreign Bodies;Human;Immune;Immune response;immunoengineering;Immunology;implantation;In Vitro;Injury;Journals;Link;Literature;Location;Manuscripts;Metabolism;Methods;Modeling;mouse model;MRL/MpJ Mouse;Mus;Muscle;Natural regeneration;Nature;Paper;Pathway interactions;Process;Publications;Publishing;Reporting;Research;Research Project Grants;response;Role;Shapes;tissue regeneration;Tissues;Trauma;trauma centers;Traumatic injury;United States National Institutes of Health;Work;wound healing;Wound models,Immunoengineering,93,NA,NA,NA,NA,5,NA,NA,873333,NA
11191244,ZIA,EB,1,N,NA,NA,NA,NA,ZIAEB000094,NA,NA,1ZIAEB000094-05,NIBIB:1627200\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING,NA,NA,NA,77858069 (contact),"CARTAGENA-RIVERA, ALEXANDER  (contact)",NA,NA,NA,3-Dimensional;Actins;Actomyosin;Anisotropy;Antibodies;Antigen-Presenting Cells;Antigens;Architecture;Atlas of Cancer Mortality in the United States;Atomic Force Microscopy;Behavior;Biological;Biology;Biomechanics;biophysical techniques;biophysical tools;Biophysics;Cancer Biology;cancer cell;Cancer cell line;Cancer Detection;cancer therapy;Cancerous;cantilever;Cause of Death;CD28 Antigens;CD3 Antigens;Cell membrane;Cell Nucleus;Cell Physiology;cell type;Cells;Cellular biology;cellular development;Cellular Structures;Characteristics;Chemicals;Communities;Complex;complex biological systems;Cytoskeleton;deafness;Development;Developmental Biology;Diagnosis;Dimensions;Disease;Disease Progression;Dissection;Distal;Dorsal;Elasticity;Engineering;Epithelium;ERM protein;Extracellular Matrix;F-Actin;fluorescence microscope;Gel;Generations;genetic regulatory protein;Glycocalyx;Goals;Growth;Hearing;Heterogeneity;Hydrostatic Pressure;Image Analysis;Immune;immune activation;immunological synapse;immunological synapse formation;Individual;Inflammation;Integrins;Knowledge;Laboratories;Labyrinth;Liquid substance;Lymphocyte;macromolecular assembly;Maintenance;Malignant neoplasm of ovary;Malignant neoplasm of pancreas;Malignant Neoplasms;Maps;materials science;mathematical model;Mathematics;Measures;mechanical force;mechanical properties;Mechanics;mechanotransduction;Mediator;Metastatic Malignant Neoplasm to the Ovary;Methods;Microscopy;Microtubules;migration;Modulus;Molecular;molecular mechanics;Monitor;mortality;Motility;multidisciplinary;Myosin Type II;nanomechanics;nanoscale;National Institute of Biomedical Imaging and Bioengineering;Neoplasm Metastasis;neoplastic cell;non-muscle myosin;novel;novel strategies;novel therapeutic intervention;Optics;Organelles;pancreatic cancer cells;Pancreatic Ductal Adenocarcinoma;Pathology;Patients;Physics;Physiological;Play;Polymers;Positioning Attribute;post-doctoral training;Postbaccalaureate;Postdoctoral Fellow;pressure;Process;Prognosis;Proliferating;Property;Regulation;Research;Resolution;response;Role;Sampling;self organization;Sensory;Side;Site;Solid Neoplasm;spatiotemporal;Spectrum Analysis;Stress;surface coating;Surface Tension;Surveys;Survival Rate;T-Lymphocyte;Techniques;Therapeutic;Tissues;tool;Traction;Traction Force Microscopy;trait;transmission process;Tumor Markers;tumor microenvironment;tumor progression;ultra high resolution;viscoelasticity;Viscosity,Mechanobiology,94,NA,NA,NA,NA,5,NA,NA,1627200,NA
11191245,ZIA,EB,1,N,NA,NA,NA,NA,ZIAEB000095,NA,NA,1ZIAEB000095-05,NIBIB:1341376\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING,NA,NA,NA,2397763 (contact),"SCHUCK, PETER  (contact)",NA,NA,NA,2019-nCoV;5&apos; Untranslated Regions;Affinity;analytical ultracentrifugation;Antigens;arm;Binding;Binding Sites;Bioinformatics;Biological Assay;biophysical analysis;biophysical techniques;C-terminal;Cells;Cellular biology;Collaborations;Coronavirus;COVID-19;crosslink;dimer;Dimerization;Disease;DNA;experimental study;Hydrophobicity;inhibitor;Journals;Laboratories;Leucine;Ligands;Link;Liquid substance;Methods;mimetics;Modeling;Molecular Conformation;mutant;Mutation;Mutation Analysis;Nucleic Acid Binding;Nucleic Acids;Nucleocapsid;Nucleocapsid Proteins;Nucleotides;Occupations;Oligonucleotides;particle;Pathway interactions;Pharmaceutical Preparations;Phase;Phosphorylation;Photometry;Physical condensation;Play;Point Mutation;Process;protein oligomer;Proteins;Publishing;Reporting;Research;Ribonucleoproteins;RNA;Role;scaffold;Scaffolding Protein;sedimentation velocity;Serology;Single-Stranded DNA;Site;small molecule therapeutics;stem;Structural Models;targeted treatment;Techniques;Therapeutic;Therapeutic Intervention;therapeutic target;Viral;Viral Genome;Viral Packaging;viral RNA;Virion;Virus Assembly;Virus Diseases;virus testing;Virus-like particle,Interactions of SARS-CoV-2 N-protein,95,NA,NA,NA,NA,5,NA,NA,1341376,NA
11191246,ZIA,EB,1,N,NA,NA,NA,NA,ZIAEB000099,NA,NA,1ZIAEB000099-03,NIBIB:574875\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING,NA,NA,NA,2397763 (contact),"SCHUCK, PETER  (contact)",NA,NA,NA,2019-nCoV;Amino Acid Sequence;Amino Acid Substitution;Amino Acids;Antigens;Attention;Behavior;biophysical properties;Biophysics;Charge;Collaborations;Consensus Sequence;Coronavirus;Correlation Studies;COVID-19 pandemic;Databases;Disease;Distant;Docking;Drug Targeting;epidemiology study;Evolution;experimental study;flexibility;Follow-Up Studies;Frequencies;Genome;genome database;Genomics;Genotype;Geography;Hydrophobicity;indexing;Link;Mediating;mimicry;mutant;Mutation;mutation screening;Nucleocapsid;Nucleocapsid Proteins;Outcome;particle;Pathway interactions;Patients;Pattern;Phase;Phenotype;Property;protein function;protein protein interaction;Protein Region;Proteins;Publishing;Reporting;repository;Ribonucleoproteins;Role;Sampling;SARS-CoV-2 B.1.1.529;SARS-CoV-2 B.1.617.2;SARS-CoV-2 genome;scaffold;Site;Source;structural biology;Structure;Tertiary Protein Structure;therapeutic target;Thermodynamics;tool;Variant;variants of concern;Viral;Viral Genome;Viral Proteins;viral RNA;Virulence;Virus;Virus Assembly;Work,The mutational landscape of SARS-CoV-2 nucleocapsid protein,99,NA,NA,NA,NA,3,NA,NA,574875,NA
11191247,ZIA,EB,1,N,NA,NA,NA,NA,ZIAEB000100,NA,NA,1ZIAEB000100-02,NIBIB:365276\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING,NA,NA,NA,79341491 (contact),"PLATT, MANU  (contact)",NA,NA,NA,3-Dimensional;Affect;Age;Amino Acid Sequence;Animals;Area;Arterial Disorder;Arteries;Atherosclerosis;Automobile Driving;Bioinformatics;Biomedical Engineering;Blood flow;Bone Diseases;Brain;Cardiac;Cardiovascular Diseases;Carotid Arteries;cathepsin K;Cathepsins;Cells;Circulation;Collaborations;Collagen;Common carotid artery;computerized tools;Cysteine;Data;Diagnostic;Diffusion Magnetic Resonance Imaging;Digital Imaging and Communications in Medicine;Disease;disease phenotype;Disease Progression;Drug Targeting;Elasticity;Elastin;Electron Microscopy;Elements;endometriosis;Enzymes;Equipment;Family;Genotype;Geometry;hemodynamics;Hemoglobin;Heterozygote;HIV;Human;Image;Infarction;interest;Kinetics;Knock-out;Liquid substance;Location;Magnetic Resonance Angiography;Magnetic Resonance Imaging;Malignant Breast Neoplasm;Malignant neoplasm of cervix uteri;Malignant neoplasm of lung;Malignant neoplasm of prostate;Mass Spectrum Analysis;mathematical model;Mechanics;Mediating;Medicine;meetings;Modeling;Molecular Biology;Molecular Profiling;mouse model;Mus;Mutation;National Institute of Biomedical Imaging and Bioengineering;Neoplasm Metastasis;novel;Output;pharmacologic;Physiological;Play;Postbaccalaureate;Postdoctoral Fellow;posters;protein expression;Protein Fragment;Proteins;Proteolysis;Publishing;Reaction;Recombinants;Research;Research Personnel;Role;Running;SARS-CoV-2 spike protein;Scholars Program;Scientist;serial imaging;shear stress;Sickle Cell;Sickle Cell Anemia;Sickle Cell Trait;sickling;Signal Pathway;simulation;single-cell RNA sequencing;Site;Societies;spatiotemporal;Stains;Stenosis;Stroke;Structure;summer internship;Surgeon;System;Tendinopathy;Testing;Thick;Thinness;Time;Tissues;trait;transcriptome sequencing;Transgenic Mice;United States National Institutes of Health;Up-Regulation;Vascular Diseases;Viral;Visualization;Work,Mechanics and Tissue Remodeling Integrating Computational and Experimental Systems (MATRICES),100,NA,NA,NA,NA,2,NA,NA,365276,NA
11191248,ZIA,EB,1,N,NA,NA,NA,NA,ZIAEB000102,NA,NA,1ZIAEB000102-02,NIBIB:226177\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING,NA,NA,NA,79341493 (contact),"FATHI, PARINAZ  (contact)",NA,NA,NA,Autoimmune Diseases;Autoimmunity;Bacterial Proteins;Biogenesis;Biological;Biology;Biomedical Engineering;Blood Vessels;Cell Culture Techniques;Cell Line;Cells;Collaborations;Communications Media;Development;Endothelial Cells;Engineering;Epitopes;Evaluation;experimental study;Extracellular Matrix;extracellular vesicles;Generations;Goals;Human;Hydrogels;Immune response;immunoengineering;Immunological Models;immunoregulation;instrument;interest;Investigation;Malignant neoplasm of thyroid;Malignant Neoplasms;Mammalian Cell;Mechanics;Microfluidic Microchips;Microfluidics;microphysiology system;Modeling;nanoengineering;nanoparticle;National Institute of Biomedical Imaging and Bioengineering;organ on a chip;Organoids;Phenotype;Property;Proteins;Proteomics;Protocols documentation;Research;Role;Sequence Homology;spheroids;systems research;Temperature;therapy development;Thyroid Gland;Tissues;zeta potential,NanoEngineering and MicroPhysiological Systems,102,NA,NA,NA,NA,2,NA,NA,226177,NA
11191249,ZIA,ES,1,N,NA,NA,NA,NA,ZIAES025045,NA,NA,1ZIAES025045-25,NIEHS:586305\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES,NA,NA,NA,9693784 (contact),"LONDON, STEPHANIE  (contact)",NA,NA,NA,Address;Adult;Blood;Bone Marrow;causal variant;Childhood Asthma;design;Disease;Epidemiology;epidemiology study;Epigenetic Process;epigenome;epigenome-wide association studies;Experimental Models;experimental study;exposure to cigarette smoke;follow-up;Genes;Genetic;genetic analysis;Genome;genome wide association study;Human;Human Genome;Immunity;Inflammation;Intervention;Journals;Knock-out;Knockout Mice;Laboratories;Life Cycle Stages;London;Lung;metabolomics;Methylation;Mothers;mouse model;Mus;Newborn Infant;novel;Paper;Pathway interactions;Phenotype;Proteomics;Publishing;pulmonary function;Respiratory Disease;Role;Sampling;Smoke;Smoking;smoking-related disease;Smooth Muscle;Statistical Data Interpretation;Testing;Tissues;trait;transcriptome sequencing;Wild Type Mouse,Genetic Analyses For Epidemiologic Studies Of Respiratory Disease,25045,NA,NA,NA,NA,25,NA,NA,586305,NA
11191250,ZIA,ES,1,N,NA,NA,NA,NA,ZIAES040006,NA,NA,1ZIAES040006-28,NIEHS:236661\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES,NA,NA,NA,9416024 (contact),"WEINBERG, CLARICE  (contact)",NA,NA,NA,Archives;Area;Beta Cell;Biological Assay;biological specimen archives;Budgets;cardiovascular disorder risk;Case/Control Studies;cohort;Cohort Analysis;Cohort Studies;Collaborations;Complication;Cost efficiency;Data;design;Disease;disorder risk;Enrollment;Environmental Risk Factor;Epidemiologic Methods;Epidemiology;follow-up;Genetic Predisposition to Disease;Gestational Diabetes;Health;human data;Hypertension;improved;Learning;Measures;Medical History;Methods;Non-Insulin-Dependent Diabetes Mellitus;non-linear transformation;Observational Study;Outcome;Pancreas;personalized approach;Persons;Physiological;Postdoctoral Fellow;Pregnancy;Pregnancy Complications;Pregnancy Histories;Pregnancy loss;Prevention;prospective;Recording of previous events;Recurrence;reproductive;Reproductive History;Research Design;Research Personnel;Risk;risk prediction;Sampling;screening;simulation;Sister;Specimen;Statistical Methods;tool;undergraduate student;Woman;Women&apos;s mortality;Work,Statistical Methods In Epidemiology--general,40006,NA,NA,NA,NA,28,NA,NA,236661,NA
11191251,ZIA,ES,1,N,NA,NA,NA,NA,ZIAES040007,NA,NA,1ZIAES040007-28,NIEHS:169044\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES,NA,NA,NA,9416024 (contact),"WEINBERG, CLARICE  (contact)",NA,NA,NA,Affect;Age;Algorithms;Asian;autism spectrum disorder;Back;Biological;Blood Pressure;case control;Chromosome Mapping;Cleft Lip;Cleft Palate;Collaborations;Complex;Congenital Abnormality;Data;Data Set;Defect;design;Detection;Disease;disorder risk;early onset;Environment;Environmental Exposure;Environmental Risk Factor;Etiology;European;Evolution;extreme prematurity;Family;fetal;First Degree Relative;Future;gene environment interaction;Genes;Genetic;genetic epidemiology;Genetic Epistasis;Genetic Programming;Genetic study;genetic variant;genome wide association study;genomic data;Genotype;Health;Heritability;improved;Individual;Joints;laboratory development;Life;Linkage Disequilibrium;Machine Learning;Malignant Breast Neoplasm;maternal cigarette smoking;Mediating;Methods;Modeling;molecular subtypes;novel strategies;oral cleft;Outcome;Paper;Parents;Pathway interactions;Pennsylvania;Phenotype;Pregnancy Complications;prenatal;Proxy;Recurrence;Risk;Severities;Siblings;Signal Transduction;simulation;Sister;smoking during pregnancy;Source;Statistical Methods;Structure;Subcategory;summer student;Survivors;Testing;Toy;trait;Universities;Variant;Work,Statistical Methods For Genetic Epidemiology,40007,NA,NA,NA,NA,28,NA,NA,169044,NA
11191252,ZIA,ES,1,N,NA,NA,NA,NA,ZIAES043012,NA,NA,1ZIAES043012-26,NIEHS:1010871\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES,NA,NA,NA,9693784 (contact),"LONDON, STEPHANIE  (contact)",NA,NA,NA,"Adult;Adult asthma;Adverse effects;African ancestry;Aging;Agriculture;Air Pollution;Allergic Disease;ambient air pollution;Asthma;Atherosclerosis Risk in Communities;Biological Markers;Candidate Disease Gene;Cardiovascular Diseases;Cardiovascular system;causal variant;Chronic Obstructive Pulmonary Disease;cohort;Cohort Studies;Collaborations;Communities;Data;Development;Diet;Disease;Early identification;Environment;Environmental Exposure;Environmental Risk Factor;environmental tobacco smoke;Epigenetic Process;epigenome;Etiology;European;European ancestry;exome;Exposure to;Extramural Activities;Farm;Funding;Genes;Genetic;Genetic Predisposition to Disease;Genetic Risk;Genetic Variation;Genome;genome wide association study;genome wide methylation;genome-wide;Genomic approach;genomic epidemiology;Genomics;Genotype;Goals;Health;Heart;Heart Diseases;Impairment;Individual;Inhalation;interest;Joints;Life Cycle Stages;longitudinal analysis;Lung;Mediating;Meta-Analysis;metabolomics;Methods;Methylation;microbiome;microbiome analysis;mouse model;multi-ethnic;National Heart, Lung, and Blood Institute;National Institute of Environmental Health Sciences;next generation sequencing;novel;novel marker;Occupational;Occupational Exposure;Outcome;Paper;Pesticides;Phenotype;pollutant;Population;Population Study;Predisposition;prescription opioid;Proteomics;Publications;Publishing;pulmonary function;rare variant;Research;Resistance;Resources;respiratory;Respiratory Disease;respiratory health;Role;Smoking;Special Population;targeted sequencing;Tobacco smoking behavior;traffic-related air pollution;trait;Variant;Visit;Vital capacity;whole genome;Work","Genetics and Environment in Adult Respiratory, Allergic and Cardiac disease",43012,NA,NA,NA,NA,26,NA,NA,1010871,NA
11191253,ZIA,ES,1,N,NA,NA,NA,NA,ZIAES049019,NA,NA,1ZIAES049019-29,NIEHS:141522\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES,NA,NA,NA,9693784 (contact),"LONDON, STEPHANIE  (contact)",NA,NA,NA,Adult;Adverse effects;African;Age;Air Pollution;alcohol consumption during pregnancy;Allergic;Asthma;atopy;bead chip;Biological;biomarker development;Biomass;Birth;Birth Order;Birth Weight;Blood specimen;Body mass index;Caffeine;Carbon;Child;Child Health;Childhood;Childhood Asthma;cohort;Cohort Studies;Collaborations;Country;Data;Developed Countries;Development;Diet;Disease;DNA;DNA Methylation;early childhood;early life exposure;Education;Environmental Exposure;Environmental Risk Factor;Epidemiology;Epigenetic Process;epigenome;epigenome-wide association studies;Etiology;Exposure to;Family;Folic Acid;follow-up;Food;Funding;Future;Genes;Genetic;Genome;genome wide association study;Genotype;Gestational Age;Gestational Diabetes;Health;high risk;Home;human disease;Hypersensitivity;in utero;Infant;Inflammation;Inhalant dose form;Intake;interest;International;Life;Life Cycle Stages;maternal anxiety;maternal cigarette smoking;Maternal Exposure;maternal hypertension;maternal stress;Measures;Meta-Analysis;Metabolism;Methylation;Morbidity - disease rate;mortality;Mothers;National Institute of Environmental Health Sciences;Newborn Infant;Nigeria;Norway;novel;Nutrient;offspring;Outcome;Paper;Parental Ages;Parents;Pathway interactions;Phenotype;Pilot Projects;Population;population based;post-doctoral training;Postdoctoral Fellow;pre-doctoral;Pregnancy;pregnancy hypertension;Pregnant Women;prenatal;prenatal exposure;Public Health;Publications;Publishing;Questionnaires;Recommendation;Recording of previous events;Research;Research Personnel;Resources;respiratory;response;Risk Factors;Role;Sample Size;Sampling;School-Age Population;season of birth;Signal Transduction;Smoking;smoking during pregnancy;Stressful Event;success;time use;Umbilical Cord Blood;United States National Institutes of Health;Work,Genetic And Environmental Factors In Childhood Respiratory and Allergic Illness,49019,NA,NA,NA,NA,29,NA,NA,141522,NA
11191254,ZIA,ES,1,N,NA,NA,NA,NA,ZIAES050165,NA,NA,1ZIAES050165-27,NIEHS:2804918\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES,NA,NA,NA,1893803 (contact),"HALL, TRACI M (contact)",NA,NA,NA,Affinity;Binding;Biochemical;Biochemistry;Biological;Biological Assay;Biological Models;biological systems;C-terminal;Cancer Biology;Cells;Collaborations;Complex;Cryoelectron Microscopy;Cues;Data;Development;Developmental Biology;Embryonic Development;environmental change;Enzyme Kinetics;Enzymes;Essential Genes;Exclusion;fascinate;fundamental research;Future;Gene Expression;Gene Expression Regulation;genetic regulatory protein;Germ Lines;Goals;Group Structure;human disease;In Vitro;in vivo;Knowledge;Lateral;Messenger RNA;Molecular;Molecular Structure;Pathway interactions;Phase;Play;Post-Transcriptional Regulation;Process;Property;protein complex;protein function;Proteins;Regulation;Regulatory Pathway;Repression;Reproduction;Research;response;RNA;RNA Binding;RNA Processing;RNA Recognition Motif;RNA-Binding Proteins;RNA-Protein Interaction;Role;Signal Transduction;Site;Specificity;stem cell biology;Stimulus;structural biology;Structure;Tail;Techniques;Touch sensation;Toxicology;Transfer RNA;Visualization;Work;X-Ray Crystallography,Structural Studies Of Post-Transcriptional Gene Regulation,50165,NA,NA,NA,NA,27,NA,NA,2804918,NA
11191255,ZIA,ES,1,N,NA,NA,NA,NA,ZIAES065070,NA,NA,1ZIAES065070-34,NIEHS:2327677\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES,NA,NA,NA,2061027 (contact),"KUNKEL, THOMAS A (contact)",NA,NA,NA,Biochemical;Cell Death;Cell Survival;Coupling;Digestion;DNA biosynthesis;DNA Double Strand Break;DNA polymerase beta2;DNA Repair;DNA Structure;DNA-Directed DNA Polymerase;Genetic;Genome;Genome Stability;Genomics;Goals;Health;in vivo;Mediating;Mitotic;Mus;Mutagenesis;Nonhomologous DNA End Joining;Nucleotides;Pathway interactions;Phosphodiesterase I;Polymerase;Process;Property;Publications;repaired;Stress;Structure;Tail;Variant;Yeasts,Structure-Function Studies Of DNA Replication Fidelity,65070,NA,NA,NA,NA,34,NA,NA,2327677,NA
11191256,ZIA,ES,1,N,NA,NA,NA,NA,ZIAES065078,NA,NA,1ZIAES065078-31,NIEHS:1556555\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES,NA,NA,NA,8547918 (contact),"COPELAND, WILLIAM  (contact)",NA,NA,NA,5&apos;-deoxyribose phosphate lyase;Affect;Affinity;Age;Alpers&apos; Syndrome;Animals;Apoproteins;Apoptosis;Area;Atomic Force Microscopy;base;Base Excision Repairs;Binding;Binding Proteins;Binding Sites;Catalytic Domain;Cells;Chemicals;Child;Chronic progressive external ophthalmoplegia;Clinical;clinically relevant;Complex;crosslink;Cryoelectron Microscopy;Data;Defect;dimer;Disease;DNA;DNA Binding;DNA biosynthesis;DNA Maintenance;DNA polymerase gamma;DNA Repair;DNA replication fork;DNA Structure;DNA-Directed DNA Polymerase;Dysarthria;Frequencies;Gene Proteins;General Population;Genes;Genetic;Genetic Diseases;genetic regulatory protein;Goals;helicase;Human;Impairment;Individual;Inherited;insight;Intervention;Link;Mass Spectrum Analysis;Mediating;Metabolic Diseases;Mitochondria;Mitochondrial Diseases;Mitochondrial DNA;mitochondrial genome;Modeling;Molecular;Mutagenesis;Mutation;neuromuscular;Neuropathy;Nuclear;Ophthalmopareses;Organ;oxidative damage;Parkinsonian Disorders;particle;Pathogenicity;Pathology;Phosphodiesterase I;Point Mutation;Polymerase;polymerization;Polymers;Premature aging syndrome;Premature Menopause;Prevalence;prevent;Prevention;Process;Production;Proteins;Proteolysis;Publishing;Regulation;repaired;Reporting;Risk;Roentgen Rays;Role;Sensory;Single-Stranded DNA;Site;Site-Directed Mutagenesis;SS DNA BP;Structure;Symptoms;System;Time;Variant;Work;X-Ray Crystallography,Molecular Characterization Of The Mitochondrial Dna Polymerase,65078,NA,NA,NA,NA,31,NA,NA,1556555,NA
11191257,ZIA,ES,1,N,NA,NA,NA,NA,ZIAES065080,NA,NA,1ZIAES065080-30,NIEHS:828162\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES,NA,NA,NA,8547918 (contact),"COPELAND, WILLIAM  (contact)",NA,NA,NA,3 year old;abacavir;Address;Adult;aged;Amino Acids;analog;Animals;Anti-viral Therapy;antiretroviral therapy;antiviral nucleoside analog;Birth;Characteristics;Child;Collaborations;cost effective;deoxyguanosine triphosphate;design;Didanosine;dideoxynucleotide;Disease;DNA;DNA analysis;DNA biosynthesis;DNA polymerase gamma;DNA-Directed DNA Polymerase;Dose;Erythrocebus patas;Event;Excision;Exposure to;Fiber;Future;genetic variant;Genome;Genomic DNA;Goals;Health;Heart;HIV;Human;Iatrogenesis;improved;In Vitro;Individual;inhibitor;Kinetics;Laboratories;Lamivudine;Libraries;Life;Methods;Mitochondria;Mitochondrial DNA;mitochondrial DNA alteration;mitochondrial DNA mutation;Mus;Muscle Mitochondria;Myopathy;Neuropathy;Nevirapine;next generation sequencing;Nuclear;nucleoside analog;nucleotide analog;Nucleotides;Patients;Persons;Pharmaceutical Preparations;pinacolyl methylphosphonic acid;Point Mutation;Polymerase;Predisposition;pregnant;Pregnant Women;prenatal exposure;Preparation;prevent;Procedures;Property;Protocols documentation;Publishing;Recombinant DNA;Risk;Role;Sampling;side effect;Stavudine;Tenofovir;Tissues;Toxic effect;tripolyphosphate;Vertical Disease Transmission;Vertical Transmission;Viral;Virus;Zalcitabine;Zidovudine,Human Mitochondrial Dna Polymerase With Anti-hiv Nucleotides,65080,NA,NA,NA,NA,30,NA,NA,828162,NA
11191258,ZIA,ES,1,N,NA,NA,NA,NA,ZIAES065086,NA,NA,1ZIAES065086-29,NIEHS:607227\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES,NA,NA,NA,9416002 (contact),"SCHAAPER, ROELAND  (contact)",NA,NA,NA,Address;Adverse effects;Affect;Allosteric Regulation;base;Base Pairing;Biochemical;Cells;Chromosomes;Dissociation;DNA;DNA biosynthesis;DNA Polymerase II;DNA Polymerase III;DNA replication fork;DNA-Directed DNA Polymerase;Enzymes;Escherichia coli;Exclusion;Genes;Genetic;Holoenzymes;In Vitro;in vivo;Individual;Laboratory Study;Measures;Mismatch Repair;model organism;mutant;Mutation;Mutation Detection;novel;Play;Polymerase;Process;Protein Complex Subunit;Protein Subunits;Replication Error;Ribonucleotide Reductase;Role;Sequence Analysis;SOS Response;Source;Specificity;Speed;System,Mechanisms Of E. coli Replication Fidelity,65086,NA,NA,NA,NA,29,NA,NA,607227,NA
11191259,ZIA,ES,1,N,NA,NA,NA,NA,ZIAES065089,NA,NA,1ZIAES065089-28,NIEHS:927126\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES,NA,NA,NA,2061027 (contact),"KUNKEL, THOMAS A (contact)",NA,NA,NA,Apoptosis;base;Base Pairing;Biochemistry;Cell Survival;Degenerative Disorder;deoxyguanosine triphosphate;Development;Discrimination;Disease;DNA;DNA biosynthesis;DNA Damage;DNA Ligases;DNA Ligation;DNA Sequence;endonuclease;Environment;Eukaryotic Cell;Event;Excision Repair;gene repair;Genetic;Genetic Recombination;Genome;genome sequencing;Genome Stability;Goals;Health;Human;Immune response;Immunoglobulin Genes;Immunoglobulin Somatic Hypermutation;Infertility;Inherited;insertion/deletion mutation;Lead;Ligation;Malignant Neoplasms;Meiotic Recombination;Mismatch Repair;MSH2 gene;Mutagenesis;mutant;Mutation;Nuclear;Nucleotides;Okazaki fragments;Polymerase;preference;prevent;protein function;Proteins;repaired;replicase;Replication Error;response;Ribonucleotides;Role;Saccharomyces cerevisiae;seal;Signal Transduction;Single base substitution;System;Trinucleotide Repeats;Variant;whole genome;Yeasts,Studies Of DNA Mismatch Repair,65089,NA,NA,NA,NA,28,NA,NA,927126,NA
11191260,ZIA,ES,1,N,NA,NA,NA,NA,ZIAES071006,NA,NA,1ZIAES071006-26,NIEHS:3081690\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES,NA,NA,NA,6481295 (contact),"ARCHER, TREVOR KEITH (contact)",NA,NA,NA,"26S proteasome;Acute;Affect;African American population;Age;Aging;American;Animals;anti-cancer;Architecture;Area;ATP phosphohydrolase;Attention;Auxins;Binding;biological research;brahma;Breast Cancer Cell;Bromodomain;cancer cell;Cell Aging;Cell Line;Cell Reprogramming;Cell surface;Cells;Chromatin;chromatin remodeling;Chromatin Remodeling Factor;Collaborations;Collagen;Communication;Complex;Computer software;Cues;Data;Deoxyribonuclease I;Dermal;Development;Disease;Distal;DNA;Dorsal;embryonic stem cell;Energy Metabolism;Enhancers;Ensure;environmental health disparity;Environmental Impact;environmental justice;Enzymes;EP300 gene;Epigenetic Process;Epithelium;Eukaryotic Cell;European;Exhibits;Extracellular Matrix;Fibroblasts;fluorescence microscope;Gene Expression;Gene Expression Regulation;Genes;genetic information;Genetic Transcription;Genome;genomic locus;Genomics;Geroscience;global health;Glucocorticoid Receptor;Goals;Health;heart function;Heterogeneity;Histone Acetylation;Homeostasis;Human;human embryonic stem cell;human pluripotent stem cell;Immune response;improved;induced pluripotent stem cell;insight;Knock-in;Length;life span;Ligands;machine learning pipeline;Malignant Neoplasms;Mammary Neoplasms;Mediating;Mesenchymal;MG132;Mission;Molecular;Morphology;multicatalytic endopeptidase complex;Mus;Mutate;National Heart, Lung, and Blood Institute;National Institute of Environmental Health Sciences;nerve stem cell;Neural Crest;Neuroectoderm;Neuronal Differentiation;Normal Cell;Nuclear;Nuclear Receptors;Nucleic Acids;Nucleosomes;Oncogenic;outreach;Pathologic;Patient Self-Report;Phenotype;Physiological;Physiology;Play;pluripotency;Pluripotent Stem Cells;Positioning Attribute;Post-Translational Protein Processing;Process;Production;programs;promoter;Proteasome Inhibitor;protein degradation;Proteins;Pseudopodia;Publishing;receptor;Reproduction;Research;RNA;RNA Polymerase II;Role;Sampling;senescence;sex;Signal Transduction;Site;small molecule inhibitor;SMARCA2 gene;SMARCA4 gene;Specific qualifier value;stem cell biology;Stem cell pluripotency;stem cells;Strategic Planning;Surface;SWI/SNF Family Complex;System;Therapeutic;Training;Transcript;transcription factor;Transcription Initiation;Transcription Initiation Site;transcriptomics;Trichostatin A;Tumor Subtype;Ubiquitin;Variant;Work",Epigenetic and Transcriptional Functions of Nuclear Receptors and Chromatin Remodeling Proteins in Stem and Cancer Cells,71006,NA,NA,NA,NA,26,NA,NA,3081690,NA
11191261,ZIA,ES,1,N,NA,NA,NA,NA,ZIAES090057,NA,NA,1ZIAES090057-29,NIEHS:2788371\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES,NA,NA,NA,1944763 (contact),"CIDLOWSKI, JOHN A. (contact)",NA,NA,NA,Asthma;Behavior;biological adaptation to stress;blood glucose regulation;Cell Death;Cell Differentiation process;cell growth;Cells;Chronic;connective tissue metabolism;Disease;Drug Prescriptions;Evaluation;Glucocorticoids;Goals;Growth;Health;Hormones;Human;hypothalamic-pituitary-adrenal axis;Immunologic Surveillance;Inflammatory;insight;Life;man;Mission;National Institute of Environmental Health Sciences;Physiology;protein metabolism;Respiratory physiology;Signal Pathway;Signal Transduction;skeletal;Stress;therapeutic development;Therapeutic Intervention;Tissues,Glucocorticoid Hormone Action,90057,NA,NA,NA,NA,29,NA,NA,2788371,NA
11191262,ZIA,ES,1,N,NA,NA,NA,NA,ZIAES090080,NA,NA,1ZIAES090080-27,NIEHS:2455841\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES,NA,NA,NA,6570854 (contact),"BLACKSHEAR, PERRY J (contact)",NA,NA,NA,3&apos; Untranslated Regions;Acquired Immunodeficiency Syndrome;Anabolism;Arthritis;Binding;Biochemical;Biological Assay;Caenorhabditis elegans;Cell Nucleus;Cells;Cessation of life;Chronic;Complex;Crohn&apos;s disease;Cytosol;Dermatitis;Dictyostelium;Disease;Drosophila melanogaster;drug development;Elements;Evaluation;Excision;Family;Family member;Fission Yeast;Gene Expression Regulation;Gene Family;Genes;Genetic Polymorphism;Genetic Transcription;Genome;Goals;Granulocyte-Macrophage Colony-Stimulating Factor;Growth Factor;Health;Human;Inflammation;Inflammatory;inhibitor;insight;Knockout Mice;Lead;Macrophage;Malignant Neoplasms;man;Mediating;Medical;member;Messenger RNA;mRNA Transcript Degradation;Mus;National Institute of Environmental Health Sciences;new therapeutic target;novel;novel therapeutics;Organism;Pathway interactions;Phenotype;Phosphorylation;Physiological;Poly(A) Tail;Process;Proteins;prototype;Regulation;response;Rheumatoid Arthritis;Rodent;screening;Serine;small molecule;Stimulus;Syndrome;TIS11 protein;TNF gene;transcriptome;Variant;wasting;ZFP36L2 gene;Zinc Fingers,TTP and related proteins in the regulation of gene expression,90080,NA,NA,NA,NA,27,NA,NA,2455841,NA
11191263,ZIA,ES,1,N,NA,NA,NA,NA,ZIAES090089,NA,NA,1ZIAES090089-28,NIEHS:2741932\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES,NA,NA,NA,2047655 (contact),"YAKEL, JERREL L (contact)",NA,NA,NA,2019-nCoV;Acetylcholine;Acute Disease;alpha-bungarotoxin receptor;Alzheimer&apos;s Disease;Alzheimer&apos;s disease patient;Amygdaloid structure;Anesthesia procedures;Animals;antagonist;Area;Behavioral;behavioral outcome;Binding;Binding Sites;Biophysics;Brain;brain control;Brain Injuries;Brain region;Cell Count;Cells;cholinergic;Cholinergic Receptors;Chronic;cognitive ability;Cognitive deficits;cognitive function;cognitive process;Communication;Corpus striatum structure;dentate gyrus;Development;Diffusion;disorder risk;Disputes;Dopamine;dopaminergic neuron;drinking water;Electrophysiology (science);entorhinal cortex;environmental agent;epidemiologic data;Epilepsy;Event;excitatory neuron;Exposure to;Fire - disasters;frontier;Functional disorder;Genetic;Genetic Transcription;granule cell;Hippocampus;Human;Impaired cognition;Impairment;improved;in utero;Individual;Infection;Infusion procedures;Insecticides;Interneurons;Ion Channel Gating;Journals;Knock-out;Ligands;Link;Location;male;Maps;Memory;memory consolidation;memory encoding;Memory impairment;Memory Loss;memory retrieval;Molecular;motor disorder;Mus;Muscarinic Acetylcholine Receptor;Mutation;National Institute of Environmental Health Sciences;Nature;Nervous System;Neurodegenerative Disorders;neurogenesis;Neurologic;Neurons;Neurosciences;neurotransmitter release;neurovirulence;Nicotine;nicotine exposure;Nicotinic Receptors;novel;Paper;Parkinson Disease;Pathology;Pathway interactions;Patients;Pattern;Physiological;Physiological Processes;Play;Postsynaptic Membrane;Pregnant Women;Presynaptic Terminals;prevent;Process;Publishing;Pyramidal Cells;Rattus;receptor;Regulation;Reporting;Reversal Learning;Reverse Transcriptase Polymerase Chain Reaction;Risk;Role;Rotenone;Schizophrenia;Severities;sex;Site;Slow-Wave Sleep;Smoke;Substantia nigra structure;Symptoms;Synapses;Synaptic Cleft;Synaptic Transmission;Techniques;Testing;Therapeutic;Tobacco Dependence;Training;transmission process;Urethane;voltage clamp;voltage/patch clamp;Work,Modulation Of Neuronal Channels and Receptors in the Brain,90089,NA,NA,NA,NA,28,NA,NA,2741932,NA
11191264,ZIA,ES,1,N,NA,NA,NA,NA,ZIAES100221,NA,NA,1ZIAES100221-23,NIEHS:3242214\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES,NA,NA,NA,7355403 (contact),"DUDEK, SERENA M (contact)",NA,NA,NA,Address;Adenosine A1 Receptor;Adult;Age;Agglutinins;aggrecan;Aggressive behavior;Animal Experiments;Animals;antagonist;Antibodies;Area;autism spectrum disorder;Axon;Behavior;behavior influence;Biochemical;Brain;brain circuitry;Brain region;Buffers;Caffeine;Calcium;Cell Nucleus;Cells;Chemosensitization;cognitive development;Collaborations;Collection;Corticosterone;Data;Dendritic Spines;dentate gyrus;Development;developmental disease;Electrophysiology (science);Embryo;Endocrine disruption;Environment;Environmental Exposure;Environmental Health;Environmental Risk Factor;Exhibits;experimental study;Exposure to;Extracellular Matrix;Fluorescence;Future;G-Protein-Coupled Receptors;Genes;Goals;GTP-Binding Protein Regulators;Hamsters;hippocampal subregions;Hippocampus;Hormonal;Hormone Receptor;Hormones;Human;Imaging Techniques;Immunofluorescence Immunologic;Impairment;Implant;in utero;In Vitro;in vivo;insight;interest;Investigation;Knock-out;Knockout Mice;Lasers;Learning;Life;Ligands;Long-Term Depression;Long-Term Potentiation;Mass Spectrum Analysis;Measures;Memory;memory recognition;Mental disorders;Messenger RNA;Methods;Microscopy;Microtus;Mineralocorticoid Receptor;Mitochondria;Modification;Molecular;Molecular Profiling;Morphology;mossy fiber;mouse model;Mus;Neonatal;neonatal brain;neonate;Nervous System;Neuroanatomy;neurobehavioral;Neurons;Neuropeptides;novel;NR3C2 gene;Organism;Oxytocin;Pair Bond;patch clamp;Pattern;pharmacologic;Physiological;Physiology;Plant Lectins;Play;postnatal;postnatal development;postnatal period;Predisposition;preference;Pregnancy;premature;prenatal;Process;Publications;Pyramidal Cells;Rattus;receptor;receptor function;Receptor Signaling;Regulation;Research;Resistance;response;Rett Syndrome;Rodent;Role;Sensory;Serum;Signal Transduction;Slice;social;Social Behavior;social cognition;Spironolactone;Stains;Stress;Structure;Synapses;Synaptic plasticity;Techniques;Testing;Tissue Stains;Tissues;Toxic Environmental Substances;toxicant;transcription factor;transcriptome sequencing;treatment group;Vasopressins;vesicular glutamate transporter 2;Wisteria,Mechanisms Of Synaptic Plasticity In The Adult And Developing Nervous System,100221,NA,NA,NA,NA,23,NA,NA,3242214,NA
11191265,ZIA,ES,1,N,NA,NA,NA,NA,ZIAES100475,NA,NA,1ZIAES100475-23,NIEHS:148917\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES,NA,NA,NA,6570860 (contact),"BELL, DOUGLAS  (contact)",NA,NA,NA,adaptive immunity;Adult;Affect;B-Cell Activation;B-Lymphocytes;Binding;Biogenesis;Bioinformatics;Biological;Biological Assay;Biological Markers;Birth;Birth Weight;Blood Cells;Blood specimen;Bronchopulmonary Dysplasia;Categories;CD14 gene;CD19 gene;CD4 Positive T Lymphocytes;CD8-Positive T-Lymphocytes;cDNA Arrays;Cell Aging;Cell Cycle;Cell Cycle Progression;Cell Line;cell type;Cells;Cytokine Signaling;Cytokinesis;Data Set;design;Development;Developmental Gene;differential expression;Disease;Disease susceptibility;disorder risk;DNA;DNA Damage;DNA Methylation;DNA Sequence;early detection biomarkers;Environment;Environmental Exposure;epigenetic marker;Epigenetic Process;epigenetic variation;epigenome;epigenome-wide association studies;epigenomic profiling;Erythroblasts;Event;Exposure to;functional genomics;Future;Gene Expression;Genes;Genetic;Genetic Polymorphism;Genetic Variation;genome wide association study;genome-wide;Genomic approach;Genomics;Genotype;Gestational Age;Goals;granulocyte;Health;Hematologic Neoplasms;Hematopoiesis;Homeostasis;Human;human tissue;Immune;Impairment;improved;Incidence;Infant;Infection;Inflammatory Response;insight;late life;Leukocytes;Leukopoiesis;Linear Regressions;Link;Linkage Disequilibrium;Lung;Lung Diseases;lung maturation;Lymphocyte;Lymphopoiesis;Memory B-Lymphocyte;Methods;Methylation;Microarray Analysis;Mission;Mitochondria;Molecular;monocyte;Mutation;Natural Immunity;Natural Killer Cells;NCAM1 gene;neonatal care;neonatal period;neonate;Nervous System Disorder;neutrophil;Neutrophil Activation;non-smoker;nucleotide metabolism;Organ;Oxygen;Oxygen Therapy Care;Pathogenesis;Pathway interactions;peripheral blood;Phagocytosis;Phenotype;Population Study;precision medicine;Predisposition;premature;Premature Infant;preterm newborn;Prevention;Prevention strategy;promoter;prospective;pulmonary function;Regression Analysis;Reproducibility;response;Response Elements;Risk;Risk Assessment;RNA;Signal Pathway;Single Nucleotide Polymorphism;Site;Smoker;Smoking;supplemental oxygen;Supplementation;Survival Rate;T-Lymphocyte;Techniques;Therapeutic;tobacco smoke exposure;Tobacco smoking behavior;TP53 gene;trait;transcriptome;transcriptome sequencing;transcriptomics;Umbilical Cord Blood;Variant;verification and validation;Whole Blood;Work,Discovery And Functional Genomics Of Environmental Response Genes,100475,NA,NA,NA,NA,23,NA,NA,148917,NA
11191266,ZIA,ES,1,N,NA,NA,NA,NA,ZIAES100485,NA,NA,1ZIAES100485-23,NIEHS:2252832\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES,NA,NA,NA,6481007 (contact),"JETTEN, ANTON M (contact)",NA,NA,NA,Alzheimer&apos;s Disease;anterior chamber;Astrocytes;Atrophic;Beta Cell;Binding;Binding Sites;Cell Differentiation process;Cell Physiology;Cell Proliferation;Characteristics;ChIP-seq;Chronic Kidney Failure;Complex;Cystic Kidney Diseases;Development;Diabetes Mellitus;Embryo;Embryonic Development;Endocrine;EP300 gene;Ependymal Cell;Epithelium;Exhibits;Exophthalmos;Fibrosis;Functional disorder;gene environment interaction;Gene Expression;gene function;gene repression;Generations;Genes;Genetic Transcription;genome wide association study;Glaucoma;GLIS2 gene;Goiter;hormone biosynthesis;Human;human disease;Hypothyroidism;Immune response;Infertility;Inflammation;Inflammatory;insight;Insulin;insulin regulation;interest;Iodides;Kidney;Kidney Failure;Knockout Mice;Laboratories;Liquid substance;Maintenance;Malignant Breast Neoplasm;Malignant Neoplasms;Mass Spectrum Analysis;member;Metabolic;Mitochondria;Mus;Mutation;neonatal diabetes mellitus;Nephronophthisis;novel;novel therapeutic intervention;Osteoblasts;overexpression;Pancreas;pancreas development;Pancreatic duct;Pathology;Physiologic Intraocular Pressure;Physiological;Play;Polycystic Kidney Diseases;Post-Translational Protein Processing;postnatal;premature;Production;progenitor;promoter;Promoter Regions;Proteins;recruit;Regulation;Renal function;Role;scaffold;Signal Pathway;Single Nucleotide Polymorphism;single-cell RNA sequencing;sperm cell;Spermatogenesis;Spermatogonia;stem cells;Structure of beta Cell of islet;Syndrome;Thyroid Function Tests;Thyroid Gland;Thyroid Hormones;Tissues;Trabecular meshwork structure;transcription factor;Transcriptional Regulation;Wild Type Mouse;Zinc Fingers,Mechanism Of Action And Functions Of The Gli-related Proteins Glis 1-3,100485,NA,NA,NA,NA,23,NA,NA,2252832,NA
11191267,ZIA,ES,1,N,NA,NA,NA,NA,ZIAES101074,NA,NA,1ZIAES101074-23,NIEHS:2229428\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES,NA,NA,NA,78332007 (contact),"RIDER, LISA  (contact)",NA,NA,NA,2019-nCoV;Adolescent;Adult;Affect;Age;Air;Air Pollution;Alcohol consumption;Alleles;American;Animal Model;Antibodies;Antinuclear Antibodies;Area;Aryl Hydrocarbon Receptor;Autoantibodies;Autoimmune;Autoimmune Diseases;autoimmune pathogenesis;Autoimmunity;B-Lymphocytes;BCL2 gene;Biological;Biological Products;Blood;Candidate Disease Gene;Caucasians;Cause of Death;CCR5 gene;Child;Chronic;Chronic Disease;Clinical;Collaborations;Complement component C4a;Complex;Cytokine Receptors;Cytoplasmic Granules;Data;Dermatomyositis;Development;Diagnosis;Diagnostic;Dioxins;Disease;disease diagnostic;Dust;dysbiosis;environmental agent;Environmental Exposure;Environmental Risk Factor;Enzymes;Epidemiology;Estrogens;European ancestry;Evaluation;Exposure to;Family;Family Study;Flagellin;Food;Gene Expression;Genes;Genetic;genetic association;genetic risk factor;Genetic Transcription;genome wide association study;genome-wide;Geography;Goals;Granzyme;gut bacteria;gut microbiome;Haplotypes;Herpes zoster disease;High Prevalence;HLA-DRB1;Hormones;Idiopathic Inflammatory Myopathies;Immune;immune activation;Immunologic Markers;Immunologics;improved;Individual;Infectious Agent;Inflammation;Inflammatory;Interferons;Investigation;Juvenile Dermatomyositis;Laboratories;Learning;Life;Lung Diseases;Major Histocompatibility Complex;Malignant Neoplasms;MAP Kinase Gene;Measures;Molecular Genetics;Monozygotic twins;Morbidity - disease rate;mortality;multidisciplinary;Muscle;Myopathy;Myositis;National Health and Nutrition Examination Survey;national surveillance;neutrophil;Not Hispanic or Latino;novel;Obesity;Occupational Exposure;older adult;Onset of illness;oral microbiome;Organic solvent product;p38 Mitogen Activated Protein Kinase;Pathogenesis;Pathogenicity;Pathologic;Pathology;Pathway Analysis;Pathway interactions;patient registry;Patients;Pattern;Peripheral;Pharmaceutical Preparations;Phenotype;PI3K/AKT;Polychlorinated Biphenyls;Polymyositis;Population;Predisposition;Pregnancy;Prevalence;Prevention strategy;proband;prognostic;protective factors;Proteins;Proteomics;prototype;Recording of previous events;Recurrence;Registries;Research Personnel;Rheumatoid Arthritis;Risk;Risk Factors;Role;Sampling;Scleroderma;Seasons;Siblings;Signal Transduction;Silicon Dioxide;Single Nucleotide Polymorphism;Sirtuins;Skin;Smoker;Smoking;STAT4 gene;Stressful Event;Subgroup;Sunburn;surveillance data;Syndrome;systemic autoimmune disease;Systemic Lupus Erythematosus;Systemic Scleroderma;T-Lymphocyte;Therapeutic;Tobacco smoke;Tobacco smoking behavior;Transcript;transcription factor;trend;Ubiquitination;Ultraviolet Rays;United States;Up-Regulation;Vaccination;Virus;Water;whole genome;Xenobiotics;young woman,Environmental/genetic Risk Factors and Pathogenesis of Autoimmune Disease,101074,NA,NA,NA,NA,23,NA,NA,2229428,NA
11191268,ZIA,ES,1,N,NA,NA,NA,NA,ZIAES101081,NA,NA,1ZIAES101081-23,NIEHS:1286209\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES,NA,NA,NA,78332007 (contact),"RIDER, LISA  (contact)",NA,NA,NA,"Adolescent;Adult;Agreement;American;Anti-Inflammatory Agents;Area;Assessment tool;Autoimmune Diseases;B-Lymphocytes;Binding;Biological;Biological Models;Calcinosis;Categories;Characteristics;chemokine;Child;Childhood;Classification;classification trees;Clinical;Clinical Research;Clinical Trials;Clinical Trials Design;Collaborations;college;Conduct Clinical Trials;Consensus;Data;data repository;Data Set;Dermatomyositis;Development;Disease;Disease Outcome;Down-Regulation;drug efficacy;Early treatment;Educational Materials;effective therapy;efficacy evaluation;Elements;Environmental Risk Factor;ESR1 gene;European;Future;Gene Expression;Gene Expression Profile;Genes;Goals;Guidelines;Heterogeneity;Idiopathic Inflammatory Myopathies;Immune;immune activation;Immunosuppression;improved;In Vitro;indexing;Inflammation;interest;Interferons;International;Janus kinase;kinase inhibitor;Laboratories;Life;Low Dose Radiation;Malignant Neoplasms;Measurement;Measures;Mediating;medical specialties;member;MicroRNAs;Modeling;Morbidity - disease rate;mortality;multidisciplinary;Muscle;Muscle Cells;Muscle Fibers;Muscle function;Myositis;National Institute of Arthritis, and Musculoskeletal, and Skin Diseases;Natural History;NF-kappa B;novel;novel therapeutics;Onset of illness;Outcome;Outcome Assessment;Outcome Measure;Pathogenesis;Patient Outcomes Assessments;Patients;Pattern;PDE 3B;Performance;peripheral blood;Physicians;Polymyositis;prevent;Prevention;Prevention strategy;Preventive Clinical Trial;Preventive therapy;Probability;protective factors;prototype;Randomized Controlled Clinical Trials;Refractory;Rehabilitation therapy;Reporting;Research;Research Personnel;research study;Resources;response;Rheumatism;Rheumatology;Risk Factors;rituximab;Screening for cancer;screening guidelines;Signal Transduction;sodium thiosulfate;Specialist;Sphingomyelinase;Standardization;standardize measure;Stratification;Subgroup;success;Surveys;Symptoms;Syndrome;systemic autoimmune disease;Testing;Therapeutic;Therapeutic Agents;Therapeutic Clinical Trial;Therapeutic Trials;tool;treatment response;treatment trial;Uncertainty;Washington;web site;Weight;Work;X-Ray Computed Tomography;X-Ray Medical Imaging","Assessment, Therapy and Prevention Of Autoimmune Disease",101081,NA,NA,NA,NA,23,NA,NA,1286209,NA
11191269,ZIA,ES,1,N,NA,NA,NA,NA,ZIAES101575,NA,NA,1ZIAES101575-22,NIEHS:95170\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES,NA,NA,NA,14747686 (contact),"FERGUSON, KELLY  (contact)",NA,NA,NA,Accidents;Address;Affect;Aliquot;Animals;Behavior;Biological;Biological Markers;Birth;bisphenol A;California;Cardiac;Chemicals;Child;Child Development;Childhood;Cognition;cohort;Cohort Studies;Collaborations;Collection;Communities;Data;Databases;Developed Countries;Development;early childhood;early life exposure;early pregnancy;Embryo;Enrollment;environmental chemical exposure;Environmental Impact;Environmental Pollutants;epidemiologic data;Epidemiology;Event;Exposure to;fetal;Fetal Development;Fetal Growth;Fetus;First Pregnancy Trimester;Freezing;Generations;Genetic;Goals;Growth;Health;health care service utilization;Human;Impairment;Inflammation;interest;Laboratories;late life;Life;man;Measures;Mediator;Medical;Medical center;metabolomics;Mothers;multidisciplinary;National Health and Nutrition Examination Survey;National Institute of Environmental Health Sciences;Netherlands;neurodevelopment;Norway;offspring;Organogenesis;Organophosphates;Outcome;Outcome Assessment;Oxidative Stress;Paper;pesticide exposure;Pesticides;phthalates;Plasma;Polypropylenes;Population;Predisposition;Pregnancy;Pregnancy Outcome;Pregnant Women;prenatal;Prospective Studies;psychologic;Publishing;Reporting;Research;Research Personnel;Resources;Sampling;Specimen;Spottings;Standardization;Statistical Data Interpretation;Testing;Third Pregnancy Trimester;ultrasound;Umbilical Cord Blood;Urine;Woman;Xenobiotics;young adult,The Generation R cohort study as an NIEHS resource,101575,NA,NA,NA,NA,22,NA,NA,95170,NA
11191270,ZIA,ES,1,N,NA,NA,NA,NA,ZIAES101586,NA,NA,1ZIAES101586-22,NIEHS:1247722\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES,NA,NA,NA,6481007 (contact),"JETTEN, ANTON M (contact)",NA,NA,NA,Adult;Agonist;anti-cancer;Anti-Inflammatory Agents;Asthma;Autoimmune Diseases;Cell Physiology;Cholecalciferol;Complex;Development;Diabetes Mellitus;diabetes risk;differential expression;Disease;Embryonic Development;Exhibits;Fatty Liver;Fibrosis;gene environment interaction;Gene Expression;Genes;Genetic Transcription;High Fat Diet;Human Pathology;IL17 gene;Immune response;Immune system;immunoregulation;Inflammation;Inflammatory;Inflammatory Response;Knockout Mice;Laboratories;Ligands;Link;Lipids;Liver;Malignant Neoplasms;MAP3K7 gene;Mediating;Mediator;Melanoma;member;Metabolic Pathway;Metabolic syndrome;Metabolism;Mus;novel therapeutic intervention;NR4A2 gene;Nuclear Receptors;Orphan;Pathology;Pathway Analysis;Phenotype;Physiological;Physiological Processes;Play;Predisposition;promoter;Property;Proteins;Psoriasis;receptor;receptor expression;Regulation;Retinoids;Role;RXR;Series;Signal Pathway;Therapeutic;therapeutic target;transcription factor;Transcriptional Activation;transcriptome sequencing;Variant;Vitamin D,"Nuclear receptors: action, functions, and roles in disease",101586,NA,NA,NA,NA,22,NA,NA,1247722,NA
11191271,ZIA,ES,1,N,NA,NA,NA,NA,ZIAES101905,NA,NA,1ZIAES101905-20,NIEHS:954214\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES,NA,NA,NA,9416002 (contact),"SCHAAPER, ROELAND  (contact)",NA,NA,NA,Allosteric Regulation;Bacteria;Bacteriophage T7;Bacteriophages;Binding;Biochemical;Catalysis;Cells;Defect;deoxyguanosine triphosphate;dGTPase;DNA;Enzymes;Escherichia coli;experimental study;Genes;genetic analysis;Glean;inhibitor;insight;Kinetics;Laboratories;Mediating;Methods;Modeling;Molecular Conformation;molecular dynamics;mutant;Mutation;novel;prevent;Prevention;Process;Property;Proteins;Regulation;Reporting;Single-Stranded DNA;Specificity;Structure;Substrate Specificity;System;Viral Physiology;Virus Inhibitors,Structure-function studies on Dgt triphosphohydrolase,101905,NA,NA,NA,NA,20,NA,NA,954214,NA
11191272,ZIA,ES,1,N,NA,NA,NA,NA,ZIAES101965,NA,NA,1ZIAES101965-20,NIEHS:2594312\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES,NA,NA,NA,1929784 (contact),"WADE, PAUL A (contact)",NA,NA,NA,Animal Model;Animals;Area;base;Base Sequence;Basic Science;Binding;Binding Sites;Biological;biological systems;Breast Cancer Cell;Calories;Catalogs;Cells;Chromatin;chromatin modification;Chromosomes;Clustered Regularly Interspaced Short Palindromic Repeats;Code;Colon;colorectal cancer risk;Data Analyses;Deposition;Development;Diagnostic;Diet;disorder risk;Dissection;DNA;DNA Modification Process;DNA Repair;Enhancers;Environment;Environmental Risk Factor;Enzymes;Epigenetic Process;epigenetic regulation;Epithelial Cells;Epithelium;Eukaryotic Cell;experimental study;Fatty acid glycerol esters;GATA3 gene;Gene Activation;Gene Expression;Gene Expression Regulation;Generations;Genes;genetic information;Genetic Screening;Genetic Transcription;Genome;Goals;Health;Human;improved;interest;Invaded;Kinetics;Laboratories;Laboratory Study;Maps;Mesenchymal;microbiome;Mission;mouse model;Mus;National Institute of Environmental Health Sciences;Nucleosomes;Obesity;Phenotype;Polymers;Positioning Attribute;Process;Productivity;programs;Proteins;recombinational repair;Regulation;Research;Role;System;Technology;Testing;Therapeutic;Thinness;Tissues;transcription factor;Transcriptional Regulation;transcriptome;tumor;tumor progression;Work;Zinc Fingers,Eukaryotic Transcriptional Regulation,101965,NA,NA,NA,NA,20,NA,NA,2594312,NA
11191273,ZIA,ES,1,N,NA,NA,NA,NA,ZIAES102005,NA,NA,1ZIAES102005-19,NIEHS:3014749\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES,NA,NA,NA,10814653 (contact),"FESSLER, MICHAEL B (contact)",NA,NA,NA,2019-nCoV;25-hydroxycholesterol;Alabama;allergen Bla g 1;Alveolar Macrophages;American;Annual Reports;Apoptotic;Area;Bacteria;Biological Models;Biology;Cell Physiology;Cells;Cellular biology;Cholesterol;cockroach allergen;cytokine;Dendritic Cells;Disease;Epithelial Cells;Failure;flotillin;General Hospitals;Goals;Granulocyte Colony-Stimulating Factor;Granulocyte-Macrophage Colony-Stimulating Factor;Host Defense;immunodeficiency;In Vitro;in vivo Model;Inflammation;Inflammatory Response;Inhalation;Innate Immune Response;Interferon Type I;Intramural Research;Investigation;Israel;Journals;Laboratories;Leukocytes;Lipopolysaccharides;Lung;Macrophage;Massachusetts;Mediating;Medical center;Membrane;Membrane Proteins;Metabolism;Modeling;Molecular;Molecular Biology;monocyte;Mus;National Institute of Environmental Health Sciences;Natural Immunity;neutrophil;novel;oxidized low density lipoprotein;Ozone;Paper;pathogen;Pathogenesis;Pathway interactions;Pattern;Pneumonia;Printing;programs;Proteins;Proteomics;Publications;Receptor Signaling;Regulation;Reporting;respiratory;Role;Signal Pathway;Signal Transduction;Smith-Lemli-Opitz Syndrome;Sterols;Stimulus;symposium;T cell regulation;T-Cell Receptor;T-Lymphocyte;Tissues;Toll-like receptors;TP53 gene;trafficking;Tumor Immunity;Universities;Validation;Visit,Cell Signaling of Host Defense,102005,NA,NA,NA,NA,19,NA,NA,3014749,NA
11191274,ZIA,ES,1,N,NA,NA,NA,NA,ZIAES102245,NA,NA,1ZIAES102245-18,NIEHS:422609\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES,NA,NA,NA,9416024 (contact),"WEINBERG, CLARICE  (contact)",NA,NA,NA,Acceleration;Affect;Age;anti-depressive agents;Biological Aging;Biological Markers;Blood;Blood specimen;Body mass index;breast cancer diagnosis;Breast Cancer Risk Factor;Breast Cancer Treatment;Calibration;Cancer Etiology;Cancer Prognosis;cell type;Clip;cohort;Cohort Studies;Collaborations;college;Computer Assisted;Data;de novo mutation;Diabetes Mellitus;Diagnosis;Disease;DNA;Endometrial Carcinoma;Enrollment;Environmental Risk Factor;Epidemiology;epidemiology study;experience;Family;family structure;follow-up;Funding;Future;Genetic;genetic analysis;Genetic study;Genitalia;genome analysis;Genotype;Gestational Diabetes;Goals;Health;Health Status;Hematopoietic Neoplasms;Hispanic Populations;Home visitation;In Situ;Incidence;interest;Iron;Joints;Leukocytes;Life Style;male;Malignant Breast Neoplasm;Malignant neoplasm of ovary;Malignant Neoplasms;Measures;Medical Records;member;Mental Depression;Metals;Methods;Methylation;methylation pattern;methylome;Microchimerism;National Institute of Environmental Health Sciences;Nature;Non-Insulin-Dependent Diabetes Mellitus;Not Hispanic or Latino;Obesity;Outcome;Paper;Parents;Participant;Performance;Perimenopause;personal care products;Pharmaceutical Preparations;Postdoctoral Fellow;Powder dose form;predictive modeling;Pregnancy Histories;Pregnancy loss;Professional counselor;prospective;Prospective Studies;Publishing;Puerto Rican;Puerto Rico;Questionnaires;Radiation;recruit;Recurrence;Reporting;Research Personnel;Risk;Risk Assessment;Risk Factors;risk prediction;Role;Saliva;Sampling;Seasons;Serum;Sister;Specimen;Structure of nail of toe;summer internship;Survivors;Telephone Interviews;Time;Trace Elements;transcriptome;treatment effect;Tumor Tissue;Urine;Vaginal Douching;Vital Status;Vitamin D;Vitamins;White Women;whole genome;Woman;Work;Y Chromosome,The Two Sister Study,102245,NA,NA,NA,NA,18,NA,NA,422609,NA
11191275,ZIA,ES,1,N,NA,NA,NA,NA,ZIAES102385,NA,NA,1ZIAES102385-17,NIEHS:513920\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES,NA,NA,NA,9693784 (contact),"LONDON, STEPHANIE  (contact)",NA,NA,NA,16S ribosomal RNA sequencing;Adult;Agricultural Health Study;airway inflammation;Allergens;Allergic;Allergic Disease;Animals;Asthma;asthmatic;atopy;Biological;Blood;cohort;Cross-Sectional Studies;Data;design;Development;Diagnosis;Diesel Exhaust;Dietary Factors;Disease;Dust;early life exposure;Eczema;Eligibility Determination;Endotoxins;Environment;Environmental Exposure;Environmental Risk Factor;environmental tobacco smoke;Epigenetic Process;epigenome;Exhalation;Exposure to;Farm;farmer;Farming environment;follow-up;Genetic;Genome;genome wide association study;genome-wide;genomic variation;Genomics;Genotype;Geographic Information Systems;Grain;Health;Home;Home visitation;House Dust;Hypersensitivity;IgE;Impairment;Individual;Inflammatory;Inflammatory Response;Innate Immune Response;International;Iowa;late life;Lead;Life;Lipopolysaccharides;Livestock;lung health;Manure;Measurement;Measures;Meta-Analysis;metagenome;Metagenomics;Methylation;microbial;microbial signature;microbiome;microbiota;mortality;multiple omics;Nested Case-Control Study;Nitric Oxide;North Carolina;novel;Occupational Exposure;opioid use;Outcome;Outcome Measure;Participant;Pathway interactions;Patient Self-Report;Pattern;pesticide exposure;Pesticides;Phase;Phenotype;Plasma;Population;population based;proteomic signature;Proteomics;Publications;pulmonary function;Questionnaires;respiratory;respiratory morbidity;response;Risk;Role;Sampling;sex;Single Nucleotide Polymorphism;Sleep Apnea Syndromes;Smoking;smoking exposure;Spouses;Techniques;Technology;Telephone Interviews;Testing;toxicant;Treatment outcome;Wheezing;Work,Lung Health Study in the Agricultural Health Study,102385,NA,NA,NA,NA,17,NA,NA,513920,NA
11191276,ZIA,ES,1,N,NA,NA,NA,NA,ZIAES102745,NA,NA,1ZIAES102745-15,NIEHS:2413625\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES,NA,NA,NA,10672658 (contact),"HU, GUANG  (contact)",NA,NA,NA,Animal Model;Candidate Disease Gene;Cell Culture Techniques;Cell model;Cell Reprogramming;Cell Therapy;cell type;Cells;chromatin remodeling;Complex;Cultured Cells;Development;Developmental Biology;developmental toxicity;Disease;disease model;drug discovery;Embryonic Development;embryonic stem cell;Environmental Health;Environmental Risk Factor;Genes;Genetic;genetic approach;Genetic Screening;Genetic Transcription;Genomic approach;genomic tools;Germ Cells;Human Development;human disease;in vitro Model;insight;interest;Maintenance;Modeling;Molecular;Mus;Pathway interactions;pluripotency;pluripotency factor;Pluripotent Stem Cells;Post-Transcriptional Regulation;Resolution;Role;Somatic Cell;Specific qualifier value;stem cell biology;stem cell fate;stem cell self renewal;stem cells;success;translational health science;Translational Research;Work,"Role of Pluripotency Factors in Pluripotent Stem Cells, Development and Disease",102745,NA,NA,NA,NA,15,NA,NA,2413625,NA
11191277,ZIA,ES,1,N,NA,NA,NA,NA,ZIAES102765,NA,NA,1ZIAES102765-15,NIEHS:3320685\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES,NA,NA,NA,15696636 (contact),"WILLIAMS, SCOTT  (contact)",NA,NA,NA,3-Dimensional;Acute;Address;Affect;Affinity;APEXL2 Gene;Architecture;base;Base Pairing;Binding;Binding Sites;Biochemical;Biological Models;Biophysics;cancer predisposition;Cell Physiology;Cell Respiration;Chaetomium;Chemicals;Chromatin;Chronic;Complex;coping;Crystallography;cytotoxic;deoxyguanosine triphosphate;Disease;DNA;DNA Adducts;DNA biosynthesis;DNA Damage;DNA glycosylase;DNA Ligases;DNA Ligation;DNA metabolism;DNA Repair;DNA Single Strand Break;DNA strand break;DNA Topoisomerases;DNA-Directed DNA Polymerase;DNA-protein crosslink;environmental stressor;Enzymes;ESR1 gene;Estrogen Therapy;Estrogens;Eukaryotic Cell;Exposure to;Failure;first responder;fungus;Fusion Protein Expression;Gene Expression;Genetic Transcription;Genome;genome integrity;Genomic DNA;genotoxicity;helicase;Heritability;Human;Human Activities;Hybrids;Hydroxyl Radical;improved;In Vitro;in vivo;in vivo Model;Inflammation;inorganic phosphate;Insertion Mutation;Ionizing radiation;Lead;Lesion;Ligase;Ligation;Limb structure;Link;Magnesium;Maintenance;Malignant Neoplasms;Mammalian Cell;Mediating;Methods;milligram;Mismatch Repair;Molecular;Molecular Conformation;molecular recognition;Molecular Structure;Motor;multicatalytic endopeptidase complex;Mutagenesis;Mutation;N-terminal;nanobodies;Neurodegenerative Disorders;Nuclear;nuclease;Nucleic Acids;Nucleotides;Okazaki fragments;Orthologous Gene;paralogous gene;Pathway interactions;Peptide Hydrolases;Pharmaceutical Preparations;Pharmacologic Substance;phosphodiester;preference;prevent;Production;programs;Protein Conformation;Protein Dynamics;Proteins;Protocols documentation;Reaction;Recombinants;Regulation;repaired;Reporter;Reporting;Research;Resolution;response;RNA;RNA analysis;RNA Processing;Role;Saccharomyces cerevisiae;seal;SETX gene;Signal Transduction;Specificity;SPO11 gene;Stress;structural biology;Superhelical DNA;Surveys;System;thermophilic organism;TOP2A gene;Topoisomerase;Topoisomerase II;Toxic Environmental Substances;Transcriptional Regulation;Tyrosine;tyrosyl-DNA phosphodiesterase;Variant;Vertebral column;Wood material;Yeasts,Structural Biology of Genome Maintenance and DNA repair,102765,NA,NA,NA,NA,15,NA,NA,3320685,NA
11191278,ZIA,ES,1,N,NA,NA,NA,NA,ZIAES102906,NA,NA,1ZIAES102906-15,NIEHS:1067574\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES,NA,NA,NA,77831834 (contact),"MUELLER, GEOFFREY  (contact)",NA,NA,NA,adaptive immune response;Adverse reactions;Affinity;Albumins;allergen Bla g 1;Allergens;Allergic;Allergic Disease;allergic response;Allergy to peanuts;Anaphylaxis;Antibodies;Antibody Affinity;Antibody Dissociations;Antibody Response;Arachis hypogaea;Area;B-Lymphocytes;Binding;Biological Markers;Blocking Antibodies;Cell Separation;Cellular Membrane;Characteristics;Clinical;clinical efficacy;clinically relevant;cockroach allergen;Complex;cross reactivity;crosslink;cytokine;cytotoxic;Data;Dermatophagoides pteronyssinus antigen p 2;design;Diagnosis;Dictyoptera;Effector Cell;Engineering;Environmental Health;Epitope Mapping;Epitopes;exposed human population;Exposure to;Fatty Acids;flexibility;Future;Generations;Goals;Health;Heat-Shock Proteins 70;Human;Human Cloning;human monoclonal antibodies;Hybridomas;Hydrophobicity;Hypersensitivity;IgE;IgG2;IgG4;Immune response;Immunochemistry;Immunoglobulin G;Immunotherapy;improved;Individual;Inflammatory;interest;Interleukin-1;Knowledge;Ligands;lipid mediator;Lipids;Mammalian Cell;Mediating;Membrane;Membrane Lipids;Modality;Molecular;Molecular Conformation;molecular diagnostics;Molecular Target;Monoclonal Antibodies;Motivation;mouse model;Mutagenesis;mutant;Mutation;National Institute of Environmental Health Sciences;neutralizing monoclonal antibodies;oral immunotherapy;Organism;Outcome;Passive Cutaneous Anaphylaxis;Pathway interactions;Patients;Pattern;Phospholipase A2;Phospholipids;Polyunsaturated Fatty Acids;Predisposition;prevent;Production;Property;Recombinant Antibody;Recombinants;Reporting;Research;Research Personnel;response;Risk Reduction;Sequence Homology;Serum;Site;Source;Structure;Symptoms;Technology;Testing;Therapeutic;Transgenic Mice;Unsaturated Fatty Acids;Viral Physiology;Work;X-Ray Crystallography,Molecular Allergy,102906,NA,NA,NA,NA,15,NA,NA,1067574,NA
11191279,ZIA,ES,1,N,NA,NA,NA,NA,ZIAES103086,NA,NA,1ZIAES103086-13,NIEHS:16904\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES,NA,NA,NA,9416024 (contact),"WEINBERG, CLARICE  (contact)",NA,NA,NA,Antibodies;Antinuclear Antibodies;Area;Autoantibodies;Autoimmune biomarker;Autoimmune Diseases;Autoimmunity;Biological;Biometry;Collaborations;Data;early pregnancy;Electronic cigarette;follow-up;former smoker;Health Surveys;Link;Measurement;Methodology;Methods;multidisciplinary;National Health and Nutrition Examination Survey;National Institute of Environmental Health Sciences;never smoker;Paper;Population;Postdoctoral Fellow;Prevalence;Publishing;Research;Role;Science;Scientist;Smoker;Surveys;Time;Time trend;Woman;Work;Xenobiotics,Applications of methods in collaborative science,103086,NA,NA,NA,NA,13,NA,NA,16904,NA
11191280,ZIA,ES,1,N,NA,NA,NA,NA,ZIAES103247,NA,NA,1ZIAES103247-10,NIEHS:2663302\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES,NA,NA,NA,14254328 (contact),"STANLEY, ROBIN  (contact)",NA,NA,NA,Amino Acids;Anticodon;Architecture;Base Pairing;Binding;Biochemical;Biochemistry;Cells;Cellular biology;Charge;Complex;Cryoelectron Microscopy;endonuclease;Endoribonucleases;Ensure;Environment;Enzymes;Eukaryota;Excision;Exoribonucleases;fitness;Gene Expression Regulation;Genetic Transcription;Goals;Health;Human;human disease;In Vitro;interdisciplinary approach;Introns;Mediating;Messenger RNA;Methods;Molecular;Mutation;Neurodevelopmental Disorder;nuclease;particle;Pathway interactions;Phosphorylation;Play;Polynucleotide 5&apos;-Hydroxyl-Kinase;Pontocerebellar hypoplasia;Post-Transcriptional RNA Processing;Process;Proteins;reconstitution;recruit;Regulation;Research;response;Ribonucleases;Ribonucleoproteins;Ribosomal RNA;Ribosomes;RNA;RNA Processing;RNA Splicing;Role;rRNA Precursor;Series;stem;Stimulus;structural biology;Structural Models;Structure;Transfer RNA;Translating;Translations;tRNA Precursor,Structure and Function of RNA Processing Machines,103247,NA,NA,NA,NA,10,NA,NA,2663302,NA
11191281,ZIA,ES,1,N,NA,NA,NA,NA,ZIAES103266,NA,NA,1ZIAES103266-10,NIEHS:1426976\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES,NA,NA,NA,15674564 (contact),"GORDENIN, DMITRY  (contact)",NA,NA,NA,Address;Affect;Alleles;base;Base Excision Repairs;Binding;Biochemical;Bioinformatics;bioinformatics tool;Biological;cancer genome;cancer genomics;cancer initiation;carcinogenesis;Cell Separation;Cells;Chemicals;Chromosomes;Complex;Cytidine Deaminase;Cytosine;Data;Data Set;Defect;design;Development;Disease;DNA;DNA biosynthesis;DNA Damage;DNA polymerase zeta;DNA Repair;DNA Sequence Alteration;DNA Viruses;DNA-Directed DNA Polymerase;Double Strand Break Repair;ds-DNA;empowerment;Environment;Environmental Risk Factor;Eukaryota;experimental study;Exposure to;fitness;Generations;Genes;Genetic;Genetic Diseases;genetic information;Genetic Recombination;Genetic Risk;Genetic Transcription;Genome;genome sequencing;Genome Stability;genome-wide;genomic data;Genomic Instability;Goals;Health;high risk;Human;human genome sequencing;human subject;improved;Individual;Induced Mutation;insight;interest;International;Intervention;Knowledge;Knowledge acquisition;large datasets;Life;life span;Malignant Neoplasms;Metabolic;Mismatch Repair;Modeling;Modification;Molecular;Mutagenesis;Mutagens;Mutation;Mutation Spectra;Natural Immunity;novel;Organism;Outcome;Pathway interactions;Phenotype;Physiological;Policies;power analysis;prevent;Probability;replication factor A;Reporter;Research;Research Subjects;Risk;Risk Factors;RNA;RNA Editing;RNA Sequences;RNA Viruses;Role;Saccharomyces cerevisiae;Saccharomycetales;Sampling;Single-Stranded DNA;Site;Somatic Mutation;Source;synergism;System;The Cancer Genome Atlas;Toxicology;tumor;Uracil;uracil-DNA glycosylase;Variant;Viral;viral RNA;whole genome;Work;Yeast Model System;Yeasts,Genome-wide hypermutation and structural instability,103266,NA,NA,NA,NA,10,NA,NA,1426976,NA
11191282,ZIA,ES,1,N,NA,NA,NA,NA,ZIAES103310,NA,NA,1ZIAES103310-09,NIEHS:2566670\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES,NA,NA,NA,14747680 (contact),"CUI, GUOHONG  (contact)",NA,NA,NA,Age;age related;alpha synuclein;alternative treatment;Alzheimer&apos;s Disease;Anatomy;Basal Ganglia;behavior test;Behavioral;Benomyl;Bilateral;Bioenergetics;biological systems;Brain;brain tissue;Cell Nucleus;Cells;Chronic;Clinical;Cognitive;cognitive function;Corpus striatum structure;Deep Brain Stimulation;Development;Diagnosis;dietary;Disease;disease model;Disease Progression;Dopamine;Dopamine D1 Receptor;dopaminergic neuron;Dose;Dyskinetic syndrome;effective therapy;Energy Metabolism;Environmental Exposure;Etiology;Event;Exercise;Fiber;field study;Frequencies;gamma-Aminobutyric Acid;gene therapy;Genetic;Glutamates;Goals;Health;Home;Hour;Human;improved;Individual;Injections;Intake;L-DOPA induced dyskinesia;Lesion;Levodopa;Measures;mitopark mouse;Molecular;Monitor;Motor;motor deficit;motor function improvement;motor symptom;mouse model;Movement;Movement Disorders;Mus;Nervous System Disorder;neural;Neurodegenerative Disorders;neuromechanism;Neurons;neurotransmitter release;nicotinamide-beta-riboside;novel;novel diagnostics;novel imaging technique;novel strategies;novel therapeutics;Oxidopamine;Parkinson Disease;parkinsonian rodent;pars compacta;Pathology;Patients;Performance;Pharmaceutical Preparations;Photometry;positive allosteric modulator;postsynaptic;presynaptic;Presynaptic Terminals;prevent;protective effect;reduce symptoms;Research;Rotarod Performance Test;Running;sensor;side effect;Sleep;Sleep disturbances;Structure;Structure of subthalamic nucleus;Substantia nigra structure;Supplementation;Survival Rate;Symptoms;Synapses;Techniques;Testing;Therapeutic;Therapeutic Effect;therapeutic evaluation;Time;Tissue Banks;tool;United States National Institutes of Health;Viral Vector,Basal Ganglia in Health and Disease,103310,NA,NA,NA,NA,9,NA,NA,2566670,NA
11191283,ZIA,ES,1,N,NA,NA,NA,NA,ZIAES103311,NA,NA,1ZIAES103311-09,NIEHS:2959363\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES,NA,NA,NA,14747682 (contact),"DEMAYO, FRANCESCO  (contact)",NA,NA,NA,Ablation;Adverse effects;Aging;Anti-Inflammatory Agents;Attenuated;Binding Sites;Bioinformatics;Biological Models;Biology;Birth;Body System;cBioPortal;Cell Differentiation process;Cell Physiology;Cell Proliferation;cell stroma;Cells;Cervix Uteri;Child;cofactor;Collagen;Communication;cytokine;cytokine release syndrome;Data Collection;Data Set;Decidual Cell;Decidual Cell Reactions;Development;Diet;dihydroxy-vitamin D3;Down-Regulation;early pregnancy;Endocrine Disruptors;Endometrial;Endometrial Carcinoma;endometrial stroma;Endometrial Stromal Cell;endometriosis;Endometrium;Enhancers;Environment;Environmental Impact;epidemiology study;Epithelium;ESR1 gene;Estrogen Therapy;Estrogens;Exhibits;Exposure to;Failure;Female;female reproductive system;female reproductive tract;Female sterility;Fertility;Fertilization;Fetal Development;Fetus;Fibroblasts;Fibrosis;Gene Expression;Genes;genetic signature;Genetic Transcription;Genetically Engineered Mouse;Gland;Goals;Growth;Health;health of the mother;Hormonal;hormonal signals;Hormones;Human;Human Cell Line;human model;Impairment;implantation;In Vitro;Infant;Infertility;Inflammation;Inflammatory;Investigation;knock-down;Laboratories;Maintenance;Mammalian Oviducts;Mediating;Mediator;Menstrual cycle;Microfilaments;Modeling;Molecular;Mothers;mouse model;Mus;Muscle Development;Mutation;myometrium;natural Blastocyst Implantation;neonatal health;novel;Nuclear Receptors;Organ;Ovarian;Ovariectomy;Pathology;Pathway interactions;Physiology;Pregnancy;pregnant;preimplantation;prevent;Process;Progesterone;Progesterone Receptors;programs;Proliferating;pup;Reaction;receptor;Regulation;Regulator Genes;Reporting;Reproduction;Reproductive Biology;reproductive function;reproductive system disorder;reproductive tract;Research;response;RNA Interference;Role;Serum Response Factor;Signal Pathway;Signal Transduction;sperm cell;steroid hormone;steroid hormone receptor;Stimulus;Stream;Stretching;Structure;success;The Cancer Genome Atlas;Tissues;transcription factor;transcriptome;transcriptomics;Uterine Diseases;Uterine Fibroids;Uterine Neoplasms;Uterus;Vagina;Vitamin D;Vitamin D Deficiency;Vitamin D3 Receptor;Vitamins;Woman;Women&apos;s Health;women&apos;s reproductive health;Work;Zinc Fingers,Environmental Signaling in Reproduction and Pregnancy,103311,NA,NA,NA,NA,9,NA,NA,2959363,NA
11191284,ZIA,ES,1,N,NA,NA,NA,NA,ZIAES103321,NA,NA,1ZIAES103321-09,NIEHS:761364\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES,NA,NA,NA,14747686 (contact),"FERGUSON, KELLY  (contact)",NA,NA,NA,37 weeks gestation;Address;adverse birth outcomes;adverse pregnancy outcome;age group;Aromatic Polycyclic Hydrocarbons;Biological Markers;Birth;Blood;Boston;case control;Chemical Exposure;Chemicals;Child Health;Childhood;cohort;Collaborations;consumer product;Data;Data Pooling;Disparity;early pregnancy;environmental chemical exposure;Environmental Exposure;Environmental Pollutants;Esters;ethnic disparity;Etiology;fatty acid oxidation;Fetal Diseases;Fetal Growth;Fetal Growth Retardation;Flame Retardants;Gestational Age;Growth;Growth Disorders;Health;Histology;Hospitals;improved;Individual;Inflammation;Inflammatory;innovation;insight;Investigation;lipidomics;Measurement;Measures;Mediating;Mediator;Metabolic;metabolomics;Metal exposure;Metals;Methods;National Institute of Environmental Health Sciences;Newborn Infant;novel;Organophosphates;Outcome;Oxidative Stress;Oxidative Stress Pathway;Paper;Participant;Pesticides;Phenols;Phenotype;phthalates;Pilot Projects;Placenta;Plasticizers;Poly-fluoroalkyl substances;Population Characteristics;Pregnancy;pregnancy health;Pregnancy Trimesters;Premature Birth;Preparation;prepregnancy;Prevention;Production;programs;prospective;Publications;Publishing;racial disparity;Reactive Oxygen Species;Research;Research Personnel;Research Project Grants;Resources;Small for Gestational Age Infant;Specimen;study characteristics;Third Pregnancy Trimester;Time;Trace metal;ultrasound;urinary;Urine;Woman,LIFECODES pregnancy cohort,103321,NA,NA,NA,NA,9,NA,NA,761364,NA
11191285,ZIA,ES,1,N,NA,NA,NA,NA,ZIAES103328,NA,NA,1ZIAES103328-07,NIEHS:1516607\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES,NA,NA,NA,15708583 (contact),"DOETSCH, PAUL  (contact)",NA,NA,NA,acquired drug resistance;acute infection;Address;Agar;Aging;Amino Acyl-tRNA Synthetases;Antibiotic Resistance;Antineoplastic Agents;Antioxidants;bacterial resistance;base;Base Excision Repairs;biological adaptation to stress;Biological Markers;bronchial epithelium;cancer genome;cancer genomics;Cancer Patient;cell transformation;Cells;Cessation of life;Chronic;Cipro;Cisplatin;Clinical;clinically relevant;Code;Complex;Contact Inhibition;cystic fibrosis infection;cystic fibrosis patients;Detection;Development;Dideoxy Chain Termination DNA Sequencing;Dimensions;DNA;DNA Damage;DNA Gyrase;DNA Repair Gene;DNA Repair Pathway;Dose;Drug resistance;Environment;Epithelial Cells;Exhibits;Exposure to;Frequencies;Generations;Genes;Genetic Transcription;genome sequencing;genomic data;Genomic Instability;Glutathione;Goals;Growth;Heterogeneity;homologous recombination;Hospitalization;Human;human disease;Hydrogen Peroxide;Hypochlorous Acid;Immune system;Individual;loss of function mutation;Lung infections;Malignant Neoplasms;Maps;Metabolic;Molecular Analysis;Multi-Drug Resistance;Mutagenesis;mutant;Mutation;Mutation Spectra;Nature;neoplastic cell;novel;Outcome;overexpression;Oxidants;Oxidation-Reduction;Paraquat;pathogen;pathogenic bacteria;Pathway interactions;Patients;Pharmaceutical Preparations;Phase;Phenotype;Pneumonia;potassium bromate;Process;Proteins;Pseudomonas aeruginosa;Pseudomonas aeruginosa infection;Reaction;Reactive Oxygen Species;repaired;replication stress;Resistance;response;S-Nitrosoglutathione;Signal Transduction;Single-Stranded DNA;Spottings;Stress;Sulfhydryl Compounds;System;Therapeutic;Tissues;Toxic effect;tumor;Tumor Suppressor Proteins;United States;Up-Regulation;whole genome;XPGC protein;Yeasts,Mechanisms of transcriptional and replicative mutagenesis,103328,NA,NA,NA,NA,7,NA,NA,1516607,NA
11191286,ZIA,ES,1,N,NA,NA,NA,NA,ZIAES103340,NA,NA,1ZIAES103340-05,NIEHS:443884\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES,NA,NA,NA,14254328 (contact),"STANLEY, ROBIN  (contact)",NA,NA,NA,2019-nCoV;Active Sites;antiviral drug development;base;Binding;Biochemistry;biophysical techniques;Coronavirus;COVID-19;COVID-19 therapeutics;Cryoelectron Microscopy;Development;Double-Stranded RNA;Drug Targeting;Endoribonucleases;global health;Goals;Immune response;Interferons;Life Cycle Stages;Mass Spectrum Analysis;Molecular;Molecular Conformation;molecular dynamics;Nonstructural Protein;novel strategies;novel therapeutics;nuclease;Pancreatic ribonuclease;pandemic disease;Play;Process;Proteins;Reaction;response;RNA;Role;sensor;Specificity;structural biology;Structure;Uracil;Uridine;Vaccines;Viral;Viral Genome;viral RNA;Virus;Work,Structural and Functional Characterization of the SARS-CoV-2 Endoribonuclease Nsp15,103340,NA,NA,NA,NA,5,NA,NA,443884,NA
11191287,ZIA,ES,1,N,NA,NA,NA,NA,ZIAES103344,NA,NA,1ZIAES103344-05,NIEHS:761364\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES,NA,NA,NA,14747686 (contact),"FERGUSON, KELLY  (contact)",NA,NA,NA,3D ultrasound;Adult;adverse outcome;adverse pregnancy outcome;Angiogenic Factor;Arteries;Assessment tool;Biological Markers;Biometry;Birth Weight;Blood flow;Breast Microcalcification;Chemical Exposure;Chemicals;Child;circulating biomarkers;cohort;Collaborations;Data;Disease;environmental chemical exposure;Exposure to;fetal;Fetal Growth;Fetal Growth Retardation;Fetus;Functional disorder;Funding;Funding Mechanisms;Future;Goals;Growth;Health;health assessment;heart function;Human;Image;implantation;improved;in utero;in vivo;Infarction;innovation;Lead;Measurement;Measures;Methodology;molecular marker;Motion;National Institute of Child Health and Human Development;Neonatal Mortality;novel;Nutrient;Organ;Outcome;Oxygen;Participant;Pathologic;Perfusion;phthalates;Placenta;Placentation;Pregnancy;pregnant;prenatal exposure;Publishing;recruit;Research;Resolution;Risk Factors;Role;Sampling;Specimen;Spottings;stillbirth;Structure of umbilical artery;Technology;Three-Dimensional Imaging;Time;Tissues;ultrasound;Umbilical Blood;urinary;Urine;Uterus;Variant;Visit;Weight;Woman;Work,Environmental phthalate exposure in the Human Placenta Project cohort,103344,NA,NA,NA,NA,5,NA,NA,761364,NA
11191288,ZIA,ES,1,N,NA,NA,NA,NA,ZIAES103345,NA,NA,1ZIAES103345-05,NIEHS:106370\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES,NA,NA,NA,6570860 (contact),"BELL, DOUGLAS  (contact)",NA,NA,NA,2019-nCoV;Antibodies;Antibody Response;Blood specimen;CD8-Positive T-Lymphocytes;cell type;COVID-19;COVID-19 incidence;COVID-19 morbidity;COVID-19 pandemic;COVID-19 vaccination;Cryopreservation;Data;Disease;FCGR3B gene;Frequencies;high risk;Immune;Immune System Diseases;immunosenescence;Individual;Morbidity - disease rate;mortality;non-smoker;Peripheral Blood Mononuclear Cell;post-COVID-19;Predisposition;Premature aging syndrome;prospective;Regulatory T-Lymphocyte;sample collection;Sampling;SARS-CoV-2 antibody;SARS-CoV-2 exposure;SARS-CoV-2 infection;SARS-CoV-2 negative;senescence;single-cell RNA sequencing;Smoker;Smoking;smoking exposure;T-Lymphocyte Subsets;Vaccinated;Vaccination;Vaccines;Visit;volunteer,SARS-CoV-2 Studies,103345,NA,NA,NA,NA,5,NA,NA,106370,NA
11191289,ZIA,ES,1,N,NA,NA,NA,NA,ZIAES103347,NA,NA,1ZIAES103347-05,NIEHS:40197\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES,NA,NA,NA,10814653 (contact),"FESSLER, MICHAEL B (contact)",NA,NA,NA,2019-nCoV;25-hydroxycholesterol;Address;airway epithelium;Albumins;antagonist;Anti-Inflammatory Agents;Biological Assay;Body Weight decreased;Cell fusion;Cells;Cholesterol;Communicable Diseases;Coronavirus;COVID-19;COVID-19 pneumonia;COVID-19 therapeutics;cytokine;Disease;enantiomer;Enzymes;Epithelial Cells;Experimental Models;Family suidae;G-Protein-Coupled Receptors;global health emergency;Histopathology;Human;in vivo;Infection;innovation;International;Investigation;Knockout Mice;Leukocytes;Lipids;Lung;Lung immune response;Lung infections;lung injury;Macaca mulatta;Measures;Metabolism;migration;Mixed Function Oxygenases;mouse model;Mus;Organoids;Pathogenicity;Plasma;Porcine respiratory and reproductive syndrome virus;preclinical safety;Publishing;rapid testing;Reporter;Respiratory Tract Infections;response;SARS-CoV-2 B.1.351;SARS-CoV-2 infection;SARS-CoV-2 inhibitor;Series;Testing;Therapeutic;therapeutic evaluation;tool;Toxic effect;Transgenic Mice;Viral;Viral Load result;Virion;Virus;Virus Diseases;virus testing;Wild Type Mouse;Work;Zika Virus,Investigation of the therapeutic potential of oxysterols in SARS-CoV-2 infection,103347,NA,NA,NA,NA,5,NA,NA,40197,NA
11191290,ZIA,HG,1,N,NA,NA,NA,NA,ZIAHG200362,NA,NA,1ZIAHG200362-17,NHGRI:3560893\,INTRAMURAL RESEARCH,2024,NATIONAL HUMAN GENOME RESEARCH INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL HUMAN GENOME RESEARCH INSTITUTE,NA,NA,NA,9694213 (contact),"ROTIMI, CHARLES  (contact)",NA,NA,NA,Adipocytes;adiponectin;Adipose tissue;Africa;African;African American;African American population;Alcohol consumption;analytical tool;Attention;bead chip;Biological;Biological Markers;Biological Process;Blood;blood lipid;Blood Pressure;Blood specimen;Cardiometabolic Disease;cardiometabolic risk;cardiometabolism;cell type;Cholesterol;Chromatin;Chromosome Mapping;Clinical;clinical care;cohort;Complex;Congresses;CRISPR/Cas technology;Data;Dedications;Developing Countries;Diabetes Mellitus;Disease;Disease susceptibility;disparity elimination;disparity reduction;DNA analysis;DNA Methylation;Endothelial Cells;Enteroendocrine Cell;Environmental Risk Factor;epidemiologic data;epidemiological model;epigenome-wide association studies;ethnic difference;ethnic diversity;Ethnic Origin;Ethnic Population;Etiology;European;European ancestry;Family Study;fasting glucose;Functional disorder;functional genomics;G6PC2 gene;Gene Frequency;Genes;Genetic;genetic epidemiology;Genetic Models;Genetic Risk;Genetic study;Genetic Variation;Genome;genome resource;genome sciences;genome sequencing;genome wide association study;genome-wide;Genomic approach;genomic data;Genomics;global health;Gluconeogenesis;Glucose;Glycolysis;Goals;Health;health disparity;health inequalities;High Density Lipoprotein Cholesterol;High Density Lipoproteins;Home;Human;Human Genetics;Human Genome;Human papilloma virus infection;Hypertension;improved;Individual;insight;Insulin Resistance;insulin secretion;International;Islets of Langerhans;Joints;Kidney Diseases;Knowledge;LDL Cholesterol Lipoproteins;Least-Squares Analysis;Life Style;Lipids;Liver;Longitudinal Studies;Low-Density Lipoproteins;men;Mendelian randomization;Metabolic Diseases;metabolomics;Methylation;methylation pattern;Migrant;Mission;Modeling;molecular phenotype;multi-ethnic;multiple omics;Nigeria;non-diabetic;Non-Insulin-Dependent Diabetes Mellitus;novel;obese person;Obesity;Overweight;Paper;Participant;Pathogenesis;Pathway interactions;Pattern;Pharmaceutical Preparations;Phenotype;Physical activity;Plasma;Play;Policies;polygenic risk score;Population;Population Heterogeneity;Positioning Attribute;Postdoctoral Fellow;Predisposition;programs;Proteomics;Protocols documentation;Publishing;Reporting;Research;Research Personnel;Resources;response;Risk;Risk Factors;risk variant;Role;Sampling;Science;Scientist;sedentary lifestyle;Services;Signal Transduction;single nucleus RNA-sequencing;Skeletal Muscle;Smoking;social culture;South Africa;Stroke;Students;Tissue Banks;Tissues;Training;Training Programs;trait;transcriptome sequencing;transcriptomics;Translating;Triglycerides;United States National Institutes of Health;Universities;Untranslated RNA;Variant;Weight;whole genome;Work;working group,Genetic epidemiology of complex diseases,200362,NA,NA,NA,NA,17,NA,NA,3560893,NA
11191291,ZIB,HG,1,N,NA,NA,NA,NA,ZIBHG000196,NA,NA,1ZIBHG000196-24,NHGRI:9523646\,INTRAMURAL RESEARCH,2024,NATIONAL HUMAN GENOME RESEARCH INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL HUMAN GENOME RESEARCH INSTITUTE,NA,NA,NA,79365586 (contact),"THOMAS, JAMES  (contact)",NA,NA,NA,Accounting;Adoption;analysis pipeline;Animals;Basic Science;Biological Sciences;Biology;Cells;ChIP-seq;clinical center;Clinical Sciences;Clinical Trials;Collaborations;comparative;complex data;Computer software;cost;Data;Data Analyses;Data Set;Dedications;design;Development;DNA;DNA sequencing;exome sequencing;Future;Genome;genome sequencing;genome-wide;Goals;Human;Human Genome;Informatics;Infrastructure;interest;Intramural Research Program;Laboratories;Management Information Systems;Medicine;meetings;member;Methods;microbiome research;Monitor;nanopore;National Human Genome Research Institute;National Institute of Allergy and Infectious Disease;novel;Patients;Positioning Attribute;Production;programs;Protocols documentation;Publications;Research;Research Personnel;Role;Sampling;SARS-CoV-2 genome;secondary analysis;sequencing platform;skin microbiome;System;Talents;targeted sequencing;Technology;telomere;Testing;transcriptome sequencing;transcriptomics;United States National Institutes of Health;whole genome;Work,Inter- and Intra-Species Comparative Sequencing,196,NA,NA,NA,NA,24,NA,NA,9523646,NA
11191292,ZIC,EB,1,N,NA,NA,NA,NA,ZICEB000101,NA,NA,1ZICEB000101-02,NIBIB:188185\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING,NA,NA,NA,79341491 (contact),"PLATT, MANU  (contact)",NA,NA,NA,"3D Print;Acceleration;Active Learning;Address;Area;Artificial Intelligence;Baltimore;Biocompatible Materials;Biomechanics;Biomedical Engineering;biomedical imaging;Biosensing Techniques;Clinical;clinical center;clinical translation;Code;Collaborations;college;Communities;community building;community center;Computer software;computing resources;Consultations;Country;Databases;Development;Devices;Discipline;Educational workshop;Eligibility Determination;Engineering;Environment;Equipment;equity, diversity, and inclusion;Event;Extramural Activities;fabrication;Fostering;Funding;Goals;graduate student;help-seeking behavior;Human Resources;Image;Informatics;instrument;instrumentation;Interdisciplinary Study;interest;Internships;Intramural Research;Intramural Research Program;Laboratories;Laboratory Research;Language;Lasers;Licensing;Linux;machine learning framework;Maintenance;meetings;Microscope;Mission;Modeling;multi-photon;nano;National Institute of Biomedical Imaging and Bioengineering;novel;Occupations;open source;Participant;Persons;physical science;Postbaccalaureate;Postdoctoral Fellow;posters;preservation;Process;Professional Competence;Programming Languages;programs;prospective;Pythons;recruit;repaired;Research;Research Personnel;Resources;Running;Schedule;Science;Scientist;Series;shared memory;simulation;skills;Societies;square foot;Staging;summer internship;symposium;synthetic biology;Systems Biology;Talents;Techniques;Technology;Testing;Time;tool;Training and Education;training opportunity;Training Programs;Translational Research;undergraduate student;United States;United States National Institutes of Health;Universities;Update;user-friendly;Visualization;Work",Center for Biomedical Engineering Technology Acceleration (BETA Center),101,NA,NA,NA,NA,2,NA,NA,188185,NA
11191293,ZIC,ES,1,N,NA,NA,NA,NA,ZICES043010,NA,NA,1ZICES043010-39,NIEHS:470939\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES,NA,NA,NA,8547918 (contact),"COPELAND, WILLIAM  (contact)",NA,NA,NA,5&apos;-deoxyribose phosphate lyase;Active Sites;Affect;Allergens;Androgen Receptor;Area;Attention;Binding;biological systems;Classical Mechanics;computational chemistry;Computers;computing resources;cost;CYP2J2 gene;dGTPase;Dimerization;Diphosphates;DNA;DNA Damage;DNA Structure;DNA-Directed DNA Polymerase;Docking;Double Strand Break Repair;drug-like compound;Estrogen Receptors;Evaluation;functional hypothalamic amenorrhea;Goals;Health;Human;improved;interest;Ions;Juvenile Dermatomyositis;Ligand Binding;Lipids;Measures;Mechanics;Memory;Metals;Methodology;Methods;Modeling;Molecular Analysis;Molecular Conformation;molecular dynamics;molecular mechanics;molecular modeling;Muscle;mutant;Mutation;N-terminal;nanosecond;National Institute of Environmental Health Sciences;Nucleotides;peptide structure;Peptides;Phosphopeptides;Polyglandular Autoimmune Syndrome Type I;Procedures;Process;Proteins;quantum;Quantum Mechanics;Reaction;Research;Research Personnel;Resort;Ribonucleotides;RNA;RNA Binding;RNA Degradation;RNA Splicing;Role;Running;Sampling;SARS-CoV-2 spike protein;Scheme;Scientist;simulation;small molecule;Structural Protein;Structure;Sum;Syndrome;System;Technology;Testing;tool;Translating;Validation;Variant;Work;Writing,Computational Chemistry and Macromolecular Modeling,43010,NA,NA,NA,NA,39,NA,NA,470939,NA
11191294,ZIC,ES,1,N,NA,NA,NA,NA,ZICES102425,NA,NA,1ZICES102425-17,NIEHS:1566921\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES,NA,NA,NA,9693788 (contact),"RAY, MANAS  (contact)",NA,NA,NA,2019-nCoV;Adopted;Alleles;Amino Acids;animal facility;Animal Husbandry;Animal Model;Animals;Annual Reports;Breeding;Budgets;Cell Line;Cell Separation;Cells;Clustered Regularly Interspaced Short Palindromic Repeats;cohort;Collaborations;Communities;Complex;conditional knockout;cost;Cost Savings;COVID-19;CRISPR/Cas technology;Cryopreservation;design;Disease;early embryonic stage;Electroporation;Embryo;embryo cell;embryo cryopreservation;Embryo Transfer;embryonic stem cell;Engineering;Event;Exons;experimental study;Extramural Activities;Face;Female;Fertilization in Vitro;Flow Cytometry;Fluorescence;Fostering;Future;gene editing technology;gene function;Gene Modified;Genes;genetically modified cells;Genome;genome editing;Genotype;Germ Lines;Glucocorticoid Receptor;Goals;Guide RNA;Heterozygote;homologous recombination;human coronavirus;human disease;improved;In Vitro;in vivo;Individual;Injections;Journals;Knock-out;Logistics;Manuscripts;meetings;member;Microinjections;Mission;Molecular;monolayer;Morphology;Mothers;mouse genome;mouse model;Mus;mutant;mutant mouse model;Mutant Strains Mice;Mutate;Mutation;National Institute of Environmental Health Sciences;Non-Commercial Sources;novel;novel coronavirus;Orphan;Ovum;payment;Peer Review;Phenotype;Play;Point Mutation;Population;preservation;Process;Production;PTGS2 gene;Publishing;Reagent;recombinase-mediated cassette exchange;Regulation;repaired;Research;Research Personnel;Research Project Grants;Research Support;Resources;RNA;Role;SARS coronavirus;Savings;screening;Services;Severe Acute Respiratory Syndrome;Signal Pathway;Site;Source;sperm cell;sperm cryopreservation;Stress;success;System;Techniques;Technology;Time;tool;Transfection;Transgenes;Transgenic Mice;vector;Vendor;wasting;Work,NIEHS Gene Editing and Mouse Model (GEMM) Core Annual Report,102425,NA,NA,NA,NA,17,NA,NA,1566921,NA
11191295,ZIC,ES,1,N,NA,NA,NA,NA,ZICES102488,NA,NA,1ZICES102488-17,NIEHS:3081019\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES,NA,NA,NA,9693800 (contact),"WILLIAMS, JASON  (contact)",NA,NA,NA,2019-nCoV;Acetylation;Acetyltransferase;Affect;Albumins;alpha 1-Antitrypsin;alpha-1-microglobulin;Amino Acids;Architecture;Autophagocytosis;Base Excision Repairs;Binding;Bleomycin;Cellular biology;Chemicals;Chimeric Proteins;Collaborations;Complex;Coupled;Cross-Linking Reagents;crosslink;Cryoelectron Microscopy;Deacetylase;Deposition;Development;Digestion;Disease;Dissociation;disulfide bond;DNA Repair Gene;E1A-associated p300 protein;Elements;Enzymes;EP300 gene;Evaluation;Event;experimental study;Fibroblasts;Functional disorder;Gel;Gene Expression;Glomerulonephritis;glycosylation;IGA Glomerulonephritis;IgA1;Immunoglobulin A;In Vitro;insight;Intramural Research;Kidney Diseases;Label;Laboratories;Life Cycle Stages;Link;lipidomics;Lung;Lysine;Malignant Neoplasms;mass spectrometer;Mass Spectrum Analysis;Mediating;Methylation;Minnesota;Modification;Molecular;molecular mass;Molecular Structure;Mus;Nature;Normal Cell;overexpression;Pathogenesis;Patients;Peptide Hydrolases;Peptides;Phosphorylation;Plasma Proteins;Platelet-Derived Growth Factor alpha Receptor;Polymerase;Polymers;Post-Translational Protein Processing;Preparation;Prevention;Principal Investigator;protein aggregation;protein complex;protein crosslink;protein expression;protein structure;Proteins;Proteome;Proteomics;Radiolabeled;ran GTP-Binding Protein;Reducing Agents;Renal Hypertension;Research;Research Project Grants;Resolution;RNA Splicing;Robin bird;Role;Sampling;Scientist;Services;Side;Signal Transduction Pathway;Site;small molecule;small molecule inhibitor;structural biology;Structure;Structure of glomerular mesangium;Sulfur;Support Groups;System;Techniques;thioether;Toxicology;Transfer RNA;Transferase;Trypsin;Ubiquitination;Universities;Variant;Western Blotting;Work,Mass Spectrometry Identification,102488,NA,NA,NA,NA,17,NA,NA,3081019,NA
11191296,ZIC,ES,1,N,NA,NA,NA,NA,ZICES102545,NA,NA,1ZICES102545-17,NIEHS:1848820\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES,NA,NA,NA,1929784 (contact),"WADE, PAUL A (contact)",NA,NA,NA,ATAC-seq;Cell Separation;ChIP-seq;Chromium;Communities;Consultations;Cost Savings;Custom;Data;Data Analyses;Disease;DNA;DNA sequencing;DNA Sequencing Facility;epigenomics;Experimental Designs;Genetic Predisposition to Disease;Genomics;Individual;Instruction;instrumentation;Investigation;Libraries;Methods;National Institute of Environmental Health Sciences;next generation sequencing;Outcome;Preparation;Process;Research;Research Personnel;Sampling;Scientist;Services;single cell analysis;single cell sequencing;single-cell RNA sequencing;System;targeted sequencing;theories;Training;transcriptome sequencing,Epigenomics and DNA Sequencing,102545,NA,NA,NA,NA,17,NA,NA,1848820,NA
11191297,ZIC,ES,1,N,NA,NA,NA,NA,ZICES102645,NA,NA,1ZICES102645-16,NIEHS:1701147\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES,NA,NA,NA,10272728 (contact),"PEDERSEN, LARS  (contact)",NA,NA,NA,Active Sites;Affinity;Allergens;Allergic;Alveolar Bone Loss;Anabolism;Anaphylaxis;Antibodies;Antibody Binding Sites;Apoptotic;Area;Behavior;Binding;Binding Sites;Biogenesis;biological systems;Biology;Bone remodeling;Bone Resorption;Breast;C-terminal;Caspase;Catalysis;cathepsin K;Cell surface;Chondroitin Sulfates;clinically relevant;Coagulation Process;Collaborations;collagenase;Communities;cross reactivity;Cryoelectron Microscopy;Crystallization;Crystallography;Cysteine Proteinase Inhibitors;design and construction;dimer;Dimerization;Disease;enzyme biosynthesis;Enzymes;Epitopes;Excision;flexibility;Foundations;Glucosamine;Glucuronic Acids;Glucuronosyltransferase;Goals;Head;Health;Heparin;Heparitin Sulfate;heparosan synthase;Human;Hypersensitivity;IgE;IgG4;Immune response;Immunotherapy;improved;Individual;Induction of Apoptosis;Industrialization;Inflammation;inhibitor;insight;interest;Location;Macromolecular Complexes;Malignant Neoplasms;Modeling;Molecular Conformation;Molecular Structure;mouse model;Multiple Myeloma;Mus;mutant;Mutate;National Institute of Environmental Health Sciences;neutralizing antibody;novel;Oligosaccharides;Osteoclasts;Osteoporosis;Paget&apos;s Disease;Passive Cutaneous Anaphylaxis;Pasteurella multocida;Patients;Peptide Hydrolases;Play;post gamma-globulins;potential biomarker;Process;Production;Property;protein complex;protein function;Proteins;Protomer;Publishing;Reaction;receptor;Research;Research Personnel;research study;Research Support;Resolution;response;Rheumatoid Arthritis;Ribosomes;Risk Reduction;Roentgen Rays;Role;scale up;Scientist;Serum;side effect;Site;Structure;Substrate Specificity;success;Sulfate;Surface;Tail;targeted treatment;Techniques;Therapeutic;Tissues;TNF-related apoptosis-inducing ligand;TNFSF10 gene;tumor;Universities;Virus Diseases;Work;X-Ray Crystallography,Crystallographic studies of macromolecular structures,102645,NA,NA,NA,NA,16,NA,NA,1701147,NA
11191298,ZIC,ES,1,N,NA,NA,NA,NA,ZICES103005,NA,NA,1ZICES103005-14,NIEHS:664399\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES,NA,NA,NA,9693800 (contact),"WILLIAMS, JASON  (contact)",NA,NA,NA,Acrylamides;Adenosine;Adopted;Adrenalectomy;Aging;Animals;Area;Area Under Curve;Beds;Bile Acids;Biological;Biological Assay;Bleomycin;Blood Platelets;Brain;cardiovascular health;cell injury;cell type;Cells;Chromatography;Circulation;cofactor;Collaborations;comparative;Computer software;Consumption;cost efficient;Custom;Data;data acquisition;deprivation;Development;Dexamethasone;Diet;Disease;DNA;DNA Repair;dosage;Dryness;Eicosanoids;Environment;Environmental Exposure;Estrus;Evaluation;experimental study;exposure to cigarette smoke;Extramural Activities;Fatty Acids;Fibroblasts;Goals;Harvest;Human;Immunoglobulin A;improved;Individual;Inflammation;Injections;Ions;Isomerism;knockout gene;Knockout Mice;Label;Laboratories;lipidomics;Lipids;Liquid Chromatography;liquid chromatography mass spectrometry;Liquid substance;Liver;London;Lung;manufacture;Mass Spectrum Analysis;Measurement;Measures;mesangial cell;Metabolic;Metabolism;Methionine;method development;Methods;mouse model;Mus;National Institute of Environmental Health Sciences;Nature;Neurons;novel;Nucleosides;Onset of illness;Output;Parkinson Disease;Pathology;Patients;Pentas;Peptides;Phosphorylation;Plasma;Plasma Proteins;Platelet-Derived Growth Factor alpha Receptor;Play;Preparation;Protein Analysis;protein complex;protein expression;Proteins;Proteome;Proteomics;Protocols documentation;Publications;Reaction;Reagent;Recommendation;Research Personnel;Research Project Grants;Ribonucleosides;Ritalin;Role;Running;Sampling;Scanning;Science;Signaling Molecule;Source;Stable Isotope Labeling;Statistical Data Interpretation;Statistical Methods;Sterilization;Stimulant;Sum;tandem mass spectrometry;Techniques;Time;Tissues;tool;uptake;Uterus;Work,Mass Spectrometry Quantitation,103005,NA,NA,NA,NA,14,NA,NA,664399,NA
11191299,ZIC,ES,1,N,NA,NA,NA,NA,ZICES103330,NA,NA,1ZICES103330-07,NIEHS:2310941\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES,NA,NA,NA,2047655 (contact),"YAKEL, JERREL L (contact)",NA,NA,NA,Anxiety;Behavior;Behavioral;Behavioral Assay;behavioral outcome;behavioral phenotyping;behavioral study;Biological Assay;Cell Physiology;circadian;Communities;Contracts;Data Analyses;Electrophysiology (science);Equipment;Experimental Designs;Functional disorder;Genetic;Goals;Home;Implant;in vivo;insight;Laboratories;Learning;Manuscripts;Memory;Mental Depression;Mental disorders;Methods;Microscope;Mission;Molecular;Monitor;Motor;Mus;National Institute of Environmental Health Sciences;Nervous System Disorder;Nervous System Physiology;neural;neurobehavioral;Neurons;Neurosciences Research;neurotechnology;novel;optical imaging;Optics;optogenetics;Phenotype;Photometry;Preparation;Reflex action;Research;Research Personnel;Sensory;Social Behavior;Standardization;synaptic function;Techniques;Training;United States National Institutes of Health,Neurobehavioral Core Laboratory,103330,NA,NA,NA,NA,7,NA,NA,2310941,NA
11191300,ZIC,ES,1,N,NA,NA,NA,NA,ZICES103362,NA,NA,1ZICES103362-04,NIEHS:909415\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES,NA,NA,NA,77831834 (contact),"MUELLER, GEOFFREY  (contact)",NA,NA,NA,Acids;Affinity;Binding;Binding Proteins;Botanicals;Brain;Chemistry;Chronic Fatigue Syndrome;Consult;Core Facility;experimental study;G-Quartets;Glutathione;Goals;Histones;Human;Laboratories;leukemia;Measures;metabolomics;Mus;National Institute of Environmental Health Sciences;Nucleotides;Patients;peptide structure;Peptides;Pharmaceutical Preparations;Poly-fluoroalkyl substances;Proteins;Research;Research Personnel;Research Project Grants;Resources;RNA;Robin bird;saliva sample;Sampling;stable isotope;stool sample;Structure;Survivors;Testing;Yeasts,NMR Research Core Facility,103362,NA,NA,NA,NA,4,NA,NA,909415,NA
11191301,ZIC,ES,1,N,NA,NA,NA,NA,ZICES103363,NA,NA,1ZICES103363-04,NIEHS:1675749\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES,NA,NA,NA,78332074 (contact),"JARMUSCH, ALAN  (contact)",NA,NA,NA,Biocompatible Materials;Biological;Biological Assay;chemical property;chemical standard;Chemicals;Chromatography;Complement;Complex;complex data;Consultations;Core Facility;Coupled;Data;data acquisition;Data Analyses;data analysis pipeline;Databases;Dedications;Drosophila genus;Environmental Exposure;Evaluation;Experimental Designs;experimental study;Health;High Pressure Liquid Chromatography;Human;hydrophilicity;improved;Intramural Research Program;ion mobility;Kidney;Laboratories;liquid chromatography mass spectrometry;Liver;mass spectrometer;Mass Spectrum Analysis;Measurement;Measures;metabolomics;Methods;Mus;National Institute of Environmental Health Sciences;novel;Phase;physical property;Plasma;Preparation;Procedures;Protocols documentation;quality assurance;Quality Control;Research;Research Personnel;Resolution;Resources;response;reversed phase chromatography;Sampling;Services;Shapes;Signal Transduction;Spectrometry;System;Time;Training;United States National Institutes of Health;Urine,Mass Spectrometry-based Untargeted Metabolomics,103363,NA,NA,NA,NA,4,NA,NA,1675749,NA
11191302,ZIC,ES,1,N,NA,NA,NA,NA,ZICES103380,NA,NA,1ZICES103380-03,NIEHS:12819574\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES,NA,NA,NA,78410011 (contact),"HOOTH, MICHELLE  (contact)",NA,NA,NA,"Academia;Address;Advisory Committees;Agreement;Area;Budgets;Chemistry;Collaborations;college;Communication;Computer software;Concept Review;Contracts;Data;Decision Making;design;Development;doctoral student;Ensure;Environment;Environmental Hazards;Environmental Health;equity, diversity, and inclusion;Fellowship Program;Goals;Health;health science research;Human Resources;improved;Industry;Infrastructure;innovation;interest;Knowledge;Lead;Leadership;Maintenance;Methods;Mission;Monograph;multidisciplinary;National Institute of Environmental Health Sciences;National Toxicology Program;next generation;operation;outreach;Peer Review;Policies;pre-doctoral;Process;Professional counselor;Program Development;programs;Public Health;PubMed;Reporting;Research;research and development;Research Contracts;Research Project Grants;Resources;science education;Science Policy;Scientist;Series;Services;Structure;tool;Toxicology;Training;translational scientist;Travel;Trust;Vision;web site;Work;Workforce Development",Research Services Supporting the Division of Translational Toxicology,103380,NA,NA,NA,NA,3,NA,NA,12819574,NA
11191303,ZIG,HG,1,N,NA,NA,NA,NA,ZIGHG200356,NA,NA,1ZIGHG200356-17,NHGRI:6798873\,INTRAMURAL RESEARCH,2024,NATIONAL HUMAN GENOME RESEARCH INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL HUMAN GENOME RESEARCH INSTITUTE,NA,NA,NA,79365624 (contact),"MACLARTY, ARTHUR  (contact)",NA,NA,NA,Accreditation;Administrative Personnel;Amendment;Analgesics;Anesthesia and Analgesia;Anesthetics;animal care;Animal Care and Use Committees;Animal Experimentation;Animal Model;Animal Welfare;Animals;Area;Behavioral Research;Biomedical Research;Blood;Caring;Collection;comparative;Consultations;Contracts;Derivation procedure;design;Disaster Planning;Educational process of instructing;Educational Status;Electronics;Employee;Ensure;environmental enrichment for laboratory animals;Euthanasia;Financial Support;follow-up;Genotype;Government;Guidelines;Hypersensitivity;Individual;Injections;Injury;International;investigator training;Laboratory Animal Medicine;Laboratory Animals;Laboratory mice;Logistics;Medicine;meetings;Methods;Mission;model development;Monitor;Mus;National Human Genome Research Institute;occupational health/safety;Operative Surgical Procedures;personal protective equipment;Preparation;Prevention;Principal Investigator;Procedures;Program Evaluation;programs;protocol development;Protocols documentation;Recommendation;Records;Regulation;Reporting;Research;Research Infrastructure;Research Personnel;Research Support;response;restraint;Rodent;Safety;Schedule;Security;skills;Surgeon;Suture Techniques;Techniques;Testing;Training;Training Programs;Training Technics;Transgenic Organisms;treatment research;United States National Institutes of Health;Update;virtual;Work,NHGRI/DIR Animal Research Infrastructure,200356,NA,NA,NA,NA,17,NA,NA,6798873,NA
11191304,ZIJ,HG,1,N,NA,NA,NA,NA,ZIJHG200355,NA,NA,1ZIJHG200355-17,NHGRI:1966933\,INTRAMURAL RESEARCH,2024,NATIONAL HUMAN GENOME RESEARCH INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL HUMAN GENOME RESEARCH INSTITUTE,NA,NA,NA,12465259 (contact),"HULL, SARA  (contact)",NA,NA,NA,"Address;Admission activity;Area;Artificial Intelligence;Awareness;career;Career Choice;career development;Career Mobility;career networking;Child;Clinical;cohort;Collaborations;Communication;community engagement;community involvement;Competence;Contractor;Development;diversity and equity;doctoral student;Documentation;Education;Education and Outreach;education resources;Educational Curriculum;Educational Status;Educational workshop;Ensure;equity, diversity, and inclusion;Ethnic equity;Event;experience;Extramural Activities;Fellowship Program;Focus Groups;Fostering;Funding Opportunities;Future;genetic approach;genetic counselor;Genetic Research;genome sciences;Genomic approach;Genomic medicine;Genomics;Goals;Grant;harassment;Health;health equity;Individual;innovation;Intramural Research Program;K-Series Research Career Programs;Lead;Leadership;Learning;member;Mental Health;Mentors;Mission;National Human Genome Research Institute;operation;outreach program;Participant;Pathway interactions;Persons;Postbaccalaureate;Postdoctoral Fellow;pre-doctoral;Procedures;professional atmosphere;programs;Public Speaking;Racial Equity;recruit;Research;Residencies;Resources;Role;Science;Scientist;Series;skills;Students;summer internship;summer program;synergism;Teacher Professional Development;Training;training opportunity;Training Programs;United States National Institutes of Health;Update;Visit;Work;working group;Writing",NHGRI/DIR Education and Outreach Programs,200355,NA,NA,NA,NA,17,NA,NA,1966933,NA
11191305,ZIK,HG,1,N,NA,NA,NA,NA,ZIKHG200358,NA,NA,1ZIKHG200358-17,NHGRI:2573005\,INTRAMURAL RESEARCH,2024,NATIONAL HUMAN GENOME RESEARCH INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL HUMAN GENOME RESEARCH INSTITUTE,NA,NA,NA,79365632 (contact),"SOLOWIEJ, ANNA  (contact)",NA,NA,NA,Agreement;Alkaptonuria;All of Us Research Program;Amendment;analog;Attention deficit hyperactivity disorder;Australia;Biocompatible Materials;Biological Assay;Biological Markers;Biological Sciences;Cell Line;Classification;clinical development;Clinical Trials;Cobalamin;cognitive skill;Collaborations;commercialization;Consult;Cooperative Research and Development Agreement;Copyright;Corynebacterium;Counseling;cybersickness;Data;data exchange;Databases;Development;Disclosure;Disease;Educational Materials;Employee;Ensure;Europe;experience;Flow Cytometry;Funding;Future;Gaucher Disease;gene therapy;Gifts;Grant;Hallux structure;Health;Histologic;Human;Image;induced pluripotent stem cell;Institution;instrument;Intellectual Property;interest;International;Internships;invention;Japan;ketotic hyperglycinemia;Laboratory Research;Lamin Type A;Laws;Lead;Legal;Legal patent;Licensing;Marketing;material transfer agreement;Mediation;Methods;methylmalonic aciduria;Mission;mouse model;National Human Genome Research Institute;Natural History;Nonprofit Organizations;Oligonucleotides;Patients;Pharmacologic Substance;Policies;Postdoctoral Fellow;prevent;Private Sector;programs;Public Health;Reporting;Research;Research Personnel;Research Support;Resources;Russia;Science Policy;Scientist;Sialic Acids;Singapore;Speed;summer student;symposium;System;Technology;Technology Transfer;tool;Training;Transact;Transfer Agreement;Treaty;United States;United States National Institutes of Health;Universities;virtual assessment;virtual reality;virtual reality intervention;Visit;Work;Writing,NHGRI/DIR Technology Transfer Program,200358,NA,NA,NA,NA,17,NA,NA,2573005,NA
11191306,R01,AI,7,N,2024-11-29,2024-11-01,2025-06-30,855,R01AI173045,EARTH SCIENCES/RESOURCES,PA-24-254,7R01AI173045-02,NIAID:526875\,NON-SBIR/STTR RPGS,2024,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,BOZEMAN,UNITED STATES,MICROBIOLOGY/IMMUN/VIROLOGY,01,625447982,US,1381004,MONTANA STATE UNIVERSITY - BOZEMAN,MT,597170000,"PROJECT NARRATIVE Lyme disease is the most common vector-borne infection in the United States, with nearly 500,000 cases per year. The bacterium Borrelia (Borreliella) burgdorferi causes Lyme disease when it is transmitted to humans by a tick vector. Bacteria, including B. burgdorferi, can themselves be infected by bacteriophages (phages), a type of virus. This application proposes to fill a knowledge gap regarding the fundamental understanding of B. burgdorferi phage biology, including the molecular basis of phage replication and the mechanisms by which phage facilitate movement of genes between bacteria, enhancing the persistence of B. burgdorferi in nature via reinfection of its hosts.",9288413 (contact),"SECOR, PATRICK R (contact)","BOWDEN, NADINE",2024-07-25,2029-06-30,NA,Phage-mediated horizontal gene transfer in Borrelia burgdorferi,173045,ZRG1,Special Emphasis Panel[ZRG1-IMII-U(01)Q],NA,NA,2,421219,105656,526875,NA
11191307,U01,FD,3,N,2024-09-20,2024-09-01,2025-08-31,103,U01FD005978,SCHOOLS OF PHARMACY,RFA-FD-23-004,3U01FD005978-09S3,FDA:350000\,NON-SBIR/STTR RPGS,2024,FOOD AND DRUG ADMINISTRATION,NA,SAN FRANCISCO,UNITED STATES,PHARMACOLOGY,11,094878337,US,577508,"UNIVERSITY OF CALIFORNIA, SAN FRANCISCO",CA,941432510,"NARRATIVE The UCSF-Stanford Center of Excellence in Regulatory Sciences and Innovation (CERSI) conducts collaborative research in innovative regulatory science. This research enhances the FDAs public health mission including the evaluation of safe and effective medical products. In addition, the CERSI develops training and outreach programs for the purpose of training students, postdoctoral fellows and career scientists in regulatory sciences.",6620309;1863167 (contact),"ALTMAN, RUSS BIAGIO;GIACOMINI, KATHLEEN M (contact)","SEPULVEDA, KRISTIN",2016-09-15,2028-08-31,NA,UCSF-Stanford Center of Excellence in Regulatory Science and Innovation,5978,ZFD1,ZFD1-OC-S(04)1,NA,S3,9,212384,137616,350000,NA
11191309,U01,FD,3,N,2024-09-22,2024-09-01,2025-08-31,103,U01FD005978,SCHOOLS OF PHARMACY,RFA-FD-23-004,3U01FD005978-09S5,FDA:250000\,NON-SBIR/STTR RPGS,2024,FOOD AND DRUG ADMINISTRATION,NA,SAN FRANCISCO,UNITED STATES,PHARMACOLOGY,11,094878337,US,577508,"UNIVERSITY OF CALIFORNIA, SAN FRANCISCO",CA,941432510,"NARRATIVE The UCSF-Stanford Center of Excellence in Regulatory Sciences and Innovation (CERSI) conducts collaborative research in innovative regulatory science. This research enhances the FDAs public health mission including the evaluation of safe and effective medical products. In addition, the CERSI develops training and outreach programs for the purpose of training students, postdoctoral fellows and career scientists in regulatory sciences.",6620309;1863167 (contact),"ALTMAN, RUSS BIAGIO;GIACOMINI, KATHLEEN M (contact)","SEPULVEDA, KRISTIN",2016-09-15,2028-08-31,NA,UCSF-Stanford Center of Excellence in Regulatory Science and Innovation,5978,ZFD1,ZFD1-OC-S(04)1,NA,S5,9,151703,98297,250000,NA
11191312,UH3,MD,3,N,2024-09-21,2024-09-30,2025-06-30,307,UH3MD018353,SCHOOLS OF PUBLIC HEALTH,PA-20-272,3UH3MD018353-03S1,NIMHD:1114452\,NON-SBIR/STTR RPGS,2024,NATIONAL INSTITUTE ON MINORITY HEALTH AND HEALTH DISPARITIES,NA,SAN DIEGO,UNITED STATES,PUBLIC HEALTH & PREV MEDICINE,51,073371346,US,513614,SAN DIEGO STATE UNIVERSITY,CA,921821901,"PROJECT NARRATIVE Transforming the process by which academic researchers, healthcare leaders, clinicians, and other stakeholders (from patients to community) determine what research questions to ask is essential for addressing the health and healthcare needs of underserved populations. This transformation is only possible with an infrastructure that supports involvement in the research identification, selection, implementation, and dissemination processes. This application seeks to build on the efforts of a Federally Qualified Health Center located in a rural, border community in California to inform new approaches for supporting the knowledge transfer process through a clinical research network.",2098047 (contact);12026439,"AYALA, GUADALUPE X (contact);BELL, YVONNE","LINARES, DEBORAH ELIZABETH",2022-09-24,2025-06-30,Address;Administrative Supplement;adverse pregnancy outcome;Advisory Committees;Awareness;Border Community;California;Characteristics;Clinical;Clinical Research;clinical research site;cohort;Cohort Studies;Collaborations;Collection;Common Data Element;Communities;community organizations;Contracts;County;Data;Data Collection;data harmonization;data interoperability;data sharing;diabetes control;diabetes management;Diabetes Mellitus;Education;Educational Status;Electronic Health Record;Equipment;Equity;Ethnic Origin;Evidence based practice;Federally Qualified Health Center;Future;Health;health disparity;health equity;Health Personnel;Healthcare;Healthcare Systems;Household;Human Resources;Immigration;implementation efforts;Income;Infrastructure;Intervention;Intervention Studies;Knowledge;Leadership;Measures;Mediation;Mental Health;novel strategies;Outcome;Participant;Patients;Personal Satisfaction;PhenX Toolkit;Poaceae;Policies;population based;Population Heterogeneity;postpartum care;Postpartum Period;pragmatic trial;Prenatal care;Procedures;Process;Protocols documentation;Provider;Race;Research;Research Activity;Research Infrastructure;Research Personnel;Research Priority;Resources;Rural;Sample Size;Sampling;secondary analysis;Site;social;social health determinants;suburb;System;Translations;treatment adherence;Treatment Effectiveness;Underserved Population;Woman,Imperial County Clinical Research Network for Health Equity (Administrative Supplement),18353,NA,NA,NA,S1,3,890940,223512,1114452,NA
11191313,U01,FD,3,N,2024-09-19,2024-09-01,2025-08-31,103,U01FD005938,SCHOOLS OF MEDICINE,RFA-FD-23-004,3U01FD005938-09S2,FDA:174880\,NON-SBIR/STTR RPGS,2024,FOOD AND DRUG ADMINISTRATION,NA,NEW HAVEN,UNITED STATES,INTERNAL MEDICINE/MEDICINE,03,043207562,US,9420201,YALE UNIVERSITY,CT,065208327,"8. PROJECT NARRATIVE The Centers of Excellence in Regulatory Science and Innovation (CERSI) program allows the U.S. Food and Drug Administration (FDA) to form extramural partnerships that foster robust and innovative research to develop new tools, standards, and approaches to assess the safety, efficacy, quality, and performance of FDA- regulated products, supporting regulatory decision-making and the overall mission of the FDA. Over the past seven years, the Yale-Mayo Clinic CERSI has pursued a series of innovative research projects that leverage real-world data sources to assess the safety, efficacy, quality, and performance of FDA-regulated products, informing regulatory decision-making as well as manufacturers, clinicians, and patients in support of optimizing patient-centered care, along with providing and supporting high-quality mentorship and training in regulatory science. The Yale-Mayo Clinic CERSI will continue this work, conducting high-quality, high-impact regulatory science research in priority areas identified by the FDA to modernize development and evaluation of FDA- regulated products, strengthen post-market surveillance and labelling of FDA-regulated products, and invigorate public health preparedness and response of FDA, patients, and consumers.",9284283 (contact),"ROSS, JOSEPH SOLOMON (contact)","BATTLES, JESSICA JOY",2016-09-30,2028-08-31,NA,Yale-Mayo Clinic FDA Center of Excellence in Regulatory Science and Innovation (CERSI),5938,ZFD1,ZFD1-OC-S(04)1,NA,S2,9,104406,70474,174880,NA
11191324,U01,FD,3,N,2024-09-18,2024-09-01,2025-08-31,103,U01FD005942,SCHOOLS OF PUBLIC HEALTH,RFA-FD-23-004,3U01FD005942-09S1,FDA:171941\,NON-SBIR/STTR RPGS,2024,FOOD AND DRUG ADMINISTRATION,NA,BALTIMORE,UNITED STATES,PUBLIC HEALTH & PREV MEDICINE,07,001910777,US,4134401,JOHNS HOPKINS UNIVERSITY,MD,212182680,"PROJECT NARRATIVE The Johns Hopkins CERSI (JH-CERSI) represents a highly innovative collaboration between the worlds leading regulatory authority and the countrys largest research university. In this renewal, we combine the remarkable success of JH-CERSI since its inception with three new elements to accelerate knowledge and enhance impact in areas of incredibly high regulatory importance. There is not a moment to lose.",8143293 (contact),"ALEXANDER, G. CALEB (contact)","BATTLES, JESSICA JOY",2016-09-15,2028-08-31,NA,Johns Hopkins Center of Excellence in Regulatory Science and Innovation,5942,ZFD1,ZFD1-OC-S(04)1,NA,S1,9,105002,66939,171941,NA
11191325,U01,FD,3,N,2024-09-19,2024-09-01,2025-08-31,103,U01FD005942,SCHOOLS OF PUBLIC HEALTH,RFA-FD-23-004,3U01FD005942-09S2,FDA:259411\,NON-SBIR/STTR RPGS,2024,FOOD AND DRUG ADMINISTRATION,NA,BALTIMORE,UNITED STATES,PUBLIC HEALTH & PREV MEDICINE,07,001910777,US,4134401,JOHNS HOPKINS UNIVERSITY,MD,212182680,"PROJECT NARRATIVE The Johns Hopkins CERSI (JH-CERSI) represents a highly innovative collaboration between the worlds leading regulatory authority and the countrys largest research university. In this renewal, we combine the remarkable success of JH-CERSI since its inception with three new elements to accelerate knowledge and enhance impact in areas of incredibly high regulatory importance. There is not a moment to lose.",8143293 (contact),"ALEXANDER, G. CALEB (contact)","BATTLES, JESSICA JOY",2016-09-15,2028-08-31,NA,Johns Hopkins Center of Excellence in Regulatory Science and Innovation,5942,ZFD1,ZFD1-OC-S(04)1,NA,S2,9,170056,89355,259411,NA
11191326,U01,FD,3,N,2024-09-20,2024-09-01,2025-08-31,103,U01FD005942,SCHOOLS OF PUBLIC HEALTH,RFA-FD-23-004,3U01FD005942-09S3,FDA:260375\,NON-SBIR/STTR RPGS,2024,FOOD AND DRUG ADMINISTRATION,NA,BALTIMORE,UNITED STATES,PUBLIC HEALTH & PREV MEDICINE,07,001910777,US,4134401,JOHNS HOPKINS UNIVERSITY,MD,212182680,"PROJECT NARRATIVE The Johns Hopkins CERSI (JH-CERSI) represents a highly innovative collaboration between the worlds leading regulatory authority and the countrys largest research university. In this renewal, we combine the remarkable success of JH-CERSI since its inception with three new elements to accelerate knowledge and enhance impact in areas of incredibly high regulatory importance. There is not a moment to lose.",8143293 (contact),"ALEXANDER, G. CALEB (contact)","BATTLES, JESSICA JOY",2016-09-15,2028-08-31,NA,Johns Hopkins Center of Excellence in Regulatory Science and Innovation,5942,ZFD1,ZFD1-OC-S(04)1,NA,S3,9,159008,101367,260375,NA
11191327,U01,FD,3,N,2024-09-19,2024-09-01,2025-08-31,103,U01FD005942,SCHOOLS OF PUBLIC HEALTH,RFA-FD-23-004,3U01FD005942-09S4,FDA:303001\,NON-SBIR/STTR RPGS,2024,FOOD AND DRUG ADMINISTRATION,NA,BALTIMORE,UNITED STATES,PUBLIC HEALTH & PREV MEDICINE,07,001910777,US,4134401,JOHNS HOPKINS UNIVERSITY,MD,212182680,"PROJECT NARRATIVE The Johns Hopkins CERSI (JH-CERSI) represents a highly innovative collaboration between the worlds leading regulatory authority and the countrys largest research university. In this renewal, we combine the remarkable success of JH-CERSI since its inception with three new elements to accelerate knowledge and enhance impact in areas of incredibly high regulatory importance. There is not a moment to lose.",8143293 (contact),"ALEXANDER, G. CALEB (contact)","BATTLES, JESSICA JOY",2016-09-15,2028-08-31,NA,Johns Hopkins Center of Excellence in Regulatory Science and Innovation,5942,ZFD1,ZFD1-OC-S(04)1,NA,S4,9,185039,117962,303001,NA
11191328,U01,FD,3,N,2024-09-21,2024-09-01,2025-08-31,103,U01FD005942,SCHOOLS OF PUBLIC HEALTH,RFA-FD-23-004,3U01FD005942-09S5,FDA:432530\,NON-SBIR/STTR RPGS,2024,FOOD AND DRUG ADMINISTRATION,NA,BALTIMORE,UNITED STATES,PUBLIC HEALTH & PREV MEDICINE,07,001910777,US,4134401,JOHNS HOPKINS UNIVERSITY,MD,212182680,"PROJECT NARRATIVE The Johns Hopkins CERSI (JH-CERSI) represents a highly innovative collaboration between the worlds leading regulatory authority and the countrys largest research university. In this renewal, we combine the remarkable success of JH-CERSI since its inception with three new elements to accelerate knowledge and enhance impact in areas of incredibly high regulatory importance. There is not a moment to lose.",8143293 (contact),"ALEXANDER, G. CALEB (contact)","BATTLES, JESSICA JOY",2016-09-15,2028-08-31,NA,Johns Hopkins Center of Excellence in Regulatory Science and Innovation,5942,ZFD1,ZFD1-OC-S(04)1,NA,S5,9,264140,168390,432530,NA
11191330,U01,FD,3,N,2024-09-22,2024-09-01,2025-08-31,103,U01FD005942,SCHOOLS OF PUBLIC HEALTH,RFA-FD-23-004,3U01FD005942-09S6,FDA:786317\,NON-SBIR/STTR RPGS,2024,FOOD AND DRUG ADMINISTRATION,NA,BALTIMORE,UNITED STATES,PUBLIC HEALTH & PREV MEDICINE,07,001910777,US,4134401,JOHNS HOPKINS UNIVERSITY,MD,212182680,"PROJECT NARRATIVE The Johns Hopkins CERSI (JH-CERSI) represents a highly innovative collaboration between the worlds leading regulatory authority and the countrys largest research university. In this renewal, we combine the remarkable success of JH-CERSI since its inception with three new elements to accelerate knowledge and enhance impact in areas of incredibly high regulatory importance. There is not a moment to lose.",8143293 (contact),"ALEXANDER, G. CALEB (contact)","BATTLES, JESSICA JOY",2016-09-15,2028-08-31,NA,Johns Hopkins Center of Excellence in Regulatory Science and Innovation,5942,ZFD1,ZFD1-OC-S(04)1,NA,S6,9,480194,306123,786317,NA
11191354,N43,CA,NA,N,NA,NA,NA,NA,75N91024C00068,NA,NA,75N91024C00068-0-9999-1,NCI:399975\,SBIR/STTR CONTRACTS,2024,NATIONAL CANCER INSTITUTE,NA,MONROVIA,UNITED STATES,NA,31,168312028,US,10005243,"CHROMOLOGIC, LLC",CA,910164244,NA,79969321 (contact),"ROGERS, CLAUDE  (contact)",NA,2024-09-16,2025-09-15,3-Dimensional;Animals;Award;Blood Vessels;Cell Survival;checkpoint therapy;drug development;Evaluation;Exposure to;Human;Immune checkpoint inhibitor;Immune response;Immune system;in vitro Model;in vivo;innovation;Interferon alpha;Interferons;Intestines;Investigation;Malignant - descriptor;Mediating;microRNA biomarkers;Modeling;Molecular;neoplastic cell;novel strategies;novel therapeutics;Organ;organ on a chip;Organoids;Outcome;Pharmacologic Substance;Pharmacotherapy;Phase;Physiological;Procedures;Production;programs;Prostate;Radiation;radiation effect;radiation response;Radiation therapy;radiation-induced tissue damage;response;Role;Science;Stimulator of Interferon Genes;Technology;Testing;Therapeutic;Tissue Model;Tissues;tool development;tumor;Up-Regulation;x-ray irradiation,PHASE I AWARD - AN ORGAN-ON-VASCULARNET MODEL FOR IN VITRO EVALUATION OF RADIATION AND DRUG THERAPIES,0,NA,NA,NA,NA,NA,NA,NA,399975,NA
11191356,N44,CA,NA,N,NA,NA,NA,NA,75N91024C00098,NA,NA,75N91024C00098-0-9999-1,NCI:1987032\,SBIR/STTR CONTRACTS,2024,NATIONAL CANCER INSTITUTE,NA,SHREWSBURY,UNITED STATES,NA,02,081233144,US,10051807,SPATIAL SURGICAL LLC,MA,015453308,NA,79979773 (contact),"MONTY, NATHAN  (contact)",NA,2024-09-12,2026-09-11,3-Dimensional;Ablation;Algorithmic Software;Area;Attention;cancer therapy;Cancerous;Carbon Dioxide;Cells;Cervical;Clinical;Collection;Colon;Colon Carcinoma;Colorectal Cancer;Custom;ergonomics;Eye;Fluorescence;Fluorescent Dyes;fluorophore;Hand;Lasers;lens;low and middle-income countries;Microscope;Modeling;Monitor;Operative Surgical Procedures;Optics;Oral;Performance;Phase;Photons;preservation;Production;Resource-limited setting;Solid Neoplasm;Spottings;Surgeon;Surgical Oncology;System;Technology;Testing;tumor;usability;Visualization,Topic Number 431Cancer Treatment Technologies for Low-Resource Settings,0,NA,NA,NA,NA,NA,NA,NA,1987032,NA
11191357,N43,CA,NA,N,NA,NA,NA,NA,75N91024C00082,NA,NA,75N91024C00082-0-9999-1,NCI:400000\,SBIR/STTR CONTRACTS,2024,NATIONAL CANCER INSTITUTE,NA,MORGANTOWN,UNITED STATES,NA,02,117745312,US,10062506,SOSTOS LLC,WV,265052031,NA,79979758 (contact),"YE, QING  (contact)",NA,2024-09-16,2025-09-15,Acceleration;Award;Biological;Biological Markers;biomarker discovery;Blood specimen;cancer biomarkers;Cancer cell line;cancer diagnosis;Cancer Prognosis;Cells;cloud based;cloud software;Comparative Study;Computer software;Computing Methodologies;Data;Data Analyses;Data Security;Data Sources;drug development;drug repurposing;Encyclopedias;Ensure;Environment;feasibility testing;Goals;graphical user interface;Immune;improved;Malignant Neoplasms;Marketing;Methods;miRNA expression profiling;Modeling;multimodal data;multiple omics;Network-based;new technology;Non-Small-Cell Lung Carcinoma;novel therapeutics;optimal treatments;Outcome;Patients;Phase;Privacy;prototype;Recommendation;Safety;Sampling;scale up;single-cell RNA sequencing;Small Business Innovation Research Grant;Technology;Testing;The Cancer Genome Atlas;tumor;usability;user-friendly;Visualization,Topic 464 Phase I Award: Network-Based Multimodal Data Analysis Cloud Software for Cancer Biomarker Discovery and Drug Development,0,NA,NA,NA,NA,NA,NA,NA,400000,NA
11191359,N44,CA,NA,N,NA,NA,NA,NA,75N91024C00085,NA,NA,75N91024C00085-0-9999-1,NCI:1998978\,SBIR/STTR CONTRACTS,2024,NATIONAL CANCER INSTITUTE,NA,TUCSON,UNITED STATES,NA,06,080295846,US,10042405,"LIGHT RESEARCH, INC.",AZ,857506064,NA,79979764 (contact),"WILDER-SMITH, PETRA  (contact)",NA,2024-09-16,2026-09-15,Achievement;advanced disease;Animal Model;Contracts;Death Rate;Diagnosis;Disease Progression;Early Diagnosis;FDA approved;Health Care Costs;high risk;high risk population;Human;image guided;imaging system;innovation;Lesion;Light;low and middle-income countries;malignant mouth neoplasm;Malignant Neoplasms;Marketing;Modality;Morbidity - disease rate;mortality;Oral;Oral Stage;Oropharyngeal Squamous Cell Carcinoma;Patients;Phase;Photochemistry;premalignant;PUVA Photochemotherapy;Research;Resource-limited setting;screening;Screening for Oral Cancer;Small Business Innovation Research Grant;System;Technology;Time;United States National Institutes of Health,"FY24 SBIR Phase 2 RD Contract - Topic 431 Light Research, Inc.",0,NA,NA,NA,NA,NA,NA,NA,1998978,NA
11191360,N01,CA,NA,N,NA,NA,NA,NA,261201500010I,NA,NA,261201500010I-P00006-759102000001-1,NCI:290828\,NON SBIR/STTR CONTRACTS,2024,NATIONAL CANCER INSTITUTE,NA,SOUTH SAN FRANCISCO,UNITED STATES,NA,NA,930243360,US,NA,NA,CA,940801934,NA,77858333 (contact),"JOBLING, MICHAEL  (contact)",NA,2020-09-29,2025-09-28,Biology;Chemical Structure;Chemicals;Collection;Databases;design;Diversity Library;Dryness;Environment;Equipment and supply inventories;Film;indexing;Individual;Informatics;interest;Knowledge;Libraries;Monitor;Mothers;Sampling;screening;small molecule;Solid;stereochemistry;Structure;Test Result;Tube;Update;Vendor;Vial device;Work,CBC LIBRARY SCREENING,0,NA,NA,NA,NA,NA,NA,NA,290828,NA
11191694,N01,CA,NA,N,NA,NA,NA,NA,75N91022D00016,NA,NA,75N91022D00016-0-759102400003-1,NCI:568068\,NON SBIR/STTR CONTRACTS,2024,NATIONAL CANCER INSTITUTE,NA,CHICAGO,UNITED STATES,NA,01,005447826,US,962701,IIT RESEARCH INSTITUTE,IL,606163717,NA,79977788 (contact),"MCCORMICK, DAVID  (contact)",NA,2024-09-16,2025-09-15,Adverse effects;Animals;base;Canis familiaris;Dose;Drug Kinetics;Hour;Organ;pre-clinical research;Rattus;Testing;Toxic effect;Toxicology,TOXICOLOGY STUDIES IN RATS AND DOGS ADMINISTERED AIT-102,0,NA,NA,NA,NA,NA,NA,NA,568068,NA
11191716,N44,CA,NA,N,NA,NA,NA,NA,75N91024C00097,NA,NA,75N91024C00097-0-9999-1,NCI:1222441\,SBIR/STTR CONTRACTS,2024,NATIONAL CANCER INSTITUTE,NA,MIDDLETON,UNITED STATES,NA,02,788084705,US,3443701,"STANDARD IMAGING, INC.",WI,535621461,NA,79977804 (contact),"HOLMES, SHANNON  (contact)",NA,2024-09-16,2026-09-15,beamline;Clinical;commercialization;Data Collection;design;design and construction;Dose;Dose Rate;dosimetry;Electrons;Frequencies;improved;ionization;Ions;irradiation;Measures;Methods;Modality;Monitor;novel;Performance;Phase;Physiologic pulse;pre-clinical;Protocols documentation;Protons;prototype;radiation detector;response;Signal Transduction;Small Business Innovation Research Grant;Structure;System;Testing;Time;time resolved data,FY24 SBIR PHASE IITOPIC NO. 434PROJECT TITLE:  NOVEL NIST TRACEABLE IONIZATION CHAMBER FOR FLASH DOSIMETRY,0,NA,NA,NA,NA,NA,NA,NA,1222441,NA
11191720,N01,OD,NA,N,NA,NA,NA,NA,75N98024C00021,NA,NA,75N98024C00021-0-9999-1,NIDCD:1198643\,NON SBIR/STTR CONTRACTS,2024,"OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH",NA,GAITHERSBURG,UNITED STATES,NA,NA,NA,US,NA,NA,MD,208772632,"NIDCD is committed to building and expanding our clinical trials program to promote the development of therapies and interventions to treat and prevent communication and other disorders in our core mission areas: hearing, balance, taste, smell, voice, speech, and language. NIDCD has a longstanding history of funding basic science research in these areas and encourages the translation of basic science discoveries to therapies that benefit patients through the conduct of clinical trials and other patient-oriented research.",NA,(contact),NA,2024-09-03,2025-09-02,Area;Award;Basic Science;Clinical Data;Clinical Trials;Communication;Conduct Clinical Trials;Contract Services;Contractor;data management;data quality;Disease;Ensure;Equilibrium;experience;Funding;Hearing;high risk;Implementation readiness;improved;Intervention;Language;Life Cycle Stages;Mission;National Institute on Deafness and Other Communication Disorders;operation;patient oriented research;Patients;Performance;prevent;programs;Recording of previous events;Research;Smell Perception;Speech;Taste Perception;therapy development;Translations;United States National Institutes of Health;Voice;Work,NIDCD Clinical Trials Program (CTP),0,NA,NA,NA,NA,NA,NA,NA,1198643,NA
11191729,I01,VA,7,N,2024-09-11,2024-04-01,2024-09-30,999,I01BX004426,NA,BX-18-001,7I01BX004426-06,NA,NON-SBIR/STTR RPGS,2024,Veterans Affairs,NA,PORTLAND,UNITED STATES,NA,01,089461255,US,481073,PORTLAND VA MEDICAL CENTER,OR,972392964,"Vascular calcification and stiffness are hallmarks of diabetic vascular disorder, a prevalent cardiovascular complication in the Veteran's population that leads to increased morbidity and mortality. Disrupted circadian clock is a common issue in military personnel, which affects many of our Veterans. The proposal will establish a novel paradigm underlying circadian regulation of O-GlcNAcylation-mediated signaling in diabetic vascular calcification. The mechanistic insights learned from this proposal can not only advance our understanding of the basic mechanisms governing pathogenesis of diabetic vascular calcification, but also provide molecular insights into the development of novel strategy or drugs for prevention and therapy of these diabetic complications.",8079676 (contact),"CHEN, YABING  (contact)",NA,2019-10-01,2024-09-30,Acceleration;Affect;Animal Model;Animals;Aorta;ARNTL gene;Arteries;Blood Vessels;calcification;Cardiovascular system;Cell Physiology;circadian;Circadian Dysregulation;circadian pacemaker;circadian regulation;Circadian Rhythms;Clinical;Complication;Complications of Diabetes Mellitus;Darkness;Development;Diabetes Mellitus;diabetic;Diabetic Angiopathies;diabetic cardiomyopathy;Diabetic mouse;Disease Progression;Dose;Echocardiography;feeding;FOXO1A gene;Genes;Health;High Fat Diet;Hyperglycemia;improved;In Vitro;in vivo;insight;Knowledge;Learning;Light;Lipids;Mass Spectrum Analysis;Mediating;Military Personnel;military veteran;Molecular;Morbidity - disease rate;mortality;mouse model;Mus;novel;novel strategies;novel therapeutics;Outcome;Outcome Study;Oxidative Stress;Pathogenesis;Pathologic;Physiological;Post-Translational Protein Processing;Prevention;Proteins;Proteomics;Proto-Oncogene Proteins c-akt;Regulation;Reporting;Role;Signal Induction;Signal Transduction;Smooth Muscle Myocytes;Streptozocin;Time;tool;United States Department of Veterans Affairs;Up-Regulation;Vascular calcification;Vascular Diseases;Vascular Smooth Muscle;Veterans,Molecular Regulation of Vascular Calcification in Diabetes,4426,ZRD1,ZRD1-CARB-R(01)1,NA,NA,6,NA,NA,NA,NA
11191732,R56,EB,1,N,2024-09-19,2024-09-23,2025-09-22,286,R56EB036069,BIOMED ENGR/COL ENGR/ENGR STA,PA-20-185,1R56EB036069-01,NIBIB:613800\,NON-SBIR/STTR RPGS,2024,NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING,NA,SALT LAKE CITY,UNITED STATES,ENGINEERING (ALL TYPES),01,009095365,US,514002,UNIVERSITY OF UTAH,UT,841129049,"PROJECT NARRATIVE: Antenna design remains one of the major challenges in the miniaturization of implantable medical devices. Conventional antenna designs are too large for next-generation miniaurized implants.This proposal will combine novel nanomaterial synthesis and innovative antenna design to create a remotely coupled and injectable antenna system. This new class of implantable antenna can be injected into the body, where they transform into a soft, conductive antenna. Once the antenna is injected, it will be able to remotely coupled with a much smaller antenna in the implantable medical device without physical attachment.",2089317 (contact),"FURSE, CYNTHIA M (contact)","FALCONE, JESSICA",2024-09-23,2025-09-22,3-Dimensional;Animal Model;biomaterial compatibility;Bionics;Body Surface;chemical property;Communication;Computers;Coupled;Data;data acquisition;design;Device Designs;Devices;Diagnostic;Disease;Electrodes;Electronics;Energy Transfer;Equipment;Evaluation;fabrication;Fatty acid glycerol esters;Foreign Bodies;Frequencies;Generations;Histology;Hydrogels;Implant;implantable device;improved;In Vitro;in vivo;in vivo imaging;Infection;Injectable;Injections;innovation;Intuition;Length;Mechanics;Medical;Medical Device;Medical Electronics;medical implant;Methods;Miniaturization;miniaturize;miniaturized device;Modeling;nanocomposite;nanomaterials;nanowire;next generation;novel;Operative Surgical Procedures;Outcome;Pathway interactions;Performance;Positioning Attribute;Property;Proxy;Publishing;Rattus;Research;response;Shapes;Signal Transduction;simulation;Skin;Solid;subcutaneous;Surgical complication;System;Techniques;Technology;Temperature;Testing;Toxic effect;transmission process;Utah;viscoelasticity;wireless,Remotely Coupled Wireless Antenna System For Implantable Electronics,36069,ISD,Instrumentation and Systems Development Study Section[ISD],NA,NA,1,405896,207904,613800,NA
11191754,N43,CA,NA,N,NA,NA,NA,NA,75N91024C00081,NA,NA,75N91024C00081-0-9999-1,NCI:399036\,SBIR/STTR CONTRACTS,2024,NATIONAL CANCER INSTITUTE,NA,Newton,UNITED STATES,NA,04,832329788,US,10025154,"LUMICELL, INC.",MA,02458,NA,10332867 (contact),"FERRER, JORGE  (contact)",NA,2024-09-16,2025-09-15,Ablation;Agreement;Barrett Esophagus;Biopsy;Clinical Protocols;Clinical Research;Computer software;Data;design;Devices;Documentation;Dysplasia;Early Diagnosis;Endoscopes;Endoscopy;Esophageal Adenocarcinoma;Esophagus;Excision;Fluorescence;Fluorescent Probes;Gastroscopes;Guidelines;High grade dysplasia;Human;Image;imaging agent;imaging platform;In Situ;Incidence;Institutional Review Boards;Lesion;Light;Malignant neoplasm of esophagus;Malignant Neoplasms;meetings;Methods;Molecular;mortality;novel;Patients;premalignant;Process;Protocols documentation;Recommendation;research clinical testing;Research Design;Secure;Small Business Innovation Research Grant;System;Testing;Therapeutic;Time;Validation,"SBIR Topic 463: Clinical evaluation for early detection of esophageal cancer with a novel fluorescence endoscope and pegulicianine, a novel fluorescent probe",0,NA,NA,NA,NA,NA,NA,NA,399036,NA
11191756,P01,CA,3,N,2024-09-11,2024-09-01,2025-08-31,NA,P01CA154292,NA,PAR-20-077,3P01CA154292-13S1,NCI:209440\,NON-SBIR/STTR RPGS,2024,NATIONAL CANCER INSTITUTE,NA,DAVIS,UNITED STATES,NA,04,047120084,US,577503,UNIVERSITY OF CALIFORNIA AT DAVIS,CA,956186153,NA,11373261 (contact),"LEE, CHRISTOPH I (contact)","CROSWELL, JENNIFER",2011-09-27,2027-05-31,NA,Project 2,154292,ZCA1,ZCA1-SRB-K(J1)S,9022,S1,13,130087,79353,NA,209440
11191768,UH3,CA,4,N,2024-09-19,2024-09-01,2025-08-31,394,UH3CA271390,SCHOOLS OF MEDICINE,PAR-20-313,4UH3CA271390-02,NCI:350358\,NON-SBIR/STTR RPGS,2024,NATIONAL CANCER INSTITUTE,NA,NEW YORK,UNITED STATES,INTERNAL MEDICINE/MEDICINE,13,078861598,US,3839801,ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI,NY,100296574,"NARRATIVE Work from our groups has recently implemented a rapid, reliable and scalable test to quantify the functionality of the T cellular response against SARS-CoV-2. There is an urgent need to assess the persistence of cellular immunity, especially in immunocompromised patients (e.g. MM patients), to assess their level of protection. This study aims at establishing a scalable assay to assess cellular immunity, possibly aiding in nationwide booster strategies or passive antibody infusion support to protect these vulnerable population.",14078747 (contact);10813009;9673591,"GUCCIONE, ERNESTO  (contact);OCHANDO, JORDI ;PAREKH, SAMIR","BHARTI, SANITA",2023-09-18,2027-08-31,2019-nCoV;Address;Antibodies;Antibody Response;antigen detection;antigen-specific T cells;Bacterial Infections;Biological Assay;Biological Markers;Biotechnology;Blood;Blood specimen;booster vaccine;Bypass;cancer cell;Cancer Patient;Cells;Cellular Immunity;chemotherapy;Clinical;cohort;Cohort Studies;comorbidity;COVID-19;COVID-19 assay;COVID-19 complications;COVID-19 vaccination;CXCL10 gene;Data;Enrollment;Flow Cytometry;Goals;Hematologic Neoplasms;Hematology;Humoral Immunities;hypogammaglobulinemia;IL2 gene;Immune;Immune response;Immunity;Immunocompromised Host;Immunoglobulin G;Immunosuppression;Individual;Infection;Infusion procedures;Institutional Review Boards;Interferon Type II;Measures;Mediating;Methods;Modeling;Monitor;monocyte;Multiple Myeloma;Nature;neutralizing antibody;neutrophil;older patient;Oncology;Outcome;passive antibodies;Pathway interactions;patient population;Patients;Peptides;Peripheral Blood Mononuclear Cell;Phase;Plasma Cells;Population;Prevalence;prevent;Production;prophylactic;Proxy;Publishing;Quality Control;Recommendation;Recurrence;Reporting;response;RNA purification;Sampling;SARS-CoV-2 antigen;SARS-CoV-2 immunity;SARS-CoV-2 infection;SARS-CoV-2 spike protein;Sensitivity and Specificity;Social Distance;Specificity;Steroids;T-Cell Activation;T-Lymphocyte;targeted treatment;Testing;Time;Vaccinated;Vaccination;vaccination strategy;Vaccinee;Vaccines;Validation;Viral;Viral Antibodies;Virus Diseases;Vulnerable Populations;Whole Blood;Work,Implementation of a qPCR-based assay for the quantification of SARS-CoV-2-specific T cells in immunocompromised patients,271390,ZCA1,ZCA1-TCRB-Q(O2),NA,NA,2,207499,142859,350358,NA
11191776,N01,AI,NA,N,NA,NA,NA,NA,75N93024D00003,NA,NA,75N93024D00003-0-759302400001-1,NIAID:3890109\,NON SBIR/STTR CONTRACTS,2024,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,DURHAM,UNITED STATES,NA,04,044387793,US,2221101,DUKE UNIVERSITY,NC,277054673,NA,1870526 (contact),"DENNY, THOMAS  (contact)",NA,2024-09-30,2031-09-29,Acute;Adjuvant;Antigens;Biological;Biological Assay;Clinical;Clinical Trials;Clinical Trials Design;co-infection;comorbidity;Contracts;Data;Emerging Communicable Diseases;Evaluation;HIV Infections;HIV vaccine;HIV/AIDS;Immunologics;International;Knowledge;Laboratories;Monitor;Monoclonal Antibodies;National Institute of Allergy and Infectious Disease;programs;quality assurance;Quality Control;Reproducibility;Research;research clinical testing;Resources;Site;Specific qualifier value;Testing;vaccine candidate;vaccine platform;Vaccines;Virus,External Quality Assurance Program Oversight Laboratory (EQAPOL),0,NA,NA,NA,NA,NA,NA,NA,3890109,NA
11191777,P20,GM,5,N,2024-08-16,2024-08-01,2025-07-31,NA,P20GM125508,NA,PAR-22-163,5P20GM125508-07,NIGMS:181874\,RESEARCH CENTERS,2024,NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES,NA,HONOLULU,UNITED STATES,NA,01,965088057,US,820005,UNIVERSITY OF HAWAII AT MANOA,HI,968222234,NA,79902447 (contact),"YUAN, MENGTING MAGGIE (contact)","PEI, WUHONG",2024-09-11,2028-07-31,Address;Affect;Amoeba genus;Bacteria;cell community;Cells;Climate;climate change;comparative genomics;data archive;Ecology;Environment;Event;Goals;Hawaii;Health;Human;Incidence;Legionella;Legionellosis;Life Style;Link;Location;Maps;metabolomics;microbial;microbiome;Modeling;Monitor;Movement;novel;pathogen;Pathogenicity;Pneumonia;Precipitation;Proliferating;Public Health;Risk;Risk Assessment;risk prediction;Sampling;Signal Transduction;Soil;soil sampling;Structure;Techniques;Temperature;Testing;Virulence Factors;Water,Legionella in soil: biotic and abiotic controls of pathogenicity,125508,ZGM1,ZGM1-RCB-4(C2),8045,NA,7,124999,56875,NA,181874
11191804,U54,CA,3,N,2024-09-17,2024-09-01,2025-08-31,NA,U54CA277846,NA,PA-20-272,3U54CA277846-02S1,NCI:124992\,RESEARCH CENTERS,2024,NATIONAL CANCER INSTITUTE,NA,NEW ORLEANS,UNITED STATES,NA,02,782627814,US,577902,LSU HEALTH SCIENCES CENTER,LA,701127021,NA,8772570 (contact),"WEST, JOHN T. (contact)","KALEEBA, JOHNAN AUGUSTINE",2023-09-01,2028-08-31,NA,Project 2,277846,ZCA1,ZCA1(O1),7353,S1,2,121189,3803,NA,124992
11191812,U54,CA,3,N,2024-09-12,2024-09-01,2025-08-31,NA,U54CA274509,NA,RFA-CA-21-048,3U54CA274509-03S1,NCI:133520\,RESEARCH CENTERS,2024,NATIONAL CANCER INSTITUTE,NA,SEATTLE,UNITED STATES,NA,07,135646524,US,4106301,INSTITUTE FOR SYSTEMS BIOLOGY,WA,981095263,NA,8126809 (contact),"HEATH, JAMES R. (contact)","ZAMISCH, MONICA",2022-09-22,2027-08-31,NA,PROJECT 1: TIME-Based Spatiotemporal Cancer Immunograms Predictive for Immunotherapy-Targeted Therapy Sequential Combinations,274509,ZCA1,ZCA1-RTRB-F(M2),9917,S1,3,76156,57364,NA,133520
11191835,N43,AI,NA,N,NA,NA,NA,NA,75N93024C00040,NA,NA,75N93024C00040-0-9999-1,NIAID:598871\,SBIR/STTR CONTRACTS,2024,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,ROCKVILLE,UNITED STATES,NA,08,965180610,US,10028042,"SIGMOVIR BIOSYSTEMS, INC.",MD,208506330,NA,NA,(contact),NA,2024-09-01,2026-08-31,NA,REAGENTS FOR IMMUNOLOGIC ANALYSIS OF COTTON RAT.,0,NA,NA,NA,NA,NA,NA,NA,598871,NA
11191858,ZIA,AA,1,N,NA,NA,NA,NA,ZIAAA000407,NA,NA,1ZIAAA000407-23,NIAAA:2496469\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM,NA,NA,NA,7359471 (contact),"LOVINGER, DAVID M (contact)",NA,NA,NA,Abstinence;Acetylcholine;Acetylcholinesterase;Acetylcholinesterase Inhibitors;Acute;Address;Adenosine;Adenosine A1 Receptor;alcohol and other drug;alcohol behavior;Alcohol consumption;alcohol effect;alcohol exposure;alcohol misuse;alcohol seeking behavior;alcohol use disorder;Alcoholic Intoxication;Alcohols;antagonist;Axon;Basal Ganglia;Behavior;Behavior Control;Brain;brain circuitry;Calcium;Cannabis;Cells;Chronic;Cognition;Corpus striatum structure;Coupling;Darkness;Decision Making;Dependence;desensitization;Dopamine;dopaminergic neuron;Dorsal;drinking;drinking water;drug action;Drug Exposure;drug misuse;drug of abuse;Electric Stimulation;Elements;Ethanol;extracellular;Frequencies;Future;Galantamine;Ganglia;Goals;Habits;Individual;Intake;interest;Intoxication;Investigation;Laboratories;Learning;Lobular Neoplasia;Measures;Mediating;Midbrain structure;Mus;neural;neural circuit;neuroadaptation;Neuromodulator;neuronal circuitry;Neurons;neuroregulation;Neurosciences;Nicotinic Antagonists;nicotinic receptor beta2;Nicotinic Receptors;Nucleus Accumbens;Parkinson Disease;Pattern;Periodicity;Photometry;Physiologic pulse;Physiological;Physiology;Play;presynaptic;Presynaptic Terminals;Procedures;Process;Prosencephalon;PubMed;receptor;Receptor Activation;Receptor Inhibition;Research;Research Personnel;response;Role;Scanning;sensor;Slice;Stimulus;substance misuse;Synapses;Synaptic Transmission;System;Technology;Thalamic structure;Ventral Striatum,"Synaptic Transmission: Modulation, Plasticity And Effects Of Drugs Of Abuse",407,NA,NA,NA,NA,23,NA,NA,2496469,NA
11191859,ZIA,AA,1,N,NA,NA,NA,NA,ZIAAA000411,NA,NA,1ZIAAA000411-21,NIAAA:3139828\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM,NA,NA,NA,8175384 (contact),"HOLMES, ANDREW  (contact)",NA,NA,NA,addiction;alcohol effect;alcohol exposure;alcohol misuse;alcohol seeking behavior;alcohol use disorder;Alcohols;Amygdaloid structure;Animal Model;antagonist;Anxiety;Anxiety Disorders;anxiety reduction;Area;Behavior;Behavior Control;Behavioral;behavioral impairment;Binding;Biological Models;Brain;Chronic;Clinical;CNR1 gene;Cognitive;cognitive performance;Collaborations;comorbidity;Corpus striatum structure;cortico-limbic circuits;Data;design;Discrimination Learning;Dorsal;Drug Delivery Systems;Emotional disorder;Endocannabinoids;Enzymes;executive function;experience;experimental study;Exposure to;Extinction;fatty acid amide hydrolase;foot;Fostering;Fright;Genetic;Genetic Engineering;Genetic study;Genomics;Goals;Human;Impairment;improved;Individual;Individual Differences;inter-individual variation;interest;Interneurons;Laboratories;Laboratory mice;Learning;Lesion;Measures;Mediating;Mental Depression;mouse model;Mouse Strains;Mus;mutant;neglect;neural;neural circuit;Neurons;neuropsychiatric disorder;Neurosciences;novel;novel therapeutics;Pattern;Performance;Pharmaceutical Preparations;Pharmacology;Play;Post-Traumatic Stress Disorders;Prefrontal Cortex;Prevention;Procedures;programs;psychological trauma;Punishment;Recovery;Research;resilience;Reversal Learning;Rewards;Risk;Role;Scheme;Shock;Stimulus;Stress;stress disorder;substance misuse;Substance Use Disorder;System;Testing;Therapeutic;Training;Trauma;Trauma recovery;Work,Mouse models of stress disorders and addiction,411,NA,NA,NA,NA,21,NA,NA,3139828,NA
11191860,ZIA,AA,1,N,NA,NA,NA,NA,ZIAAA000416,NA,NA,1ZIAAA000416-19,NIAAA:2496469\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM,NA,NA,NA,7359471 (contact),"LOVINGER, DAVID M (contact)",NA,NA,NA,Acetylcholine;Acetylcholinesterase;Adult;Adult women;Affect;aged;Agonist;alcohol abuse therapy;Alcohol consumption;alcohol effect;alcohol exposure;alcohol use disorder;Alcohols;antagonist;Basal Ganglia;Behavior;Behavioral;Body Weight;Brain;Brain region;Breathing;cannabinoid drug;Caring;Cells;Child;cholinergic;Consumption;Control Groups;Corpus striatum structure;Deglutition;Development;Disease;Dopamine;drinking;Drug Design;drug misuse;Drug usage;Electric Stimulation;Electrophysiology (science);Enzymes;Event;Exhibits;experience;experimental study;Exposure to;Extinction;extracellular;Female;fetal;first grade;Future;Ganglia;Genetic;Goals;Grooming;habit learning;Habits;Health;Hormonal;Human;Impairment;improved;in vivo;Inhalation;Injections;interest;Interneurons;Lead;learned behavior;Learning;learning extinction;Learning Skill;Life;male;Maternal Behavior;Measures;Mediating;member;Midbrain structure;Modeling;Molecular;Mothers;Motor Skills;motor symptom;mouse model;Mus;neural circuit;Neurobiology;neuromechanism;Neuromodulator;Neurons;neuroregulation;Nicotinic Receptors;offspring;Operant Conditioning;Outcome;Performance;performance tests;Periodicity;postnatal;preference;Pregnancy;prenatal;Process;Public Health;pup;receptor;Receptor Activation;Regimen;response;Retrieval;Rewards;Rod;Role;Rotation;Scanning;sensor;sex;skills;Sleep;Sleep Architecture;Sleep disturbances;Slice;smoking cessation;social;Social Behavior;Social Interaction;Specificity;Speed;statistics;Stereotyping;Stimulus;Study Section;Substance Use Disorder;Symptoms;Synapses;Task Performances;Testing;therapy development;Third Pregnancy Trimester;Time;United States;varenicline;Weight;Women&apos;s Group,Corticostriatal mechanisms of action learning and habit formation,416,NA,NA,NA,NA,19,NA,NA,2496469,NA
11191861,ZIA,AA,1,N,NA,NA,NA,NA,ZIAAA000421,NA,NA,1ZIAAA000421-17,NIAAA:710446\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM,NA,NA,NA,9690770 (contact),"ALVAREZ, VERONICA A (contact)",NA,NA,NA,Absence of pain sensation;Affect;Agonist;alcohol behavior;alcohol use disorder;Behavioral;Behavioral Assay;Brain;cell type;Cells;Cocaine;cocaine related behaviors;cocaine self-administration;Cocaine use disorder;Compulsive Behavior;Corpus striatum structure;Cre-LoxP;Data;Development;Dopamine;Dopamine D2 Receptor;dopamine D3 receptor;dopaminergic neuron;DRD2 gene;drug action;drug misuse;Drug usage;Environment;Ethanol;Exploratory Behavior;Genetic;Globus Pallidus;Goals;Hyperactivity;In Situ Hybridization;In Vitro;in vivo;Individual;Intake;Knock-out;Laboratories;Locomotion;Mediating;mesolimbic system;Methods;Microdialysis;Midbrain structure;motivated behavior;mouse model;Mus;neural circuit;Neurobiology;Neurons;novel;Nucleus Accumbens;Opioid;optogenetics;Oxycodone;oxycodone self-administration;Pathway interactions;Periodicity;Pharmaceutical Preparations;Physiologic pulse;Physiology;Play;Population;postsynaptic;presynaptic;Psychological reinforcement;receptor;receptor expression;Research;response;Reverse Transcriptase Polymerase Chain Reaction;Rewards;Role;Scanning;Stimulant;substance misuse;Synapses;Techniques;tool,Synaptic mechanisms underlying reward seeking and compulsive drug use,421,NA,NA,NA,NA,17,NA,NA,710446,NA
11191862,ZIA,CL,1,N,NA,NA,NA,NA,ZIACL000910,NA,NA,1ZIACL000910-04,NA,INTRAMURAL RESEARCH,2024,CLINICAL CENTER,NA,NA,NA,NA,NA,NA,NA,NA,CLINICAL CENTER,NA,NA,NA,78359277 (contact),"FARMER, NICOLE  (contact)",NA,NA,NA,"Adult;Affect;African American;African American population;Baptist Church;Behavior;Behavior Therapy;Blood;Cardiovascular Diseases;cardiovascular disorder risk;cardiovascular risk factor;clinical center;Communities;Contracts;cooking;Data;Data Analyses;Data Collection;data management;design;Diet Habits;dietary;Disease;Eating;electronic consent;Electronics;Eligibility Determination;Evaluation;Event;Feasibility Studies;Focus Groups;Food;food security;Genetic Transcription;heart disease risk;Heart Diseases;Home;Hour;Intervention;Interview;Journals;Knowledge;Lead;Learning;Life Style;Location;Manuscripts;Medical History;Methodology;Modification;National Heart, Lung, and Blood Institute;National Institute of Diabetes and Digestive and Kidney Diseases;nutrition;Occupational Therapist;Paper;Participant;Patient Self-Report;Pattern;Pennsylvania;Phase;phase 2 study;Pilot Projects;Preparation;Procedures;Process;programs;Protocols documentation;Publishing;Questionnaires;recruit;Research;Research Personnel;Resources;Risk Factors;Risk Reduction;Sampling;Services;skills;Stress;Surveys;symposium;telehealth;Training;Transportation;United States National Institutes of Health;virtual;virtual group;Visit;ward;Washington",Dietary Behavior Intervention in African-Americans at Risk for Cardiovascular Disease,910,NA,NA,NA,NA,4,NA,NA,0,NA
11191863,ZIA,CL,1,N,NA,NA,NA,NA,ZIACL010536,NA,NA,1ZIACL010536-15,NA,INTRAMURAL RESEARCH,2024,CLINICAL CENTER,NA,NA,NA,NA,NA,NA,NA,NA,CLINICAL CENTER,NA,NA,NA,6480145 (contact),"WENDLER, DAVID S (contact)",NA,NA,NA,Address;Caring;clinical practice;Data;Decision Making;design;Emotional;emotional distress;experience;Face;Future;Goals;improved;interest;Interview;Medical;Medical Records;Methods;Patient Preferences;Patients;preference;Process;Research;shared decision making;surrogate decision making;Surveys;Work,Surrogate Decision Making,10536,NA,NA,NA,NA,15,NA,NA,0,NA
11191864,ZIA,CL,1,N,NA,NA,NA,NA,ZIACL010537,NA,NA,1ZIACL010537-11,NA,INTRAMURAL RESEARCH,2024,CLINICAL CENTER,NA,NA,NA,NA,NA,NA,NA,NA,CLINICAL CENTER,NA,NA,NA,6480145 (contact),"WENDLER, DAVID S (contact)",NA,NA,NA,Address;Adult;Area;Attention;Benefits and Risks;Biological;Caring;Child;Childhood;Clinical;clinical care;Clinical Research;Collaborations;Compensation;Computers;Data;design;Empirical Research;Enrollment;Ensure;Ethics;Evaluation;Exposure to;Goals;Guidelines;health care availability;Individual;Informed Consent;Institutional Review Boards;Intervention;Intuition;Life;Medical Research;Methods;minimal risk;National Institute of Child Health and Human Development;Organizational Ethics;Participant;participant enrollment;Pediatric Research;Pediatrics;Pregnant Women;Prisoner;Procedures;Publishing;Regulation;Research;Research Subjects;Risk;risk minimization;Safety;Sampling;Scientific Advances and Accomplishments;Specimen;Spinal Puncture;Systematic Bias;Testing;Vulnerable Populations;Work,Research and care with vulnerable individuals,10537,NA,NA,NA,NA,11,NA,NA,0,NA
11191865,ZIA,CL,1,N,NA,NA,NA,NA,ZIACL010538,NA,NA,1ZIACL010538-10,NA,INTRAMURAL RESEARCH,2024,CLINICAL CENTER,NA,NA,NA,NA,NA,NA,NA,NA,CLINICAL CENTER,NA,NA,NA,14280167 (contact),"KIM, SCOTT  (contact)",NA,NA,NA,Address;Architecture;Benefits and Risks;Canada;Clinical;Collaborations;comparative;comparative effectiveness trial;comparison intervention;Consent;Data;Data Collection;Decision Making;design;Dialysis procedure;electronic medical record system;Ethical Issues;Ethics;evidence base;Goals;Individual;Informed Consent;interest;Intervention;Methods;minimal risk;personalized decision;Pragmatic clinical trial;pragmatic trial;Procedures;Randomized;Research;Risk;standard of care;Testing;trial design;Work;working group,Ethics of Emerging RCT Designs: Risk analysis and informed consent,10538,NA,NA,NA,NA,10,NA,NA,0,NA
11191866,ZIA,CL,1,N,NA,NA,NA,NA,ZIACL010539,NA,NA,1ZIACL010539-10,NA,INTRAMURAL RESEARCH,2024,CLINICAL CENTER,NA,NA,NA,NA,NA,NA,NA,NA,CLINICAL CENTER,NA,NA,NA,14280167 (contact),"KIM, SCOTT  (contact)",NA,NA,NA,Agreement;analytical method;Assisted Suicide;Attitude;Canada;Caring;Categories;Country;Decision Making;end of life;end of life care;Ethical Issues;Ethicists;Euthanasia;Evaluation;Human Rights;Inequity;Injections;Interview;Knowledge;Laws;Lawyers;Legal;Life;Literature;Medical;Medical Assistance;Medicine;Methods;Modeling;Monitor;Nature;Netherlands;neuropsychiatry;Patients;Persons;Pharmaceutical Preparations;Philosophy;Physician-Assisted Suicides;Physicians;preference;Reporting;Resort;Role;Surveys;Terminal Disease;trend,"End of life decision-making, euthanasia, and physician assisted suicide in persons with neuropsychiatric conditions",10539,NA,NA,NA,NA,10,NA,NA,0,NA
11191867,ZIA,CL,1,N,NA,NA,NA,NA,ZIACL010541,NA,NA,1ZIACL010541-08,NA,INTRAMURAL RESEARCH,2024,CLINICAL CENTER,NA,NA,NA,NA,NA,NA,NA,NA,CLINICAL CENTER,NA,NA,NA,14280167 (contact),"KIM, SCOTT  (contact)",NA,NA,NA,Address;Adult;Affective;Benefits and Risks;cognitive enhancement;comparative effectiveness trial;Data;Decision Making;Drug usage;Emerging Technologies;Enhancers;Ethical Issues;experimental study;Government;Individual;Inequality;Informed Consent;Institution;Justice;Label;Logit Models;Medical Societies;Participant;Personal Satisfaction;Persons;Pharmacologic Substance;Physicians;Policy Making;Population;Publications;Reporting;Research Ethics;Risk;Sampling;side effect;social;Societies;Stimulant;therapeutic misconception;Universities,Issues in Research Ethics,10541,NA,NA,NA,NA,8,NA,NA,0,NA
11191868,ZIA,CL,1,N,NA,NA,NA,NA,ZIACL010542,NA,NA,1ZIACL010542-08,NA,INTRAMURAL RESEARCH,2024,CLINICAL CENTER,NA,NA,NA,NA,NA,NA,NA,NA,CLINICAL CENTER,NA,NA,NA,14280167 (contact),"KIM, SCOTT  (contact)",NA,NA,NA,Address;aging population;Area;Assisted Suicide;Attention;Awareness;Bioethics;Clinical;court;Dangerousness;Decision Making;decision-making capacity;Disputes;Eligibility Determination;Evaluation;Germany;Impaired cognition;Impairment;Intuition;Laws;Manuscripts;Mental Health;Persons;Prevalence;Published Comment;Publishing;Research;Review Literature;Risk;Role;Uncertainty,Decision-making capacity in clinical and research settings,10542,NA,NA,NA,NA,8,NA,NA,0,NA
11191869,ZIA,CL,1,N,NA,NA,NA,NA,ZIACL090095,NA,NA,1ZIACL090095-03,NA,INTRAMURAL RESEARCH,2024,CLINICAL CENTER,NA,NA,NA,NA,NA,NA,NA,NA,CLINICAL CENTER,NA,NA,NA,78359277 (contact),"FARMER, NICOLE  (contact)",NA,NA,NA,Adult;Affect;Ambulatory Care Facilities;amino acid metabolism;Area;Behavior;Blood Tests;chronic pain;Clinical;clinical center;Clinical Research;Data;data management;dietary;Dietary intake;Dietary Practices;DNA Sequence Alteration;electronic consent;Electronics;Enrollment;food environment;food insecurity;Genes;Goals;Health;Heart;Hematology;Hemoglobin;Inflammation;Informed Consent;Interview;Journals;Manuscripts;Nutrient;nutrition;Outpatients;Oxidative Stress;Participant;Pathway interactions;Patient Recruitments;Peer Review;Personal Satisfaction;Persons;pre-clinical;Procedures;Process;Protocols documentation;Provider;psychosocial;recruit;research study;Resources;Risk;Role;Services;Severity of illness;Sickle Cell Anemia;social health determinants;Stroke;Surveys;telehealth;Telemedicine;United States National Institutes of Health;Venous blood sampling;Visit,Observational Dietary Intake and Dietary Behvaiors among Adults Living with Sickle Cell Disease,90095,NA,NA,NA,NA,3,NA,NA,0,NA
11191870,ZIA,CL,1,N,NA,NA,NA,NA,ZIACL090104,NA,NA,1ZIACL090104-02,NA,INTRAMURAL RESEARCH,2024,CLINICAL CENTER,NA,NA,NA,NA,NA,NA,NA,NA,CLINICAL CENTER,NA,NA,NA,79338953 (contact),"ASADA, YUKIKO  (contact)",NA,NA,NA,Adolescent;Adult;Attention;Behavioral;Characteristics;Childhood;Country;Data;Data Collection;Decision Trees;Development;Disability status;Disadvantaged;Disparity population;Education;Ethics;Ethnic Origin;Floods;Gender;Health;health difference;Health Disparities Research;health disparity;health inequalities;Hot Spot;Immigration;Income;intersectionality;Label;Life Cycle Stages;Literature;Longitudinal Studies;Measurement;Measures;Methodology;Methods;Modeling;Morbidity - disease rate;multilevel analysis;National Longitudinal Survey of Adolescent to Adult Health;Outcome;Patient Self-Report;Persons;Population;psychosocial;Race;Reduce health disparities;Research;Sampling;secondary analysis;Sex Orientation;social;social group;Societies;socioeconomics;sound;Surveys;Time;tool;United States,Social group inequality and intersectionality,90104,NA,NA,NA,NA,2,NA,NA,0,NA
11191871,ZIA,CL,1,N,NA,NA,NA,NA,ZIACL090105,NA,NA,1ZIACL090105-02,NA,INTRAMURAL RESEARCH,2024,CLINICAL CENTER,NA,NA,NA,NA,NA,NA,NA,NA,CLINICAL CENTER,NA,NA,NA,79338953 (contact),"ASADA, YUKIKO  (contact)",NA,NA,NA,Affect;Articulation;Behavior;Childhood;Ethics;Exercise;Goals;Health;Health and Retirement Study;health equity;health inequalities;Individual;Inequality;Inequity;Mathematics;Measurement;Measures;Modeling;models and simulation;older adult;Play;Policies;Role;simulation;social group;Societies;socioeconomics;theories;United States,Egalitarianism and its empirical operationalization,90105,NA,NA,NA,NA,2,NA,NA,0,NA
11191872,ZIA,CL,1,N,NA,NA,NA,NA,ZIACL090106,NA,NA,1ZIACL090106-02,NA,INTRAMURAL RESEARCH,2024,CLINICAL CENTER,NA,NA,NA,NA,NA,NA,NA,NA,CLINICAL CENTER,NA,NA,NA,79338953 (contact),"ASADA, YUKIKO  (contact)",NA,NA,NA,Articulation;Assisted Suicide;Canada;Communities;Demographic Survey;design;Disadvantaged;Economics;Feedback;General Population;Health;Health Fairs;Health Policy;Health system;high risk;Hour;improved;Individual;insight;Laboratories;Laboratory Study;Learning;Life;Medical;member;Methodology;Methods;Participant;Persons;Philosophy;Pilot Projects;Play;Population;prevent;Resources;Running;Science;social;Social Concepts;social disparities;Societies;sociodemographics;socioeconomics;System;Techniques;theories;Thinking;United States;United States National Institutes of Health;Work,FairLab: Fairness Dialogues Field Laboratory,90106,NA,NA,NA,NA,2,NA,NA,0,NA
11191873,ZIA,CL,1,N,NA,NA,NA,NA,ZIACL090110,NA,NA,1ZIACL090110-01,NA,INTRAMURAL RESEARCH,2024,CLINICAL CENTER,NA,NA,NA,NA,NA,NA,NA,NA,CLINICAL CENTER,NA,NA,NA,79979520 (contact),"MAKI, KATHERINE  (contact)",NA,NA,NA,Alcohol consumption;alcohol use disorder;Assessment tool;Behavior assessment;Behavioral;Biological;Biological Markers;Blood specimen;clinical phenotype;cognitive interview;Data;Data Collection;data management;Dental;Dental Hygiene;Enrollment;feasibility testing;Goals;Health behavior;Heavy Drinking;Incidence;Individual;Infection;Inflammation;Institutional Review Boards;Measures;Oral;Oral health;Pathologic;Patients;Periodontal Diseases;Population;Process;Questionnaires;Research;Risk;saliva sample;Salivary;Signal Transduction;Stress;Systemic disease;systemic inflammatory response;Tooth Diseases,"Quantifying Associations of Stress and Inflammation-Associated Oral Biomarkers with Oral Health, Oral Health Behaviors, Systemic Biomarkers & Clinical Phenotype in Individuals with Alcohol Use Disorde",90110,NA,NA,NA,NA,1,NA,NA,0,NA
11191874,ZIA,CL,1,N,NA,NA,NA,NA,ZIACL090112,NA,NA,1ZIACL090112-01,NA,INTRAMURAL RESEARCH,2024,CLINICAL CENTER,NA,NA,NA,NA,NA,NA,NA,NA,CLINICAL CENTER,NA,NA,NA,79338953 (contact),"ASADA, YUKIKO  (contact)",NA,NA,NA,Canada;Data;Eligibility Determination;Financial Hardship;health care service;Health Services;Health Services Accessibility;Link;Medial;Medical Assistance;meetings;Netherlands;Newspapers;Paper;Persons;programs;Publishing;Radio;Reporting;Resources;Service provision;Social Work;standard care;Wait Time,Medical assistance in dying and health services access in Canada,90112,NA,NA,NA,NA,1,NA,NA,0,NA
11191875,ZIA,DE,1,N,NA,NA,NA,NA,ZIADE000101,NA,NA,1ZIADE000101-21,NIDCR:2033164\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH,NA,NA,NA,8153686 (contact),"CHEN, WANJUN  (contact)",NA,NA,NA,Animal Model;Antigens;Apoptosis;Apoptotic;Attention;Autoimmune Diseases;autoimmune inflammation;Autoimmunity;Basic Science;Cells;Communicable Diseases;Dendritic Cells;design;Development;Disease;FOXP3 gene;Generations;Genes;Genetically Engineered Mouse;Glycolysis;Goals;human disease;IL2RA gene;Immune Tolerance;Immunity;Immunosuppression;Inflammation;Insulin-Dependent Diabetes Mellitus;interest;intraepithelial;Knockout Mice;Knowledge;Lymphocyte;Lymphoid;Lymphoid Tissue;Macrophage;malignant mouth neoplasm;Malignant Neoplasms;Mannose;Mediating;Metabolism;Mission;Molecular;mouse model;Mucous Membrane;National Institute of Dental and Craniofacial Research;Oral cavity;Oral mucous membrane structure;Pathogenesis;Pathway interactions;Peptides;Peripheral;Play;Production;Pulmonary Inflammation;Regulation;Regulatory T-Lymphocyte;Research;Role;Sepsis;Signal Transduction;System;T cell regulation;T-Lymphocyte;Therapeutic Intervention;Thymus Gland;Time;transcription factor;Transforming Growth Factor beta;Transforming Growth Factor beta Receptors;tumor;wound healing,TGF-beta Regulation of Mucosal and Systemic T Cell Immunity and Tolerance,101,NA,NA,NA,NA,21,NA,NA,2033164,NA
11191876,ZIA,DE,1,N,NA,NA,NA,NA,ZIADE000524,NA,NA,1ZIADE000524-34,NIDCR:409388\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH,NA,NA,NA,9415013 (contact),"YAMADA, KENNETH  (contact)",NA,NA,NA,3-Dimensional;Actins;Address;Adhesives;Binding Sites;Biochemical;Biological Models;biophysical properties;cancer cell;Cell Adhesion;Cell Adhesion Molecules;Cell Communication;cell motility;Cell-Cell Adhesion;Cells;Cellular biology;Chimera organism;Chimeric Proteins;Chondrocytes;collagenase 3;Complement;Complex;Conflict (Psychology);Cytoskeletal Proteins;Cytoskeleton;Degenerative polyarthritis;Disease;ECM receptor;Embryonic Development;Environment;Extracellular Matrix;Extracellular Matrix Proteins;Fascia;Feedback;Fibronectins;Funding;Future;Goals;Health;Human;Human Development;In Vitro;Integrin alpha5beta1;Integrins;Invaded;Lead;Malignant Neoplasms;Mammalian Cell;Manuscripts;Matrix Metalloproteinases;Mediating;Mentors;Methods;Microscopy;migration;Molecular;Molecular Biology;Motor;Mus;mutant;Myosin Type II;non-muscle myosin;Normal Cell;novel strategies;Pathogenesis;Pathologic;paxillin;Peptide Hydrolases;Physiological;Play;polypeptide;Process;Production;Productivity;programs;Protein Isoforms;Proteins;receptor;Regenerative Medicine;Regulation;Research;Research Project Grants;response;Role;Signal Pathway;Signal Transduction;Source;Suggestion;synergism;System;Testing;Tissue Engineering;two-photon,Cell-Matrix Interactions and Migration,524,NA,NA,NA,NA,34,NA,NA,409388,NA
11191877,ZIA,DE,1,N,NA,NA,NA,NA,ZIADE000525,NA,NA,1ZIADE000525-34,NIDCR:682313\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH,NA,NA,NA,9415013 (contact),"YAMADA, KENNETH  (contact)",NA,NA,NA,3-Dimensional;Acinar Cell;Acinus organ component;Address;Adhesives;Apical;Architecture;Basement membrane;Cell Adhesion;cell motility;Cell Transplantation;cell type;Cell-Cell Adhesion;Cell-Matrix Junction;Cells;Characteristics;Collaborations;Complex;craniofacial;craniofacial development;craniofacial tissue;Cytoskeleton;Deposition;Development;Disease;Drosophila genus;egg;Electron Microscopy;Embryo;embryo cell;Embryonic Development;Endoplasmic Reticulum;Epithelial Cells;Epithelium;experimental study;Fibroblasts;Fluorescent in Situ Hybridization;Gene Expression;Gene Expression Alteration;Gene Expression Profile;gene induction;Genes;Gland;Goals;Golgi Apparatus;Image;Immunofluorescence Immunologic;in vivo;Integrins;Intramural Research;Kinesin;Laboratories;Location;Maintenance;Mammalian Cell;Mediating;membrane assembly;Membrane Proteins;Mesenchymal;Mesenchyme;Messenger RNA;Methods;Microscopy;Microtubules;Molecular;Morphogenesis;Motor;Mucous body substance;Mus;Muscle;Myoepithelial;Myoepithelial cell;National Institute of Dental and Craniofacial Research;Neural Crest;novel;Organ;organ growth;Parotid Gland;Positioning Attribute;Process;Production;Protein Biosynthesis;Proteins;Recording of previous events;Regulation;Research;restoration;RNA;Role;Salivary;Salivary Glands;Signal Transduction;single molecule;single-cell RNA sequencing;Site;Specificity;stem cells;Switch Genes;System;Testing;Tissue Engineering;Tissue Recombination;Tissue Transplantation;Tissues;transcriptomics;Ubiquitination;Vesicle;Writing,Craniofacial Developmental Dynamics,525,NA,NA,NA,NA,34,NA,NA,682313,NA
11191878,ZIA,DE,1,N,NA,NA,NA,NA,ZIADE000561,NA,NA,1ZIADE000561-32,NIDCR:1798530\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH,NA,NA,NA,6480473 (contact),"RYBA, NICHOLAS J (contact)",NA,NA,NA,Animals;Behavior;Biology;bone;Brain;Cells;Code;Complex;craniofacial;Detection;detection platform;Discrimination;Electrophysiology (science);Environment;Esthesia;Eye;Face;Genetic;Goals;imaging approach;Individual;Inflammation;Injury;Logic;Meninges;Molecular;Muscle;Nasal cavity;Oral cavity;Pain;Pathway interactions;Peripheral;Physiological;Receptor Cell;response;Response to stimulus physiology;Sensory;sensory input;sensory stimulus;Signal Transduction;Skin;somatosensory;Specificity;Stimulus;Surface;System;Taste Perception;Tooth structure;Touch sensation;Work,Sensory Biology,561,NA,NA,NA,NA,32,NA,NA,1798530,NA
11191879,ZIA,DE,1,N,NA,NA,NA,NA,ZIADE000664,NA,NA,1ZIADE000664-29,NIDCR:1123168\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH,NA,NA,NA,9693106 (contact),"KULKARNI, ASHOK  (contact)",NA,NA,NA,Ablation;Acidity;Action Potentials;addiction;Adult;Affect;Afferent Neurons;allodynia;Analgesics;Animal Experiments;Animal Model;Back;Behavior;behavior test;Behavioral;behavioral response;behavioral study;Biochemical;Calcium;calcium indicator;Candidate Disease Gene;Capsaicin;Categories;Cell Death Process;cell injury;Cells;Chemical Injury;Chemicals;chronic neuropathic pain;chronic pain;chronic painful condition;Cinnamon - dietary;Clinical;Clustered Regularly Interspaced Short Palindromic Repeats;cohort;Collaborations;Consultations;cost;Coupled;craniofacial development;CRISPR/Cas technology;Cyclin-Dependent Kinase 5;Cyclin-Dependent Kinase Inhibitor;Detection;Development;Devices;Diabetes Mellitus;Diabetic Neuralgia;differential expression;Disease;Distal;endoplasmic reticulum stress;Engineering;Environment;Enzymes;Etiology;Exhibits;experience;Face;Fire - disasters;foot;functional genomics;Ganglia;gene editing technology;Gene Expression;Gene Expression Regulation;gene-editing approach;Genes;genetic signature;Genetically Engineered Mouse;Goals;Green Fluorescent Proteins;Hand;Heart Diseases;Human;Hyperactivity;Hyperalgesia;Hyperglycemia;Hypersensitivity;Image;Immune response;in vivo;Individual;Inflammation;inflammatory pain;Ion Channel;Kinetics;Knock-out;Length;Light;Limb structure;Long term disability;Malignant Neoplasms;mammalian genome;Metabolic;metabolomics;Mitochondria;Molecular;mouse genome;mouse model;multiple omics;Mus;mustard oil;Nervous System Physiology;Neurodegenerative Disorders;neurodevelopment;neuron loss;neuronal cell body;neuronal excitability;Neuronal Injury;Neuronal Plasticity;Neurons;Neuropathy;neurophysiology;neurotransmitter release;Nociception;Nociceptors;non-diabetic;Non-Insulin-Dependent Diabetes Mellitus;Non-Steroidal Anti-Inflammatory Agents;Olfactory Nerve;Opioid;Oral health;Organ Donor;orofacial;Orofacial Pain;overexpression;Oxidative Stress;Pain;Pain Measurement;Pain Research;pain sensitivity;pain signal;painful neuropathy;Paper;patch clamp;Pathway Analysis;Pathway interactions;Patients;Persistent pain;Phosphorylation;Phosphotransferases;Plants;Play;Process;Productivity;Property;Proteomics;Publishing;Quality of life;receptor;Refractory;Reporting;Research;Research Project Grants;response;Rheumatoid Arthritis;Rodent;Rodent Model;Role;Sampling;sensor;Signal Pathway;Signal Transduction;Societies;Spinal Cord;Spinal Ganglia;Stimulus;Structure;Structure of trigeminal ganglion;success;Techniques;Testing;tissue injury;Tissues;transcriptome;transcriptomics;Transgenic Mice;Transgenic Organisms;Trigeminal nerve structure;TRP channel;TRPV1 gene;Up-Regulation;Visualization;Work,Characterization of Molecular Pathways in Chronic Pain Conditions,664,NA,NA,NA,NA,29,NA,NA,1123168,NA
11191880,ZIA,DE,1,N,NA,NA,NA,NA,ZIADE000695,NA,NA,1ZIADE000695-25,NIDCR:2426071\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH,NA,NA,NA,15711687 (contact),"CHIORINI, JAY  (contact)",NA,NA,NA,adeno-associated viral vector;Antinuclear Antibodies;Apoptosis;Apoptotic;AQP1 gene;aquaporin 5;Autoantibodies;Autoantigens;Autoimmune;Autoimmune Responses;Autoimmunity;Biology;Biopsy;Cannulations;Caspase;Cathepsins B;Cell Communication;Cell Culture Techniques;Cell Death;Cell Death Induction;Cell Physiology;Cells;Characteristics;Chloroquine;Chronic;Clinical;Complex;computerized tools;Data Set;Dependovirus;Development;differential expression;Disease;effective therapy;Epithelial Cells;Epithelium;Estradiol;Event;experimental study;Exposure to;extracellular;extracellular vesicles;Female;fodrin;Functional disorder;functional genomics;Future;G-Protein-Coupled Receptors;Gene Expression;Gene Expression Regulation;gene therapy;Gene Transfer;gene transfer vector;Genes;Gland;gland development;Goals;Gonadal Steroid Hormones;Human;Hydroxychloroquine;Hypergammaglobulinemia;image visualization;improved;In Vitro;indexing;Induction of Apoptosis;Liquid substance;live cell imaging;Lysosomes;male;Mediating;Membrane;Membrane Proteins;Messenger RNA;Methods;Minor salivary gland structure;Modeling;Molecular;mouse model;Movement;mRNA Expression;Mus;novel strategies;novel therapeutics;Orphan;Other Genetics;overexpression;particle;Pathogenicity;Pathway interactions;patient response;patient stratification;patient subsets;Patients;personalized medicine;Pharmaceutical Preparations;Phenotype;Play;prevent;Production;Proteins;Proteomics;Reagent;Recombinants;response;Role;saliva secretion;Salivary;Salivary Glands;Sampling;Satellite Viruses;Serotyping;Serum;Severities;Sex Bias;Sialadenitis;Sjogren&apos;s Syndrome;Sodium-Potassium-Chloride Symporters;Subgroup;Symptoms;Syndrome;Testing;Therapeutic;Therapeutic Intervention;tool;transcriptomic profiling;transcriptomics;Transfection;Transgenic Mice;Tropism;uptake;vector;Virus;Work;Xerostomia,Adeno-associated Virus Biology And Utilization For Gene Transfer,695,NA,NA,NA,NA,25,NA,NA,2426071,NA
11191881,ZIA,DE,1,N,NA,NA,NA,NA,ZIADE000699,NA,NA,1ZIADE000699-25,NIDCR:1942173\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH,NA,NA,NA,6790860 (contact),"BUGGE, THOMAS H (contact)",NA,NA,NA,Acute;Alveolar Macrophages;Animal Model;Antifibrinolytic Agents;Bacteria;Binding;Biochemistry;Biology;Blood Coagulation Disorders;Blood Vessels;canine model;Canis familiaris;CD36 Antigens;Cell surface;Cells;Chinese Hamster Ovary Cell;Chronic;Clinical;Coagulation Process;Collaborations;Collagen;Collagen Receptors;Collectins;crosslink;Data;Denmark;Deposition;Development;Encapsulated;Endocytosis;Enzyme Precursors;Epithelium;experimental study;Extracellular Matrix;Extracellular Matrix Degradation;Extracellular Matrix Proteins;Factor XIII;Family;Family member;Fibrin;Fibrinogen;Fibrinolysis;Fibrinolytic Agents;Fibronectins;Glycoproteins;Health;Hemophilia A;Hemorrhage;Hemostatic Agents;Hemostatic function;Homologous Gene;Immobilization;improved;Incidence;Inflammatory;Injury;interest;knock-down;Lectin;Ligands;lipid nanoparticle;Liquid substance;Lung;lung injury;Macrophage;Malignant - descriptor;Malignant Neoplasms;mannose receptor;medical schools;member;Membrane Glycoproteins;Modeling;mouse model;Mus;Natural regeneration;novel;Operative Surgical Procedures;oral tissue;Pathologic;Pathology;Pathway interactions;Pattern recognition receptor;Peptide Hydrolases;Periodontal Diseases;Phenotype;Pilot Projects;Plasmin;Plasminogen;polymerization;Polymers;prevent;Proteins;Proteolysis;Proteomics;receptor;receptor function;Recombinants;Recurrence;Regulation;Research;Residual state;response;Saphenous Vein;Small Interfering RNA;stem;Therapeutic;Thrombin;Thrombolytic Therapy;Thrombospondin 1;thrombospondin 4;Thrombospondins;tissue injury;tissue regeneration;tissue repair;Tranexamic Acid;Transfection;triple helix;Universities;uptake;Urokinase Plasminogen Activator Receptor;Wild Type Mouse;Wisconsin,"Cell surface proteolysis in development, tissue repair, and malignancy",699,NA,NA,NA,NA,25,NA,NA,1942173,NA
11191882,ZIA,DE,1,N,NA,NA,NA,NA,ZIADE000714,NA,NA,1ZIADE000714-20,NIDCR:1582395\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH,NA,NA,NA,6091819 (contact),"MEZEY, EVA M. (contact)",NA,NA,NA,adult stem cell;Affect;Anemia;Autoimmune;Blood Cells;bone;Bone Marrow;Bone Marrow Cells;Bone Marrow Stem Cell;cancer therapy;Cartilage;Cell Lineage;Cell Separation;Cells;chemotherapy;Clinic;Disease;Environment;Erythrocytes;Fatty acid glycerol esters;fighting;follow-up;Growth Factor;healing;healthy volunteer;Hematopoiesis;Hematopoietic stem cells;Human;Immune;immune function;Immune system;immunoregulation;In Vitro;Inflammatory;Infusion procedures;interest;Iron;Knowledge;Learning;Leukocytes;Mesenchymal Stem Cells;Mus;novel therapeutics;Organ;Patients;Persons;Pharmaceutical Preparations;Population;Production;Radiation therapy;skeletal stem cell;Stromal Cells;System;Therapeutic;tissue culture;tissue regeneration;tissue repair,"Contribution of bone marrow cells to tissue regeneration, immune function and hematopoiesis",714,NA,NA,NA,NA,20,NA,NA,1582395,NA
11191883,ZIA,DE,1,N,NA,NA,NA,NA,ZIADE000718,NA,NA,1ZIADE000718-18,NIDCR:272926\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH,NA,NA,NA,9415013 (contact),"YAMADA, KENNETH  (contact)",NA,NA,NA,3-Dimensional;Actomyosin;Address;Adult;Antigen-Presenting Cells;Architecture;Basement membrane;Biochemical;Biophysics;cancer cell;Cell Adhesion;Cell Communication;Cell Culture Techniques;cell type;Cell-Matrix Junction;Cells;Collagen;Collagen Fibril;Collagen Type I;Complex;Confocal Microscopy;Dimensions;Embryonic Development;Encapsulated;Environment;Epithelial Cells;Event;Extracellular Matrix;Fibrillar Collagen;Fibroblasts;Fibronectins;Focal Adhesions;Gel;Genes;Goals;Homeostasis;Human;In Vitro;in vivo;insight;Integrin alpha2beta1;Integrin alpha5beta1;Integrins;interstitial;Invaded;Lateral;Macrophage;Malignant Neoplasms;Mammalian Cell;Mediating;migration;Modeling;Morphogenesis;Morphology;Motility;Mouse Cell Line;Nature;Neoplasm Metastasis;novel;Organ;Pathologic;Perforation;Play;Process;Property;Publishing;Recording of previous events;response;Role;Signal Transduction;spheroids;System;tissue culture;Tissue Engineering;Tissues;tumor;two-dimensional;Visualization;wound healing,Matrix Organization and Dimensionality,718,NA,NA,NA,NA,18,NA,NA,272926,NA
11191884,ZIA,DE,1,N,NA,NA,NA,NA,ZIADE000719,NA,NA,1ZIADE000719-18,NIDCR:2042071\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH,NA,NA,NA,9415013 (contact),"YAMADA, KENNETH  (contact)",NA,NA,NA,3-Dimensional;Actins;Adhesions;articular cartilage;Basement membrane;cancer cell;cartilage degradation;Cartilage Matrix;Cell Adhesion;cell behavior;Cell Communication;Cell surface;Cell Surface Receptors;Cells;Chondrocytes;Collaborations;Collagen;collagenase 3;Complement;Connective Tissue;Cytoskeleton;Degenerative Disorder;Degenerative polyarthritis;Dental Faculty;Development;Diagnostic;Disease;Early Endosome;Embryonic Development;Encapsulated;Endosomes;Environment;Enzymes;extracellular;Extracellular Matrix;Extracellular Matrix Proteins;Feedback;Fibronectins;Goals;Growth Factor;Head and Neck Cancer;Homeostasis;Human;In Vitro;in vivo;Integrin alpha5beta1;Integrins;Invaded;Joints;Length;Malignant - descriptor;Malignant Neoplasms;Matrix Metalloproteinases;Mediating;Mediator;Medicine;Microtubules;Modeling;Molecular;Morphogenesis;Myosin Type II;Neoplasm Metastasis;Normal Cell;novel;Oral health;Organelles;Oxidation-Reduction;pain receptor;pain signal;Pathogenesis;Pathologic;Pathologist;Patients;Peptide Hydrolases;Perforation;Phosphotransferases;polypeptide;prevent;Production;Protein Fragment;Proteins;Radiation;Radiation therapy;Reactive Oxygen Species;Recycling;Regulatory Pathway;Research;Research Project Grants;response;Role;Salivary Glands;Signal Induction;Signal Transduction;spheroids;Therapeutic;therapy development;Thinness;Tissues;trafficking;transcriptome sequencing;Tumor Cell Invasion;Universities;Vesicle;Xerostomia,Cell-Surface Interactions in Pathogenesis,719,NA,NA,NA,NA,18,NA,NA,2042071,NA
11191885,ZIA,DE,1,N,NA,NA,NA,NA,ZIADE000737,NA,NA,1ZIADE000737-04,NIDCR:677722\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH,NA,NA,NA,8153686 (contact),"CHEN, WANJUN  (contact)",NA,NA,NA,Animal Model;Antigens;Apoptosis;Autoimmune Diseases;autoimmune pathogenesis;Autoimmunity;Cells;Cellular Metabolic Process;Chronic;Development;Disease;effector T cell;Experimental Animal Model;Experimental Models;Future;Goals;Homeostasis;immune function;Immune response;Immune system;Immune Tolerance;Immunity;Immunotherapy;Inflammation;Knowledge;Macrophage;Malignant Neoplasms;Metabolic syndrome;Metabolism;microbiota;mucosal microbiota;Oral cavity;Pathogenesis;Patients;prevent;Regulation;Regulatory T-Lymphocyte;Role;T-Lymphocyte;Therapeutic;Transforming Growth Factor beta;Translating;Tumor Antigens,"Immunotherapy of  inflammation, autoimmune disease and cancer",737,NA,NA,NA,NA,4,NA,NA,677722,NA
11191886,ZIA,DE,1,N,NA,NA,NA,NA,ZIADE000739,NA,NA,1ZIADE000739-13,NIDCR:944623\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH,NA,NA,NA,1866772 (contact),"TABAK, LAWRENCE A. (contact)",NA,NA,NA,Ablation;Acetylgalactosamine;Animals;Biological Process;Biology;Chemicals;Classification;Complex;Computer software;Congenital Disorders;Consensus;Core Protein;Development;differential expression;Dissociation;Electron Transport;Event;Family;GALNT3 gene;Genes;Glycoproteins;glycoproteomics;glycosylation;glycosyltransferase;Goals;Golgi Apparatus;Individual;Ions;Isoenzymes;Knockout Mice;Laboratories;Link;Maps;metabolic phenotype;mineralization;Molecular;mouse model;Mucins;Mus;Oligosaccharides;Ontology;Phenocopy;Phenotype;Phosphorylation Site;polypeptide;Polypeptide N-acetylgalactosaminyltransferase;Post-Translational Protein Processing;Proteins;Proteomics;Regulation;Serine;sexual dimorphism;Site;Structure;Sublingual Gland;Submandibular gland;sugar;Threonine;Tissues;Tn antigen;Transferase;Whole Blood;Work,Structure and Function of UDP-GalNAc:polypeptide alpha-GalNAc transferases,739,NA,NA,NA,NA,13,NA,NA,944623,NA
11191887,ZIA,DE,1,N,NA,NA,NA,NA,ZIADE000747,NA,NA,1ZIADE000747-09,NIDCR:1939380\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH,NA,NA,NA,14755673 (contact),"MAYS, JACQUELINE  (contact)",NA,NA,NA,2019-nCoV;academic review;Acinus organ component;Affect;Allogenic;Autoimmune;Biological Assay;care providers;Cells;Chilblains;chronic graft versus host disease;clinical care;clinical center;Clinical Trials;Collaborations;Conduct Clinical Trials;COVID-19;curative treatments;Dental Care;Dermatology;Development;Diagnosis;Diffuse;Disease;Duct (organ) structure;Environment;Evaluable Disease;fecal microbiome;Fibrosis;Functional disorder;Goals;Hematologic Neoplasms;Hematopoietic Stem Cell Transplantation;human model;Immune;Immune response;Immunobiology;Immunocompromised Host;Infiltration;Interferon Type I;Intervention;Investigation;Laboratory Study;Lesion;Link;longitudinal analysis;Lymphocyte Subset;Lymphocytic Infiltrate;metagenomic sequencing;Methods;mouse model;Mucous Membrane;Multi-Institutional Clinical Trial;National Institute of Dental and Craniofacial Research;Oral;oral care;Oral cavity;Oral Examination;Oral health;oral microbiome;Oral mucous membrane structure;Organ;pandemic disease;Parents;Pathogenesis;Pathogenicity;Pathologic;Patient advocacy;Patient Education;Patients;photobiomodulation;Physiological;Population;post-transplant;Process;Publishing;Quality of life;randomized placebo controlled trial;Research;Salivary Gland Diseases;Salivary Glands;Sampling;SARS-CoV-2 exposure;screening;Site;skin lesion;Streptococcus salivarius;System;targeted treatment;therapeutic target;Tissue Transplantation;Toes;tool;Translating;Transplant Recipients;Transplantation;United States National Institutes of Health;Veillonella parvula;viral RNA;Virus;Work,Immunobiology and therapy of oral mucosal and salivary gland chronic graft-versus-host disease,747,NA,NA,NA,NA,9,NA,NA,1939380,NA
11191888,ZIA,DE,1,N,NA,NA,NA,NA,ZIADE000749,NA,NA,1ZIADE000749-07,NIDCR:2268776\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH,NA,NA,NA,15711690 (contact),"WERNER, ACHIM  (contact)",NA,NA,NA,"Affect;Age;Anterior;autoinflammation;autoinflammatory;autoinflammatory diseases;Automobile Driving;Biochemical;Blood;Brain;CDC42 gene;Cell Differentiation process;Cell Fate Control;Cell Nucleus;Cells;Chick Embryo;Clinical;clinical investigation;Collaborations;Complex;craniofacial;craniofacial development;CUL3 gene;Cytoplasm;Cytoskeleton;Data;Defect;Development;developmental disease;Disease;Dissection;Ectoderm;Ectoderm Cell;Embryonic Development;Ensure;Enzymes;Future;Genetic;Genetic Transcription;Genotype;Goals;Head;Hematological Disease;Hematopoietic;Hematopoietic stem cells;High Prevalence;Human Development;human disease;human embryonic stem cell;Human Genetics;imaging approach;induced pluripotent stem cell;Inflammatory;inhibitor;insight;Lead;Ligation;Link;Malignant neoplasm of lung;member;men;Missense Mutation;Modeling;Molecular;Monomeric GTP-Binding Proteins;Morphology;Mutation;National Institute of Arthritis, and Musculoskeletal, and Skin Diseases;Neural Crest;Neural tube;Neural Tube Closure;Neurons;never smoker;novel;novel therapeutic intervention;p21 activated kinase;Pathogenesis;Pathogenicity;Pattern;Post-Translational Protein Processing;programs;Property;Protein Isoforms;Proteins;Proteomics;Regulation;Reporting;Research;Role;screening;self-renewal;Signal Pathway;Signal Transduction;Site;Skeleton;Skin;Somatic Mutation;Spinal Muscular Atrophy;stem cells;Syndrome;Therapeutic;Translations;Ubiquitin;ubiquitin ligase;Ubiquitin-Activating Enzymes;Ubiquitination;Vacuole;Variant;X Chromosome",Ubiquitin-dependent cell-fate decisions during human development and disease,749,NA,NA,NA,NA,7,NA,NA,2268776,NA
11191889,ZIA,DE,1,N,NA,NA,NA,NA,ZIADE000754,NA,NA,1ZIADE000754-05,NIDCR:734097\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH,NA,NA,NA,77827445 (contact),"SAMARA, NADINE  (contact)",NA,NA,NA,Acetylgalactosamine;Active Sites;Affect;Alternative Splicing;Binding;Biochemical;biochemical tools;C-terminal;CA-15-3 Antigen;Catalysis;Catalytic Domain;Charge;Collaborations;college;Colorectal Cancer;Computing Methodologies;Development;developmental disease;Drosophila melanogaster;Enzymes;Epithelium;Family;flexibility;follow-up;Functional disorder;GALNT12 gene;Glycopeptides;Glycoproteins;glycoproteomics;glycosylation;Goals;Golgi Apparatus;Human;in vivo;Infection;Isoenzymes;Lectin;London;Malignant Neoplasms;Membrane;microbiota;Modeling;Modification;Morphology;Mucins;Mucous body substance;Mutation;National Institute of Allergy and Infectious Disease;National Institute of Dental and Craniofacial Research;Nervous System Disorder;Pathogenesis;Patients;Peptides;Polypeptide N-acetylgalactosaminyltransferase;preference;Property;Protein Isoforms;Proteins;Publishing;recruit;Regulation;RNA Splicing;Roentgen Rays;Role;Salivary Glands;Secretory Vesicles;Specificity;structural biology;Structure;Substrate Specificity;Testing;Toxoplasma gondii;Work,Structural and functional studies of polypeptide N-acetylgalactosaminyltransferases (GalNAc-Ts),754,NA,NA,NA,NA,5,NA,NA,734097,NA
11191890,ZIA,DE,1,N,NA,NA,NA,NA,ZIADE000755,NA,NA,1ZIADE000755-05,NIDCR:279246\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH,NA,NA,NA,6091819 (contact),"MEZEY, EVA M. (contact)",NA,NA,NA,Anatomy;Blood Vessels;Brain;brain parenchyma;Cells;Central Nervous System;Connective Tissue Cells;COVID-19;Cranial Nerves;Data;Elements;glossopharyngeal;Goals;Human;Infection;interstitial;Journals;Lymph;Lymphatic;Lymphatic Endothelial Cells;Lymphatic Endothelium;Lymphatic System;lymphatic vessel;Maps;Meninges;Mus;Nerve;Nervous System;Oral cavity;oral pathogen;Pathway interactions;Patients;Peripheral;Process;Publishing;Respiratory Center;Respiratory physiology;Route;Site;System;Travel;Trigeminal System;Vascular Endothelial Cell;Virus;Waste Products;wasting,Lymphatic endothelial marker positive cells in the mouse and human nervous system,755,NA,NA,NA,NA,5,NA,NA,279246,NA
11191891,ZIA,DE,1,N,NA,NA,NA,NA,ZIADE000757,NA,NA,1ZIADE000757-05,NIDCR:1520113\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH,NA,NA,NA,77834422 (contact),"LIU, YUANYUAN  (contact)",NA,NA,NA,Acquired Immunodeficiency Syndrome;Affect;Brain;Brain region;central sensitization;chronic pain;Clinical;Communicable Diseases;Communication;design;Disinhibition;Dissection;Electrophysiology (science);Herpes zoster disease;Hypersensitivity;Imaging Techniques;Light;mechanical allodynia;Medicine;Metabolic;Mind;mind/body;Mission;Nature;neural;neural circuit;Neurons;Neuropathy;Nociception;novel therapeutic intervention;Pain;Pain management;painful neuropathy;Pathway interactions;Patients;Pattern;Perception;Peripheral;Peripheral Nerves;Signal Transduction;single cell sequencing;somatosensory;Specificity;Spinal Cord;Tactile;transmission process;Trauma;Viral,Somatosensation and pain,757,NA,NA,NA,NA,5,NA,NA,1520113,NA
11191892,ZIA,DE,1,N,NA,NA,NA,NA,ZIADE000760,NA,NA,1ZIADE000760-04,NIDCR:977072\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH,NA,NA,NA,77827445 (contact),"SAMARA, NADINE  (contact)",NA,NA,NA,adverse pregnancy outcome;Anabolism;Antibiotic Resistance;Biochemical;bioinformatics tool;Biological;Code;Colorectal Cancer;Communities;Disease;dysbiosis;Environment;Enzyme Inhibition;Enzymes;Genetic;Genome;glycosylation;glycosyltransferase;Link;Methods;Microbial Biofilms;microbial community;microorganism;Mouth Diseases;Nucleic Acids;Operon;oral bacteria;oral biofilm;oral microbiome;Pathway interactions;Periodontitis;Polysaccharides;prevent;Proteins;Role;Systemic disease,Characterizing exopolysaccharide (EPS) biosynthesis pathways in oral biofilm,760,NA,NA,NA,NA,4,NA,NA,977072,NA
11191893,ZIA,DE,1,N,NA,NA,NA,NA,ZIADE000761,NA,NA,1ZIADE000761-04,NIDCR:728925\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH,NA,NA,NA,77827445 (contact),"SAMARA, NADINE  (contact)",NA,NA,NA,Anabolism;Antibiotic Resistance;antimicrobial;Bacteria;Biochemical;Cells;design;Enzymes;fungus;glycosylation;glycosyltransferase;Goals;Immune Evasion;Immune response;inhibitor;interest;Knowledge;Microbe;microbial;pathogenic bacteria;pathogenic microbe;Pathogenicity;Polysaccharides;Protocols documentation;Role;Surface;Virulence Factors,Structural and functional studies of microbial O-glycosyltransferases that synthesize virulence factors,761,NA,NA,NA,NA,4,NA,NA,728925,NA
11191894,ZIA,DE,1,N,NA,NA,NA,NA,ZIADE000762,NA,NA,1ZIADE000762-03,NIDCR:1898854\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH,NA,NA,NA,78860774 (contact),"EMIOLA, AKINTUNDE  (contact)",NA,NA,NA,Address;antimicrobial;Bacteriophages;base;Ciprofloxacin;Clinical;colonization resistance;comparative efficacy;Disease;dysbiosis;efficacy evaluation;Genes;Goals;Health;Human;Human Microbiome;improved;interest;Intervention;Ligature;Link;Messenger RNA;Methods;Microbe;microbial;microbial community;microbiome;microbiome alteration;microbiome composition;microbiome research;microbiome therapeutics;mouse model;novel strategies;novel therapeutics;Nutrient;Outcome;pathogen;Periodontitis;Porphyromonas gingivalis;preservation;Prodrugs;Pseudouridine;Research;Resolution;Sampling;Techniques;tool;Work,Microbial exploration for new antimicrobial discovery,762,NA,NA,NA,NA,3,NA,NA,1898854,NA
11191895,ZIA,DK,1,N,NA,NA,NA,NA,ZIADK075149,NA,NA,1ZIADK075149-06,NIDDK:2757763\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES,NA,NA,NA,16146679 (contact),"AFZALI, BEHDAD  (contact)",NA,NA,NA,2019-nCoV;Acceleration;Acute Renal Failure with Renal Papillary Necrosis;airway epithelium;American;Animal Model;antagonist;anti-fungal agents;Anti-Inflammatory Agents;autocrine;Autoimmune;Autoimmune Diseases;Autoimmunity;Automobile Driving;BACH2 gene;Behavior;Benchmarking;Biological;Biological Markers;Biology;CD4 Positive T Lymphocytes;CDK2 gene;Cell Lineage;cell motility;Cells;Cicatrix;Clinical;Collaborations;Communicable Diseases;Communication;Complement;Complement component C5;Complex;Computing Methodologies;COVID-19;COVID-19 patient;Data;Data Set;Discipline;Disease;EGR2 gene;Encephalitis;Enhancers;Environment;Epidemiology;Epigenetic Process;Epithelial Cells;Event;Failure;Folic Acid;Functional impairment;Gene Expression;Gene Expression Regulation;Genes;Genetic Transcription;genome-wide;healing;Human;Immune;Immune system;Immunity;Immunology;immunoregulation;Immunosuppression;Immunosuppressive Agents;improved;Infection;Inflammation;Inflammatory;inhibitor;Injury;injury and repair;insight;interest;Interferon Type I;Journals;JUN gene;Kidney;Kidney Diseases;Knowledge;Life;Link;Lymphocyte;Malignant neoplasm of urinary bladder;Malignant Neoplasms;Mammals;Mediating;Mediator;Medical;Medicine;Modeling;Molecular;Morbidity - disease rate;mortality;Mus;Myeloid Cell Activation;National Center for Advancing Translational Sciences;Nature;Neoplastic Cell Transformation;New England;novel;Occupations;Organ;Paper;paracrine;Pathogenicity;Pathway interactions;Patients;Pharmaceutical Preparations;Physiology;Plasma;Polyglandular Autoimmune Syndrome Type I;post SARS-CoV-2 infection;prevent;Process;prognostic;programs;Psoriasis;Publications;Publishing;recruit;Regulation;Regulatory T-Lymphocyte;Renal function;Repression;Research;Research Personnel;Resolution;Resources;response;Risk;Role;Science;severe COVID-19;Shapes;Signal Induction;Signal Transduction;Skin;STAT3 gene;Syndrome;System;T cell differentiation;T-Cell Activation;T-Lymphocyte;Therapeutic;Tissues;tool;transcription factor;transcriptome;Untranslated RNA;Vitamin D;Vitamin D Deficiency;Work,Unravelling immunoregulatory circuits of tissue inflammation,75149,NA,NA,NA,NA,6,NA,NA,2757763,NA
11191896,ZIA,ES,1,N,NA,NA,NA,NA,ZIAES021196,NA,NA,1ZIAES021196-31,NIEHS:1083344\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES,NA,NA,NA,1933783 (contact),"DIXON, DARLENE  (contact)",NA,NA,NA,3-Dimensional;Address;Affect;analog;Archives;Benign;Biological;Biological Models;bisphenol A;Cadmium;carcinogenesis;cell growth;Cell Line;Cell Proliferation;Cells;Chemicals;Clinical;Clinical Treatment;Data;Development;Disease;disorder prevention;environmental agent;environmental chemical;Environmental Exposure;Environmental Impact;Environmental Risk Factor;ESR1 gene;Estrogen Receptors;Estrogens;Exposure to;Extracellular Matrix;Fibroid Tumor;Fibrosis;gene induction;Genistein;Genomics;Goals;GPER gene;Growth;Growth and Development function;Growth Factor;Hormones;Human;Human Cell Line;improved;In Vitro;in vitro Model;in vivo;Knowledge;Leiomyoma;Ligands;Malignant Neoplasms;Membrane;Metals;Mission;Mitotic Activity;Modeling;Molecular;Morphology;Mus;Myometrial;myometrium;neoplastic cell;novel;overexpression;Pathogenesis;Pathway interactions;Patients;Phase;Phenotype;Phytoestrogens;Play;Premenopause;Prevention strategy;Preventive measure;Production;proliferative phase Menstrual cycle;prospective;Public Health;receptor;Receptor Protein-Tyrosine Kinases;reproductive tract;Research;Risk Factors;Rodent;Role;Sampling;Signal Pathway;Telomerase;Therapeutic Intervention;three dimensional cell culture;Tissue Sample;Tissues;Treatment Protocols;tumor;Tumor Expansion;tumor growth;tumorigenesis;Uterine Fibroids;Uterus;Woman,Pathobiology Of Uterine Leiomyomas (fibroids),21196,NA,NA,NA,NA,31,NA,NA,1083344,NA
11191897,ZIA,ES,1,N,NA,NA,NA,NA,ZIAES103364,NA,NA,1ZIAES103364-04,NIEHS:216669\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES,NA,NA,NA,78332042 (contact),"SCHMITT, CHARLES  (contact)",NA,NA,NA,climate change;Committee Members;Computer Models;Data;Data Discovery;data ecosystem;data harmonization;Data Management Resources;data repository;Data Science;Data Set;Development;digital;diverse data;Environment;Environmental Health;Environmental Risk Factor;epidemiology study;Funding;Genes;Goals;graph learning;Health;Intramural Research;Knowledge;knowledge graph;Language;large language model;Machine Learning;Manuals;Manuscripts;Metadata;Methodology;Methods;Modeling;National Institute of Environmental Health Sciences;Nutritional;Outcomes Research;Paper;Patient-Focused Outcomes;predictive modeling;Process;programs;reproductive system disorder;Research;Research Personnel;Resources;Science;stem;Strategic Planning;System;Text;Toxicology;Trust;United States National Institutes of Health;unstructured data;Wildfire;Work;working group,Development of Data Science Methods,103364,NA,NA,NA,NA,4,NA,NA,216669,NA
11191898,ZIA,ES,1,N,NA,NA,NA,NA,ZIAES103368,NA,NA,1ZIAES103368-04,NIEHS:1372236\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES,NA,NA,NA,78332044 (contact),"MESSIER, KYLE  (contact)",NA,NA,NA,Address;Air Pollutants;Air Pollution;Autoimmune Diseases;Bayesian Method;Cardiovascular system;Censuses;Chemicals;climate change;climate-related health;Complex;complex data;CYP1A1 gene;Data;Development;Dose;environmental chemical;Environmental Health;Exposure to;fine particles;Floods;gene regulatory network;Genetic Transcription;gradient boosting;ground water;Health;Health protection;Humidity;improved;Information Systems;Left;Maps;Messenger RNA;Methodology;Modeling;Molecular Target;North Carolina;novel;open source;Outcome;Outcomes Research;Pesticides;Process;Public Health;Research;Resolution;response;Risk;Risk Assessment;Science;Skin;social vulnerability;spatiotemporal;Statistical Methods;Temperature;Toxicokinetics;Toxicology;Up-Regulation;Update,Spatiotemporal Health Analytics: Geospatial connections to toxicology,103368,NA,NA,NA,NA,4,NA,NA,1372236,NA
11191899,ZIA,ES,1,N,NA,NA,NA,NA,ZIAES103378,NA,NA,1ZIAES103378-03,NIEHS:2925030\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES,NA,NA,NA,78847065 (contact),"CRIZER, DAVID  (contact)",NA,NA,NA,3-Dimensional;Adoption;Area;Attention;Benchmarking;Cell model;Charge;Collaborations;Communities;cost;cost estimate;Data;Development;Discipline;Dose;Ensure;Environmental Exposure;Evaluation;Exposure to;Genes;Genomics;Goals;Health;Human;improved;innovation;insight;Investments;Knowledge;Laboratories;Lead;Leadership;Link;metabolomics;Mission;Modification;Multinational Perspectives;new technology;novel;novel strategies;Positioning Attribute;programs;Proteomics;Public Health;Reproducibility of Results;Research;Research Design;Resources;Risk;Signal Transduction;Source;success;Technology;Testing;Time;tool;Toxic effect;Toxicology;transcriptomics;Translations;Validation,Novel Tools and Approaches Research Program,103378,NA,NA,NA,NA,3,NA,NA,2925030,NA
11191900,ZIA,ES,1,N,NA,NA,NA,NA,ZIAES103382,NA,NA,1ZIAES103382-03,NIEHS:2166691\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES,NA,NA,NA,79341498 (contact),"BEVERLY, BRANDY  (contact)",NA,NA,NA,American;Animal Model;Animals;Area;Artificial Intelligence;Biological Assay;Biology;Biomedical Engineering;Blood Vessels;Cardiotoxicity;Cardiovascular Diseases;cardiovascular health;Cardiovascular system;Categories;Chemicals;Chronic;Clinical;Coculture Techniques;Collaborations;Communication;comorbidity;Complex;computational toxicology;Data;data integration;Databases;design;Development;Disease;Endothelial Cells;environmental chemical;Environmental Epidemiology;Environmental Exposure;Environmental Hazards;Environmental Health;evidence base;Exposure to;Failure;Functional disorder;Future;Goals;Government;hazard;Hazard Assessment;Health Disparities Research;Health Hazards;Human;Human Biology;human data;Hypertension;improved;in silico;In Vitro;in vivo;Industry;Injury;innovation;insight;International;Knowledge;Knowledge Management;Link;Manuscripts;Maps;Measures;Mediator;meetings;Mission;Modeling;Morbidity - disease rate;mortality;National Center for Advancing Translational Sciences;National Institute of Environmental Health Sciences;novel;Outcome;Peer Review;Physiological;Postdoctoral Fellow;Pre-Eclampsia;pregnancy disorder;programs;psychosocial stressors;Public Health;Publications;Qualifying;Quantitative Structure-Activity Relationship;Research;Risk;Scientist;screening;Skeletal Muscle;Societies;Structure;symposium;System;Testing;Tissue Engineering;Toxic effect;Toxicology;United States;Universities;Work,Cardiovascular Health Effects Innovation Research Program,103382,NA,NA,NA,NA,3,NA,NA,2166691,NA
11191901,ZIA,ES,1,N,NA,NA,NA,NA,ZIAES103383,NA,NA,1ZIAES103383-03,NIEHS:3791705\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES,NA,NA,NA,77850492 (contact),"PANDIRI, ARUN KUMAR  (contact)",NA,NA,NA,3-Dimensional;agent orange;Air;Alveolar;Animals;Austria;Benzene;Bioinformatics;bioinformatics pipeline;Biological Assay;Biological Sciences;Breast Adenocarcinoma;Breeding;Bronchiolo-Alveolar Adenocarcinoma;Cancer Center;Cancer Etiology;carcinogenesis;carcinogenicity;Carcinogens;Cells;chemical carcinogenesis;Chemical Exposure;Chronic;Collaborations;Colon;Colorectal Cancer;Complex;contaminated water;CRISPR/Cas technology;Data;Data Analyses;data mining;data repository;Deposition;Development;DNA Sequence Alteration;early onset colorectal cancer;England;Environment;environment related cancer;Environmental Exposure;epigenomics;Etiology;Evaluation;exome;exome sequencing;Exposure to;Fatty acid glycerol esters;Fibroadenoma;Fructose;Genes;genomic data;Genomics;genotoxicity;Goals;ground water;hazard;Hazard Identification;Health;Health Sciences;Human;human data;improved;in silico;In Vitro;in vivo;in vivo Model;induced pluripotent stem cell;innovation;inorganic phosphate;insight;International;Italy;Joints;Knowledge;Laboratories;Liquid substance;Literature;Malignant Breast Neoplasm;Malignant Neoplasms;mammary;Manuscripts;material transfer agreement;Medical;Methods;MicroRNAs;Military Personnel;Mining;Mission;Modeling;Molecular;molecular pathology;Multiomic Data;multiple omics;Mus;Mutate;Mutation;National Institute of Environmental Health Sciences;next generation sequencing;Pathology;Pilot Projects;polyposis;Postdoctoral Fellow;predictive marker;Preparation;Primary carcinoma of the liver cells;Probability;programs;Proteomics;Public Health;Rattus;Registries;Renal Cell Carcinoma;Research;response;Rodent;Role;Sampling;Site;Structure;System;technical report;Technology;Testing;The Cancer Genome Atlas;Tissues;tool;Toxic effect;Toxicology;Trichloroethylene;tumor;tumor registry;United States Department of Veterans Affairs;Universities;University Health Services;Vinyl Chloride;western diet;whole genome;Work,Carcinogenicity Health Effects Innovation Research Program,103383,NA,NA,NA,NA,3,NA,NA,3791705,NA
11191902,ZIA,TR,1,N,NA,NA,NA,NA,ZIATR000043,NA,NA,1ZIATR000043-10,NCATS:470392\,INTRAMURAL RESEARCH,2024,NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES,NA,NA,NA,14380133 (contact),"THOMAS, CRAIG  (contact)",NA,NA,NA,Biological;Biological Assay;Biology;Chemicals;Collection;cost;Development;Disease;disease model;drug discovery;Environment;Evaluation;fitness;Goals;improved;Industrialization;Libraries;Molecular;new chemical entity;novel;Phenotype;Play;Process;programs;Property;Research Personnel;Role;screening;small molecule;small molecule libraries;System;tool,Novel small molecule library development,43,NA,NA,NA,NA,10,NA,NA,470392,NA
11191903,ZIA,TR,1,N,NA,NA,NA,NA,ZIATR000047,NA,NA,1ZIATR000047-10,NCATS:1881570\,INTRAMURAL RESEARCH,2024,NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES,NA,NA,NA,14380133 (contact),"THOMAS, CRAIG  (contact)",NA,NA,NA,Adult T-Cell Leukemia/Lymphoma;B-Lymphocytes;Basic Science;Biological Assay;cancer type;Carcinoma;Caring;Clinical;Clinical Trials;combinatorial;Combined Modality Therapy;Cyclophosphamide;Disease;Doxorubicin;Drug Combinations;Ebola;Evaluation;Hematologic Neoplasms;Human;Immunotoxins;Informatics;inhibitor;Interleukin-2;Kyocristine;Malaria;Malignant Neoplasms;Methods;National Center for Advancing Translational Sciences;Non-Hodgkin&apos;s Lymphoma;novel;novel drug combination;Outcome;Outcome Study;Pharmaceutical Preparations;Phenotype;pre-clinical;Prednisone;Regimen;research clinical testing;Research Personnel;rituximab;screening;Signal Pathway;Technology;Vincristine;Visualization,HTS enabled examination of drug combinations,47,NA,NA,NA,NA,10,NA,NA,1881570,NA
11191904,ZIA,TR,1,N,NA,NA,NA,NA,ZIATR000052,NA,NA,1ZIATR000052-10,NCATS:255534\,INTRAMURAL RESEARCH,2024,NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES,NA,NA,NA,14380140 (contact),"INGLESE, JAMES  (contact)",NA,NA,NA,Adolescent;Adult;Affect;Age;alpha 1-Antitrypsin;alpha 1-Antitrypsin Deficiency;Alzheimer&apos;s Disease;Anti-malarials;Apoptosis;Applications Grants;assay development;Autoimmune Diseases;Autophagocytosis;autosome;Axon;Basic Science;Biogenesis;Biological Assay;Biological Models;Blindness;Calcinosis;Carbon;Categories;CD86 gene;Cell Cycle;Cell Line;Cells;Cellular Assay;Charcot-Marie-Tooth Disease;Chemicals;Child;Chromosome abnormality;Chromosomes;Chronic;Classification;Clinical Research;Clustered Regularly Interspaced Short Palindromic Repeats;Collaborations;Collection;Communicable Diseases;Communities;Congenital Disorders;Contracture;Cystic Fibrosis;Data Analyses;Defect;Demyelinations;Dental Enamel Hypoplasia;design;Development;Disease;Distal;DNA Sequence Alteration;drug discovery;early screening;Endoplasmic Reticulum;Engineering;environmental agent;Enzymes;Evaluation;Exanthema;experience;Extramural Activities;falls;Fatigue;Fibroblasts;Fission Yeast;functional genomics;Gametogenesis;Gene Library;Generations;Genes;Genetic;Genetic Screening;Genetic Transcription;genome editing;genome-wide;genomic locus;Genomics;Ghana;Glucose;Goals;hearing impairment;Hepatocyte;Hereditary Disease;Hereditary Motor and Sensory-Neuropathy Type II;high throughput screening;Human;Immune system;Immunity;Impairment;Individual;infancy;Infection;Inherited;inhibitor;innovation;Intellectual functioning disability;interest;Interferons;Investigation;Jordan;Kidney Calculi;Knowledge;Laboratories;Lead;Libraries;Life;Limb structure;Link;liver development;Liver diseases;Liver Dysfunction;loss of function;Lung Diseases;malaria infection;Malignant Neoplasms;Mediating;Membrane;Messenger RNA;Metabolic;method development;Microscopy;Missense Mutation;Modality;model organism;Modeling;Molecular;Molecular Biology;Molecular Conformation;monomer;Motor;multicatalytic endopeptidase complex;Multienzyme Complexes;Mus;Muscle Weakness;mutant;Mutation;Myositis;National Center for Advancing Translational Sciences;National Institute of Allergy and Infectious Disease;neglect;Nervous System Disorder;Newborn Infant;Non-Insulin-Dependent Diabetes Mellitus;novel;novel therapeutic intervention;Organism;Osteopenia;oxidation;Pain;Parents;Pathway interactions;Patients;Peripheral Nervous System Diseases;peroxisome;Pharmaceutical Preparations;pharmacologic;Phenocopy;Phenotype;PMP22 gene;Polymers;Production;programs;Protein Biosynthesis;Protein Conformation;protein expression;Proteins;Proteolysis;prototype;Quantitative Microscopy;Reporter;Reporter Genes;Reporting;repository;research and development;Research Personnel;response;Retinal Degeneration;Retinal Dystrophy;Retinitis Pigmentosa;RNA Interference;RNA Splicing;RPE65 protein;Science;Scientist;screening;Sensory;Services;Signal Transduction;Site;small molecule;small molecule libraries;Stress;Symptoms;System;T-Cell Activation;Technology;Testing;therapy development;Tissues;Toxin;trafficking;Translational Research;Translations;ubiquitin-protein ligase;Ubiquitination;Ulcer;Uniparental Disomy;Universities;Work;Yeasts,Phenotypic Assay Design and Development for Rare and Neglected Diseases,52,NA,NA,NA,NA,10,NA,NA,255534,NA
11191905,ZIA,TR,1,N,NA,NA,NA,NA,ZIATR000053,NA,NA,1ZIATR000053-10,NCATS:766601\,INTRAMURAL RESEARCH,2024,NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES,NA,NA,NA,14380140 (contact),"INGLESE, JAMES  (contact)",NA,NA,NA,2019-nCoV;Active Sites;Adenylate Cyclase;Affinity;Agonist;Allosteric Site;Anabolism;Analytical Chemistry;antagonist;anti-microbial drug;Antibiotic Resistance;antibiotic resistant infections;antimicrobial resistant infection;Antineoplastic Agents;Applications Grants;Aromatic Amino Acids;assay development;atrial natriuretic factor receptor B;Attenuated;beta-Lactamase;Binding;Biochemical;Biochemistry;Biological Assay;Brain natriuretic peptide;Carbapenems;Cell Differentiation process;Cells;Cessation of life;Chemicals;Cholesterol;Chorismate Mutase;chronic itch;Clinical;Collaborations;Colorado;Complex;Coupling;Cyclic AMP;Cyclic Peptides;design;Development;dietary;Disease;Doctor of Philosophy;drug discovery;Embryo;embryo cell;Enzyme Inhibitor Drugs;Enzymes;Erinaceidae;Evaluation;Extramural Activities;G-Protein-Coupled Receptors;Gene Expression;GTP-Binding Proteins;Guanylate Cyclase;high throughput screening;inhibitor;Interferons;Laboratories;Lactamase;Lactams;Lead;Link;Machine Learning;Malignant Neoplasms;Mammals;McCune-Albright Syndrome;medical schools;Messenger RNA;method development;Methods;microorganism;Missense Mutation;Modeling;Molecular Conformation;Morphology;mutant;Mutation;National Center for Advancing Translational Sciences;National Institute of Child Health and Human Development;National Institute of Dental and Craniofacial Research;Natriuretic Peptides;Natural Products;Nerve;novel;Nucleic Acids;Osteitis Fibrosa Disseminata;palmitoylation;Pathway interactions;peptide analog;Peptide Library;Peptide Receptor;Peptides;Peripheral;Pharmaceutical Preparations;pharmacologic;Pharmacological Treatment;Phenylalanine;Plants;Process;programs;Protein Precursors;Proteins;prototype;Pruritus;Public Health;Quality of life;receptor;research and development;response;SARS coronavirus;SARS-CoV-2 inhibitor;Scientist;screening;Series;Signal Pathway;Signal Transduction;small molecule;small molecule libraries;Source;Spectrophotometry;Spinal Cord;synthetic peptide;Technology;Therapeutic;Tokyo;Transferase;Translations;transmission process;Tyrosine;United States National Institutes of Health;Universities;vaccine trial;Validation;Viral;Viral Nonstructural Proteins;virology;Virulence Factors;Virus;Work,Target-based Assays and Screening Strategies for Chemical Probe and Therapeutic Lead Discovery,53,NA,NA,NA,NA,10,NA,NA,766601,NA
11191906,ZIA,TR,1,N,NA,NA,NA,NA,ZIATR000063,NA,NA,1ZIATR000063-10,NCATS:245724\,INTRAMURAL RESEARCH,2024,NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES,NA,NA,NA,77844220 (contact),"HENDERSON, MARK  (contact)",NA,NA,NA,analog;antagonist;Biotin;Calcium;Development;Diabetes Mellitus;Diazomethane;Disease;Functional disorder;Future;Homeostasis;Link;Monitor;Parkinson Disease;Pharmaceutical Chemistry;Progressive Disease;Proteins;Research;scaffold;small molecule;Testing;Thapsigargin;tool,Modulators of Secreted ER Ca2+ Monitoring Protein (SERCaMP),63,NA,NA,NA,NA,10,NA,NA,245724,NA
11191907,ZIA,TR,1,N,NA,NA,NA,NA,ZIATR000086,NA,NA,1ZIATR000086-10,NCATS:491448\,INTRAMURAL RESEARCH,2024,NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES,NA,NA,NA,14380300 (contact),"MARUGAN, JUAN  (contact)",NA,NA,NA,Agonist;assay development;Automobile Driving;Basic Science;Biology;Collaborations;Disease;drug candidate;drug development;drug discovery;Drug Kinetics;Evaluation;Extramural Activities;Family;Goals;Health;Human;Human Genome;improved;Informatics;lead optimization;male fertility;Modeling;mouse model;National Center for Advancing Translational Sciences;new technology;novel;novel therapeutics;Osteoporosis;Peptide Receptor;Pharmaceutical Chemistry;pharmacologic;Phenotype;Process;programs;Property;Rare Diseases;Relaxin;Reporting;Research;Research Personnel;screening;Screening Result;small molecule;small molecule therapeutics;Synthesis Chemistry;therapeutic development;tool;Translations;United States National Institutes of Health;Validation;Work,Identification of novel agonist of the Relaxin family peptide receptor 2 (RXFP2) as potential new therapeutics for testicular maldescent,86,NA,NA,NA,NA,10,NA,NA,491448,NA
11191908,ZIA,TR,1,N,NA,NA,NA,NA,ZIATR000096,NA,NA,1ZIATR000096-10,NCATS:491448\,INTRAMURAL RESEARCH,2024,NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES,NA,NA,NA,14380300 (contact),"MARUGAN, JUAN  (contact)",NA,NA,NA,antagonist;assay development;Atherosclerosis;Biological Assay;Biology;Cell Line;Cells;Chronic stress;Collaborations;Disease;drug development;drug discovery;Extramural Activities;Follow-Up Studies;Goals;high throughput screening;Informatics;lead optimization;Mental Depression;Modeling;molecular modeling;Neuroblastoma;neuroblastoma cell;new technology;novel;PACAPR-1 protein;Pharmaceutical Chemistry;Phenotype;Process;Reporter;Research;Research Personnel;screening;small molecule;small molecule therapeutics;Synthesis Chemistry;Testing;therapeutic development;tool;Translations;United States National Institutes of Health;Validation;virtual screening;Work,PAC1 receptor antagonists as potential treatments for depression and atherosclerosis associated with chronic stress,96,NA,NA,NA,NA,10,NA,NA,491448,NA
11191909,ZIA,TR,1,N,NA,NA,NA,NA,ZIATR000102,NA,NA,1ZIATR000102-05,NCATS:245724\,INTRAMURAL RESEARCH,2024,NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES,NA,NA,NA,77844220 (contact),"HENDERSON, MARK  (contact)",NA,NA,NA,analog;Automobile Driving;Basic Science;Biological Assay;Cells;Collaborations;Disease;drug candidate;Enhancers;Extramural Activities;galactosylceramidase;Globoid cell leukodystrophy;Goals;Health;high throughput screening;Human;Human Genome;improved;induced pluripotent stem cell;Informatics;Lipids;Mass Spectrum Analysis;Modeling;mutant;National Center for Advancing Translational Sciences;Neurologic;novel;Oligodendroglia;Patients;Pharmaceutical Chemistry;pharmacologic;Process;programs;Psychosine;Rare Diseases;Reporting;Research;Residual state;screening;small molecule;small molecule therapeutics;therapeutic development;tool;Training;Translations;United States National Institutes of Health;Validation;Work,A Novel Cell-Based Assay to Identify Small Molecules for Galactocerebrosidase (GALC),102,NA,NA,NA,NA,5,NA,NA,245724,NA
11191910,ZIA,TR,1,N,NA,NA,NA,NA,ZIATR000106,NA,NA,1ZIATR000106-10,NCATS:245724\,INTRAMURAL RESEARCH,2024,NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES,NA,NA,NA,14380209 (contact),"HALL, MATTHEW  (contact)",NA,NA,NA,analog;Automobile Driving;Base Pairing;Basic Science;Chemicals;drug candidate;Drug Kinetics;Dystonia;early onset;Genes;Health;Human;Human Genome;improved;Inclusion Bodies;inhibitor;Lead;Membrane;mutant;Mutation;National Center for Advancing Translational Sciences;novel;Pathology;Pattern;Pharmaceutical Chemistry;pharmacologic;Primary Dystonias;programs;Property;Proteins;Rare Diseases;Research;Series;small molecule;tool;TorsinA;Translations,qHTS to Identify Inhibitors of DYT1 Inclusion Formation,106,NA,NA,NA,NA,10,NA,NA,245724,NA
11191911,ZIA,TR,1,N,NA,NA,NA,NA,ZIATR000110,NA,NA,1ZIATR000110-10,NCATS:327632\,INTRAMURAL RESEARCH,2024,NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES,NA,NA,NA,14380209 (contact),"HALL, MATTHEW  (contact)",NA,NA,NA,anti-cancer treatment;Apoptotic;Automobile Driving;Basic Science;Binding;Biological Assay;Chemicals;Chemistry;Clinical;Data;DNA Damage;drug candidate;Drug Kinetics;Environment;Family;Fluorescence;Health;Human;Human Genome;improved;inhibitor;lead optimization;lead series;Malignant Neoplasms;Mass Spectrum Analysis;member;National Center for Advancing Translational Sciences;novel;overexpression;pharmacologic;PPM1D gene;Prognosis;programs;protein phosphatase 2C;Protein Serine/Threonine Phosphatase;Proteins;Rare Diseases;Reporter;Research;response;scaffold;screening;small molecule;Surface Plasmon Resonance;Testing;therapeutic development;tool;TP53 gene;Translations;tumor growth;Work,qHTS to Identify Activators and Inhibitors of Wip1,110,NA,NA,NA,NA,10,NA,NA,327632,NA
11191912,ZIA,TR,1,N,NA,NA,NA,NA,ZIATR000131,NA,NA,1ZIATR000131-06,NCATS:163816\,INTRAMURAL RESEARCH,2024,NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES,NA,NA,NA,14380209 (contact),"HALL, MATTHEW  (contact)",NA,NA,NA,ABCB1 gene;ABCG2 gene;Antineoplastic Agents;Binding;Biological Assay;Blood - brain barrier anatomy;cancer cell;cancer type;Cell Line;Cells;Homologous Gene;Human Activities;Libraries;Membrane;neoplastic cell;overexpression;Pharmaceutical Preparations;small molecule;solute;Therapeutic;Tissues;Translations;Zebrafish,qHTS to Identify Substrates of P-glycoprotein (P-gp) and Collateral Sensitivity agents of P-gp-expressing Cancer Cells,131,NA,NA,NA,NA,6,NA,NA,163816,NA
11191913,ZIA,TR,1,N,NA,NA,NA,NA,ZIATR000192,NA,NA,1ZIATR000192-10,NCATS:491448\,INTRAMURAL RESEARCH,2024,NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES,NA,NA,NA,77875535 (contact),"RAI BANTUKALLU, GANESHA  (contact)",NA,NA,NA,3-Dimensional;aldehyde dehydrogenases;Aldehydes;Anabolism;analog;Biological;Biological Assay;cancer cell;Cancer cell line;cancer drug resistance;Cancer Relapse;cancer stem cell;Carboxylic Acids;Cells;Cyclophosphamide;cytotoxicity;design;Development;Dopamine;Drug Kinetics;Drug Metabolic Detoxication;Enzymes;Ethanol Metabolism;Exhibits;gamma-Aminobutyric Acid;high throughput screening;Homeostasis;Human;in vivo;inhibitor;Isoenzymes;Malignant neoplasm of ovary;member;Metabolism;miniaturize;Neurotransmitters;novel;oxidation;Oxidative Stress;Paclitaxel;Pharmaceutical Chemistry;Prognosis;quinoline;Research;Resistance;Series;small molecule;spheroids;Structure-Activity Relationship;Therapeutic;therapeutic target;Tretinoin;Work,Selective Inhibitors of ALDH1A1,192,NA,NA,NA,NA,10,NA,NA,491448,NA
11191914,ZIA,TR,1,N,NA,NA,NA,NA,ZIATR000201,NA,NA,1ZIATR000201-10,NCATS:163816\,INTRAMURAL RESEARCH,2024,NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES,NA,NA,NA,14380300 (contact),"MARUGAN, JUAN  (contact)",NA,NA,NA,autosome;Cells;Disease;enzyme replacement therapy;Gaucher Disease;Genes;glucosylceramidase;Glucosylceramides;high throughput screening;induced pluripotent stem cell;large scale production;Lead;Lipids;lysosomal proteins;Lysosomes;Molecular Chaperones;molecular modeling;mutant;Mutation;Patients;Phenotype;Physiological;prevent;Proteins;Reporting;small molecule;Study models;Testing;Therapeutic;trafficking;Variant;virtual screening,Identification of Modulators of the N370S Mutant Form of Glucocerebrosidase as a Potential Therapy for Gaucher Disease,201,NA,NA,NA,NA,10,NA,NA,163816,NA
11191915,ZIA,TR,1,N,NA,NA,NA,NA,ZIATR000203,NA,NA,1ZIATR000203-10,NCATS:491431\,INTRAMURAL RESEARCH,2024,NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES,NA,NA,NA,14380300 (contact),"MARUGAN, JUAN  (contact)",NA,NA,NA,ABL1 gene;Alzheimer&apos;s Disease;Alzheimer&apos;s disease model;Amyloid beta-Protein;Automobile Driving;Basic Science;Biological Assay;blood-brain barrier penetration;Clinic;cognitive recovery;drug candidate;Drug Kinetics;Enzymes;Epilepsy;Evaluation;Exposure to;Health;high throughput screening;Human;Human Genome;Impaired cognition;improved;inflammatory marker;inhibitor;mouse model;National Center for Advancing Translational Sciences;Neurodegenerative Disorders;Neurons;novel;pharmacologic;Phosphotransferases;pre-clinical;programs;Rare Diseases;Research;small molecule inhibitor;Structure;Structure-Activity Relationship;tool;Translations,HTS to Identify Inhibitors of c-Abl kinase for the Potential Treatment of Epilepsy and Neurodegenerative diseases,203,NA,NA,NA,NA,10,NA,NA,491431,NA
11191916,ZIA,TR,1,N,NA,NA,NA,NA,ZIATR000208,NA,NA,1ZIATR000208-10,NCATS:491448\,INTRAMURAL RESEARCH,2024,NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES,NA,NA,NA,14380300 (contact),"MARUGAN, JUAN  (contact)",NA,NA,NA,analog;Animals;Brain;cancer cell;Cancer Model;cancer type;Cell Nucleus;Chemicals;Complex;Critical Pathways;Disseminated Malignant Neoplasm;Goals;high throughput screening;In Vitro;in vivo;inhibitor;mouse model;Nature;Neoplasm Metastasis;neoplastic cell;neurotoxicity;Nuclear;Patients;Penetration;Prevalence;Solid;Structure;Structure-Activity Relationship;tool;Translations;Tumor Cell Invasion,Progression of Metarrestin that Reduces PNC Prevalence and Elucidation of its Mechanism of Action,208,NA,NA,NA,NA,10,NA,NA,491448,NA
11191917,ZIA,TR,1,N,NA,NA,NA,NA,ZIATR000209,NA,NA,1ZIATR000209-10,NCATS:491448\,INTRAMURAL RESEARCH,2024,NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES,NA,NA,NA,14380300 (contact),"MARUGAN, JUAN  (contact)",NA,NA,NA,Agonist;analog;assay development;Automobile Driving;Basic Science;Binding;Biological Assay;Biology;Collaborations;Cryoelectron Microscopy;Data;Disease;drug candidate;drug development;drug discovery;Drug Kinetics;Extramural Activities;Formulation;Goals;Health;Human;Human Genome;improved;in vitro Assay;in vivo;in vivo Model;Informatics;Lead;lead optimization;Metabolic;Modeling;National Center for Advancing Translational Sciences;new technology;novel;Pharmaceutical Chemistry;pharmacologic;Phenotype;Process;programs;Rare Diseases;receptor;Relaxin;Research;Research Personnel;screening;small molecule;small molecule therapeutics;Synthesis Chemistry;Testing;therapeutic development;tool;Translations;United States National Institutes of Health;Validation;Work,Small molecule agonists of the relaxin 1 receptor,209,NA,NA,NA,NA,10,NA,NA,491448,NA
11191918,ZIA,TR,1,N,NA,NA,NA,NA,ZIATR000212,NA,NA,1ZIATR000212-10,NCATS:491448\,INTRAMURAL RESEARCH,2024,NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES,NA,NA,NA,14380300 (contact),"MARUGAN, JUAN  (contact)",NA,NA,NA,Animal Model;antagonist;Bipolar Disorder;Catalepsy;Dopamine D2 Receptor;DRD2 gene;efficacy study;Evaluation;Gilles de la Tourette syndrome;Human;improved;in vivo;Intervention;Lead;Legal patent;novel;Pharmaceutical Chemistry;pharmacologic;preclinical development;Property;Psychoses;Research;Schizophrenia;Series;side effect;Structure-Activity Relationship;Translations,Discovery of Novel Modulators of the Human D2 Dopamine Receptor,212,NA,NA,NA,NA,10,NA,NA,491448,NA
11191919,ZIA,TR,1,N,NA,NA,NA,NA,ZIATR000214,NA,NA,1ZIATR000214-10,NCATS:245724\,INTRAMURAL RESEARCH,2024,NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES,NA,NA,NA,14380300 (contact),"MARUGAN, JUAN  (contact)",NA,NA,NA,Agonist;antagonist;Antibody Activation;Autoimmune Diseases;Automobile Driving;Basic Science;Binding;Biological Assay;Cells;Cyclic AMP;Development;Disease;Dose;drug candidate;Germ-Line Mutation;Goals;Graves&apos; Disease;Health;Human;Human Genome;Hyperthyroidism;improved;Lead;lead optimization;Metabolic;mouse model;National Center for Advancing Translational Sciences;novel therapeutics;Pathogenesis;Patients;Pharmaceutical Preparations;pharmacologic;Population;Prevalence;Production;programs;Rare Diseases;receptor function;Receptor Signaling;Research;response;scale up;small molecule;Testing;Therapeutic;thyroid associated ophthalmopathies;Thyroid Gland;Thyroid Hormones;Thyroid stimulating immunoglobulins;Thyrotropin Receptor;Tissues;tool;Translations;Treatment Protocols;Vision,Assay for Small-Molecule Antagonists of the TSH Receptor,214,NA,NA,NA,NA,10,NA,NA,245724,NA
11191920,ZIA,TR,1,N,NA,NA,NA,NA,ZIATR000230,NA,NA,1ZIATR000230-10,NCATS:245724\,INTRAMURAL RESEARCH,2024,NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES,NA,NA,NA,14380204 (contact),"SHEN, MIN  (contact)",NA,NA,NA,advanced disease;Antineoplastic Agents;Automobile Driving;Autophagocytosis;Basic Science;Biochemical;biological adaptation to stress;Biological Assay;Biological Availability;cancer cell;Cell Physiology;Cells;Development;Disease;disease model;drug candidate;Enzymes;Growth;Health;Human;Human Genome;improved;inhibitor;insulin signaling;kinase inhibitor;Lipids;Malignant Neoplasms;Modality;mutant;National Center for Advancing Translational Sciences;novel;pharmacokinetics and pharmacodynamics;pharmacologic;Phosphatidylinositols;Phosphotransferases;Play;pre-clinical;programs;Proliferating;Rare Diseases;Research;Role;Signal Transduction;small molecule inhibitor;Therapeutic;tool;TP53 gene;Translations;Work,Identification of Inhibitors of the Lipid Kinase PI5P4Ka/B as Potential Anti-Cancer Agents,230,NA,NA,NA,NA,10,NA,NA,245724,NA
11191921,ZIA,TR,1,N,NA,NA,NA,NA,ZIATR000251,NA,NA,1ZIATR000251-09,NCATS:245724\,INTRAMURAL RESEARCH,2024,NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES,NA,NA,NA,14380204 (contact),"SHEN, MIN  (contact)",NA,NA,NA,analog;Animal Cancer Model;Attenuated;Biological Assay;Biology;Cancer Cell Growth;Cancer Etiology;Cessation of life;Chemicals;Death Rate;Disease;Dose;Drug Kinetics;Enzymes;experimental study;Female Genital Neoplasms;Fibroblasts;Greater sac of peritoneum;Human;improved;In Vitro;in vivo;inhibitor;Investigational Therapies;knock-down;Malignant neoplasm of ovary;Malignant Neoplasms;Mammalian Oviducts;member;Metabolic;Mus;Mutation;Neoplasm Metastasis;Nicotinamide N-Methyltransferase;Ovary;Pathway interactions;Patients;Pharmaceutical Chemistry;Pharmaceutical Preparations;Pharmacodynamics;Prognosis;programs;Property;Quality of life;Recombinants;Recurrence;Reporting;Role;Serous;Site;Structure;Symptoms;Therapeutic;therapeutically effective;TP53 gene;tumor;tumor heterogeneity;Woman,qHTS to Identify Inhibitors of NNMT1,251,NA,NA,NA,NA,9,NA,NA,245724,NA
11191922,ZIA,TR,1,N,NA,NA,NA,NA,ZIATR000267,NA,NA,1ZIATR000267-09,NCATS:491448\,INTRAMURAL RESEARCH,2024,NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES,NA,NA,NA,14380300 (contact),"MARUGAN, JUAN  (contact)",NA,NA,NA,Agonist;analog;assay development;Biological Assay;Biology;Cells;Collaborations;Disease;drug development;drug discovery;Evaluation;Extramural Activities;G-Protein-Coupled Receptors;Goals;Informatics;Lead;lead optimization;Measures;Metabolic;Modeling;mouse model;Multiple Sclerosis;nerve damage;Neurons;new technology;novel;Optic Nerve;Pharmaceutical Chemistry;Phenotype;Process;Research;Research Personnel;screening;small molecule;small molecule therapeutics;Structure-Activity Relationship;Synthesis Chemistry;therapeutic development;tool;Translations;Traumatic Brain Injury;United States National Institutes of Health;Validation;Work,Medicinal chemistry campaign to synthesize synaptamide analogs (GPR110),267,NA,NA,NA,NA,9,NA,NA,491448,NA
11191923,ZIA,TR,1,N,NA,NA,NA,NA,ZIATR000298,NA,NA,1ZIATR000298-08,NCATS:327632\,INTRAMURAL RESEARCH,2024,NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES,NA,NA,NA,14380091 (contact),"SIMEONOV, ANTON  (contact)",NA,NA,NA,beta catenin;Biological Assay;Biological Process;cancer immunotherapy;cancer type;colon cancer cell line;Development;Disease;Eukaryota;Excision;Family;Genes;Glioblastoma;high throughput screening;Human;human disease;in silico;Inflammatory;inhibitor;interest;Knockout Mice;Lead;Machine Learning;Malignant Breast Neoplasm;Malignant neoplasm of ovary;Malignant Neoplasms;Melanoma;mouse model;Neurodegenerative Disorders;NF-kappa B;overexpression;Pathway interactions;Play;Post-Translational Protein Processing;prospective;Proteins;Role;screening;Signal Pathway;small molecule;small molecule inhibitor;Structure;T-Cell Activation;Testing;TP53 gene;Transforming Growth Factor beta;tumorigenesis;Ubiquitin;ubiquitin isopeptidase;ubiquitin-specific protease;Ubiquitination;Virus Diseases;Work,Identification of small molecule inhibitors of USP15,298,NA,NA,NA,NA,8,NA,NA,327632,NA
11191924,ZIA,TR,1,N,NA,NA,NA,NA,ZIATR000302,NA,NA,1ZIATR000302-08,NCATS:491448\,INTRAMURAL RESEARCH,2024,NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES,NA,NA,NA,14380300 (contact),"MARUGAN, JUAN  (contact)",NA,NA,NA,Automobile Driving;Binding;Biological Assay;Clinical Trials;Collaborations;Communities;Cryoelectron Microscopy;Development;Disease;drug discovery;Extramural Activities;Fostering;General Population;high throughput screening;Host Defense;human disease;Immune checkpoint inhibitor;Immunomodulators;improved;In Vitro;in vivo;Informatics;Ligands;Link;Macrophage;Molecular Medicine;molecular modeling;novel;novel therapeutics;peptide analog;Peptides;Pharmaceutical Chemistry;Pharmaceutical Preparations;Phenotype;Process;Publications;recruit;Research;Research Personnel;Resources;screening;Signal Transduction;Site;small molecule;Structure;Surface;synthetic peptide;Translations;tumor;United States National Institutes of Health;Work,CD206 activators as novel immunomodulators,302,NA,NA,NA,NA,8,NA,NA,491448,NA
11191925,ZIA,TR,1,N,NA,NA,NA,NA,ZIATR000305,NA,NA,1ZIATR000305-08,NCATS:245724\,INTRAMURAL RESEARCH,2024,NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES,NA,NA,NA,77875535 (contact),"RAI BANTUKALLU, GANESHA  (contact)",NA,NA,NA,Animals;Anti-viral Agents;Antibodies;Biological;Biological Assay;Blood - brain barrier anatomy;Brain;candidate identification;Chemicals;Clinical Trials;Collaborations;Collection;design;Development;Disease;drug repurposing;efficacy study;Failure;Fatality rate;Hamsters;HepG2;Human;In Vitro;Infection;inhibitor;Libraries;Luciferases;Modeling;Mus;National Center for Advancing Translational Sciences;novel;Pharmaceutical Chemistry;pharmacologic;Pharmacologic Substance;Phenotype;prevent;Prophylactic treatment;Quantitative Structure-Activity Relationship;Rabies;Rabies virus;Recombinants;Reporter;Research;screening;Series;Site;small molecule;small molecule inhibitor;small molecule therapeutics;Therapeutic;Therapeutic Intervention;Toxic effect;Translations;Triage;Vaccination;Viral;viral transmission;Work,qHTS to Identify Inhibitors of Rabies Virus,305,NA,NA,NA,NA,8,NA,NA,245724,NA
11191926,ZIA,TR,1,N,NA,NA,NA,NA,ZIATR000314,NA,NA,1ZIATR000314-08,NCATS:245724\,INTRAMURAL RESEARCH,2024,NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES,NA,NA,NA,14380091 (contact),"SIMEONOV, ANTON  (contact)",NA,NA,NA,Apoptosis;biological adaptation to stress;Biological Assay;cancer cell;Cell Survival;Cytosol;design;Disease;Dislocations;Endoplasmic Reticulum;Environment;HepG2;inhibitor;interest;Luciferases;Malignant Neoplasms;misfolded protein;Process;Proteasome Inhibitor;protein misfolding;Proteins;Rabies;Rabies virus;Recombinants;Reporter;response;Role;screening;small molecule;small molecule inhibitor;therapeutic development;Toxic effect;Triage;Viral;Work,Identifying inhibitors of ER retrotranslocation/dislocation,314,NA,NA,NA,NA,8,NA,NA,245724,NA
11191927,ZIA,TR,1,N,NA,NA,NA,NA,ZIATR000316,NA,NA,1ZIATR000316-08,NCATS:245724\,INTRAMURAL RESEARCH,2024,NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES,NA,NA,NA,14380091 (contact),"SIMEONOV, ANTON  (contact)",NA,NA,NA,analog;Atherosclerosis;Blood Platelets;Cardiovascular system;Carotid Artery Diseases;Chronic Granulomatous Disease;Endothelial Cells;Exhibits;Generations;Genes;Goals;Immune System Diseases;inhibitor;loss of function;Mutation;NADPH Oxidase;Patients;Phagocytes;Reactive Oxygen Species;Research;Site;small molecule inhibitor,NADPH-oxidase 2 inhibitors for cardiovascular indications,316,NA,NA,NA,NA,8,NA,NA,245724,NA
11191928,ZIA,TR,1,N,NA,NA,NA,NA,ZIATR000331,NA,NA,1ZIATR000331-08,NCATS:245724\,INTRAMURAL RESEARCH,2024,NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES,NA,NA,NA,78353074 (contact),"ZAKHAROV, ALEXEY  (contact)",NA,NA,NA,analog;Binding Sites;Biological Assay;Cells;Genetic Transcription;Goals;high throughput screening;Human;inhibitor;Malignant Neoplasms;Messenger RNA;miniaturize;novel;Oncogenes;overexpression;Pharmaceutical Chemistry;programs;Proteins;Proteome;Role;screening;small molecule;Testing;Translational Repression;Translations;Treatment Efficacy;tumor progression,Identification of Myc translation inhibitors,331,NA,NA,NA,NA,8,NA,NA,245724,NA
11191929,ZIA,TR,1,N,NA,NA,NA,NA,ZIATR000338,NA,NA,1ZIATR000338-06,NCATS:245724\,INTRAMURAL RESEARCH,2024,NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES,NA,NA,NA,14380300 (contact),"MARUGAN, JUAN  (contact)",NA,NA,NA,Agonist;analog;Automobile Driving;Basic Science;Binding Sites;Biological Assay;Cancer Model;Cells;Coupling;drug candidate;Fabry Disease;Health;Human;Human Genome;improved;Lipids;Measures;Metabolism;Mitochondria;Modeling;mouse model;National Center for Advancing Translational Sciences;novel;paralogous gene;pharmacologic;Phenotype;Production;programs;Rare Diseases;Research;tool;Translations,Identification of modulators of TRAP1,338,NA,NA,NA,NA,6,NA,NA,245724,NA
11191930,ZIA,TR,1,N,NA,NA,NA,NA,ZIATR000355,NA,NA,1ZIATR000355-07,NCATS:163816\,INTRAMURAL RESEARCH,2024,NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES,NA,NA,NA,14380091 (contact),"SIMEONOV, ANTON  (contact)",NA,NA,NA,Antibiotic Therapy;Antibiotics;antimicrobial;Awareness;Bacteria;Binding;Biological Assay;biophysical techniques;Borrelia;Borrelia burgdorferi;Chronic;Clinical;Collaborations;counterscreen;Development;Disease;Etiology;experience;follow-up;Goals;Infection;inhibitor;Libraries;Lyme Disease;Measures;Methods;miniaturize;mouse model;novel;Order Spirochaetales;Pathogenicity;Patients;Post Treatment Lyme Disease Syndrome;Prevalence;protein protein interaction;Proteins;Reporting;screening;Series;small molecule inhibitor;Testing;Tick-Borne Diseases,Identification of inhibitors of BB323 and BB238 interaction in Borrelia burgdorferi (chronic Lyme disease),355,NA,NA,NA,NA,7,NA,NA,163816,NA
11191931,ZIA,TR,1,N,NA,NA,NA,NA,ZIATR000362,NA,NA,1ZIATR000362-07,NCATS:327632\,INTRAMURAL RESEARCH,2024,NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES,NA,NA,NA,14380209 (contact),"HALL, MATTHEW  (contact)",NA,NA,NA,Bacteria;Beta-glucuronidase;Biochemical;Biological Assay;Cells;Chemicals;Disease;Dose Limiting;Drug toxicity;Enzymes;Exhibits;follow-up;high throughput screening;Homology Modeling;in vitro Assay;inhibitor;Lead;microbiome;miniaturize;National Center for Advancing Translational Sciences;novel;Orthologous Gene;Pharmaceutical Chemistry;Pharmaceutical Preparations;Powder dose form;programs;Series;small molecule;small molecule libraries;Therapeutic;Toxic effect;Validation;virtual screening,qHTS to Identify Small Molecule GUS Inhibitors,362,NA,NA,NA,NA,7,NA,NA,327632,NA
11191932,ZIA,TR,1,N,NA,NA,NA,NA,ZIATR000367,NA,NA,1ZIATR000367-07,NCATS:245724\,INTRAMURAL RESEARCH,2024,NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES,NA,NA,NA,78353074 (contact),"ZAKHAROV, ALEXEY  (contact)",NA,NA,NA,Acute Renal Failure with Renal Papillary Necrosis;analog;Arachidonate 15-Lipoxygenase;Biological Assay;Cells;design;Disease;disease model;Goals;improved;In Vitro;in vivo Model;inhibitor;Pharmaceutical Chemistry;protein complex;Proteins;Research;Research Personnel;Role;screening;small molecule;small molecule inhibitor;Structure;Traumatic Brain Injury;Work,Improving 15-LOX-2 small molecule inhibitors through medicinal chemistry and structure-guided design,367,NA,NA,NA,NA,7,NA,NA,245724,NA
11191933,ZIA,TR,1,N,NA,NA,NA,NA,ZIATR000369,NA,NA,1ZIATR000369-07,NCATS:5131109\,INTRAMURAL RESEARCH,2024,NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES,NA,NA,NA,14380111 (contact),"XU, XIN  (contact)",NA,NA,NA,absorption;Acceleration;Address;Adult;Agonist;Aldehyde oxidase;Animals;Antibodies;antibody detection;antibody test;aqueous;artificial intelligence model;Bile fluid;Binding Proteins;Biodistribution;Biological;Biological Assay;Biological Products;Biophysics;Blood;Caco-2 Cells;Cell Membrane Permeability;Cell Survival;Cells;Chemicals;Child;Clinic;Clinical Trials;Collaborations;cost;Country;COVID-19;CYP2C9 gene;CYP3A4 gene;Cytosol;Data;Data Set;design;Development;Devices;Dose;drug candidate;drug development;drug discovery;Drug Kinetics;drug metabolism;drug-like compound;Duchenne muscular dystrophy;efficacy study;Electrical Resistance;Ensure;Enzymes;Evaluation;Excretory function;Extramural Activities;Failure;falls;first-in-human;Gene Expression;gene therapy;Generations;Goals;good laboratory practice;Grant;GS-441524;Hepatic;Hepatocyte;High Pressure Liquid Chromatography;high throughput screening;Human;Human Cell Line;human study;immunogenicity;in silico;In Vitro;in vivo;Incubated;innovation;International;Intestines;Intramural Research;Investigational New Drug Application;Kinetics;Laboratory Animals;Lead;Libraries;Liquid Chromatography;Liquid substance;Liver Microsomes;Machine Learning;macromolecule;Manuscripts;Mass Spectrum Analysis;Measurement;Measures;Medicine;meetings;Membrane;Metabolic;Metabolism;Metaphyseal chondrodysplasia;method development;Methods;Microsomes;Mission;model development;Modeling;models and simulation;Monitor;Mus;National Center for Advancing Translational Sciences;novel;novel therapeutics;open label;Oral;Oral Administration;Peptides;Performance;Permeability;Pharmaceutical Preparations;Phase;Phase II Clinical Trials;Plasma;Plasma Proteins;Play;pre-clinical;preclinical study;Process;Prodrugs;Property;Protein Engineering;Proteins;Protocols documentation;PTH gene;PubChem;Publications;Publishing;Rattus;Reagent;Recombinants;Regimen;remdesivir;Reproducibility;Research;Research Personnel;Research Project Grants;Resolution;Resources;Role;Safety;safety study;Sampling;Scientist;Small Business Innovation Research Grant;small molecule;Solubility;Structure;subcutaneous;Sulfhydryl Compounds;symposium;System;tandem mass spectrometry;Techniques;Technology;therapeutic candidate;therapeutic development;Tight Junctions;Tissue Extracts;tool;Toxic effect;toxicant;Toxicology;Translational Research;United States National Institutes of Health;Urine;Validation;wasting;web site;Work,Pharmacokinetics and Drug Metabolism,369,NA,NA,NA,NA,7,NA,NA,5131109,NA
11191934,ZIA,TR,1,N,NA,NA,NA,NA,ZIATR000377,NA,NA,1ZIATR000377-06,NCATS:491448\,INTRAMURAL RESEARCH,2024,NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES,NA,NA,NA,14380300 (contact),"MARUGAN, JUAN  (contact)",NA,NA,NA,Automobile Driving;Basic Science;bcr-abl Fusion Proteins;Binding;blood-brain barrier crossing;Brain;Brain Neoplasms;Cells;Clinical;Collaborations;drug candidate;Glioblastoma;Health;Human;Human Genome;improved;In Vitro;in vivo;inhibitor;interest;Modality;Myristates;National Center for Advancing Translational Sciences;novel;Oncogenic;pharmacologic;Phosphotransferases;programs;Rare Diseases;Reporting;Research;Resistance;resistance mutation;Testing;Therapeutic;tool;Translations;tumor initiation;Tyrosine Kinase Inhibitor,Characterizing inhibitors of tyrosine protein kinase ABL1 (ABL1) in human glioblastoma,377,NA,NA,NA,NA,6,NA,NA,491448,NA
11191935,ZIA,TR,1,N,NA,NA,NA,NA,ZIATR000378,NA,NA,1ZIATR000378-04,NCATS:163816\,INTRAMURAL RESEARCH,2024,NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES,NA,NA,NA,14380300 (contact),"MARUGAN, JUAN  (contact)",NA,NA,NA,Anti-Bacterial Agents;Antibiotics;Automobile Driving;bacterial metabolism;Basic Science;Biological Assay;Cells;clinical practice;Complex;cyanine dye 5;Development;drug candidate;Drug Targeting;Elongation Factor;Escherichia coli;Fluorescence Resonance Energy Transfer;Fluorescent Dyes;Formulation;Future;Gram-Negative Bacteria;Guanosine Triphosphate;Health;high throughput screening;Homologous Gene;Human;Human Genome;improved;In Vitro;in vivo;Infectious Skin Diseases;inhibitor;Modeling;Mycobacterium tuberculosis;National Center for Advancing Translational Sciences;natural product derivative;novel;Organism;pathogen;Permeability;pharmacologic;Phenylalanine-Specific tRNA;programs;Protein Biosynthesis;Rare Diseases;Reagent;Reporting;Research;screening;small molecule libraries;Streptomyces;Testing;tool;Transfer RNA Aminoacylation;Translations;Work,Identifying novel antibiotics by targeting the EF-Tu complex formation,378,NA,NA,NA,NA,4,NA,NA,163816,NA
11191936,ZIA,TR,1,N,NA,NA,NA,NA,ZIATR000379,NA,NA,1ZIATR000379-06,NCATS:327632\,INTRAMURAL RESEARCH,2024,NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES,NA,NA,NA,14380300 (contact),"MARUGAN, JUAN  (contact)",NA,NA,NA,Affect;Anti-Inflammatory Agents;Antiinflammatory Effect;Autoimmune Diseases;Automobile Driving;Basic Science;Biological Assay;Body System;cell immortalization;Cell Line;cell type;Cells;Chromosome Mapping;Clinical;Development;Dose Limiting;drug candidate;Drug Prescriptions;Engineering;Exposure to;Gene Expression Profiling;Generations;Genes;Genomics;Glucocorticoids;Goals;Health;healthy volunteer;high throughput screening;Human;Human Genome;Immune;Immune Targeting;Immunosuppression;improved;In Vitro;in vivo Model;Inflammatory;Measures;mimetics;Molecular;monocyte;nanobodies;National Center for Advancing Translational Sciences;novel drug class;Pathway interactions;Performance;Pharmaceutical Preparations;pharmacologic;Production;programs;Protocols documentation;Rare Diseases;Reporter;Reporting;Reproducibility;Research;response;side effect;small molecule;Testing;tool;transcriptome sequencing;Translations;Work,Selective targeting of immune-specific glucocorticoid-sensitive genes,379,NA,NA,NA,NA,6,NA,NA,327632,NA
11191937,ZIA,TR,1,N,NA,NA,NA,NA,ZIATR000383,NA,NA,1ZIATR000383-05,NCATS:163816\,INTRAMURAL RESEARCH,2024,NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES,NA,NA,NA,78353074 (contact),"ZAKHAROV, ALEXEY  (contact)",NA,NA,NA,Amphotericin B;antagonist;anti-fungal agents;Antifungal Therapy;Aspergillus fumigatus;Automobile Driving;Azoles;Basic Science;Biological Assay;Candida albicans;Candida glabrata;clinical efficacy;Cryptococcus neoformans;Death Rate;drug candidate;Fungal Drug Resistance;Health;high throughput screening;Human;Human Genome;improved;Mycoses;National Center for Advancing Translational Sciences;pathogenic fungus;Patients;Pharmaceutical Preparations;pharmacologic;Predisposition;programs;Rare Diseases;Reporting;Research;resistance mechanism;screening;tool;Translations;Work,Antifungal Antagonism Screening,383,NA,NA,NA,NA,5,NA,NA,163816,NA
11191938,ZIA,TR,1,N,NA,NA,NA,NA,ZIATR000391,NA,NA,1ZIATR000391-06,NCATS:163816\,INTRAMURAL RESEARCH,2024,NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES,NA,NA,NA,14380300 (contact),"MARUGAN, JUAN  (contact)",NA,NA,NA,"addiction;Alcohols;Automobile Driving;Basic Science;Binding Sites;Biological Assay;Databases;drug candidate;Early identification;Electrophysiology (science);Fluorescence;GIRK2 subunit, G protein-coupled inwardly-rectifying potassium channel;Health;Homology Modeling;Human;Human Genome;improved;in silico;Ion Channel;Molecular Bank;molecular modeling;N-terminal;National Center for Advancing Translational Sciences;Pharmaceutical Preparations;pharmacologic;programs;Rare Diseases;Reporting;Research;screening;Screening Result;tool;Translations;Work",Identification of GIRK2 channel modulators,391,NA,NA,NA,NA,6,NA,NA,163816,NA
11191939,ZIA,TR,1,N,NA,NA,NA,NA,ZIATR000393,NA,NA,1ZIATR000393-06,NCATS:163816\,INTRAMURAL RESEARCH,2024,NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES,NA,NA,NA,77875535 (contact),"RAI BANTUKALLU, GANESHA  (contact)",NA,NA,NA,aldehyde dehydrogenases;Aldehydes;ALDH1A2 gene;Betaine;Biochemical;Biological Assay;Cells;Cellular Assay;Chemicals;Data Set;Development;Disease;Environmental Pollutants;Enzymes;Family;follow-up;Future;gamma-Aminobutyric Acid;Goals;high throughput screening;in silico;Inflammation;inhibitor;Libraries;Malignant Neoplasms;Molecular Probes;National Center for Advancing Translational Sciences;nutrient metabolism;Obesity;Pharmaceutical Preparations;pharmacologic;Process;Protein Isoforms;Role;screening;Signal Transduction;Specificity;Therapeutic;Tretinoin,Identification of isoform-selective ALDH inhibitors,393,NA,NA,NA,NA,6,NA,NA,163816,NA
11191940,ZIA,TR,1,N,NA,NA,NA,NA,ZIATR000397,NA,NA,1ZIATR000397-05,NCATS:994550\,INTRAMURAL RESEARCH,2024,NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES,NA,NA,NA,14380167 (contact),"FERRER, MARC  (contact)",NA,NA,NA,"3-Dimensional;Anti-viral Agents;Atopic Dermatitis;biofabrication;Biological Assay;bioprinting;cancer cell;Cancer Model;Cells;Chemosensitization;chemotherapeutic agent;clinical predictors;cohort;Collaborations;Collection;cytokine;Dermis;Disease;disease model;disease phenotype;disease-in-a-dish;drug discovery;Drug Modelings;Drug Screening;Endothelial Cells;Epidermis;Fibroblasts;Fibrosis;Fluorescence Microscopy;Goals;high throughput screening;Human;Immune;in vitro Assay;induced pluripotent stem cell;Infection;keratinocyte;Label;Libraries;Macrophage;Malignant Neoplasms;Measures;Melanoma;Mesenchymal Stem Cells;microbiome;Modeling;Morphology;National Center for Advancing Translational Sciences;National Institute of Arthritis, and Musculoskeletal, and Skin Diseases;Oncology;Outcome;Patients;Permeability;Pharmaceutical Preparations;pharmacologic;Phenotype;Physiological;Protocols documentation;Psoriasis;Reporter;response;Scleroderma;screening;Simplexvirus;Skin;Skin Cancer;skin disorder;skin fibrosis;skin squamous cell carcinoma;Skin Tissue;Stress;stressor;Techniques;Testing;Th2 Cells;Therapeutic Effect;Thick;Tissue Engineering;Tissue Model;Tissues;Universities;Vascularization;Virus;Virus Diseases;Virus Replication;Washington",3D Bioprinted skin models for drug screening,397,NA,NA,NA,NA,5,NA,NA,994550,NA
11191941,ZIA,TR,1,N,NA,NA,NA,NA,ZIATR000398,NA,NA,1ZIATR000398-05,NCATS:994549\,INTRAMURAL RESEARCH,2024,NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES,NA,NA,NA,14380167 (contact),"FERRER, MARC  (contact)",NA,NA,NA,3-Dimensional;Aftercare;airway epithelium;angiogenesis;anti-cancer therapeutic;Antitumor Drug Screening Assays;Biological Assay;biomarker discovery;bioprinting;Bladder;Breast;cancer cell;Cancer Cell Growth;Cancer Detection;Cancer Model;Cell Line;Cell model;Cells;cellular imaging;Collection;Development;drug development;drug discovery;Drug Modelings;Drug Screening;efficacy testing;Endothelial Cells;Epithelial Cells;Epithelium;Fibroblasts;Fluorescence;Fluorescence Microscopy;Functional disorder;Goals;Growth;Human;Image Analysis;Immune;Immunodeficient Mouse;In Vitro;Label;lentivirally transduced;Lung;Macrophage;Malignant neoplasm of lung;Malignant Neoplasms;Mesothelial Cell;Mesothelioma;Modeling;Monitor;monolayer;Morphology;Neoplasm Metastasis;neoplastic cell;new therapeutic target;Non-Small-Cell Lung Carcinoma;Oncology;Pericytes;pharmacologic;Physiological;Physiology;preclinical efficacy;Preclinical Testing;predictive test;prevent;Proliferating;Proteins;Protocols documentation;Recurrent disease;response;screening;Structure of parenchyma of lung;Surface;Therapeutic;Therapeutic Intervention;Tissue Model;Tissues;transcriptomics;tumor;tumor growth;Vascularization;vasculogenesis;Xenograft procedure,3D Bioprinted lung cancer models for drug screening,398,NA,NA,NA,NA,5,NA,NA,994549,NA
11191942,ZIA,TR,1,N,NA,NA,NA,NA,ZIATR000399,NA,NA,1ZIATR000399-05,NCATS:994549\,INTRAMURAL RESEARCH,2024,NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES,NA,NA,NA,14380167 (contact),"FERRER, MARC  (contact)",NA,NA,NA,3-Dimensional;angiogenesis;bevacizumab;bioprinting;Blood-Retinal Barrier;Bruch&apos;s basal membrane structure;Choroid;Choroidal Neovascularization;clinically relevant;Disease;Drug Modelings;Drug Screening;Engineering;Extracellular Matrix;Exudative age-related macular degeneration;Goals;human induced pluripotent stem cells;hypoxia inducible factor 1;improved;in vitro Model;Macrophage;Modeling;new therapeutic target;Pathologic Neovascularization;Phenotype;Photoreceptors;Prevention;Recovery;Recurrence;Retina;Retinal Diseases;senescence;Structure of retinal pigment epithelium;Techniques;Therapeutic;therapeutic development;therapeutic target;Tissue Model;Tissues;Vascular Endothelium;Vascularization;Virus Diseases;Vision;ZIKV infection,3D Bioprinted retina models for drug screening,399,NA,NA,NA,NA,5,NA,NA,994549,NA
11191943,ZIA,TR,1,N,NA,NA,NA,NA,ZIATR000400,NA,NA,1ZIATR000400-05,NCATS:163816\,INTRAMURAL RESEARCH,2024,NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES,NA,NA,NA,14380209 (contact),"HALL, MATTHEW  (contact)",NA,NA,NA,Biochemical;Biological Assay;Biology;Chemical Structure;Chemicals;cheminformatics;Collection;Data;Enzymes;Family;Goals;Individual;interest;Libraries;member;Methods;Methyltransferase;Molecular;Molecular Bank;Process;Reporting;scaffold;Scientist;screening;small molecule;Specificity,Profiling of methyltransferases,400,NA,NA,NA,NA,5,NA,NA,163816,NA
11191944,ZIA,TR,1,N,NA,NA,NA,NA,ZIATR000401,NA,NA,1ZIATR000401-05,NCATS:163816\,INTRAMURAL RESEARCH,2024,NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES,NA,NA,NA,14380300 (contact),"MARUGAN, JUAN  (contact)",NA,NA,NA,Adenoviruses;Automobile Driving;Basic Science;Binding;Biological Assay;biophysical techniques;candidate identification;design;drug candidate;Health;Human;Human Genome;improved;Lead;National Center for Advancing Translational Sciences;novel;pharmacologic;programs;Rare Diseases;Reagent;Reporting;Research;small molecule;Testing;tool;Translations;Viral Physiology;virtual screening;Work,Modulators of RPS14 with broad antiviral activity,401,NA,NA,NA,NA,5,NA,NA,163816,NA
11191945,ZIA,TR,1,N,NA,NA,NA,NA,ZIATR000404,NA,NA,1ZIATR000404-05,NCATS:327632\,INTRAMURAL RESEARCH,2024,NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES,NA,NA,NA,77844220 (contact),"HENDERSON, MARK  (contact)",NA,NA,NA,Automobile Driving;Autosomal Dominant Polycystic Kidney;Basic Science;Cations;Cell membrane;disease-causing mutation;drug candidate;Health;high throughput screening;Human;Human Genome;improved;Integral Membrane Protein;molecular modeling;Mutation;National Center for Advancing Translational Sciences;novel;pharmacologic;polycystic kidney disease 1 protein;programs;Rare Diseases;Research;Testing;tool;Translations;virtual screening,High-throughput screening to identify modulators of PKD2 function,404,NA,NA,NA,NA,5,NA,NA,327632,NA
11191946,ZIA,TR,1,N,NA,NA,NA,NA,ZIATR000405,NA,NA,1ZIATR000405-05,NCATS:491448\,INTRAMURAL RESEARCH,2024,NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES,NA,NA,NA,77844220 (contact),"HENDERSON, MARK  (contact)",NA,NA,NA,Automobile Driving;Basic Science;Brain;brain cell;Breast;Cells;combinatorial;drug candidate;Drug Kinetics;efficacy study;Formulation;Health;high throughput screening;Human;Human Genome;improved;inhibitor;Metastatic malignant neoplasm to brain;National Center for Advancing Translational Sciences;novel;pharmacologic;programs;Rare Diseases;Research;screening;small molecule;tool;Toxic effect;Translations,High-throughput screening to identify inhibitors of breast-to-brain metastasis,405,NA,NA,NA,NA,5,NA,NA,491448,NA
11191947,ZIA,TR,1,N,NA,NA,NA,NA,ZIATR000406,NA,NA,1ZIATR000406-05,NCATS:163816\,INTRAMURAL RESEARCH,2024,NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES,NA,NA,NA,14380300 (contact),"MARUGAN, JUAN  (contact)",NA,NA,NA,Binding;Biological Assay;Cell Membrane Permeability;Complex;data acquisition;Development;Devices;Dose;Environment;experimental study;Heating;high throughput screening;improved;Kinetics;lead optimization;luminescence;melting;Methods;nanoluciferase;Proteins;prototype;rapid testing;response;screening;small molecule;Technology;Time;Variant,Development of high-throughput CETSA target engagement assays,406,NA,NA,NA,NA,5,NA,NA,163816,NA
11191948,ZIA,TR,1,N,NA,NA,NA,NA,ZIATR000411,NA,NA,1ZIATR000411-05,NCATS:245724\,INTRAMURAL RESEARCH,2024,NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES,NA,NA,NA,14380091 (contact),"SIMEONOV, ANTON  (contact)",NA,NA,NA,advanced disease;Androgens;Binding;Biochemical;Biological Assay;breast cancer progression;Cellular Assay;Chemicals;Clinical;Collection;Estrogens;Excision;Goals;hormone therapy;Hormones;inhibitor;Ligands;Malignant Breast Neoplasm;Malignant neoplasm of prostate;Malignant Neoplasms;Mediating;multicatalytic endopeptidase complex;National Center for Advancing Translational Sciences;novel strategies;Nuclear Hormone Receptors;Nuclear Receptors;Pharmaceutical Chemistry;Polyubiquitin;prevent;Production;receptor;receptor function;Reporting;Research;RNA Interference;small molecule inhibitor;System;Therapeutic Intervention;Ubiquitin;ubiquitin isopeptidase,Identification of small molecule inhibitors of DUB3,411,NA,NA,NA,NA,5,NA,NA,245724,NA
11191949,ZIA,TR,1,N,NA,NA,NA,NA,ZIATR000412,NA,NA,1ZIATR000412-05,NCATS:327632\,INTRAMURAL RESEARCH,2024,NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES,NA,NA,NA,78353074 (contact),"ZAKHAROV, ALEXEY  (contact)",NA,NA,NA,Antibiotic Therapy;Antibiotics;antimicrobial;Area;assay development;Awareness;Bacteria;Biological Assay;Borrelia;Borrelia burgdorferi;Caseins;Cells;Characteristics;Chronic;Development;Disease;Enzymes;Etiology;experience;extracellular;Fluorescence Resonance Energy Transfer;fluorophore;Genetic Transcription;Growth;Helicobacter pylori;High temperature of physical object;high throughput screening;Homologous Gene;Immune response;Impairment;inhibitor;Label;Literature;Lyme Disease;Molecular Chaperones;Order Spirochaetales;Pathogenesis;Pathogenicity;Patients;Peptides;periplasm;Post Treatment Lyme Disease Syndrome;Prevalence;Protein Family;Proteins;Quality Control;Recombinants;redshift;Reporting;screening;Series;Serine Protease;small molecule;small molecule inhibitor;Specificity;Surface;Testing;Therapeutic Effect;Tick-Borne Diseases;Tissues;tool;Validation;virtual screening;Virulence,Screening for small molecule inhibitors of B. burgdorferi HtrA,412,NA,NA,NA,NA,5,NA,NA,327632,NA
11191950,ZIA,TR,1,N,NA,NA,NA,NA,ZIATR000413,NA,NA,1ZIATR000413-05,NCATS:327632\,INTRAMURAL RESEARCH,2024,NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES,NA,NA,NA,77875535 (contact),"RAI BANTUKALLU, GANESHA  (contact)",NA,NA,NA,Antibiotics;Automobile Driving;Basic Science;Biological Assay;Borrelia;Borrelia burgdorferi;cytotoxicity;Diagnosis;Doxycycline;drug candidate;Focal Infection;Health;Human;Human Genome;improved;interest;Luciferases;Lyme Disease;microbial;Miniaturization;National Center for Advancing Translational Sciences;Pathway interactions;Pharmaceutical Preparations;pharmacologic;programs;Rare Diseases;Recombinants;Reporting;Research;Ribosomes;screening;small molecule libraries;standard care;Structure;Tick-Borne Diseases;tool;Translations;Treatment Protocols;United States;Work,Screening for B. burgdorferi borreliacidal/borreliastatic compounds,413,NA,NA,NA,NA,5,NA,NA,327632,NA
11191951,ZIA,TR,1,N,NA,NA,NA,NA,ZIATR000414,NA,NA,1ZIATR000414-05,NCATS:85450\,INTRAMURAL RESEARCH,2024,NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES,NA,NA,NA,14380167 (contact),"FERRER, MARC  (contact)",NA,NA,NA,2019-nCoV;3-Dimensional;Address;Air;airway epithelium;Alveolar;Alveolar Cell;Anti-viral Agents;Anti-viral Therapy;antiviral drug development;Area;atypical pneumonia;betacoronavirus;biofabrication;bioprinting;Brain;Cells;Clinical;clinical efficacy;Communities;Community Developments;Coronavirus;COVID-19;COVID-19 patient;COVID-19 pneumonia;Disease;drug development;drug repurposing;Epithelial Cells;Epithelium;Event;Hepatocyte;Human;Immune;in vitro Assay;Infection;influenzavirus;Intestines;Laboratories;Liquid substance;Liver;Lung;Microfluidics;Modeling;National Center for Advancing Translational Sciences;neural;Neurons;novel;pandemic disease;parainfluenza virus;Pathology;Perfusion;Permeability;Pharmaceutical Preparations;Physiological;Positioning Attribute;programs;Protocols documentation;Public Health;Research Activity;research and development;Research Support;respiratory;respiratory virus;response;SARS-CoV-2 infection;Societies;spheroids;Structure of parenchyma of lung;System;Testing;Therapeutic Intervention;thrombotic;Tissue Model;Tissues;Tracheobronchial;Translational Research;United States National Institutes of Health;Vaccines;Variant;Vascularization;Viral;Viral Physiology;Virus;Virus Diseases,COVID-19: 3D Bioprinted Tissue Models for Respiratory Viruses,414,NA,NA,NA,NA,5,NA,NA,85450,NA
11191952,ZIA,TR,1,N,NA,NA,NA,NA,ZIATR000418,NA,NA,1ZIATR000418-05,NCATS:163816\,INTRAMURAL RESEARCH,2024,NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES,NA,NA,NA,14380209 (contact),"HALL, MATTHEW  (contact)",NA,NA,NA,analog;anti-cancer therapeutic;cancer cell;cancer type;Cell Death;Cell Line;Chemistry;chemotherapy;Coupling;Cytoprotection;Diversity Library;Glutathione Disulfide;glutathione peroxidase;Human;Hydrogen Peroxide;inhibitor;Libraries;Methods;National Center for Advancing Translational Sciences;Non-Small-Cell Lung Carcinoma;novel;Oxidative Stress;Pathway interactions;Powder dose form;Radiation therapy;Reactive Oxygen Species;Recombinants;Role;screening;Selenocysteine;selenoenzyme;small molecule;small molecule inhibitor;Testing;therapy resistant;triple-negative invasive breast carcinoma,Screening for novel inhibitors of Glutathione Peroxidase 1 and 4,418,NA,NA,NA,NA,5,NA,NA,163816,NA
11191953,ZIA,TR,1,N,NA,NA,NA,NA,ZIATR000428,NA,NA,1ZIATR000428-05,NCATS:409540\,INTRAMURAL RESEARCH,2024,NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES,NA,NA,NA,77844220 (contact),"HENDERSON, MARK  (contact)",NA,NA,NA,5&apos;-AMP-activated protein kinase;Adenosine Monophosphate;Autophagocytosis;Biological Assay;Cells;Cholesterol;Data;Disease;efficacy study;Homeostasis;improved;in vivo;Lysosomal Storage Diseases;Mass Spectrum Analysis;Measures;Metabolism;methyl-beta-cyclodextrin;Modeling;National Center for Advancing Translational Sciences;novel;Pathway interactions;Pharmaceutical Chemistry;Protein Kinase;response;Scientist;small molecule;Stress;Testing;Work,AMPK synthetic activators,428,NA,NA,NA,NA,5,NA,NA,409540,NA
11191954,ZIA,TR,1,N,NA,NA,NA,NA,ZIATR000430,NA,NA,1ZIATR000430-04,NCATS:255534\,INTRAMURAL RESEARCH,2024,NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES,NA,NA,NA,14380140 (contact),"INGLESE, JAMES  (contact)",NA,NA,NA,Alleles;alpha synuclein;American;Anti-Infective Agents;Area;autosome;behavioral phenotyping;Biological Assay;Biological Models;Caenorhabditis;Caenorhabditis elegans;Cell Culture Techniques;Cell Line;Cell Membrane Permeability;cell type;Characteristics;Chemical Agents;Chemical Exposure;Chemicals;Collaborations;Cyclic Peptides;Cytometry;Data;design;Development;Disease;disease phenotype;DNA Sequence Alteration;dopaminergic neuron;Drug Screening;drug-like compound;Engineering;Enhancers;Exhibits;experimental study;Fluorescence;follow-up;Foundations;Funding;Future;gene conservation;gene function;Gene Mutation;Genes;Genetic;Genetic Transcription;genome editing;Genotype;Goals;Health;high throughput screening;Homologous Gene;Human;human disease;Human Pathology;Image;in vivo;Infectious Agent;inhibitor;instrumentation;interest;Investigational Therapies;Knock-out;Label;Laboratories;Laser Scanning Cytometry;Lasers;Lead;Libraries;Life;Link;LRRK2 gene;Measures;Medical center;meetings;membrane activity;Methods;Mitochondria;model organism;Monitor;Motility;mutant;Mutation;National Institute of Neurological Disorders and Stroke;Nematoda;Nerve Degeneration;neuron loss;neuronal survival;Neurons;novel;novel therapeutic intervention;Organism;Parkin;Parkinson Disease;Pathogenicity;Pathway interactions;Patients;Pharmaceutical Preparations;pharmacologic;Pharmacology;Phenotype;Phosphoglycerate Mutase;Process;Proteins;Proteomics;Reporter;screening;small molecule libraries;Societies;Sorting;System;Testing;Therapeutic;Therapeutic Agents;Time;Tissues;United States National Institutes of Health;Variant;Work,C. elegans as a model organism for human disease through the application of phenologs,430,NA,NA,NA,NA,4,NA,NA,255534,NA
11191955,ZIA,TR,1,N,NA,NA,NA,NA,ZIATR000432,NA,NA,1ZIATR000432-04,NCATS:491448\,INTRAMURAL RESEARCH,2024,NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES,NA,NA,NA,77844220 (contact),"HENDERSON, MARK  (contact)",NA,NA,NA,Automobile Driving;Basic Science;Collaborations;Disease;drug candidate;efficacy study;Evaluation;Goals;Health;Human;Human Genome;improved;inhibitor;Modeling;mouse model;mutant;National Center for Advancing Translational Sciences;Nerve Degeneration;Parkinson Disease;pharmacologic;Phosphotransferases;programs;Rare Diseases;Research;Role;Testing;tool;Translations,Evaluation of cAbl allosteric inhibitors in Gaucher-Parkinson,432,NA,NA,NA,NA,4,NA,NA,491448,NA
11191956,ZIA,TR,1,N,NA,NA,NA,NA,ZIATR000436,NA,NA,1ZIATR000436-04,NCATS:327632\,INTRAMURAL RESEARCH,2024,NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES,NA,NA,NA,78353074 (contact),"ZAKHAROV, ALEXEY  (contact)",NA,NA,NA,autoinflammatory diseases;Biochemical;Biological Assay;Blindness;Cells;Disease;Fever;Goals;Gout;Headache;Helicobacter pylori;high throughput screening;Immune;Inflammation;Inflammatory Bowel Diseases;Inherited;Inhibition of NF-KB activation;inhibitor;Lead;Link;Malignant Neoplasms;Monitor;Mutation;Periodicals;Phosphorylation;Phosphotransferases;Recombinants;reduce symptoms;Reporter;Reporter Genes;Reporting;Role;sensor;Signal Transduction;small molecule;small molecule inhibitor;small molecule libraries,Identification of ALPK1 inhibitors,436,NA,NA,NA,NA,4,NA,NA,327632,NA
11191957,ZIA,TR,1,N,NA,NA,NA,NA,ZIATR000442,NA,NA,1ZIATR000442-03,NCATS:327632\,INTRAMURAL RESEARCH,2024,NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES,NA,NA,NA,14380091 (contact),"SIMEONOV, ANTON  (contact)",NA,NA,NA,antagonist;Anti-Retroviral Agents;Biological Assay;brain tissue;Cells;Cerebrospinal Fluid;Combined Modality Therapy;Detection;Diversity Library;Hela Cells;HIV;lead optimization;Miniaturization;National Center for Advancing Translational Sciences;Peripheral Blood Mononuclear Cell;Pharmaceutical Chemistry;Proteins;screening;success;T-Lymphocyte;tat Protein;Transcript;Validation;Viral Load result;Virus;Virus Diseases;Virus Replication;Work,HTS screening and identification of HIV-Tat antagonists,442,NA,NA,NA,NA,3,NA,NA,327632,NA
11191958,ZIA,TR,1,N,NA,NA,NA,NA,ZIATR000443,NA,NA,1ZIATR000443-03,NCATS:327632\,INTRAMURAL RESEARCH,2024,NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES,NA,NA,NA,14380209 (contact),"HALL, MATTHEW  (contact)",NA,NA,NA,Binding;Biochemical;Biological Assay;Biological Process;Chemicals;Clinic;Collection;Complex;Development;Docking;Enzyme Inhibitor Drugs;enzyme substrate;Epigenetic Process;Histamine;Individual;inhibitor;methyl group;Methyltransferase;Norepinephrine;novel;Pharmaceutical Chemistry;Play;protein structure;Rare Diseases;S-Adenosylhomocysteine;S-Adenosylmethionine;Signal Pathway;simulation;small molecule;small molecule inhibitor;small molecule libraries;Structure;therapeutic candidate;virtual;Work,Identification and development of a small molecule probe for GNMT,443,NA,NA,NA,NA,3,NA,NA,327632,NA
11191959,ZIA,TR,1,N,NA,NA,NA,NA,ZIATR000444,NA,NA,1ZIATR000444-03,NCATS:327632\,INTRAMURAL RESEARCH,2024,NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES,NA,NA,NA,14380091 (contact),"SIMEONOV, ANTON  (contact)",NA,NA,NA,Address;Antibiotic Resistance;Bacterial Drug Resistance;Bacterial Infections;Biological Assay;Clinical;Combined Modality Therapy;Drug Combinations;Drug Kinetics;Drug resistance;Fiber;Infection;Kinetics;Liquid substance;Measures;miniaturize;Modeling;National Center for Advancing Translational Sciences;Pharmaceutical Preparations;Public Health;response;screening;System,Assay optimization and screening for measuring the kinetics of antibacterial resistance emergence,444,NA,NA,NA,NA,3,NA,NA,327632,NA
11191960,ZIA,TR,1,N,NA,NA,NA,NA,ZIATR000446,NA,NA,1ZIATR000446-03,NCATS:327632\,INTRAMURAL RESEARCH,2024,NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES,NA,NA,NA,14380091 (contact),"SIMEONOV, ANTON  (contact)",NA,NA,NA,Address;Anti-Bacterial Agents;Antibiotics;Bacterial Infections;Bacteriophages;Biological Assay;Cells;density;Drug Combinations;Emerging infection;Evaluation;Measurement;Mediating;Multi-Drug Resistance;novel;Optics;Pharmaceutical Preparations;preclinical development;Pseudomonas aeruginosa;Risk;screening;Testing;Work,Challenges in Detecting Synergistic Activity of Phage-Mediated Bacterial Killing with Antibiotics in High-Throughput Format,446,NA,NA,NA,NA,3,NA,NA,327632,NA
11191961,ZIA,TR,1,N,NA,NA,NA,NA,ZIATR000447,NA,NA,1ZIATR000447-03,NCATS:327632\,INTRAMURAL RESEARCH,2024,NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES,NA,NA,NA,14380091 (contact),"SIMEONOV, ANTON  (contact)",NA,NA,NA,Automobile Driving;Basic Science;Biological Assay;Cells;Cessation of life;drug candidate;Health;Human;Human Genome;improved;Lipoxygenase;National Center for Advancing Translational Sciences;new therapeutic target;pathogenic bacteria;pharmacologic;Polyunsaturated Fatty Acids;programs;Pseudomonas aeruginosa;Rare Diseases;Research;screening;small molecule inhibitor;Theft;tool;Translations;Work,Identification of small molecule inhibitors of Pseudomonas aeruginosa lipoxygease (pLOXA)-induced ferroptosis,447,NA,NA,NA,NA,3,NA,NA,327632,NA
11191962,ZIA,TR,1,N,NA,NA,NA,NA,ZIATR000448,NA,NA,1ZIATR000448-03,NCATS:327632\,INTRAMURAL RESEARCH,2024,NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES,NA,NA,NA,77844220 (contact),"HENDERSON, MARK  (contact)",NA,NA,NA,Biological Assay;Biology;cancer cell;Cells;Chemicals;Chromatin;Collaborations;Collection;cost effective;Development;Dose;Enzymes;Epigenetic Process;Ewings sarcoma;Goals;high throughput screening;Investigational Therapies;Measures;National Center for Advancing Translational Sciences;Pattern;Research;response;screening;small molecule;Testing,Development of a HT-ATACseq assay to identify epigenetic regulators of Ewing Sarcoma cancer cells (Chemical Biology Consortium/NCI Experimental Therapeutics Collaboration),448,NA,NA,NA,NA,3,NA,NA,327632,NA
11191963,ZIA,TR,1,N,NA,NA,NA,NA,ZIATR000449,NA,NA,1ZIATR000449-03,NCATS:163816\,INTRAMURAL RESEARCH,2024,NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES,NA,NA,NA,77844220 (contact),"HENDERSON, MARK  (contact)",NA,NA,NA,cancer cell;Cell model;Cells;Chemicals;chemotherapy;Clinical;Collection;cytotoxic;drug sensitivity;Follow-Up Studies;high throughput screening;Invaded;Libraries;Muscle;Neoplasm Metastasis;novel;Oncology;Organ;Phase;prostate cancer cell;prostate cancer cell line;Resistance;small molecule;Smooth Muscle;taxane;Testing;Toxic effect,Identifying small molecules with selective toxicity towards muscle invasive prostate cancer cells,449,NA,NA,NA,NA,3,NA,NA,163816,NA
11191964,ZIA,TR,1,N,NA,NA,NA,NA,ZIATR000450,NA,NA,1ZIATR000450-03,NCATS:327632\,INTRAMURAL RESEARCH,2024,NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES,NA,NA,NA,77844220 (contact),"HENDERSON, MARK  (contact)",NA,NA,NA,autism spectrum disorder;Automobile Driving;Basic Science;Cell surface;drug candidate;Health;high throughput screening;Human;Human Genome;improved;Investigation;molecular modeling;National Center for Advancing Translational Sciences;novel;pharmacologic;programs;Proteins;Rare Diseases;Reporting;Research;small molecule;Testing;tool;trafficking;Translations;virtual screening;Work,Identification of small molecules that improve trafficking of NLGN4X/Y for autism,450,NA,NA,NA,NA,3,NA,NA,327632,NA
11191965,ZIA,TR,1,N,NA,NA,NA,NA,ZIATR000451,NA,NA,1ZIATR000451-03,NCATS:327632\,INTRAMURAL RESEARCH,2024,NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES,NA,NA,NA,77844220 (contact),"HENDERSON, MARK  (contact)",NA,NA,NA,Affinity;Automobile Driving;Basic Science;cytokine;Disease;drug candidate;ERCC3 gene;Health;high throughput screening;Human;Human Genome;improved;Inflammatory;interest;Methods;National Center for Advancing Translational Sciences;Nuclear Protein;pharmacologic;Phenocopy;Production;programs;Proteins;Proteomics;Rare Diseases;Research;screening;small molecule;Spironolactone;tool;Translations,Identification of small molecule degraders of XPB for inflammatory diseases,451,NA,NA,NA,NA,3,NA,NA,327632,NA
11191966,ZIA,TR,1,N,NA,NA,NA,NA,ZIATR000452,NA,NA,1ZIATR000452-03,NCATS:327632\,INTRAMURAL RESEARCH,2024,NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES,NA,NA,NA,77844220 (contact),"HENDERSON, MARK  (contact)",NA,NA,NA,Automobile Driving;Basic Science;Behavior;Biotin;Biotinylation;Dasatinib;drug candidate;Extramural Activities;Health;Human;Human Genome;improved;Label;Ligase;Mass Spectrum Analysis;Methods;Methotrexate;Molecular;National Center for Advancing Translational Sciences;pharmacologic;programs;Proteins;Rare Diseases;Research;small molecule;System;tool;Translations,Characterizing molecular interactomes using TurboID,452,NA,NA,NA,NA,3,NA,NA,327632,NA
11191967,ZIA,TR,1,N,NA,NA,NA,NA,ZIATR000454,NA,NA,1ZIATR000454-03,NCATS:327632\,INTRAMURAL RESEARCH,2024,NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES,NA,NA,NA,77844220 (contact),"HENDERSON, MARK  (contact)",NA,NA,NA,Antibodies;Automobile Driving;Basic Science;Blood - brain barrier anatomy;Cerebral endothelium;Chemistry;drug candidate;Encapsulated;exosome;Fc domain;Health;Human;Human Genome;improved;Ligands;Methods;National Center for Advancing Translational Sciences;novel strategies;pharmacologic;Phospholipids;Polysaccharides;programs;Rare Diseases;Research;System;tool;transcytosis;Translations;Vesicle,New approaches for facilitating transcytosis of biologically active molecules,454,NA,NA,NA,NA,3,NA,NA,327632,NA
11191968,ZIA,TR,1,N,NA,NA,NA,NA,ZIATR000455,NA,NA,1ZIATR000455-03,NCATS:327632\,INTRAMURAL RESEARCH,2024,NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES,NA,NA,NA,77875535 (contact),"RAI BANTUKALLU, GANESHA  (contact)",NA,NA,NA,Adopted;Biological Assay;cancer type;Cell Physiology;Cells;Collection;Complex;Development;Disease;drug repurposing;Drug Screening;Family member;Goals;high throughput screening;Libraries;Mediating;miniaturize;Monitor;multicatalytic endopeptidase complex;nanoluciferase;National Center for Advancing Translational Sciences;Play;Protein Family;Proteins;Publications;Reporter;Reporting;Role;screening;Signal Transduction;small molecule;Triage;ubiquitin ligase;ubiquitin-protein ligase;Validation,Screening for small molecule modulators of SCFbTrCP ubiquitin ligase complex,455,NA,NA,NA,NA,3,NA,NA,327632,NA
11191969,ZIA,TR,1,N,NA,NA,NA,NA,ZIATR000456,NA,NA,1ZIATR000456-03,NCATS:327632\,INTRAMURAL RESEARCH,2024,NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES,NA,NA,NA,14380091 (contact),"SIMEONOV, ANTON  (contact)",NA,NA,NA,Adopted;Automobile Driving;Basic Science;Biological Assay;Breast Cancer cell line;Cancer Cell Growth;Cell Differentiation process;Cells;Collection;demethylation;Development;drug candidate;drug repurposing;Drug resistance;Drug Screening;Genes;Goals;Health;histone demethylase;Histone H3;Human;Human Genome;improved;in vivo;KDM5B gene;Libraries;Lysine;Malignant Neoplasms;miniaturize;Monitor;National Center for Advancing Translational Sciences;Neoplasm Metastasis;novel;overexpression;pharmacologic;programs;Proteins;Rare Diseases;Reporter;Reporting;Research;screening;small molecule;small molecule inhibitor;Specificity;tool;Translations;tumor growth;Validation;Western Blotting;Work,Screening for small molecule degraders of KDM5A & B,456,NA,NA,NA,NA,3,NA,NA,327632,NA
11191970,ZIA,TR,1,N,NA,NA,NA,NA,ZIATR000458,NA,NA,1ZIATR000458-03,NCATS:163816\,INTRAMURAL RESEARCH,2024,NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES,NA,NA,NA,14380091 (contact),"SIMEONOV, ANTON  (contact)",NA,NA,NA,Automobile Driving;Basic Science;Biological Assay;Cancer Control;cell motility;Cell Physiology;Cells;Cytoplasm;design;Development;Disease;drug candidate;Drug Targeting;Enzymes;Family;Health;Human;Human Genome;improved;In Vitro;inhibitor;Inositol;Inositol Phosphates;insight;lead optimization;Lipids;Malignant Neoplasms;member;Miniaturization;National Center for Advancing Translational Sciences;novel drug class;Pharmaceutical Chemistry;pharmacologic;pharmacophore;Pharmacotherapy;Phosphorylation;Phosphotransferases;Play;Positioning Attribute;programs;Protein Kinase;Proteins;Publications;Rare Diseases;Recombinants;Research;Role;screening;Signal Transduction;small molecule inhibitor;Structure;tool;Translations;tumor growth;tumor metabolism;Validation,In vitro screen for inhibitors of the inositol kinases ITPK1 and PPIP5K,458,NA,NA,NA,NA,3,NA,NA,163816,NA
11191971,ZIA,TR,1,N,NA,NA,NA,NA,ZIATR000459,NA,NA,1ZIATR000459-03,NCATS:327632\,INTRAMURAL RESEARCH,2024,NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES,NA,NA,NA,14380209 (contact),"HALL, MATTHEW  (contact)",NA,NA,NA,Alzheimer&apos;s Disease;Amyotrophic Lateral Sclerosis;Autophagocytosis;Biological Assay;Cells;Cluster Analysis;Disease;Drug Screening;Golgi Apparatus;Neurodegenerative Disorders;Parkinson Disease;Pathway interactions;Property;protein aggregation;screening;small molecule;Spastic Paraplegia;Syndrome,"Screening for drugs that mobilize ATG9A from the Golgi as a potential therapy for SPG type 47, 50, 51 and 52 diseases",459,NA,NA,NA,NA,3,NA,NA,327632,NA
11191972,ZIA,TR,1,N,NA,NA,NA,NA,ZIATR000461,NA,NA,1ZIATR000461-03,NCATS:327632\,INTRAMURAL RESEARCH,2024,NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES,NA,NA,NA,14380209 (contact),"HALL, MATTHEW  (contact)",NA,NA,NA,Affect;Bilirubin;Biliverdin reductase;Biliverdine;Binding;Biochemical;Biological Assay;Biophysics;Catabolism;Characteristics;Crigler-Najjar Syndrome;Development;DNA;Heme;high throughput screening;Hyperbilirubinemia;in vivo;inhibitor;Libraries;Neuronal Dysfunction;Newborn Infant;novel;Pharmaceutical Preparations;Production;Proteins;Reporting;screening;Serum;Services;virtual screening,Development of inhibitors of biliverdin reductase for toxic hyperbilirubinemia,461,NA,NA,NA,NA,3,NA,NA,327632,NA
11191973,ZIA,TR,1,N,NA,NA,NA,NA,ZIATR000462,NA,NA,1ZIATR000462-03,NCATS:327632\,INTRAMURAL RESEARCH,2024,NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES,NA,NA,NA,14380209 (contact),"HALL, MATTHEW  (contact)",NA,NA,NA,Binding;Biological Assay;Biophysics;Bone Marrow Transplantation;Development;Disease;Fetal Hemoglobin;Future;high throughput screening;inhibitor;Laboratories;Length;Methods;new therapeutic target;Phosphotransferases;Production;Proteins;Protocols documentation;Reporting;Sickle Cell Anemia;Treatment Cost;Work,Development of inhibitors of RIOK3 for sickle cell anemia,462,NA,NA,NA,NA,3,NA,NA,327632,NA
11191974,ZIA,TR,1,N,NA,NA,NA,NA,ZIATR000463,NA,NA,1ZIATR000463-02,NCATS:327632\,INTRAMURAL RESEARCH,2024,NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES,NA,NA,NA,14380091 (contact),"SIMEONOV, ANTON  (contact)",NA,NA,NA,Affect;anti-cancer;Automobile Driving;Basic Science;Binding;Biological Assay;Cells;Complex;Development;drug candidate;Genes;Goals;Health;high throughput screening;Human;Human Genome;Immune;Immune response;Immunity;improved;Inflammatory Response;Interferon alpha;Interferon Type I;Interferons;ISG15 gene;JAK1 gene;Knock-out;Malignant neoplasm of cervix uteri;Malignant neoplasm of lung;Malignant Neoplasms;Messenger RNA;National Center for Advancing Translational Sciences;Oncogenic;pharmacologic;programs;Proteins;Rare Diseases;receptor;Reporting;Research;Role;screening;Signal Transduction;small molecule inhibitor;small molecule libraries;Specificity;T cell differentiation;Testing;tool;Translations;tumor;tumor growth;tumor microenvironment;ubiquitin-specific protease,Identification of small molecule inhibitors of USP18,463,NA,NA,NA,NA,2,NA,NA,327632,NA
11191975,ZIA,TR,1,N,NA,NA,NA,NA,ZIATR000464,NA,NA,1ZIATR000464-02,NCATS:327632\,INTRAMURAL RESEARCH,2024,NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES,NA,NA,NA,79334257 (contact),"PATNAIK, SAMARJIT  (contact)",NA,NA,NA,Binding;Biological Availability;Biological Process;Clinic;Collection;Crystallization;Development;Drug Design;Histamine;improved;inhibitor;methyl group;Methyltransferase;Norepinephrine;Oral;Pharmaceutical Chemistry;Pharmaceutical Preparations;Play;Property;Rare Diseases;Reporting;Roentgen Rays;S-Adenosylhomocysteine;S-Adenosylmethionine;Series;Signal Pathway;small molecule;Structure;therapeutic candidate;Transferase;Work,Identification and development of a small molecule probe for HNMT,464,NA,NA,NA,NA,2,NA,NA,327632,NA
11191976,ZIA,TR,1,N,NA,NA,NA,NA,ZIATR000465,NA,NA,1ZIATR000465-02,NCATS:327632\,INTRAMURAL RESEARCH,2024,NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES,NA,NA,NA,14380204 (contact),"SHEN, MIN  (contact)",NA,NA,NA,anti-cancer;Biological Assay;Bortezomib;Cell Line;cellular targeting;Collaborations;Collection;cytotoxic;cytotoxicity;drug discovery;Ewings sarcoma;FDA approved;Follow-Up Studies;high throughput screening;Jurkat Cells;lactacystin;Libraries;Malignant Neoplasms;multicatalytic endopeptidase complex;National Center for Advancing Translational Sciences;new therapeutic target;Pharmaceutical Preparations;screening;small molecule;small molecule libraries;Source;Technology;Testing;Universities;Work,Cytotoxicity profiling of Genesis library in A673 and Jurkat cells,465,NA,NA,NA,NA,2,NA,NA,327632,NA
11191977,ZIA,TR,1,N,NA,NA,NA,NA,ZIATR000466,NA,NA,1ZIATR000466-02,NCATS:327632\,INTRAMURAL RESEARCH,2024,NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES,NA,NA,NA,77844220 (contact),"HENDERSON, MARK  (contact)",NA,NA,NA,Adaptor Signaling Protein;Automobile Driving;Autophagocytosis;Autophagosome;Basic Science;Binding;Binding Sites;Biological Assay;Cells;Chimera organism;Complement;design;drug candidate;Fluorescence Polarization;Health;high throughput screening;Homeostasis;Human;Human Genome;improved;interest;Lysosomes;National Center for Advancing Translational Sciences;novel;Pathway interactions;pharmacologic;programs;Protac;Rare Diseases;receptor;Recycling;Reporter;Reporting;Research;small molecule;Stress;Testing;tool;Translations;virtual screening,Identifying LC3 binders to develop lysosome-targeting chimeras,466,NA,NA,NA,NA,2,NA,NA,327632,NA
11191978,ZIA,TR,1,N,NA,NA,NA,NA,ZIATR000468,NA,NA,1ZIATR000468-02,NCATS:150500\,INTRAMURAL RESEARCH,2024,NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES,NA,NA,NA,14380167 (contact),"FERRER, MARC  (contact)",NA,NA,NA,3-Dimensional;amnion;Anti-Inflammatory Agents;Arum;Award;Biological Assay;bioprinting;Cell Culture Techniques;cell growth;Cell Survival;Cells;Collaborations;cytokine;Decidual Cell;Disease;Drug Screening;Ensure;Epithelial Cells;Exposure to;fetal;fetus cell;Goals;Grant;healthy pregnancy;Inflammation;Inflammatory;Lipopolysaccharides;Maternal-Fetal Exchange;Metabolic;Microfluidics;Modeling;National Center for Advancing Translational Sciences;pharmacologic;Premature Birth;prevent;Side;Testing;Tissue Model;Tissues,3D Bioprinting of feto-maternal barrier tissue models,468,NA,NA,NA,NA,2,NA,NA,150500,NA
11191979,ZIA,TR,1,N,NA,NA,NA,NA,ZIATR000469,NA,NA,1ZIATR000469-02,NCATS:150500\,INTRAMURAL RESEARCH,2024,NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES,NA,NA,NA,14380167 (contact),"FERRER, MARC  (contact)",NA,NA,NA,3-Dimensional;Actins;antifibrotic treatment;Award;BAY 54-9085;Biological Assay;bioprinting;Cell Proliferation;Cell Survival;Cells;Cirrhosis;Clinic;Collaborations;Data;Disease;disease model;Disease Progression;drug candidate;Drug Controls;drug discovery;drug induced liver injury;Drug Screening;Endothelial Cells;Engineering;Environmental Risk Factor;Fatty Acids;Fatty Liver;Fibrosis;Funding;Generations;Genetic;Glucose;Goals;hepatic acinus structure;Hepatocyte;high-throughput drug screening;Human;Immunofluorescence Immunologic;in silico;Inflammatory;Kupffer Cells;Lipids;Liver;Liver diseases;Liver Fibrosis;Measures;Medical;Modeling;Molecular;Monitor;National Center for Advancing Translational Sciences;National Institute of Environmental Health Sciences;non-alcoholic fatty liver;non-alcoholic fatty liver disease;nonalcoholic steatohepatitis;Pharmaceutical Preparations;pharmacologic;Phenotype;predictive modeling;prevent;Primary carcinoma of the liver cells;Procollagen;progression marker;Reactive Oxygen Species;response;screening;Severity of illness;Signal Transduction;Smooth Muscle;spheroids;stellate cell;Testing;Therapeutic;Tissue Model;Toxic effect;toxicant;Toxicology;United States National Institutes of Health;Universities;Vascularization,3D bioprinting of liver tissue models,469,NA,NA,NA,NA,2,NA,NA,150500,NA
11191980,ZIA,TR,1,N,NA,NA,NA,NA,ZIATR000470,NA,NA,1ZIATR000470-02,NCATS:150500\,INTRAMURAL RESEARCH,2024,NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES,NA,NA,NA,14380167 (contact),"FERRER, MARC  (contact)",NA,NA,NA,3-Dimensional;Acetylcholine;bioink;Biological Assay;bioprinting;Cells;Chemical Stimulation;Clinical;Clustered Regularly Interspaced Short Palindromic Repeats;Collaborations;Congenital Myasthenic Syndromes;Contracts;Development;Disease;Drug Screening;Elasticity;Electric Stimulation;Engineering;Foundations;gene therapy;Goals;In Vitro;Individual;induced pluripotent stem cell;instrument;Laboratories;magnetic field;manufacturing scale-up;Measures;mechanical properties;Modeling;Motor Neurons;Muscle;Muscle Contraction;muscle engineering;Muscle Fibers;mutant;Myoblasts;Myopathy;National Center for Advancing Translational Sciences;National Institute of Neurological Disorders and Stroke;Neuromuscular Diseases;Neuromuscular Junction;Neurons;Output;Patients;Process;programs;Reader;response;Robot;Skeletal Muscle;Testing;Therapeutic;therapeutic development;Time;tissue culture;Tissue Engineering;Tissue Model;Virus;ward,3D bioprinting of skeletal muscle and neuromuscular junction tissue models,470,NA,NA,NA,NA,2,NA,NA,150500,NA
11191981,ZIA,TR,1,N,NA,NA,NA,NA,ZIATR000471,NA,NA,1ZIATR000471-02,NCATS:766601\,INTRAMURAL RESEARCH,2024,NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES,NA,NA,NA,14380140 (contact),"INGLESE, JAMES  (contact)",NA,NA,NA,Acids;Amino Acids;analog;Antineoplastic Agents;Applications Grants;ATP-Binding Cassette Transporters;Autoimmune;Autoimmune Diseases;Binding;Biochemical;Biochemistry;Biological Assay;Cancer cell line;Carbon;Chemicals;Clinical;cofactor;Collaborations;Complex;design;Development;Dihydrofolate Reductase;Dihydrofolate Reductase Inhibitor;Disease;DNA biosynthesis;drug discovery;Enzymes;Evaluation;Extramural Activities;Folic Acid;Folic Acid Antagonists;gamma-Glutamyl Hydrolase;high throughput screening;Hydrolysis;improved;insight;Intracellular Transport;Laboratories;member;Metabolism;Methotrexate;methotrexate analog;Mutate;Names;National Center for Advancing Translational Sciences;novel;Nucleic Acids;nucleobase;overexpression;Pathway interactions;Pharmacology;Phenotype;polyglutamates;Prodrugs;programs;Protac;protein expression;Proteins;prototype;Purines;Reaction;resistance mechanism;Rheumatoid Arthritis;Scientist;Series;side effect;Specificity;Technology;Tetrahydrofolates;Therapeutic;therapy resistant;thymidylate;Translations;Work,Anti-folate chemotype protein degraders,471,NA,NA,NA,NA,2,NA,NA,766601,NA
11191982,ZIA,TR,1,N,NA,NA,NA,NA,ZIATR000472,NA,NA,1ZIATR000472-02,NCATS:1881569\,INTRAMURAL RESEARCH,2024,NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES,NA,NA,NA,14380133 (contact),"THOMAS, CRAIG  (contact)",NA,NA,NA,Acute Myelocytic Leukemia;antagonist;anti-depressive agents;cancer cell;Cancer Control;cellular targeting;Collaborations;Communities;Development;Drug Kinetics;Dysmyelopoietic Syndromes;Enzymes;FLT3 gene;high throughput screening;inhibitor;Ions;IRAK4 gene;Ketamine;Lead;Metabolic;Methods;Molecular Conformation;Multiple Partners;novel;Pathway interactions;Pharmaceutical Chemistry;pharmacologic;Phenotype;Protein Isoforms;Pyruvate Kinase;receptor;Reporting;Research;research clinical testing;scaffold;side effect;small molecule;tool,Bioactive small molecule development,472,NA,NA,NA,NA,2,NA,NA,1881569,NA
11191983,ZIA,TR,1,N,NA,NA,NA,NA,ZIATR000473,NA,NA,1ZIATR000473-02,NCATS:470392\,INTRAMURAL RESEARCH,2024,NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES,NA,NA,NA,14380133 (contact),"THOMAS, CRAIG  (contact)",NA,NA,NA,3-Dimensional;Architecture;Biopsy;Cell model;Cells;comparative;Complex;Data;Disease;disease model;drug discovery;drug repurposing;Evaluation;experimental study;facsimile;Genomics;Heterogeneity;Human;innovation;insight;Manuscripts;metabolomics;Methodology;Methods;model design;Modeling;Molecular;Molecular and Cellular Biology;next generation;novel;novel drug class;novel therapeutics;Organoids;Outcome;Patients;Peer Review;Physiological;Proteomics;Publishing;screening;small molecule;spheroids;Techniques;Technology;three dimensional cell culture;tissue culture;Tissue Model;Tissue Sample;tissue/cell culture;Tissues;transcriptomics,Disease model design and evaluation,473,NA,NA,NA,NA,2,NA,NA,470392,NA
11191984,ZIA,TR,1,N,NA,NA,NA,NA,ZIATR000476,NA,NA,1ZIATR000476-01,NINDS:75760\,INTRAMURAL RESEARCH,2024,NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES,NA,NA,NA,79299645 (contact),"TRISTAN, CARLOS  (contact)",NA,NA,NA,Absence of pain sensation;addiction;Address;Afferent Neurons;Analgesics;Cell model;chronic pain;chronic pain management;Clinic;Clustered Regularly Interspaced Short Palindromic Repeats;Dependovirus;drug development;Engineering;Epigenetic Process;epigenome;experimental study;Fingers;gene repression;Genes;Genetic study;Genomics;Goals;Guide RNA;Human;Human Genetics;human induced pluripotent stem cells;In Vitro;in vivo;induced pluripotent stem cell;Inherited;inhibitor;innovation;loss of function mutation;mouse model;Mus;National Center for Advancing Translational Sciences;Nociception;Nociceptors;Opioid;Outcome Study;Pain;pain model;Promoter Regions;Proteins;Protocols documentation;Reagent;Repression;Risk;Serotyping;side effect;Sodium Channel;System;Testing;Therapeutic;transcriptome sequencing;transgene expression;Translations;Vertebral column;voltage;Zinc Fingers,Optimization of Long-lasting Analgesia via Targeted Epigenetic Repression (LATER) for human use,476,NA,NA,NA,NA,1,NA,NA,75760,NA
11191985,ZIA,TR,1,N,NA,NA,NA,NA,ZIATR000477,NA,NA,1ZIATR000477-01,NINDS:75760\,INTRAMURAL RESEARCH,2024,NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES,NA,NA,NA,79299645 (contact),"TRISTAN, CARLOS  (contact)",NA,NA,NA,Affect;Afferent Neurons;Agreement;Analgesics;assay development;axon growth;Biological Assay;Boston;Calcium;Cell Culture Techniques;cell type;Cells;Clinical Trials;Coculture Techniques;Collaborations;commercialization;Communities;Cyclic AMP-Dependent Protein Kinases;differentiation protocol;disease model;Electrophysiology (science);Film;Gene Expression Profile;Health;Human;Human Biology;Image;induced pluripotent stem cell;inflammatory pain;inhibitor;Injury;Legal patent;Licensing;Microglia;Modeling;Molecular;Motor Neurons;Mus;National Center for Advancing Translational Sciences;Neurites;Neuroglia;Neurons;Nociceptors;novel;outcome prediction;Pediatric Hospitals;Peripheral;Peripheral Nervous System Diseases;Pharmaceutical Preparations;pharmacologic;Phenotype;prevent;Proteomics;Protocols documentation;Publications;Publishing;Reporter;Reporting;Research;response;Schwann Cells;screening;Screening procedure;single cell analysis;stem cells;Time;transcriptome sequencing,Characterization of human induced nociceptors produced by a novel iPSC differentiation protocol for disease modeling,477,NA,NA,NA,NA,1,NA,NA,75760,NA
11191986,ZIA,TR,1,N,NA,NA,NA,NA,ZIATR000479,NA,NA,1ZIATR000479-01,NINDS:75760\,INTRAMURAL RESEARCH,2024,NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES,NA,NA,NA,79299645 (contact),"TRISTAN, CARLOS  (contact)",NA,NA,NA,Address;Afferent Neurons;Collaborations;diabetic;Diabetic Neuropathies;diabetic patient;differentiation protocol;Genetic;Goals;individual patient;induced pluripotent stem cell;Measures;multiple omics;National Center for Advancing Translational Sciences;Neuropathy;new therapeutic target;Nociceptors;Organoids;Pain;pain reduction;pain sensation;patient derived induced pluripotent stem cells;patient population;Patients;Peripheral Nervous System Diseases;Phenotype;Proteomics;Protocols documentation;Sensory;Stimulus;Testing;transcriptomics;Type 2 diabetic;Variant,Multi-omic analysis of diabetic neuropathy in iPSC derived sensory neurons,479,NA,NA,NA,NA,1,NA,NA,75760,NA
11191987,ZIA,TR,1,N,NA,NA,NA,NA,ZIATR000480,NA,NA,1ZIATR000480-01,NINDS:75761\,INTRAMURAL RESEARCH,2024,NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES,NA,NA,NA,79299645 (contact),"TRISTAN, CARLOS  (contact)",NA,NA,NA,Adult;Affect;Afferent Neurons;Animal Model;axonal degeneration;Back;Cancer Patient;cancer therapy;Carboplatin;Cells;chemotherapy;Chemotherapy-induced peripheral neuropathy;Coculture Techniques;Collaborations;Collecting Cell;differential expression;Disease;dosage;Dose;effective therapy;Family member;Gap Junctions;Genetic;Human;In Vitro;in vitro Model;in vivo;induced pluripotent stem cell;Induced pluripotent stem cell derived human neuron;Induced pluripotent stem cell derived neurons;Intervention;Malignant Female Reproductive System Neoplasm;Manuscripts;Methods;mimetics;Modeling;Molecular;Morphology;Muscarinic Acetylcholine Receptor;National Center for Advancing Translational Sciences;Neuroglia;Newly Diagnosed;novel therapeutics;Paclitaxel;Pain;Pathologic;Patients;Peripheral;Peripheral Blood Mononuclear Cell;Peripheral Nervous System Diseases;Physiological;plexin;Pluripotent Stem Cells;Predisposition;premature;prevent;Quality of life;receptor expression;research and development;Risk Factors;Rodent;Semaphorins;side effect;Signal Transduction;stem cells;Symptoms;taxane;therapy development,Studies of Chemotherapy Induced Peripheral Neuropathy (CIPN) in iPSC-derived,480,NA,NA,NA,NA,1,NA,NA,75761,NA
11191988,ZIA,TR,1,N,NA,NA,NA,NA,ZIATR000481,NA,NA,1ZIATR000481-01,NINDS:246267\,INTRAMURAL RESEARCH,2024,NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES,NA,NA,NA,14380167 (contact),"FERRER, MARC  (contact)",NA,NA,NA,3-Dimensional;3D Print;Acceleration;Address;Afferent Neurons;Anatomy;Animal Model;Architecture;biocompatible polymer;biofabrication;Biological Assay;Biomedical Engineering;bioprinting;Capsaicin;Cell Differentiation process;Cell Line;Cell model;Cell Physiology;Cells;Cellular Assay;Cellular biology;Chemical Agents;Clinic;clinical development;Clinical Trials;Development;Disease;drug candidate;drug development;drug discovery;Drug Modelings;Drug Screening;drug structure;efficacy study;Electrophysiology (science);Engineering;Ensure;Failure;first-in-human;Genetic;Goals;Health;Helping to End Addiction Long-term;high throughput screening;Human;Human Biology;human model;human tissue;Hydrogels;IL4 gene;Immune;improved;In Vitro;in vivo;induced pluripotent stem cell;Infrastructure;Intervention;Lead;Libraries;manufacture;Measures;Methods;Modeling;Morphology;National Center for Advancing Translational Sciences;Nociceptors;Normal tissue morphology;novel;novel therapeutics;Opiate Addiction;opioid epidemic;opioid misuse;opioid use;Pain;Patients;Pattern;Pharmaceutical Preparations;pharmacologic;Pharmacological Treatment;Pharmacology;Physiological;Physiology;pre-clinical;preclinical efficacy;Predictive Value;preservation;Printing;Process;programs;Protocols documentation;Pruritus;Public Health;Risk;safety study;Science;screening;Skin;Skin Tissue;small molecule libraries;Source;Stimulus;stressor;Techniques;Technology;Testing;Therapeutic;Tissue Engineering;Tissue Microarray;Tissues;Toxic effect;Translational Research;United States Food and Drug Administration;United States National Institutes of Health;Vascularization;Work,Innervated 3D skin models for pain sensing,481,NA,NA,NA,NA,1,NA,NA,246267,NA
11191989,ZIA,TR,1,N,NA,NA,NA,NA,ZIATR000482,NA,NA,1ZIATR000482-01,NINDS:202487\,INTRAMURAL RESEARCH,2024,NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES,NA,NA,NA,14380167 (contact),"FERRER, MARC  (contact)",NA,NA,NA,3-Dimensional;Acceleration;addiction;Address;Agonist;allodynia;Analgesics;Animal Model;Animals;antagonist;Binding;Biological Assay;Biology;bioprinting;Cell Line;Cell model;Chemicals;Chemistry;chronic itch;chronic pain;clinic ready;Clinical;Clinical Trials;Collaborations;design;Disease;drug candidate;efficacy study;Engineering;Extramural Activities;first-in-human;Genes;Genomics;Goals;Health;Helping to End Addiction Long-term;high throughput screening;Human;Human Biology;human model;human subject;improved;induced pluripotent stem cell;Infrastructure;Inherited;inhibitor;insight;Intervention;Investigational Drugs;Ion Channel;Ion Channel Gating;Lead;Libraries;Link;loss of function;loss of function mutation;Machine Learning;mechanical allodynia;Mechanics;Mechanoreceptors;Methodology;Modeling;nanobodies;National Center for Advancing Translational Sciences;novel;novel therapeutic intervention;novel therapeutics;Opiate Addiction;opioid epidemic;opioid misuse;opioid overdose;Overdose;Pain;Pain management;Patients;Pharmaceutical Chemistry;Pharmaceutical Preparations;pharmacologic;Piezo 1 ion channel;Piezo 2 ion channel;pre-clinical;preclinical efficacy;Process;Pruritus;Public Health;Quantitative Structure-Activity Relationship;response;Risk;safety study;Science;screening;small molecule;stable cell line;Stretching;System;Tactile;Testing;Tissue Microarray;Tissues;tool;Touch sensation;Translational Research;Translations;United States Food and Drug Administration;United States National Institutes of Health;virtual;virtual screening;Work,Chemical Modulators of the PIEZO2 Mechanoreceptor for the Study and Treatment of Pain,482,NA,NA,NA,NA,1,NA,NA,202487,NA
11191990,ZIA,TR,1,N,NA,NA,NA,NA,ZIATR000483,NA,NA,1ZIATR000483-01,NINDS:202486\,INTRAMURAL RESEARCH,2024,NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES,NA,NA,NA,14380167 (contact),"FERRER, MARC  (contact)",NA,NA,NA,3-Dimensional;Acceleration;addiction;Address;Affinity;Analgesics;Animal Model;Animals;antagonist;Antibodies;Biological Assay;Biology;bioprinting;Blood - brain barrier anatomy;Brain;Cell model;Cells;Chemicals;Chemistry;chronic pain;chronic pain management;clinic ready;Clinical;Clinical Trials;design;Disease;drug candidate;Effectiveness;efficacy study;Extramural Activities;first-in-human;Genomics;Health;Helping to End Addiction Long-term;high throughput screening;Human;Human Biology;human model;improved;induced pluripotent stem cell;Inflammatory;Infrastructure;insight;Intervention;Investigational Drugs;Lead;Methodology;Migraine;migraine treatment;Modeling;nanobodies;National Center for Advancing Translational Sciences;Neuropeptides;neutralizing antibody;nociceptin;novel;novel therapeutics;Opiate Addiction;opioid epidemic;opioid misuse;opioid overdose;Overdose;Pain;Patients;peptide P;Peptides;Pharmaceutical Chemistry;Pharmaceutical Preparations;pharmacologic;Play;pre-clinical;preclinical efficacy;prevent;Process;Public Health;receptor;response;Risk;Role;safety study;Science;screening;small molecule;Substance P;success;System;Testing;Tissue Microarray;Tissues;tool;Translational Research;Translations;United States Food and Drug Administration;United States National Institutes of Health;Work,Developing Brain-penetrant Antibodies Against Substance P and CGRP Neuropeptides for Treatment of Migraines,483,NA,NA,NA,NA,1,NA,NA,202486,NA
11191991,ZIA,TR,1,N,NA,NA,NA,NA,ZIATR000484,NA,NA,1ZIATR000484-01,NIDA:433870\,INTRAMURAL RESEARCH,2024,NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES,NA,NA,NA,14380167 (contact),"FERRER, MARC  (contact)",NA,NA,NA,3-Dimensional;Absence of pain sensation;abuse liability;Acceleration;addiction;Address;Agonist;Analgesics;analog;Animal Model;Animals;antagonist;Binding;Biological Assay;Biological Models;Biology;bioprinting;blood-brain barrier crossing;Boston;Cell model;Cells;Chemicals;Chemistry;clinic ready;Clinical;Clinical Trials;Complex;Cryoelectron Microscopy;design;Development;Disease;drug candidate;druggable target;efficacy study;exhibitions;Extramural Activities;first-in-human;Galanin;galanin receptor;Galectin 1;GALR1 Galanin Receptor;Genomics;GTP-Binding Proteins;Health;Helping to End Addiction Long-term;high throughput screening;Human;Human Biology;human model;improved;induced pluripotent stem cell;Infrastructure;insight;International;Intervention;Investigational Drugs;Lead;lead optimization;lead series;Libraries;Ligand Binding;Ligands;Mediating;Medicine;Methodology;Methods;Midbrain structure;Modeling;mu opioid receptors;Mutagenesis;National Center for Advancing Translational Sciences;Natural Products;Neuropeptides;novel;novel therapeutics;Opiate Addiction;Opioid;opioid epidemic;opioid misuse;opioid overdose;Opioid Receptor;opioid use disorder;Overdose;Pain;Patients;Peptides;Pharmaceutical Chemistry;Pharmaceutical Preparations;pharmacologic;positive allosteric modulator;pre-clinical;preclinical efficacy;Process;Public Health;receptor;response;Rewards;Risk;safety study;Science;screening;small molecule;Spinal Cord;Structure;Structure-Activity Relationship;symposium;System;Testing;Tissue Microarray;Tissues;tool;Translational Research;Translations;United States;United States Food and Drug Administration;United States National Institutes of Health;Work,Targeting -opioid Receptor-Galanin Gal1 Receptor Heterodimers for the Treatment of Opioid Use Disorder (OUD),484,NA,NA,NA,NA,1,NA,NA,433870,NA
11191992,ZIA,TR,1,N,NA,NA,NA,NA,ZIATR000485,NA,NA,1ZIATR000485-01,NIDA:433871\,INTRAMURAL RESEARCH,2024,NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES,NA,NA,NA,14380167 (contact),"FERRER, MARC  (contact)",NA,NA,NA,3-Dimensional;Acceleration;addiction;Address;Analgesics;analog;Animal Model;Animals;beta-arrestin;Binding;Biological Assay;Biology;bioprinting;Cell model;Central Nervous System;Chemicals;Chemistry;clinic ready;Clinical;Clinical Trials;Collaborations;Data;design;Development;Disease;drug candidate;drug-like compound;efficacy study;Electrophysiology (science);Extramural Activities;first-in-human;G-Protein-Coupled Receptors;Genomics;Habenula;Health;Helping to End Addiction Long-term;high throughput screening;Human;Human Biology;human model;Immune system;improved;Individual;induced pluripotent stem cell;Infrastructure;insight;Intervention;Investigational Drugs;Lead;lead optimization;Libraries;long term abstinence;Manuscripts;Medial;Methodology;Modeling;Morphine;Motivation;mu opioid receptors;Mus;National Center for Advancing Translational Sciences;Natural Products;Neurons;novel;novel therapeutics;Opiate Addiction;Opioid;opioid epidemic;opioid misuse;opioid overdose;Orphan;Overdose;Oxycodone;Pain;Patients;Pharmaceutical Chemistry;Pharmaceutical Preparations;pharmacologic;Play;pre-clinical;preclinical efficacy;Process;Property;Public Health;receptor;response;Risk;Role;safety study;Science;screening;Series;Structural Models;System;Testing;Tissue Microarray;Tissues;tool;Translational Research;Translations;United States Food and Drug Administration;United States National Institutes of Health;Work,Development of Gpr151 Modulators for the Treatment of Opioid Dependence,485,NA,NA,NA,NA,1,NA,NA,433871,NA
11191993,ZIA,TR,1,N,NA,NA,NA,NA,ZIATR000486,NA,NA,1ZIATR000486-01,NINDS:202486\,INTRAMURAL RESEARCH,2024,NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES,NA,NA,NA,14380167 (contact),"FERRER, MARC  (contact)",NA,NA,NA,3-Dimensional;Acceleration;addiction;Address;Analgesics;analog;Animal Model;Animals;Biological Assay;Biological Availability;Biology;bioprinting;Cell model;Chemicals;Chemistry;Chemotherapy-induced peripheral neuropathy;chronic pain;chronic pain management;clinic ready;Clinical;clinical candidate;Clinical Trials;Collaborations;cytotoxicity;design;Disease;Docking;drug candidate;Drug Kinetics;efficacy study;Equilibrium;Extramural Activities;first-in-human;Genomics;Goals;Health;Helping to End Addiction Long-term;high throughput screening;Human;Human Biology;human induced pluripotent stem cells;human model;improved;induced pluripotent stem cell;Infrastructure;inhibitor;insight;Intervention;Investigational Drugs;Lead;lead series;Legal patent;Machine Learning;Medicine;Methodology;Microsomes;Modeling;National Center for Advancing Translational Sciences;Nociceptors;non-opioid analgesic;novel;novel therapeutics;Opiate Addiction;Opioid;opioid epidemic;opioid misuse;opioid overdose;Oral;Overdose;Pain;painful neuropathy;Patients;Periodicity;Pharmaceutical Chemistry;Pharmaceutical Preparations;pharmacologic;pharmacophore;pre-clinical;preclinical efficacy;Process;Public Health;Quality of life;Quantitative Structure-Activity Relationship;response;Risk;safety study;Science;screening;Sodium Channel;Sumoylation Pathway;Surface;System;Testing;Tissue Microarray;Tissues;tool;Translational Research;Translations;United States Food and Drug Administration;United States National Institutes of Health;virtual;virtual screening;voltage;Work,Optimization of Allosteric Regulators of the NaV1.7 Sodium Channel for Chemotherapy-induced Peripheral Neuropathy (CIPN),486,NA,NA,NA,NA,1,NA,NA,202486,NA
11191994,ZIA,TR,1,N,NA,NA,NA,NA,ZIATR000487,NA,NA,1ZIATR000487-01,NINDS:202487\,INTRAMURAL RESEARCH,2024,NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES,NA,NA,NA,14380167 (contact),"FERRER, MARC  (contact)",NA,NA,NA,3-Dimensional;Acceleration;addiction;Address;Affinity;Analgesics;Animal Model;Animals;Binding;Biological Assay;Biological Availability;Biology;bioprinting;Brain;Cell Membrane Permeability;Cell model;Chemicals;Chemistry;Clinic;clinic ready;Clinical;Clinical Trials;design;Disease;drug candidate;efficacy study;extracellular;Extramural Activities;first-in-human;FOLH1 gene;follow-up;Genomics;Glutamates;Health;Helping to End Addiction Long-term;high throughput screening;Human;Human Biology;human model;Hydrolysis;improved;induced pluripotent stem cell;Infrastructure;inhibitor;insight;Intervention;Investigational Drugs;Lead;Ligands;Liquid Chromatography;liquid chromatography mass spectrometry;melting;Membrane;metalloenzyme;Methodology;Modeling;N-acetylaspartate;National Center for Advancing Translational Sciences;Neuropeptides;novel;novel therapeutics;Opiate Addiction;opioid epidemic;opioid misuse;opioid overdose;Oral;Overdose;Pain;Pain management;pain sensation;Patients;Penetration;Pharmaceutical Chemistry;Pharmaceutical Preparations;pharmacologic;pilot test;Powder dose form;pre-clinical;preclinical efficacy;Process;Public Health;Radioactivity;response;Risk;Running;safety study;Science;screening;small molecule;small molecule inhibitor;Stream;System;tandem mass spectrometry;Testing;Tissue Microarray;Tissues;tool;Translational Research;Translations;transmission process;United States Food and Drug Administration;United States National Institutes of Health;Validation;Work;Zinc,High Throughput Screen to Identify Glutamate Carboxypeptidase II (GCPII) Brain-Penetrable-Inhibitors for the Treatment of Pain,487,NA,NA,NA,NA,1,NA,NA,202487,NA
11191995,ZIA,TR,1,N,NA,NA,NA,NA,ZIATR000488,NA,NA,1ZIATR000488-01,NINDS:202487\,INTRAMURAL RESEARCH,2024,NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES,NA,NA,NA,14380167 (contact),"FERRER, MARC  (contact)",NA,NA,NA,3-Dimensional;Acceleration;addiction;Address;adenylyl cyclase 1;Analgesics;Animal Model;Animals;Binding;Binding Sites;Biological Assay;Biology;bioprinting;blood-brain barrier permeabilization;Cell model;Chemicals;Chemistry;Chronic inflammatory pain;chronic pain management;clinic ready;Clinical;Clinical Trials;Cyclic AMP;design;Development;Disease;drug candidate;efficacy study;Enzymes;Extramural Activities;first-in-human;Follow-Up Studies;Genomics;Health;Helping to End Addiction Long-term;high throughput screening;Human;Human Biology;human model;improved;induced pluripotent stem cell;Infrastructure;inhibitor;insight;Intervention;Investigational Drugs;Knockout Mice;Lead;Libraries;Literature;Methodology;miniaturize;Modeling;National Center for Advancing Translational Sciences;Natural Products;Neuronal Plasticity;Neurons;non-opioid analgesic;novel;novel therapeutics;Opiate Addiction;Opioid;opioid epidemic;opioid misuse;opioid overdose;Overdose;Pain;pain processing;Patients;Pharmaceutical Chemistry;Pharmaceutical Preparations;pharmacologic;pre-clinical;preclinical efficacy;preclinical study;Process;Public Health;Research;response;Rewards;Risk;safety study;Science;screening;Site;small molecule inhibitor;System;Testing;Tissue Microarray;Tissues;tool;Translational Research;Translations;United States Food and Drug Administration;United States National Institutes of Health;Work,Adenylyl Cyclase 1 (AC1) Inhibitors as Opioid Alternatives for Chronic and Inflammatory Pain,488,NA,NA,NA,NA,1,NA,NA,202487,NA
11191996,ZIA,TR,1,N,NA,NA,NA,NA,ZIATR000489,NA,NA,1ZIATR000489-01,NINDS:202487\,INTRAMURAL RESEARCH,2024,NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES,NA,NA,NA,14380167 (contact),"FERRER, MARC  (contact)",NA,NA,NA,3-Dimensional;Ablation;Acceleration;addiction;Address;Analgesics;analog;Animal Model;Animals;antagonist;atrial natriuretic factor receptor A;atrial natriuretic factor receptor B;Attenuated;Biological Assay;Biology;bioprinting;Cell Line;Cell model;Characteristics;Chemicals;Chemistry;clinic ready;Clinical;Clinical Trials;Collaborations;Data;design;Disease;drug candidate;Drug Kinetics;efficacy study;Extramural Activities;first-in-human;follow-up;Genomics;Goals;Health;Helping to End Addiction Long-term;high throughput screening;Human;Human Biology;human model;improved;induced pluripotent stem cell;Infrastructure;insight;Interneurons;Intervention;Investigational Drugs;Laboratories;Lead;Libraries;Ligand Binding;Methodology;Modeling;Mus;National Center for Advancing Translational Sciences;Natural Products;Neurons;novel;novel therapeutics;Opiate Addiction;opioid epidemic;opioid misuse;opioid overdose;Overdose;Pain;Patients;Perception;Peripheral;Pharmaceutical Chemistry;Pharmaceutical Preparations;pharmacologic;polypeptide;pre-clinical;preclinical efficacy;Preclinical Testing;Process;Pruritus;Public Health;receptor;response;Risk;safety study;saluretic;Science;screening;selective expression;Sensory Ganglia;Signal Pathway;small molecule;Source;Specificity;Spinal;Spinal Cord;System;Testing;Tissue Microarray;Tissues;tool;Translational Research;Translations;United States Food and Drug Administration;United States National Institutes of Health;virtual;Work,Npr1 Antagonists for Pain and Itch,489,NA,NA,NA,NA,1,NA,NA,202487,NA
11191997,ZIA,TR,1,N,NA,NA,NA,NA,ZIATR000495,NA,NA,1ZIATR000495-01,NCATS:511067\,INTRAMURAL RESEARCH,2024,NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES,NA,NA,NA,14380140 (contact),"INGLESE, JAMES  (contact)",NA,NA,NA,Active Sites;Affinity;Amides;Anabolism;analog;Animals;Anti-malarials;Aromatic Amino Acids;Bacteria;Basic Science;Binding;Binding Sites;Biological;Biological Assay;Biotechnology;Boston;Caenorhabditis elegans;Categories;Cell Membrane Permeability;Cells;Chemicals;Chemistry;Chorismate Mutase;Collaborations;Cyclic Peptides;design;Development;Disease;Economic Burden;Enzymes;Fermentation;fungus;Goals;Health;improved;In Vitro;in vivo;Infectious Agent;inhibitor;insight;interfacial;Kansas;Laboratories;Lead;Libraries;Ligands;marine;Mediating;Medicine;membrane activity;Metabolic;Methodology;Michigan;microorganism;Modality;model organism;Molecular;Natural product discovery;natural product inspired;Natural Products;Nature;Nematoda;novel;Organism;Orthologous Gene;pathogen;Pathogenesis;pathogenic microbe;Pathogenicity;Pathway interactions;Peptide Library;Peptides;Pharmaceutical Preparations;Pharmacologic Substance;Pharmacology;Phase;Plants;Plasmodium falciparum;programs;Property;Publishing;repository;Resistance;Resources;screening;shikimate;Source;Staphylococcus aureus;Structure;Structure-Activity Relationship;System;Testing;Therapeutic;Tokyo;Translations;Tuberculosis;Universities;Virulence Factors;Work,Discovery and Design of Novel Molecular Modalities for Chemical Probe and Therapeutic Lead Discovery,495,NA,NA,NA,NA,1,NA,NA,511067,NA
11191998,ZIA,TR,1,N,NA,NA,NA,NA,ZIATR000504,NA,NA,1ZIATR000504-01,NCATS:327632\,INTRAMURAL RESEARCH,2024,NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES,NA,NA,NA,77844220 (contact),"HENDERSON, MARK  (contact)",NA,NA,NA,Adopted;Automobile Driving;Basic Science;Biochemical;Biological Assay;cancer clinical trial;Cell membrane;Cell Physiology;Cells;Colorectal;cytotoxic;Diffuse intrinsic pontine glioma;drug candidate;Early Endosome;Endosomes;Goals;Health;high throughput screening;Human;Human Genome;improved;inhibitor;Malignant Neoplasms;National Center for Advancing Translational Sciences;Neuroblastoma;Oncology;Pancreas;Performance;pharmacologic;Play;Polyamines;polycation;programs;Proteins;Putrescine;Rare Diseases;Recycling;Reporting;Research;Role;small molecule;Specificity;Spermidine;Spermine;System;tool;trafficking;Translations;tumorigenic;uptake;Work,Identification of inhibitors of the polyamine transporter ATP13A3,504,NA,NA,NA,NA,1,NA,NA,327632,NA
11191999,ZIA,TR,1,N,NA,NA,NA,NA,ZIATR000505,NA,NA,1ZIATR000505-01,NCATS:327632\,INTRAMURAL RESEARCH,2024,NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES,NA,NA,NA,77844220 (contact),"HENDERSON, MARK  (contact)",NA,NA,NA,Adopted;Alzheimer&apos;s Disease;Alzheimer&apos;s disease patient;Alzheimer&apos;s disease related dementia;Amyloid;antagonist;Automobile Driving;Basic Science;Binding;Biological Assay;Brain;Cognitive;Dementia;Deposition;Development;Disease;drug candidate;Excision;Goals;Health;high throughput screening;Human;Human Genome;immunotherapy clinical trials;improved;Intervention;Measures;Messenger RNA;miniaturize;National Center for Advancing Translational Sciences;Neurons;Pathologic;Pathology;pharmacologic;Poly(A)+ RNA;Polyadenylation;Predisposition;preservation;programs;Property;Rare Diseases;Research;RNA Binding;Severities;small molecule;small molecule inhibitor;targeted treatment;tau Proteins;Tauopathies;Therapeutic;therapeutic effectiveness;tool;Toxic effect;Translations;Work,Targeting MSUT2 binding to polyA mRNA for Alzheimer's disease,505,NA,NA,NA,NA,1,NA,NA,327632,NA
11192000,ZIA,TR,1,N,NA,NA,NA,NA,ZIATR000506,NA,NA,1ZIATR000506-01,NCATS:327632\,INTRAMURAL RESEARCH,2024,NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES,NA,NA,NA,77844220 (contact),"HENDERSON, MARK  (contact)",NA,NA,NA,1-Phosphatidylinositol 4-Kinase;Automobile Driving;Basic Science;Biological Assay;Cell Therapy;Cells;design;Disease;drug candidate;Endosomes;Enzymes;Gaucher Disease;Generations;Health;Human;Human Genome;improved;Lipids;Measurement;Measures;Membrane;Minor;molecular modeling;National Center for Advancing Translational Sciences;novel;Pharmaceutical Chemistry;pharmacologic;phosphatidylinositol 4-phosphate;Phospholipids;Phosphotransferases;PIK3CG gene;programs;Rare Diseases;Research;small molecule;Specificity;Study models;tool;trafficking;Translations,Identification of small molecules for PI4K2a BRET measurements,506,NA,NA,NA,NA,1,NA,NA,327632,NA
11192001,ZIA,TR,1,N,NA,NA,NA,NA,ZIATR000507,NA,NA,1ZIATR000507-01,NCATS:327632\,INTRAMURAL RESEARCH,2024,NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES,NA,NA,NA,14380091 (contact),"SIMEONOV, ANTON  (contact)",NA,NA,NA,2019-nCoV;Acceleration;Binding;Complex;Cryoelectron Microscopy;drug development;Future;Generations;Goals;Image;insight;interest;Methods;Molecular Weight;Mutation;nanobodies;National Center for Advancing Translational Sciences;Procedures;protein complex;protein structure;Proteins;System,Incorporating NCATS' single-domain antibodies into the Legobody system,507,NA,NA,NA,NA,1,NA,NA,327632,NA
11192002,ZIA,TR,1,N,NA,NA,NA,NA,ZIATR000508,NA,NA,1ZIATR000508-01,NCATS:327632\,INTRAMURAL RESEARCH,2024,NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES,NA,NA,NA,14380091 (contact),"SIMEONOV, ANTON  (contact)",NA,NA,NA,Adopted;Anti-Inflammatory Agents;antimicrobial;Binding;Blood Vessels;CD47 gene;Cells;Generations;Goals;Immune;Immune response;Inflammatory;Innate Immune Response;Macrophage;nanobodies;National Center for Advancing Translational Sciences;neoplastic cell;pathogenic bacteria;Phenotype;programmed cell death ligand 1;programs;response;Therapeutic;Tissues;tumor;Tumor-associated macrophages;wound healing,Discovery of single-domain antibodies targeting CD206,508,NA,NA,NA,NA,1,NA,NA,327632,NA
11192003,ZIA,TR,1,N,NA,NA,NA,NA,ZIATR000509,NA,NA,1ZIATR000509-01,NCATS:81908\,INTRAMURAL RESEARCH,2024,NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES,NA,NA,NA,14380091 (contact),"SIMEONOV, ANTON  (contact)",NA,NA,NA,Bacteriophages;Calcium;Cells;Chlorides;Cryoelectron Microscopy;Disease;experimental study;Family;Goals;improved;insight;Integral Membrane Protein;Ions;Kidney;Link;lipopigments;Liver;Lysosomal Storage Diseases;member;Mutation;Myocardium;nanobodies;nanodisk;Nerve Degeneration;Neuronal Ceroid-Lipofuscinosis;Neurons;Organ;protein structure;Proteins;Resolution;Role;solute;Spleen;Structure;Testing;Tube,Discovery of single-domain antibodies targeting MFSD8,509,NA,NA,NA,NA,1,NA,NA,81908,NA
11192004,ZIA,TR,1,N,NA,NA,NA,NA,ZIATR000510,NA,NA,1ZIATR000510-01,NCATS:81908\,INTRAMURAL RESEARCH,2024,NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES,NA,NA,NA,14380091 (contact),"SIMEONOV, ANTON  (contact)",NA,NA,NA,Alzheimer&apos;s Disease;Bacteriophages;Binding;Characteristics;Disease;Generations;Goals;monomer;nanobodies;Parkinson Disease;Proteins;tau Proteins;Testing,Discovery of single-domain antibodies targeting fibril plaques,510,NA,NA,NA,NA,1,NA,NA,81908,NA
11192005,ZIA,TR,1,N,NA,NA,NA,NA,ZIATR000511,NA,NA,1ZIATR000511-01,NCATS:327632\,INTRAMURAL RESEARCH,2024,NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES,NA,NA,NA,14380091 (contact),"SIMEONOV, ANTON  (contact)",NA,NA,NA,Automobile Driving;Basic Science;Biological Assay;Carrier Proteins;Cryoelectron Microscopy;deafness;Development;Disease;Drosophila genus;drug candidate;Family;Glutamates;Goals;Health;Human;Human Genome;improved;In Vitro;in vivo;insight;interest;member;Mutation;nanobodies;National Center for Advancing Translational Sciences;Neurons;pharmacologic;programs;Proteins;Rare Diseases;Research;Structure;Synaptic Vesicles;therapeutic development;tool;Translations;Transportation,Discovery of single-domain antibodies targeting VGLUT,511,NA,NA,NA,NA,1,NA,NA,327632,NA
11192006,ZIA,TR,1,N,NA,NA,NA,NA,ZIATR000512,NA,NA,1ZIATR000512-01,NCATS:327632\,INTRAMURAL RESEARCH,2024,NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES,NA,NA,NA,14380091 (contact),"SIMEONOV, ANTON  (contact)",NA,NA,NA,Automobile Driving;Basic Science;Cryoelectron Microscopy;Disease;Disease Progression;drug candidate;Gene Silencing;Goals;Health;Human;Human Genome;Image;improved;Missense Mutation;Muscular Dystrophies;Mutation;nanobodies;National Center for Advancing Translational Sciences;pharmacologic;programs;Proteins;Rare Diseases;Research;Research Personnel;Resolution;Testing;tool;Translations,Discovery of single-domain antibodies targeting SMCHD1,512,NA,NA,NA,NA,1,NA,NA,327632,NA
11192007,ZIA,TR,1,N,NA,NA,NA,NA,ZIATR000513,NA,NA,1ZIATR000513-01,NCATS:327632\,INTRAMURAL RESEARCH,2024,NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES,NA,NA,NA,14380091 (contact),"SIMEONOV, ANTON  (contact)",NA,NA,NA,Automobile Driving;Basic Science;Cells;drug candidate;Dysplasia;Goals;Health;Hip region structure;Human;Human Genome;improved;Ion Channel;Molecular Conformation;Movement;Mutation;nanobodies;nanodisk;National Center for Advancing Translational Sciences;pharmacologic;Piezo 2 ion channel;programs;Proteins;Protocols documentation;Rare Diseases;Research;scoliosis;skeletal abnormality;tool;Touch sensation;Translations,Discovery of single-domain antibodies targeting Piezo2,513,NA,NA,NA,NA,1,NA,NA,327632,NA
11192008,ZIA,TR,1,N,NA,NA,NA,NA,ZIATR000514,NA,NA,1ZIATR000514-01,NCATS:327632\,INTRAMURAL RESEARCH,2024,NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES,NA,NA,NA,14380091 (contact),"SIMEONOV, ANTON  (contact)",NA,NA,NA,Automobile Driving;Basic Science;Cryoelectron Microscopy;Diacylglycerol Kinase;Disease;drug candidate;Enzymes;flexibility;Goals;Health;Human;Human body;Human Genome;Image;improved;Methods;Movement;nanobodies;National Center for Advancing Translational Sciences;pharmacologic;Phosphotransferases;programs;Proteins;Rare Diseases;Research;Resolution;Tertiary Protein Structure;tool;Translations,Discovery of single-domain antibodies targeting DGKq,514,NA,NA,NA,NA,1,NA,NA,327632,NA
11192009,ZIA,TR,1,N,NA,NA,NA,NA,ZIATR000515,NA,NA,1ZIATR000515-01,NCATS:81908\,INTRAMURAL RESEARCH,2024,NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES,NA,NA,NA,14380209 (contact),"HALL, MATTHEW  (contact)",NA,NA,NA,Antigen Presentation Pathway;antigenic peptide transporter;ATP-Binding Cassette Transporters;Automobile Driving;Basic Science;Biological Assay;CD8B1 gene;Cell surface;Cells;clinical application;Collaborations;Complex;Cytosol;drug candidate;Endoplasmic Reticulum;Family;Goals;Health;Human;Human Genome;Immunity;improved;inhibitor;Libraries;Major Histocompatibility Complex;Membrane;National Center for Advancing Translational Sciences;National Institute of Allergy and Infectious Disease;Nuclear Pore Complex;Peptide Transport;Peptides;pharmacologic;Play;programs;protein complex;Proteins;Rare Diseases;Reporting;Research;Role;Sampling;screening;small molecule inhibitor;small molecule libraries;Surveys;T-Lymphocyte;TAP1 gene;TAP2 gene;tool;Translations,Identification of small molecule inhibitors of TAP protein,515,NA,NA,NA,NA,1,NA,NA,81908,NA
11192010,ZIA,TR,1,N,NA,NA,NA,NA,ZIATR000516,NA,NA,1ZIATR000516-01,NCATS:81908\,INTRAMURAL RESEARCH,2024,NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES,NA,NA,NA,79334257 (contact),"PATNAIK, SAMARJIT  (contact)",NA,NA,NA,Ablation;antagonist;Appetite Stimulants;blood glucose regulation;Data;Diabetes Mellitus;Energy Metabolism;Enteroendocrine Cell;experimental study;G-Protein-Coupled Receptors;Genetic;Glucose;glucose tolerance;Goals;GPR17 gene;gut-brain axis;Hypothalamic structure;improved;Insulin;insulin secretion;Intervention;intestinal epithelium;Leptin;Ligands;Manuscripts;Medical;Neurons;Obesity;Orphan;Peptides;receptor;reduced food intake;Reporting;Role;screening;Signal Transduction;small molecule;small molecule libraries;Writing,Identification of small molecule antagonist of GPR17 receptor,516,NA,NA,NA,NA,1,NA,NA,81908,NA
11192011,ZIA,TR,1,N,NA,NA,NA,NA,ZIATR000517,NA,NA,1ZIATR000517-01,NCATS:81908\,INTRAMURAL RESEARCH,2024,NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES,NA,NA,NA,79334257 (contact),"PATNAIK, SAMARJIT  (contact)",NA,NA,NA,Antibody-drug conjugates;Automobile Driving;Basic Science;BCL2 gene;BRCA mutations;cancer cell;Cancer cell line;Cells;Data;drug candidate;Goals;Health;Human;Human Genome;improved;inhibitor;Libraries;Malignant Female Reproductive System Neoplasm;Malignant neoplasm of ovary;mutant;National Center for Advancing Translational Sciences;Pathway interactions;Patients;pharmacologic;Poly(ADP-ribose) Polymerase Inhibitor;programs;Proteins;Rare Diseases;Reporting;Research;Resistance;Resistance development;screening;small molecule;synergism;tool;Translations;Treatment Efficacy,Identification of IMMU-132-synergistic small molecules in Olaparib-resistant ovarian cancer cells,517,NA,NA,NA,NA,1,NA,NA,81908,NA
11192012,ZIC,DE,1,N,NA,NA,NA,NA,ZICDE000763,NA,NA,1ZICDE000763-01,NIDCR:942521\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH,NA,NA,NA,79979660 (contact),"SZABO, ROMAN  (contact)",NA,NA,NA,Archives;Clustered Regularly Interspaced Short Palindromic Repeats;Consultations;Cryopreservation;Derivation procedure;Electroporation;Embryo;Embryo Transfer;experimental study;Fertilization in Vitro;gain of function;gene editing technology;Gene Modified;Gene Targeting;Generations;Genes;Injections;Knock-in;Knock-in Mouse;Knock-out;Knockout Mice;Location;loss of function;mouse model;Mouse Strains;Mus;National Institute of Dental and Craniofacial Research;Operative Surgical Procedures;preservation;Principal Investigator;Research;Research Personnel;Services;Shipping;sperm cell;sperm cryopreservation;Transgenic Organisms,"Gene Targeting Core, NIDCR DIR",763,NA,NA,NA,NA,1,NA,NA,942521,NA
11192013,ZIC,HD,1,N,NA,NA,NA,NA,ZICHD008958,NA,NA,1ZICHD008958-09,NICHD:2288755\,INTRAMURAL RESEARCH,2024,EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT,NA,NA,NA,NA,NA,NA,NA,NA,EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT,NA,NA,NA,79979662 (contact),"MAHADEVAN, VIVEK  (contact)",NA,NA,NA,base;Bioinformatics;bioinformatics tool;Biological Assay;Biological Sciences;bisulfite sequencing;Cells;ChIP-seq;Chromium;Collaborations;Communities;computerized data processing;Core Facility;Counseling;Custom;Data;Data Analyses;Data Collection;design;Diagnosis;differential expression;Dissociation;DNA;DNA Sequence;DNA sequencing;DNA Sequencing Facility;exome;exome sequencing;Generations;Genes;Genetic Research;genome sequencing;Genomics;Hereditary Disease;Image;innovation;Ions;Libraries;methylome;microbiome sequencing;MicroRNAs;miRNA expression profiling;Mission;Molecular;National Institute of Child Health and Human Development;next generation sequencing;Production;Research;Research Personnel;ribosome profiling;RNA;Running;Sampling;Services;single cell ATAC-seq;single molecule;single-cell RNA sequencing;Sulfate;targeted exome sequencing;Technology;technology platform;transcriptome sequencing;transcriptomics;Update;Variant;whole genome,Molecular Genomics Sequencing Core Facility,8958,NA,NA,NA,NA,9,NA,NA,2288755,NA
11192014,ZIG,AA,1,N,NA,NA,NA,NA,ZIGAA000600,NA,NA,1ZIGAA000600-16,NIAAA:4421001\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM,NA,NA,NA,7359471 (contact),"LOVINGER, DAVID M (contact)",NA,NA,NA,Accreditation;Anesthesia procedures;animal care;Animal Care and Use Committees;Animal Experimentation;Animal Husbandry;Animal Welfare;Animals;Area;biological research;Breeding;Clinical Research;Communicable Diseases;Communities;comparative;Containment;Cryopreservation;Derivation procedure;Development;disease diagnosis;Ensure;environmental enrichment for laboratory animals;Equipment;Euthanasia;Evaluation;Food;hazard;Health;Healthcare;Hemorrhage;Hour;Injections;International;Intramural Research Program;Laboratory Animal Science;Laboratory Animals;Logistics;Maryland;Medicine;Mission;model development;Modification;Monitor;Mus;National Institute on Alcohol Abuse and Alcoholism;Operative Surgical Procedures;Oral;Participant;Pathologic;Phenotype;Play;Policies;policy recommendation;Preparation;Principal Investigator;Procedures;programs;Rattus;Regulation;Research;Research Personnel;Research Support;restraint;Role;sample collection;Services;Substance administration;Tissue Banks;Training;United States National Institutes of Health;Veterinarians;Water;Weaning,Office of Laboratory Animal Science,600,NA,NA,NA,NA,16,NA,NA,4421001,NA
11192018,U01,FD,3,N,2024-09-16,2024-06-01,2025-05-31,103,U01FD007974,NA,RFA-FD-23-010,3U01FD007974-02S3,FDA:295000\,NON-SBIR/STTR RPGS,2024,FOOD AND DRUG ADMINISTRATION,NA,HONOLULU,UNITED STATES,NA,01,054787481,US,6813401,QUEEN'S MEDICAL CENTER,HI,968132402,"Project Narrative Our project will create a Hawaii Health Equity Research and Outreach Network (HAWAII HERON) that will provide resources to support efforts to improve health equity for Asian American, Native Hawaiian and other Pacific Islander (AA-NHPI) populations. This work will be in collaboration with the Food and Drug Administration and other minority-serving institutions and will include a pilot study examining AA-NHPI patient preferences for diabetes medications. HAWAII HERON has the potential to strengthen health equity focused research, outreach and communications, and training and mentoring of diverse students and junior researchers.",2660382 (contact);11441005,"SETO, TODD B (contact);TAIRA, DEBORAH ANN","LEE, CHRISTINE",2023-06-01,2025-05-31,NA,Hawaii Health Equity Research and Outreach Network (HAWAII HERON),7974,ZFD1,ZFD1-OC-S(10)1,NA,S3,2,165731,129269,295000,NA
11192060,N01,CA,NA,N,NA,NA,NA,NA,261200800001E,NA,NA,261200800001E-P00167-9999-10,NCI:25362\,NON SBIR/STTR CONTRACTS,2024,NATIONAL CANCER INSTITUTE,NA,FREDERICK,UNITED STATES,NA,06,159990456,US,10008928,"LEIDOS BIOMEDICAL RESEARCH, INC.",MD,217029242,NA,14267998 (contact),"HEIMBROOK, DAVID  (contact)",NA,2008-09-26,2019-08-30,Amendment;American College of Radiology Imaging Network;Annual Reports;Authorization documentation;Back;bench to bedside;Biological;Blood;Brain Neoplasms;cancer Biomedical Informatics Grid;cancer imaging;cancer therapy;Cetuximab;Clinical;clinical center;Clinical Data;clinical database;Clinical Research;Clinical Trials;Collaborations;Communities;computer-assisted diagnostics;Contracts;Contrast Media;Cyclotrons;data management;Databases;Decision Making;Dedications;Deoxycytidine;Development;Diagnosis;diagnostic tool;drug development;early phase clinical trial;Education and Outreach;Educational workshop;Estrogen Receptors;Ferumoxtran-10;ferumoxytol;Goals;Growth;Half-Life;Hypoxia;Image;imaging agent;imaging informatics;imaging platform;imaging program;Informatics;infrastructure development;innovation;interest;Internet;Investigation;Investigational Drugs;Joints;Letters;lymph nodes;Magnetic Resonance Imaging;Malignant neoplasm of cervix uteri;Malignant neoplasm of lung;Malignant Neoplasms;Manufacturer;Medical;Medical Imaging;meetings;Metastatic breast cancer;Metastatic Neoplasm to the Bone;Metastatic Prostate Cancer;Mission;Modality;molecular imaging;Monitor;outreach;Pamphlets;patient stratification;Patients;Pharmaceutical Preparations;Pharmacologic Substance;Phase;Positioning Attribute;preclinical study;Preparation;Procedures;Program Development;programs;Proliferating;Radiopharmaceuticals;Regulatory Affairs;Reporting;Research;Research Personnel;Scientific Societies;Serious Adverse Event;single photon emission computed tomography;Site;Systems Biology;Testing;Tetrahydrouridine;text searching;The Cancer Imaging Archive;Therapeutic;therapeutic development;Thymidine;tomography;Tracer;Translations;treatment response;United States National Institutes of Health;virtual;Work;Writing,DCTD Cancer Imaging,0,NA,NA,NA,NA,NA,NA,NA,25362,NA
11192197,N01,AI,NA,N,NA,NA,NA,NA,75N93021D00014,NA,NA,75N93021D00014-P00002-759302200001-1,NIAID:207029\,NON SBIR/STTR CONTRACTS,2024,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,FORT COLLINS,UNITED STATES,NA,02,785979618,US,1725201,COLORADO STATE UNIVERSITY,CO,805232002,NA,78841399 (contact),"SLAYDEN, RICHARD  (contact)",NA,2022-09-01,2025-11-30,Acquired Immunodeficiency Syndrome;Animal Model;Basic Science;Clinical Trials;Collaborations;Communities;Contracts;Development;Devices;Drug Combinations;drug testing;Extramural Activities;Hepatitis B Virus;Hepatitis C virus;HIV;Investigational New Drug Application;Investigator-Initiated Research;Licensure;Mus;Mycobacterium tuberculosis;Mycobacterium tuberculosis complex;National Institute of Allergy and Infectious Disease;novel therapeutics;pre-clinical;Private Sector;product development;repository;Research;research clinical testing;research study;Resources;Services;Testing;Therapeutic;therapeutic development;United States Food and Drug Administration;Work,Testing of Drug Combinations For Mycobacterium tuberculosis (MTB) in Mice,0,NA,NA,NA,NA,NA,NA,NA,207029,NA
11192198,N01,AI,NA,N,NA,NA,NA,NA,75N93021C00010,NA,NA,75N93021C00010-P00007-9999-1,NIAID:1650162\NICHD:300000\,NON SBIR/STTR CONTRACTS,2024,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,DURHAM,UNITED STATES,NA,04,044387793,US,2221101,DUKE UNIVERSITY,NC,277054673,NA,78232628 (contact),"DENNY, THOMAS  (contact)",NA,2024-09-30,2025-09-29,Accreditation;Acquired Immunodeficiency Syndrome;Biological;Biological Assay;Biometry;CD4 Positive T Lymphocytes;Clinical;Clinical Research;comorbidity;computerized;Contracts;Cryopreservation;Data;Data Management Resources;data submission;Educational workshop;electronic data;European;Evaluation Methodology;Freezing;Funding;HIV Seropositivity;HIV/AIDS;Human;Immunologic Tests;Immunologics;Immunology;Immunology procedure;International;Laboratories;Leukapheresis;Libraries;Medicine;Methodology;Monitor;National Institute of Allergy and Infectious Disease;performance tests;Peripheral Blood Mononuclear Cell;Plasma;Prevention;Process;programs;Qualifying;Quality Control;Reagent;Resources;Respondent;Sampling;Site;Specific qualifier value;Standardization;Support Contracts;Testing;Training;United States Food and Drug Administration;Validation;Viral Load result;Whole Blood,Immunology Quality Assessment (IQA) Program,0,NA,NA,NA,NA,NA,NA,NA,1950162,NA
11192199,N02,HD,NA,N,NA,NA,NA,NA,75N94022F00177,NA,NA,75N94022F00177-P00016-0-1,NICHD:5225718\,NON SBIR/STTR CONTRACTS,2024,EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT,NA,NA,NA,NA,NA,187107958,NA,NA,NA,NA,NA,NA,NA,(contact),NA,2022-09-26,2025-09-25,Authorization documentation;biobank;Catalogs;Clinical Data;cloud based;Cloud Service;Communities;Contracts;dashboard;Data;data access;Data Collection;data dashboard;data ecosystem;data hub;data management;data repository;data resource;Data Science;Data Set;data sharing;Data Storage and Retrieval;data tools;diverse data;Documentation;Extramural Activities;FAIR principles;Funding;Generations;Goals;Human;Individual;Information Systems;International;Intramural Research;Intuition;Investments;Link;Location;Medical center;Metadata;Modernization;National Institute of Child Health and Human Development;Office of Administrative Management;online resource;Participant;Policies;population health;Privacy;Publications;rehabilitation research;Reporting;Reproducibility;Research;research and development;Research Personnel;research study;Research Support;Resources;secondary analysis;Secure;Specimen;Strategic Planning;System;tool;United States National Institutes of Health;usability;web app;web services,NICHD DATA AND SPECIMEN HUB (DASH) MODERNIZATION,0,NA,NA,NA,NA,NA,NA,NA,5225718,NA
11192200,Y01,DK,NA,N,NA,NA,NA,NA,ADK20005001,NA,NA,ADK20005001-1-0-1,NIDDK:4950\,INTERAGENCY AGREEMENTS,2024,NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES,NA,NA,NA,NA,(contact),NA,NA,NA,Affect;authority;Businesses;Caring;Characteristics;clinical care;Communication;Communities;community organizations;Complications of Diabetes Mellitus;Counseling;Deductibles;design;diabetes management;Diabetes Mellitus;diabetes risk;diabetogenic;Diet;Disparity;disparity reduction;Effectiveness;Environment;Epidemic;Evaluation;evidence base;experimental study;Funding;Glucose;Goals;Health;Health behavior;health care model;health care service organization;health goals;health plan;Health system;Healthcare;Home;improved;innovation;Intervention;Local Government;Logistics;Medicaid;Modeling;Natural experiment;Non-Insulin-Dependent Diabetes Mellitus;Obesity;Observational Study;payment;Persons;Physical activity;Play;Policies;Population;Prediabetes syndrome;prevent;Prevention;primary care setting;Productivity;Program Evaluation;programs;Public Health;Research;response;Risk Factors;social health determinants;System;Target Populations;Translations;Work,Interdepartmental Designation of Authority (IDDA) NEXT-D3,200050,NA,NA,NA,NA,NA,NA,NA,4950,NA
11192201,N02,CA,NA,N,NA,NA,NA,NA,75N91023C00055,NA,NA,75N91023C00055-P00002-9999-1,NCI:2466253\,NON SBIR/STTR CONTRACTS,2024,NATIONAL CANCER INSTITUTE,NA,SAN JOSE,UNITED STATES,NA,17,602744732,US,2083701,"CCS ASSOCIATES, INC.",CA,95130,NA,79366083 (contact),"SIGMAN, CAROLINE  (contact)",NA,2023-09-30,2025-09-29,cancer prevention;Development;Information Management;Qualifying,PROVIDE A VARIETY OF CRITICAL CANCER PREVENTION INFORMATION MANAGEMENT FUNCTIONS,0,NA,NA,NA,NA,NA,NA,NA,2466253,NA
11192202,N01,DA,NA,N,NA,NA,NA,NA,271201600006I,NA,NA,271201600006I-P00009-27100001-1,NINDS:82132\,NON SBIR/STTR CONTRACTS,2024,NATIONAL INSTITUTE ON DRUG ABUSE,NA,MENLO PARK,UNITED STATES,NA,16,009232752,US,8042701,SRI INTERNATIONAL,CA,940253493,Developing therapies for neurological disorders,3118394 (contact),"GREEN, CAROL E (contact)",NA,2016-09-13,2025-09-12,"Animal Welfare;Award;bench to bedside;Biological Products;Chemistry;Client;Contractor;Contracts;design;Dosage Forms;Equipment;experience;flexibility;Formulation;good laboratory practice;Good Manufacturing Process;Heart Diseases;Hematological Disease;International;Laboratory Animals;Lung Diseases;manufacture;member;Modernization;National Heart, Lung, and Blood Institute;National Institute of Allergy and Infectious Disease;National Institute of Child Health and Human Development;National Institute of Diabetes and Digestive and Kidney Diseases;National Institute of Drug Abuse;National Institute of Mental Health;National Institute of Neurological Disorders and Stroke;Nervous System Disorder;novel;novel therapeutics;Office for Human Research Protections;operation;Pharmacologic Substance;Pharmacology;Principal Investigator;Production;programs;Qualifying;Regulation;Request for Proposals;research and development;Resources;response;Science;Scientist;screening;Services;small molecule;small molecule therapeutics;Testing;therapy development;Toxicology;Translational Research;United States Food and Drug Administration;United States National Institutes of Health;Work",IGF::OT::IGF TASK ORDER #001  PERFORMANCE AREA 1  MANAGEMENT AND OPERATIONS SUPPORT,0,NA,NA,NA,NA,NA,NA,NA,82132,NA
11192437,N43,CA,NA,N,NA,NA,NA,NA,75N91024C00070,NA,NA,75N91024C00070-0-9999-1,NCI:399985\,SBIR/STTR CONTRACTS,2024,NATIONAL CANCER INSTITUTE,NA,CHALFONT,UNITED STATES,NA,01,NA,US,10071005,POLYGON HEALTH ANALYTICS LLC,PA,189141337,NA,79977794 (contact),"YAO, LIXIA  (contact)",NA,2024-09-12,2025-09-11,anti-cancer research;Clinical;Clinical Data;clinical practice;cloud based;commercialization;Computer software;Data;Data Analyses;Data Commons;data modeling;design;Development;Diagnosis;efficacious treatment;Genomics;Goals;Health;Image;innovation;insight;Knowledge;Malignant Neoplasms;multimodal data;Multiomic Data;Natural Language Processing;Ontology;Pathology;Pathology Report;petabyte;Phase;prototype;repository;risk stratification;Scanning;Small Business Innovation Research Grant;Specific qualifier value;Squamous cell carcinoma;The Cancer Genome Atlas;tool;user-friendly,TOPIC NUMBER:  464 SBIR PHASE ICLOUD-BASED MULTIMODAL DATA ANALYSIS SOFTWARE FOR THE CANCER RESEARCH DATA COMMONS,0,NA,NA,NA,NA,NA,NA,NA,399985,NA
11192442,P50,CA,3,N,2024-09-12,2024-09-01,2025-08-31,NA,P50CA261605,NA,PAR-18-313,3P50CA261605-04S1,NCI:89990\,RESEARCH CENTERS,2024,NATIONAL CANCER INSTITUTE,NA,Aurora,UNITED STATES,NA,06,041096314,US,1199905,UNIVERSITY OF COLORADO DENVER,CO,800452571,NA,7838047 (contact),"WANG, XIAO-JING  (contact)","HUBBARD, LEAH",2021-09-01,2026-08-31,NA,Treating recurrent HNSCC with radiation and dual TGF-Beta/PD-L1.,261605,ZCA1,ZCA1-RPRB-6(M1)P,5435,S1,4,89990,NA,NA,89990
11192460,N43,CA,NA,N,NA,NA,NA,NA,75N91024C00080,NA,NA,75N91024C00080-0-9999-1,NCI:399828\,SBIR/STTR CONTRACTS,2024,NATIONAL CANCER INSTITUTE,NA,AUSTIN,UNITED STATES,NA,37,052762307,US,10075593,"ANACONDA, INC",TX,787286523,NA,79977797 (contact),"BEDNAR, JAMES  (contact)",NA,2024-09-16,2025-09-15,Address;anti-cancer research;Awareness;Big Data;cancer type;Cells;Clinical Research;Collaborations;Communication;Communities;Complement;Complex;Computer software;Data;data access;Data Analyses;Data Commons;data exploration;Data Files;Data Science;Data Set;data visualization;Development Plans;Dimensions;flexibility;Foundations;Funding;improved;Individual;insight;interactive visualization;large datasets;Libraries;Malignant Neoplasms;Modality;multidimensional data;multimodal data;multimodality;open data;open source;patient population;Performance;Phase;prototype;Pythons;Reproducibility;Research;Research Personnel;Sampling;software development;Source;Specific qualifier value;symposium;Techniques;Testing;Text;tool;Training;usability;Visualization;Visualization software;web app;web site;Work,TOPIC 464: CLOUD-BASED MULTIMODAL DATA ANALYSIS SOFTWARE FOR THE CANCER RESEARCH DATA COMMONS,0,NA,NA,NA,NA,NA,NA,NA,399828,NA
11192462,N43,CA,NA,N,NA,NA,NA,NA,75N91024C00069,NA,NA,75N91024C00069-0-9999-1,NCI:395613\,SBIR/STTR CONTRACTS,2024,NATIONAL CANCER INSTITUTE,NA,PRINCETON,UNITED STATES,NA,12,109162409,US,10059462,IMPACT BUSINESS INFORMATION SOLUTIONS INC.,NJ,085424600,NA,79973107 (contact),"KRISHNAMOORTHY, RAJ  (contact)",NA,2024-09-11,2025-09-10,Address;Adopted;Clinical Data;cloud based;cohort;Data;Data Commons;data de-identification;data harmonization;data integration;data privacy;data resource;Data Set;Development;Ecosystem;Encapsulated;Environment;Genomic Data Commons;Genomics;Healthcare;hospital organization;Hospitals;Image;indexing;Metadata;Modality;Modeling;multimodal data;multimodality;Patients;Phase;Production;prototype;Public Domains;Radiology Specialty;Records;repository;Research;Research Personnel;Retrieval;Security;Small Business Innovation Research Grant;Testing;Textiles;Training,"TOPIC NUMBER: 464 SBIR PHASE I - UNIFIED DATA COMMONS SOLUTION FOR PUBLIC DOMAIN,IN-HOUSE AND THIRD-PARTY MULTIMODAL CLINICAL DATA.",0,NA,NA,NA,NA,NA,NA,NA,395613,NA
11192496,U54,CA,3,N,2024-09-12,2024-09-06,2025-08-31,NA,U54CA272691,NA,PA-20-272,3U54CA272691-02S1,NCI:186712\,RESEARCH CENTERS,2024,NATIONAL CANCER INSTITUTE,NA,HOUSTON,UNITED STATES,NA,09,051113330,US,481201,BAYLOR COLLEGE OF MEDICINE,TX,770303411,NA,8146758 (contact),"LI, YONG  (contact)","VLAD, ANDA MIOARA",2023-09-01,2027-08-31,NA,Administrative Core,272691,ZCA1,ZCA1(M3),8722,S1,2,116695,70017,NA,186712
11192503,U54,CA,3,N,2024-09-12,2024-09-01,2025-08-31,NA,U54CA274371,NA,PA-20-272,3U54CA274371-03S1,NCI:199862\,RESEARCH CENTERS,2024,NATIONAL CANCER INSTITUTE,NA,HOUSTON,UNITED STATES,NA,09,800772139,US,578407,UNIVERSITY OF TX MD ANDERSON CAN CTR,TX,770304009,NA,7626839 (contact),"MAITRA, ANIRBAN  (contact)","BERA, TAPAN K",2022-09-21,2027-08-31,NA,TBEL Admin Core,274371,ZCA1,ZCA1(M1),9680,S1,3,122240,77622,NA,199862
11192515,OT2,OD,3,N,2024-09-16,2024-09-16,2025-02-28,310,OT2OD027060,NA,NA,3OT2OD027060-02S7,NCI:2265000\NHGRI:250000\NHLBI:101800\OD:86400\,OTHERS,2024,"OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH",NA,RESTON,UNITED STATES,NA,11,088365767,US,10051506,CARAHSOFT TECHNOLOGY CORPORATION,VA,201905328,NA,15584968 (contact),"DRINKWINE, TERRY  (contact)","WEBER, MICHAEL NICHOLAS N",2023-03-01,2033-02-28,Acceleration;Address;Biomedical Research;Cloud Computing;Cloud Service;cloud storage;Communities;computerized tools;Data;Data Commons;data ecosystem;data repository;Data Science;Data Set;Economics;FAIR principles;Funding;Goals;Image;Individual;large datasets;Modeling;Modernization;Phase;Policies;Procedures;Process;programs;Research Infrastructure;Research Personnel;Science;Series;service providers;Services;Strategic Planning;Technology;Testing;United States National Institutes of Health;Work,STRIDES,27060,ZHL1,ZHL1-SRC(99),NA,S7,2,2703200,0,2703200,NA
11192519,OT2,OD,3,N,2024-09-17,2024-09-17,2025-02-28,310,OT2OD027852,NA,OTA-18-038,3OT2OD027852-02S7,NCI:5193984\NEI:3000\NIAMS:50000\OD:8625000\,OTHERS,2024,"OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH",NA,CHANTILLY,UNITED STATES,NA,11,089896737,US,10052403,"FOUR POINTS TECHNOLOGY, LLC",VA,201513834,NA,15679024 (contact),"LIPKIN, JOEL A (contact)","WEBER, MICHAEL NICHOLAS N",2023-03-01,2033-02-28,Acceleration;Address;Biomedical Research;Cloud Computing;Cloud Service;cloud storage;Communities;computerized tools;Data;Data Commons;data ecosystem;data repository;Data Science;Data Set;Economics;FAIR principles;Funding;Goals;Image;Individual;large datasets;Modeling;Modernization;Phase;Policies;Procedures;Process;programs;Research Infrastructure;Research Personnel;Science;Series;service providers;Services;Strategic Planning;Technology;Testing;United States National Institutes of Health;Work,STRIDES,27852,ZOD1,ZOD1-SRC(99),NA,S7,2,13871984,0,13871984,NA
11192524,P50,CA,3,N,2024-09-26,2024-07-01,2025-06-30,397,P50CA225450,SCHOOLS OF MEDICINE,PA-20-272,3P50CA225450-05S1,NCI:896274\,RESEARCH CENTERS,2024,NATIONAL CANCER INSTITUTE,NA,NEW YORK,UNITED STATES,DERMATOLOGY,12,121911077,US,5998304,NEW YORK UNIVERSITY SCHOOL OF MEDICINE,NY,10016,"OVERALL PROJECT NARRATIVE Physicians currently lack robust and reliable personalized tools to guide patient management in a landscape of expanded adjuvant immune checkpoint inhibition (ICI) treatment. The NYU Melanoma SPORE is directed at discovering, refining, and validating predictive and prognostic biomarkers for high-risk resected melanoma patients considering ICI treatment. The successful validation of these novel biomarkers has immense potential to improve melanoma patient clinical management and outcomes and could be extended to the increasing number of cancers treated with ICI.",1938112 (contact);1888523,"OSMAN, IMAN  (contact);WEBER, JEFFREY S","KUZMIN, IGOR A",2021-07-19,2025-06-30,Address;Adjuvant;Adjuvant Study;Adjuvant Therapy;Area;Autoantibodies;Award;Biology;biomarker identification;Cancer Patient;checkpoint inhibition;Clinical;clinical care;clinical development;Clinical Management;Custom;Data;expectation;Funding;Genetic Transcription;genomic biomarker;high risk;Immune;Immunobiology;Immunologic Adjuvants;Immunotherapy;improved;Infrastructure;insight;Maintenance;Malignant Neoplasms;Melanoma;Melanoma patient;Modality;mouse model;multiple omics;New York;novel;novel marker;optimal treatments;Organ;Outcome;Paper;patient biomarkers;patient response;Patient-Focused Outcomes;Patients;Peripheral;personalized biomarkers;Physicians;pre-clinical;predictive marker;Prognostic Marker;programs;Publications;Publishing;Recurrence;Research Project Grants;Resected;Resources;response;response biomarker;Science;Selection for Treatments;Serum;Site;success;SYK gene;T-Lymphocyte;therapeutic evaluation;Tissues;tool;Toxic effect;Treatment-related toxicity;Universities;Validation;Work,NYU Melanoma SPORE,225450,NA,NA,NA,S1,5,528775,367499,896274,NA
11192537,P20,GM,5,N,2024-09-11,2024-07-01,2025-06-30,NA,P20GM121288,NA,PAR-19-312,5P20GM121288-08,NIGMS:249900\,RESEARCH CENTERS,2024,NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES,NA,NEW ORLEANS,UNITED STATES,NA,02,782627814,US,577902,LSU HEALTH SCIENCES CENTER,LA,701127021,NA,79208182 (contact),"MOAVEN, OMEED  (contact)","CUPIT, PAULINE",2024-09-12,2027-06-30,Antibodies;anticancer activity;Area;Biomedical Engineering;cancer immunotherapy;checkpoint inhibition;chemotherapy;Clinical Trials Design;conventional therapy;design;Disease;Enzymes;Excision;Extracellular Matrix;fighting;immune checkpoint;Immune checkpoint inhibitor;Immune response;Immune system;Immunologics;Immunooncology;immunoregulation;Immunotherapeutic agent;Immunotherapy;improved;interest;Malignant neoplasm of pancreas;Malignant Neoplasms;Modality;multimodality;Nature;neoplastic cell;novel;Oncology;Oncolytic viruses;Operative Surgical Procedures;pancreatic cancer patients;Patients;PD-1 inhibitors;Pre-Clinical Model;prevent;Recommendation;Recurrence;Research;Resistance;resistance mechanism;response;Safety;Solid Neoplasm;therapy resistant;Toxic effect;Treatment Efficacy;tumor;Tumor Escape;tumor microenvironment;Vertebral column;Vesicular stomatitis Indiana virus;Viral,A novel oncolytic virus for pancreatic cancer immunotherapy,121288,ZGM1,ZGM1-RCB-3(C2),8090,NA,8,170000,79900,NA,249900
11192541,N01,AI,NA,N,NA,NA,NA,NA,75N93024D00044,NA,NA,75N93024D00044-0-759302400002-1,NIAID:54517\,NON SBIR/STTR CONTRACTS,2024,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,YEMASSEE,UNITED STATES,NA,NA,199145954,US,NA,ALPHA GENESIS INC,SC,299457115,NA,79969331 (contact),"WESTERGAARD, GREG  (contact)",NA,2024-09-30,2031-09-29,Accreditation;aged;animal care;Animals;Breeding;Caring;clinical translation;Communicable Diseases;Contractor;cooperative study;Ethics;Funding;Genetic;genetic pedigree;Genetic Variation;germ free condition;Government;Human;Immunology;Individual;Infrastructure;Institution;International;Laboratory Animals;Macaca;Macaca fascicularis;Macaca mulatta;Maintenance;Major Histocompatibility Complex;Medical;Modeling;Monkeys;National Institute of Allergy and Infectious Disease;nonhuman primate;novel therapeutics;operation;Physiology;Research;Research Personnel;Risk;sound;Testing;Therapeutic immunosuppression;Transplantation;Transplantation Tolerance,NIAID SPF MACAQUE BREEDING COLONIES,0,NA,NA,NA,NA,NA,NA,NA,54517,NA
11192542,N01,AI,NA,N,NA,NA,NA,NA,75N93024D00044,NA,NA,75N93024D00044-0-759302400001-1,NIAID:8046548\,NON SBIR/STTR CONTRACTS,2024,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,YEMASSEE,UNITED STATES,NA,NA,199145954,US,NA,ALPHA GENESIS INC,SC,299457115,NA,79953730 (contact),"WESTERGAARD, GREG  (contact)",NA,2024-09-30,2025-09-29,Accreditation;aged;animal care;Animals;Breeding;Caring;clinical translation;Communicable Diseases;Contractor;cooperative study;Ethics;Funding;Genetic;genetic pedigree;Genetic Variation;germ free condition;Government;Human;Immunology;Individual;Infrastructure;Institution;International;Laboratory Animals;Macaca;Macaca fascicularis;Macaca mulatta;Maintenance;Major Histocompatibility Complex;Medical;Modeling;Monkeys;National Institute of Allergy and Infectious Disease;nonhuman primate;novel therapeutics;operation;Physiology;Research;Research Personnel;Risk;sound;Testing;Therapeutic immunosuppression;Transplantation;Transplantation Tolerance,NIAID SPF MACAQUE BREEDING COLONIES,0,NA,NA,NA,NA,NA,NA,NA,8046548,NA
11192543,R56,AG,1,N,2024-09-25,2024-09-30,2025-08-31,866,R56AG083336,EARTH SCIENCES/RESOURCES,PA-20-185,1R56AG083336-01A1,NIA:795542\,NON-SBIR/STTR RPGS,2024,NATIONAL INSTITUTE ON AGING,NA,DAVIS,UNITED STATES,NUTRITION,04,047120084,US,577503,UNIVERSITY OF CALIFORNIA AT DAVIS,CA,956186153,"PROJECT NARRATIVE (Public Health Relevance Statement) Alzheimers disease (AD) causes neuronal damage and loss over time, but underlying mechanisms remain unknown. The proposed research aims to close this knowledge gap by investigating how lipid pathways that control neuronal survival and repair are dysregulated in a transgenic rat model of AD, and by testing whether targeting defective lipid repair pathways in rats delays AD-related neuronal damage and loss. The proposed research will lay the scientific foundation for developing therapies that counteract neurodegeneration in AD by stimulating lipid-mediated brain repair pathways.",12281783 (contact),"TAHA, AMEER  (contact)","DIBATTISTA, AMANDA",2024-09-30,2025-08-31,Acceleration;Address;Affect;Age;age related;Alzheimer&apos;s Disease;Alzheimer&apos;s disease model;Alzheimer&apos;s disease pathology;Amyloid;Autopsy;Behavioral;behavioral impairment;Binding;Biological Availability;Brain;Brain Diseases;brain repair;Cholesterol Esters;Cognition;Cognitive;Cognitive deficits;Data;Dementia;Disease;Enzymes;Esterification;Etiology;Foundations;Goals;Human;human old age (65+);Impaired cognition;Impairment;improved;Individual;Inflammation;Infusion procedures;insight;Knowledge;Ligase;Lipase;lipid mediator;Lipids;Measures;Mediating;Mediator;Membrane;Nerve Degeneration;Neurofibrillary Tangles;neuroinflammation;neuron loss;neuronal survival;Neurons;neuroprotection;novel;Pathogenesis;Pathogenicity;Pathologic;Pathologic Processes;Pathway interactions;Persons;Phospholipids;Polyunsaturated Fatty Acids;public health relevance;Rat Transgene;Rattus;repaired;Research;Rodent;Rodent Model;Role;Senile Plaques;Source;Synapses;targeted treatment;tau Proteins;Testing;therapy development;Time;Tracer;Transferase;Transgenic Organisms;TRAP Complex;Triglycerides,Identifying lipid mediator pathways involved in neuronal survival and repair in Alzheimer's disease,83336,NOMD,Neural Oxidative Metabolism and Death Study Section[NOMD],NA,A1,1,499999,295543,795542,NA
11192545,U01,FD,3,N,2024-09-19,2024-09-01,2025-08-31,103,U01FD007857,SCHOOLS OF PHARMACY,RFA-FD-23-004,3U01FD007857-02S2,FDA:2033969\,NON-SBIR/STTR RPGS,2024,FOOD AND DRUG ADMINISTRATION,NA,CHAPEL HILL,UNITED STATES,NONE,04,608195277,US,578206,UNIV OF NORTH CAROLINA CHAPEL HILL,NC,275995023,"PROJECT NARRATIVE To address the FDAs need for expanded regulatory science capabilities, the Research Triangle Center of Excellence in Regulatory Science and Innovation (Triangle CERSI) will provide a generative community for regulators, academia, and industry while serving as a one-stop-shop accelerator to meet current and evolving needs of regulatory science. The Triangle CERSI represents a collaboration of four leading academic institutions in North Carolina that are in close proximity (the University of North Carolina at Chapel Hill, Duke University, North Carolina State University, and North Carolina Central University). The Triangle CERSI aims to fully deploy our broad, collective expertise and close collaborations with FDA personnel to create and expedite utilization of important new knowledge in regulatory science and to provide an infrastructure of flexible and innovative toolsets to enrich the efficiency and value of FDA activities as part of the national CERSI program.",2794302;11911688;7129835;1883242 (contact),"HALABI, SUSAN ;MENTZ, ROBERT JOHN;SAMEI, EHSAN ;WATKINS, PAUL B (contact)","CHEN, TRACY",2023-09-01,2028-08-31,NA,Research Triangle Center of Excellence in Regulatory Science and Innovation,7857,ZFD1,ZFD1-OC-S(04)1,NA,S2,2,2010375,23594,2033969,NA
11192547,U01,FD,3,N,2024-09-24,2024-09-01,2025-08-31,103,U01FD007857,SCHOOLS OF PHARMACY,RFA-FD-23-004,3U01FD007857-02S7,FDA:376307\,NON-SBIR/STTR RPGS,2024,FOOD AND DRUG ADMINISTRATION,NA,CHAPEL HILL,UNITED STATES,NONE,04,608195277,US,578206,UNIV OF NORTH CAROLINA CHAPEL HILL,NC,275995023,"PROJECT NARRATIVE To address the FDAs need for expanded regulatory science capabilities, the Research Triangle Center of Excellence in Regulatory Science and Innovation (Triangle CERSI) will provide a generative community for regulators, academia, and industry while serving as a one-stop-shop accelerator to meet current and evolving needs of regulatory science. The Triangle CERSI represents a collaboration of four leading academic institutions in North Carolina that are in close proximity (the University of North Carolina at Chapel Hill, Duke University, North Carolina State University, and North Carolina Central University). The Triangle CERSI aims to fully deploy our broad, collective expertise and close collaborations with FDA personnel to create and expedite utilization of important new knowledge in regulatory science and to provide an infrastructure of flexible and innovative toolsets to enrich the efficiency and value of FDA activities as part of the national CERSI program.",2794302;11911688;7129835;1883242 (contact),"HALABI, SUSAN ;MENTZ, ROBERT JOHN;SAMEI, EHSAN ;WATKINS, PAUL B (contact)","CHEN, TRACY",2023-09-01,2028-08-31,NA,Research Triangle Center of Excellence in Regulatory Science and Innovation,7857,ZFD1,ZFD1-OC-S(04)1,NA,S7,2,369899,6408,376307,NA
11192570,R01,NS,3,N,2024-09-16,2024-06-01,2025-05-31,853,R01NS125137,SCHOOLS OF MEDICINE,PAR-19-158,3R01NS125137-03S1,NINDS:58839\,NON-SBIR/STTR RPGS,2024,NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE,NA,PHILADELPHIA,UNITED STATES,NEUROLOGY,03,042250712,US,6463801,UNIVERSITY OF PENNSYLVANIA,PA,191046205,"Project Narrative The proposed research is relevant to public health because developing new quantitative methods to target and test epilepsy surgery in computer models before doing these procedures in the operating room will improve patient outcomes and reduce surgery side effects and costs. In this research we are also working with 15 major epilepsy centers to standardize treatment. For these reasons the proposal is relevant to part of the NIHs mission to foster fundamental, creative discoveries and innovative research strategies that will ultimately protect and improve human health for the United States 3.3 million people with epilepsy.",10936990;7838057 (contact),"BASSETT, DANIELLE SMITH;LITT, BRIAN  (contact)","CHURN, SEVERN BORDEN",2022-06-01,2026-05-31,Ablation;Acceleration;Adoption;Algorithms;Anatomy;Archives;Biomedical Engineering;Brain Mapping;Brain region;Caring;Clinical;clinical care;clinical practice;clinical translation;Clinical Trials;Code;Collaborations;computational neuroscience;computer code;Computer Models;Computing Methodologies;cost;Creativeness;Data;Data Aggregation;data sharing;Diffuse;Eastern Cooperative Oncology Group;Electrodes;Electroencephalography;Engineering;Ensure;Epilepsy;Excision;Fostering;Foundations;Generations;Goals;Grant;Health;Human;Image;Implant;implantable device;improved;Individual;individual patient;Information Theory;innovation;Intervention;Letters;Machine Learning;Magnetic Resonance Imaging;Manuals;Maps;Measures;Metadata;Methods;Mission;Modeling;Morbidity - disease rate;Multi-Institutional Clinical Trial;network models;neuroimaging;Neurology;neuroregulation;Neurosciences;neurosurgery;novel;open source;Operating Rooms;Operative Surgical Procedures;Outcome;outcome prediction;Patient Care;Patient-Focused Outcomes;Patients;Pennsylvania;Persons;Pharmaceutical Preparations;Phase;Philosophy;Population;predictive tools;Probability;Procedures;prospective;Protocols documentation;Public Health;Quality of Care;Regional Anatomy;Research;Resected;Sampling;Sampling Biases;Sampling Errors;Seizures;side effect;Standardization;Structure;success;Testing;Tissues;Tonic-Clonic Epilepsy;tool;Translating;United States;United States National Institutes of Health;Universities;Validation;virtual;Work,Guiding epilepsy surgery using network models and Stereo EEG,125137,ZRG1,Special Emphasis Panel[ZRG1-ETTN-A(91)S],NA,S1,3,58839,0,58839,NA
11192577,U01,FD,3,N,2024-09-20,2024-09-01,2025-08-31,103,U01FD007857,SCHOOLS OF PHARMACY,RFA-FD-23-004,3U01FD007857-02S3,FDA:450533\,NON-SBIR/STTR RPGS,2024,FOOD AND DRUG ADMINISTRATION,NA,CHAPEL HILL,UNITED STATES,NONE,04,608195277,US,578206,UNIV OF NORTH CAROLINA CHAPEL HILL,NC,275995023,"PROJECT NARRATIVE To address the FDAs need for expanded regulatory science capabilities, the Research Triangle Center of Excellence in Regulatory Science and Innovation (Triangle CERSI) will provide a generative community for regulators, academia, and industry while serving as a one-stop-shop accelerator to meet current and evolving needs of regulatory science. The Triangle CERSI represents a collaboration of four leading academic institutions in North Carolina that are in close proximity (the University of North Carolina at Chapel Hill, Duke University, North Carolina State University, and North Carolina Central University). The Triangle CERSI aims to fully deploy our broad, collective expertise and close collaborations with FDA personnel to create and expedite utilization of important new knowledge in regulatory science and to provide an infrastructure of flexible and innovative toolsets to enrich the efficiency and value of FDA activities as part of the national CERSI program.",2794302;11911688;7129835;1883242 (contact),"HALABI, SUSAN ;MENTZ, ROBERT JOHN;SAMEI, EHSAN ;WATKINS, PAUL B (contact)","CHEN, TRACY",2023-09-01,2028-08-31,NA,Research Triangle Center of Excellence in Regulatory Science and Innovation,7857,ZFD1,ZFD1-OC-S(04)1,NA,S3,2,405536,44997,450533,NA
11192578,U01,FD,3,N,2024-09-21,2024-09-01,2025-08-31,103,U01FD007857,SCHOOLS OF PHARMACY,RFA-FD-23-004,3U01FD007857-02S4,FDA:454318\,NON-SBIR/STTR RPGS,2024,FOOD AND DRUG ADMINISTRATION,NA,CHAPEL HILL,UNITED STATES,NONE,04,608195277,US,578206,UNIV OF NORTH CAROLINA CHAPEL HILL,NC,275995023,"PROJECT NARRATIVE To address the FDAs need for expanded regulatory science capabilities, the Research Triangle Center of Excellence in Regulatory Science and Innovation (Triangle CERSI) will provide a generative community for regulators, academia, and industry while serving as a one-stop-shop accelerator to meet current and evolving needs of regulatory science. The Triangle CERSI represents a collaboration of four leading academic institutions in North Carolina that are in close proximity (the University of North Carolina at Chapel Hill, Duke University, North Carolina State University, and North Carolina Central University). The Triangle CERSI aims to fully deploy our broad, collective expertise and close collaborations with FDA personnel to create and expedite utilization of important new knowledge in regulatory science and to provide an infrastructure of flexible and innovative toolsets to enrich the efficiency and value of FDA activities as part of the national CERSI program.",2794302;11911688;7129835;1883242 (contact),"HALABI, SUSAN ;MENTZ, ROBERT JOHN;SAMEI, EHSAN ;WATKINS, PAUL B (contact)","CHEN, TRACY",2023-09-01,2028-08-31,NA,Research Triangle Center of Excellence in Regulatory Science and Innovation,7857,ZFD1,ZFD1-OC-S(04)1,NA,S4,2,292166,162152,454318,NA
11192582,U01,FD,3,N,2024-09-22,2024-09-01,2025-08-31,103,U01FD007857,SCHOOLS OF PHARMACY,RFA-FD-23-004,3U01FD007857-02S5,FDA:867730\,NON-SBIR/STTR RPGS,2024,FOOD AND DRUG ADMINISTRATION,NA,CHAPEL HILL,UNITED STATES,NONE,04,608195277,US,578206,UNIV OF NORTH CAROLINA CHAPEL HILL,NC,275995023,"PROJECT NARRATIVE To address the FDAs need for expanded regulatory science capabilities, the Research Triangle Center of Excellence in Regulatory Science and Innovation (Triangle CERSI) will provide a generative community for regulators, academia, and industry while serving as a one-stop-shop accelerator to meet current and evolving needs of regulatory science. The Triangle CERSI represents a collaboration of four leading academic institutions in North Carolina that are in close proximity (the University of North Carolina at Chapel Hill, Duke University, North Carolina State University, and North Carolina Central University). The Triangle CERSI aims to fully deploy our broad, collective expertise and close collaborations with FDA personnel to create and expedite utilization of important new knowledge in regulatory science and to provide an infrastructure of flexible and innovative toolsets to enrich the efficiency and value of FDA activities as part of the national CERSI program.",2794302;11911688;7129835;1883242 (contact),"HALABI, SUSAN ;MENTZ, ROBERT JOHN;SAMEI, EHSAN ;WATKINS, PAUL B (contact)","CHEN, TRACY",2023-09-01,2028-08-31,NA,Research Triangle Center of Excellence in Regulatory Science and Innovation,7857,ZFD1,ZFD1-OC-S(04)1,NA,S5,2,567435,300295,867730,NA
11192585,U01,FD,3,N,2024-09-23,2024-09-01,2025-08-31,103,U01FD007857,SCHOOLS OF PHARMACY,RFA-FD-23-004,3U01FD007857-02S6,FDA:949206\,NON-SBIR/STTR RPGS,2024,FOOD AND DRUG ADMINISTRATION,NA,CHAPEL HILL,UNITED STATES,NONE,04,608195277,US,578206,UNIV OF NORTH CAROLINA CHAPEL HILL,NC,275995023,"PROJECT NARRATIVE To address the FDAs need for expanded regulatory science capabilities, the Research Triangle Center of Excellence in Regulatory Science and Innovation (Triangle CERSI) will provide a generative community for regulators, academia, and industry while serving as a one-stop-shop accelerator to meet current and evolving needs of regulatory science. The Triangle CERSI represents a collaboration of four leading academic institutions in North Carolina that are in close proximity (the University of North Carolina at Chapel Hill, Duke University, North Carolina State University, and North Carolina Central University). The Triangle CERSI aims to fully deploy our broad, collective expertise and close collaborations with FDA personnel to create and expedite utilization of important new knowledge in regulatory science and to provide an infrastructure of flexible and innovative toolsets to enrich the efficiency and value of FDA activities as part of the national CERSI program.",2794302;11911688;7129835;1883242 (contact),"HALABI, SUSAN ;MENTZ, ROBERT JOHN;SAMEI, EHSAN ;WATKINS, PAUL B (contact)","CHEN, TRACY",2023-09-01,2028-08-31,NA,Research Triangle Center of Excellence in Regulatory Science and Innovation,7857,ZFD1,ZFD1-OC-S(04)1,NA,S6,2,946061,3145,949206,NA
11192610,ZIA,AI,1,N,NA,NA,NA,NA,ZIAAI000646,NA,NA,1ZIAAI000646-33,NIAID:450646\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,9691549 (contact),"HOLLAND, STEVEN  (contact)",NA,NA,NA,"Affect;African ancestry;Alleles;Aneurysm;Animals;Area;arterial tortuosity;autosome;B-Lymphocytes;Biochemical;Biological;Bone Marrow;Bone Marrow Transplantation;Cardiovascular system;Cells;chemokine;Chronic Granulomatous Disease;Clinical;Coccidioides;cohort;Collaborations;congenital immunodeficiency;Cyst;cytokine;Defect;Dental;Diagnosis;Disease;Distant;DOCK8 deficiency;dominant genetic mutation;Dominant-Negative Mutation;Endothelial Cells;Enzymes;Etiology;Evaluation;Extramural Activities;Functional disorder;gain of function;gastrointestinal;Generations;Genes;Genetic;Genotype;Genus staphylococcus;Goals;Hematopoietic;Histopathology;Histoplasma;Human;human model;Hyper-IgE Syndrome;Hypersensitivity;IgE;IL17 gene;Immune;immune function;immunopathology;Impaired wound healing;Impairment;In Vitro;Infection;Inflammation;Inflammatory;Inflammatory Bowel Diseases;Innate Immune Response;intercellular communication;interest;Interferon Type II;Intestines;Investigation;Job&apos;s Syndrome;Laboratories;Link;loss of function;Lung;Lymphopenia;Malignant Neoplasms;Metabolism;microbiome research;minority health;Molecular;Molecular Genetics;mouse model;Mus;Muscle Cells;Mutation;Mycoses;Myelogenous;NADPH Oxidase;National Heart, Lung, and Blood Institute;National Institute of Allergy and Infectious Disease;National Institute of Arthritis, and Musculoskeletal, and Skin Diseases;Natural Immunity;Newly Diagnosed;Occupations;Operative Surgical Procedures;Organism;Osteopenia;Pathogenesis;Pathogenicity;Patients;Peroxides;Persons;Phagocytes;Phenotype;Portugal;Predisposition;Production;Productivity;programs;Protocols documentation;rac2 GTP-binding protein;Recurrence;recurrent infection;Reporting;Research Personnel;Resistance;Respiratory Tract Infections;Role;Sarcoidosis;Specimen;STAT1 gene;STAT3 gene;Superoxides;Syndrome;T-Lymphocyte;TNF gene;Transgenic Animals;Transplant-Related Disorder;Vascular Endothelial Cell;Work",Transgenic Animal Models Of Human Immune Defects,646,NA,NA,NA,NA,33,NA,NA,450646,NA
11192611,ZIA,AI,1,N,NA,NA,NA,NA,ZIAAI000647,NA,NA,1ZIAAI000647-33,NIAID:658891\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,9691549 (contact),"HOLLAND, STEVEN  (contact)",NA,NA,NA,Acquired Immunodeficiency Syndrome;Adult;Affect;Bronchiectasis;Child;Coccidioidomycosis;Cryptococcosis;Cutaneous;Cystic Fibrosis;cytokine;Cytokine Receptors;Cytokine Signaling;cytokine therapy;Defect;Development;Diagnosis;Disease;Disease Resistance;Drug resistance;drug-sensitive;Dysmyelopoietic Syndromes;Epidemiology;Epigenetic Process;Epithelium;Etiology;experimental study;Functional disorder;fungus;gene product;Genes;Genetic;Genus Mycobacterium;Granulomatous;Granulomatous disease;Histoplasmosis;Host Defense;Human;IL17 gene;Immune;Immune response;Immunity;Immunobiology;Immunocompromised Host;Immunologic Adjuvants;In Vitro;Infection;Inflammatory;Innate Immune Response;interest;Interferon Type II;Interleukin-12;interleukin-23;Knowledge;Lesion;Lung;Lung Diseases;Lymphocyte;Macrophage;Malignant Neoplasms;Microbe;microbial;Microbiology;Mutation;mycobacterial;Mycobacterium Infections;Mycoses;Nature;non-tuberculosis mycobacteria;non-tuberculous mycobacterial infection;novel therapeutic intervention;Organism;Outcome;participant enrollment;pathogen;Pathogenesis;Pathway interactions;Patients;Phagocytes;Predisposition;Production;Regulation;response;Role;Salmonella;Sarcoidosis;Signal Pathway;Syndrome;Therapeutic;TNF gene;Tuberculosis;tuberculosis treatment,Genes And Gene Products As Immunoadjuvants,647,NA,NA,NA,NA,33,NA,NA,658891,NA
11192612,ZIA,AI,1,N,NA,NA,NA,NA,ZIAAI001069,NA,NA,1ZIAAI001069-17,NIAID:150216\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,9691549 (contact),"HOLLAND, STEVEN  (contact)",NA,NA,NA,Acquired Immunodeficiency Syndrome;Adult;Antibodies;Asia;Autoantibodies;Biological Assay;Blood Banks;Chickenpox;Chronic Disease;cohort;Country;Cryptococcal Meningitis;Cryptococcosis;Cryptococcus gattii;cytokine;Data;Defect;design;Diagnostic;Disease;disease natural history;East Asian;Enrollment;Epitopes;Far East;Granulocyte-Macrophage Colony-Stimulating Factor;Herpes zoster disease;Histoplasmosis;HIV;Human;Immune System Diseases;immunodeficiency;Immunologics;Infection;Interferon Type II;interleukin-23;International;Natural History;Nocardia Infections;non-tuberculosis mycobacteria;non-tuberculous mycobacterial infection;Opportunistic Infections;Patients;Pneumocystis;Proteome;Pulmonary Tuberculosis;Reporting;Research;rituximab;Salmonella infections;Sampling;screening;Site;Syndrome;Taiwan;Thailand;Thymoma;Tuberculosis;United States,International Research in Thailand,1069,NA,NA,NA,NA,17,NA,NA,150216,NA
11192613,ZIA,AI,1,N,NA,NA,NA,NA,ZIAAI001182,NA,NA,1ZIAAI001182-12,NIAID:150216\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,9691549 (contact),"HOLLAND, STEVEN  (contact)",NA,NA,NA,18 year old;Affect;anti-CD20;Antibodies;Antigens;arm;Autoantibodies;Autoimmune Diseases;B-Lymphocyte Subsets;B-Lymphocytes;Blood;Bronchoscopy;Candidiasis;CD40 Ligand;Clinical;conventional therapy;cytokine;Disease;Endoscopy;Flow Cytometry;follow-up;Granulocyte-Macrophage Colony-Stimulating Factor;IL17 gene;Image;immunodeficiency;Immunologics;Infection;inflammatory marker;Infusion procedures;insight;Interferon Type II;Intravenous infusion procedures;Laboratories;Mediator;Methods;Monoclonal Antibody CD20;Mucocutaneous Candidiasis;Myasthenia Gravis;non-tuberculous mycobacterial infection;open label;participant enrollment;Pathogenicity;Patients;Pemphigus Vulgaris;phase I trial;Process;Production;Progressive Disease;Pulmonary Alveolar Proteinosis;Quality of life;Refractory;Rheumatoid Arthritis;rituximab;Safety;screening;Surveys;Syndrome;Toxic effect;Visit;X-Ray Computed Tomography,Rituximab for Anticytokine Autoantibody-Associated Syndromes,1182,NA,NA,NA,NA,12,NA,NA,150216,NA
11192614,ZIA,AI,1,N,NA,NA,NA,NA,ZIAAI001216,NA,NA,1ZIAAI001216-09,NIAID:120173\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,9691549 (contact),"HOLLAND, STEVEN  (contact)",NA,NA,NA,Adult;Affect;attenuation;Birth;carcinogenesis;cell type;Cells;Characteristics;Chronic;Chronic Granulomatous Disease;Clinical Protocols;Clinical Treatment;Colitis;Colon;Complex;congenital immunodeficiency;Defect;Disease;Disease susceptibility;early onset;Enzymes;epithelial repair;Epithelium;Family member;FPR1 gene;Gastrointestinal tract structure;Generations;Genetic Diseases;Goals;gut inflammation;gut microbiome;Health;Hematopoietic;Hematopoietic Stem Cell Transplantation;Homeostasis;Host Defense;Human;Immunologics;In Vitro;Infection;Inflammation;Inflammatory Response;interest;intestinal barrier;Intestines;Investigation;Lactobacillus;Large Intestine;Lead;Mediating;Methods;microbiome;microbiome research;microbiome signature;Modeling;mouse model;Mus;NADP;neutrophil cytosol factor 40K;neutrophil cytosol factor 67K;new therapeutic target;Oxidases;Pathogenesis;Pathologic;Patients;Pattern;Phagocytes;Physiological Processes;Predisposition;Production;Proteins;Reactive Oxygen Species;recurrent infection;Role;signal recognition particle receptor;Signaling Molecule;Single Nucleotide Polymorphism;Small Intestines;Source;Specimen;Surrogate Markers;Tissues;Translational Research;Treatment Protocols;Variant,Role of reactive oxygen species and the microbiome in intestinal barrier homeostasis,1216,NA,NA,NA,NA,9,NA,NA,120173,NA
11192615,ZIA,AI,1,N,NA,NA,NA,NA,ZIAAI001312,NA,NA,1ZIAAI001312-05,NIAID:19619\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,9691549 (contact),"HOLLAND, STEVEN  (contact)",NA,NA,NA,antibody test;Autoantibodies;Biological Assay;clinical center;Clinical Protocols;cohort;Country;COVID-19;COVID-19 patient;COVID-19 surveillance;cytokine;Disease Outcome;Employee;Enrollment;Goals;Individual;Infection;Interferon Type I;Italy;Longitudinal cohort study;Manuscripts;nasopharyngeal swab;neutralizing antibody;Patients;Polymerase Chain Reaction;prospective;Protocols documentation;Publishing;Reporting;Reverse Transcription;saliva sample;Sampling;SARS-CoV-2 exposure;SARS-CoV-2 infection;Science;screening;severe COVID-19;Severity of illness;Swab;Testing;United States National Institutes of Health,Anticytokine Autoantibodies in COVID-19,1312,NA,NA,NA,NA,5,NA,NA,19619,NA
11192616,ZIA,AI,1,N,NA,NA,NA,NA,ZIAAI001379,NA,NA,1ZIAAI001379-01,NIAID:1201719\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,79981541 (contact),"UZEL, GULBU  (contact)",NA,NA,NA,arm;Biological Assay;Biological Markers;Clinical Protocols;Clinical Trials;Collaborations;congenital immunodeficiency;Defect;Disease;Dose;Genetic;Immune;immunoregulation;Institutional Review Boards;Link;Measures;multiple omics;open label;participant enrollment;Pathway interactions;patient population;Patients;Pharmacodynamics;Phosphatidylinositols;Phosphotransferases;PIK3CG gene;programs;response;Role;Safety;Signal Transduction;small molecule inhibitor;targeted treatment;treatment response,Leniolisib for immunedysregulation,1379,NA,NA,NA,NA,1,NA,NA,1201719,NA
11192617,ZIA,DA,1,N,NA,NA,NA,NA,ZIADA000522,NA,NA,1ZIADA000522-17,NIDA:748318\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE ON DRUG ABUSE,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE ON DRUG ABUSE,NA,NA,NA,14739417 (contact),"BAUMANN, MICHAEL  (contact)",NA,NA,NA,"abuse liability;Acute;Advocate;Agonist;analog;antagonist;Anxiety;ARRB2;Biological;Biological Assay;Brain;Buprenorphine;Carrier Proteins;cigarette smoking;Clinical Research;Cocaine;Cocaine use disorder;Cognition;Development;Dopamine;dopamine transporter;drug development;drug of abuse;drug seeking behavior;experimental study;extracellular;FDA approved;Fentanyl;Hallucinogens;Head;heroin use;HTR2A gene;Hybrids;Illicit Drugs;In Vitro;Ingestion;interest;Investigation;Journals;Laboratories;Ligands;Lisuride;Locomotion;Long-Term Effects;Lysergic Acid Diethylamide;male;Mediating;medication administration;Mental Depression;Mental disorders;Methamphetamine;monoamine;Mus;N,N-Dimethyltryptamine;natural hypothermia;Neurobiology;nicotine gum;novel;overdose death;Paper;Peer Review;Perception;Pharmaceutical Preparations;Pharmacology;Pharmacotherapy;pre-clinical;preclinical development;Property;Psilocybin;Publications;Publishing;Rattus;receptor;recruit;Reporting;Research;response;Rodent Model;Self Administration;Serotonin;Serotonin Receptor 5-HT1A;Serotonin Receptor 5-HT2A;serotonin transporter;Severities;Signal Transduction;Site;Stimulant;stimulant dependence;stimulant use;stimulant use disorder;Substance Use Disorder;synthetic opioid;Testing;Therapeutic Effect;Tryptamines;United States;Work",Preclinical medication development for stimulant use disorder,522,NA,NA,NA,NA,17,NA,NA,748318,NA
11192618,ZIA,DA,1,N,NA,NA,NA,NA,ZIADA000523,NA,NA,1ZIADA000523-17,NIDA:1746074\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE ON DRUG ABUSE,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE ON DRUG ABUSE,NA,NA,NA,14739417 (contact),"BAUMANN, MICHAEL  (contact)",NA,NA,NA,abuse liability;addiction;Adverse effects;Affinity;analog;Animal Model;bath salts;behavioral study;Binding;Biological Assay;biological systems;Blood specimen;Body Temperature;Brain;Cannabinoids;Cells;Clinical;clinically relevant;Conscious;Data;Dopamine;driving force;Drug Kinetics;drug market;drug metabolism;drug of abuse;drug reward;Epidemic;experience;Exposure to;extracellular;Fentanyl;Goals;Human;Illicit Drugs;In Vitro;in vivo;interest;K2/Spice;Length;Life;manufacture;Membrane;Methods;Microdialysis;Molecular Mechanisms of Action;Morphine;Motor Activity;mu opioid receptors;Mus;nanomolar;Neurons;Opioid;Opioid agonist;opioid epidemic;opioid overdose;Overdose;Pathway interactions;Pharmaceutical Preparations;Pharmacology and Toxicology;Public Health;Publications;radioligand;Rattus;Recreation;Recreational Drugs;Research;Research Project Grants;research study;Risk;Self Administration;Serotonin;Structure-Activity Relationship;synthetic cannabinoid;synthetic drug;synthetic opioid;Transfection;Ventilatory Depression,Pharmacology and toxicology of new psychoactive substances,523,NA,NA,NA,NA,17,NA,NA,1746074,NA
11192619,ZIA,DA,1,N,NA,NA,NA,NA,ZIADA000599,NA,NA,1ZIADA000599-11,NIDA:565376\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE ON DRUG ABUSE,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE ON DRUG ABUSE,NA,NA,NA,9414875 (contact),"LUPICA, CARL  (contact)",NA,NA,NA,addiction;Affect;Aggressive behavior;Agonist;Amygdaloid structure;Anatomy;Animals;antagonist;Anxiety;Area;Association Learning;Behavior;Behavioral;Brain;Cells;Clinical;Cocaine;Cocaine Dependence;cocaine exposure;cocaine self-administration;Cocaine Users;Cocaine withdrawal;Cognitive;cognitive ability;Data;Decision Making;Dementia;differential expression;Disease;dorsal raphe nucleus;Drug Addiction;drug craving;Drug Utilization;Electrophysiology (science);Exhibits;experimental study;extracellular;Female;flexibility;Functional disorder;Glutamates;hippocampal pyramidal neuron;HTR2A gene;Human;Impairment;Impulsivity;Infusion procedures;inhibitory neuron;insight;Interneurons;Ketanserin;Learning;Lesion;Limbic System;Link;male;Medial Dorsal Nucleus;Mediating;Mental Depression;Mental disorders;Metabolic;Modality;Modeling;nerve supply;Neuromodulator;Neurons;neuropsychiatric disorder;neuropsychiatry;Neurotransmitters;novel;novel therapeutic intervention;Obsessive-Compulsive Disorder;Outcome;Output;Parvalbumins;Pharmaceutical Preparations;pharmacologic;Pharmacologic Actions;Pharmacology Study;Physiological;Play;Positioning Attribute;Post-Traumatic Stress Disorders;postsynaptic;presynaptic;Pyramidal Cells;raphe nuclei;Rattus;receptor;Receptor Activation;receptor function;reinforcer;Reporting;response;Reversal Learning;Rewards;Role;SB 242084;Sensory;sensory input;Serotonergic System;Serotonin;Serotonin Agents;serotonin receptor;Serotonin Receptor 5-HT2A;Serotonin Receptor 5-HT2C;sex;Signal Transduction;Slice;Smell Perception;Synapses;synaptic function;Synaptic Transmission;Taste Perception;Training;Ventral Striatum;Vision;Visual;Withdrawal,Cocaine Addiction and the Role of Serotonin in Orbitofrontal Cortex Function,599,NA,NA,NA,NA,11,NA,NA,565376,NA
11192620,ZIA,DA,1,N,NA,NA,NA,NA,ZIADA000611,NA,NA,1ZIADA000611-09,NIDA:2820374\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE ON DRUG ABUSE,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE ON DRUG ABUSE,NA,NA,NA,14750670 (contact),"TANDA, GIANLUIGI  (contact)",NA,NA,NA,Absence of pain sensation;Acute;addiction;Affect;Affinity;Agonist;alcohol use disorder;analog;Attenuated;Autoreceptors;Behavioral;Behavioral Assay;Brain;Brain Diseases;Brain region;calmodulin-dependent protein kinase II;cell type;Cells;Chemical Structure;Clinical Research;Clinical Treatment;Clinical Trials;Cocaine;cocaine self-administration;Cocaine use disorder;Cocaine Users;comorbidity;Computer Models;Coupling;Crack Cocaine;Cre-LoxP;Data;Dopamine;Dopamine D1 Receptor;Dopamine D2 Receptor;dopamine D3 receptor;Dopamine Receptor;dopamine transporter;dopaminergic neuron;Dose;Drug Addiction;Drug Design;Drug Interactions;Drug Prescriptions;Drug Targeting;effective therapy;Electrochemistry;enantiomer;Environment;Exploratory Behavior;extracellular;FDA approved;Female;Future;Gender;Goals;Hyperactivity;Immunohistochemistry;In Situ Hybridization;inhibitor;Investigation;Knock-out;Locomotion;male;Measures;Mediating;Medical;Membrane;mesolimbic system;Metabolic Clearance Rate;Metabolic Pathway;Methamphetamine;Methamphetamine use disorder;Microdialysis;Midbrain structure;Modafinil;Molecular;Molecular Conformation;Mus;nanomolar;Nerve;neural circuit;Neurobiology;neurochemistry;Neurons;Neurotransmitters;novel;Nucleus Accumbens;Opioid;optogenetics;Oxycodone;oxycodone self-administration;Pathologic;Periodicity;Pharmaceutical Preparations;pharmacologic;Phosphorylation;Phosphotransferases;Physiologic pulse;Physiological;Polymerase Chain Reaction;Population;postsynaptic;Pre-Clinical Model;preclinical study;predictive modeling;presynaptic;Presynaptic Receptors;Procedures;psychostimulant;Publications;receptor;receptor expression;receptor function;Research;response;reuptake;Rewards;Ritalin;Rodent;Role;Scanning;sex;Sex Differences;sigma receptors;Sleep Disorders;Sprague-Dawley Rats;stimulant use disorder;Substance Use Disorder;substance use treatment;Synapses;Synapsins;Synaptic Receptors;System;Techniques;Testing;Therapeutic;Time;Vesicle;virtual;Work,Investigation On The Behavioral Effects And Related Neuro-Electrochemistry Of Potential Medications For The Treatment Of Substance Use Disorders.,611,NA,NA,NA,NA,9,NA,NA,2820374,NA
11192621,ZIA,DA,1,N,NA,NA,NA,NA,ZIADA000633,NA,NA,1ZIADA000633-05,NIDA:210447\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE ON DRUG ABUSE,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE ON DRUG ABUSE,NA,NA,NA,77836576 (contact),"XI, ZHENG-XIONG  (contact)",NA,NA,NA,Affect;Affinity;Agonist;Amygdaloid structure;Anatomy;Animal Model;Animals;antagonist;Behavior;Behavioral Assay;Behavioral Model;Beta-caryophyllene;Binding;Biological Psychiatry;Brain;brain cell;Cannabinoids;Cannabis;Cells;CNR1 gene;CNR2 gene;Cocaine;Cocaine Dependence;cocaine use;Cognition;Collaborations;Decision Making;Dopamine;dopamine D3 receptor;dopaminergic neuron;Drug abuse;Drug Addiction;drug reward;experimental study;Feeling;gamma-Aminobutyric Acid;Glutamates;GPR55 receptor;heroin use;Human;Immune;Impulsivity;interest;International;Journals;Learning;Ligands;Magnetic Resonance Imaging;marijuana use;Midbrain structure;Molecular;Mus;National Institute of Drug Abuse;Natural Compound;Neurons;Neuropharmacology;neuropsychopharmacology;Nicotine;Nicotine Use Disorder;novel;Opiate Addiction;Opioid;Optics;optogenetics;Paper;Peripheral;Pharmaceutical Chemistry;Pharmaceutical Preparations;PPAR alpha;PPAR gamma;Psychiatry;Publishing;Reaction;receptor;Reporter;Research;Research Personnel;response;Rewards;rimonabant;Rodent;Role;Science;Self Stimulation;side effect;Substance Use Disorder;substance use treatment;Testing;Therapeutic;Training;Transgenic Mice,Cannabinoid CB1 and CB2 receptors and drug abuse,633,NA,NA,NA,NA,5,NA,NA,210447,NA
11192622,ZIA,DA,1,N,NA,NA,NA,NA,ZIADA000643,NA,NA,1ZIADA000643-03,NIDA:2261506\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE ON DRUG ABUSE,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE ON DRUG ABUSE,NA,NA,NA,9414875 (contact),"LUPICA, CARL  (contact)",NA,NA,NA,Acetylcholine;Acute;Area;Attention deficit hyperactivity disorder;basal forebrain;Behavior;behavioral study;Bipolar Disorder;Brain;Brain Injuries;Brain region;Cannabis;CNR1 gene;Cocaine;cocaine seeking;drug abstinence;Drug usage;Drug Use Disorder;endogenous cannabinoid system;Food;Future;gamma-Aminobutyric Acid;Globus Pallidus;Glutamates;Goals;Habenula;Impulsive Behavior;Impulsivity;Ion Channel;Lateral;Learning;Light;Link;marijuana use;Mental disorders;Modeling;Muscarinic Acetylcholine Receptor;Neuroanatomy;Neurons;non-drug;Nucleus Accumbens;Obsessive-Compulsive Disorder;optogenetics;Pathway interactions;Pharmaceutical Preparations;Physiological;Plants;Play;prevent;Property;Psychological reinforcement;psychostimulant;Rattus;reinforced behavior;response;Role;Self Administration;Soldier;Source;Stimulus;synaptic inhibition;System;Tetrahydrocannabinol;Training;Traumatic Brain Injury;Ventral Tegmental Area;Viral;Work,Role of the lateral habenula in impulsive behavior,643,NA,NA,NA,NA,3,NA,NA,2261506,NA
11192623,ZIA,ES,1,N,NA,NA,NA,NA,ZIAES049013,NA,NA,1ZIAES049013-30,NIEHS:951705\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES,NA,NA,NA,2073424 (contact),"BAIRD, DONNA D. (contact)",NA,NA,NA,Address;African;African American Women;African ancestry;age related;aged;Animal Model;Area;Bacterial Vaginosis;Benign;Biometry;black women;Blood specimen;Body mass index;Boston;Cell Survival;Characteristics;Chemicals;Chlamydia;Clinic Visits;clinical diagnosis;cohort;Collaborations;Contraceptive Agents;Contraceptive Usage;Cytogenetics;Data;Data Collection;Data Files;Depo Provera;depressive symptoms;design;Development;Diagnosis;Diameter;DNA;Dysmenorrhea;Endocrine Disruptors;Enrollment;Environment;epidemiology study;Estrogens;Ethnic Population;European;Exclusion Criteria;Extramural Activities;feeding;Fertility;Fibroid Tumor;follow-up;Frequencies;Funding;Genistein;genital herpes;Genotype;Goals;Growth;Growth and Development function;Health;Herpesviridae Infections;high body mass index;Histologic;Hormonal;Hormonal Change;Hormones;Hypertension;Hysterectomy;Incidence;Incidence Study;Infant formula;Inflammatory;Injectable;interest;Investigation;Laboratories;Life;Life Style;Literature;Magnetic Resonance Imaging;Measurement;Measures;Medical Care Costs;Menstrual cycle;Methods;Michigan;Modeling;Monitor;Morbidity - disease rate;Mutation;National Institute of Child Health and Human Development;National Institute of Environmental Health Sciences;Normal Range;North Carolina;Operative Surgical Procedures;Outcome;Ovarian aging;ovarian reserve;Participant;personal care products;Phytoestrogens;Polycystic Ovary Syndrome;Postmenopause;Pregnancy Outcome;Progesterone;Progestins;prospective;Prospective Studies;Psychosocial Factor;Puberty;Reporting;reproductive tract;Reproductive Tract Infections;Research;research study;Resources;Risk;Risk Factors;risk variant;Sampling;Sampling Studies;Serology;Serum;side effect;Sleep;sleep health;Smooth Muscle Tumor;Somatic Mutation;soy;Statistical Data Interpretation;Study models;Suggestion;Supplementation;survivorship;Swab;Symptoms;Testing;Time;Tissues;tumor;Tumor Tissue;tumorigenesis;ultrasound;United States;Universities;Urine;Uterine Fibroids;Vagina;Visit;Vitamin D;Vitamin D Deficiency;White Women;Whole Blood;Woman,Uterine Leiomyomas,49013,NA,NA,NA,NA,30,NA,NA,951705,NA
11192624,ZIA,ES,1,N,NA,NA,NA,NA,ZIAES101765,NA,NA,1ZIAES101765-21,NIEHS:1690437\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES,NA,NA,NA,8219752 (contact),"LI, LEPING  (contact)",NA,NA,NA,Adult;Affect;Age;Alpha Rhythm;Alzheimer&apos;s Disease;Apnea;Area;autism spectrum disorder;Bioinformatics;Brain;Brain region;Breathing;Cardiovascular system;Characteristics;Chromosome 21;Chronic;circadian;Classification;clinical diagnosis;Clinical Trials;cognitive function;Congenital chromosomal disease;Data;Delta Rhythm;Depressed mood;Depressive disorder;Diabetes Mellitus;Diagnosis;Disease;Down&apos;s Syndrome;Drowsiness;Early Diagnosis;Early Onset Alzheimer Disease;Early treatment;Eating;Electroencephalography;Electrophysiology (science);Etiology;Event;Exhibits;experience;Eye;Frequencies;Genetic;Genetic Diseases;Glucose;Goals;Health;Health Benefit;Heart Rate;Height;High Prevalence;Hour;Human;Hypertension;Impaired cognition;improved;indexing;Intellectual functioning disability;interest;Interruption;Laboratories;Machine Learning;machine learning algorithm;machine learning method;Major Depressive Disorder;male;Measures;men;Mental disorders;Methodology;Modeling;Monitor;National Institute of Mental Health;Nervous System Disorder;non rapid eye movement;Obesity;Obstructive Sleep Apnea;Oxygen;Parkinson Disease;patient response;Patients;Performance;Peripheral;Persons;Physiologic pulse;pleasure;Polysomnography;Population Study;predictive tools;Prevalence;Public Health;Quality of life;REM Sleep;Research;respiratory;Rest;Risk;screening;Seizures;Severities;sex;Signal Transduction;single episode major depressive disorder;Sleep;Sleep Apnea Syndromes;Sleep Disorders;sleep spindle;Sleep Stages;Specificity;statistical and machine learning;Surrogate Markers;Testing;Time;Time trend;tool;Training;trend;United States;user-friendly;Validation;web site;Weight;Weight Gain;Woman;Work,Bioinformatics,101765,NA,NA,NA,NA,21,NA,NA,1690437,NA
11192625,ZIA,ES,1,N,NA,NA,NA,NA,ZIAES102025,NA,NA,1ZIAES102025-19,NIEHS:2676688\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES,NA,NA,NA,7373319 (contact),"COOK, DONALD N (contact)",NA,NA,NA,Adjuvant;Affect;Airway Disease;airway epithelium;airway hyperresponsiveness;Allergens;Allergic;Allergic inflammation;Animals;Antigens;Asthma;asthma model;Cell Differentiation process;Cell Line;Cell Physiology;Cell surface;cell type;Cells;cytokine;Cytometry;Dendritic cell activation;Dendritic Cells;draining lymph node;Environment;environmental agent;Eosinophilia;Epithelial Cells;Epithelium;Experimental Designs;Extrinsic asthma;Flagellin;Flow Cytometry;gene product;Genes;Goals;IL17 gene;Immune response;improved;Individual;Inhalation;interest;Interleukin-13;ITGAM gene;Laboratories;Ligands;Lipopolysaccharides;Lung;Lung Diseases;Mediating;migration;Molecular;mouse model;Mus;Mutation;Neutrophilia;novel;Ovalbumin;Pathway interactions;Peptide Hydrolases;Peptides;Population;prevent;Quality of life;Regulation;response;Role;Signal Transduction;single-cell RNA sequencing;stem;T-Lymphocyte;Testing;Thoracic Lymph Node;tissue resident memory T cell;TNF gene;Toll-like receptors,Allergic sensitization through the airway,102025,NA,NA,NA,NA,19,NA,NA,2676688,NA
11192626,ZIA,ES,1,N,NA,NA,NA,NA,ZIAES102205,NA,NA,1ZIAES102205-18,NIEHS:3264743\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES,NA,NA,NA,9416020 (contact),"LI, XIAOLING  (contact)",NA,NA,NA,Acute;acyl group;Acylation;age acceleration;age related;age-related disease;Aging;aging related;amidation;Anabolism;Animals;anti-microbial peptide;Area;Biochemical Reaction;biological adaptation to stress;Biological Models;Biology;cancer cell;cancer type;Cell Death;cell growth regulation;Cell Physiology;Cells;Cellular Metabolic Process;chemically induced colitis;Chemicals;clinical investigation;cofactor;Colitis;Consumption;Coupled;Cultured Cells;Deacetylase;deamidation;Development;Diet;dietary;Disease;DNA Repair;Electrons;Endocrinology;endoplasmic reticulum stress;Energy Metabolism;Environment;Environmental Risk Factor;environmental stressor;Enzymes;epigenetic regulation;Epithelial Cells;Equilibrium;Family;fecal transplantation;gastrointestinal;gastrointestinal epithelium;gene environment interaction;Genes;Genetic;genetic approach;Genetic Transcription;Genome Stability;Goals;Growth;gut inflammation;gut microbiota;Histones;Homeostasis;host-microbe interactions;Human;human disease;Immune;Impairment;improved;Inflammation;Inflammatory;Intestinal Diseases;Intestines;intraepithelial;Journals;Life Style;Link;Lysine;Maintenance;Malignant Neoplasms;Mediating;member;Metabolic;Metabolic Diseases;Metabolic syndrome;Metabolism;Microbe;microbiome;microbiota;Molecular;Monitor;Mus;Neurodegenerative Disorders;Niacinamide;Nicotinamide adenine dinucleotide;Nicotinic Acids;novel strategies;Nuclear;Nuclear Receptors;Nutrient;old mice;Paneth Cells;Paper;Pathogenesis;Pathologic;Pathway interactions;Physiological;Physiology;Play;Poly(ADP-ribose) Polymerases;Post-Translational Protein Processing;Prevention;Process;Production;Prognosis;Protein Acetylation;Proteins;Publishing;Regulation;Reporting;Research;Resistance;response;RNA Splicing;Role;sensor;Signal Transduction;SIRT1 gene;Sirtuins;Site;stem cell niche;stem cells;Stress;stressor;tissue stress;Tissues;transcription factor;Transcription Repressor;Transferase;trend;tumor;Tumor Promotion;tumorigenesis;WNT Signaling Pathway,Sirtuins and nuclear receptors in aging and age-associated diseases,102205,NA,NA,NA,NA,18,NA,NA,3264743,NA
11192627,ZIA,ES,1,N,NA,NA,NA,NA,ZIAES102405,NA,NA,1ZIAES102405-17,NIEHS:1227943\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES,NA,NA,NA,9693786 (contact),"WILLIAMS, CARMEN  (contact)",NA,NA,NA,Adolescent;Adult;Affect;Age;Biological Models;Biology;Birth;Cell Differentiation process;Chemical Exposure;Chromatin;Development;Diethylstilbestrol;DNA Methylation;Dose;Enhancers;Environment;environmental chemical;environmental chemical exposure;Epigenetic Process;Epithelial Cells;estrogenic;Estrous Cycle;Female;female reproductive tract;Fertility;Fertilization;Functional disorder;Genes;genetic approach;Genistein;genome-wide;Germ Cells;Goals;Human;Infant formula;Infertility;Knowledge;Long-Term Effects;male;malformation;Malignant Neoplasms;Measures;Mediating;mouse model;Mus;Neonatal;older adult;Organism;Pattern;Phase;Physiological;Phytoestrogens;postnatal;Pre-implantation Embryo Development;preimplantation;prenatal;Process;Publications;Publishing;Reproduction;reproductive;Reproductive Medicine;reproductive tract;Research;single-cell RNA sequencing;Site;soy;Time;transcription factor;Uterine Cancer;Uterus;Work,Environmental influence on reproductive tract function,102405,NA,NA,NA,NA,17,NA,NA,1227943,NA
11192628,ZIA,ES,1,N,NA,NA,NA,NA,ZIAES102605,NA,NA,1ZIAES102605-17,NIEHS:2411680\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES,NA,NA,NA,9693814 (contact),"GARANTZIOTIS, STAVROS  (contact)",NA,NA,NA,Affect;airway hyperresponsiveness;angiogenesis;Area;asthma model;Binding;CD44 gene;Cell Communication;Clinical Research;Complement;Environmental Exposure;epithelial wound;Extracellular Matrix;Extravasation;fibrotic lung;Gases;Goals;Grant;healing;Human;Hyaluronan;Immunologic Receptors;Inhalation;Injury;inter-alpha-inhibitor;interstitial;Legal patent;Lung;lung injury;Mediation;Modality;Molecular Weight;mouse model;neovascularization;novel;ozone exposure;Participant;Patients;Production;Pulmonary Fibrosis;Pulmonary Inflammation;receptor;Receptor Cell;Research;response;Role;Serum;Serum Proteins;Stimulus;Tenascin;Therapeutic;Therapeutic Uses;tissue injury;Tissues;TLR4 gene;TLR5 gene;Touch sensation;Vitronectin;wound healing,The Role of Hyaluronan And Inter-Alpha-Trypsin Inhibitor in Tissue Injury,102605,NA,NA,NA,NA,17,NA,NA,2411680,NA
11192629,ZIA,ES,1,N,NA,NA,NA,NA,ZIAES102625,NA,NA,1ZIAES102625-16,NIEHS:1944066\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES,NA,NA,NA,10272725 (contact),"JOTHI, RAJA  (contact)",NA,NA,NA,Aberrant DNA Methylation;Adult;Affect;Architecture;Behavior;Binding;Biochemical;Biochemistry;Biological Process;C-terminal;cancer cell;Cell Differentiation process;Cell Fate Control;Cell Physiology;Cells;cellular development;Chromatin;chromatin remodeling;Complex;Cues;Data;Development;Developmental Gene;diagnostic development;Disease;DNA;DNA Methylation;Embryonic Development;embryonic stem cell;Environment;environmental change;Enzymes;Epiblast;Epigenetic Process;epigenome;epigenomics;exportin 1 protein;Exportins;Foundations;functional genomics;Gene Expression;Gene Expression Regulation;gene network;gene regulatory network;gene repression;Genes;Genetic study;Genetic Transcription;Genome;genome-wide;Genomics;Goals;Health;histone modification;Homeostasis;Hydrophobicity;Hypermethylation;implantation;improved;interdisciplinary approach;interest;Knowledge;Laboratories;Malignant Neoplasms;Manuscripts;MAP Kinase Gene;Maps;Mediating;Modeling;Modification;Mouse Embryonic Stem Cells;Nuclear Export;Outcome;Phenotype;Polycomb;Predisposition;Preparation;programs;promoter;Protein Export Pathway;Publishing;receptor;recruit;Regulation;Regulatory Element;Repression;Research;response;Role;self-renewal;Signal Transduction;Site;stem cells;Stimulant;System;Systems Biology;Tail;Testing;Therapeutic;transcription factor,"Gene regulatory elements, networks, and mechanisms",102625,NA,NA,NA,NA,16,NA,NA,1944066,NA
11192630,ZIA,ES,1,N,NA,NA,NA,NA,ZIAES102646,NA,NA,1ZIAES102646-16,NIEHS:203201\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES,NA,NA,NA,10272731 (contact),"RESNIK, DAVID  (contact)",NA,NA,NA,"Animals;Authorship;Collaborations;Collection;commercialization;Conflict of Interest;Data;data management;Environmental Health;Environmental Risk Factor;ethical, legal, and social implication;Ethics;Focus Groups;Goals;Human;human subject;Human Subject Research;Informed Consent;Intellectual Property;International;Interview;Laws;Legal;Peer Review;Philosophy;Publications;Regulation;Research;Research Ethics;Research Methodology;Research Misconduct;Research Project Grants;Review Literature;Risk;Risk Management;Social Responsibility;Surveys","Ethical, social, and legal issues in environmental health research",102646,NA,NA,NA,NA,16,NA,NA,203201,NA
11192631,ZIA,ES,1,N,NA,NA,NA,NA,ZIAES102805,NA,NA,1ZIAES102805-15,NIEHS:1961481\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES,NA,NA,NA,10672664 (contact),"JENSEN, PATRICIA  (contact)",NA,NA,NA,Address;Adult;Area;Attention;Behavioral;Brain;Brain Stem;Cells;Central Nervous System;Cognition Disorders;critical period;Desire for food;Development;developmental neurobiology;Disease;Emotions;Exposure to;Functional disorder;Genetic;genetic approach;Goals;innovation;insight;Investigation;Life;Long-Term Effects;Memory;Molecular;Mood Disorders;mouse model;Mus;Neurodegenerative Disorders;Neurodevelopmental Disorder;neuron development;Neurons;noradrenergic;Norepinephrine;Optics;Phenotype;Population Heterogeneity;Predisposition;response;Signal Transduction;Stress;Structure;System;Viral;virtual,Central Noradrenergic Neuron Subtype Development and Function,102805,NA,NA,NA,NA,15,NA,NA,1961481,NA
11192632,ZIA,ES,1,N,NA,NA,NA,NA,ZIAES102965,NA,NA,1ZIAES102965-14,NIEHS:2842268\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES,NA,NA,NA,78326602 (contact),"YAO, HUMPHREY  (contact)",NA,NA,NA,Address;Adult;Affect;Anatomy;Animal Model;Atlases;Bisexual;Cell Communication;Cell Lineage;Cell Nucleus;cell type;Cells;Chromatin;climate change;cohort;Congenital Abnormality;congenital anomaly;Cues;Data;Decision Making;Development;Developmental Biology;Disease;EGF gene;Embryo;Embryology;Embryonic Development;Endocrine Disruptors;Environment;Environmental Risk Factor;estrogenic;Estrogens;Exhibits;Exposure to;external genitalia;Family;Female;Female genitalia;Female urethral structure;Fertility;fetal;Foundations;Gene Expression;Gene Expression Profile;gene network;gene regulatory network;Genes;Genetic;Genitalia;Germ Cells;Goals;Gonadal structure;health of the mother;Heat Stress;High Risk Woman;High temperature of physical object;Hindgut;Histology;Human;Hypospadias;Image;Incidence;Infection;Infertility;interest;Joints;Kidney Diseases;Knowledge;Life;Link;male;Maps;Mesenchymal;Modeling;Molecular;Molecular Profiling;multimodality;multiple omics;Mus;neonatal mice;Neuregulins;Newborn Infant;novel;Nuclear Orphan Receptor;offspring;Ontology;Organ;organ growth;Outcomes Research;paracrine;Pathway interactions;Pattern;Population;population migration;postnatal;Predisposition;Pregnancy;Pregnant Women;prenatal exposure;Process;Quality of life;Recurrence;Regulatory Element;Reporting;reproductive;reproductive organ;reproductive outcome;Reproductive Process;reproductive tract;Research;response;RNA;sex;sex determination;sexual dimorphism;Sexual Reproduction;Signal Transduction;single nucleus RNA-sequencing;Somatic Cell;Source;Specific qualifier value;Spermatocytes;stem cells;steroid hormone;Steroids;Structure of primordial sex cell;Supporting Cell;timeline;Tissues;transcription factor;transcriptome;transcriptome sequencing;Urethra;urogenital tract;Work;XCL1 gene,Impacts of Genetic and Environmental Factors on Reproductive Organ Development,102965,NA,NA,NA,NA,14,NA,NA,2842268,NA
11192633,ZIA,ES,1,N,NA,NA,NA,NA,ZIAES102985,NA,NA,1ZIAES102985-14,NIEHS:1700229\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES,NA,NA,NA,9693786 (contact),"WILLIAMS, CARMEN  (contact)",NA,NA,NA,Affect;assisted reproduction;Behavior;Biology;blastocyst;Calcium;Calcium Oscillations;Calcium Signaling;Cell membrane;Development;Disease;Divalent Cations;egg;Embryo;embryo culture;Embryonic Development;Environment;environmental chemical;Environmental Risk Factor;Epigenetic Process;Event;Exposure to;Female;Fertility;Fertilization;Genetic Processes;Genetic Transcription;Genome;Germ Cells;Goals;Health;Hour;Human;human disease;Infertility;Knowledge;Learning;Magnesium;male;Mammals;Maternal Messenger RNA;Mediator;Membrane Fusion;Molecular;mouse model;Mus;offspring;oocyte maturation;Pattern;Phase;Phospholipase C;pluripotency;PMCA1 protein;Pre-implantation Embryo Development;preimplantation;Procedures;Process;programs;Publishing;recruit;Regulation;release of sequestered calcium ion into cytoplasm;Reproduction;Reproductive Medicine;Research;response;Role;Series;Signal Transduction Pathway;sperm cell;Sperm Head;Testis;Totipotency;transcription factor;Translations;Work,Environmental influence on gametes and embryos,102985,NA,NA,NA,NA,14,NA,NA,1700229,NA
11192634,ZIA,ES,1,N,NA,NA,NA,NA,ZIAES103307,NA,NA,1ZIAES103307-10,NIEHS:845219\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES,NA,NA,NA,14254333 (contact),"ZHAO, SHANSHAN  (contact)",NA,NA,NA,Acceleration;Algorithms;Area;Biological Assay;Biology;biomarker selection;Birth;Breast Cancer Risk Factor;Clinical;cohort;Data;Data Analyses;design;detection limit;Diagnostic;disorder risk;epidemiology study;Failure;Goals;Health;high risk population;interest;Joints;Linear Models;Mediation;Methodology;Methods;Modeling;Outcome;Oxidative Stress;Pathway interactions;Performance;Pregnant Women;Procedures;prognostic;Research;Risk Assessment;Risk Factors;risk prediction;Selection for Treatments;semiparametric;Sister;Statistical Methods;survival outcome;Time;tool;Trace metal;urinary,Statistical Methods in Disease Risk Assessment and Prediction,103307,NA,NA,NA,NA,10,NA,NA,845219,NA
11192635,ZIA,ES,1,N,NA,NA,NA,NA,ZIAES103308,NA,NA,1ZIAES103308-10,NIEHS:223138\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES,NA,NA,NA,14254333 (contact),"ZHAO, SHANSHAN  (contact)",NA,NA,NA,Address;Basic Science;Chemicals;Classification;Collaborations;Data;Development;Epidemiology;epidemiology study;Goals;Health;Manuscripts;Methods;Outcome;Research Design;Sampling;Scheme;Scientist;Statistical Methods,Application of Statistical Methods in Epidemiology Studies,103308,NA,NA,NA,NA,10,NA,NA,223138,NA
11192636,ZIA,ES,1,N,NA,NA,NA,NA,ZIAES103315,NA,NA,1ZIAES103315-09,NIEHS:693279\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES,NA,NA,NA,14747689 (contact),"SHAW, NATALIE  (contact)",NA,NA,NA,Adipose tissue;Adult;Age;Androgens;Automobile Driving;Bile Acids;Blood;Body fat;Body Weight;bone age;Breast;Childhood;Clinical Research;Collection;Data;Development;Dryness;Dual-Energy X-Ray Absorptiometry;Endometrial;Enrollment;Entire hair of pubis;Epithelial Cells;Estradiol;Estrogens;Estrone;Genitourinary system;girls;Gonadal Steroid Hormones;Hand;Height;Hormones;indexing;inhibin B;Mammary Gland Parenchyma;Mammary Ultrasonography;Measures;Menarche;Menstrual cycle;Methods;Monitor;Morphology;National Institute of Environmental Health Sciences;Obesity;Obesity Epidemic;Organ;Ovarian;Overweight;Pelvis;Peripheral;Phenotype;Physiological;Population;Pregnanediol;Procedures;Protocols documentation;Puberty;Reporting;reproductive axis;reproductive hormone;Roentgen Rays;Serum;Source;Staging;Testing;Thick;Time;Tissues;trend;Ultrasonography;ultrasound;urinary;Urine;Uterus;Vagina;Visit;Waist-Hip Ratio;Weight,Investigating the impact of obesity on pubertal development in girls,103315,NA,NA,NA,NA,9,NA,NA,693279,NA
11192637,ZIA,ES,1,N,NA,NA,NA,NA,ZIAES103322,NA,NA,1ZIAES103322-08,NIEHS:83722\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES,NA,NA,NA,15187753 (contact),"HALL, JANET  (contact)",NA,NA,NA,Anosmia;Development;Diagnosis;Disease;Estradiol;Failure;Female;Fertility;Functional disorder;General Hospitals;Genetic;Genotype;Gonadotropin Hormone Releasing Hormone;Gonadotropins;hormone deficiency;Hospitals;Hypothalamic structure;Idiopathic Hypogonadotropic Hypogonadism;Incidence;Inherited;Kallmann Syndrome;Klinefelter&apos;s Syndrome;male;Massachusetts;men;Molecular;Neurosecretory Systems;Patients;Phenotype;Physiological;Pituitary Gland;Protocols documentation;Puberty;Rare Diseases;Regimen;Regulation;Reproduction;reproductive function;reproductive system disorder;Research Personnel;Role;Smell Perception;Testosterone;Woman,Studies in Patients with Congenital GnRH Deficiency,103322,NA,NA,NA,NA,8,NA,NA,83722,NA
11192638,ZIA,ES,1,N,NA,NA,NA,NA,ZIAES103323,NA,NA,1ZIAES103323-08,NIEHS:125583\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES,NA,NA,NA,15187753 (contact),"HALL, JANET  (contact)",NA,NA,NA,Age;Amenorrhea;androgen excess;Bioinformatics;Body Weight;Body Weight Changes;Characteristics;Clinical;Clinical Endocrinology;clinical heterogeneity;Clomiphene Citrate;Collaborations;Computer software;Constitution;Control Groups;Data;Delayed Puberty;Development;Discrimination;Disease;Eating Disorders;Endocrine;Endocrinology;Environmental Risk Factor;epidemiology study;Equilibrium;Estrogens;Exercise;exome sequencing;feeding;Female;Fertility;Functional disorder;functional hypothalamic amenorrhea;Genes;Genetic Determinism;Genetic Diseases;Genetic Predisposition to Disease;girls;GNRH1 gene;Height;Hemorrhage;Heterozygote;Hyperprolactinemia;Hypogonadism;Hypothalamic structure;hypothalamic-pituitary-adrenal axis;improved;Individual;individual response;insight;inter-individual variation;Journals;Manuscripts;Menstruation;Metabolic;Metabolic stress;Methodology;Modeling;Mutation;National Human Genome Research Institute;nonhuman primate;Nutritional;Oligonucleotides;Pathway interactions;Patients;Pattern;Peripheral;Phenotype;phenotypic data;physiologic stressor;Polycystic Ovary Syndrome;Population;Predisposition;Pregnancy;Prevalence;Progestins;programs;psychologic;Psychological Stress;public database;Publications;Publishing;Quality Control;Questionnaires;Rare Diseases;rare variant;Recontacts;Recording of previous events;reproductive;reproductive axis;Reproductive system;Research;Research Personnel;response;Risk;Risk Factors;Role;Running;Sample Size;Satiation;screening;Signal Transduction;Signs and Symptoms;Statistical Methods;Stress;Testing;Thyroid Gland;Time;Update;Variant;Weight;Withdrawal;Woman;women&apos;s outcomes,Genetic Determinants of Hypothalamic Amenorrhea,103323,NA,NA,NA,NA,8,NA,NA,125583,NA
11192639,ZIA,ES,1,N,NA,NA,NA,NA,ZIAES103324,NA,NA,1ZIAES103324-08,NIEHS:837221\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES,NA,NA,NA,15187753 (contact),"HALL, JANET  (contact)",NA,NA,NA,Acute;adipokines;adiponectin;Adipose tissue;Affect;Age;Algorithms;Amenorrhea;Anovulation;Attitude;Biochemical Markers;Biological Markers;Body Composition;Body mass index;Body Weight decreased;Breast Feeding;Caloric Restriction;Cerebrospinal Fluid;Characteristics;Chronic;Clinical;Clinical Markers;college;Conjugated Estrogens;Controlled Study;Cross-Sectional Studies;Delayed Puberty;deprivation;Desire for food;dietary;Dose;energy balance;Energy Intake;Energy Metabolism;Environment;environmental stressor;Equilibrium;Etiology;Evaluation;Exercise;Exposure to;Family;Family history of;Fasting;fitness;Follow-Up Studies;Frequencies;Functional disorder;ghrelin;Glucose;GNRH1 gene;Goals;Gonadotropins;Height;Homeostasis;hormonal signals;Hormone secretion;Hydrocortisone;Hypothalamic structure;improved;Individual;Infertility;Insulin;Intake;Intervention;Intervention Studies;Interview;Laboratories;lean body mass;Length;Leptin;Life Style;Link;Longterm Follow-up;Luteal Phase;Manuscripts;Measures;Mediating;Medical History;men;Menarche;Menstrual cycle;Metabolic;Metabolic hormone;Metabolism;Mutation;Neurons;Neurosecretory Systems;nutrition;Nutritional;Outcome Measure;Ovulation;Oxygen Consumption;Parents;Pathway interactions;Patients;peptide hormone;Physiologic pulse;physiologic stressor;Pituitary Gland;Plasma;Play;Predictive Factor;Predisposition;Pregnancy;Pregnanediol;primary outcome;proliferative phase Menstrual cycle;Questionnaires;receptor;Recording of previous events;Regulation;Reproduction;reproductive;reproductive axis;reproductive function;Reproductive History;response;Rest;restrictive eating;Risk;Role;Sampling;Satiation;secondary outcome;Serum;Signal Transduction;Sleep;Somatotropin;Stomach;Stress;stressor;System;Thyroid Function Tests;Thyroid Hormones;Urine;Visit;VO2max;Woman;Women&apos;s study;young woman,"Caloric Restriction, Environment, and Fitness: Reproductive Effects Evaluation Study (CaREFREE Study)",103324,NA,NA,NA,NA,8,NA,NA,837221,NA
11192640,ZIA,ES,1,N,NA,NA,NA,NA,ZIAES103325,NA,NA,1ZIAES103325-08,NIEHS:2021420\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES,NA,NA,NA,15187759 (contact),"JACKSON, CHANDRA  (contact)",NA,NA,NA,actigraphy;Address;Adult;adverse childhood events;Affect;African American;African American Women;Age;age effect;age related changes;age related decline;aged;Aging;Air Pollution;Alzheimer&apos;s Disease;Alzheimer&apos;s disease related dementia;Area;Athletic;Baltimore;Behavior;Biological;Black American;Black Populations;Black race;black women;Breast;Cancer Survivor;cardiometabolism;Cardiovascular Diseases;cardiovascular health;Censuses;Characteristics;Child;Childhood;circadian;Circadian Rhythms;Clinical;Cognitive;cohort;Cohort Studies;Collaborations;college;comorbidity;Complex;Country;Data;Diabetes Mellitus;Diagnosis;Disadvantaged;Discrimination;disease registry;Disparity;Education;Enrollment;Environment;Environmental Epidemiology;Environmental Hazards;Environmental Impact;Environmental Risk Factor;ethnic discrimination;ethnic disparity;ethnic minority population;Ethnic Origin;experience;Exposure to;Fibroid Tumor;food insecurity;food security;Functional disorder;Health;health determinants;health disparity;health equity;health equity promotion;Health Food;health inequalities;high risk;Hispanic;Homeostasis;Housing;Human;Hypertension;improved;improved outcome;Individual;Inequity;Intervention;Jet Lag Syndrome;killings;Latinx;Life Cycle Stages;Life Style;lifestyle factors;Light;Lighting;Link;longitudinal analysis;Longitudinal Studies;Malignant Neoplasms;marijuana use;men;Modeling;National Health Interview Survey;Native Hawaiian;neighborhood disadvantage;Neighborhoods;Noise;Non-Insulin-Dependent Diabetes Mellitus;Not Hispanic or Latino;novel;Obesity;obesity risk;Occupational;Occupations;Outcome;Pacific Islander;Pattern;Performance;Personal Satisfaction;Persons;Physical environment;Physiological;Play;Policies;poor health outcome;poor sleep;Population;Poverty;Prevalence;prevent;professional atmosphere;Protocols documentation;Psychosocial Stress;Public Health;Race;racial determinant;racial difference;racial discrimination;racial disparity;racial minority population;Recommendation;Recording of previous events;Research;response;Risk;Role;rural area;Schedule;Services;sex;Sister;Skin Carcinoma;Sleep;Sleep Deprivation;Sleep disturbances;sleep health;sleep quality;Sleeplessness;social;Social Environment;social health determinants;socioeconomic disparity;Socioeconomic Status;South Carolina;Special Population;Specialist;student athlete;substance use;Surveys;Survivors;symposium;Symptoms;Temperature;Travel;Woman;young adult,Social and Environmental Determinants of Health Equity,103325,NA,NA,NA,NA,8,NA,NA,2021420,NA
11192641,ZIA,ES,1,N,NA,NA,NA,NA,ZIAES103327,NA,NA,1ZIAES103327-08,NIEHS:1138958\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES,NA,NA,NA,14747689 (contact),"SHAW, NATALIE  (contact)",NA,NA,NA,Arhinia choanal atresia microphthalmia;clinical center;cohort;Collaborations;craniofacial;Defect;Exons;experimental study;Facioscapulohumeral Muscular Dystrophy;Family member;Fibroblasts;genetic architecture;Genotype;Goals;Heterozygote;in vitro Model;induced pluripotent stem cell;International;Investigation;Missense Mutation;Molecular;Muscular Dystrophies;neuromuscular;Patient Recruitments;patient subsets;Patients;Phenotype;Punch Biopsy;reproductive;Skin;structural biology;United States National Institutes of Health;X-Ray Crystallography,Investigation of the genetic architecture and phenotypic spectrum of Bosma arhinia microphthalmia syndrome,103327,NA,NA,NA,NA,8,NA,NA,1138958,NA
11192642,ZIA,ES,1,N,NA,NA,NA,NA,ZIAES103331,NA,NA,1ZIAES103331-06,NIEHS:2201909\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES,NA,NA,NA,16164256 (contact),"RODRIGUEZ, JOSEPH  (contact)",NA,NA,NA,Acute;antagonist;Binding;Biochemical Process;Biological Assay;Breast Cancer Cell;breast cancer diagnosis;Cancer cell line;Cell Differentiation process;Cell Proliferation;Cells;Characteristics;Chemicals;Chromatin;chromatin remodeling;Chromosomes;cofactor;Complex;Data;Disease;Distal;Dose;effective therapy;Endocrine Disruptors;Enhancers;Environment;Environmental Exposure;Epigenetic Process;ESR1 gene;Estradiol;Estrogen receptor positive;Estrogen Receptors;Estrogen Therapy;Estrogens;Exhibits;Exposure to;Food;Gene Expression;Gene Expression Regulation;gene product;gene repression;Genes;Genetic;Genetic Transcription;genome-wide;genomic locus;Goals;Grouping;Heterogeneity;Hormone Responsive;Hormones;Imaging technology;Individual;Inflammation;interest;knock-down;Light;Malignant Breast Neoplasm;Malignant Neoplasms;Mammary gland;Mediating;Memory;Modeling;Molecular;Mus;Mutation;Nature;Neoplasm Metastasis;non-genetic;Normal tissue morphology;Nuclear Receptors;Organism;permissiveness;Phenotype;Population;Process;progenitor;promoter;Reagent;receptor expression;recruit;Regulation;Repression;Resistance;response;RNA;RNA chemical synthesis;Signal Pathway;Signal Transduction;single molecule;stem cells;Steroids;Stimulus;Stress;System;Tamoxifen;Temperature;Therapeutic;Time;Tissues;transcription factor;Transcription Initiation;Transcription Process;tumor;Visualization;Vitamins;Work;Xenobiotics,Environmental regulation of estrogen responsive genes in single living cells,103331,NA,NA,NA,NA,6,NA,NA,2201909,NA
11192643,ZIA,ES,1,N,NA,NA,NA,NA,ZIAES103332,NA,NA,1ZIAES103332-06,NIEHS:1484659\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES,NA,NA,NA,16164258 (contact),"WHITE, ALEXANDRA  (contact)",NA,NA,NA,Air Pollutants;Air Pollution;Area;Biological;Biological Markers;black women;blood-based biomarker;Breast;Breast Cancer Risk Factor;cancer diagnosis;cancer epidemiology;cancer risk;carcinogenesis;Characteristics;Chemical Exposure;Clinical Markers;cohort;Cohort Studies;combustion product;criteria air pollutant;Data;deprivation;Development;DNA Methylation;Enrollment;Environment;environment related cancer;environmental chemical;Environmental Exposure;Environmental Health;Environmental Risk Factor;epigenetic aging;epigenetic marker;Exposure to;fine particles;Geography;Goals;Hair;Health;high risk;High Risk Woman;improved;Incidence;Individual;Industrialization;interest;Malignant Breast Neoplasm;Malignant Female Reproductive System Neoplasm;Malignant neoplasm of ovary;Malignant Neoplasms;Mammary Gland Parenchyma;Measures;Meta-Analysis;Metals;modifiable risk;Nature;Nitrogen Dioxide;Not Hispanic or Latino;Ovarian;Pathway interactions;personal care products;pollutant;Pollution;Poly-fluoroalkyl substances;Population;Population Study;prospective;Prospective cohort;Prospective Studies;Questionnaires;Radiation;Research;Research Design;Risk;Risk Factors;Role;Sister;Site;Source;Specimen;Structure of nail of toe;study population;Surrogate Endpoint;systematic review;United States;United States National Institutes of Health;Uterine Cancer;Uterus;White Women;Woman;women&apos;s diagnosis;Women&apos;s study;Work,Environment and Cancer Epidemiology,103332,NA,NA,NA,NA,6,NA,NA,1484659,NA
11192644,ZIA,ES,1,N,NA,NA,NA,NA,ZIAES103333,NA,NA,1ZIAES103333-06,NIEHS:1541761\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES,NA,NA,NA,16164260 (contact),"JUKIC, ANNE MARIE  (contact)",NA,NA,NA,25-hydroxyvitamin D;Age;Age at Menarche;Air Pollution;Animal Model;bone health;calcium absorption;Child;Chronic;Climate;clinical biomarkers;Clinical Trials;cohort;Communities;Conceptions;Development;dietary supplements;digital;digital health;early pregnancy;Emotional;Endocrine;Epigenetic Process;Event;extracellular vesicles;Female;Fertility;First Pregnancy Trimester;Food Supplements;Goals;health application;Hormones;Human;implantation;improved;Inflammation;interest;Irregular Menstruation;Length;Life Cycle Stages;Liver;Malignant Breast Neoplasm;Measures;Menopause;Menstrual cycle;MicroRNAs;mullerian-inhibiting hormone;Natural History;Ovarian aging;ovarian reserve;Ovulation;ovulation time;Participant;Pattern;Placentation;pregnancy health;Pregnancy loss;Pregnancy Outcome;Probability;public health relevance;Publishing;Reporting;Reproduction;reproductive function;Reproductive Health;Reproductive History;reproductive senescence;Research;response;Role;Sampling;Seasons;Signal Transduction;Skin;subfertility;Sunlight;symposium;systematic review;Testing;Time;Ultraviolet Rays;Vitamin D;Vitamin D Deficiency;Vitamin D supplementation;Vitamins;Woman;Women&apos;s Health,Environmental influences on fertility and reproductive health,103333,NA,NA,NA,NA,6,NA,NA,1541761,NA
11192645,ZIA,ES,1,N,NA,NA,NA,NA,ZIAES103339,NA,NA,1ZIAES103339-06,NIEHS:2308989\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES,NA,NA,NA,16164262 (contact),"MORGAN, MARCOS  (contact)",NA,NA,NA,Affect;Animal Model;Cells;Complex;Couples;detection method;Environmental Risk Factor;Enzymes;Equilibrium;Etiology;Female;Gametogenesis;Generations;Genetic;Genetic study;Germ Lines;Goals;Infertility;insight;male;Male Infertility;Measures;men;Messenger RNA;Methodology;Modification;Molecular;mouse model;Pathway interactions;Phenotype;Physiological;Poly(A) Tail;Polyadenylation;posttranscriptional;Process;Production;protein complex;reproductive system disorder;Resolution;RNA;RNA metabolism;RNA Processing;RNA-Binding Proteins;Rodent;Role;sex;Sorting;sperm cell;Spermatogenesis;Transcript;Transferase;Translations;Woman,Role of RNA modifications in spermatogenesis.,103339,NA,NA,NA,NA,6,NA,NA,2308989,NA
11192646,ZIA,ES,1,N,NA,NA,NA,NA,ZIAES103341,NA,NA,1ZIAES103341-05,NIEHS:727531\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES,NA,NA,NA,15704809 (contact),"BORGNIA, MARIO  (contact)",NA,NA,NA,2019-nCoV;Acquired Immunodeficiency Syndrome;Antigens;Biocompatible Materials;Biological;Biological Preservation;Biophysics;Cell membrane;Cells;Characteristics;Chimeric Proteins;Collaborations;Coronavirus spike protein;COVID-19;COVID-19 pandemic;Cryo-electron tomography;Cryoelectron Microscopy;cryogenics;Data;Development;Disease Outbreaks;Dissection;Ebola virus;Electron Microscope;Environment;Epithelium;Epitopes;fighting;Glycoproteins;glycosylation;Goals;HIV;HIV/AIDS;Human;Image;image processing;immunogenicity;Infection;instrumentation;interest;Ions;Light;Lipid Bilayers;Macromolecular Complexes;macromolecule;Mammalian Cell;Maps;Mediating;Membrane;Methods;Modeling;Molecular;Molecular Conformation;Molecular Machines;Molecular Structure;mutant;Names;National Institute of Environmental Health Sciences;neutralizing antibody;novel strategies;particle;Pathogenesis;Peptides;Personal Satisfaction;Population;Process;Proteins;receptor;Resolution;Resort;Sampling;SARS-CoV-2 spike protein;Scanning;Series;Specimen;Structure;Surface;System;Techniques;temporal measurement;Thick;Thinness;tool;Universities;vaccine development;Vaccines;Viral;Viral Vector;Virion;Virus;Virus Diseases,Epitope dynamics and functional analysis of viral envelope glycoprotein by cryo-electron tomography and single particle cryo-EM,103341,NA,NA,NA,NA,5,NA,NA,727531,NA
11192647,ZIA,ES,1,N,NA,NA,NA,NA,ZIAES103342,NA,NA,1ZIAES103342-05,NIEHS:83161\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES,NA,NA,NA,9693814 (contact),"GARANTZIOTIS, STAVROS  (contact)",NA,NA,NA,2019-nCoV;Acute Lung Injury;Acute Respiratory Distress Syndrome;Address;Anti-Inflammatory Agents;Binding;CD44 Antigens;Cells;Clinical Trials;Coagulation Process;COVID-19;COVID-19 complications;COVID-19 treatment;Development;Disease;effective therapy;Endothelium;Epithelium;Extracellular Matrix;fighting;global health emergency;Glycosaminoglycans;Human;Hyaluronan;in vivo;Infection;Inflammation;Influenza;Inhalation;inhibitor;inhibitor therapy;Injury;inter-alpha-inhibitor;Legal patent;Life;Lung;Lung infections;lung injury;lung repair;Mediating;Mediator;Modeling;Molecular Weight;Morbidity - disease rate;mortality;mouse model;pandemic disease;Paper;Patients;Peptides;Process;Property;Protease Inhibitor;Proteins;receptor;repaired;Reporting;research clinical testing;Resolution;Respiratory Failure;response;SARS-CoV-2 entry inhibitor;SARS-CoV-2 infection;Sepsis;Serine Protease;Serine Proteinase Inhibitors;severe COVID-19;Source;sugar;Therapeutic;Thrombosis;Toxicant exposure;Viral;viral entry inhibitor;Viral Physiology;Virus Diseases;Work,Harnessing the power of extracellular matrix to treat COVID-19 ARDS,103342,NA,NA,NA,NA,5,NA,NA,83161,NA
11192648,ZIA,ES,1,N,NA,NA,NA,NA,ZIAES103346,NA,NA,1ZIAES103346-05,NIEHS:148560\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES,NA,NA,NA,14747689 (contact),"SHAW, NATALIE  (contact)",NA,NA,NA,2019-nCoV;Ablation;ACE2;Angiotensin II;Angiotensins;Binding;Binding Proteins;Biological Assay;Cell surface;Cells;ChIP-seq;Chromatin;Chromatin Remodeling Factor;Cryoelectron Microscopy;Data;druggable target;Epigenetic Process;epigenetic regulation;Equilibrium;gene repression;Genomics;heart cell;Hi-C;Human;Infection;Mechanical Stress;Molecular;mRNA Expression;Mus;novel;Organ;programs;promoter;protein expression;receptor;recruit;Repression;Sensory;structural biology;Tissues;transcriptome sequencing;Up-Regulation;X-Ray Crystallography,SMCHD1 and epigenetic regulation of ACE2,103346,NA,NA,NA,NA,5,NA,NA,148560,NA
11192649,ZIA,ES,1,N,NA,NA,NA,NA,ZIAES103350,NA,NA,1ZIAES103350-05,NIEHS:845220\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES,NA,NA,NA,77844864 (contact),"ANCHANG, BENEDICT  (contact)",NA,NA,NA,Algorithms;Antigens;autoencoder;Automobile Driving;B-Lymphocytes;Back;Behavior;Beta Cell;Biological Markers;Biological Phenomena;Biological Process;biological systems;cell behavior;Cell Differentiation process;Cell Physiology;Cells;Collaborations;Communication;Data;data integration;data reduction;Data Set;data visualization;Dependence;design;Development;Developmental Process;differential expression;Disease;Drug Targeting;Effectiveness;Endocrine;Endocrine system;Epithelial Cells;Epithelium;Gene Expression Profile;gene regulatory network;Genes;Genetic;Genetic Transcription;Goals;high dimensionality;Immune;Immune response;Immune system;Immunotherapy;improved;Individual;Injury;insight;interest;Interleukin-2;Interleukin-4;Knockout Mice;Location;Lung;lymphocyte proliferation;Malignant Neoplasms;Maps;Measures;Melanoma;Mesenchymal;Methods;Modeling;mouse model;multidimensional data;multiplexed imaging;Mutation;Neighborhoods;network models;Network-based;novel;Pathway interactions;Pattern;Performance;pharmacologic;Phenotype;Placentation;Plasma;Process;Proliferating;Proteins;Publishing;Reporting;reproductive;Reproductive system;respiratory;Respiratory System;single cell analysis;single-cell RNA sequencing;spatial relationship;spatiotemporal;Spermatogenesis;Stem cell pluripotency;System;Systems Biology;T-Cell Activation;T-Lymphocyte;Techniques;Time;Tissue imaging;Tissues;tool;tool development;treatment response;Trees;tumor microenvironment;tumor progression;Validation;Variant;Visualization;Work,Single-cell Analysis of Normal and Perturbed Dynamic and Spatial  Biological Systems,103350,NA,NA,NA,NA,5,NA,NA,845220,NA
11192650,ZIA,ES,1,N,NA,NA,NA,NA,ZIAES103353,NA,NA,1ZIAES103353-05,NIEHS:2708567\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES,NA,NA,NA,77904719 (contact),"PAREKH, ANANT  (contact)",NA,NA,NA,A kinase anchoring protein;Address;airborne allergen;Animal Disease Models;Apoptosis;Area;Asthma;Atopic Dermatitis;Autoimmunity;Biochemical;Calcium;Calcium Channel;Calcium Signaling;Cell membrane;Cell model;Cell Physiology;cell type;Cells;Chemicals;Clinical;Complex;Confocal Microscopy;cytokine;Disease;Electrophysiology (science);Endoplasmic Reticulum;Environment;environmental intervention;Exocytosis;fluorescence imaging;Fluorescence Resonance Energy Transfer;Gene Expression;Goals;Growth;Health;Hypersensitivity;Immune system;immunocytochemistry;In Vitro;in vivo;interdisciplinary approach;interest;Malignant Neoplasms;mathematical model;Measurement;Membrane;Microscopy;mitochondrial metabolism;Molecular;Molecular Biology;Motility;mouse model;patch clamp;Pathologic Processes;Pathway interactions;Physiological Processes;prevent;Production;Proteins;pulmonary function;Pyroglyphidae;receptor;Regulation;release of sequestered calcium ion into cytoplasm;Research;Role;Scaffolding Protein;sensor;Signal Pathway;Signal Transduction;Site-Directed Mutagenesis;skin organogenesis;small molecule;Surface;System;Techniques;Transfection;Transgenic Mice,Calcium Signaling in Health and Disease,103353,NA,NA,NA,NA,5,NA,NA,2708567,NA
11192651,ZIA,ES,1,N,NA,NA,NA,NA,ZIAES103355,NA,NA,1ZIAES103355-05,NIEHS:7460\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES,NA,NA,NA,16164262 (contact),"MORGAN, MARCOS  (contact)",NA,NA,NA,2019-nCoV;Affect;Book Chapters;Cells;Coronavirus;Data;Enzymes;established cell line;Family;genetic regulatory protein;Genome;Goals;Infection;insight;Length;Manuscripts;Measures;meetings;Metabolism;Methods;Modification;Molecular;Oral;Pathway interactions;Peer Review;Poly(A) Tail;Poly(A)+ RNA;previous pandemic;Process;Proteins;Protocols documentation;Publishing;RNA;RNA chemical synthesis;RNA Processing;RNA replication;RNA-Binding Proteins;Role;viral RNA;Virus;Virus Replication,Role of RNA modifications in coronaviruses replication,103355,NA,NA,NA,NA,5,NA,NA,7460,NA
11192652,ZIA,ES,1,N,NA,NA,NA,NA,ZIAES103359,NA,NA,1ZIAES103359-05,NIEHS:1568017\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES,NA,NA,NA,77854899 (contact),"GJONESKA, ELIZABETA  (contact)",NA,NA,NA,Adult;Alzheimer&apos;s Disease;Alzheimer&apos;s disease brain;Alzheimer&apos;s disease model;Alzheimer&apos;s disease patient;Autopsy;Brain;brain cell;brain tissue;Chromatin;Chromatin Remodeling Factor;Development;Disease;Disease Progression;DNA;Encephalitis;Environmental Risk Factor;Event;fetal;Functional disorder;Gene Expression;Genetic;Genetic Predisposition to Disease;Genetic Risk;genetic risk factor;Genetic Transcription;genomic tools;Immune;immune function;Immune response;Impaired cognition;in vivo;insight;Maps;Mediating;Microglia;Molecular;mouse model;Nerve Degeneration;novel therapeutic intervention;Nucleic Acid Regulatory Sequences;Pathologic;Pathway interactions;Predisposition;programs;Proteins;Regional Disease;Regulation;Research;risk variant;Role;sensor;Symptoms;systemic inflammatory response;transcription factor;treatment strategy;Untranslated RNA,MECHANISMS UNDERLYING MICROGLIA DYSFUNCTION DURING NEURODEGENERATION,103359,NA,NA,NA,NA,5,NA,NA,1568017,NA
11192653,ZIA,ES,1,N,NA,NA,NA,NA,ZIAES103361,NA,NA,1ZIAES103361-04,NIEHS:2175406\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES,NA,NA,NA,78332040 (contact),"WATTS, JASON  (contact)",NA,NA,NA,Acute Renal Failure with Renal Papillary Necrosis;Affect;Base Pairing;Base Sequence;Cell Nucleus;Cell Physiology;cell type;Cells;Code;Coupled;Couples;Disease;DNA;DNA Polymerase II;DNA-Directed RNA Polymerase;Elements;Enhancers;Environmental Exposure;Focus Groups;Gene Expression;Gene Expression Regulation;Generations;Genes;genetic regulatory protein;Genetic Transcription;Genome;genome-wide;Goals;Guanine;Heavy Metals;Human;human disease;Impairment;Kidney;Link;Location;Mediating;Mitochondria;Mitochondrial RNA;Modeling;Movement;nucleic acid structure;Nucleic Acids;Osmosis;Output;Pattern;Pesticides;Polymerase;Production;promoter;Property;protein complex;Proteins;Regulation;Regulatory Element;response;RNA;RNA Processing;Role;Site;small molecule;Specificity;Stress;stressor;Structure;System;Transcription Elongation;transcription factor;Transcriptional Regulation;Work,cis-regulation of RNA polymerase pausing,103361,NA,NA,NA,NA,4,NA,NA,2175406,NA
11192654,ZIA,ES,1,N,NA,NA,NA,NA,ZIAES103370,NA,NA,1ZIAES103370-03,NIEHS:2730962\OD:549600\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES,NA,NA,NA,78841182 (contact),"GUARDIA, CARLOS  (contact)",NA,NA,NA,adverse outcome;Affect;Alleles;Autophagocytosis;Biochemical;Biochemistry;Cardiovascular Diseases;Cell fusion;Cell Line;Cell Physiology;Cells;Cellular biology;Child;Clustered Regularly Interspaced Short Palindromic Repeats;Complex;cytotoxicity;Development;Disease;Electrons;Embryo;Embryo Deaths;Embryonic Development;endothelial dysfunction;Environment;experimental study;extracellular vesicles;Face;Failure;Fetal Death;Fetal Development;Fetal Growth;Fetal Growth Retardation;Fetus;Fluorescence;Gene Expression;Genes;Goals;Hormone secretion;Hospitals;Human;Hypertension;In Vitro;Kidney Diseases;Knock-out;Life;LoxP-flanked allele;Maintenance;Microscopy;Modeling;Molecular;Monitor;Mothers;mouse model;Mus;novel;novel therapeutics;Organ;Pathway interactions;Physiological;Placenta;Placenta Diseases;Placental Biology;placental trophoblasts;Placentation;Play;Poly-fluoroalkyl substances;Pre-Eclampsia;Pregnancy;Pregnancy Complications;Pregnant Women;Proteinuria;Protocols documentation;Research;Role;Specific qualifier value;stillbirth;Stress;Techniques;Technology;Testing;Tissues;tool;Toxic effect;trafficking;trophoblast;Vascular blood supply,Autophagy and Intracellular Trafficking in Placental Biology,103370,NA,NA,NA,NA,3,NA,NA,3280562,NA
11192655,ZIA,ES,1,N,NA,NA,NA,NA,ZIAES103388,NA,NA,1ZIAES103388-03,NIEHS:169044\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES,NA,NA,NA,77844864 (contact),"ANCHANG, BENEDICT  (contact)",NA,NA,NA,Address;Adopted;Algorithms;autoencoder;Bayesian Modeling;Benchmarking;Biological;Biological Process;Biomedical Research;Cell Communication;Cells;Complex;complex data;computer framework;computerized tools;Data;data complexity;data integration;data reduction;Data Set;Dependence;design;Developmental Process;dimension reduction;Dimensions;Disease;Epithelium;gradient boosting;Heterogeneity;high dimensionality;Immune;improved;indexing;Individual;insight;interest;Lead;Mesenchymal;Methods;multidimensional data;Neurons;novel;Occupations;Organ;Output;Performance;Placenta;Placentation;Pregnancy;preservation;Process;single cell analysis;spatiotemporal;Spermatogenesis;Stem cell pluripotency;Stromal Cells;Structure;Time;Tissues;tool;Translating;trophoblast;Visual;Visualization,Benchmarking and Computational framework for Optimal Visualization and Interpretability of high-dimensional Spatiotemporal Data,103388,NA,NA,NA,NA,3,NA,NA,169044,NA
11192656,ZIA,ES,1,N,NA,NA,NA,NA,ZIAES103389,NA,NA,1ZIAES103389-02,NIEHS:1081880\OD:299336\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES,NA,NA,NA,8549570 (contact),"PEDDADA, SHYAMAL  (contact)",NA,NA,NA,Affect;Aridity;Biological;Biology;Biomedical Research;Birth;Birth Rate;Birth Weight;Childbirth;circadian pacemaker;Climate;climate change;Cohort Studies;cold temperature;Colorado;Complex;Conceptions;Country;Data;Data Analyses;Data Set;Databases;Dependence;Disease;Dose;economic indicator;Ecosystem;Endocrinology;Evaluation;Experimental Designs;experimental group;female fertility;Fertility;fetal;Fetal Development;Genes;Goals;high dimensionality;Hormones;Human;Human Chorionic Gonadotropin;Illinois;interest;Iowa;Linear Regressions;Literature;male fertility;Manuscripts;Measures;Mediation;Mediator;Methodology;Methods;Michigan;Microbe;microbiome;microbiome research;Modeling;multidimensional data;National Institute of Child Health and Human Development;National Oceanic and Atmospheric Administration;Nature;New York;novel;Operative Surgical Procedures;Outcome;Participant;Patients;Pattern;Pennsylvania;Periodicity;pesticide exposure;Pesticides;Placenta;Population;population health;Pregnancy;Premature Birth;prenatal testing;Procedures;Publications;Publishing;Reporting;Reproductive Health;reproductive outcome;Research;Research Personnel;response;screening program;Shapes;socioeconomics;Soil;spatiotemporal;Structure;tau Proteins;Technology;Testing;Texas;Time;Utah;Work;Yin,Constrained Statistical Inference,103389,NA,NA,NA,NA,2,NA,NA,1381216,NA
11192657,ZIA,ES,1,N,NA,NA,NA,NA,ZIAES103390,NA,NA,1ZIAES103390-02,NIEHS:270470\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES,NA,NA,NA,8549570 (contact),"PEDDADA, SHYAMAL  (contact)",NA,NA,NA,Acquired Immunodeficiency Syndrome;Adolescence;Adolescent;Adverse effects;Antibiotics;Bacteria;Biological Markers;Biology;Biometry;Birth;Blood;C-Peptide;Cesarean section;Chemicals;Child;cohort;Collaborations;Communication;Complex;County;cytokine;Data;Development;Developmental Delay Disorders;early life exposure;Education;Environment;Exposure to;Extramural Activities;Feces;follow-up;Genetic;gut microbiota;Health;high risk sexual behavior;HIV-1;Human;Immune response;Individual;Infection;Inflammatory;Insulin Resistance;interest;Joints;Link;Literature;low socioeconomic status;Manuscripts;Mediating;Mediation;men who have sex with men;Metabolic syndrome;microbiome;microbiota composition;Mothers;Nature;Neonatal;neonatal exposure;Norway;novel;Obesity;Outcome;Overweight;Parenting Education;Pathogenicity;Personal Satisfaction;prevent;Process;Prospective Studies;Publications;recruit;Reporting;Research;Research Project Grants;Risk;Sampling;Scientist;Sex Behavior;Sexual Partners;socioeconomics;Techniques;Time;ward;Weight;Women&apos;s study;Work,Collaborative Biostatistical Research,103390,NA,NA,NA,NA,2,NA,NA,270470,NA
11192658,ZIA,ES,1,N,NA,NA,NA,NA,ZIAES103393,NA,NA,1ZIAES103393-02,NIEHS:792319\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES,NA,NA,NA,14747689 (contact),"SHAW, NATALIE  (contact)",NA,NA,NA,Affect;Animal Model;Bioinformatics;Blood specimen;Candidate Disease Gene;Clinical;clinical heterogeneity;Collaborations;Collection;Data;data sharing;Delayed Puberty;Development;Disease;DNA;Enrollment;exome;exome sequencing;Family;Family member;Functional disorder;Future;Genes;Genetic;genetic analysis;genetic linkage analysis;genetic variant;Genome;genomic data;Genomics;GNRH1 gene;Gonadotropins;Growth;Hereditary Disease;Human;human model;Hypogonadism;Idiopathic Hypogonadotropic Hypogonadism;Impairment;Individual;insight;Investigation;Klinefelter&apos;s Syndrome;member;Mutation;National Human Genome Research Institute;National Institute of Environmental Health Sciences;Neurons;novel;Oligonucleotides;Participant;Pathway interactions;Patients;Phenotype;Precocious Puberty;proband;Puberty;Questionnaires;Regulation;Reproduction;reproductive;saliva sample;Sampling;Services;Sexual Maturation;smell test;Syndrome,Investigation of the genetic cause of inherited disorders of reproduction,103393,NA,NA,NA,NA,2,NA,NA,792319,NA
11192659,ZIA,ES,1,N,NA,NA,NA,NA,ZIAES103397,NA,NA,1ZIAES103397-01,NIEHS:495508\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES,NA,NA,NA,79981585 (contact),"ELANGO, RAJULA  (contact)",NA,NA,NA,Address;Binding;BRCA1 gene;BRCA2 gene;Bypass;Camptothecin;Cell Cycle;Chemicals;chemotherapeutic agent;clinically relevant;CRISPR/Cas technology;DNA;DNA Double Strand Break;DNA lesion;DNA Repair;DNA Repair Gene;DNA replication fork;DNA-protein crosslink;Endonuclease I;Engineered Gene;environmental stressor;Event;Excision;Exposure to;FLP recombinase;gene-targeted therapy;Generations;Genetic;Genetic Engineering;Genomic Instability;Goals;Health;High-Throughput Nucleotide Sequencing;homologous recombination;Human;Lesion;Ligation;Mammalian Cell;Mammals;Mediating;Modeling;Molecular;Outcome;Pathway interactions;Poison;Process;Regulation;repaired;Resolution;Role;S phase;Single Strand Break Repair;Site;System;Techniques;Technology;Type I DNA Topoisomerases;Tyrosine,Unraveling the molecular mechanisms of DNA-protein crosslink repair in mammals and understanding its impact on human health,103397,NA,NA,NA,NA,1,NA,NA,495508,NA
11192660,ZIA,ES,1,N,NA,NA,NA,NA,ZIAES103398,NA,NA,1ZIAES103398-01,NIEHS:67617\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES,NA,NA,NA,8549570 (contact),"PEDDADA, SHYAMAL  (contact)",NA,NA,NA,Address;Antibiotics;Antimicrobial Resistance;antiretroviral therapy;Birth;climate change;Clinical;Computing Methodologies;Data;DNA;drug resistant pathogen;Escherichia coli;Feces;Gender;geographic difference;Geographic Locations;Geography;gut microbiome;gut microbiota;HIV;HIV anti-retroviral;HIV Infections;Infection;Intervention;Klebsiella pneumoniae;Literature;Metagenomics;microbiome;microbiota;multidimensional data;novel;Oral;oral microbial community;oral microbiome;Participant;Persons;Phase;Process;Public Health;Radiation;resistance gene;Salmonella;Sampling;sex;Sex Behavior;Shigella;Shotguns;Staphylococcus aureus;stool sample;Streptococcus pneumoniae;The Multicenter AIDS Cohort Study;transmission process;Universities;Women&apos;s Interagency HIV Study,Antimicrobial resistance genes and interactions with the microbiota in people with HIV,103398,NA,NA,NA,NA,1,NA,NA,67617,NA
11192661,ZIA,ES,1,N,NA,NA,NA,NA,ZIAES103400,NA,NA,1ZIAES103400-01,NIEHS:236661\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES,NA,NA,NA,8549570 (contact),"PEDDADA, SHYAMAL  (contact)",NA,NA,NA,Acquired Immunodeficiency Syndrome;Address;Anatomy;Antigens;Biological Assay;Biological Markers;Biological Specimen Banks;Categories;Chronic;Clinic Visits;Clinical;Complex;Data;Development;Disease;Disease Progression;dysbiosis;Ecosystem;Feces;Goals;Growth;gut microbiome;gut microbiota;Health;HIV;HIV Infections;HIV Seronegativity;HIV Seropositivity;HIV/AIDS;immune activation;Immunity;Inflammation;interest;Investigation;Knowledge;Link;Literature;men who have sex with men;men&apos;s group;metabolomics;metagenome;Metagenomics;Microbe;microbial;microbial genome;microbiome;Onset of illness;Oral;oral microbial community;oral microbiome;Pathogenesis;Pathogenicity;Phase;Plasma;potential biomarker;Process;public database;Quality Control;Reporting;Research;Risk;Risk Estimate;Role;Sampling;screening;seroconversion;stool sample;Time;Uncertainty;Visit,Investigation of dysbiosis in oral and gut microbiome in HIV infection,103400,NA,NA,NA,NA,1,NA,NA,236661,NA
11192662,ZIA,ES,1,N,NA,NA,NA,NA,ZIAES103403,NA,NA,1ZIAES103403-01,NIEHS:975274\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES,NA,NA,NA,79981589 (contact),"LISCHINSKY, JULIETA  (contact)",NA,NA,NA,Adult;Aggressive behavior;Amygdaloid structure;Behavior;behavioral outcome;Brain;Caring;Cell Physiology;Cells;Cues;Development;early life adversity;Ejaculation;Embryo;Environment;experience;FOXP2 gene;Generations;Goals;Hypothalamic structure;in vivo;infancy;information processing;Instinct;interest;life span;Limbic System;male;Medial;Molecular;Motor output;Mus;Nature;Neurons;Partner in relationship;Physiological;Population;Process;response;Sensory;sex;Shapes;social;Social Behavior;Testing;Toxic Environmental Substances;transcription factor;Work,"Developmental, cellular and circuit mechanisms for social behaviors in the limbic system across sexes.",103403,NA,NA,NA,NA,1,NA,NA,975274,NA
11192663,ZIC,AI,1,N,NA,NA,NA,NA,ZICAI001239,NA,NA,1ZICAI001239-07,NIAID:3147878\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,9691549 (contact),"HOLLAND, STEVEN  (contact)",NA,NA,NA,2019-nCoV;Acute;Animals;Anti-Inflammatory Agents;anti-microbial peptide;Antitubercular Agents;Attenuated;bevacizumab;Blood Vessels;Callithrix;Callithrix jacchus jacchus;Cellular biology;chemotherapy;Clinical assessments;Clinical Research;Collaborations;Combined Modality Therapy;Computed Tomography Scanners;COVID-19;cytokine;Data;Data Set;Development;Discipline of Nuclear Medicine;Disease;Disease Progression;Dose;Drug Delivery Systems;drug efficacy;Drug Transport;efficacy evaluation;enzyme activity;Evaluation;experimental study;Extracellular Matrix;Extramural Activities;FDA approved;fluorodeoxyglucose;Gene Expression;General Hospitals;Genus Mycobacterium;Goals;Granuloma;Image;Image Analysis;imaging program;Imaging Techniques;immunogenicity;Immunologics;Immunology;improved;in silico;in vivo;Individual;Infection;Infectious Diseases Research;Inflammatory;inflammatory marker;Interferon Type II;Interleukin-10;Intramural Research Program;Investigation;Lesion;Losartan;Lung;lung lesion;Macaca;Macaca mulatta;male;Measures;Mediating;Medical Imaging;Methods;Modeling;Molecular Medicine;Monitor;Moxifloxacin;multidisciplinary;Murine pneumonia virus;Mus;Mycobacterium tuberculosis;National Institute of Allergy and Infectious Disease;novel;nuclear imaging;Nutrient;Oryctolagus cuniculus;Oxygen;Penetration;Pharmaceutical Preparations;Pharmacotherapy;Positron-Emission Tomography;preventive intervention;Procedures;programs;protective efficacy;Proteins;prototype;Publishing;quantitative imaging;Regimen;Reporter;Research;Research Activity;Research Design;Research Personnel;Research Project Grants;Resolution;response;RNA Viruses;Role;SARS-CoV-2 infection;Serum Markers;Speed;T memory cell;T-Lymphocyte;Therapeutic;Therapeutic Intervention;Tissues;Tracer;transcriptome sequencing;treatment effect;Treatment outcome;Trehalose;trend;Tuberculosis;tuberculosis drugs;tuberculosis granuloma;tuberculosis treatment;tumor;Universities;unvaccinated;uptake;vaccination strategy;vaccine candidate;vaccine efficacy;Vaccine Research;vector;Viral;Virus;Virus Replication;Work;X-Ray Computed Tomography,Tuberculosis Imaging Program,1239,NA,NA,NA,NA,7,NA,NA,3147878,NA
11192664,ZIC,AI,1,N,NA,NA,NA,NA,ZICAI001244,NA,NA,1ZICAI001244-06,NIAID:2839363\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,9691549 (contact),"HOLLAND, STEVEN  (contact)",NA,NA,NA,"Address;algorithmic methodologies;Algorithms;Anxiety;Atopic Dermatitis;Attention;Awareness;Behavioral;Behavioral Research;Caring;Certification;Classification;Clinical;clinical center;clinical diagnostics;clinical implementation;Clinical Research;Cognitive;cohort;Collaborations;Communities;Complex;Comprehension;Confidentiality of Patient Information;Consent;Consultations;Data;Data Collection;data sharing;database of Genotypes and Phenotypes;Decision Making;deep sequencing;Deposition;design;Development;Diagnosis;Diagnostic Services;Disease;Education;Emotional;Enrollment;Evaluation;Evolution;exome;experience;Feedback;follow-up;GATA2 deficiency;Genes;Genetic;Genetic Counseling;genetic counselor;genetic testing;Genome;genomic data;genomic variation;Genomics;Genotype;Guidelines;Health Services Accessibility;Hospitals;improved;Individual;Infrastructure;interest;Interview;Intramural Research;Intramural Research Program;Job&apos;s Syndrome;Knowledge;knowledge base;Language;lectures;Life;Manuscripts;Measures;Medical;Medicine;meetings;Mental Depression;Mental Health;Methods;Minority;Mission;Modeling;Molecular;molecular diagnostics;National Heart, Lung, and Blood Institute;National Human Genome Research Institute;National Institute of Allergy and Infectious Disease;National Institute of Arthritis, and Musculoskeletal, and Skin Diseases;National Institute of Child Health and Human Development;National Institute of Dental and Craniofacial Research;National Institute of Diabetes and Digestive and Kidney Diseases;National Institute of Mental Health;National Institute of Neurological Disorders and Stroke;Newly Diagnosed;Participant;participant enrollment;Pathogenicity;patient portal;Patients;Pharmaceutical Preparations;Pharmacogenomics;Phenotype;Policies;polygenic risk score;Population;Preparation;proband;Productivity;programs;Protocols documentation;psychologic;Psychological adjustment;psychological outcomes;Publications;Quality of Care;Rare Diseases;Reaction;Recommendation;Reporting;reproductive;Research;Research Personnel;Risk;Robotics;Rotation;Running;sample collection;Secure;Series;Services;Shapes;social;Somatic Mutation;Source;Structure;success;Surveys;Technology;technology development;Testing;Time;Training;treatment-resistant depression;Trinucleotide Repeats;Uncertainty;United States National Institutes of Health;Variant;Work",Centralized Sequencing Program,1244,NA,NA,NA,NA,6,NA,NA,2839363,NA
11192665,ZIC,ES,1,N,NA,NA,NA,NA,ZICES102445,NA,NA,1ZICES102445-17,NIEHS:1730046\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES,NA,NA,NA,14732168 (contact),"GERRISH, KEVIN  (contact)",NA,NA,NA,Address;Bioinformatics;Computer software;Custom;Development;DNA Methylation;Embryo;Ensure;Environment;experimental study;Gene Expression;Gene Expression Profiling;genome-wide;genome-wide analysis;Genomics;Health;Human;human disease;improved;Lasers;MicroRNAs;Mission;Modification;Molecular;nano-string;National Institute of Environmental Health Sciences;programs;Protocols documentation;RNA;Sampling;Scientist;Source;System;Technology;Testing;Tissues;transcriptome,Gene Expression and Microarrays,102445,NA,NA,NA,NA,17,NA,NA,1730046,NA
11192666,ZIC,ES,1,N,NA,NA,NA,NA,ZICES102485,NA,NA,1ZICES102485-17,NIEHS:1233386\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES,NA,NA,NA,14732170 (contact),"TUCKER, CHARLES  (contact)",NA,NA,NA,3-Dimensional;ABCB1 gene;Alleles;Alprostadil;analog;APOCEC3G gene;Area;base;Bibliography;Birds;bisphenol A;Blood - brain barrier anatomy;Brain;Bromodomain;Catecholamines;Cells;Cervical;channel blockers;Cisplatin;Collaborations;Development;Diphosphates;Endocrinology;Ensure;entorhinal cortex;Epithelial Cells;epithelial to mesenchymal transition;Epithelium;Equipment;erastin;ESR1 gene;Exposure to;Extracellular Matrix;Fibroblasts;Fibrosis;Fluorescence;fluorescence imaging;Fluorescence Microscopy;Fright;Gene Expression Regulation;Glucocorticoids;Goals;Hamsters;hazard;Heart failure;Heterogeneity;Hippocampus;Hormone Receptor;HPV positive;Human;human induced pluripotent stem cells;imaging facilities;Immune;Innate Immune Response;inorganic phosphate;Inositol;insight;investigator training;Investments;Knock-in;Knowledge;Laboratories;Life;Lip structure;Lung;lung cancer cell;Malignant Neoplasms;Mediating;meetings;memory consolidation;Microglia;Microtus;Mineralocorticoids;Mission;Modeling;Monitor;Moon;Morphology;Mus;Naloxone;National Institute of Environmental Health Sciences;non-genomic;Non-Small-Cell Lung Carcinoma;Norepinephrine;Optics;Organelles;Physical condensation;Platelet-Derived Growth Factor alpha Receptor;Protocols documentation;Psychiatry;Publications;PubMed;receptor;Receptor Activation;receptor function;Receptor Protein-Tyrosine Kinases;recombinase;Regulation;Research;Research Personnel;Respiratory Syncytial Virus Infections;Role;Scientist;Services;sex;Signal Transduction;skills;Smith-Lemli-Opitz Syndrome;stem cells;Sterol Biosynthesis Pathway;Stress;Techniques;Technology;TGFB1 gene;Thyroid Gland;Tobacco smoke;tool;TP53 gene;Training;uptake;Uterine Fibroids;ward;Wine;Work,Fluorescence Microscopy,102485,NA,NA,NA,NA,17,NA,NA,1233386,NA
11192667,ZIC,ES,1,N,NA,NA,NA,NA,ZICES102486,NA,NA,1ZICES102486-17,NIEHS:1922053\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES,NA,NA,NA,9693796 (contact),"BORTNER, CARL  (contact)",NA,NA,NA,Area;Biochemical;burden of illness;Cell Cycle;Cell Death;Cell Separation;Cell Size;Cells;Clinical Research;Color;computer program;Computer software;Cytometry;Data Analyses;Dedications;Energy Transfer;Environment;environmental agent;Experimental Designs;Flow Cytometry;Fluorescence;Functional disorder;Goals;Human;Immunophenotyping;Individual;Injections;instrument;instrumentation;Investigation;Ions;Knowledge;Mission;National Institute of Environmental Health Sciences;operation;Organelles;Phosphorylation;protein expression;release of sequestered calcium ion into cytoplasm;Research Personnel;Resources;Sampling;Scientist;single cell analysis;Sorting;Technology;Training;translational study,Flow Cytometry,102486,NA,NA,NA,NA,17,NA,NA,1922053,NA
11192668,ZIC,ES,1,N,NA,NA,NA,NA,ZICES102487,NA,NA,1ZICES102487-17,NIEHS:1303146\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES,NA,NA,NA,9693798 (contact),"PETROVICH, ROBERT  (contact)",NA,NA,NA,2019-nCoV;Allergens;Allergy to peanuts;Antibodies;Apoferritin;ATP phosphohydrolase;Bacteria;Baculoviruses;Biological Assay;biophysical properties;C-terminal;Cell Culture Techniques;Cell Line;Cells;Chinese Hamster Ovary Cell;Cloning;Co-Immunoprecipitations;Codon Nucleotides;Collaborations;Collection;COVID-19;Cryoelectron Microscopy;Crystallography;Culture Media;Data;Dermatophagoides pteronyssinus antigen p 2;Dermatophagoides pteronyssinus antigen p 7;design;design and construction;Escherichia coli;experimental study;expression vector;Felis catus;Future;Gene Targeting;Generations;Genes;genome integrity;Glutathione S-Transferase;Grouping;Hand;Hela Cells;Hydrostatic Pressure;Hypersensitivity;Immunotherapy;in vivo;Inclusion Bodies;India;Infection;Insecta;interest;Laboratories;Learning;Lipopolysaccharides;Macromolecular Complexes;maltose-binding protein;Mammalian Cell;Mediating;member;Methodology;Methods;Mission;Modeling;Molecular Chaperones;Monoclonal Antibodies;Motor;multicatalytic endopeptidase complex;mutant;N-terminal;nanobodies;National Institute of Environmental Health Sciences;NuRD complex;Open Reading Frames;particle;Patients;Persons;Physicians;Plant Resins;Post-Translational Protein Processing;Principal Investigator;Process;protein aggregation;protein complex;protein expression;protein folding;Protein Fragment;protein purification;Proteins;Protocols documentation;Research;Research Personnel;response;Ribosomes;Roentgen Rays;Running;Sampling;SARS-CoV-2 B.1.1.529;SARS-CoV-2 B.1.1.7;SARS-CoV-2 B.1.351;SARS-CoV-2 B.1.617.2;SARS-CoV-2 P.1;SARS-CoV-2 variant;scale up;Series;stable cell line;structural biology;Structure;Support Groups;System;Techniques;Technology;Temperature;Testing;Time;Transfection;TXN gene;United States National Institutes of Health;Variant;vector;Viral;Viral Proteins;Viral Vector;Virus;Virus Diseases;virus testing;Work;X-Ray Crystallography,Protein Expression Facility,102487,NA,NA,NA,NA,17,NA,NA,1303146,NA
11192669,ZIC,ES,1,N,NA,NA,NA,NA,ZICES102506,NA,NA,1ZICES102506-17,NIEHS:1719113\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES,NA,NA,NA,2047655 (contact),"YAKEL, JERREL L (contact)",NA,NA,NA,"2019-nCoV;Accountability;Adenoviruses;animal tissue;Biochemical;Biological;Biological Assay;cell immortalization;Cell Line;Cells;Clinical Research;Clustered Regularly Interspaced Short Palindromic Repeats;Consultations;Core Facility;Coronavirus;cost;cost effective;Dependovirus;Development;Developmental Biology;Disease;embryo cell;Ensure;Epigenetic Process;Gene Delivery;Genes;Genetic;genome integrity;Guidelines;Hematopoietic;HIV;HIV-1;Hormone Receptor;human coronavirus;Immunity;Immunologics;In Vitro;in vivo;Inflammation;Influenza A virus;influenzavirus;Integrase;Ion Channel;knock-down;Laboratories;Lentivirus;Lentivirus Vector;Lymphocytic choriomeningitis virus;Mission;Modification;Mus;National Center for Complementary and Integrative Health;National Heart, Lung, and Blood Institute;National Institute of Allergy and Infectious Disease;National Institute of Child Health and Human Development;National Institute of Diabetes and Digestive and Kidney Diseases;National Institute of Environmental Health Sciences;National Institute of Mental Health;National Institute of Neurological Disorders and Stroke;Neurobiology;Pathway interactions;Primary Cell Cultures;Principal Investigator;Production;programs;protein expression;protein purification;Protein Secretion;Protocols documentation;Rabies;Rattus;Reagent;Recombinants;Reproductive Biology;Research;Research Personnel;Research Support;Respiratory syncytial virus;Retroviridae;Safety;Sampling;SARS coronavirus;SARS-CoV-2 spike protein;Services;Signal Transduction;Simplexvirus;Sindbis Virus;small hairpin RNA;stable cell line;stem cell biology;structural biology;System;Technology;Time;tissue culture;Tissues;Toxicology;Training;transcription factor;Transfection;Transgenic Animals;United States National Institutes of Health;Validation;vector;Vesicular stomatitis Indiana virus;Viral;viral gene delivery;Viral Vector;Virion;Virus;Zika Virus",Viral Vector Core,102506,NA,NA,NA,NA,17,NA,NA,1719113,NA
11192670,ZIC,ES,1,N,NA,NA,NA,NA,ZICES102546,NA,NA,1ZICES102546-17,NIEHS:1730046\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES,NA,NA,NA,14732168 (contact),"GERRISH, KEVIN  (contact)",NA,NA,NA,Acceleration;Automation;Bioinformatics;clinical phenotype;Complex;Consumption;cost;Cost aspects;Data Analyses;design;Development;Disease;DNA;DNA Resequencing;Environment;Environmental Health;Gel;gene environment interaction;Genes;Genetic;Genetic study;genetic technology;Genetic Variation;Genomics;Genotype;Goals;human disease;Infrastructure;Manuals;method development;Methods;Molecular Genetics;Mus;National Institute of Environmental Health Sciences;novel therapeutics;Nucleic Acids;Prevention therapy;Productivity;Reaction;Research;Research Personnel;Research Support;Resources;Role;Sampling;Scientist;Services;Susceptibility Gene;Tail;Technology;Time;tool;Toxic effect;working group,Molecular Genetics Support to Identify Gene/Environment Interactions in Disease,102546,NA,NA,NA,NA,17,NA,NA,1730046,NA
11192671,ZIC,ES,1,N,NA,NA,NA,NA,ZICES103326,NA,NA,1ZICES103326-08,NIEHS:2321261\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES,NA,NA,NA,15704809 (contact),"BORGNIA, MARIO  (contact)",NA,NA,NA,Acceleration;Acquired Immunodeficiency Syndrome;Adoption;Antineoplastic Agents;Bacterial Drug Resistance;Biological Process;Cellular Stress;Collaborations;collaborative environment;Complex;Computer software;Core Facility;COVID-19;Cryoelectron Microscopy;cryogenics;Crystallization;Data;Data Collection;Dementia;Deposition;Development;Disease;Drug Delivery Systems;Electron Microscope;Electron Microscopy;electron tomography;Engineering;Ensure;Equipment;Evaluation;Genetic Diseases;Goals;image processing;improved;In Situ;Machine Learning;Macromolecular Complexes;macromolecule;Membrane Proteins;Metabolic Pathway;method development;Methods;Microscopy;Mission;Mitochondria;Molecular;Molecular Structure;National Institute of Environmental Health Sciences;new technology;novel strategies;Nuclear Magnetic Resonance;Pain;Parkinson Disease;particle;Preparation;Process;Publications;Research;Research Project Grants;Resolution;response;Robot;Robotics;Role;Sampling;Specimen;Structural Biologist;structural biology;Structure;Techniques;Time;Titan;tomography;tool;Training;Viral Proteins;X-Ray Crystallography,NIEHS Cryo-EM Core Facility,103326,NA,NA,NA,NA,8,NA,NA,2321261,NA
11192672,ZIC,ES,1,N,NA,NA,NA,NA,ZICES103354,NA,NA,1ZICES103354-05,NIEHS:1590720\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES,NA,NA,NA,15187753 (contact),"HALL, JANET  (contact)",NA,NA,NA,2019-nCoV;Address;Affect;Alcohol consumption;Alcohols;Area;Asthma;Back;Behavior;biobank;Biological;Blood;Characteristics;Chemical Exposure;Clinical Research;Code;Cohort Studies;Collaborations;Complex;Coupled;COVID-19;Data;Data Collection;Dedications;demographics;design;Diabetes Mellitus;Diagnosis;Diet;Disease;disorder risk;DNA;Eligibility Determination;Enrollment;Environment;Environmental Exposure;Environmental Health;Environmental Risk Factor;epigenomics;Extramural Activities;Family;Family history of;follow-up;Follow-Up Studies;Future;gene environment interaction;Gene Expression;Genes;Genetic;Genetic Polymorphism;Genetic study;Genome;genome sequencing;Genotype;Goals;Health;health determinants;Heart Diseases;Home;Human;human coronavirus;human disease;Individual;Infrastructure;instrument;knowledge base;Life;Life Cycle Stages;life span;Life Style;lifestyle data;lifestyle factors;Link;Malignant Neoplasms;Measurement;Measures;Medical;Medical History;National Health and Nutrition Examination Survey;National Institute of Environmental Health Sciences;Nature;novel coronavirus;Occupational Exposure;Operative Surgical Procedures;Participant;participant enrollment;Pathogenesis;perceived stress;Pharmaceutical Preparations;Phenotype;PhenX Toolkit;Physical activity;Physicians;Physiological;Population;precision medicine;Predisposition;prevent;Questionnaires;Recontacts;Recording of previous events;Registries;Research;Research Personnel;research study;Resources;response;Risk;Sampling;SARS coronavirus;Scientist;Self Administration;Severe Acute Respiratory Syndrome;Sleep;Smoking;Smoking History;Socioeconomic Status;Stress;study population;Study Subject;Surveys;tool;translational health science;United States National Institutes of Health;Update;Variant;Visit;whole genome;Work,Personalized Environment and Genes Study (PEGS),103354,NA,NA,NA,NA,5,NA,NA,1590720,NA
11192673,ZIC,ES,1,N,NA,NA,NA,NA,ZICES103371,NA,NA,1ZICES103371-03,NIEHS:2844821\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES,NA,NA,NA,78843870 (contact),"LI, JIAN-LIANG  (contact)",NA,NA,NA,2019-nCoV;Atlases;Bioinformatics;bioinformatics resource;bioinformatics tool;Biological;Biometry;Cells;Collaborations;Collection;Communities;Complex;Computer Analysis;computer infrastructure;Computer software;Core Facility;Data;Data Analyses;data standards;Dedications;design;Development;diverse data;Educational workshop;empowerment;Endocrine;experience;experimental study;genome annotation;Goals;improved;Individual;Informatics;Internships;Intramural Research;Knowledge;Learning;member;metabolomics;Methods;microbiome;multiple omics;National Human Genome Research Institute;National Institute of Environmental Health Sciences;next generation sequence data;Participant;Play;Postdoctoral Fellow;programs;Proteomics;Publications;PubMed;Reporting;Research;Research Personnel;Resources;Role;Scientist;Series;single cell analysis;skills;Sorting;Students;Support Groups;tool;Training;transcriptome sequencing;transcriptomics;Visit;Work,Integrative Bioinformatics,103371,NA,NA,NA,NA,3,NA,NA,2844821,NA
11192674,ZID,DA,1,N,NA,NA,NA,NA,ZIDDA000535,NA,NA,1ZIDDA000535-17,NIDA:7699121\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE ON DRUG ABUSE,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE ON DRUG ABUSE,NA,NA,NA,77869872 (contact),"LEGGIO, LORENZO  (contact)",NA,NA,NA,"Academia;Acute;addiction;Advanced Development;Advertisements;Agreement;Area;Baltimore;base;Basic Science;Behavioral;brain dysfunction;Care given by nurses;Caring;Certification;Chronic;Clinical;clinical care;Clinical Investigator;Clinical Research;clinical training;Clinical Trials Data Monitoring Committees;cognitive process;Collaborations;Communities;community engagement;Community Outreach;Contracts;Data Collection;data management;Dependence;Development;Education;Educational Materials;equity, diversity, and inclusion;Ethics;Experimental Psychology;Fortification;Fostering;Functional Imaging;Future Generations;Goals;Harm Reduction;Head;Health;health communication;health inequalities;Human;Human Resources;improved;Individual Differences;Infrastructure;innovation;Inpatients;Intervention;Intramural Research Program;Investigation;Joints;Laboratories;Leadership;Magnetic Resonance Imaging;Marketing;Maryland;Medical center;Medicine;member;Mentors;Methodology;Mobile Health Application;Molecular Genetics;Naloxone Training;National Institute of Drug Abuse;National Institute on Alcohol Abuse and Alcoholism;neuroimaging;neuroregulation;Neurosciences;novel;Nurses;opioid overdose;Outpatients;outreach;Overdose reduction;Participant;Patient Care;Patient Recruitments;Patients;Persons;Pharmaceutical Preparations;pharmacologic;Physician Assistants;Policies;Population Study;pre-clinical;Private Sector;Procedures;Professional counselor;programs;protocol development;racial disparity;recruit;Regulatory Affairs;Relapse;Remunerations;Research;Research Personnel;Research Support;Resources;Role;Safety;Science;Scientist;screening;Services;Smoking;Specialist;Spectrum Analysis;Statistical Data Interpretation;structural imaging;Substance Use Disorder;Techniques;Telephone;tenure track;Time;Tissues;Training;Training and Education;Training Programs;Transcranial magnetic stimulation;Translational Research;Transportation;United States National Institutes of Health;Universities;Vendor;virtual reality;Vision",Office of the Clinical Director,535,NA,NA,NA,NA,17,NA,NA,7699121,NA
11192675,ZID,DA,1,N,NA,NA,NA,NA,ZIDDA000623,NA,NA,1ZIDDA000623-07,NIDA:1683955\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE ON DRUG ABUSE,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE ON DRUG ABUSE,NA,NA,NA,77869872 (contact),"LEGGIO, LORENZO  (contact)",NA,NA,NA,Acquired Immunodeficiency Syndrome;addiction;Address;Adherence;Adult;Advertising;aging brain;alcohol use disorder;Area;Baltimore;Biometry;Black race;Characteristics;Clinical;clinical care;Clinical Investigator;Clinical Research;Clinical Trials Data Monitoring Committees;co-infection;Cognitive;college;Communities;Community Outreach;comorbidity;Compensation;Consult;Contracts;Counseling;Cross-Sectional Studies;Data;Data Analyses;data management;Data Scientist;Decision Making;Dedications;deep learning;design;Development;digital phenotyping;Disease;Drug Addiction;Drug usage;Education;Emergency Care;emotion regulation;Environment;Esthesia;executive function;Head;Health Benefit;health disparity;Hepatitis C virus;high risk;HIV;HIV diagnosis;HIV Infections;HIV risk;HIV Seropositivity;Home;Human;Human immunodeficiency virus test;human subject protection;Impaired cognition;improved;Impulsivity;Incidence;Individual;Infrastructure;inpatient service;Institutional Review Boards;Intramural Research Program;intravenous drug use;Laboratories;Learning;Left;Link;Liver diseases;Magnetic Resonance Imaging;male;Maryland;Medical;medication compliance;Medicine;meetings;men who have sex with men;metropolitan;Monitor;National Institute of Drug Abuse;Neighborhoods;neuroimaging;neuropsychopharmacology;Newly Diagnosed;novel;Outcome;outreach;Paper;Participant;participant safety;Personal Satisfaction;Persons;Pharmaceutical Preparations;pharmacologic;Pharmacy facility;pre-exposure prophylaxis;Prefrontal Cortex;Preparation;Printing;programs;Psychoneuroendocrinology;Publications;Radiology Specialty;recruit;Reporting;Research;Research Personnel;Research Support;Resources;Retirement;Risk;Risk Behaviors;Role;Safety;Sampling;screening;secondary analysis;Self-control as a personality trait;Services;Sexual and Gender Minorities;Spectrum Analysis;substance use;Substance Use Disorder;System;Technology;tenure track;Testing;Transcranial magnetic stimulation;Translational Research;transmission process;treatment research;Underserved Population;United States National Institutes of Health;Work,NIDA IRP Clinical Core support of the NIDA IRP HIV Clinical Program,623,NA,NA,NA,NA,7,NA,NA,1683955,NA
11192676,ZID,ES,1,N,NA,NA,NA,NA,ZIDES102465,NA,NA,1ZIDES102465-17,NIEHS:5483797\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES,NA,NA,NA,15187753 (contact),"HALL, JANET  (contact)",NA,NA,NA,2019-nCoV;Address;Agreement;Area;Asthma;Autoimmunity;Callback;Cardiovascular Diseases;Centrifugation;Client satisfaction;Clinical;Clinical Protocols;Clinical Research;clinical research site;clinical training;Clinical Trials Database;cohort;Collaborations;Core Facility;COVID-19;COVID-19 pandemic effects;Development;DNA;DNA Damage;Drug Kinetics;drug testing;Education;Educational workshop;electronic health record system;Electronics;Endocrine;Endothelium;Enrollment;Environmental Exposure;Ethics;Follow-Up Studies;Generations;Genetic Polymorphism;Goals;Guidelines;Human;human coronavirus;Human Rights;Human Subject Research;Immunology;improved;Individual;Inflammation;injury and repair;Institution;Institutional Review Boards;Investigation;Lung Diseases;Malignant Neoplasms;Metabolic Diseases;Mission;Monitor;National Institute of Environmental Health Sciences;Neuroendocrinology;North Carolina;novel coronavirus;Nursing Research;operation;Participant;Patient Recruitments;Patients;Phenotype;Procedures;programs;protocol development;Protocols documentation;quality assurance;receptor;Registries;Regulation;Research;Research Design;Research Personnel;Research Project Grants;Sampling;SARS coronavirus;Scientist;Series;Services;Severe Acute Respiratory Syndrome;Specimen;Structure;Susceptibility Gene;symposium;System;tenure track;Testing;Training;Training and Education;Training Programs;Translational Research;translational scientist;translational study;United States National Institutes of Health;Universities;web site;welfare,"Program in Clinical Research, Clinical Support Services and Clinical Training",102465,NA,NA,NA,NA,17,NA,NA,5483797,NA
11192677,ZIG,DA,1,N,NA,NA,NA,NA,ZIGDA000533,NA,NA,1ZIGDA000533-17,NIDA:3718190\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE ON DRUG ABUSE,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE ON DRUG ABUSE,NA,NA,NA,79360180 (contact),"WILSON, QUENTIN  (contact)",NA,NA,NA,Accreditation;Adherence;Administrator;Analgesics;Anesthetics;animal care;Animal Care and Use Committees;Animal Experimentation;animal facility;Animal Feed;Animal Husbandry;Animal Technicians;Animal Welfare;Animals;Area;Breeding;care systems;Caring;clinical diagnostics;Communicable Diseases;Consult;Contractor;Contracts;disorder prevention;Early Diagnosis;Ensure;Equipment;Euthanasia;federal policy;Goals;Health;Housekeeping;Human Resources;Intramural Research Program;Laboratory Animals;Maintenance;Medical;member;Mission;Monitor;Morbidity - disease rate;Mus;National Institute of Drug Abuse;Parasites;Physical Examination;Policies;Policy Compliance;Production;programs;Protocols documentation;Quarantine;Rat Transgene;Rattus;Regulation;Reporting;Research;Research Support;Rodent;Schedule;Scientist;Services;Source;Techniques;Training;Transgenic Organisms;Veterinarians;Water,Animal Care,533,NA,NA,NA,NA,17,NA,NA,3718190,NA
11192678,ZIG,ES,1,N,NA,NA,NA,NA,ZIGES022120,NA,NA,1ZIGES022120-27,NIEHS:2300332\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES,NA,NA,NA,11593730 (contact),"KURTZ, DAVID  (contact)",NA,NA,NA,Acceleration;Adolescent;Adverse effects;Affect;American;Animal Experimentation;Animal Feed;Animals;Annual Reports;Beds;Biological;Chemicals;Clinical;Collaborations;comparative;Coronavirus;Crowns;daidzein;Diet;Disease;Dryness;Ecosystem;Endocrine Disruptors;Environmental Exposure;Escherichia coli;Exposure to;Fatty acid glycerol esters;Female;Genistein;Goals;Health;health science research;irradiation;Laboratories;Laboratory Animal Science;Laboratory Study;Manuscripts;Mass Spectrum Analysis;Medicine;meetings;metabolomics;Methods;microorganism;Monitor;mouse genome;Multimedia;multiplex detection;Mus;Mycotoxins;National Institute of Environmental Health Sciences;Operon;Outcome Study;Oxidoreductase;pan-genome;pathogen;Pathogen detection;Physiological;Phytoestrogens;Poly-fluoroalkyl substances;programs;Publishing;quality assurance;reproductive development;Research;research study;response;Rodent;Shigella;Soil;Source;Sterilization;Students;summer internship;Support Groups;Testing;Toxic effect;United States Environmental Protection Agency;United States National Institutes of Health;Universities;Water;welfare;Zearalenone,Physiological Effects of Natural or Contaminating Compounds in a Rodent's Microenvironment,22120,NA,NA,NA,NA,27,NA,NA,2300332,NA
11192679,ZIG,ES,1,N,NA,NA,NA,NA,ZIGES102585,NA,NA,1ZIGES102585-17,NIEHS:7391056\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES,NA,NA,NA,78843880 (contact),"COBLE, DONDRAE  (contact)",NA,NA,NA,Accreditation;animal care;Animal Care and Use Committees;Animal Experimentation;animal imaging;Animals;Beds;behavioral phenotyping;Clinical;comparative;Consultations;Cryopreservation;Derivation procedure;disease diagnosis;Embryo Transfer;Ensure;Equipment and supply inventories;Food;Guidelines;Health;International;Intramural Research;Intramural Research Program;investigator training;Medicine;National Institute of Environmental Health Sciences;National Toxicology Program;Operative Surgical Procedures;Policies;programs;quality assurance;Research Personnel;Research Project Grants;Research Support;Rodent;Scientist;Services;United States Public Health Service;Water,Animal Research Support,102585,NA,NA,NA,NA,17,NA,NA,7391056,NA
11192680,ZIG,ES,1,N,NA,NA,NA,NA,ZIGES102825,NA,NA,1ZIGES102825-15,NIEHS:1620873\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES,NA,NA,NA,79981608 (contact),"WEBB, DONNA  (contact)",NA,NA,NA,Analgesics;Anesthesia and Analgesia;Anesthetics;Animal Behavior;animal care;animal colony;Animal Experimentation;Animal Model;Animal Welfare;Animals;Behavior assessment;Behavioral Assay;Blood specimen;Bupivacaine;Buprenorphine;Collaborations;comparative;Distress;Dose;Goals;Health;Home;Image;imaging study;improved;Injectable;Intramural Research Program;Investigation;Laboratories;Manuals;Medicine;Metabolic;Methods;Modeling;mouse model;Mus;National Institute of Environmental Health Sciences;Operative Surgical Procedures;Pain;Pain management;Personal Satisfaction;Pharmaceutical Preparations;Phenotype;Physiological;Procedures;Rattus;Research;Research Personnel;Rodent;Rodent Model;skills;Splenectomy;Surgeon;Surgical Models;System;Techniques;Therapeutic;Tissues;Training;Triage;Veterinary Medicine;welfare;Work,Animal Refinement for Laboratory Rodents,102825,NA,NA,NA,NA,15,NA,NA,1620873,NA
11192681,ZIH,DA,1,N,NA,NA,NA,NA,ZIHDA000534,NA,NA,1ZIHDA000534-17,NIDA:3091348\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE ON DRUG ABUSE,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE ON DRUG ABUSE,NA,NA,NA,78851503 (contact),"LIN, JIA LING  (contact)",NA,NA,NA,addiction;Area;Automatic Data Processing;Baltimore;Basic Science;Behavioral;Biological;biomedical informatics;Chemicals;Clinical;Clinical Decision Support Systems;Clinical Research;Collaborations;Computational Science;computer program;Computer Systems;computerized tools;cyber security;Data;data interoperability;data mining;Data Science;Databases;design;Ensure;Exposure to;Extramural Activities;Fostering;Goals;Guidelines;health data;Illicit Drugs;Informatics;Information Management;Information Systems;Information Technology;Infrastructure;Knowledge Discovery;Knowledge Management;Laboratories;Laws;Location;Medical;Medical Research;Methods;mHealth;National Institute of Drug Abuse;new technology;novel strategies;Nurses;Patient Recruitments;Pharmacy facility;Physicians;Policies;pre-clinical research;Procedures;programs;Psychosocial Stress;Recommendation;Regulation;Research;Research Personnel;Resources;Science;scientific computing;Secure;Services;Site;Specific qualifier value;support network;System;Systems Analysis;Techniques;telework;Time;Training;Work,Scientific Computing & Informatics Core (SCIC),534,NA,NA,NA,NA,17,NA,NA,3091348,NA
11192682,ZIH,DA,1,N,NA,NA,NA,NA,ZIHDA000631,NA,NA,1ZIHDA000631-05,NIDA:296085\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE ON DRUG ABUSE,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE ON DRUG ABUSE,NA,NA,NA,78851503 (contact),"LIN, JIA LING  (contact)",NA,NA,NA,Adherence;aging brain;alcohol use disorder;Area;Automatic Data Processing;Basic Science;Behavioral;Big Data;Biological;biomedical informatics;Brain;Clinical;Clinical Research;Cognitive;Collaborations;Collection;comorbidity;Computational Science;computer program;computer science;Computer Systems;computerized tools;Consultations;Counseling;cyber security;Data;Data Collection;data communication;data management;data platform;Data Science;Data Set;design;digital phenotyping;Electronics;Ensure;Extramural Activities;Fostering;gender minority;Goals;Guidelines;Health Benefit;health data;Health protection;HIV;HIV Infections;HIV risk;HIV-associated neurocognitive disorder;Human immunodeficiency virus test;Image;Impaired cognition;improved;Incidence;Informatics;Information Management;Information Systems;Information Technology;Knowledge Management;Laws;Left;Maintenance;marijuana use;Medical Records;Medical Research;Methodology;Methods;Mission;Modeling;National Institute of Drug Abuse;neuroinflammation;neurotoxicity;new technology;novel;Outcome;Personally Identifiable Information;Persons;Pharmaceutical Preparations;Policies;pre-clinical;pre-clinical research;Prefrontal Cortex;Process;programs;Rat Transgene;Rattus;Recommendation;Regulation;Research;Research Personnel;Research Project Grants;Resources;Retrieval;Risk Behaviors;Rodent Model;scientific computing;Secure;Services;sexual minority men;Specific qualifier value;Substance Use Disorder;support network;System;Systems Analysis;Techniques;Time;Transcranial magnetic stimulation;Work,Scientific Computing & Informatics Core (SCIC) project support of high-priority HIV projects,631,NA,NA,NA,NA,5,NA,NA,296085,NA
11192683,ZII,AI,1,N,NA,NA,NA,NA,ZIIAI001050,NA,NA,1ZIIAI001050-17,NIAID:24390011\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,15217013 (contact),"HANSON, CHRISTOPHER  (contact)",NA,NA,NA,Bacteriology;Basic Science;biodefense;built environment;Certification;Clinical;Clinical Research;Communicable Diseases;COVID-19;Emerging Communicable Diseases;Goals;HIV/AIDS;Infectious Disease Immunology;Infectious Diseases Research;Infrastructure;Intramural Research;Laboratories;Maintenance;Mission;National Institute of Allergy and Infectious Disease;Principal Investigator;programs;Research;research facility;Research Priority;tenure track;tool;Translational Research;United States National Institutes of Health;virology;Vision,"Activation, Maintenance and Certification of Infectious Diseases Labs",1050,NA,NA,NA,NA,17,NA,NA,24390011,NA
11192727,U2C,CA,3,N,2024-09-19,2024-09-01,2025-08-31,NA,U2CCA252973,NA,RFA-CA-19-045,3U2CCA252973-04S1,NCI:137728\,OTHER RESEARCH-RELATED,2024,NATIONAL CANCER INSTITUTE,NA,ALBUQUERQUE,UNITED STATES,NA,01,829868723,US,10021612,UNIVERSITY OF NEW MEXICO HEALTH SCIS CTR,NM,871310001,NA,1968804 (contact),"TRENT, JEFFREY M. (contact)","MECHANIC, LEAH E",2020-09-02,2027-08-31,NA,Genome Characterization Unit,252973,ZCA1,ZCA1-TCRB-O(M1),8223,S1,4,137728,0,NA,137728
11192732,N01,AI,NA,N,NA,NA,NA,NA,75N93019C00045,NA,NA,75N93019C00045-P00023-9999-3,NIAID:253399\,NON SBIR/STTR CONTRACTS,2024,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,MISSOULA,UNITED STATES,NA,01,010379790,US,1381006,UNIVERSITY OF MONTANA,MT,598124104,NA,78634275 (contact),"EVANS, JAY  (contact)",NA,2021-09-30,2025-09-30,Adjuvant;Antigens;Development;efficacy testing;Lead;Messenger RNA;Modeling;Mus;prevent;programs;Recombinant Proteins;Recombinants;Specific qualifier value;Tuberculosis;Tuberculosis Vaccines;Vaccine Adjuvant;Vaccines,Development of an Optimized Adjuvanted TB Vaccine,0,NA,NA,NA,NA,NA,NA,NA,253399,NA
11192774,R01,HS,5,N,2024-09-20,2024-08-01,2025-07-31,226,R01HS029343,SCHOOLS OF MEDICINE,PA-18-795,5R01HS029343-03,AHRQ:399999\,NON-SBIR/STTR RPGS,2024,AGENCY FOR HEALTHCARE RESEARCH AND QUALITY,NA,ANN ARBOR,UNITED STATES,SURGERY,06,073133571,US,1506502,UNIVERSITY OF MICHIGAN AT ANN ARBOR,MI,481091276,"PROJECT NARRATIVE Although lung cancer is the leading cause of cancer-related death in the United States, over 540,000 Americans survive with treatment, making it the fourth leading diagnosis among cancer survivors, a 20% increase in 2022. Lung cancer surveillance plays an important role in survivorship care through the detection of both recurrent disease and new, `second primary' lung cancer, monitoring of toxicity associated with adjuvant treatment, reinforcement of smoking cessation, and management of fear and anxiety over potential recurrence; yet only 26% of patients receive the guideline-recommended imaging and 39% are lost to all follow-up after lung cancer resection. This proposal seeks to leverage RETURNS, a telehealth lung cancer surveillance program, to develop and test a remote lung cancer surveillance approach, combining Patient Reported Outcome (PRO) and community chest computed tomography (CT) assessment, in a learning health system to improve adherence to recommended surveillance guidelines by reducing barriers and making care more efficient and effective for patients, providers, and the healthcare system.",14349661 (contact),"ODELL, DAVID D. (contact)","CHANEY, KEVIN",2023-09-30,2028-07-31,NA,Development and Implementation of the REmote Telehealth User-Reported caNcer Surveillance (RETURNS) Program for Lung Cancer,29343,HEOR,Healthcare Effectiveness and Outcomes Research[HEOR],NA,NA,3,257438,142561,399999,NA
11192950,N02,HL,NA,N,NA,NA,NA,NA,75N92022C00039,NA,NA,75N92022C00039-P00003-9999-2,NICHD:60000\,NON SBIR/STTR CONTRACTS,2024,"NATIONAL HEART, LUNG, AND BLOOD INSTITUTE",NA,DANA POINT,UNITED STATES,NA,NA,NA,US,NA,NA,CA,926291794,NA,79739002 (contact),"CARO, ELIAS  (contact)",NA,2022-09-23,2024-05-22,Address;Biomedical Technology;Businesses;Clinic;commercialization;Contracts;design;Development;Development Plans;Educational Curriculum;experience;Fostering;Funding;Grant;innovation;interest;Learning;learning strategy;Marketing;Medical Device;Mentors;Outcome Assessment;Process;programs;recruit;Research;Research Personnel;Services;Small Business Innovation Research Grant;Small Business Technology Transfer Research;tool;Training;Training Programs;Translations;United States National Institutes of Health,CONCEPT TO CLINIC: COMMERCIALIZING INNOVATION (C3I) PROGRAM TRAINING,0,NA,NA,NA,NA,NA,NA,NA,60000,NA
11192951,R56,HL,1,N,2024-09-25,2024-09-25,2025-08-31,838,R56HL171620,NA,PA-20-185,1R56HL171620-01,NHLBI:827753\,NON-SBIR/STTR RPGS,2024,"NATIONAL HEART, LUNG, AND BLOOD INSTITUTE",NA,BOSTON,UNITED STATES,NA,07,076593722,US,1504801,BOSTON CHILDREN'S HOSPITAL,MA,021155724,"Idiopathic Pulmonary Fibrosis (IPF) inflicts a significant healthcare burden and high rate of mortality in the U.S. As a rare polygenic disorder, however, IPF poses challenges to existing disease gene-mapping strategies due to the extensive locus heterogeneity and difficulty of assembling massive sample sizes typical of common polygenic disorders. This project aims to develop more effective gene-mapping methods for rare polygenic disorders such as IPF. Our approach combines network-based approaches with analysis of pleiotropy with gene expression, polygenic risk score and heterogeneity of comorbidity to map novel IPF genes using whole- exome-sequencing and genome-wide association data.",11902472 (contact),"CHUN, SUNG  (contact)","VUGA, LOUIS J",2024-09-25,2025-08-31,Accounting;Address;biobank;Biogenesis;Biological;Candidate Disease Gene;cell type;Cells;Chromosome Mapping;Clinic;cohort;comorbidity;Computing Methodologies;Data;Data Set;Death Rate;Development;Disease;disease heterogeneity;Disease Outcome;drug development;exome;exome sequencing;Gene Cluster;Gene Expression;Genes;Genetic;genetic analysis;genetic approach;Genetic Heterogeneity;Genetic Risk;Genetic study;genome wide association study;Genotype;Goals;healthcare burden;Heterogeneity;high risk;Human Genetics;human old age (65+);idiopathic pulmonary fibrosis;Individual;Libraries;loss of function;Lysosomes;Maps;Medical;Mendelian disorder;Methods;Modeling;Mutation;network models;Network-based;novel;novel therapeutics;Participant;Pathway interactions;Patients;Pattern;Penetrance;phenomics;pleiotropism;polygenic risk score;Population;Positioning Attribute;Prevalence;Process;pulmonary function decline;Pulmonary Surfactants;Quantitative Trait Loci;Rare Diseases;rare variant;Rest;reverse genetics;Rheumatoid Arthritis;risk prediction;Sample Size;Sampling;Scientist;severe COVID-19;Signal Transduction;Statistical Models;Structure;System;Techniques;Telomere Maintenance;Testing;Time;Tissues;trait;Trans-Omics for Precision Medicine;Validation;Variant,Computational Methods for Systems Genetic Analysis of Rare Polygenic Disorder,171620,GHD,Genetics of Health and Disease Study Section[GHD],NA,NA,1,547475,280278,827753,NA
11192952,R56,HL,2,N,2024-09-20,2024-09-20,2025-08-31,839,R56HL145053,SCHOOLS OF PHARMACY,PA-20-185,2R56HL145053-06,NHLBI:762367\,NON-SBIR/STTR RPGS,2024,"NATIONAL HEART, LUNG, AND BLOOD INSTITUTE",NA,COLLEGE STATION,UNITED STATES,PHARMACOLOGY,10,835607441,US,8266910,TEXAS A&M UNIVERSITY HEALTH SCIENCE CTR,TX,778454375,"Collectively, the experiments presented in this application, some of which are translational in nature, address fundamental, epigenetic and mechanistic concerns regarding the cardiovascular health effects of paternal exposure to Electronic Nicotine Delivery Systems (ENDS), an increasingly popular forms of tobacco, namely e-waterpipes and e-cigarettes, by employing a systematic platelet function and related animal model and disease analysis approach. Results obtained from these studies should promote further smoking cessation, as well as lay down the foundation for understanding, and advancing policy and means for evidence-based therapeutic management, prevention and control efforts of tobacco- associated thrombosis-based disease states.",10037651 (contact),"KHASAWNEH, FADI T (contact)","WARREN, RONALD Q",2024-09-20,2025-08-31,Address;Adult;Animal Diseases;Animal Model;Automobile Driving;Awareness;Biology;Blood Cells;Blood Coagulation Factor;Blood Platelets;Cardiovascular Diseases;cardiovascular health;Cells;Child;clinically relevant;Coagulation Process;Conceptions;Data;Dependence;design;Development;developmental plasticity;Disease;Electronic cigarette;Electronic Nicotine Delivery Systems;Elements;Endothelial Cells;Environmental Risk Factor;Epigenetic Process;evidence base;experimental study;Exposure to;Fathers;Fetal Development;Foundations;Future;Goals;Growth;Health;Hemostatic function;histone modification;hookah;Inflammation;Knowledge;Life;Life Style;Maternal Health;Mediating;Nature;neutrophil;offspring;Onset of illness;Paternal Exposure;Pathogenesis;Phenotype;Placenta;Plasma;Platelet Activation;Platelet Count measurement;platelet function;Policies;Prevention;Public Health;response;Risk;Role;sex;Shapes;Smoke;Smoking;smoking cessation;sperm cell;Stimulus;System;Therapeutic;thrombogenesis;Thrombosis;Time;Tobacco;tobacco control;Tobacco Use Cessation;transcriptome;Untranslated RNA;Work,The Mechanistic Impact of Paternal Electronic Nicotine Delivery Systems Exposure on Thrombogenesis,145053,ZRG1,Special Emphasis Panel[ZRG1-IVBH-V(02)M],NA,NA,6,499913,262454,762367,NA
11192953,R56,HL,1,N,2024-09-24,2024-09-24,2025-08-31,838,R56HL172049,SCHOOLS OF MEDICINE,PA-20-185,1R56HL172049-01,NHLBI:752555\,NON-SBIR/STTR RPGS,2024,"NATIONAL HEART, LUNG, AND BLOOD INSTITUTE",NA,STANFORD,UNITED STATES,PEDIATRICS,16,009214214,US,8046501,STANFORD UNIVERSITY,CA,943052004,"PROJECT NARRATIVE Our comprehensive analysis of the rare, but physiologically important pulmonary neuroendocrine cells, identified myriad combination of neuropeptides, neurotransmitters, receptors, and channel genes in individual pulmonary neuroendocrine cells (PNECs), indicating PNECs serve as sentinels to perceive multiple airway stimuli and express a variety of signals that regulate homeostasis. Achieving the aims of this proposal will identify the locations of cells expressing human PNEC peptides and hormones, their expression patterns in neuroendocrine stem cells, and their cellular targets in human tissue. This work is fundamental to developing new treatments and diagnostic strategies across the spectrum of pediatric and adult lung neuroendocrine diseases.",11950656 (contact),"KUO, CHRISTIN SUCHENG (contact)","LIN, SARA",2024-09-24,2025-08-31,Acute;Adult;Afferent Neurons;airway obstruction;Anatomy;Asthma;Brain;Bronchial Tree;Bronchiolitis;cell motility;Cell Proliferation;cell transformation;Cells;cellular targeting;Childhood;Clinical;Clinical Research;Clonal Expansion;Color;combinatorial;Common Core;Coughing;Data;daughter cell;Defect;Development;Diagnosis;diagnostic strategy;Diffuse;Disease;Distal;Dyspnea;Epithelial Cells;epithelial injury;Epithelium;Exhibits;experimental study;Foundations;Future;Genes;genetic approach;Genetic Transcription;Goals;Heterogeneity;Homeostasis;Hormones;Human;human tissue;Hyperplasia;Hypoxemia;Hypoxia;Image;In Situ;In Situ Hybridization;in vivo;Individual;infancy;Injury;Interstitial Lung Diseases;Investigation;Label;Lesion;Ligands;Location;Lung;Lung Diseases;Lung Neuroendocrine Neoplasm;Maps;Measures;Mediating;Methods;Modeling;Molecular;Molecular Profiling;molecular subtypes;Monitor;mouse model;Mus;nerve supply;Neuroendocrine Cell;neuroendocrine differentiation;Neuropeptides;Neurosecretory Systems;Neurotransmitter Receptor;Neurotransmitters;novel diagnostics;novel therapeutic intervention;Pathologic;Patients;Pattern;Peptide Receptor;Peptides;Physiological;Population;Preneoplastic Conditions;programs;Proliferating;Pulmonary Edema;receptor;receptor expression;Regional Anatomy;repaired;Resolution;respiratory;Respiratory Disease;Respiratory physiology;Respiratory Signs and Symptoms;response to injury;Role;sensor;Sensory;Sentinel;Signal Transduction;single molecule;single-cell RNA sequencing;Site;Slice;stem cell expansion;stem cell population;stem cells;Stimulus;System;Testing;Three-Dimensional Imaging;Trachea;transcriptome;transcriptomics;United States;Visualization;Work,Identifying and characterizing human pulmonary neuroendocrine stem cells and their diversity,172049,LIRR,"Lung Injury, Repair, and Remodeling Study Section[LIRR]",NA,NA,1,492880,259675,752555,NA
11192954,R56,HL,2,N,2024-09-20,2024-09-20,2025-08-31,839,R56HL144712,SCHOOLS OF MEDICINE,PA-20-185,2R56HL144712-05,NHLBI:417000\,NON-SBIR/STTR RPGS,2024,"NATIONAL HEART, LUNG, AND BLOOD INSTITUTE",NA,HERSHEY,UNITED STATES,PHYSIOLOGY,10,129348186,US,1524204,PENNSYLVANIA STATE UNIV HERSHEY MED CTR,PA,170332360,"Project narrative: This grant application proposes to study how histone deacetylase 1 (HDAC1), an important epigenetic regulator for eukaryotic gene transcription, controls erythropoiesis through regulating a key transcription factor, GATA-1.",8837132 (contact),"QIU, YI  (contact)","BAI, C BRIAN",2019-01-15,2025-08-31,Acetylation;Adult;Affect;Alanine;Antineoplastic Agents;Applications Grants;Arginine;Attenuated;Binding;Cell Physiology;Chromatin;Cleavage Under Targets and Release Using Nuclease;Collaborations;Complex;Deacetylation;Defect;Development;differentiation in vitro;Enhancers;Enzymes;Epigenetic Process;epigenetic regulation;Erythrocytes;Erythroid Cells;erythroid differentiation;Erythropoiesis;Fetal Hemoglobin;GATA1 gene;Gene Activation;Gene Expression;Gene Expression Profile;gene repression;Genes;genetic corepressor;Genetic Transcription;Genome;Globin;HDAC1 gene;HDAC4 gene;Hematopoiesis;Histone Deacetylase Inhibitor;In Vitro;insight;Knock-in Mouse;Lead;Learning;Lysine;Mediating;Megakaryocytes;mouse model;Mus;mutant;Mutation;novel;NuRD complex;programs;promoter;Proteins;Proteomics;recruit;Reporting;Repression;Role;Site;transcription factor;transcriptome sequencing;Up-Regulation;Work,Epigenetic regulation of erythropoiesis,144712,BBHV,"Basic Biology of Blood, Heart and Vasculature Study Section [BBHV]",NA,NA,5,250000,167000,417000,NA
11192955,R56,HL,1,N,2024-09-24,2024-09-24,2025-08-31,837,R56HL173608,SCHOOLS OF MEDICINE,PA-20-185,1R56HL173608-01,NHLBI:506984\,NON-SBIR/STTR RPGS,2024,"NATIONAL HEART, LUNG, AND BLOOD INSTITUTE",NA,PITTSBURGH,UNITED STATES,PEDIATRICS,12,004514360,US,2059802,UNIVERSITY OF PITTSBURGH AT PITTSBURGH,PA,152133320,Project Narrative The proposed research is relevant to public health because it will lead to the understanding of unexplored pathways of congenital heart disease (CHD) and the development of appropriate treatment for CHD. Identifying the cause of CHD will help mitigate the development of this genetic disease to build healthier lives for individuals born with CHD and the potential benefit of preventing CHD.,14316933 (contact),"LIN, JIUANN-HUEY IVY (contact)","SCHRAMM, CHARLENE A",2024-09-24,2025-08-31,Adult;Affect;Alleles;atrioventricular septal defect;Cardiac;Cardiac ablation;cardiogenesis;Cardiovascular system;Cell Lineage;cell motility;Cells;Chemicals;Clinical Management;clinically relevant;Clustered Regularly Interspaced Short Palindromic Repeats;cohort;Complex;conditional knockout;Congenital Abnormality;congenital heart abnormality;Congestive Heart Failure;Cre driver;Data;Defect;Development;Disease;disease model;disease phenotype;Dominant Genetic Conditions;Double Outlet Right Ventricle;Embryo;Ensure;Epidermal Growth Factor;Ethylnitrosourea;Exhibits;experimental study;Genes;Genetic;genetic analysis;Genetic Diseases;Genetic Heterogeneity;Genetic Predisposition to Disease;Genetic Screening;Heart;heart cell;heart disease prevention;Heart failure;Heterozygote;hindbrain;Human;human disease;implantation;In Vitro;in vivo;Inbred Mouse;Individual;insight;Knock-in Mouse;Knock-out;Knockout Mice;LDL-Receptor Related Protein 1;Lipoprotein Receptor;LoxP-flanked allele;Maps;Mesenchymal;migration;Missense Mutation;Molecular;Morbidity - disease rate;mortality;Mus;Mutagenesis;mutant;Mutant Strains Mice;Mutation;mutation screening;neonate;Neural Crest;Neural Crest Cell;Neural tube;Nitrosourea Compounds;novel;Pathogenesis;Pathogenicity;Pathway interactions;Patients;Pediatric Cardiac Genomics Consortium;Pediatric Hospitals;Penetrance;Phenotype;Population;prenatal;prevent;protein transport;Proteins;Public Health;receptor;recessive genetic trait;Recovery;Reporter;Research;Role;Signal Pathway;Signal Transduction;single-cell RNA sequencing;Supporting Cell;targeted treatment;Time;trafficking;transcriptomic profiling;United States;Variant;Ventricular Septal Defects,Multi-Lineage Modulation of cardiac neural crest cells during cardiac development,173608,ZRG1,Special Emphasis Panel[ZRG1-CDD-Q(81)],NA,NA,1,318858,188126,506984,NA
11192956,R56,HL,1,N,2024-09-24,2024-09-24,2025-08-31,838,R56HL173214,NA,PA-20-183,1R56HL173214-01,NHLBI:477290\,NON-SBIR/STTR RPGS,2024,"NATIONAL HEART, LUNG, AND BLOOD INSTITUTE",NA,ROCHESTER,UNITED STATES,NA,01,006471700,US,4976101,MAYO CLINIC ROCHESTER,MN,559050001,PROJECT NARRATIVE The underlying behavioral mechanisms that contribute to a higher likelihood of successful and sustainable increases in adherence and daily physical activity in chronic obstructive pulmonary disease (COPD) patients participating in pulmonary rehabilitation (PR) programs are not understood. We believe that modifiable habitual behavioral patterns play a significant mitigating role in slowing the progression of COPD symptoms. This project will bridge these mechanistic gaps in knowledge to allow us to better refine and individualize our novel home-based PR program to optimize improvements in physical activity and subsequent health benefits across the COPD population.,12001665 (contact),"FORTUNE, EMMA  (contact)","STEFAN, MIHAELA STEFANIA",2024-09-24,2025-08-31,Acceleration;Accelerometer;Address;Adherence;Adult;Affect;aging population;Algorithms;Behavioral;Behavioral Mechanisms;Chronic Obstructive Pulmonary Disease;clinical diagnosis;clinical practice;Cognitive;comorbidity;Data;disability;Dyspnea;Effectiveness;Exercise;exercise intervention;Exhibits;Fatigue;Fortune;Goals;Health;Health Benefit;high risk;Home;improved;innovation;Intervention;Knowledge;Longitudinal Studies;Measurement;Measures;Mediation;middle age;Modification;Moods;negative mood;novel;Outcome;Participant;Patient Participation;Patients;Pattern;persistent symptom;Physical activity;Physical assessment;Physical Function;Play;Population;Prevalence;Process;programs;pulmonary rehabilitation;Quality of life;Randomized;Recommendation;reduce symptoms;remote monitoring;Role;sedentary;sedentary lifestyle;Self Efficacy;Sleep;sleep behavior;Sleep disturbances;sleep pattern;sleep quality;Stress;Surveys;Symptoms;telephone coaching;Time;Translating;treatment as usual;wearable sensor technology;Wrist,The Impact of Underlying Behavioral Mechanisms on a Home-Based Pulmonary Rehabilitation Program,173214,LCBH,Lifestyle Change and Behavioral Health Study Section[LCBH],NA,NA,1,295719,181571,477290,NA
11192958,R56,HL,1,N,2024-09-24,2024-09-24,2025-08-31,837,R56HL169434,SCHOOLS OF MEDICINE,PA-20-185,1R56HL169434-01A1,NHLBI:639151\,NON-SBIR/STTR RPGS,2024,"NATIONAL HEART, LUNG, AND BLOOD INSTITUTE",NA,AUGUSTA,UNITED STATES,PHYSIOLOGY,12,966668691; 809593387,US,676605,AUGUSTA UNIVERSITY,GA,309120004,"PROJECT NARRATIVE Hypertension is the number one risk factor for cardiovascular disease, which is the leading cause of death worldwide; salt-sensitive hypertensive patients have a 3-fold higher risk of developing cardiovascular disease. We know that the gut microbiota and the immune system are linked and play critical roles in salt-sensitive hypertension in males, but this is largely understudied in females. The present studies will address this significant knowledge gap in our understanding of sex differences in salt-sensitive hypertension by investigating previously unrecognized gut microbiota- and immune-related mechanisms in both salt-sensitive rats and human samples, aiding in the development of more effective, sex-specific therapeutics for the control of blood pressure and kidney disease.",11038213 (contact),"ABAIS-BATTAD, JUSTINE M (contact)","VARAGIC, JASMINA",2024-09-24,2025-08-31,Ablation;Address;American;Amines;Antibiotics;Bioenergetics;Biological;Blood Pressure;blood pressure control;blood pressure regulation;Cardiovascular Diseases;cardiovascular disorder risk;cardiovascular risk factor;Cardiovascular system;Carnitine;Cause of Death;Cell Physiology;Choline;cohort;Colon;Correlative Study;cytokine;Dahl Hypertensive Rats;Data;Development;Disease;Disease Progression;Exhibits;Experimental Models;experimental study;fecal microbiota;Feces;Female;Fermentation;Fiber;Genetic;Grant;gut microbiota;high risk;Hormones;Human;Hypertension;hypertensive;Immune;Immune system;Immunity;immunoregulation;improved;Injury to Kidney;Intervention;Kidney;Kidney Diseases;Knowledge;Link;male;Mediating;Mediator;men;microbial;microbiota;microbiota composition;microbiota metabolites;Modeling;novel;novel therapeutics;Organ;Oxides;Pathologic;Patients;Peripheral Blood Mononuclear Cell;Physiological;Play;Population;pre-clinical;Pre-Clinical Model;Premenopause;Production;Propionates;Rattus;renal damage;Research Design;Role;salt sensitive;salt sensitive hypertension;Sampling;Serum;Severities;Severity of illness;sex;Sex Differences;sexual dimorphism;Sodium Chloride;T cell infiltration;T cell therapy;T-Cell Activation;T-Lymphocyte;Testing;Therapeutic;Translating;translational study;Twin Multiple Birth;Twin Studies;Urine;Volatile Fatty Acids;Woman;women versus men;Women&apos;s study;Work,Sex Differences in Gut Metabolite-Immune Interplay in Hypertension and Renal End-Organ Damage,169434,PBKD,Pathobiology of Kidney Disease Study Section[PBKD],NA,A1,1,427519,211632,639151,NA
11192959,R56,HL,1,N,2024-09-25,2024-09-25,2025-09-24,233,R56HL167681,SCHOOLS OF NURSING,PAR-21-038,1R56HL167681-01A1,NHLBI:704186\,NON-SBIR/STTR RPGS,2024,"NATIONAL HEART, LUNG, AND BLOOD INSTITUTE",NA,SEATTLE,UNITED STATES,OTHER HEALTH PROFESSIONS,07,605799469,US,9087701,UNIVERSITY OF WASHINGTON,WA,981959472,"PROJECT NARRATIVE Most (70%) SAH participants in our prior study experienced sleep disturbance, thus, a tailored intervention focused on sleep self-management is a critical step for improving their health. This study has high potential for offering a cost-effective intervention that could be implemented on a large scale to improve sleep and quality of life in SAH survivors. If effective, our technology-based intervention may be easily translated to clinical practice for SAH survivors and could be easily modified for other at-risk clinical populations.",10096179 (contact),"BYUN, EEESEUNG  (contact)","ALFINI, ALFONSO JOSEPH",2024-09-25,2025-09-24,"acceptability and feasibility;Accounting;actigraphy;Address;Adult;Age;Age Years;Area;Beds;Behavior;Behavioral;behavioral sleep intervention;Biological;Caregivers;Caring;Chronic Disease;Clinic Visits;Clinical;clinical care;clinical practice;clinical risk;Cognitive;Cognitive deficits;cost effective intervention;cost estimate;daily functioning;Data;design;Development;digital;drinking;Drowsiness;Eating;Economics;effective intervention;Employment;Enrollment;Environment;Event;Exercise;exercise intensity;experience;falls;Fatigue;Friends;Frustration;Geography;handheld mobile device;Health;Health Personnel;Health Promotion;health training;Healthcare;High Prevalence;HIV;Human;human centered design;Impaired cognition;Impairment;improved;improvement on sleep;innovation;Internet;Intervention;intervention refinement;Interview;Knowledge;Life;Life Style;Literature;Measures;Mental Health;Methods;motor impairment;Outcome;Participant;Patient Self-Report;Patients;Performance at work;Personal Satisfaction;Persons;Phase;physical conditioning;Population;programs;Protocols documentation;Qualitative Methods;Quality of life;Randomized, Controlled Trials;Reduce health disparities;Relaxation;Reporting;Research;Research Personnel;Research Project Grants;Resources;routine screening;Self Management;skills;Sleep;Sleep Deprivation;Sleep Disorders;Sleep disturbances;sleep health;sleep quality;Social support;Specialist;Stroke;stroke survivor;Structure;Subarachnoid Hemorrhage;success;successful intervention;Survivors;Symptoms;System;Tablet Computer;Techniques;Technology;technology intervention;Testing;Time;Training;Translating;United States;usability;willingness;Work;years of life lost;young adult",Technology-based Sleep Self-Management Intervention for Adults with Subarachnoid Hemorrhage,167681,BMHO,Biobehavioral Medicine and Health Outcomes Study Section[BMHO],NA,A1,1,468609,235577,704186,NA
11192960,R56,HL,1,N,2024-09-24,2024-09-24,2025-08-31,837,R56HL173828,BIOMED ENGR/COL ENGR/ENGR STA,PA-20-185,1R56HL173828-01,NHLBI:407975\,NON-SBIR/STTR RPGS,2024,"NATIONAL HEART, LUNG, AND BLOOD INSTITUTE",NA,TEMPE,UNITED STATES,ENGINEERING (ALL TYPES),04,943360412,US,488301,ARIZONA STATE UNIVERSITY-TEMPE CAMPUS,AZ,852876011,"PROJECT NARRATIVE Vascular injuries from endovascular procedures can cause smooth muscle cell dysfunction, leading to neointimal hyperplasia and ultimately stenosis. This project seeks to combat this by developing a lesion-targeted RNA nanotherapeutic, which delivers the transcripts of lncRNA CARMN to restore smooth muscle cell functions and reduce neointima formation. The insights gained from this study could pave the way for innovative strategies to treat stenotic vascular diseases and improve the outcome of medical interventions.",12276076 (contact),"WANG, MARK KUEI-CHUN  (contact)","DANTHI, NARASIMHAN",2024-09-24,2025-08-31,Acute;Address;American;Anastomosis - action;Angioplasty;antiproliferative drugs;Arteries;artery stenosis;Attenuated;Biodistribution;Biological Assay;Biological Process;Biomimetics;Blood flow;Blood Platelets;Blood Vessels;Cardiac;Cardiac ablation;Carotid Arteries;Cell Differentiation process;Cell Lineage;Cell Maintenance;Cell Physiology;Cells;Circulation;Clinical;combat;cytokine;Development;Disease;disease model;Dose;Drug Kinetics;Effectiveness;Enhancers;Ensure;Evaluation;Exposure to;Face;Foundations;Functional disorder;Gene Expression;gene function;Genes;Genetic;Genetic Transcription;Health;hemodynamics;Human;Hyperplasia;improved;improved mobility;improved outcome;In Vitro;in vivo;Inflammatory;injured;Injury;innovation;insight;Intervention;intravenous administration;Investigation;Knock-out;Lesion;Life;Link;Maintenance;Mediator;Medical;Membrane;Mesoderm;Messenger RNA;migration;Modeling;mouse model;Mus;Myopathy;nanoparticle;Nanotechnology;nanotherapeutic;neointima formation;novel strategies;Nuclear;Nuclear Localization Signal;Nuclear RNA;Operative Surgical Procedures;Outcome;overexpression;Pathologic;Peptides;Pharmaceutical Preparations;Pharmacodynamics;pharmacologic;Pharmacologic Substance;Pharmacotherapy;Phenotype;Play;post intervention;prevent;Procedures;Proliferating;Rattus;Regulation;Research;Research Project Grants;response;restenosis;restoration;RNA;Rodent;Role;Series;Site;Smooth Muscle;Smooth Muscle Myocytes;Solid;Stenosis;Stents;System;targeted delivery;Testing;Therapeutic;therapeutic RNA;Time;Tissues;Toxic effect;Toxicology;Transcript;transcriptome sequencing;Treatment Efficacy;Untranslated RNA;uptake;Vascular Diseases;vascular injury;Vascular Smooth Muscle;Vascular System;Wild Type Mouse,Development of lesion-targeted lncRNA nanotherapeutic for vascular smooth muscle dysfunction,173828,AVI,Atherosclerosis and Vascular Inflammation Study Section[AVI],NA,NA,1,275123,132852,407975,NA
11192961,R56,HL,1,N,2024-09-25,2024-09-25,2025-09-24,837,R56HL169445,NA,PA-20-185,1R56HL169445-01A1,NHLBI:760708\,NON-SBIR/STTR RPGS,2024,"NATIONAL HEART, LUNG, AND BLOOD INSTITUTE",NA,HOUSTON,UNITED STATES,NA,09,185641052,US,10005742,METHODIST HOSPITAL RESEARCH INSTITUTE,TX,77030,PROJECT NARRATIVE Right ventricular failure is characterized by an increase in deposition of extracellular matrix (ECM) because of cardiac fibroblast differentiation into myofibroblasts. We have evidence showing that alternative polyadenylation (APA) events lead to global 3UTR shortening of fibrosis genes allowing them to evade micro RNA regulation and thus increasing their translation. An understanding of how APA regulators enhance 3UTR shortening of fibrotic mediators may lead to identification of a new therapeutic target in right ventricular failure.,12350898 (contact),"AMIRTHALINGAM THANDAVARAYAN, RAJARAJAN  (contact)","ADHIKARI, BISHOW B",2024-09-25,2025-09-24,3&apos; Untranslated Regions;4 hydroxynonenal;adduct;aldehyde dehydrogenases;Aldehydes;Amino Acids;Attenuated;Binding Sites;Cardiac;Cardiovascular Diseases;Clinical;coronary fibrosis;Data;Deposition;design;Development;Down-Regulation;Enzymes;Etiology;Event;Exhibits;Extracellular Matrix;Extracellular Matrix Proteins;Fibroblasts;Fibrosis;Functional disorder;Gene Expression;Genes;Genetic;Impairment;improved;In Vitro;in vivo;knock-down;Lead;Length;Lipid Peroxidation;Mass Spectrum Analysis;Mediating;Mediator;Messenger RNA;MicroRNAs;Modeling;Molecular;molecular modeling;mortality;Mus;mutant;Myofibroblast;new therapeutic target;novel;Outcome;overexpression;Oxidative Stress;Oxidative Stress Induction;Pathogenesis;Pathway Analysis;Patients;pharmacologic;Polyadenylation;Process;Production;protein expression;Proteins;Public Health;Pulmonary Hypertension;Pulmonary Vascular Resistance;Rattus;receptor;Regulation;Regulatory Element;Research;restoration;right ventricular failure;Right Ventricular Function;right ventricular remodeling;Role;Site;Site-Directed Mutagenesis;targeted treatment;Techniques;Testing;Therapeutic;therapeutic development;Therapeutic Intervention;therapeutic target;Tissues;Transcript;Translations;Up-Regulation;Validation;Ventricular,Alternative polyadenylation in Right Ventricular Fibrosis,169445,TDPS,Therapeutic Development and Preclinical Studies Study Section[TDPS],NA,A1,1,489642,271066,760708,NA
11192962,R56,HL,1,N,2024-09-26,2024-09-26,2025-08-31,837,R56HL169267,SCHOOLS OF MEDICINE,PA-20-185,1R56HL169267-01A1,NHLBI:678445\,NON-SBIR/STTR RPGS,2024,"NATIONAL HEART, LUNG, AND BLOOD INSTITUTE",NA,BALTIMORE,UNITED STATES,INTERNAL MEDICINE/MEDICINE,07,188435911,US,820104,UNIVERSITY OF MARYLAND BALTIMORE,MD,212011508,PROJECT NARRATIVE Human heart has limited capacity for regeneration and repair post heart attacks due to the low exchange rate in cardiomyocytes throughout life. It is largely unknown how adult cardiomyocytes may be induced to cell cycle reentry thus replenish the cellular loss during cardiovascular diseases. This research will define the roles of the previously uncharacterized factor C5ORF51/RIMOC1 and its novel regulatory function in cardiomyocyte homeostasis and heart function. This research is relevant to the public health because it will reveal a novel mechanism contributing to myocardial loss and heart failure. The proposed research is rele- vant to the NIH mission because it will promote fundamental understanding and potential mechanisms con- tributing to cardiomyocyte turnover and maturation thereby promoting disease prevention and treatment.,11686552 (contact),"LIU, RUYA  (contact)","TJURMINA, OLGA A",2024-09-26,2025-08-31,Acceleration;Address;Adult;Binding;Binding Sites;Bioenergetics;Biological;Biological Process;Biology;Birth;Calcium;Cardiac;Cardiac Myocytes;cardiogenesis;Cardiomegaly;Cardiovascular Diseases;Cell Cycle;Cell Cycle Arrest;Cell Cycle Progression;Cell Line;Cell Maturation;Cell Nucleus;Cells;cofactor;Cytokinesis;Development;Dilated Cardiomyopathy;Diploidy;disorder prevention;DNA;DNA Binding;Endowment;Enhancers;Entropy;fetal;Functional disorder;gain of function;Gatekeeping;Gene Activation;Gene Expression;Genes;Genetic Transcription;Goals;Heart;heart dimension/size;Heart failure;heart function;Heart Injuries;Homeostasis;Human;Impairment;In Vitro;in vivo;in vivo Model;induced pluripotent stem cell;Injury;innovation;interest;Knock-out;Knockout Mice;Knowledge;Life;loss of function;Mediating;Mission;Mitosis;Modality;Modeling;Molecular;Mononuclear;Morbidity - disease rate;mortality;mouse model;Mus;Myocardial;Myocardial Infarction;Nature;Neonatal;neonatal mice;Nodal;novel;Nucleic Acid Regulatory Sequences;Pathway interactions;Pattern;Play;Ploidies;Population;postmitotic;Premature Mortality;prevent;primitive cell;programs;Proliferating;Proteins;Public Health;Recovery of Function;Regenerative capacity;regenerative therapy;Regulation;repaired;Research;Role;screening;Signal Transduction;Specific qualifier value;Testing;transcription factor;transcriptome sequencing;United States National Institutes of Health,C5ORF51 - a Novel Regulator of Cardiomyocyte Function and Homeostasis,169267,ZRG1,Special Emphasis Panel[ZRG1-CDD-Q(81)],NA,A1,1,471606,206839,678445,NA
11192963,R56,HL,1,N,2024-09-24,2024-09-24,2025-08-31,837,R56HL174836,SCHOOLS OF MEDICINE,PA-20-185,1R56HL174836-01,NHLBI:812403\,NON-SBIR/STTR RPGS,2024,"NATIONAL HEART, LUNG, AND BLOOD INSTITUTE",NA,PHILADELPHIA,UNITED STATES,INTERNAL MEDICINE/MEDICINE,03,042250712,US,6463801,UNIVERSITY OF PENNSYLVANIA,PA,191046205,Project Summary Cardiovascular disease is the leading cause of death in the United States with ventricular arrhythmias being a major source of morbidity and mortality in patients with structural heart disease. This proposal seeks to develop and investigate the role of non-invasive cardiac stereotactic body radiation therapy (cSBRT) for the treatment of patients with refractory lethal ventricular arrhythmias.,14928486 (contact),"TSCHABRUNN, CORY MICHAEL (contact)","SHI, YANG",2024-09-24,2025-08-31,Ablation;Anatomy;Animal Model;Animals;Anti-Arrhythmia Agents;Area;Arrhythmia;Body Surface;Cardiac;Cardiac ablation;Cardiac Electrophysiologic Techniques;cardiac magnetic resonance imaging;Cardiovascular Diseases;Cardiovascular system;Cause of Death;Cessation of life;Chronic;Cicatrix;Clinical;clinical efficacy;clinical practice;Clinical Research;clinically relevant;comparison control;Complex;Data;Disease;Dose;Electrocardiogram;Electrophysiology (science);Evaluation;experimental study;Failure;Family suidae;Fibrosis;follow-up;Follow-Up Studies;Foundations;Functional disorder;Future;Gap Junctions;Goals;Heart;Heart Diseases;heart function;High Prevalence;Human;Image;Implantable Defibrillators;Implantation procedure;improved;Incidence;Infarction;innovation;Left;Left Ventricular Ejection Fraction;Life;Longterm Follow-up;Magnetic Resonance Imaging;Maps;Measures;Molecular;Morbidity - disease rate;mortality;Myocardial Infarction;non-invasive imaging;novel therapeutics;Patient Selection;Patients;Pharmacotherapy;Photons;porcine model;preclinical study;prevent;Procedures;programs;Publishing;Radiation;Radiation Dose Unit;Radiation therapy;Reaction Time;Recurrence;Refractory;Registries;Resolution;response;Risk Reduction;Role;Series;Shock;Source;structural heart disease;Structure;success;sudden cardiac death;targeted treatment;Techniques;Technology;Time;Tissues;United States;Ventricular;Ventricular Arrhythmia;Ventricular End-Diastolic Volumes;Ventricular Fibrillation;Ventricular Tachycardia;voltage,Determining the Mechanisms of Radiation Biomodulation of the Ventricular Tachycardia Arrhythmogenic Substate,174836,CCHS,Clinical Integrative Cardiovascular and Hematological Sciences Study Section[CCHS],NA,NA,1,499940,312463,812403,NA
11192964,R56,HL,1,N,2024-09-25,2024-09-25,2025-08-31,837,R56HL173010,ORGANIZED RESEARCH UNITS,PA-20-185,1R56HL173010-01,NHLBI:719261\,NON-SBIR/STTR RPGS,2024,"NATIONAL HEART, LUNG, AND BLOOD INSTITUTE",NA,Newark,UNITED STATES,MISCELLANEOUS,10,090299830,US,10034168,RUTGERS BIOMEDICAL AND HEALTH SCIENCES,NJ,071073001,"Projective Narrative Examining biopsychological mechanisms through which psychosocial stress contributes to poor cardiometabolic health in older Asian American immigrants is a critical area for public health, as cardiometabolic diseases are leading causes of death among Asian American immigrants. This study aims to investigate the psychosocial and cultural determinants of cardiometabolic health and key biopsychological processes underlying these relationships using a prospective design. Study results will inform future culturally- tailored public health interventions to promote cardiometabolic health for older Asian American immigrants.",78444692 (contact),"JIANG, YANPING  (contact)","CAMPO, REBECCA A",2024-09-25,2025-08-31,Acculturation;Address;Adult;Affect;aged;Area;Asian;Asian Americans;Blood Pressure;blood pressure elevation;Buffers;Cardiometabolic Disease;cardiometabolic risk;cardiometabolism;Cause of Death;Cessation of life;Chinese;Chinese American;Data;Data Collection;design;Discrimination;Disease;Dyslipidemias;Ecological momentary assessment;effective intervention;Emotions;epidemiology study;experience;Female;follow-up;Future;Glycosylated hemoglobin A;Goals;Health;Heterogeneity;high risk;Hydrocortisone;Hypertension;Immigrant;indexing;Individual;insight;Intervention;Knowledge;Language;low socioeconomic status;marginalization;Measures;Mediation;metropolitan;Minority;Modeling;multilevel analysis;multimodality;Neighborhoods;New York;Non-Insulin-Dependent Diabetes Mellitus;novel;Older Population;Outcome;Participant;Pathway interactions;Penetration;personalized intervention;physical inactivity;Physiological;Population;Process;prospective;psychosocial;Psychosocial Stress;psychosocial stressors;Public Health;public health intervention;racism;Research;response;Risk Factors;Role;Saliva;Salivary;Sampling;sleep quality;social cohesion;social culture;social engagement;Social Interaction;Social isolation;Social support;sociocultural determinant;Stereotyping;Stress;Testing;Time;Treatment/Psychosocial Effects;Unhealthy Diet;United States National Institutes of Health;Work,Psychosocial and cultural determinants of cardiometabolic health among older Chinese Americans,173010,SPIP,"Social Psychology, Personality and Interpersonal Processes Study Section[SPIP]",NA,NA,1,463670,255591,719261,NA
11192965,R56,HL,1,N,2024-09-25,2024-09-25,2025-08-31,837,R56HL164328,SCHOOLS OF PHARMACY,PAR-21-038,1R56HL164328-01A1,NHLBI:323277\,NON-SBIR/STTR RPGS,2024,"NATIONAL HEART, LUNG, AND BLOOD INSTITUTE",NA,LARAMIE,UNITED STATES,PHARMACOLOGY,00,069690956,US,9412601,UNIVERSITY OF WYOMING,WY,820712000,"PROJECT NARRATIVE Heart failure in the presence of diabetes is common and deadly. While commonly thought of as occurring in the left side of the heart, right ventricular (RV) dysfunction is also present in diabetes and contributes to poor health outcomes. The purpose of this proposal is to identify the mechanisms of RV dysfunction in diabetes with the long-term goal of identifying new therapies for the failing RV.",10669840 (contact),"BRUNS, DANIELLE REULAND (contact)","WONG, RENEE P",2024-09-25,2025-08-31,antioxidant enzyme;Biology;Cardiomyopathies;Cardiovascular Diseases;CD36 Antigens;CD36 gene;Clinical;Development;Diabetes Mellitus;diabetic;diabetic cardiomyopathy;Disease;fatty acid metabolism;Fatty Acids;functional decline;Functional disorder;Future;gain of function;Genetic;Genetic Models;glucose uptake;Goals;Heart;Heart failure;Impairment;improved;innovation;Insulin Resistance;Investigation;Left;Left Ventricular Dysfunction;Left Ventricular Function;Left ventricular structure;Link;loss of function;Metabolic;Metabolic dysfunction;metabolic phenotype;Metabolism;Mitochondria;mitochondrial dysfunction;Modeling;molecular phenotype;mortality;Myocardial;Myopathy;Needles;non-diabetic;Non-Insulin-Dependent Diabetes Mellitus;novel;novel therapeutics;overexpression;oxidative damage;Oxidative Stress;Pathogenesis;Pathologic;Patient-Focused Outcomes;Patients;poor health outcome;Production;Public Health;Reactive Oxygen Species;Reporting;Research;Research Personnel;Resolution;response;Right Ventricular Dysfunction;Right Ventricular Function;right ventricular remodeling;Right ventricular structure;Side;Signal Transduction;SOD2 gene;Spirometry;Testing;Therapeutic;uptake;Ventricular;Ventricular Remodeling,Mechanisms of right ventricular dysfunction in type 2 diabetes,164328,MPPB,Integrative Myocardial Physiology/Pathophysiology B Study Section[MPPB],NA,A1,1,227403,95874,323277,NA
11192966,R56,HL,1,N,2024-09-21,2024-09-21,2025-08-31,837,R56HL169176,SCHOOLS OF MEDICINE,PA-20-185,1R56HL169176-01A1,NHLBI:620371\,NON-SBIR/STTR RPGS,2024,"NATIONAL HEART, LUNG, AND BLOOD INSTITUTE",NA,SAINT LOUIS,UNITED STATES,BIOCHEMISTRY,01,050220722,US,7915401,SAINT LOUIS UNIVERSITY,MO,631032006,"PROJECT NARRATIVE The primary goal of this application is to understand how a crucial family of cardiac voltage-activated cation channels sense membrane voltage, which will potentially lead to new targets of treatment for heart diseases especially arrhythmias. Using advanced electrophysiology and fluorescence imaging methods, our experiments will provide mechanistic insights into disease-associated mutations of this family of ion channels and strategies for cardiac arrhythmia therapy.",12413427 (contact),"DAI, GUCAN  (contact)","BALIJEPALLI, RAVI C",2024-09-21,2025-08-31,Action Potentials;Address;Affect;Amino Acids;Arrhythmia;Atrial Fibrillation;Attention;Behavior;Binding;biophysical techniques;Bypass;Cardiac;Cardiomyopathies;Cations;Characteristics;Chemistry;comparative;Coupling;Cyclic Nucleotides;cyclic-nucleotide gated ion channels;delayed rectifier potassium channel;Disease;electrical property;Electrocardiogram;Electrophysiology (science);Ethers;Exhibits;experimental study;Family;Fluorescence;Fluorescence Anisotropy;fluorescence imaging;fluorescence lifetime imaging;Fluorescence Resonance Energy Transfer;Fluorometry;Foundations;Frequencies;Genes;Goals;Heart;Heart Arrest;Heart Atrium;Heart Diseases;Heart failure;heart rhythm;Heterogeneity;Homo;Human;Human Cell Line;Hydrogen Bonding;imaging approach;imaging modality;improved;Inherited;insight;Ion Channel;Ion Channel Gating;Ions;Kinetics;Knowledge;Label;Lead;Link;Long QT Syndrome;Measurement;Measures;Mediating;member;Membrane;Methodology;Methods;Modeling;Molecular Computations;Molecular Conformation;molecular dynamics;Movement;Mutation;Myocardial;Nature;Pacemakers;patch clamp;Phase;Physiology;Play;Potassium Channel;Process;Recombinants;Risk;Role;sensor;Shapes;Signal Transduction;Sinoatrial Node;Site;Structure;sudden cardiac death;Syndrome;Techniques;Testing;Therapeutic;Time;Transition Elements;Translating;Ventricular Arrhythmia;voltage;voltage gated channel,ELECTROMECHANICAL COUPLING AND DISEASE MECHANISMS OF MYOCARDIAL CNBD FAMILY CHANNELS,169176,BBM,Biochemistry and Biophysics of Membranes Study Section[BBM],NA,A1,1,467070,153301,620371,NA
11192968,R56,HL,1,N,2024-09-24,2024-09-24,2025-08-31,837,R56HL171144,NA,PA-20-185,1R56HL171144-01A1,NHLBI:777674\,NON-SBIR/STTR RPGS,2024,"NATIONAL HEART, LUNG, AND BLOOD INSTITUTE",NA,BOSTON,UNITED STATES,NA,08,073130411,US,4907701,MASSACHUSETTS GENERAL HOSPITAL,MA,021142621,"Narrative The proposed research is relevant to public health because it will clarify and strengthen the currently ambiguous treatment recommendations for guideline-directed medical therapies in heart failure with mid-range ejection fraction. As such, clinicians will then have clearer tools to reduce mortality for individuals with this phenotype of heart failure. Thus, the work proposed here is highly relevant to the part of the NHLBIs mission to promote the treatment of heart disease and enhance the health of all individuals.",12651989 (contact),"WASFY, JASON HARMON (contact)","ANAYA, GABRIEL",2024-09-24,2025-08-31,"Address;adjudication;Adrenergic beta-Antagonists;Angiotensin Receptor;Angiotensin-Converting Enzyme Inhibitors;Angiotensins;antagonist;Clinical;Clinical Data;Clinical Practice Guideline;Community Hospitals;comorbidity;comparative effectiveness;Comparative Effectiveness Research;Data;Data Aggregation;Defibrillators;Echocardiography;Economics;Effectiveness;EFRAC;Ensure;Frequencies;Future;Glucose;Goals;Guidelines;Health;Heart Diseases;Heart failure;heart failure with reduced ejection fraction;Hospitals;Image;improved;Individual;Influentials;inhibitor;innovation;Left Ventricular Ejection Fraction;Link;Manuals;Mathematics;Measurement;Measures;Medical;Methods;Mineralocorticoid Receptor;Mission;mortality;multimodality;National Heart, Lung, and Blood Institute;Natural Language Processing;Needs Assessment;Neprilysin;novel;Observational Study;Outcome;Patients;Pharmaceutical Preparations;Phenotype;Physiological;Population;Primary Prevention;prospective;Public Health;Recommendation;Registries;Reporting;Research;Resources;Scoring Method;Side;Sodium;Structure;Subgroup;symporter;Testing;Therapy trial;tool;treatment effect;Treatment Failure;treatment guidelines;treatment strategy;United States;Work",Effectiveness of Therapies for Heart Failure with Mid-Range Ejection Fraction,171144,ZRG1,Special Emphasis Panel[ZRG1-HSS-B(90)S],NA,A1,1,576917,200757,777674,NA
11192971,R56,HL,1,N,2024-09-20,2024-09-20,2025-08-31,837,R56HL174856,BIOMED ENGR/COL ENGR/ENGR STA,PA-20-185,1R56HL174856-01,NHLBI:547020\,NON-SBIR/STTR RPGS,2024,"NATIONAL HEART, LUNG, AND BLOOD INSTITUTE",NA,DENTON,UNITED STATES,ENGINEERING (ALL TYPES),13,614168995,US,6108501,UNIVERSITY OF NORTH TEXAS,TX,762035017,"PROJECT NARRATIVES This study will develop a comprehensive human organoid-artificial intelligence (AI) system for assessing tyrosine kinase inhibitors (TKI)-induced cardiotoxicity, increasing the efficiency and accuracy of preclinical drug safety evaluation in both cardiovascular structure and function. The preliminary assessment results will redefine or suggest existing FDA-approved TKIs in clinical practice, and further extend the organoid-AI systems applications in assessing new TKIs and other general drugs with potential cardiotoxicity concerns.",14145686 (contact),"YANG, HUAXIAO  (contact)","THAKAR, RAHUL GAUTAM",2024-09-20,2025-08-31,Action Potentials;Address;Animals;antitumor effect;Arrhythmia;Artificial Intelligence;artificial intelligence algorithm;Calcium;Cancer Patient;cancer therapy;Cardiac;Cardiotoxicity;cardiovascular effects;cardiovascular imaging;Cardiovascular Physiology;Cardiovascular system;Categories;Cell Line;Cell Survival;Cells;Cellular Structures;Classification;clinical application;clinical development;clinical diagnosis;clinical practice;Color;Congestive Heart Failure;Data;Data Analyses;Development;directed differentiation;Double-Blind Method;drug discovery;Drug Evaluation;Drug Industry;Drug toxicity;Evaluation;experimental study;Expert Systems;Failure;FDA approved;Fluorescence;fluorescence imaging;Functional disorder;Generations;generative adversarial network;generative artificial intelligence;Goals;Heart;Heart Abnormalities;Human;human model;human pluripotent stem cell;Hypertension;In Vitro;Individual;Ischemia;Label;large datasets;Left Ventricular Dysfunction;live cell imaging;machine learning algorithm;Malignant Neoplasms;Measurable;Measurement;Measures;medication safety;Molecular;Myocardial Infarction;network models;Nitric Oxide;novel;Organoids;Pattern;Pharmaceutical Preparations;Phenotype;pre-clinical;preclinical trial;Production;Property;Protein Tyrosine Kinase;Proteomics;Reactive Oxygen Species;Reporter;Reporter Genes;response;small molecule inhibitor;Specific qualifier value;Structure;System;Therapeutic;Toxic effect;Training;transcriptome sequencing;Tyrosine Kinase Inhibitor;Vascularization;Visualization,Assessing Tyrosine Kinase Inhibitors-induced Cardiotoxicity with an Organoid-AI System,174856,MPPA,Integrative Myocardial Physiology/Pathophysiology A Study Section [MPPA],NA,NA,1,399443,147577,547020,NA
11192972,R56,HL,1,N,2024-09-26,2024-09-26,2025-08-31,837,R56HL169223,SCHOOLS OF MEDICINE,PAR-21-038,1R56HL169223-01A1,NHLBI:511702\,NON-SBIR/STTR RPGS,2024,"NATIONAL HEART, LUNG, AND BLOOD INSTITUTE",NA,COLUMBIA,UNITED STATES,ANATOMY/CELL BIOLOGY,06,041387846,US,1524302,UNIVERSITY OF SOUTH CAROLINA AT COLUMBIA,SC,292080001,"PROJECT NARRATIVE Diabetics are more likely to have a stroke, have greater brain injury after ischemia, and have compromised recovery. Given that the principal cause of these outcomes in people with diabetes is vascular damage, a critical barrier to our progress in reducing morbidity and mortality is understanding how diabetes affects the integrity of the cerebral vasculature. We hypothesize that in diabetes, cerebrovascular O-GlcNAcylation, a post-translational modification that alters target protein function, activity, subcellular localization, and stability, is a novel and causal mechanism of the increased predisposition, aggravated neurovascular injury, and impaired recovery after stroke.",15267624 (contact),"MCCARTHY, CAMERON  (contact)","CHARETTE, MARC F",2024-09-26,2025-08-31,Ablation;Acute;Address;Affect;basilar artery;Behavior;behavior test;Blood - brain barrier anatomy;Blood Vessels;Brain;brain endothelial cell;Brain Injuries;Brain Ischemia;Calcium;Cells;cerebral microvasculature;cerebrovascular;Cerebrovascular Circulation;Cerebrovascular system;Cerebrum;Chronic;Cognitive;Cognitive deficits;cost;Coupled;Dependovirus;Diabetes Mellitus;diabetic;Disease;Dose;Endothelial Cells;Enzymes;Exposure to;Functional disorder;Functional impairment;Gene Expression;Glucose;High Fat Diet;Hospitalization;Hyperglycemia;Impairment;improved;In Vitro;in vivo;Infarction;Inflammatory;insight;Ischemia;Knock-out;Link;Literature;Measurement;Mechanics;Methods;middle cerebral artery;Middle Cerebral Artery Occlusion;migration;Modeling;Modification;Morbidity - disease rate;Morphology;mortality;Mus;neovascularization;neurovascular injury;new therapeutic target;Non-Insulin-Dependent Diabetes Mellitus;novel;O-GlcNAc transferase;Obesity;Outcome;Palmitates;parenchymal arterioles;Pathologic;Patients;peptide O-linked N-acetylglucosamine-beta-N-acetylglucosaminidase;Permeability;Persons;post stroke;Post-Translational Protein Processing;Predisposition;Proliferating;protein expression;protein function;Proteins;Proteomics;Public Health;Recovery;Recovery of Function;repaired;Reporting;Research;Research Personnel;response;Role;Signal Transduction;single-cell RNA sequencing;Smooth Muscle Myocytes;Streptozocin;Stress;Stroke;Stroke prevention;stroke recovery;stroke risk;Structure;Testing;therapeutic target;Vascular Diseases;Vascular Endothelium;Vascular Smooth Muscle,Cerebrovascular O-GlcNAcylation Worsens Diabetes-associated Neurovascular Injury and Recovery Post-stroke,169223,ZRG1,Special Emphasis Panel[ZRG1-IVBH-B(02)M],NA,A1,1,349999,161703,511702,NA
11192986,R01,EY,7,N,2024-11-19,2024-12-01,2025-12-31,867,R01EY030864,SCHOOLS OF OPTOMETRY/OPHT TECH,PA-24-254,7R01EY030864-06,NEI:370956\,NON-SBIR/STTR RPGS,2024,NATIONAL EYE INSTITUTE,NA,HOUSTON,UNITED STATES,NONE,18,036837920,US,1449402,UNIVERSITY OF HOUSTON,TX,772042610,"Project Narrative: Corneal pain is an important mechanism to detect injury or damage, leading to protective responses to limit injury if possible (tearing to remove a foreign object), initiate healing and protect the ocular surface required for clear vision. When maladaptive, corneal pain can be so debilitating as to limit daily function, dramatically reduce quality of life, and cause significant economic burden. The proposed research will elucidate the molecular, cellular, anatomical and neurobiological mechanisms of ocular pain and hypersensitivity including photoallodynia by investigating corneal nerves and their responses in non- human disease models of corneal surface injury/dry eye, allergic eye disease and migraine.",11610105 (contact),"MATYNIA, ANNA  (contact)","ARAJ, HOUMAM H",2020-02-01,2025-12-31,NA,"Molecular, cellular, anatomical and neurobiological investigation of melanopsin-expressing corneal innervation, and its role in pain and photophobia",30864,ZRG1,Special Emphasis Panel[ZRG1-BDCN-J(81)S],NA,NA,6,236278,134678,370956,NA
11192999,P50,CA,3,N,2024-09-26,2024-08-01,2025-07-31,397,P50CA098131,NA,PA-20-272,3P50CA098131-21S2,NCI:896275\,RESEARCH CENTERS,2024,NATIONAL CANCER INSTITUTE,NA,NASHVILLE,UNITED STATES,NA,07,079917897,US,10040927,VANDERBILT UNIVERSITY MEDICAL CENTER,TN,372320011,"PROJECT NARRATIVE: OVERALL The Vanderbilt-Ingram Cancer Center SPORE in Breast Cancer has made notable advancements across the spectrum of breast cancer research. With supplemental funding, our primary objective is to conduct collaborative and impactful translational research for those affected by or at risk of breast cancer. We propose to further our research on three translational projects, primarily targeting triple-negative breast cancer, with essential support from three cores: Pathology and Tissue Informatics, Biostatistics and Bioinformatics and Administrative and Engagement; and patient advocates, to ensure that we are inclusive of the patient perspective in meeting our goals.",1931278;1938512 (contact),"PARK, BEN HO;PIETENPOL, JENNIFER A (contact)","BASA JANAKIRAM, NAVEENA",2024-08-01,2025-07-31,Academic Medical Centers;Administrative Coordination;Advocate;Affect;Agonist;Animal Model;Animals;anti-cancer research;Antigen Presentation;Antigen Targeting;Atlases;Bioinformatics;Biometry;Blood specimen;Body Fluids;Breast;Breast Cancer Risk Factor;Cancer Center;Cell Line;CLIA certified;Clinical;Clinical Research;Clinical Trials;Collaborations;Collection;Communication;comparison control;Consent;Consult;Data;Data Analyses;data quality;data repository;Databases;Development;Diagnostic;Enrollment;Ensure;Epithelium;Evaluation;Experimental Designs;Fostering;Funding;gene panel;Genes;Genomics;Goals;Histology;Human Resources;Immune;Immunohistochemistry;immunoregulation;Immunotherapy;improved;improved outcome;Informatics;innovative technologies;International;Laboratories;liquid biopsy;Malignant Breast Neoplasm;Mammary Gland Parenchyma;Mammary Neoplasms;Manuscripts;Medical;meetings;men;Methods;molecular diagnostics;Monitor;multidisciplinary;Mutation;Occupational activity of managing finances;Organoids;Pathologic;Pathology;Patient Participation;Patients;Policies;Process;Productivity;Prognostic Marker;programs;Protocols documentation;Publications;Quality Control;recruit;Regulation;Report (document);Reporting;repository;Reproduction spores;Research;research and development;Research Design;Research Personnel;Research Project Grants;Resource Sharing;Resources;response;Sample Size;Services;Standardization;Tissues;tool;Training;Translational Research;translational study;treatment response;triple-negative invasive breast carcinoma;tumor;United States National Institutes of Health;Woman;Work;Writing,SPORE in Breast Cancer,98131,NA,NA,NA,S2,21,512157,384118,896275,NA
11193012,P50,CA,3,N,2024-09-25,2024-06-01,2025-05-31,397,P50CA217691,SCHOOLS OF MEDICINE,PA-20-272,3P50CA217691-05S1,NCI:896274\,RESEARCH CENTERS,2024,NATIONAL CANCER INSTITUTE,NA,ATLANTA,UNITED STATES,INTERNAL MEDICINE/MEDICINE,05,066469933,US,2384501,EMORY UNIVERSITY,GA,303221007,"OVERALL NARRATIVE Lung cancer remains the leading cause of cancer-related deaths, with more than 1.6 million deaths/year globally. We plan to conduct translational and innovative research to enhance the efficacy of immunotherapy (project 1) and to develop novel molecularly targeted approaches to overcome resistance to treatment (projects 2 and 3) in lung cancer. The Emory Lung Cancer SPORE program brings together an outstanding and multi-disciplinary team of oncologists, immunologists, drug discovery experts, and translational researchers to address critical questions that will improve the outcome for patients with this lethal disease.",1893676;8576769 (contact),"FU, HAIAN ;RAMALINGAM, SURESH S (contact)","UJHAZY, PETER",2019-07-10,2025-05-31,Address;Administrative Supplement;anti-cancer;anti-cancer research;anti-PD1 antibodies;anti-PD1 therapy;Antibodies;Area;artificial intelligence model;Award;B-Lymphocytes;Biological;biomedical informatics;Biometry;Cancer Etiology;Cancer Patient;cancer therapy;career;CD8-Positive T-Lymphocytes;Cessation of life;Circadian Dysregulation;clinical application;clinical efficacy;Collaborations;Combined Modality Therapy;Comprehensive Cancer Center;Contracts;COVID-19 pandemic;COVID-19 patient;COVID-19 vaccination;COVID-19 vaccine;Data;Dedications;Development;Diagnosis;Disease;Dose;drug discovery;Drug resistance;Epidermal Growth Factor Receptor;exhaustion;experience;flexibility;Funding;Health Sciences;Healthcare Systems;Hematology;Immune checkpoint inhibitor;Immunologic Factors;Immunologist;Immunotherapy;improved;improved outcome;innovation;insight;Institution;Interleukin-2;Journals;KRAS2 gene;Location;Lung Adenocarcinoma;Malignant neoplasm of lung;Malignant Neoplasms;Medical Oncology;medical schools;member;Memory B-Lymphocyte;MERTK gene;Modernization;Molecular Target;molecular targeted therapies;mortality;multidisciplinary;mutant;Mutate;Non-Small-Cell Lung Carcinoma;novel;novel therapeutic intervention;Oncologist;Outcome;Pathology;patient population;Patient-Focused Outcomes;Patients;PD-1 blockade;pembrolizumab;Phenotype;Pilot Projects;Play;programmed cell death protein 1;programs;Property;prospective;Publishing;Recommendation;Research;Research Personnel;Resistance;resistance mechanism;Resource Sharing;response;Risk Reduction;Role;Scientist;Secondary Immunization;severe COVID-19;Signal Transduction;Site;stem;stemness;STK11 gene;T cell response;T-Lymphocyte;targeted agent;targeted treatment;Testing;therapy resistant;translational goal;translational scientist;treatment and outcome;Treatment Efficacy;tumor;Universities;Work,Administrative Supplement: Interim Funding for Emory Lung Cancer SPORE,217691,NA,NA,NA,S1,5,572699,323575,896274,NA
11193024,P50,CA,3,N,2024-09-26,2024-06-01,2025-05-31,397,P50CA236733,NA,PA-20-272,3P50CA236733-05S2,NCI:896274\,RESEARCH CENTERS,2024,NATIONAL CANCER INSTITUTE,NA,NASHVILLE,UNITED STATES,NA,07,079917897,US,10040927,VANDERBILT UNIVERSITY MEDICAL CENTER,TN,372320011,"PROJECT NARRATIVE This application is a Supplement to support the Vanderbilt-Ingram Cancer Center GI SPORE, which will continue to focus on colorectal cancer, the second leading cause of cancer-related deaths in the United States. We narrowly missed being funded on the A0 submission in September 2023. We are preparing our A1 submission for the imminent September 25, 2024 deadline and we are requesting funds to carry out crucial experiments to continue the trajectory of our 3 Projects and supporting Cores, as well as the salary support of key personnel.",1901947 (contact),"COFFEY, ROBERT J. (contact)","NOTHWEHR, STEVEN F",2024-06-01,2025-05-31,Award;Berlin;beta catenin;Bioinformatics;Biological;Biometry;Cancer Center;Cancer Etiology;Cell membrane;Cells;Cessation of life;Clinical;Clinical Trials;Colorectal Cancer;experimental study;Funding;Grant;Human;Human Resources;Institution;Jordan;Lead;Malignant neoplasm of gastrointestinal tract;molecular imaging;Mus;Pathology;Pharmaceutical Preparations;pharmacologic;Pre-Clinical Model;Protac;Reproduction spores;Research Support;skills;Tissues;tumor initiation;United States;Update;Wages;WNT Signaling Pathway,Vanderbilt-Ingram Cancer Center SPORE in Gastrointestinal Cancer,236733,NA,NA,NA,S2,5,660568,235706,896274,NA
11193045,R01,AI,7,N,2024-11-21,2024-10-18,2025-04-30,855,R01AI179037,NA,PA-24-254,7R01AI179037-02,NIAID:660642\,NON-SBIR/STTR RPGS,2024,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NASHVILLE,UNITED STATES,NA,07,079917897,US,10040927,VANDERBILT UNIVERSITY MEDICAL CENTER,TN,372320011,"PROJECT NARRATIVE Mycobacterium tuberculosis (Mtb) is an exquisitely evolved, incredibly successful, and difficult to treat human pathogen that currently infects one-quarter of the worlds population. We discovered that during Mtb infection of macrophages, mitochondrial reactive oxygen species (ROS) licenses a necrotic cell death pathway that promotes hyperinflammation and poor disease outcomes. We predict that blocking this newly described cell death pathway may benefit tuberculosis patients with underlying genetics or conditions that are associated with ROS accumulation.",9803040;9427418 (contact),"PATRICK, KRISTIN LEIGH;WATSON, ROBERT OWEN (contact)","ROBINSON, RICHARD THOMAS",2024-06-24,2029-04-30,Acute;acute infection;Alleles;Anti-Bacterial Agents;Apoptosis;Cardiolipins;Catalogs;Cell Death;Cell membrane;cell type;Cells;Cellular biology;Cellular Membrane;Cellular Stress;chronic inflammatory disease;co-infection;comorbidity;Cytolysis;Data;Diabetes Mellitus;Disease;Disease Outcome;Equilibrium;experience;experimental study;Generations;Genes;Genetic;glutathione peroxidase;Goals;Heterogeneity;high risk;HIV;Human;human disease;human pathogen;immunogenic;Immunologics;immunopathology;in vivo;Individual;Infection;Inflammasome;Inflammation;Inflammatory;Intervention;Leprosy;Licensing;Link;Lipid Peroxidation;Lipids;LRRK2 gene;Lung;Macrophage;Malnutrition;Measures;Mediating;Mediator;member;Mitochondria;mitochondrial dysfunction;Modality;Modeling;mouse model;Mus;Mutation;Mycobacterium tuberculosis;Nature;Necrosis;Neutrophil Infiltration;novel;Outcome;Outer Mitochondrial Membrane;overexpression;oxidation;Oxidation-Reduction;Oxidative Stress;Parkinson Disease;Pathogenesis;Pathogenicity;Pathway interactions;Patients;pharmacologic;Phospholipids;Phosphorylation;Phosphotransferases;Play;Population;Predisposition;Production;Protein Biochemistry;Protein Family;Proteins;Reactive Oxygen Species;recruit;response;RIPK1 gene;RIPK3 gene;Role;Smoking;Stress;Testing;Therapeutic Intervention;Tuberculosis;tuberculosis immunity;VDAC1 gene;Vitamin K 3;Work,Targeting mediators of oxidative stress to limit hyperinflammatory cell death modalities during Mycobacterium tuberculosis infection,179037,ZRG1,Special Emphasis Panel[ZRG1-IIDB-X(02)],NA,NA,2,397108,263534,660642,NA
11193066,N43,CA,NA,N,NA,NA,NA,NA,75N91024C00094,NA,NA,75N91024C00094-0-9999-1,NCI:400000\,SBIR/STTR CONTRACTS,2024,NATIONAL CANCER INSTITUTE,NA,Newton,UNITED STATES,NA,04,802270988,US,10015346,"BIOSENSICS, LLC",MA,024581080,NA,9642247 (contact),"VAZIRI, ASHKAN  (contact)",NA,2024-09-11,2025-09-10,Adipose tissue;Artificial Intelligence;biomedical imaging;Body Composition;Body mass index;Cancer Patient;Classification Scheme;Early identification;Food Aversion;imaging Segmentation;Interview;machine learning model;Malnutrition;Modeling;Muscle;novel;Phase;prototype;Questionnaires;screening;Skeletal Muscle;Small Business Innovation Research Grant;software development;tool;Validation;X-Ray Computed Tomography,FY24 SBIR PHASE I TOPIC NO. 459 PROJECT TITLE: AN AUTOMATED SCREENING PLATFORM FOR EARLY IDENTIFICATION OF MALNUTRITION IN CANCER PATIENTS,0,NA,NA,NA,NA,NA,NA,NA,400000,NA
11193099,ZIA,AA,1,N,NA,NA,NA,NA,ZIAAA000135,NA,NA,1ZIAAA000135-04,NIAAA:323186\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM,NA,NA,NA,78351012 (contact),"JOSEPH, PAULE  (contact)",NA,NA,NA,Address;Affect;Age;Area;Behavioral;Blood;chemokine;clinical center;cohort;comorbidity;cytokine;Data Analyses;design;Diet;Dietary Intervention;Eating;Eating Behavior;effective intervention;Enrollment;exosome;Food;food consumption;Fostering;gut microbiota;Hour;improved;Individual;individual variation;Inflammation;inflammatory marker;Institutional Review Boards;Intervention;Investigation;Measures;metropolitan;microbiome composition;microbiota;nasal microbiome;Neurons;Non obese;novel;obese person;Obesity;obesity development;obesity treatment;oral microbiome;Outcome Measure;Participant;pharmacologic;Plasma;prevent;Prevention;primary outcome;Public Health;recruit;Risk Factors;Risk Reduction;screening;secondary outcome;sex;Smell Perception;success;System;Taste Perception;Time;transcriptomics;Unhealthy Diet;United States National Institutes of Health;Variant;Visit;Washington,Mechanisms Underlying Individual Variations of Taste and Smell in Obesity,135,NA,NA,NA,NA,4,NA,NA,323186,NA
11193100,ZIA,AA,1,N,NA,NA,NA,NA,ZIAAA000136,NA,NA,1ZIAAA000136-04,NIAAA:565575\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM,NA,NA,NA,78351012 (contact),"JOSEPH, PAULE  (contact)",NA,NA,NA,"Acute;Address;Adult;Affect;alcohol use disorder;Area;Auditory;behavior influence;Binge Eating;Black race;blood oxygenation level dependent response;Blood Pressure;Body mass index;brain reward regions;Calories;cardiometabolism;Chronic;Clinical;Clinical Protocols;Collaborations;Consummatory Behavior;Consumption;Controlled Environment;COVID-19 impact;Crossover Design;Cues;Desire for food;Diagnosis;Diet;Dietary intake;Disinhibition;Double-Blind Method;Eating;Eating Behavior;Eating Disorders;Esthesia;Exposure to;Food;Functional Magnetic Resonance Imaging;Genetic;Genetic Variation;Genomics;Goals;Health;High Fat Diet;Human;Hunger;Hylobates Genus;Hypertension;improved;Individual;individual variation;Inpatients;interest;International;Journals;Laboratories;lifestyle factors;Link;Literature;Measures;Metabolic Diseases;Metabolic syndrome;Metabolism;metabolomics;microbiome research;Modernization;Molecular;Motivation;multiple omics;multisensory;National Human Genome Research Institute;National Institute of Diabetes and Digestive and Kidney Diseases;National Institute on Alcohol Abuse and Alcoholism;neural;Neurons;nutrition;Obesity;obesity risk;Outcome;Outpatients;Participant;Pathway interactions;Patient Self-Report;Perception;Persons;Phenotype;Physiological;Play;Population;preference;Process;Questionnaires;Randomized, Controlled Trials;Reporting;Research;response;retention rate;Rewards;Role;Sampling;satisfaction;Science;Sensory;sensory system;Shapes;Smell Perception;Sodium;Sodium Chloride;Stimulus;sugar;sweet taste perception;Taste Buds;Taste Perception;Taste preferences;taste system;transcriptomics;Translational Research;Variant;Waiting Lists;Weight",Sensory Science and Metabolism; Molecular and Neuronal Mechanisms,136,NA,NA,NA,NA,4,NA,NA,565575,NA
11193101,ZIA,AA,1,N,NA,NA,NA,NA,ZIAAA000350,NA,NA,1ZIAAA000350-24,NIAAA:1726510\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM,NA,NA,NA,6997028 (contact),"KUNOS, GEORGE  (contact)",NA,NA,NA,5&apos;-AMP-activated protein kinase;adenylate kinase;Adipocytes;Alcohol consumption;Alcoholic Fatty Liver;Anabolism;antagonist;Biological;Biological Assay;Breeding;Carbohydrates;CB1 knockout;CD36 gene;Cell Line;Cells;Central obesity;Chronic;Cirrhosis;CNR1 gene;Code;Complementary DNA;conditional knockout;Desire for food;Development;Diabetic Nephropathy;Diet;diet-induced obesity;Disease;Endocannabinoids;endogenous cannabinoid system;Energy Intake;Energy Metabolism;Energy-Generating Resources;Enzymes;Excision;Exposure to;extracellular;Extrahepatic;fatty acid oxidation;fatty acid transport;Fatty Acids;fatty liver disease;Fibrosis;Food;Gene Expression;Gene Expression Profiling;Genes;Genetic Transcription;Glucose;Goals;Health;Hemorrhage;Hepatic;Hepatocyte;Heterozygote;High Fat Diet;Homeostasis;homologous recombination;Hybrids;in vivo;Incubated;Individual;interest;Knockout Mice;lipid metabolism;Liver;Luciferases;Manuscripts;marijuana use;Mediating;Metabolic syndrome;meter;Microinjections;Minor;Mitochondria;Modeling;Mus;Mutant Strains Mice;nano-string;Non obese;non-alcoholic fatty liver;Non-Insulin-Dependent Diabetes Mellitus;NOS2A gene;novel;Obese Mice;Obesity;offspring;Oleic Acids;Oxygen Consumption;Pathway interactions;Pattern;Peripheral;Phosphorylation;Play;prevent;Primary carcinoma of the liver cells;Probability;Process;programs;promoter;protein expression;Proteins;Pulmonary Fibrosis;receptor;Recombinants;Regulation;Reporter;Reporting;Resistance;Respiration;Reverse Transcriptase Polymerase Chain Reaction;Role;Signal Pathway;Signal Transduction;Site;skin fibrosis;Source;stable cell line;stem cells;Technology;Terminator Codon;Testing;Thinness;Threonine;Time;transcriptome sequencing;Transfection;Transgenic Organisms;translocase;Treatment Efficacy;Triglycerides;uptake;Weight Gain;Western Blotting;Wild Type Mouse,Endocannabinoids And Energy Homeostasis,350,NA,NA,NA,NA,24,NA,NA,1726510,NA
11193102,ZIA,AA,1,N,NA,NA,NA,NA,ZIAAA000466,NA,NA,1ZIAAA000466-19,NIAAA:1904646\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM,NA,NA,NA,11757953 (contact),"RAMCHANDANI, VIJAY ARJUN (contact)",NA,NA,NA,acute stress;addiction;Affect;Age;Agonist;Alcohol abuse;alcohol abuse therapy;alcohol consequences;Alcohol consumption;alcohol cue;alcohol effect;alcohol exposure;alcohol misuse;alcohol response;alcohol reward;alcohol seeking behavior;alcohol use disorder;Alcoholic beverage heavy drinker;Alcohols;Algorithms;Annual Reports;anxiety symptoms;bariatric surgery;Behavior;Behavior assessment;Behavioral;binge drinking;biobehavior;Biological Markers;Brain;Categories;Cholinergic Receptors;Classification;Clinical;Clinical Data;Clinical Pharmacology;Clinical Trials;Closure by clamp;Collaborations;Complement;Computer Assisted;Consumption;consumption measures;Coping Behavior;Coping Skills;COVID-19;COVID-19 pandemic effects;craving;Cues;Data;depressive symptoms;Development;Dimensions;disorder risk;Disparate;domain mapping;drinking;Drug Kinetics;emotional functioning;Enrollment;Etiology;executive function;Face;Family history of;flexibility;Fright;Functional Magnetic Resonance Imaging;Future;Genes;Genetic;genomic data;ghrelin;Goals;health disparity;hedonic;Height;Heterogeneity;Human;Image;image translation;imaging genetics;Impairment;improved;Impulsivity;incentive salience;Individual;Infusion procedures;insight;inter-individual variation;Intoxication;Intravenous;intravenous administration;Intravenous infusion procedures;Ketones;Laboratories;Link;Loneliness;Longitudinal Surveys;male;Measures;Mediator;Medicine;Mental Depression;Mental Health;Methodology;Methods;Modeling;mood symptom;Motivation;nalmefene;National Institute on Alcohol Abuse and Alcoholism;Natural History;negative affect;Negative Valence;neural;Neurobiology;Neuropsychology;Nicotinic Receptors;novel;novel therapeutics;Nucleus Accumbens;Occupations;Opioid Antagonist;Opioid Receptor;Outcome;pandemic disease;Paraosmias;Perception;Personal Satisfaction;personalized medicine;Pharmaceutical Preparations;Pharmacodynamics;pharmacokinetic model;pharmacokinetics and pharmacodynamics;pharmacologic;Phase;Phenotype;Physiological;Placebos;post-pandemic;preclinical study;Property;prospective;psychologic;Psychophysiology;Public Health;Publishing;Questionnaires;Receptor Gene;Recording of previous events;Reporting;Research;research clinical testing;Research Personnel;response;Rewards;Risk;Risk Factors;Role;Self Administration;Severities;sex;smoking cessation;social;social media;Stimulus;Stress;stressor;Structure;System;targeted treatment;Testing;Therapeutic;Time;transcriptomics;translational study;varenicline;Variant;Weight;Withdrawal;Work;young adult,Alcohol Pharmacokinetics and Pharmacodynamics in Humans,466,NA,NA,NA,NA,19,NA,NA,1904646,NA
11193103,ZIA,CL,1,N,NA,NA,NA,NA,ZIACL010357,NA,NA,1ZIACL010357-08,NA,INTRAMURAL RESEARCH,2024,CLINICAL CENTER,NA,NA,NA,NA,NA,NA,NA,NA,CLINICAL CENTER,NA,NA,NA,11613051 (contact),"HAMMOUD, DIMA A (contact)",NA,NA,NA,animal data;Blinded;Brain;Data Analyses;Exposure to;Functional disorder;Hand;HIV;HIV Infections;HIV Seronegativity;Human;Image;Infection;Institutional Review Boards;Manuscripts;Molecular;neuron loss;Neurotransmitters;Paper;Patient Recruitments;Patients;Positron-Emission Tomography;postsynaptic;presynaptic;Protocols documentation;Publishing;Rat Transgene;recruit;Scanning;socioeconomics;System;Thalamic structure;Update;uptake;Viral Proteins;Writing,PET imaging of presynaptic nigrostriatal dopaminergic function in optimally treated HIV+ patients,10357,NA,NA,NA,NA,8,NA,NA,0,NA
11193104,ZIA,CL,1,N,NA,NA,NA,NA,ZIACL010358,NA,NA,1ZIACL010358-05,NA,INTRAMURAL RESEARCH,2024,CLINICAL CENTER,NA,NA,NA,NA,NA,NA,NA,NA,CLINICAL CENTER,NA,NA,NA,11613051 (contact),"HAMMOUD, DIMA A (contact)",NA,NA,NA,"2019-nCoV;ACE2;Acids;Acute Lung Injury;Address;Affinity;Aftercare;Albumins;alveolar epithelium;animal imaging;Animal Model;Animals;aspirate;Binding;Binding Sites;Biological Assay;Blood;Bone Marrow;Brain;cecal ligation puncture;Cells;central nervous system injury;Characteristics;Collaborations;COVID-19;Development;Diagnosis;Diagnostic;Disease;Disease Progression;Down-Regulation;Drug Kinetics;Ebola;Ebola virus;Endothelium;experimental study;Extravasation;Functional disorder;Genes;Goals;HIV;HIV Envelope Protein gp120;HIV Infections;Human;Image;imaging modality;improved;in vivo;in vivo imaging;Infection;K-18 conjugate;Knockout Mice;Label;Lassa;Lassa virus;Ligands;Lipopolysaccharides;Lung;lung injury;Magnetic Resonance Imaging;Manuscripts;Marburgvirus;Measurement;Mediating;Methods;microPET/CT;Modeling;Molecular Biology;molecular imaging;Molecular Target;mouse model;Mus;nanobodies;nanolabel;National Heart, Lung, and Blood Institute;natural antibodies;Nature;Nipah;Nipah Virus;non-invasive imaging;Organ;Pathology;Peripheral;Positron-Emission Tomography;Process;protective pathway;Proteins;Publications;Publishing;Pulmonary Pathology;Radiolabeled;receptor;Recombinants;research facility;Research Personnel;response;Role;SARS-CoV-2 infection;SARS-CoV-2 spike protein;Severities;Site;Spleen;Testing;Therapeutic Intervention;Tissues;tumor;Type II Epithelial Receptor Cell;Viral;Virus;Virus Diseases;Virus Replication;Wild Type Mouse;Writing;X-Ray Computed Tomography",Molecular imaging of viral infections,10358,NA,NA,NA,NA,5,NA,NA,0,NA
11193105,ZIA,CL,1,N,NA,NA,NA,NA,ZIACL040011,NA,NA,1ZIACL040011-17,NA,INTRAMURAL RESEARCH,2024,CLINICAL CENTER,NA,NA,NA,NA,NA,NA,NA,NA,CLINICAL CENTER,NA,NA,NA,9692774 (contact),"WOOD, BRADFORD  (contact)",NA,NA,NA,Ablation;Address;Adopted;Adoption;Anatomy;Annual Reports;anti-cancer research;anti-cancer therapeutic;anti-cancer treatment;Antineoplastic Agents;Area;artery occlusion;Artificial Intelligence;artificial intelligence model;Augmented Reality;Automation;Beds;bench to bedside;Biological Markers;Biopsy;Bronchoscopy;cancer therapy;Caring;Catheters;Cellular Phone;checkpoint therapy;Chemoembolization;Clinic;Clinical;clinical center;Clinical Research;Clinical Treatment;Clinical Trials;clinically relevant;Clip;commercialization;Computer software;cone-beam computed tomography;cost effective;cost effectiveness;Data;design;Development;Device or Instrument Development;Devices;Diagnosis;Disease;Dose;Drug Combinations;Drug Delivery Systems;drug discovery;Drug Targeting;Electromagnetics;empowerment;Endoscopy;Engineering;Equipment;experience;falls;Feedback;first-in-human;Fluoroscopy;Focused Ultrasound Therapy;Future;Goals;Goggles;Grant;Heterogeneity;Human Resources;Image;image guided;image guided intervention;image guided therapy;image processing;Imaging Device;imaging modality;immune activation;Immunotherapy;improved;improved outcome;In Vitro;in vivo;instrumentation;Intervention;Interventional radiology;Intramural Research Program;Lasers;Liposomes;Liver;Localized Disease;Lung;Magnetic Resonance Imaging;Malignant neoplasm of prostate;Malignant Neoplasms;Marketing;Medical;Medical Device;Medicine;Metabolic;Methods;microwave electromagnetic radiation;Miniaturization;minimally invasive;Mission;Modality;Modeling;molecular targeted therapies;Monitor;Morphology;multi-component intervention;multidisciplinary;Multimodal Imaging;multimodality;Needles;Normal tissue morphology;novel;novel therapeutics;Oncology;Operating Rooms;Operative Surgical Procedures;Optics;Paper;Patients;personalized therapeutic;Pharmaceutical Preparations;pharmacologic;Pharmacologic Substance;Phase;Positioning Attribute;Positron-Emission Tomography;Pre-Clinical Model;precision drugs;Privatization;Procedures;Process;programs;Property;Prostate;Prostate Ablation;prostate biopsy;prototype;radio frequency;Radiofrequency Interstitial Ablation;Radiology Specialty;Rectum;Research;Resolution;Resources;Robotics;Route;Science;side effect;Site;Solid Neoplasm;Standardization;System;Systemic disease;targeted treatment;Techniques;Technology;Temperature;temporal measurement;Testing;Therapeutic;Therapeutic Agents;Therapeutic Embolization;Therapeutic Intervention;Thermal Ablation Therapy;Time;Tissues;tomography;tool;tool development;Toxic effect;Training Programs;Translating;translational potential;Translational Research;treatment planning;tumor;tumor ablation;tumor heterogeneity;ultrasound;United States National Institutes of Health;Urethra;validation studies;Vendor;Vision;Visualization;Work,Navigation Tools for Image Guided Minimally invasive Therapies,40011,NA,NA,NA,NA,17,NA,NA,0,NA
11193106,ZIA,CL,1,N,NA,NA,NA,NA,ZIACL040012,NA,NA,1ZIACL040012-17,NA,INTRAMURAL RESEARCH,2024,CLINICAL CENTER,NA,NA,NA,NA,NA,NA,NA,NA,CLINICAL CENTER,NA,NA,NA,9692774 (contact),"WOOD, BRADFORD  (contact)",NA,NA,NA,Ablation;Acceleration;adaptive immunity;Algorithms;Animals;Annual Reports;antitumor effect;Back;Benign;Biological;Bladder;Bladder irrigation procedure;Body Temperature;cancer immunotherapy;cancer therapy;Cancer Vaccines;Cell Death;checkpoint inhibition;Chemosensitization;chemotherapy;Child;Clinical;clinical application;clinical practice;clinical translation;Clinical Trials;Clinical Trials Design;cold temperature;comparative;Computer Simulation;Contrast Media;Cryosurgery;Dendritic Cells;Deposition;design;Detection;Development;Device or Instrument Development;Devices;dosimetry;Doxorubicin;Drug Delivery Systems;Drug Regulations;electric field;Electroporation;Emerging Technologies;Endothelial Cells;Engineering;Feedback;Finite Element Analysis;Focused Ultrasound;Focused Ultrasound Therapy;Foundations;Future;Gel;Goals;Grant;Heating;Hyperthermia;Image;image guided;image-guided drug delivery;Immune;immune activation;Immune checkpoint inhibitor;immune modulating agents;immune resistance;Immune response;immune stimulant;Immune system;immunogenic;Immunologic Factors;Immunologic Stimulation;Immunomodulators;immunoregulation;Immunotherapy;improved;In Vitro;in vivo;in vivo Model;Industry;Infrastructure;Injections;Institutional Review Boards;interdisciplinary approach;Investigation;Irrigation;Lasers;liposome vector;Liposomes;Magnetic Resonance Imaging;Malignant neoplasm of prostate;Malignant neoplasm of urinary bladder;Malignant Neoplasms;Maps;mathematical model;Mechanics;Medical center;Methods;Mitomycins;Modeling;multimodality;Mus;Muscle;nano;nanoDroplet;nanoparticle;Natural Immunity;neoplasm immunotherapy;new technology;non-invasive imaging;novel;Operative Surgical Procedures;Pathology;Patients;Perfusion;Permeability;Pharmaceutical Preparations;Pharmacotherapy;Phase Transition;Physicians;Physiologic pulse;Polyvinyls;pre-clinical;Pre-Clinical Model;preclinical safety;preclinical study;programs;Prostate;Prostate Cancer therapy;Publishing;radio frequency;Radiosensitization;Research;Research Personnel;Risk;Robotics;Rodent;Safety;Saline;Solid Neoplasm;System;Technology;technology/technique;Temperature;Thermal Ablation Therapy;Thermometry;Time;Tissues;tool;translational potential;Translations;treatment optimization;treatment planning;tumor;Tumor Antigens;Tumor Tissue;Ultrasonic Therapy;ultrasound;ultrasound ablation;United States National Institutes of Health;Universities;Up-Regulation;Urology;Uterine Fibroids;vaccine delivery;Vaccines;Validation;vector;Visualization;Water;Work,Image Guided Focused Ultrasound For Drug Delivery and Tissue Ablation,40012,NA,NA,NA,NA,17,NA,NA,0,NA
11193107,ZIA,CL,1,N,NA,NA,NA,NA,ZIACL040015,NA,NA,1ZIACL040015-16,NA,INTRAMURAL RESEARCH,2024,CLINICAL CENTER,NA,NA,NA,NA,NA,NA,NA,NA,CLINICAL CENTER,NA,NA,NA,9692774 (contact),"WOOD, BRADFORD  (contact)",NA,NA,NA,3-Dimensional;Ablation;Acceleration;Address;Animals;Annual Reports;Antigen Presentation;Antineoplastic Agents;Artificial Intelligence;Atmosphere;Augmented Reality;automated segmentation;Automation;Award;Basic Science;bench to bedside;Biological Markers;Biomedical Engineering;Biopsy;cancer classification;cancer clinical trial;Cancer Patient;cancer therapy;Catheters;CCR;Cellular Phone;checkpoint inhibition;chemotherapy;Clinic;Clinical;clinical center;Clinical Protocols;Clinical Research;Clinical Trials;Clip;Collaborations;collaborative environment;combination cancer therapy;Communities;Computer software;Computers;Cooperative Research and Development Agreement;cost;cost effective;Data;Data Science;Data Scientist;Databases;deep learning;deep learning model;Detection;Development;Devices;Diagnosis;digital pathology;Discipline;Disease;Doctor of Philosophy;Dose;Down-Regulation;Drug Combinations;Drug Delivery Systems;drug discovery;Drug Modelings;Drug Targeting;Ecosystem;Education;education pathway;Electroporation;Emerging Technologies;Energy-Generating Resources;Engineering;Environment;Exposure to;Faculty;Family suidae;Fine needle aspiration biopsy;first-in-human;Fluoroscopy;Focused Ultrasound Therapy;Freezing;Gel;Goals;Goggles;Hepatitis;Human;Image;image guided;Image Guided Biopsy;image guided therapy;image processing;image-guided drug delivery;Imaging Device;imaging modality;imaging scientist;imaging system;Imaging technology;Immune;Immune checkpoint inhibitor;immune modulating agents;immune resistance;immunoregulation;Infusion procedures;Injections;innovation;Intervention;Interventional radiology;Intramural Research Program;Investigation;Kidney;Lasers;Light;Liposomes;Liver;Local Therapy;Localized Malignant Neoplasm;Location;lymph nodes;Magnetic Resonance Imaging;Malignant neoplasm of liver;Malignant neoplasm of prostate;Malignant neoplasm of urinary bladder;Malignant Neoplasms;Mechanics;Medical;Medical Oncology;Medicine;Mentors;Methods;Microspheres;microwave electromagnetic radiation;minimally invasive;Modeling;Molecular;Molecular Target;multidisciplinary;Multimodal Imaging;multimodality;nanoparticle;nanoscale;National Institute of Biomedical Imaging and Bioengineering;Needle biopsy procedure;Needles;new technology;novel;Oncologist;Oncology;Operative Surgical Procedures;Organ;Paint;pandemic disease;Pathology;Pathway interactions;Patient Care;Patients;Pharmaceutical Preparations;Physicians;Population;post-COVID-19;pre-clinical;precision drugs;Procedures;prognostication;programs;Prostate;prostate biopsy;Protocols documentation;Radiation;Radiation Oncology;radio frequency;radiologist;Radiology Specialty;Rectum;Reporting;Research;Research Personnel;Resources;Robotics;Saline;Science;Scientist;Screening for cancer;Signal Transduction;small molecule;software development;sound;Standardization;Structure of base of prostate;Students;Surgical Oncology;System;targeted treatment;Techniques;Technology;technology/technique;Testing;Therapeutic Embolization;Thermal Ablation Therapy;Thinness;Time;tool;Training;Training and Education;Translating;translational model;Translational Research;treatment planning;trial planning;tumor;tumor ablation;ultrasound;United States National Institutes of Health;Urethra;urologic;Urologic Oncology;vector;Vision;Visit;Visualization;Voice;web app;Woodchuck,Interventional Oncology,40015,NA,NA,NA,NA,16,NA,NA,0,NA
11193108,ZIA,CL,1,N,NA,NA,NA,NA,ZIACL090055,NA,NA,1ZIACL090055-07,NA,INTRAMURAL RESEARCH,2024,CLINICAL CENTER,NA,NA,NA,NA,NA,NA,NA,NA,CLINICAL CENTER,NA,NA,NA,11613051 (contact),"HAMMOUD, DIMA A (contact)",NA,NA,NA,Affinity;Animals;Antibodies;Area;Aspergillus;Aspergillus fumigatus;Autoradiography;Bacteria;beta-Glucosidase;Brain;Cell Wall;Cellular Structures;Chitin;clinical translation;cross reactivity;Endothelium;Enzymes;Escherichia coli;Evaluation;Excretory function;Fab Immunoglobulins;fungus;Glucose;Hour;Human;Hydrolysis;Image;Immunoglobulin Fragments;improved;In Vitro;in vitro testing;Inflammation;Injections;Kidney;Label;laminaran;Ligands;Lung;Metabolic;microPET;Modeling;Mucormycosis;Mus;Mycoses;Myositis;nanobodies;Parents;pathogenic fungus;Permeability;Positron-Emission Tomography;Preparation;Production;Protocols documentation;Radioactivity;radiochemical;Radioimmunoconjugate;Radiolabeled;Site;Specificity;Sterility;sugar;Testing;Time;translation to humans;uptake,Imaging of fungal infections,90055,NA,NA,NA,NA,7,NA,NA,0,NA
11193109,ZIA,CL,1,N,NA,NA,NA,NA,ZIACL090072,NA,NA,1ZIACL090072-05,NA,INTRAMURAL RESEARCH,2024,CLINICAL CENTER,NA,NA,NA,NA,NA,NA,NA,NA,CLINICAL CENTER,NA,NA,NA,9692774 (contact),"WOOD, BRADFORD  (contact)",NA,NA,NA,3-Dimensional;3D Print;air filtration;Algorithms;Angiography;Antibodies;Artificial Intelligence;artificial intelligence model;Atelectasis;automated segmentation;Bacterial Pneumonia;Biological Markers;Biopsy;Bridge to Artificial Intelligence;cancer invasiveness;CCR;Cellular Phone;chest computed tomography;Classification;Clinical;clinical imaging;Clinical Trials;Coagulation Process;Collaborations;commercialization;Communicable Diseases;Communication;Computer software;COVID-19;COVID-19 detection;COVID-19 pandemic;COVID-19 patient;Critical Care;crosslink;Custom;Data;data curation;Data Science;Data Set;data sharing;deep learning;deep learning model;design;Detection;Development;Devices;Disease;disease classification;Disease Outbreaks;drug discovery;Epidemiology;Event;Extramural Activities;Family suidae;federated learning;flu;forging;fungal pneumonia;Future;generative artificial intelligence;generative models;Goals;health care settings;Healthcare;Hearing Tests;Home;Image;image guided therapy;image processing;in vivo;Industry;industry partner;Infection;influenza pneumonia;Institution;Institutional Review Boards;Interventional radiology;Investigation;Journals;Knowledge;large datasets;large language model;Learning;Licensing;Link;Liver;Lung;Lung Diseases;Magnetic Resonance Imaging;Malignant neoplasm of prostate;Malignant Neoplasms;Masks;Measures;Medical;Medical Imaging;Medical Research;medical specialties;Medicine;member;Methodology;Methods;migration;minimally invasive;Modality;Modeling;multidisciplinary;multimodal modeling;multimodality;National Center for Advancing Translational Sciences;National Institute of Allergy and Infectious Disease;National Institute of Biomedical Imaging and Bioengineering;Nature;nonhuman primate;novel;Organ;outcome prediction;Oxygen;Oxygen saturation measurement;pandemic disease;Pathway interactions;Patients;Pattern;Performance;Phenotype;point of care;post-COVID-19;Postoperative Period;Postpartum Period;pre-clinical;Pre-Clinical Model;Prevention;Privacy;Privatization;public-private partnership;Publications;Publishing;Reporting;Research;Research Personnel;Resources;response;Running;screening;Signal Transduction;skills;smartphone application;smartphone based device;Social Distance;social media;Source;Standardization;Starvation;Suggestion;Techniques;Testing;Text;The Cancer Imaging Archive;Thermal Ablation Therapy;Thoracic Radiography;tool;Training;transfer learning;Triage;tumor;United States National Institutes of Health;Vasculitis;Ventilator;Voice;wearable data;wearable device;web site;Weight;Work;working group;X-Ray Computed Tomography,"Artificial Intelligence in COVID-19, Procedural Medicine and Cancer",90072,NA,NA,NA,NA,5,NA,NA,0,NA
11193110,ZIA,CL,1,N,NA,NA,NA,NA,ZIACL090073,NA,NA,1ZIACL090073-05,NA,INTRAMURAL RESEARCH,2024,CLINICAL CENTER,NA,NA,NA,NA,NA,NA,NA,NA,CLINICAL CENTER,NA,NA,NA,9692774 (contact),"WOOD, BRADFORD  (contact)",NA,NA,NA,Abdomen;Biopsy;Cancer Intervention;Cancerous;Carcinoma;Clinical;clinical center;Clinical Trials;Computer software;Core Biopsy;Custom;Cytology;design;Detection;Devices;Diagnosis;diagnostic accuracy;Electromagnetics;Elements;Endoscopy;Enhancing Lesion;Excision;Feedback;first-in-human;Fluorescence;fluorescence imaging;Future;Goals;Hepatic;Human;human study;Image;image guided therapy;in vivo;in vivo Model;Indocyanine Green;Institutional Review Boards;Intervention;Intravenous;Lesion;Liver;liver biopsy;liver cancer model;Liver diseases;Liver neoplasms;Localized Malignant Neoplasm;Location;Metastatic Neoplasm to the Liver;Methods;minimally invasive;Modeling;molecular imaging;Needle biopsy procedure;Needles;Nodule;novel;Operative Surgical Procedures;optical imaging;Optics;Patient Recruitments;Patients;Pharmaceutical Preparations;point of care;point of care testing;Point-of-Care Systems;Primary carcinoma of the liver cells;Process;real-time images;regenerative;Regulatory Pathway;Sampling;Signal Transduction;Specific qualifier value;Specimen;Structure;System;Technology;technology platform;Time;Tissues;translational clinical trial;United States National Institutes of Health;Validation;Visualization;Woodchuck;Work,Optical and electromagnetic tracking guidance for hepatic interventions,90073,NA,NA,NA,NA,5,NA,NA,0,NA
11193111,ZIA,DK,1,N,NA,NA,NA,NA,ZIADK043400,NA,NA,1ZIADK043400-25,NIDDK:499612\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES,NA,NA,NA,6256993 (contact),"STAR, ROBERT A (contact)",NA,NA,NA,Acute Kidney Failure;Acute Renal Failure with Renal Papillary Necrosis;Animal Model;Biological Markers;Biopsy;Blood Tests;candidate identification;candidate marker;Characteristics;clinical diagnostics;Collaborations;Contrast Media;diagnostic assay;Disease;Early Diagnosis;Elements;exosome;follow-up;Functional disorder;Graft Rejection;Hepatotoxicity;Injury to Kidney;Kidney;Kidney Diseases;Lung Transplantation;Magnetic Resonance Imaging;Methods;microRNA biomarkers;MicroRNAs;Monitor;Nephrons;nephrotoxicity;next generation sequencing;Patients;Plasma;Property;Proteins;Proteomics;Sampling;Sepsis;Source;Techniques;Testing;treatment response;Urine;Validation;Work,Early Detection Of Renal Injury,43400,NA,NA,NA,NA,25,NA,NA,499612,NA
11193112,ZIA,DK,1,N,NA,NA,NA,NA,ZIADK053100,NA,NA,1ZIADK053100-36,NIDDK:922054\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES,NA,NA,NA,9415487 (contact),"JENSEN, ROBERT  (contact)",NA,NA,NA,"Address;Agonist;Alcohols;antagonist;Area;Bombesin Receptor;bombesin receptor subtype 3;British;Central Nervous System Diseases;Chimera organism;Cholecystokinin;Classification;Clinical Trials;Consensus;Data;Ectopic Expression;Family;Family member;G-Protein-Coupled Receptors;Gastrin releasing peptide;Gastrins;Gastrointestinal Hormone Receptors;Gastrointestinal Hormones;Goals;Headache;Hormones;human disease;Journals;Lead;Ligands;Literature;Migraine;Molecular;Neuroepithelial, Perineurial, and Schwann Cell Neoplasm;neuromedin B;Neurotransmitters;new therapeutic target;Paper;Pathogenesis;Peptides;Pharmaceutical Preparations;Pharmacology;Pharmacology Study;Physiological;pituitary adenylate cyclase activating polypeptide;Post-Traumatic Stress Disorders;Protocols documentation;receptor;receptor expression;Reporting;Research Personnel;response;Role;Safety;Satiation;Secretin;side effect;Signal Transduction;Site-Directed Mutagenesis;smoking addiction;Somatostatin;Specificity;State-of-the-Art Reviews;Therapeutic;Therapeutic Uses;Time;tool;United States National Institutes of Health;Update;Vasoactive Intestinal Peptide",Characterization And Pharmacology Of Receptors For Gastrointestinal Peptides,53100,NA,NA,NA,NA,36,NA,NA,922054,NA
11193113,ZIA,DK,1,N,NA,NA,NA,NA,ZIADK053101,NA,NA,1ZIADK053101-36,NIDDK:922054\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES,NA,NA,NA,9415487 (contact),"JENSEN, ROBERT  (contact)",NA,NA,NA,Acinar Cell;Acinar cell tumor;Acinus organ component;Actins;Address;Affect;Area;Bombesin;Bombesin Receptor;cell growth;Cell Physiology;Cells;Central Nervous System;Cholecystokinin;cofilin;Consensus;Development;Endothelin;Enzymes;Exocrine pancreas;experimental study;Family;G-Protein-Coupled Receptors;gastrointestinal;Gastrointestinal Hormones;Gastrointestinal tract structure;genetic regulatory protein;Growth;Growth Factor;Growth Factor Receptors;Hormones;Human;insulin secretion;islet;Malignant Neoplasms;MAP Kinase Gene;MAPK8 gene;Mediating;Mediator;migration;Motility;neoplastic;Neurotensin;Neurotransmitters;novel;novel therapeutic intervention;Pancreas;pancreatic cancer cells;Pancreatitis;Paper;Pathologic Processes;Peptides;Pharmacology;Physiological;pituitary adenylate cyclase activating polypeptide;Play;Positioning Attribute;Process;Proliferating;Protein Tyrosine Kinase;Protein-Serine-Threonine Kinases;receptor;Receptor Protein-Tyrosine Kinases;response;Role;Serine;Serine/Threonine Phosphorylation;Signal Transduction;Tissues;Transactivation;Transfection;Tumor Cell Line;tumor growth;Tyrosine;Tyrosine Phosphorylation;tyrosine receptor;Writing,Cellular Basis Of Action Of Gastrointestinal Peptides/Growth factors,53101,NA,NA,NA,NA,36,NA,NA,922054,NA
11193114,ZIA,DK,1,N,NA,NA,NA,NA,ZIADK053200,NA,NA,1ZIADK053200-33,NIDDK:204901\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES,NA,NA,NA,9415487 (contact),"JENSEN, ROBERT  (contact)",NA,NA,NA,absorption;Acids;Address;American;Area;Case Study;Clinical;Collaborations;Critiques;Data;Databases;Development;Diagnosis;Disease;Dose;Drug usage;European;follow-up;Food;Gastrinoma;Goals;Guidelines;Individual;Islet Cell Tumor;Knowledge;Literature;Malignant - descriptor;Medical;Medical Societies;Medicine;Molecular;Monitor;Multiple Endocrine Neoplasia Type 1;Natural History;Neuroendocrine Tumors;Operative Surgical Procedures;Paper;Patients;pet animal;Pharmaceutical Preparations;Positron-Emission Tomography;Prognosis;Prognostic Factor;Prospective Studies;Protocols documentation;Published Comment;Series;side effect;Societies;Textbooks;Time Management;tumor;Tumor Biology;Vitamin B 12 Deficiency;Writing;Zollinger-Ellison Syndrome,"Diagnosis, Natural History, Management, tumor biology of Gastrinomas/PETs/Neuroendocrine tumors",53200,NA,NA,NA,NA,33,NA,NA,204901,NA
11193115,ZIA,ES,1,N,NA,NA,NA,NA,ZIAES044005,NA,NA,1ZIAES044005-26,NIEHS:1922443\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES,NA,NA,NA,9814774 (contact),"SANDLER, DALE P (contact)",NA,NA,NA,Accounting;Acne;Adolescent;Adult;Affect;African American population;Age;aged;Agreement;Air Pollutants;Air Pollution;Area;Biological;biological age;Biological Aging;black women;Blood;Blood Cells;Blood Donations;Blood Pressure;Body mass index;breast cancer diagnosis;Breast Cancer gene;Breast Cancer Risk Factor;Breast Cancer survivorship;Burn injury;Chemical Exposure;Chemicals;Childhood;Chromium;Chronic Disease;coarse particles;cohort;Collaborations;Collection;Complex;Computer Assisted;conditioning;Data;Data Pooling;depressive symptoms;deprivation;design;Diagnosis;Diagnostic;Diet;Dietary Factors;dietary supplements;Discrimination;Disease;Dust;Dyes;early adolescence;Education;endometriosis;Enrollment;Environment;Environmental Exposure;Environmental Risk Factor;Ethnic Origin;Ethnic Population;Etiology;Exercise;experience;Exposure to;falls;Feces;Female;Fibroid Tumor;fine particles;follow-up;Frequencies;gene environment interaction;Genes;Genetic;genetic risk factor;Genitalia;Genomics;Goals;good diet;Gynecologic;Hair;Health;Home visitation;Hormonal;Hormones;Human;Hypertension;Hysterectomy;indexing;Inflammatory Bowel Diseases;interest;International;Investigation;Iron;Lead;Leadership;Leisures;Life;Light;Link;Malignant Breast Neoplasm;Malignant neoplasm of lung;Malignant neoplasm of ovary;Malignant Neoplasms;Manuscripts;Measurement;Measures;Medical;Medical Records;Metals;Nail plate;National Institute of Environmental Health Sciences;Neighborhoods;never smoker;Nitrogen Dioxide;Non-Insulin-Dependent Diabetes Mellitus;Obesity;Occupations;Onset of illness;Paper;Parkinson Disease;Participant;Perfume;Perimenopause;personal care products;Pesticides;Physical activity;Positioning Attribute;Premenopause;prospective;Prospective Studies;Publishing;Questionnaires;Race;racial population;Recording of previous events;Reporting;Research;Research Personnel;Research Project Grants;research study;response;Retrospective Studies;Risk;Risk Factors;Role;Running;Sampling;Seasons;Sister;Skin Care;sleep pattern;Smell Perception;social factors;social health determinants;Socioeconomic Status;Sports;Structure of nail of toe;Surveys;Survivors;Talc;Telephone Interviews;Testing;Time;treatment response;Trees;Tumor Tissue;Urine;Uterine Cancer;Uterine Fibroids;Vaginal Douching;Walking;White Women;Woman;Women&apos;s Health;Wood material,Environmental and Genetic Risk Factors For Breast Cancer: The Sister Study,44005,NA,NA,NA,NA,26,NA,NA,1922443,NA
11193116,ZIA,ES,1,N,NA,NA,NA,NA,ZIAES045002,NA,NA,1ZIAES045002-29,NIEHS:84522\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES,NA,NA,NA,6570585 (contact),"UMBACH, DAVID M (contact)",NA,NA,NA,Algorithms;Alleles;Cataloging;Complex;Control Groups;coping;Data;Data Discovery;design;detection method;Disease;disorder risk;Environment;Environmental Risk Factor;gene environment interaction;Gene Frequency;gene interaction;Genes;Genetic;Genetic Epistasis;genetic makeup;Genetic Predisposition to Disease;Genetic Programming;genetic variant;genome-wide analysis;Genotype;Individual;Investigation;Machine Learning;method development;Modification;Nuclear Family;offspring;Paper;Parents;Population;Procedures;Research Personnel;Risk;Siblings;simulation;Statistical Methods;Structure;Techniques;Testing;Time;tool;Work,Statistical Methods For Gene/environment Interaction And Genetic Susceptibility,45002,NA,NA,NA,NA,29,NA,NA,84522,NA
11193117,ZIA,ES,1,N,NA,NA,NA,NA,ZIAES049004,NA,NA,1ZIAES049004-33,NIEHS:118331\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES,NA,NA,NA,6570585 (contact),"UMBACH, DAVID M (contact)",NA,NA,NA,Body mass index;Breast;Clinical Research;Collaborations;Data Collection;Development;epidemiology study;Estrogens;Growth;Human Development;Infant;Measures;Neonatal;neonate;novel;Paper;Pediatric Hospitals;Phenols;Philadelphia;Publications;Publishing;Role;soy;Statistical Methods;Techniques;Testis;Testosterone;ultrasound;Urine;Work;World Health Organization,Statistical Methods In Human Development/clinical Studies,49004,NA,NA,NA,NA,33,NA,NA,118331,NA
11193118,ZIA,ES,1,N,NA,NA,NA,NA,ZIAES049028,NA,NA,1ZIAES049028-28,NIEHS:83750\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES,NA,NA,NA,9814774 (contact),"SANDLER, DALE P (contact)",NA,NA,NA,"12 year old;Acute;Acute Renal Failure with Renal Papillary Necrosis;Address;Adult;African American;Age;age group;Aging;aging related disease;agricultural community;Agriculture;Anti-citrullinated peptide antibody;Antigen Presentation;Antinuclear Antibodies;Autoantibodies;Autoimmune Diseases;Autoimmunity;Baltimore;Brazil;cancer risk;caregiving;Chemicals;Chronic Disease;Chronic Kidney Failure;Clinical;cohort;Collaborations;contextual factors;Cross-Sectional Studies;Data;Data Analyses;Data Set;Death Certificates;Dermatomyositis;Diabetes Mellitus;Disease;disease registry;disorder subtype;DNA;early life adversity;Enrollment;Environmental Exposure;Environmental Risk Factor;environmental stressor;Epidemiology;Event;Expenditure;Exposure to;Farm;farmer;Fertilizers;field study;Focus Groups;follow-up;Health;Health Surveys;Hobbies;Hormonal;Hospitalization;human old age (65+);Hygiene;Hypertension;Immune;Incidence;Individual;Kidney;Kidney Diseases;large cell Diffuse non-Hodgkin&apos;s lymphoma;Life;Longitudinal cohort;Longitudinal Studies;Lung;Malignant Breast Neoplasm;Malignant Neoplasms;Measures;men;Metals;Morality;mortality;multiple chronic conditions;Myositis;National Institute of Environmental Health Sciences;Non-Insulin-Dependent Diabetes Mellitus;Nuclear Antigens;Nutrition Surveys;Obesity;Occupational;Occupational Exposure;Occupations;Outcome;Oxidative Stress;Participant;Partner Abuse;Patients;Peptide antibodies;Persons;Pesticides;Phenotype;Polychlorinated Biphenyls;Population;population survey;Predisposition;Prevalence;programs;Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial;psychosocial stressors;Public Health;Research;Research Personnel;Rheumatoid Arthritis;Risk;Risk Factors;Role;Sampling;Sex Differences;sex variable;Silicon Dioxide;Smoker;Social support;sociodemographic factors;Solvents;Stressful Event;Subgroup;Sunscreening Agents;systemic autoimmune disease;Systemic Lupus Erythematosus;Time;Time trend;traumatic stress;trend;Universities;UV Radiation Exposure;Vitamin D;Woman;Women&apos;s Health;young adult",Environmental Exposures And Risk For Cancer and Chronic Diseases In Adults,49028,NA,NA,NA,NA,28,NA,NA,83750,NA
11193119,ZIA,ES,1,N,NA,NA,NA,NA,ZIAES049030,NA,NA,1ZIAES049030-28,NIEHS:449205\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES,NA,NA,NA,9814774 (contact),"SANDLER, DALE P (contact)",NA,NA,NA,"21 year old;active lifestyle;Acute;Address;Age;aged;Agricultural Health Study;Agriculture;Algorithms;Alzheimer&apos;s Disease;Animal Feed;Antinuclear Antibodies;Asthma;Autoimmune Diseases;autoimmune rheumatologic disease;Biological Markers;Black Populations;Black race;Breast;cancer risk;cancer type;Cardiovascular Diseases;Cause of Death;Cells;Censuses;Characteristics;Chemicals;Child;Childhood;Chlorinated Hydrocarbons;Chronic;climate change;climate impact;climate-related exposures;cognitive function;cohort;Collaborations;Communities;comparison control;Crohn&apos;s disease;dalton;Data;Data Pooling;Databases;Dementia;Diabetes Mellitus;Diagnosis;dietary nitrate;Dietary Nitrite;disability;Disasters;Disease;DNA;drinking water;Elderly;eligible participant;End stage renal failure;Enrollment;Environmental Risk Factor;Epidemic;Event;Exposure to;Family;Farm;farmer;Female;follow-up;Food;Frequencies;Genetic;Genetic study;glyphosate;hazard;Health;health disparity;healthy lifestyle;Heat Stress;Herbicides;Herpes zoster disease;high risk;Hospitalization;House Dust;Humidity;Immune;Immune System Diseases;Incidence;indexing;Infection;infection risk;Inflammatory Bowel Diseases;Information Systems;Injury;Insecticides;Iowa;Kidney;Kidney Diseases;kidney dysfunction;Licensing;Life Style;Link;Locales;London;longitudinal, prospective study;lung health;male;Malignant neoplasm of ovary;Malignant Neoplasms;Manuscripts;Measures;Mediating;Medical Records;Medicare;Medicare claim;member;Michigan;microbial;microbial composition;microbiome;mortality;National Cancer Institute;National Institute for Occupational Safety and Health;National Institute of Environmental Health Sciences;neoplasm registry;Nerve Degeneration;Neurodegenerative Disorders;Neurologic;Neurological outcome;Nitrates;Nitrites;North Carolina;novel;Occupational Exposure;older adult;Olfactory dysfunction;operation;Organophosphates;Outcome;Oxidative Stress;Pain;Parkinson Disease;Participant;Patient Self-Report;pesticide exposure;Pesticides;Population;Positioning Attribute;pre-clinical;Preparation;Privatization;Processed Meats;Publishing;pulmonary function;Questionnaires;racial disparity;Reporting;Research;Research Personnel;research study;resilience factor;Resistance;respiratory;Respiratory Disease;Respiratory Signs and Symptoms;response;Rheumatoid Arthritis;Risk;Risk Factors;Role;Sampling;Sampling Studies;Shotguns;Sjogren&apos;s Syndrome;social vulnerability;Spouses;Stress;stressor;Subgroup;Surveys;Symptoms;Systemic Lupus Erythematosus;Temperature;Thyroid Diseases;Thyroid Gland;Time;Ulcerative Colitis;United States Environmental Protection Agency;Universities;Update;urinary;Vital Statistics;Water;Weather;whole genome;young adult",Health Effects Of Exposures In Agriculture,49030,NA,NA,NA,NA,28,NA,NA,449205,NA
11193120,ZIA,ES,1,N,NA,NA,NA,NA,ZIAES102865,NA,NA,1ZIAES102865-15,NIEHS:169044\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES,NA,NA,NA,10672669 (contact),"SHOCKLEY, KEITH  (contact)",NA,NA,NA,Adverse effects;Agonist;Algorithms;Analysis of Variance;beta-Lactamase;Biochemical;Biological Assay;Categories;Cells;Chemicals;Classification;Cluster Analysis;Complement;Complex;cost;cytotoxicity;Data;Data Set;Diagnostic;Dimethyl Sulfoxide;Disease;Dose;Drug Industry;Entropy;Environment;environmental chemical;Equation;Equipment and supply inventories;Estrogen Receptors;Evaluation;experimental study;Flare;Generations;heuristics;high throughput screening;Human;improved;In Vitro;in vivo;Individual;interest;Libraries;Luciferases;Measurement;Measures;Methods;Modeling;National Center for Advancing Translational Sciences;National Toxicology Program;Noise;nonlinear regression;novel;Parameter Estimation;Pattern;Pharmacologic Substance;Phase;Play;Quality Control;rate of change;Reader;Regression Analysis;Reporter Genes;Reproducibility;Residual state;response;risk minimization;Role;Running;Science;Shapes;Signal Transduction;simulation;Specific qualifier value;Structure;Subgroup;System;Testing;Titrations;Toxicity Tests;Toxicology;trustworthiness;Uncertainty;user-friendly;Vision;Visualization;web app,Analysis of Quantitative High Throughput Screening Data,102865,NA,NA,NA,NA,15,NA,NA,169044,NA
11193121,ZIA,ES,1,N,NA,NA,NA,NA,ZIAES102945,NA,NA,1ZIAES102945-15,NIEHS:2112784\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES,NA,NA,NA,9814774 (contact),"SANDLER, DALE P (contact)",NA,NA,NA,Age Years;Agreement;Alabama;Anxiety;Area;Back;Biological;Blood;Blood Pressure;Calibration;Cardiovascular Diseases;Cardiovascular system;Cessation of life;Chemical Exposure;chemical spill;Chemicals;Chromium;cigarette smoking;Clinic;Clinic Visits;Clinical;Clinical assessments;clinical examination;Clip;Collaborations;Collection;Communities;Coronary heart disease;Data;Data Collection;Databases;depressive symptoms;Dermal;Disasters;Distress;DNA Damage;DNA Methylation;Economics;Emergency Situation;Enrollment;Epigenetic Process;epigenome;Equipment and supply inventories;Evaluation;Event;experience;Explosion;Exposure to;fine particles;Flare;Floods;follow-up;Gases;Green space;gulf coast;hazard;Health;heart disease risk;Hematology;Hepatic;Home;Home visitation;Human;Hurricane;Hydrocarbons;Immunologics;Impairment;In Situ;indexing;Individual;Inductively Coupled Plasma Mass Spectrometry;interest;Interview;Joints;Lead;Leg;Leukocytes;Life Style;Link;Location;Longterm Follow-up;Louisiana;male;Malignant Neoplasms;man-made disasters;Manganese;marijuana use;marine;Measurement;Measures;medically underserved population;Mental Depression;Mental Health;Mercury;Meta-Analysis;Metals;Methods;Mexico;Mood Disorders;Motor;National Health and Nutrition Examination Survey;neoplasm registry;Nerve;Nervous System Physiology;Neurologic;Neurologic Effect;never smoking;Occupations;Oils;Outcome;Participant;Persons;Petroleum;Phase;physical symptom;Population;Post-Traumatic Stress Disorders;Process;Public Health Schools;Publications;pulmonary function;Pulmonary function tests;Questionnaires;Recording of previous events;Registries;Renal function;Reporting;Reproductive Health;Research;Research Personnel;respiratory;response;Risk;sample collection;Sampling;Sensory;Short-Term Memory;Site;social;socioeconomic disadvantage;socioeconomics;solar radiation;Stress;Structure of nail of toe;study population;Styrenes;Suggestion;sustained attention;System;Telephone;Testing;Toes;toxicant;United States National Aeronautics and Space Administration;virtual;volatile organic compound;Volatilization;Water;Work,Gulf Longitudinal Follow-up (GuLF) Study,102945,NA,NA,NA,NA,15,NA,NA,2112784,NA
11193122,ZIA,ES,1,N,NA,NA,NA,NA,ZIAES103126,NA,NA,1ZIAES103126-13,NIEHS:135235\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES,NA,NA,NA,6570585 (contact),"UMBACH, DAVID M (contact)",NA,NA,NA,Adult;Affect;age difference;Agriculture;airway inflammation;Apnea;Back;Characteristics;Chemicals;Chronic;Clinical;Collaborations;Data;Data Analyses;Development;Dose;Down&apos;s Syndrome;Electroencephalography;Electronic Health Record;Environmental Health;Epidemiology;Exposure to;Goals;health record;House Dust;Individual;Laboratories;Laboratory Study;London;lung health;Metagenomics;Methods;microbial signature;microorganism;National Institute of Environmental Health Sciences;Obstructive Sleep Apnea;Patients;pulmonary function;Research Personnel;respiratory health;response;risk prediction;Scientist;Sex Differences;Side;Sleep;Software Tools;Statistical Methods;Supination;Symptoms;Techniques;Work,Statistical techniques applied to environmental health sciences,103126,NA,NA,NA,NA,13,NA,NA,135235,NA
11193123,ZIA,ES,1,N,NA,NA,NA,NA,ZIAES103166,NA,NA,1ZIAES103166-12,NIEHS:169044\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES,NA,NA,NA,10672669 (contact),"SHOCKLEY, KEITH  (contact)",NA,NA,NA,adenoma;Age;Archives;Bioinformatics;Biological Assay;carcinogenicity;Carcinoma;Chemical Exposure;Cholestasis;Data Analyses;design;Diethylhexyl Phthalate;DNA Microarray Chip;Event;experimental group;Exposure to;Freezing;Gene Chips;Gene Expression Profiling;Genetic Transcription;Goals;Hepatic;High Prevalence;improved;Incidence;interest;Micro Array Data;National Toxicology Program;Nuclear Receptors;Pancreas;Pathway interactions;phthalates;Rattus;response;Rodent;RXR;Sampling;sex;Statistical Methods;Tissue Sample;Toxicology;tumor,DNA Microarray Data Analysis,103166,NA,NA,NA,NA,12,NA,NA,169044,NA
11193124,ZIA,ES,1,N,NA,NA,NA,NA,ZIAES103335,NA,NA,1ZIAES103335-06,NIEHS:1521394\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES,NA,NA,NA,16151739 (contact),"MOTSINGER-REIF, ALISON  (contact)",NA,NA,NA,Area;Clinical Research;Collaborations;Epidemiology;Epigenetic Process;Gene Expression Profiling;Manuscripts;metabolomics;method development;Methods;National Institute of Environmental Health Sciences;Paper;Reporting;Research Personnel;Science;Scientist;statistics;Work;Writing,Collaborative Applied Statistics,103335,NA,NA,NA,NA,6,NA,NA,1521394,NA
11193125,ZIA,ES,1,N,NA,NA,NA,NA,ZIAES103336,NA,NA,1ZIAES103336-06,NIEHS:135235\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES,NA,NA,NA,16151739 (contact),"MOTSINGER-REIF, ALISON  (contact)",NA,NA,NA,Affect;anti-CD20;Antineoplastic Agents;B-Lymphocytes;Biological Models;Cancer Center;Characteristics;Collaborations;colon cancer patients;Colorectal Cancer;cost effectiveness;Development;Disease;doctoral student;Dose;Follow-Up Studies;Gene Expression;Genes;Genetic;Genetic Predisposition to Disease;genetic variant;Genetic Variation;genome wide association study;Glioblastoma;Glioma;Goals;improved;in vivo;Link;lymphoblastoid cell line;Malignant Neoplasms;Methodology;MGMT gene;Modeling;Monoclonal Antibody Therapy;Mutation;North Carolina;outcome prediction;oxaliplatin;patient response;Patient-Focused Outcomes;Patients;Pharmacogenomics;potential biomarker;predictive marker;prednisolone;Research;Resistance;response;success;survival prediction;temozolomide;Therapeutic;Toxicogenomics;trait;Treatment outcome;tumor;Universities;Work,Statistical Genetics of Dose Response Traits,103336,NA,NA,NA,NA,6,NA,NA,135235,NA
11193126,ZIA,ES,1,N,NA,NA,NA,NA,ZIAES103337,NA,NA,1ZIAES103337-06,NIEHS:912836\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES,NA,NA,NA,16151739 (contact),"MOTSINGER-REIF, ALISON  (contact)",NA,NA,NA,Address;Algorithms;base;Bayesian Modeling;Biological;Biological Process;Cells;Chemicals;Code;Collaborations;Complex;computational toxicology;Computer software;COVID-19 risk;Data;data reduction;Data Set;detection method;Development;Dose;Ensure;epidemiology study;flexibility;Future;gene environment interaction;gene interaction;Genes;Genetic Programming;genome wide association study;Genomics;gradient boosting;high dimensionality;improved;improved outcome;indexing;Machine Learning;metabolomics;method development;Methods;microbiome;Modeling;National Health and Nutrition Examination Survey;National Institute of Environmental Health Sciences;open source;Performance;Poly-fluoroalkyl substances;Polymorphism Analysis;programs;Quantitative Trait Loci;Research;response;Sampling;Single Nucleotide Polymorphism;single-cell RNA sequencing;Surveys;Testing;tool;Toxic effect;Toxicogenomics;Toxicology;trend;usability;Visualization;Visualization software;Weight;Work,"Methods development for ""Omics"" data",103337,NA,NA,NA,NA,6,NA,NA,912836,NA
11193127,ZIA,ES,1,N,NA,NA,NA,NA,ZIAES103338,NA,NA,1ZIAES103338-06,NIEHS:338087\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES,NA,NA,NA,16151739 (contact),"MOTSINGER-REIF, ALISON  (contact)",NA,NA,NA,African;African ancestry;Anti-Hypertensive Agents;biobank;Blood Glucose;blood glucose regulation;blood lipid;Blood Pressure;Cardiovascular Diseases;cardiovascular disorder risk;cardiovascular risk factor;Cardiovascular system;Caring;Chromosome Mapping;Clinic;Clinical Trials;cohort;Collaborations;comorbidity;Complications of Diabetes Mellitus;Coupled;Data;diabetes management;Diabetes Mellitus;diabetic;Diabetic Retinopathy;Diagnosis;Diuretics;Dyslipidemias;epidemiology study;Erythrocytes;Event;experience;Failure;fasting plasma glucose;Genetic;genetic association;genetic variant;Genetic Variation;genome wide association study;Genotype;Glucose;Glucosephosphate Dehydrogenase Deficiency;Glycosylated Hemoglobin;Glycosylated hemoglobin A;Goals;High Density Lipoprotein Cholesterol;high risk;Hypertension;IGF2R gene;improved;indexing;Individual;individual response;individualized medicine;International;LDL Cholesterol Lipoproteins;life span;Link;Manuscripts;MAS1 gene;Measurement;medical schools;Meta-Analysis;mortality;non-diabetic;Non-Insulin-Dependent Diabetes Mellitus;Organ;Outcome;Participant;Patients;Persons;Pharmaceutical Preparations;Pharmacogenomics;pharmacologic;Phenotype;Population;Regimen;Research Personnel;Resistant Hypertension;response;Risk;Risk Reduction;sex;Therapeutic;Trans-Omics for Precision Medicine;Triglycerides;Universities;Variant;Virginia;Work,Statistical Genetics of Outcomes and Drug Response in Patients with Type 2 Diabetes.,103338,NA,NA,NA,NA,6,NA,NA,338087,NA
11193128,ZIA,ES,1,N,NA,NA,NA,NA,ZIAES103357,NA,NA,1ZIAES103357-05,NIEHS:101426\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES,NA,NA,NA,77844866 (contact),"WHEELER, MATTHEW  (contact)",NA,NA,NA,2019-nCoV;Bayesian Method;Biological;Biological Assay;complex data;Computational algorithm;COVID-19;Data;Data Set;Data Sources;data streams;Development;Genes;Goals;high throughput analysis;human coronavirus;Journals;large datasets;Manuscripts;method development;Methodology;Mission;National Institute of Environmental Health Sciences;neuroimaging;Noise;novel;novel coronavirus;Output;programs;Research;research and development;Research Personnel;response;SARS coronavirus;Science;Scientist;Severe Acute Respiratory Syndrome;Signal Transduction;Statistical Models;Techniques,Non-parametric Bayesian Method Development,103357,NA,NA,NA,NA,5,NA,NA,101426,NA
11193129,ZIA,ES,1,N,NA,NA,NA,NA,ZIAES103358,NA,NA,1ZIAES103358-05,NIEHS:101426\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES,NA,NA,NA,77844866 (contact),"WHEELER, MATTHEW  (contact)",NA,NA,NA,Bayesian Analysis;Benchmarking;Biological Assay;Biological Process;Chemicals;Complex;Data;data streams;Dose;Estimation Techniques;gene network;Genes;Goals;Literature;method development;Methodology;Mission;Modeling;National Toxicology Program;novel;Research;response;Techniques;tool;Toxic effect;Toxicogenomics;Toxicology,"Dose-response Methods Development for High Throughput, Nontraditional, and Standard Bioassays",103358,NA,NA,NA,NA,5,NA,NA,101426,NA
11193130,ZIA,ES,1,N,NA,NA,NA,NA,ZIAES103360,NA,NA,1ZIAES103360-04,NIEHS:236661\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES,NA,NA,NA,78332038 (contact),"SHI, MIN  (contact)",NA,NA,NA,Affect;Age;Area;Autoimmune Diseases;Biological;Blood Glucose;Brain;Budgets;Calcinosis;Carotenoids;Clinical Trials;clinically relevant;Cohort Studies;Collaborations;Complications of Diabetes Mellitus;Data;Data Analyses;Dermatomyositis;design;Diabetes Mellitus;Diagnosis;Early Diagnosis;Early Intervention;Environmental Health;epidemiology study;Equity;Event;experimental study;Extramural Activities;fatty acid supplementation;fetal;Genetic;Genetic Programming;Genetic study;genome wide association study;Goals;Health;Inflammatory;Lateral;Leadership;Life;London;Lutein;Manuscripts;method development;Methods;Mus;Myositis;Neurologic;Omega-3 Fatty Acids;Paper;Parents;Patients;Phenotype;Positioning Attribute;pulmonary function;racial disparity;Research;Research Design;Research Personnel;Research Project Grants;Rheumatism;Sampling;sex;Sex Differences;Sleep;Sleep Apnea Syndromes;Sleep Disorders;Statistical Methods;Supination;tool;trend;Twin Multiple Birth;United States National Institutes of Health;Wages;Work;Writing;zeaxanthin,Statistical methods in collaborative research,103360,NA,NA,NA,NA,4,NA,NA,236661,NA
11193131,ZIA,ES,1,N,NA,NA,NA,NA,ZIAES103385,NA,NA,1ZIAES103385-03,NIEHS:4188931\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES,NA,NA,NA,79358408 (contact),"WALKER, VICKIE  (contact)",NA,NA,NA,Address;Area;Automation;Bibliography;biomarker identification;Chemicals;cluster computing;Communication;Communities;cost;cyber infrastructure;Data;data dictionary;data infrastructure;data integration;data management;data mining;data pipeline;data repository;data resource;Data Set;data sharing;data visualization;Databases;Development;diverse data;Dose;Ensure;Environment;environmental chemical;Environmental Health;evidence base;FAIR principles;Generations;GENIE;Genomics;High Performance Computing;Ice;improved;In Vitro;in vivo;Informatics;informatics infrastructure;International;interoperability;Investments;Knowledge;Knowledge Management;Language;large language model;Libraries;meetings;Methods;middleware;Modeling;Molecular;Names;National Institute of Environmental Health Sciences;novel strategies;online resource;Ontology;Pathology;Phenotype;Practice Management;Process;programs;Property;Provider;Publications;query tools;Research;Resources;response;skill acquisition;software development;software systems;Source;Standardization;Strategic Planning;structured data;synthetic data;System;Terminology;Tissues;tool;Toxicology;Training;TRUST principles;United States National Institutes of Health;Update;web site;Work,Scientific Cyberinfrastructure Research Program,103385,NA,NA,NA,NA,3,NA,NA,4188931,NA
11193132,ZIA,ES,1,N,NA,NA,NA,NA,ZIAES103392,NA,NA,1ZIAES103392-02,NIEHS:418750\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES,NA,NA,NA,79042719 (contact),"MONTIEL ISHINO, FRANCISCO ALEJANDRO (contact)",NA,NA,NA,Accounting;Acculturation;Address;Adult;Affect;Anger;Anxiety;Area;Atherosclerosis;Attenuated;Attitude;Award;Behavior;Bhutanese;biobehavior;Biological;Body mass index;Cardiometabolic Disease;cardiometabolic risk;cardiometabolism;Categories;Chronic Disease;cohesion;Collection;Communities;community health study;community organizations;comorbidity;Complex;COVID-19 pandemic;Crime;Cross-Sectional Studies;Data;Data Collection;depressive symptoms;design;dietary;Discrimination;Disease;Disparity;Disparity population;Distal;Distress;Doctor of Philosophy;Education;effective intervention;Environment;Environmental Risk Factor;Epidemiology;epidemiology study;Etiology;evidence base;experience;Feasibility Studies;Foundations;Friends;Funding;Future;Goals;Health;Health behavior;health care availability;health care service;health determinants;Health Disparities Research;health disparity;health equity;health outcome disparity;high risk;Hispanic Women;Hypertension;Immigrant;Incidence;Inequity;innovation;interest;Intervention;intimate partner violence;Language;Linguistics;Literature;Low income;Malignant Neoplasms;marginalization;Measures;Mediator;medically underserved;Mental Health;Methodology;Methods;minimally invasive;minority health;minority health disparity;model generalizability;Modeling;Morbidity - disease rate;mortality;National Institute of Environmental Health Sciences;Neighborhoods;Non-Insulin-Dependent Diabetes Mellitus;novel;novel marker;Ohio;Outcome;Participant;Pathway interactions;Patient Self-Report;Phase;physical conditioning;Population;Populations at Risk;Prevalence;Process;Prospective cohort;Proxy;Publishing;recruit;Refugees;Religiosity;Reporting;resilience;Risk;Risk Factors;Role;Safety;sample collection;Sampling;Sister;Sleep;sleep abnormalities;Sleep disturbances;Sleeplessness;social;social cohesion;Social Environment;social factors;Social support;socioenvironmental factor;South Asian;Spirituality;Stress;Study Section;substance use;Symptoms;syndemic;Syndrome;telehealth;trait;Transportation;United States National Institutes of Health,SocioEnvironmental & Ecological Disparities Group: Identifying the Health Impacts of Dynamic Inequities,103392,NA,NA,NA,NA,2,NA,NA,418750,NA
11193133,ZIA,ES,1,N,NA,NA,NA,NA,ZIAES103394,NA,NA,1ZIAES103394-02,NIEHS:1200210\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES,NA,NA,NA,16151739 (contact),"MOTSINGER-REIF, ALISON  (contact)",NA,NA,NA,Address;Affect;Asthma;Chromosome Mapping;chronic respiratory disease;cohort;Complex;Data;data sharing;Development;Diabetes Mellitus;Disease;Environment;Epigenetic Process;ethnic difference;Ethnic Population;Etiology;Exposure to;Fishes;gene environment interaction;Genes;Genetic;Genetic study;genetic variant;genome sequencing;Goals;Health;Lead;Life;lifestyle factors;Link;Maps;method development;Methodology;Methods;Migraine;Modeling;North Carolina;Occupational Exposure;Participant;personalized medicine;pollutant;pregnancy hypertension;Publishing;Questionnaires;racial difference;racial population;Recording of previous events;Research;Research Personnel;Resources;Science;Surveys;tool;Update;Variant;Visualization software;web-based tool;Weight;whole genome;Work,The Personalized Environment and Genes Study,103394,NA,NA,NA,NA,2,NA,NA,1200210,NA
11193134,ZIA,ES,1,N,NA,NA,NA,NA,ZIAES103395,NA,NA,1ZIAES103395-02,NIEHS:659271\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES,NA,NA,NA,79352865 (contact),"DIAZ-SANTANA, MARY  (contact)",NA,NA,NA,Algorithms;Breast;Breast Cancer Risk Assessment Tool;Breast Cancer Risk Factor;Breast Cancer Treatment;cancer health disparity;cancer survival;clinical practice;Data;Death Rate;Discrimination;Disease;Early Diagnosis;Early treatment;Goals;Hispanic;Hispanic Populations;Hispanic Women;improved;Incidence;Lead;Malignant Breast Neoplasm;Malignant Neoplasms;Modeling;mortality;Ovarian;Performance;Play;polygenic risk score;Population;Poverty;predictive tools;Puerto Rican;Puerto Rico;Reporting;Risk;Risk Estimate;risk prediction;risk prediction model;Role;Sister;Social Environment;sociodemographics;socioeconomic disparity;Socioeconomic Factors;Subgroup;tool;United States;Woman;Women&apos;s mortality;Work,Breast Cancer Risk prediction for Hispanic women.,103395,NA,NA,NA,NA,2,NA,NA,659271,NA
11193135,ZIA,ES,1,N,NA,NA,NA,NA,ZIAES103396,NA,NA,1ZIAES103396-02,NIEHS:914695\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES,NA,NA,NA,79360167 (contact),"PACKENHAM, JOAN  (contact)",NA,NA,NA,Acute;adverse pregnancy outcome;Age;Agreement;Area;Awareness;Biological Assay;biomarker selection;Blood;cardiovascular health;Chronic;Chronic Disease;Clinical;cohort;Collaborations;Collection;Communities;community intervention;COVID-19 disparity;COVID-19 impact;COVID-19 intervention;COVID-19 morbidity;COVID-19 mortality;COVID-19 pandemic;COVID-19 pandemic effects;Data;design;Dimensions;Disease Progression;Disparity;disparity reduction;Dust;Enrollment;Equity;experience;Family;Follow-Up Studies;Health;health equity;high risk population;Incidence;Individual;Literature;long term consequences of COVID-19;Longterm Follow-up;maternal morbidity;Maternal Mortality;Minority Women;Outcome;pandemic impact;Parents;Participant;Population;population based;pre-pandemic;Process;promote resilience;Psyche structure;public health intervention;Recovery;recruit;reproductive;Research;research study;resilience;Risk Factors;Saliva;Sampling;SARS-CoV-2 infection;Severities;Socioeconomic Status;Structure of nail of toe;Subgroup;Surveys;syndemic;Treatment outcome;Urine;Woman;Women&apos;s Health;wristband;young woman,"Women's Health Awareness Community Resiliency, Environmental Action and Collaborations for Health Equity - (WHA REACH Equity Study)",103396,NA,NA,NA,NA,2,NA,NA,914695,NA
11193136,ZIA,ES,1,N,NA,NA,NA,NA,ZIAES103399,NA,NA,1ZIAES103399-01,NIEHS:765170\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES,NA,NA,NA,79983131 (contact),"GOLDBERG, MANDY  (contact)",NA,NA,NA,Adolescent;Adult;Age;Age Months;Automobile Driving;Biological;Biological Markers;Biological Monitoring;Birth;Black race;Body mass index;Body Size;Breast;Breast Cancer Risk Factor;cancer epidemiology;carcinogenesis;Child;Childhood;cohort;Cohort Studies;Collaborations;consumer product;critical period;Data;Development;early thelarche;Endocrine Disruptors;Enrollment;environmental chemical;Environmental Exposure;Exposure to;feeding;follow-up;girls;Goals;Gonadal Steroid Hormones;Growth;Growth and Development function;Hair;Health;Hispanic;Hormonal;Hormones;Incidence;infancy;Infant;Joints;Latina;Life;Life Cycle Stages;Link;Literature;Malignant Breast Neoplasm;Malignant neoplasm of ovary;Malignant Neoplasms;Measures;Nail plate;National Institute of Environmental Health Sciences;Parabens;Participant;Pathway interactions;Pattern;personal care products;Phenols;population based;Predisposition;Pregnancy;programs;pubertal timing;Puberty;puberty transition;Publications;racial difference;Reporting;reproductive development;Research;Risk;Risk Factors;Self Care;Sister;Source;Toddler;urinary;Uterine Cancer;White Women;Women&apos;s Health;Work,Puberty and Cancer Epidemiology,103399,NA,NA,NA,NA,1,NA,NA,765170,NA
11193137,ZIA,ES,1,N,NA,NA,NA,NA,ZIAES103401,NA,NA,1ZIAES103401-01,NIEHS:84522\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES,NA,NA,NA,16151739 (contact),"MOTSINGER-REIF, ALISON  (contact)",NA,NA,NA,Address;Ancillary Study;Area;Biochemical;Biological Assay;Cardiovascular Diseases;cohort;Cohort Studies;Contracts;Data;data acquisition;data integration;Data Set;Diabetes Mellitus;Electronic Health Record;Environment;Environmental Exposure;Environmental Risk Factor;gene environment interaction;Genes;genomic data;Genomics;Health;health data;Human;Link;National Institute of Environmental Health Sciences;Non-Insulin-Dependent Diabetes Mellitus;Participant;Recording of previous events;Research;Resources;social factors;social health determinants;success,Exposomics Ancillary Study in All of Us,103401,NA,NA,NA,NA,1,NA,NA,84522,NA
11193138,ZIA,ES,1,N,NA,NA,NA,NA,ZIAES103402,NA,NA,1ZIAES103402-01,NIEHS:168054\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES,NA,NA,NA,79983134 (contact),"SHEKHAR, SKAND  (contact)",NA,NA,NA,Adult;Child;Clinical assessments;clinical care;Clinical Data;clinical phenotype;Data;Endocrine;Endocrine System Diseases;Enrollment;Environment;Environmental Exposure;Exposure to;Functional disorder;Human;Hyperandrogenism;Hypogonadism;Inherited;insight;interest;Life Style;Participant;Patients;Polycystic Ovary Syndrome;prospective;Protocols documentation;recruit;reproductive;reproductive function;reproductive neuroendocrinology;reproductive system disorder;response;Secondary to;Study Subject;Touch sensation;treatment response,Observation of Environment and Reproductive-Endocrine Effects,103402,NA,NA,NA,NA,1,NA,NA,168054,NA
11193139,ZIA,MD,1,N,NA,NA,NA,NA,ZIAMD000006,NA,NA,1ZIAMD000006-10,NIMHD:804411\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE ON MINORITY HEALTH AND HEALTH DISPARITIES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE ON MINORITY HEALTH AND HEALTH DISPARITIES,NA,NA,NA,14285133 (contact),"CHOI, KELVIN  (contact)",NA,NA,NA,Address;Adolescent;Adult;Advertising;Age;aged;Agreement;Alcohol consumption;Area;Asthma;Attitude;Awareness;Behavior;Behavioral;behavioral health;Behavioral Research;Behavioral Risk Factor Surveillance System;Black race;Body mass index;California;Cannabis;Cessation of life;Characteristics;Child;Cigar;Cigarette;cigarette smoking;cigarillos;Classification;cohort;Complex;Cotinine;Data;Databases;demographics;Disability status;discount;discounting;Disparity;Disparity population;e-cigarette cessation;Economics;Education;Educational Status;Electronic cigarette;electronic cigarette use;environmental tobacco smoke;environmental tobacco smoke exposure;Epidemiology;Ethnic Origin;Evaluation;Expenditure;General Population;Goals;Health;health communication;health disparity;Health Personnel;Health Status;High Prevalence;High School Student;Hispanic;Home;Hour;Household;Income;Individual;Industry;insight;interest;Intervention;Knowledge;Light;Link;marijuana use;Market Research;Marketing;Mediating;Mental Health;Modeling;mortality;National Health and Nutrition Examination Survey;Nicotine;novel;Outcome;Patient Self-Report;Pattern;pediatric health outcomes;Persons;Physical activity;Policy Maker;Population;Population Assessment of Tobacco and Health;population based;population health;Predisposition;Prevalence;Price;protective factors;Public Health;Public Health Education;public policy on tobacco;Race;Reaction;Recommendation;Reduce health disparities;reduce tobacco use;Reporting;Research;response;return to use;Risk;Risk Factors;Sampling;secondary analysis;Serum;Services;sex;Sleep;Sleep Deprivation;Sleep disturbances;sleep quality;Smoke;smokeless tobacco use;Smoker;Smoking;smoking initiation;smoking prevalence;Smoking Status;social;social determinants;social health determinants;social influence;Social Marketing;socioeconomics;substance use;Surgeon;Surveys;Target Populations;Taxes;Testing;thirdhand smoke;Tobacco;tobacco advertising;tobacco control;tobacco exposure;Tobacco Industry;tobacco products;tobacco smoke exposure;Tobacco use;tobacco user;Vision;Work;young adult;Youth,Understanding and reducing health disparities through social and behavioral research,6,NA,NA,NA,NA,10,NA,NA,804411,NA
11193140,ZIA,MD,1,N,NA,NA,NA,NA,ZIAMD000021,NA,NA,1ZIAMD000021-04,NIMHD:399283\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE ON MINORITY HEALTH AND HEALTH DISPARITIES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE ON MINORITY HEALTH AND HEALTH DISPARITIES,NA,NA,NA,78351094 (contact),"ZENK, SHANNON  (contact)",NA,NA,NA,Affect;authority;Baltimore;Behavior;Bibliography;built environment;career;climate change;Collaborations;Communities;Complex;Data Collection;data collection methodology;data quality;design;Development;energy balance;Ensure;Environment;ethnic disparity;Extramural Activities;falls;farmer;Fruit;Geographic Locations;Growth and Development function;Health;Health behavior and outcomes;Health Care Costs;health data;health disparity;health disparity populations;Health equity research;Hispanic Community Health Study/Study of Latinos;Housing;Human Resources;innovation;Institutional Review Boards;Intervention;Journals;laboratory development;Manuscripts;Measures;medical schools;member;Mentors;Metabolic;Methods;minority health;National Institute on Minority Health and Health Disparities;Neighborhoods;Oral;Paper;Pathway interactions;Physical environment;Policies;Postbaccalaureate;Postdoctoral Fellow;posters;Preparation;programs;Publications;Publishing;PubMed;racial disparity;Reduce health disparities;Research;Schools;Science;secondary analysis;Services;Social Environment;Surveys;symposium;Temperature;Testing;Time;Training;United States National Institutes of Health;Update;Urban Health;volunteer;wearable data;Woman;Work,Neighborhoods and Health Lab,21,NA,NA,NA,NA,4,NA,NA,399283,NA
11193141,ZIC,DE,1,N,NA,NA,NA,NA,ZICDE000729,NA,NA,1ZICDE000729-16,NIDCR:2134880\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH,NA,NA,NA,79983138 (contact),"ABSHARI, MEHRNOOSH  (contact)",NA,NA,NA,Blood Platelets;Cell Separation;cell type;Cells;craniofacial;Cytometry;Dental;digital;Disease;DNA sequencing;Flow Cytometry;Goals;Histology;Hour;Image;Image Cytometry;Imaging Device;monocyte;National Institute of Dental and Craniofacial Research;operation;Oral;Peripheral Blood Mononuclear Cell;Reaction;Research;Research Personnel;Research Support;Resources;Sampling;Scanning;Services;Sorting;Stains;Students;T-Lymphocyte;Technology;tissue processing;Tissues;Training,NIDCR DIR Scientific Cores (Combined Technical Research Core),729,NA,NA,NA,NA,16,NA,NA,2134880,NA
11193142,ZIC,ES,1,N,NA,NA,NA,NA,ZICES103376,NA,NA,1ZICES103376-03,NIEHS:7222295\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES,NA,NA,NA,79341516 (contact),"TRAVLOS, GREGORY  (contact)",NA,NA,NA,Anatomy;Archives;Artificial Intelligence;Autopsy;Biological Assay;carcinogenesis;Cardiovascular Diseases;Clinical;Clinical Chemistry;Clinical Pathology;Collaborations;Communities;Consultations;Data;Development;dietary restriction;digital imaging;Disease;Electron Microscopy;Embryo;Equipment and supply inventories;Gene Expression;Gene Expression Regulation;Goals;Hematology;Histology;Image;Image Analysis;Immune;Immunoassay;Immunohistochemistry;improved;Inflammatory;Infrastructure;Kidney Diseases;Knowledge;Laboratories;Laboratory Research;Lasers;Lesion;Mediating;Medical;Methods;Microdissection;Mission;Modernization;Mus;National Institute of Environmental Health Sciences;neoplastic;new technology;Non-Insulin-Dependent Diabetes Mellitus;Obesity;Pathogenesis;Pathologist;Pathology;Phenotype;Procedures;Process;programs;Protocols documentation;Public Health;Research;Research Personnel;Respiratory Disease;Retrospective Studies;sample collection;Science;Services;Skeletal Development;System;Technical Expertise;Techniques;Testing;Toxicology;Work,Pathology Services Supporting the Division Translational Toxicology,103376,NA,NA,NA,NA,3,NA,NA,7222295,NA
11193143,ZIC,MD,1,N,NA,NA,NA,NA,ZICMD000017,NA,NA,1ZICMD000017-05,NIMHD:7203726\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE ON MINORITY HEALTH AND HEALTH DISPARITIES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE ON MINORITY HEALTH AND HEALTH DISPARITIES,NA,NA,NA,14285133 (contact),"CHOI, KELVIN  (contact)",NA,NA,NA,Age;age difference;Area;Asian;Behavioral;Blood Pressure;burden of illness;cancer epidemiology;cancer genetics;Cirrhosis;Clinical;clinical center;Clinical Research;clinical translation;Collaborations;Collection;Communities;computer framework;Contractor;Contracts;County;Data;data visualization;Databases;Descriptive Epidemiology;Dimensions;disability;disability-adjusted life years;Disease;Disease stratification;disparities in morbidity;Disparity;Doctor of Philosophy;Education;Environmental Exposure;Epidemiologist;Epidemiology;Equity;ethnic disparity;ethnic minority population;Ethnic Origin;Evaluation;Exposure to;Faculty;falls;fasting plasma glucose;Gender;gender minority group;genome sciences;geographic difference;Health;health disparity;health equity;Health Status Indicators;high body mass index;high reward;high risk;Human Resources;Immunologic Epidemiology;improved;Incidence;Individual;Infection;Interdisciplinary Study;Interest Group;intersectionality;Intervention;Knowledge;Laboratories;Leadership;Life;Life Expectancy;Location;Malignant neoplasm of liver;Measures;medical schools;Methodology;Minnesota;Minority Groups;Minority Health Research;Mission;Morbidity - disease rate;mortality;multi-racial;multiple datasets;National Institute of Dental and Craniofacial Research;National Institute on Minority Health and Health Disparities;Native Hawaiian or Other Pacific Islander;Neighborhoods;Obesity;Outcome;Patient Participation;Pattern;Personal Satisfaction;Population;Population Attributable Risks;Positioning Attribute;Premature Mortality;Prevalence;Procedures;Professional counselor;professor;Public Health;Publishing;Race;racial disparity;racial minority population;racial population;Recommendation;Reporting;Research;Research Personnel;Resources;Risk;Risk Factors;Scientific Advances and Accomplishments;Scientist;Series;sex;Sexual and Gender Minorities;social;social disparities;social health determinants;Socioeconomic Status;Sum;tenure track;Translational Research;Underserved Population;underserved rural area;United States;United States National Institutes of Health;Universities;Update;Vulnerable Populations;Work;working group;years lived with disability;years of life lost,Office of the Scientific Director,17,NA,NA,NA,NA,5,NA,NA,7203726,NA
11193144,ZIE,MD,1,N,NA,NA,NA,NA,ZIEMD000007,NA,NA,1ZIEMD000007-10,NIMHD:45436\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE ON MINORITY HEALTH AND HEALTH DISPARITIES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE ON MINORITY HEALTH AND HEALTH DISPARITIES,NA,NA,NA,14285133 (contact),"CHOI, KELVIN  (contact)",NA,NA,NA,"American Indian Population;anti-cancer research;Award;Biomedical Research;career;Characteristics;Communities;Dedications;diversity and inclusion;Division of Cancer Epidemiology and Genetics;Doctor of Philosophy;Educational workshop;Emergency department visit;Endocrinologist;Endocrinology;Equity;equity, diversity, and inclusion;ethnic difference;Ethnic equity;Exposure to;Funding;Goals;Growth;Health Disparities Research;health disparity;innovation;Internal Medicine;Interview;Intramural Research;Intramural Research Program;Lead;Leadership;Manufactured basketball;Manuscripts;Medical;Medical Research;meetings;member;Mentors;minority health;minority health disparity;Minority Health Research;National Institute of Dental and Craniofacial Research;National Institute of Neurological Disorders and Stroke;National Institute on Minority Health and Health Disparities;next generation;Oral health;Participant;Patient Self-Report;Physicians;Post-Acute Sequelae of SARS-CoV-2 Infection;Postbaccalaureate;Postdoctoral Fellow;posters;Principal Investigator;programs;Quality of life;racial difference;Racial Equity;Research;Research Personnel;Research Support;Research Training;Resource Allocation;Scholars Program;Science;Scientist;Services;Site;Spottings;Statistical Data Interpretation;Structural Racism;summer internship;symposium;Symptoms;tenure track;Traineeship;Training;Training Programs;tribal community;Underrepresented Populations;United States National Institutes of Health;Woman;Work;working group",Intramural Diversity in Medical Research Initiatives,7,NA,NA,NA,NA,10,NA,NA,45436,NA
11193145,ZII,MD,1,N,NA,NA,NA,NA,ZIIMD000004,NA,NA,1ZIIMD000004-13,NIMHD:548699\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE ON MINORITY HEALTH AND HEALTH DISPARITIES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE ON MINORITY HEALTH AND HEALTH DISPARITIES,NA,NA,NA,14285133 (contact),"CHOI, KELVIN  (contact)",NA,NA,NA,Behavioral Sciences;Clinical;Clinical Research;Community Health;Dryness;Epidemiology;epidemiology study;Floor;Future;Genetic;Goals;Health Disparities Research;health disparity;Health Sciences;high risk;Intramural Research;Intramural Research Program;minority health;minority health disparity;Minority Health Research;Mission;multidisciplinary;National Institute on Minority Health and Health Disparities;Open Reading Frames;population health;Privatization;programs;Research;Research Personnel;Secure;Social Sciences;tenure track;United States National Institutes of Health;Work,NIMHD Space Activation,4,NA,NA,NA,NA,13,NA,NA,548699,NA
11193146,ZIJ,MD,1,N,NA,NA,NA,NA,ZIJMD000008,NA,NA,1ZIJMD000008-08,NIMHD:94106\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE ON MINORITY HEALTH AND HEALTH DISPARITIES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE ON MINORITY HEALTH AND HEALTH DISPARITIES,NA,NA,NA,14285133 (contact),"CHOI, KELVIN  (contact)",NA,NA,NA,African;African ancestry;American;Asian ancestry;Asian population;Black Populations;Certification;Clinic;clinical center;clinical practice;Clinical Research;clinical training;Data;design;diabetes educator;diabetes management;Diabetes Mellitus;Diagnosis;Diagnostic;Doctor of Philosophy;efficacy evaluation;Endocrinology;Environment;Ethnic Origin;European;experience;Fellowship;Fellowship Program;Funding;Genocides;global health;Glucose;Health;health equity;Hour;Immigrant;Individual;innovation;International;Journals;Learning;low income country;Medical;meetings;Meta-Analysis;National Institute of Diabetes and Digestive and Kidney Diseases;National Institute on Minority Health and Health Disparities;New York;Obesity;OGTT;Physiological;programs;Publications;Publishing;Recommendation;Recording of previous events;Reporting;Research;Research Methodology;Research Personnel;Running;Rwanda;Scholarship;Screening procedure;Training;Travel;United States National Institutes of Health;Universities;Wages,Rwandan Research Fellowship,8,NA,NA,NA,NA,8,NA,NA,94106,NA
11193147,ZIJ,MD,1,N,NA,NA,NA,NA,ZIJMD000009,NA,NA,1ZIJMD000009-08,NIMHD:74774\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE ON MINORITY HEALTH AND HEALTH DISPARITIES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE ON MINORITY HEALTH AND HEALTH DISPARITIES,NA,NA,NA,14285133 (contact),"CHOI, KELVIN  (contact)",NA,NA,NA,"adaptive immune response;Address;Adherence;Adrenal Glands;African American;African American Women;Age;age related;Aging;aging biomarker;Alcohol consumption;alcohol craving;Alkaline Single-Cell Gel Electrophoresis Assay;Alleles;Allergens;anti-cancer research;Antibodies;anxiety symptoms;Area;Award;Behavioral Sciences;biological age;Biological Aging;Biological Assay;Black Populations;Black race;Breast Cancer survivor;Cardiac;Cardiovascular Diseases;Catecholamines;Cell Physiology;Cells;Chemicals;Chronic;Chronic stress;Clinical;cognitive interview;cohort;Cohort Studies;Communities;Community Health;cue reactivity;cytokine;Data;Data Sources;Dedications;depressive symptoms;design;Development;dietary;Discrimination;Disparity;DNA;DNA Damage;DNA Repair;Doctor of Medicine;Doctor of Philosophy;environmental chemical;Epidemiology;epigenomics;ethnic discrimination;Ethnic Origin;Ethnic Population;evidence base;exercise physiologist;Exhibits;experience;Feedback;Female Breast Carcinoma;Frequencies;functional decline;Funding;Future;Genus Hippocampus;Goals;good diet;Haplogroup;Health;Health Disparities Research;health disparity;health inequalities;Health Personnel;Heart;Heart failure;Helicobacter Infections;high risk;Human Biology;Hypertension;Hypothalamic structure;Immigrant;immunoregulation;In Vitro;Individual;Inflammation;Inflammatory;inflammatory marker;Innate Immune Response;innovation;interest;Intervention;Intramural Research Program;Investigation;Investments;Joints;Latino;Latino Population;Legal Status;Life Cycle Stages;Lipopolysaccharide Biosynthesis Pathway;Malignant Breast Neoplasm;Measures;medically underserved;member;Mentors;Methods;Minority Groups;minority health;minority health disparity;Mitochondria;Mitochondrial DNA;Modeling;Mood Disorders;mortality;Multi-Ethnic Study of Atherosclerosis;multiplex assay;National Heart, Lung, and Blood Institute;National Institute of Environmental Health Sciences;National Institute on Aging;National Institute on Minority Health and Health Disparities;Natural Killer Cells;Nuclear;obesity risk;Oncologist;Oxidative Stress;Participant;Patient Self-Report;perceived discrimination;Physical activity;physical conditioning;Pituitary Gland;population health;Postdoctoral Fellow;pre-clinical;preference;premature;Principal Investigator;Proxy;psychologic;psychological distress;psychological outcomes;Psychosocial Stress;Race;racial discrimination;racial minority population;Recommendation;Recording of previous events;Recurrence;repaired;Research;Research Personnel;Research Project Grants;response;Review Committee;Risk;Risk Factors;Role;Sampling;Scientist;Serum;Sister;Smoke;social;Social Sciences;Stress;stressor;Structure;substance use;Surveys;Sympathetic Nervous System;Symptoms;Testing;theories;Tobacco;Tobacco use;Toxic Environmental Substances;Toxicant exposure;Training;United States;United States National Institutes of Health;vapor;vigilance;Visit;Work",William G. Coleman Award,9,NA,NA,NA,NA,8,NA,NA,74774,NA
11193148,ZIJ,MD,1,N,NA,NA,NA,NA,ZIJMD000010,NA,NA,1ZIJMD000010-08,NIMHD:429520\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE ON MINORITY HEALTH AND HEALTH DISPARITIES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE ON MINORITY HEALTH AND HEALTH DISPARITIES,NA,NA,NA,14285133 (contact),"CHOI, KELVIN  (contact)",NA,NA,NA,"Address;admixture mapping;Adult;African;African American;African American population;African ancestry;Age;age related decline;Air Pollution;Amino Acids;Appointment;Area;Asian ancestry;Athletic;Autoimmune;Award;Behavior;Behavior Therapy;Biological Process;Black American;Black Populations;black women;Calcinosis;cancer health disparity;cancer prevention;Cardiometabolic Disease;cardiometabolism;Cardiovascular Diseases;cardiovascular health;cardiovascular risk factor;Cardiovascular system;Catabolism;Cell Cycle Regulation;Censuses;Childhood;Chronic stress;Circulation;climate change;Clinical Investigator;Clinical Management;clinical practice;cohort;Cohort Studies;Collaborations;college;Coronavirus;Data;Data Science;Decidua Basalis;Dementia;Development;Diabetes Mellitus;Diagnosis;digital health;Disabled Persons;Disease;Disease Outcome;Disparity;diversity and inclusion;Early Intervention;Environment;environmental chemical;epigenome;ethnic discrimination;Ethnic Origin;Ethnic Population;European;Event;experience;Exposure to;Female;fetal;Fetal Growth;Floods;Follow-Up Studies;food insecurity;frailty;Funding;Gases;Gene Expression;Genes;Genetic;genetic analysis;genetic testing;Genome;Glucose;Goals;Growth;Health;Health behavior;health determinants;Health Disparities Research;health disparity;health equity;Health Technology;healthy aging;high risk;higher education;Hispanic Populations;Home;Hypertension;improved;Individual;Inflammation;inorganic phosphate;insight;International;Intervention;Intramural Research;Journals;killings;Knowledge;Laboratories;late life;Life;life span;Link;loss of function;male;Malignant Breast Neoplasm;Malignant neoplasm of prostate;Manuscripts;Maps;marijuana use;Mentors;Meta-Analysis;Metabolism;Methods;minority health;minority health disparity;Modeling;Molecular;Molecular Epidemiology;Musculoskeletal Physiology;National Heart, Lung, and Blood Institute;National Institute of Arthritis, and Musculoskeletal, and Skin Diseases;National Institute of Child Health and Human Development;National Institute of Diabetes and Digestive and Kidney Diseases;National Institute of Environmental Health Sciences;National Institute on Minority Health and Health Disparities;Native Hawaiian;neighborhood disadvantage;Neighborhoods;NOTCH4 gene;novel;Occupations;Outcome;Pacific Islander;Pathogenesis;Pathway Analysis;Pathway interactions;Patients;Peripheral Blood Mononuclear Cell;Phase;Phenotype;Physiological;Placenta;Population;Postdoctoral Fellow;Predisposition;Pregnant Women;programs;Publications;Race;racial discrimination;racial minority population;racial population;Recommendation;Research;Research Personnel;Research Training;Resource-limited setting;Resources;Review Committee;Risk;Risk Factors;Schedule;Scleroderma;sex;sex variable;Skin;Sleep;Sleep disturbances;sleep health;sleep quality;Sleeplessness;social;social vulnerability;South Carolina;spatiotemporal;Strategic Planning;Susceptibility Gene;Systemic Scleroderma;T cell receptor repertoire sequencing;tenure track;therapy development;Tissue-Specific Gene Expression;Toxicokinetics;Toxicology;transcriptome;Translational Research;Travel;Tumor Biology;Tumor Promotion;United States;United States National Institutes of Health;Variant;Vascular Diseases;volatile organic compound;Work;young adult",NIMHD Adjunct Investigator Program,10,NA,NA,NA,NA,8,NA,NA,429520,NA
11193149,R56,AA,2,N,2024-09-24,2024-09-25,2025-08-31,273,R56AA026272,NA,PA-20-185,2R56AA026272-06,NIAAA:399987\,NON-SBIR/STTR RPGS,2024,NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM,NA,WASHINGTON,UNITED STATES,NA,98,143983562,US,1518602,CHILDREN'S RESEARCH INSTITUTE,DC,200102916,"Project Narrative The proposed study will test the hypothesis that reduced APOE expression in the brain contributes to neurobehavioral deficits in FASD and that treatment with APOE mimetics alleviates these deficits. This study will not only uncover novel APOE-mediated mechanisms in FASD, but will also test the potential for a novel intervention approach to FASD.",9631503;9496410 (contact),"HASHIMOTO-TORII, KAZUE ;TORII, MASAAKI  (contact)","LORANG-LEINS, DOMINIQUE",2019-01-25,2025-08-31,Alcohols;Apolipoprotein E;Biological Availability;Brain;Brain region;Calcium-Activated Potassium Channel;calmodulin-dependent protein kinase II;cell type;Cells;Cerebral cortex;Child;Chromatin;clinically relevant;Cognitive;Cognitive deficits;CREB1 gene;Data;Development;Dose;effective therapy;effectiveness evaluation;efficacy evaluation;efficacy testing;Enhancers;Fetal alcohol effects;Fetal Alcohol Exposure;Fetal Alcohol Spectrum Disorder;Functional disorder;Funding;Gene Expression;Genes;genome-wide;Goals;Human;Immunohistochemistry;improved;insight;Intervention;Intraperitoneal Injections;Investigation;Lead;Learning;Longitudinal Studies;Mediating;Mediator;mimetics;Modeling;Molecular;Motor Cortex;motor learning;multiple omics;Mus;neurobehavior;neurobehavioral;Neuronal Plasticity;Neurons;Neurosciences;novel;novel therapeutics;offspring;Organ;Pathway interactions;peptidomimetics;pharmacologic;Phosphorylation;Plasma;Play;postnatal;Potassium Channel;restoration;Risk Factors;Role;Route;Signal Transduction;Single Nucleotide Polymorphism;Specificity;Structure;symptom treatment;targeted treatment;Testing;Therapeutic;Therapeutic Effect;therapeutic target;Time;Translating;Treatment Efficacy;Western Blotting,Mechanisms and treatments of learning deficits in Fetal Alcohol Spectrum Disorders,26272,NAL,Neurotoxicology and Alcohol Study Section[NAL],NA,NA,6,219773,180214,399987,NA
11193187,N01,AI,NA,N,NA,NA,NA,NA,272201700010I,NA,NA,272201700010I-P00009-27200001-1,NIAID:154735\,NON SBIR/STTR CONTRACTS,2024,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,KENSINGTON,UNITED STATES,NA,08,094888294,US,319502,"ADVANCED BIOSCIENCE LABORATORIES, INC.",MD,208951042,NA,16489709 (contact),"FOUTS, TIMOTHY  (contact)",NA,2017-06-10,2024-06-09,Antigens;Area;Award;Clinical Trials;Contractor;Contracts;Databases;Development;Documentation;efficacy study;Equipment;Equipment and supply inventories;HIV vaccine;HIV-1;Human;Human Resources;immunogenicity;In Vitro;Information Systems;Investigational Drugs;Laboratories;Laboratory Animals;manufacture;meetings;National Institute of Allergy and Infectious Disease;Phase;plasmid DNA;preclinical development;Preclinical Testing;Preventive vaccine;product development;Production;Proteins;Protocols documentation;prototype;quality assurance;Quality Control;Reagent;Reporting;research clinical testing;Secure;Specimen;System;Temperature;Testing;Time;timeline;Toxicology;Vaccines;Viral Vector,NIAID Preclinical Development Support: Essential Core Activities,0,NA,NA,NA,NA,NA,NA,NA,154735,NA
11193188,N01,AI,NA,N,NA,NA,NA,NA,75N93020C00048,NA,NA,75N93020C00048-P00011-9999-1,NIAID:198329\,NON SBIR/STTR CONTRACTS,2024,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,VEINNA,AUSTRIA,NA,NA,300364873,AU,10043149,"EVELIQURE BIOTECHNOLOGIES, GMBH",NA,NA,NA,79983696 (contact),"MALINOWSKI, FRANK  (contact)",NA,2020-09-01,2026-05-31,Advanced Development;Animal Model;Bacterial Antibiotic Resistance;Bacterial Drug Resistance;bacterial resistance;Clinical;Combating Antibiotic Resistant Bacteria;Communicable Diseases;Contracts;Disease Outbreaks;efficacy evaluation;efficacy testing;Emerging Communicable Diseases;Escherichia coli;Formulation;immunogenicity;Individual;manufacture;response;Safety;stability testing;Toxicology;vaccine candidate;vaccine development;Vaccines,Advanced Development of Vaccine Candidates for Antibiotic Resistant Bacteria,0,NA,NA,NA,NA,NA,NA,NA,198329,NA
11193275,U18,FD,3,N,2024-09-25,2024-09-01,2025-08-31,103,U18FD005292,SCHOOLS OF MEDICINE,RFA-FD-24-040,3U18FD005292-11S1,FDA:689300\,OTHER RESEARCH-RELATED,2024,FOOD AND DRUG ADMINISTRATION,NA,DURHAM,UNITED STATES,INTERNAL MEDICINE/MEDICINE,04,044387793,US,2221101,DUKE UNIVERSITY,NC,277054673,"Clinical trials have become overly complex and expensive, resulting in major gaps in the availability of and knowledge about medical products. The Clinical Trials Transformation Initiative (CTTI), a public-private partnership co-founded by the FDA and Duke University, and involving all interested parties across the clinical trials ecosystem, develops and drives the adoption of recommendations and resources to improve the quality and efficiency of clinical trials. Through the support of this cooperative agreement, Duke will host and support CTTI's work to shape better the clinical trials of the future.",8661808 (contact),"ALEXANDER, JOHN H (contact)","LAUDA, MARK",2014-09-01,2029-08-31,NA,Increasing the Quality and Efficiency of Clinical Trials (U18),5292,ZFD1,ZFD1-CDER-T(13)1,NA,S1,11,689300,0,689300,NA
11193277,U2F,FD,3,N,2024-09-17,2024-05-01,2025-04-30,103,U2FFD007646,NA,RFA-FD-22-021,3U2FFD007646-03S1,FDA:452982\,NON-SBIR/STTR RPGS,2024,FOOD AND DRUG ADMINISTRATION,NA,YORK,UNITED STATES,NA,10,194580973,US,959901,ASSOCIATION OF FOOD AND DRUG OFFICIALS,PA,17401,"RFA-FD-22-021 AFDOs System for Agriculture, Food, Health, E-Inspections and Registration (SAFHER): Project Narrative The Association of Food and Drug Officials (AFDO) efforts under this cooperative agreement are intended to support the planning, development, implementation, operation, and maintenance of data management system to be utilized by State, Local, Tribal, and Territorial (SLTT) partners in both human and animal food programs. AFDO will build on an already established user community of stakeholders to enhance FDAs ORA Data Exchange capabilities by utilizing software development methodologies (i.e. Agile) to ensure a long-term sustainable data management system that is easy to use and maintain by state regulatory partners during and after this cooperative agreement. Through effective governance, vendor procurement, and resource management, this project will deliver a national regulatory data repository that will work towards achieving a national Integrated Food Safety System (IFSS) while promoting One Health and supporting domestic mutual reliance initiatives to protect the food supply and advance public health.",10889095 (contact),"MANDERNACH, STEVEN  (contact)","LAC, ANH",2022-09-15,2025-04-30,NA,"System for Agriculture, Food, Health, E-inspection, and Registration (SAFHER)",7646,ZFD1,ZFD1-ORA-K(02)1,NA,S1,3,452982,0,452982,NA
11193301,ZIA,AI,1,N,NA,NA,NA,NA,ZIAAI005003,NA,NA,1ZIAAI005003-23,NIAID:3550000\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,78395963 (contact),"KANEKIYO, MASARU  (contact)",NA,NA,NA,Adjuvant;Adult;Animal Model;Animals;Antibody Response;Antigens;Biological Assay;combat;design;Disease;Effectiveness;Enrollment;Ferrets;Ferritin;Goals;Hemagglutinin;human subject;Immune response;Immunity;Immunization;Immunize;immunogenic;immunogenicity;Immunologics;improved;Individual;Infection;Influenza;Influenza A virus;influenza virus strain;influenza virus vaccine;influenzavirus;Licensing;manufacture;Membrane Glycoproteins;Messenger RNA;Methodology;mosaic;Mus;Mutation;nanoparticle;Neuraminidase;neutralizing antibody;new pandemic;next generation;nonhuman primate;Nucleic Acid Vaccines;pandemic disease;pandemic influenza;pandemic potential;pandemic virus;Phase I Clinical Trials;pre-clinical;Pre-Clinical Model;pre-pandemic;preclinical study;Production;programs;Public Health;Research;response;Risk Reduction;safety assessment;seasonal influenza;self assembly;stem;Structure;Testing;Time;tool;universal influenza vaccine;Vaccinated;vaccination strategy;vaccine candidate;vaccine development;vaccine immunogenicity;vaccine platform;Vaccine Production;Vaccine Research;Vaccines;Virus;Work,Influenza Vaccine Research and Development,5003,NA,NA,NA,NA,23,NA,NA,3550000,NA
11193302,ZIA,AI,1,N,NA,NA,NA,NA,ZIAAI005014,NA,NA,1ZIAAI005014-23,NIAID:1429323\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,7510051 (contact),"KOUP, RICHARD A (contact)",NA,NA,NA,Anti-Retroviral Agents;Biological Models;CD4 Positive T Lymphocytes;HIV;Human;Immune response;in vivo;Individual;nonhuman primate;Patients;Persons;simian human immunodeficiency virus;SIV;T-Lymphocyte;Vaccines;Virus Replication,HIV/SIV Replication In Vivo,5014,NA,NA,NA,NA,23,NA,NA,1429323,NA
11193303,ZIA,AI,1,N,NA,NA,NA,NA,ZIAAI005015,NA,NA,1ZIAAI005015-23,NIAID:1029324\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,7510051 (contact),"KOUP, RICHARD A (contact)",NA,NA,NA,Antibodies;Antibody Response;Antigen-Antibody Complex;Antigens;B-Lymphocytes;Biology;CD4 Positive T Lymphocytes;Cell Communication;Cells;Characteristics;Chronic;Complex;Defect;Development;Goals;Helper-Inducer T-Lymphocyte;HIV;Human;Immunoglobulins;Infection;lymph nodes;Molecular;Monkeys;Mus;neutralizing antibody;nonhuman primate;Pathogenesis;Phenotype;Population;Predisposition;Process;programs;Proteins;recruit;response;Signal Transduction;SIV;spatiotemporal;Structure of germinal center of lymph node;T-Lymphocyte;Vaccination;vaccination protocol;Virus,Tfh and B cells in HIV/SIV pathogenesis and vaccination,5015,NA,NA,NA,NA,23,NA,NA,1029324,NA
11193304,ZIA,AI,1,N,NA,NA,NA,NA,ZIAAI005022,NA,NA,1ZIAAI005022-23,NIAID:1554806\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,77882456 (contact),"ZHOU, TONGQING  (contact)",NA,NA,NA,2019-nCoV;Antibodies;B-Lymphocytes;Binding Sites;Cell Ontogeny;Clinical;clinical application;Collaborations;Epitopes;HIV;HIV Infections;HIV-1;human pathogen;Immune system;improved;Infection prevention;influenzavirus;insight;Lassa virus;manufacture;neutralizing antibody;pathogen;Pathway interactions;Prevention;Structure;Therapeutic Agents;Vaccine Design;vaccine-induced antibodies;Vaccines;Work,Antibody Neutralization Mechanisms,5022,NA,NA,NA,NA,23,NA,NA,1554806,NA
11193305,ZIA,AI,1,N,NA,NA,NA,NA,ZIAAI005023,NA,NA,1ZIAAI005023-23,NIAID:1369871\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,77882456 (contact),"ZHOU, TONGQING  (contact)",NA,NA,NA,2019-nCoV;Alpha Virus;Antibodies;Bypass;Cryoelectron Microscopy;design;Development;Disease;Electrons;Glycoproteins;glycosylation;Goals;HIV Envelope Protein gp120;HIV-1;HIV-1 vaccine;human pathogen;Immune Evasion;Immune response;Immune system;Individual;Infection;Influenza A virus;interest;Investigation;Lassa virus;Location;Malaria;Maps;Minority;Molecular Conformation;molecular dynamics;neutralizing antibody;pathogen;Polysaccharides;Proteins;Publishing;Respiratory syncytial virus;response;single-molecule FRET;Structure;Tomogram;Vaccines;Variant;Virion;Virus;X-Ray Crystallography,Mechanisms Of Humoral Evasion,5023,NA,NA,NA,NA,23,NA,NA,1369871,NA
11193306,ZIA,AI,1,N,NA,NA,NA,NA,ZIAAI005024,NA,NA,1ZIAAI005024-23,NIAID:1212338\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,77882456 (contact),"ZHOU, TONGQING  (contact)",NA,NA,NA,2019-nCoV;Antibodies;Antigens;B-Lymphocytes;Binding Sites;Carrier Proteins;Cell Ontogeny;Clinical Trials;Coupled;Cryoelectron Microscopy;design;Developmental Process;disabled;Epitopes;Exposure to;General Population;Glycoproteins;HIV-1;HIV-1 vaccine;Homologous Protein;Hospitalized Child;human pathogen;immune activator;Immune response;Immunization;immunogenic;immunogenicity;improved;influenzavirus;insight;Knowledge;Lassa virus;Malaria;manufacture;Medicine;N-terminal;nanoparticle;neutralizing antibody;NMR Spectroscopy;Norovirus;pathogen;Peptides;Phase;Process;protein data bank;Proteins;Reagent;Respiratory syncytial virus;response;scaffold;Scaffolding Protein;self assembly;Structure;Surface;Technology;tool;Transplantation;Vaccine Design;vaccine evaluation;X-Ray Crystallography,Design Of Immunogens,5024,NA,NA,NA,NA,23,NA,NA,1212338,NA
11193307,ZIA,AI,1,N,NA,NA,NA,NA,ZIAAI005031,NA,NA,1ZIAAI005031-23,NIAID:886728\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,7510169 (contact),"DOUEK, DANIEL CESAR (contact)",NA,NA,NA,Affect;Africa;antiretroviral therapy;CD4 Positive T Lymphocytes;Cell Count;Cell Physiology;Cells;circulating biomarkers;Clinical;cohort;Communicable Diseases;Fibrin fragment D;HIV;HIV Infections;Human;Immune;Individual;Inflammation;inflammatory marker;Influenza;interest;Interleukin-6;Malaria;Malignant Neoplasms;Measures;Metabolic Marker;Metabolic Pathway;microbial;microbial products;Morbidity - disease rate;mortality;Outcome;Persons;Plasma;Sampling;systemic inflammatory response;Systems Biology;T cell reconstitution;T-Cell Activation;Thailand;transcriptome;Viral load measurement,Inflammation,5031,NA,NA,NA,NA,23,NA,NA,886728,NA
11193308,ZIA,AI,1,N,NA,NA,NA,NA,ZIAAI005033,NA,NA,1ZIAAI005033-23,NIAID:912355\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,7510169 (contact),"DOUEK, DANIEL CESAR (contact)",NA,NA,NA,adaptive immune response;antibody conjugate;Antibody Response;Antigen Receptors;antigen-specific T cells;Antigens;B-Lymphocytes;Cancer Model;Cavia;Cell surface;Cells;Cellular Indexing of Transcriptomes and Epitopes by Sequencing;Chromium;COVID-19;Custom;Evolution;Genomics;HIV;Immune;Immune response;Immunoglobulins;Immunologic Receptors;Infection;Influenza;Libraries;Macaca fascicularis;Macaca mulatta;Malignant Neoplasms;mouse model;Nature;next generation sequencing;pathogen;Proteomics;Protocols documentation;response;Sampling;T cell receptor repertoire sequencing;T-Lymphocyte;transcriptome;transcriptomics;Vaccination,Immune Responses To HIV And Other Pathogens,5033,NA,NA,NA,NA,23,NA,NA,912355,NA
11193309,ZIA,AI,1,N,NA,NA,NA,NA,ZIAAI005034,NA,NA,1ZIAAI005034-23,NIAID:306178\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,7510169 (contact),"DOUEK, DANIEL CESAR (contact)",NA,NA,NA,acute infection;Attention;CD4 Positive T Lymphocytes;Cells;cellular targeting;Disabling;Genome;Goals;HIV;Molecular;molecular targeted therapies;Persons;Proteins;Rest;Role;T-Cell Activation;therapy design;Work,The HIV Reservoir,5034,NA,NA,NA,NA,23,NA,NA,306178,NA
11193310,ZIA,AI,1,N,NA,NA,NA,NA,ZIAAI005035,NA,NA,1ZIAAI005035-23,NIAID:5702542\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,78846301 (contact),"DROPULIC, LESIA  (contact)",NA,NA,NA,Acquired Immunodeficiency Syndrome;adaptive immune response;Adenovirus Vector;Adenoviruses;Adjuvant;Adult;Adverse event;AIDS prevention;AIDS Vaccines;aluminum sulfate;Antibody Response;Antibody titer measurement;base;Binding;Clinic;Clinical;clinical center;clinical development;Clinical Research;Clinical Trials;Clinical Trials Network;Collaborations;Conjugate Vaccines;Data;design;Development;Devices;DNA;DNA Vaccines;dosage;Dose;efficacy study;Eligibility Determination;Enrollment;env Glycoproteins;Epidemic;Epitopes;follow-up;Futility;Future;gag Gene Products;Goals;HIV;HIV Infections;HIV prevention trial;HIV prevention trials network;HIV vaccine;HIV Vaccine Trials Network;HIV-1;HIV-1 vaccine;Human;Immune;Immunize;immunogenicity;Injections;Innate Immune Response;Intramuscular;Investigation;Kinetics;manufacture;meetings;member;Methods;Multicenter Trials;Needles;nef Protein;neutralizing antibody;novel;novel strategies;open label;Pattern;Peptides;Phase;phase 1 study;Phase I Clinical Trials;Physicians;Placebos;plasmid DNA;Plasmids;pol Gene Products;Polyproteins;Polysaccharides;Preventive;Preventive vaccine;programs;prospective;Protocols documentation;prototype;Public Health;Publishing;Randomized;Recombinants;Recommendation;Regimen;Research Personnel;response;Route;Safety;Schedule;Secondary Immunization;Serotyping;Site;subcutaneous;Syringes;Therapeutic Studies;therapeutic vaccine;Vaccination;vaccination protocol;vaccine candidate;vaccine development;vaccine evaluation;vaccine evaluation center;Vaccine Research;vaccine trial;Vaccines;vector vaccine;Viral Load result;Work,HIV Vaccine Studies,5035,NA,NA,NA,NA,23,NA,NA,5702542,NA
11193311,ZIA,AI,1,N,NA,NA,NA,NA,ZIAAI005037,NA,NA,1ZIAAI005037-23,NIAID:2369376\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,78846301 (contact),"DROPULIC, LESIA  (contact)",NA,NA,NA,Binding Sites;Biological Assay;Biological Factors;Blood;Blood Component Removal;Body Fluids;Bone Marrow;Cells;clinical center;Clinical Trials;Communicable Diseases;Correlation Studies;Data;Development;Eligibility Determination;Emerging Communicable Diseases;Enrollment;experience;healthy volunteer;HIV;HIV envelope protein;Human;Image;Immune;immune function;Immune response;Immunity;Immunology procedure;influenza virus vaccine;Laboratories;Licensing;lymph nodes;Methods;Monoclonal Antibodies;Mononuclear;mosaic;Mucous Membrane;nanoparticle;next generation;novel;Pathogenesis;Plasma;Procedures;programs;Protocols documentation;radiological imaging;recruit;Research;research clinical testing;Research Personnel;research study;sample collection;Sampling;screening;screening program;Severity of illness;Skin;skin biopsy;Specimen;Swab;Tissues;transfusion medicine;United States National Institutes of Health;Vaccinated;Vaccination;vaccine candidate;Vaccine Clinical Trial;vaccine development;Vaccine Research;vaccine-induced antibodies;Vaccines;Validation;Venous blood sampling;Virus Diseases;volunteer;Work,Sample Collection and General Screening Protocols,5037,NA,NA,NA,NA,23,NA,NA,2369376,NA
11193312,ZIA,AI,1,N,NA,NA,NA,NA,ZIAAI005047,NA,NA,1ZIAAI005047-22,NIAID:2658032\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,78846301 (contact),"DROPULIC, LESIA  (contact)",NA,NA,NA,"2019-nCoV;Adult;Age Years;Avian Influenza;biodefense;booster vaccine;Chikungunya virus;Clinic;Clinical Trials;Communicable Diseases;Data;Data Analyses;DNA;DNA Vaccines;Dose;Eastern Equine Encephalomyelitis;Ebola;Ebola Vaccines;Ebola virus;Emerging Communicable Diseases;emerging pathogen;Encephalitis Viruses;Enrollment;Evaluation;Ferritin;first-in-human;Generations;Genes;healthy volunteer;Human;Immunization Programs;immunogenicity;Infection;Influenza;Influenza A Virus, H5N1 Subtype;Influenza A Virus, H7N9 Subtype;Influenza Hemagglutinin;influenza virus vaccine;influenzavirus;Intramuscular;Intravenous;intravenous administration;Licensing;lumazine;lymph nodes;Malaria;malaria infection;Manuscripts;Marburgvirus;Messenger RNA;Mission;mosaic;nanoparticle;neutralizing antibody;Nipah;Nipah Virus;novel;open label;pandemic disease;Participant;particle;pathogen;Phase;phase 1 study;phase I trial;Plasmodium falciparum vaccine;programs;Publications;Publishing;Regimen;research clinical testing;Respiratory syncytial virus;Respiratory Syncytial Virus Vaccines;RNA vaccine;Route;Safety;safety assessment;Sampling;SARS coronavirus;Science;Scientist;seasonal influenza;Seasons;Severe Acute Respiratory Syndrome;Site;stem;Structure of germinal center of lymph node;Uganda;Vaccination;vaccine candidate;vaccine development;vaccine evaluation;Vaccine Research;vaccine trial;Vaccines;Venezuelan Equine Encephalitis Virus;Virus-like particle;West Nile;West Nile virus;Work;Zika Virus",Biodefense and Emerging Infectious Disease and Influenza Vaccine Studies,5047,NA,NA,NA,NA,22,NA,NA,2658032,NA
11193313,ZIA,AI,1,N,NA,NA,NA,NA,ZIAAI005048,NA,NA,1ZIAAI005048-22,NIAID:4954063\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,78846301 (contact),"DROPULIC, LESIA  (contact)",NA,NA,NA,adeno-associated viral vector;Adult;AIDS prevention;Anti-Retroviral Agents;Anti-viral Therapy;Antibodies;Antibody Binding Sites;antiretroviral therapy;Binding Sites;clinical center;Clinical Trials;Data Analyses;Development;Dose;Drug Kinetics;Enrollment;Epidemic;Evaluation;follow-up;healthy volunteer;HIV;HIV envelope protein;HIV-1;human monoclonal antibodies;Immunotherapeutic agent;Infection;Infusion procedures;insight;intravenous administration;Manuscripts;Monoclonal Antibodies;neutralizing monoclonal antibodies;next generation;novel strategies;Parents;Participant;Passive Immunity;Pharmaceutical Preparations;Phase;phase 1 study;pre-clinical;Preparation;programs;Public Health;Publications;Publishing;Recombinant adeno-associated virus (rAAV);Regimen;Research Project Grants;Safety;safety study;Scientist;Serum;side effect;Signal Transduction;subcutaneous;Subcutaneous Injections;Therapeutic;Time;United States National Institutes of Health;vaccine development;Vaccine Research;Viremia;volunteer,HIV Monoclonal Antibody Studies,5048,NA,NA,NA,NA,22,NA,NA,4954063,NA
11193314,ZIA,AI,1,N,NA,NA,NA,NA,ZIAAI005066,NA,NA,1ZIAAI005066-21,NIAID:706178\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,7510169 (contact),"DOUEK, DANIEL CESAR (contact)",NA,NA,NA,acquired factor;Behavioral;cohort;Communicable Diseases;Data Set;Disease susceptibility;Epidemiology;Genetic;Genetic Polymorphism;genome wide association study;Genomics;Genotype;Geography;high risk;HIV;HIV Infections;HIV Vaccine Trials Network;Human Herpesvirus 2;Infection;infection rate;Male Circumcision;Nature;novel;Persons;precision medicine;Predisposition;Prevalence;Risk;Risk Factors;Sexually Transmitted Diseases;vaccine efficacy;Vaccines;Viral load measurement,Host Genomic Factors in Infectious Disease Susceptibility,5066,NA,NA,NA,NA,21,NA,NA,706178,NA
11193315,ZIA,AI,1,N,NA,NA,NA,NA,ZIAAI005073,NA,NA,1ZIAAI005073-21,NIAID:1029324\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,7510051 (contact),"KOUP, RICHARD A (contact)",NA,NA,NA,Antigen Presentation;Antigen-Presenting Cells;Antigens;B-Lymphocytes;Chronic;clinical development;Development;Disease Progression;exhaustion;Goals;HIV Infections;Immune;immune activation;Immune response;Infection;lymph nodes;Mediating;pathogen;Pathway interactions;T cell response;T-Lymphocyte;Time;Vaccination;vaccine development;Vaccines;Viral Vaccines;Virus Diseases,Immune correlates of protection,5073,NA,NA,NA,NA,21,NA,NA,1029324,NA
11193316,ZIA,AI,1,N,NA,NA,NA,NA,ZIAAI005095,NA,NA,1ZIAAI005095-17,NIAID:739943\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,78846320 (contact),"DORIA-ROSE, NICOLE  (contact)",NA,NA,NA,Adult;Animals;Antibodies;Antibody Response;antibody test;Antigens;B-Cell Development;B-Lymphocytes;Binding;Biochemical;Cells;Clinical Research;cross reactivity;deep sequencing;design;Development;Donor Selection;Engineering;Epitopes;glycoprotein structure;Glycoproteins;high throughput screening;HIV;HIV Antibodies;HIV envelope protein;HIV Infections;HIV vaccine;HIV-1;Immunize;Immunoglobulin G;improved;Individual;Infection;Macaca mulatta;Mammalian Cell;manufacturability;Methods;Modeling;Monoclonal Antibodies;Mutate;neutralizing antibody;next generation;next generation sequencing;nonhuman primate;novel;Patients;pediatric human immunodeficiency virus;Prevention;Reagent;Sampling;Serum;simian human immunodeficiency virus;SIV;Techniques;Testing;Time;Vaccinated;vaccine candidate;Vaccine Design;vaccine immunogenicity;Vaccines;Variant;Viral;Virus;Work,"HIV Neutralizing Antibodies: Isolation, characterization, and interaction with viral variants",5095,NA,NA,NA,NA,17,NA,NA,739943,NA
11193317,ZIA,AI,1,N,NA,NA,NA,NA,ZIAAI005107,NA,NA,1ZIAAI005107-15,NIAID:422573\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,6568699 (contact),"SEDER, ROBERT A (contact)",NA,NA,NA,Adjuvant;Adult;Affinity;Animal Model;Antibodies;Antigens;Area;B-Lymphocytes;Blood;Characteristics;Child;circumsporozoite protein;Clinical Trials;Development;Drug Kinetics;Erythrocytes;Formulation;Goals;Human;Immunity;immunogenicity;Immunologic Adjuvants;improved;In Vitro;in vivo;in vivo Model;Infant;Infection;Kenya;Knock-in Mouse;malaria infection;Malaria Vaccines;Mali;Mediating;Modeling;Monoclonal Antibodies;Mus;neutralizing monoclonal antibodies;Phase I/II Trial;Phase II Clinical Trials;Plasmodium falciparum;Plasmodium vivax;prevent;Proteins;Role;Safety;safety assessment;Seasons;Sporozoites;T-Lymphocyte;Testing;transmission blocking;Vaccination;vaccine development;vaccine-induced antibodies;Vaccines;Yeasts,Development of Pre-Erythrocytic Malaria Vaccines and antibodies,5107,NA,NA,NA,NA,15,NA,NA,422573,NA
11193318,ZIA,AI,1,N,NA,NA,NA,NA,ZIAAI005126,NA,NA,1ZIAAI005126-10,NIAID:976284\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,16169666 (contact),"MASON, ROSEMARIE  (contact)",NA,NA,NA,Antibodies;Antibody Therapy;Antigens;Chimeric Proteins;clinically relevant;Development;Employee;Glycoproteins;Hendra Virus;Henipavirus;HIV;HIV-1;human monoclonal antibodies;Individual;Intervention;invention;Link;Macaca mulatta;Messenger RNA;Methods;Monoclonal Antibodies;neutralizing antibody;neutralizing monoclonal antibodies;Nipah Virus;pathogen;pathogenic virus;Peripheral Blood Mononuclear Cell;prevent;Prevention;Reporting;Sampling Studies;screening;single cell technology;Vaccination;Virus;Virus Diseases;virus testing,Monoclonal antibody isolation and characterization,5126,NA,NA,NA,NA,10,NA,NA,976284,NA
11193319,ZIA,AI,1,N,NA,NA,NA,NA,ZIAAI005128,NA,NA,1ZIAAI005128-09,NIAID:1272981\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,78395963 (contact),"KANEKIYO, MASARU  (contact)",NA,NA,NA,acute flaccid myelitis;adaptive immune response;Adverse event;Antigens;Attenuated;Attenuated Vaccines;burden of illness;candidate identification;Childhood;Chimeric Proteins;clinical development;Clinical Research;Coronavirus;design;Disease Outbreaks;Dose;Enterovirus;Enterovirus 68;Enterovirus 71;Family Picornaviridae;Formulation;Genes;Goals;Health;Herpesviridae;Herpesvirus Vaccines;Human;Human Herpesvirus 4;Immune response;Immunity;Immunization;immunodeficiency;immunogenicity;Immunologics;Knowledge;Licensing;Life;Maternal antibody;Measles;Membrane Glycoproteins;Messenger RNA;Molecular Conformation;Mumps;Mus;nanoparticle;neutralizing antibody;neutralizing vaccine;next generation;nonhuman primate;novel vaccines;Paramyxovirus;paramyxovirus vaccine;Passive Transfer of Immunity;Persons;Phase;Pneumovirus;Population;preclinical study;Predisposition;Proteins;research clinical testing;respiratory;respiratory challenge;Respiratory syncytial virus;response;Secondary Immunization;Structural Protein;Structure;T-Lymphocyte;Testing;universal coronavirus vaccine;Vaccination;Vaccine Antigen;vaccine candidate;Vaccine Design;vaccine development;vaccine evaluation;vaccine hesitancy;vaccine platform;Vaccine Research;Vaccines;Viral;Viral Fusion Proteins;Virus;Virus-like particle;Work;ZIKA,"Vaccine Research and Development for Endemic, Emerging, and Resurgent Viruses",5128,NA,NA,NA,NA,9,NA,NA,1272981,NA
11193320,ZIA,AI,1,N,NA,NA,NA,NA,ZIAAI005131,NA,NA,1ZIAAI005131-08,NIAID:1279134\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,15193586 (contact),"BORITZ, ELI  (contact)",NA,NA,NA,Affect;antiretroviral therapy;Blood specimen;CD4 Positive T Lymphocytes;Cell Physiology;Cell Proliferation;cell type;Cells;Chronic;Detection;Development;Emulsions;Epigenetic Process;Flow Cytometry;Gene Expression Profile;Genomic DNA;Goals;HIV;HIV Infections;Immunologics;in vivo;Individual;Institution;Interruption;Morbidity - disease rate;mortality;novel;Oils;Participant;Phenotype;Population;prevent;proteomic signature;Sorting;T-Lymphocyte Subsets;therapy design;Tissue Sample;transcriptomics;Virus;Virus Replication;Water;Work,HIV persistence in vivo,5131,NA,NA,NA,NA,8,NA,NA,1279134,NA
11193321,ZIA,AI,1,N,NA,NA,NA,NA,ZIAAI005136,NA,NA,1ZIAAI005136-06,NIAID:1680146\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,6568699 (contact),"SEDER, ROBERT A (contact)",NA,NA,NA,Adolescent;Adult;Aerosols;Antigens;Attenuated;Bacille Calmette-Guerin vaccination;BCG Live;BCG Vaccine;Birth;Blood;Bronchoalveolar Lavage;Cause of Death;CD8B1 gene;Cells;Cessation of life;Child;Confocal Microscopy;Development;Disease;disease transmission;Dose;experimental study;Flow Cytometry;follow-up;Frequencies;Genetic Transcription;global health;Goals;Granuloma;Growth;Health Priorities;HIV;Immune;Immune response;Immunity;Immunization;Immunize;Immunodominant Antigens;immunogenicity;Individual;Infant;Infection;Intravenous;Licensing;Lung;Lung Diseases;Lung infections;lymph nodes;M. tuberculosis genome;Maps;Meningitis;Miliary Tuberculosis;Modeling;mortality;mycobacterial;Mycobacterium bovis;Mycobacterium tuberculosis;Mycobacterium tuberculosis antigens;nonhuman primate;Pathology;Peptides;Persons;PET/CT scan;prevent;Pulmonary Tuberculosis;response;RNA;RNA vaccine;Route;Spleen;Structure of parenchyma of lung;T cell response;T-Lymphocyte;Tissues;Tuberculosis;Tuberculosis Vaccines;Vaccination;vaccine development;Vaccines;Virulent;X-Ray Computed Tomography,Development of Vaccines to Prevent Tuberculosis,5136,NA,NA,NA,NA,6,NA,NA,1680146,NA
11193322,ZIA,AI,1,N,NA,NA,NA,NA,ZIAAI005143,NA,NA,1ZIAAI005143-06,NIAID:6981494\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,79365480 (contact),"ANDREWS, SARAH  (contact)",NA,NA,NA,2019-nCoV;B-Lymphocytes;Biological Assay;Clinical;clinical investigation;clinical trial analysis;Collaborations;Communicable Diseases;Development;Ebola;Emerging Communicable Diseases;Extramural Activities;Goals;HIV;Immunobiology;Immunology;Influenza;Licensure;Malaria;Prevention trial;programs;Public Health;Qualifying;Research Personnel;Therapeutic Trials;Vaccine Clinical Trial;vaccine development;Vaccine Research;vaccine trial;Vaccines;ZIKA,Vaccine Immunology Program,5143,NA,NA,NA,NA,6,NA,NA,6981494,NA
11193323,ZIA,AI,1,N,NA,NA,NA,NA,ZIAAI005144,NA,NA,1ZIAAI005144-06,NIAID:5852957\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,9413846 (contact),"ROEDERER, MARIO  (contact)",NA,NA,NA,animal care;Animal Experimentation;animal model development;animal model selection;Animals;Caring;Data Collection;Development;improved;Laboratory Animals;Methodology;model development;Modeling;Monitor;operation;Policies;Principal Investigator;Procedures;programs;Regulation;Research;Research Personnel;research study;Research Support;translational research program;United States National Institutes of Health;Vaccine Research,Laboratory Animal Research Support & Model Development,5144,NA,NA,NA,NA,6,NA,NA,5852957,NA
11193324,ZIA,AI,1,N,NA,NA,NA,NA,ZIAAI005147,NA,NA,1ZIAAI005147-05,NIAID:427403\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,77882456 (contact),"ZHOU, TONGQING  (contact)",NA,NA,NA,2019-nCoV;ACE2;Adjuvant;Affinity;antagonist;Antibodies;Antigens;B-Cell Activation;B-Lymphocytes;Binding;causal variant;COVID-19;COVID-19 vaccine;cross reactivity;Dendritic Cells;design;Effectiveness;Future;Generations;Goals;Growth;Humoral Immunities;Immune response;Immune system;Infection;Inflammatory;Innate Immune Response;insight;Macrophage;Mediating;Moderna COVID-19 vaccine;Molecular Probes;neutralizing antibody;nonhuman primate;pandemic disease;Peripheral;Plasma Cells;receptor;response;SARS-CoV-2 antibody;SARS-CoV-2 infection;SARS-CoV-2 inhibitor;SARS-CoV-2 spike protein;SARS-CoV-2 variant;Stains;Structure;T-Cell Activation;T-Lymphocyte;Therapeutic;Therapeutic Agents;Vaccination;vaccine development;vaccine efficacy;Vaccines;Variant;Virus;Virus Replication;Work,"Identification, structures and ontogenies of SARS-CoV-2 antibodies",5147,NA,NA,NA,NA,5,NA,NA,427403,NA
11193325,ZIA,AI,1,N,NA,NA,NA,NA,ZIAAI005149,NA,NA,1ZIAAI005149-05,NIAID:284935\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,77882456 (contact),"ZHOU, TONGQING  (contact)",NA,NA,NA,2019-nCoV;Antibodies;Antigens;Carrier Proteins;Coupled;COVID-19;COVID-19 vaccine;Cryoelectron Microscopy;design;disabled;FDA approved;Generations;HIV-1;Immune Evasion;Immune response;immunogenic;immunogenicity;improved;Influenza;insight;Knowledge;nanoparticle;neutralizing antibody;NMR Spectroscopy;pathogen;prevent;response;SARS-CoV-2 infection;SARS-CoV-2 spike protein;self assembly;Structure;vaccine development;Vaccines;X-Ray Crystallography,Immunogen Design for SARS-CoV-2,5149,NA,NA,NA,NA,5,NA,NA,284935,NA
11193326,ZIA,AI,1,N,NA,NA,NA,NA,ZIAAI005150,NA,NA,1ZIAAI005150-05,NIAID:845146\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,6568699 (contact),"SEDER, ROBERT A (contact)",NA,NA,NA,2019-nCoV;ACE2;Adenoviruses;Antibodies;Antibody Response;Blood;Cell membrane;Chimeric Proteins;Clinical Data;Clinical Research;Clinical Trials;COVID-19;COVID-19 vaccine;Development;Devices;DNA;Formulation;global health;Goals;Health Priorities;Human;Immune;Immune response;Immunity;Immunize;immunogenicity;Immunoglobulin A;Immunoglobulin G;Infection;Lung;Membrane Fusion;Messenger RNA;Modeling;mucosal vaccination;mucosal vaccine;Nasal Lavage Fluid;Nucleic Acid Vaccines;pandemic disease;Protein Subunits;Proteins;receptor binding;response;RNA;RNA vaccine;Route;Safety;SARS-CoV-2 B.1.1.529;SARS-CoV-2 infection;SARS-CoV-2 spike protein;Structure of mucous membrane of nose;T cell response;Vaccination;vaccine candidate;vaccine development;vaccine formulation;Vaccines;variants of concern;Viral;Viral Vaccines,Development of a COVID Vaccine Model in NHP,5150,NA,NA,NA,NA,5,NA,NA,845146,NA
11193327,ZIA,AI,1,N,NA,NA,NA,NA,ZIAAI005151,NA,NA,1ZIAAI005151-05,NIAID:153089\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,7510169 (contact),"DOUEK, DANIEL CESAR (contact)",NA,NA,NA,2019-nCoV;adaptive immune response;Affect;antibody conjugate;Antigens;B-Lymphocytes;Body Fluids;Cell Physiology;Cell surface;Cells;Cellular Indexing of Transcriptomes and Epitopes by Sequencing;Chromium;Custom;Evolution;Genomics;Human;Immune;Immunoglobulins;Immunologic Receptors;Infection;inflammatory marker;Libraries;Macaca mulatta;Measures;Metabolic Marker;microbial;microbial products;Modeling;Nature;next generation sequencing;nonhuman primate;Nucleic Acids;Plasma;Proteomics;Protocols documentation;response;Sampling;SARS-CoV-2 infection;systemic inflammatory response;T cell receptor repertoire sequencing;T cell response;T-Lymphocyte;transcriptome;transcriptomics;Vaccinated;Vaccination,Innate and Adaptive Immune Responses in SARS-CoV-2 infection (COVID-19),5151,NA,NA,NA,NA,5,NA,NA,153089,NA
11193328,ZIA,AI,1,N,NA,NA,NA,NA,ZIAAI005155,NA,NA,1ZIAAI005155-05,NIAID:629324\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,7510051 (contact),"KOUP, RICHARD A (contact)",NA,NA,NA,2019-nCoV;Blood specimen;CD8B1 gene;Characteristics;COVID-19;COVID-19 vaccination;cytokine;Disease;enzyme linked immunospot assay;Epitopes;Evolution;Future;Genomics;Goals;Individual;Infection;Intervention;Maps;Peptides;Peripheral Blood Mononuclear Cell;Proteome;recruit;response;Sampling;SARS-CoV-2 infection;Sorting;Stains;T cell response;T-Cell Receptor;T-Lymphocyte;Therapeutic;Time;transcriptomics;Vaccines;volunteer,T cell analysis of COVID infection and vaccination,5155,NA,NA,NA,NA,5,NA,NA,629324,NA
11193329,ZIA,AI,1,N,NA,NA,NA,NA,ZIAAI005156,NA,NA,1ZIAAI005156-05,NIAID:633831\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,15193586 (contact),"BORITZ, ELI  (contact)",NA,NA,NA,Address;Anti-viral Response;Anti-viral Therapy;Antibody Response;Base Pairing;Bioinformatics;Clinical;Complex;Disease;Evolution;Gene Proteins;Gene Targeting;Generations;genetic analysis;genetic variant;Genetic Variation;Goals;high throughput technology;High-Throughput Nucleotide Sequencing;HIV;HIV drug resistance;Human;Immune response;in vivo;Individual;influenzavirus;insight;Intervention;Laboratories;Length;Mediating;Medical;Methods;Mutation;neutralizing antibody;novel;Outcome;Persons;Population;Population Heterogeneity;rare variant;Sampling;seasonal coronavirus;Sequence Analysis;single molecule;Therapeutic;Variant;Viral;Viral Genome;Virus;Virus Replication;Work,"High-throughput, single-molecule sequence analysis of virus populations in vivo",5156,NA,NA,NA,NA,5,NA,NA,633831,NA
11193330,ZIA,AI,1,N,NA,NA,NA,NA,ZIAAI005157,NA,NA,1ZIAAI005157-05,NIAID:333830\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,15193586 (contact),"BORITZ, ELI  (contact)",NA,NA,NA,2019-nCoV;acute COVID-19;Anatomy;B-Lymphocytes;Blood;Cell Separation;cell type;Clinical;Confocal Microscopy;COVID-19;deep sequencing;Disease;DNA Sequence Alteration;Evolution;Genetic Variation;Image;Image Cytometry;Immune response;Immunologics;in vivo;Individual;Laboratories;Lower respiratory tract structure;Lymphoid Cell;Memory B-Lymphocyte;Molecular Analysis;Mutation;Myeloid Cells;Outcome;Peripheral Blood Mononuclear Cell;Persons;Population;Prevalence;respiratory;Reverse Transcriptase Polymerase Chain Reaction;RNA;Sampling;SARS-CoV-2 genome;Sequence Analysis;single molecule;Site;stem;T cell response;Testing;Tissue Sample;Tissues;Upper respiratory tract;Virus;virus genetics,Persistence and Evolution of SARS-CoV-2,5157,NA,NA,NA,NA,5,NA,NA,333830,NA
11193331,ZIA,AI,1,N,NA,NA,NA,NA,ZIAAI005161,NA,NA,1ZIAAI005161-05,NIAID:1037303\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,9413846 (contact),"ROEDERER, MARIO  (contact)",NA,NA,NA,Acquired Immunodeficiency Syndrome;AIDS Vaccines;Animal Model;Animals;Antibodies;Antibody-mediated protection;Binding;biodefense;Cells;Cessation of life;chikungunya;Clinical Trials;COVID-19 pandemic;cross reactivity;Development;Encephalitis Viruses;Enterovirus;Epitopes;Equilibrium;Equine Encephalomyelitis;Fatality rate;Goals;Homeostasis;Human;human pathogen;Immune response;Immunology;in vitro Model;Individual;Infection;Intervention;Lymphoid Tissue;Macaca;Macaca mulatta;man;Methodology;model development;Modeling;Monoclonal Antibodies;Monoclonal Antibody Therapy;Mucous Membrane;nonhuman primate;Norovirus;pathogen;Pathogenesis;Pathogenicity;Pattern;Persons;Phase;Primates;Privatization;SARS-CoV-2 infection;Surface;System;Testing;Therapeutic;therapeutic evaluation;Therapeutic Monoclonal Antibodies;trafficking;vaccine development;Vaccine Research;vaccine response;vaccine-induced antibodies;Vaccines;Venezuelan;Virus;Virus Diseases,Development of NHP Models for Infectious Pathogens of Man,5161,NA,NA,NA,NA,5,NA,NA,1037303,NA
11193332,ZIA,AI,1,N,NA,NA,NA,NA,ZIAAI005163,NA,NA,1ZIAAI005163-05,NIAID:17731\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,16169666 (contact),"MASON, ROSEMARIE  (contact)",NA,NA,NA,2019-nCoV;Antibody Therapy;Antigens;Cell Separation;Coronavirus;COVID-19;Development;Dissociation;Epitopes;Manuscripts;Monoclonal Antibodies;neutralizing monoclonal antibodies;Prevention;Resolution;SARS-CoV-2 antibody;SARS-CoV-2 infection;SARS-CoV-2 spike protein;Severe Acute Respiratory Syndrome;Structure;vaccine development;variants of concern;Virus Diseases,Monoclonal antibody isolation and characterization for COVID-19 Effort,5163,NA,NA,NA,NA,5,NA,NA,17731,NA
11193333,ZIA,AI,1,N,NA,NA,NA,NA,ZIAAI005166,NA,NA,1ZIAAI005166-03,NIAID:4771281\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,7510169 (contact),"DOUEK, DANIEL CESAR (contact)",NA,NA,NA,Acceleration;Antigens;Biological Assay;cohort;Country;cross reactivity;Data;data resource;detection assay;Diagnostic;diagnostic assay;Early Diagnosis;genetic analysis;Human;human pathogen;Immune response;Immunologic Epidemiology;Immunologic Surveillance;Immunology procedure;Laboratories;microbial;Monoclonal Antibodies;novel virus;pandemic potential;pandemic preparedness;pandemic response;Population;Prevention;programs;prophylactic;Reagent;repository;response;Serology;Therapeutic;Translating;vaccine development;vaccine discovery;Zoonoses,PREMISE: Pandemic Response Repository through Microbial and Immune Surveillance and Epidemiology,5166,NA,NA,NA,NA,3,NA,NA,4771281,NA
11193334,ZIA,AI,1,N,NA,NA,NA,NA,ZIAAI005168,NA,NA,1ZIAAI005168-03,NIAID:17731\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,9413846 (contact),"ROEDERER, MARIO  (contact)",NA,NA,NA,Acute Respiratory Distress Syndrome;Antibody Response;Antigens;Bangladesh;bat-borne;candidate selection;Case Fatality Rates;Chimera organism;Chimeric Proteins;clinical development;Coughing;design;Development;Disease Outbreaks;effector T cell;Elements;Family;Family suidae;Fever;Headache;Henipavirus;Human;human disease;immunogenicity;improved;India;Licensing;Link;Malaysia;Messenger RNA;Molecular Conformation;Monoclonal Antibodies;monomer;mRNA delivery;Mus;Nervous System Disorder;neutralizing antibody;Nipah Virus;Paramyxovirus;Protein Engineering;Proteins;Structure;T cell response;Therapeutic;vaccine-induced antibodies;Vaccines;Virus,Nipah virus vaccines and monoclonal antibodies,5168,NA,NA,NA,NA,3,NA,NA,17731,NA
11193335,ZIA,AI,1,N,NA,NA,NA,NA,ZIAAI005170,NA,NA,1ZIAAI005170-02,NIAID:1317404\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,16169666 (contact),"MASON, ROSEMARIE  (contact)",NA,NA,NA,African Green Monkey;Amendment;Antibodies;Antibody Response;B-Lymphocytes;Binding;Biological Assay;candidate identification;Cessation of life;Chimeric Proteins;Coma;Development;Disease;Dose;Enzyme-Linked Immunosorbent Assay;experimental study;Follow-Up Studies;Frequencies;Glycoproteins;Immune;Immune response;Immunologic Tests;International;Licensing;Link;Messenger RNA;monomer;Nipah Virus;Phase I Clinical Trials;Phenotype;Pilot Projects;programs;Reporting;RNA vaccine;Specificity;T cell response;Testing;Time;vaccine candidate;vaccine-induced antibodies;Vaccines;Virus;Virus Diseases;World Health Organization,Development of Nipah virus mRNA vaccine,5170,NA,NA,NA,NA,2,NA,NA,1317404,NA
11193336,ZIA,TR,1,N,NA,NA,NA,NA,ZIATR000038,NA,NA,1ZIATR000038-10,NCATS:1016978\,INTRAMURAL RESEARCH,2024,NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES,NA,NA,NA,14380131 (contact),"XIA, MENGHANG  (contact)",NA,NA,NA,"3-Dimensional;Acetylcholine;Acrylates;Active Sites;Adult;Advocate;Affinity;Aftercare;Agonist;All-Trans-Retinol;Androgen Receptor;Animal Testing;antagonist;Binding;Biochemical;Biochemical Pathway;Biological;biological adaptation to stress;Biological Assay;Biological Process;biological systems;Biomedical Engineering;Biotechnology;Brain;Carbachol;Cell Differentiation process;cell dimension;Cell Survival;Cells;Chemicals;Cholinergic Agonists;Collaborations;computational toxicology;consumer product;Consumption;Cosmetics;counterscreen;CYP26B1 gene;CYP2C9 gene;Cysteine;Cytochrome P450;cytokine;Data;design;Docking;Dose;drug metabolism;Elements;Endocrinology;Environment;environmental chemical;environmental toxicology;Enzyme Inhibitor Drugs;Enzymes;Epithelium;ESR1 gene;Evaluation;Exhibits;Exposure to;Family;Fatty Acids;Fetal Development;Follow-Up Studies;FOS gene;frontier;Genes;Genomics;GNRH1 gene;Goals;Hazardous Substances;Health;High Pressure Liquid Chromatography;high throughput screening;Homeostasis;Human;Human Cell Line;Hypothalamic structure;IL8 gene;In Vitro;in vitro Assay;in vivo;induced pluripotent stem cell;inhibitor;irritation;Isomerism;Journals;JUN gene;KISS1 gene;Larva;Leadership;Libraries;Ligands;Lysine;Manuscripts;Mass Spectrum Analysis;Measures;Mediating;Metabolism;meter;methacholine;Methods;Microsomes;miniaturize;Mission;Mitotic Cell Cycle;Modeling;Molecular;Monitor;monolayer;Mus;nanomolar;National Center for Advancing Translational Sciences;National Health and Nutrition Examination Survey;National Institute of Environmental Health Sciences;Neurons;Non-Steroidal Anti-Inflammatory Agents;novel;Nuclear Receptors;Occupations;orphan nuclear receptor ROR-gamma;Outcome;Pathway interactions;Peptides;Persons;Pharmaceutical Preparations;Pituitary Gland;Play;Poly-fluoroalkyl substances;PPAR alpha;predictive modeling;programs;Protein Isoforms;Publishing;receptor;Receptors, Adrenergic, beta-1;Reporting;Reproduction;Research Personnel;response;retinoic acid 4-hydroxylase;Retinoic Acid Receptor;Retinoids;robotic system;Role;Safety;screening;screening program;Serum;Signal Transduction;Skin;Specificity;steroid hormone;substance use;System;Testing;Thick;Tight Junctions;Time;Topical application;Toxic effect;Toxicology;Tretinoin;United States Environmental Protection Agency;United States Food and Drug Administration;United States National Institutes of Health;Validation;Vitamin A;Vitamin K;Work;Zebrafish",Toxicology in the 21st Century Program (Tox21) - Systems Toxicology,38,NA,NA,NA,NA,10,NA,NA,1016978,NA
11193337,ZIA,TR,1,N,NA,NA,NA,NA,ZIATR000039,NA,NA,1ZIATR000039-10,NCATS:960480\,INTRAMURAL RESEARCH,2024,NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES,NA,NA,NA,14380347 (contact),"GERHOLD, DAVID  (contact)",NA,NA,NA,3-Dimensional;Adverse effects;Affect;anakinra;Animal Testing;Anti-Inflammatory Agents;Atherosclerosis;base;Biochemical Pathway;biochip;Biological;biological adaptation to stress;Biological Assay;biological systems;Blood Platelets;Blood Vessels;Canis familiaris;cardiovascular health;Cardiovascular system;Cell Culture Techniques;Cell Line;Cell model;Cells;Chemicals;Coagulation Process;Coculture Techniques;Collaborations;computational toxicology;Consumption;CYP1A1 gene;CYP1B1 gene;cytokine;design;Development;Drug Combinations;drug development;Drug resistance;Drug Targeting;Endothelial Cells;Environment;environmental chemical;Ephedra;Etanercept;Evaluation;Failure;fluid flow;Gene Expression;Genomics;Goals;Health;Heart;Human;human disease;improved;In Vitro;in vivo;Inflammation;Inflammatory;innovation;Libraries;Luciferases;Measures;Metals;Methods;Mission;Modeling;Myocardial Infarction;National Center for Advancing Translational Sciences;National Institute of Environmental Health Sciences;National Toxicology Program;Neoplasm Metastasis;Neurodegenerative Disorders;Neurons;neurotoxicity;new technology;Oxidative Stress;Parkinson Disease;Pathway interactions;Patients;Pharmaceutical Preparations;Poison;predictive modeling;programs;Reporter;resistance mechanism;response;screening;stem cell differentiation;System;Technology;Testing;Therapeutics for Rare and Neglected Diseases;Time;Tissue Model;Toxic effect;Toxic Environmental Substances;toxicant;Toxicology;transcriptomics;translation to humans;Tumor necrosis factor receptor 11b;tumorigenesis;United States Environmental Protection Agency;United States Food and Drug Administration;Vascular Endothelial Cell;Work,Toxicology in the 21st Century Program (Tox21) - Genomic Toxicology,39,NA,NA,NA,NA,10,NA,NA,960480,NA
11193338,ZIA,TR,1,N,NA,NA,NA,NA,ZIATR000040,NA,NA,1ZIATR000040-10,NCATS:847482\,INTRAMURAL RESEARCH,2024,NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES,NA,NA,NA,14380349 (contact),"HUANG, RUILI  (contact)",NA,NA,NA,2019-nCoV;Adverse drug effect;Affect;Algorithmic Software;Algorithms;Analytical Chemistry;Animal Testing;Animals;Anti-viral Agents;Area;Auranofin;Biochemical Pathway;Biological;Biological Assay;biological systems;Biology;Cardiotoxicity;Cells;Charge;Chemical Exposure;Chemical Structure;Chemicals;Classification;Clinical Trials;Collaborations;Communication;computational toxicology;Computer Models;computerized data processing;Consumption;curve fitting;Data;Data Analyses;data pipeline;Data Set;design;Development;drug induced liver injury;drug repurposing;Eligibility Determination;environmental chemical;Evaluation;Exposure to;Follow-Up Studies;Food;Gene Expression;Genes;genetic linkage analysis;genome-wide linkage;Genomics;Goals;Health;high throughput screening;Household;Human;improved;In Vitro;in vivo;in vivo Model;Informatics;Leadership;Libraries;Machine Learning;Malaria;Manuscripts;Maryland;Measures;medical schools;medical specialties;Medicine;Methods;Mission;Modeling;National Center for Advancing Translational Sciences;National Institute of Allergy and Infectious Disease;National Institute of Environmental Health Sciences;National Toxicology Program;Nature;neurotoxicity;novel;olfactory receptor;Online Systems;Paper;Parasitic infection;Pathway interactions;Performance;Persons;Pharmaceutical Preparations;Pharmacologic Substance;Pharmacology;preclinical study;predictive modeling;Preparation;programs;Proteomics;PubChem;Public Health;Publications;Publishing;Rare Diseases;Reproducibility;Research;Research Personnel;response;Safety;Scientist;screening;Software Tools;Structure-Activity Relationship;System;Testing;Time;tool;Toxic effect;Toxicology;United States Environmental Protection Agency;United States Food and Drug Administration;United States National Institutes of Health;United States National Library of Medicine;Universities;Update;Viral;Visualization;Water;web site;Work,Toxicology in the 21st Century Program (Tox21) - Computational Toxicology,40,NA,NA,NA,NA,10,NA,NA,847482,NA
11193339,ZIA,TR,1,N,NA,NA,NA,NA,ZIATR000083,NA,NA,1ZIATR000083-10,NCATS:491448\,INTRAMURAL RESEARCH,2024,NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES,NA,NA,NA,14380300 (contact),"MARUGAN, JUAN  (contact)",NA,NA,NA,absorption;addiction;Addictive Behavior;analog;Animal Model;Behavioral;Behavioral Assay;beta-arrestin;Binding;Biochemical;Biological Assay;biophysical techniques;Characteristics;Clinical;clinical candidate;Collaborations;Cryoelectron Microscopy;Development;Docking;Drug Addiction;drug discovery;Drug or Chemical;drug testing;Eating;Eating Disorders;Endosomes;Evaluation;Excretory function;G-Protein-Coupled Receptors;Gene Modified;ghrelin;ghrelin receptor;GHS-R1a;Goals;GTP-Binding Proteins;humanized mouse;improved;in silico;in vivo;Laboratories;Lead;lead optimization;lead series;Ligands;Measures;Metabolic;Metabolism;Modeling;molecular modeling;Mus;Mutagenesis;novel therapeutic intervention;Outcome;pharmacologic;Pharmacology;Physiological;pre-clinical;Production;Property;protein activation;Proteins;receptor;recruit;Signal Transduction;small molecule;Structure-Activity Relationship;tool;trafficking;Validation,Identification of small molecule that selectively modulate Ghrelin receptor (GHSR1a) b-arrestin signaling as a new therapeutic approach for the treatment of addiction,83,NA,NA,NA,NA,10,NA,NA,491448,NA
11193340,ZIA,TR,1,N,NA,NA,NA,NA,ZIATR000244,NA,NA,1ZIATR000244-10,NCATS:6511091\,INTRAMURAL RESEARCH,2024,NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES,NA,NA,NA,79299645 (contact),"TRISTAN, CARLOS  (contact)",NA,NA,NA,"Absence of pain sensation;Address;Adult;Afferent Neurons;Alexander Disease;Amyotrophic Lateral Sclerosis;Area;Astrocytes;Baltimore;Basic Science;bean;Biomanufacturing;Cell Aggregation;cell community;Cell Differentiation process;Cell Line;Cell Survival;Cell Therapy;cell type;Cells;Chemotherapy-induced peripheral neuropathy;Clinical;clinical application;Clone Cells;Clustered Regularly Interspaced Short Palindromic Repeats;Collaborations;college;Communities;County;Cryopreserved Cell;Cultured Cells;diabetic;differentiation protocol;Disease;disease model;dopaminergic neuron;drug development;Educational workshop;Electrophysiology (science);Embryoid bodies;fitness;Funding;gene-editing approach;Genetic;Genetic Screening;genome editing;Goals;Hepatocyte;human induced pluripotent stem cells;Hypothalamic structure;improved;induced pluripotent stem cell;Insulin;Insulin-Dependent Diabetes Mellitus;interest;Laboratories;Laboratory Scientists;Liver Failure;Manuscripts;Maryland;Medicine;meetings;Metabolic Diseases;Methods;Modeling;Motor Neurons;multiple omics;National Center for Advancing Translational Sciences;National Human Genome Research Institute;Nervous System Disorder;Neuroglia;Neuronal Differentiation;Neurons;Nociceptors;Non-Insulin-Dependent Diabetes Mellitus;novel;Opioid;Oranges;Organoids;Paper;Paris, France;Parkinson Disease;patient derived induced pluripotent stem cells;Pediatric Hospitals;Peripheral;Peripheral Nervous System Diseases;Phase;Placentation;pluripotency;pluripotent stem cell differentiation;Pluripotent Stem Cells;preclinical development;programs;Publishing;Quality Control;Reagent;Recombinant Proteins;Regenerative Medicine;reproductive system disorder;Research;Robotics;Sialic Acids;small molecule;stem cell biology;Stem Cell Research;stem cell therapy;stem cells;Stress;symposium;Testing;Therapeutic;therapeutic genome editing;transcriptomics;translational applications;Translational Research;translational scientist;Translations;United States National Institutes of Health;Universities;Variant;virtual;Visit;webinar",Stem Cell Translation Laboratory (SCTL),244,NA,NA,NA,NA,10,NA,NA,6511091,NA
11193341,ZIB,AI,1,N,NA,NA,NA,NA,ZIBAI005063,NA,NA,1ZIBAI005063-21,NIAID:66352968\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,77873541 (contact),"GALL, JASON  (contact)",NA,NA,NA,"Adjuvant;Area;Biological Products;Buffers;Clinic;Clinical;clinical material;Clinical Trials;Conjugate Vaccines;Dedications;Development;Ebola Vaccines;Equipment;Facility Designs;Good Manufacturing Process;HIV;HIV vaccine;Human;Influenza;Influenza A Virus, H5N1 Subtype;influenza virus vaccine;Laboratories;large scale production;Malaria;manufacture;manufacturing facility;manufacturing process;Marburgvirus;Monoclonal Antibodies;nanoparticle;National Institute of Allergy and Infectious Disease;next generation;operation;pandemic influenza;Peptides;Phase I/II Clinical Trial;Placebos;Plants;Process;programs;Proteins;Quality Control;Respiratory Syncytial Virus Vaccines;Techniques;Testing;United States Food and Drug Administration;universal influenza vaccine;vaccine evaluation;Vaccine Production;vaccine-induced antibodies;Vaccines;Vial device;Work;Zika virus vaccine",Establishment and operation of a Vaccine Pilot Plant,5063,NA,NA,NA,NA,21,NA,NA,66352968,NA
11193342,ZIB,AI,1,N,NA,NA,NA,NA,ZIBAI005109,NA,NA,1ZIBAI005109-16,NIAID:8780594\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,77873541 (contact),"GALL, JASON  (contact)",NA,NA,NA,Clinic;clinical material;Clinical Research;Clinical Trials;Dedications;Development;Effectiveness;Evaluation;Future;Good Manufacturing Process;Human;Human Volunteers;Immunity;influenza virus strain;influenza virus vaccine;Laboratories;large scale production;manufacture;manufacturing facility;manufacturing process;Monitor;nanoparticle;National Institute of Allergy and Infectious Disease;Phase;Phase I/II Clinical Trial;Placebos;Production;programs;Safety;Seasons;Techniques;Testing;universal influenza vaccine;vaccine immunogenicity;Vaccine Production;Vaccines;Virus,Development/production of universal influenza vaccines,5109,NA,NA,NA,NA,16,NA,NA,8780594,NA
11193343,ZIB,AI,1,N,NA,NA,NA,NA,ZIBAI005121,NA,NA,1ZIBAI005121-14,NIAID:12979030\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,77873541 (contact),"GALL, JASON  (contact)",NA,NA,NA,"analytical method;assay development;Biological Products;Biological Response Modifier Therapy;Biotechnology;cell bank;cGMP production;Clinical;clinical application;clinical material;Clinical Trials;Contracts;Democratic Republic of the Congo;Development;Disease Outbreaks;Documentation;Ebola;Formulation;HIV Antibodies;HIV-1;improved;Industry;interest;Laboratories;Licensing;lot production;manufacture;manufacturing process;manufacturing test;Methods;Monoclonal Antibodies;neutralizing antibody;neutralizing monoclonal antibodies;Pathway interactions;Pharmaceutical Preparations;Phase;phase 1 study;phase 2 study;Plants;Process;Production;programs;Protocols documentation;Public Health;Randomized, Controlled Trials;Research;Services;stability testing;Therapeutic;Therapeutic antibodies;Toxicology;vaccine development;Vaccine Production;Vaccines",Production of a Broadly Neutralizing HIV Antibodies,5121,NA,NA,NA,NA,14,NA,NA,12979030,NA
11193344,ZIB,AI,1,N,NA,NA,NA,NA,ZIBAI005153,NA,NA,1ZIBAI005153-05,NIAID:106967\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,77873541 (contact),"GALL, JASON  (contact)",NA,NA,NA,analytical method;Anti-malarials;Antibodies;assay development;Biotechnology;Buffers;cell bank;cGMP production;Clinical;clinical application;clinical material;Clinical Trials;Contracts;COVID-19 pandemic;Development;Documentation;Dose;Enrollment;Formulation;Human;improved;Industry;Infection prevention;Investigational New Drug Application;Kenya;Laboratories;Malaria;malaria infection;Malaria prevention;Mali;manufacture;manufacturing process;manufacturing test;Methods;Monoclonal Antibodies;Pharmaceutical Preparations;Phase;phase 1 study;phase 2 study;Phase I Clinical Trials;Phase II Clinical Trials;Plants;Process;Production;Productivity;programs;Research;Route;stability testing;Therapeutic Monoclonal Antibodies;Toxicology;vaccine development;Vaccine Production;Vaccines,Development and Production of Anti-Malarial Biologicals,5153,NA,NA,NA,NA,5,NA,NA,106967,NA
11193345,ZIB,AI,1,N,NA,NA,NA,NA,ZIBAI005154,NA,NA,1ZIBAI005154-05,NIAID:10557332\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,77873541 (contact),"GALL, JASON  (contact)",NA,NA,NA,Adjuvant;aluminum sulfate;Antibodies;Carbopol;Clinic;clinical material;Clinical Trials;Dedications;Development;Evaluation;Good Manufacturing Process;HIV;HIV vaccine;HIV-1;Human;Human Volunteers;Immunity;immunogenicity;improved;Joints;Laboratories;large scale production;Lecithin;manufacture;manufacturing facility;manufacturing process;National Institute of Allergy and Infectious Disease;Peptides;Phase;Phase I/II Clinical Trial;Placebos;Process;Production;programs;Protein Subunits;Recombinants;Safety;Sterilization;Subunit Vaccines;Techniques;Technology Transfer;Testing;Tetanus Toxoid;Vaccine Design;vaccine immunogenicity;Vaccine Production;Vaccines,Development and Production of HIV Vaccines and Adjuvants,5154,NA,NA,NA,NA,5,NA,NA,10557332,NA
11193346,ZIB,AI,1,N,NA,NA,NA,NA,ZIBAI005165,NA,NA,1ZIBAI005165-04,NIAID:629324\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,77873541 (contact),"GALL, JASON  (contact)",NA,NA,NA,2019-nCoV;betacoronavirus;Biological Products;Clinic;clinical material;Clinical Trials;Collaborations;coronavirus vaccine;Dedications;Development;Evaluation;Good Manufacturing Process;Human;Human Volunteers;Immunity;influenza virus vaccine;Laboratories;large scale production;manufacture;manufacturing facility;manufacturing process;National Institute of Allergy and Infectious Disease;Phase;Phase I/II Clinical Trial;Placebos;Production;programs;Proteins;Reagent;Research;RNA vaccine;Safety;Techniques;Testing;vaccine immunogenicity;Vaccine Production;Vaccines;Variant,Development and Production of SARS-CoV2 Biologicals and Vaccines,5165,NA,NA,NA,NA,4,NA,NA,629324,NA
11193347,ZIC,AI,1,N,NA,NA,NA,NA,ZICAI005002,NA,NA,1ZICAI005002-23,NIAID:2325099\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,78836556 (contact),"CHENG, CHENG  (contact)",NA,NA,NA,Adjuvant;Affinity;aluminum sulfate;Animal Model;Animals;Antibodies;Antibody Response;Antigens;Autologous;base;Binding Sites;Biological Assay;biophysical properties;Biotechnology;Carrier Proteins;Categories;Cavia;Cells;Chimeric Proteins;Clinical;clinical development;clinical predictors;Clinical Trials;Collaborations;Data;design;Development;Dose;Drug Kinetics;env Gene Products;Evaluation;flexibility;Generations;glycosylation;Half-Life;HIV;HIV vaccine;HIV-1;HIV-1 vaccine;Human;human monoclonal antibodies;Immune;Immune response;Immunize;immunogenicity;Immunoglobulin G;improved;in vivo;Infection;Link;manufacturability;Methods;Monkeys;mouse model;Mus;Mutation;nanoparticle;neoantigens;neonatal Fc receptor;neutralizing antibody;next generation;nonhuman primate;novel;novel vaccines;Outcome;Pathway interactions;Patients;Peptide antibodies;Peptide Vaccines;Peptides;Peripheral Blood Mononuclear Cell;Phase I Clinical Trials;Polysaccharides;Population;preclinical study;predictive tools;Prevention;Preventive;Proteins;rational design;Regimen;Research;Resistance;response;RNA vaccine;Route;safety testing;Serum;simian human immunodeficiency virus;Site;Specificity;structural biology;Structure;Surface;T-Lymphocyte;Testing;Therapeutic;Transgenic Mice;Transmembrane Domain;Treatment Efficacy;Vaccination;vaccine candidate;vaccine evaluation;vaccine strategy;Vaccines;Variant;Viral;viral resistance;Virus;Virus Diseases;Work,HIV/AIDS Vaccine and Antibody Development,5002,NA,NA,NA,NA,23,NA,NA,2325099,NA
11193348,ZIC,AI,1,N,NA,NA,NA,NA,ZICAI005010,NA,NA,1ZICAI005010-23,NIAID:892443\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,78846320 (contact),"DORIA-ROSE, NICOLE  (contact)",NA,NA,NA,Animals;Antibodies;antibody engineering;antibody test;Biological Assay;candidate selection;clinical candidate;Clinical Trials;Data;Data Analyses;Genes;HIV;HIV Antibodies;HIV vaccine;HIV-1;Immune response;Immunology procedure;improved;Individual;Industry Collaboration;Infection;Infrastructure;Liquid substance;manufacturability;mutant;National Institute of Allergy and Infectious Disease;neutralizing antibody;Persons;Protocols documentation;Reagent;Robotics;Role;Running;Sampling;Serum;Services;Standardization;Vaccinated;Vaccine Research;Vaccines;Variant;Virus;Work,Quantitative Immunological Assays to Assess HIV Antibodies and Vaccines,5010,NA,NA,NA,NA,23,NA,NA,892443,NA
11193349,ZIC,AI,1,N,NA,NA,NA,NA,ZICAI005101,NA,NA,1ZICAI005101-16,NIAID:2289001\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,16169734 (contact),"PERFETTO, STEPHEN  (contact)",NA,NA,NA,antibody conjugate;Basic Science;Cell Separation;Cells;Clinical;Clinical Trials;Collaborations;Color;Communities;Complex;Computers and Advanced Instrumentation;Core Facility;COVID-19 pandemic;Data Analyses;Data Collection;design;Detection;detector;Development;Dimensions;Dyes;Emerging Communicable Diseases;Ensure;Environment;experimental study;Flow Cytometry;Fluorochrome;Immunology;instrument;instrumentation;Laboratories;Lasers;Maintenance;Manufacturer;Measures;multidimensional data;nanocrystal;National Institute of Allergy and Infectious Disease;novel;operation;Optics;Performance;Procedures;programs;quality assurance;Quality Control;Reagent;Research;Research Personnel;Robotics;Role;Running;Sampling;Schedule;Services;Software Tools;Specimen;Speed;Techniques;Technology;tool;Training;vaccine development;Vaccine Research;Validation;Viola;Work,Flow Cytometry Core,5101,NA,NA,NA,NA,16,NA,NA,2289001,NA
11193350,ZIC,AI,1,N,NA,NA,NA,NA,ZICAI005103,NA,NA,1ZICAI005103-16,NIAID:1670979\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,16169736 (contact),"FOULDS, KATHRYN  (contact)",NA,NA,NA,Adjuvant;Animal Care and Use Committees;Animals;Basic Science;Biological Assay;Cell Separation;Clinical;Collaborations;Contracts;Cryopreserved Cell;Data;Data Analyses;design;Ensure;Evaluation;experimental study;Flow Cytometry;Generations;good laboratory practice;Human;IACUC;immune function;immunogenicity;Immunologics;International;Laboratories;Laboratory Animal Medicine;Laboratory Research;Lymphocyte;lymphocyte trafficking;Maintenance;Memory;Methods;Modeling;mucosal site;Mucous Membrane;nonhuman primate;operation;Oral;Pathogenesis;Practice Guidelines;preclinical study;Preclinical Testing;Procedures;Protocols documentation;Qualifying;Reproducibility;Research Personnel;research study;Research Support;response;sample collection;Schedule;Site;SIV;Specimen;Specimen Handling;Technology;Testing;Tissues;Training;Translational Research;translational study;Translations;Vaccination;vaccine evaluation;Vaccine Research;vector;Virus Diseases;Writing,Non-Human Primate Core,5103,NA,NA,NA,NA,16,NA,NA,1670979,NA
11193351,ZIC,AI,1,N,NA,NA,NA,NA,ZICAI005111,NA,NA,1ZICAI005111-15,NIAID:258129\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,79365590 (contact),"SHEN, CHEN-HSIANG  (contact)",NA,NA,NA,2019-nCoV;Adsorption;Antibodies;Antibody Response;Antigens;B-Cell Antigen Receptor;B-Lymphocytes;Binding;Binding Sites;Bioinformatics;bioinformatics tool;Biological;Biological Assay;Computational Biology;computerized tools;design;Development;Elements;Epitopes;Evaluation;experimental study;flexibility;General Population;genomic locus;Glycoproteins;Goals;Hepatitis B Virus;HIV-1;Immune system;improved;Individual;Infection;insight;Macaca;Membrane;neutralizing antibody;next generation sequencing;novel;pathogen;pathogenic virus;Pathway interactions;Patients;Peptides;physical property;Play;Process;Proteins;response;Role;SARS-CoV-2 spike protein;Serology;Serum;Specificity;structural biology;Structure;Surface;Techniques;Therapeutic;tool;Vaccinated;Vaccination;Vaccinee;Vaccines;Variant;Viral;Virus;virus core,Design of Antigenically-Specific Probes for Sera Analysis and MAb Isolation,5111,NA,NA,NA,NA,15,NA,NA,258129,NA
11193352,ZIC,AI,1,N,NA,NA,NA,NA,ZICAI005112,NA,NA,1ZICAI005112-15,NIAID:258129\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,77882474 (contact),"RAWI, REDA  (contact)",NA,NA,NA,Architecture;Bioinformatics;Biological;Characteristics;Comprehension;computerized tools;Computing Methodologies;Cryoelectron Microscopy;Crystallization;Data;disulfide bond;Epitopes;flexibility;glycosylation;Homology Modeling;Hydrophobicity;Investigation;Link;Membrane Proteins;Methods;Modeling;Molecular;molecular dynamics;Play;Process;Protein Engineering;protein structure;Proteins;Research;Role;Sequence Analysis;Site;Solvents;Structure;Techniques;Vaccine Design;Viral;Viral Antigens;Viral Proteins,Computational Tools for Structural Analysis,5112,NA,NA,NA,NA,15,NA,NA,258129,NA
11193353,ZIC,AI,1,N,NA,NA,NA,NA,ZICAI005114,NA,NA,1ZICAI005114-15,NIAID:258129\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,77882474 (contact),"RAWI, REDA  (contact)",NA,NA,NA,Antibodies;Antibody Response;Antigens;Binding;Cholesterol;Computing Methodologies;design;Development;Engineering;Ensure;Epitopes;Half-Life;Human;human pathogen;Immune response;Immunization;Immunize;immunogenicity;in silico;inhibiting antibody;iterative design;Low Density Lipoprotein Receptor;Low-Density Lipoproteins;Macaca fascicularis;Membrane Proteins;Methodology;Methods;Molecular Conformation;mouse model;Myocardial Infarction;Plasma Proteins;Positioning Attribute;Prevention;Proprotein Convertases;Proteins;Regulation;Research;Resistance;scaffold;Serum;Site;Structure;Subtilisins;tool;Vaccination;vaccine efficacy;vaccine response;vaccine strategy;Vaccines;Variant;Viral,Rational Immunogen Design Using Computational Methods,5114,NA,NA,NA,NA,15,NA,NA,258129,NA
11193354,ZIC,AI,1,N,NA,NA,NA,NA,ZICAI005133,NA,NA,1ZICAI005133-06,NIAID:2224710\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,7510169 (contact),"DOUEK, DANIEL CESAR (contact)",NA,NA,NA,Antibodies;antibody conjugate;Antigens;B-Lymphocytes;Cavia;Cell surface;Cells;Cellular Indexing of Transcriptomes and Epitopes by Sequencing;Chromium;Clinical Research;Custom;design;Evolution;Genes;genome analysis;Genomics;Goals;HIV;Human;Immunoglobulin Genes;Immunoglobulin Somatic Hypermutation;Immunoglobulins;Immunology;Infectious Agent;influenza virus vaccine;Libraries;Macaca fascicularis;Macaca mulatta;Malaria Vaccines;Methodology;microbiome sequencing;Molecular;Monitor;mRNA sequencing;Mus;neutralizing antibody;next generation sequencing;passive antibodies;Persons;programs;Proteomics;Protocols documentation;Research Project Grants;Respiratory Syncytial Virus Vaccines;Sampling;Series;Specialist;T cell receptor repertoire sequencing;targeted sequencing;Techniques;Testing;transcriptome sequencing;Tuberculosis Vaccines;vaccine candidate;vaccine effectiveness;vaccine evaluation;Vaccine Research;Variant,The Genome Analysis Core,5133,NA,NA,NA,NA,6,NA,NA,2224710,NA
11193355,ZIC,AI,1,N,NA,NA,NA,NA,ZICAI005140,NA,NA,1ZICAI005140-05,NIAID:784697\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,77882474 (contact),"RAWI, REDA  (contact)",NA,NA,NA,Accounting;Address;Algorithms;Antibodies;Antibody Binding Sites;antigen binding;Antigens;Binding;Bioinformatics;Characteristics;combinatorial;Complex;Computational algorithm;Computational Biology;Computer Assisted;Data;design;Development;Effectiveness;Evaluation;flexibility;HIV-1;Immune;improved;Investigation;Ligands;machine learning classifier;Methodology;Methods;Modeling;novel;Post-Translational Protein Processing;Process;Property;Protein Engineering;Protein Glycosylation;protein structure;Proteins;Protocols documentation;Quaternary Protein Structure;Scaffolding Protein;structural biology;success;Techniques;Technology;tool;Transplantation;Virus,"Computational Algorithms, Methods, and Tools for Antibody Design",5140,NA,NA,NA,NA,5,NA,NA,784697,NA
11193356,ZIC,AI,1,N,NA,NA,NA,NA,ZICAI005152,NA,NA,1ZICAI005152-05,NIAID:1368169\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,16176359 (contact),"KONG, WING PUI  (contact)",NA,NA,NA,2019-nCoV;aged;Antibodies;Antibody Response;Collaborations;combat;COVID-19;COVID-19 pandemic;COVID-19 patient;COVID-19 vaccine;Development;DNA;FDA Emergency Use Authorization;future outbreak;Genetic;Hepatitis B Surface Antigens;Human;Immunization;Laboratories;Length;Mus;nanoparticle;National Institute of Allergy and Infectious Disease;neutralizing antibody;pandemic disease;pre-clinical;prevent;Proline;RNA vaccine;Sarbecovirus;SARS coronavirus;SARS-CoV-2 infection;SARS-CoV-2 spike protein;Vaccinee;Vaccines;virology,Pre-clinical Vaccine and Antibody Development for Coronavirus Disease 2019 (COVID-19),5152,NA,NA,NA,NA,5,NA,NA,1368169,NA
11193357,ZIC,AI,1,N,NA,NA,NA,NA,ZICAI005164,NA,NA,1ZICAI005164-05,NIAID:17731\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,16169736 (contact),"FOULDS, KATHRYN  (contact)",NA,NA,NA,Adjuvant;Animal Care and Use Committees;Animals;Basic Science;Biological Assay;Cell Separation;Clinical;Collaborations;Contracts;COVID-19;Cryopreserved Cell;Data;Data Analyses;design;Ensure;Evaluation;experimental study;Flow Cytometry;Generations;good laboratory practice;Human;IACUC;immune function;immunogenicity;Immunologics;International;Laboratories;Laboratory Animal Medicine;Laboratory Research;Lymphocyte;lymphocyte trafficking;Maintenance;Memory;Methods;Modeling;mucosal site;Mucous Membrane;nonhuman primate;operation;Oral;Pathogenesis;Practice Guidelines;preclinical study;Preclinical Testing;Procedures;Protocols documentation;Qualifying;Reproducibility;Research Personnel;research study;Research Support;response;sample collection;Schedule;Site;Specimen;Specimen Handling;Technology;Testing;Tissues;Training;Translational Research;translational study;Translations;Vaccination;vaccine evaluation;Vaccine Research;vector;Virus Diseases;Writing,Non-Human Primate Core for COVID Effort,5164,NA,NA,NA,NA,5,NA,NA,17731,NA
11193358,ZIC,TR,1,N,NA,NA,NA,NA,ZICTR000041,NA,NA,1ZICTR000041-10,NCATS:1301773\,INTRAMURAL RESEARCH,2024,NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES,NA,NA,NA,79983617 (contact),"CHENG, KEN  (contact)",NA,NA,NA,3-Dimensional;Acceleration;Adaptive Immune System;Address;Adverse effects;Algorithmic Analysis;Area;assay development;Automation;Awareness;Bacteria;Bacteriophages;Binding;Biological Assay;Biological Process;Biology;Biotechnology;Cells;Cellular biology;cellular imaging;Chemicals;Clustered Regularly Interspaced Short Palindromic Repeats;Collaborations;Communicable Diseases;Complex;computerized tools;CRISPR interference;CRISPR library;CRISPR screen;CRISPR-mediated transcriptional activation;CRISPR/Cas technology;Data;Data Analyses;Databases;Development;Devices;Diabetes Mellitus;Disease;DNA;DNA biosynthesis;DNA Double Strand Break;DNA Sequence;Drug Targeting;Ebola virus;Education and Outreach;Effectiveness;Enhancers;experimental study;Fragile X Syndrome;functional genomics;Gene Expression;gene function;Genes;genetic corepressor;genetic element;Genetic Recombination;Genetic Screening;Genetic Transcription;Genome;genome editing;genome-wide;genomic locus;Goals;Health;Hepatitis C virus;HIV;Human;Incidence;Informatics;inhibitor;innovation;interest;Intramural Research Program;knock-down;Knock-in;knockout gene;Laboratories;Libraries;Life;loss of function;Malignant Neoplasms;Methodology;Methods;MicroRNAs;Mission;Molecular Target;Mutation;National Center for Advancing Translational Sciences;Nematoda;Neoplasm Metastasis;new technology;nuclease;Parkinson Disease;Pathway Analysis;Pathway interactions;Pharmaceutical Preparations;Phenotype;Play;pre-clinical;Private Sector;Process;Prokaryotic Cells;PubChem;public database;Reading;recruit;repaired;Research Personnel;Resistance;Resource Sharing;reverse genetics;RNA;RNA Interference;RNA interference screen;RNA Sequences;Robotics;Role;Science;Scientist;screening;small hairpin RNA;Small Interfering RNA;small molecule;System;Techniques;Technology;Testing;Time;tool;United States National Institutes of Health;United States National Library of Medicine;Validation;Virus Diseases;Virus Replication;Work;Zika Virus,Functional Genomics Laboratory (FGL),41,NA,NA,NA,NA,10,NA,NA,1301773,NA
11193359,ZID,AI,1,N,NA,NA,NA,NA,ZIDAI005159,NA,NA,1ZIDAI005159-05,NIAID:526716\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,79365480 (contact),"ANDREWS, SARAH  (contact)",NA,NA,NA,2019-nCoV;Acceleration;Accreditation;assay development;B-Lymphocytes;Binding;Biological Assay;Clinical;clinical investigation;Collaborations;Coronavirus;COVID-19;COVID-19 pandemic;COVID-19 vaccine;data exchange;Development;Documentation;efficacy trial;Emerging Communicable Diseases;emerging pathogen;Enzyme-Linked Immunosorbent Assay;Equipment;Generations;Goals;Human Resources;Immune;Immunobiology;Immunocompromised Host;immunogenicity;Immunology;improved;Individual;Industry;instrumentation;interest;Investigation;Laboratories;Licensure;Maintenance;Manuscripts;mucosal vaccine;National Institute of Allergy and Infectious Disease;operation;Pharmaceutical Preparations;Phase;phase 1 testing;Phase III Clinical Trials;phase III trial;Pre-Clinical Model;programs;Proteins;Protocols documentation;Public Health;Publishing;Qualifying;Readiness;Regimen;Reporting;Research;response;Sampling;SARS-CoV-2 transmission;screening;Serology;Speed;Standardization;T-Lymphocyte;Technology Transfer;Testing;Therapeutic;Vaccine Clinical Trial;vaccine development;vaccine distribution;vaccine efficacy;vaccine evaluation;Vaccines;Validation;Variant;variants of concern,COVID-19 Clinical Support and Research,5159,NA,NA,NA,NA,5,NA,NA,526716,NA
11193360,ZIG,AI,1,N,NA,NA,NA,NA,ZIGAI005099,NA,NA,1ZIGAI005099-12,NIAID:15543641\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,9413846 (contact),"ROEDERER, MARIO  (contact)",NA,NA,NA,animal care;Animal Care and Use Committees;animal resource;Animals;Caring;Development;Infrastructure;Laboratory Animals;Medicine;Monitor;operation;Policies;Principal Investigator;programs;Regulation;Research;Research Support;translational research program;Vaccine Research,Animal Medicine Infrastructure Support - Animal Care,5099,NA,NA,NA,NA,12,NA,NA,15543641,NA
11193361,ZIG,AI,1,N,NA,NA,NA,NA,ZIGAI005158,NA,NA,1ZIGAI005158-05,NIAID:836137\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,9413846 (contact),"ROEDERER, MARIO  (contact)",NA,NA,NA,Accreditation;Agreement;Alpha Virus;Analgesics;Anesthesia procedures;animal care;Animal Care and Use Committees;animal facility;Animal Husbandry;Animal Model;animal model development;Animals;biodefense;Blood;Breeding;Caring;Clinical Trials;Collaborations;Collection;Consultations;Contracts;COVID-19;Development;Disease;Educational process of instructing;Electroporation;Emerging Communicable Diseases;Ensure;good laboratory practice;Guidelines;Human;in vivo;Influenza;Injections;Institution;Laboratory Animals;Medicine;Methods;model development;Modeling;Monitor;Mus;novel;novel vaccines;operation;Operative Surgical Procedures;Oral Administration;Policies;pre-clinical;preclinical safety;Preparation;Preventive medical care;Principal Investigator;Procedures;product development;programs;quality assurance;Regulation;Research;Research Personnel;Research Project Grants;Research Support;Resources;Rodent;Safety;Serum;Services;Tissues;Toxicology;Training;Translational Research;translational research program;vaccine delivery;vaccine efficacy;Vaccine Research;Vaccines;Vendor,Animal Medicine COVID Support,5158,NA,NA,NA,NA,5,NA,NA,836137,NA
11193362,N01,AI,NA,N,NA,NA,NA,NA,75N93020D00007,NA,NA,75N93020D00007-0-759302400002-1,NIAID:1722748\,NON SBIR/STTR CONTRACTS,2024,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NEW ORLEANS,UNITED STATES,NA,01,053785812,US,8424601,TULANE UNIVERSITY OF LOUISIANA,LA,701185665,NA,79981725 (contact),"VEAZEY, RONALD  (contact)",NA,2024-09-13,2027-04-11,AIDS prevention;AIDS Vaccines;Breeding;clinical efficacy;cross reactivity;Development;Evaluation;evaluation/testing;flexibility;HIV;HIV Envelope Protein gp120;HIV vaccine;Housing;Immune response;immunogenicity;Maintenance;Modality;Modeling;Mucosal Immune Responses;National Institute of Allergy and Infectious Disease;neutralizing antibody;nonhuman primate;Peptides;preclinical evaluation;preclinical study;prevent;Prevention Research;Prevention strategy;programs;Regimen;research clinical testing;Research Personnel;Resources;Risk;Site;Testing;United States National Institutes of Health;vaccine efficacy;vaccine evaluation;vaccine platform;Vaccine Research;Vaccines;Virus;Virus Diseases,Assessment of Heterologous Prime-boost HIV Vaccine Regimen to Elicit Cross-reactive Neutralizing Antibodies Targeting HIV Fusion Peptide,0,NA,NA,NA,NA,NA,NA,NA,1722748,NA
11193419,N01,CA,NA,N,NA,NA,NA,NA,75N91019D00024,NA,NA,75N91019D00024-P00002-759102100015-1,NCI:14407995\,NON SBIR/STTR CONTRACTS,2024,NATIONAL CANCER INSTITUTE,NA,FREDERICK,UNITED STATES,NA,06,159990456,US,10008928,"LEIDOS BIOMEDICAL RESEARCH, INC.",MD,217029242,NA,78379282 (contact),"DMITROVSKY, ETHAN  (contact)",NA,2021-09-16,2025-09-15,Acceleration;Address;Adoptive Cell Transfers;Allogenic;Animal Model;Autologous;Biological Assay;cancer therapy;Cell Therapy;cell type;Cells;Cellular immunotherapy;Chemotherapy and/or radiation;chimeric antigen receptor T cells;Clinical;clinical application;clinical efficacy;clinical research site;Clinical Trials;Collaborations;Complex;Credentialing;Cyclic GMP;Dendritic Cells;Discipline;engineered T cells;Engineering;fitness;Fostering;Funding;Hematologic Agents;Hematologic Neoplasms;Hematopoietic stem cells;high standard;Human;Immune;Immunotherapy;induced pluripotent stem cell;innovation;Institution;leukemia;Lymphocyte;Lymphoma;Macrophage;Malignant Neoplasms;manufacture;manufacturing process;member;Mesenchymal;Mesenchymal Stem Cells;Multi-site clinical study;Multiple Myeloma;Normal tissue morphology;novel;paracrine;Patients;Pharmaceutical Preparations;pilot trial;preservation;Radiation induced damage;rare cancer;Research;Research Personnel;Resources;Safety;Science;Site;Solid Neoplasm;Standardization;stem cell therapy;Study models;success;T-Cell Receptor;T-Lymphocyte;Therapeutic;tissue stem cells;Tissues;tumor;Tumor-Infiltrating Lymphocytes;United States National Institutes of Health;Work,CORE SUPPORT FOR THE IMMUNE CELL NETWORK,0,NA,NA,NA,NA,NA,NA,NA,14407995,NA
11193420,N01,HD,NA,N,NA,NA,NA,NA,275201400003I,NA,NA,275201400003I-P00010-27500038-1,NICHD:40106\,NON SBIR/STTR CONTRACTS,2024,EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT,NA,ROCKVILLE,UNITED STATES,NA,08,161157953,US,3601801,"FISHER BIOSERVICES, INC.",MD,208505312,NA,15719372 (contact),"MANDACI, OGUZ  (contact)",NA,2018-09-26,2025-09-25,Architecture;archived data;Archives;Biological Specimen Banks;Communication;Data;data archive;Data Collection;data de-identification;data dissemination;data sharing;design;diverse data;Ensure;Equipment and supply inventories;FAIR principles;flexibility;Funding;Human;National Institute of Child Health and Human Development;Participant;Process;repository;Research;Research Personnel;research study;Residual state;Resources;secondary analysis;Services;Site;Specimen,REPOSITORY SERVICES FOR THE NICHD DATA AND SPECIMEN HUB (DASH),0,NA,NA,NA,NA,NA,NA,NA,40106,NA
11193421,N01,HD,NA,N,NA,NA,NA,NA,275201400003I,NA,NA,275201400003I-P00008-27500037-1,NICHD:203512\,NON SBIR/STTR CONTRACTS,2024,EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT,NA,ROCKVILLE,UNITED STATES,NA,08,161157953,US,3601801,"FISHER BIOSERVICES, INC.",MD,208505312,NA,15719360 (contact),"MANDACI, OGUZ  (contact)",NA,2018-09-27,2025-09-26,adverse pregnancy outcome;Aliquot;Arteries;Bar Codes;California;clinical research site;Collection;Data Coordinating Center;demographics;DNA;Enrollment;Ensure;Equipment and supply inventories;Etiology;Evaluation;Family;Fetal Growth;Fetal Growth Retardation;First Pregnancy Trimester;Indiana;International;Intervention;Label;maternal serum;Measurement;Measures;Medical History;Monitor;Mothers;National Institute of Child Health and Human Development;Nulliparity;nutrition;Observational Study;Ohio;Online Systems;Outcome Study;Participant;Pennsylvania;Perinatology;Placenta;Plasma;Pre-Eclampsia;Pregnancy;Pregnancy Outcome;Pregnant Women;Premature Birth;prospective;Psychosocial Assessment and Care;Psychosocial Factor;Recording of previous events;repository;Research;Risk;Sampling;Services;Shipping;Specimen;System;Temperature;Tube;ultrasound;United States;Universities;Update;Urine;Utah;Uterus;Woman;Women&apos;s study,STORAGE OF NUMOM2B SPECIMENS FOR THE PREGNANCY AND PERINATOLOGY BRANCH OF NICHD,0,NA,NA,NA,NA,NA,NA,NA,203512,NA
11193422,N01,ES,NA,N,NA,NA,NA,NA,273201800005I,NA,NA,273201800005I-P00011-27300002-1,NIEHS:3577967\,NON SBIR/STTR CONTRACTS,2024,NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES,NA,SILVER SPRING,UNITED STATES,NA,08,091340943,US,10007277,"SOCIAL AND SCIENTIFIC SYSTEMS,  INC.",MD,209103737,NA,77897916 (contact),"SANDLER, DALE  (contact)",NA,2018-09-26,2029-09-22,abstracting;Anniversary;Area;Biological;Blood;Chronic Disease;Collection;Complement;computerized data processing;Contractor;Contracts;Data;Data Analyses;data management;Data Security;detection limit;Development;Equipment;experience;Funding;Funding Agency;Government;Government Agencies;Human;Human Resources;Medical Records;Methods;Participant;Pathologic;Phase;Physicians;Preparation;Qualifying;Quality Control;Questionnaires;Recommendation;Recurrence;Research;Sampling;Services;Sister;Statistical Data Interpretation;stool sample;Update;Urine;Validation;Work,Sister Study TASK ORDER 02: CHRONIC DISEASE VALIDATION & ANALYSES IN THE SISTER STUDY,0,NA,NA,NA,NA,NA,NA,NA,3577967,NA
11193553,N01,HD,NA,N,NA,NA,NA,NA,75N94020D00003,NA,NA,75N94020D00003-0-759402400002-1,NICHD:1017684\,NON SBIR/STTR CONTRACTS,2024,EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT,NA,MENLO PARK,UNITED STATES,NA,16,009232752,US,8042701,SRI INTERNATIONAL,CA,940253493,NA,79983720 (contact),"BURNIN, DEBRA  (contact)",NA,2024-09-27,2026-09-26,absorption;Acute;analytical method;Animals;authority;Binding Proteins;Biological;Biological Assay;Biological Availability;Biological Products;Biological Testing;Blood;Canis familiaris;Cervical;Chemicals;Chronic;Clinical;clinical lot;Clinical Trials;Contraceptive Agents;Contraceptive Devices;Contraceptive methods;Contractor;Contracts;Country;cytotoxicity;Data;data sharing;design;Development;Device or Instrument Development;Devices;Documentation;Drug Exposure;Drug Formulations;Drug Kinetics;Drug Stability;drug testing;egg;Endocrine;Evaluation;Excretory function;Female Contraceptive Agents;Fertility;Formulation;Generations;Genetic;good laboratory practice;Good Manufacturing Process;Implant;In Vitro;in vivo;in vivo Model;Injectable;Intramuscular;Intravenous;Investigational Drugs;lot production;Male Contraceptive Agents;manufacture;Measures;Medical Device;men;Metabolism;Microsomes;Mission;Mus;National Institute of Child Health and Human Development;nonhuman primate;novel;novel therapeutics;Oogenesis;Oral;Oryctolagus cuniculus;Ovary;Ovulation;penis;Pharmaceutical Preparations;pharmacokinetics and pharmacodynamics;Pharmacologic Substance;Pharmacology;Phase;Placebos;Plasma;Plasma Proteins;Play;pre-clinical;preclinical development;preclinical study;Preparation;Prevention;Process;product development;Program Development;Progress Reports;Property;Protocols documentation;Rattus;Reporting;reproductive;reproductive organ;Research;research clinical testing;Research Support;Role;Route;Safety;Seminal fluid;Services;Sheep;sperm cell;sperm function;Sperm Maturation;Spermatogenesis;subcutaneous;System;Teleconferences;Testing;timeline;Tissues;Toxic effect;Toxicokinetics;Toxicology;United States Food and Drug Administration;Uterus;Vagina;vaginal fluid;vaginal microbiome;Woman;Work,BIOLOGICAL TESTING FACILITY (BTF) - PRECLINICAL DEVELOPMENT OF CONTRACEPTIVE PRODUCTS,0,NA,NA,NA,NA,NA,NA,NA,1017684,NA
11193559,P01,CA,3,N,2024-09-26,2024-09-20,2025-08-31,NA,P01CA261669,NA,PA-20-272,3P01CA261669-04S1,NCI:250000\,NON-SBIR/STTR RPGS,2024,NATIONAL CANCER INSTITUTE,NA,BOSTON,UNITED STATES,NA,08,073130411,US,4907701,MASSACHUSETTS GENERAL HOSPITAL,MA,021142621,"CORE 2: TRANSLATIONAL BIOSPECIMEN AND IMAGING BIOMARKER - NARRATIVE The Translational Biospecimen and Imaging Biomarker Core Component (Core 2) is building a unique centralized resource to support biospecimen and imaging data collection from radiation-treated patients, will support sample processing and sharing using standardized protocols. Such activities will be carried out for patients enrolled on the NIH-funded clinical trials as well as from other clinical studies of radiotherapy relevant to the hypotheses tested in this grant. Core 2 will establish a database repository with the goals of: (i) creating a standardized patient consent and enrollment process to create efficiencies of scale; (ii) streamlining logistics and processes, reducing redundancy and maximizing the use of human and laboratory resources; (iii) diminishing data loss due to inconsistencies between protocols; and (iv) creating a central resource for translational research and molecular studies at the MD Anderson and MGH Cancer Centers.",11706204 (contact),"SHAITELMAN, SIMONA  (contact)","OBCEMEA, CEFERINO H",2021-09-21,2026-08-31,Algorithms;analysis pipeline;automated segmentation;Basic Science;Biological;Biological Markers;Biopsy Specimen;Blood;Brain;cancer care;Cancer Center;Cancer Patient;Cardiology;Cardiopulmonary;Catalogs;cell culture collection;Cell Line;Central Nervous System;Characteristics;circulating biomarkers;Clinical;clinical care;Clinical Data;Clinical Research;Clinical Trials;clinically relevant;Collection;Consent;Data;Data Collection;data de-identification;data exchange;Data Set;Databases;Dedications;Development;digital twin;Dose;Enrollment;experience;Functional Imaging;Funding;General Hospitals;Goals;Grant;Hepatic;Human;human tissue;Image;Image Analysis;imaging biomarker;imaging modality;Immune system;Immunologics;Immunophenotyping;Immunosuppression;improved;In Vitro;in vivo;individualized medicine;Informed Consent;innovation;Institution;interest;Laboratories;liver imaging;Logistics;Lung;Lymphocyte;Magnetic Resonance Imaging;Massachusetts;Medical;Mission;Molecular;Normal tissue morphology;novel;Oncology;participant enrollment;particle therapy;patient derived xenograft model;patient population;Patient-Focused Outcomes;Patients;personalized medicine;Photons;Physicians;pre-clinical research;precision medicine;Procedures;Process;Program Research Project Grants;prospective;Protein Analysis;Protocols documentation;proton therapy;Protons;Provider;Publications;Radiation;radiation adverse effect;Radiation Oncologist;Radiation therapy;Recommendation;repository;Research;Research Personnel;Resources;sample collection;Sampling;Scientist;Secure;Site;Specimen;Standardization;Technical Expertise;Testing;tissue culture;Tissues;Toxic effect;Translational Research;Treatment-related toxicity;Tumor Biology;Tumor Subtype;United States National Institutes of Health;Universities;University of Texas M D Anderson Cancer Center,Core 2: Translational Biospecimens and Imaging Biomarkers,261669,ZCA1,ZCA1,5931,S1,4,154158,95842,NA,250000
11193565,U54,CA,3,N,2024-09-26,2024-08-01,2025-07-31,NA,U54CA274291,NA,PA-20-272,3U54CA274291-03S1,NCI:246001\,RESEARCH CENTERS,2024,NATIONAL CANCER INSTITUTE,NA,NEW YORK,UNITED STATES,NA,12,060217502,US,1514803,WEILL MEDICAL COLL OF CORNELL UNIV,NY,100654805,NA,1858119 (contact),"DEASY, JOSEPH O (contact)","VIKRAM, BHADRASAIN",2022-09-21,2027-07-31,Anatomy;anti-cancer research;Bioinformatics;Biological;Biology;Blood;Characteristics;Clinical Data;Collaborations;Data;Data Commons;data ecosystem;data exchange;data quality;Data Set;data sharing;Diagnostic;digital data;Digital Imaging and Communications in Medicine;digital twin;Dose;Ensure;Factor Analysis;Goals;Human;Image;Immune;Immunologic Markers;Infrastructure;innovation;insight;Learning;Link;Machine Learning;Magnetic Resonance Imaging;Maps;Methods;microbiome;Mission;Modeling;Molecular;Molecular Profiling;multimodality;Multivariate Analysis;novel;Operative Surgical Procedures;Patients;Pattern;Peripheral Blood Mononuclear Cell;Phenotype;Privatization;Publications;Radiation;Radiation therapy;radiomics;Reaction Time;Rectal Cancer;Research;Resources;Specimen;tool;Training;transcriptomics;treatment planning;tumor;X-Ray Computed Tomography,Data Sharing and Integrative Analysis Core,274291,ZCA1,ZCA1,9652,S1,3,228626,17375,NA,246001
11193570,U54,CA,3,N,2024-09-26,2024-09-20,2025-08-31,NA,U54CA274516,NA,PA-20-272,3U54CA274516-02S1,NCI:249999\,RESEARCH CENTERS,2024,NATIONAL CANCER INSTITUTE,NA,BOSTON,UNITED STATES,NA,07,076580745,US,1464901,DANA-FARBER CANCER INST,MA,022155450,NA,9272296 (contact),"MICHOR, FRANZISKA  (contact)","VIKRAM, BHADRASAIN",2023-09-19,2028-08-31,"access restrictions;Address;Age;analysis pipeline;Anatomy;Artificial Intelligence;Biological;Biological Assay;Blood flow;cancer genomics;Cells;Childhood;Clinical;clinically significant;Clonal Evolution;Collaborations;Communities;Complex;Computer Models;Computing Methodologies;Data;Data Collection;data exchange;data hub;data integrity;data management;data repository;Data Science;Data Science Core;Data Security;Data Set;Data Storage and Retrieval;Databases;design;diffuse midline glioma;digital twin;DNA Repair;Dose;dosimetry;Ensure;Epigenetic Process;Evolution;exome;experience;Face;Funding;genomic data;Genomics;Goals;Grant;Image;Immunofluorescence Immunologic;improved;individual patient;Infrastructure;interest;Link;Malignant Neoplasms;member;metaiodobenzylguanidine;Methodology;Methods;miRNA expression profiling;Modeling;Molecular;Natural Language Processing;neoplastic cell;Neuroblastoma;Neuroepithelial, Perineurial, and Schwann Cell Neoplasm;novel;Outcome;Patients;Pediatric Neoplasm;Peripheral Blood Involvement;Population;profiles in patients;Publishing;radiation effect;Radiation Oncology;radiation resistance;radiation response;Radiation therapy;radiomics;Radionuclide therapy;repository;Research Personnel;Resistance;Resource Sharing;Resources;single cell ATAC-seq;single-cell RNA sequencing;Specimen;Structure;structured data;System;The Cancer Genome Atlas;Training;transcriptome sequencing;transcriptomics;treatment planning;tumor;tumor heterogeneity;tumor microenvironment;Tumor Tissue;Weight;whole genome;Work",Shared Resource Core 1: Molecular Data Science and Advanced Dosimetry,274516,ZCA1,ZCA1,5513,S1,2,200198,49801,NA,249999
11193573,U54,CA,3,N,2024-09-18,2024-09-01,2025-08-31,NA,U54CA156734,NA,PA-20-272,3U54CA156734-14S3,NCI:200000\,RESEARCH CENTERS,2024,NATIONAL CANCER INSTITUTE,NA,BOSTON,UNITED STATES,NA,08,808008122,US,850902,UNIVERSITY OF MASSACHUSETTS BOSTON,MA,021253300,NA,77954170 (contact),"ESCALERA, LIYA  (contact)","WALI, ANIL",2010-09-28,2026-08-31,NA,Research Education Core,156734,ZCA1,ZCA1(A1)-S,8821,S3,14,141103,58897,NA,200000
11193576,R01,AI,3,N,2024-09-16,2024-09-17,2025-08-31,855,R01AI157459,SCHOOLS OF MEDICINE,PA-20-185,3R01AI157459-04S1,NIAID:68896\,NON-SBIR/STTR RPGS,2024,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,AMHERST,UNITED STATES,MICROBIOLOGY/IMMUN/VIROLOGY,26,038633251,US,5992614,STATE UNIVERSITY OF NEW YORK AT BUFFALO,NY,142282567,"Invasive fungal infections are a major cause of complications and death in people living with weakened immune systems, and there are limited treatment options and emergence of resistance to available antifungal drugs. A well-vetted target for antimicrobial drugs is the ribosome, and though the fundamental core of the ribosome is conserved between humans and fungi, we have identified unique proteins that associate with the ribosome under stresses encountered by a particular fungal pathogen, Cryptococcus neoformans, when it enters the host. This proposal will explore these novel ribosome-associated factors for roles in stress adaptation, pathogenesis, and translation regulation, and will identify those with development potential for targeting the ribosome with specificity in fungal pathogens.",9352308 (contact),"PANEPINTO, JOHN C (contact)","LOVE, DONA",2021-09-24,2026-08-31,5&apos; Untranslated Regions;Affect;anti-fungal agents;anti-microbial drug;Antifungal Therapy;antimicrobial;Basidiomycota;Binding;biological adaptation to stress;Biology;Catalytic Domain;Cellular Stress;Cessation of life;comorbidity;Complex;Cryptococcus;Cryptococcus neoformans;Data;Defect;Development;Drug Targeting;Eukaryota;Exhibits;experimental study;Fungal Drug Resistance;fungus;Future;Goals;Growth;Heterogeneity;Homologous Gene;Human;human pathogen;Hypoxia;Immune system;immunodeficiency;Impairment;In Vitro;Intervention;Investigation;knock-down;Lung;Maps;Messenger RNA;Molecular Chaperones;mortality;mRNA capping;mRNA Decay;mutant;Mycoses;Names;novel;Oxidative Stress;pathogen;Pathogenesis;pathogenic fungus;Pathway interactions;Patients;Peptide Initiation Factors;Persons;Pharmacologic Substance;Phenotype;Phosphorylation;Process;Prokaryotic Cells;Protein Biosynthesis;Protein Isoforms;Proteins;Proteomics;recruit;Regulon;Resistance;Ribosomes;RNA;RNA Recognition Motif;RNA-Binding Proteins;RNA-Protein Interaction;Role;scaffold;Sedimentation process;Signal Pathway;Specificity;Stress;stress tolerance;Structure;Techniques;Temperature;Testing;Therapeutic;Translating;translation factor;Translation Initiation;Translational Regulation;Translations;translatome;Transplantation;Virulence;Work,Ribosome Heterogeneity in Cryptococcus neoformans,157459,ZRG1,Special Emphasis Panel[ZRG1-IDIA-U(02)M],NA,S1,4,45762,23134,68896,NA
11193585,P01,CA,3,N,2024-09-17,2024-09-01,2025-06-30,NA,P01CA233432,NA,PA-23-189,3P01CA233432-05S1,NCI:154093\,NON-SBIR/STTR RPGS,2024,NATIONAL CANCER INSTITUTE,NA,Oakland,UNITED STATES,NA,12,150829349,US,3497005,KAISER FOUNDATION RESEARCH INSTITUTE,CA,946123610,NA,1917949 (contact),"KUSHI, LAWRENCE H (contact)","MOLLICA, MICHELLE A",2020-09-15,2026-06-30,NA,Core A: Administrative Core,233432,ZCA1,ZCA1(O1),8748,S1,5,154093,0,NA,154093
11193588,OT2,OD,3,N,2024-09-25,2024-09-24,2025-08-31,279,OT2OD037639,SCHOOLS OF MEDICINE,OTA-22-006,3OT2OD037639-01S1,NIDA:1250000\,OTHERS,2024,"OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH",NA,PITTSBURGH,UNITED STATES,INTERNAL MEDICINE/MEDICINE,12,004514360,US,2059802,UNIVERSITY OF PITTSBURGH AT PITTSBURGH,PA,152133320,NA,1916078 (contact);9301413,"REIS, STEVEN E (contact);VISWESWARAN, SHYAM","MCNEIL FORD, NICOLE",2024-09-24,2025-08-31,Acceleration;Address;Adult;All of Us Research Program;Area;Biomedical Research;Black church;Black Populations;Black race;career;Caring;Child;Cities;Clinical Management;Clinical Sciences;cohort;Communication;Communities;community advisory board;community engaged research;community engagement;Community Health;community organizations;community partnership;Community Pharmacy;community research;Community Services;County;Data;Data Analytics;data exchange;Dedications;design;disability;Disabled Persons;Empathy;empowerment;Enrollment;Environment;Epidemic;Equity;ethnic diversity;ethnic minority;Evaluation;Event;experience;Faith;Fostering;Friends;Goals;health care availability;health care delivery;Health Personnel;Healthcare;Helping to End Addiction Long-term;Hispanic;hispanic community;Hospitals;Human;human centered design;Human Engineering;Immigrant;improved;Independent Living;Individual;Informatics;Infrastructure;Institutional Review Boards;interest;Laboratory Research;Latino;Leadership;Learning;Lived experience;Location;Maps;marginalized population;Marketing;Media Campaign;meetings;member;Methods;Minority;Mission;Modeling;Multimedia;neighborhood disadvantage;Neighborhoods;operation;Opiate Addiction;Opioid;opioid epidemic;opioid misuse;opioid overdose;opioid use disorder;Outpatients;outreach;Parents;Participant;participant enrollment;participant retention;patient engagement;Pennsylvania;Pharmacists;Pharmacy facility;Philadelphia;physically handicapped;Population;Process;programs;Protocols documentation;prototype;Public Health;racial diversity;racial minority;Ramp;Registries;Research;research and development;Research Ethics;Research Support;Research Training;Resources;Rural;rural area;Rural Community;Self-Help Devices;service organization;Services;Site;skills;Speed;Spinal;stimulant use disorder;success;Time;Training;Training Activity;Translational Research;trustworthiness;United States;United States National Institutes of Health;Universities;virtual;Work,All of Us Pennsylvania (AOU PA) Research Program,37639,ZOD1,ZOD1-SRC(99),NA,S1,1,786163,463837,1250000,NA
11193591,U18,FD,3,N,2024-09-16,2024-06-01,2025-05-31,103,U18FD006180,SCHOOLS OF VETERINARY MEDICINE,PAR-22-063,3U18FD006180-08S1,FDA:17000\,OTHER RESEARCH-RELATED,2024,FOOD AND DRUG ADMINISTRATION,NA,PULLMAN,UNITED STATES,VETERINARY SCIENCES,05,041485301,US,9082001,WASHINGTON STATE UNIVERSITY,WA,991641060,"Project Narrative: The FDA Vet-LIRN Veterinary Diagnostic Laboratory Program enables, nationwide, the analyses of animal diagnostic samples and animal food/drug products. The Program fills a gap for the FDA Office of Regulatory Affairs (ORA) regarding veterinary diagnostic samples that greatly facilitates early detection of and response to animal food/drug adulteration and contamination events. Through the Vet- LIRN program, FDA leverages the expertise of a national system of university, state and federal veterinary diagnostic laboratories to provide additional capacity and capability, obtain veterinary diagnostic information critical to ORA response, and strengthen the overall national food safety system.",2204006 (contact),"SNEKVIK, KEVIN ROY (contact)","CERIC, OLGICA",2012-09-01,2027-05-31,NA,FDA Veterinary Laboratory Investigation and Response Network Cooperative Agreement Program-WA,6180,ZFD1,ZFD1-CVM-R(03)1,NA,S1,8,12500,4500,17000,NA
11193592,OT2,OD,3,N,2024-09-24,2024-09-24,2025-08-31,279,OT2OD037907,NA,OTA-22-006,3OT2OD037907-01S1,NIDA:1250000\,OTHERS,2024,"OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH",NA,CORAL GABLES,UNITED STATES,NA,27,052780918,US,5221250,UNIVERSITY OF MIAMI SCHOOL OF MEDICINE,FL,331462926,NA,6926889;8147824 (contact),"MCCAULEY, JACOB L;ZUCHNER, STEPHAN  (contact)","RAHMAN, MD MIZANUR",2024-09-24,2025-08-31,Academic Medical Centers;Address;Adoption;Advanced Malignant Neoplasm;Age;Agriculture;All of Us Research Program;Ally;Artificial Intelligence;Asian;Attention;Authorization documentation;Awareness;Baptist Church;big-data science;biobank;Biomedical Research;Black American;Black race;Calendar;cancer genetics;cancer therapy;catalyst;Categories;Child;Child health care;Childhood;Climate;Clinic;cohort;Collaborations;Collection;Communication;Communities;Community Networks;community organizations;community partners;community-centered;Comprehensive Cancer Center;Computers;Consent;Contracts;County;dashboard;Data;Data Set;data streams;Development;Devices;digital;digital measure;disability;Education;Education and Outreach;Elements;Enrollment;Ensure;Environment;Epidemic;Equipment and supply inventories;Equity;ethnic minority population;Ethnic Origin;Evaluation;experience;Eye diseases;Face;Faculty;Family;Feedback;Florida;follow-up;Food;Fostering;Foundations;Funding;Future;Gastrointestinal Diseases;gene therapy;Genetic;Genetic study;Geographic Locations;Geography;Goals;Greek;Health;health data;Health Personnel;Health Status;Height;Helping to End Addiction Long-term;Hispanic;Historically Black Colleges and Universities;Home;Hospitals;human old age (65+);Human Resources;improved;Independent Living;Individual;information gathering;Informed Consent;Infrastructure;innovation;insight;Institution;interest;Internet;Island;Joints;Language;Lead;Learning;Letters;Libraries;life span;Location;Maintenance;Marketing;Measurement;Measures;Medical;Medical center;Medical Records;Medical Research;Methodology;Modeling;Morehouse School of Medicine;novel;Nurses;Opiate Addiction;Opioid;opioid epidemic;opioid misuse;opioid overdose;opioid use disorder;outreach;outreach program;Participant;participant enrollment;participant retention;patient engagement;patient registry;Patients;Pediatric Hospitals;Personal Satisfaction;Persons;Pharmaceutical Preparations;Phase;Phenotype;Physicians;Population;population health;Population Heterogeneity;Private Hospitals;Procedures;Process;programs;Progress Reports;Protocols documentation;Public Health;Public Hospitals;Puerto Rico;Race;racial minority population;Rare Diseases;Recording of previous events;Records;recruit;Regulation;Research;Research Personnel;research study;Research Support;Resources;retention rate;Role;Rotation;Rural;rural area;Saliva;Science;segregation;Self Direction;Site;Slide;social media;Speed;stimulant use disorder;success;Surveys;symposium;synergism;System;telehealth;Telephone;Testing;tool;Touch sensation;Training;Transportation;Travel;Trust;trustworthiness;United States;United States National Institutes of Health;United States National Library of Medicine;Universities;Update;Vision;volunteer;Weight;Work,Southeast Enrollment Center Consortium 2 (SEEC-2),37907,ZOD1,ZOD1-SRC(99),NA,S1,1,814333,435667,1250000,NA
11193608,OT2,OD,1,N,2024-09-25,2024-09-25,2025-09-24,310,OT2OD039723,NA,OTA-24-022,1OT2OD039723-01,OD:3999961\,OTHERS,2024,"OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH",NA,North Bethesda,UNITED STATES,NA,08,015936529,US,10039543,FOUNDATION FOR THE NIH,MD,20852,NA,78183753 (contact),"ADAM, STACEY  (contact)","SHEELEY, DOUGLAS",2024-09-25,2025-09-24,Acceleration;Address;Architecture;cloud based;complex data;Computer Security;Contractor;cost;Data;data access;Data Analyses;Data Collection;data exchange;data infrastructure;data ingestion;data modeling;data standards;design;Developed Countries;Development;Electronic Health Record;empowerment;experience;Foundations;Future;Goals;Health;health data;Health Sciences;Healthcare Systems;improved;Industry;interoperability;meetings;Modeling;Modernization;novel;novel strategies;Outcome;patient engagement;Patients;Performance;Phase;Process;programs;public-private partnership;Research Personnel;Risk;Science;Secure;Security;Speed;Strategic Planning;System;Time;transmission process;Treatment Factor;Treatment outcome;Trust;United States;United States National Institutes of Health,"Creation of a Trusted Data Broker, Development of a Data Access Platform and Design of a Public Private Partnership to Implement the NIH's Data COUNTS Program for Access to Quality Data.",39723,ZOD1,ZOD1-SRC(99),NA,NA,1,3999961,0,3999961,NA
11193615,P01,CA,5,N,2024-09-17,2024-05-01,2025-04-30,NA,P01CA225618,NA,PAR-18-290,5P01CA225618-06,NCI:20652\,NON-SBIR/STTR RPGS,2024,NATIONAL CANCER INSTITUTE,NA,BALTIMORE,UNITED STATES,NA,07,001910777,US,4134401,JOHNS HOPKINS UNIVERSITY,MD,212182680,NA,1878415 (contact),"JONES, RICHARD J (contact)","HENDERSON, LORI A",2019-05-21,2025-04-30,NA,Targeting Cancer Stem Cells,225618,ZCA1,ZCA1-RTRB-R(J1),8242,NA,6,13266,7386,NA,20652
11193616,P01,CA,5,N,2024-09-17,2024-05-01,2025-04-30,NA,P01CA225618,NA,PAR-18-290,5P01CA225618-06,NCI:20652\,NON-SBIR/STTR RPGS,2024,NATIONAL CANCER INSTITUTE,NA,BALTIMORE,UNITED STATES,NA,07,001910777,US,4134401,JOHNS HOPKINS UNIVERSITY,MD,212182680,NA,3113090 (contact),"LUZNIK, LEO  (contact)","HENDERSON, LORI A",2019-05-21,2025-04-30,NA,Marrow-Infiltrating Lymphocytes,225618,ZCA1,ZCA1-RTRB-R(J1),8243,NA,6,13266,7386,NA,20652
11193617,P01,CA,5,N,2024-09-17,2024-05-01,2025-04-30,NA,P01CA225618,NA,PAR-18-290,5P01CA225618-06,NCI:19524\,NON-SBIR/STTR RPGS,2024,NATIONAL CANCER INSTITUTE,NA,BALTIMORE,UNITED STATES,NA,07,001910777,US,4134401,JOHNS HOPKINS UNIVERSITY,MD,212182680,NA,8160777 (contact),"BOLLARD, CATHERINE M. (contact)","HENDERSON, LORI A",2019-05-21,2025-04-30,NA,Antigen Specific T Cells,225618,ZCA1,ZCA1-RTRB-R(J1),8244,NA,6,11583,7941,NA,19524
11193618,P01,CA,5,N,2024-09-17,2024-05-01,2025-04-30,NA,P01CA225618,NA,PAR-18-290,5P01CA225618-06,NCI:41325\,NON-SBIR/STTR RPGS,2024,NATIONAL CANCER INSTITUTE,NA,BALTIMORE,UNITED STATES,NA,07,001910777,US,4134401,JOHNS HOPKINS UNIVERSITY,MD,212182680,NA,1882915 (contact),"COOKE, KENNETH R (contact)","HENDERSON, LORI A",2019-05-21,2025-04-30,NA,BMT in Solid Tumors,225618,ZCA1,ZCA1-RTRB-R(J1),8245,NA,6,33940,7385,NA,41325
11193619,P01,CA,5,N,2024-09-17,2024-05-01,2025-04-30,NA,P01CA225618,NA,PAR-18-290,5P01CA225618-06,NCI:112699\,NON-SBIR/STTR RPGS,2024,NATIONAL CANCER INSTITUTE,NA,BALTIMORE,UNITED STATES,NA,07,001910777,US,4134401,JOHNS HOPKINS UNIVERSITY,MD,212182680,NA,1878415 (contact),"JONES, RICHARD J (contact)","HENDERSON, LORI A",2019-05-21,2025-04-30,NA,Administrative Core,225618,ZCA1,ZCA1-RTRB-R(J1),8246,NA,6,76465,36234,NA,112699
11193620,P01,CA,5,N,2024-09-17,2024-05-01,2025-04-30,NA,P01CA225618,NA,PAR-18-290,5P01CA225618-06,NCI:71417\,NON-SBIR/STTR RPGS,2024,NATIONAL CANCER INSTITUTE,NA,BALTIMORE,UNITED STATES,NA,07,001910777,US,4134401,JOHNS HOPKINS UNIVERSITY,MD,212182680,NA,9068388 (contact),"VARADHAN, RAVI  (contact)","HENDERSON, LORI A",2019-05-21,2025-04-30,NA,Biostatistics Core,225618,ZCA1,ZCA1-RTRB-R(J1),8247,NA,6,45876,25541,NA,71417
11193621,P01,CA,5,N,2024-09-17,2024-05-01,2025-04-30,NA,P01CA225618,NA,PAR-18-290,5P01CA225618-06,NCI:157383\,NON-SBIR/STTR RPGS,2024,NATIONAL CANCER INSTITUTE,NA,BALTIMORE,UNITED STATES,NA,07,001910777,US,4134401,JOHNS HOPKINS UNIVERSITY,MD,212182680,NA,3113090 (contact),"LUZNIK, LEO  (contact)","HENDERSON, LORI A",2019-05-21,2025-04-30,NA,Immune Monitoring Core,225618,ZCA1,ZCA1-RTRB-R(J1),8248,NA,6,101097,56286,NA,157383
11193622,P01,CA,5,N,2024-09-17,2024-05-01,2025-04-30,NA,P01CA225618,NA,PAR-18-290,5P01CA225618-06,NCI:164504\,NON-SBIR/STTR RPGS,2024,NATIONAL CANCER INSTITUTE,NA,BALTIMORE,UNITED STATES,NA,07,001910777,US,4134401,JOHNS HOPKINS UNIVERSITY,MD,212182680,NA,1874807 (contact),"LEMAS, VICTOR M (contact)","HENDERSON, LORI A",2019-05-21,2025-04-30,NA,Cell Therapy Core,225618,ZCA1,ZCA1-RTRB-R(J1),8249,NA,6,127133,37371,NA,164504
11193623,N01,AI,NA,N,NA,NA,NA,NA,272201800007I,NA,NA,272201800007I-0-759302400001-1,NIAID:67783\,NON SBIR/STTR CONTRACTS,2024,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,SAINT CHARLES,UNITED STATES,NA,02,078652667,US,10089014,"EUROFINS PANLABS, INC.",MO,633045685,NA,79983651 (contact),"BODE, JACOB  (contact)",NA,2024-09-13,2025-03-12,Antibiotic Resistance;Antimicrobial Resistance;Biological;Chemistry;Combating Antibiotic Resistant Bacteria;Communicable Diseases;Development;Development Plans;Drug Design;Drug Kinetics;Evaluation;In Vitro;in vivo;Interventional Agent Development;Lead;manufacture;pathogen;pre-clinical;product development;programs;Safety;Services;Therapeutic;therapeutic development;Toxicology;Toxin,Task B31: Bulk Intermediate Scaleup for Antibiotic-Resistant Drug Design,0,NA,NA,NA,NA,NA,NA,NA,67783,NA
11193636,OT2,OD,3,N,2024-09-24,2024-09-24,2025-08-31,368,OT2OD037643,SCHOOLS OF MEDICINE,OTA-22-006,3OT2OD037643-01S1,NIDA:1250000\,OTHERS,2024,"OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH",NA,NEW YORK,UNITED STATES,INTERNAL MEDICINE/MEDICINE,13,078861598,US,3839801,ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI,NY,100296574,NA,6724273;1882936 (contact);12510359;79780060;79020619,"HOROWITZ, CAROL R;KRAFT, MONICA  (contact);NADKARNI, GIRISH NITIN;SHROFF, NANDINI ;SHUMAN, SASKIA","LOPEZ-CLASS, MARIA",2024-09-24,2025-08-31,Academic Medical Centers;Adult;Advocate;All of Us Research Program;Area;Arizona;Asian population;biobank;Biomedical Research;Child;Childhood;Cities;Clinical;clinical infrastructure;Clinical Trials Network;Collaborations;Communities;community collaboration;community consultation;community engagement;Community Health Aides;Community Networks;community organizations;Country;COVID-19;dashboard;Data Set;data tools;Databases;Enrollment;Ensure;Equity;ethnic minority population;experience;Family health status;Federally Qualified Health Center;Funding;Genomics;Geography;Goals;Grant;Health;health care delivery;Health equity research;Health system;Healthcare;Helping to End Addiction Long-term;Hospitals;improved;Infrastructure;Inpatients;insight;Institution;interest;Lead;Learning;Link;Marketing;Medicine;meetings;metropolitan;Municipalities;Neighborhoods;New York;New York City;non-genomic;Opiate Addiction;Opioid;opioid misuse;Outpatients;outreach;Participant;Patient Recruitments;Patient-Focused Outcomes;Patients;Population Heterogeneity;programs;Provider;Public Health;Qualifying;racial minority population;Recording of previous events;Recovery;recruit;Research;Research Institute;Research Personnel;Researching COVID to Enhance Recovery;retention rate;Services;Site;Speed;success;System;Training Programs;Trust;Underrepresented Populations;United States;United States Health Resources and Services Administration;United States National Institutes of Health;Universities,All of Us Research Program New York Consortium,37643,ZOD1,ZOD1-SRC(99),NA,S1,1,1250000,0,1250000,NA
11193643,K43,TW,3,N,2024-09-17,2024-09-19,2025-04-30,989,K43TW012648,NA,PAR-21-252,3K43TW012648-02S1,FIC:3488\OD:45000\,OTHER RESEARCH-RELATED,2024,FOGARTY INTERNATIONAL CENTER,NA,LAGOS,NIGERIA,NA,NA,850493663,NI,10029158,NIGERIAN INSTITUTE OF MEDICAL RESEARCH,NA,2013,"PROJECT NARRATIVE Persistent low-level viremia (LLV) in persons with HIV who are on antiretroviral therapy (ART) is a barrier to achieving the goal of zero transmission and eradication of HIV, but not much is known about the impact of LLV on attaining the ART goal of viral suppression in West Africa. The proposed research will use pharmacoepidemiologic methods to assess the prevalence of LLV and impact on ART outcomes. The study will also use mathematical modeling to predict future LLV with adherence to ART measured by innovative pharmacological techniques.",16136018 (contact),"HERBERTSON, EBIERE CLARA (contact)","BANSAL, GEETHA PARTHASARATHY",2023-07-15,2028-04-30,"Acquired Immunodeficiency Syndrome;Adherence;adolescent health;Adult;advanced analytics;Africa;Africa South of the Sahara;African;Anti-Retroviral Agents;Anti-retroviral drug resistance;antiretroviral therapy;Appointment;Award;biological sex;Blood;career;career development;Caring;Cells;Cessation of life;Chronic;Clinical;clinical care;Clinical Pharmacology;clinical prognosis;cohort;Collection;Communicable Diseases;comorbidity;comparative;Country;Data;Data Analyses;Databases;Development Plans;Diphosphates;Drug Exposure;Drug resistance;Dryness;Epidemic;Epidemiologist;Epidemiology;Event;evidence base;experience;Failure;follow-up;Funding;Future;Goals;Guidelines;Hair;HIV;HIV-1;HIV-2;improved;Individual;innovation;insight;Intake;International;Intervention;K-Series Research Career Programs;Knowledge;Learning;Literature;longitudinal, prospective study;mathematical model;Measurement;Measures;Mentors;Methods;Monitor;Names;Nigeria;Outcome;Patient Self-Report;Patients;Persons;Pharmaceutical Preparations;Pharmacoepidemiology;pharmacologic;Pharmacology;Pharmacy facility;pill;point of care;point of care testing;Policies;Policy Maker;population health;Predictive Value;Prevalence;prognostic value;Prospective cohort;Public Health;Records;Regimen;Reproductive Health;Research;Research Design;Research Personnel;Resistance;Resistance development;Resource-limited setting;Retrospective cohort;scale up;Scientist;Site;skills;socioeconomics;Source;Specialist;Spottings;statistics;study population;Techniques;Tenofovir;Testing;therapy outcome;Training;translational physician;translational scientist;transmission process;treatment guidelines;Treatment outcome;Urine;Viral;Viral load measurement;Viral Load result;Viral reservoir;Viremia;Virus Activation;Women&apos;s Health",Use of Pharmacoepidemiology to Understand Predictors and Impact of Low-level Viremia in Persons with HIV in West Africa,12648,ZRG1,Special Emphasis Panel[ZRG1-ICP-J(55)R],NA,S1,2,45000,3488,48488,NA
11193651,R00,AR,4,N,2024-09-24,2024-09-25,2025-08-31,846,R00AR080745,SCHOOLS OF VETERINARY MEDICINE,PA-20-188,4R00AR080745-03,NIAMS:248998\,NON-SBIR/STTR RPGS,2024,NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES,NA,MADISON,UNITED STATES,BIOLOGY,02,161202122,US,578503,UNIVERSITY OF WISCONSIN-MADISON,WI,537151218,"PROJECT NARRATIVE Osteoporosis is a prevalent disease characterized by low bone mineral density, bone fragility, and fractures. Mice lacking the potassium ion channel Girk3 have elevated bone mass and reduced circulating cytokines in adulthood, making Girk3 a novel target for bone remodeling. This research will determine the physiological and cellular mechanisms by which Girk3 regulates cytokine production and bone mass and test whether Girk3 deletion prevents ovariectomy-induced osteoporosis in a cytokine-dependent manner.",15624068 (contact),"WEAVER, SAMANTHA R (contact)","NICKS, KRISTY",2023-05-01,2027-08-31,Adult;Affect;Age;aged;aging process;Applied Skills;Award;Bioinformatics;Biological Assay;Biological Markers;Biology;Blood;bone;bone cell;Bone Density;Bone Development;Bone Diseases;bone fragility;bone loss;Bone Marrow;Bone Marrow Cells;bone mass;Bone remodeling;Bone Resorption;Calvaria;career;career development;Cell Lineage;Cells;Cellularity;Clinic;Continuous Infusion;cytokine;Cytometry;Data;Development;Development Plans;Disease;Educational workshop;Endocrinology;Enzyme-Linked Immunosorbent Assay;experimental study;Female;Foundations;Fracture;Goals;GTP-Binding Proteins;Harvest;Hematopoietic;IL3 Gene;improved;In Vitro;Inflammation Process;Inflammatory;innovation;Interleukin-1;Interleukin-1 beta;inward rectifier potassium channel;Ion Channel;Ion Channel Gating;Ions;Knowledge;Laboratories;Lead;Learning;Macrophage;male;Measures;Mechanics;meetings;Membrane;men;Mentors;Mentorship;Messenger RNA;Methods;microCT;Modeling;Molecular;monocyte;mouse model;Mus;Musculoskeletal;novel;old mice;Osteoblasts;Osteoclasts;Osteocytes;Osteogenesis;Osteoporosis;osteoporosis with pathological fracture;Ovariectomy;Phase;Physiological;Physiological Processes;Population;Positioning Attribute;Postdoctoral Fellow;Postmenopausal Osteoporosis;Potassium;Potassium Channel;pre-doctoral;prevent;Production;programs;Publications;Publishing;Research;research and development;Research Personnel;Role;Safety;Serum;Signal Pathway;Signal Transduction;single-cell RNA sequencing;skeletal;Skeleton;skills;success;symposium;synergism;Testing;Time;tool;Training;transcriptome;transcriptomics;Wild Type Mouse;Woman;Work,Girk3 in bone biology and disease,80745,AMS,Arthritis and Musculoskeletal and Skin Diseases Special Grants Study Section[AMS],NA,NA,3,166552,82446,248998,NA
11193654,N01,CA,NA,N,NA,NA,NA,NA,75N91024D00004,NA,NA,75N91024D00004-0-759102400002-1,NCI:551730\,NON SBIR/STTR CONTRACTS,2024,NATIONAL CANCER INSTITUTE,NA,HOUSTON,UNITED STATES,NA,09,800772139,US,578407,UNIVERSITY OF TX MD ANDERSON CAN CTR,TX,770304009,NA,9809050 (contact),"VILAR SANCHEZ, EDUARDO  (contact)",NA,2024-09-20,2026-03-19,Biological Markers;biomarker identification;cancer prevention;Development;Diet;efficacy evaluation;Fasting;Goals;immune cell infiltrate;Intervention;Malignant neoplasm of pancreas;microbiome composition;mouse model;Mus;pancreatic cancer model;Pancreatic Intraepithelial Neoplasia;Prevention;Regimen;Time-restricted feeding;Treatment Efficacy;tumor growth,TIME-RESTRICTED FEEDING FOR PANCREATIC CANCER PREVENTION,0,NA,NA,NA,NA,NA,NA,NA,551730,NA
11193665,U54,CA,3,N,2024-09-17,2024-09-01,2025-08-31,NA,U54CA274507,NA,PA-23-189,3U54CA274507-02S1,NCI:67476\,RESEARCH CENTERS,2024,NATIONAL CANCER INSTITUTE,NA,TAMPA,UNITED STATES,NA,15,139301956,US,3736101,H. LEE MOFFITT CANCER CTR & RES INST,FL,336129497,NA,9790902 (contact),"ANDERSON, ALEXANDER ROBERTSON ALLAN (contact)","ZAMISCH, MONICA",2023-09-15,2028-08-31,"Adherence;Award;Budgets;Cancer Center;Collaborations;Communication;dashboard;Development;Ecology;Education;Education and Outreach;Educational workshop;Ensure;equity, diversity, and inclusion;Evaluation;Fostering;Funding;Funding Opportunities;high school;Information Distribution;innovation;Institution;interest;Internships;Investigation;Letters;Malignant Neoplasms;meetings;member;Mission;Non-Small-Cell Lung Carcinoma;Organization and Administration;outreach;Pilot Projects;Play;Preparation;Process;programs;Progress Reports;Reporting;Research;Research Personnel;Resources;Role;social media;symposium;Systems Biology;Travel;web site",Administrative Core,274507,ZCA1,ZCA1,7465,S1,2,40045,27431,NA,67476
11193680,U54,CA,3,N,2024-09-17,2024-09-01,2025-08-31,NA,U54CA261701,NA,PA-20-272,3U54CA261701-04S2,NCI:179325\,RESEARCH CENTERS,2024,NATIONAL CANCER INSTITUTE,NA,NEW YORK,UNITED STATES,NA,12,071037113,US,7056601,ROCKEFELLER UNIVERSITY,NY,100656399,NA,9829283 (contact),"MUCIDA, DANIEL S (contact)","GRIL, BRUNILDE M",2021-09-23,2026-08-31,NA,Project-2:Defining the role of compartmentalized neuro-lymphatic networks on CRC and metastatic progression,261701,ZCA1,ZCA1(M1),5958,S2,4,127200,52125,NA,179325
11193704,ZIA,AR,1,N,NA,NA,NA,NA,ZIAAR041203,NA,NA,1ZIAAR041203-10,NIAMS:2739109\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES,NA,NA,NA,14282194 (contact),"MAMMEN, ANDREW  (contact)",NA,NA,NA,Adolescent;Adult;Antibodies;Autoantibodies;Autoantigens;Autoimmune;Biopsy;Cell Nucleus;Clinical;cohort;Dermatomyositis;Diagnosis;Disease;Family;Gene Expression;Goals;Idiopathic Inflammatory Myopathies;Immune;Immunogenetics;improved;Inclusion Body Myositis;Laboratories;Ligase;Mediating;Messenger RNA;MicroRNAs;multi-ethnic;Muscle;Muscle Cells;Myopathy;Myositis;novel;Pathogenesis;Patient Care;Patients;Phenotype;Proteins;Publishing;Raynaud Disease;Risk Factors;Syndrome;therapeutic target;transcriptional intermediary factor 1;transcriptomics,Muscle Disease Unit,41203,NA,NA,NA,NA,10,NA,NA,2739109,NA
11193705,ZIA,CL,1,N,NA,NA,NA,NA,ZIACL060062,NA,NA,1ZIACL060062-21,NA,INTRAMURAL RESEARCH,2024,CLINICAL CENTER,NA,NA,NA,NA,NA,NA,NA,NA,CLINICAL CENTER,NA,NA,NA,8215669 (contact),"SHEEHAN, FRANCES T (contact)",NA,NA,NA,3-Dimensional;Activities of Daily Living;Adolescent;Adult;Agreement;Anatomy;Animals;Ankle;anterior cruciate ligament injury;Architecture;Area;Athletic Injuries;automated segmentation;Award;Biological Markers;bone;Cadaver;Cartilage;Categories;Cerebral Palsy;Child;Clinical;Clinical Data;clinical diagnosis;clinical diagnostics;Clinical Treatment;cohort;Collaborations;Computer Models;Connective Tissue;Data;Data Analyses;Databases;design;Development;Diagnosis;Diagnostic;Diagnostic radiologic examination;diagnostic tool;digital imaging;disability;Discipline;Disease;Dislocations;Dystonia;Ehlers-Danlos Syndrome;Engineering;Evaluation;experimental study;Femur;France;functional loss;functional restoration;Future;Goals;hamstring;Image;Impairment;improved;in vivo;Individual;Injury;International;Intervention;joint function;Joints;Journals;kinematics;Kinetics;Knee;Knowledge;Ligaments;Magnetic Resonance Imaging;Manuscripts;Matched Group;Measurement;Measures;Medical;Methodology;Methods;millimeter;Modeling;motor impairment;Movement;Muscle;muscle degeneration;Muscular Dystrophies;Musculoskeletal;musculoskeletal injury;Musculoskeletal System;National Human Genome Research Institute;Natural History;Neurodegenerative Disorders;Neurologic;neuromuscular;neuromusculoskeletal;Pain;Paper;Patellar Dislocation;Pathology;Patients;Pattern;physically handicapped;Population;Positioning Attribute;Preparation;Process;Property;Protocols documentation;Publishing;Recording of previous events;Recovery of Function;Recurrence;Research;Research Personnel;Resolution;Role;segmentation algorithm;Shapes;Shoulder;skeletal;soft tissue;Spinal;Stress;Structure;Surface;Syndrome;System;Tendon structure;three-dimensional visualization;Tissues;tool;two-dimensional;ultrasound;United States National Institutes of Health;Validation;virtual;Work;Wrist,Virtual Functional Anatomy,60062,NA,NA,NA,NA,21,NA,NA,0,NA
11193706,ZIA,CL,1,N,NA,NA,NA,NA,ZIACL060078,NA,NA,1ZIACL060078-15,NA,INTRAMURAL RESEARCH,2024,CLINICAL CENTER,NA,NA,NA,NA,NA,NA,NA,NA,CLINICAL CENTER,NA,NA,NA,8215669 (contact),"SHEEHAN, FRANCES T (contact)",NA,NA,NA,3-Dimensional;American;analog;Analysis of Variance;anatomic imaging;Anterior;Area;arm;Award;Biomechanics;bone;Cartilage;Clinical;clinical diagnostics;cohort;Coin;Complex;Data;diagnostic tool;Enrollment;Equilibrium;Etiology;Event;Exclusion Criteria;Femur;Fostering;Freedom;Future;Goals;Image;in vivo;Individual;Injections;International;Intervention;Joints;kinematics;Knee;Knee bone;Knee joint;knee pain;Knowledge;Kolmogorov-Smirnov Test;Lateral;Lead;Leg;Length;Lidocaine;Ligaments;Linear Regressions;Link;Location;loss of function;Magnetic Resonance Imaging;Measurement;Measures;Medial;Methodology;Modeling;Motion;Motor;Movement;Muscle;Musculoskeletal;Nerve Block;next generation;Normalcy;Operative Surgical Procedures;Pain;patellar ligament;Patellofemoral Pain Syndrome;Pathologic;Patients;Pattern;Periodicity;Phase;Population;Property;quadriceps muscle;Recording of previous events;Reporting;Rotation;Running;Series;Shapes;skeletal;Societies;Source;statistics;Stress;Structure;Subgroup;Techniques;Testing;theories;Therapeutic;tibia;Time;tool;Torque;Translations;Trauma;treatment optimization;trend;two-dimensional;Validation;Variant;Visit;Visual;volunteer;Work,Vasti Control of Patellofemoral Kinematics in Asymptomatic Volunteers,60078,NA,NA,NA,NA,15,NA,NA,0,NA
11193707,ZIA,CL,1,N,NA,NA,NA,NA,ZIACL060088,NA,NA,1ZIACL060088-11,NA,INTRAMURAL RESEARCH,2024,CLINICAL CENTER,NA,NA,NA,NA,NA,NA,NA,NA,CLINICAL CENTER,NA,NA,NA,8215669 (contact),"SHEEHAN, FRANCES T (contact)",NA,NA,NA,3-Dimensional;Address;Analysis of Variance;Anterior;Bupivacaine;Chronic;Complex;Confounding Factors (Epidemiology);Data;Data Collection;Degenerative polyarthritis;Enrollment;Equilibrium;Event;Exercise;Extensor;Freedom;Goals;Iatrogenesis;Individual;Injections;Isometric Exercise;Joints;kinematics;Knee;Knee bone;Knee joint;knee pain;Kolmogorov-Smirnov Test;Lateral;Lead;Leg;Lidocaine;Linear Regressions;Link;Local Anesthetics;loss of function;Magnetic Resonance Imaging;Measurement;Measures;Medial;Modeling;Motion;Movement;Muscle;Nerve Block;Normalcy;Operative Surgical Procedures;Pain;pain reduction;pain relief;Patellofemoral Pain Syndrome;Patients;Peripheral Nerves;Phase;Protocols documentation;quadriceps muscle;Recording of previous events;Rotation;Running;skeletal;Source;statistics;Stress;Structure;Techniques;Testing;theories;tool;Translations;Trauma;vastus lateralis;vastus medialis;Visit;volunteer;Work,Vasti Control of Patellofemoral Kinematics in Patients with chronic Patellofemoral pain,60088,NA,NA,NA,NA,11,NA,NA,0,NA
11193708,ZIA,CL,1,N,NA,NA,NA,NA,ZIACL060098,NA,NA,1ZIACL060098-04,NA,INTRAMURAL RESEARCH,2024,CLINICAL CENTER,NA,NA,NA,NA,NA,NA,NA,NA,CLINICAL CENTER,NA,NA,NA,8215669 (contact),"SHEEHAN, FRANCES T (contact)",NA,NA,NA,Address;Adolescent;Affect;Agreement;Architecture;arm;arthropathies;automated segmentation;Biomechanics;Career Choice;Childhood;computerized data processing;Data;data sharing;Databases;deep learning model;Development;Dimensions;Disease;education pathway;effective intervention;Human;Image;in vivo;Individual;Intervention;joint destruction;Knee bone;knee pain;Lateral;Manuscripts;Measures;Mental Health;Modeling;Muscle;Musculoskeletal;Musculoskeletal Pain;Musculoskeletal System;Nervous System control;Pain;Paper;Patellofemoral Pain Syndrome;Pathology;Physiology;Population;prevent;quadriceps muscle;Queensland;rectus femoris;Recurrent pain;Reporting;Research;Resolution;Rest;Role;Social Interaction;Sports;Techniques;tool;Torque;Universities;vastus lateralis;vastus medialis;Work,Balancing Muscle Force in Patellofemoral Pain,60098,NA,NA,NA,NA,4,NA,NA,0,NA
11193709,ZIA,CL,1,N,NA,NA,NA,NA,ZIACL080012,NA,NA,1ZIACL080012-17,NA,INTRAMURAL RESEARCH,2024,CLINICAL CENTER,NA,NA,NA,NA,NA,NA,NA,NA,CLINICAL CENTER,NA,NA,NA,9692813 (contact),"ZELAZNY, ADRIAN MARCELO (contact)",NA,NA,NA,accurate diagnostics;Antimicrobial Resistance;Award;Bacteria;Biochemical;Biological Assay;cell free DNA;Clinical;clinically significant;Clustered Regularly Interspaced Short Palindromic Repeats;CRISPR/Cas technology;Databases;Detection;detection assay;detection method;Development;Diagnostic;fungus;genome sequencing;Genomics;Genus Mycobacterium;Goals;Hydrolysis;improved;Laboratories;Lung;lung injury;Mass Spectrum Analysis;Methodology;Methods;Microbe;microbial;Microbiology;microorganism;Microscopy;Molds;Molecular;Morphology;mycobacterial;novel;Organism;Pathogen detection;Peptides;Phenotype;point of care;Process;Property;Proteins;Proteomics;respiratory;Sampling;Serum;targeted sequencing;Techniques;Testing;United States National Institutes of Health;whole genome;Yeasts,Identification of Clinically Important Microbes by Genomic and Proteomic Methods,80012,NA,NA,NA,NA,17,NA,NA,0,NA
11193710,ZIA,CL,1,N,NA,NA,NA,NA,ZIACL080013,NA,NA,1ZIACL080013-17,NA,INTRAMURAL RESEARCH,2024,CLINICAL CENTER,NA,NA,NA,NA,NA,NA,NA,NA,CLINICAL CENTER,NA,NA,NA,9692813 (contact),"ZELAZNY, ADRIAN MARCELO (contact)",NA,NA,NA,Address;Affect;Amikacin;anti-microbial drug;antimicrobial;Antimicrobial Resistance;Bacteria;beta-Lactam Resistance;Cell Communication;chemotherapy;chronic infection;Clarithromycin;Clinical Data;Development;Disease Outbreaks;drug repurposing;Epidemiology;epidemiology study;Evolution;fungus;Genes;Goals;indexing;Individual;individual patient;Investigation;Laboratories;Microbe;microbial;Microbiology;microorganism;Molecular;Multi-Drug Resistance;Mycobacterium abscessus;Nitric Oxide;novel;pathogen;pathogenic bacteria;pathogenic fungus;pathogenic microbe;Pathogenicity;patient population;Patients;Pharmacotherapy;Phenotype;Population;Process;Reporting;Resistance;Respiratory Tract Infections;synthetic peptide;trait;Virulence,Molecular and Virulence Traits of Bacteria & Fungi Causing Persistent Infections,80013,NA,NA,NA,NA,17,NA,NA,0,NA
11193711,ZIA,CL,1,N,NA,NA,NA,NA,ZIACL090025,NA,NA,1ZIACL090025-15,NA,INTRAMURAL RESEARCH,2024,CLINICAL CENTER,NA,NA,NA,NA,NA,NA,NA,NA,CLINICAL CENTER,NA,NA,NA,10687261 (contact),"CALVO, KATHERINE  (contact)",NA,NA,NA,Abnormal megakaryocyte;Age;Algorithms;Aplastic Anemia;Apoptosis;Autoimmune;autoinflammatory;autosome;Benign;Binding;Biological Assay;Biology;Blood Platelets;Bone Marrow;Bone Marrow Cells;Bone Marrow Diseases;Bone marrow failure;cancer predisposition;candidate selection;Cell Line;Cell Physiology;Clinical;Clonal Evolution;Core Biopsy;CTLA4 gene;Custom;Cytogenetics;cytokine;cytopenia;Data;Data Analyses;Data Correlations;Development;Diagnosis;diagnostic accuracy;diagnostic criteria;differential expression;digital;Disease;Disease Progression;Dysmorphology;Dysmyelopoietic Syndromes;Dysplasia;Dysplastic Megakaryocyte;Ensure;Erythroid;Evaluation;Failure;Familial Platelet Disorder;Flow Cytometry;GATA2 deficiency;Gene Expression Profile;Genes;Genetic;Genome Mappings;Genotype;Germ Lines;Germ-Line Mutation;Goals;Hematologic Neoplasms;Hematological Disease;Hematology;Hematopoiesis;Hematopoietic Neoplasms;Immunophenotyping;Impairment;Individual;Inherited;insight;ITGB3 gene;lifetime risk;Malignant Neoplasms;Marrow;meetings;Megakaryocytes;Messenger RNA;Methylation;MicroRNAs;Molecular;Monoclonal gammopathy of uncertain significance;Morphology;Mutation;Mutation Analysis;Myelogenous;Myeloid Cells;Myeloproliferative disease;Neoplasms;Neoplastic Processes;next generation sequencing;novel;Optics;Outcome;Pathologic;Pathologist;Pathology;patient subsets;Patients;Pattern;peripheral blood;Phenotype;Plasma Cells;Population;Post-Transcriptional Regulation;Predisposition;Production;Proliferating;Publications;Regulation;RUNX1 gene;Somatic Mutation;Specimen;Syndrome;Technology;Time;Transcript;transcriptomics;Translational Repression;treatment response;tumorigenesis;validation studies;Work,"microRNA, immunophenotypic, and somatic alterations in hematologic malignancies",90025,NA,NA,NA,NA,15,NA,NA,0,NA
11193712,ZIA,CL,1,N,NA,NA,NA,NA,ZIACL090086,NA,NA,1ZIACL090086-03,NA,INTRAMURAL RESEARCH,2024,CLINICAL CENTER,NA,NA,NA,NA,NA,NA,NA,NA,CLINICAL CENTER,NA,NA,NA,78833916 (contact),"DAS, SANCHITA  (contact)",NA,NA,NA,2019-nCoV;Address;adenovirus penton protein;Adenoviruses;Affect;Algorithms;Allogenic;Amino Acids;Archives;Area;B-Lymphocytes;Bioinformatics;Biological Assay;Capsid;Capsid Proteins;chronic infection;Clinical;Code;cohort;Communicable Diseases;Complex;COVID-19 detection;COVID-19 pandemic;Defect;DNA;emerging virus;Environment;Epidemiology;Evolution;gastrointestinal;Genes;Genetic Drift;Genetic Recombination;Genetic Variation;Genotype;Goals;Hematological Disease;Hematopoietic Stem Cell Transplantation;Homologous Transplantation;Immunocompromised Host;immunosuppressed;Infection;insight;Journals;Length;Libraries;Life;Lymphocyte;metagenomic sequencing;Metagenomics;Methods;microbiome;mortality;Mutation;novel;pathogen;pathogenic bacteria;pathogenic virus;Pathway interactions;patient population;Patients;Phylogenetic Analysis;Phylogeny;Plasma;Preparation;pressure;Publications;Reporting;Research;respiratory;SARS-CoV-2 infection;SARS-CoV-2 variant;Satellite Viruses;Shotgun Sequencing;Shotguns;Source;Specimen;T-Cell Depletion;Time;Transplant Recipients;Urinary system;Variant;variant detection;Viral;Viral Epidemiology;Viral Load result;Viremia;virome;Virus;Virus Activation;Virus Diseases;Virus Replication;Wit,Understanding the Epidemiology of Adenovirus and its Evolution in Patients with Viremia,90086,NA,NA,NA,NA,3,NA,NA,0,NA
11193713,ZIA,CL,1,N,NA,NA,NA,NA,ZIACL090088,NA,NA,1ZIACL090088-03,NA,INTRAMURAL RESEARCH,2024,CLINICAL CENTER,NA,NA,NA,NA,NA,NA,NA,NA,CLINICAL CENTER,NA,NA,NA,78836527 (contact),"SEYEDMOUSAVI, AMIR  (contact)",NA,NA,NA,Acute;Adrenal Cortex Hormones;Affect;Animals;anti-fungal agents;Behavior;biological research;Biology;Chronic;Clinical Trials;comparative genomics;congenital immunodeficiency;Disease;Epidemiology;Evaluation;functional genomics;Fungal Drug Resistance;fungus;Genes;genome sequencing;Goals;Health;Hospitalization;Human;Hypersensitivity;Immunity;Immunocompetent;Immunocompromised Host;immunodeficiency;Individual;Infection;interest;Life;Location;Malignant Neoplasms;Medical;Molecular;Molecular Epidemiology;mouse model;Mycoses;Organ Transplantation;participant enrollment;pathogenic fungus;Pathogenicity;Patients;Pattern;Persons;Phylogenetic Analysis;pre-clinical research;Predisposition;Proteomics;Risk;screening;Taxonomy;Translational Research;Trauma;United States National Institutes of Health;Variant;Virulence;Virulence Factors,Comparative Genomics and Pathogenicity of Agents of Human and Animal Fungal Infections,90088,NA,NA,NA,NA,3,NA,NA,0,NA
11193714,ZIA,CL,1,N,NA,NA,NA,NA,ZIACL090089,NA,NA,1ZIACL090089-03,NA,INTRAMURAL RESEARCH,2024,CLINICAL CENTER,NA,NA,NA,NA,NA,NA,NA,NA,CLINICAL CENTER,NA,NA,NA,78836527 (contact),"SEYEDMOUSAVI, AMIR  (contact)",NA,NA,NA,Acute Myelocytic Leukemia;Algorithms;Animals;anti-fungal agents;Antibodies;Antifungal Therapy;antigen test;antimicrobial;Area;Biological;Biological Markers;Clinical;Complex;Detection;Diagnosis;Diagnostic;Diagnostic Procedure;diagnostic technologies;diagnostic tool;Disease;Evolution;Fungal Drug Resistance;fungus;Genetic;genome-wide;Hospitalization;Human;Immunocompromised Host;improved;In Vitro;in vivo;Intensive Care Units;interest;Laboratories;Laboratory Research;Life;Molds;Molecular;mortality;Mycoses;next generation sequencing;novel;novel diagnostics;Nucleic Acid Amplification Tests;Operative Surgical Procedures;pathogenic fungus;Patients;pharmacokinetics and pharmacodynamics;point of care;Prevalence Study;Research;Sampling;Sensitivity and Specificity;Serology test;Specimen;Technology;Testing;The science of Mycology;Therapeutic;Trauma;United States National Institutes of Health;Yeasts,Antifungal Resistance and Novel Mycology Diagnostics,90089,NA,NA,NA,NA,3,NA,NA,0,NA
11193715,ZIA,CL,1,N,NA,NA,NA,NA,ZIACL090107,NA,NA,1ZIACL090107-02,NA,INTRAMURAL RESEARCH,2024,CLINICAL CENTER,NA,NA,NA,NA,NA,NA,NA,NA,CLINICAL CENTER,NA,NA,NA,78833916 (contact),"DAS, SANCHITA  (contact)",NA,NA,NA,Achromobacter;Achromobacter xylosoxidans;Alcaligenes;American;anti-microbial drug;Anti-microbial susceptibility;Antimicrobial Resistance;Ceftazidime;Clinical;efflux pump;genome sequencing;genomic data;Genomics;Laboratories;Lactamase;Literature;Mediating;meetings;Methods;Microbe;Microbiology;Minimum Inhibitory Concentration measurement;Molecular;Nature;Organism;pathogen;patient population;Patients;Pattern;Pharmaceutical Preparations;Phenotype;Resistance;resistance mechanism;Resistance profile;Rod;Societies;Testing;Time;trait;whole genome;Work,Antimicrobial Susceptibility of Achromobacter spp. vs ASA spp,90107,NA,NA,NA,NA,2,NA,NA,0,NA
11193716,ZIA,DK,1,N,NA,NA,NA,NA,ZIADK032101,NA,NA,1ZIADK032101-27,NIDDK:521544\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES,NA,NA,NA,9415259 (contact),"BEWLEY, CAROLE  (contact)",NA,NA,NA,Binding;Biological Assay;Chemistry;Data Analyses;Development;Educational process of instructing;Goals;Laboratories;Methodology;Mission;molecular dynamics;NMR Spectroscopy;Research;Research Personnel;Research Project Grants;Scientist;Services;Structure;Techniques;United States National Institutes of Health,NMR Facility Management and Application of NMR Spectroscopy,32101,NA,NA,NA,NA,27,NA,NA,521544,NA
11193717,ZIA,DK,1,N,NA,NA,NA,NA,ZIADK043403,NA,NA,1ZIADK043403-25,NIDDK:1350803\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES,NA,NA,NA,6256993 (contact),"STAR, ROBERT A (contact)",NA,NA,NA,Ablation;Acute;Acute Kidney Failure;Acute Renal Failure with Renal Papillary Necrosis;Age;Anemia;Angiotensin II;Angiotensin Receptor;Animal Model;Animals;Antibiotics;Biological Markers;biomarker discovery;Blood Pressure;Body Temperature;CD36 gene;cecal ligation puncture;Chronic;Chronic Kidney Failure;clinically relevant;Collaborations;Combined Modality Therapy;comorbidity;Complex;Conscious;coronary fibrosis;Death Rate;Disease;disease model;Dissociation;Drug Screening;effective therapy;effectiveness testing;epidemiologic data;epidemiological model;Fibrosis;Functional disorder;glomerulosclerosis;Heart Rate;Hospitals;Hypertension;in vivo;Incidence;Injury;Injury to Kidney;interstitial;Kidney;Kidney Diseases;kidney dysfunction;Knock-out;Liquid substance;Modeling;Morbidity - disease rate;mortality;mouse model;Mouse Strains;Mus;Nephrectomy;Nephrology;non-invasive monitor;novel;novel therapeutic intervention;old mice;olmesartan;Operative Surgical Procedures;Organ;Outcome;Pathway interactions;patient subsets;Patients;Peritonitis;Phenotype;Predisposition;Procedures;Process;Proteinuria;Rattus;renal ischemia;Reperfusion Therapy;resistant strain;Sampling;Sepsis;Syndrome;systemic inflammatory response;Telemetry;Testing;Tubular formation;Work,Inhibition Of Renal Injury,43403,NA,NA,NA,NA,25,NA,NA,1350803,NA
11193718,ZIA,DK,1,N,NA,NA,NA,NA,ZIADK075121,NA,NA,1ZIADK075121-09,NIDDK:75266\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES,NA,NA,NA,14759023 (contact),"NIEMAN, LYNNETTE  (contact)",NA,NA,NA,adenoma;Adrenal Gland Hyperfunction;Classification;Clinical Trials;Consensus;Corticotropin;Cushing Syndrome;Disease;Disease remission;Frequencies;GNRH1 gene;Gonadotropins;Hydrocortisone;Hypogonadism;Hypothalamic structure;improved;insight;Intervention;Logistic Regressions;Malignant Neoplasms;Measurement;Mediating;men;Neuroendocrine Tumors;Operative Surgical Procedures;Outcome Measure;Patients;Physiologic pulse;Physiology;Pituitary-dependent Cushing&apos;s disease;Plasma;Postoperative Period;reproductive axis;response;restoration;SHBG gene;symposium;Testosterone;Thyroid Hormones;Time;trend;tumor,The Physiology Of Hypercortisolism,75121,NA,NA,NA,NA,9,NA,NA,75266,NA
11193719,ZIA,DK,1,N,NA,NA,NA,NA,ZIADK075163,NA,NA,1ZIADK075163-04,NIDDK:304843\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES,NA,NA,NA,14269697 (contact),"CHUNG, STEPHANIE THERESE (contact)",NA,NA,NA,Abdomen;acceptability and feasibility;Address;Adult;Adverse effects;Age;Bacteria;Chronic;Clinical;clinical center;clinical practice;clinically significant;COVID-19 pandemic;Cross-Over Trials;Data;Data Analyses;design;Diabetes Mellitus;Diarrhea;Diet;Double-Blind Method;Eating;Enrollment;falls;FDA approved;Feces;Fiber;Food;gastrointestinal;gastrointestinal symptom;Glucose;Hormones;improved;Individual;Insulin;Intervention;Manuscripts;Marketing;medication compliance;Metformin;microbial;microbiome;microbiome therapeutics;Muscle Cramp;Nature;Non-Insulin-Dependent Diabetes Mellitus;Notification;Obesity;open label;Oral;Outpatients;Participant;Pharmaceutical Preparations;Phase;Pilot Projects;Placebos;Plasma;polyphenol;prebiotics;Procedures;Protocols documentation;Publishing;Randomized;recruit;Schedule;screening;side effect;Standardization;Testing;Time;trial planning;United States National Institutes of Health;Visit;Volatile Fatty Acids;young adult;Youth,Prebiotics and Metformin Influences Gut and Hormones in Type 2 Diabetes Youth (MIGHTY-Fiber),75163,NA,NA,NA,NA,4,NA,NA,304843,NA
11193720,ZIA,DK,1,N,NA,NA,NA,NA,ZIADK075176,NA,NA,1ZIADK075176-02,NIDDK:914529\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES,NA,NA,NA,14269697 (contact),"CHUNG, STEPHANIE THERESE (contact)",NA,NA,NA,actigraphy;Adult;adult obesity;aged;Biological;Biological Clocks;Body Temperature;circadian;cohort;Cross-Over Studies;Dietary Fats;Eating;Fatty acid glycerol esters;Glucose;Hour;Individual;Insulin;Light;Link;Melatonin;men;Metabolic;Nutritional;Obesity;Oral;Outcome;oxidation;Palmitates;Participant;Persons;Phase;Phenotype;Prediabetes syndrome;Protocols documentation;Randomized;recruit;Schedule;sex;Sleep;Time;United States National Institutes of Health;Universities;Visit;volunteer;Weight;Woman;Wrist,Dinner Time for Obesity and Prediabetes (DTOP),75176,NA,NA,NA,NA,2,NA,NA,914529,NA
11193721,ZIA,DK,1,N,NA,NA,NA,NA,ZIADK075178,NA,NA,1ZIADK075178-01,NIDDK:762108\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES,NA,NA,NA,14269697 (contact),"CHUNG, STEPHANIE THERESE (contact)",NA,NA,NA,Antiinflammatory Effect;beta-Hydroxybutyrate;biological sex;Biology;cardiometabolism;CD4 Positive T Lymphocytes;Cells;Classification;clinical translation;design;Desire for food;dietary;Dietary Intervention;Enrollment;Fasting;gastrointestinal symptom;Guidelines;Hormonal;Immune;immunoregulation;in vivo;Individual;Inflammation;Inflammatory;Institutional Review Boards;interest;Intermittent fasting;Interruption;Isotopes;ketogenesis;Ketone Bodies;Ketones;Mediating;men;Metabolic;Metabolism;Obesity;Outcome;Participant;Pathway interactions;Phenotype;Pilot Projects;Process;Protocols documentation;recruit;Regimen;Research;response;Role;sex;Signal Transduction;stability testing;stable isotope;stress symptom;supply chain;T cell response;T-Cell Activation;T-Lymphocyte;Techniques;Testing;Thinness;Time;Time-restricted feeding;translational study;United States National Institutes of Health;Woman;women versus men,Pilot Study of Isocaloric Time Restricted Eating on Ketone Metabolism andImmunoregulation,75178,NA,NA,NA,NA,1,NA,NA,762108,NA
11193723,ZIA,HG,1,N,NA,NA,NA,NA,ZIAHG200371,NA,NA,1ZIAHG200371-14,NHGRI:1583024\,INTRAMURAL RESEARCH,2024,NATIONAL HUMAN GENOME RESEARCH INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL HUMAN GENOME RESEARCH INSTITUTE,NA,NA,NA,11142903 (contact),"KASTNER, DANIEL  (contact)",NA,NA,NA,"2019-nCoV;Adenitis;admixture mapping;Adult;Affect;African American;African American population;African ancestry;Alleles;American;Amino Acids;angiogenesis;Anticoagulation;Antigens;Aphthous Stomatitis;Area;Arthritis;Attenuated;Autoantibodies;Autoantigens;Autoimmune Diseases;Autoimmunity;autoinflammation;autoinflammatory;autoinflammatory diseases;Behcet Syndrome;Binding Sites;Blood;Calcinosis;Calcium;Cardiac;Cell Line;Cells;Centromere;Cervical;Child;Childhood;Chronic;CHS1 gene;Clinical;Clinical Investigator;Clone Cells;cohort;Collaborations;Complex;Coronavirus;cross reactivity;cytokine;Data;Deposition;Dermis;Diffuse;Disease;DNA;Endothelial Cells;Endothelium;Enzymes;exome;Extramural Activities;Faculty;Family;FDA approved;Fever;fibrillarin;Fibrosis;follow-up;Frequencies;Functional disorder;GDF9 gene;Gene Expression;Gene Mutation;Gene Proteins;Genes;Genetic;genetic analysis;Genetic Predisposition to Disease;Genetic study;genetic testing;genome-wide;Genomics;Genotype;Glucocorticoid Receptor;Goals;Haplotypes;high risk;Human;Incidence;Inflammation;Inflammatory;inhibitor therapy;inorganic phosphate;interest;Interleukin-1;interleukin-1 receptor accessory protein;Interleukin-1 Receptors;Interleukin-13;Investigation;Journals;Kidney;Ligands;Link;Logistic Regressions;loss of function;Lung;lymphoblastoid cell line;Manuscripts;Mediating;Medicine;Mesenchymal;Metabolism;Molecular Mimicry;Morbidity - disease rate;mortality;mouse model;Mucous Membrane;multi-ethnic;Myelogenous;National Institute of Allergy and Infectious Disease;National Institute of Arthritis, and Musculoskeletal, and Skin Diseases;Nature;New England;New York;NOTCH4 gene;novel;Organ;Outcome;overexpression;Paper;pathogen;Pathway interactions;Patients;Periodicals;Pharyngitis;Play;Population;Positioning Attribute;Predisposition;promoter;protein expression;Publishing;pulmonary arterial hypertension;Pulmonary Embolism;Quality of life;Race;racial difference;rare variant;receptor;Recurrence;Reporting;Research Personnel;Rheumatism;Rheumatoid Arthritis;Rheumatology;Risk;Risk Factors;risk variant;Role;Sampling;Scleroderma;Sequence Analysis;Sequence Homology;Signal Transduction;single-cell RNA sequencing;Skin;skin fibrosis;Somatic Mutation;Subcutaneous Tissue;Susceptibility Gene;Symptoms;Syndrome;System;systemic juvenile idiopathic arthritis;T cell receptor repertoire sequencing;T-Lymphocyte;tenure track;Testing;Thrombosis;Time;Tonsillar Tissue;Topoisomerase;Transcript;Tube;Ubiquitin-Activating Enzymes;Underserved Population;United States National Institutes of Health;Universities;Vacuole;Variant;Vascular Diseases;Venous;venous thromboembolism",Genetic Analysis of Complex Inflammatory Disorders,200371,NA,NA,NA,NA,14,NA,NA,1583024,NA
11193724,ZIA,HG,1,N,NA,NA,NA,NA,ZIAHG200372,NA,NA,1ZIAHG200372-14,NHGRI:1583024\,INTRAMURAL RESEARCH,2024,NATIONAL HUMAN GENOME RESEARCH INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL HUMAN GENOME RESEARCH INSTITUTE,NA,NA,NA,11142903 (contact),"KASTNER, DANIEL  (contact)",NA,NA,NA,Adenoidectomy;Alleles;Animal Model;Animals;Apoptosis;Arthritis;Autoimmune;autoinflammation;autoinflammatory;autoinflammatory diseases;Axillary lymph node group;B-Cell Development;B-Lymphocytes;Biochemical;Biology;Case Study;CASP3 gene;CASP8 gene;Cell Death;Cell Line;checkup examination;Chronic;Clinical;clinical center;Colitis;Complex;cytokine;Data;Dermatitis;Development;Diagnosis;Disease;Ear;Enzymes;Exhibits;experimental study;Fibroblasts;Frameshift Mutation;France;Functional disorder;Genes;Genetic;Goals;Helper-Inducer T-Lymphocyte;Hereditary Disease;high dimensionality;Histologic;Homologous Gene;Homozygote;Human;Human Herpesvirus 4;immunodeficiency;Immunology;Impairment;improved;India;Inflammatory;Inherited;inhibitor;Knock-out;knockin animal;Laboratories;Lead;Link;loss of function mutation;Loss of Heterozygosity;Lymphoid Follicle;Lymphoid Tissue;Manuscripts;Marriage;member;monocyte;Mus;Mutation;Nature;NF-kappa B;Nose;Organ;Otitis Media;Paper;Parotitis;Patients;Pharyngeal structure;Phenotype;Post-Translational Protein Processing;Proteins;Publishing;Recommendation;Reporting;Resistance;RIPK1 gene;Sampling;secondary analysis;Series;sharpin;Signal Induction;Signal Transduction;skin disorder;Son;Structural Protein;Structure of germinal center of lymph node;Syndrome;Tissues;TNF gene;TNFSF5 gene;TRADD gene;TRAF2 gene;Transcend;Ubiquitin;United States National Institutes of Health;Visit,"Genetics, Pathophysiology, and Treatment of Recessive Autoinflammatory Diseases",200372,NA,NA,NA,NA,14,NA,NA,1583024,NA
11193725,ZIA,HG,1,N,NA,NA,NA,NA,ZIAHG200373,NA,NA,1ZIAHG200373-14,NHGRI:1630994\,INTRAMURAL RESEARCH,2024,NATIONAL HUMAN GENOME RESEARCH INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL HUMAN GENOME RESEARCH INSTITUTE,NA,NA,NA,11142903 (contact),"KASTNER, DANIEL  (contact)",NA,NA,NA,Acne;Acute suppurative arthritis due to bacteria;Affinity;anakinra;Animal Model;Animals;Antigen Receptors;Arthritis;Attenuated;autoinflammation;autoinflammatory diseases;B-Lymphocytes;Binding;Binding Proteins;Biology;Blood;Bone Marrow;Carcinoma;Cell Line;Clinical;Clostridium botulinum;Colitis;de novo mutation;Dermis;Development;Disease;disease model;early onset;Edema;Exanthema;exome sequencing;experimental study;Familial Mediterranean Fever;Feedback;Foundations;Functional disorder;Future;gain of function;Gene Expression Profile;Genes;Genetic;Goals;healing;Hereditary Disease;Heterozygote;Human;humoral immunity deficiency;hypogammaglobulinemia;IL18 gene;Immune;improved;In Vitro;Inflammasome;Inflammation;Inflammatory;Inherited;inhibitor;inhibitor therapy;Interferon Type I;Interferon Type II;Interleukin-1;Interleukin-1 alpha;Janus kinase;kinase inhibitor;Knock-in;Knock-in Mouse;Knock-out;knockin animal;Laboratories;Lead;Leukocytes;loss of function mutation;Loss of Heterozygosity;Lymphocyte;Lymphoma;Macrophage;marenostrin;Mediating;Modeling;Molecular;monocyte;mouse model;Mus;mutant;Mutate;Mutation;Myeloid Cells;myeloid leukemia cell;new technology;NF-kappa B;novel;PAPA syndrome;Paper;Pathway interactions;Patients;Phenotype;PLCG2 gene;Production;Protein Dephosphorylation;Proteins;Publishing;Pyoderma Gangrenosum;Recurrence;Refractory;Reporting;Respiratory Tract Infections;retroviral transduction;Rheumatism;Safety;Sampling Studies;Serine;Sinusitis;success;T-Cell Lymphoma;T-Lymphocyte;targeted treatment;Time;TNF gene;Toxin;Variant,"Genetics, Pathophysiology, and Treatment of Dominant Autoinflammatory Diseases",200373,NA,NA,NA,NA,14,NA,NA,1630994,NA
11193726,ZIE,DK,1,N,NA,NA,NA,NA,ZIEDK075005,NA,NA,1ZIEDK075005-21,NIDDK:93441\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES,NA,NA,NA,15191619 (contact),"KLUBO-GWIEZDZINSKA, JOANNA  (contact)",NA,NA,NA,accurate diagnosis;Autoimmune Diseases;autoimmune thyroid disease;Biological;Blood;Blood Tests;Board Certification;Body Composition;Cell Differentiation process;cell growth;Clinical;Clinical Data;Collaborations;Data;data exchange;Databases;Development;Diagnosis;Diagnostic Procedure;Discipline of Nuclear Medicine;Disease;Dose;Endocrine;Endocrinology;Energy Metabolism;Enrollment;Family history of;Functional disorder;Genetic;Germany;Health;HLA Antigens;human leukocyte antigen testing;Hyperthyroidism;Hypothyroidism;imaging study;Laboratory Study;Magnetic Resonance Imaging;mathematical model;Measurement;Metabolism;National Institute of Diabetes and Digestive and Kidney Diseases;Natural History;participant enrollment;patient screening;Patients;Pattern;Physical Examination;Pituitary Gland Adenoma;Protocols documentation;Public Health;Radioactive Iodine;Rare Diseases;Recording of previous events;Research Personnel;research study;Scanning;Symptoms;Technetium;Testing;Thyroid Diseases;Thyroid Function Tests;Thyroid Gland;Thyroid Hormone Resistance Syndrome;Thyroid Hormones;Thyrotropin;Thyroxine;Training;Training Programs;Transfer Agreement;treatment optimization;United States National Institutes of Health;Update;uptake;Urine;X-Ray Computed Tomography,Studies of Thyroid Function in Health and Disease,75005,NA,NA,NA,NA,21,NA,NA,93441,NA
11193731,P20,GM,5,N,2024-03-28,2024-03-01,2025-02-28,NA,P20GM135000,SCHOOLS OF VETERINARY MEDICINE,PAR-19-313,5P20GM135000-04,NIGMS:221920\,RESEARCH CENTERS,2024,NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES,NA,BATON ROUGE,UNITED STATES,VETERINARY SCIENCES,06,075050765,US,577907,LOUISIANA STATE UNIV A&M COL BATON ROUGE,LA,708030001,NA,16355295 (contact),"SU, SHANG  (contact)","PEI, WUHONG",2024-09-17,2026-02-28,Agonist;anti-cancer research;bone;Breast Cancer Model;cancer cell;Cancer Patient;Cells;Clinical;Data;Development;Epigenetic Process;Genes;Genetic Transcription;Goals;Head and Neck Squamous Cell Carcinoma;in vivo Model;Knock-out;Malignant neoplasm of prostate;Malignant Neoplasms;Malignant Squamous Cell Neoplasm;Metastatic Neoplasm to the Bone;Neoplasm Metastasis;neoplastic cell;novel;Nuclear Receptors;overexpression;pre-clinical;prevent;prognostic;programs;Proliferating;Prostate;prostate cancer cell;Proteins;Proteomics;Relapse;response;Signal Induction;targeted treatment;Testing;therapeutic development;transcriptome sequencing;Tretinoin;tumor,Deciphering Prostate Cancer Cell Dormancy Drivers,135000,ZGM1,ZGM1-RCB-9(C1),8133,NA,4,149946,71974,NA,221920
11193761,U01,FD,5,N,2024-09-20,2024-09-01,2025-08-31,103,U01FD006921,NA,RFA-FD-23-031,5U01FD006921-05,FDA:1000000\,NON-SBIR/STTR RPGS,2024,FOOD AND DRUG ADMINISTRATION,NA,WASHINGTON,UNITED STATES,NA,98,080208543,US,10041615,NATIONAL FARMERS UNION FOUNDATION,DC,200016700,"U.S. Food and Drug Administration (FDA) Center for Food Safety and Applied Nutrition (CFSAN) RFA-FD-23-031: Renewal - Local Food Producer Outreach, Education, and Training to Enhance Food Safety and FDA Food Safety Modernization Act (FSMA) Compliance (U01) Local Food Safety Collaborative | National Farmers Union Foundation July 11, 2023 Project Narrative This project is dedicated to helping local food producer audiences who have a unique place within Food Safety Modernization Act (FSMA) regulations. Local food producers experience challenges as they attempt to understand and satisfy food safety requirements. The Local Food Safety Collaborative (LFSC), remains dedicated to helping local farmers and processors advance their food safety knowledge and capacity to increase compliance, enhance the economic viability of their operations, and enable them to continue providing consumers with safe, healthy local food.",78912841 (contact),"MCCARTHY, WILLIAM  (contact)","ALLEN, MARION",2020-05-15,2025-08-31,NA,Local Food Safety Collaborative,6921,ZFD1,ZFD1-CFSN-K(01)1,NA,NA,5,720022,279978,1000000,NA
11194020,R01,AR,3,N,2024-09-18,2024-03-01,2025-02-28,846,R01AR078414,SCHOOLS OF MEDICINE,PA-19-056,3R01AR078414-04S1,NIAMS:162961\,NON-SBIR/STTR RPGS,2024,NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES,NA,Aurora,UNITED STATES,ORTHOPEDICS,06,041096314,US,1199905,UNIVERSITY OF COLORADO DENVER,CO,800452571,"NARRATIVE This project aims to 1) definitively establish that a pro-inflammatory dysbiotic gut microbiome is causal in the OA of obesity, and 2) demonstrate that correction of this dysbiosis using strategies to expand B. pseudolongum will decelerate the progression of OA in the obese context.",2080688;1953547 (contact),"GILL, STEVEN R.;ZUSCIK, MICHAEL J (contact)","PINTUCCI, GIUSEPPE",2021-04-01,2026-02-28,Ablation;Acceleration;Actinobacteria class;Address;Arthritis;B-Lymphocytes;Bifidobacterium;Blood;Cells;Circulation;Colon;Communication;Communities;comorbidity;cytokine;Data;Deceleration;Degenerative polyarthritis;Development;diet-induced obesity;Dietary Supplementation;Disease;dysbiosis;Epithelium;Experimental Designs;experimental study;Family member;Fiber;gut dysbiosis;gut microbiome;Health;High Fat Diet;Human;Immune;Inflammation;Inflammatory;Intestines;joint destruction;joint loading;Joints;Knee;Knee joint;Link;Macrophage;Mechanics;Medial meniscus structure;Messenger RNA;Metabolic;Metabolism;metabolome;metagenome;metatranscriptome;Methods;microbial;microbiome composition;microbiota;Modeling;mouse model;Movement;multiple omics;multiplex assay;Mus;nano-string;novel therapeutic intervention;Obese Mice;Obesity;Operative Surgical Procedures;Oral;Organoids;palliative;Pathogenicity;Peptococcaceae;prebiotics;Probiotics;Process;resident commensals;Role;Serum;Supplementation;Synovial Membrane;systemic inflammatory response;Taxonomy;Testing;Thinness;Time;Tissue Harvesting;Tissues;transcriptomics;Transgenic Mice;Transplantation;Up-Regulation;Work,Studies on gut microbiome-joint connections in arthritis,78414,SBSR,Skeletal Biology Structure and Regeneration Study Section[SBSR],NA,S1,4,104798,58163,162961,NA
11194030,OT2,OD,3,N,2024-09-20,2021-09-25,2025-09-24,310,OT2OD032100,NA,OTA-24-200,3OT2OD032100-01SA,NCCIH:1500\NHGRI:35000\NIA:100000\NIAID:133237\NIAMS:45000\NIBIB:350000\NIDCD:15000\NIEHS:67000\NINR:6000\NLM:195000\OD:2343400\,OTHERS,2024,"OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH",NA,ROUND ROCK,UNITED STATES,NA,17,149530219,US,10065401,DELL FEDERAL SYSTEMS L.P.,TX,786827000,NA,78171056 (contact);78362163,"HAMMONDODWYER, AMY K (contact);SIDDIQUI, ERUM","WEBER, MICHAEL NICHOLAS N",2021-09-25,2026-06-30,Acceleration;Address;Biomedical Research;Cloud Computing;Cloud Service;cloud storage;Communities;computerized tools;Data;Data Commons;data ecosystem;data repository;Data Science;Data Set;Economics;FAIR principles;Funding;Goals;Image;Individual;large datasets;Modeling;Modernization;Phase;Policies;Procedures;Process;programs;Research Infrastructure;Research Personnel;Science;Series;service providers;Services;Strategic Planning;Technology;Testing;Training;United States National Institutes of Health;Work,NIH STRIDES - Azure and Associated Services and Training.,32100,ZOD1,ZOD1-SRC(99),NA,SA,1,3291137,0,3291137,NA
11194032,R56,HG,1,N,2024-09-25,2024-09-25,2025-08-31,172,R56HG013865,BIOMED ENGR/COL ENGR/ENGR STA,PAR-21-254,1R56HG013865-01,NHGRI:644578\,NON-SBIR/STTR RPGS,2024,NATIONAL HUMAN GENOME RESEARCH INSTITUTE,NA,GAINESVILLE,UNITED STATES,ENGINEERING (ALL TYPES),03,969663814,US,513806,UNIVERSITY OF FLORIDA,FL,326115500,"PROJECT NARRATIVE This research will develop the means to build a pangenomic reference genome, which will be applied in order to construct a novel human reference genome that encapsulates variation within the population. This will, in turn, facilitate the study of complex traits and diseases that require the use of a multifactorial, high-quality reference genome. Examples of such diseases and traits include cancer sub-types, autism, schizophrenia, and Parkinsons disease.",11643492 (contact);10456417,"BOUCHER, CHRISTINA  (contact);LANGMEAD, BENJAMIN THOMAS","DAYAL, JYOTI",2024-09-25,2025-08-31,Achievement;Address;Adopted;Algorithms;Area;autism spectrum disorder;Bioinformatics;Biology;cancer subtypes;Collaborations;Collection;Complex;Computer software;cost;Data;data structure;Development;Disease;effectiveness evaluation;Encapsulated;Ensure;Feedback;Genetic study;genetic variant;Genetic Variation;Genome;Goals;Human Genome;human reference genome;improved;indexing;interest;Licensing;Maintenance;Methods;Monitor;novel;open source;pan-genome;Parkinson Disease;Performance;Population;prevent;public database;reference genome;Reference Standards;Research;Research Personnel;Scheme;Schizophrenia;Scoring Method;Sequence Alignment;Statistical Models;Structure;telomere;Time;trait;Update;usability;user-friendly;Variant;variant detection;Work,Fully Realizing Pangenomics Alignment,13865,ZRG1,Special Emphasis Panel[ZRG1-BBBT-V(03)M],NA,NA,1,504285,140293,644578,NA
11194033,P50,MD,3,N,2024-09-19,2024-05-01,2025-04-30,NA,P50MD017342,NA,PA-23-189,3P50MD017342-04S3,NIMHD:117318\,RESEARCH CENTERS,2024,NATIONAL INSTITUTE ON MINORITY HEALTH AND HEALTH DISPARITIES,NA,MINNEAPOLIS,UNITED STATES,NA,05,555917996,US,1450402,UNIVERSITY OF MINNESOTA,MN,554552070,NA,7608807 (contact);9240800;6475572,"ALLEN, MICHELE L (contact);HARDEMAN, RACHEL R;PATTEN, CHRISTI A","STINSON, NATHANIEL",2024-05-01,2026-06-30,NA,Understanding facilitators and barriers for the utilization of an Indigenized meal kit amongst urban Minnesota Native American youth and families,17342,ZMD1,ZMD1(A1),8134,S3,4,103568,13750,NA,117318
11194034,U01,FD,3,N,2024-09-23,2024-09-01,2025-08-31,103,U01FD005946,SCHOOLS OF PHARMACY,RFA-FD-23-004,3U01FD005946-09S7,FDA:28000\,NON-SBIR/STTR RPGS,2024,FOOD AND DRUG ADMINISTRATION,NA,BALTIMORE,UNITED STATES,PHARMACOLOGY,07,188435911,US,820104,UNIVERSITY OF MARYLAND BALTIMORE,MD,212011508,"Narrative Statement We propose continuation of M-CERSI that fosters FDA-oriented research, as well as regulatory science information sharing opportunities. The Center's mission is to foster the development of regulatory science  the science of developing new tools, standards and approaches to assess the safety, efficacy, quality and performance of FDA-regulated products. Activities leverage the close geographic proximity between University of Maryland and FDA's main campus.",7026380;7747747 (contact),"BENTLEY, WILLIAM E.;POLLI, JAMES E (contact)","SEPULVEDA, KRISTIN",2016-09-15,2028-08-31,NA,University of Maryland Center of Excellence in Regulatory Science and Innovation,5946,ZFD1,ZFD1-OC-S(04)1,NA,S7,9,23333,4667,28000,NA
11194038,R01,MD,7,N,2024-09-23,2024-09-23,2025-01-31,307,R01MD018012,SCHOOLS OF MEDICINE,PA-24-254,7R01MD018012-03,NIMHD:423837\,NON-SBIR/STTR RPGS,2024,NATIONAL INSTITUTE ON MINORITY HEALTH AND HEALTH DISPARITIES,NA,AMHERST,UNITED STATES,INTERNAL MEDICINE/MEDICINE,26,038633251,US,5992614,STATE UNIVERSITY OF NEW YORK AT BUFFALO,NY,142282567,"Project Narrative This study seeks to use novel methods and data to address the following aims: 1) Examine the relationship between regional exposure to structural racism and the propensity of hospital and clinic closures; 2) examine the relationship between hospital and clinic closures and community assets (pertaining to employment, income, and education) and community health outcomes (across mortality, disability, and chronic disease burden); 3) predict risk of closure among urban hospitals and clinics that are disproportionately serving racial/ethnic minorities from neighborhoods with exposure to structural racism (defined as historic redlining); 4) undertake stakeholder engagement to address prevention of future closures and/or examine ways to decrease the potential adverse community impact of hospital and clinic closures.",6725783 (contact);77879194,"EGEDE, LEONARD E. (contact);LINDE, SEBASTIAN","STINSON, NATHANIEL",2023-07-10,2027-01-31,Acute;Address;Affect;Area;Attention;burden of chronic illness;Caring;Clinic;Clinics and Hospitals;Code;Communities;Community Health;COVID-19 pandemic;Crows;Data;Diabetes Mellitus;differences in access;disability;Discrimination;disparity gap;econometrics;Economics;Education;Employment;ethnic health disparity;ethnic minority;ethnic minority population;Ethnic Origin;Event;explainable machine learning;Exposure to;Fostering;Future;gaps in access;Goals;Health;health care availability;health disparity;Hospital Closures;Hospitals;Housing;Income;Individual;Inequity;inner city;innovation;Insurance;intergenerational;Investments;Knowledge;Laws;Legal;Link;Literature;machine learning method;Measures;Methodology;Methods;mortality;Myocardial;Neighborhoods;novel;Outcome;Pathway interactions;Policies;poor health outcome;Prevention;Primary Care;Quality of Care;Race;racial health disparity;racial minority;racial minority population;Resources;Risk;Risk Factors;risk prediction;Rural;Rural Hospitals;Schools;segregation;Services;Shock;social;Societies;Structural Racism;System;trend;United States Agency for Healthcare Research and Quality;Urban Community;Urban Hospitals;urban setting;Work,"Impact of structural racism on hospital/clinic closures, community assets, and health outcomes in urban communities",18012,HHD,Healthcare and Health Disparities Study Section[HHD],NA,NA,3,283883,139954,423837,NA
11194039,R56,HG,1,N,2024-09-25,2024-09-25,2025-08-31,172,R56HG013312,BIOMED ENGR/COL ENGR/ENGR STA,PA-20-185,1R56HG013312-01A1,NHGRI:636648\,NON-SBIR/STTR RPGS,2024,NATIONAL HUMAN GENOME RESEARCH INSTITUTE,NA,SEATTLE,UNITED STATES,BIOSTATISTICS & OTHER MATH SCI,07,605799469,US,9087701,UNIVERSITY OF WASHINGTON,WA,981959472,"NARRATIVE This research seeks to develop models for predicting how genetic variation affects mRNA stability and translation efficiency. To train these models, we will collect data from massively parallel reporter assays in multiple cell lines targeting the UTR and CDS mRNA regions. We will also develop a new technology for characterizing protein expression levels using high-throughput nanopore sequencing of barcoded protein reporters, which will allow us to improve the sensitivity and accuracy of our protein measurements by surpassing the limitations of current methods such as ribosome loading.",12462164 (contact);10119009,"NIVALA, JEFFREY MATTHEW (contact);SEELIG, GEORG","FUFA, TEMESGEN D",2024-09-25,2025-08-31,3&apos; Untranslated Regions;5&apos; Untranslated Regions;Address;Affect;Amino Acid Sequence;Bar Codes;Behavior;Biological;Biological Assay;Catalogs;Cell Line;cell type;ClinVar;Clustered Regularly Interspaced Short Palindromic Repeats;Code;Complement;Conserved Sequence;CRISPR interference;Data;Data Set;Databases;de novo mutation;deep learning;deep learning model;design;Development;disease phenotype;experimental study;falls;Gene Expression;gene function;Genes;Genetic Transcription;genetic variant;Genetic Variation;genome sequencing;genome wide association study;Goals;Human;Human Genome;improved;insight;Investigation;knock-down;Learning;Length;Libraries;Link;Location;Machine Learning;Measurement;Measures;Messenger RNA;Methods;Modeling;Molecular;molecular phenotype;mRNA Stability;mRNA Translation;nanopore;new technology;novel;novel strategies;Pathogenicity;Peptide Sequence Determination;Phenotype;Polyadenylation;polysome profiling;Positioning Attribute;predictive modeling;pressure;Process;Production;protein expression;Proteins;Proxy;rare variant;recurrent neural network;Regulation;Regulatory Element;Reporter;Research;Resolution;ribosome profiling;Ribosomes;RNA Splicing;RNA-Binding Proteins;screening;sensor;sequence learning;Signal Transduction;Specificity;Statistical Methods;Stratification;synthetic biology;Technology;Testing;Tissues;Training;training data;Transcript;transcriptome;translational model;Translations;Untranslated Regions;Untranslated RNA;Variant;variant detection;Work,Integrating the impacts of genetic variation with massively parallel mRNA and protein barcoding,13312,GCAT,"Genomics, Computational Biology and Technology Study Section[GCAT]",NA,A1,1,423433,213215,636648,NA
11194052,UH3,MD,4,N,2024-09-18,2024-09-01,2026-06-30,310,UH3MD018296,SCHOOLS OF PUBLIC HEALTH,PAR-22-115,4UH3MD018296-04,OD:3230000\,NON-SBIR/STTR RPGS,2024,NATIONAL INSTITUTE ON MINORITY HEALTH AND HEALTH DISPARITIES,NA,WASHINGTON,UNITED STATES,PUBLIC HEALTH & PREV MEDICINE,98,043990498,US,2863301,GEORGE WASHINGTON UNIVERSITY,DC,200520042,"This cooperative agreement project entails formative research to finalize intervention elements and data collection protocols, followed by the implementation and evaluation of a unique community-level intervention to prevent firearm violence among youth in a Washington, DC community.",1872990 (contact),"EDBERG, MARK  (contact)","JOHNSON, JARRETT AINSWORTH",2022-09-15,2026-06-30,Academic support;Address;Affect;African American;Age;Area;Attitude;authority;Baseline Surveys;Behavior;Behavioral;Cause of Death;Cities;cohort;Collaborations;Collection;Communication;Communities;community center;community collaboration;Community Health;community intervention;community organizations;community partners;Data;Data Analyses;Data Collection;data sharing;design;Development;District of Columbia;Elements;Ethnic Population;Evaluation;expectation;Female;Firearms;follow-up;Gender;Genus Mentha;gun violence;health disparity;Health Service Area;Homicide;Housing;Information Dissemination;instrument;Intervention;intervention effect;journal article;Lawyers;Life;Life Cycle Stages;Link;male;Manuals;marginalization;Mediator;meetings;Mentors;metropolitan;minority children;Outcome;Parents;Pathway interactions;Pattern;Persons;Phase;pilot test;Police;positive youth development;Poverty;prevent;Prevention;preventive intervention;Process;programs;Protocols documentation;Public Health;Public Health Schools;Quasi-experiment;racial population;racism;recruit;Research;Sampling;Shotguns;social media;social norm;socioeconomics;study population;Surveys;theories;Time;Training;U-Series Cooperative Agreements;Universities;Violence;violence prevention;violent crime;Washington;web site;Youth,Changing the Narrative on Firearms Violence: A Community Collaborative Intervention,18296,ZRG1,Special Emphasis Panel[ZRG1-CCHI-B(50)],NA,NA,4,2000000,1230000,3230000,NA
11194054,R01,MD,7,N,2024-11-25,2024-11-25,2024-12-31,307,R01MD017574,SCHOOLS OF MEDICINE,PA-24-254,7R01MD017574-03,NIMHD:513604\,NON-SBIR/STTR RPGS,2024,NATIONAL INSTITUTE ON MINORITY HEALTH AND HEALTH DISPARITIES,NA,AMHERST,UNITED STATES,INTERNAL MEDICINE/MEDICINE,26,038633251,US,5992614,STATE UNIVERSITY OF NEW YORK AT BUFFALO,NY,142282567,"Project Narrative This study will use novel methods and extensive data sources to: 1) Examine the relationship between regional exposure to structural racism (defined as: historic redlining) and present-day social risk factors, human capital, and health care resources; 2) examine the direct and indirect effects of regional exposure to structural racism on health outcomes via social risk, human capital, and healthcare resources; 3) assess policy levers of federal, state, and local governments that can be used to reduce area vulnerabilities to historic structural racism, and that can reduce present-day racial/ethnic disparity gaps in health outcomes; and 4) Engage a diverse set of key stakeholders to identify and prioritize strategies for mitigating social risk, building human capital, and improving health care resources and outcomes for regions exposed to structural racism through historical redlining.",6725783 (contact);77879194,"EGEDE, LEONARD E. (contact);LINDE, SEBASTIAN","BARKSDALE, CRYSTAL",2023-05-13,2026-12-31,NA,"Structural Racism and Disparities in Social Risk, Human Capital, Health Care Resources, and Health Outcomes: A Multi-level Analysis of Pathways and Policy Levers for Change",17574,HHD,Healthcare and Health Disparities Study Section[HHD],NA,NA,3,345279,168325,513604,NA
11194080,P20,GM,5,N,2024-09-17,2024-09-17,2025-06-30,NA,P20GM121307,NA,PAR-22-163,5P20GM121307-07,NIGMS:219000\,RESEARCH CENTERS,2024,NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES,NA,SHREVEPORT,UNITED STATES,NA,04,095439774,US,577905,LOUISIANA STATE UNIV HSC SHREVEPORT,LA,711034228,NA,78352162 (contact),"BHUIYAN, MOHAMMAD ALFRAD NOBEL  (contact)","BERNAL, FEDERICO",2024-09-17,2027-06-30,8-hydroxy-2&apos;-deoxyguanosine;Applications Grants;Biological Markers;Biology;biomarker identification;Cardiovascular Diseases;cardiovascular disorder risk;cardiovascular health;central database;Clinical Data;clinically significant;Data;data repository;Disease;Environmental Exposure;epidemiologic data;Equilibrium;Individual;Information Management;Intervention;Link;Measures;metabolomics;novel strategies;Oxidation-Reduction;oxidative damage;Oxidative Stress;Oxidative Stress Induction;Participant;Patients;Plasma;potential biomarker;Proteins;Public Health;Research;Sampling;Science;substance use;Substance Use Disorder;therapeutic target;United States National Center for Health Statistics;volatile organic compound;Work,"Redox, Environmental, and Metabolomics: investigating Disease Yield (REMEDY)",121307,ZGM1,ZGM1-RCB-3(C2),8143,NA,7,150000,69000,NA,219000
11194082,U2C,HL,3,N,2024-09-24,2024-09-25,2025-08-31,837,U2CHL156291,NA,RFA-OD-20-007,3U2CHL156291-05S3,OD:985000\,OTHER RESEARCH-RELATED,2024,"NATIONAL HEART, LUNG, AND BLOOD INSTITUTE",NA,PHILADELPHIA,UNITED STATES,NA,03,073757627,US,1499101,CHILDREN'S HOSP OF PHILADELPHIA,PA,191462305,"PROJECT NARRATIVE  Overall. People with Down syndrome are strongly predisposed to develop a wide range of comorbidities that shorten their lifespan and decrease their quality of life, such as Alzheimers disease, congenital heart disease, leukemias, autoimmune disorders, and diverse neurological conditions. The proposed activities under this project seek to create a world-class resource for collaborative discovery, data sharing, data access, and integrative analysis that would enable novel investigations into all DS comorbidities across the lifespan and further integrating across datasets for related diseases occurring in the general population, thus paving the way for a precision medicine approach to DS. Furthermore, this resource and associated platforms will also have broader impacts by empowering physicians, educators, government officials, and advocates with the tools required to elicit evidence- based transformative action in the clinic, the classroom, the government, and society at large.",10600717;14376558;8235921;10817313;1869835;9238231 (contact),"CARROLL, ROBERT J;DIGIOVANNA, JACK ;ESPINOSA, JOAQUIN M.;FERRETTI, VINCENT ;HAENDEL, MELISSA A;RESNICK, ADAM CAIN (contact)","SCHRAMM, CHARLENE A",2020-09-26,2025-08-31,Acceleration;Advocacy;Advocate;Affect;Alzheimer&apos;s Disease;Alzheimer&apos;s disease related dementia;Amyloid Beta A4 Precursor Protein;Area;autism spectrum disorder;Autoimmune Diseases;Automobile Driving;bench to bedside;biobank;Biomedical Research;Child;Chromosome 21;Chromosomes;Clinic;Clinical;Cohort Studies;Collaborations;Communities;community empowerment;comorbidity;Complex;congenital heart abnormality;Data;data access;Data Coordinating Center;data ecosystem;data hub;data integration;data management;data modalities;data portal;data resource;Data Set;data sharing;data sharing networks;design;Development;Discipline;Disease;diverse data;Down&apos;s Syndrome;Ecosystem;Education;empowerment;Ensure;Environmental Risk Factor;epidemiology study;Epigenetic Process;Epilepsy;evidence base;Family;General Population;Genetic Diseases;Genetic Variation;Goals;Government;Government Officials;Human;Human Biology;Image;Individual;Infrastructure;innovation;interoperability;Intuition;Investigation;leukemia;Life Cycle Stages;Life Expectancy;life span;lifestyle factors;Link;Malignant Neoplasms;metabolome;Methods;microbiome;Mission;Multiomic Data;Neurologic;novel;novel diagnostics;novel therapeutics;outreach;Participant;Pathogenicity;Persons;Phenotype;Physicians;Population;precision medicine;prenatal;Proteome;Quality of life;Research;Resources;Risk;Schools;Scientist;Societies;Solid;Surveys;synergism;Technology;Time;timeline;tool;Training;transcriptome;United States National Institutes of Health;Variant;virtual,Integrating Imaging-based Infrastructure into the INCLUDE Data Hub,156291,ZRG1,Special Emphasis Panel[ZRG1-IFCN-U(50)R],NA,S3,5,803146,181854,985000,NA
11194142,R01,AR,3,N,2024-09-18,2024-09-01,2025-08-31,846,R01AR077760,SCHOOLS OF MEDICINE,PA-20-185,3R01AR077760-04S1,NIAMS:94525\,NON-SBIR/STTR RPGS,2024,NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES,NA,NEW YORK,UNITED STATES,ORTHOPEDICS,13,621889815,US,1833205,COLUMBIA UNIVERSITY HEALTH SCIENCES,NY,100323725,"Discogenic back pain, is a leading cause of disability, and involves degenerative changes of the intervertebral disc. Only a small subset of patients responds favorably to existing treatments, and there is a need for alternative options, including regenerative therapies. We are developing and optimizing use of anti-inflammatory cells for disc repair in hope that it improves outcomes for patients with back pain and degeneration.",9260150 (contact),"CHAHINE, NADEEN O. (contact)","MARQUITZ, ARON",2021-09-01,2026-08-31,Address;Animal Model;Animals;Anti-Inflammatory Agents;Architecture;Area;Back Pain;Biochemistry;Biological;Biomechanics;bone marrow mesenchymal stem cell;Cell Transplantation;Cells;clinical efficacy;Clinical Research;Coculture Techniques;combat;Consensus;conventional therapy;Custom;cytokine;Data;disability;discogenic pain;Disease;Economic Burden;enhancing factor;Environment;Extracellular Matrix;Extracellular Matrix Degradation;Frequencies;Future;Goals;Height;Human;Hydrostatic Pressure;Immobilization;immunoregulation;improved;improved outcome;In Vitro;in vivo;Inflammation;Inflammatory;inflammatory milieu;Inflammatory Response;injured;Injury;innovation;Intervertebral disc structure;intervertebral disk degeneration;Label;Low Back Pain;Macrophage;mechanical load;Mediating;Mesenchymal Stem Cell Transplantation;Mesenchymal Stem Cells;Methods;migration;Modeling;Motion;Nitric Oxide;Operative Surgical Procedures;Opiate Addiction;Organ Culture Techniques;Outcome;pain behavior;Pain management;pain outcome;Paracrine Communication;patient subsets;Patient-Focused Outcomes;Physical therapy;Physiological;pre-clinical;Pre-Clinical Model;Production;Puncture procedure;Rattus;regenerative therapy;repaired;Research;response;Role;Severities;Signal Transduction;socioeconomics;Stem cell transplant;stem cells;Stimulus;Structural defect;Symptoms;System;Therapeutic;Tissues;TNF gene;Transforming Growth Factor beta;Transplantation;Treatment Efficacy;Up-Regulation,Anti-inflammatory Cell Based Repair of Intervertebral Disc Degeneration,77760,MTE,Musculoskeletal Tissue Engineering Study Section[MTE],NA,S1,4,57462,37063,94525,NA
11194145,Y01,CA,NA,N,NA,NA,NA,NA,ACO21003001,NA,NA,ACO21003001-1-0-1,OD:190000\,INTERAGENCY AGREEMENTS,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,(contact),NA,NA,NA,2019-nCoV;Address;Award;Cellular Phone;Common Data Element;Communities;Computer Analysis;Computerized Medical Record;computerized tools;conditioning;Contracts;COVID-19;COVID-19 pandemic;Data;Data Analyses;data de-identification;Data Discovery;data hub;data integration;data management;data modeling;data pipeline;data repository;Data Set;Deposition;Development;digital health;digital repositories;future pandemic;Goals;Institution;insurance claims;Laboratories;Learning;Link;machine learning model;Modeling;multiple data sources;National Cancer Institute;National Institute of Biomedical Imaging and Bioengineering;pandemic disease;population health;predictive modeling;privacy preservation;programs;quality assurance;Quality Control;RADx;Research;Research Personnel;response;Source;Standardization;Surveys;Technology;tool;United States National Institutes of Health;Virus;wearable sensor technology,CSSI MIT/LL Digital Health Solutions (DHS) for COVID-19,210030,NA,NA,NA,NA,NA,NA,NA,190000,NA
11194149,OT2,OD,3,N,2024-09-19,2023-09-19,2025-02-28,310,OT2OD027060,NA,OTA-24-200,3OT2OD027060-02S8,NHGRI:85000\NIA:72000\NIAAA:1000\NIAID:504534\NIBIB:50000\NIDDK:6000\NIMHD:348500\NINR:200000\NLM:13345000\OD:1014494\,OTHERS,2024,"OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH",NA,RESTON,UNITED STATES,NA,11,088365767,US,10051506,CARAHSOFT TECHNOLOGY CORPORATION,VA,201905328,NA,15584968 (contact),"DRINKWINE, TERRY  (contact)","WEBER, MICHAEL NICHOLAS N",2023-03-01,2033-02-28,Acceleration;Address;Biomedical Research;Cloud Computing;Cloud Service;cloud storage;Communities;computerized tools;Data;Data Commons;data ecosystem;data repository;Data Science;Data Set;Economics;FAIR principles;Funding;Goals;Image;Individual;large datasets;Modeling;Modernization;Phase;Policies;Procedures;Process;programs;Research Infrastructure;Research Personnel;Science;Series;service providers;Services;Strategic Planning;Technology;Testing;United States National Institutes of Health;Work,STRIDES,27060,ZHL1,ZHL1-SRC(99),NA,S8,2,15626528,0,15626528,NA
11194169,K00,MH,7,N,2024-11-26,2024-09-17,2025-04-30,242,K00MH134674,SCHOOLS OF MEDICINE,PA-24-254,7K00MH134674-05,NIMH:58926\,OTHER RESEARCH-RELATED,2024,NATIONAL INSTITUTE OF MENTAL HEALTH,NA,Aurora,UNITED STATES,INTERNAL MEDICINE/MEDICINE,06,041096314,US,1199905,UNIVERSITY OF COLORADO DENVER,CO,800452571,"PROJECT NARRATIVE Dysregulation of inhibitory synapses, specifically GABAARs, alters excitatory-inhibitory balance and has been implicated in a number of neurological disorders, including ischemia. GABAAR trafficking regulates overall inhibitory synaptic strength and is influenced by phosphorylation status of the receptor. Here, I propose to test the hypothesis that GABAAR trafficking during OGD is differentially regulated based on neuronal populations, and this contributes to defined synaptic and cellular alterations based on the susceptibility of these neuronal populations.",11813478 (contact),"GARCIA, JOSHUA DAYLON (contact)","DRISCOLL, JAMIE",2024-09-17,2027-04-30,NA,The role of dendritic excitability in controlling GABAergic synapse maturation,134674,ZNS1,ZNS1-SRB-B(80),NA,NA,5,54561,4365,58926,NA
11194172,ZIA,AI,1,N,NA,NA,NA,NA,ZIAAI001209,NA,NA,1ZIAAI001209-09,NIAID:1718620\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,9413770 (contact),"PIERSON, THEODORE  (contact)",NA,NA,NA,Acceleration;Adult;Antibodies;Antibody Repertoire;Antibody Response;Arboviruses;Area;Arthralgia;Arthritis;Binding;Biology;Breathing;Characteristics;Complex;Conjunctivitis;Country;Coupled;Culicidae;Data;Defect;Degree requirements;Development;diagnostic strategy;diagnostic value;Disease;Disease Outbreaks;env Gene Products;Epidemic;Epitopes;Evaluation;Exanthema;Fever;Flavivirus;Flavivirus Infections;Goals;Guillain Barr Syndrome;human disease;Humoral Immunities;Immune;Immune Sera;immunogenicity;in vivo;Infant;Infection;insight;Intervention;Island;Laboratories;Lead;Learning;Microcephaly;Micronesia;Molecular Conformation;Monoclonal Antibodies;National Institute of Allergy and Infectious Disease;Neurologic;neutralizing antibody;novel diagnostics;Pacific Islands;Pathogenesis;polyclonal antibody;Population;pregnant;Public Health;rational design;Reporting;Research;Resolution;response;RNA Viruses;Sampling;Source;South America;Structural Models;Structure;Surface;System;tool;translational impact;transmission process;United States;Vaccination;vaccine development;Vaccines;Viral;Viral Antigens;Viral Envelope Proteins;viral transmission;Virion;Virus;Virus Diseases;Woman;Work;Zika Virus;Zika virus vaccine;ZIKV infection,The humoral response to Zika virus infection and vaccination,1209,NA,NA,NA,NA,9,NA,NA,1718620,NA
11194173,ZIA,AI,1,N,NA,NA,NA,NA,ZIAAI005171,NA,NA,1ZIAAI005171-01,NIAID:1000000\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,9413770 (contact),"PIERSON, THEODORE  (contact)",NA,NA,NA,adverse pregnancy outcome;Africa;Antibodies;Arboviruses;Biology;Bunyamwera virus;Canada;Caribbean region;Central America;Childhood;Dengue;Development;Disease;Disease Outbreaks;Fever;Human;Immune response;Immunity;Immunization;Infection;La Crosse virus;Monoclonal Antibodies;mouse model;Nervous System Disorder;Oropouche virus;Orthobunyavirus;Prevention;programs;Research;South America;Therapeutic;Vaccination;Vaccine Antigen;Vaccine Design;Vaccines;Viral Hemorrhagic Fevers;Virus;Virus Diseases;Work,"Bunyavirus biology, immunity, and countermeasure development",5171,NA,NA,NA,NA,1,NA,NA,1000000,NA
11194174,ZIA,CL,1,N,NA,NA,NA,NA,ZIACL060065,NA,NA,1ZIACL060065-17,NA,INTRAMURAL RESEARCH,2024,CLINICAL CENTER,NA,NA,NA,NA,NA,NA,NA,NA,CLINICAL CENTER,NA,NA,NA,9692799 (contact),"CHAN, LEIGHTON  (contact)",NA,NA,NA,Activities of Daily Living;Address;adjudication;Agreement;Algorithms;analytical tool;Area;Articulation;Assessment tool;beneficiary;Boston;career development;Characteristics;Classification;Clinical;Cognition;Collaborations;collected works;Communication;Communities;comparative;Computer software;Computerized Medical Record;Computers;Data;Decision Making;Development;Device or Instrument Development;Diagnosis;diagnostic tool;disability;Disability Evaluation;disability payment;Disabled Persons;Documentation;Emotions;Ensure;Equity;functional disability;Health;Health Personnel;Impairment;Individual;Informal Social Control;innovation;instrument;International;Interpersonal Relations;Language;Life;Longitudinal Studies;Machine Learning;Measures;Medical;Medical Electronics;Medical Records;Mental Health;mental representation;Methods;Modeling;Moods;Motor;Natural Language Processing;new technology;novel;Occupations;Patient Self-Report;Persons;Physical Function;Pilot Projects;pressure;Process;programs;Records;Regulation;Reporting;Research;Research Project Grants;research study;resilience;Respondent;response;safety net;Sampling;Science;Security;Self Assessment;Self Care;Social Functioning;Source;Statutes and Laws;Strategic Planning;Structure;Supported Employment;System;Technology;Testing;Text;theories;Time;timeline;Translating;United States National Institutes of Health;United States Social Security Administration;Universities;Update;Validity and Reliability;Work;Workplace,Analyzing the SSA Disability Evaluation Process,60065,NA,NA,NA,NA,17,NA,NA,0,NA
11194175,ZIA,CL,1,N,NA,NA,NA,NA,ZIACL060068,NA,NA,1ZIACL060068-17,NA,INTRAMURAL RESEARCH,2024,CLINICAL CENTER,NA,NA,NA,NA,NA,NA,NA,NA,CLINICAL CENTER,NA,NA,NA,9692799 (contact),"CHAN, LEIGHTON  (contact)",NA,NA,NA,Aerobic;Aerobic Exercise;Algorithms;American;arm;Behavioral;Cardiac Output;Cardiology;cardiorespiratory fitness;Cell Respiration;Chronic Obstructive Pulmonary Disease;Chronic pulmonary heart disease;Clinical Research;Clinical Trials;college;Congestive Heart Failure;Consensus;Data;Data Analyses;Disease Management;Drops;Education;Effectiveness;Energy Metabolism;Enrollment;evidence based guidelines;Exercise;exercise intensity;exercise rehabilitation;Exercise Test;exercise training;exhaustion;Fatigue;follow-up;Gases;health related quality of life;improved;indexing;International;Interstitial Lung Diseases;Level of Evidence;Lung;Manuscripts;Measurement;Measures;Medical;Metabolic;Modality;Moods;Muscle;open data;Outcome;Oxygen;Oxygen Consumption;Participant;Patient Education;Patient Self-Report;Patients;Performance;Phase II Clinical Trials;Physical activity;Physical Performance;Physicians;Physiological;Preparation;Protocols documentation;psychosocial;Publishing;Pulmonary Hypertension;pulmonary rehabilitation;Qualifying;Quality of life;Questionnaires;Randomized;randomized trial;Readiness;Recommendation;recruit;Regimen;Rehabilitation therapy;Reporting;Research;response;Rest;Safety;Sample Size;screening;sedentary;Severities;Strenuous Exercise;symposium;Symptoms;Test Result;Testing;Time;Training;Training and Education;Training Programs;treadmill;Treadmill Tests;Update;Walking;Work,Response to Aerobic Exercise in Patients with Pulmonary Hypertension,60068,NA,NA,NA,NA,17,NA,NA,0,NA
11194176,ZIA,CL,1,N,NA,NA,NA,NA,ZIACL060079,NA,NA,1ZIACL060079-15,NA,INTRAMURAL RESEARCH,2024,CLINICAL CENTER,NA,NA,NA,NA,NA,NA,NA,NA,CLINICAL CENTER,NA,NA,NA,9692799 (contact),"CHAN, LEIGHTON  (contact)",NA,NA,NA,"Address;Affect;Age;Agreement;Amendment;arm;Auditory;Behavior;biobank;Biological Markers;Blood;Case Study;Cells;Clinical;clinical phenotype;Cognitive;cohort;Common Data Element;Communities;comorbidity;Contrast Media;Control Groups;Data;data dissemination;Data Set;Databases;demographics;diagnostic biomarker;Diagnostic Imaging;Discourse analysis;Educational Status;Employee;Energy-Generating Resources;Enrollment;Exposure to;flexibility;Future;Gender;Generations;Grant;healthy volunteer;Hematology;Image;inclusion criteria;Individual;Injury;Institutional Review Boards;interest;Language;Longitudinal Studies;Magnetic Resonance Imaging;Measures;Medical History;Natural History;non-verbal;novel diagnostics;Outcome;Outcome Measure;outcome prediction;Participant;Pathology;patient population;Patient Recruitments;Patients;Peer Review;Persons;PET/CT scan;Phenotype;Population;Population Control;Positron-Emission Tomography;Prospective, cohort study;Protocols documentation;Publications;Publishing;Records;recruit;Recruitment Activity;Research;Research Personnel;Resources;Saliva;Sampling;Scanning;Schedule;Series;Serum;Severities;social cognition;study population;Taxonomy;TBI Patients;Techniques;Testing;Time;tomography;Traumatic Brain Injury;Travel;United States National Institutes of Health;vestibular system;Video Recording","Long Term Clinical Correlates of TBI: Imaging, Biomarkers, Clinical Phenotyping",60079,NA,NA,NA,NA,15,NA,NA,0,NA
11194177,ZIA,CL,1,N,NA,NA,NA,NA,ZIACL060093,NA,NA,1ZIACL060093-10,NA,INTRAMURAL RESEARCH,2024,CLINICAL CENTER,NA,NA,NA,NA,NA,NA,NA,NA,CLINICAL CENTER,NA,NA,NA,9692799 (contact),"CHAN, LEIGHTON  (contact)",NA,NA,NA,Aerobic;Aerobic Exercise;Affect;Behavioral;Cell Respiration;Chronic Obstructive Pulmonary Disease;COVID-19 pandemic;Data;Data Analyses;efficacy evaluation;Energy Metabolism;Enrollment;Etiology;Exercise;exercise rehabilitation;Exercise Test;Exercise Therapy;exercise training;Fatigue;Guidelines;health related quality of life;Health Status;Health Surveys;Human Activities;improved;indexing;Interstitial Lung Diseases;Intervention;Life;Lung;Lung Diseases;Manuscripts;Measures;Medical;Metabolic;Modality;Moods;Muscle;Outcome;Outcome Measure;participant enrollment;Patient Care;patient safety;Patients;Pharmaceutical Preparations;Physical activity;Preparation;primary outcome;Protocols documentation;psychosocial;Public Health;Pulmonary Gas Exchange;Pulmonary Hypertension;pulmonary rehabilitation;Questionnaires;recruit;Regimen;Registries;Rehabilitation therapy;Reporting;Research;Research Activity;respiratory;response;Safety;SARS-CoV-2 exposure;secondary outcome;Serious Adverse Event;Severities;standard of care;Suspensions;Symptoms;Test Result;Testing;Time;Training;Training Programs;treadmill;Uncontrolled Study;Walking;Work,Exercise Therapy for Advanced Lung Disease Trials: Response and Adaptation to Aerobic Exercise in Patients with Interstitial Lung Disease,60093,NA,NA,NA,NA,10,NA,NA,0,NA
11194178,ZIA,CL,1,N,NA,NA,NA,NA,ZIACL060096,NA,NA,1ZIACL060096-05,NA,INTRAMURAL RESEARCH,2024,CLINICAL CENTER,NA,NA,NA,NA,NA,NA,NA,NA,CLINICAL CENTER,NA,NA,NA,9692799 (contact),"CHAN, LEIGHTON  (contact)",NA,NA,NA,"Adult;Aerobic Exercise;Anaerobic Threshold;Blood flow;Cardiac;Cardiopulmonary;Clinic;Clinical;clinical center;COVID-19 pandemic;Data;Data Analyses;debilitating symptom;Disease;Enrollment;Evaluable Disease;Exercise;Exercise Test;exercise training;Fatigue;Goals;heart function;Heart Rate;Impairment;improved;Information Systems;life span;Lung;Lupus;Manuscripts;Measurement;Measures;Mediating;Motivation;Muscle;National Institute of Arthritis, and Musculoskeletal, and Skin Diseases;Outcome Measure;Patient Outcomes Assessments;Patients;Perception;Performance;peripheral blood;Physical activity;Physical Function;Pilot Projects;Preparation;primary outcome;Protocols documentation;Pulmonary Gas Exchange;Questionnaires;Recommendation;recruit;Registries;Reporting;Research;Research Activity;Review Committee;secondary outcome;sedentary;Severities;Severity of illness;Sex Bias;social;Stable Disease;Systemic Lupus Erythematosus;Testing;Time;treadmill;United States National Institutes of Health;Visit;Walking;Woman",Pilot Study Characterizing Aerobic Exercise in Women with Systemic Lupus Erythematosus (Exercise SLE Pilot),60096,NA,NA,NA,NA,5,NA,NA,0,NA
11194179,ZIA,CL,1,N,NA,NA,NA,NA,ZIACL060097,NA,NA,1ZIACL060097-04,NA,INTRAMURAL RESEARCH,2024,CLINICAL CENTER,NA,NA,NA,NA,NA,NA,NA,NA,CLINICAL CENTER,NA,NA,NA,9692799 (contact),"CHAN, LEIGHTON  (contact)",NA,NA,NA,"2019-nCoV;Accelerometer;Aerobic Exercise;Affect;Anxiety;arm;Attention;Biological Markers;Blood;Blood Vessels;Caring;Chest Pain;Chronic;Clinical;Cognition;Cognitive;cognitive testing;Collaborations;Collection;Control Groups;COVID-19;COVID-19 long hauler;COVID-19 survivors;Critical Illness;daily functioning;Dyspnea;Education;Enrollment;Exercise;Exercise Test;exercise training;experience;Failure;Fatigue;follow-up;Functional disorder;functional improvement;Goals;health related quality of life;Hospitalization;improved outcome;Intervention;Length;Long COVID;long term recovery;Measurement;Measures;Mental Depression;metabolomics;Monitor;Muscle;novel coronavirus;Outcome;Outcome Measure;pandemic disease;Participant;participant enrollment;Patient Education;Patient Outcomes Assessments;Patients;persistent symptom;Persons;Phase;Physical activity;Physical Function;physical symptom;Post-Acute Sequelae of SARS-CoV-2 Infection;primary outcome;Procedures;Protocols documentation;psychological symptom;Public Health;Pulmonary Gas Exchange;Quality of life;Randomized;Randomized, Controlled Trials;Recovery;Recovery of Function;recruit;Recruitment Activity;Rehabilitation therapy;Reporting;Research;Research Design;Resources;response;SARS-CoV-2 infection;Scientist;secondary outcome;Serious Adverse Event;Site;sleep health;sleep quality;Symptoms;System;Testing;Time;Training Programs;ultrasound;United States National Institutes of Health;Visit;Waiting Lists;Walking","COVID-19, Chronic Adaptation and Response to Exercise (COVID-CARE): A Randomized Controlled Trial",60097,NA,NA,NA,NA,4,NA,NA,0,NA
11194180,ZIA,CL,1,N,NA,NA,NA,NA,ZIACL090108,NA,NA,1ZIACL090108-01,NA,INTRAMURAL RESEARCH,2024,CLINICAL CENTER,NA,NA,NA,NA,NA,NA,NA,NA,CLINICAL CENTER,NA,NA,NA,9692799 (contact),"CHAN, LEIGHTON  (contact)",NA,NA,NA,"Address;Adult;Affect;Age;All of Us Research Program;Ancillary Study;barrier to care;Calibration;cohort;Communities;community engaged approach;community engagement;Community Participation;comorbidity;Data;Development;Disabilities experience;disability;Disabled Persons;evidence base;experience;Family;Feedback;functional disability;functional improvement;General Population;Health;health care availability;Health Care Costs;health care delivery;health data;health disparity populations;Health Status;Healthcare;Healthcare Systems;Income;Individual;information gathering;Insurance Coverage;Intervention;Life;Lived experience;Longitudinal Studies;longitudinal, prospective study;Measures;member;Mental Health;Modification;Outcome;participant enrollment;patient oriented;Patient Self-Report;peer;Phase;Population;Population Group;precision medicine;Process;Research Infrastructure;Self-Help Devices;Shapes;social health determinants;Societies;sociodemographics;Spanish;Surveys;System;therapy development;Translations;Uninsured Medical Expense;Work",Longitudinal study of health and functioning among adults with disabilities in All of Us,90108,NA,NA,NA,NA,1,NA,NA,0,NA
11194182,ZIC,AI,1,N,NA,NA,NA,NA,ZICAI005134,NA,NA,1ZICAI005134-06,NIAID:912113\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,16176359 (contact),"KONG, WING PUI  (contact)",NA,NA,NA,Animals;Antibodies;Antigens;Autologous;betacoronavirus;Binding;Collaborations;Coronavirus;Coronavirus Infections;Coronavirus spike protein;coronavirus vaccine;Coupling;COVID-19 vaccine;design;Emerging Communicable Diseases;Epitopes;Human;Hybrids;Immunization;Immunize;mosaic;Mus;Mutation;nanoparticle;National Institute of Allergy and Infectious Disease;next generation;pathogen;pre-clinical;Proteins;Sarbecovirus;SARS coronavirus;SARS-CoV-2 spike protein;SARS-CoV-2 variant;self assembly;Self Assessment;Subunit Vaccines;System;vaccine development;vaccine platform;Variant;virology,Pre-clinical Vaccine Development for Emerging and Re-emerging Infectious Diseases,5134,NA,NA,NA,NA,6,NA,NA,912113,NA
11194183,ZIC,AI,1,N,NA,NA,NA,NA,ZICAI005135,NA,NA,1ZICAI005135-06,NIAID:912113\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,16176359 (contact),"KONG, WING PUI  (contact)",NA,NA,NA,Animals;Antigens;burden of illness;Chimeric Proteins;Cryoelectron Microscopy;design;Discrimination;disulfide bond;Disulfides;Elderly;Engineering;flexibility;Generations;Glycoproteins;Human;human pathogen;Immune response;Immunization;Immunocompromised Host;immunogenicity;improved;Individual;Infection;Macaca mulatta;Modification;mosaic;Mus;Mutation;nanoparticle;Newborn Infant;nonhuman primate;novel;Para-Influenza Virus Type 1;Paramyxovirus;pathogen;Pneumovirus;pre-clinical;Proteins;Publishing;respiratory;respiratory virus;response;Rhesus;self assembly;Site;Structure;Surface;Vaccine Antigen;vaccine candidate;vaccine development;vaccine immunogenicity;vaccine response;Vaccines;Virus,Pre-clinical Vaccine Development for Respiratory Viruses,5135,NA,NA,NA,NA,6,NA,NA,912113,NA
11194184,ZIC,AI,1,N,NA,NA,NA,NA,ZICAI005169,NA,NA,1ZICAI005169-03,NIAID:1368169\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,78846320 (contact),"DORIA-ROSE, NICOLE  (contact)",NA,NA,NA,2019-nCoV;Animals;Basic Science;Biological Assay;Blood;Clinical Trials;Collaborations;Computer software;COVID-19;cross reactivity;Disease;Dose;Government;Human;human subject;Immunity;Immunize;Immunology procedure;Individual;Laboratories;lonely individuals;Measures;Moderna COVID-19 vaccine;Monoclonal Antibodies;National Institute of Allergy and Infectious Disease;neutralizing antibody;pre-clinical;Prevention;Procedures;Reagent;Research;RNA vaccine;Sampling;SARS-CoV-2 antibody;SARS-CoV-2 spike protein;SARS-CoV-2 variant;Serum;Therapeutic;Vaccinated;vaccine candidate;vaccine evaluation;Vaccines;Variant;Viral;virology;Virus;volunteer,Quantitative Immunological Assays to Assess SARS-CoV-2 Antibodies and Vaccines,5169,NA,NA,NA,NA,3,NA,NA,1368169,NA
11194209,N01,AI,NA,N,NA,NA,NA,NA,272201700010I,NA,NA,272201700010I-P00005-27200005-1,NIAID:43368\,NON SBIR/STTR CONTRACTS,2024,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,KENSINGTON,UNITED STATES,NA,08,094888294,US,319502,"ADVANCED BIOSCIENCE LABORATORIES, INC.",MD,208951042,NA,15711700 (contact),"VANCOTT, THOMAS  (contact)",NA,2018-09-30,2021-02-28,Antigens;Chemistry;Clinical Trials;Contractor;Contracts;Databases;Development;Documentation;Dosage Forms;efficacy study;Equipment and supply inventories;Formulation;Glycopeptides;HIV vaccine;HIV-1;Human;immunogenicity;In Vitro;Investigational Drugs;Laboratories;Laboratory Animals;manufacture;nanoparticle;National Institute of Allergy and Infectious Disease;particle;Phase;plasmid DNA;preclinical development;Preclinical Testing;Preventive vaccine;Process;product development;Production;programs;Proteins;Protocols documentation;prototype;Qualifying;quality assurance;Quality Control;research clinical testing;Running;scale up;stability testing;Sterility;Technology Transfer;Testing;Toxicology;Translations;Vaccines;Viral Vector,Synthesize and Produce HIV-1 Envelope Glycopeptide Immunogen Nanoparticle Vaccine(s),0,NA,NA,NA,NA,NA,NA,NA,43368,NA
11194210,N01,HL,NA,N,NA,NA,NA,NA,75N92019C00006,NA,NA,75N92019C00006-P00014-9999-1,NIDCR:3772997\,NON SBIR/STTR CONTRACTS,2024,"NATIONAL HEART, LUNG, AND BLOOD INSTITUTE",NA,Durham,UNITED STATES,NA,04,362726007,US,3709001,"RHO FEDERAL SYSTEMS DIVISION, INC.",NC,27713,NA,16188252 (contact),"YOVETICH, NANCY  (contact)",NA,2019-09-30,2025-09-29,Adverse event;central database;Clinical;Clinical Research;clinical research site;Clinical Trials;Collaborations;Collection;Computers;Consult;Contractor;Contracts;Data;Data Analyses;Data Collection;data management;Data Reporting;design;Development;Devices;experience;Extramural Activities;Human Resources;Intramural Research;Investigational Drugs;Investigational New Drug Application;Knowledge;Laboratory Research;Management Information Systems;Monitor;National Institute of Dental and Craniofacial Research;Operations Research;pharmacovigilance;Phase;Preparation;Procedures;programs;protocol development;Protocols documentation;Quality Control;Reporting;Research;Research Contracts;Research Design;Research Personnel;research study;Resources;Role;Safety;Secure;Serious Adverse Event;Services;Site;sound;Statistical Data Interpretation;System;tool;Training;Update;web site;Work,Clinical Research Operations and Management Support (CROMS),0,NA,NA,NA,NA,NA,NA,NA,3772997,NA
11194212,Y01,AG,NA,N,NA,NA,NA,NA,AAG22003001,NA,NA,AAG22003001-1-0-1,NIA:362500\,INTERAGENCY AGREEMENTS,2024,NATIONAL INSTITUTE ON AGING,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE ON AGING,NA,NA,NA,NA,(contact),NA,NA,NA,Aging;Censuses,Census - Aging,220030,NA,NA,NA,NA,NA,NA,NA,362500,NA
11194213,N01,AI,NA,N,NA,NA,NA,NA,75N93020D00011,NA,NA,75N93020D00011-P00002-759302200001-1,OD:2133733\,NON SBIR/STTR CONTRACTS,2024,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,MENLO PARK,UNITED STATES,NA,16,009232752,US,8042701,SRI INTERNATIONAL,CA,940253493,NA,3086600 (contact),"CHANG, POLLY YEE (contact)",NA,2022-09-01,2025-09-30,animal efficacy;Animal Model;biodosimetry;Contracts;Development;efficacy study;Exposure to;Injury;medical countermeasure;Radiation exposure;Radiation Injuries;Recurrence;Sampling;Services;Testing;Work,NON-CLINICAL STUDIES IN SUPPORT OF IND/NDA/BLA SUBMISSIONS,0,NA,NA,NA,NA,NA,NA,NA,2133733,NA
11194534,OT2,OD,3,N,2024-09-23,2024-09-23,2025-02-28,310,OT2OD027852,NA,OTA-24-200,3OT2OD027852-02S8,NCCIH:1500\NEI:5000\NIA:110000\NIAID:10877889\NIAMS:90000\NIBIB:50000\NICHD:500000\NIDA:5000\NIDDK:15000\NIEHS:12000\NLM:12350000\OD:1356292\,OTHERS,2024,"OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH",NA,CHANTILLY,UNITED STATES,NA,11,089896737,US,10052403,"FOUR POINTS TECHNOLOGY, LLC",VA,201513834,NA,15679024 (contact),"LIPKIN, JOEL A (contact)","WEBER, MICHAEL NICHOLAS N",2023-03-01,2033-02-28,Acceleration;Address;Biomedical Research;Cloud Computing;Cloud Service;cloud storage;Communities;computerized tools;Data;Data Commons;data ecosystem;data repository;Data Science;Data Set;Economics;FAIR principles;Funding;Goals;Image;Individual;large datasets;Modeling;Modernization;Phase;Policies;Procedures;Process;programs;Research Infrastructure;Research Personnel;Science;Series;service providers;Services;Strategic Planning;Technology;Testing;United States National Institutes of Health;Work,STRIDES,27852,ZOD1,ZOD1-SRC(99),NA,S8,2,25372681,0,25372681,NA
11194535,OT2,OD,3,N,2024-09-20,2024-04-15,2025-06-01,368,OT2OD036113,NA,OTA-23-003,3OT2OD036113-02S1,OD:450000\,OTHERS,2024,"OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH",NA,CHAPEL HILL,UNITED STATES,NA,04,608195277,US,578206,UNIV OF NORTH CAROLINA CHAPEL HILL,NC,275995023,NA,7569861;1869835 (contact);11175792;14084463,"CHUTE, CHRISTOPHER G;HAENDEL, MELISSA A (contact);MOFFITT, RICHARD AUSTIN;PFAFF, EMILY ROSE","BERMAN, LEWIS EVAN",2023-09-02,2025-06-01,Address;Affect;African American population;All of Us Research Program;analytical method;Back;Bayesian Modeling;Biomedical Research;Caring;Classification;Clinical;Clinical Data;cloud based;Collaborations;Communicable Diseases;community intervention;dashboard;Data;data acquisition;Data Collection;data de-identification;data integration;Data Linkages;data pipeline;data quality;Data Set;Data Sources;data streams;design;Diabetes Mellitus;Diagnosis;Disclosure;Electronic Health Record;Enhancement Technology;Ensure;environmental justice;Environmental Risk Factor;experience;Expert Opinion;Federally Qualified Health Center;Foundations;General Population;Genes;Genetic;Genomics;Goals;Health;health data;Health system;Heart Diseases;Hispanic Populations;improved;indexing;Individual;Ingestion;insight;interoperability;Intervention;Iron;Life;Link;Malignant Neoplasms;Measurement;Medicaid;Methods;Modeling;mortality;novel;Opiate Addiction;Outcome;Participant;patient stratification;Patients;Patterns of Care;Persons;Phenotype;precision medicine;Prevention strategy;Privacy;privacy preservation;Process;Prognosis;quality assurance;Recontacts;Recording of previous events;remediation;repaired;Reporting;Research;Research Personnel;Risk;Risk Assessment;Secure;Security;sexual minority;Site;social factors;Source;Standardization;Statistical Models;Stroke;Surveys;Terminology;tool;treatment strategy;Underrepresented Populations;Underserved Population;Uninsured;United States National Institutes of Health;Variant;wearable device,Iron-CLAD: securely advancing AoU participant characterization with proven platforms and collaborations,36113,ZPM1,ZPM1(99),NA,S1,2,450000,0,450000,NA
11194543,P20,CA,3,N,2024-09-19,2024-09-01,2025-08-31,NA,P20CA264076,NA,PA-23-189,3P20CA264076-04S1,NCI:73439\,RESEARCH CENTERS,2024,NATIONAL CANCER INSTITUTE,NA,NEW YORK,UNITED STATES,NA,13,078861598,US,3839801,ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI,NY,100296574,"PROJECT NARRATIVE Lung cancer is the leading cause of cancer mortality in the United States. Targeted therapies, such as growth  factor receptor (EGFR) inhibitors, and immunotherapy have improved survival outcomes, but require genetic  testing as a basis for treatment, which may not be performed equally across patients. We propose to study  disparities in access to genetic testing as one of the ways to explain existing gaps in non-small cell lung cancer  (NSCLC) prognosis between Black and White patients, as well as rural and urban patients.",9550274 (contact),"BENN, EMMA KATHERINE TARA (contact)","RODRIGUEZ, LARITZA MARIA",2021-09-21,2025-08-31,access disparities;Address;Adjuvant;anaplastic lymphoma kinase;anti-cancer research;Area;beneficiary;black patient;Black race;BRAF gene;Cancer Etiology;cancer genomics;cancer health disparity;Cancer Patient;Cancer Prognosis;cancer therapy;chemotherapy;clinical practice;Complement;Data;Data Set;design;Disparity;druggable target;education research;Eligibility Determination;Epidermal Growth Factor Receptor;Ethnic Origin;Genetic;genetic testing;Growth Factor Receptors;Health Disparities Research;Hispanic;Histology;Hospitals;Immunotherapy;improved;Incidence;Income;inhibitor;KRAS2 gene;large datasets;Life;Low income;Malignant neoplasm of lung;Malignant Neoplasms;Medicaid;Medicare;Medicare claim;Methods;Minority;Mission;Molecular;mortality;Mutation;Neoplasm Metastasis;new therapeutic target;Non-Small-Cell Lung Carcinoma;novel;novel therapeutics;Oncogenic;Operative Surgical Procedures;Outcome;parent grant;Pathology;Pathway interactions;Patients;Pharmaceutical Preparations;population based;precision medicine;Prevalence;Procedures;programmed cell death ligand 1;programmed cell death protein 1;programs;Proteins;Quality of Care;Race;Receptor Protein-Tyrosine Kinases;Recommendation;Research;Rural;rural area;Socioeconomic Status;Statistical Data Interpretation;survival disparity;survival outcome;Survival Rate;Systemic Therapy;targeted treatment;Testing;Training;training opportunity;tumor;United States;urban area;Work,Cancer research education program (C-REP),264076,ZCA1,ZCA1(M2),5682,S1,4,43455,29984,NA,73439
11194582,U01,NS,3,N,2024-09-18,2024-09-13,2025-07-31,853,U01NS126052,BIOMED ENGR/COL ENGR/ENGR STA,PA-24-254,3U01NS126052-03S1,NINDS:76583\,NON-SBIR/STTR RPGS,2024,NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE,NA,WEST LAFAYETTE,UNITED STATES,ENGINEERING (ALL TYPES),04,072051394,US,1481402,PURDUE UNIVERSITY,IN,47906,"NARRATIVE The proposed studies are in the area of electrical microstimulation for neuroprostheses, which has potential applications in many human diseases or injuries. Our work will further advance research by generating transformative and efficacious software and hardware technology that will be used widely throughout the research community. Thus, the proposed research is relevant to the translational focus of the NIH's mission and will potentially help to reduce the burdens of human disability.",14873938;8624842 (contact),"ORAZEM, MARK E.;OTTO, KEVIN J. (contact)","HWANG, GRACE MEI-HUA",2022-08-01,2026-07-31,Address;Area;Charge;Communities;Computer Models;Computer software;design;disability;Electric Stimulation;electrical microstimulation;Elements;Engineering;Evaluation;Goals;Human;human disease;in vivo;Injury;innovation;Measurement;Microelectrodes;microstimulation;Mission;Modeling;Nervous System;neural;Neurons;neuroprosthesis;neuroregulation;Neurosciences;Outcome Assessment;Performance;Research;Resolution;response;Technology;temporal measurement;Testing;tool;United States National Institutes of Health;user-friendly;Work,Engineering the Neuronal Response to Electrical Microstimulation,126052,ZNS1,ZNS1-SRB-O(16),NA,S1,3,76583,0,76583,NA
11194616,R01,AA,3,N,2024-09-24,2024-09-25,2025-08-31,273,R01AA029804,BIOMED ENGR/COL ENGR/ENGR STA,PAR-20-243,3R01AA029804-03S1,NIAAA:269533\,NON-SBIR/STTR RPGS,2024,NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM,NA,MADISON,UNITED STATES,ENGINEERING (ALL TYPES),02,161202122,US,578503,UNIVERSITY OF WISCONSIN-MADISON,WI,537151218,"PROJECT NARRATIVE The combination of COVID-19 and alcohol/substance use disorders exacerbates a wide range of existing problems, including the likelihood of contracting COVID and the severity of consequences, pandemic-related stresses that trigger alcohol and substance use, loss of jobs and healthcare access, and increased interpersonal violence, to name a few. This project will test whether an evidence-based smartphone app that is developed for heavy drinkers plus a family member partner and that offers services related to alcohol/substance use, COVID, and couple behavioral therapy will improve multiple quality of life and drinking measures in comparison to 1) the evidence-based app for heavy drinkers alone minus the couple therapy services and 2) smartphones alone. The proposed study has the potential to impact outcomes for millions of American adults with alcohol and substance use problems, whether in treatment or not, at a time when effective, affordable, accessible interventions are needed more than ever to address the many serious problems likely to persist even after widespread availability of COVID vaccines.",1864813 (contact);10709802,"GUSTAFSON, DAVID H (contact);MARES, MARIE-LOUISE","KWAKO, LAURA ELIZABETH",2021-09-25,2025-08-31,addiction;Address;Adult;Adult Children;Al-Anon;Alcohol consumption;alcohol intervention;Alcoholic beverage heavy drinker;Alcohols;American;arm;behavior change;Behavior Therapy;Behavioral;Cellular Phone;Communication;comorbidity;Competence;Conflict (Psychology);Contracts;Control Groups;Couples Therapy;COVID-19;COVID-19 impact;COVID-19 risk;COVID-19 stress;COVID-19 vaccination;COVID-19 vaccine;Data;design;digital health;digital intervention;Disease;drinking;Drug usage;effectiveness testing;evidence base;Evidence based intervention;Family;Family member;Feedback;follow up assessment;follow-up;formative assessment;Funding;Health;health care availability;health disparity;Health Insurance;Healthcare;Heavy Drinking;high risk drinking;Hybrids;implementation science;implementation study;improved;Inequity;Interpersonal Violence;Intervention;Job loss;Measures;Mediating;Mediation;Mediator;member;Modeling;Motivation;Names;National Institute on Alcohol Abuse and Alcoholism;Outcome;pandemic impact;pandemic stress;Perception;Personal Satisfaction;Persons;Pharmaceutical Preparations;Phase;primary outcome;psychoeducation;psychologic;Quality of life;Randomized;randomized trial;Recovery;recruit;relapse prevention;Resources;response;Risk;risk mitigation;satisfaction;secondary outcome;Service delivery model;Services;Severities;sex;smartphone application;social;Spouses;Stress and Coping;substance use;Substance Use Disorder;Support System;Technology;Telephone;Testing;theories;Time;tool;United States National Institutes of Health;usability,Family-focused vs. Drinker-focused Smartphone Interventions to Reduce Drinking-related Consequences of COVID-19,29804,ZRG1,Special Emphasis Panel[ZRG1-HDM-M(54)R],NA,S1,3,173333,96200,269533,NA
11194631,OT2,HL,3,N,2024-09-24,2024-05-24,2025-05-23,838,OT2HL161847,SCHOOLS OF MEDICINE,OTA-21-015,3OT2HL161847-01S3,NHLBI:109438442\,OTHERS,2024,"NATIONAL HEART, LUNG, AND BLOOD INSTITUTE",NA,NEW YORK,UNITED STATES,INTERNAL MEDICINE/MEDICINE,12,121911077,US,5998304,NEW YORK UNIVERSITY SCHOOL OF MEDICINE,NY,10016,No PHR,10829359;9770421;1882834 (contact);1939736,"GROSS, RACHEL SHARON;HORWITZ, LEORA ;KATZ, STUART D (contact);TROXEL, ANDREA B","SCHWARTZ, LISA",2021-05-24,2025-05-23,biobank;Bioinformatics;Biometry;Clinical Sciences;Communication;Data Collection;data infrastructure;Data Management Resources;data portal;Data Science;Data Science Core;Epidemiology;Health;open data;Post-Acute Sequelae of SARS-CoV-2 Infection;Quality Control,"OTA-21-015A Post-Acute Sequelae of SARS-CoV-2 Infection Initiative: NYU Langone Health Clinical Science Core, Data Resource Core, and PASC Biorepository Core",161847,ZHL1,ZHL1-SRC,NA,S3,1,109438442,0,109438442,NA
11194672,OT2,OD,1,N,2024-09-25,2024-09-25,2025-09-24,310,OT2OD039735,NA,OTA-24-017,1OT2OD039735-01,OD:3255169\,OTHERS,2024,"OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH",NA,North Bethesda,UNITED STATES,NA,08,015936529,US,10039543,FOUNDATION FOR THE NIH,MD,20852,NA,78183753 (contact),"ADAM, STACEY  (contact)","SHEELEY, DOUGLAS",2024-09-25,2025-09-24,Acceleration;Address;Agreement;Categories;Clinical;Clinical Research;Collaborations;Communication;Communities;community engagement;Congresses;Contracts;design;Educational workshop;effective therapy;Ensure;Evaluation;Feedback;Fostering;Future;Goals;Industry;industry partner;Intellectual Property;Lead;Leadership;Legal;Letters;Long COVID;Mediation;meetings;member;Mission;Modeling;Nonprofit Organizations;Patients;Policies;Privatization;Protocols documentation;public-private partnership;Recovery;Recovery Support;research clinical testing;Research Personnel;Researching COVID to Enhance Recovery;Role;Sampling;Scientist;Selection for Treatments;Structure;Subgroup;Surveys;symposium;Testing;Therapeutic;therapeutic development;United States Food and Drug Administration;United States National Institutes of Health;Universities;volunteer;working group,Establishment of a Public-Private Partnership (PPP) to Support Therapy Selection and Testing within RECOVER-TLC,39735,ZDA1,ZDA1-SRC(99),NA,NA,1,3255169,0,3255169,NA
11194674,OT3,HL,3,N,2024-09-26,2018-09-28,2026-12-31,837,OT3HL147798,NA,OTA-18-004,3OT3HL147798-01S4,NHLBI:2836378\,OTHERS,2024,"NATIONAL HEART, LUNG, AND BLOOD INSTITUTE",NA,RESEARCH TRIANGLE PARK,UNITED STATES,NA,04,004868105,US,6939101,RESEARCH TRIANGLE INSTITUTE,NC,277092194,NA,6302805 (contact),"KRONER, BARBARA L (contact)","MONDORO, TRACI",2018-09-28,2026-12-31,"Advanced Development;Area;Clinical Trials;Common Data Element;Data;Data Collection;data harmonization;data interoperability;data management;data registry;data repository;data resource;data sharing;Data Sources;data standards;Dedications;Development;experience;federated data;gene therapy;Goals;Human;Human Resources;improved;Individual;Infant;innovation;Interdisciplinary Study;International;Knowledge;Leadership;National Heart, Lung, and Blood Institute;patient registry;Patients;programs;Provider;Registries;repository;Research Institute;Research Personnel;Resources;Sickle Cell;Sickle Cell Anemia;United States",CURE SICKLE CELL INITIATIVE DATA STRATEGY AND DATA RESOURCES PROGRAM,147798,ZHL1,ZHL1-SRC(99),NA,S4,1,2836378,0,2836378,NA
11194675,OT3,HL,3,N,2024-09-26,2019-09-27,2026-09-30,837,OT3HL152932,NA,OTA-19-010,3OT3HL152932-01S4,NHLBI:700774\,OTHERS,2024,"NATIONAL HEART, LUNG, AND BLOOD INSTITUTE",NA,DUARTE,UNITED STATES,NA,31,027176833,US,3058203,BECKMAN RESEARCH INSTITUTE/CITY OF HOPE,CA,910103012,NA,9038309 (contact),"CARDOSO, ANGELO A. (contact)","MONDORO, TRACI",2019-09-27,2026-09-30,"Address;Agreement;Annual Reports;assay development;Award;Biotechnology;CD34 gene;cell community;Cells;Cities;Clinical Trials;Communities;cost;Doctor of Philosophy;Ensure;Evaluation;expectation;experience;Funding;gene therapy;Goals;Gold;Human Resources;Infrastructure;interest;Leadership;Lentivirus;manufacture;Manufacturer;Measures;meetings;member;Modification;National Heart, Lung, and Blood Institute;Needs Assessment;Participant;Persons;Process;Production;programs;prospective;Reagent;Research Personnel;Resources;Role;Science;Sickle Cell;Site;Site Visit;Structure;Surveys;symposium;Time;Travel;Treatment Efficacy;United States Food and Drug Administration;vector;Work",CureSC Manufacturing Resource Platform,152932,ZHL1,ZHL1-SRC(99),NA,S4,1,700774,0,700774,NA
11194676,P50,CA,3,N,2024-09-20,2024-08-01,2025-07-31,NA,P50CA265793,NA,PA-20-272,3P50CA265793-02S2,NCI:194375\,RESEARCH CENTERS,2024,NATIONAL CANCER INSTITUTE,NA,SAINT LOUIS,UNITED STATES,NA,01,068552207,US,9083901,WASHINGTON UNIVERSITY,MO,631304862,NA,1865399;1884469;9171534 (contact),"BENBROOK, DORIS MANGIARACINA;LESLIE, KIMBERLY K.;MUTCH, DAVID G (contact)","BASA JANAKIRAM, NAVEENA",2023-08-23,2028-07-31,Advocacy;Advocate;Amendment;Bioinformatics;Biometry;Biostatistics Core;Body System;Budgets;career;Caring;Clinical Trials;Collaborations;Committee Members;Communication;Conduct Clinical Trials;Contracts;Decision Making;Development;Documentation;Electronics;Endometrial;Endometrial Carcinoma;Enrollment;Ensure;Equity;Ethics;Fostering;Goals;Grant;Human Resources;innovation;Institution;Institutional Review Boards;Instruction;Malignant Neoplasms;meetings;metabolomics;mindfulness;Mission;National Cancer Institute;New Mexico;Newsletter;next generation;Oklahoma;operation;Participant;Pathology;Patients;payment;programs;Progress Reports;Publications;Reporting;Research;Research Personnel;Route;Services;Site;Specialized Program of Research Excellence;success;Sum;Time;Underrepresented Minority;Universities;Washington;web site,Admin-Core-001,265793,ZCA1,ZCA1(M1)-S,8164,S2,2,125000,69375,NA,194375
11194679,OT3,HL,3,N,2024-09-26,2018-09-28,2026-09-30,837,OT3HL147741,SCHOOLS OF MEDICINE,OTA-18-003,3OT3HL147741-01S5,NHLBI:352315\,OTHERS,2024,"NATIONAL HEART, LUNG, AND BLOOD INSTITUTE",NA,MILWAUKEE,UNITED STATES,INTERNAL MEDICINE/MEDICINE,04,937639060,US,46001,MEDICAL COLLEGE OF WISCONSIN,WI,532263548,NA,8252430 (contact);1955394,"EAPEN, MARY  (contact);HOROWITZ, MARY MARESCA","MONDORO, TRACI",2018-09-28,2026-09-30,"Advocate;biopharmaceutical industry;Caregivers;Collaborations;Communities;Family member;gene therapy;Government Agencies;improved;Individual;innovation;National Heart, Lung, and Blood Institute;Patients;public-private partnership;Research Personnel;Sickle Cell;Sickle Cell Anemia;Technology;Work",Cure Sickle Cell,147741,ZHL1,ZHL1-SRC(99),NA,S5,1,352315,0,352315,NA
11194685,ZIA,AT,1,N,NA,NA,NA,NA,ZIAAT000028,NA,NA,1ZIAAT000028-11,NCCIH:2810890\,INTRAMURAL RESEARCH,2024,NATIONAL CENTER FOR COMPLEMENTARY & INTEGRATIVE HEALTH,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL CENTER FOR COMPLEMENTARY & INTEGRATIVE HEALTH,NA,NA,NA,12449987 (contact),"CHESLER, ALEXANDER  (contact)",NA,NA,NA,afferent nerve;Afferent Neurons;Alleles;allodynia;Architecture;Biological Models;Biology;Brain;Brain region;Cell Line;Cells;Collaborations;Detection;detection platform;Development;Disease;exome sequencing;Frequencies;Functional Imaging;Genes;Genetic;Goals;Hair;Human;Hyperalgesia;Image;in vivo;Inflammation;Inherited;Injury;insight;Interoception;Ion Channel;Ion Channel Gating;Life;Link;Maps;mechanical stimulus;Mechanics;millimeter;model organism;Molecular;Monitor;Morphology;mouse genetics;Movement;Mus;Muscle;Mutation;National Institute of Neurological Disorders and Stroke;neurochemistry;Neuromuscular Diseases;Neurons;Nociception;Organ;Pain;patient screening;Patients;Peripheral;Physiological;Physiology;Piezo 2 ion channel;Play;Proprioception;Proprioceptor;receptor;Research;Role;Sensory;sensory stimulus;Skin;somatosensory;Stimulus;Stretching;Temperature;Tendon structure;Testing;Tissues;Touch sensation;Translating;Well in self,"Studies on the molecular, cells, and circuit that underlie somatosensation and pain",28,NA,NA,NA,NA,11,NA,NA,2810890,NA
11194686,ZIA,AT,1,N,NA,NA,NA,NA,ZIAAT000029,NA,NA,1ZIAAT000029-11,NCCIH:2531792\,INTRAMURAL RESEARCH,2024,NATIONAL CENTER FOR COMPLEMENTARY & INTEGRATIVE HEALTH,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL CENTER FOR COMPLEMENTARY & INTEGRATIVE HEALTH,NA,NA,NA,12449989 (contact),"CARRASQUILLO, YARIMAR  (contact)",NA,NA,NA,Absence of pain sensation;Acute Pain;Address;Affective;affective disturbance;Amygdaloid structure;Analgesics;Anatomy;Automobile Driving;Behavior;Behavioral;Behavioral Model;behavioral response;Brain;Brain region;cell type;Cells;chronic neuropathic pain;chronic pain;chronic pain patient;Colitis;Collaborations;comorbidity;Computer Models;Dimensions;Disease Progression;Electrophysiology (science);expectation;experience;experimental study;Goals;Hypersensitivity;Image;in vivo;Inflammation;Injury;Intestines;Link;Maintenance;Modeling;Molecular;Molecular Genetics;Morphology;Mus;nerve injury;Neurons;Nociception;novel;Pain;pain chronification;Pain management;pain processing;parabrachial nucleus;Pathology;Pathway interactions;Peripheral;Population;Population Decreases;Positioning Attribute;programs;Prosencephalon;Publishing;Reducing Agents;Reporting;Research;response;severe injury;sex;sex as a biological variable;Sex Differences;Signal Transduction;simulation;Site;Solid;somatosensory;Stimulus;Stress;Structure;Subthalamic structure;Synapses;System;Texas;Tobacco;Visceral;Work;zona incerta,Molecular and cellular mechanisms for bidirectional control of pain in the brain,29,NA,NA,NA,NA,11,NA,NA,2531792,NA
11194687,ZIA,AT,1,N,NA,NA,NA,NA,ZIAAT000030,NA,NA,1ZIAAT000030-10,NCCIH:682733\,INTRAMURAL RESEARCH,2024,NATIONAL CENTER FOR COMPLEMENTARY & INTEGRATIVE HEALTH,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL CENTER FOR COMPLEMENTARY & INTEGRATIVE HEALTH,NA,NA,NA,14282208 (contact),"ATLAS, LAUREN  (contact)",NA,NA,NA,Acute Pain;Affective;affective neuroscience;Animal Model;Atlases;Attention;Brain;Calibration;Central Nervous System;Clinical;Cognitive;Computer Models;contextual factors;Cues;Data Collection;Decision Making;design;Dissociation;Eligibility Determination;emotional experience;Emotions;Enhancing Lesion;Expectancy;expectation;experience;Experimental Psychology;experimental study;Feedback;Female;Functional Magnetic Resonance Imaging;Goals;heat stimulus;hedonic;Human;human model;human subject;Individual;Instruction;interest;Journals;Learning;Lesion;Link;male;Manuscripts;matriculation;Measures;Mediating;Modality;Nervous System;neural;neurobiological mechanism;Neurobiology;neuroimaging;neuromechanism;Neurosciences;Organism;Outcome;Pain;Pain management;pain perception;pain processing;pain relief;pain sensitivity;Pain Threshold;Paper;Participant;Pathway interactions;Patient Self-Report;Patient-Focused Outcomes;Physiological;Pilot Projects;placebo analgesia;Placebo Effect;Placebos;Population;Postbaccalaureate;Postdoctoral Fellow;pre-doctoral;Prefrontal Cortex;Procedures;Progress Reports;Protocols documentation;psychologic;Psychological Factors;Psychophysiology;Publishing;Questionnaires;recruit;Reporting;Research;Research Design;response;screening;Sex Differences;Shapes;Shock;Signal Transduction;Stimulus;Taste Perception;Temperature;Testing;verbal;Visit;Work,Neural and psychological mechanisms of pain perception,30,NA,NA,NA,NA,10,NA,NA,682733,NA
11194688,ZIA,AT,1,N,NA,NA,NA,NA,ZIAAT000035,NA,NA,1ZIAAT000035-07,NCCIH:227578\,INTRAMURAL RESEARCH,2024,NATIONAL CENTER FOR COMPLEMENTARY & INTEGRATIVE HEALTH,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL CENTER FOR COMPLEMENTARY & INTEGRATIVE HEALTH,NA,NA,NA,14282208 (contact),"ATLAS, LAUREN  (contact)",NA,NA,NA,American;Atlases;Belief;Clinic;contextual factors;COVID-19 pandemic effects;Cues;Data;Environment;Ethnic Origin;expectation;Geography;health disparity;Healthcare;Image;Inequity;Laboratories;Manuscripts;Measures;Mental Health;National Institute of Mental Health;Pain;Pain Measurement;pain outcome;pain relief;pandemic disease;Paper;Patients;Perception;Persons;physical conditioning;Placebo Effect;Population Heterogeneity;Process;Protocols documentation;Provider;Research Activity;Research Design;Sampling;Social Environment;social influence;Social isolation;socioeconomics;Stereotyping;Stimulus;Survey Methodology;Surveys;Testing;Visual;Work,Large-Scale Online stimulus Norming and Surveys about Perceptions in Healthcare,35,NA,NA,NA,NA,7,NA,NA,227578,NA
11194689,ZIA,AT,1,N,NA,NA,NA,NA,ZIAAT000036,NA,NA,1ZIAAT000036-07,NCCIH:1137888\,INTRAMURAL RESEARCH,2024,NATIONAL CENTER FOR COMPLEMENTARY & INTEGRATIVE HEALTH,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL CENTER FOR COMPLEMENTARY & INTEGRATIVE HEALTH,NA,NA,NA,14282208 (contact),"ATLAS, LAUREN  (contact)",NA,NA,NA,Address;adverse outcome;Affect;Algorithmic Software;Amendment;Arousal;Attention;Behavioral;biobehavior;Biological;Biological Factors;Biological Process;Black Populations;Computer Models;Data;Data Analyses;Data Collection;Databases;directed attention;Disease;Disparity;Disparity population;doctoral student;efficacy testing;Empathy;Environment;experience;Face;Feedback;Fellowship;forging;Foundations;Functional Magnetic Resonance Imaging;Galvanic Skin Response;gaze;Health;health disparity;Health Personnel;healthy volunteer;Image;improved;Individual;insight;Institutional Review Boards;Instruction;Intervention;Learning;Link;Manuscripts;Measures;Medical;minority patient;Movement;Mydriasis;non-verbal;outcome disparities;Pain;Pain intensity;Pain management;Pain Measurement;pain perception;pain reduction;Pain Research;Pain Threshold;Participant;Physiological;Population Heterogeneity;Positioning Attribute;Postdoctoral Fellow;Process;programs;Protocols documentation;Provider;Psychophysiology;psychosocial;public database;Reporting;Research;Research Design;response;Role;Series;Shapes;social;social culture;social factors;social neuroscience;Social Processes;sociocultural determinant;Stimulus;Symptoms;Testing;therapy design;Visual attention;visual tracking;volunteer;Work,Sociocultural & biobehavioral influences on pain expression and assessment,36,NA,NA,NA,NA,7,NA,NA,1137888,NA
11194690,ZIA,AT,1,N,NA,NA,NA,NA,ZIAAT000041,NA,NA,1ZIAAT000041-01,NCCIH:227578\,INTRAMURAL RESEARCH,2024,NATIONAL CENTER FOR COMPLEMENTARY & INTEGRATIVE HEALTH,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL CENTER FOR COMPLEMENTARY & INTEGRATIVE HEALTH,NA,NA,NA,14282208 (contact),"ATLAS, LAUREN  (contact)",NA,NA,NA,Affect;Benchmarking;biobehavior;computer generated;Data;Data Set;Databases;Demographic Factors;Disparity;diverse data;Emotions;experience;Facial Expression;Facial Pain;Future;Goals;health disparity;Image;Individual;Institutional Review Boards;Judgment;Laboratories;Learning;Literature;Mechanics;Modality;Pain;Pain Measurement;pain perception;Painless;Participant;Perception;Persons;Pilot Projects;Process;programs;Protocols documentation;psychologic;Publishing;Research;showing emotion;social;social culture;social factors;Social Processes;sociocultural determinant;sociodemographic factors;Stimulus;Surveys;Testing,Evaluating perception of pain-related social stimuli,41,NA,NA,NA,NA,1,NA,NA,227578,NA
11194691,ZIA,CL,1,N,NA,NA,NA,NA,ZIACL090077,NA,NA,1ZIACL090077-05,NA,INTRAMURAL RESEARCH,2024,CLINICAL CENTER,NA,NA,NA,NA,NA,NA,NA,NA,CLINICAL CENTER,NA,NA,NA,77873535 (contact),"BIASSOU, NADIA  (contact)",NA,NA,NA,Adult;Age;American;Attention;Auditory;auditory processing;Automobile Driving;Bilateral;Brain;Brain Mapping;brain size;brain tissue;central nervous system injury;Cerebral hemisphere;Clinical;Cognitive;cohort;computational network modeling;Computer Models;connectome;Contralateral;Data;Data Set;Databases;Educational Status;Elderly;Epilepsy;Gender;Goals;healthy volunteer;Hearing;Human;imaging modality;Individual;Injury;Institutional Review Boards;interest;Intervention;Journals;Language;language processing;Legal patent;Machine Learning;Manuscripts;mental state;National Institute of Neurological Disorders and Stroke;neural network;neuromechanism;Neurons;Neurosciences;Operative Surgical Procedures;Outcome;Pathway Analysis;Patients;Performance;Protocols documentation;Recovery;recruit;Rest;Risk;Seizures;Side;simulation game;Speech;Statistical Data Interpretation;surgical risk;symposium;Testing;Time;Work,Using Static and Dynamic connectivity analyses of Eloquent brain tissue to assess surgical risk in patients with intractable seizures,90077,NA,NA,NA,NA,5,NA,NA,0,NA
11194692,ZIA,CL,1,N,NA,NA,NA,NA,ZIACL090099,NA,NA,1ZIACL090099-03,NA,INTRAMURAL RESEARCH,2024,CLINICAL CENTER,NA,NA,NA,NA,NA,NA,NA,NA,CLINICAL CENTER,NA,NA,NA,78889532 (contact),"BULEA, THOMAS  (contact)",NA,NA,NA,Amendment;Ankle;Architecture;biomechanical test;Biomechanics;Bionics;Brain;Canada;Cerebral Palsy;Child;Childhood;Clinical;cohort;Cohort Studies;Cooperative Research and Development Agreement;crouch gait;Custom;Data Collection;design;Devices;direct application;Electroencephalography;Evaluation;Excision;exoskeleton;Extensor;Flexor;foot;Future;Gait;gait rehabilitation;Gait speed;Generations;improved;Intervention Trial;Knee;Knee joint;Length;Marketing;Movement Disorders;Muscle;Muscular Dystrophies;neuromuscular;novel;novel strategies;operation;Orthotic Devices;Outcome Measure;pandemic disease;Participant;Phase;Population;primary outcome;Protocols documentation;prototype;recruit;Research;research clinical testing;Research Design;Resistance;resistance exercise;response;Risk;Risk Assessment;robot exoskeleton;robotic device;Robotics;Scheme;secondary outcome;sensor;Spinal cord injury;Spinal Dysraphism;Technology;Time;Torque;United States National Institutes of Health;Visit;Walking,Evaluating a pediatric exoskeleton to improve walking function in children with movement disorders,90099,NA,NA,NA,NA,3,NA,NA,0,NA
11194693,ZIA,CL,1,N,NA,NA,NA,NA,ZIACL090103,NA,NA,1ZIACL090103-02,NA,INTRAMURAL RESEARCH,2024,CLINICAL CENTER,NA,NA,NA,NA,NA,NA,NA,NA,CLINICAL CENTER,NA,NA,NA,78889532 (contact),"BULEA, THOMAS  (contact)",NA,NA,NA,Adult;Articular Range of Motion;Biomechanics;Categories;Cerebral Palsy;Child;Childhood;Classification;Clinic;Clinical;clinical center;Communities;Computers;Cross-Over Studies;Cross-Over Trials;crouch gait;design;Devices;Diagnosis;Disability Evaluation;Disease;dosage;Educational Intervention;Effectiveness;effectiveness evaluation;Effectiveness of Interventions;Electronics;Enrollment;Equipment and supply inventories;exoskeleton;Extensor;Flexor;Freedom;functional improvement;Gait;gait rehabilitation;Gait speed;Genetic Crossing Over;Goals;Home;Hour;improved;Intervention;Isometric Exercise;Knee;Knee joint;laboratory experience;Length;Limb structure;Measures;Monitor;Motor;Movement Disorders;Muscle;Muscle Spasticity;muscle strength;Muscular Dystrophies;neurological rehabilitation;neuromuscular activity;Neuromuscular Diseases;novel;Orthotic Devices;Outcome Assessment;Outpatients;Participant;patient population;Patients;Phase;Phase I/II Trial;Physical Medicine;post intervention;Posture;primary endpoint;Procedures;Protocols documentation;Randomized;recruit;rectus femoris;Rehabilitation therapy;Research Design;robot exoskeleton;Robotics;Safety;safety and feasibility;sensor;Site;Spinal cord injury;Spinal Dysraphism;strength training;Structure;System;Target Populations;Technology;Testing;Time;Torque;Training;United States National Institutes of Health;vastus lateralis;Visit;Walking;Withdrawal,A phase I/II trial evaluating long-term use of a Pediatric Robotic Exoskeleton (P.REX/Agilik) to improve gait in children with movement disorders,90103,NA,NA,NA,NA,2,NA,NA,0,NA
11194694,ZIA,DA,1,N,NA,NA,NA,NA,ZIADA000389,NA,NA,1ZIADA000389-29,NIDA:1660663\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE ON DRUG ABUSE,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE ON DRUG ABUSE,NA,NA,NA,6480289 (contact),"NEWMAN, AMY HAUCK (contact)",NA,NA,NA,abuse liability;Affect;Affinity;analog;Animal Model;associated symptom;Attention;Attention deficit hyperactivity disorder;Axon;Behavior;Behavioral;Benztropine;Binding;Brain;brain tissue;Cardiotoxicity;Carrier Proteins;Cells;Citalopram;Clinic;Clinical Treatment;Cocaine;Cocaine Abuse;Cocaine Dependence;Cocaine misuse;Cocaine use disorder;Computer Models;computer studies;design;Detection;Development;Disabling;Disease;DNA Sequence Alteration;Dopamine;dopamine transporter;Dopamine Uptake Inhibitors;Drug Design;drug discovery;Drug Kinetics;Effectiveness;Electrophysiology (science);Endoplasmic Reticulum;Exhibits;experimental study;Flow Cytometry;fluorophore;Food;Human;Human Genetics;Ibogaine;improved;in vivo;inhibitor;insight;Intake;Label;Lead;Ligands;Macaca mulatta;Measures;Membrane;Metabolic;Metabolism;Methamphetamine;methamphetamine abuse;Methamphetamine dependence;Modafinil;Modeling;Modification;Molecular;Molecular Conformation;Monkeys;monoamine;monocyte;motor disorder;Movement Disorders;Mus;mutant;neurochemistry;Neurons;neuropsychiatric disorder;nisoxetine;nonhuman primate;noradrenaline transporter;Norepinephrine;novel;novel therapeutics;off-label use;Oregon;Parents;patch clamp;Patients;peripheral blood;Pharmaceutical Preparations;pharmacologic;Pharmacology;pharmacophore;Procedures;Property;Proteins;psychostimulant;Publishing;Rattus;reduce symptoms;reuptake;Rhodamine;Rodent;Rodent Model;Role;scaffold;screening;Selective Serotonin Reuptake Inhibitor;Series;Serotonin;serotonin transporter;Sleep Disorders;Slice;small molecule;Stimulant;stimulant use disorder;Structure;Structure-Activity Relationship;Study models;success;superresolution imaging;superresolution microscopy;tool;trafficking;Translations;Tropanes;Visualization;Work,Novel Probes for the Monoamine Transporters,389,NA,NA,NA,NA,29,NA,NA,1660663,NA
11194695,ZIA,DA,1,N,NA,NA,NA,NA,ZIADA000424,NA,NA,1ZIADA000424-26,NIDA:1660663\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE ON DRUG ABUSE,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE ON DRUG ABUSE,NA,NA,NA,6480289 (contact),"NEWMAN, AMY HAUCK (contact)",NA,NA,NA,Absence of pain sensation;addiction liability;Affinity;Agonist;Amides;Amino Acids;Analgesics;analog;antagonist;Attention;Behavioral;Binding;Binding Sites;Biological Assay;Biological Availability;Bipolar Disorder;blood-brain barrier penetration;Brain;Brain region;Cells;Chimera organism;Chromatography;Cocaine;cocaine seeking;cocaine self-administration;comorbidity;Computer Models;Coupled;Cryoelectron Microscopy;Data;design;Development;Diagnosis;Disorientation;Dopamine;Dopamine D2 Receptor;Dopamine Receptor;DRD2 gene;Drug Design;drug discovery;Drug Kinetics;Effectiveness;enantiomer;eticlopride;Evaluation;extracellular;Family;Future;Goals;GTP-Binding Proteins;improved;in vivo;in vivo Model;Indoles;interest;Investigation;Investigational New Drug Application;Ion Channel;Kinetics;Lead;Learning;Ligand Binding;Ligands;Link;Loperamide;member;Mental disorders;Metabolic;Methamphetamine;Microsomes;Modeling;Modification;Mood Disorders;Motor;mu opioid receptors;neuropsychiatric disorder;Neurotransmitters;new therapeutic target;next generation;nonhuman primate;novel;Opiate Addiction;Opioid;Opioid Antagonist;opioid misuse;opioid use disorder;oxycodone self-administration;Parents;patient population;Patients;Penetrance;Penetration;Pharmaceutical Preparations;pharmacologic;Pharmacology;pharmacophore;phenylpiperazine;Physiological;Piperazines;Play;pre-clinical;preference;prescription opioid addiction;prevent;Property;Proteins;Publishing;Rattus;receptor;Reporting;Rewards;Risk;Rodent Model;Role;scaffold;Schizophrenia;Series;side effect;Site;Site-Directed Mutagenesis;small molecule;Stimulant;stimulant use disorder;Structure;Substance Use Disorder;substance use treatment;Sumanirole;Testing;Therapeutic;therapy development;tool;Translations;Transmembrane Domain;Treatment Efficacy;Withdrawal;Work,Novel Dopamine D3/D2 Receptor Ligands,424,NA,NA,NA,NA,26,NA,NA,1660663,NA
11194696,ZIA,DE,1,N,NA,NA,NA,NA,ZIADE000713,NA,NA,1ZIADE000713-20,NIDCR:2147446\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH,NA,NA,NA,6687130 (contact),"TEN HAGEN, KELLY G (contact)",NA,NA,NA,25-hydroxyvitamin D;absorption;Acetylgalactosamine;activation-induced cytidine deaminase;Adaptor Signaling Protein;Affect;American;Anabolism;Animals;Behavior;Binding;Binding Proteins;Biochemistry;Biological;Blood;bone;Bone Density;Bone Development;Bone Diseases;Bone remodeling;C-terminal;calcification;Calcium;Calcium ion;Cells;Chronic Kidney Failure;Colon Carcinoma;Congenital Heart Defects;cortical bone;Cysteine;Cysteine-Rich Domain;Cystic Fibrosis;Cytoplasmic Granules;Defect;Development;Dihydroxycholecalciferols;Disease;Disease Progression;Disease susceptibility;Drosophila genus;egg;Enzymes;Epithelium;Extracellular Matrix Proteins;Familial tumoral calcinosis;Family;Female;female reproductive system;female reproductive tract;functional decline;GALNT3 gene;Gastrointestinal tract structure;Genes;genome wide association study;Gland;glycosylation;glycosyltransferase;High Density Lipoprotein Cholesterol;Homeostasis;Hormones;human disease;hydroxyl group;in vivo;Inflammatory Bowel Diseases;inorganic phosphate;insight;Journals;Kidney;Kidney Diseases;LDL-Receptor Related Protein 2;Lectin;Ligands;Link;male;Mammals;Maps;mating behavior;Mediating;member;Membrane;Minerals;model organism;Modeling;Molecular Weight;Morphology;mouse model;Mucins;Mus;Mutation;Neoplasm Metastasis;novel;Organ;organ growth;Osteogenesis;Osteomalacia;Osteoporosis;Partner in relationship;Physiological;Play;Polysaccharides;Population;Post-Translational Protein Processing;Production;Proteins;Proteinuria;PTH gene;Publishing;receptor;reproductive tract;Research;Respiratory Disease;Respiratory Tract Diseases;response;Rickets;Role;role model;Salivary Glands;Science;Secretory Vesicles;Seminal;Seminal fluid;Serine;Serum;skeletal;Skeletal system;small molecule;sperm cell;Sperm Tail;substantia spongiosa;sugar;Surface;Syndrome;Text;Threonine;Tissues;treatment strategy;Triglycerides;tumor progression;Vitamin D;Vitamin D-Binding Protein;Work,Role of O-glycosylation in Animal Development,713,NA,NA,NA,NA,20,NA,NA,2147446,NA
11194697,ZIA,DE,1,N,NA,NA,NA,NA,ZIADE000732,NA,NA,1ZIADE000732-15,NIDCR:1345764\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH,NA,NA,NA,10672185 (contact),"MOUTSOPOULOS, NIKI  (contact)",NA,NA,NA,Adverse effects;Autoimmune Diseases;Clinical;clinical center;clinical phenotype;Clinical Research;cohort;Collaborations;Color;congenital immunodeficiency;CXCL9 gene;Defect;Dental Clinics;Disease;disease phenotype;Disease remission;Disease susceptibility;early onset;Environment;Evaluation;Genes;Health;Human;Immune;Immune response;Immune System Diseases;Immunity;Immunologics;Immunophenotyping;interest;Interferon Type II;ITGB2 gene;Janus kinase;kinase inhibitor;Laboratories;Link;loss of function mutation;microbial;Mouth Diseases;Mucosal Immune Responses;Mucositis;Mucous Membrane;Mutation;Mycoses;National Institute of Allergy and Infectious Disease;neutrophil;Oral;Oral cavity;Oral Characters;oral fungal;oral microbiome;Oral mucous membrane structure;oral tissue;Oral Ulcer;Pathogenicity;Pathway interactions;patient population;Patients;Periodontal Diseases;Periodontitis;Phenotype;Polyglandular Autoimmune Syndrome Type I;Predisposition;Research Personnel;Role;Science;single cell sequencing;T-Lymphocyte;therapeutic target;Tissues;translational study;United States National Institutes of Health;Virus Diseases;Work,Oral Microbial and Immunological Characterization of Patients with Immune Dysfun,732,NA,NA,NA,NA,15,NA,NA,1345764,NA
11194698,ZIA,DE,1,N,NA,NA,NA,NA,ZIADE000736,NA,NA,1ZIADE000736-15,NIDCR:1345764\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH,NA,NA,NA,10672185 (contact),"MOUTSOPOULOS, NIKI  (contact)",NA,NA,NA,Affect;American;bench to bedside;bone;Cells;Chronic;Clinical Trials;Connective Tissue;cytokine;Dentition;Disease;Distal;dysbiosis;Elements;Epithelial Cells;Epithelium;Flagellin;Gene Mutation;General Population;Gingiva;Health;Health Care Costs;Human;IL17 gene;Immune;Immunity;Impairment;Individual;Inflammation;Inflammatory;Inflammatory Response;insight;interest;interleukin-23;Interleukin-6;ITGB2 gene;Leukocyte Adhesion Deficiency;Link;Mediating;Microbe;microbial;microbiome;microbiota;migration;Modeling;Molecular;Mucous Membrane;neutrophil;Oral;oral immunity;oral microbiome;Oral mucous membrane structure;Pathogenesis;Pathogenicity;Pathology;Periodontitis;Population;Predisposition;programs;Quality of life;Research;response;Role;Site;Source;Structure;Testing;Therapeutic;Tissues;Tooth Loss;Tooth structure;Virulence Factors;Work,Mechanisms of Chronic Inflammation in Periodontitis,736,NA,NA,NA,NA,15,NA,NA,1345764,NA
11194699,ZIA,DE,1,N,NA,NA,NA,NA,ZIADE000748,NA,NA,1ZIADE000748-07,NIDCR:2248791\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH,NA,NA,NA,16162190 (contact),"KEROSUO, LAURA  (contact)",NA,NA,NA,Biochemical;Biological Assay;Cell Maintenance;Cells;Cellular biology;Chick;Chick Embryo;Communication;Congenital Abnormality;Cytoskeleton;Development;Developmental Process;DiGeorge Syndrome;Disease;Ectoderm;Embryo;Event;gastrulation;gene regulatory network;Genes;Genotype;Germ Layers;Goals;Heterogeneity;Human;Human Development;human embryonic stem cell;Image;In Vitro;in vivo Model;induced pluripotent stem cell;interest;knock-down;Knowledge;Malignant Neoplasms;Methodology;Modernization;Molecular;Molecular Biology;Molecular Biology Techniques;Mus;Nature;Neural Crest;Neural Crest Cell;Neuroblastoma;novel;Pathology;Pathway interactions;Patients;Pattern;pluripotency;Process;Publishing;Research;Role;Signal Transduction;stem cells;Technology;transcriptomics;Ubiquitin;Work,Neural Crest Development and Disease,748,NA,NA,NA,NA,7,NA,NA,2248791,NA
11194700,ZIA,DE,1,N,NA,NA,NA,NA,ZIADE000752,NA,NA,1ZIADE000752-06,NIDCR:1902017\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH,NA,NA,NA,16199406 (contact),"TUSSIWAND, ROXANE  (contact)",NA,NA,NA,adaptive immune response;adaptive immunity;Address;Antigen Presentation;Antigen-Presenting Cells;Antigens;Autoimmune Diseases;Autoimmunity;Bone Marrow;Cells;Cellular biology;clinical practice;Complex;Cues;cytokine;Dendritic Cells;Development;draining lymph node;Effector Cell;Ensure;Epithelial Cells;Equilibrium;frontier;Gene Expression Profile;Genetic Transcription;Hematopoietic;Heterogeneity;Human;human disease;Immune;Immune response;Immune system;Immune Targeting;Immunity;Immunologics;immunoregulation;Immunotherapy;improved;in vivo;inflammatory milieu;Inflammatory Response;interest;Interferon Type I;Knowledge;Link;Macrophage Colony-Stimulating Factor;Maintenance;mouse model;Mus;Natural Immunity;novel;pathogen;Pathway interactions;Pattern recognition receptor;personalized medicine;Phase;Play;Production;progenitor;Property;Psoriasis;recruit;Research;response;Role;self-renewal;Site;Skin;Source;Specific qualifier value;Specificity;stem cells;T-Lymphocyte;Tissues;transcription factor;Transcriptional Regulation;Translating;tumor;Tumor Immunity;uptake;vaccine strategy;Viral;Virus Diseases,Dendritic cells heterogeneity and function,752,NA,NA,NA,NA,6,NA,NA,1902017,NA
11194701,ZIA,DE,1,N,NA,NA,NA,NA,ZIADE000758,NA,NA,1ZIADE000758-04,NIDCR:2482792\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH,NA,NA,NA,78331990 (contact),"BOYCE, ALISON  (contact)",NA,NA,NA,Adult;Antibodies;Biological Models;Blood;bone;Bone Diseases;Caring;Cell Proliferation;Child;Child Welfare;Childhood;Clinical;Clinical Trials;Complex;Cyclic AMP;Development;disability;Disease;Endocrine System Diseases;Enrollment;Fibrous Dysplasia;G-Protein-Coupled Receptors;gain of function mutation;Goals;Health;Hormones;Hypercalcemia;Hypophosphatemia;improved;Individual;Knowledge;Lead;Lesion;Ligands;McCune-Albright Syndrome;Medical;Metabolic Bone Diseases;Mission;Morbidity - disease rate;Mosaicism;Natural History;novel;novel therapeutic intervention;Osteoclasts;osteoprogenitor cell;Pathogenesis;Patients;phase II trial;Phosphorus;Physiological;Physiology;prevent;Proliferating;Quality of life;Rare Diseases;Retrospective Studies;Role;Signal Pathway;skeletal;skeletal disorder;TNFSF11 gene;tool;translational study;Variant;Work,Metabolic Bone Disorders Unit,758,NA,NA,NA,NA,4,NA,NA,2482792,NA
11194702,ZIA,LM,1,N,NA,NA,NA,NA,ZIALM010008,NA,NA,1ZIALM010008-09,NLM:1454664\,INTRAMURAL RESEARCH,2024,NATIONAL LIBRARY OF MEDICINE,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL LIBRARY OF MEDICINE,NA,NA,NA,9694404 (contact),"MCDONALD, CLEMENT  (contact)",NA,NA,NA,Address;Adrenergic alpha-Antagonists;Adrenergic beta-Antagonists;Adult;Adverse drug effect;Adverse effects;alfuzosin;Alzheimer&apos;s Disease;Ambulatory Care;Angiotensin-Converting Enzyme Inhibitors;Anti-Hypertensive Agents;Anticoagulants;Antiplatelet Drugs;beneficiary;Benefits and Risks;Benign Prostatic Hypertrophy;Big Data;bisphosphonate;Bone Density;Bone structure;Breast;Calcium Channel Blockers;Cardiovascular Diseases;Cessation of life;Chronic;Chronic Disease;Clinical;clinical database;Clinical Trials;cognitive function;Cohort Studies;comparative effectiveness;Consensus;COVID-19;COVID-19 severity;Cox Models;Cox Proportional Hazards Models;Data;Data Analyses;Deterioration;Diagnosis;Disease;disease diagnosis;Diuretics;drug maintenance;Drug usage;effective therapy;Elderly;Elderly woman;Enrollment;Epidemiology;Estrogens;Event;Female;Femoral Fractures;flu;follow-up;Fracture;fracture risk;frailty;Goals;Guidelines;hazard;Health;health care service utilization;Hip region structure;Hormone replacement therapy;Hot flushes;human old age (65+);Hyperlipidemia;Hypertension;Hypogonadism;Incidence;indexing;Informatics;informatics infrastructure;Life;Lipids;Long COVID;Longevity;lower urinary tract symptoms;machine learning method;male;Malignant neoplasm of prostate;Malignant Neoplasms;Masks;Medicare;medication safety;men;Menopause;Methodology;Methods;molnupiravir;Moods;mortality;mortality risk;muscle form;muscle strength;Myocardial Ischemia;neural network;Neurodegenerative Disorders;Night Sweating;nirmatrelvir;older patient;Osteoporosis;Outcome;Parkinson Disease;Pathogenesis;Patient-Focused Outcomes;Patients;Performance;Pharmaceutical Preparations;Pharmacotherapy;post-COVID-19;Postmenopausal Osteoporosis;Prevention;Progestins;Prostatic hypertrophy;Publishing;Pythons;Raloxifene;Recommendation;Reference Values;Regression Analysis;Reporting;Research;Rheumatism;Risk;Risk Estimate;rituximab;SARS-CoV-2 infection;Sex Functioning;Stroke;Survival Analysis;symptomatic improvement;symptomatology;Symptoms;Syndrome;tamsulosin;terazosine;Testing;Testosterone;testosterone replacement therapy;Thinness;Time;tocilizumab;United States Food and Drug Administration;Update;Urology;venous thromboembolism;women&apos;s treatment,Clinical and Informatics Research on Large Clinical Databases,10008,NA,NA,NA,NA,9,NA,NA,1454664,NA
11194703,ZIA,LM,1,N,NA,NA,NA,NA,ZIALM010018,NA,NA,1ZIALM010018-04,NLM:1370493\,INTRAMURAL RESEARCH,2024,NATIONAL LIBRARY OF MEDICINE,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL LIBRARY OF MEDICINE,NA,NA,NA,14765974 (contact),"ANTANI, SAMEER  (contact)",NA,NA,NA,Address;Adult;Affect;Anatomy;Appearance;Architecture;Area;Artificial Intelligence;artificial intelligence algorithm;automated segmentation;biomedical imaging;Biomedical Research;Biopsy;Cancerous;Cardiac;Cardiovascular Diseases;Characteristics;Child;Childhood;Classification;Clinical;clinical decision-making;Code;Collaborations;Communicable Diseases;comorbidity;Complex;computer-assisted diagnostics;COVID-19 detection;Darkness;Data;data quality;Data Set;Decision Making;deep learning;deep learning model;Dentists;design;Detection;Devices;Diagnosis;Diagnostic;diagnostic tool;Disease;Echocardiography;Entropy;Evaluation;forgetting;General Population;generative artificial intelligence;global health;Goals;health application;Histopathology;HIV;Human;Image;Image Analysis;Image Enhancement;image processing;Imaging Device;Impairment;improved;indexing;innovation;insight;interest;International;Kaposi Sarcoma;Lateral;Learning;learning network;Legal patent;Lesion;Literature;Location;Lung;Machine Learning;machine learning method;Malignant - descriptor;malignant mouth neoplasm;Malignant neoplasm of cervix uteri;Malignant Neoplasms;Maps;Medical Imaging;Metadata;Methods;Modality;model generalizability;Modeling;mortality;multidimensional data;multimodality;National Institute of Allergy and Infectious Disease;National Institute of Dental and Craniofacial Research;novel;Oncology;Oral;Oral cavity;Outcome;Patients;Performance;Population;Population Heterogeneity;portability;pre-trained model;premalignant;Process;Property;Pulmonary Edema;Quality Control;radiologist;Real-Time Systems;Research;Resource-limited setting;Role;Running;Sampling;self supervised learning;Semantics;Sickle Cell Anemia;Skin;Source;synthetic data;task analysis;Techniques;Testing;Text;Thoracic Radiography;Tissues;Training;training data;treatment planning;Tuberculosis;Ultrasonography;United States National Institutes of Health;Update;Variant;Visualization;Weight;Woman;Work;X-Ray Medical Imaging,Machine learning and artificial intelligence research for clinical medical image processing,10018,NA,NA,NA,NA,4,NA,NA,1370493,NA
11194704,ZIA,LM,1,N,NA,NA,NA,NA,ZIALM010019,NA,NA,1ZIALM010019-04,NLM:2235922\,INTRAMURAL RESEARCH,2024,NATIONAL LIBRARY OF MEDICINE,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL LIBRARY OF MEDICINE,NA,NA,NA,10687426 (contact),"DEMNER-FUSHMAN, DINA  (contact)",NA,NA,NA,Abbreviations;Access to Information;Address;Administrator;Affect;Anatomy;breast exam;California;Characteristics;Child;Clinical;clinical decision support;clinical decision-making;clinically relevant;Clip;Collaborations;Collection;Communities;Computational Linguistics;Data;Data Analyses;Databases;deep learning;Disease;Education;Educational process of instructing;Educational workshop;Emotional;Evaluation;Evidence Based Medicine;Eye;Family;Formulation;Foundations;Generations;Goals;Growth;Health;History of Medicine;Home;Hybrids;Image;improved;Indiana;Instruction;interest;International;Intervention;Knowledge;Label;Language;language processing;large language model;Lead;Literature;Location;machine learning method;Malignant Breast Neoplasm;Medical;Medical Libraries;Medicine;MedlinePlus;Methods;model organism;Modeling;Names;Natural Language Processing;neural;novel strategies;Orthopedics;Outcome;Paper;Patients;Persons;Pharmaceutical Preparations;prototype;Publications;PubMed;radiological imaging;Radiology Specialty;Reporting;repository;Research;Resources;Retrieval;Role;search engine;Services;Social support;Source;spelling;Study Subject;supervised learning;support network;System;systematic review;Techniques;Testing;Text;Thoracic Radiography;tool;Training;Translating;Translations;United States National Institutes of Health;United States National Library of Medicine;Universities;Update;Visual;Writing,Providing timely and effortless access to reliable health-related information for decision support and education,10019,NA,NA,NA,NA,4,NA,NA,2235922,NA
11194705,ZIA,LM,1,N,NA,NA,NA,NA,ZIALM010024,NA,NA,1ZIALM010024-02,NLM:915608\,INTRAMURAL RESEARCH,2024,NATIONAL LIBRARY OF MEDICINE,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL LIBRARY OF MEDICINE,NA,NA,NA,79356199 (contact),"WEISS, JEREMY  (contact)",NA,NA,NA,Accounting;Active Learning;Address;Agreement;Algorithms;Artificial Intelligence;censorship;Classification;Clinical;clinical care;Clinical Data;clinical predictors;clinical risk;Collection;Critical Care;Data;Data Element;data quality;Data Science;Data Set;Dependence;Disease;Disease Progression;Dropout;Electronic Health Record;Environment;Equity;Event;follow-up;Goals;graph neural network;Healthcare;human-in-the-loop;improved;Individual;inpatient service;large language model;Machine Learning;machine learning method;machine learning model;Measures;Methodology;Modeling;multimodal learning;opioid abuse;Outcome;Patients;Performance;pharmacovigilance;Pilot Projects;prediction algorithm;prevent;Process;Research;Research Personnel;Resources;Risk;risk prediction;Sepsis;Survival Analysis;Text;Time;Training;Translations;Variant;Visualization;Work,Machine learning methods in data science for clinical prediction and characterization,10024,NA,NA,NA,NA,2,NA,NA,915608,NA
11194707,ZIA,LM,1,N,NA,NA,NA,NA,ZIALM092404,NA,NA,1ZIALM092404-21,NLM:1073571\,INTRAMURAL RESEARCH,2024,NATIONAL LIBRARY OF MEDICINE,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL LIBRARY OF MEDICINE,NA,NA,NA,8184820 (contact),"YU, YI-KUO  (contact)",NA,NA,NA,"Address;Agreement;Algorithms;American;Antibiotic Resistance;Antibiotics;Area;Back;Berlin;Biological;Biological Markers;Biomass;Biomedical Research;clinical center;clinical diagnosis;Collaborations;Committee Members;Computational algorithm;Computational Biology;Computer software;Data;Data Analyses;data visualization;Databases;deep learning;design;Evaluation;expectation;experimental study;Feedback;Forensic Medicine;Goals;graphical user interface;improved;Information Retrieval;instrument;International;Ions;Isotopes;Journals;Label;Maps;mass spectrometer;Mass Spectrum Analysis;Mathematics;Measures;member;Metadata;metaproteomics;Methods;Microbe;microbial;microorganism;microorganism classification;National Heart, Lung, and Blood Institute;National Security;Pacific Northwest;Paris, France;pathogen;Peptide Fragments;Peptides;Performance;Phase;Posttranslational Amino Acid Modification;prevent;programs;Proteins;Proteome;Proteomics;Public Health;Publications;Publishing;Reporter;Reporting;Reproducibility;Research;Safety;Sampling;Scientist;Sensitivity and Specificity;Signal Transduction;Societies;Speed;Standardization;statistics;Sum;Sweden;Systems Biology;tandem mass spectrometry;Textbooks;Time;tool;United States National Institutes of Health;Universities;usability;Weight;Work;Writing",Robust Accurate Identification of peptides from tandem mass spectrometry data,92404,NA,NA,NA,NA,21,NA,NA,1073571,NA
11194708,ZIA,LM,1,N,NA,NA,NA,NA,ZIALM200601,NA,NA,1ZIALM200601-19,NLM:852974\,INTRAMURAL RESEARCH,2024,NATIONAL LIBRARY OF MEDICINE,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL LIBRARY OF MEDICINE,NA,NA,NA,8184820 (contact),"YU, YI-KUO  (contact)",NA,NA,NA,Address;Agreement;Behavior;Binding;Binding Sites;Biological;Biological Process;biological systems;Bypass;Charge;chemical bond;Chemicals;Complex;Computer Assisted;computing resources;Coupled;density;Development;dielectric property;DNA;DNA Binding;Electrolytes;electron cloud;electronic structure;Electronics;Electrostatics;Elements;European;flexibility;Formulation;Foundations;Geometry;Goals;Hydrogen Bonding;improved;Individual;insight;Investigation;Ions;Journals;Ligands;Mechanics;meetings;Methods;Modeling;Molecular;molecular dynamics;Outcome;Physics;Physiological;Process;Proteins;Publishing;quantum;Quantum Mechanics;receptor binding;Research Personnel;Rotation;Scheme;screening;simulation;Solvents;Speed;Surface;System;Testing;theories;transcription factor;Water;Work,Physical Foundation of Biomolecular Interactions,200601,NA,NA,NA,NA,19,NA,NA,852974,NA
11194709,ZIA,LM,1,N,NA,NA,NA,NA,ZIALM594244,NA,NA,1ZIALM594244-18,NLM:1264755\,INTRAMURAL RESEARCH,2024,NATIONAL LIBRARY OF MEDICINE,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL LIBRARY OF MEDICINE,NA,NA,NA,8184822 (contact),"ARAVIND, L  (contact)",NA,NA,NA,Amino Acids;analog;Apoptosis;ATP phosphohydrolase;ATPase Domain;Back;Bacteria;Bacteriophages;Binding;Biological;biological adaptation to stress;Biological Process;Biology;Biotechnology;Calcineurin;Cells;Clustered Regularly Interspaced Short Palindromic Repeats;Collaborations;comparative genomics;Complex;Computer Analysis;Conflict (Psychology);Coupled;Cytosine;Discrimination;DNA;DNA Binding;DNA Binding Domain;DNA Restriction Enzymes;Down-Regulation;Elements;Environment;Enzymes;Eukaryota;gene conservation;Gene Modified;Genes;genetic information;Genetic Transcription;Genome;genome editing;Guanosine Triphosphate Phosphohydrolases;Heat-Shock Proteins 70;Heat-Shock Proteins 90;Homeostasis;Housekeeping;Human;Immune;Immune system;Immunity;inorganic phosphate;Intercept;interoperability;Life;Logic;Lyme Disease;Magnesium;Manganese;Membrane;Metals;Methyltransferase;Microscopic;Modification;Molecular;Molecular Mechanisms of Action;Names;National Institute of Child Health and Human Development;Neighborhoods;novel;nuclease;Nucleic Acids;nucleobase;Nucleotides;Organism;pathogen;Pathway interactions;Peptide Signal Sequences;periplasm;phosphorothioate;Phosphotransferases;Post-Transcriptional Regulation;Prokaryotic Cells;Proteins;Proteolysis;Pump;Reagent;recruit;Regulation;replicator;Research;Research Personnel;response;Scanning;science education;Second Messenger Systems;segregation;Signal Transduction;Source;Specificity;Stimulus;Structure;Suicide;syntax;System;Systems Biology;Tertiary Protein Structure;Testing;Toxin;Universities;Variant;Vertebral column;Viral;Virus;Water;whole genome;Whole Organism;Wisconsin;Work,Evolutionary Analysis and Comparative Genomics of Protein Superfamilies,594244,NA,NA,NA,NA,18,NA,NA,1264755,NA
11194710,ZIA,MH,1,N,NA,NA,NA,NA,ZIAMH002032,NA,NA,1ZIAMH002032-48,NIMH:1319597\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF MENTAL HEALTH,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF MENTAL HEALTH,NA,NA,NA,6571765 (contact),"RICHMOND, BARRY J (contact)",NA,NA,NA,Address;Behavior;Behavioral;Brain;Brain region;Canis familiaris;Categories;Code;cognitive process;Depressed mood;design;Electrodes;Elements;Emotional disorder;Esthesia;Event;Failure;Family member;Feeling;Felis catus;Food;Grouping;Image;Individual;Inferior;information processing;irritation;Learning;Lesion;Measures;Memory;Monkeys;Movement;neural;Neurons;nonhuman primate;parallel processing;Perception;Physiologic pulse;Population;Primates;Process;Psyche structure;response;Role;sensory stimulus;Series;Stimulus;Temporal Lobe;Utah;Visual;visual coding;visual memory;Visual Perception;visual stimulus,Neural Coding of Visual Stimuli,2032,NA,NA,NA,NA,48,NA,NA,1319597,NA
11194711,ZIA,MH,1,N,NA,NA,NA,NA,ZIAMH002386,NA,NA,1ZIAMH002386-38,NIMH:1578747\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF MENTAL HEALTH,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF MENTAL HEALTH,NA,NA,NA,6230215 (contact),"EIDEN, LEE E. (contact)",NA,NA,NA,allodynia;Amines;Amygdaloid structure;Area;Aversive Stimulus;Behavior;Behavioral;behavioral impairment;behavioral outcome;behavioral plasticity;behavioral response;Biochemical;biological adaptation to stress;Brain;Ca(2+)-Calmodulin Dependent Protein Kinase;Calcium;Calendar;Cells;Chemicals;Chronic;Code;Collaborations;combinatorial;conditioned fear;conditioned place preference;Conditioned Stimulus;conditioning;Coupled;CRH gene;Cues;Cyclic AMP;Cyclic AMP-Dependent Protein Kinases;Dependence;Development;Dopamine;Dopamine D1 Receptor;Electrophysiology (science);Elements;Endocrine;Event;FOS gene;Foundations;Freezing;Fright;G-Protein-Coupled Receptors;gene induction;Genes;Genetic;genetic signature;Glutamates;hippocampal pyramidal neuron;Hippocampus;Hypothalamic structure;Immediate-Early Genes;Impairment;information processing;Interneurons;Interruption;Intracellular Signaling Proteins;Investigation;Knock-out;Laboratories;Learning;Link;Mediating;Messenger RNA;Molecular;Mus;National Center for Complementary and Integrative Health;National Institute of Mental Health;nerve injury;Neuroendocrine Cell;neuronal circuitry;Neurons;Neuropeptides;neuropsychiatric disorder;neuroregulation;Neurosciences;neurotransmission;Neurotransmitters;novel;Nucleus Accumbens;PACAPR-1 protein;Pain;pain sensation;paraventricular nucleus;Pathway interactions;Peripheral nerve injury;Pharmaceutical Preparations;Phenocopy;Phenotype;Phosphorylation;pituitary adenylate cyclase activating polypeptide;Play;Population;postsynaptic;Process;Prosencephalon;Protein Kinase;Publications;Publishing;RAPGEF2 gene;receptor;Receptor Activation;Reporting;response;restraint;restraint stress;reward processing;Role;Scientist;Shock;Signal Pathway;Signal Transduction;small molecule;Stimulant;Stimulus;Stress;Synapses;Synaptic plasticity;Syndrome;System;Testing;Transcription Initiation;Transducers;transmission process;Universities;Wild Type Mouse;Work,Chemical Coding of Neurotransmission,2386,NA,NA,NA,NA,38,NA,NA,1578747,NA
11194712,ZIA,MH,1,N,NA,NA,NA,NA,ZIAMH002497,NA,NA,1ZIAMH002497-35,NIMH:948032\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF MENTAL HEALTH,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF MENTAL HEALTH,NA,NA,NA,2034559 (contact),"GERFEN, CHARLES R (contact)",NA,NA,NA,Affect;Amygdaloid structure;Animal Behavior;Animal Model;Anterior;Anxiety;Area;arm;association cortex;Atlases;Attention deficit hyperactivity disorder;Axon;Bacterial Artificial Chromosomes;Basal Ganglia;Basal Ganglia Diseases;Behavior;Behavior Control;Bilateral;Brain;brain circuitry;Brain imaging;Brain region;California;Cerebral cortex;clinical movement disorder;Collaborations;Communities;Complex;Contralateral;Corpus striatum structure;Cre driver;Decision Making;Development;Disease;Dopamine;Dopamine D2 Receptor;dopaminergic neuron;Engineering;Enterobacteria phage P1 Cre recombinase;Enzymes;Equilibrium;Esthesia;Experimental Designs;Eye;Face;fear memory;Feedback;feeding;frontal lobe;Functional disorder;Funding;Gene Expression Regulation;Genes;Genetic Engineering;Genetic Techniques;Glutamates;Image;information model;information organization;inhibitory neuron;insight;interest;Ipsilateral;L-DOPA induced dyskinesia;Label;Laboratories;Laboratory Research;Lesion;Light;LoxP-flanked allele;Maps;Mediating;Mental disorders;Methods;Microscopy;Midbrain structure;Molecular Genetics;Motor;Motor Activity;motor behavior;Motor Cortex;Movement;Movement Disorders;Mus;National Institute of Drug Abuse;National Institute of Mental Health;National Institute of Neurological Disorders and Stroke;National Institute on Alcohol Abuse and Alcoholism;neural;neural circuit;Neural Pathways;Neuroanatomy;Neurologic Dysfunctions;Neuromodulator;Neuronal Plasticity;Neurons;Neurosciences;Neurosciences Research;Neurotransmitter Receptor;optogenetics;Outcome;Output;Paper;Parkinson Disease;Pathway interactions;Pattern;Pennsylvania;Physiological;Population;postsynaptic;Process;programs;Prosencephalon;protein activation;Protein Kinase;Psychotropic Drugs;Publications;Publishing;rabies viral tracing;Regulation;Research;Research Personnel;response;Role;San Francisco;segregation;Sensory;sensory cortex;sensory integration;Signal Pathway;Signal Transduction Pathway;Somatosensory Cortex;superior colliculus Corpora quadrigemina;Synapses;System;Techniques;Tectum Mesencephali;Thalamic Nuclei;Thalamic structure;Time;tool;transcription factor;Transcriptional Activation;Transgenic Mice;transmission process;United States National Institutes of Health;Universities;Viral Vector;Visual Cortex;visual information;Visual Motion;Work,Functional Organization of the Cerebral Cortex and Basal Ganglia,2497,NA,NA,NA,NA,35,NA,NA,948032,NA
11194713,ZIA,MH,1,N,NA,NA,NA,NA,ZIAMH002537,NA,NA,1ZIAMH002537-35,NIMH:1295417\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF MENTAL HEALTH,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF MENTAL HEALTH,NA,NA,NA,9416711 (contact),"SCHMIDT, PETER  (contact)",NA,NA,NA,"Accounting;Affective;Agonist;animal data;anti-depressive agents;Anti-Inflammatory Agents;Behavior;Behavioral;Biological;Blinded;Blood;Brain;burden of illness;Cardiovascular Diseases;cardiovascular disorder risk;Cardiovascular system;Cell Line;Characteristics;Circadian Rhythms;Clinic Visits;Clinical;Clinical Protocols;Clinical Research;Cognition;Communities;CXCL10 gene;Data;dehydroepiandrosterone;dementia risk;density;depressive symptoms;Development;Diagnostic;Direct Costs;Double-Blind Method;Early-life trauma;effective therapy;Endometrial;Enzymes;epidemiology study;ESR1 gene;Estradiol;Estrogen deficiency;Estrogen Receptor 2;Estrogen Therapy;Event;experience;Experimental Designs;Facilities and Administrative Costs;Family;Formulation;functional genomics;Genes;Genetic Transcription;Goals;Growth;hearing impairment;High Risk Woman;Hormonal;hormonal signals;hormone therapy;Hormones;Hot flushes;hypothalamic-pituitary-adrenal axis;Impaired cognition;in vitro Model;Inflammatory;Interview;Life;life span;Link;longitudinal, prospective study;lymphoblastoid cell line;Major Depressive Disorder;Measures;Medical;member;menopausal hormone therapy;Menopause;Menstruation;Mental Depression;Metabolic syndrome;Metabolism;middle age;Midlife women;minor depressive disorder;modifiable risk;Monitor;Mood Disorders;mood symptom;Moods;Morbidity - disease rate;mortality;negative mood;Neurosecretory Systems;neurotransmission;NF-kappa B;novel;novel therapeutic intervention;novel therapeutics;open label;Osteoporosis;Outcome;Ovarian;Ovarian aging;oxysterol 7-alpha-hydroxylase;Participant;Pathway Analysis;Pattern;Perimenopause;Placebo Control;Placebos;Plasma;Postmenopause;Predisposition;Premenopause;Presbycusis;Prevalence;prevent;Progestins;proliferative phase Menstrual cycle;psychobiology;Randomized;randomized placebo controlled trial;Recording of previous events;Recurrence;recurrent depression;Regulation;RELA gene;Relative Risks;Reporting;reproductive;reproductive senescence;Research Design;response;Risk;Risk Marker;Role;Safety;Sampling;Signal Transduction;single episode major depressive disorder;Source;steroid hormone;Steroids;suicide rate;Symptoms;Therapeutic;Time;Transcript;transcriptome;vasomotor symptoms;Withdrawal;Woman;Women&apos;s Health;Women&apos;s mortality;Work",Psychobiology and Treatment of Perimenopausal Mood Disorders,2537,NA,NA,NA,NA,35,NA,NA,1295417,NA
11194714,ZIA,MH,1,N,NA,NA,NA,NA,ZIAMH002588,NA,NA,1ZIAMH002588-34,NIMH:2536196\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF MENTAL HEALTH,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF MENTAL HEALTH,NA,NA,NA,6482398 (contact),"MARTIN, ALEX  (contact)",NA,NA,NA,Address;Animals;animation;Behavior;Behavioral;Biology;Brain;Brain imaging;Brain region;Candy;Categories;Clinical Protocols;Code;Cognition;Communication;Complex;Coupled;Data;Democracy;Electroencephalography;Emotions;experience;falls;Food;Food Preferences;food quality;Foundations;Freedom;frontier;Functional Magnetic Resonance Imaging;functional magnetic resonance imaging/electroencephalography;Future;Goals;Human;Imagination;imaging modality;Impairment;implicit memory;improved;insight;Insula of Reil;Journals;Justice;Knowledge;Language;Learning;Magnetoencephalography;Maps;Measures;Memory;multimodality;Nature;neural;neural circuit;Neurobiology;neuromechanism;neuropsychiatric disorder;Neurosciences;object recognition;Participant;Performance;Population;Process;Property;Psyche structure;Psychology;Research;Resolution;Retrieval;Semantic memory;Sensory;Series;social;social cognition;Social Interaction;Stimulus;Structure;System;Taste Perception;tool;United States National Academy of Sciences;Visual Perception;Work,The Neural Foundations for Memory and Social Cognition in the Human Brain,2588,NA,NA,NA,NA,34,NA,NA,2536196,NA
11194715,ZIA,MH,1,N,NA,NA,NA,NA,ZIAMH002619,NA,NA,1ZIAMH002619-33,NIMH:1319596\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF MENTAL HEALTH,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF MENTAL HEALTH,NA,NA,NA,6571765 (contact),"RICHMOND, BARRY J (contact)",NA,NA,NA,Ablation;Amygdaloid structure;Anterior;Behavior;Behavioral;Behavioral Mechanisms;behavioral study;Brain;brain reward regions;Cells;cost;Decision Making;Drug abuse;drug of abuse;Emotional;emotional stimulus;Equilibrium;experimental study;Feedback;Feeling hopeless;Hunger;Image;Individual;Learning;Mental Depression;Mental disorders;Molecular;Monkeys;Motivation;neural;neuromechanism;Neurons;neurotransmission;Pathway interactions;Performance;Play;Prefrontal Cortex;Process;putamen;receptor;Reporter;Reporter Genes;Rewards;Role;Sensory;sensory stimulus;Signal Transduction;social;Stimulus;stimulus processing;System;Theoretical Studies;Thirst;transmission process;Virus;Work,Neural Mechanisms of Motivation and Reward,2619,NA,NA,NA,NA,33,NA,NA,1319596,NA
11194716,ZIA,MH,1,N,NA,NA,NA,NA,ZIAMH002652,NA,NA,1ZIAMH002652-32,NIMH:1735409\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF MENTAL HEALTH,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF MENTAL HEALTH,NA,NA,NA,8469065 (contact),"BERMAN, KAREN FAITH (contact)",NA,NA,NA,Address;Affect;Agreement;Antipsychotic Agents;Automobile Driving;Autopsy;Biological Assay;Biological Markers;Blood flow;Brain;brain tissue;case control;Cerebrovascular Circulation;Clinical;clinical care;Clinical Research;Cognition;Cognitive;cognitive function;cohort;Cohort Studies;collected works;Corpus striatum structure;Data;Data Collection;data reduction;Data Set;Databases;Development;Dimensions;Disease;Dopamine;Dopamine Receptor;dopamine system;dopaminergic neuron;drug withdrawal;effective therapy;Etiology;experimental study;Foundations;Functional disorder;Functional Magnetic Resonance Imaging;Gene Expression;Generations;Genes;Genetic;genetic association;Genetic Risk;genome wide association study;genome-wide;Genotype;Goals;Heritability;Heterogeneity;Human;Image;imaging modality;in vivo evaluation;indexing;Individual;innovation;Inpatients;Intramural Research Program;longitudinal positron emission tomography;Magnetic Resonance Imaging;Magnetoencephalography;Measurement;Measures;Methods;millisecond;Modeling;Molecular;Molecular Target;Motor;multimodality;National Institute of Mental Health;Nature;neural;neural circuit;neural correlate;Neurobiology;neurochemistry;Neurocognitive;neurocognitive test;neuroimaging;Neurons;neurophysiology;neuropsychiatric disorder;neuropsychiatry;Neurotransmitters;Noise;novel;Outcome;Oxygen;Parkinson Disease;Pathogenesis;Patients;personalized medicine;Pharmaceutical Preparations;Phenotype;Placebos;polygenic risk score;Positron-Emission Tomography;postsynaptic;Prefrontal Cortex;presynaptic;Procedures;Process;programs;Protocols documentation;radioligand;receptor;Regulation;Reporting;Research;research facility;Resolution;response;reward anticipation;Rewards;risk variant;Schizophrenia;schizophrenia risk;Series;Short-Term Memory;Signal Transduction;spatiotemporal;Symptom Burden;Symptoms;System;Task Performances;Testing;theories;therapeutic target;Tissue Banks;translational genetics;transmission process;treatment response;Update;volunteer;Water;Work,Imaging of Neuropsychiatric Disorders with Developmental and Genetic Mechanisms,2652,NA,NA,NA,NA,32,NA,NA,1735409,NA
11194717,ZIA,MH,1,N,NA,NA,NA,NA,ZIAMH002717,NA,NA,1ZIAMH002717-30,NIMH:1843873\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF MENTAL HEALTH,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF MENTAL HEALTH,NA,NA,NA,8469065 (contact),"BERMAN, KAREN FAITH (contact)",NA,NA,NA,7q11.23;8 year old;Adolescent;Adrenal Glands;Adrenal hormone preparation;Adult;Affect;Age;Age at Menarche;Androgens;Anterior;Autopsy;Behavior;Behavior Disorders;Behavioral;Biological;Brain;brain based;brain circuitry;Brain imaging;Child;cingulate cortex;Clinical;Cognition;Cognition Disorders;Cognitive;cognitive function;cognitive neuroscience;Collaborations;comorbidity;Complex;Corpus striatum structure;cost;course development;Data;Data Set;Decision Making;Dedications;Dehydroepiandrosterone Sulfate;Delayed Puberty;Dependence;Development;developmental disease;Dimensions;Dopamine;Dopamine Receptor;Endocrine;Endocrinology;Environment;Environmental Risk Factor;Epidemiology;Estradiol;Estrogens;Event;experimental study;Face Processing;Failure;Functional disorder;Gene Dosage;gene interaction;General Population;Genes;Genetic;Genetic Transcription;genome wide association study;genomic locus;Gonadal Hormones;Growth;Health;Hormonal;Hormonal Change;Hormones;Human;Image;imaging modality;Impairment;improved;Individual;insight;interest;Investigation;Knowledge;life span;Light;Link;longitudinal design;Longitudinal Studies;Magnetic Resonance;Magnetic Resonance Imaging;Measurement;Measures;Menarche;Menstruation;Mental Depression;Mental disorders;Molecular;Multimodal Imaging;multimodal neuroimaging;Nature;neural;neural circuit;Neurobiology;neurochemistry;neurodevelopment;Neuroendocrinology;neurogenetics;neuroimaging;neuropsychiatry;Neuropsychological Tests;Neuropsychology;novel;Onset of illness;operation;Ovarian Ablation;Ovarian Steroid Hormone;Pattern;Persons;Pharmaceutical Preparations;Phenotype;Pituitary Gland;Plasma;Play;Positron-Emission Tomography;Postpartum Period;postsynaptic;premenstrual dysphoric disorder;prepuberty;presynaptic;primary ovarian insufficiency;Progesterone;Protocols documentation;Psychoses;pubertal timing;Puberty;Resources;reward processing;Rewards;Risk;Role;Scientific Inquiry;severe mental illness;Sex Differences;Syndrome;System;Testing;Testosterone;Time;Translating;Variant;Williams Syndrome;Woman;Work,Neuroimaging of Brain Circuits and Molecular Mechanisms in Normal Cognition,2717,NA,NA,NA,NA,30,NA,NA,1843873,NA
11194718,ZIA,MH,1,N,NA,NA,NA,NA,ZIAMH002736,NA,NA,1ZIAMH002736-29,NIMH:756169\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF MENTAL HEALTH,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF MENTAL HEALTH,NA,NA,NA,1905955 (contact),"MURRAY, ELISABETH A (contact)",NA,NA,NA,Amnesia;Amygdaloid structure;Animals;arm;base;Bilateral;Brain;Collection;Computers;design;Disputes;Effectiveness;Episodic memory;Event;excitotoxicity;Failure;Familiarity;Feeling;frontal lobe;Gambling;Goals;habituation;Hippocampus;Human;Impairment;Knowledge;Lesion;Life;Life Experience;Location;long term memory;Measures;Medial;Memory;Memory impairment;memory process;memory recognition;Meta-Analysis;Motivation;neural;object recognition;Paired Comparison;Patients;Perceptual learning;preference;Process;reward processing;ROC Curve;Rodent;Sampling;Semantic memory;Severities;Short-Term Memory;skills;Stimulus;Structure;Techniques;Testing;Thalamic structure;Time;touchscreen;Visual;visual memory;Weight;Work,Neural Substrates of Stimulus Recognition and Association Memory,2736,NA,NA,NA,NA,29,NA,NA,756169,NA
11194719,ZIA,MH,1,N,NA,NA,NA,NA,ZIAMH002781,NA,NA,1ZIAMH002781-23,NIMH:4441757\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF MENTAL HEALTH,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF MENTAL HEALTH,NA,NA,NA,9416709 (contact),"PINE, DANIEL  (contact)",NA,NA,NA,"Adolescent;Adult;Animal Model;Anxiety;Anxiety Disorders;anxious;Area;Attention;attentional bias;attentional modulation;Behavior;Biological;Biological Markers;Brain;Brain imaging;Brain region;Child;Child Welfare;Childhood;Clinical;clinical practice;Clinical Trials;Cognitive Therapy;cognitive training;Collaborations;Data;Depressive disorder;effective therapy;efficacy evaluation;Emotional;Enrollment;Exhibits;Extinction;Extramural Activities;Fright;Functional disorder;Functional Magnetic Resonance Imaging;Health;Impairment;Individual;Individual Differences;insight;interest;International;Journals;large datasets;Leadership;Life;Magnetoencephalography;Major Depressive Disorder;Measures;Memory;Mental Depression;Mental disorders;Methods;Mood Disorders;National Institute of Mental Health;neural;neural circuit;neural correlate;Neurocognitive;Neuropsychology;Neurosciences;next generation;novel;novel therapeutics;Paper;Participant;Pathway interactions;patient response;Patients;Pattern;Play;Prediction of Response to Therapy;Protocols documentation;Psychopathology;Public Health;Publications;Publishing;Randomized, Controlled Trials;Recruitment Activity;Reporting;Research;response;Role;Site;Standardization;Stimulus;Symptoms;Syndrome;Techniques;Testing;therapy resistant;Training;Transcranial magnetic stimulation;Treatment outcome;treatment research;treatment response;United States National Institutes of Health;web site;Work",fMRI Studies of Pediatric Mood and Anxiety Disorders,2781,NA,NA,NA,NA,23,NA,NA,4441757,NA
11194720,ZIA,MH,1,N,NA,NA,NA,NA,ZIAMH002782,NA,NA,1ZIAMH002782-23,NIMH:1480585\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF MENTAL HEALTH,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF MENTAL HEALTH,NA,NA,NA,9416709 (contact),"PINE, DANIEL  (contact)",NA,NA,NA,Address;Adolescence;Adolescent;Adult;Amygdaloid structure;Anxiety;Anxiety Disorders;anxiety symptoms;Area;behavior prediction;Behavioral;Behavioral inhibition;Biological;Brain;Brain imaging;Child;Childhood;Classification;cohort;Collaborations;Corpus striatum structure;Data;Data Collection;depressive symptoms;Development;developmental disease;early childhood;Electrophysiology (science);Emotional;experience;Exposure to;Extramural Activities;Functional Magnetic Resonance Imaging;Funding;Goals;Grant;Health;high risk;indexing;Individual;infancy;Infant;insight;International;Investigation;Journals;Lead;Life;Maryland;Measures;Mediating;Medical;Mental Depression;Mental disorders;Mood Disorders;morphogens;Nature;neural;Neurocognitive;novel;Outcome;Paper;Participant;Prefrontal Cortex;Prevention;preventive intervention;programs;prospective;Protocols documentation;psychologic;Psychopathology;Public Health;Publishing;Recording of previous events;Reporting;Research;resilience;Resources;response;reward processing;Risk;Risk Factors;Sampling;SARS-CoV-2 exposure;Series;severe mental illness;social;Societies;Stimulus;Stream;Task Performances;Temperament;Testing;Thinking;transition to adulthood;United States National Institutes of Health;Universities;Washington;Well in self;Work;young adult,fMRI Studies of Risk for Mood and Anxiety Disorders in Children,2782,NA,NA,NA,NA,23,NA,NA,1480585,NA
11194721,ZIA,MH,1,N,NA,NA,NA,NA,ZIAMH002783,NA,NA,1ZIAMH002783-23,NIMH:3514361\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF MENTAL HEALTH,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF MENTAL HEALTH,NA,NA,NA,9416723 (contact),"BANDETTINI, PETER  (contact)",NA,NA,NA,Affect;Afterimage;Algorithms;analytical method;Anterior;Arousal;Attention;Auditory;Awareness;Behavioral;Blood Vessels;Brain;Brain Mapping;Characteristics;Classification;Clinical;clinical phenotype;clinical predictors;Clinical Protocols;clinically relevant;Cognition;Cognitive;cognitive neuroscience;Collaborations;Communication;computer scientist;Conscious;constriction;Core Facility;Data;Data Collection;data sharing;denoising;Dependence;detection method;Development;Dreams;Engineering;Event;Excision;experience;Feedback;follow-up;Functional Imaging;Functional Magnetic Resonance Imaging;functional magnetic resonance imaging/electroencephalography;Fusiform gyrus;Goals;gray matter;hemodynamics;Human;Imagery;imaging modality;imprint;improved;independent component analysis;Individual;innovation;insight;Insula of Reil;interest;Intramural Research Program;Laboratories;Machine Learning;Magnetic Resonance Imaging;Magnetoencephalography;Manuscripts;Maps;Measurement;Measures;meetings;mental imagery;method development;Methodology;Methods;Modeling;Monitor;Morphologic artifacts;multimodal neuroimaging;multimodality;multisensory;Names;Nature;Neocortex;neural;neuromechanism;Neurons;Neurosciences;Noise;novel;novel strategies;open source;Participant;Pattern;Peer Review;Perception;Performance;Personality;Phenotype;Physiologic pulse;Physiological;Physiology;Population Study;posters;preservation;Prevalence;Printing;Procedures;Process;Property;Proxy;Publications;Publishing;Pupil;real time monitoring;Reporting;Research;Research Personnel;Resolution;response;Rest;Role;scientific computing;Second Look Surgery;Sensitivity and Specificity;Sensory;sensory integration;sensory mechanism;Series;Signal Transduction;Slide;Societies;spatiotemporal;Statistical Computing;Stimulus;symposium;Technology;temporal measurement;Testing;Thinking;Time;trend;ultra high resolution;United States National Institutes of Health;Vision;Visual;visual imagery;Visual Perception;Work,Functional MRI Method Development,2783,NA,NA,NA,NA,23,NA,NA,3514361,NA
11194722,ZIA,MH,1,N,NA,NA,NA,NA,ZIAMH002784,NA,NA,1ZIAMH002784-23,NIMH:2200643\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF MENTAL HEALTH,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF MENTAL HEALTH,NA,NA,NA,7348303 (contact),"CAMERON, HEATHER A (contact)",NA,NA,NA,Adult;adult neurogenesis;Affect;approach behavior;Automobile Driving;Behavior;Behavioral;Birth;Brain;Brain region;Curiosities;Development;Environmental Risk Factor;experience;Female;Food;Formulation;Future;Goals;good diet;Growth;hippocampal pyramidal neuron;Hippocampus;Human;interest;Learning;Magnetic Resonance Imaging;male;Maze Learning;Memory;Mood Disorders;Mus;neurogenesis;Neurons;Pathologic;Pathway interactions;Play;Population;preference;Primates;Production;Rattus;Regulation;response;Rewards;Role;Stress;Stressful Event;sugar;Testing;Time;Training;Work,Neurogenesis in the Adult Brain,2784,NA,NA,NA,NA,23,NA,NA,2200643,NA
11194723,ZIA,MH,1,N,NA,NA,NA,NA,ZIAMH002793,NA,NA,1ZIAMH002793-23,NIMH:5074591\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF MENTAL HEALTH,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF MENTAL HEALTH,NA,NA,NA,7348327 (contact),"PIKE, VICTOR W (contact)",NA,NA,NA,Academia;Affect;Alzheimer&apos;s Disease;Animals;Anti-Inflammatory Agents;Anxiety;Aspirin;autism spectrum disorder;Behavior;Binding Sites;Biochemical;Biochemical Process;Biological Models;Biology;biomathematics;Brain;Carbon;carbon emissions;Chemicals;Clinical;clinical application;clinical center;Clinical Research;Collaborations;CSF1R gene;cyclooxygenase 1;cyclooxygenase 2;Cyclotrons;Dementia;design;Development;Diagnosis;Disease;Disease remission;Drug Addiction;drug development;drug discovery;Enzymes;Epilepsy;Evaluation;experimental study;Fluorine;fluoroform;Foundations;Fragile X Syndrome;Functional disorder;genetic technology;Glutamates;Good Manufacturing Process;Human;human subject;hypocretin;Ibuprofen;Image;imaging facilities;Imaging Techniques;improved;insight;interest;International;Investigational New Drug Application;Investigational Therapies;Ions;Label;Laboratories;LRRK2 gene;Macrophage Colony-Stimulating Factor Receptor;Measures;Medicine;Mental Depression;Mental disorders;Metabolism;Methodology;Methods;mild cognitive impairment;Mission;Mitochondria;Modeling;Modernization;Molecular;molecular imaging;molecular site;Monkeys;N-Methyl-D-Aspartate Receptors;N-Methylaspartate;National Institute of Drug Abuse;National Institute of Mental Health;Nature;Nerve Degeneration;neuroimaging;neuroinflammation;Neurologic;neuropsychiatric disorder;neuropsychiatry;neurotransmission;Neurotransmitter Receptor;Neurotransmitters;new therapeutic target;nonhuman primate;novel;Oncology;Organic Chemistry;Pathogenesis;PDE4B;Performance;Pharmaceutical Chemistry;Pharmaceutical Preparations;pharmacologic;Pharmacology;phosphoric diester hydrolase;Phosphotransferases;Physics;Positron;Positron-Emission Tomography;Postdoctoral Fellow;pre-clinical;Production;programs;Property;Prostaglandin-Endoperoxide Synthase;Proteins;Protocols documentation;Psychiatry;Publishing;Radio;Radioactive;Radiochemistry;Radioisotopes;Radiolabeled;Radiopharmaceuticals;radiotracer;receptor;Reporting;Research;response;Rewards;Risk;Rodent;Schizophrenia;Science;Scientist;Sensory Receptors;Source;Specificity;Stroke;Synaptic Vesicles;targeted imaging;Techniques;Therapeutic Intervention;Tracer;Training;Translating;Traumatic Brain Injury;United States Food and Drug Administration;United States National Institutes of Health;Universities;Work,PET Radiopharmaceutical Sciences,2793,NA,NA,NA,NA,23,NA,NA,5074591,NA
11194724,ZIA,MH,1,N,NA,NA,NA,NA,ZIAMH002795,NA,NA,1ZIAMH002795-23,NIMH:2751148\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF MENTAL HEALTH,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF MENTAL HEALTH,NA,NA,NA,8469041 (contact),"INNIS, ROBERT  (contact)",NA,NA,NA,Acute;Affinity;alcohol abuse therapy;Alcohol consumption;Alcohol dependence;alcohol exposure;alcohol use disorder;Alcohol withdrawal syndrome;Alcohols;Amyloid beta-Protein;Animal Model;Animals;Annual Reports;anti-depressive agents;Automobile Driving;Binding;Biological Markers;Blood;Brain;Brain imaging;Cell Culture Techniques;Characteristics;Chemicals;Chronic;clinically relevant;Collaborations;comorbidity;comparison control;Contralateral;Control Groups;Cyclic AMP;Cyclic AMP-Dependent Protein Kinases;Data;Depressive disorder;Disease;Dose;Drug Kinetics;Effectiveness;Ensure;Ethanol;Evaluation;experience;follow-up;Genetic Polymorphism;Goals;healthy volunteer;Hour;Human;human subject;Image;improved;in vivo;Individual;Inflammatory;Infusion procedures;inhibitor;Injections;Intoxication;Ketamine;Laboratories;Laboratory Finding;Legal;Lipopolysaccharides;Major Depressive Disorder;Measurement;Measures;Methods;Modeling;molecular imaging;Mood Disorders;National Institute of Drug Abuse;National Institute on Alcohol Abuse and Alcoholism;neuroinflammation;neuropsychiatric disorder;nonhuman primate;novel;Participant;Pathway interactions;patient population;Patients;Pattern;PDE4B;pharmacologic;phosphodiesterase IV;Phosphorylation;Positron-Emission Tomography;preference;procedure safety;Process;Proteins;Radiolabeled;radioligand;radiotracer;Rattus;recruit;Reproducibility;Research;Resistance;Rodent;Rolipram;Saline;Scanning;Schizophrenia;Second Messenger Systems;Selective Serotonin Reuptake Inhibitor;severe mental illness;Signal Transduction;single episode major depressive disorder;sobriety;Sum;Testing;Therapeutic;Time;Tracer;uptake;Withdrawal Symptom;Work,Translational Evaluation of PET Radiotracers,2795,NA,NA,NA,NA,23,NA,NA,2751148,NA
11194725,ZIA,MH,1,N,NA,NA,NA,NA,ZIAMH002797,NA,NA,1ZIAMH002797-23,NIMH:2591263\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF MENTAL HEALTH,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF MENTAL HEALTH,NA,NA,NA,7512789 (contact),"PLENZ, DIETMAR  (contact)",NA,NA,NA,Action Potentials;Animals;awake;Behavior;Biological Markers;Brain;brain abnormalities;brain cell;Cell Communication;Clinical Data;Cognition;Communication;Complex;Computer Simulation;Correlation Studies;Crackles;Data;detection method;Development;Diagnosis;Disease;Entropy;Equilibrium;excitatory neuron;Exhibits;Fire - disasters;frontal lobe;Goals;Grain;Human;Image;In Vitro;in vivo;information processing;inhibitory neuron;insight;interdisciplinary approach;International;Intramural Research Program;Ising model;Laboratories;large datasets;Laws;Mediating;Mental disorders;Methods;model building;Modeling;Monitor;Monkeys;Movement;multiphoton imaging;Mus;Neocortex;Nervous System Disorder;Neurons;Neurosciences;Noise;Pattern;Perception;Phase;Phase Transition;Physics;Population;Process;Publishing;Rattus;Reporting;Research;Research Support;Rest;Rodent;Role;Sampling;spatiotemporal;System;Temperature;Testing;theories;Thermodynamics;Time;Translational Research;two-photon;United States National Institutes of Health;Work,Neuronal Avalanches in the Neocortex,2797,NA,NA,NA,NA,23,NA,NA,2591263,NA
11194726,ZIA,MH,1,N,NA,NA,NA,NA,ZIAMH002800,NA,NA,1ZIAMH002800-22,NIMH:2305171\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF MENTAL HEALTH,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF MENTAL HEALTH,NA,NA,NA,7869045 (contact),"WHITE, BENJAMIN H (contact)",NA,NA,NA,Achievement;Adult;Alleles;Anatomy;Animals;Anterior;Anxiety Disorders;Behavior;Behavioral;Behavioral Mechanisms;Biological Metamorphosis;Bipolar Disorder;Body Regions;Brain;brain cell;Brain region;calcium indicator;Cells;Custom;Depressive disorder;Development;Drosophila genus;Drosophila melanogaster;Environment;Exclusion;Exhibits;Exons;exoskeleton;Face;fly;Genes;Genetic;Goals;Homeobox Genes;homeodomain;Hormonal;hormonal signals;Hormones;Human;Image;Insecta;insight;Instruction;intein;interest;Investigation;Knowledge;Laboratories;Light;Maps;Mediating;Mental disorders;Methods;Microscope;Microscopy;Molting;Motivation;Motor;Motor Neurons;Motor output;Movement;Muscle;Nervous System;neural;neural circuit;neural network;neuromechanism;Neuromodulator;neuron component;neuronal patterning;Neurons;Neurophysiology - biologic function;neuroregulation;Neurosciences;Obsessive-Compulsive Disorder;operation;Organism;Output;Paper;Pattern;Phase;Play;Positioning Attribute;Preparation;Process;Programming Languages;programs;Protein Truncation;Proteins;Publishing;Recurrence;Research;Research Personnel;Resolution;response;Role;Schizophrenia;Signal Transduction;Specific qualifier value;Study models;Technology;technology development;Time;tool;transcription factor;transgene expression;Wing;Work;Writing,Identifying Neural Substrates of Behavior in Drosophila Melanogaster,2800,NA,NA,NA,NA,22,NA,NA,2305171,NA
